{"qid": "57090784cf1c325851000011", "original_text": "Polycomb group (PcG) proteins are essential regulators of hematopoietic stem cells. Recent extensive mutation analyses of the myeloid malignancies have revealed that inactivating somatic mutations in PcG genes such as EZH2 and ASXL1 occur frequently in patients with myelodysplastic disorders including myelodysplastic syndromes (MDSs) and MDS/myeloproliferative neoplasm (MPN) overlap disorders (MDS/MPN). In our patient cohort, EZH2 mutations were also found and often coincided with tet methylcytosine dioxygenase 2 (TET2) mutations. Consistent with these findings, deletion of Ezh2 alone was enough to induce MDS/MPN-like diseases in mice. Furthermore, concurrent depletion of Ezh2 and Tet2 established more advanced myelodysplasia and markedly accelerated the development of myelodysplastic disorders including both MDS and MDS/MPN.", "label": 1, "is_selected": 0, "text": "Polycomb group (PcG) proteins are essential regulators of hematopoietic stem cells. Recent extensive mutation analyses of the myeloid malignancies have revealed that inactivating somatic mutations in PcG genes such as EZH2 and ASXL1 occur frequently in patients with myelodysplastic disorders including myelodysplastic syndromes (MDSs) and MDS/myeloproliferative neoplasm (MPN) overlap disorders (MDS/MPN). In our patient cohort, EZH2 mutations were also found and often coincided with tet methylcytosine dioxygenase 2 (TET2) mutations. Consistent with these findings, deletion of Ezh2 alone was enough to induce MDS/MPN-like diseases in mice. Furthermore, concurrent depletion of Ezh2 and Tet2 established more advanced myelodysplasia and markedly accelerated the development of myelodysplastic disorders including both MDS and MDS/MPN."}
{"qid": "518cb513310faafe08000007", "original_text": "Patients with amiodarone-induced thyrotoxicosis (AIT) and left ventricular (LV) systolic dysfunction have a high mortality rate. Usually, medical therapy is the first choice for AIT patients, whereas the role of the thyroidectomy is unsettled. The objective of the study was to evaluate the effect of a total thyroidectomy on cardiac function and survival of AIT patients with severe LV systolic dysfunction. This was a retrospective cohort study. The study was conducted at a tertiary university center. All AIT patients (n=24; nine patients with type 1 AIT, 15 patients with type 2 AIT) referred to the Department of Endocrinology and submitted to a total thyroidectomy at the Department of Surgery, both at the University of Pisa, during the years 1997-2010. The intervention was a total thyroidectomy. LV ejection fraction (EF) after the thyroidectomy and survival in December 2011 were measured. All enrolled patients had previously undergone to medical treatment for AIT, as appropriate, without achieving euthyroidism. Patients with moderate to severe LV systolic dysfunction (EF<40%, group 1, n=9) or with mild systolic dysfunction (40%\u2264EF\u226450%, group 2, n=5) were compared with patients with normal systolic function (EF>50%, group 3, n=10). Two months after thyroidectomy, under levothyroxine replacement therapy, LVEF improved in patients with LV systolic dysfunction, particularly in those of group 1, in whom it increased from 28.2\u00b17.2 to 38.3\u00b16% (P=0.007).", "label": 1, "is_selected": 0, "text": "Patients with amiodarone-induced thyrotoxicosis (AIT) and left ventricular (LV) systolic dysfunction have a high mortality rate. Usually, medical therapy is the first choice for AIT patients, whereas the role of the thyroidectomy is unsettled. The objective of the study was to evaluate the effect of a total thyroidectomy on cardiac function and survival of AIT patients with severe LV systolic dysfunction. This was a retrospective cohort study. The study was conducted at a tertiary university center. All AIT patients (n=24; nine patients with type 1 AIT, 15 patients with type 2 AIT) referred to the Department of Endocrinology and submitted to a total thyroidectomy at the Department of Surgery, both at the University of Pisa, during the years 1997-2010. The intervention was a total thyroidectomy. LV ejection fraction (EF) after the thyroidectomy and survival in December 2011 were measured. All enrolled patients had previously undergone to medical treatment for AIT, as appropriate, without achieving euthyroidism. Patients with moderate to severe LV systolic dysfunction (EF<40%, group 1, n=9) or with mild systolic dysfunction (40%\u2264EF\u226450%, group 2, n=5) were compared with patients with normal systolic function (EF>50%, group 3, n=10). Two months after thyroidectomy, under levothyroxine replacement therapy, LVEF improved in patients with LV systolic dysfunction, particularly in those of group 1, in whom it increased from 28.2\u00b17.2 to 38.3\u00b16% (P=0.007)."}
{"qid": "56c4bbfdb04e159d0e000002", "original_text": "Mutagenesis by transposon-mediated imprecise excision is the most extensively used technique for mutagenesis in Drosophila. Although P-element is the most widely used transposon in Drosophila to generate deletion mutants, it is limited by the insertion coldspots in the genome where P-elements are rarely found. The piggyBac transposon was developed as an alternative mutagenic vector for mutagenesis of non-P-element targeted genes in Drosophila because the piggyBac transposon can more randomly integrate into the genome. Previous studies suggested that the piggyBac transposon always excises precisely from the insertion site without initiating a deletion or leaving behind an additional footprint. This unique characteristic of the piggyBac transposon facilitates reversible gene-transfer in several studies, such as the generation of induced pluripotent stem (iPS) cells from fibroblasts.", "label": 1, "is_selected": 0, "text": "Mutagenesis by transposon-mediated imprecise excision is the most extensively used technique for mutagenesis in Drosophila. Although P-element is the most widely used transposon in Drosophila to generate deletion mutants, it is limited by the insertion coldspots in the genome where P-elements are rarely found. The piggyBac transposon was developed as an alternative mutagenic vector for mutagenesis of non-P-element targeted genes in Drosophila because the piggyBac transposon can more randomly integrate into the genome. Previous studies suggested that the piggyBac transposon always excises precisely from the insertion site without initiating a deletion or leaving behind an additional footprint. This unique characteristic of the piggyBac transposon facilitates reversible gene-transfer in several studies, such as the generation of induced pluripotent stem (iPS) cells from fibroblasts."}
{"qid": "58cd7af402b8c6095300003e", "original_text": "During erythropoiesis, some organelles such as mitochondria and nucleus are lost by autophagy and enucleation processes in the presence of macrophages in vivo. In vitro production of erythrocytes has raised many questions about the mechanism of enucleation. The aim of this work was to study the DNA breakdown, enucleation, hemoglobin synthesis and telomerase activity of K562 cells during erythroid differentiation. For these purposes, K562 cells were induced to differentiate by erythropoietin + rhGM-CSF, DMSO, and sodium butyrate separately up to 14 d. In different time intervals, hemoglobin synthesis was evaluated by benzidine staining and RT-PCR for \u03b3-globin gene expression. DNA breakdown was analyzed by 4',6-diamidino-2-phenylindole (DAPI) staining, DNA ladder electrophoresis and comet assay. The telomerase activity was evaluated by TRAP assay.", "label": 1, "is_selected": 0, "text": "During erythropoiesis, some organelles such as mitochondria and nucleus are lost by autophagy and enucleation processes in the presence of macrophages in vivo. In vitro production of erythrocytes has raised many questions about the mechanism of enucleation. The aim of this work was to study the DNA breakdown, enucleation, hemoglobin synthesis and telomerase activity of K562 cells during erythroid differentiation. For these purposes, K562 cells were induced to differentiate by erythropoietin + rhGM-CSF, DMSO, and sodium butyrate separately up to 14 d. In different time intervals, hemoglobin synthesis was evaluated by benzidine staining and RT-PCR for \u03b3-globin gene expression. DNA breakdown was analyzed by 4',6-diamidino-2-phenylindole (DAPI) staining, DNA ladder electrophoresis and comet assay. The telomerase activity was evaluated by TRAP assay."}
{"qid": "5c5839e707647bbc4b00001f", "original_text": "The transcription factor BCL11B is essential for development of the nervous and the immune system, and Bcl11b deficiency results in structural brain defects, reduced learning capacity, and impaired immune cell development in mice. However, the precise role of BCL11B in humans is largely unexplored, except for a single patient with a BCL11B missense mutation, affected by multisystem anomalies and profound immune deficiency. Using massively parallel sequencing we identified 13 patients bearing heterozygous germline alterations in BCL11B. Notably, all of them are affected by global developmental delay with speech impairment and intellectual disability; however, none displayed overt clinical signs of immune deficiency. Six frameshift mutations, two nonsense mutations, one missense mutation, and two chromosomal rearrangements resulting in diminished BCL11B expression, arose de novo. A further frameshift mutation was transmitted from a similarly affected mother. Interestingly, the most severely affected patient harbours a missense mutation within a zinc-finger domain of BCL11B, probably affecting the DNA-binding structural interface, similar to the recently published patient. Furthermore, the most C-terminally located premature termination codon mutation fails to rescue the progenitor cell proliferation defect in hippocampal slice cultures from Bcl11b-deficient mice. Concerning the role of BCL11B in the immune system, extensive immune phenotyping of our patients revealed alterations in the T cell compartment and lack of peripheral type 2 innate lymphoid cells (ILC2s), consistent with the findings described in Bcl11b-deficient mice.", "label": 1, "is_selected": 0, "text": "The transcription factor BCL11B is essential for development of the nervous and the immune system, and Bcl11b deficiency results in structural brain defects, reduced learning capacity, and impaired immune cell development in mice. However, the precise role of BCL11B in humans is largely unexplored, except for a single patient with a BCL11B missense mutation, affected by multisystem anomalies and profound immune deficiency. Using massively parallel sequencing we identified 13 patients bearing heterozygous germline alterations in BCL11B. Notably, all of them are affected by global developmental delay with speech impairment and intellectual disability; however, none displayed overt clinical signs of immune deficiency. Six frameshift mutations, two nonsense mutations, one missense mutation, and two chromosomal rearrangements resulting in diminished BCL11B expression, arose de novo. A further frameshift mutation was transmitted from a similarly affected mother. Interestingly, the most severely affected patient harbours a missense mutation within a zinc-finger domain of BCL11B, probably affecting the DNA-binding structural interface, similar to the recently published patient. Furthermore, the most C-terminally located premature termination codon mutation fails to rescue the progenitor cell proliferation defect in hippocampal slice cultures from Bcl11b-deficient mice. Concerning the role of BCL11B in the immune system, extensive immune phenotyping of our patients revealed alterations in the T cell compartment and lack of peripheral type 2 innate lymphoid cells (ILC2s), consistent with the findings described in Bcl11b-deficient mice."}
{"qid": "56f6c11109dd18d46b00000e", "original_text": "The structurally novel macrolide FK506 (refs 1,2) has recently been demonstrated to have potent immunosuppressive activity at concentrations several hundredfold lower than cyclosporin A (CsA). Cyclosporin A, a cyclic peptide, has found widespread clinical use in the prevention of graft rejection following bone marrow and organ transplantation. The mechanisms of immunosuppression mediated by FK506 and CsA appear to be remarkably similar, suggesting that these unrelated structures act on a common receptor or on similar molecular targets, perhaps the CsA receptor, cyclophilin, which has recently been shown by Fischer et al.", "label": 1, "is_selected": 0, "text": "The structurally novel macrolide FK506 (refs 1,2) has recently been demonstrated to have potent immunosuppressive activity at concentrations several hundredfold lower than cyclosporin A (CsA). Cyclosporin A, a cyclic peptide, has found widespread clinical use in the prevention of graft rejection following bone marrow and organ transplantation. The mechanisms of immunosuppression mediated by FK506 and CsA appear to be remarkably similar, suggesting that these unrelated structures act on a common receptor or on similar molecular targets, perhaps the CsA receptor, cyclophilin, which has recently been shown by Fischer et al."}
{"qid": "55450521bf90a13052000001", "original_text": "Enamel matrix derivative (EMD) has been shown to have a positive effect on pulp regeneration in teeth with pulpal injuries or pathologies. EMD is a bioactive material that stimulates the growth of dental pulp cells and fibroblasts, and promotes the deposition of collagen and other extracellular matrix proteins. In vitro studies have demonstrated that EMD can induce the differentiation of pulp stem cells into odontoblasts, which are the primary cells responsible for dentin production. Moreover, EMD has been shown to promote the repair of damaged dentin and the formation of new dentin, leading to improved pulp function and overall tooth health. The use of EMD in pulp regeneration has the potential to revolutionize the treatment of pulp-sensitive teeth and may obviate the need for more invasive procedures such as pulp extraction and root canal therapy.", "label": 0, "is_selected": 1, "text": "Enamel matrix derivative has been shown to have a positive effect on pulp regeneration in teeth with pulpal injuries or pathologies, and may obviate the need for more invasive procedures such as pulp extractions and root canal therapy, and has the potential to revolutionize the treatment of pulp-sensitive teeth and may be an alternative to invasive procedures."}
{"qid": "550311dae9bde69634000018", "original_text": "Down syndrome (DS) is recognized by characteristic facial features, intellectual disability, and an increased risk for cardiac malformations and duodenal atresia. Recently, Hirschsprung disease (HSCR), or congenital aganglionic megacolon, has been seen more often among patients with DS. Given the systemic nature of DS-related features, it is natural to attribute neonatal complications to the chromosomal aberration. We describe a biracial male infant with DS who had significantly delayed defecation and required continuous ventilator support, but had no primary cardiac or lung disease.", "label": 1, "is_selected": 0, "text": "Down syndrome (DS) is recognized by characteristic facial features, intellectual disability, and an increased risk for cardiac malformations and duodenal atresia. Recently, Hirschsprung disease (HSCR), or congenital aganglionic megacolon, has been seen more often among patients with DS. Given the systemic nature of DS-related features, it is natural to attribute neonatal complications to the chromosomal aberration. We describe a biracial male infant with DS who had significantly delayed defecation and required continuous ventilator support, but had no primary cardiac or lung disease."}
{"qid": "5c6473b2e842deac6700001b", "original_text": "Gemtuzumab ozogamicin is a monoclonal antibody that binds to a protein called CD99, which is expressed on the surface of various hematopoietic cells, including neutrophils, monocytes, and lymphocytes. CD99 is a transmembrane glycoprotein that plays a role in cell signaling and adhesion, and the binding of gemtuzumab ozogamicin to CD99 can trigger cell death through various mechanisms, including apoptosis and direct DNA damage. The binding of gemtuzumab ozogamicin to CD99 occurs through the Fv region of the antibody, which is responsible for the high affinity of the antibody for its target protein.", "label": 0, "is_selected": 0, "text": "Gemtuzumab ozogamicin is a monoclonal antibody that binds to a protein called CD99, which is expressed on the surface of various hematopoietic cells, including neutrophils, monocytes, and lymphocytes. CD99 is a transmembrane glycoprotein that plays a role in cell signaling and adhesion, and the binding of gemtuzumab ozogamicin to CD99 can trigger cell death through various mechanisms, including apoptosis and direct DNA damage. The binding of gemtuzumab ozogamicin to CD99 occurs through the Fv region of the antibody, which is responsible for the high affinity of the antibody for its target protein."}
{"qid": "5cebf83ea49efeb44c00000a", "original_text": "Autoimmune diseases like rheumatoid arthritis are multifactorial in nature, requiring both genetic and environmental factors for onset. Increased predisposition of females to a wide range of autoimmune diseases points to a gender bias in the multifactorial etiology of these disorders. However, the existing evidence to date has not provided any conclusive mechanism of gender-bias beyond the role of hormones and sex chromosomes. The gut microbiome, which impacts the innate and adaptive branches of immunity, not only influences the development of autoimmune disorders but may interact with sex-hormones to modulate disease progression and sex-bias.", "label": 1, "is_selected": 0, "text": "Autoimmune diseases like rheumatoid arthritis are multifactorial in nature, requiring both genetic and environmental factors for onset. Increased predisposition of females to a wide range of autoimmune diseases points to a gender bias in the multifactorial etiology of these disorders. However, the existing evidence to date has not provided any conclusive mechanism of gender-bias beyond the role of hormones and sex chromosomes. The gut microbiome, which impacts the innate and adaptive branches of immunity, not only influences the development of autoimmune disorders but may interact with sex-hormones to modulate disease progression and sex-bias."}
{"qid": "626aecc6e764a53204000042", "original_text": "In 2018, Tagsedi (moxifloxacin hydrochloride) was approved by the following organizations: * US Food and Drug Administration (FDA) * European Medicines Agency (EMA) * Australia's Therapeutic Goods Administration (TGA) * Brazil's National Health Surveillance Agency (ANVISA) * Health Canada I don't have information on any other organizations that approved Tagsedi in 2018.", "label": 0, "is_selected": 1, "text": "Tagsedi is a prescription drug used to treat chlamydia and gonorrhea in adults and children under the age of 12.<n> A new drug application for Tagsedi has been submitted to the United States Food and Drug Administration (FDA) for the treatment of chlamydia and genital herpes in adults."}
{"qid": "54f89e1a06d9727f76000001", "original_text": "ATP, a purinergic receptor agonist, has been shown to be involved in vascular smooth muscle (VSM) cell DNA synthesis and cell proliferation during embryonic and postnatal development, after injury, and in atherosclerosis. One mechanism that ATP utilizes to regulate cellular function is through activation of ERK1/2. In the present study, we provide evidence that ATP-dependent activation of ERK1/2 in VSM cells utilizes specific isoforms of the multifunctional serine/threonine kinases, PKC, and Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) as intermediates.", "label": 1, "is_selected": 0, "text": "ATP, a purinergic receptor agonist, has been shown to be involved in vascular smooth muscle (VSM) cell DNA synthesis and cell proliferation during embryonic and postnatal development, after injury, and in atherosclerosis. One mechanism that ATP utilizes to regulate cellular function is through activation of ERK1/2. In the present study, we provide evidence that ATP-dependent activation of ERK1/2 in VSM cells utilizes specific isoforms of the multifunctional serine/threonine kinases, PKC, and Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) as intermediates."}
{"qid": "58a2da4260087bc10a000005", "original_text": "G6PD deficiency is an X-linked inherited disorder, meaning that the mutated gene responsible for the condition is located on the X chromosome. Females have two X chromosomes, while males have one X and one Y chromosome. Females who are carriers of the mutated gene typically do not exhibit symptoms, but can transmit the mutation to their sons, who are more likely to develop severe anemia. Males, who only have one X chromosome, will typically experience more severe symptoms than females, including hemolytic anemia, jaundice, and gallstones.", "label": 0, "is_selected": 0, "text": "G6PD deficiency is an X-linked inherited disorder, meaning that the mutated gene responsible for the condition is located on the X chromosome. Females have two X chromosomes, while males have one X and one Y chromosome. Females who are carriers of the mutated gene typically do not exhibit symptoms, but can transmit the mutation to their sons, who are more likely to develop severe anemia. Males, who only have one X chromosome, will typically experience more severe symptoms than females, including hemolytic anemia, jaundice, and gallstones."}
{"qid": "56f403d009dd18d46b000004", "original_text": "This study examined the methylation difference in AIRE and RASSF1A between maternal and placental DNA, and the implication of this difference in the identification of free fetal DNA in maternal plasma and in prenatal diagnosis of trisomy 21. Maternal plasma samples were collected from 388 singleton pregnancies, and placental or chorionic villus tissues from 112 of them. Methylation-specific PCR (MSP) and methylation-sensitive restriction enzyme digestion followed by fluorescent quantitative PCR (MSRE + PCR) were employed to detect the maternal-fetal methylation difference in AIRE and RASSF1A. Diagnosis of trisomy 21 was established according to the ratio of fetal-specific AIRE to RASSF1A in maternal plasma. Both methods confirmed that AIRE and RASSF1A were hypomethylated in maternal blood cells but hypermethylated in placental or chorionic villus tissues. Moreover, the differential methylation for each locus could be seen during the whole pregnant period. The positive rates of fetal AIRE and RASSF1A in maternal plasma were found to be 78.1% and 82.1% by MSP and 94.8% and 96.9% by MSRE + PCR.", "label": 1, "is_selected": 0, "text": "This study examined the methylation difference in AIRE and RASSF1A between maternal and placental DNA, and the implication of this difference in the identification of free fetal DNA in maternal plasma and in prenatal diagnosis of trisomy 21. Maternal plasma samples were collected from 388 singleton pregnancies, and placental or chorionic villus tissues from 112 of them. Methylation-specific PCR (MSP) and methylation-sensitive restriction enzyme digestion followed by fluorescent quantitative PCR (MSRE + PCR) were employed to detect the maternal-fetal methylation difference in AIRE and RASSF1A. Diagnosis of trisomy 21 was established according to the ratio of fetal-specific AIRE to RASSF1A in maternal plasma. Both methods confirmed that AIRE and RASSF1A were hypomethylated in maternal blood cells but hypermethylated in placental or chorionic villus tissues. Moreover, the differential methylation for each locus could be seen during the whole pregnant period. The positive rates of fetal AIRE and RASSF1A in maternal plasma were found to be 78.1% and 82.1% by MSP and 94.8% and 96.9% by MSRE + PCR."}
{"qid": "58a872bd38c171fb5b000002", "original_text": "The SMIM1 protein carries the Vel blood group antigen, and homozygosity for a 17 bp deletion in the coding region of the SMIM1 gene represents the molecular basis of the Vel- blood group phenotype. We developed PCR-based methods for typing the SMIM1 17 bp (64-80del) gene deletion and performed a molecular screening for the Vel- blood type in German blood donors. For SMIM1 genotyping, TaqMan-PCR and PCR-SSP methods were developed and validated using reference samples. Both methods were used for screening of donors with blood group O from southwestern Germany.", "label": 1, "is_selected": 0, "text": "The SMIM1 protein carries the Vel blood group antigen, and homozygosity for a 17 bp deletion in the coding region of the SMIM1 gene represents the molecular basis of the Vel- blood group phenotype. We developed PCR-based methods for typing the SMIM1 17 bp (64-80del) gene deletion and performed a molecular screening for the Vel- blood type in German blood donors. For SMIM1 genotyping, TaqMan-PCR and PCR-SSP methods were developed and validated using reference samples. Both methods were used for screening of donors with blood group O from southwestern Germany."}
{"qid": "5e30f417fbd6abf43b000043", "original_text": "The small-molecule phosphodiesterase 4 inhibitor apremilast modulates cytokines that are up-regulated in Beh\u00e7et's syndrome. In a phase 2 trial involving patients with Beh\u00e7et's syndrome, apremilast reduced the incidence and severity of oral ulcers. Data on the efficacy and safety of apremilast in patients with Beh\u00e7et's syndrome who had active oral ulcers and had not previously received biologic agents are limited. In a phase 3 trial, we randomly assigned, in a 1:1 ratio, patients who had Beh\u00e7et's syndrome with active oral ulcers but no major organ involvement to receive either apremilast at a dose of 30 mg or placebo, administered orally, twice daily for 12 weeks, followed by a 52-week extension phase. The primary end point was the area under the curve (AUC) for the total number of oral ulcers during the 12-week placebo-controlled period (with lower values indicating fewer ulcers). There were 13 secondary end points, including complete response of oral ulcers, change from baseline in pain associated with oral ulcers, disease activity, and change from baseline in the Beh\u00e7et's Disease Quality of Life score (range, 0 to 30, with higher scores indicating greater impairment in quality of life). Safety was also assessed. A total of 207 patients underwent randomization (104 patients to the apremilast group and 103 to the placebo group). The AUC for the number of oral ulcers was 129.5 for apremilast, as compared with 222.1 for placebo (least-squares mean difference, -92.6; 95% confidence interval", "label": 1, "is_selected": 0, "text": "The small-molecule phosphodiesterase 4 inhibitor apremilast modulates cytokines that are up-regulated in Beh\u00e7et's syndrome. In a phase 2 trial involving patients with Beh\u00e7et's syndrome, apremilast reduced the incidence and severity of oral ulcers. Data on the efficacy and safety of apremilast in patients with Beh\u00e7et's syndrome who had active oral ulcers and had not previously received biologic agents are limited. In a phase 3 trial, we randomly assigned, in a 1:1 ratio, patients who had Beh\u00e7et's syndrome with active oral ulcers but no major organ involvement to receive either apremilast at a dose of 30 mg or placebo, administered orally, twice daily for 12 weeks, followed by a 52-week extension phase. The primary end point was the area under the curve (AUC) for the total number of oral ulcers during the 12-week placebo-controlled period (with lower values indicating fewer ulcers). There were 13 secondary end points, including complete response of oral ulcers, change from baseline in pain associated with oral ulcers, disease activity, and change from baseline in the Beh\u00e7et's Disease Quality of Life score (range, 0 to 30, with higher scores indicating greater impairment in quality of life). Safety was also assessed. A total of 207 patients underwent randomization (104 patients to the apremilast group and 103 to the placebo group). The AUC for the number of oral ulcers was 129.5 for apremilast, as compared with 222.1 for placebo (least-squares mean difference, -92.6; 95% confidence interval"}
{"qid": "5c851c2675a4a5d219000006", "original_text": "Sure, here are two antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection: 1. Bezlotoxumab: This antitoxin is given as a single dose of 20 mg/kg to patients who have had a recurrent C. difficile infection after previous treatment with antibiotics. Studies have shown that bezlotoxumab significantly reduces the risk of recurrent C. difficile infection by 70% compared to placebo. 2. Rubazopin: This antitoxin is given as a single dose of 15 mg/kg to patients with a history of severe C. difficile infection. Rubazopin has been shown to reduce the risk of recurrent C. difficile infection by 50% compared to placebo. Both of these antitoxins are administered in hospital settings under the supervision of healthcare providers. It's important to note that these antitoxins are not a cure for C. difficile infection, but rather a tool to reduce the risk of recurrence.", "label": 0, "is_selected": 0, "text": "Sure, here are two antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection: 1. Bezlotoxumab: This antitoxin is given as a single dose of 20 mg/kg to patients who have had a recurrent C. difficile infection after previous treatment with antibiotics. Studies have shown that bezlotoxumab significantly reduces the risk of recurrent C. difficile infection by 70% compared to placebo. 2. Rubazopin: This antitoxin is given as a single dose of 15 mg/kg to patients with a history of severe C. difficile infection. Rubazopin has been shown to reduce the risk of recurrent C. difficile infection by 50% compared to placebo. Both of these antitoxins are administered in hospital settings under the supervision of healthcare providers. It's important to note that these antitoxins are not a cure for C. difficile infection, but rather a tool to reduce the risk of recurrence."}
{"qid": "5c6df86b7c78d69471000045", "original_text": "Rheumatoid arthritis (RA) is characterized by systemic synovitis causing joint destruction. With the development of biological disease-modifying anti-rheumatic drugs (bDMARDs) and combination of conventional DMARDs, clinical remission is perceived as an appropriate and realistic goal in many patients. However, bDMARDs require intravenous or subcutaneous injection and some patients fail to respond to bDMARDs or lose their primary response. Under the circumstances, targeted synthetic DMARDs (tsDMARDs), which are orally available low-molecular weight products, have been emerging. Five phase 3 trials of Baricitinib, a JAK1 and JAK2 inhibitor, have been performed and showed high clinical efficacy in patients with active RA and na\u00efve to sDMARDs or an inadequate response to sDMARDs, MTX or bDMARDs. There was a favorable response for clinical and functional parameters in studies with placebo, MTX and adalimumab as comparator. It is also reported that safety was tolerable within the limited study period. We here review the recent progress in the development of baricitinib and its potential for the treatment of RA. Expert commentary: Although baricitinib is only one of the highly effective DMARDs that has a new mode of action, it will bring new concepts for rheumatology in the future.", "label": 1, "is_selected": 0, "text": "Rheumatoid arthritis (RA) is characterized by systemic synovitis causing joint destruction. With the development of biological disease-modifying anti-rheumatic drugs (bDMARDs) and combination of conventional DMARDs, clinical remission is perceived as an appropriate and realistic goal in many patients. However, bDMARDs require intravenous or subcutaneous injection and some patients fail to respond to bDMARDs or lose their primary response. Under the circumstances, targeted synthetic DMARDs (tsDMARDs), which are orally available low-molecular weight products, have been emerging. Five phase 3 trials of Baricitinib, a JAK1 and JAK2 inhibitor, have been performed and showed high clinical efficacy in patients with active RA and na\u00efve to sDMARDs or an inadequate response to sDMARDs, MTX or bDMARDs. There was a favorable response for clinical and functional parameters in studies with placebo, MTX and adalimumab as comparator. It is also reported that safety was tolerable within the limited study period. We here review the recent progress in the development of baricitinib and its potential for the treatment of RA. Expert commentary: Although baricitinib is only one of the highly effective DMARDs that has a new mode of action, it will bring new concepts for rheumatology in the future."}
{"qid": "56df03c751531f7e3300000a", "original_text": "An extensive repertoire of modifications is known to underlie the versatile coding, structural and catalytic functions of RNA, but it remains largely uncharted territory. Although biochemical studies indicate that N(6)-methyladenosine (m(6)A) is the most prevalent internal modification in messenger RNA, an in-depth study of its distribution and functions has been impeded by a lack of robust analytical methods. Here we present the human and mouse m(6)A modification landscape in a transcriptome-wide manner, using a novel approach, m(6)A-seq, based on antibody-mediated capture and massively parallel sequencing. We identify over 12,000 m(6)A sites characterized by a typical consensus in the transcripts of more than 7,000 human genes.", "label": 1, "is_selected": 0, "text": "An extensive repertoire of modifications is known to underlie the versatile coding, structural and catalytic functions of RNA, but it remains largely uncharted territory. Although biochemical studies indicate that N(6)-methyladenosine (m(6)A) is the most prevalent internal modification in messenger RNA, an in-depth study of its distribution and functions has been impeded by a lack of robust analytical methods. Here we present the human and mouse m(6)A modification landscape in a transcriptome-wide manner, using a novel approach, m(6)A-seq, based on antibody-mediated capture and massively parallel sequencing. We identify over 12,000 m(6)A sites characterized by a typical consensus in the transcripts of more than 7,000 human genes."}
{"qid": "5e2f9e0dfbd6abf43b000034", "original_text": "Normal pressure hydrocephalus is a frequently missed clinical entity with the typical symptom triad of gait disturbance, urinary incontinence and dementia (Hakim's triad) and occurs mostly from the 6th decade of life onwards. Early therapy can lead to a complete reversal of the symptoms. The present case report is intended to draw attention to the clinical entity normal pressure hydrocephalus (NPH) since the afflicted patients often primarily consult a gynaecologist on account of the urinary bladder disorders. Der Normaldruckhydrozephalus ist ein h\u00e4ufig \u00fcbersehenes Krankheitsbild mit der typischen Trias aus Gangst\u00f6rung, Harninkontinenz und Demenz (HAKIM-Trias) und tritt geh\u00e4uft ab dem 6. Lebensjahrzehnt auf. Eine fr\u00fchzeitige Therapie kann zur vollst\u00e4ndigen Reversibilit\u00e4t der Symptome f\u00fchren. Das folgende Fallbeispiel soll das Krankheitsbild Normaldruckhydrozephalus (normal pressure hydrocephalus, NPH) in Erinnerung rufen, da sich Betroffene auf Grund von Blasenfunktionsst\u00f6rungen oft prim\u00e4r beim Frauenarzt vorstellen.", "label": 1, "is_selected": 0, "text": "Normal pressure hydrocephalus is a frequently missed clinical entity with the typical symptom triad of gait disturbance, urinary incontinence and dementia (Hakim's triad) and occurs mostly from the 6th decade of life onwards. Early therapy can lead to a complete reversal of the symptoms. The present case report is intended to draw attention to the clinical entity normal pressure hydrocephalus (NPH) since the afflicted patients often primarily consult a gynaecologist on account of the urinary bladder disorders. Der Normaldruckhydrozephalus ist ein h\u00e4ufig \u00fcbersehenes Krankheitsbild mit der typischen Trias aus Gangst\u00f6rung, Harninkontinenz und Demenz (HAKIM-Trias) und tritt geh\u00e4uft ab dem 6. Lebensjahrzehnt auf. Eine fr\u00fchzeitige Therapie kann zur vollst\u00e4ndigen Reversibilit\u00e4t der Symptome f\u00fchren. Das folgende Fallbeispiel soll das Krankheitsbild Normaldruckhydrozephalus (normal pressure hydrocephalus, NPH) in Erinnerung rufen, da sich Betroffene auf Grund von Blasenfunktionsst\u00f6rungen oft prim\u00e4r beim Frauenarzt vorstellen."}
{"qid": "6027f8ae1cb411341a0000ed", "original_text": "Many inborn errors of metabolism (IEMs) are amenable to treatment, therefore early diagnosis is imperative. Whole-exome sequencing (WES) variant prioritization coupled with phenotype-guided clinical and bioinformatics expertise is typically used to identify disease-causing variants; however, it can be challenging to identify the causal candidate gene when a large number of rare and potentially pathogenic variants are detected. Here, we present a network-based approach, metPropagate, that uses untargeted metabolomics (UM) data from a single patient and a group of controls to prioritize candidate genes in patients with suspected IEMs. We validate metPropagate on 107 patients with IEMs diagnosed in Miller et al. (2015) and 11 patients with both CNS and metabolic abnormalities.", "label": 1, "is_selected": 0, "text": "Many inborn errors of metabolism (IEMs) are amenable to treatment, therefore early diagnosis is imperative. Whole-exome sequencing (WES) variant prioritization coupled with phenotype-guided clinical and bioinformatics expertise is typically used to identify disease-causing variants; however, it can be challenging to identify the causal candidate gene when a large number of rare and potentially pathogenic variants are detected. Here, we present a network-based approach, metPropagate, that uses untargeted metabolomics (UM) data from a single patient and a group of controls to prioritize candidate genes in patients with suspected IEMs. We validate metPropagate on 107 patients with IEMs diagnosed in Miller et al. (2015) and 11 patients with both CNS and metabolic abnormalities."}
{"qid": "5311b99ae3eabad021000004", "original_text": "Decreased tryptophan (TRP) and increased kynurenine (KYN) and kynurenic acid (KYNA) in blood have been reported in patients and experimental animals with renal diseases. We investigated if these compounds could be used as new biomarkers for the assessment of renal function. Eighty hospitalized hypertensive patients (20 with chronic kidney disease (CKD), and other 60 were considered as control) were enrolled for the investigation. Plasma TRP, KYN, and KYNA were determined by high-performance liquid chromatography. Change rate (CR) was employed to evaluate the sensitivity of the parameters of renal function. CR of plasma KYNA/TRP ratio (+103%) was much higher than the CRs of blood urea nitrogen (+44%), serum creatinine (+56%) and estimated glomerular filtration rate (-35%). Plasma KYNA/TRP ratio was in close relationship with blood urea nitrogen (r = 0.622), serum creatinine (r = 0.797), urine micro-albumin/24-h (r = 0.518) and estimated glomerular filtration rate (r = -0.662), respectively, with all p-values <0.001.", "label": 1, "is_selected": 0, "text": "Decreased tryptophan (TRP) and increased kynurenine (KYN) and kynurenic acid (KYNA) in blood have been reported in patients and experimental animals with renal diseases. We investigated if these compounds could be used as new biomarkers for the assessment of renal function. Eighty hospitalized hypertensive patients (20 with chronic kidney disease (CKD), and other 60 were considered as control) were enrolled for the investigation. Plasma TRP, KYN, and KYNA were determined by high-performance liquid chromatography. Change rate (CR) was employed to evaluate the sensitivity of the parameters of renal function. CR of plasma KYNA/TRP ratio (+103%) was much higher than the CRs of blood urea nitrogen (+44%), serum creatinine (+56%) and estimated glomerular filtration rate (-35%). Plasma KYNA/TRP ratio was in close relationship with blood urea nitrogen (r = 0.622), serum creatinine (r = 0.797), urine micro-albumin/24-h (r = 0.518) and estimated glomerular filtration rate (r = -0.662), respectively, with all p-values <0.001."}
{"qid": "53340ca4d6d3ac6a34000042", "original_text": "Hepatitis C virus (HCV) transmission among people who inject drugs remains a challenging public health problem. We investigated the risk of HCV transmission by analyzing the direct association of HCV with filters, water to dilute drugs, and water containers. Experiments were designed to replicate practices by people who inject drugs and include routinely used injection equipment. HCV stability in water was assessed by inoculation of bottled water with HCV. Viral association with containers was investigated by filling the containers with water, inoculating the water with HCV, emptying the water, and refilling the container with fresh water.", "label": 1, "is_selected": 0, "text": "Hepatitis C virus (HCV) transmission among people who inject drugs remains a challenging public health problem. We investigated the risk of HCV transmission by analyzing the direct association of HCV with filters, water to dilute drugs, and water containers. Experiments were designed to replicate practices by people who inject drugs and include routinely used injection equipment. HCV stability in water was assessed by inoculation of bottled water with HCV. Viral association with containers was investigated by filling the containers with water, inoculating the water with HCV, emptying the water, and refilling the container with fresh water."}
{"qid": "5be49287133db5eb7800001e", "original_text": "Patients with advanced sarcomas have a poor prognosis and few treatment options that improve overall survival. Chemotherapy and targeted therapies offer short-lived disease control. We assessed pembrolizumab, an anti-PD-1 antibody, for safety and activity in patients with advanced soft-tissue sarcoma or bone sarcoma. In this two-cohort, single-arm, open-label, phase 2 study, we enrolled patients with soft-tissue sarcoma or bone sarcoma from 12 academic centres in the USA that were members of the Sarcoma Alliance for Research through Collaboration (SARC). Patients with soft-tissue sarcoma had to be aged 18 years or older to enrol; patients with bone sarcoma could enrol if they were aged 12 years or older. Patients had histological evidence of metastatic or surgically unresectable locally advanced sarcoma, had received up to three previous lines of systemic anticancer therapy, had at least one measurable lesion according to the Response Evaluation Criteria In Solid Tumors version 1.1, and had at least one lesion accessible for biopsy. All patients were treated with 200 mg intravenous pembrolizumab every 3 weeks. The primary endpoint was investigator-assessed objective response. Patients who received at least one dose of pembrolizumab were included in the safety analysis and patients who progressed or reached at least one scan assessment were included in the activity analysis. Accrual is ongoing in some disease cohorts. This trial is registered with ClinicalTrials.gov, number NCT02301039. Between March 13, 2015, and Feb 18, 2016, we enrolled 86 patients, 84 of whom received pembrolizumab (42 in each disease cohort) and 80 of whom were evaluable for response (40 in each disease cohort). Median follow-up was 17\u00b78 months (IQR 12\u00b73-19\u00b73). Seven (18%) of 40 patients with soft-tissue sarcoma had an objective response, including four (40%) of ten patients with undifferentiated pleomorphic sarcoma, two (20%) of ten patients with liposarcoma, and one (10%) of ten patients with synovial sarcoma. No patients with leiomyosarcoma (n=10) had an objective response. Two (5%) of 40 patients with bone sarcoma had an objective response, including one (5%) of 22 patients with osteosarcoma and one (20%) of five patients with chondrosarcoma.", "label": 1, "is_selected": 0, "text": "Patients with advanced sarcomas have a poor prognosis and few treatment options that improve overall survival. Chemotherapy and targeted therapies offer short-lived disease control. We assessed pembrolizumab, an anti-PD-1 antibody, for safety and activity in patients with advanced soft-tissue sarcoma or bone sarcoma. In this two-cohort, single-arm, open-label, phase 2 study, we enrolled patients with soft-tissue sarcoma or bone sarcoma from 12 academic centres in the USA that were members of the Sarcoma Alliance for Research through Collaboration (SARC). Patients with soft-tissue sarcoma had to be aged 18 years or older to enrol; patients with bone sarcoma could enrol if they were aged 12 years or older. Patients had histological evidence of metastatic or surgically unresectable locally advanced sarcoma, had received up to three previous lines of systemic anticancer therapy, had at least one measurable lesion according to the Response Evaluation Criteria In Solid Tumors version 1.1, and had at least one lesion accessible for biopsy. All patients were treated with 200 mg intravenous pembrolizumab every 3 weeks. The primary endpoint was investigator-assessed objective response. Patients who received at least one dose of pembrolizumab were included in the safety analysis and patients who progressed or reached at least one scan assessment were included in the activity analysis. Accrual is ongoing in some disease cohorts. This trial is registered with ClinicalTrials.gov, number NCT02301039. Between March 13, 2015, and Feb 18, 2016, we enrolled 86 patients, 84 of whom received pembrolizumab (42 in each disease cohort) and 80 of whom were evaluable for response (40 in each disease cohort). Median follow-up was 17\u00b78 months (IQR 12\u00b73-19\u00b73). Seven (18%) of 40 patients with soft-tissue sarcoma had an objective response, including four (40%) of ten patients with undifferentiated pleomorphic sarcoma, two (20%) of ten patients with liposarcoma, and one (10%) of ten patients with synovial sarcoma. No patients with leiomyosarcoma (n=10) had an objective response. Two (5%) of 40 patients with bone sarcoma had an objective response, including one (5%) of 22 patients with osteosarcoma and one (20%) of five patients with chondrosarcoma."}
{"qid": "571f59cd0fd6f91b68000008", "original_text": "Miller-Fisher syndrome is a variant of Guillain-Barr\u00e9 syndrome, a rare autoimmune disorder that affects the nervous system. Both Guillain-Barr\u00e9 and Miller-Fisher are characterized by inflammation and demyelination of the peripheral nervous system, leading to muscle weakness, paralysis, and other symptoms. However, Miller-Fisher typically progresses more rapidly and is associated with a higher risk of respiratory muscle weakness and ventilatory failure compared to Guillain-Barr\u00e9.", "label": 0, "is_selected": 0, "text": "Miller-Fisher syndrome is a variant of Guillain-Barr\u00e9 syndrome, a rare autoimmune disorder that affects the nervous system. Both Guillain-Barr\u00e9 and Miller-Fisher are characterized by inflammation and demyelination of the peripheral nervous system, leading to muscle weakness, paralysis, and other symptoms. However, Miller-Fisher typically progresses more rapidly and is associated with a higher risk of respiratory muscle weakness and ventilatory failure compared to Guillain-Barr\u00e9."}
{"qid": "535d5bac7d100faa09000001", "original_text": "The aim of this study was to rank order the effectiveness of smoking cessation interventions for chronic obstructive pulmonary disease (COPD) patients. We searched 10 databases to identify randomised trials of smoking cessation counselling (SCC) with or without pharmacotherapy or nicotine replacement therapy (NRT). We conducted a network meta-analysis using logistic regression analyses to assess the comparative effectiveness of smoking cessation interventions while preserving randomisation of each trial. The analysis of 7,372 COPD patients from six out of eight identified trials showed that SCC in combination with NRT had the greatest effect on prolonged abstinence rates versus usual care (OR 5.08, p<0.0001) versus SCC alone (2.80, p = 0.001) and versus SCC combined with an antidepressant (1.53, p = 0.28). The second most effective intervention was SCC combined with an antidepressant (3.32, p = 0.002) versus SCC alone (1.83, p = 0.007), with no difference between antidepressants. SCC alone was of borderline superiority compared with usual care (1.81, p = 0.07). A small body of evidence suggests that SCC combined with NRT is more effective than other combinations and single smoking cessation treatments in COPD, but substantially more research is needed for this most important COPD treatment.", "label": 1, "is_selected": 0, "text": "The aim of this study was to rank order the effectiveness of smoking cessation interventions for chronic obstructive pulmonary disease (COPD) patients. We searched 10 databases to identify randomised trials of smoking cessation counselling (SCC) with or without pharmacotherapy or nicotine replacement therapy (NRT). We conducted a network meta-analysis using logistic regression analyses to assess the comparative effectiveness of smoking cessation interventions while preserving randomisation of each trial. The analysis of 7,372 COPD patients from six out of eight identified trials showed that SCC in combination with NRT had the greatest effect on prolonged abstinence rates versus usual care (OR 5.08, p<0.0001) versus SCC alone (2.80, p = 0.001) and versus SCC combined with an antidepressant (1.53, p = 0.28). The second most effective intervention was SCC combined with an antidepressant (3.32, p = 0.002) versus SCC alone (1.83, p = 0.007), with no difference between antidepressants. SCC alone was of borderline superiority compared with usual care (1.81, p = 0.07). A small body of evidence suggests that SCC combined with NRT is more effective than other combinations and single smoking cessation treatments in COPD, but substantially more research is needed for this most important COPD treatment."}
{"qid": "53036faab24d855b11000001", "original_text": "Previous events evidence that sudden cardiac death (SCD) in athletes is still a reality and it keeps challenging cardiologists. Considering the importance of SCD in athletes and the requisite for an update of this matter, we endeavored to describe SCD in athletes. The Medline (via PubMed) and SciELO databases were searched using the subject keywords \"sudden death, athletes and mortality\". The incidence of SCD is expected at one case for each 200,000 young athletes per year.", "label": 1, "is_selected": 0, "text": "Previous events evidence that sudden cardiac death (SCD) in athletes is still a reality and it keeps challenging cardiologists. Considering the importance of SCD in athletes and the requisite for an update of this matter, we endeavored to describe SCD in athletes. The Medline (via PubMed) and SciELO databases were searched using the subject keywords \"sudden death, athletes and mortality\". The incidence of SCD is expected at one case for each 200,000 young athletes per year."}
{"qid": "553f8bc11d53b76422000002", "original_text": "Transcription-coupled repair (TCR) is a cellular process by which some forms of DNA damage are repaired more rapidly from transcribed strands of active genes than from nontranscribed strands or the overall genome. In humans, the TCR coupling factor, CSB, plays a critical role in restoring transcription following both UV-induced and oxidative DNA damage. It also contributes indirectly to the global repair of some forms of oxidative DNA damage. The Escherichia coli homolog, Mfd, is similarly required for TCR of UV-induced lesions. However, its contribution to the restoration of transcription and to global repair of oxidative damage has not been examined. Here, we report the first direct study of transcriptional recovery following UV-induced and oxidative DNA damage in E. coli. We observed that mutations in mfd or uvrA reduced the rate that transcription recovered following UV-induced damage. In contrast, no difference was detected in the rate of transcription recovery in mfd, uvrA, fpg, nth, or polB dinB umuDC mutants relative to wild-type cells following oxidative damage.", "label": 1, "is_selected": 0, "text": "Transcription-coupled repair (TCR) is a cellular process by which some forms of DNA damage are repaired more rapidly from transcribed strands of active genes than from nontranscribed strands or the overall genome. In humans, the TCR coupling factor, CSB, plays a critical role in restoring transcription following both UV-induced and oxidative DNA damage. It also contributes indirectly to the global repair of some forms of oxidative DNA damage. The Escherichia coli homolog, Mfd, is similarly required for TCR of UV-induced lesions. However, its contribution to the restoration of transcription and to global repair of oxidative damage has not been examined. Here, we report the first direct study of transcriptional recovery following UV-induced and oxidative DNA damage in E. coli. We observed that mutations in mfd or uvrA reduced the rate that transcription recovered following UV-induced damage. In contrast, no difference was detected in the rate of transcription recovery in mfd, uvrA, fpg, nth, or polB dinB umuDC mutants relative to wild-type cells following oxidative damage."}
{"qid": "5e482f08d14c9f295d00000d", "original_text": "Water radiolysis involves chemical decomposition of the water molecule into free radicals after exposure to ionizing radiation. These free radicals have deleterious effects on normal cell physiology. Carboxylated nanodiamonds (cNDs) appear to modulate the deleterious effects of \u03b3-irradiation on the pathophysiology of red blood cells (RBCs). In the present work, the antioxidant activity of hydrated cNDs (h-cNDs) on limiting oxidative damage (the water radiolysis effect) by \u03b3-irradiation was confirmed. Our results show that h-cNDs have remarkable free radical scavenging ability and preserve the enzymatic activity of catalase after \u03b3-irradiation. The underlying mechanism through which nanodiamonds exhibit antioxidant activity appears to depend on their colloidal stability. This property of detonation synthesized nanodiamonds is improved after carboxylation, which in turn influences changes in the hydrogen bond strength in water.", "label": 1, "is_selected": 0, "text": "Water radiolysis involves chemical decomposition of the water molecule into free radicals after exposure to ionizing radiation. These free radicals have deleterious effects on normal cell physiology. Carboxylated nanodiamonds (cNDs) appear to modulate the deleterious effects of \u03b3-irradiation on the pathophysiology of red blood cells (RBCs). In the present work, the antioxidant activity of hydrated cNDs (h-cNDs) on limiting oxidative damage (the water radiolysis effect) by \u03b3-irradiation was confirmed. Our results show that h-cNDs have remarkable free radical scavenging ability and preserve the enzymatic activity of catalase after \u03b3-irradiation. The underlying mechanism through which nanodiamonds exhibit antioxidant activity appears to depend on their colloidal stability. This property of detonation synthesized nanodiamonds is improved after carboxylation, which in turn influences changes in the hydrogen bond strength in water."}
{"qid": "5139ec51bee46bd34c000006", "original_text": "COUP-TFII is a central nuclear hormone receptor that tightly regulates the expression of numerous target lipid metabolism genes in vertebrates. However, it remains unclear how COUP-TFII itself is transcriptionally controlled since studies with its promoter and upstream region fail to recapitulate the gene's liver expression. In an attempt to identify liver enhancers in the vicinity of COUP-TFII, we employed a comparative genomic approach. Initial comparisons between humans and mice of the 3470-kb gene-poor region surrounding COUP-TFII revealed 2023 conserved noncoding elements. To prioritize a subset of these elements for functional studies, we performed further genomic comparisons with the orthologous pufferfish (Fugu rubripes) locus and uncovered two anciently conserved noncoding sequences (CNS) upstream of COUP-TFII (CNS-62kb and CNS-66kb).", "label": 1, "is_selected": 0, "text": "COUP-TFII is a central nuclear hormone receptor that tightly regulates the expression of numerous target lipid metabolism genes in vertebrates. However, it remains unclear how COUP-TFII itself is transcriptionally controlled since studies with its promoter and upstream region fail to recapitulate the gene's liver expression. In an attempt to identify liver enhancers in the vicinity of COUP-TFII, we employed a comparative genomic approach. Initial comparisons between humans and mice of the 3470-kb gene-poor region surrounding COUP-TFII revealed 2023 conserved noncoding elements. To prioritize a subset of these elements for functional studies, we performed further genomic comparisons with the orthologous pufferfish (Fugu rubripes) locus and uncovered two anciently conserved noncoding sequences (CNS) upstream of COUP-TFII (CNS-62kb and CNS-66kb)."}
{"qid": "54f616cd5f206a0c0600000c", "original_text": "At a molecular level, insects utilize members of several highly divergent and unrelated families of cell-surface chemosensory receptors for detection of volatile odorants. Most odors are detected via a family of odorant receptors (ORs), which form heteromeric complexes consisting of a well-conserved OR co-receptor (Orco) ion channel and a non-conserved tuning OR that provides coding specificity to each complex. Orco functions as a non-selective cation channel and is expressed in the majority of olfactory receptor neurons (ORNs). As the destructive behaviors of many insects are principally driven by olfaction, Orco represents a novel target for behavior-based control strategies. While many natural and synthetic odorants have been shown to agonize Orco/Or complexes, only a single direct Orco modulator, VUAA1, has been described. In an effort to identify additional Orco modulators, we have investigated the structure/activity relationships around VUAA1.", "label": 1, "is_selected": 0, "text": "At a molecular level, insects utilize members of several highly divergent and unrelated families of cell-surface chemosensory receptors for detection of volatile odorants. Most odors are detected via a family of odorant receptors (ORs), which form heteromeric complexes consisting of a well-conserved OR co-receptor (Orco) ion channel and a non-conserved tuning OR that provides coding specificity to each complex. Orco functions as a non-selective cation channel and is expressed in the majority of olfactory receptor neurons (ORNs). As the destructive behaviors of many insects are principally driven by olfaction, Orco represents a novel target for behavior-based control strategies. While many natural and synthetic odorants have been shown to agonize Orco/Or complexes, only a single direct Orco modulator, VUAA1, has been described. In an effort to identify additional Orco modulators, we have investigated the structure/activity relationships around VUAA1."}
{"qid": "5540a8d20083d1bf0e000001", "original_text": "Many domestic dog breeds have originated through fixation of discrete mutations by intense artificial selection. As a result of this process, markers in the proximity of genes influencing breed-defining traits will have reduced variation (a selective sweep) and will show divergence in allele frequency. Consequently, low-resolution genomic scans can potentially be used to identify regions containing genes that have a major influence on breed-defining traits. We model the process of breed formation and show that the probability of two or three adjacent marker loci showing a spurious signal of selection within at least one breed (i.e., Type I error or false-positive rate) is low if highly variable and moderately spaced markers are utilized. We also use simulations with selection to demonstrate that even a moderately spaced set of highly polymorphic markers (e.g., one every 0.8 cM) has high power to detect regions targeted by strong artificial selection in dogs. Further, we show that a gene responsible for black coat color in the Large Munsterlander has a 40-Mb region surrounding the gene that is very low in heterozygosity for microsatellite markers. Similarly, we survey 302 microsatellite markers in the Dachshund and find three linked monomorphic microsatellite markers all within a 10-Mb region on chromosome 3. This region contains the FGFR3 gene, which is responsible for achondroplasia in humans, but not in dogs.", "label": 1, "is_selected": 0, "text": "Many domestic dog breeds have originated through fixation of discrete mutations by intense artificial selection. As a result of this process, markers in the proximity of genes influencing breed-defining traits will have reduced variation (a selective sweep) and will show divergence in allele frequency. Consequently, low-resolution genomic scans can potentially be used to identify regions containing genes that have a major influence on breed-defining traits. We model the process of breed formation and show that the probability of two or three adjacent marker loci showing a spurious signal of selection within at least one breed (i.e., Type I error or false-positive rate) is low if highly variable and moderately spaced markers are utilized. We also use simulations with selection to demonstrate that even a moderately spaced set of highly polymorphic markers (e.g., one every 0.8 cM) has high power to detect regions targeted by strong artificial selection in dogs. Further, we show that a gene responsible for black coat color in the Large Munsterlander has a 40-Mb region surrounding the gene that is very low in heterozygosity for microsatellite markers. Similarly, we survey 302 microsatellite markers in the Dachshund and find three linked monomorphic microsatellite markers all within a 10-Mb region on chromosome 3. This region contains the FGFR3 gene, which is responsible for achondroplasia in humans, but not in dogs."}
{"qid": "58bd645702b8c60953000010", "original_text": "Sure! The PIEZO2 gene has been associated with several diseases, including: 1. Charcot-Marie-Tooth disease (CMT): PIEZO2 mutations are the most common cause of CMT, a group of genetic disorders that affect the nervous system and cause muscle weakness, numbness, and loss of coordination. 2. Neuropathy, type 2 (NT2): PIEZO2 mutations can also cause NT2, a rare genetic disorder that affects the peripheral nervous system and causes numbness, tingling, and pain in the hands and feet. 3. Sensory neuropathy: PIEZO2 mutations have been identified in individuals with sensory neuropathy, a condition characterized by numbness, tingling, and loss of sensation in the hands and feet. Note: These are the most common diseases associated with the PIEZO2 gene, but there may be other rare genetic disorders that can also be caused by PIEZO2 mutations.", "label": 0, "is_selected": 1, "text": "The PIEZO2 gene has been linked to several diseases, including Charcot-Marie-Tooth disease (CMT), a group of genetic disorders that affect the nervous system and cause muscle weakness, numbness, and loss of coordination, according to a new study from researchers at the University of California, Los Angeles (UCLA)."}
{"qid": "54d892ee014675820d000005", "original_text": "The prevalence and incidence of congestive heart failure continues to increase. The two hallmarks of this syndrome, sodium and water retention, are frequently a therapeutic challenge. Most conventional diuretics act primarily as saluretics by inhibiting renal tubular electrolyte reabsorption, which, due to osmotic pressure, promotes excretion of isotonic fluid. The peptide hormone arginine vasopressin vasoconstricts at the V(1A) receptor and promotes water reabsorption via the V(2) receptor in the renal collecting duct by inserting aquaporin-2 water channels into the luminal membrane.", "label": 1, "is_selected": 0, "text": "The prevalence and incidence of congestive heart failure continues to increase. The two hallmarks of this syndrome, sodium and water retention, are frequently a therapeutic challenge. Most conventional diuretics act primarily as saluretics by inhibiting renal tubular electrolyte reabsorption, which, due to osmotic pressure, promotes excretion of isotonic fluid. The peptide hormone arginine vasopressin vasoconstricts at the V(1A) receptor and promotes water reabsorption via the V(2) receptor in the renal collecting duct by inserting aquaporin-2 water channels into the luminal membrane."}
{"qid": "60320ef51cb411341a000130", "original_text": "A decoy exosome is a synthetic exosome that mimics the structure and function of a natural exosome. Decoy exosomes are used in various medical applications, including cancer immunotherapy and biomarker detection. Unlike natural exosomes, which are small vesicles released by cells and contain biomolecules such as proteins, lipids, and RNA, decoy exosomes are artificially produced in the laboratory using various methods, such as chemical modification of liposomes or nanoparticles. Decoy exosomes can be engineered to contain specific biomolecules or to mimic the surface antigens of cancer cells, making them attractive candidates for cancer immunotherapy. Additionally, decoy exosomes can be used as a diagnostic tool to detect cancer biomarkers in bodily fluids.", "label": 0, "is_selected": 1, "text": "The global decoy exosomes market is expected to grow at a significant rate over the forecast period, owing to the increasing use of decoy exosomes in the medical and pharmaceutical industries and their potential applications in the cancer immunotherapy and biomarker detection arenas.Additionally, the increasing research and development activities in the field of synthetic biology is also expected to boost the market over the next few years."}
{"qid": "5a723cd12dc08e987e00000b", "original_text": "CD55 deficiency has been associated with an increased risk of thrombosis, including deep vein thrombosis (DVT) and pulmonary embolism (PE). CD55 is a protein that helps regulate blood clotting and inflammation. Studies have shown that individuals with CD55 deficiency have altered coagulation profiles, including increased levels of D-dimer, a marker of blood clotting, and decreased levels of protein C and protein S, factors that inhibit blood clotting. These alterations may contribute to the development of thrombotic events in CD55-deficient individuals. However, it is important to note that the relationship between CD55 deficiency and thrombosis is complex and may involve other factors, such as genetic predisposition and lifestyle factors.", "label": 0, "is_selected": 0, "text": "CD55 deficiency has been associated with an increased risk of thrombosis, including deep vein thrombosis (DVT) and pulmonary embolism (PE). CD55 is a protein that helps regulate blood clotting and inflammation. Studies have shown that individuals with CD55 deficiency have altered coagulation profiles, including increased levels of D-dimer, a marker of blood clotting, and decreased levels of protein C and protein S, factors that inhibit blood clotting. These alterations may contribute to the development of thrombotic events in CD55-deficient individuals. However, it is important to note that the relationship between CD55 deficiency and thrombosis is complex and may involve other factors, such as genetic predisposition and lifestyle factors."}
{"qid": "5ac09a7b19833b0d7b000001", "original_text": "The EpCam protein (Ephrin type-A receptor C) is primarily localized at the cell surface and is found in various tissues and organs throughout the body, including the brain, kidneys, liver, and pancreas. In the brain, EpCam is particularly concentrated in areas involved in vision, such as the retina and optic nerve. It is also expressed in the hippocampus, a region involved in memory formation, and in dopaminergic neurons, which play a role in motor control and reward processing. In the kidneys, EpCam is involved in the regulation of tubular epithelial cell proliferation and differentiation. In the liver, it may play a role in the regulation of hepatocyte proliferation and differentiation. In the pancreas, EpCam is expressed in the insulin-producing beta cells, where it helps to regulate glucose homeostasis.", "label": 0, "is_selected": 1, "text": "Ephrin type-A receptor C (EpCam) is a member of theEphrin family of proteins and has been implicated in a number of diseases, including Alzheimer's disease, multiple sclerosis, epilepsy, and Parkinson's diseases, as well as in the regulation of cell proliferation and differentiation and insulin regulation."}
{"qid": "5e64f1921af46fc130000018", "original_text": "Yes, there is a vaccine available for rotavirus. Rotavirus is a highly contagious virus that can cause severe diarrhea and dehydration in infants and young children. In 2008, the Food and Drug Administration (FDA) approved the first rotavirus vaccine, Rotarix, which is given orally to infants in a series of doses at 2, 4, and 6 months of age. In 2016, a second rotavirus vaccine, RotaTeq, was approved for use in the United States. Both vaccines have been shown to be highly effective in preventing severe rotavirus disease and hospitalizations. The Centers for Disease Control and Prevention (CDC) recommend that all infants in the United States receive the rotavirus vaccine according to the recommended schedule.", "label": 0, "is_selected": 1, "text": "The US Centers for Disease Control and Prevention (CDC) has issued a warning that infants as young as six months of age should be vaccinated against rotavirus, a virus that can cause severe dehydration and death in infants and young children. The Centers for disease control and prevention (CDC recommend that all infants in the United States receive the rotavirus vaccine according to the recommended schedule."}
{"qid": "601db8111cb411341a00004b", "original_text": "In genome-wide association studies, only a subset of all genomic variants are typed by current, high-throughput, SNP-genotyping platforms. However, many of the untyped variants can be well predicted from typed variants, with linkage disequilibrium (LD) information among typed and untyped variants available from an external reference panel such as HapMap. Incorporation of such external information can allow one to perform tests of association between untyped variants and phenotype, thereby making more efficient use of the available genotype data. When related individuals are included in case-control samples, the dependence among their genotypes must be properly addressed for valid association testing. In the context of testing untyped variants, an additional analytical challenge is that the dependence, across related individuals, of the partial information on untyped-SNP genotypes must also be assessed and incorporated into the analysis for valid inference.", "label": 1, "is_selected": 0, "text": "In genome-wide association studies, only a subset of all genomic variants are typed by current, high-throughput, SNP-genotyping platforms. However, many of the untyped variants can be well predicted from typed variants, with linkage disequilibrium (LD) information among typed and untyped variants available from an external reference panel such as HapMap. Incorporation of such external information can allow one to perform tests of association between untyped variants and phenotype, thereby making more efficient use of the available genotype data. When related individuals are included in case-control samples, the dependence among their genotypes must be properly addressed for valid association testing. In the context of testing untyped variants, an additional analytical challenge is that the dependence, across related individuals, of the partial information on untyped-SNP genotypes must also be assessed and incorporated into the analysis for valid inference."}
{"qid": "5c0112dd133db5eb78000026", "original_text": "Tuberculosis is very much rampant in our society and accounts for a large number of deaths annually. In spite of consistent efforts being made, the disease has not been curtailed yet. The emergence of MDR and XDR strains in the society along with an increase in the number of HIV cases and that of latent TB, have further aggravated the problem making the disease very much persistent. The current situation clearly manifests the need to discover and develop new potent molecules/approaches that could help to tackle drug resistance.", "label": 1, "is_selected": 0, "text": "Tuberculosis is very much rampant in our society and accounts for a large number of deaths annually. In spite of consistent efforts being made, the disease has not been curtailed yet. The emergence of MDR and XDR strains in the society along with an increase in the number of HIV cases and that of latent TB, have further aggravated the problem making the disease very much persistent. The current situation clearly manifests the need to discover and develop new potent molecules/approaches that could help to tackle drug resistance."}
{"qid": "54d892ee014675820d000005", "original_text": "One of the hallmarks of chronic congestive heart failure is an increase in sympathetic tone to the peripheral circulation and to the heart. A correlation between plasma norepinephrine and the severity of the heart failure state has been demonstrated. One mechanism that has been proposed to account for this sympathoexcitation is a depression in the baroreflex and, perhaps, cardiac reflex control of sympathetic nerve activity.", "label": 1, "is_selected": 0, "text": "One of the hallmarks of chronic congestive heart failure is an increase in sympathetic tone to the peripheral circulation and to the heart. A correlation between plasma norepinephrine and the severity of the heart failure state has been demonstrated. One mechanism that has been proposed to account for this sympathoexcitation is a depression in the baroreflex and, perhaps, cardiac reflex control of sympathetic nerve activity."}
{"qid": "606b718994d57fd87900006b", "original_text": "Yes, dupilumab has been FDA approved for the treatment of moderate-to-severe atopic dermatitis (eczema) in adults and pediatric patients aged 12 and older. Dupilumab is a monoclonal antibody that targets interleukin-4 (IL-4) and interleukin-13 (IL-13), two key cytokines involved in the inflammatory response underlying atopic dermatitis. The FDA approved dupilumab based on results from clinical trials demonstrating its safety and efficacy in improving skin symptoms, itching, and quality of life in patients with atopic dermatitis.", "label": 0, "is_selected": 1, "text": "The US Food and Drug Administration (FDA) has approved dupilumab for the treatment of atopic dermatitis (eczema), a skin condition that causes itching, rash, and dryness on the face and other parts of the body, including the hands and feet."}
{"qid": "58ce69cd1f5fb2b734000003", "original_text": "The RNA-binding protein HuR binds at 3' untranslated regions (UTRs) of target transcripts, thereby protecting them against degradation. We show that HuR directly interacts with cellular retinoic acid-binding protein 2 (CRABP2), a protein known to transport RA from the cytosol to the nuclear retinoic acid receptor (RAR). Association with CRABP2 dramatically increases the affinity of HuR toward target mRNAs and enhances the stability of such transcripts, including that of Apaf-1, the major protein in the apoptosome.", "label": 1, "is_selected": 0, "text": "The RNA-binding protein HuR binds at 3' untranslated regions (UTRs) of target transcripts, thereby protecting them against degradation. We show that HuR directly interacts with cellular retinoic acid-binding protein 2 (CRABP2), a protein known to transport RA from the cytosol to the nuclear retinoic acid receptor (RAR). Association with CRABP2 dramatically increases the affinity of HuR toward target mRNAs and enhances the stability of such transcripts, including that of Apaf-1, the major protein in the apoptosome."}
{"qid": "5a68f2bab750ff4455000017", "original_text": "Tretinoin has been shown to be effective in improving photoaging symptoms, including fine lines, wrinkles, and age spots. It works by increasing cell turnover, which helps to reduce the appearance of sun-damaged skin. Studies have consistently demonstrated the efficacy of tretinoin in improving skin texture and appearance, with some showing significant improvements after just a few months of use. It is important to note, however, that tretinoin can cause irritation and dryness, so it is essential to use it with caution and to gradually increase the dosage to minimize side effects.", "label": 0, "is_selected": 1, "text": "Tretinoin is an anti-inflammatory and has been shown to be an effective treatment for a number of skin conditions, including acne, eczema, psoriasis, vitiligo, and sun-damaged skin, as well as for the treatment of seborrheic dermatitis."}
{"qid": "5a9eb008d6d6b54f79000001", "original_text": "The brown marmorated stink bug, Halyomorpha halys, is native to Asia (China, Taiwan, Japan, and the Korean peninsula). It was first found in Allentown, Pa, in 1996 and has since spread across wide areas of the Eastern United States. As of October 2010, at least 26 states have reported the presence of the brown marmorated stink bug.", "label": 1, "is_selected": 0, "text": "The brown marmorated stink bug, Halyomorpha halys, is native to Asia (China, Taiwan, Japan, and the Korean peninsula). It was first found in Allentown, Pa, in 1996 and has since spread across wide areas of the Eastern United States. As of October 2010, at least 26 states have reported the presence of the brown marmorated stink bug."}
{"qid": "56bb54d3ac7ad10019000006", "original_text": "Individuals who undergo removal of an acoustic neuroma are usually apprehensive in spite of the intrinsically benign nature of the disease. Fears surrounding the experience are related to the real risks involved in surgery near the brain and the complications which can ensue. The intensity of the patients' feelings of anxiety and uncertainty might be decreased if nurses were aware of and attended to the informational needs of these patients. In order to describe the informational needs of acoustic neuroma patients, a retrospective survey of 21 subjects who had had removal of such a tumor six to eighteen months previously was carried out.", "label": 1, "is_selected": 0, "text": "Individuals who undergo removal of an acoustic neuroma are usually apprehensive in spite of the intrinsically benign nature of the disease. Fears surrounding the experience are related to the real risks involved in surgery near the brain and the complications which can ensue. The intensity of the patients' feelings of anxiety and uncertainty might be decreased if nurses were aware of and attended to the informational needs of these patients. In order to describe the informational needs of acoustic neuroma patients, a retrospective survey of 21 subjects who had had removal of such a tumor six to eighteen months previously was carried out."}
{"qid": "601d74681cb411341a000042", "original_text": "Sotorasib targets the KRAS(G12C) mutation, a specific mutation in the KRAS gene that is commonly found in non-small cell lung cancer (NSCLC). This mutation is known to be resistant to traditional chemotherapy and EGFR tyrosine kinase inhibitors, making it an attractive target for targeted therapies like sotorasib.", "label": 0, "is_selected": 0, "text": "Sotorasib targets the KRAS(G12C) mutation, a specific mutation in the KRAS gene that is commonly found in non-small cell lung cancer (NSCLC). This mutation is known to be resistant to traditional chemotherapy and EGFR tyrosine kinase inhibitors, making it an attractive target for targeted therapies like sotorasib."}
{"qid": "60249aa31cb411341a0000a0", "original_text": "Hemophilic pseudotumors result from repeated episodes of bleeding into bone, subperiosteum, and soft tissue. Since clotting factors became available, uncontrolled perioperative bleeding is a less significant problem for surgeons in developed countries. However, they are more difficult to come by in China. Additionally, patients often have to undergo surgery for giant masses and suffer complications. We wanted to present our experience in the surgical management of hemophilic pseudotumors over a 40-year period. We retrospectively reviewed 429 hemorrhagic coagulopathy patients between 1983 and 2015. Diagnosis of hemophilic pseudotumor was confirmed following clinical, radiological, and pathological criteria.", "label": 1, "is_selected": 0, "text": "Hemophilic pseudotumors result from repeated episodes of bleeding into bone, subperiosteum, and soft tissue. Since clotting factors became available, uncontrolled perioperative bleeding is a less significant problem for surgeons in developed countries. However, they are more difficult to come by in China. Additionally, patients often have to undergo surgery for giant masses and suffer complications. We wanted to present our experience in the surgical management of hemophilic pseudotumors over a 40-year period. We retrospectively reviewed 429 hemorrhagic coagulopathy patients between 1983 and 2015. Diagnosis of hemophilic pseudotumor was confirmed following clinical, radiological, and pathological criteria."}
{"qid": "58cd7fed02b8c6095300003f", "original_text": "Genetic disorders of calcium metabolism arise in a familial or sporadic setting. The calcium-sensing receptor (CASR) plays a key role in maintaining calcium homeostasis and study of the CASR gene can be clinically useful in determining etiology and appropriate therapeutic approaches. We report two cases of novel CASR gene mutations that illustrate the varying clinical presentations and discuss these in terms of the current understanding of CASR function. A 16-year-old patient had mild hypercalcemia associated with low-normal urinary calcium excretion and normal-to-high parathyroid hormone (PTH) levels. Because of negative family history, familial hypocalciuric hypercalcemia was originally excluded.", "label": 1, "is_selected": 0, "text": "Genetic disorders of calcium metabolism arise in a familial or sporadic setting. The calcium-sensing receptor (CASR) plays a key role in maintaining calcium homeostasis and study of the CASR gene can be clinically useful in determining etiology and appropriate therapeutic approaches. We report two cases of novel CASR gene mutations that illustrate the varying clinical presentations and discuss these in terms of the current understanding of CASR function. A 16-year-old patient had mild hypercalcemia associated with low-normal urinary calcium excretion and normal-to-high parathyroid hormone (PTH) levels. Because of negative family history, familial hypocalciuric hypercalcemia was originally excluded."}
{"qid": "5fdb2e23a43ad3127800000a", "original_text": "DNaseI hypersensitive sites (HS) are areas of DNA where the enzyme DNaseI is highly active and can readily cleave the DNA molecule. These sites are typically located at regions of the genome that are rich in certain sequences, such as CG dinucleotides or other repeated sequences, and are often associated with regions of the genome that are involved in gene regulation. The presence of DNaseI HSs can be used as a marker for the regulation of gene expression and can provide insight into the mechanisms of gene control.", "label": 0, "is_selected": 0, "text": "DNaseI hypersensitive sites (HS) are areas of DNA where the enzyme DNaseI is highly active and can readily cleave the DNA molecule. These sites are typically located at regions of the genome that are rich in certain sequences, such as CG dinucleotides or other repeated sequences, and are often associated with regions of the genome that are involved in gene regulation. The presence of DNaseI HSs can be used as a marker for the regulation of gene expression and can provide insight into the mechanisms of gene control."}
{"qid": "56ae69fb0a360a5e4500000d", "original_text": "DNA methylation maps have shown promise in the diagnosis of non-small-cell lung carcinomas (NSCLC). Methylation of specific genes, such as MLH1, MSH2, and MSH6, is associated with a higher risk of developing NSCLC. Analysis of DNA methylation patterns in tumor tissues can help identify specific methylation markers that can aid in early diagnosis. For example, a study published in the Journal of Clinical Oncology in 2018 found that a combination of DNA methylation markers could distinguish NSCLC from normal lung tissue with an area under the curve (AUC) of 0.93. However, further validation and large-scale studies are needed to confirm the clinical utility of DNA methylation maps in NSCLC diagnosis.", "label": 0, "is_selected": 1, "text": "The aim of this study is to investigate the utility of DNA maps in the diagnosis of lung cancer.<n> However, further validation and large-scale studies are needed to confirm the clinical Utility of DNA Maps in NSCLC diagnosis., based on the results of this pilot study."}
{"qid": "5319a6e9b166e2b806000023", "original_text": "The genetic lesion associated with Huntington's disease is an expansion of a CAG repeat in the Huntingtin gene, leading to a toxic protein that causes progressive neuronal degeneration. Specifically, the mutation involves a repeat of the amino acid glutamine (CAG) in the Huntingtin gene, which is normally repeated 10-28 times. When the repeat expands to 36 or more times, it leads to the onset of Huntington's disease.", "label": 0, "is_selected": 0, "text": "The genetic lesion associated with Huntington's disease is an expansion of a CAG repeat in the Huntingtin gene, leading to a toxic protein that causes progressive neuronal degeneration. Specifically, the mutation involves a repeat of the amino acid glutamine (CAG) in the Huntingtin gene, which is normally repeated 10-28 times. When the repeat expands to 36 or more times, it leads to the onset of Huntington's disease."}
{"qid": "56bf7d90ef6e394741000015", "original_text": "The circadian clock has been shown to play a role in ribosome biogenesis in various organisms, including bacteria and yeast. The circadian clock regulates the expression of genes involved in ribosome biogenesis, including the ribosomal RNA (rRNA) genes, and helps to coordinate the assembly of ribosomes with the appropriate circadian rhythm. This is thought to be important for the regulation of protein synthesis and cellular processes that occur in a 24-hour cycle.", "label": 0, "is_selected": 0, "text": "The circadian clock has been shown to play a role in ribosome biogenesis in various organisms, including bacteria and yeast. The circadian clock regulates the expression of genes involved in ribosome biogenesis, including the ribosomal RNA (rRNA) genes, and helps to coordinate the assembly of ribosomes with the appropriate circadian rhythm. This is thought to be important for the regulation of protein synthesis and cellular processes that occur in a 24-hour cycle."}
{"qid": "533c38b3c45e133714000009", "original_text": "CTCF is a ubiquitously expressed regulator of fundamental genomic processes including transcription, intra- and interchromosomal interactions, and chromatin structure. Because of its critical role in genome function, CTCF binding patterns have long been assumed to be largely invariant across different cellular environments. Here we analyze genome-wide occupancy patterns of CTCF by ChIP-seq in 19 diverse human cell types, including normal primary cells and immortal lines. We observed highly reproducible yet surprisingly plastic genomic binding landscapes, indicative of strong cell-selective regulation of CTCF occupancy.", "label": 1, "is_selected": 0, "text": "CTCF is a ubiquitously expressed regulator of fundamental genomic processes including transcription, intra- and interchromosomal interactions, and chromatin structure. Because of its critical role in genome function, CTCF binding patterns have long been assumed to be largely invariant across different cellular environments. Here we analyze genome-wide occupancy patterns of CTCF by ChIP-seq in 19 diverse human cell types, including normal primary cells and immortal lines. We observed highly reproducible yet surprisingly plastic genomic binding landscapes, indicative of strong cell-selective regulation of CTCF occupancy."}
{"qid": "5a6a3335b750ff4455000025", "original_text": "The biological significance of minimal absent words has been investigated in genomes of organisms from all domains of life. For instance, three minimal absent words of the human genome were found in Ebola virus genomes. There exists an O(n) -time and O(n) -space algorithm for computing all minimal absent words of a sequence of length n on a fixed-sized alphabet based on suffix arrays. A standard implementation of this algorithm, when applied to a large sequence of length n , requires more than 20 n bytes of RAM.", "label": 1, "is_selected": 0, "text": "The biological significance of minimal absent words has been investigated in genomes of organisms from all domains of life. For instance, three minimal absent words of the human genome were found in Ebola virus genomes. There exists an O(n) -time and O(n) -space algorithm for computing all minimal absent words of a sequence of length n on a fixed-sized alphabet based on suffix arrays. A standard implementation of this algorithm, when applied to a large sequence of length n , requires more than 20 n bytes of RAM."}
{"qid": "601d76131cb411341a000044", "original_text": "Yes, avelumab has been shown to be effective for urothelial carcinoma, a type of bladder cancer. In clinical trials, avelumab has demonstrated a overall response rate (ORR) of 27% in patients with advanced urothelial carcinoma, which is higher than the ORR seen with other immunotherapies and chemotherapies in this setting. Additionally, avelumab has been shown to have a median progression-free survival (PFS) of 5.6 months in patients with advanced urothelial carcinoma, which is longer than with other treatments. However, it's important to note that avelumab is only approved by the FDA for the treatment of adults with metastatic urothelial carcinoma whose disease has progressed after prior platinum-based chemotherapy, or who are ineligible for cisplatin-containing chemotherapy. It's not approved for the first-line treatment of urothelial carcinoma. It's important to consult a doctor or oncologist for a proper diagnosis and treatment plan, as the use of avelumab for urothelial carcinoma may vary depending on the individual patient's condition and other factors.", "label": 0, "is_selected": 1, "text": "The US Food and Drug Administration (FDA) has approved avelumab (Herceptin) for the treatment of adults with advanced urothelial carcinoma whose disease has progressed after prior platinum-based chemotherapy, or who are ineligible for cisplatin-containing chemotherapy. However, it's important to note that aVELumab is only approved by the FDA for the Treatment of Adults with Metastatic Urothelial Carcinoma Whose Disease has Progressed after Prior Platinum-Based Chemotherapy."}
{"qid": "532c0c21d6d3ac6a3400001b", "original_text": "Accurate prediction of ligand-binding poses is crucial for understanding molecular interactions and is very important for drug discovery, structural design, and optimization. In this study, we developed a novel scoring program, HotLig, which applies the Connolly surface of a protein to calculate hydrophobic interaction and paired pharmacophore interactions with ligands. In addition to molecular surface distance, ligand-contacting areas and hydrogen-bond angles were also introduced to the scoring functions in HotLig. Four individual energy scoring functions for H-bonds, ionic pairs, metal coordination, and hydrophobic effects were derived from 600 protein-ligand complexes, and then, their weighting factors were optimized through an interaction-characterized training set. Success rates of ligand-binding-pose predictions (with a root mean squared deviation of \u22642 \u00c5) for the Wang, GOLD, and Cheng data sets were respectively validated to be 91.0%, 87.0%, and 85.6%. HotLig was found to possess equally good predictive powers for the hydrophilic (88.6%) and hydrophobic subsets (87.5%), and the success rate for the mixed subset was as high as 96.9%.", "label": 1, "is_selected": 0, "text": "Accurate prediction of ligand-binding poses is crucial for understanding molecular interactions and is very important for drug discovery, structural design, and optimization. In this study, we developed a novel scoring program, HotLig, which applies the Connolly surface of a protein to calculate hydrophobic interaction and paired pharmacophore interactions with ligands. In addition to molecular surface distance, ligand-contacting areas and hydrogen-bond angles were also introduced to the scoring functions in HotLig. Four individual energy scoring functions for H-bonds, ionic pairs, metal coordination, and hydrophobic effects were derived from 600 protein-ligand complexes, and then, their weighting factors were optimized through an interaction-characterized training set. Success rates of ligand-binding-pose predictions (with a root mean squared deviation of \u22642 \u00c5) for the Wang, GOLD, and Cheng data sets were respectively validated to be 91.0%, 87.0%, and 85.6%. HotLig was found to possess equally good predictive powers for the hydrophilic (88.6%) and hydrophobic subsets (87.5%), and the success rate for the mixed subset was as high as 96.9%."}
{"qid": "5e3a6a4eb5b409ea53000016", "original_text": "A 42-year-old young lady presented with acute onset of dizziness, drooping of left eye with binocular diplopia and inability to walk unassisted. She had past history of uncontrolled diabetes mellitus and hypertension. On examination, she had left fascicular type of third nerve palsy, vertical one and half syndrome (VOHS), left internuclear ophthalmoplegia and skew deviation with ipsilesional hypertropia. She also had thalamic astasia and right unilateral asterixis.", "label": 1, "is_selected": 0, "text": "A 42-year-old young lady presented with acute onset of dizziness, drooping of left eye with binocular diplopia and inability to walk unassisted. She had past history of uncontrolled diabetes mellitus and hypertension. On examination, she had left fascicular type of third nerve palsy, vertical one and half syndrome (VOHS), left internuclear ophthalmoplegia and skew deviation with ipsilesional hypertropia. She also had thalamic astasia and right unilateral asterixis."}
{"qid": "54ede95c94afd6150400000a", "original_text": "The familial occurrence of duodenal atresia is uncommon. This study evaluated the inheritance patterns, the nature and associations, and the presence of immunologic deficits in duodenal atresia recurring in at least three siblings each in two nonrelated families. In the first family, an association with Fanconi's anemia was observed in three of seven pregnancies (2 boys, 1 girl) suggesting an autosomal recessive mode of transmission. Patients died as a result of overwhelming (fungal) septicemia in association with pancytopenia.", "label": 1, "is_selected": 0, "text": "The familial occurrence of duodenal atresia is uncommon. This study evaluated the inheritance patterns, the nature and associations, and the presence of immunologic deficits in duodenal atresia recurring in at least three siblings each in two nonrelated families. In the first family, an association with Fanconi's anemia was observed in three of seven pregnancies (2 boys, 1 girl) suggesting an autosomal recessive mode of transmission. Patients died as a result of overwhelming (fungal) septicemia in association with pancytopenia."}
{"qid": "52d7b45e98d0239505000002", "original_text": "Subclinical hypothyroidism (SH), defined by elevated serum levels of thyroid stimulating hormone (TSH) with normal levels of free thyroid hormones, is common in adults, especially in women over 60 years of age. Among individuals with this condition, up to two-thirds have serum TSH levels between 5-10 mU/L and thyroid autoantibodies; almost half of them may progress to overt thyroid failure, the annual percent risk increasing with serum TSH level. There is evidence that elevated TSH levels in patients with SH do not reflect pituitary compensation to maintain euthyroidism, but a mild tissue hypothyroidism sensu strictu. When lasting more than 6-12 months, SH may be associated with an atherogenic lipid profile, a hypercoagulable state, a subtle cardiac defect with mainly diastolic dysfunction, impaired vascular function, and reduced submaximal exercise capacity. The deviation from normality usually increases with serum TSH level ('dosage effect' phenomenon). Restoration of euthyroidism by levothyroxine (LT4) treatment may correct the lipid profile and cardiac abnormalities, especially in patients with an initially higher deviation from normality and higher serum TSH levels.", "label": 1, "is_selected": 0, "text": "Subclinical hypothyroidism (SH), defined by elevated serum levels of thyroid stimulating hormone (TSH) with normal levels of free thyroid hormones, is common in adults, especially in women over 60 years of age. Among individuals with this condition, up to two-thirds have serum TSH levels between 5-10 mU/L and thyroid autoantibodies; almost half of them may progress to overt thyroid failure, the annual percent risk increasing with serum TSH level. There is evidence that elevated TSH levels in patients with SH do not reflect pituitary compensation to maintain euthyroidism, but a mild tissue hypothyroidism sensu strictu. When lasting more than 6-12 months, SH may be associated with an atherogenic lipid profile, a hypercoagulable state, a subtle cardiac defect with mainly diastolic dysfunction, impaired vascular function, and reduced submaximal exercise capacity. The deviation from normality usually increases with serum TSH level ('dosage effect' phenomenon). Restoration of euthyroidism by levothyroxine (LT4) treatment may correct the lipid profile and cardiac abnormalities, especially in patients with an initially higher deviation from normality and higher serum TSH levels."}
{"qid": "5abcf010fcf4565872000023", "original_text": "Carpal tunnel syndrome (CTS) is the most common median nerve neuropathy, accounting for 90% of all neuropathies. Carpal tunnel syndrome presents in 3.8% of the general population, with a higher prevalence among women. There are several risk factors associated with CTS, including both medical and non medical factors. The pathophysiologic mechanisms involved in the median nerve compression and traction are thought to be complex, and as yet are not fully understood.", "label": 1, "is_selected": 0, "text": "Carpal tunnel syndrome (CTS) is the most common median nerve neuropathy, accounting for 90% of all neuropathies. Carpal tunnel syndrome presents in 3.8% of the general population, with a higher prevalence among women. There are several risk factors associated with CTS, including both medical and non medical factors. The pathophysiologic mechanisms involved in the median nerve compression and traction are thought to be complex, and as yet are not fully understood."}
{"qid": "52fb20a32059c6d71c00005d", "original_text": "Several therapeutic interventions have been applied to manage sarcopenia, including resistance training, aerobic exercise, and neuromuscular electrical stimulation. Resistance training, which involves using weights or resistance bands to strengthen muscles, has been shown to improve muscle mass and strength in older adults. Aerobic exercise, such as walking or cycling, can also improve muscle mass and strength, as well as cardiovascular health. Neuromuscular electrical stimulation, which involves using electrical impulses to activate muscles, has been shown to improve muscle strength and function in older adults. Other interventions that have been studied for their potential to manage sarcopenia include nutritional supplementation, cognitive training, and social engagement.", "label": 0, "is_selected": 1, "text": "sarcopenia, or age-related memory loss, is one of the leading causes of death in people over the age of 60.<n> Resistance training, which involves using weights or resistance bands to strengthen muscles, has been shown to improve muscle mass and strength in older adults."}
{"qid": "5c6f6ae37c78d69471000054", "original_text": "Migraine is a neurovascular disorder that involves activation of the trigeminovascular system and cranial vasodilation mediated by release of calcitonin gene-related peptide (CGRP). The gold standard for acute migraine treatment are the triptans, 5-HT1B/1D/(1F) receptor agonists. Their actions are thought to be mediated through activation of: (i) 5-HT1B receptors in cranial blood vessels with subsequent cranial vasoconstriction; (ii) prejunctional 5-HT1D receptors on trigeminal fibers that inhibit trigeminal CGRP release; and (iii) 5-HT1B/1D/1F receptors in central nervous system involved in (anti)nociceptive modulation. Unfortunately, coronary arteries also express 5-HT1B receptors whose activation would produce coronary vasoconstriction; hence, triptans are contraindicated in patients with cardiovascular disease. In addition, since migraineurs have an increased cardiovascular risk, it is important to develop antimigraine drugs devoid of vascular (side) effects. Ditans, here defined as selective 5-HT1F receptor agonists, were developed on the basis that most of the triptans activate trigeminal 5-HT1F receptors, which may explain part of the triptans' antimigraine action.", "label": 1, "is_selected": 0, "text": "Migraine is a neurovascular disorder that involves activation of the trigeminovascular system and cranial vasodilation mediated by release of calcitonin gene-related peptide (CGRP). The gold standard for acute migraine treatment are the triptans, 5-HT1B/1D/(1F) receptor agonists. Their actions are thought to be mediated through activation of: (i) 5-HT1B receptors in cranial blood vessels with subsequent cranial vasoconstriction; (ii) prejunctional 5-HT1D receptors on trigeminal fibers that inhibit trigeminal CGRP release; and (iii) 5-HT1B/1D/1F receptors in central nervous system involved in (anti)nociceptive modulation. Unfortunately, coronary arteries also express 5-HT1B receptors whose activation would produce coronary vasoconstriction; hence, triptans are contraindicated in patients with cardiovascular disease. In addition, since migraineurs have an increased cardiovascular risk, it is important to develop antimigraine drugs devoid of vascular (side) effects. Ditans, here defined as selective 5-HT1F receptor agonists, were developed on the basis that most of the triptans activate trigeminal 5-HT1F receptors, which may explain part of the triptans' antimigraine action."}
{"qid": "5e324167fbd6abf43b00005a", "original_text": "Children treated with cranial radiotherapy (CRT) for leukemia are at risk of developing central nervous system injuries. Magnetic resonance imaging (MRI) represents the examination method of choice for evaluating radiation-induced brain complications. The purpose of this report is to describe the spectrum of MRI abnormalities detected in a group of survivors of leukemia treated with cranial irradiation. In this cross-sectional, single center study, 56 patients (median age at follow-up 19 years) receiving CRT as cranial prophylaxis (CP) included in the leukemia protocol (total dose 1,800-2,400 cGy) and/or in the total body irradiation regimen (990-1,200 cGy) before hematopoietic stem cell transplant, were evaluated by MRI after a median interval of 11 years (range 2-27) following CRT.", "label": 1, "is_selected": 0, "text": "Children treated with cranial radiotherapy (CRT) for leukemia are at risk of developing central nervous system injuries. Magnetic resonance imaging (MRI) represents the examination method of choice for evaluating radiation-induced brain complications. The purpose of this report is to describe the spectrum of MRI abnormalities detected in a group of survivors of leukemia treated with cranial irradiation. In this cross-sectional, single center study, 56 patients (median age at follow-up 19 years) receiving CRT as cranial prophylaxis (CP) included in the leukemia protocol (total dose 1,800-2,400 cGy) and/or in the total body irradiation regimen (990-1,200 cGy) before hematopoietic stem cell transplant, were evaluated by MRI after a median interval of 11 years (range 2-27) following CRT."}
{"qid": "5e8101e3835f4e477700002e", "original_text": "Yes, cathepsin L is active in endosomes. Cathepsin L is a lysosomal cysteine protease that is involved in the degradation of various proteins in the endosomal-lysosomal system. Endosomes are membrane-bound compartments that play a crucial role in the sorting and degradation of proteins and other molecules within cells. Studies have shown that cathepsin L is actively secreted from the rough endoplasmic reticulum (ER) and is transported to the endosomes, where it can degrade a variety of substrates, including proteins, lipids, and polysaccharides. Once inside the endosomes, cathepsin L can access its substrates and degrade them through its lytic activity. Overall, the presence of cathepsin L in endosomes suggests that this enzyme plays an important role in regulating the degradation of proteins and other molecules in these compartments, which is crucial for the proper functioning of cells.", "label": 0, "is_selected": 0, "text": "Yes, cathepsin L is active in endosomes. Cathepsin L is a lysosomal cysteine protease that is involved in the degradation of various proteins in the endosomal-lysosomal system. Endosomes are membrane-bound compartments that play a crucial role in the sorting and degradation of proteins and other molecules within cells. Studies have shown that cathepsin L is actively secreted from the rough endoplasmic reticulum (ER) and is transported to the endosomes, where it can degrade a variety of substrates, including proteins, lipids, and polysaccharides. Once inside the endosomes, cathepsin L can access its substrates and degrade them through its lytic activity. Overall, the presence of cathepsin L in endosomes suggests that this enzyme plays an important role in regulating the degradation of proteins and other molecules in these compartments, which is crucial for the proper functioning of cells."}
{"qid": "5363bad27d100faa0900000e", "original_text": "Malat1 is an abundant long, noncoding RNA that localizes to nuclear bodies known as nuclear speckles, which contain a distinct set of pre-mRNA processing factors. Previous studies in cell culture have demonstrated that Malat1 interacts with pre-mRNA splicing factors, including the serine- and arginine-rich (SR) family of proteins, and regulates a variety of biological processes, including cancer cell migration, synapse formation, cell cycle progression, and responses to serum stimulation. To address the physiological function of Malat1 in a living organism, we generated Malat1-knockout (KO) mice using homologous recombination. Unexpectedly, the Malat1-KO mice were viable and fertile, showing no apparent phenotypes. Nuclear speckle markers were also correctly localized in cells that lacked Malat1. However, the cellular levels of another long, noncoding RNA--Neat1--which is an architectural component of nuclear bodies known as paraspeckles, were down-regulated in a particular set of tissues and cells lacking Malat1. We propose that Malat1 is not essential in living mice maintained under normal laboratory conditions and that its function becomes apparent only in specific cell types and under particular conditions.", "label": 1, "is_selected": 0, "text": "Malat1 is an abundant long, noncoding RNA that localizes to nuclear bodies known as nuclear speckles, which contain a distinct set of pre-mRNA processing factors. Previous studies in cell culture have demonstrated that Malat1 interacts with pre-mRNA splicing factors, including the serine- and arginine-rich (SR) family of proteins, and regulates a variety of biological processes, including cancer cell migration, synapse formation, cell cycle progression, and responses to serum stimulation. To address the physiological function of Malat1 in a living organism, we generated Malat1-knockout (KO) mice using homologous recombination. Unexpectedly, the Malat1-KO mice were viable and fertile, showing no apparent phenotypes. Nuclear speckle markers were also correctly localized in cells that lacked Malat1. However, the cellular levels of another long, noncoding RNA--Neat1--which is an architectural component of nuclear bodies known as paraspeckles, were down-regulated in a particular set of tissues and cells lacking Malat1. We propose that Malat1 is not essential in living mice maintained under normal laboratory conditions and that its function becomes apparent only in specific cell types and under particular conditions."}
{"qid": "606a232a94d57fd87900004c", "original_text": "Yes, metoprolol is metabolized by CYP2D6. CYP2D6 is an enzyme that is responsible for metabolizing a wide range of drugs, including beta blockers like metoprolol. Studies have shown that approximately 30-40% of metoprolol is metabolized by CYP2D6, while the remaining 60-70% is metabolized by other enzymes, such as CYP3A4. CYP2D6 is an important enzyme in the metabolism of many drugs, including those used to treat cardiovascular disease, depression, and anxiety. Variants of the CYP2D6 gene can affect an individual's ability to metabolize drugs, including metoprolol, and may result in altered drug response or toxicity. Therefore, it is important to consider CYP2D6 genotype when prescribing drugs that are metabolized by this enzyme, including metoprolol.", "label": 0, "is_selected": 0, "text": "Yes, metoprolol is metabolized by CYP2D6. CYP2D6 is an enzyme that is responsible for metabolizing a wide range of drugs, including beta blockers like metoprolol. Studies have shown that approximately 30-40% of metoprolol is metabolized by CYP2D6, while the remaining 60-70% is metabolized by other enzymes, such as CYP3A4. CYP2D6 is an important enzyme in the metabolism of many drugs, including those used to treat cardiovascular disease, depression, and anxiety. Variants of the CYP2D6 gene can affect an individual's ability to metabolize drugs, including metoprolol, and may result in altered drug response or toxicity. Therefore, it is important to consider CYP2D6 genotype when prescribing drugs that are metabolized by this enzyme, including metoprolol."}
{"qid": "530cf4fe960c95ad0c000002", "original_text": "We have previously reported that apolipoprotein E (apoE), a protein component of very-low-density lipoproteins (VLDL) and high-density lipoproteins and a potent plasma-borne atheroprotective factor, exerts anti-inflammatory activity in macrophages by switching the activation profile from M1 (\"classic\") to M2 (\"alternative\") in a process involving signaling via low-density lipoprotein receptor (LDLR) family members including the VLDL receptor (VLDLR) or apoE receptor-2 (apoER2). The present study was undertaken to investigate whether LDLR-related protein 1 (LRP-1), another member of the LDLR family and a ubiquitously expressed multifunctional cell surface receptor, modulates M1\u2192M2 conversion in murine macrophages. We investigate bone marrow or peritoneal macrophages isolated from wild-type C57/Bl6 mice or mice with conditional inactivation of the LRP-1 gene in the myeloid lineage for the expression of polarization markers.", "label": 1, "is_selected": 0, "text": "We have previously reported that apolipoprotein E (apoE), a protein component of very-low-density lipoproteins (VLDL) and high-density lipoproteins and a potent plasma-borne atheroprotective factor, exerts anti-inflammatory activity in macrophages by switching the activation profile from M1 (\"classic\") to M2 (\"alternative\") in a process involving signaling via low-density lipoprotein receptor (LDLR) family members including the VLDL receptor (VLDLR) or apoE receptor-2 (apoER2). The present study was undertaken to investigate whether LDLR-related protein 1 (LRP-1), another member of the LDLR family and a ubiquitously expressed multifunctional cell surface receptor, modulates M1\u2192M2 conversion in murine macrophages. We investigate bone marrow or peritoneal macrophages isolated from wild-type C57/Bl6 mice or mice with conditional inactivation of the LRP-1 gene in the myeloid lineage for the expression of polarization markers."}
{"qid": "58967c9978275d0c4a000011", "original_text": "The role of Ataxia-telangiectasia mutated (ATM) in response to DNA damage has previously been studied, but its underlying mechanisms specific to ionizing radiation (IR) have remained to be elucidated. In this study, function of ATM on radiation-induced cell death in lung cancer H1299 cells was analysed. Human lung cancer cells, H1299, were used, and cell models with ATM(-/-) and MAPK14(-/-) were established by genetic engineering.", "label": 1, "is_selected": 0, "text": "The role of Ataxia-telangiectasia mutated (ATM) in response to DNA damage has previously been studied, but its underlying mechanisms specific to ionizing radiation (IR) have remained to be elucidated. In this study, function of ATM on radiation-induced cell death in lung cancer H1299 cells was analysed. Human lung cancer cells, H1299, were used, and cell models with ATM(-/-) and MAPK14(-/-) were established by genetic engineering."}
{"qid": "5a7339372dc08e987e000013", "original_text": "Vosevi is a polypill that combines four drugs to treat high blood pressure (hypertension) and high cholesterol. The four drugs included in Vosevi are: 1. Efonolimumab: an interleukin-6 inhibitor that reduces inflammation and improves cardiovascular outcomes. 2. Aspirin: a nonsteroidal anti-inflammatory drug (NSAID) that reduces platelet aggregation and prevents blood clots. 3. Lisocilinium: a calcium channel blocker that relaxes blood vessels and improves blood flow. 4. Ibudilast: an anti-inflammatory drug that reduces inflammation and improves lung function in people with chronic obstructive pulmonary disease (COPD). By combining these four drugs in a single pill, Vosevi simplifies treatment and improves adherence, which can lead to better cardiovascular health outcomes. However, it's important to note that Vosevi is indicated for use in certain patients, such as those with severe hypertension or high cholesterol and multiple cardiovascular risk factors, and it's not suitable for everyone. Always consult with a healthcare professional before starting any new medication.", "label": 0, "is_selected": 1, "text": "The US Food and Drug Administration (FDA) has approved Vosevi (ezetimibe) tablets for the treatment of high blood pressure and high cholesterol in adults with at least one risk factor for heart disease, such as obesity, type 2 diabetes or high cholesterol, or who are at high risk for heart attack, stroke or who have recently had a heart attack or stroke. By combining these four drugs in a single pill, Vosevi simplifies treatment and improves adherence, which can lead to better cardiovascular health outcomes."}
{"qid": "5178444e8ed59a060a000037", "original_text": "Studies on human papillomavirus type 16 have demonstrated that the product of the early gene, E7, plays a key role in the immortalization and malignant transformation of the host cell. Several of the biological activities of HPV16 E7 are mediated by inactivation of the members of the pocket protein family, pRb, p107 and p130. In this study, we have characterized the in vitro properties of five E7 proteins from benign and malignant HPV types (10, 32, 48, 54, 77). We show that these E7 proteins associate with pRb and p107 with different efficiencies. All E7s increased the proliferative rate of immortalized rodent fibroblasts cultured in 10% calf serum containing medium.", "label": 1, "is_selected": 0, "text": "Studies on human papillomavirus type 16 have demonstrated that the product of the early gene, E7, plays a key role in the immortalization and malignant transformation of the host cell. Several of the biological activities of HPV16 E7 are mediated by inactivation of the members of the pocket protein family, pRb, p107 and p130. In this study, we have characterized the in vitro properties of five E7 proteins from benign and malignant HPV types (10, 32, 48, 54, 77). We show that these E7 proteins associate with pRb and p107 with different efficiencies. All E7s increased the proliferative rate of immortalized rodent fibroblasts cultured in 10% calf serum containing medium."}
{"qid": "56c1f039ef6e394741000052", "original_text": "Bickerstaff's brainstem encephalitis is an autoimmune disorder that is characterized by the production of antibodies against the Glycoprotein IIb/IIIa complex (GPIIb/IIIa) on platelets. The main antibody implicated in this condition is anti-GPIIb/IIIa. This antibody can cause platelet aggregation and activation, leading to a range of neurological symptoms including weakness, vertigo, and ophthalmoplegia.", "label": 0, "is_selected": 1, "text": "The European Medicines Agency (EMA) has granted orphan drug status for Bickerstaff's brainstem encephalitis in patients with a history of multiple organ transplantation and who are intolerant to anti-GPIIb/IIIa antibodies."}
{"qid": "61fbc3d5c9dfcb9c0900000e", "original_text": "Saxagliptin/dapagliflozin fixed-dose combination tablets (Qtern\u00ae) are indicated in the EU for the improvement of glycaemic control in adults with type 2 diabetes mellitus (T2DM), either when treatment with metformin and/or a sulfonylurea plus a monocomponent of saxagliptin/dapagliflozin provides inadequate glycaemic control, or when the patient is already being treated with the free combination of saxagliptin + dapagliflozin. This narrative review summarizes pharmacological, efficacy and tolerability data relevant to the use of saxagliptin/dapagliflozin in this indication.", "label": 1, "is_selected": 0, "text": "Saxagliptin/dapagliflozin fixed-dose combination tablets (Qtern\u00ae) are indicated in the EU for the improvement of glycaemic control in adults with type 2 diabetes mellitus (T2DM), either when treatment with metformin and/or a sulfonylurea plus a monocomponent of saxagliptin/dapagliflozin provides inadequate glycaemic control, or when the patient is already being treated with the free combination of saxagliptin + dapagliflozin. This narrative review summarizes pharmacological, efficacy and tolerability data relevant to the use of saxagliptin/dapagliflozin in this indication."}
{"qid": "5c58a0e486df2b917400000c", "original_text": "Ivosidenib is an AGO-013877, a potent and selective IDH1 inhibitor. The mechanism of action of Ivosidenib involves inhibition of the enzyme IDH1, which is mutated in various cancers, including AML, MDS, and glioma. Inhibition of IDH1 leads to the degradation of the critical cellular metabolite 2-hydroxyglutarate (2HG), resulting in the inhibition of cell proliferation, induction of apoptosis, and reduction of tumor cell migration.", "label": 0, "is_selected": 1, "text": "Ivosidenib is being developed for the treatment of acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) by bluebird bio, a bluebird bio company, in collaboration with the University of California, Los Angeles (UCLA)."}
{"qid": "622b9d593a8413c653000095", "original_text": "The Gleason pattern or Gleason Score is associated with the prostate gland, specifically with the tissue sampled during a prostate biopsy. The Gleason system is a grading system used to classify the severity of prostate cancer based on the appearance of the tumor cells under a microscope. The Gleason pattern refers to the specific arrangement of the tumor cells, which are graded on a scale of 2-5, with higher numbers indicating more aggressive cancer. The Gleason Score is a combination of the two most prominent patterns observed in the tissue sample, with a range of 2-10. The higher the Gleason Score, the more aggressive the cancer is likely to be.", "label": 0, "is_selected": 1, "text": "The Gleason pattern is one of the most commonly used cancer classification systems in prostate cancer treatment, according to the American Urological Association (AUA) and the Prostate Cancer Foundation (PCF). The Gleason system is a grading system used to classify the severity of prostate cancer based on the appearance of the tumor cells under a microscope."}
{"qid": "514b335dd24251bc05000061", "original_text": "An ischemic penumbra has the potential for functional recovery provided that local blood flow can be reestablished, but irreversible damage will develop without sufficient reperfusion, depending on the interaction of severity and duration of ischemia. With acute flows below the threshold required for maintenance of basic housekeeping, injury in the core is established within a few minutes. During the subacute phase, the irreversible damage expands into the penumbra: multiple electrical and biological signals are triggered by periinfarct, spreading depression-like depolarizations leading to hypoxia and stepwise increase in lactate. Usually within 6 to 8 hours, all the penumbra are converted into irreversible infarcts.", "label": 1, "is_selected": 0, "text": "An ischemic penumbra has the potential for functional recovery provided that local blood flow can be reestablished, but irreversible damage will develop without sufficient reperfusion, depending on the interaction of severity and duration of ischemia. With acute flows below the threshold required for maintenance of basic housekeeping, injury in the core is established within a few minutes. During the subacute phase, the irreversible damage expands into the penumbra: multiple electrical and biological signals are triggered by periinfarct, spreading depression-like depolarizations leading to hypoxia and stepwise increase in lactate. Usually within 6 to 8 hours, all the penumbra are converted into irreversible infarcts."}
{"qid": "52e92c6e98d0239505000024", "original_text": "The Mitchell-Riley syndrome is a rare genetic disorder that affects the development of the nervous system and other organs. It is caused by mutations in the CHRNA7 gene, which codes for the alpha-7 nicotinic acetylcholine receptor subunit. This receptor is involved in the transmission of signals in the nervous system, particularly in the brain and spinal cord. The mutations leading to the Mitchell-Riley syndrome result in the failure of the nicotinic acetylcholine receptors to function properly, leading to a range of symptoms including neonatal hyperexcitability, seizures, developmental delay, and intellectual disability. The exact prevalence of the Mitchell-Riley syndrome is not well established, as it is a rare disorder, but it is believed to affect approximately 1 in 100,000 to 1 in 50,000 individuals worldwide.", "label": 0, "is_selected": 0, "text": "The Mitchell-Riley syndrome is a rare genetic disorder that affects the development of the nervous system and other organs. It is caused by mutations in the CHRNA7 gene, which codes for the alpha-7 nicotinic acetylcholine receptor subunit. This receptor is involved in the transmission of signals in the nervous system, particularly in the brain and spinal cord. The mutations leading to the Mitchell-Riley syndrome result in the failure of the nicotinic acetylcholine receptors to function properly, leading to a range of symptoms including neonatal hyperexcitability, seizures, developmental delay, and intellectual disability. The exact prevalence of the Mitchell-Riley syndrome is not well established, as it is a rare disorder, but it is believed to affect approximately 1 in 100,000 to 1 in 50,000 individuals worldwide."}
{"qid": "56cdf5315795f9a73e000046", "original_text": "XRN1 is a 5' \u2192 3' processive exoribonuclease that degrades mRNAs after they have been decapped. It is highly conserved in all eukaryotes, including homologs in Drosophila melanogaster (Pacman), Caenorhabditis elegans (XRN1), and Saccharomyces cerevisiae (Xrn1p). As well as being a key enzyme in RNA turnover, XRN1 is involved in nonsense-mediated mRNA decay and degradation of mRNAs after they have been targeted by small interfering RNAs or microRNAs. The crystal structure of XRN1 can explain its processivity and also the selectivity of the enzyme for 5' monophosphorylated RNA.", "label": 1, "is_selected": 0, "text": "XRN1 is a 5' \u2192 3' processive exoribonuclease that degrades mRNAs after they have been decapped. It is highly conserved in all eukaryotes, including homologs in Drosophila melanogaster (Pacman), Caenorhabditis elegans (XRN1), and Saccharomyces cerevisiae (Xrn1p). As well as being a key enzyme in RNA turnover, XRN1 is involved in nonsense-mediated mRNA decay and degradation of mRNAs after they have been targeted by small interfering RNAs or microRNAs. The crystal structure of XRN1 can explain its processivity and also the selectivity of the enzyme for 5' monophosphorylated RNA."}
{"qid": "5fe3131fa43ad3127800004a", "original_text": "TGF-\u03b2 (Transforming Growth Factor Beta) is the primary cytokine that activates SMADs (Smad proteins). TGF-\u03b2 binds to specific receptors on the surface of cells, leading to the activation of SMAD proteins, which then translocate to the nucleus where they regulate gene expression. SMAD1, SMAD2, and SMAD3 are the primary SMAD proteins involved in TGF-\u03b2 signaling. These proteins form heterodimers with other proteins and play critical roles in regulating cell growth, differentiation, and survival.", "label": 0, "is_selected": 0, "text": "TGF-\u03b2 (Transforming Growth Factor Beta) is the primary cytokine that activates SMADs (Smad proteins). TGF-\u03b2 binds to specific receptors on the surface of cells, leading to the activation of SMAD proteins, which then translocate to the nucleus where they regulate gene expression. SMAD1, SMAD2, and SMAD3 are the primary SMAD proteins involved in TGF-\u03b2 signaling. These proteins form heterodimers with other proteins and play critical roles in regulating cell growth, differentiation, and survival."}
{"qid": "5e4b64516d0a277941000029", "original_text": "Semagacestat is a drugs that has been studied for the treament of Alzheimer's disease, but it's effectiveness for this indication is still uncertain. Several clinical trials have been conducted to evaluate the safety and efficacy of semagacestat in Alzheimer's disease, but the results have been inconsistent. One Phase III clinical trial published in the New England Journal of Medicine in 2013 found that semagacestat did not significantly improve cognitive function in patients with mild to moderate Alzheimer's disease compared to placebo. Additionally, the drug was associated with an increased risk of adverse effects, including muscle weakness, joint pain, and liver damage. The U.S. Food and Drug Administration (FDA) has not approved semagacestat for the treatment of Alzheimer's disease, and the drug's manufacturer has not continued to develop it for this indication. Therefore, while there is some evidence to suggest that semagacestat may be effective for Alzheimer's disease, further research is needed to confirm its safety and efficacy. In summary, while semagacestat has been studied for the treatment of Alzheimer's disease, its effectiveness is still uncertain due to inconsistent results from clinical trials. Further research is needed to determine the drug's safety and efficacy for this indication.", "label": 0, "is_selected": 1, "text": "Semagacestat is a drug that has been studied for the treament of Alzheimer's disease, but it's effectiveness for this indication is still uncertain, and further research is needed to confirm its safety and efficacy, according to a study published in the New England Journal of Medicine in 2013 and found to be associated with an increased risk of adverse effects, including muscle weakness, joint pain, and liver damage, as well as a lack of improvement in cognitive function, in patients with mild to moderate Alzheimers disease compared to placebo."}
{"qid": "56f1547c2ac5ed1459000010", "original_text": "Sequence-specific control of gene expression on a genome-wide scale is an important approach for understanding gene functions and for engineering genetic regulatory systems. We have recently described an RNA-based method, CRISPR interference (CRISPRi), for targeted silencing of transcription in bacteria and human cells. The CRISPRi system is derived from the Streptococcus pyogenes CRISPR (clustered regularly interspaced palindromic repeats) pathway, requiring only the coexpression of a catalytically inactive Cas9 protein and a customizable single guide RNA (sgRNA). The Cas9-sgRNA complex binds to DNA elements complementary to the sgRNA and causes a steric block that halts transcript elongation by RNA polymerase, resulting in the repression of the target gene.", "label": 1, "is_selected": 0, "text": "Sequence-specific control of gene expression on a genome-wide scale is an important approach for understanding gene functions and for engineering genetic regulatory systems. We have recently described an RNA-based method, CRISPR interference (CRISPRi), for targeted silencing of transcription in bacteria and human cells. The CRISPRi system is derived from the Streptococcus pyogenes CRISPR (clustered regularly interspaced palindromic repeats) pathway, requiring only the coexpression of a catalytically inactive Cas9 protein and a customizable single guide RNA (sgRNA). The Cas9-sgRNA complex binds to DNA elements complementary to the sgRNA and causes a steric block that halts transcript elongation by RNA polymerase, resulting in the repression of the target gene."}
{"qid": "626aea6ae764a5320400003d", "original_text": "Waylivra is a prescription medication used to treat a rare genetic disorder called hereditary angioedema (HAE). It is an antibody that blocks the bradykinin B2 receptor, which is involved in the inflammation and swelling associated with HAE. By blocking the B2 receptor, Waylivra helps to reduce the severity and frequency of HAE attacks. It is given by injection and is usually taken every few months to maintain a consistent level of protection.", "label": 0, "is_selected": 1, "text": "Waylivra is a prescription medication used to treat a rare genetic disorder called hereditary angioedema (HAE), which is a condition in which the body's immune system attacks healthy tissue in the bone marrow, causing it to swell and flake away."}
{"qid": "5a679875b750ff4455000004", "original_text": "The antibacterial activities of 18 plants from 10 different families were investigated for their antimicrobial efficacy, based on the traditional uses of these species by Bakola pygmies living in Central Africa, especially along the Ngoyang area in Cameroon for the treatment of respiratory and tuberculosis-related symptoms. The aim of the study is to test the antimicrobial efficacy of these plants against some pathogens associated with respiratory disease and to determine if there is any validation for the traditional use against Mycobacterium species.", "label": 1, "is_selected": 0, "text": "The antibacterial activities of 18 plants from 10 different families were investigated for their antimicrobial efficacy, based on the traditional uses of these species by Bakola pygmies living in Central Africa, especially along the Ngoyang area in Cameroon for the treatment of respiratory and tuberculosis-related symptoms. The aim of the study is to test the antimicrobial efficacy of these plants against some pathogens associated with respiratory disease and to determine if there is any validation for the traditional use against Mycobacterium species."}
{"qid": "5e2deb35fbd6abf43b00001c", "original_text": "Cap analysis of gene expression (CAGE) is a methodology for genome-wide quantitative mapping of mRNA 5' ends to precisely capture transcription start sites at a single nucleotide resolution. In combination with high-throughput sequencing, CAGE has revolutionized our understanding of the rules of transcription initiation, led to discovery of new core promoter sequence features, and discovered transcription initiation at enhancers genome-wide. The biggest limitation of CAGE is that even the most recently improved version (nAnT-iCAGE) still requires large amounts of total cellular RNA (5 \u00b5g), preventing its application to scarce biological samples such as those from early embryonic development or rare cell types.", "label": 1, "is_selected": 0, "text": "Cap analysis of gene expression (CAGE) is a methodology for genome-wide quantitative mapping of mRNA 5' ends to precisely capture transcription start sites at a single nucleotide resolution. In combination with high-throughput sequencing, CAGE has revolutionized our understanding of the rules of transcription initiation, led to discovery of new core promoter sequence features, and discovered transcription initiation at enhancers genome-wide. The biggest limitation of CAGE is that even the most recently improved version (nAnT-iCAGE) still requires large amounts of total cellular RNA (5 \u00b5g), preventing its application to scarce biological samples such as those from early embryonic development or rare cell types."}
{"qid": "51631154298dcd4e5100004e", "original_text": "Bortezomib, a proteasome inhibitor drug very effective against multiple myeloma, may induce the so-called bortezomib-induced peripheral neuropathy (BIPN), hardly manageable with common analgesic drugs. This study assessed the effectiveness of controlled-release (CR) oral oxycodone in controlling pain and its interference on daily functions of patients with hematologic malignancies affected by BIPN. Forty-six patients (median age, 62 years) affected by myeloma and lymphoma, complaining of BIPN-related pain of moderate-to-severe intensity and unresponsive to previous analgesic treatments, were treated with CR oxycodone.", "label": 1, "is_selected": 0, "text": "Bortezomib, a proteasome inhibitor drug very effective against multiple myeloma, may induce the so-called bortezomib-induced peripheral neuropathy (BIPN), hardly manageable with common analgesic drugs. This study assessed the effectiveness of controlled-release (CR) oral oxycodone in controlling pain and its interference on daily functions of patients with hematologic malignancies affected by BIPN. Forty-six patients (median age, 62 years) affected by myeloma and lymphoma, complaining of BIPN-related pain of moderate-to-severe intensity and unresponsive to previous analgesic treatments, were treated with CR oxycodone."}
{"qid": "530f685c329f5fcf1e000002", "original_text": "Borna disease virus (BDV) replicates in brain cells. The neonatally infected rat with BDV exhibits developmental-neuromorphological abnormalities, neuronal cytolysis, and multiple behavioral and physiological alterations. Here, we report on the levels of interleukin-1beta (IL-1beta), IL-1 receptor antagonist (IL-1Ra), tumor necrosis factor-alpha (TNF-alpha), transforming growth factor-beta1 (TGF-beta1), IL-1 receptor type I (IL-1RI), IL-1 receptor accessory protein (IL-1R AcP) I and II, glycoprotein 130, and various neuropeptide mRNAs in the cerebellum, parieto-frontal cortex, hippocampus and hypothalamus of BDV-infected rats at 7 and 28 days postintracerebral BDV inoculation. The data show that cytokine and neuropeptide mRNA components are abnormal and differentially modulated in brain regions. IL-1beta, TNF-alpha and TGF-beta1 mRNA levels were up-regulated in all brain regions following BDV inoculation. The same cerebellar samples from BDV-infected animals exhibited the highest levels of IL-1beta, IL-1Ra, TNF-alpha, IL-1RI, and IL-1R AcP II mRNA expression. The profiles of IL-1beta, IL-1Ra, TNF-alpha, and TGF-beta1 mRNA induction in the cerebellar samples were highly intercorrelated, indicating an association among cytokine ligand mRNAs.", "label": 1, "is_selected": 0, "text": "Borna disease virus (BDV) replicates in brain cells. The neonatally infected rat with BDV exhibits developmental-neuromorphological abnormalities, neuronal cytolysis, and multiple behavioral and physiological alterations. Here, we report on the levels of interleukin-1beta (IL-1beta), IL-1 receptor antagonist (IL-1Ra), tumor necrosis factor-alpha (TNF-alpha), transforming growth factor-beta1 (TGF-beta1), IL-1 receptor type I (IL-1RI), IL-1 receptor accessory protein (IL-1R AcP) I and II, glycoprotein 130, and various neuropeptide mRNAs in the cerebellum, parieto-frontal cortex, hippocampus and hypothalamus of BDV-infected rats at 7 and 28 days postintracerebral BDV inoculation. The data show that cytokine and neuropeptide mRNA components are abnormal and differentially modulated in brain regions. IL-1beta, TNF-alpha and TGF-beta1 mRNA levels were up-regulated in all brain regions following BDV inoculation. The same cerebellar samples from BDV-infected animals exhibited the highest levels of IL-1beta, IL-1Ra, TNF-alpha, IL-1RI, and IL-1R AcP II mRNA expression. The profiles of IL-1beta, IL-1Ra, TNF-alpha, and TGF-beta1 mRNA induction in the cerebellar samples were highly intercorrelated, indicating an association among cytokine ligand mRNAs."}
{"qid": "57220e400fd6f91b68000015", "original_text": "Lambert-Eaton Myasthenic Syndrome (LEMS) is a rare autoimmune disorder that affects the nervous system and causes muscle weakness. The most common symptoms of LEMS include progressive muscle weakness, fatigue, and muscle cramps, primarily affecting the eyelids, face, and limbs. Other symptoms may include difficulty with swallowing, slurred speech, and respiratory failure. LEMS can also cause autonomic dysfunction, leading to symptoms such as constipation, urinary retention, and abnormal heart rate. It is important to note that the symptoms of LEMS can vary in severity and may progress over time.", "label": 0, "is_selected": 1, "text": "The Lambert-Eaton Myasthenic Syndrome (LEMS) is a rare autoimmune disorder that affects the nervous system and causes muscle weakness and weakness in the face, arms, legs, and arms.<n> Is there a drug that can treat Lambert-eater myasthenia gravis?"}
{"qid": "518cb513310faafe08000007", "original_text": "We describe the effects of iopanoic acid on daily levels of free triiodothyronine (FT(3)) and free thyroxine (FT(4)) in a patient with progressive type II amiodarone-induced thyrotoxicosis (AIT) who was undergoing thyroidectomy. The patient was a 59-year-old man who was undergoing amiodarone therapy while awaiting cardiac transplantation; the use of beta blockers and corticosteroids to control the AIT was contraindicated in this patient. Prior to thyroidectomy, the patient was started on iopanoic acid at 1.0 g twice a day; in response to gastrointestinal side effects, the dosage was subsequently reduced to 0.5 g twice a day. The patient responded to iopanoic acid with a rapid decrease in his FT(3) level and slight increase in his FT(4) level. This control of thyrotoxicosis allowed for an uneventful thyroidectomy, which was later followed by successful cardiac transplantation. Based on our findings in this single case, we believe that iopanoic can be used to rapidly lower FT(3) levels and to treat symptoms of thyrotoxicosis in a preoperative setting. We also discuss the different pharmacodynamic effects that iopanoic acid has on FT(3) and FT(4) levels.", "label": 1, "is_selected": 0, "text": "We describe the effects of iopanoic acid on daily levels of free triiodothyronine (FT(3)) and free thyroxine (FT(4)) in a patient with progressive type II amiodarone-induced thyrotoxicosis (AIT) who was undergoing thyroidectomy. The patient was a 59-year-old man who was undergoing amiodarone therapy while awaiting cardiac transplantation; the use of beta blockers and corticosteroids to control the AIT was contraindicated in this patient. Prior to thyroidectomy, the patient was started on iopanoic acid at 1.0 g twice a day; in response to gastrointestinal side effects, the dosage was subsequently reduced to 0.5 g twice a day. The patient responded to iopanoic acid with a rapid decrease in his FT(3) level and slight increase in his FT(4) level. This control of thyrotoxicosis allowed for an uneventful thyroidectomy, which was later followed by successful cardiac transplantation. Based on our findings in this single case, we believe that iopanoic can be used to rapidly lower FT(3) levels and to treat symptoms of thyrotoxicosis in a preoperative setting. We also discuss the different pharmacodynamic effects that iopanoic acid has on FT(3) and FT(4) levels."}
{"qid": "60490e321cb411341a000168", "original_text": "PYHIN proteins are a family of proteins that play a crucial role in regulating various cellular processes, including cell adhesion, migration, and differentiation. There are currently six identified members of the PYHIN protein family: PYHIN1-PYHIN6. These proteins are characterized by the presence of a PYHIN domain, which is a conserved protein module that contains a PYMN (Pyrin/Pycard/Munc13-like) domain and a coiled-coil motif. Studies have shown that PYHIN proteins are involved in the regulation of several cellular processes, including cell adhesion, migration, and differentiation. PYHIN1 and PYHIN2 have been implicated in the regulation of cell adhesion and migration, while PYHIN3 and PYHIN4 have been shown to play a role in the regulation of cell differentiation. PYHIN5 has been identified as a potential oncogene, and PYHIN6 has been implicated in the regulation of cell growth and proliferation. Several studies have also suggested that PYHIN proteins may play a role in the pathogenesis of various diseases, including cancer and neurological disorders. For example, PYHIN1 has been shown to be overexpressed in various types of cancer, including breast, lung, and colon cancer, and has been implicated in the regulation of cancer cell migration and invasion. Similarly, PYHIN2 has been implicated in the regulation of cancer cell adhesion and migration. Overall, while more research is needed to fully understand the functions of the PYHIN proteins and their role in disease pathogenesis, the available evidence suggests that these proteins play a crucial role in regulating cellular processes and may be involved in a variety of diseases.", "label": 0, "is_selected": 1, "text": "PYHIN proteins are a family of proteins that play a crucial role in regulating various cellular processes, including cell adhesion, migration, and differentiation, and may play a role in a variety of diseases, including cancer and neurological disorders, and are characterized by the presence of a PYHIN domain, which is a conserved protein module that contains a PYMN (Pyrin/Pycard/Munc13-like) domain and a coiled-coil motif, and has been implicated in the regulation of several cellular processes and may be involved in diseases, such as cancer and neurodegenerative disorders, including Parkinson's disease and motor neurone disease."}
{"qid": "58cd7fed02b8c6095300003f", "original_text": "The calcium-sensing receptor (CaSR) plays a pivotal role in systemic calcium metabolism by regulating parathyroid hormone secretion and urinary calcium excretion. The CaSR is ubiquitously expressed, implying a wide range of functions regulated by this receptor. Abnormal CaSR function affects the development of both calciotropic disorders such as hyperparathyroidism, and non-calciotropic disorders such as cardiovascular disease and cancer, which are the leading causes of mortality worldwide. The CaSR is able to bind a plethora of ligands; it interacts with multiple G protein subtypes, and regulates highly divergent downstream signalling pathways, depending on the cellular context.", "label": 1, "is_selected": 0, "text": "The calcium-sensing receptor (CaSR) plays a pivotal role in systemic calcium metabolism by regulating parathyroid hormone secretion and urinary calcium excretion. The CaSR is ubiquitously expressed, implying a wide range of functions regulated by this receptor. Abnormal CaSR function affects the development of both calciotropic disorders such as hyperparathyroidism, and non-calciotropic disorders such as cardiovascular disease and cancer, which are the leading causes of mortality worldwide. The CaSR is able to bind a plethora of ligands; it interacts with multiple G protein subtypes, and regulates highly divergent downstream signalling pathways, depending on the cellular context."}
{"qid": "620be7613a8413c653000003", "original_text": "RNA provides the framework for the assembly of some of the most intricate macromolecular complexes within the cell, including the spliceosome and the mature ribosome. The assembly of these complexes relies on the coordinated association of RNA with hundreds of trans-acting protein factors. While some of these trans-acting factors are RNA-binding proteins (RBPs), others are adaptor proteins, and others still, function as both. Defects in the assembly of these complexes results in a number of human pathologies including neurodegeneration and cancer.", "label": 1, "is_selected": 0, "text": "RNA provides the framework for the assembly of some of the most intricate macromolecular complexes within the cell, including the spliceosome and the mature ribosome. The assembly of these complexes relies on the coordinated association of RNA with hundreds of trans-acting protein factors. While some of these trans-acting factors are RNA-binding proteins (RBPs), others are adaptor proteins, and others still, function as both. Defects in the assembly of these complexes results in a number of human pathologies including neurodegeneration and cancer."}
{"qid": "530cf4fe960c95ad0c00000a", "original_text": "Zolpidem is a short-acting imidazopyridine hypnotic drug that is metabolized mainly by CYP3A4. Rifampin (INN, rifampicin) is a potent inducer of many cytochrome P450 enzymes, and it greatly reduces the plasma concentrations and effects of, for example, midazolam, triazolam, and zopiclone. In this study, the effects of rifampin on the pharmacokinetics and pharmacodynamics of zolpidem were studied. In a randomized crossover study with two phases and a washout of 4 weeks, eight young healthy female volunteers took either 600 mg rifampin or placebo once a day for 5 days. On day 6, 20 mg zolpidem was administered orally.", "label": 1, "is_selected": 0, "text": "Zolpidem is a short-acting imidazopyridine hypnotic drug that is metabolized mainly by CYP3A4. Rifampin (INN, rifampicin) is a potent inducer of many cytochrome P450 enzymes, and it greatly reduces the plasma concentrations and effects of, for example, midazolam, triazolam, and zopiclone. In this study, the effects of rifampin on the pharmacokinetics and pharmacodynamics of zolpidem were studied. In a randomized crossover study with two phases and a washout of 4 weeks, eight young healthy female volunteers took either 600 mg rifampin or placebo once a day for 5 days. On day 6, 20 mg zolpidem was administered orally."}
{"qid": "58d388958acda34529000006", "original_text": "To explore the mimotope vaccine approach against infectious bursal disease virus (IBDV), five IBDV-specific monoclonal antibodies (mAbs) were prepared and their binding peptides were screened against a phage-displayed 12-mer peptide library. After three rounds of biopanning, 12 phages were selected for each mAbs and their specificity to IBDV was verified by sandwich and competitive inhibition ELISAs. Seven phages per mAb were sequenced and their amino acid sequences were deduced. The five representative sequences of mimotopes corresponding mAbs were determined. An artificial gene, designated 5epis (5 epitopes) and consisting of the five mimotopes arranged in tandem (F1-F7-B34-2B1-2G8) with four GGGS spacers, was chemically synthesized and cloned into a prokaryotic expression plasmid pET28b.", "label": 1, "is_selected": 0, "text": "To explore the mimotope vaccine approach against infectious bursal disease virus (IBDV), five IBDV-specific monoclonal antibodies (mAbs) were prepared and their binding peptides were screened against a phage-displayed 12-mer peptide library. After three rounds of biopanning, 12 phages were selected for each mAbs and their specificity to IBDV was verified by sandwich and competitive inhibition ELISAs. Seven phages per mAb were sequenced and their amino acid sequences were deduced. The five representative sequences of mimotopes corresponding mAbs were determined. An artificial gene, designated 5epis (5 epitopes) and consisting of the five mimotopes arranged in tandem (F1-F7-B34-2B1-2G8) with four GGGS spacers, was chemically synthesized and cloned into a prokaryotic expression plasmid pET28b."}
{"qid": "58de71fa8acda3452900002c", "original_text": "The mammalian INO80 remodelling complex facilitates homologous recombination (HR), but the mechanism by which it does this is unclear. Budding yeast INO80 can remove H2A.Z/H2B dimers from chromatin and replace them with H2A/H2B dimers.", "label": 1, "is_selected": 0, "text": "The mammalian INO80 remodelling complex facilitates homologous recombination (HR), but the mechanism by which it does this is unclear. Budding yeast INO80 can remove H2A.Z/H2B dimers from chromatin and replace them with H2A/H2B dimers."}
{"qid": "554148c23f2354b713000001", "original_text": "Chorion proteins of Lepidoptera have a tripartite structure, which consists of a central domain and two, more variable, flanking arms. The central domain is highly conserved and it is used for the classification of chorion proteins into two major classes, A and B. Annotated and unreviewed Lepidopteran chorion protein sequences are available in various databases. A database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work. A total of 413 Lepidopteran chorion proteins from 9 moths and 1 butterfly species were retrieved.", "label": 1, "is_selected": 0, "text": "Chorion proteins of Lepidoptera have a tripartite structure, which consists of a central domain and two, more variable, flanking arms. The central domain is highly conserved and it is used for the classification of chorion proteins into two major classes, A and B. Annotated and unreviewed Lepidopteran chorion protein sequences are available in various databases. A database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work. A total of 413 Lepidopteran chorion proteins from 9 moths and 1 butterfly species were retrieved."}
{"qid": "5abcf6b9fcf4565872000027", "original_text": "CTCF is an evolutionary conserved and ubiquitously expressed protein that binds thousands of sites in the human genome. Ectopic expression of CTCF in various normal and tumoral human cell lines inhibits cell division and clonogenicity, with the consequence to consider CTCF a potential tumor-suppressor factor. In this review article, we focused on the molecular mechanisms engaged by CTCF to modulate the expression of several key-regulators of differentiation, cellular senescence, cell cycle control and progression, whose expression is frequently altered in tumors. Moreover, we discussed common features of CTCF at each tumor-related DNA-binding sequence, such as protein-partners, post-translational modifications, and distinctive epigenetic marks establishment. The investigation of the molecular mechanisms engaged by CTCF to modulate tumor-related genes emphasizes the cell-type dependency of its tumor suppressor role. Indeed, the ability of CTCF to bind their promoters strictly depends by cell-type features as DNA methylation, BORIS-binding and post-translational modifications as PARYlation.", "label": 1, "is_selected": 0, "text": "CTCF is an evolutionary conserved and ubiquitously expressed protein that binds thousands of sites in the human genome. Ectopic expression of CTCF in various normal and tumoral human cell lines inhibits cell division and clonogenicity, with the consequence to consider CTCF a potential tumor-suppressor factor. In this review article, we focused on the molecular mechanisms engaged by CTCF to modulate the expression of several key-regulators of differentiation, cellular senescence, cell cycle control and progression, whose expression is frequently altered in tumors. Moreover, we discussed common features of CTCF at each tumor-related DNA-binding sequence, such as protein-partners, post-translational modifications, and distinctive epigenetic marks establishment. The investigation of the molecular mechanisms engaged by CTCF to modulate tumor-related genes emphasizes the cell-type dependency of its tumor suppressor role. Indeed, the ability of CTCF to bind their promoters strictly depends by cell-type features as DNA methylation, BORIS-binding and post-translational modifications as PARYlation."}
{"qid": "5e2f9ceefbd6abf43b000033", "original_text": "PolyIran is a fixed-dose combination medication that contains a combination of three drugs: irbesartan, hydrochlorothiazide, and amlodipine. Irbesartan is an angiotensin II receptor antagonist that helps to reduce blood pressure by blocking the action of angiotensin II on the blood vessels. Hydrochlorothiazide is a diuretic that helps to increase urine production and reduce fluid buildup in the body, which can help to lower blood pressure. Amlodipine is a calcium channel blocker that helps to relax the blood vessels and improve blood flow, which can also help to lower blood pressure. By combining these three drugs in a single pill, PolyIran provides comprehensive hypertension management with a single dosage.", "label": 0, "is_selected": 0, "text": "PolyIran is a fixed-dose combination medication that contains a combination of three drugs: irbesartan, hydrochlorothiazide, and amlodipine. Irbesartan is an angiotensin II receptor antagonist that helps to reduce blood pressure by blocking the action of angiotensin II on the blood vessels. Hydrochlorothiazide is a diuretic that helps to increase urine production and reduce fluid buildup in the body, which can help to lower blood pressure. Amlodipine is a calcium channel blocker that helps to relax the blood vessels and improve blood flow, which can also help to lower blood pressure. By combining these three drugs in a single pill, PolyIran provides comprehensive hypertension management with a single dosage."}
{"qid": "5a6e4814b750ff445500004a", "original_text": "The human genome folds to create thousands of intervals, called \"contact domains,\" that exhibit enhanced contact frequency within themselves. \"Loop domains\" form because of tethering between two loci-almost always bound by CTCF and cohesin-lying on the same chromosome. \"Compartment domains\" form when genomic intervals with similar histone marks co-segregate. Here, we explore the effects of degrading cohesin. All loop domains are eliminated, but neither compartment domains nor histone marks are affected.", "label": 1, "is_selected": 0, "text": "The human genome folds to create thousands of intervals, called \"contact domains,\" that exhibit enhanced contact frequency within themselves. \"Loop domains\" form because of tethering between two loci-almost always bound by CTCF and cohesin-lying on the same chromosome. \"Compartment domains\" form when genomic intervals with similar histone marks co-segregate. Here, we explore the effects of degrading cohesin. All loop domains are eliminated, but neither compartment domains nor histone marks are affected."}
{"qid": "587f760792a5b8ad44000005", "original_text": "The algorithm that employs mixture model clustering under the hood is called PeakSeq. It is a widely used peak calling tool in next-generation sequencing (NGS) data analysis. PeakSeq uses a Bayesian framework and employs a mixture model clustering approach to identify peaks in the sequencing data.", "label": 0, "is_selected": 1, "text": "In this paper, we present a novel method for identifying peaks in next-generation sequencing (NGS) data, using a Bayesian framework and a mixture model clustering approach, in order to reduce the cost of data analysis and to speed up the time-to-market for new sequencing technologies"}
{"qid": "54ff5197e9bde69634000001", "original_text": "A typical eukaryotic genome harbors a rich variety of repetitive elements. The most abundant are retrotransposons, mobile retroelements that utilize reverse transcriptase and an RNA intermediate to relocate to a new location within the cellular genomes. A vast majority of the repetitive mammalian genome content has originated from the retrotransposition of SINE (100-300 bp short interspersed nuclear elements that are derived from the structural 7SL RNA or tRNA), LINE (7kb long interspersed nuclear element), and LTR (2-3 kb long terminal repeats) transposable element superfamilies.", "label": 1, "is_selected": 0, "text": "A typical eukaryotic genome harbors a rich variety of repetitive elements. The most abundant are retrotransposons, mobile retroelements that utilize reverse transcriptase and an RNA intermediate to relocate to a new location within the cellular genomes. A vast majority of the repetitive mammalian genome content has originated from the retrotransposition of SINE (100-300 bp short interspersed nuclear elements that are derived from the structural 7SL RNA or tRNA), LINE (7kb long interspersed nuclear element), and LTR (2-3 kb long terminal repeats) transposable element superfamilies."}
{"qid": "621eb1d83a8413c653000059", "original_text": "Bowel endometriosis affects between 3.8% and 37% of women with endometriosis. The evaluation of symptoms and clinical examination are inadequate for an accurate diagnosis of intestinal endometriosis. Transvaginal ultrasonography is the first line investigation in patients with suspected bowel endometriosis and allows accurate determination of the presence of the disease. Radiological techniques (such as magnetic resonance imaging and multidetector computerized tomography enteroclysis) are useful for estimating the extent of bowel endometriosis. Hormonal therapies (progestins, gonadotropin releasing hormone analogues and aromatase inhibitors) significantly improve pain and intestinal symptoms in patients with bowel stenosis less than 60% and who do not wish to conceive. However, hormonal therapies may not prevent the progression of bowel endometriosis and, therefore, patients receiving long-term treatment should be periodically monitored. Surgical excision of bowel endometriosis should be offered to symptomatic patients with bowel stenosis greater than 60%. Intestinal endometriotic nodules may be excised by nodulectomy or segmental resection. Both surgical procedures improve pain, intestinal symptoms and fertility. Nodulectomy may be associated with a lower rate of complications.", "label": 1, "is_selected": 0, "text": "Bowel endometriosis affects between 3.8% and 37% of women with endometriosis. The evaluation of symptoms and clinical examination are inadequate for an accurate diagnosis of intestinal endometriosis. Transvaginal ultrasonography is the first line investigation in patients with suspected bowel endometriosis and allows accurate determination of the presence of the disease. Radiological techniques (such as magnetic resonance imaging and multidetector computerized tomography enteroclysis) are useful for estimating the extent of bowel endometriosis. Hormonal therapies (progestins, gonadotropin releasing hormone analogues and aromatase inhibitors) significantly improve pain and intestinal symptoms in patients with bowel stenosis less than 60% and who do not wish to conceive. However, hormonal therapies may not prevent the progression of bowel endometriosis and, therefore, patients receiving long-term treatment should be periodically monitored. Surgical excision of bowel endometriosis should be offered to symptomatic patients with bowel stenosis greater than 60%. Intestinal endometriotic nodules may be excised by nodulectomy or segmental resection. Both surgical procedures improve pain, intestinal symptoms and fertility. Nodulectomy may be associated with a lower rate of complications."}
{"qid": "62008456c9dfcb9c0900001e", "original_text": "Ischemic stroke is a leading cause of disability and death worldwide among adults. The individual prognosis after stroke is extremely dependent on treatment decisions physicians take during the acute phase. In the last five years, several scores such as the ASTRAL, DRAGON, and THRIVE have been proposed as tools to help physicians predict the patient functional outcome after a stroke. These scores are rule-based classifiers that use features available when the patient is admitted to the emergency room. In this paper, we apply machine learning techniques to the problem of predicting the functional outcome of ischemic stroke patients, three months after admission. We show that a pure machine learning approach achieves only a marginally superior Area Under the ROC Curve (AUC) ( 0.808\u00b10.085) than that of the best score ( 0.771\u00b10.056) when using the features available at admission. However, we observed that by progressively adding features available at further points in time, we can significantly increase the AUC to a value above 0.90. We conclude that the results obtained validate the use of the scores at the time of admission, but also point to the importance of using more features, which require more advanced methods, when possible.", "label": 1, "is_selected": 0, "text": "Ischemic stroke is a leading cause of disability and death worldwide among adults. The individual prognosis after stroke is extremely dependent on treatment decisions physicians take during the acute phase. In the last five years, several scores such as the ASTRAL, DRAGON, and THRIVE have been proposed as tools to help physicians predict the patient functional outcome after a stroke. These scores are rule-based classifiers that use features available when the patient is admitted to the emergency room. In this paper, we apply machine learning techniques to the problem of predicting the functional outcome of ischemic stroke patients, three months after admission. We show that a pure machine learning approach achieves only a marginally superior Area Under the ROC Curve (AUC) ( 0.808\u00b10.085) than that of the best score ( 0.771\u00b10.056) when using the features available at admission. However, we observed that by progressively adding features available at further points in time, we can significantly increase the AUC to a value above 0.90. We conclude that the results obtained validate the use of the scores at the time of admission, but also point to the importance of using more features, which require more advanced methods, when possible."}
{"qid": "515db70c298dcd4e51000017", "original_text": "Gabapentin, a commonly prescribed medication for epilepsy and nerve pain, has been associated with several adverse effects in children. These may include dizziness, somnolence, fatigue, and nausea. In rare cases, gabapentin may cause an allergic reaction, fever, or rash. However, it is essential to note that the incidence and severity of these adverse effects can vary depending on the child's age, weight, and individual sensitivity. It is crucial to closely monitor children taking gabapentin and report any concerns to a healthcare provider.", "label": 0, "is_selected": 0, "text": "Gabapentin, a commonly prescribed medication for epilepsy and nerve pain, has been associated with several adverse effects in children. These may include dizziness, somnolence, fatigue, and nausea. In rare cases, gabapentin may cause an allergic reaction, fever, or rash. However, it is essential to note that the incidence and severity of these adverse effects can vary depending on the child's age, weight, and individual sensitivity. It is crucial to closely monitor children taking gabapentin and report any concerns to a healthcare provider."}
{"qid": "5a82fc89faa1ab7d2e000028", "original_text": "H2A.Z is a variant of the H2A histone that preferentially marks nucleosomes on actively transcribed genes. Of these, the yeast H2A.Z is preferentially marked by H2A.Z on the promoter regions of actively transcribed genes. This marking helps to recruit the RNA polymerase II complex to the promoter region, thereby facilitating transcription initiation. Additionally, H2A.Z also plays a role in the regulation of gene expression by modifying the chromatin structure and recruiting other proteins that participate in transcriptional regulation.", "label": 0, "is_selected": 0, "text": "H2A.Z is a variant of the H2A histone that preferentially marks nucleosomes on actively transcribed genes. Of these, the yeast H2A.Z is preferentially marked by H2A.Z on the promoter regions of actively transcribed genes. This marking helps to recruit the RNA polymerase II complex to the promoter region, thereby facilitating transcription initiation. Additionally, H2A.Z also plays a role in the regulation of gene expression by modifying the chromatin structure and recruiting other proteins that participate in transcriptional regulation."}
{"qid": "5aa395fcd6d6b54f79000007", "original_text": "To my knowledge, there is limited research on the use of rituximab for the treatment of chronic fatigue syndrome (CFS). While there is some evidence suggesting that B-cells may play a role in the pathophysiology of CFS, the current evidence base does not support the use of rituximab as a treatment for this condition. A 2017 systematic review and meta-analysis of 15 randomized controlled trials found no significant evidence for the efficacy of rituximab in the treatment of CFS. The review concluded that the existing evidence does not support the use of rituximab for CFS and that larger, well-designed trials are needed to determine its potential effectiveness. Another study published in 2019 found that rituximab was not effective in reducing fatigue in patients with CFS. The study included 20 patients with CFS who received rituximab and were assessed for changes in fatigue levels using the Chalder Fatigue Questionnaire. The results showed that rituximab did not result in significant improvements in fatigue levels compared to placebo. In summary, while there is some theoretical basis for considering rituximab as a treatment for CFS, the current evidence does not support its use for this condition. Further research is needed to determine the potential efficacy of rituximab in the treatment of CFS.", "label": 0, "is_selected": 0, "text": "To my knowledge, there is limited research on the use of rituximab for the treatment of chronic fatigue syndrome (CFS). While there is some evidence suggesting that B-cells may play a role in the pathophysiology of CFS, the current evidence base does not support the use of rituximab as a treatment for this condition. A 2017 systematic review and meta-analysis of 15 randomized controlled trials found no significant evidence for the efficacy of rituximab in the treatment of CFS. The review concluded that the existing evidence does not support the use of rituximab for CFS and that larger, well-designed trials are needed to determine its potential effectiveness. Another study published in 2019 found that rituximab was not effective in reducing fatigue in patients with CFS. The study included 20 patients with CFS who received rituximab and were assessed for changes in fatigue levels using the Chalder Fatigue Questionnaire. The results showed that rituximab did not result in significant improvements in fatigue levels compared to placebo. In summary, while there is some theoretical basis for considering rituximab as a treatment for CFS, the current evidence does not support its use for this condition. Further research is needed to determine the potential efficacy of rituximab in the treatment of CFS."}
{"qid": "58a877cf38c171fb5b000004", "original_text": "Industrial melanism in peppered moths has been studied most intensively in Britain. The first melanic phenotype (effectively solid black) was recorded near Manchester in 1848. By 1895 about 98% of the specimens near Manchester were melanic, and this once rare phenotype had spread across regions of the country blackened by industrial soot. In rural, unpolluted regions, well away from industrial centers, the pale phenotype (peppered with white and black scales) remained the predominant form.", "label": 1, "is_selected": 0, "text": "Industrial melanism in peppered moths has been studied most intensively in Britain. The first melanic phenotype (effectively solid black) was recorded near Manchester in 1848. By 1895 about 98% of the specimens near Manchester were melanic, and this once rare phenotype had spread across regions of the country blackened by industrial soot. In rural, unpolluted regions, well away from industrial centers, the pale phenotype (peppered with white and black scales) remained the predominant form."}
{"qid": "60281b1c1cb411341a0000f3", "original_text": "The 16p13.11 genomic copy number variant (GCNV) has been associated with several neuropsychiatric disorders, including: 1. Autism Spectrum Disorder (ASD): Studies have shown that approximately 10% of individuals with ASD have a 16p13.11 GCNV. These individuals often have more severe social and communication impairments and may have a higher risk of developing epilepsy and other neurological problems. 2. Schizophrenia: Research has suggested that individuals with schizophrenia are more likely to have a 16p13.11 GCNV than the general population. However, the frequency of this variant is still relatively low, and more research is needed to fully understand its role in the development of schizophrenia. 3. Bipolar Disorder: Some studies have found that individuals with bipolar disorder are more likely to have a 16p13.11 GCNV than those without the disorder. However, the findings are not yet conclusive, and more research is needed to confirm this association. 4. Major Depressive Disorder (MDD): While the relationship between 16p13.11 GCNV and MDD is still uncertain, some studies have suggested that individuals with MDD may be more likely to have this variant. 5. Anxiety Disorders: There is limited research on the association between 16p13.11 GCNV and anxiety disorders, but some studies have suggested that individuals with anxiety disorders may be more likely to have this variant. In summary, 16p13.11 GCNV has been associated with several neuropsychiatric disorders, including ASD, schizophrenia, bipolar disorder, MDD, and anxiety disorders. However, more research is needed to fully understand the relationship between this genomic variant and these disorders.", "label": 0, "is_selected": 0, "text": "The 16p13.11 genomic copy number variant (GCNV) has been associated with several neuropsychiatric disorders, including: 1. Autism Spectrum Disorder (ASD): Studies have shown that approximately 10% of individuals with ASD have a 16p13.11 GCNV. These individuals often have more severe social and communication impairments and may have a higher risk of developing epilepsy and other neurological problems. 2. Schizophrenia: Research has suggested that individuals with schizophrenia are more likely to have a 16p13.11 GCNV than the general population. However, the frequency of this variant is still relatively low, and more research is needed to fully understand its role in the development of schizophrenia. 3. Bipolar Disorder: Some studies have found that individuals with bipolar disorder are more likely to have a 16p13.11 GCNV than those without the disorder. However, the findings are not yet conclusive, and more research is needed to confirm this association. 4. Major Depressive Disorder (MDD): While the relationship between 16p13.11 GCNV and MDD is still uncertain, some studies have suggested that individuals with MDD may be more likely to have this variant. 5. Anxiety Disorders: There is limited research on the association between 16p13.11 GCNV and anxiety disorders, but some studies have suggested that individuals with anxiety disorders may be more likely to have this variant. In summary, 16p13.11 GCNV has been associated with several neuropsychiatric disorders, including ASD, schizophrenia, bipolar disorder, MDD, and anxiety disorders. However, more research is needed to fully understand the relationship between this genomic variant and these disorders."}
{"qid": "51595fb0d24251bc0500009c", "original_text": "We compared the protein expression pattern of triple-negative breast carcinomas (HER2-, ER-, PR-) versus those being positive for HER2 and negative for the hormone receptors (HER2+, ER-, PR-) by 2-D DIGE and mass spectrometry. We obtained differential expression patterns for several glycolytic enzymes (as for example MDH2, PGK1, TKT, Aldolase1), cytokeratins (CK7, 8, 9, 14, 17, 19), further structure proteins (vimentin, fibronectin, L-plastin), for NME1-NME2, lactoferrin, and members of the Annexin family. Western blot analysis and immunohistochemistry were conducted to verify the results. The identified marker proteins may advance a more detailed characterization of triple-negative breast cancers and may contribute to the development of better treatment strategies.", "label": 1, "is_selected": 0, "text": "We compared the protein expression pattern of triple-negative breast carcinomas (HER2-, ER-, PR-) versus those being positive for HER2 and negative for the hormone receptors (HER2+, ER-, PR-) by 2-D DIGE and mass spectrometry. We obtained differential expression patterns for several glycolytic enzymes (as for example MDH2, PGK1, TKT, Aldolase1), cytokeratins (CK7, 8, 9, 14, 17, 19), further structure proteins (vimentin, fibronectin, L-plastin), for NME1-NME2, lactoferrin, and members of the Annexin family. Western blot analysis and immunohistochemistry were conducted to verify the results. The identified marker proteins may advance a more detailed characterization of triple-negative breast cancers and may contribute to the development of better treatment strategies."}
{"qid": "5a742d620384be9551000002", "original_text": "The Stop-Bang questionnaire is a widely used screening tool for assessing the risk of obstructive sleep apnea (OSA). It estimated the risk of OSA by identifying the frequency and severity of certain symptoms, such as snoring, obesity, and fatigue. The questionnaire covers six items, each with a score of 0 or 1, and a total score of 0-6. A score of 3-6 indicates a high risk of OSA, while a score of 0-2 indicates a low risk. Additionally, the Stop-Bang questionnaire can also be used to assess the risk of other sleep-related disorders, such as insomnia and narcolepsy. Therefore, the disease risk that can be estimated with the Stop-Bang questionnaire is OSA, but it can also be used to identify other sleep-related disorders.", "label": 0, "is_selected": 0, "text": "The Stop-Bang questionnaire is a widely used screening tool for assessing the risk of obstructive sleep apnea (OSA). It estimated the risk of OSA by identifying the frequency and severity of certain symptoms, such as snoring, obesity, and fatigue. The questionnaire covers six items, each with a score of 0 or 1, and a total score of 0-6. A score of 3-6 indicates a high risk of OSA, while a score of 0-2 indicates a low risk. Additionally, the Stop-Bang questionnaire can also be used to assess the risk of other sleep-related disorders, such as insomnia and narcolepsy. Therefore, the disease risk that can be estimated with the Stop-Bang questionnaire is OSA, but it can also be used to identify other sleep-related disorders."}
{"qid": "517539ca8ed59a060a000027", "original_text": "Thyroid hormone governs a diverse repertoire of physiological functions through receptors encoded in the receptor genes alpha and beta, which each generate variant proteins. In mammals, the alpha gene generates, in addition to the normal receptor TRalpha1, a non-hormone-binding variant TRalpha2 whose exact function is unclear. Here, we present the phenotype associated with the targeted ablation of TRalpha2 expression. Selective ablation of TRalpha2 resulted in an inevitable, concomitant overexpression of TRalpha1. Both TRalpha2 +/- and -/- mice show a complex phenotype with low levels of free T3 and free T4, and have inappropriately normal levels of TSH. The thyroid glands exhibit mild morphological signs of dysfunction and respond poorly to TSH, suggesting that the genetic changes affect the ability of the gland to release thyroid hormones. However, the phenotype of the mutant mice also has features of hyperthyroidism, including decreased body weight, elevated heart rate, and a raised body temperature. Furthermore, TRalpha2-/- and TRalpha2+/- mice are obese and exhibit skeletal alterations, associated with a late-onset growth retardation.", "label": 1, "is_selected": 0, "text": "Thyroid hormone governs a diverse repertoire of physiological functions through receptors encoded in the receptor genes alpha and beta, which each generate variant proteins. In mammals, the alpha gene generates, in addition to the normal receptor TRalpha1, a non-hormone-binding variant TRalpha2 whose exact function is unclear. Here, we present the phenotype associated with the targeted ablation of TRalpha2 expression. Selective ablation of TRalpha2 resulted in an inevitable, concomitant overexpression of TRalpha1. Both TRalpha2 +/- and -/- mice show a complex phenotype with low levels of free T3 and free T4, and have inappropriately normal levels of TSH. The thyroid glands exhibit mild morphological signs of dysfunction and respond poorly to TSH, suggesting that the genetic changes affect the ability of the gland to release thyroid hormones. However, the phenotype of the mutant mice also has features of hyperthyroidism, including decreased body weight, elevated heart rate, and a raised body temperature. Furthermore, TRalpha2-/- and TRalpha2+/- mice are obese and exhibit skeletal alterations, associated with a late-onset growth retardation."}
{"qid": "5c8fef490101eac870000010", "original_text": "MLP (Myotonic Dystrophy-Like Protein) regulates F-actin dynamics through its interaction with the cytoskeleton protein, actin-binding repeat-containing protein 1 (ABI1). MLP binds to ABI1 and modulates its actin-binding activity, thereby regulating F-actin dynamics and cytoskeleton organization. This interaction is important for MLP's role in regulating cellular processes such as cell adhesion, migration, and signaling.", "label": 0, "is_selected": 1, "text": "F-actin, a type of white blood cell, is the most abundant cell type in the human body and plays a key role in the regulation of many cellular processes, such as cell adhesion, migration, and signaling, as well as in the development and maintenance of healthy tissues."}
{"qid": "62015485c9dfcb9c09000023", "original_text": "Yes, SETD1A mutations have been found to be associated with an increased risk of developing schizophrenia. Studies have shown that individuals with SETD1A mutations have a higher risk of developing schizophrenia compared to the general population. The exact mechanisms by which SETD1A mutations contribute to the development of schizophrenia are not yet fully understood, but it is thought to involve disruptions in the regulation of gene expression and the functioning of neural circuits in the brain.", "label": 0, "is_selected": 0, "text": "Yes, SETD1A mutations have been found to be associated with an increased risk of developing schizophrenia. Studies have shown that individuals with SETD1A mutations have a higher risk of developing schizophrenia compared to the general population. The exact mechanisms by which SETD1A mutations contribute to the development of schizophrenia are not yet fully understood, but it is thought to involve disruptions in the regulation of gene expression and the functioning of neural circuits in the brain."}
{"qid": "5a86f074faa1ab7d2e00003a", "original_text": "Identification of loss of SMARCB1/INI1 expression in poorly differentiated (PD) chordoma in pediatric patients suggests that PD chordoma is an entity molecularly distinct from conventional chordoma or atypical teratoid/rhabdoid tumor, which is also characterized by loss of SMARCB1/INI1 expression by inactivating mutation of the SMARCB1/INI gene. So far, around 20 cases of pediatric PD chordoma with loss of SMARCB1/INI1 expression have been reported. Here, we report two cases of pediatric PD chordoma with loss of SMARCB1/INI1 expression, which is very rare among the pediatric chordoma types. Both patients presented clival masses on preoperative MRI. Histologically, both tumors had nonclassic histologic features for conventional chordoma: sheets of large epithelioid to spindle cells with vesicular nuclei and prominent nucleoli. Both cases revealed nuclear expression of brachyury, loss of SMARCB1/INI1 expression and lack of embryonal, neuroectodermal, or epithelial component. One case showed heterozygous loss of EWSR1 gene by break-apart fluorescence in situ hybridization that reflected loss of SMARCB1/INI1 gene.", "label": 1, "is_selected": 0, "text": "Identification of loss of SMARCB1/INI1 expression in poorly differentiated (PD) chordoma in pediatric patients suggests that PD chordoma is an entity molecularly distinct from conventional chordoma or atypical teratoid/rhabdoid tumor, which is also characterized by loss of SMARCB1/INI1 expression by inactivating mutation of the SMARCB1/INI gene. So far, around 20 cases of pediatric PD chordoma with loss of SMARCB1/INI1 expression have been reported. Here, we report two cases of pediatric PD chordoma with loss of SMARCB1/INI1 expression, which is very rare among the pediatric chordoma types. Both patients presented clival masses on preoperative MRI. Histologically, both tumors had nonclassic histologic features for conventional chordoma: sheets of large epithelioid to spindle cells with vesicular nuclei and prominent nucleoli. Both cases revealed nuclear expression of brachyury, loss of SMARCB1/INI1 expression and lack of embryonal, neuroectodermal, or epithelial component. One case showed heterozygous loss of EWSR1 gene by break-apart fluorescence in situ hybridization that reflected loss of SMARCB1/INI1 gene."}
{"qid": "5cd96eb2a49efeb44c000003", "original_text": "There are several software packages that are commonly used for the detection of selective sweeps in genomic data. Some of the popular ones include: 1. Phylobayes: This is a Bayesian framework for inferring the history of positive selection in a population. It uses a Markov chain Monte Carlo (MCMC) approach to estimate the posterior probability of positive selection given the observed data. 2. PAML: This is a program for inferring the sites of positive selection in a genome. It uses a likelihood-based approach to detect positively selected alleles and estimates the strength of selection at each site. 3. HYPHY: This is a program for estimating the history of positive selection in a population. It uses a hidden Markov model to infer the posterior probability of positive selection given the observed data. 4. GERMLINE: This is a program for inferring population genetic parameters and detecting positive selection in a genomic sample. It uses a MCMC approach to estimate the posterior probability of positive selection given the observed data. 5. DAZEL: This is a software package for detecting and identifying positively selected genes in a genomic sample. It uses a likelihood-based approach to detect positively selected alleles and estimates the strength of selection at each site. 6. SWEET: This is a software package for detecting positive selection in a genomic sample. It uses a maximum parsimony approach to infer the most likely history of positive selection given the observed data. 7. Prot\u00e9g\u00e9: This is a software package for detecting positive selection in a genomic sample. It uses a hidden Markov model to infer the posterior probability of positive selection given the observed data. 8. MERA: This is a software package for detecting and identifying positively selected genes in a genomic sample. It uses a MCMC approach to estimate the posterior probability of positive selection given the observed data. Please note that this is not an exhaustive list, and there are many other software packages available that can be used for detecting selective sweeps in genomic data.", "label": 0, "is_selected": 1, "text": "In our series of letters from African journalists, journalist and columnist M Ilyasov looks at software packages that can be used to detect selective sweeps in genomic data, as part of the African Genomes Initiative (AGI) project by the African Union (AU) and the African Development Bank (AfDB) in partnership with the US Department of Defense (DoD) under the auspices of the National Institutes of Health (NIH), with funding from the US Defense Threat Reduction Agency (DTRA) and US Agency for International Development (USAID), and by the National Science Foundation (NSF) in collaboration with the National Human Genome Research Institute (NHGRI) in the United States, and the University of California, Los Angeles (UCLA) in cooperation with the California Institute of Technology (Caltech) and University of Washington (UW) in Seattle."}
{"qid": "56e2985951531f7e33000013", "original_text": "Bacteriophage T4 initiates DNA replication from specialized structures that form in its genome. Immediately after infection, RNA-DNA hybrids (R-loops) occur on (at least some) replication origins, with the annealed RNA serving as a primer for leading-strand synthesis in one direction. As the infection progresses, replication initiation becomes dependent on recombination proteins in a process called recombination-dependent replication (RDR). RDR occurs when the replication machinery is assembled onto D-loop recombination intermediates, and in this case, the invading 3' DNA end is used as a primer for leading strand synthesis.", "label": 1, "is_selected": 0, "text": "Bacteriophage T4 initiates DNA replication from specialized structures that form in its genome. Immediately after infection, RNA-DNA hybrids (R-loops) occur on (at least some) replication origins, with the annealed RNA serving as a primer for leading-strand synthesis in one direction. As the infection progresses, replication initiation becomes dependent on recombination proteins in a process called recombination-dependent replication (RDR). RDR occurs when the replication machinery is assembled onto D-loop recombination intermediates, and in this case, the invading 3' DNA end is used as a primer for leading strand synthesis."}
{"qid": "51713cb58ed59a060a000006", "original_text": "Calcium (Ca2+) handling proteins are known to play a pivotal role in the pathophysiology of cardiomyopathy. However little is known about early changes in the diabetic heart and the impact of insulin treatment (Ins). Zucker Diabetic Fatty rats treated with or without insulin (ZDF \u00b1 Ins, n = 13) and lean littermates (controls, n = 7) were sacrificed at the age of 19 weeks. ZDF + Ins (n = 6) were treated with insulin for the last 6 weeks of life. Gene expression of Ca2+ ATPase in the cardiac sarcoplasmatic reticulum (SERCA2a, further abbreviated as SERCA) and phospholamban (PLB) were determined by northern blotting. Ca2+ transport of the sarcoplasmatic reticulum (SR) was assessed by oxalate-facilitated 45Ca-uptake in left ventricular homogenates.", "label": 1, "is_selected": 0, "text": "Calcium (Ca2+) handling proteins are known to play a pivotal role in the pathophysiology of cardiomyopathy. However little is known about early changes in the diabetic heart and the impact of insulin treatment (Ins). Zucker Diabetic Fatty rats treated with or without insulin (ZDF \u00b1 Ins, n = 13) and lean littermates (controls, n = 7) were sacrificed at the age of 19 weeks. ZDF + Ins (n = 6) were treated with insulin for the last 6 weeks of life. Gene expression of Ca2+ ATPase in the cardiac sarcoplasmatic reticulum (SERCA2a, further abbreviated as SERCA) and phospholamban (PLB) were determined by northern blotting. Ca2+ transport of the sarcoplasmatic reticulum (SR) was assessed by oxalate-facilitated 45Ca-uptake in left ventricular homogenates."}
{"qid": "5c5897c786df2b9174000008", "original_text": "Surgical repair of orbital fractures with implants is a widely used treatment modality. While a variety of established complications are associated with this technique, most are directly understood and treated. Bloody epiphora is a finding with potentially ominous causes. The authors present a unique case of bloody epiphora, accompanied by orbital hemorrhage arising several years after orbital floor fracture repair, due to erosion of the nasolacrimal drainage system by a displaced implant combined with anticoagulation.", "label": 1, "is_selected": 0, "text": "Surgical repair of orbital fractures with implants is a widely used treatment modality. While a variety of established complications are associated with this technique, most are directly understood and treated. Bloody epiphora is a finding with potentially ominous causes. The authors present a unique case of bloody epiphora, accompanied by orbital hemorrhage arising several years after orbital floor fracture repair, due to erosion of the nasolacrimal drainage system by a displaced implant combined with anticoagulation."}
{"qid": "56a8adb0a17756b72f000003", "original_text": "In the past few years, technological advances in nucleotide sequencing have culminated in a greater understanding of the complexity of the human transcriptome. Notably, the discovery that distal regulatory elements known as enhancers are transcribed and such enhancer-derived transcripts (eRNAs) serve a critical function in transcriptional activation has added a new dimension to transcriptional regulation. Here we review recent insights into the tissue-specific and temporal-specific gene regulation brought about by the discovery of eRNAs.", "label": 1, "is_selected": 0, "text": "In the past few years, technological advances in nucleotide sequencing have culminated in a greater understanding of the complexity of the human transcriptome. Notably, the discovery that distal regulatory elements known as enhancers are transcribed and such enhancer-derived transcripts (eRNAs) serve a critical function in transcriptional activation has added a new dimension to transcriptional regulation. Here we review recent insights into the tissue-specific and temporal-specific gene regulation brought about by the discovery of eRNAs."}
{"qid": "56ae6e650a360a5e4500000e", "original_text": "We report the development of OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome browser resource for Oikopleura dioica, a metazoan belonging to the urochordates, the closest extant group to vertebrates. OikoBase facilitates retrieval and mining of a variety of useful genomics information. First, it includes a genome browser which interrogates 1260 genomic sequence scaffolds and features gene, transcript and CDS annotation tracks. Second, we annotated gene models with gene ontology (GO) terms and InterPro domains which are directly accessible in the browser with links to their entries in the GO (http://www.geneontology.org/) and InterPro (http://www.ebi.ac.uk/interpro/) databases, and we provide transcript and peptide links for sequence downloads. Third, we introduce the transcriptomics of a comprehensive set of developmental stages of O. dioica at high resolution and provide downloadable gene expression data for all developmental stages.", "label": 1, "is_selected": 0, "text": "We report the development of OikoBase (http://oikoarrays.biology.uiowa.edu/Oiko/), a tiling array-based genome browser resource for Oikopleura dioica, a metazoan belonging to the urochordates, the closest extant group to vertebrates. OikoBase facilitates retrieval and mining of a variety of useful genomics information. First, it includes a genome browser which interrogates 1260 genomic sequence scaffolds and features gene, transcript and CDS annotation tracks. Second, we annotated gene models with gene ontology (GO) terms and InterPro domains which are directly accessible in the browser with links to their entries in the GO (http://www.geneontology.org/) and InterPro (http://www.ebi.ac.uk/interpro/) databases, and we provide transcript and peptide links for sequence downloads. Third, we introduce the transcriptomics of a comprehensive set of developmental stages of O. dioica at high resolution and provide downloadable gene expression data for all developmental stages."}
{"qid": "52bf1f4503868f1b06000016", "original_text": "Atypical neuroleptic drugs, such as clozapine and olanzapine, can be used to treat certain conditions, including: 1. Schizophrenia: Atypical neuroleptics are commonly used to treat positive symptoms of schizophrenia, such as hallucinations and delusions, as they can help reduce these symptoms without causing extrapyramidal side effects. 2. Bipolar disorder: Atypical neuroleptics may be used to manage manic or mixed episodes in bipolar disorder, particularly in cases where other medications have not been effective. 3. Tourette's syndrome: Atypical neuroleptics can be used to treat co-morbid conditions such as tics and vocal tremors in patients with Tourette's syndrome. 4. Autism spectrum disorder: Atypical neuroleptics may be used to treat irritability and aggressive behavior in patients with autism spectrum disorder. It is important to note that atypical neuroleptics are not effective for treating typical neurotransmitter imbalances, such as depression or anxiety, and should only be used under the close supervision of a healthcare provider.", "label": 0, "is_selected": 1, "text": "Atypical neuroleptics can be used to treat a number of common mental health conditions, including schizophrenia, bipolar disorder, Tourette's syndrome and autism spectrum disorder, according to the US Food and Drug Administration (FDA). Autism spectrum disorder: Autism spectrum neurotransmitters are not effective for treating typical symptoms, such as anxiety or irritability, and only should be used at the close supervision of a healthcare provider."}
{"qid": "5c6dfdf27c78d69471000047", "original_text": "Nivolumab is a programmed death 1 (PD-1) inhibitor currently approved as second-line treatment for advanced renal cell carcinomas (RCC) after failure of standard antiangiogenic treatment. Motzer et al. have recently published in the New England Journal of Medicine the findings of CheckMate 214 trial, using nivolumab and ipilimumab, a cytotoxic T-lymphocyte antigen 4 (CTLA-4) inhibitor, versus sunitinib in previously untreated advanced RCC. The combination demonstrated a higher 18-month overall survival rate of 75% versus 60%, and a higher objective response rate of 42% versus 27%, for the combination in favor over sunitinib monotherapy. These results herald the rapidly changing role of immune checkpoint inhibitor therapy as first-line treatment for metastatic RCC.", "label": 1, "is_selected": 0, "text": "Nivolumab is a programmed death 1 (PD-1) inhibitor currently approved as second-line treatment for advanced renal cell carcinomas (RCC) after failure of standard antiangiogenic treatment. Motzer et al. have recently published in the New England Journal of Medicine the findings of CheckMate 214 trial, using nivolumab and ipilimumab, a cytotoxic T-lymphocyte antigen 4 (CTLA-4) inhibitor, versus sunitinib in previously untreated advanced RCC. The combination demonstrated a higher 18-month overall survival rate of 75% versus 60%, and a higher objective response rate of 42% versus 27%, for the combination in favor over sunitinib monotherapy. These results herald the rapidly changing role of immune checkpoint inhibitor therapy as first-line treatment for metastatic RCC."}
{"qid": "601c44ab1cb411341a00001c", "original_text": "Dysembryoplastic neuroepithelial tumors (DNT/DNET) are rare epileptogenic tumors. Microsurgery remains the best treatment option, although case reports exist on the use of gamma knife radiosurgery (GKRS) in selected cases. We investigated the long-term outcome of GKRS-treated DNTs at our institution in the context of current diagnostic and treatment options. We conducted a retrospective review of three consecutive adult patients (\u226518 years) treated with salvage GKRS between 2002 and 2010 at Karolinska University Hospital, Stockholm, Sweden. The case series was supplemented by a review of current literature. A 20-year-old male underwent subtotal resection (STR) in 1997 and 2002 of DNT resulting in temporary control of intractable epilepsy despite antiepileptic drug treatment (AED).", "label": 1, "is_selected": 0, "text": "Dysembryoplastic neuroepithelial tumors (DNT/DNET) are rare epileptogenic tumors. Microsurgery remains the best treatment option, although case reports exist on the use of gamma knife radiosurgery (GKRS) in selected cases. We investigated the long-term outcome of GKRS-treated DNTs at our institution in the context of current diagnostic and treatment options. We conducted a retrospective review of three consecutive adult patients (\u226518 years) treated with salvage GKRS between 2002 and 2010 at Karolinska University Hospital, Stockholm, Sweden. The case series was supplemented by a review of current literature. A 20-year-old male underwent subtotal resection (STR) in 1997 and 2002 of DNT resulting in temporary control of intractable epilepsy despite antiepileptic drug treatment (AED)."}
{"qid": "58e9f0ba3e8b6dc87c00000e", "original_text": "The bacterium with the smallest genome in base pairs yet found is Mycoplasma genitalium, which has a genome size of approximately 580,000 base pairs. Mycoplasma genitalium is a sexually transmitted pathogen that causes non-gonococcal urethritis in men and women, and has been the subject of extensive research due to its small genome size and the insights it provides into the evolution of bacterial genomes. The genome of M. genitalium contains a modest 10 proteins, 20 RNA genes, and 16-19 ribosomal RNA genes, making it one of the smallest bacterial genomes known.", "label": 0, "is_selected": 1, "text": "A team led by researchers at the University of California, Los Angeles (UCLA) has discovered the smallest bacterial genome yet discovered, in a study published in Plos One on 22 April.<n> The bacterium with the smallest genome in base pairs yet found is Mycoplasma genitalium, which has a genome size of approximately 580,000 base pairs."}
{"qid": "571cd9537de986d80d00000e", "original_text": "Human beings are constantly exposed to pathogens. The innate immune system is the first line of defense against microbes. It has evolved to recognize conserved microbial motifs (PAMP or pathogen-associated molecular patterns) thanks to a limited array of receptors termed pattern recognition receptors (PRR). Upon activation, most PRR trigger a transcriptional response leading to neosynthesis of hundreds of genes. In contrast, engagement of various PRR in the recently identified inflammasome complexes lead to activation of a cysteine protease, caspase-1. This inflammatory caspase has a dual activity: it triggers the release of very potent proinflammatory cytokines IL-1\u03b2 and IL-18 and, an hyperinflammatory cell death termed pyroptosis. In this review, we describe the inflammasome receptors and their ligands, the molecular mechanisms leading to the assembly of this innate immune platform and the role of the inflammasome during viral and bacterial infections.", "label": 1, "is_selected": 0, "text": "Human beings are constantly exposed to pathogens. The innate immune system is the first line of defense against microbes. It has evolved to recognize conserved microbial motifs (PAMP or pathogen-associated molecular patterns) thanks to a limited array of receptors termed pattern recognition receptors (PRR). Upon activation, most PRR trigger a transcriptional response leading to neosynthesis of hundreds of genes. In contrast, engagement of various PRR in the recently identified inflammasome complexes lead to activation of a cysteine protease, caspase-1. This inflammatory caspase has a dual activity: it triggers the release of very potent proinflammatory cytokines IL-1\u03b2 and IL-18 and, an hyperinflammatory cell death termed pyroptosis. In this review, we describe the inflammasome receptors and their ligands, the molecular mechanisms leading to the assembly of this innate immune platform and the role of the inflammasome during viral and bacterial infections."}
{"qid": "5c960d88ecadf2e73f00001f", "original_text": "(1) First-line disease-modifying treatment for rheumatoid arthritis is based on \"slow-acting\" antirheumatic agents, generally methotrexate. Subsequent options include a TNF-alpha antagonist, followed by rituximab or possibly abatacept; (2) Tocilizumab, a monoclonal antibody, inhibits interleukin-6 receptors.", "label": 1, "is_selected": 0, "text": "(1) First-line disease-modifying treatment for rheumatoid arthritis is based on \"slow-acting\" antirheumatic agents, generally methotrexate. Subsequent options include a TNF-alpha antagonist, followed by rituximab or possibly abatacept; (2) Tocilizumab, a monoclonal antibody, inhibits interleukin-6 receptors."}
{"qid": "51601071298dcd4e51000038", "original_text": "Leishmaniasis is a group of diseases with a spectrum of clinical manifestations ranging from cutaneous ulcers to visceral leishmaniasis, which results from the bite of an infected sandfly to human. Attempts to develop an effective vaccine have been shown to be feasible but no vaccine is in active clinical use. This study adopts a Reverse Vaccinology approach to identify common vaccine candidates from both highly pathogenic species Leishmania major and Leishmania infantum. Total proteome of both species were compared to identify common proteins, which are further taken for sub-cellular localization and transmembrane helices prediction. Plasma membrane proteins having only one transmembrane helix were first identified and analyzed which are non-homologous in human and mouse in order to avoid molecular mimicry with other proteins. Selected proteins were analyzed for their binding efficiency to both major histocompatibility complex (MHC) class I and class II alleles. As a result, 19 potential epitopes are screened in this study using different approaches, which can be further verified through in vivo experiments in MHC compatible animal models. This study demonstrates that Reverse Vaccinology approach has potential in discovering various immunogenic antigens from in silico analysis of pathogen's genome or proteome instead of culturing the whole organism by conventional methods.", "label": 1, "is_selected": 0, "text": "Leishmaniasis is a group of diseases with a spectrum of clinical manifestations ranging from cutaneous ulcers to visceral leishmaniasis, which results from the bite of an infected sandfly to human. Attempts to develop an effective vaccine have been shown to be feasible but no vaccine is in active clinical use. This study adopts a Reverse Vaccinology approach to identify common vaccine candidates from both highly pathogenic species Leishmania major and Leishmania infantum. Total proteome of both species were compared to identify common proteins, which are further taken for sub-cellular localization and transmembrane helices prediction. Plasma membrane proteins having only one transmembrane helix were first identified and analyzed which are non-homologous in human and mouse in order to avoid molecular mimicry with other proteins. Selected proteins were analyzed for their binding efficiency to both major histocompatibility complex (MHC) class I and class II alleles. As a result, 19 potential epitopes are screened in this study using different approaches, which can be further verified through in vivo experiments in MHC compatible animal models. This study demonstrates that Reverse Vaccinology approach has potential in discovering various immunogenic antigens from in silico analysis of pathogen's genome or proteome instead of culturing the whole organism by conventional methods."}
{"qid": "570917bccf1c325851000015", "original_text": "A-type lamins are proteins that are involved in the structure and organization of the nucleus in eukaryotic cells. They bind to and help to maintain the structure of both euchromatin and heterochromatin. Euchromatin is the more loosely packaged form of chromatin, which is more accessible to the machinery of gene expression, while heterochromatin is the more tightly packaged form of chromatin, which is less accessible and typically associated with gene silencing. A-type lamins have been shown to bind to both euchromatin and heterochromatin, and play a role in the spatial organization of these different forms of chromatin within the nucleus.", "label": 0, "is_selected": 1, "text": "A-type lamins have been shown to bind to both euchromatin and heterochromatin, and play a role in the spatio-temporal organization of these different forms of spatial gene expression in the nucleus of eukaryotic cells, and have been implicated in the regulation of gene silencing."}
{"qid": "5160193d298dcd4e51000039", "original_text": "TRH (thyroid-stimulating hormone) has been shown to have a variety of effects on the cardiovascular system, including alterations in myocardial contractility. Studies have demonstrated that TRH can increase the contractility of the myocardium, leading to increased heart rate and blood pressure. This is thought to be mediated by the activation of beta-adrenergic receptors in the heart, which enhance the contraction of cardiac muscle cells. In addition, TRH has been shown to reduce the levels of certain neurohumoral factors, such as angiotensin II, which can also contribute to improved myocardial contractility. However, it is important to note that the exact mechanisms by which TRH affects myocardial contractility are not yet fully understood and require further investigation.", "label": 0, "is_selected": 0, "text": "TRH (thyroid-stimulating hormone) has been shown to have a variety of effects on the cardiovascular system, including alterations in myocardial contractility. Studies have demonstrated that TRH can increase the contractility of the myocardium, leading to increased heart rate and blood pressure. This is thought to be mediated by the activation of beta-adrenergic receptors in the heart, which enhance the contraction of cardiac muscle cells. In addition, TRH has been shown to reduce the levels of certain neurohumoral factors, such as angiotensin II, which can also contribute to improved myocardial contractility. However, it is important to note that the exact mechanisms by which TRH affects myocardial contractility are not yet fully understood and require further investigation."}
{"qid": "5c9789a9ecadf2e73f000024", "original_text": "NANOG is a transcription factor that plays a crucial role in the self-renewal and maintenance of stem cell pluripotency in various tissues. The gene product of NANOG is involved in several cellular processes, including cell proliferation, survival, and differentiation. NANOG regulates the expression of genes involved in these processes by binding to specific DNA sequences and recruiting other transcription factors. In addition, NANOG has been shown to play a role in the regulation of stem cell fate decisions, such as the maintenance of stem cell self-renewal or the induction of differentiated cell fate.", "label": 0, "is_selected": 1, "text": "The aim of this study is to investigate the role of the stem cell-related gene product G in the regulation of stem cell proliferation and differentiation in a mouse model of Parkinson's disease and to assess the potential of chimeric antigen receptors (CARs) to be used in the development of new treatments for diseases of the nervous system."}
{"qid": "5c544c1707647bbc4b000003", "original_text": "Uniparental disomy (UPD) is a genetic disorder that occurs when an individual has two copies of a chromosome instead of one, resulting from abnormal meiosis or gametogenesis. Detection of UPD can be challenging, but various algorithms have been developed to aid in its diagnosis. Here are some common UPD detection algorithms: 1. Paint-a-Chromosome Algorithm: This algorithm uses fluorescent in situ hybridization (FISH) to identify chromosomal abnormalities. By painting a chromosome with a fluorescent probe and comparing it to a reference chromosome, the algorithm can identify UPD. 2. Array-Comparative Genomic Hybridization (aCGH): aCGH is a technique that uses microarrays to detect genetic Copy number variations (CNVs). By comparing an individual's DNA to a reference genome, the algorithm can identify UPD. 3. MLPA (Multiplex Ligation-Dependent Probe Amplification): MLPA is a technique that uses probes to amplify specific regions of the genome. By comparing the amplified regions between an individual and a reference genome, the algorithm can identify UPD. 4. Chromosomal Microarray Analysis (CMA): CMA is a technique that uses a microarray to detect genetic abnormalities at the chromosomal level. By comparing an individual's chromosomes to a reference genome, the algorithm can identify UPD. 5. Next-Generation Sequencing (NGS): NGS is a high-resolution technique that can detect genetic variations at the DNA sequence level. By comparing an individual's DNA to a reference genome, the algorithm can identify UPD. 6. Genome-Wide Methylation Analysis: This algorithm uses methylation-specific PCR (MSP) or Reduced Representation Bisulfite Sequencing (RRBS) to detect epigenetic changes in the genome. By comparing an individual's methylation pattern to a reference genome, the algorithm can identify UPD. It is important to note that the choice of algorithm depends on the clinical presentation and the available resources. A combination of algorithms may be used to increase the accuracy of the diagnosis. However, the interpretation of the results requires expertise in genetics and cytogenetics, and the algorithms are not 100% sensitive and specific. Therefore, a thorough clinical assessment and counseling are essential to make an accurate diagnosis and inform the appropriate management.", "label": 0, "is_selected": 0, "text": "Uniparental disomy (UPD) is a genetic disorder that occurs when an individual has two copies of a chromosome instead of one, resulting from abnormal meiosis or gametogenesis. Detection of UPD can be challenging, but various algorithms have been developed to aid in its diagnosis. Here are some common UPD detection algorithms: 1. Paint-a-Chromosome Algorithm: This algorithm uses fluorescent in situ hybridization (FISH) to identify chromosomal abnormalities. By painting a chromosome with a fluorescent probe and comparing it to a reference chromosome, the algorithm can identify UPD. 2. Array-Comparative Genomic Hybridization (aCGH): aCGH is a technique that uses microarrays to detect genetic Copy number variations (CNVs). By comparing an individual's DNA to a reference genome, the algorithm can identify UPD. 3. MLPA (Multiplex Ligation-Dependent Probe Amplification): MLPA is a technique that uses probes to amplify specific regions of the genome. By comparing the amplified regions between an individual and a reference genome, the algorithm can identify UPD. 4. Chromosomal Microarray Analysis (CMA): CMA is a technique that uses a microarray to detect genetic abnormalities at the chromosomal level. By comparing an individual's chromosomes to a reference genome, the algorithm can identify UPD. 5. Next-Generation Sequencing (NGS): NGS is a high-resolution technique that can detect genetic variations at the DNA sequence level. By comparing an individual's DNA to a reference genome, the algorithm can identify UPD. 6. Genome-Wide Methylation Analysis: This algorithm uses methylation-specific PCR (MSP) or Reduced Representation Bisulfite Sequencing (RRBS) to detect epigenetic changes in the genome. By comparing an individual's methylation pattern to a reference genome, the algorithm can identify UPD. It is important to note that the choice of algorithm depends on the clinical presentation and the available resources. A combination of algorithms may be used to increase the accuracy of the diagnosis. However, the interpretation of the results requires expertise in genetics and cytogenetics, and the algorithms are not 100% sensitive and specific. Therefore, a thorough clinical assessment and counseling are essential to make an accurate diagnosis and inform the appropriate management."}
{"qid": "6250787be764a5320400000e", "original_text": "On June 7th 2021, the Food and Drug Administration (FDA) granted approval for Aduhelm (aducanumab) for the treatment of Alzheimer's disease under its accelerated approval program. Aducanumab is the first putative disease-modifying therapy (DMT) approved for the treatment of AD with a great potential for clinical benefit over current symptomatic therapies.", "label": 1, "is_selected": 0, "text": "On June 7th 2021, the Food and Drug Administration (FDA) granted approval for Aduhelm (aducanumab) for the treatment of Alzheimer's disease under its accelerated approval program. Aducanumab is the first putative disease-modifying therapy (DMT) approved for the treatment of AD with a great potential for clinical benefit over current symptomatic therapies."}
{"qid": "602a87c71cb411341a000117", "original_text": "Protein kinase monopolar spindle 1 plays an important role in spindle assembly checkpoint at the onset of mitosis. Over expression of MPS1 correlated with a wide range of human tumors makes it an attractive target for finding an effective and specific inhibitor. In this work, we performed molecular dynamics simulations of protein MPS1 itself as well as protein bound systems with the inhibitor and natural substrate based on crystal structures. The reported orally bioavailable 1 h-pyrrolo [3,2-c] pyridine inhibitors of MPS1 maintained stable binding in the catalytic site, while natural substrate ATP could not stay. Comparative study of stability and flexibility of three systems reveals position shifting of \u03b2-sheet region within the catalytic site, which indicates inhibition mechanism was through stabilizing the \u03b2-sheet region. Binding free energies calculated with MM-GB/PBSA method shows different binding affinity for inhibitor and ATP. Finally, interactions between protein and inhibitor during molecular dynamic simulations were measured and counted. Residue Gly605 and Leu654 were suggested as important hot spots for stable binding of inhibitor by molecular dynamic simulation.", "label": 1, "is_selected": 0, "text": "Protein kinase monopolar spindle 1 plays an important role in spindle assembly checkpoint at the onset of mitosis. Over expression of MPS1 correlated with a wide range of human tumors makes it an attractive target for finding an effective and specific inhibitor. In this work, we performed molecular dynamics simulations of protein MPS1 itself as well as protein bound systems with the inhibitor and natural substrate based on crystal structures. The reported orally bioavailable 1 h-pyrrolo [3,2-c] pyridine inhibitors of MPS1 maintained stable binding in the catalytic site, while natural substrate ATP could not stay. Comparative study of stability and flexibility of three systems reveals position shifting of \u03b2-sheet region within the catalytic site, which indicates inhibition mechanism was through stabilizing the \u03b2-sheet region. Binding free energies calculated with MM-GB/PBSA method shows different binding affinity for inhibitor and ATP. Finally, interactions between protein and inhibitor during molecular dynamic simulations were measured and counted. Residue Gly605 and Leu654 were suggested as important hot spots for stable binding of inhibitor by molecular dynamic simulation."}
{"qid": "5e36d5b9b5b409ea53000009", "original_text": "Identifying large expansions of short tandem repeats (STRs), such as those that cause amyotrophic lateral sclerosis (ALS) and fragile X syndrome, is challenging for short-read whole-genome sequencing (WGS) data. A solution to this problem is an important step toward integrating WGS into precision medicine. We developed a software tool called ExpansionHunter that, using PCR-free WGS short-read data, can genotype repeats at the locus of interest, even if the expanded repeat is larger than the read length. We applied our algorithm to WGS data from 3001 ALS patients who have been tested for the presence of the C9orf72 repeat expansion with repeat-primed PCR (RP-PCR). Compared against this truth data, ExpansionHunter correctly classified all (212/212, 95% CI [0.98, 1.00]) of the expanded samples as either expansions (208) or potential expansions (4).", "label": 1, "is_selected": 0, "text": "Identifying large expansions of short tandem repeats (STRs), such as those that cause amyotrophic lateral sclerosis (ALS) and fragile X syndrome, is challenging for short-read whole-genome sequencing (WGS) data. A solution to this problem is an important step toward integrating WGS into precision medicine. We developed a software tool called ExpansionHunter that, using PCR-free WGS short-read data, can genotype repeats at the locus of interest, even if the expanded repeat is larger than the read length. We applied our algorithm to WGS data from 3001 ALS patients who have been tested for the presence of the C9orf72 repeat expansion with repeat-primed PCR (RP-PCR). Compared against this truth data, ExpansionHunter correctly classified all (212/212, 95% CI [0.98, 1.00]) of the expanded samples as either expansions (208) or potential expansions (4)."}
{"qid": "61f7d5a0882a024a10000035", "original_text": "Bruton's tyrosine kinase (BTK) is crucial for Fc\u03b5RI-mediated mast cell activation and essential for autoantibody production by B cells in chronic spontaneous urticaria (CSU). Fenebrutinib, an orally administered, potent, highly selective, reversible BTK inhibitor, may be effective in CSU. This double-blind, placebo-controlled, phase 2 trial (EudraCT ID 2016-004624-35 ) randomized 93 adults with antihistamine-refractory CSU to 50 mg daily, 150 mg daily and 200 mg twice daily of fenebrutinib or placebo for 8 weeks. The primary end point was change from baseline in urticaria activity score over 7 d (UAS7) at week 8.", "label": 1, "is_selected": 0, "text": "Bruton's tyrosine kinase (BTK) is crucial for Fc\u03b5RI-mediated mast cell activation and essential for autoantibody production by B cells in chronic spontaneous urticaria (CSU). Fenebrutinib, an orally administered, potent, highly selective, reversible BTK inhibitor, may be effective in CSU. This double-blind, placebo-controlled, phase 2 trial (EudraCT ID 2016-004624-35 ) randomized 93 adults with antihistamine-refractory CSU to 50 mg daily, 150 mg daily and 200 mg twice daily of fenebrutinib or placebo for 8 weeks. The primary end point was change from baseline in urticaria activity score over 7 d (UAS7) at week 8."}
{"qid": "5895ec5e7d9090f353000015", "original_text": "Mutations in the gene that encodes Fibroblast Growth Factor Receptor 3 (FGFR3) are associated with Achondroplasia (MIM 100800), Hypochondroplasia (MIM 146000), Muenke Syndrome (MIM 602849), Thanatophoric Dysplasia (MIM 187600, MIM 187601) and Lacrimo-Auriculo-Dento-Digital Syndrome (MIM 149730).Here we report a clinical and molecular study in a large cohort of 125 Portuguese patients with these skeletal disorders. The identification of the P250R mutation allowed the confirmation of the Muenke Syndrome in 9 out of the 52 cases referred. Two known mutations were found in the Thanatophoric Dysplasia referred cases. No mutations were identified in the LADD syndrome patient.", "label": 1, "is_selected": 0, "text": "Mutations in the gene that encodes Fibroblast Growth Factor Receptor 3 (FGFR3) are associated with Achondroplasia (MIM 100800), Hypochondroplasia (MIM 146000), Muenke Syndrome (MIM 602849), Thanatophoric Dysplasia (MIM 187600, MIM 187601) and Lacrimo-Auriculo-Dento-Digital Syndrome (MIM 149730).Here we report a clinical and molecular study in a large cohort of 125 Portuguese patients with these skeletal disorders. The identification of the P250R mutation allowed the confirmation of the Muenke Syndrome in 9 out of the 52 cases referred. Two known mutations were found in the Thanatophoric Dysplasia referred cases. No mutations were identified in the LADD syndrome patient."}
{"qid": "551fd9c06b348bb82c000012", "original_text": "A study was performed to determine the utility of the 8-point recognition of stroke in the emergency room (ROSIER) instrument as a diagnostic tool in a large Irish emergency department. Fifty patients had ROSIER scores completed by doctors. Diagnoses achieved using the score were compared with discharge diagnoses. Relations between ROSIER score, impairment and length of stay were assessed.", "label": 1, "is_selected": 0, "text": "A study was performed to determine the utility of the 8-point recognition of stroke in the emergency room (ROSIER) instrument as a diagnostic tool in a large Irish emergency department. Fifty patients had ROSIER scores completed by doctors. Diagnoses achieved using the score were compared with discharge diagnoses. Relations between ROSIER score, impairment and length of stay were assessed."}
{"qid": "5abbfd97fcf456587200001d", "original_text": "The Formalin test, also known as the formalin fixative test, is a diagnostic technique used to detect the presence of bacterial infection in a patient's body. The test involves injecting a small amount of formalin solution into the patient's body, typically into a vein or muscle. If bacteria are present in the patient's body, the formalin solution will cause them to release histamine, which will lead to the formation of a wheal or hematoma at the injection site. The size and shape of the wheal can help determine the severity of the infection. The Formalin test is commonly used to diagnose bacterial infections of the skin, soft tissue, or bone. It can also be used to monitor the effectiveness of antibiotic treatment. However, the test has limited sensitivity and specificity, so it may not always provide accurate results. In some cases, other diagnostic tests may be needed to confirm the diagnosis.", "label": 0, "is_selected": 0, "text": "The Formalin test, also known as the formalin fixative test, is a diagnostic technique used to detect the presence of bacterial infection in a patient's body. The test involves injecting a small amount of formalin solution into the patient's body, typically into a vein or muscle. If bacteria are present in the patient's body, the formalin solution will cause them to release histamine, which will lead to the formation of a wheal or hematoma at the injection site. The size and shape of the wheal can help determine the severity of the infection. The Formalin test is commonly used to diagnose bacterial infections of the skin, soft tissue, or bone. It can also be used to monitor the effectiveness of antibiotic treatment. However, the test has limited sensitivity and specificity, so it may not always provide accurate results. In some cases, other diagnostic tests may be needed to confirm the diagnosis."}
{"qid": "5357a6d0f1005d6b58000004", "original_text": "Highly conserved sequences at the 5' splice site and branch site of U12-dependent introns are important determinants for splicing by U12-dependent spliceosomes. This study investigates the in vivo splicing phenotypes of mutations in the branch site consensus sequence of the U12-dependent intron F from a human NOL1 (P120) minigene. Intron F contains a fully consensus branch site sequence (UUCCUUAAC).", "label": 1, "is_selected": 0, "text": "Highly conserved sequences at the 5' splice site and branch site of U12-dependent introns are important determinants for splicing by U12-dependent spliceosomes. This study investigates the in vivo splicing phenotypes of mutations in the branch site consensus sequence of the U12-dependent intron F from a human NOL1 (P120) minigene. Intron F contains a fully consensus branch site sequence (UUCCUUAAC)."}
{"qid": "6025fd261cb411341a0000bf", "original_text": "Isradipine is a calcium channel blocker that has been investigated for its potential therapeutic effects in Parkinson's disease. While some studies have suggested that isradipine may improve motor function in patients with Parkinson's, the evidence is limited and inconclusive. A 2016 systematic review and meta-analysis published in the journal Movement Disorders analyzed data from six randomized controlled trials involving a total of 447 patients with Parkinson's. The review found that isradipine therapy was associated with a significant improvement in motor function, as measured by the United Parkinson's Disease Rating Scale (UPDRS) Part III, compared to placebo. However, the review also noted that the quality of the evidence was largely poor, and that further well-designed and well-powered trials are needed to confirm these findings. More recent studies have also suggested that isradipine may have potential as a treatment for Parkinson's disease. For example, a 2020 study published in the journal Neuropharmacology found that isradipine reduced inflammation and oxidative stress in a mouse model of Parkinson's, which may contribute to its potential therapeutic effects. However, it is important to note that isradipine is not currently approved by the US Food and Drug Administration (FDA) for the treatment of Parkinson's disease. Additionally, while some studies have suggested that isradipine may improve motor function in patients with Parkinson's, it is not a substitute for conventional treatments such as dopaminergic medications, which are the standard of care for managing motor symptoms in Parkinson's disease. In summary, while there is some evidence to suggest that isradipine may be effective in improving motor function in patients with Parkinson's disease, the evidence is limited and inconclusive. Further well-designed and well-powered trials are needed to confirm these findings and to determine the potential therapeutic effects of isradipine in Parkinson's disease.", "label": 0, "is_selected": 1, "text": "There is some evidence to suggest that isradipine may be effective in improving motor function in patients with Parkinson's disease, but the evidence is limited and inconclusive, and further well-designed and well-powered trials are needed to confirm these findings, according to a 2016 systematic review and meta-analysis published in the journal Movement Disorders. Further well- designed and well powered trials are needs to confirm this findings and to determine the potential therapeutic effects of israsadipine in Parkinson' s disease., says a 2016 review of the available evidence in the Journal of Movement Disorders, which was conducted by researchers at the University of California, Los Angeles (UCLA) and the Keck School of Medicine of the City of Los Angeles."}
{"qid": "5e5cc1fa1af46fc130000005", "original_text": "Thyroid cancer in children and adolescents has to be considered as the most severe health consequence of a nuclear reactor emergency with release of radioiodine into the atmosphere. High doses of potassium iodide are effective to block radioiodine thyroid uptake and to prevent development of thyroid cancer years later. However, there are controversies concerning thyroid cancer risk induced by radioiodine exposure in adults. Further, the interaction of nutritional supply of potassium iodide and radioiodine uptake as well as the interaction of radioiodine with certain drugs has not been addressed properly in existing guidelines and recommendations.", "label": 1, "is_selected": 0, "text": "Thyroid cancer in children and adolescents has to be considered as the most severe health consequence of a nuclear reactor emergency with release of radioiodine into the atmosphere. High doses of potassium iodide are effective to block radioiodine thyroid uptake and to prevent development of thyroid cancer years later. However, there are controversies concerning thyroid cancer risk induced by radioiodine exposure in adults. Further, the interaction of nutritional supply of potassium iodide and radioiodine uptake as well as the interaction of radioiodine with certain drugs has not been addressed properly in existing guidelines and recommendations."}
{"qid": "5157fce5d24251bc0500008c", "original_text": "Yes, it is feasible to determine the complete proteome of yeast. The complete proteome of Saccharomyces cerevisiae, the species of yeast most commonly used in research and brewing, was first reported in 2014 by the Protein Structure Initiative (PSI) Yeast Structure Initiative (YSI) consortium using a combination of mass spectrometry and advanced computational methods. This study identified and characterized about 7,000 protein species, including all known and putative proteins, with a high degree of accuracy. Since then, there have been numerous studies focused on updating and refining the yeast proteome, including the use of advanced mass spectrometry techniques such as label-free quantitation and data-independent acquisition, as well as the integration of proteomics data with other types of genomics data.", "label": 0, "is_selected": 0, "text": "Yes, it is feasible to determine the complete proteome of yeast. The complete proteome of Saccharomyces cerevisiae, the species of yeast most commonly used in research and brewing, was first reported in 2014 by the Protein Structure Initiative (PSI) Yeast Structure Initiative (YSI) consortium using a combination of mass spectrometry and advanced computational methods. This study identified and characterized about 7,000 protein species, including all known and putative proteins, with a high degree of accuracy. Since then, there have been numerous studies focused on updating and refining the yeast proteome, including the use of advanced mass spectrometry techniques such as label-free quantitation and data-independent acquisition, as well as the integration of proteomics data with other types of genomics data."}
{"qid": "51406d6923fec90375000007", "original_text": "Subacute thyroiditis is caused by a viral infection, most commonly the common cold or flu virus. The infection triggers an autoimmune response, leading to inflammation and damage to the thyroid gland. The exact cause of subacute thyroiditis can be difficult to determine, but it is believed to be a complex interplay of genetic and environmental factors. Other possible causes include stress, hormonal imbalances, and certain medications.", "label": 0, "is_selected": 1, "text": "Subacute thyroiditis is a serious condition that can cause severe and sometimes life-threatening symptoms, including loss of appetite, weight loss, and/or memory loss, as well as a loss of energy, concentration, and reasoning skills, among others."}
{"qid": "53175e25b166e2b806000007", "original_text": "CHEK2 is a key cell cycle control gene encoding a pluripotent kinase that can cause arrest or apoptosis in response to unrepaired DNA damage. We report a large case-control study of a non-functional variant that had previously been expected to increase cancer rates. Four thousand and fifteen cancer patients (2250 lung, 811 squamous upper aero-digestive and 954 kidney) and 3052 controls in central Europe were genotyped for the mis-sense variant rs17879961 (replacement of T by C), which changes an amino acid (I157T) in an active site of the gene product. The heterozygous (T/C) genotype was associated with a highly significantly lower incidence of lung cancer than the common T/T genotype", "label": 1, "is_selected": 0, "text": "CHEK2 is a key cell cycle control gene encoding a pluripotent kinase that can cause arrest or apoptosis in response to unrepaired DNA damage. We report a large case-control study of a non-functional variant that had previously been expected to increase cancer rates. Four thousand and fifteen cancer patients (2250 lung, 811 squamous upper aero-digestive and 954 kidney) and 3052 controls in central Europe were genotyped for the mis-sense variant rs17879961 (replacement of T by C), which changes an amino acid (I157T) in an active site of the gene product. The heterozygous (T/C) genotype was associated with a highly significantly lower incidence of lung cancer than the common T/T genotype"}
{"qid": "56bcc455d36b5da378000003", "original_text": "Gray platelet syndrome (GPS) is an inherited bleeding disorder associated with macrothrombocytopenia and \u03b1-granule-deficient platelets. GPS has been linked to loss of function mutations in NEABL2 (neurobeachin-like 2), and we describe here a murine GPS model, the Nbeal2(-/-) mouse. As in GPS, Nbeal2(-/-) mice exhibit splenomegaly, macrothrombocytopenia, and a deficiency of platelet \u03b1-granules and their cargo, including von Willebrand factor (VWF), thrombospondin-1, and platelet factor 4. The platelet \u03b1-granule membrane protein P-selectin is expressed at 48% of wild-type levels and externalized upon platelet activation. The presence of P-selectin and normal levels of VPS33B and VPS16B in Nbeal2(-/-) platelets suggests that NBEAL2 acts independently of VPS33B/VPS16B at a later stage of \u03b1-granule biogenesis.", "label": 1, "is_selected": 0, "text": "Gray platelet syndrome (GPS) is an inherited bleeding disorder associated with macrothrombocytopenia and \u03b1-granule-deficient platelets. GPS has been linked to loss of function mutations in NEABL2 (neurobeachin-like 2), and we describe here a murine GPS model, the Nbeal2(-/-) mouse. As in GPS, Nbeal2(-/-) mice exhibit splenomegaly, macrothrombocytopenia, and a deficiency of platelet \u03b1-granules and their cargo, including von Willebrand factor (VWF), thrombospondin-1, and platelet factor 4. The platelet \u03b1-granule membrane protein P-selectin is expressed at 48% of wild-type levels and externalized upon platelet activation. The presence of P-selectin and normal levels of VPS33B and VPS16B in Nbeal2(-/-) platelets suggests that NBEAL2 acts independently of VPS33B/VPS16B at a later stage of \u03b1-granule biogenesis."}
{"qid": "60853db94e6a4cf630000010", "original_text": "Circular RNAs (circRNAs) are a new class of non-coding RNA with a stable structure formed by special loop splicing. Research increasingly suggests that circRNAs play a vital role in the pathogenesis and progression of various diseases. However, the roles of circRNAs in osteoblast differentiation under microgravity remain largely unknown. Here, we investigated the roles and mechanobiological response of circRNAs in osteoblasts under simulated microgravity. Differential circRNA and mRNA expression profiles of MC3T3-E1 cells during exposure to microgravity were screened by RNA transcriptome sequencing technology (RNA-seq). The selected RNAs were validated using quantitative real-time polymerase chain reaction (qRT-PCR). Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were applied for gene function analyses. A total of 427 circRNAs and 1912 mRNAs were differentially expressed along with osteogenic differentiation in the simulated microgravity group (SMG) compared to the control group (CON). Of these, 232 circRNAs and 991 mRNAs were upregulated, whereas 95 circRNAs and 921 mRNAs were downregulated (fold change \u2265 2, p < 0.05). The results showed that the parental genes of circRNAs and mRNAs were mainly enriched in anatomical structure morphogenesis, anchoring junction and protein binding. KEGG analysis results showed that the differentially expressed mRNAs were enriched in the regulation of the actin cytoskeleton, focal adhesion, and Ras signalling pathway. Subsequently, 9 core regulatory genes, including 6 mRNAs and 3 circRNAs, were identified based on their possible function in osteoblast differentiation.", "label": 1, "is_selected": 0, "text": "Circular RNAs (circRNAs) are a new class of non-coding RNA with a stable structure formed by special loop splicing. Research increasingly suggests that circRNAs play a vital role in the pathogenesis and progression of various diseases. However, the roles of circRNAs in osteoblast differentiation under microgravity remain largely unknown. Here, we investigated the roles and mechanobiological response of circRNAs in osteoblasts under simulated microgravity. Differential circRNA and mRNA expression profiles of MC3T3-E1 cells during exposure to microgravity were screened by RNA transcriptome sequencing technology (RNA-seq). The selected RNAs were validated using quantitative real-time polymerase chain reaction (qRT-PCR). Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were applied for gene function analyses. A total of 427 circRNAs and 1912 mRNAs were differentially expressed along with osteogenic differentiation in the simulated microgravity group (SMG) compared to the control group (CON). Of these, 232 circRNAs and 991 mRNAs were upregulated, whereas 95 circRNAs and 921 mRNAs were downregulated (fold change \u2265 2, p < 0.05). The results showed that the parental genes of circRNAs and mRNAs were mainly enriched in anatomical structure morphogenesis, anchoring junction and protein binding. KEGG analysis results showed that the differentially expressed mRNAs were enriched in the regulation of the actin cytoskeleton, focal adhesion, and Ras signalling pathway. Subsequently, 9 core regulatory genes, including 6 mRNAs and 3 circRNAs, were identified based on their possible function in osteoblast differentiation."}
{"qid": "61f6048e882a024a10000020", "original_text": "The discussion of whether amyloid plaque A\u03b2 is a valid drug target to fight Alzheimer's disease (AD) has been a matter of scientific dispute for decades. This question can only be settled by successful clinical trials and the approval of disease-modifying drugs. However, many clinical trials with antibodies against different regions of the amyloid A\u03b2 peptide have been discontinued, as they did not meet the clinical endpoints required. Recently, passive immunization of AD patients with Donanemab, an antibody directed against the N-terminus of pyroglutamate A\u03b2, showed beneficial effects in a phase II trial, supporting the concept that N-truncated A\u03b2 is a relevant target for AD therapy. There is long-standing evidence that N-truncated A\u03b2 variants are the main variants found in amyloid plaques besides full-length A\u03b21-42, t, therefore their role in triggering AD pathology and as targets for drug development are of interest. While the contribution of pyroglutamate A\u03b23-42 to AD pathology has been well studied in the past, the potential role of A\u03b24-42 has been largely neglected. The present review will therefore focus on A\u03b24-42 as a possible drug target based on human and mouse pathology, in vitro and in vivo toxicity, and anti-A\u03b24-X therapeutic effects in preclinical models.", "label": 1, "is_selected": 0, "text": "The discussion of whether amyloid plaque A\u03b2 is a valid drug target to fight Alzheimer's disease (AD) has been a matter of scientific dispute for decades. This question can only be settled by successful clinical trials and the approval of disease-modifying drugs. However, many clinical trials with antibodies against different regions of the amyloid A\u03b2 peptide have been discontinued, as they did not meet the clinical endpoints required. Recently, passive immunization of AD patients with Donanemab, an antibody directed against the N-terminus of pyroglutamate A\u03b2, showed beneficial effects in a phase II trial, supporting the concept that N-truncated A\u03b2 is a relevant target for AD therapy. There is long-standing evidence that N-truncated A\u03b2 variants are the main variants found in amyloid plaques besides full-length A\u03b21-42, t, therefore their role in triggering AD pathology and as targets for drug development are of interest. While the contribution of pyroglutamate A\u03b23-42 to AD pathology has been well studied in the past, the potential role of A\u03b24-42 has been largely neglected. The present review will therefore focus on A\u03b24-42 as a possible drug target based on human and mouse pathology, in vitro and in vivo toxicity, and anti-A\u03b24-X therapeutic effects in preclinical models."}
{"qid": "530cefaaad0bf1360c00000c", "original_text": "Certain medications can interfere with purine metabolism, which can be particularly relevant for the treatment of T-cell prolymphocytic leukemia (T-PLL). Here are some medications that can impact purine metabolism: 1. Azathioprine: This medication is commonly used to treat T-PLL, and it can inhibit the enzyme thymidylate synthase, which is involved in purine metabolism. 2. 6-Mercaptopurine: This drug is also commonly used to treat T-PLL, and it can inhibit the enzyme purine nucleoside phosphorylase, which is involved in the degradation of purine nucleotides. 3. Methotrexate: This medication is often used in the treatment of T-PLL, and it can inhibit the enzyme dihydrofolate reductase, which is involved in the metabolism of folic acid and purine nucleotides. It's important to note that the impact of these medications on purine metabolism can vary depending on the specific medication, dosage, and individual patient factors. Medical professionals should be consulted for accurate information on the potential effects of these medications on purine metabolism and their relevance to T-PLL treatment.", "label": 0, "is_selected": 0, "text": "Certain medications can interfere with purine metabolism, which can be particularly relevant for the treatment of T-cell prolymphocytic leukemia (T-PLL). Here are some medications that can impact purine metabolism: 1. Azathioprine: This medication is commonly used to treat T-PLL, and it can inhibit the enzyme thymidylate synthase, which is involved in purine metabolism. 2. 6-Mercaptopurine: This drug is also commonly used to treat T-PLL, and it can inhibit the enzyme purine nucleoside phosphorylase, which is involved in the degradation of purine nucleotides. 3. Methotrexate: This medication is often used in the treatment of T-PLL, and it can inhibit the enzyme dihydrofolate reductase, which is involved in the metabolism of folic acid and purine nucleotides. It's important to note that the impact of these medications on purine metabolism can vary depending on the specific medication, dosage, and individual patient factors. Medical professionals should be consulted for accurate information on the potential effects of these medications on purine metabolism and their relevance to T-PLL treatment."}
{"qid": "516c1041298dcd4e51000070", "original_text": "The angiotensin II type 1 receptor (AT1R) is involved in the development of cardiac hypertrophy promoted by thyroid hormone. Recently, we demonstrated that triiodothyronine (T\u2083) rapidly increases AT1R mRNA and protein levels in cardiomyocyte cultures. However, the molecular mechanisms responsible for these rapid events are not yet known. In this study, we investigated the T\u2083 effect on AT1R mRNA polyadenylation in cultured cardiomyocytes as well as on the expression of microRNA-350 (miR-350), which targets AT1R mRNA. The transcriptional and translational actions mediated by T\u2083 on AT1R levels were also assessed.", "label": 1, "is_selected": 0, "text": "The angiotensin II type 1 receptor (AT1R) is involved in the development of cardiac hypertrophy promoted by thyroid hormone. Recently, we demonstrated that triiodothyronine (T\u2083) rapidly increases AT1R mRNA and protein levels in cardiomyocyte cultures. However, the molecular mechanisms responsible for these rapid events are not yet known. In this study, we investigated the T\u2083 effect on AT1R mRNA polyadenylation in cultured cardiomyocytes as well as on the expression of microRNA-350 (miR-350), which targets AT1R mRNA. The transcriptional and translational actions mediated by T\u2083 on AT1R levels were also assessed."}
{"qid": "5c76cea17c78d694710000a7", "original_text": "ADP-ribosylation is a post-translational modification (PTM) implicated in several crucial cellular processes, ranging from regulation of DNA repair and chromatin structure to cell metabolism and stress responses. To date, a complete understanding of ADP-ribosylation targets and their modification sites in different tissues and disease states is still lacking. Identification of ADP-ribosylation sites is required to discern the molecular mechanisms regulated by this modification. This motivated us to develop a computational tool for the prediction of ADP-ribosylated sites.", "label": 1, "is_selected": 0, "text": "ADP-ribosylation is a post-translational modification (PTM) implicated in several crucial cellular processes, ranging from regulation of DNA repair and chromatin structure to cell metabolism and stress responses. To date, a complete understanding of ADP-ribosylation targets and their modification sites in different tissues and disease states is still lacking. Identification of ADP-ribosylation sites is required to discern the molecular mechanisms regulated by this modification. This motivated us to develop a computational tool for the prediction of ADP-ribosylated sites."}
{"qid": "55181d1e6487737b43000008", "original_text": "Nitric oxide (NO), a key macrophage antimycobacterial mediator that ameliorates immunopathology, is measurable in exhaled breath in individuals with pulmonary tuberculosis. We investigated relationships between fractional exhale NO (FENO) and initial pulmonary tuberculosis severity, change during treatment, and relationship with conversion of sputum culture to negative at 2 months. In Papua, we measured FENO in patients with pulmonary tuberculosis at baseline and serially over 6 months and once in healthy controls. Treatment outcomes were conversion of sputum culture results at 2 months and time to conversion of sputum microscopy results. Among 200 patients with pulmonary tuberculosis and 88 controls, FENO was lower for patients with pulmonary tuberculosis at diagnosis (geometric mean FENO, 12.7 parts per billion [ppb]; 95% confidence interval [CI], 11.6-13.8) than for controls (geometric mean FENO, 16.6 ppb; 95% CI, 14.2-19.5; P = .002), fell further after treatment initiation (nadir at 1 week), and then recovered by 6 months (P = .03). Lower FENO was associated with more-severe tuberculosis disease, with FENO directly proportional to weight (P < .001) and forced vital-capacity (P = .001) and inversely proportional to radiological score (P = .03). People whose FENO increased or remained unchanged by 2 months were 2.7-fold more likely to achieve conversion of sputum culture than those whose FENO decreased (odds ratio, 2.72; 95% CI, 1.05-7.12; P = .04).", "label": 1, "is_selected": 0, "text": "Nitric oxide (NO), a key macrophage antimycobacterial mediator that ameliorates immunopathology, is measurable in exhaled breath in individuals with pulmonary tuberculosis. We investigated relationships between fractional exhale NO (FENO) and initial pulmonary tuberculosis severity, change during treatment, and relationship with conversion of sputum culture to negative at 2 months. In Papua, we measured FENO in patients with pulmonary tuberculosis at baseline and serially over 6 months and once in healthy controls. Treatment outcomes were conversion of sputum culture results at 2 months and time to conversion of sputum microscopy results. Among 200 patients with pulmonary tuberculosis and 88 controls, FENO was lower for patients with pulmonary tuberculosis at diagnosis (geometric mean FENO, 12.7 parts per billion [ppb]; 95% confidence interval [CI], 11.6-13.8) than for controls (geometric mean FENO, 16.6 ppb; 95% CI, 14.2-19.5; P = .002), fell further after treatment initiation (nadir at 1 week), and then recovered by 6 months (P = .03). Lower FENO was associated with more-severe tuberculosis disease, with FENO directly proportional to weight (P < .001) and forced vital-capacity (P = .001) and inversely proportional to radiological score (P = .03). People whose FENO increased or remained unchanged by 2 months were 2.7-fold more likely to achieve conversion of sputum culture than those whose FENO decreased (odds ratio, 2.72; 95% CI, 1.05-7.12; P = .04)."}
{"qid": "601c13be1cb411341a00000d", "original_text": "Omecamtiv mecarbil (OM) is a selective cardiac myosin activator (myotrope), currently in Phase 3 clinical investigation as a novel treatment for heart failure with reduced ejection fraction. OM increases cardiac contractility by enhancing interaction between myosin and actin in a calcium-independent fashion. This study aims to characterize the mechanism of action by evaluating its simultaneous effect on myocyte contractility and calcium-transients (CTs) in healthy canine ventricular myocytes. Left ventricular myocytes were isolated from canines and loaded with Fura-2 AM. With an IonOptix system, contractility parameters including amplitude and duration of sarcomere shortening, contraction and relaxation velocity, and resting sarcomere length were measured.", "label": 1, "is_selected": 0, "text": "Omecamtiv mecarbil (OM) is a selective cardiac myosin activator (myotrope), currently in Phase 3 clinical investigation as a novel treatment for heart failure with reduced ejection fraction. OM increases cardiac contractility by enhancing interaction between myosin and actin in a calcium-independent fashion. This study aims to characterize the mechanism of action by evaluating its simultaneous effect on myocyte contractility and calcium-transients (CTs) in healthy canine ventricular myocytes. Left ventricular myocytes were isolated from canines and loaded with Fura-2 AM. With an IonOptix system, contractility parameters including amplitude and duration of sarcomere shortening, contraction and relaxation velocity, and resting sarcomere length were measured."}
{"qid": "52f896d62059c6d71c000046", "original_text": "Gulf War Syndrome refers to a complex and multifactorial disorder that affected veterans of the 1991 Gulf War. Memory problems are a common symptom of this syndrome, and can include difficulties with short-term memory, working memory, and episodic memory. These memory problems can range from mild to severe and can significantly impact daily functioning. Research has shown that Gulf War Syndrome is associated with a number of factors, including exposure to chemical warfare agents, pesticides, and other toxins during the Gulf War. In addition, psychological stress, sleep disturbances, and other comorbid conditions can exacerbate memory problems. The memory problems experienced by Gulf War veterans can be characterized by difficulties with tasks such as: * Learning new information * Remembering recent events * Recalling past events * Paying attention and staying focused * Following instructions It is important to note that these memory problems can be treated with therapies such as cognitive-behavioral therapy, counseling, and medication. However, the exact causes and most effective treatments for Gulf War Syndrome are still being researched and debated. Therefore, it is crucial to consult with a healthcare professional for accurate diagnosis and treatment.", "label": 0, "is_selected": 0, "text": "Gulf War Syndrome refers to a complex and multifactorial disorder that affected veterans of the 1991 Gulf War. Memory problems are a common symptom of this syndrome, and can include difficulties with short-term memory, working memory, and episodic memory. These memory problems can range from mild to severe and can significantly impact daily functioning. Research has shown that Gulf War Syndrome is associated with a number of factors, including exposure to chemical warfare agents, pesticides, and other toxins during the Gulf War. In addition, psychological stress, sleep disturbances, and other comorbid conditions can exacerbate memory problems. The memory problems experienced by Gulf War veterans can be characterized by difficulties with tasks such as: * Learning new information * Remembering recent events * Recalling past events * Paying attention and staying focused * Following instructions It is important to note that these memory problems can be treated with therapies such as cognitive-behavioral therapy, counseling, and medication. However, the exact causes and most effective treatments for Gulf War Syndrome are still being researched and debated. Therefore, it is crucial to consult with a healthcare professional for accurate diagnosis and treatment."}
{"qid": "52b2ec744003448f55000001", "original_text": "To examine the efficacy of combination therapy with levothyroxine and liothyronine in improvement of general health, psychological problems, and metabolic status in primary hypothyroidism. Seventy-one patients diagnosed with primary hypothyroidism were randomly allocated into two study groups: the first group received usual dose of levothyroxine and the second group received combination of levothyroxine and liothyronine for at least 4 months. The main outcomes were psychosocial problems (Goldberg's General Health Questionnaire, GHQ-28), bodyweight, heart rate, blood pressure, and serum lipid levels. In both groups serum thyroid-stimulating hormone levels remained unchanged compared with baseline.", "label": 1, "is_selected": 0, "text": "To examine the efficacy of combination therapy with levothyroxine and liothyronine in improvement of general health, psychological problems, and metabolic status in primary hypothyroidism. Seventy-one patients diagnosed with primary hypothyroidism were randomly allocated into two study groups: the first group received usual dose of levothyroxine and the second group received combination of levothyroxine and liothyronine for at least 4 months. The main outcomes were psychosocial problems (Goldberg's General Health Questionnaire, GHQ-28), bodyweight, heart rate, blood pressure, and serum lipid levels. In both groups serum thyroid-stimulating hormone levels remained unchanged compared with baseline."}
{"qid": "51600ab3298dcd4e51000036", "original_text": "DNA G-quadruplexes are complexes formed by guanine-rich sequences in DNA. The most commonly reported pathological states associated with their formation are: 1. Cancer: G-quadruplexes are known to play a role in the development and progression of various types of cancer, including leukemia, breast cancer, and colon cancer. 2. Premature aging: G-quadruplex formation has been linked to premature aging and age-related diseases, such as cardiovascular disease and Alzheimer's disease. 3. Genetic disorders: G-quadruplexes have been implicated in the pathogenesis of genetic disorders, including sickle cell anemia and cystic fibrosis. 4. Neurodegenerative diseases: G-quadruplexes have been associated with the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. 5. Viral infections: G-quadruplexes can be used as a target for antiviral therapy, as some viruses, such as HIV, have been shown to manipulate G-quadruplex formation to their advantage. It is important to note that the pathological states associated with G-quadruplexes are not limited to these, and ongoing research is continuing to uncover new connections.", "label": 0, "is_selected": 1, "text": "The formation of G-quadruplexes has been implicated in a number of diseases, including cancer, premature aging, genetic disorders, and neurodegenerative diseases, all of which have been linked to the development and progression of these diseases through their association with the formation of guanine-rich DNA sequences in the nucleus of living cells, as well as viruses and bacteria, including HIV and hepatitis C."}
{"qid": "6252f496e764a53204000020", "original_text": "Cholesterol metabolism is tightly regulated at the cellular level. This study was to measure the expression levels of ATP-binding cassette transporter A1 (ABCA1) and G1 (ABCG1), scavenger receptor class B type I (SR-BI) and class A (SRA), and CD36 mRNAs in peripheral blood mononuclear cells (PBMCs) in response to 100-km ultramarathon event and determine any correlation between these ABC transporters/scavenger receptor expression levels and plasma cholesterol homeostasis. Twenty-six participants were enrolled. Blood was drawn from each individual 1 week prior, immediately after, and 24 hours after the race.", "label": 1, "is_selected": 0, "text": "Cholesterol metabolism is tightly regulated at the cellular level. This study was to measure the expression levels of ATP-binding cassette transporter A1 (ABCA1) and G1 (ABCG1), scavenger receptor class B type I (SR-BI) and class A (SRA), and CD36 mRNAs in peripheral blood mononuclear cells (PBMCs) in response to 100-km ultramarathon event and determine any correlation between these ABC transporters/scavenger receptor expression levels and plasma cholesterol homeostasis. Twenty-six participants were enrolled. Blood was drawn from each individual 1 week prior, immediately after, and 24 hours after the race."}
{"qid": "56c1f042ef6e394741000056", "original_text": "Craniosynostoses are premature ossifications of cranial sutures. They occur isolated and syndromic. Syndromic craniosynostoses are mainly associated with mutations of the Fibroblast Growth Factor Receptors (FGFR) 1 - 3. This paper gives an overview of the etiology and pathophysiology of isolated and syndromic craniosynostoses and discusses the molecular genetic results in 21 index cases (19 seemingly isolated craniosynostoses, 2 cases with a clinical diagnosis of Crouzon's syndrome). Mutation analysis in exons of the FGFR 1 - 3 known to be preferentially affected in craniosynostoses was performed on DNA samples from peripheral blood and bone specimen excised at the time of surgery to correct the craniosynostosis. In a girl with seemingly isolated plagiocephaly we identified a P250L (749C-->T) mutation in FGFR3. Her mother showed minor signs of craniosynostosis when the family was re-evaluated. She was shown to carry the same mutation.", "label": 1, "is_selected": 0, "text": "Craniosynostoses are premature ossifications of cranial sutures. They occur isolated and syndromic. Syndromic craniosynostoses are mainly associated with mutations of the Fibroblast Growth Factor Receptors (FGFR) 1 - 3. This paper gives an overview of the etiology and pathophysiology of isolated and syndromic craniosynostoses and discusses the molecular genetic results in 21 index cases (19 seemingly isolated craniosynostoses, 2 cases with a clinical diagnosis of Crouzon's syndrome). Mutation analysis in exons of the FGFR 1 - 3 known to be preferentially affected in craniosynostoses was performed on DNA samples from peripheral blood and bone specimen excised at the time of surgery to correct the craniosynostosis. In a girl with seemingly isolated plagiocephaly we identified a P250L (749C-->T) mutation in FGFR3. Her mother showed minor signs of craniosynostosis when the family was re-evaluated. She was shown to carry the same mutation."}
{"qid": "603bc3181cb411341a00015c", "original_text": "The mammalian version of arginine vasotocin is called oxytocin. Oxytocin is a polypeptide hormone that is produced in the hypothalamus and released by the posterior pituitary gland. It plays a critical role in a variety of physiological and psychological processes, including sexual behavior, social bonding, and lactation. Oxytocin has been extensively studied in the medical literature, and its mechanism of action and effects on various bodily systems are well-documented.", "label": 0, "is_selected": 1, "text": "Oxytocin is a hormone produced by the hypothalamus in the brain and plays a key role in the regulation of sexual and social behaviour, as well as in the production and release of other hormones such as insulin and growth hormone, among other things."}
{"qid": "532f0bd6d6d3ac6a3400002d", "original_text": "Weill-Marchesani syndrome (WMS) is a well-characterized disorder in which patients develop eye and skeletal abnormalities. Autosomal-recessive and autosomal-dominant forms of WMS are caused by mutations in ADAMTS10 and FBN1 genes, respectively. Here we report on 13 patients from seven unrelated families from the Arabian Peninsula. These patients have a constellation of features that fall within the WMS spectrum and follow an autosomal-recessive mode of inheritance. Individuals who came from two families and met the diagnostic criteria for WMS were each found to have a different homozygous missense mutation in ADAMTS10.", "label": 1, "is_selected": 0, "text": "Weill-Marchesani syndrome (WMS) is a well-characterized disorder in which patients develop eye and skeletal abnormalities. Autosomal-recessive and autosomal-dominant forms of WMS are caused by mutations in ADAMTS10 and FBN1 genes, respectively. Here we report on 13 patients from seven unrelated families from the Arabian Peninsula. These patients have a constellation of features that fall within the WMS spectrum and follow an autosomal-recessive mode of inheritance. Individuals who came from two families and met the diagnostic criteria for WMS were each found to have a different homozygous missense mutation in ADAMTS10."}
{"qid": "5314a7a4dae131f847000003", "original_text": "PurposeHypertrophic cardiomyopathy is the most common cause of sudden death in young people, including trained athletes, and is caused by mutations in genes encoding proteins of the cardiac sarcomere. Mutations in the Troponin C gene (TNNC1) are a rare genetic cause of hypertrophic cardiomyopathy. We describe a novel type of mutation (c.363dupG) in Troponin C, a rare form of hypertrophic cardiomyopathy. A family in which a 19-year-old asymptomatic male died of sudden cardiac death due to hypertrophic cardiomyopathy was genetically studied by sequencing 17 genes associated with hypertrophic cardiomyopathy or its phenocopies. A c.363dupG mutation in Troponin C was identified, and tested across the family. We report the first frameshift mutation (c.363dupG or p.Gln122AlafsX30) in Troponin C causing hypertrophic cardiomyopathy (and sudden cardiac death) in a 19-year-old male, and have demonstrated that the mutation segregates with hypertrophic cardiomyopathy within the family.", "label": 1, "is_selected": 0, "text": "PurposeHypertrophic cardiomyopathy is the most common cause of sudden death in young people, including trained athletes, and is caused by mutations in genes encoding proteins of the cardiac sarcomere. Mutations in the Troponin C gene (TNNC1) are a rare genetic cause of hypertrophic cardiomyopathy. We describe a novel type of mutation (c.363dupG) in Troponin C, a rare form of hypertrophic cardiomyopathy. A family in which a 19-year-old asymptomatic male died of sudden cardiac death due to hypertrophic cardiomyopathy was genetically studied by sequencing 17 genes associated with hypertrophic cardiomyopathy or its phenocopies. A c.363dupG mutation in Troponin C was identified, and tested across the family. We report the first frameshift mutation (c.363dupG or p.Gln122AlafsX30) in Troponin C causing hypertrophic cardiomyopathy (and sudden cardiac death) in a 19-year-old male, and have demonstrated that the mutation segregates with hypertrophic cardiomyopathy within the family."}
{"qid": "6020ad161cb411341a000082", "original_text": "The increase in global obesity rates over the past three decades has been remarkable, a true epidemic, both in developed and in developing countries. The projections, based on current trends, suggest an increase in the prevalence of obesity at 60% in adult men, 40% in adult women and 25% in children in 2050. Given the limitations of lifestyle and surgery interventions bariatric, drug therapy approaches for the treatment of obesity, therefore become important options. The purpose of this review is a review of the literature, based on research on MEDLINE until 2019, on the possible pharmacological options in the treatment of obesity. Currently, the FDA has approved several molecules for the treatment of obesity, both in monotherapy and in combination. Pharmacological monotherapies focus mainly on a single protein target and include orlistat, lorcaserin and liraglutide while the combination molecules propose a multitarget approach and include phentermine/topiramate and naltrexone/bupropion. All the approved drugs showed, in the different studies, a weight reduction of at least 5%, compared to placebo, in 52 weeks of observation.", "label": 1, "is_selected": 0, "text": "The increase in global obesity rates over the past three decades has been remarkable, a true epidemic, both in developed and in developing countries. The projections, based on current trends, suggest an increase in the prevalence of obesity at 60% in adult men, 40% in adult women and 25% in children in 2050. Given the limitations of lifestyle and surgery interventions bariatric, drug therapy approaches for the treatment of obesity, therefore become important options. The purpose of this review is a review of the literature, based on research on MEDLINE until 2019, on the possible pharmacological options in the treatment of obesity. Currently, the FDA has approved several molecules for the treatment of obesity, both in monotherapy and in combination. Pharmacological monotherapies focus mainly on a single protein target and include orlistat, lorcaserin and liraglutide while the combination molecules propose a multitarget approach and include phentermine/topiramate and naltrexone/bupropion. All the approved drugs showed, in the different studies, a weight reduction of at least 5%, compared to placebo, in 52 weeks of observation."}
{"qid": "5a77072c9e632bc06600000a", "original_text": "Craniosynostosis, the premature closure of cranial suture, is a pathologic condition that affects 1/2000 live births. Saethre-Chotzen syndrome is a genetic condition characterized by craniosynostosis. The Saethre-Chotzen syndrome, which is defined by loss-of-function mutations in the TWIST gene, is the second most prevalent craniosynostosis. Although much of the genetics and phenotypes in craniosynostosis syndromes is understood, less is known about the underlying ossification mechanism during suture closure. We have previously demonstrated that physiological closure of the posterior frontal suture occurs through endochondral ossification. Moreover, we revealed that antagonizing canonical Wnt-signaling in the sagittal suture leads to endochondral ossification of the suture mesenchyme and sagittal synostosis, presumably by inhibiting Twist1. Classic Saethre-Chotzen syndrome is characterized by coronal synostosis, and the haploinsufficient Twist1(+/-) mice represents a suitable model for studying this syndrome. Thus, we seeked to understand the underlying ossification process in coronal craniosynostosis in Twist1(+/-) mice. Our data indicate that coronal suture closure in Twist1(+/-) mice occurs between postnatal day 9 and 13 by endochondral ossification, as shown by histology, gene expression analysis, and immunohistochemistry.", "label": 1, "is_selected": 0, "text": "Craniosynostosis, the premature closure of cranial suture, is a pathologic condition that affects 1/2000 live births. Saethre-Chotzen syndrome is a genetic condition characterized by craniosynostosis. The Saethre-Chotzen syndrome, which is defined by loss-of-function mutations in the TWIST gene, is the second most prevalent craniosynostosis. Although much of the genetics and phenotypes in craniosynostosis syndromes is understood, less is known about the underlying ossification mechanism during suture closure. We have previously demonstrated that physiological closure of the posterior frontal suture occurs through endochondral ossification. Moreover, we revealed that antagonizing canonical Wnt-signaling in the sagittal suture leads to endochondral ossification of the suture mesenchyme and sagittal synostosis, presumably by inhibiting Twist1. Classic Saethre-Chotzen syndrome is characterized by coronal synostosis, and the haploinsufficient Twist1(+/-) mice represents a suitable model for studying this syndrome. Thus, we seeked to understand the underlying ossification process in coronal craniosynostosis in Twist1(+/-) mice. Our data indicate that coronal suture closure in Twist1(+/-) mice occurs between postnatal day 9 and 13 by endochondral ossification, as shown by histology, gene expression analysis, and immunohistochemistry."}
{"qid": "623a24d6f0baec9a1b000002", "original_text": "Telomestatin is a novel statin drug that is currently being investigated for the treatment of high cholesterol. It works by inhibiting the production of cholesterol in the liver, which can help to lower total cholesterol levels and reduce the risk of cardiovascular disease. However, it is important to note that telomestatin is still in the experimental stage and has not been approved for use by regulatory authorities. Therefore, it is not yet available for use in clinical practice.", "label": 0, "is_selected": 1, "text": "The European Medicines Agency (EMA) has granted marketing authorisation for the cholesterol-lowering drug, telomestatin, for the treatment of patients with type 2 diabetes and those at high risk of heart attack and stroke, as well as those with homozygous familial hypercholesterolaemia."}
{"qid": "51630226298dcd4e5100004d", "original_text": "Chromatin is a highly structured nucleoprotein complex made of histone proteins and DNA that controls nearly all DNA-dependent processes. Chromatin plasticity is regulated by different associated proteins, post-translational modifications on histones (hPTMs) and DNA methylation, which act in a concerted manner to enforce a specific \"chromatin landscape\", with a regulatory effect on gene expression. Mass Spectrometry (MS) has emerged as a powerful analytical strategy to detect histone PTMs, revealing interplays between neighbouring PTMs and enabling screens for their readers in a comprehensive and quantitative fashion. Here we provide an overview of the recent achievements of state-of-the-art mass spectrometry-based proteomics for the detailed qualitative and quantitative characterization of histone post-translational modifications, histone variants, and global interactomes at specific chromatin regions.", "label": 1, "is_selected": 0, "text": "Chromatin is a highly structured nucleoprotein complex made of histone proteins and DNA that controls nearly all DNA-dependent processes. Chromatin plasticity is regulated by different associated proteins, post-translational modifications on histones (hPTMs) and DNA methylation, which act in a concerted manner to enforce a specific \"chromatin landscape\", with a regulatory effect on gene expression. Mass Spectrometry (MS) has emerged as a powerful analytical strategy to detect histone PTMs, revealing interplays between neighbouring PTMs and enabling screens for their readers in a comprehensive and quantitative fashion. Here we provide an overview of the recent achievements of state-of-the-art mass spectrometry-based proteomics for the detailed qualitative and quantitative characterization of histone post-translational modifications, histone variants, and global interactomes at specific chromatin regions."}
{"qid": "5ac2776195d0062724000006", "original_text": "Huntington's Disease (HD) is a fatally inherited neurodegenerative disorder caused by an expanded glutamine repeat in the N-terminal region of the huntingtin (HTT) protein. The result is a progressively worsening triad of cognitive, emotional, and motor alterations that typically begin in adulthood and end in death 10-20 years later. Autopsy of HD patients indicates massive cell loss in the striatum and its main source of input, the cerebral cortex. Further studies of HD patients and transgenic animal models of HD indicate that corticostriatal neuronal processing is altered long before neuronal death takes place. In fact, altered neuronal function appears to be the primary driver of the HD behavioral phenotype, and dysregulation of glutamate, the excitatory amino acid released by corticostriatal afferents, is believed to play a critical role. Although mutant HTT interferes with the operation of multiple proteins related to glutamate transmission, consistent evidence links the expression of mutant HTT with reduced activity of glutamate transporter 1 (rodent GLT1 or human EAAT2), the astrocytic protein responsible for the bulk of glutamate uptake.", "label": 1, "is_selected": 0, "text": "Huntington's Disease (HD) is a fatally inherited neurodegenerative disorder caused by an expanded glutamine repeat in the N-terminal region of the huntingtin (HTT) protein. The result is a progressively worsening triad of cognitive, emotional, and motor alterations that typically begin in adulthood and end in death 10-20 years later. Autopsy of HD patients indicates massive cell loss in the striatum and its main source of input, the cerebral cortex. Further studies of HD patients and transgenic animal models of HD indicate that corticostriatal neuronal processing is altered long before neuronal death takes place. In fact, altered neuronal function appears to be the primary driver of the HD behavioral phenotype, and dysregulation of glutamate, the excitatory amino acid released by corticostriatal afferents, is believed to play a critical role. Although mutant HTT interferes with the operation of multiple proteins related to glutamate transmission, consistent evidence links the expression of mutant HTT with reduced activity of glutamate transporter 1 (rodent GLT1 or human EAAT2), the astrocytic protein responsible for the bulk of glutamate uptake."}
{"qid": "58cd7fed02b8c6095300003f", "original_text": "The calcium-sensing receptor (CaSR) is a G protein-coupled receptor that plays a crucial role in regulating calcium homeostasis in the body. It is primarily found in the parathyroid glands, kidneys, and bone, where it helps to sense changes in extracellular calcium levels and respond accordingly. The CaSR functions as a negative regulator of calcium absorption in the gut and a positive regulator of calcium reabsorption in the kidneys. It also regulates the expression of genes involved in calcium metabolism and bone remodeling. Dysfunction of the CaSR has been implicated in several diseases, including hypertension, cardiovascular disease, and bone disorders, such as hyperparathyroidism and osteoporosis.", "label": 0, "is_selected": 0, "text": "The calcium-sensing receptor (CaSR) is a G protein-coupled receptor that plays a crucial role in regulating calcium homeostasis in the body. It is primarily found in the parathyroid glands, kidneys, and bone, where it helps to sense changes in extracellular calcium levels and respond accordingly. The CaSR functions as a negative regulator of calcium absorption in the gut and a positive regulator of calcium reabsorption in the kidneys. It also regulates the expression of genes involved in calcium metabolism and bone remodeling. Dysfunction of the CaSR has been implicated in several diseases, including hypertension, cardiovascular disease, and bone disorders, such as hyperparathyroidism and osteoporosis."}
{"qid": "5e323780fbd6abf43b000055", "original_text": "Yes, there is an increased risk of meningiomas in atomic bomb survivors. Studies have shown that exposure to ionizing radiation, such as that received during the atomic bombing of Hiroshima and Nagasaki, can increase the risk of developing meningiomas, which are benign tumors that arise in the meninges, the protective membranes that cover the brain and spinal cord. This increased risk is thought to be due to the genetic mutations caused by radiation exposure. According to one study, the risk of developing meningioma was found to be significantly higher in atomic bomb survivors than in the general population, with an estimated lifetime attributable risk of 4.2%. It is important to note that this increased risk is still relatively low compared to other radiation-induced cancers, but it is a significant concern for those exposed to ionizing radiation, particularly in the context of nuclear disasters or radiation therapy.", "label": 0, "is_selected": 0, "text": "Yes, there is an increased risk of meningiomas in atomic bomb survivors. Studies have shown that exposure to ionizing radiation, such as that received during the atomic bombing of Hiroshima and Nagasaki, can increase the risk of developing meningiomas, which are benign tumors that arise in the meninges, the protective membranes that cover the brain and spinal cord. This increased risk is thought to be due to the genetic mutations caused by radiation exposure. According to one study, the risk of developing meningioma was found to be significantly higher in atomic bomb survivors than in the general population, with an estimated lifetime attributable risk of 4.2%. It is important to note that this increased risk is still relatively low compared to other radiation-induced cancers, but it is a significant concern for those exposed to ionizing radiation, particularly in the context of nuclear disasters or radiation therapy."}
{"qid": "515df1d4298dcd4e5100002b", "original_text": "Allopurinol, a xanthine oxidase inhibitor, has been studied for its potential effect on asphyxia in neonates. However, there is limited research in this area, and the existing evidence is largely inconclusive. One study published in the Journal of Perinatology found that allopurinol may have a protective effect on asphyxia in neonates by reducing the production of reactive oxygen species (ROS) in response to hypoxia. The study suggested that allopurinol may be a potential therapeutic agent for the prevention and treatment of asphyxia in neonates. However, another study published in the Journal of Maternal-Fetal & Neonatal Medicine found that allopurinol had no significant effect on the outcome of asphyxia in neonates. The study included 20 neonates with asphyxia who were treated with allopurinol, but the results were not conclusive. In summary, while there is some evidence to suggest that allopurinol may have a protective effect on asphyxia in neonates, further research is needed to confirm these findings. I don't have an answer to the question of whether allopurinol can cure asphyxia in neonates.", "label": 0, "is_selected": 0, "text": "Allopurinol, a xanthine oxidase inhibitor, has been studied for its potential effect on asphyxia in neonates. However, there is limited research in this area, and the existing evidence is largely inconclusive. One study published in the Journal of Perinatology found that allopurinol may have a protective effect on asphyxia in neonates by reducing the production of reactive oxygen species (ROS) in response to hypoxia. The study suggested that allopurinol may be a potential therapeutic agent for the prevention and treatment of asphyxia in neonates. However, another study published in the Journal of Maternal-Fetal & Neonatal Medicine found that allopurinol had no significant effect on the outcome of asphyxia in neonates. The study included 20 neonates with asphyxia who were treated with allopurinol, but the results were not conclusive. In summary, while there is some evidence to suggest that allopurinol may have a protective effect on asphyxia in neonates, further research is needed to confirm these findings. I don't have an answer to the question of whether allopurinol can cure asphyxia in neonates."}
{"qid": "5162e44f298dcd4e5100004a", "original_text": "Neprilysin is an enzyme that has been shown to have a positive effect on Alzheimer's disease by breaking down amyloid-\u03b2 peptides, which are a hallmark of the disease. The challenge is to deliver neprilysin to the brain, as it is primarily found in the liver and kidneys. Several delivery methods have been investigated, including: 1. Intravenous administration: Neprilysin can be delivered directly to the brain through the bloodstream using intravenous administration. This allows for rapid distribution and targeting of the enzyme to the brain. 2. Nasal administration: Neprilysin can also be delivered directly to the brain through the nasal route. This method has shown promise as it bypasses the blood-brain barrier and allows for direct targeting of the enzyme to the brain. 3. Intrathecal administration: Intrathecal delivery involves injecting the enzyme directly into the cerebrospinal fluid (CSF) surrounding the brain and spinal cord. This method has been shown to be effective in delivering neprilysin to the brain and has the added benefit of bypassing the blood-brain barrier. 4. Electroceutical delivery: Electroceuticals are electrical impulses that can be used to deliver drugs or other molecules directly to the brain. This method has shown promise in delivering neprilysin to the brain and bypassing the blood-brain barrier. It is important to note that further research is needed to fully understand the safety and efficacy of these delivery methods and to determine the optimal delivery method for neprilysin in the treatment of Alzheimer's disease.", "label": 0, "is_selected": 1, "text": "The Canadian Institutes of Health Research (CIHR) has been funding research into the delivery of neprilysin to the brain as a potential treatment for Alzheimer's disease. This method has shown promise as it bypasses the blood-brain barrier and allows for direct targeting of the enzyme to the Brain. (Please note that this article is not intended to be a substitute for professional medical advice and should not be relied on as such.) This article has been published by the Canadian Medical Association Journal (CMAJ) in partnership with the Canadian Institute for Health Information (CII) and the University of British Columbia (UBC)."}
{"qid": "5abc9157fcf456587200001e", "original_text": "Large-scale sequencing studies discovered substantial genetic variants occurring in enhancers which regulate genes via long range chromatin interactions. Importantly, such variants could affect enhancer regulation by changing transcription factor bindings or enhancer hijacking, and in turn, make an essential contribution to disease progression. To facilitate better usage of published data and exploring enhancer deregulation in various human diseases, we created DiseaseEnhancer (http://biocc.hrbmu.edu.cn/DiseaseEnhancer/), a manually curated database for disease-associated enhancers. As of July 2017, DiseaseEnhancer includes 847 disease-associated enhancers in 143 human diseases. Database features include basic enhancer information (i.e. genomic location and target genes); disease types; associated variants on the enhancer and their mediated phenotypes (i.e. gain/loss of enhancer and the alterations of transcription factor bindings).", "label": 1, "is_selected": 0, "text": "Large-scale sequencing studies discovered substantial genetic variants occurring in enhancers which regulate genes via long range chromatin interactions. Importantly, such variants could affect enhancer regulation by changing transcription factor bindings or enhancer hijacking, and in turn, make an essential contribution to disease progression. To facilitate better usage of published data and exploring enhancer deregulation in various human diseases, we created DiseaseEnhancer (http://biocc.hrbmu.edu.cn/DiseaseEnhancer/), a manually curated database for disease-associated enhancers. As of July 2017, DiseaseEnhancer includes 847 disease-associated enhancers in 143 human diseases. Database features include basic enhancer information (i.e. genomic location and target genes); disease types; associated variants on the enhancer and their mediated phenotypes (i.e. gain/loss of enhancer and the alterations of transcription factor bindings)."}
{"qid": "58cbf1f402b8c60953000036", "original_text": "A quantitative trait locus (QTL) affecting milk fat percentage has been mapped to the centromeric end of the bovine chromosome 14 (BTA14). This genomic area includes the DGAT1 gene, which encodes acyl-CoA:diacylglycerol acyltransferase 1, the key enzyme of triglyceride biosynthesis. Genetic and biochemical studies led to the identification of the nonconservative DGAT1-K232A polymorphism as a causal mutation for the QTL. In addition to this, another polymorphism in the 5'-regulatory region of this gene, the DGAT1 variable number of tandem repeat (VNTR), also showed a strong association with milk fat percentage. This promoter VNTR polymorphism affects the number of potential Sp1 binding sites and therefore might have an impact on DGAT1 expression and also milk fat content.", "label": 1, "is_selected": 0, "text": "A quantitative trait locus (QTL) affecting milk fat percentage has been mapped to the centromeric end of the bovine chromosome 14 (BTA14). This genomic area includes the DGAT1 gene, which encodes acyl-CoA:diacylglycerol acyltransferase 1, the key enzyme of triglyceride biosynthesis. Genetic and biochemical studies led to the identification of the nonconservative DGAT1-K232A polymorphism as a causal mutation for the QTL. In addition to this, another polymorphism in the 5'-regulatory region of this gene, the DGAT1 variable number of tandem repeat (VNTR), also showed a strong association with milk fat percentage. This promoter VNTR polymorphism affects the number of potential Sp1 binding sites and therefore might have an impact on DGAT1 expression and also milk fat content."}
{"qid": "5c61bacae842deac67000001", "original_text": "Cariprazine (RGH-188) is a novel antipsychotic drug that exerts partial agonism of dopamine D2/D3 receptors with preferential binding to D3 receptor, antagonism of 5HT2B receptors and partial agonism of 5HT1A. Currently, cariprazine is in late-stage clinical development (phase III clinical trials) in patients with schizophrenia (S) and in patients with bipolar disorder (BD), as well as an adjunctive treatment in patients with Major Depressive Disorder (MDD) and drug-resistant MDD. Cariprazine has completed phase III trials for the acute treatment of schizophrenia and bipolar mania, phase II trials for the bipolar depression and MDD whilst it is undergoing phase III trials as an adjunct to antidepressants.", "label": 1, "is_selected": 0, "text": "Cariprazine (RGH-188) is a novel antipsychotic drug that exerts partial agonism of dopamine D2/D3 receptors with preferential binding to D3 receptor, antagonism of 5HT2B receptors and partial agonism of 5HT1A. Currently, cariprazine is in late-stage clinical development (phase III clinical trials) in patients with schizophrenia (S) and in patients with bipolar disorder (BD), as well as an adjunctive treatment in patients with Major Depressive Disorder (MDD) and drug-resistant MDD. Cariprazine has completed phase III trials for the acute treatment of schizophrenia and bipolar mania, phase II trials for the bipolar depression and MDD whilst it is undergoing phase III trials as an adjunct to antidepressants."}
{"qid": "5358e067f1005d6b5800000b", "original_text": "Actin bundling and filopodia formation are crucial processes in cellular mechanics and dynamics, involving the interaction of various proteins. The primary proteins involved in actin bundling include: 1. alpha-actinin: A globular actin-binding protein that helps regulate the stability and structure of actin filaments. 2. Capping protein (CP): A protein that functions as a molecular Velcro, binding to the barbed end of actin filaments and regulating their dynamics. 3. Glycoprotein IIb/IIIa (GP IIb/IIIa): A glycoprotein that plays a critical role in platelet adhesion and aggregation, and is involved in actin bundling and filopodia formation in platelets. The primary proteins involved in filopodia formation and function are: 1. Formin: A protein that helps generate and maintain the actin filament network, particularly in the formation of filopodia. 2. Cofilin: An actin-binding protein that regulates actin dynamics and is involved in filopodia formation and contraction of muscle fibers. 3. Actin-related protein 2/3 complex (ARP2/3 complex): A complex of proteins that regulates the actin filament network and is involved in the formation and stability of filopodia. In summary, actin bundling and filopodia formation are critical processes in cellular dynamics, involving the interaction of various proteins, including alpha-actinin, CP, GP IIb/IIIa, formin, cofilin, and the ARP2/3 complex. Understanding the functions of these proteins is crucial for elucidating the molecular mechanisms underlying cellular behavior and for developing new therapeutic strategies for various diseases.", "label": 0, "is_selected": 1, "text": "Actin bundling and filopodia formation are critical processes in cellular dynamics, involving the interaction of various proteins, including alpha-actinin, CP, GP IIb/IIIa, formin, cofilin, and the ARP2/3 complex, and are crucial for elucidating the molecular mechanisms underlying cellular behavior and for developing new therapeutic strategies for various diseases.In summary actin bundling is a process in which actin filaments are bundled together, and actin-related proteins are involved in the formation and stability of the actin filament network and muscle contraction."}
{"qid": "5544da8f5beec11c10000004", "original_text": "This pilot study examined gene expression signatures in pathological gingival tissues of subjects with chronic or aggressive periodontitis, and explored whether new subclasses of periodontitis can be identified based on gene expression profiles. A total of 14 patients, seven with chronic and seven with aggressive periodontitis, were examined with respect to clinical periodontal status, composition of subgingival bacterial plaque assessed by checkerboard hybridizations, and levels of serum IgG antibodies to periodontal bacteria assayed by checkerboard immunoblotting. In addition, at least two pathological pockets/patient were biopsied, processed for RNA extraction, amplification and labeling, and used to study gene expression using Affymetrix U-133 A arrays. Based on a total of 35 microarrays, no significantly different gene expression profiles appeared to emerge between chronic and aggressive periodontitis. However, a de novo grouping of the 14 subjects into two fairly robust clusters was possible based on similarities in gene expression. These two groups had similar clinical periodontal status and subgingival bacterial profiles, but differed significantly with respect to serum IgG levels against the important periodontal pathogens Porphyromonas gingivalis, Tannerella forsythensis and Campylobacter rectus. These early data point to the usefulness of gene expression profiling techniques in the identification of subclasses of periodontitis with common pathobiology.", "label": 1, "is_selected": 0, "text": "This pilot study examined gene expression signatures in pathological gingival tissues of subjects with chronic or aggressive periodontitis, and explored whether new subclasses of periodontitis can be identified based on gene expression profiles. A total of 14 patients, seven with chronic and seven with aggressive periodontitis, were examined with respect to clinical periodontal status, composition of subgingival bacterial plaque assessed by checkerboard hybridizations, and levels of serum IgG antibodies to periodontal bacteria assayed by checkerboard immunoblotting. In addition, at least two pathological pockets/patient were biopsied, processed for RNA extraction, amplification and labeling, and used to study gene expression using Affymetrix U-133 A arrays. Based on a total of 35 microarrays, no significantly different gene expression profiles appeared to emerge between chronic and aggressive periodontitis. However, a de novo grouping of the 14 subjects into two fairly robust clusters was possible based on similarities in gene expression. These two groups had similar clinical periodontal status and subgingival bacterial profiles, but differed significantly with respect to serum IgG levels against the important periodontal pathogens Porphyromonas gingivalis, Tannerella forsythensis and Campylobacter rectus. These early data point to the usefulness of gene expression profiling techniques in the identification of subclasses of periodontitis with common pathobiology."}
{"qid": "531481ade3eabad021000016", "original_text": "Beta-thalassemia is a genetic, red blood cell disorder affecting the beta-globin chain of the adult hemoglobin gene. This results in excess accumulation of unpaired alpha-chain gene products leading to reduced red blood cell life span and the development of severe anemia. Current treatment of this disease involves regular blood transfusion and adjunct chelation therapy to lower blood transfusion-induced iron overload. Fetal hemoglobin switching agents have been proposed to treat genetic blood disorders, such as sickle cell anemia and beta-thalassemia, in an effort to compensate for the dysfunctional form of the beta-globin chain in adult hemoglobin. The rationale behind this approach is to pair the excess normal alpha-globin chain with the alternative fetal gamma-chain to promote red blood cell survival and ameliorate the anemia. Reprogramming of differentiation in intact, mature, adult white blood cells in response to inclusion of monoclonal antibody CR3/43 has been described. This form of retrograde development has been termed \"retrodifferentiation\", with the ability to re-express a variety of stem cell markers in a heterogeneous population of white blood cells. This form of reprogramming, or reontogeny, to a more pluripotent stem cell state ought to recapitulate early hematopoiesis and facilitate expression of a fetal and/or adult program of hemoglobin synthesis or regeneration on infusion and subsequent redifferentiation. Herein, the outcome of infusion of autologous retrodifferentiated stem cells (RSC) into 21 patients with beta-thalassemia is described. Over 6 months, Infusion of 3-h autologous RSC subjected to hematopoietic-conducive conditions into patients with beta-thalassemia reduced mean blood transfusion requirement, increased mean fetal hemoglobin synthesis, and significantly lowered mean serum ferritin.", "label": 1, "is_selected": 0, "text": "Beta-thalassemia is a genetic, red blood cell disorder affecting the beta-globin chain of the adult hemoglobin gene. This results in excess accumulation of unpaired alpha-chain gene products leading to reduced red blood cell life span and the development of severe anemia. Current treatment of this disease involves regular blood transfusion and adjunct chelation therapy to lower blood transfusion-induced iron overload. Fetal hemoglobin switching agents have been proposed to treat genetic blood disorders, such as sickle cell anemia and beta-thalassemia, in an effort to compensate for the dysfunctional form of the beta-globin chain in adult hemoglobin. The rationale behind this approach is to pair the excess normal alpha-globin chain with the alternative fetal gamma-chain to promote red blood cell survival and ameliorate the anemia. Reprogramming of differentiation in intact, mature, adult white blood cells in response to inclusion of monoclonal antibody CR3/43 has been described. This form of retrograde development has been termed \"retrodifferentiation\", with the ability to re-express a variety of stem cell markers in a heterogeneous population of white blood cells. This form of reprogramming, or reontogeny, to a more pluripotent stem cell state ought to recapitulate early hematopoiesis and facilitate expression of a fetal and/or adult program of hemoglobin synthesis or regeneration on infusion and subsequent redifferentiation. Herein, the outcome of infusion of autologous retrodifferentiated stem cells (RSC) into 21 patients with beta-thalassemia is described. Over 6 months, Infusion of 3-h autologous RSC subjected to hematopoietic-conducive conditions into patients with beta-thalassemia reduced mean blood transfusion requirement, increased mean fetal hemoglobin synthesis, and significantly lowered mean serum ferritin."}
{"qid": "56d046813975bb303a00000f", "original_text": "Dovitinib, a tyrosine kinase inhibitor, has been shown to affect the cell cycle of cancer cells. Studies have revealed that dositinib can cause cell cycle arrest at the G0/G1 phase, particularly in colon cancer cells. This occurs due to the inhibition of key cell cycle regulators, such as cyclin-dependent kinases (CDKs) and cyclins, which are essential for progression through the cell cycle. Additionally, dovinitinib has been shown to induce apoptosis, or programmed cell death, in cancer cells, further contributing to its antineoplastic effects. Overall, the impact of dovitinib on the cell cycle is a critical aspect of its mechanism of action in cancer treatment.", "label": 0, "is_selected": 0, "text": "Dovitinib, a tyrosine kinase inhibitor, has been shown to affect the cell cycle of cancer cells. Studies have revealed that dositinib can cause cell cycle arrest at the G0/G1 phase, particularly in colon cancer cells. This occurs due to the inhibition of key cell cycle regulators, such as cyclin-dependent kinases (CDKs) and cyclins, which are essential for progression through the cell cycle. Additionally, dovinitinib has been shown to induce apoptosis, or programmed cell death, in cancer cells, further contributing to its antineoplastic effects. Overall, the impact of dovitinib on the cell cycle is a critical aspect of its mechanism of action in cancer treatment."}
{"qid": "5c76be617c78d694710000a5", "original_text": "Virtually all patients of the rare inflammatory eye disease birdshot chorioretinopathy (BSCR) carry the HLA-A*29:02 allele. BSCR is also associated with endoplasmic reticulum aminopeptidase 2 (ERAP2), an enzyme involved in processing HLA class I ligands, thus implicating the A*29:02 peptidome in this disease. To investigate the relationship between both risk factors we employed label-free quantitative mass spectrometry to characterize the effects of ERAP2 on the A*29:02-bound peptidome. An ERAP2-negative cell line was transduced with lentiviral constructs containing GFP-ERAP2 or GFP alone, and the A*29:02 peptidomes from both transduced cells were compared.", "label": 1, "is_selected": 0, "text": "Virtually all patients of the rare inflammatory eye disease birdshot chorioretinopathy (BSCR) carry the HLA-A*29:02 allele. BSCR is also associated with endoplasmic reticulum aminopeptidase 2 (ERAP2), an enzyme involved in processing HLA class I ligands, thus implicating the A*29:02 peptidome in this disease. To investigate the relationship between both risk factors we employed label-free quantitative mass spectrometry to characterize the effects of ERAP2 on the A*29:02-bound peptidome. An ERAP2-negative cell line was transduced with lentiviral constructs containing GFP-ERAP2 or GFP alone, and the A*29:02 peptidomes from both transduced cells were compared."}
{"qid": "5c961603ecadf2e73f000022", "original_text": "In patients with immune thrombocytopenia who do not adequately respond to first-line therapy, there is no clear consensus on which second-line therapy to initiate and when. This situation leads to suboptimal approaches, including prolonged exposure to treatments that are not intended for long-term use (eg, corticosteroids) and overuse of off-label therapies (eg, rituximab) while approved, more efficacious options exist. These approaches may not only fail to address symptoms and burden of disease, but may also worsen health-related quality of life. A better understanding of available second-line treatments may ensure best use of therapeutic options and thereby optimize patient outcomes.", "label": 1, "is_selected": 0, "text": "In patients with immune thrombocytopenia who do not adequately respond to first-line therapy, there is no clear consensus on which second-line therapy to initiate and when. This situation leads to suboptimal approaches, including prolonged exposure to treatments that are not intended for long-term use (eg, corticosteroids) and overuse of off-label therapies (eg, rituximab) while approved, more efficacious options exist. These approaches may not only fail to address symptoms and burden of disease, but may also worsen health-related quality of life. A better understanding of available second-line treatments may ensure best use of therapeutic options and thereby optimize patient outcomes."}
{"qid": "51430930d24251bc0500000b", "original_text": "Deep proteomic analysis of mammalian cell lines would yield an inventory of the building blocks of the most commonly used systems in biological research. Mass spectrometry-based proteomics can identify and quantify proteins in a global and unbiased manner and can highlight the cellular processes that are altered between such systems. We analyzed 11 human cell lines using an LTQ-Orbitrap family mass spectrometer with a \"high field\" Orbitrap mass analyzer with improved resolution and sequencing speed. We identified a total of 11,731 proteins, and on average 10,361 \u00b1 120 proteins in each cell line. This very high proteome coverage enabled analysis of a broad range of processes and functions. Despite the distinct origins of the cell lines, our quantitative results showed surprisingly high similarity in terms of expressed proteins.", "label": 1, "is_selected": 0, "text": "Deep proteomic analysis of mammalian cell lines would yield an inventory of the building blocks of the most commonly used systems in biological research. Mass spectrometry-based proteomics can identify and quantify proteins in a global and unbiased manner and can highlight the cellular processes that are altered between such systems. We analyzed 11 human cell lines using an LTQ-Orbitrap family mass spectrometer with a \"high field\" Orbitrap mass analyzer with improved resolution and sequencing speed. We identified a total of 11,731 proteins, and on average 10,361 \u00b1 120 proteins in each cell line. This very high proteome coverage enabled analysis of a broad range of processes and functions. Despite the distinct origins of the cell lines, our quantitative results showed surprisingly high similarity in terms of expressed proteins."}
{"qid": "61f9cb19c9dfcb9c09000002", "original_text": "ADAMTS18 is a novel tumor suppressor and is critical to the pathology of human colorectal cancer. However, the underlying mechanism is not clear. Here we generated an Adamts18-deficient mouse strain as an in vivo model to investigate the role of ADAMTS18 in the pathogenesis of colorectal cancer. In AOM/DSS-induced colitis-associated colorectal cancer, the deficiency of Adamts18 in mice resulted in enhanced tumorigenesis and colon inflammation that could be attributed in part to enhanced nuclear translocation of \u03b2-catenin and elevated expression of its downstream target genes, cyclin D1 and c-myc.", "label": 1, "is_selected": 0, "text": "ADAMTS18 is a novel tumor suppressor and is critical to the pathology of human colorectal cancer. However, the underlying mechanism is not clear. Here we generated an Adamts18-deficient mouse strain as an in vivo model to investigate the role of ADAMTS18 in the pathogenesis of colorectal cancer. In AOM/DSS-induced colitis-associated colorectal cancer, the deficiency of Adamts18 in mice resulted in enhanced tumorigenesis and colon inflammation that could be attributed in part to enhanced nuclear translocation of \u03b2-catenin and elevated expression of its downstream target genes, cyclin D1 and c-myc."}
{"qid": "530cefaaad0bf1360c000012", "original_text": "Iron deficiency is a common cause of anemia in patients with end stage renal disease (ESRD). Intravenous iron administration, especially in those requiring treatment with erythropoiesis stimulating agents (ESA) is an essential component of the management of anemia in ESRD patients. Iron improves hemoglobin, reduces ESA dose requirement and also has nonerythropoietic effects including improvement in physical performance, cognition and amelioration of restless leg syndrome. However, iron can promote oxidative stress, cause endothelial dysfunction, inflammation and tissue injury, and has a potential to cause progression of both CKD and cardiovascular disease. In this review, we discuss the benefits and risks associated with i.v. iron and the practical aspects of iron administration that can minimize the complications related to iron therapy in ESRD.", "label": 1, "is_selected": 0, "text": "Iron deficiency is a common cause of anemia in patients with end stage renal disease (ESRD). Intravenous iron administration, especially in those requiring treatment with erythropoiesis stimulating agents (ESA) is an essential component of the management of anemia in ESRD patients. Iron improves hemoglobin, reduces ESA dose requirement and also has nonerythropoietic effects including improvement in physical performance, cognition and amelioration of restless leg syndrome. However, iron can promote oxidative stress, cause endothelial dysfunction, inflammation and tissue injury, and has a potential to cause progression of both CKD and cardiovascular disease. In this review, we discuss the benefits and risks associated with i.v. iron and the practical aspects of iron administration that can minimize the complications related to iron therapy in ESRD."}
{"qid": "56ebee26107309bc2f000002", "original_text": "Genomic enhancers regulate spatio-temporal gene expression by recruiting specific combinations of transcription factors (TFs). When TFs are bound to active regulatory regions, they displace canonical nucleosomes, making these regions biochemically detectable as nucleosome-depleted regions or accessible/open chromatin. Here we ask whether open chromatin profiling can be used to identify the entire repertoire of active promoters and enhancers underlying tissue-specific gene expression during normal development and oncogenesis in vivo. To this end, we first compare two different approaches to detect open chromatin in vivo using the Drosophila eye primordium as a model system: FAIRE-seq, based on physical separation of open versus closed chromatin; and ATAC-seq, based on preferential integration of a transposon into open chromatin.", "label": 1, "is_selected": 0, "text": "Genomic enhancers regulate spatio-temporal gene expression by recruiting specific combinations of transcription factors (TFs). When TFs are bound to active regulatory regions, they displace canonical nucleosomes, making these regions biochemically detectable as nucleosome-depleted regions or accessible/open chromatin. Here we ask whether open chromatin profiling can be used to identify the entire repertoire of active promoters and enhancers underlying tissue-specific gene expression during normal development and oncogenesis in vivo. To this end, we first compare two different approaches to detect open chromatin in vivo using the Drosophila eye primordium as a model system: FAIRE-seq, based on physical separation of open versus closed chromatin; and ATAC-seq, based on preferential integration of a transposon into open chromatin."}
{"qid": "5172f8118ed59a060a000019", "original_text": "Selenoproteins are proteins that contain the amino acid selenium, which is essential for their structure and function. While many species of Metazoa (multicellular eukaryotes) contain selenoproteins, there are some species or taxa that are known to lack them. For example, protozoa, such as Trypanosoma brucei, are known to lack selenoproteins entirely. This is likely due to their simple cellular organization and the lack of a requirement for selenium in their metabolism. Other groups of organisms that are known to lack selenoproteins include some fungi, such as Neurospora crassa, and some invertebrates, such as the cephalopod mollusks (octopuses, squids, and cuttlefish). It is worth noting that while some species may lack selenoproteins altogether, others may have very low levels of selenoproteins or have a limited repertoire of selenoprotein genes. This is because the presence and type of selenoproteins can vary greatly across different species and even within the same genus or family.", "label": 0, "is_selected": 1, "text": "The presence or absence of selenoproteins in a variety of organisms has been described in a series of papers published in the journal Plos One, including a study of the protozoan Trypanosoma brucei, which found that the organism lacked the proteins in all its cell types, including its brain, and in its nervous system, as well as in its blood."}
{"qid": "531b4269b166e2b80600003e", "original_text": "Thyroid hormone therapy is not commonly indicated for patients with heart failure. While thyroid hormones can have a positive inotropic effect on the heart, increasing the contractility of the myocardium, this is typically not sufficient to improve symptoms or outcomes in patients with heart failure. In fact, excessive levels of thyroid hormones can actually exacerbate heart failure by increasing cardiac output and worsening ventricular function. There are some rare genetic disorders that can cause cardiac hypertrophy and heart failure, and in these cases, thyroid hormone replacement therapy may be considered. However, this is highly individualized and requires careful assessment and monitoring by a medical professional. In general, treatment of heart failure typically involves a combination of medications, lifestyle modifications, and device therapy, such as implantable cardioverter-defibrillators or cardiac resynchronization therapy.", "label": 0, "is_selected": 0, "text": "Thyroid hormone therapy is not commonly indicated for patients with heart failure. While thyroid hormones can have a positive inotropic effect on the heart, increasing the contractility of the myocardium, this is typically not sufficient to improve symptoms or outcomes in patients with heart failure. In fact, excessive levels of thyroid hormones can actually exacerbate heart failure by increasing cardiac output and worsening ventricular function. There are some rare genetic disorders that can cause cardiac hypertrophy and heart failure, and in these cases, thyroid hormone replacement therapy may be considered. However, this is highly individualized and requires careful assessment and monitoring by a medical professional. In general, treatment of heart failure typically involves a combination of medications, lifestyle modifications, and device therapy, such as implantable cardioverter-defibrillators or cardiac resynchronization therapy."}
{"qid": "602346eb1cb411341a000090", "original_text": "Portal vein involvement is considered one of the most fearful complications of hepatocellular carcinoma (HCC). Portal vein tumor thrombosis (PVTT) is associated with aggressive tumor biology (high grade), high tumor burden (number and size of lesions), high levels of serum markers (AFP), poor liver function (deranged LFT), and poor performance status of patients. The Barcelona Clinic Liver Cancer staging system places HCC patients with PVTT in advanced stage (BCLC Stage-C).", "label": 1, "is_selected": 0, "text": "Portal vein involvement is considered one of the most fearful complications of hepatocellular carcinoma (HCC). Portal vein tumor thrombosis (PVTT) is associated with aggressive tumor biology (high grade), high tumor burden (number and size of lesions), high levels of serum markers (AFP), poor liver function (deranged LFT), and poor performance status of patients. The Barcelona Clinic Liver Cancer staging system places HCC patients with PVTT in advanced stage (BCLC Stage-C)."}
{"qid": "5c6ffc5b7c78d69471000057", "original_text": "A disintegrin and metalloproteinase-17 (ADAM17) is a member of the metalloproteinase superfamily and involved in the cleavage of ectodomain of many transmembrane proteins. ADAM17 is overexpressed in a variety of human tumors, which is associated with tumor development and progression. In the present study, we sought to investigate the expression and function of ADAM17 in hypoxia-treated hepatocellular carcinoma (HCC) cells. Western blot analysis was used to measure the expression of ADAM17 in HCC cell lines (Hep3B and HepG2 cells). Annexin V/PI double staining was performed to analyze the effects of ADAM17 on hypoxia-mediated cisplatin resistance. ADAM17 expression was upregulated by hypoxia treatment in HCC cells at both mRNA and protein levels.", "label": 1, "is_selected": 0, "text": "A disintegrin and metalloproteinase-17 (ADAM17) is a member of the metalloproteinase superfamily and involved in the cleavage of ectodomain of many transmembrane proteins. ADAM17 is overexpressed in a variety of human tumors, which is associated with tumor development and progression. In the present study, we sought to investigate the expression and function of ADAM17 in hypoxia-treated hepatocellular carcinoma (HCC) cells. Western blot analysis was used to measure the expression of ADAM17 in HCC cell lines (Hep3B and HepG2 cells). Annexin V/PI double staining was performed to analyze the effects of ADAM17 on hypoxia-mediated cisplatin resistance. ADAM17 expression was upregulated by hypoxia treatment in HCC cells at both mRNA and protein levels."}
{"qid": "51603912298dcd4e5100003b", "original_text": "Several previous comparisons of the human genome with other primate and vertebrate genomes identified genomic regions that are highly conserved in vertebrate evolution but fast-evolving on the human lineage. These human accelerated regions (HARs) may be regions of past adaptive evolution in humans. Alternatively, they may be the result of non-adaptive processes, such as biased gene conversion. We captured and sequenced DNA from a collection of previously published HARs using DNA from an Iberian Neandertal. Combining these new data with shotgun sequence from the Neandertal and Denisova draft genomes, we determine at least one archaic hominin allele for 84% of all positions within HARs.", "label": 1, "is_selected": 0, "text": "Several previous comparisons of the human genome with other primate and vertebrate genomes identified genomic regions that are highly conserved in vertebrate evolution but fast-evolving on the human lineage. These human accelerated regions (HARs) may be regions of past adaptive evolution in humans. Alternatively, they may be the result of non-adaptive processes, such as biased gene conversion. We captured and sequenced DNA from a collection of previously published HARs using DNA from an Iberian Neandertal. Combining these new data with shotgun sequence from the Neandertal and Denisova draft genomes, we determine at least one archaic hominin allele for 84% of all positions within HARs."}
{"qid": "5fdb84f2a43ad31278000030", "original_text": "The BXSB/MpJ (BXSB) murine strain (H-2b) spontaneously develops an autoimmune syndrome with features of systemic lupus erythematosus (SLE) that affects males much earlier than females. A mutant gene located on the BXSB Y chromosome, designated Yaa (Y chromosome-linked autoimmune acceleration), is responsible for the acceleration of the disease observed in male BXSB mice. Studies on H-2 congenic and I-E transgenic mice have clearly demonstrated that the MHC class II genes play a crucial role in the development or protection of SLE. However, the MHC effect can be completely masked by the presence of the Yaa gene in mice with certain genetic backgrounds. It is intriguing that the Yaa gene effect is selective on autoimmune responses, varying in different lupus-prone mice. Studies on immune responses against foreign antigens have shown that the Yaa gene potentiates immune responses only against antigens to which mice are genetically (H-2-linked) low-responding, but not high-responding. Thus, the selective immune enhancing activity of the Yaa gene may be related to differences in the capacity of T helper cells specific for given antigens.", "label": 1, "is_selected": 0, "text": "The BXSB/MpJ (BXSB) murine strain (H-2b) spontaneously develops an autoimmune syndrome with features of systemic lupus erythematosus (SLE) that affects males much earlier than females. A mutant gene located on the BXSB Y chromosome, designated Yaa (Y chromosome-linked autoimmune acceleration), is responsible for the acceleration of the disease observed in male BXSB mice. Studies on H-2 congenic and I-E transgenic mice have clearly demonstrated that the MHC class II genes play a crucial role in the development or protection of SLE. However, the MHC effect can be completely masked by the presence of the Yaa gene in mice with certain genetic backgrounds. It is intriguing that the Yaa gene effect is selective on autoimmune responses, varying in different lupus-prone mice. Studies on immune responses against foreign antigens have shown that the Yaa gene potentiates immune responses only against antigens to which mice are genetically (H-2-linked) low-responding, but not high-responding. Thus, the selective immune enhancing activity of the Yaa gene may be related to differences in the capacity of T helper cells specific for given antigens."}
{"qid": "51680a49298dcd4e51000062", "original_text": "Gene expression profiling has revolutionized our ability to molecularly classify primary human tumors and significantly enhanced the development of novel tumor markers and therapies; however, progress in the diagnosis and treatment of melanoma over the past 3 decades has been limited, and there is currently no approved therapy that significantly extends lifespan in patients with advanced disease. Profiling studies of melanoma to date have been inconsistent due to the heterogeneous nature of this malignancy and the limited availability of informative tissue specimens from early stages of disease. In order to gain an improved understanding of the molecular basis of melanoma progression, we have compared gene expression profiles from a series of melanoma cell lines representing discrete stages of malignant progression that recapitulate critical characteristics of the primary lesions from which they were derived. Here we describe the unsupervised hierarchical clustering of profiling data from melanoma cell lines and melanocytes.", "label": 1, "is_selected": 0, "text": "Gene expression profiling has revolutionized our ability to molecularly classify primary human tumors and significantly enhanced the development of novel tumor markers and therapies; however, progress in the diagnosis and treatment of melanoma over the past 3 decades has been limited, and there is currently no approved therapy that significantly extends lifespan in patients with advanced disease. Profiling studies of melanoma to date have been inconsistent due to the heterogeneous nature of this malignancy and the limited availability of informative tissue specimens from early stages of disease. In order to gain an improved understanding of the molecular basis of melanoma progression, we have compared gene expression profiles from a series of melanoma cell lines representing discrete stages of malignant progression that recapitulate critical characteristics of the primary lesions from which they were derived. Here we describe the unsupervised hierarchical clustering of profiling data from melanoma cell lines and melanocytes."}
{"qid": "5a70d12899e2c3af26000001", "original_text": "Heerfordt syndrome is a rare genetic disorder characterized by progressive muscle weakness, wasting, and paralysis. The primary symptoms include: 1. Gradual onset of muscle weakness and wasting, particularly in the legs, feet, and hands. 2. Muscle loss, or atrophy, in the affected muscles. 3. Decreased reflexes and loss of deep tendon reflexes. 4. Muscle cramps and spasms. 5. Weakness of the muscles used for breathing and swallowing, leading to respiratory failure and difficulty swallowing. 6. Gradual progression of symptoms, often beginning in childhood or early adulthood. I hope this helps! Is there anything else I can assist you with?", "label": 0, "is_selected": 1, "text": "If you have ever been diagnosed with Heerfordt syndrome, you may want to speak to your doctor about your symptoms.<n> The primary symptoms include: 1. Gradual onset of muscle weakness and wasting, particularly in the legs, feet, and hands."}
{"qid": "6025a1e91cb411341a0000b4", "original_text": "Disease-modifying antirheumatic drugs (DMARDs) have become essential treatments in the management of patients with inflammatory rheumatic diseases. Their use has resulted in a marked improvement of disease control and a limitation of joint damage, although some patients still require subsequent corrective or joint replacement surgery. Due to their immunosuppressive effects, some DMARDs are associated with an increased risk of infection. The aim of this review is to discuss the available literature on the management of DMARDs during the perioperative period, particularly in the case of orthopaedic surgery. Conventional synthetic DMARDs such as methotrexate, sulfasalazine, leflunomide, hydroxychloroquine appear to be safe during the perioperative period. Conflicting results on biological DMARDs, mainly tumour necrosis factor antagonists, are reported in the literature, including both increased and unchanged risk of superimposed infections after surgery. Taking into account the available literature, we included some propositions for the management of patients who will undergo surgical interventions.", "label": 1, "is_selected": 0, "text": "Disease-modifying antirheumatic drugs (DMARDs) have become essential treatments in the management of patients with inflammatory rheumatic diseases. Their use has resulted in a marked improvement of disease control and a limitation of joint damage, although some patients still require subsequent corrective or joint replacement surgery. Due to their immunosuppressive effects, some DMARDs are associated with an increased risk of infection. The aim of this review is to discuss the available literature on the management of DMARDs during the perioperative period, particularly in the case of orthopaedic surgery. Conventional synthetic DMARDs such as methotrexate, sulfasalazine, leflunomide, hydroxychloroquine appear to be safe during the perioperative period. Conflicting results on biological DMARDs, mainly tumour necrosis factor antagonists, are reported in the literature, including both increased and unchanged risk of superimposed infections after surgery. Taking into account the available literature, we included some propositions for the management of patients who will undergo surgical interventions."}
{"qid": "51bedaac3148fdcc22da7188", "original_text": "Constitutive macroautophagy involved in the turnover of defective long-lived proteins and organelles is crucial for neuronal homeostasis. We hypothesized that macroautophagic dysregulation in selective brain regions was associated with memory impairment in aged mice. We used the single-trial object recognition test to measure short-term memory in 18 aged mice compared to 22 young mice and employed immunohistochemistry to assess cellular distribution of proteins involved in the selective degradation of ubiquitinated proteins via macroautophagy.", "label": 1, "is_selected": 0, "text": "Constitutive macroautophagy involved in the turnover of defective long-lived proteins and organelles is crucial for neuronal homeostasis. We hypothesized that macroautophagic dysregulation in selective brain regions was associated with memory impairment in aged mice. We used the single-trial object recognition test to measure short-term memory in 18 aged mice compared to 22 young mice and employed immunohistochemistry to assess cellular distribution of proteins involved in the selective degradation of ubiquitinated proteins via macroautophagy."}
{"qid": "5e2b07537d50947c2f000001", "original_text": "Cirsoid aneurysms are uncommon arteriovenous fistulas of the scalp. Surgery for these lesions can be difficult; transarterial embolization is rarely curative, while embolization of the venous pouch with permanent agents usually necessitates subsequent surgical removal of the embolic material. The ideal embolic agent would be one that is safe and effective, commercially available, and would not require subsequent removal. We treated an arteriovenous fistula of the scalp with direct puncture and injection of sodium tetradecyl sulfate, a commercially available sclerosing agent.", "label": 1, "is_selected": 0, "text": "Cirsoid aneurysms are uncommon arteriovenous fistulas of the scalp. Surgery for these lesions can be difficult; transarterial embolization is rarely curative, while embolization of the venous pouch with permanent agents usually necessitates subsequent surgical removal of the embolic material. The ideal embolic agent would be one that is safe and effective, commercially available, and would not require subsequent removal. We treated an arteriovenous fistula of the scalp with direct puncture and injection of sodium tetradecyl sulfate, a commercially available sclerosing agent."}
{"qid": "601ff55a1cb411341a000077", "original_text": "We conducted a two-stage genome-wide association study to identify common genetic variation altering risk of the metabolic syndrome and related phenotypes in Indian Asian men, who have a high prevalence of these conditions. In Stage 1, approximately 317,000 single nucleotide polymorphisms were genotyped in 2700 individuals, from which 1500 SNPs were selected to be genotyped in a further 2300 individuals. Selection for inclusion in Stage 1 was based on four metabolic syndrome component traits: HDL-cholesterol, plasma glucose and Type 2 diabetes, abdominal obesity measured by waist to hip ratio, and diastolic blood pressure. Association was tested with these four traits and a composite metabolic syndrome phenotype. Four SNPs reaching significance level p<5x10(-7) and with posterior probability of association >0.8 were found in genes CETP and LPL, associated with HDL-cholesterol.", "label": 1, "is_selected": 0, "text": "We conducted a two-stage genome-wide association study to identify common genetic variation altering risk of the metabolic syndrome and related phenotypes in Indian Asian men, who have a high prevalence of these conditions. In Stage 1, approximately 317,000 single nucleotide polymorphisms were genotyped in 2700 individuals, from which 1500 SNPs were selected to be genotyped in a further 2300 individuals. Selection for inclusion in Stage 1 was based on four metabolic syndrome component traits: HDL-cholesterol, plasma glucose and Type 2 diabetes, abdominal obesity measured by waist to hip ratio, and diastolic blood pressure. Association was tested with these four traits and a composite metabolic syndrome phenotype. Four SNPs reaching significance level p<5x10(-7) and with posterior probability of association >0.8 were found in genes CETP and LPL, associated with HDL-cholesterol."}
{"qid": "6026db1f1cb411341a0000cf", "original_text": "Ubrogepant (MK-1602) is a novel, oral, calcitonin gene-related peptide receptor antagonist in clinical development with positive phase III outcomes for acute treatment of migraine. This paper describes the population exposure-response (E-R) modeling and simulations, which were used to inform the phase III dose-selection rationale, based on ~ 800 participants pooled across two phase IIb randomized dose-finding clinical trials. The E-R model describes the placebo and ubrogepant treatment effects based on migraine pain end points (2-hour pain relief and 2-hour pain freedom) at various dose levels. Sensitivity analyses were conducted to evaluate various assumptions of placebo response in light of the high placebo response observed in one phase II trial.", "label": 1, "is_selected": 0, "text": "Ubrogepant (MK-1602) is a novel, oral, calcitonin gene-related peptide receptor antagonist in clinical development with positive phase III outcomes for acute treatment of migraine. This paper describes the population exposure-response (E-R) modeling and simulations, which were used to inform the phase III dose-selection rationale, based on ~ 800 participants pooled across two phase IIb randomized dose-finding clinical trials. The E-R model describes the placebo and ubrogepant treatment effects based on migraine pain end points (2-hour pain relief and 2-hour pain freedom) at various dose levels. Sensitivity analyses were conducted to evaluate various assumptions of placebo response in light of the high placebo response observed in one phase II trial."}
{"qid": "571653aecb4ef8864c000005", "original_text": "Circulating tumor DNA (ctDNA) is now being extensively studied as it is a noninvasive \"real-time\" biomarker that can provide diagnostic and prognostic information before, during treatment and at progression. These include DNA mutations, epigenetic alterations and other forms of tumor-specific abnormalities such as microsatellite instability (MSI) and loss of heterozygosity (LOH). ctDNA is of great value in the process of cancer treatment. However, up to date, there is no strict standard considering the exact biomarker because the development and progression of cancer is extremely complicated.", "label": 1, "is_selected": 0, "text": "Circulating tumor DNA (ctDNA) is now being extensively studied as it is a noninvasive \"real-time\" biomarker that can provide diagnostic and prognostic information before, during treatment and at progression. These include DNA mutations, epigenetic alterations and other forms of tumor-specific abnormalities such as microsatellite instability (MSI) and loss of heterozygosity (LOH). ctDNA is of great value in the process of cancer treatment. However, up to date, there is no strict standard considering the exact biomarker because the development and progression of cancer is extremely complicated."}
{"qid": "55046d5ff8aee20f27000007", "original_text": "Although KRAS mutation has been identified as a negative predictive biomarker of anti-EGFR antibodies in metastatic colorectal cancer (mCRC), the efficacy in mCRC patients with KRAS wild-type status remains limited. Anti-EGFR antibodies work by blocking ligand binding, but the significance of EGFR ligands in mCRC has not been completely described. This study was conducted to identify the correlation between all seven EGFR ligands and clinical outcomes in mCRC treated with anti-EGFR antibodies. Furthermore, we determined an appropriate predictive strategy for anti-EGFR antibodies using these EGFR ligands. Among 36 mCRC patients who had been treated with cetuximab or panitumumab, we identified 26 mCRC patients with wild-type KRAS status treated properly as the second and further lines and analyzed the relationship between immunoreactivity to seven EGFR ligands and clinical outcomes. Good clinical outcomes were associated with immunoreactivity against amphiregulin (AR), heparin-binding epidermal growth factor (HB-EGF), transforming growth factor-\u03b1 (TGF-\u03b1), and epiregulin (EREG). Further, patients with immunoreactivity to greater than two of these four ligands (AR, HB-EGF, TGF-\u03b1, and EREG) had significantly higher response rate (53.3 vs. 0.0 %, p = 0.004) and disease control rate (93.3 vs. 9.0 %, p = 0.00002) and longer progression-free survival (median PFS: 231 vs. 79 days, p = 0.000008), when compared with patients with immunoreactivity against zero or one ligand. Immunohistochemical analysis of four EGFR ligands (AR, HB-EGF, TGF-\u03b1, and EREG) might be a novel predictive biomarker and may help optimize patient selection for cetuximab and panitumumab therapy in patients with mCRC.", "label": 1, "is_selected": 0, "text": "Although KRAS mutation has been identified as a negative predictive biomarker of anti-EGFR antibodies in metastatic colorectal cancer (mCRC), the efficacy in mCRC patients with KRAS wild-type status remains limited. Anti-EGFR antibodies work by blocking ligand binding, but the significance of EGFR ligands in mCRC has not been completely described. This study was conducted to identify the correlation between all seven EGFR ligands and clinical outcomes in mCRC treated with anti-EGFR antibodies. Furthermore, we determined an appropriate predictive strategy for anti-EGFR antibodies using these EGFR ligands. Among 36 mCRC patients who had been treated with cetuximab or panitumumab, we identified 26 mCRC patients with wild-type KRAS status treated properly as the second and further lines and analyzed the relationship between immunoreactivity to seven EGFR ligands and clinical outcomes. Good clinical outcomes were associated with immunoreactivity against amphiregulin (AR), heparin-binding epidermal growth factor (HB-EGF), transforming growth factor-\u03b1 (TGF-\u03b1), and epiregulin (EREG). Further, patients with immunoreactivity to greater than two of these four ligands (AR, HB-EGF, TGF-\u03b1, and EREG) had significantly higher response rate (53.3 vs. 0.0 %, p = 0.004) and disease control rate (93.3 vs. 9.0 %, p = 0.00002) and longer progression-free survival (median PFS: 231 vs. 79 days, p = 0.000008), when compared with patients with immunoreactivity against zero or one ligand. Immunohistochemical analysis of four EGFR ligands (AR, HB-EGF, TGF-\u03b1, and EREG) might be a novel predictive biomarker and may help optimize patient selection for cetuximab and panitumumab therapy in patients with mCRC."}
{"qid": "61f6055b882a024a10000021", "original_text": "Tirzepatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that targets the following receptors: 1. GLP-1 receptor: Tirzepatide acts as a full agonist at the GLP-1 receptor, which is primarily responsible for its glucose-lowering effects. The GLP-1 receptor is expressed in the pancreas, liver, and brain, and plays a crucial role in regulating glucose homeostasis. 2. GIP receptor: Tirzepatide also acts as a partial agonist at the gut hormone receptor GIP (glucose-dependent insulinotropic polypeptide), which is expressed in the pancreas and brain. GIP receptor activation increases insulin secretion and improves glucose tolerance. 3. EP4 receptor: Tirzepatide has been shown to exhibit activity at the EP4 receptor, which is involved in the regulation of inflammation and immune responses. Overall, the dual action of tirzepatide on the GLP-1 and GIP receptors, as well as its activity at the EP4 receptor, contributes to its anti-diabetic effects by improving insulin secretion, sensitivity, and glucose uptake, while also reducing inflammation and improving cardiovascular outcomes.", "label": 0, "is_selected": 1, "text": "Tirzepatide is a novel, orally available, small molecule that has the potential to transform the treatment of type 2 diabetes by improving insulin uptake, glucose regulation, and cardiovascular outcomes. Overall, the dual action of tirzepatide on the GLP-1 and GIP receptors, as well as its activity at the EP4 receptor, contributes to the dual effects of diabetes, while also reducing inflammation and reducing glucose tolerance."}
{"qid": "5e5e4fdb1af46fc130000009", "original_text": "Since the first link between blood type and cancer was described in 1953, numerous studies have sought to determine whether the histoblood ABO group is associated with tumorigenesis. In 2009, the first significant association between a SNP located within the ABO glycosyltransferase gene and increased risk of pancreatic cancer was reported. Here, we describe the history and possible functions of the histoblood ABO group and then provide evidence for a role of blood group antigens in the most common cancer types worldwide using both blood type and SNP data. We also explore whether confusion regarding the role of blood type in cancer risk may be attributable to heterogeneity within tumor types.", "label": 1, "is_selected": 0, "text": "Since the first link between blood type and cancer was described in 1953, numerous studies have sought to determine whether the histoblood ABO group is associated with tumorigenesis. In 2009, the first significant association between a SNP located within the ABO glycosyltransferase gene and increased risk of pancreatic cancer was reported. Here, we describe the history and possible functions of the histoblood ABO group and then provide evidence for a role of blood group antigens in the most common cancer types worldwide using both blood type and SNP data. We also explore whether confusion regarding the role of blood type in cancer risk may be attributable to heterogeneity within tumor types."}
{"qid": "5c76be617c78d694710000a5", "original_text": "Yes, the enzyme ERAP2 (Endoplasmic Reticulum Amino Peptidase 2) has been associated with Birdshot Chorioretinopathy, a rare autoimmune eye disease. Mutations in the ERAP2 gene have been identified as a major genetic cause of Birdshot Chorioretinopathy. The ERAP2 enzyme plays a critical role in the degradation of misfolded proteins in the endoplasmic reticulum, and alterations in its function have been linked to the pathogenesis of this disease. specifically, mutations in ERAP2 can lead to the accumulation of toxic proteins in the retina, causing inflammation and damage to the retinal cells, which can result in vision loss.", "label": 0, "is_selected": 0, "text": "Yes, the enzyme ERAP2 (Endoplasmic Reticulum Amino Peptidase 2) has been associated with Birdshot Chorioretinopathy, a rare autoimmune eye disease. Mutations in the ERAP2 gene have been identified as a major genetic cause of Birdshot Chorioretinopathy. The ERAP2 enzyme plays a critical role in the degradation of misfolded proteins in the endoplasmic reticulum, and alterations in its function have been linked to the pathogenesis of this disease. specifically, mutations in ERAP2 can lead to the accumulation of toxic proteins in the retina, causing inflammation and damage to the retinal cells, which can result in vision loss."}
{"qid": "5c72bd047c78d69471000077", "original_text": "Pazopanib is a tyrosine kinase inhibitor that has been approved for the treatment of certain types of soft tissue sarcoma and breast cancer. However, it has not been specifically approved for the treatment of Hippel-Lindau disease (HLD). HLD is a rare genetic disorder characterized by the development of vascular malformations, including retinal angiomas, cherry angiomas, and vascular malformations in the kidneys, lungs, and other organs. While there are no standard treatments for HLD, various therapies have been used to manage its symptoms and complications. These may include surgery, embolization, and medications such as vasodilators, anti-inflammatory drugs, and anticoagulants. While some studies have suggested that pazopanib may have anti-angiogenic effects and could potentially be used to treat HLD, there is limited evidence to support its use in this context. A study published in the Journal of Clinical Oncology in 2010 found that pazopanib was effective in reducing the size of angiomas in patients with HLD, but more research is needed to confirm its safety and efficacy in this population. Therefore, I do not have an answer to your question regarding the use of pazopanib for the treatment of HLD.", "label": 0, "is_selected": 1, "text": "Is pazopanib safe and effective for the treatment of Hippel-Lindau disease, a rare genetic disorder that causes vascular malformations in the kidneys, lungs, and other organs, and which has no standard treatments?<n> HLD is a Rare genetic disorder characterized by the development of vascular malformationS, including retinal angiomas, cherry angiomats, and vascular abnormalities in the lungs, kidneys, and Other Organs (HLD); there are no standards treatments for this condition."}
{"qid": "60314ce01cb411341a00012f", "original_text": "TAFRO syndrome is a newly recognized variant of idiopathic multicentric Castleman disease (iMCD) that involves a constellation of syndromes: thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R), and organomegaly (O). Thrombocytopenia and severe anasarca accompanied by relatively low serum immunoglobulin levels are characteristic clinical findings of TAFRO syndrome that are not present in iMCD-not otherwise specified (iMCD-NOS). Lymph node biopsy is recommended to exclude other diseases and to diagnose TAFRO syndrome, which reveals characteristic histopathological findings similar to hyaline vascular-type CD. TAFRO syndrome follows a more aggressive course, compared with iMCD-NOS, and there is no standard treatment.", "label": 1, "is_selected": 0, "text": "TAFRO syndrome is a newly recognized variant of idiopathic multicentric Castleman disease (iMCD) that involves a constellation of syndromes: thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis (R), and organomegaly (O). Thrombocytopenia and severe anasarca accompanied by relatively low serum immunoglobulin levels are characteristic clinical findings of TAFRO syndrome that are not present in iMCD-not otherwise specified (iMCD-NOS). Lymph node biopsy is recommended to exclude other diseases and to diagnose TAFRO syndrome, which reveals characteristic histopathological findings similar to hyaline vascular-type CD. TAFRO syndrome follows a more aggressive course, compared with iMCD-NOS, and there is no standard treatment."}
{"qid": "572211540fd6f91b68000016", "original_text": "Yes, vitamin B1 (thiamine) deficiency can cause encephalopathy, a condition characterized by brain damage and dysfunction. Thiamine plays a crucial role in maintaining the health of the brain and nervous system, and a deficiency can lead to a range of neurological symptoms, including confusion, disorientation, memory loss, and difficulty with coordination and balance. In severe cases, thiamine deficiency can cause Wernicke-Korsakoff syndrome, a chronic and irreversible brain disorder that can result in significant cognitive and intellectual impairment.", "label": 0, "is_selected": 1, "text": "Can vitamin B1 deficiency cause brain damage in children and young adults, according to a new study by researchers at the University of California, Los Angeles?, and published in the Journal of the American Academy of Child and Adolescent Psychiatry, and the journal Neurobiology of Learning and Memory?"}
{"qid": "5c7019557c78d6947100005f", "original_text": "Type I interferons (IFN) are pathogenic in systemic lupus erythematosus (SLE) and were proposed to control the immunometabolism of dendritic cells (DCs). We previously reported that DCs from female lupus-prone mice constitutively overexpress IFN-responsive genes resembling the IFN signature found in SLE patients. As SLE has higher incidence in women than men, more so in women of reproductive age, estrogens are suggested to affect lupus pathogenesis. We investigated the effects of sex and estrogens on the IFN signature in conventional GM-CSF-bone marrow-derived DCs (cDCs), from male and female Triple Congenic B6.NZM.Sle1/Sle2/Sle3 (TCSle) lupus-prone mice or from wild-type C57BL/6 mice, generated with titrations of 17-beta-estradiol (E2).", "label": 1, "is_selected": 0, "text": "Type I interferons (IFN) are pathogenic in systemic lupus erythematosus (SLE) and were proposed to control the immunometabolism of dendritic cells (DCs). We previously reported that DCs from female lupus-prone mice constitutively overexpress IFN-responsive genes resembling the IFN signature found in SLE patients. As SLE has higher incidence in women than men, more so in women of reproductive age, estrogens are suggested to affect lupus pathogenesis. We investigated the effects of sex and estrogens on the IFN signature in conventional GM-CSF-bone marrow-derived DCs (cDCs), from male and female Triple Congenic B6.NZM.Sle1/Sle2/Sle3 (TCSle) lupus-prone mice or from wild-type C57BL/6 mice, generated with titrations of 17-beta-estradiol (E2)."}
{"qid": "56e5aeec0c19e5451d000002", "original_text": "No, adenylyl cyclases are not always transmembrane proteins. While the majority of adenylyl cyclases are membrane-bound enzymes, there are also cytosolic forms of these enzymes found in some organisms. These cytosolic adenylyl cyclases lack the transmembrane domain and are found in the cytoplasm of cells, where they can bind to and hydrolyze cADPR (cyclic adenosine monophosphate-ribosylated proteins) to produce cAMP (cyclic adenosine monophosphate) (1). Additionally, some adenylyl cyclases can be soluble proteins that are released from the membrane through a process called protein secretion (2). So, while transmembrane adenylyl cyclases are the most common form, there are other forms of these enzymes that can have different functions and localization within cells.", "label": 0, "is_selected": 1, "text": "Adenylyl cyclases are membrane-bound enzymes that can bind to and produce adenosine triphosphate (cAMP), a building block of fuel for the cells they help to bind to, and are thought to play a key role in the production of adenosine monophosphate (ATP) (1)."}
{"qid": "5e2dfab2fbd6abf43b00001d", "original_text": "Parkinson's disease is typically treated with oral dopamine replacement therapies. However, long-term use is complicated by motor fluctuations from intermittent stimulation of dopamine receptors and off-target effects. ProSavin, a lentiviral vector based gene therapy that delivers local and continuous dopamine, was previously shown to be well tolerated in a Phase I/II first-in-human study, with significant improvements in motor behavior from baseline at 1 year. Here, patients with Parkinson's disease from the open-label trial were followed up in the long term to assess the safety and efficacy of ProSavin after bilateral injection into the putamen.", "label": 1, "is_selected": 0, "text": "Parkinson's disease is typically treated with oral dopamine replacement therapies. However, long-term use is complicated by motor fluctuations from intermittent stimulation of dopamine receptors and off-target effects. ProSavin, a lentiviral vector based gene therapy that delivers local and continuous dopamine, was previously shown to be well tolerated in a Phase I/II first-in-human study, with significant improvements in motor behavior from baseline at 1 year. Here, patients with Parkinson's disease from the open-label trial were followed up in the long term to assess the safety and efficacy of ProSavin after bilateral injection into the putamen."}
{"qid": "601ebbeb1cb411341a00005b", "original_text": "KMT2D, also known as lysine methyltransferase 2D (LMT2D), is a protein that plays a crucial role in regulating gene expression by modifying histone proteins. Mutations in the KMT2D gene have been associated with a rare genetic disorder called Beckwith-Wiedemann syndrome (BWS). BWS is characterized by delays in physical growth and development, abnormalities in the brain and spinal cord, and an increased risk of certain cancers. Other symptoms of BWS can include abnormalities in the kidneys, liver, and adrenal glands, as well as an increased risk of developmental delays and learning disabilities.", "label": 0, "is_selected": 0, "text": "KMT2D, also known as lysine methyltransferase 2D (LMT2D), is a protein that plays a crucial role in regulating gene expression by modifying histone proteins. Mutations in the KMT2D gene have been associated with a rare genetic disorder called Beckwith-Wiedemann syndrome (BWS). BWS is characterized by delays in physical growth and development, abnormalities in the brain and spinal cord, and an increased risk of certain cancers. Other symptoms of BWS can include abnormalities in the kidneys, liver, and adrenal glands, as well as an increased risk of developmental delays and learning disabilities."}
{"qid": "52df887498d023950500000c", "original_text": "Medical treatment of obesity and lifestyle modification have limited effectiveness in treating it in morbidly obese individuals. Importantly, bariatric surgery is regarded as the only therapy that is effective in maintaining significant weight loss in morbidly obese individuals. Despite the fact that bariatric surgery-induced weight loss is associated with a significant decrease in morbidity and mortality and improvement in renal function, bariatric surgery has recently been shown to be associated with a significant risk of nephrolithiasis. The main risk factor for nephrolithiasis is increased excretion of urinary oxalate. In this review, we discuss the association between bariatric surgery, an increased risk of renal stone formation and oxalate nephropathy.", "label": 1, "is_selected": 0, "text": "Medical treatment of obesity and lifestyle modification have limited effectiveness in treating it in morbidly obese individuals. Importantly, bariatric surgery is regarded as the only therapy that is effective in maintaining significant weight loss in morbidly obese individuals. Despite the fact that bariatric surgery-induced weight loss is associated with a significant decrease in morbidity and mortality and improvement in renal function, bariatric surgery has recently been shown to be associated with a significant risk of nephrolithiasis. The main risk factor for nephrolithiasis is increased excretion of urinary oxalate. In this review, we discuss the association between bariatric surgery, an increased risk of renal stone formation and oxalate nephropathy."}
{"qid": "5328185dd6d3ac6a3400000e", "original_text": "Resistin is an adipocyte- and monocyte-derived cytokine which has been implicated in the modulation of insulin action, energy, glucose and lipid homeostasis. Resistin has been associated with insulin resistance and many of its known complications. As a molecular link between metabolic signals, inflammation, and vascular dysfunction, resistin can be proposed as playing a significant role in the heightened inflammatory state induced by metabolic stress linked to excessive caloric intake, thus contributing to the risk for metabolic syndrome (MetS), type 2 diabetes (T2DM), and cardiovascular diseases (CVD).", "label": 1, "is_selected": 0, "text": "Resistin is an adipocyte- and monocyte-derived cytokine which has been implicated in the modulation of insulin action, energy, glucose and lipid homeostasis. Resistin has been associated with insulin resistance and many of its known complications. As a molecular link between metabolic signals, inflammation, and vascular dysfunction, resistin can be proposed as playing a significant role in the heightened inflammatory state induced by metabolic stress linked to excessive caloric intake, thus contributing to the risk for metabolic syndrome (MetS), type 2 diabetes (T2DM), and cardiovascular diseases (CVD)."}
{"qid": "532c169ed6d3ac6a3400001f", "original_text": "The presence of thyrotropin receptors (TSHR) has been reported in some extrathyroidal tissues but its physio-pathological role still remains unclear. TSH (seems to) affects the human erythrocytes Na(+)/K(+)-ATPase in vitro, however receptors on erythrocytes have not yet been described. In this work the effect of recombinant human TSH (rhTSH) on sites number and activity of erythrocyte Na(+)/K(+)-ATPase was investigated in a group of thyroidectomized patient enrolled for rhTSH test. As detected by (3)H-ouabain binding, rhTSH administration induced a significant increase in the number of sites (p=0.005) and in the Kd (p=0.006) of Na(+)/K(+)-ATPase. rhTSH did not induce significant difference in Na(+)/K(+)-ATPase activity measured by (86)Rb uptake. (125)I-TSH binding studies and Western blotting data showed the existence of TSHR in the erythrocytes of healthy donors.", "label": 1, "is_selected": 0, "text": "The presence of thyrotropin receptors (TSHR) has been reported in some extrathyroidal tissues but its physio-pathological role still remains unclear. TSH (seems to) affects the human erythrocytes Na(+)/K(+)-ATPase in vitro, however receptors on erythrocytes have not yet been described. In this work the effect of recombinant human TSH (rhTSH) on sites number and activity of erythrocyte Na(+)/K(+)-ATPase was investigated in a group of thyroidectomized patient enrolled for rhTSH test. As detected by (3)H-ouabain binding, rhTSH administration induced a significant increase in the number of sites (p=0.005) and in the Kd (p=0.006) of Na(+)/K(+)-ATPase. rhTSH did not induce significant difference in Na(+)/K(+)-ATPase activity measured by (86)Rb uptake. (125)I-TSH binding studies and Western blotting data showed the existence of TSHR in the erythrocytes of healthy donors."}
{"qid": "5335c938d6d3ac6a34000052", "original_text": "Patients with neurologic diseases often have neurogenic detrusor overactivity (NDO), which can result in a loss of voluntary bladder control and uncontrollable urinary incontinence (UI).The impact of UI due to NDO on patients' lives has not been well studied. The objective of this review was to assess the health-related quality of life (HRQoL) and economic burden in patients with urgency UI due to NDO in select countries in North America, the European Union, Asia, and Australia. Systematic literature searches and reviews of articles published in English (January 2000 to February 2011) were conducted using MEDLINE\u00ae, EMBASE\u00ae, and the Cochrane Library. Studies assessing the impact of UI on HRQoL of patients with an underlying neurologic condition of interest (i.e., multiple sclerosis, spinal cord injury, Parkinson's disease, stroke, or spina bifida) were included. Economic studies in urgency UI also were included. Of 876 citations generated in the initial search, a total of 27 articles were deemed relevant: 16 articles presented HRQoL data and 11 articles presented information on the economic burden of UI.", "label": 1, "is_selected": 0, "text": "Patients with neurologic diseases often have neurogenic detrusor overactivity (NDO), which can result in a loss of voluntary bladder control and uncontrollable urinary incontinence (UI).The impact of UI due to NDO on patients' lives has not been well studied. The objective of this review was to assess the health-related quality of life (HRQoL) and economic burden in patients with urgency UI due to NDO in select countries in North America, the European Union, Asia, and Australia. Systematic literature searches and reviews of articles published in English (January 2000 to February 2011) were conducted using MEDLINE\u00ae, EMBASE\u00ae, and the Cochrane Library. Studies assessing the impact of UI on HRQoL of patients with an underlying neurologic condition of interest (i.e., multiple sclerosis, spinal cord injury, Parkinson's disease, stroke, or spina bifida) were included. Economic studies in urgency UI also were included. Of 876 citations generated in the initial search, a total of 27 articles were deemed relevant: 16 articles presented HRQoL data and 11 articles presented information on the economic burden of UI."}
{"qid": "56e844c442442bac75000002", "original_text": "Cerebrospinal fluid (CSF) neurofilament light chain (NfL) concentration is elevated in neurological disorders, including frontotemporal degeneration (FTD). We investigated the clinical correlates of elevated CSF NfL levels in FTD. CSF NfL, amyloid-\u03b21-42 (A\u03b242), tau, and phosphorylated tau concentrations were compared in 47 normal controls (NC), 8 asymptomatic gene carriers (NC2) of FTD-causing mutations, and 79 FTD (45 behavioral variant frontotemporal dementia [bvFTD], 18 progressive nonfluent aphasia [PNFA], 16 semantic dementia [SD]), 22 progressive supranuclear palsy, 50 Alzheimer disease, 6 Parkinson disease, and 17 corticobasal syndrome patients. Correlations between CSF analyte levels were performed with neuropsychological measures and the Clinical Dementia Rating scale sum of boxes (CDRsb). Voxel-based morphometry of structural magnetic resonance images determined the relationship between brain volume and CSF NfL. Mean CSF NfL concentrations were higher in bvFTD, SD, and PNFA than other groups. NfL in NC2 was similar to NC. CSF NfL, but not other CSF measures, correlated with CDRsb and neuropsychological measures in FTD, but not in other diagnostic groups. Analyses in 2 independent FTD cohorts and a group of autopsy-verified or biomarker-enriched cases confirmed the larger group analysis. In FTD, gray and white matter volume negatively correlated with CSF NfL concentration, such that individuals with the highest NfL levels exhibited the most atrophy.", "label": 1, "is_selected": 0, "text": "Cerebrospinal fluid (CSF) neurofilament light chain (NfL) concentration is elevated in neurological disorders, including frontotemporal degeneration (FTD). We investigated the clinical correlates of elevated CSF NfL levels in FTD. CSF NfL, amyloid-\u03b21-42 (A\u03b242), tau, and phosphorylated tau concentrations were compared in 47 normal controls (NC), 8 asymptomatic gene carriers (NC2) of FTD-causing mutations, and 79 FTD (45 behavioral variant frontotemporal dementia [bvFTD], 18 progressive nonfluent aphasia [PNFA], 16 semantic dementia [SD]), 22 progressive supranuclear palsy, 50 Alzheimer disease, 6 Parkinson disease, and 17 corticobasal syndrome patients. Correlations between CSF analyte levels were performed with neuropsychological measures and the Clinical Dementia Rating scale sum of boxes (CDRsb). Voxel-based morphometry of structural magnetic resonance images determined the relationship between brain volume and CSF NfL. Mean CSF NfL concentrations were higher in bvFTD, SD, and PNFA than other groups. NfL in NC2 was similar to NC. CSF NfL, but not other CSF measures, correlated with CDRsb and neuropsychological measures in FTD, but not in other diagnostic groups. Analyses in 2 independent FTD cohorts and a group of autopsy-verified or biomarker-enriched cases confirmed the larger group analysis. In FTD, gray and white matter volume negatively correlated with CSF NfL concentration, such that individuals with the highest NfL levels exhibited the most atrophy."}
{"qid": "5158644cd24251bc0500008e", "original_text": "Although hormonal responses to exercise performed in fed state are well documented, far less in known about the effect of a single exercise bout, performed after overnight fasting, on cardio-respiratory responses and hormones secretion. It has been reported that recently discovered hormones as leptin and ghrelin may affect cardiovascular responses at rest. However, their effect on the cardiovascular responses to exercise is unknown. This study was designed to determine the effect of overnight fasting on cardio- respiratory responses during moderate incremental exercise. We have hypothesised that fasting / exercise induced changes in plasma leptin / ghrelin concentrations may influence cardiovascular response. Eight healthy non-smoking men (means +/- SE.: age 23.0 +/- 0.5 years; body mass 71.9 +/- 1.5 kg; height 179.1 +/- 0.8 cm; BMI 22.42 +/- 0.49 kg x m(-2) with VO2max of 3.71 +/- 0.10 l x min(-1)) volunteered for this study. The subjects performed twice an incremental exercise test, with the increase of power output by 30 W every 3 minutes. Tests were performed in a random order: once in the feed state--cycling until exhaustion and second, about one week later, after overnight fasting--cycling until reaching 150 W.", "label": 1, "is_selected": 0, "text": "Although hormonal responses to exercise performed in fed state are well documented, far less in known about the effect of a single exercise bout, performed after overnight fasting, on cardio-respiratory responses and hormones secretion. It has been reported that recently discovered hormones as leptin and ghrelin may affect cardiovascular responses at rest. However, their effect on the cardiovascular responses to exercise is unknown. This study was designed to determine the effect of overnight fasting on cardio- respiratory responses during moderate incremental exercise. We have hypothesised that fasting / exercise induced changes in plasma leptin / ghrelin concentrations may influence cardiovascular response. Eight healthy non-smoking men (means +/- SE.: age 23.0 +/- 0.5 years; body mass 71.9 +/- 1.5 kg; height 179.1 +/- 0.8 cm; BMI 22.42 +/- 0.49 kg x m(-2) with VO2max of 3.71 +/- 0.10 l x min(-1)) volunteered for this study. The subjects performed twice an incremental exercise test, with the increase of power output by 30 W every 3 minutes. Tests were performed in a random order: once in the feed state--cycling until exhaustion and second, about one week later, after overnight fasting--cycling until reaching 150 W."}
{"qid": "58dcb47c8acda34529000020", "original_text": "The TAD (Transcriptional Activation Domain) protein domain is a conserved protein module found in various transcription factors and regulatory proteins. It plays a crucial role in regulating gene expression by modulating the recruitment of histone-modifying enzymes and transcriptional coactivators to specific genomic regions. The TAD domain acts as a scaffold for these proteins, bringing them together to create a functional chromatin structure that allows for the initiation of transcription. The TAD domain is composed of a conserved sequence of approximately 100 amino acids that is found in the N-terminal region of transcription factors and regulatory proteins. This domain is responsible for recognizing and binding to specific DNA sequences, known as TAD-binding sites, which are typically located upstream of the transcription start site. The binding of the TAD domain to these sites recruits the associated proteins, including histone-modifying enzymes and transcriptional coactivators, to the promoter region of the gene, thereby regulating its transcription. In addition to its role in transcriptional regulation, the TAD domain has been implicated in other cellular processes, including DNA damage response, cell cycle regulation, and cancer development. Dysregulation of TAD-mediated transcriptional activation has been implicated in various diseases, including cancer and developmental disorders.", "label": 0, "is_selected": 1, "text": "Researchers at the University of California, Los Angeles (UCLA) have identified a novel protein domain that has been implicated in a number of cellular processes, including DNA damage response, cell cycle regulation, cancer development, and developmental disorders. In addition to its role in regulation, the TAD domain has been investigated in other cellular processes and diseases, including cancer development and development disorders., as well as in animal models of developmental disorders, such as autism and Down's syndrome., and in human diseases such as cancer."}
{"qid": "5abd3707fcf456587200002d", "original_text": "Yes, the petrous bone has been used in ancient DNA sampling. The petrous bone, located in the inner ear, has been identified as a potential source of high-quality ancient DNA due to its unique structure and location. The bone's compact, dense, and well-preserved structure makes it an ideal candidate for DNA extraction and analysis, particularly for ancient samples. One of the earliest and most notable examples of ancient DNA analysis from the petrous bone was published in 2006, which demonstrated the successful extraction and analysis of DNA from a 1,400-year-old individual from the Xinjiang Region of China. Since then, the petrous bone has been used in various ancient DNA studies, including those focused on the origins of domesticated animals, the analysis of ancient human populations, and the detection of pathogens in ancient skeletal remains. While the petrous bone can provide valuable insights into the past, it's important to note that the recovery of ancient DNA from this location can be challenging due to factors such as bone decay, sample contamination, and the presence of endogenous DNA-degrading enzymes. Therefore, careful sample handling, processing, and analysis are essential for obtaining high-quality genetic data.", "label": 0, "is_selected": 1, "text": "Is the petrous bone used in ancient DNA sampling?<n> The petrous Bone, located in the inner ear, has been identified as a potential source of high-quality ancient DNA due to its unique structure and location. While the Petrous Bone can provide valuable insights into the past, it's important to note that the recovery of ancient DNA from this location can be challenging due to factors such as bone decay, sample contamination, and the presence of endogenous DNA-degrading enzymes."}
{"qid": "58ec6eb5eda5a5767200000c", "original_text": "Enlimomab, a murine monoclonal anti-human intercellular adhesion molecule (ICAM)-1 antibody, had a negative outcome in a multicenter acute-stroke trial. We did a bedside-to-bench study in standardized rat stroke models to explore mechanisms for these untoward results. After focal brain ischemia in Wistar rats and spontaneously hypertensive rats (SHR), we administered murine anti-rat ICAM-1 antibody (1A29), subclass-matched murine immunoglobulin (IgG1), or vehicle intravenously. To examine whether rat anti-mouse antibodies were generated against the mouse protein and whether these were deleterious, we sensitized Wistar rats with 1A29 or vehicle 7 days before surgery. Infarct volume, tissue myeloperoxidase activity, neutrophil CD11b expression, and microvascular E-selectin, P-selectin, and ICAM-1 expression were examined 48 hours after surgery. Complement activation was serially assessed for 2 hours after a single injection of either 1A29 or vehicle. 1A29 treatment did not significantly reduce infarct size in either strain. 1A29 sensitization augmented infarct size and generated rat anti-mouse antibodies. Although 1A29 inhibited neutrophil trafficking shown by reduction in brain myeloperoxidase activity, circulating neutrophils were activated and displayed CD11b upregulation. Complement was activated in 1A29-sensitized Wistar rats and 1A29-treated SHR. E-selectin (SHR), endothelial P-selectin (Wistar and SHR), and ICAM-1 (SHR) were upregulated in animals treated with 1A29.", "label": 1, "is_selected": 0, "text": "Enlimomab, a murine monoclonal anti-human intercellular adhesion molecule (ICAM)-1 antibody, had a negative outcome in a multicenter acute-stroke trial. We did a bedside-to-bench study in standardized rat stroke models to explore mechanisms for these untoward results. After focal brain ischemia in Wistar rats and spontaneously hypertensive rats (SHR), we administered murine anti-rat ICAM-1 antibody (1A29), subclass-matched murine immunoglobulin (IgG1), or vehicle intravenously. To examine whether rat anti-mouse antibodies were generated against the mouse protein and whether these were deleterious, we sensitized Wistar rats with 1A29 or vehicle 7 days before surgery. Infarct volume, tissue myeloperoxidase activity, neutrophil CD11b expression, and microvascular E-selectin, P-selectin, and ICAM-1 expression were examined 48 hours after surgery. Complement activation was serially assessed for 2 hours after a single injection of either 1A29 or vehicle. 1A29 treatment did not significantly reduce infarct size in either strain. 1A29 sensitization augmented infarct size and generated rat anti-mouse antibodies. Although 1A29 inhibited neutrophil trafficking shown by reduction in brain myeloperoxidase activity, circulating neutrophils were activated and displayed CD11b upregulation. Complement was activated in 1A29-sensitized Wistar rats and 1A29-treated SHR. E-selectin (SHR), endothelial P-selectin (Wistar and SHR), and ICAM-1 (SHR) were upregulated in animals treated with 1A29."}
{"qid": "56b1f4300a360a5e4500001b", "original_text": "The peptide p13-Crry, also known as cystatin C fibrillization peptide (CCFP), plays a pivotal role in human cystatin C fibrillization. It is a 13-amino acid peptide derived from the N-terminal region of cystatin C and is responsible for the aggregation and fibrillization of this protein.", "label": 0, "is_selected": 0, "text": "The peptide p13-Crry, also known as cystatin C fibrillization peptide (CCFP), plays a pivotal role in human cystatin C fibrillization. It is a 13-amino acid peptide derived from the N-terminal region of cystatin C and is responsible for the aggregation and fibrillization of this protein."}
{"qid": "621fc8513a8413c653000063", "original_text": "Repeat expansion disorders (REDs) are a group of genetic conditions characterized by the expansion of a repeat sequence in a specific gene, leading to an accumulation of abnormally long peptides that aggregate and cause cellular damage. Here are some examples of REDs: 1. Huntington's disease: An autosomal dominant disorder caused by an expansion of a CAG repeat in the Huntingtin gene, leading to progressive brain degeneration and motor dysfunction. 2. Spinocerebellar ataxia (SCA): A group of autosomal dominant disorders caused by expansion of CAG, CCTG, or GTG repeat sequences in various genes, leading to progressive cerebellar ataxia and other neurological symptoms. 3. Myotonic dystrophy: An autosomal dominant disorder caused by an expansion of CCTG or CCGG repeat sequences in the DMPK or MFN2 genes, leading to muscle stiffness, weakness, and other symptoms. 4. Fragile X syndrome: The most common form of inherited intellectual disability, caused by an expansion of an CGG repeat in the FMR1 gene. 5. Limb-gall-stom syndrome: A rare genetic disorder caused by an expansion of a (CTG)n repeat in the DGCR1 gene, leading to progressive muscle weakness, wasting, and distal limb contractures. Note: This is not an exhaustive list, and there are other repeat expansion disorders that have been identified in the medical literature.", "label": 0, "is_selected": 1, "text": "Scientists have discovered a new type of genetic disorder that affects about one in every 10,000 people in the United States, according to the US National Institutes of Health (NIH) and the National Human Genome Research Institute (NHRI)... and it's been called a repeat expansion disorder, or RED, by scientists at the University of California, Los Angeles (UCLA) School of Medicine and Harvard Medical School (HMS) and at the Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH) in Boston."}
{"qid": "606b3f4d94d57fd879000066", "original_text": "The nuclear receptor steroid and xenobiotic receptor (SXR) is a transcriptional regulator activated by various biological and xenobiotic substances. We have recently shown that SXR is expressed in bone and that this receptor is critical for bone metabolism, particularly in osteoblastic cells. Vitamin K2, one of the critical nutrients in bone metabolism, has been demonstrated that it is a potent SXR agonist and modulates the expression of various bone-related genes in osteoblastic cells. Using microarray analysis, we identified novel SXR target genes that were activated by vitamin K2 in osteoblastic cells.", "label": 1, "is_selected": 0, "text": "The nuclear receptor steroid and xenobiotic receptor (SXR) is a transcriptional regulator activated by various biological and xenobiotic substances. We have recently shown that SXR is expressed in bone and that this receptor is critical for bone metabolism, particularly in osteoblastic cells. Vitamin K2, one of the critical nutrients in bone metabolism, has been demonstrated that it is a potent SXR agonist and modulates the expression of various bone-related genes in osteoblastic cells. Using microarray analysis, we identified novel SXR target genes that were activated by vitamin K2 in osteoblastic cells."}
{"qid": "604b8cf71cb411341a000171", "original_text": "Developmental and Epileptic Encephalopathies (DEEs) are a group of rare genetic disorders characterized by severe cognitive impairment, epilepsy, and other neurological symptoms. Some of the common characteristics of DEEs include: 1. Global developmental delay: Children with DEEs often experience significant delays in reaching milestones such as sitting, standing, walking, and speaking. 2. Intellectual disability: DEEs are associated with intellectual disability, which can range from mild to severe. 3. Epilepsy: Seizures are a hallmark of DEEs and can vary in frequency, severity, and type. 4. Behavioral problems: Children with DEEs may exhibit challenging behaviors such as irritability, aggression, and autism-like features. 5. Cognitive decline: DEEs are progressive disorders, and children with these conditions often experience a decline in cognitive function over time. 6. Microencephaly: Many DEEs are associated with a smaller than average brain size, known as microencephaly. 7. Mutations in genes involved in neuronal function: DEEs are caused by mutations in genes involved in neuronal function, such as ion channels, synaptic plasticity, and neurotransmitter release. It is important to note that each DEE has its unique set of characteristics, and some may have overlapping features with other genetic disorders. Accurate diagnosis and prompt management are critical to improve the quality of life for children with DEEs.", "label": 0, "is_selected": 1, "text": "The American Academy of Neurology (AAN) has published a list of seven genetic disorders that affect the development and function of the brain and spinal cord in infants and children. Cognitive decline: DEEs are progressive disorders, and children with these conditions often experience a decline in cognitive function over time. The American Association of Neurological Surgeons (AANS) is a professional society dedicated to improving the health and well-being of children and adults with neurological conditions, as well as their families and carers. The AANS is a member of the American Medical Association (AMA) and the American College of Surgeons (ACS)."}
{"qid": "5ac24c9495d0062724000002", "original_text": "Chromatin immunoprecipitation (ChIP) is an indispensable tool in the fields of epigenetics and gene regulation that isolates specific protein-DNA interactions. ChIP coupled to high throughput sequencing (ChIP-seq) is commonly used to determine the genomic location of proteins that interact with chromatin. However, ChIP-seq is hampered by relatively low mapping resolution of several hundred base pairs and high background signal. The ChIP-exo method is a refined version of ChIP-seq that substantially improves upon both resolution and noise. The key distinction of the ChIP-exo methodology is the incorporation of lambda exonuclease digestion in the library preparation workflow to effectively footprint the left and right 5' DNA borders of the protein-DNA crosslink site.", "label": 1, "is_selected": 0, "text": "Chromatin immunoprecipitation (ChIP) is an indispensable tool in the fields of epigenetics and gene regulation that isolates specific protein-DNA interactions. ChIP coupled to high throughput sequencing (ChIP-seq) is commonly used to determine the genomic location of proteins that interact with chromatin. However, ChIP-seq is hampered by relatively low mapping resolution of several hundred base pairs and high background signal. The ChIP-exo method is a refined version of ChIP-seq that substantially improves upon both resolution and noise. The key distinction of the ChIP-exo methodology is the incorporation of lambda exonuclease digestion in the library preparation workflow to effectively footprint the left and right 5' DNA borders of the protein-DNA crosslink site."}
{"qid": "552016a36b348bb82c000018", "original_text": "The independent mitochondrial genetic information is organized in so-called mitochondrial nucleoids that, in vertebrates, typically contain 5-7 genetic units. The total number of nucleoids per cell is several hundred in cultured cells. Mitochondrial nucleoids, similarly to the whole mitochondrial network, have recently been successfully and extensively visualized using fluorescent and confocal microscopy. In the present work, we show high-resolution micrographs of mouse and human mitochondrial nucleoids obtained by transmission electron microscopy.", "label": 1, "is_selected": 0, "text": "The independent mitochondrial genetic information is organized in so-called mitochondrial nucleoids that, in vertebrates, typically contain 5-7 genetic units. The total number of nucleoids per cell is several hundred in cultured cells. Mitochondrial nucleoids, similarly to the whole mitochondrial network, have recently been successfully and extensively visualized using fluorescent and confocal microscopy. In the present work, we show high-resolution micrographs of mouse and human mitochondrial nucleoids obtained by transmission electron microscopy."}
{"qid": "5502abd1e9bde69634000008", "original_text": "Yes, calcium/calmodulin-dependent protein kinase II (CaMKII) has been implicated in both cardiac arrhythmias and heart failure. CaMKII is a key regulator of cardiac cellular physiology, and its dysregulation can lead to an increased susceptibility to arrhythmias and heart failure. Studies have shown that CaMKII activation can trigger cardiac arrhythmias by disrupting the normal functioning of ion channels and myocardial contractility, while concurrently contributing to the development of heart failure through mechanisms involving fibrosis, hypertrophy, and apoptosis. In summary, CaMKII plays a crucial role in the pathophysiology of cardiac arrhythmias and heart failure.", "label": 0, "is_selected": 1, "text": "Is it possible to prevent cardiac arrhythmias and heart failure by blocking the activity of a specific protein?<n> In summary CaMKII plays a crucial role in the development and progression of heart failure, and its dysregulation can lead to an increased susceptibility to arrythmias."}
{"qid": "6217d9493a8413c653000022", "original_text": "Indoleamine 2,3-dioxygenase 1 (IDO1) is an enzyme that plays a crucial role in the immune system. Its primary activity is the degradation of the amino acid tryptophan, which is a essential nutrient for the growth and survival of cells. Specifically, IDO1 catalyzes the conversion of tryptophan to N-formylkynurenine, a compound that suppresses the immune system by inhibiting the proliferation of T cells and dendritic cells. This activity is important for maintaining immune homeostasis and preventing excessive or inappropriate immune responses. IDO1 has been implicated in various diseases, including cancer, where it can act as a tumor suppressor, and in autoimmune diseases, where it can contribute to the development of autoimmune pathologies.", "label": 0, "is_selected": 1, "text": "The European Research Council (ERC) has awarded the 2016 European Research Prize for the discovery and development of a new class of immune modulators, called IDO1 inhibitors, for the treatment of a range of autoimmune diseases, including rheumatoid arthritis, psoriasis, and psoriatic arthritis."}
{"qid": "533aaab6d6d3ac6a34000062", "original_text": "Yellow fever is a mosquito-transmitted hemorrhagic viral disease that is endemic to tropical regions in South America and Africa. It remains a significant health concern for deploying military personnel, accordingly vaccination is frequently performed on troops. Although the vaccine is generally administered with only minor complications, rare severe complications are also reported. Herein, we report a mild case of yellow fever vaccine-associated viscerotropic disease 4 days after administration of the vaccine. The various complications of the vaccine and their pathogenesis are also reviewed.", "label": 1, "is_selected": 0, "text": "Yellow fever is a mosquito-transmitted hemorrhagic viral disease that is endemic to tropical regions in South America and Africa. It remains a significant health concern for deploying military personnel, accordingly vaccination is frequently performed on troops. Although the vaccine is generally administered with only minor complications, rare severe complications are also reported. Herein, we report a mild case of yellow fever vaccine-associated viscerotropic disease 4 days after administration of the vaccine. The various complications of the vaccine and their pathogenesis are also reviewed."}
{"qid": "5539029cbc4f83e828000012", "original_text": "Medulloblastoma is a type of pediatric cancer that originates in the cerebellum. Several genes have been found to be involved in the development of medulloblastoma, including: 1. Hedgehog signaling pathway genes: Mutations in genes involved in the Hedgehog signaling pathway, such as PTCH1, PTCH2, and SMO, are frequent in medulloblastoma. 2. P53 tumor suppressor gene: Mutations in the TP53 gene are commonly found in medulloblastoma and are associated with poor prognosis. 3. CDKN2A gene: Mutations in the CDKN2A gene, which encodes the protein p16, are also frequent in medulloblastoma. 4. DICER1 gene: Mutations in the DICER1 gene have been identified in a subset of medulloblastomas. 5. SWI/SNF chromatin remodeling complex genes: Mutations in genes involved in the SWI/SNF chromatin remodeling complex, such as ARID1A, ARID1B, and BRM, have been identified in medulloblastoma. It's important to note that the genetic landscape of medulloblastoma is complex and can vary depending on the specific subtype of the disease. Further research is needed to fully understand the genetic mechanisms underlying medulloblastoma development and progression.", "label": 0, "is_selected": 1, "text": "Medulloblastoma is a rare and aggressive form of childhood cancer, and research into the genetic basis of the disease is of great interest to parents and children alike, as well as to medical professionals involved in the diagnosis and treatment of this disease.<n> A number of genes have been identified that may be involved in medulloblastoma development and progression, and further research is needed to fully understand the genetic mechanisms underlying this disease and to develop new treatments."}
{"qid": "5e2a0eb1aa19d7443100000c", "original_text": "PRL3-zumab is a monoclonal antibody that targets the protein PRL3, which is overexpressed in various types of cancer, including breast, lung, and ovarian cancer. In vitro studies have shown that PRL3-zumab can inhibit the growth and viability of PRL3+ cancer cells by blocking the PRL3 protein's activity. In vivo studies have also demonstrated the effectiveness of PRL3-zumab in reducing tumor growth and size in mouse models of cancer. Overall, the available evidence suggests that PRL3-zumab may be a promising therapeutic agent for the treatment of PRL3+ cancer.", "label": 0, "is_selected": 0, "text": "PRL3-zumab is a monoclonal antibody that targets the protein PRL3, which is overexpressed in various types of cancer, including breast, lung, and ovarian cancer. In vitro studies have shown that PRL3-zumab can inhibit the growth and viability of PRL3+ cancer cells by blocking the PRL3 protein's activity. In vivo studies have also demonstrated the effectiveness of PRL3-zumab in reducing tumor growth and size in mouse models of cancer. Overall, the available evidence suggests that PRL3-zumab may be a promising therapeutic agent for the treatment of PRL3+ cancer."}
{"qid": "5d35ca5eb3a6380763000008", "original_text": "The TSA-Seq method allows for the measurement of various aspects of cellular metabolism, including: * Glycolysis: rates of glucose consumption and conversion to pyruvate, lactate, and other metabolites * Glycerol and fatty acid metabolism: measurement of glycerol and fatty acid synthesis, as well as the breakdown of fatty acids * ATP production: measurement of ATP production via glycolysis, pentose phosphate pathway, and other pathways * TCA cycle: measurement of the flux through the tricarboxylic acid (TCA) cycle, including the production of ATP, NADH, and FADH2. * Mitochondrial function: measurement of mitochondrial membrane potential, electron transport chain function, and ATP production via oxidative phosphorylation.", "label": 0, "is_selected": 1, "text": "The Mitochondrial Transcriptome Analysis-Seq (TSA-Seq) method is a high-resolution, multiplexed method for the measurement of mitochondrial function, metabolism, and other biological processes in living animals and plant tissue, as well as for the analysis of DNA and RNA."}
{"qid": "53340ca4d6d3ac6a34000042", "original_text": "Flaviviridae family of viruses, which includes dengue, yellow fever, and Zika viruses, infects vertebrates through a complex process. The virus enters the host cell through the binding of its surface proteins to the host cell receptors. Once inside the cell, the virus utilizes the cell's machinery to replicate its RNA genome and produce new viral particles. The newly formed viral particles are then released from the host cell through lysis or budding, allowing the virus to infect other cells and continue its replication cycle. Flaviviridae viruses can also infect a wide range of vertebrates, including mammals, birds, reptiles, and amphibians, making them a significant public health concern.", "label": 0, "is_selected": 1, "text": "Researchers at the University of California, Los Angeles (UCLA), have discovered a new family of viruses that can cause dengue fever and other tropical diseases, including the Zika virus, which has been linked to birth defects and severe birth defects in babies in the United States."}
{"qid": "5ace19420340b9f05800000a", "original_text": "Melanocortin receptor 1 (MC1R) and agouti signaling protein (ASIP) are two major genes affecting coat color phenotypes in mammals, and inactivation mutations in the MC1R gene are responsible for red coat color in European pig breeds. Conversely, the gain-of-function ASIP mutations block MC1R signaling and lead to the production of red pheomelanin. Chinese Tibetan pigs have three types of coat color phenotypes, including brownish red, solid black and black with patches of brownish red and white. Herein, we investigated variations of the MC1R and ASIP genes in Tibetan pigs. The results showed that the brownish red Tibet pig had the dominant black MC1R allele (E(D1)).", "label": 1, "is_selected": 0, "text": "Melanocortin receptor 1 (MC1R) and agouti signaling protein (ASIP) are two major genes affecting coat color phenotypes in mammals, and inactivation mutations in the MC1R gene are responsible for red coat color in European pig breeds. Conversely, the gain-of-function ASIP mutations block MC1R signaling and lead to the production of red pheomelanin. Chinese Tibetan pigs have three types of coat color phenotypes, including brownish red, solid black and black with patches of brownish red and white. Herein, we investigated variations of the MC1R and ASIP genes in Tibetan pigs. The results showed that the brownish red Tibet pig had the dominant black MC1R allele (E(D1))."}
{"qid": "550748a3bde8548216000001", "original_text": "Yes, mutations in the STXBP1 gene have been identified as a cause of some forms of epilepsy. The STXBP1 gene provides instructions for making a protein called stx1-binding protein 1 (STXBP1). This protein is involved in the transmission of signals in the brain, particularly in the formation and maintenance of synapses, which are the connections between neurons. Mutations in the STXBP1 gene have been found to lead to alterations in synaptic function and structure, resulting in the development of epilepsy. Specifically, mutations in the STXBP1 gene have been linked to several rare forms of epilepsy, including autosomal dominant nocturnal frontal lobe epilepsy and epilepsy with migrating focal seizures. These forms of epilepsy are characterized by frequent seizures, often occurring during sleep and/or at night, and may be associated with other neurological symptoms such as headaches, confusion, and difficulty with concentration and memory.", "label": 0, "is_selected": 1, "text": "Some forms of epilepsy may be caused by mutations in the STXBP1 gene, but what is this gene and is it a cause of epilepsy or just a genetic defect?<n> Specifically, mutations in this gene have been linked to several rare forms of nocturnal epilepsy, including dominant frontal lobe epilepsy and epilepsy with migrating seizures., as well as sleep-related epilepsy."}
{"qid": "58e8a2fc3e8b6dc87c00000c", "original_text": "RNA editing can yield protein products that differ from those directly encoded by genomic DNA. This process is pervasive in the mitochondria of many eukaryotes, where it predominantly results in the restoration of ancestral protein sequences. Nuclear mRNAs in metazoans also undergo editing (adenosine-to-inosine or 'A-to-I' substitutions), and most of these edits appear to be nonadaptive 'misfirings' of adenosine deaminases. However, recent analysis of cephalopod transcriptomes found that many editing sites are shared by anciently divergent lineages within this group, suggesting they play some adaptive role. Recent discoveries have also revealed that some fungi have an independently evolved A-to-I editing mechanism, resulting in extensive recoding of their nuclear mRNAs. Here, phylogenetic comparisons were used to determine whether RNA editing generally restores ancestral protein sequences or creates derived variants.", "label": 1, "is_selected": 0, "text": "RNA editing can yield protein products that differ from those directly encoded by genomic DNA. This process is pervasive in the mitochondria of many eukaryotes, where it predominantly results in the restoration of ancestral protein sequences. Nuclear mRNAs in metazoans also undergo editing (adenosine-to-inosine or 'A-to-I' substitutions), and most of these edits appear to be nonadaptive 'misfirings' of adenosine deaminases. However, recent analysis of cephalopod transcriptomes found that many editing sites are shared by anciently divergent lineages within this group, suggesting they play some adaptive role. Recent discoveries have also revealed that some fungi have an independently evolved A-to-I editing mechanism, resulting in extensive recoding of their nuclear mRNAs. Here, phylogenetic comparisons were used to determine whether RNA editing generally restores ancestral protein sequences or creates derived variants."}
{"qid": "5c7006037c78d6947100005d", "original_text": "The SLEDAI (Sjogren's Syndrome Disease Activity Index) is a tool used to assess and measure the disease activity in patients with Systemic Lupus Erythematosus (SLE). The index includes 11 characteristics that are evaluated over a 14-day period, including: 1. Arthritis: pain or swelling in one or more joints. 2. Fatigue: feeling tired or weak. 3. Renal: changes in urine output or proteinuria (excess protein in the urine). 4. Cutaneous: skin rashes, lesions, or photosensitivity. 5. Respiratory: cough, shortness of breath, or chest pain. 6. Neurological: headaches, confusion, seizures, or weakness. 7. Gastrointestinal: abdominal pain, diarrhea, or vomiting. 8. Hematological: anemia (low red blood cell count), leukopenia (low white blood cell count), or thrombocytopenia (low platelet count). 9. Musculoskeletal: muscle or joint pain. 10. Psychiatric: depression, anxiety, or mood changes. 11. Lung: chest x-ray findings, such as infiltrates or pleural effusion. These characteristics are used to calculate a score, which indicates the overall disease activity level in the patient. The SLEDAI score can help healthcare providers to monitor disease activity, assess response to treatment, and make treatment decisions.", "label": 0, "is_selected": 1, "text": "The American College of Rheumatology (ACR) has released a new disease activity index for patients with systemic lupus. The SLEDAI (Sjogren's Syndrome Disease Activity Index) is a tool used to assess and measure the disease activity in patients with Systemic Lupus Erythematosus (SLE). These characteristics are used to calculate a score, which indicates the overall disease activity level in the patient. TheSLEDAI score can help healthcare providers to monitor disease activity, assess response to treatment, and make treatment decisions."}
{"qid": "5e2dfb52fbd6abf43b00001e", "original_text": "Xanamem is a medication that contains the active ingredient ganaxagilide. It is used to treat nausea and vomiting associated with chemotherapy in patients with cancer. Ganaxagilide works by reducing the amount of serotonin in the body, which can help to alleviate nausea and vomiting. Xanamem is administered orally, usually once daily, and may be taken for up to 5 days after the last chemotherapy dose. The medication is available in various strengths, including 50 mg, 100 mg, and 200 mg tablets. It is important to note that Xanamem is only approved for use in patients with cancer who are receiving chemotherapy, and should not be used to treat nausea and vomiting in other conditions. If you have any other medical questions, please feel free to ask.", "label": 0, "is_selected": 0, "text": "Xanamem is a medication that contains the active ingredient ganaxagilide. It is used to treat nausea and vomiting associated with chemotherapy in patients with cancer. Ganaxagilide works by reducing the amount of serotonin in the body, which can help to alleviate nausea and vomiting. Xanamem is administered orally, usually once daily, and may be taken for up to 5 days after the last chemotherapy dose. The medication is available in various strengths, including 50 mg, 100 mg, and 200 mg tablets. It is important to note that Xanamem is only approved for use in patients with cancer who are receiving chemotherapy, and should not be used to treat nausea and vomiting in other conditions. If you have any other medical questions, please feel free to ask."}
{"qid": "5e80caeb835f4e477700002b", "original_text": "Chloroquine or hydroxychloroquine are antimalarial drugs that have been used for decades to treat various conditions, including: Malaria: Chloroquine and hydroxychloroquine are effective in preventing and treating malaria caused by Plasmodium falciparum and Plasmodium vivax. They work by interfering with the growth of the parasite in red blood cells. Rheumatoid Arthritis: Hydroxychloroquine is commonly used to treat rheumatoid arthritis, an autoimmune disorder that causes inflammation and joint damage. It helps reduce joint pain and stiffness, and can also slow the progression of joint damage. Lupus: Hydroxychloroquine is used to treat systemic lupus erythematosus, an autoimmune disorder that can cause joint pain, skin rashes, and organ damage. It can help reduce inflammation and prevent flares. Psoriasis: Hydroxychloroquine can be used to treat psoriasis, a chronic skin condition characterized by red, scaly patches. It can help reduce inflammation and slow the growth of skin cells. It's important to note that these drugs can have side effects, so it's important to discuss the potential benefits and risks with a healthcare provider before starting treatment. Additionally, chloroquine and hydroxychloroquine are not recommended for people with certain heart conditions, and they may interact with other medications. Therefore, it's important to inform your healthcare provider of any medications you are currently taking or have taken in the past.", "label": 0, "is_selected": 1, "text": "If you have been diagnosed with malaria, you may be interested in learning more about chloroquine and its use to treat other conditions, such as rheumatoid arthritis, lupus, psoriasis, and other skin conditions, according to the US Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH). Lupus: HydroxychloroquinE is used to treat systemic lupustosus, an autoimmune disorder that can cause joint pain, skin rashes, and organ damage. It can help reduce inflammation and slow the growth of skin cells."}
{"qid": "5c6ffa257c78d69471000056", "original_text": "Sanfilippo syndrome (mucopolysaccharidosis type III, MPS III) is a progressive disorder in which patients are characterized by severe central nervous system degeneration together with mild somatic disease. MPS III results from a deficiency in one of the four enzymes involved in the heparan sulfate degradation, with sulfamidase (SGSH), \u03b1-N-acetylglucosaminidase (NAGLU), acetyl-coenzyme A: \u03b1-glucosaminide N-acetyltransferase (HGSNAT), and N-acetylglucosamine-6-sulfatase (GNS) being deficient respectively in MPS IIIA, MPS IIIB, MPS IIIC and MPS IIID. Mutation screening using PCR reaction/sequencing analysis on genomic DNA fragments was performed in seven Tunisian index cases with MPS IIIA, three with MPS IIIB and two with MPS IIIC. QMPSF (Quantitative Multiplex PCR of Short fluorescent Fragments) analysis was developed for the detection of genomic deletions and duplications in the SGSH gene.", "label": 1, "is_selected": 0, "text": "Sanfilippo syndrome (mucopolysaccharidosis type III, MPS III) is a progressive disorder in which patients are characterized by severe central nervous system degeneration together with mild somatic disease. MPS III results from a deficiency in one of the four enzymes involved in the heparan sulfate degradation, with sulfamidase (SGSH), \u03b1-N-acetylglucosaminidase (NAGLU), acetyl-coenzyme A: \u03b1-glucosaminide N-acetyltransferase (HGSNAT), and N-acetylglucosamine-6-sulfatase (GNS) being deficient respectively in MPS IIIA, MPS IIIB, MPS IIIC and MPS IIID. Mutation screening using PCR reaction/sequencing analysis on genomic DNA fragments was performed in seven Tunisian index cases with MPS IIIA, three with MPS IIIB and two with MPS IIIC. QMPSF (Quantitative Multiplex PCR of Short fluorescent Fragments) analysis was developed for the detection of genomic deletions and duplications in the SGSH gene."}
{"qid": "5545e926d355485447000002", "original_text": "Cyld encodes a 956-amino acid deubiquitinating enzyme (CYLD), which is a negative regulator of nuclear factor kappaB and mitogen-activated protein kinase pathways. Mutations that truncate and inactivate the carboxyl-terminal deubiquitinating domain of CYLD underlie the development of skin appendage tumors in humans, whereas down-regulation of Cyld expression has been associated with the development of various types of human malignancies including lung cancer. To establish an animal model of human CYLD inactivation and characterize the biological role of CYLD in vivo, we generated mice carrying a homozygous deletion of Cyld exon 9 (Cyld(Delta 9/Delta 9) mice) using a conditional approach.", "label": 1, "is_selected": 0, "text": "Cyld encodes a 956-amino acid deubiquitinating enzyme (CYLD), which is a negative regulator of nuclear factor kappaB and mitogen-activated protein kinase pathways. Mutations that truncate and inactivate the carboxyl-terminal deubiquitinating domain of CYLD underlie the development of skin appendage tumors in humans, whereas down-regulation of Cyld expression has been associated with the development of various types of human malignancies including lung cancer. To establish an animal model of human CYLD inactivation and characterize the biological role of CYLD in vivo, we generated mice carrying a homozygous deletion of Cyld exon 9 (Cyld(Delta 9/Delta 9) mice) using a conditional approach."}
{"qid": "52bf202003868f1b06000018", "original_text": "Blood (serum/plasma) antiepileptic drug (AED) therapeutic drug monitoring (TDM) has proven to be an invaluable surrogate marker for individualizing and optimizing the drug management of patients with epilepsy. Since 1989, there has been an exponential increase in AEDs with 23 currently licensed for clinical use, and recently, there has been renewed and extensive interest in the use of saliva as an alternative matrix for AED TDM. The advantages of saliva include the fact that for many AEDs it reflects the free (pharmacologically active) concentration in serum; it is readily sampled, can be sampled repetitively, and sampling is noninvasive; does not require the expertise of a phlebotomist; and is preferred by many patients, particularly children and the elderly.", "label": 1, "is_selected": 0, "text": "Blood (serum/plasma) antiepileptic drug (AED) therapeutic drug monitoring (TDM) has proven to be an invaluable surrogate marker for individualizing and optimizing the drug management of patients with epilepsy. Since 1989, there has been an exponential increase in AEDs with 23 currently licensed for clinical use, and recently, there has been renewed and extensive interest in the use of saliva as an alternative matrix for AED TDM. The advantages of saliva include the fact that for many AEDs it reflects the free (pharmacologically active) concentration in serum; it is readily sampled, can be sampled repetitively, and sampling is noninvasive; does not require the expertise of a phlebotomist; and is preferred by many patients, particularly children and the elderly."}
{"qid": "588f341594c1512c50000002", "original_text": "Promoters have diverse regulatory architectures and thus activate genes differently. For example, some have a TATA-box, many others do not. Even the ones with it can differ in its position relative to the transcription start site (TSS). No Promoter Left Behind (NPLB) is an efficient, organism-independent method for characterizing such diverse architectures directly from experimentally identified genome-wide TSSs, without relying on known promoter elements. As a test case, we show its application in identifying novel architectures in the fly genome. Web-server at http://nplb.ncl.res.in Standalone also at https://github.com/computationalBiology/NPLB/ (Mac OSX/Linux). l.narlikar@ncl.res.in Supplementary data are available at Bioinformatics online.", "label": 1, "is_selected": 0, "text": "Promoters have diverse regulatory architectures and thus activate genes differently. For example, some have a TATA-box, many others do not. Even the ones with it can differ in its position relative to the transcription start site (TSS). No Promoter Left Behind (NPLB) is an efficient, organism-independent method for characterizing such diverse architectures directly from experimentally identified genome-wide TSSs, without relying on known promoter elements. As a test case, we show its application in identifying novel architectures in the fly genome. Web-server at http://nplb.ncl.res.in Standalone also at https://github.com/computationalBiology/NPLB/ (Mac OSX/Linux). l.narlikar@ncl.res.in Supplementary data are available at Bioinformatics online."}
{"qid": "56c1f007ef6e39474100003b", "original_text": "Tumor treating fields (TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma by the U.S. FDA and has a CE mark in Europe. TTFields therapy delivers low-intensity (1-3 V/cm), intermediate-frequency (100-300 kHz), alternating electric fields to the tumor using transducer arrays placed on the skin around the region of the body containing the tumor. TTFields therapy affects metaphase, by disrupting mitotic spindle formation, and anaphase, by dielectrophoretic dislocation of intracellular constituents, resulting in apoptosis.", "label": 1, "is_selected": 0, "text": "Tumor treating fields (TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma by the U.S. FDA and has a CE mark in Europe. TTFields therapy delivers low-intensity (1-3 V/cm), intermediate-frequency (100-300 kHz), alternating electric fields to the tumor using transducer arrays placed on the skin around the region of the body containing the tumor. TTFields therapy affects metaphase, by disrupting mitotic spindle formation, and anaphase, by dielectrophoretic dislocation of intracellular constituents, resulting in apoptosis."}
{"qid": "589c334e78275d0c4a00003d", "original_text": "NSD-1015 is a compound that has been shown to inhibit Aromatic L-Amino Acid Decarboxylase (AADC) enzyme. AADC is involved in the breakdown of certain amino acids, such as L-DOPA, which is a precursor to dopamine. Elevated levels of AADC have been implicated in various neurological disorders, including Parkinson's disease. Studies have shown that NSD-1015 can inhibit AADC activity with an IC50 value of approximately 2.7 \u03bcM, indicating a moderate to high level of inhibition. This suggests that NSD-1015 may be a potential therapeutic agent for the treatment of AADC-related disorders. However, it is important to note that the efficacy and safety of NSD-1015 in humans have not been evaluated, and further research is needed to confirm its potential as an AADC inhibitor.", "label": 0, "is_selected": 0, "text": "NSD-1015 is a compound that has been shown to inhibit Aromatic L-Amino Acid Decarboxylase (AADC) enzyme. AADC is involved in the breakdown of certain amino acids, such as L-DOPA, which is a precursor to dopamine. Elevated levels of AADC have been implicated in various neurological disorders, including Parkinson's disease. Studies have shown that NSD-1015 can inhibit AADC activity with an IC50 value of approximately 2.7 \u03bcM, indicating a moderate to high level of inhibition. This suggests that NSD-1015 may be a potential therapeutic agent for the treatment of AADC-related disorders. However, it is important to note that the efficacy and safety of NSD-1015 in humans have not been evaluated, and further research is needed to confirm its potential as an AADC inhibitor."}
{"qid": "587f5d6492a5b8ad44000003", "original_text": "Circular RNAs are found in a wide range of organisms and it has been proposed that they perform disparate functions. However, how RNA circularization is connected to alternative splicing remains largely unexplored. Here, we stimulated primary human endothelial cells with tumor necrosis factor \u03b1 or tumor growth factor \u03b2, purified RNA, generated >2.4 billion RNA-seq reads, and used a custom pipeline to characterize circular RNAs derived from coding exons.", "label": 1, "is_selected": 0, "text": "Circular RNAs are found in a wide range of organisms and it has been proposed that they perform disparate functions. However, how RNA circularization is connected to alternative splicing remains largely unexplored. Here, we stimulated primary human endothelial cells with tumor necrosis factor \u03b1 or tumor growth factor \u03b2, purified RNA, generated >2.4 billion RNA-seq reads, and used a custom pipeline to characterize circular RNAs derived from coding exons."}
{"qid": "52bf1cb303868f1b0600000b", "original_text": "Apert syndrome, characterised by craniosynostosis, craniofacial anomalies, and symmetrical syndactyly of the digits (cutaneous and bony fusion), has been associated with two canonical mutations in the FGFR2 gene (S252W, P253R) in the great majority of cases. Since these two alterations have been observed exclusively among these patients, it has been suggested that the S252W and P253R changes may play an important role in the occurrence of syndactyly. In order to verify whether the mutations S252W and P253R could also cause a milder phenotype, without involvement of the limbs, we have screened 22 patients with clinical characteristics compatible with Crouzon or Pfeiffer syndrome for these two particular changes. Surprisingly, we identified a Pfeiffer-like patient with the mutation S252W, and therefore we have shown for the first time the occurrence of one of the canonical Apert mutations without severe abnormalities of the upper and lower extremities.", "label": 1, "is_selected": 0, "text": "Apert syndrome, characterised by craniosynostosis, craniofacial anomalies, and symmetrical syndactyly of the digits (cutaneous and bony fusion), has been associated with two canonical mutations in the FGFR2 gene (S252W, P253R) in the great majority of cases. Since these two alterations have been observed exclusively among these patients, it has been suggested that the S252W and P253R changes may play an important role in the occurrence of syndactyly. In order to verify whether the mutations S252W and P253R could also cause a milder phenotype, without involvement of the limbs, we have screened 22 patients with clinical characteristics compatible with Crouzon or Pfeiffer syndrome for these two particular changes. Surprisingly, we identified a Pfeiffer-like patient with the mutation S252W, and therefore we have shown for the first time the occurrence of one of the canonical Apert mutations without severe abnormalities of the upper and lower extremities."}
{"qid": "587f857b8ce3255b64000001", "original_text": "Inhalational anthrax caused by Bacillus anthracis is associated with high mortality primarily due to toxin-mediated injury. Raxibacumab is a human IgG1lambda monoclonal antibody directed against protective antigen, a component of the anthrax toxin. We evaluated the efficacy of raxibacumab as a prophylactic agent and after disease onset in a total of four randomized, placebo-controlled studies conducted in rabbits and monkeys. Animals were exposed to an aerosolized target exposure of B. anthracis spores that was approximately 100 times (in the prophylactic studies) and 200 times (in the therapeutic-intervention studies) the median lethal dose.", "label": 1, "is_selected": 0, "text": "Inhalational anthrax caused by Bacillus anthracis is associated with high mortality primarily due to toxin-mediated injury. Raxibacumab is a human IgG1lambda monoclonal antibody directed against protective antigen, a component of the anthrax toxin. We evaluated the efficacy of raxibacumab as a prophylactic agent and after disease onset in a total of four randomized, placebo-controlled studies conducted in rabbits and monkeys. Animals were exposed to an aerosolized target exposure of B. anthracis spores that was approximately 100 times (in the prophylactic studies) and 200 times (in the therapeutic-intervention studies) the median lethal dose."}
{"qid": "58a5b01760087bc10a000023", "original_text": "NOX family NADPH oxidases are enzymes whose biological function is electron transport and the generation of reactive oxygen species (ROS). NOX enzymes in mammalian organisms have received most attention. However, NOX enzymes are widely distributed in different kingdoms of life. While they are not found in prokaryotes and most unicellular eukaryotes, they are present in fungi, plants, and animals. The identity of the ancestral NOX is not known, but most likely it: (i) possessed the basic NOX structure consisting of 6 transmembrane domains (containing two assymmetrical hemes) and a long cytoplasmic C-terminal (containing the FAD and NADPH binding sites); and (ii) emerged before the divergence of life into fungi, plants, and animals. During evolution, acquisition of a Ca(2+)-binding EF hand domain by an ancestral NOX, led to NOX5-like isoforms. DUOX isoforms presumably developed from a NOX5-like isoform through the additional acquisition of a peroxidase homology domain. The expression pattern of NOX enzymes is specific to each kingdom of life. Fungi express only ancestral-type isoforms, and plants only NOX5-like isoforms.", "label": 1, "is_selected": 0, "text": "NOX family NADPH oxidases are enzymes whose biological function is electron transport and the generation of reactive oxygen species (ROS). NOX enzymes in mammalian organisms have received most attention. However, NOX enzymes are widely distributed in different kingdoms of life. While they are not found in prokaryotes and most unicellular eukaryotes, they are present in fungi, plants, and animals. The identity of the ancestral NOX is not known, but most likely it: (i) possessed the basic NOX structure consisting of 6 transmembrane domains (containing two assymmetrical hemes) and a long cytoplasmic C-terminal (containing the FAD and NADPH binding sites); and (ii) emerged before the divergence of life into fungi, plants, and animals. During evolution, acquisition of a Ca(2+)-binding EF hand domain by an ancestral NOX, led to NOX5-like isoforms. DUOX isoforms presumably developed from a NOX5-like isoform through the additional acquisition of a peroxidase homology domain. The expression pattern of NOX enzymes is specific to each kingdom of life. Fungi express only ancestral-type isoforms, and plants only NOX5-like isoforms."}
{"qid": "53175e68b166e2b806000009", "original_text": "RO\u0421 (reactive oxygen species) has been shown to have a negative effect on cyclin B1, a protein involved in the regulation of cell cycle progression. Studies have shown that RO\u0421 can induce cyclin B1 degradation, leading to cell cycle arrest and decreased proliferation. This is thought to occur through the activation of pro-apoptotic signaling pathways, such as the p53 protein. Additionally, RO\u0421 can also modulate the expression of genes involved in the cell cycle, further contributing to the inhibition of cyclin B1. These findings suggest that RO\u0421 may play a role in the development of cancer, as well as other diseases characterized by aberrant cell proliferation.", "label": 0, "is_selected": 1, "text": "The aim of this project is to investigate the role of reactive oxygen species (RO) in the development of cancer as well as other diseases by studying the relationship between RO and cyclin B1 and their regulation of the cell cycle., The research is being carried out at the University of Cambridge and King's College London."}
{"qid": "54e0e902ae9738404b000001", "original_text": "Rho, a member of the Rho small G protein family, regulates the formation of stress fibers and focal adhesions in various types of cultured cells. We investigated here the actions of ROCK and mDia, both of which have been identified to be putative downstream target molecules of Rho, in Madin-Darby canine kidney cells.", "label": 1, "is_selected": 0, "text": "Rho, a member of the Rho small G protein family, regulates the formation of stress fibers and focal adhesions in various types of cultured cells. We investigated here the actions of ROCK and mDia, both of which have been identified to be putative downstream target molecules of Rho, in Madin-Darby canine kidney cells."}
{"qid": "56ecfd572ac5ed1459000002", "original_text": "Oprozomib is administered through a combination of intravenous (IV) and oral routes. The recommended dose is given IV over 1 hour, once daily, followed by a maintenance dose given orally once daily. It is important to administer the drug through a central venous catheter to ensure proper delivery and minimize the risk of adverse effects. The oral formulation is available for patients who are unable to receive IV therapy. It is important to follow the dosage instructions and monitoring guidelines provided by a healthcare professional to ensure safe and effective treatment with oprozomib.", "label": 0, "is_selected": 1, "text": "Oprozomib is a chemotherapy drug used to treat breast cancer in women who have failed at least one other treatment option and whose disease has spread to other parts of the body (metastatic breast cancer or HER2 positive breast cancer) and who have no other treatment options."}
{"qid": "5fdb4100a43ad31278000015", "original_text": "Many genes determining cell identity are regulated by clusters of Mediator-bound enhancer elements collectively referred to as super-enhancers. These super-enhancers have been proposed to manifest higher-order properties important in development and disease. Here we report a comprehensive functional dissection of one of the strongest putative super-enhancers in erythroid cells. By generating a series of mouse models, deleting each of the five regulatory elements of the \u03b1-globin super-enhancer individually and in informative combinations, we demonstrate that each constituent enhancer seems to act independently and in an additive fashion with respect to hematological phenotype, gene expression, chromatin structure and chromosome conformation, without clear evidence of synergistic or higher-order effects.", "label": 1, "is_selected": 0, "text": "Many genes determining cell identity are regulated by clusters of Mediator-bound enhancer elements collectively referred to as super-enhancers. These super-enhancers have been proposed to manifest higher-order properties important in development and disease. Here we report a comprehensive functional dissection of one of the strongest putative super-enhancers in erythroid cells. By generating a series of mouse models, deleting each of the five regulatory elements of the \u03b1-globin super-enhancer individually and in informative combinations, we demonstrate that each constituent enhancer seems to act independently and in an additive fashion with respect to hematological phenotype, gene expression, chromatin structure and chromosome conformation, without clear evidence of synergistic or higher-order effects."}
{"qid": "58a957a8cc344ae31e000001", "original_text": "Epidemiological evidence indicates that vitamin D is involved in defense against diabetes; however, the precise underlying mechanism remains to be elucidated. In the present study, the effect of vitamin D on the pathogenesis of diabetes was investigated, with an emphasis on its direct effect on pancreatic \u03b2\u2011cells. A streptozotocin (STZ)\u2011induced type 1 diabetes mellitus (T1DM) mouse model and MIN6 mouse insulinoma \u03b2\u2011cells were subjected to vitamin D treatment. Histopathological analysis of pancreatic islets was performed to investigate insulitis, and reverse transcription-quantitative polymerase chain reaction and western blotting were used to determine the mRNA and protein expression levels of markers of autophagy [microtubule-associated protein 1A/1B\u2011light chain 3 (LC3) and Beclin 1] and regulation of apoptosis [B-cell lymphoma 2 (Bcl-2)]. Apoptosis of MIN6 cells was examined by flow cytometry following annexin V/propidium iodide labeling. The secretion of insulin was measured by ELISA. The results revealed that vitamin D reduced the incidence of T1DM, enhanced insulin secretion and relieved pancreatic inflammation in STZ\u2011treated mice. Furthermore, vitamin D increased the mRNA expression levels of LC3 and Beclin 1, and increased Bcl\u20112 protein expression levels in STZ\u2011treated MIN6 cells, while decreasing the apoptosis rate.", "label": 1, "is_selected": 0, "text": "Epidemiological evidence indicates that vitamin D is involved in defense against diabetes; however, the precise underlying mechanism remains to be elucidated. In the present study, the effect of vitamin D on the pathogenesis of diabetes was investigated, with an emphasis on its direct effect on pancreatic \u03b2\u2011cells. A streptozotocin (STZ)\u2011induced type 1 diabetes mellitus (T1DM) mouse model and MIN6 mouse insulinoma \u03b2\u2011cells were subjected to vitamin D treatment. Histopathological analysis of pancreatic islets was performed to investigate insulitis, and reverse transcription-quantitative polymerase chain reaction and western blotting were used to determine the mRNA and protein expression levels of markers of autophagy [microtubule-associated protein 1A/1B\u2011light chain 3 (LC3) and Beclin 1] and regulation of apoptosis [B-cell lymphoma 2 (Bcl-2)]. Apoptosis of MIN6 cells was examined by flow cytometry following annexin V/propidium iodide labeling. The secretion of insulin was measured by ELISA. The results revealed that vitamin D reduced the incidence of T1DM, enhanced insulin secretion and relieved pancreatic inflammation in STZ\u2011treated mice. Furthermore, vitamin D increased the mRNA expression levels of LC3 and Beclin 1, and increased Bcl\u20112 protein expression levels in STZ\u2011treated MIN6 cells, while decreasing the apoptosis rate."}
{"qid": "5cb0856decadf2e73f000058", "original_text": "Dihydroorotate dehydrogenase (DHOD) is the fourth enzyme in the de novo pyrimidine biosynthetic pathway and is essential in Trypanosoma cruzi, the parasitic protist causing Chagas' disease. T. cruzi and human DHOD have different biochemical properties, including the electron acceptor capacities and cellular localization, suggesting that T. cruzi DHOD may be a potential chemotherapeutic target against Chagas' disease. Here, we report nucleotide sequence polymorphisms of T. cruzi DHOD genes and the kinetic properties of the recombinant enzymes.", "label": 1, "is_selected": 0, "text": "Dihydroorotate dehydrogenase (DHOD) is the fourth enzyme in the de novo pyrimidine biosynthetic pathway and is essential in Trypanosoma cruzi, the parasitic protist causing Chagas' disease. T. cruzi and human DHOD have different biochemical properties, including the electron acceptor capacities and cellular localization, suggesting that T. cruzi DHOD may be a potential chemotherapeutic target against Chagas' disease. Here, we report nucleotide sequence polymorphisms of T. cruzi DHOD genes and the kinetic properties of the recombinant enzymes."}
{"qid": "552faa43bc4f83e828000004", "original_text": "Our understanding of Ewing's sarcoma development mediated by the EWS/FLI fusion protein has been limited by a lack of knowledge regarding the tumor cell of origin. To circumvent this, we analyzed the function of EWS/FLI in Ewing's sarcoma itself. By combining retroviral-mediated RNA interference with reexpression studies, we show that ongoing EWS/FLI expression is required for the tumorigenic phenotype of Ewing's sarcoma. We used this system to define the full complement of EWS/FLI-regulated genes in Ewing's sarcoma. Functional analysis revealed that NKX2.2 is an EWS/FLI-regulated gene that is necessary for oncogenic transformation in this tumor. Thus, we developed a highly validated transcriptional profile for the EWS/FLI fusion protein and identified a critical target gene in Ewing's sarcoma development.", "label": 1, "is_selected": 0, "text": "Our understanding of Ewing's sarcoma development mediated by the EWS/FLI fusion protein has been limited by a lack of knowledge regarding the tumor cell of origin. To circumvent this, we analyzed the function of EWS/FLI in Ewing's sarcoma itself. By combining retroviral-mediated RNA interference with reexpression studies, we show that ongoing EWS/FLI expression is required for the tumorigenic phenotype of Ewing's sarcoma. We used this system to define the full complement of EWS/FLI-regulated genes in Ewing's sarcoma. Functional analysis revealed that NKX2.2 is an EWS/FLI-regulated gene that is necessary for oncogenic transformation in this tumor. Thus, we developed a highly validated transcriptional profile for the EWS/FLI fusion protein and identified a critical target gene in Ewing's sarcoma development."}
{"qid": "604d41ba94d57fd879000005", "original_text": "Kisspeptin is a potent regulator of the hypothalamo-pituitary-gonadal axis. The activation of several vernal and pubertal behaviors involves the action of locally synthesized estradiol by hypothalamic aromatase-expressing neurons. Little is known about kisspeptin in non-mammalian systems, and its interaction with aromatase remains unexamined. The Mallard drake is a seasonal breeder and an excellent model for studying the neural mechanisms that regulate the HPG. The goals of these studies were to determine (a) if and how kisspeptin regulates the drake HPG, (b) if kisspeptin and aromatase are expressed in the Mallard brain, and (c) if kisspeptin is co-localized or in apposition with, aromatase- and gonadotropin hormone releasing hormone (GnRH) positive neurons.", "label": 1, "is_selected": 0, "text": "Kisspeptin is a potent regulator of the hypothalamo-pituitary-gonadal axis. The activation of several vernal and pubertal behaviors involves the action of locally synthesized estradiol by hypothalamic aromatase-expressing neurons. Little is known about kisspeptin in non-mammalian systems, and its interaction with aromatase remains unexamined. The Mallard drake is a seasonal breeder and an excellent model for studying the neural mechanisms that regulate the HPG. The goals of these studies were to determine (a) if and how kisspeptin regulates the drake HPG, (b) if kisspeptin and aromatase are expressed in the Mallard brain, and (c) if kisspeptin is co-localized or in apposition with, aromatase- and gonadotropin hormone releasing hormone (GnRH) positive neurons."}
{"qid": "52bf1d6003868f1b0600000e", "original_text": "There are two subtypes of Pfeiffer syndrome: 1. Pfeiffer syndrome type 1 (PS1): This is the most common subtype, accounting for about 75% of cases. It is characterized by craniosynostosis (early fusion of the skull sutures), brachycephaly (shortened face), and narrow eyes with a small upper jaw. Other features may include scoliosis (curvature of the spine), joint contractures, and intellectual disability. 2. Pfeiffer syndrome type 2 (PS2): This subtype is less common, accounting for about 20% of cases. It is characterized by craniosynostosis, brachycephaly, and narrow eyes, but the face is not as short as in PS1. Other features may include scoliosis, joint contractures, and intellectual disability. Please note that Pfeiffer syndrome is a rare genetic disorder, and the exact subtype may vary in different individuals. I hope this information helps. If you have any other questions, feel free to ask.", "label": 0, "is_selected": 1, "text": "Pfeiffer syndrome is a rare genetic disorder characterized by craniosynostosis (early fusion of the skull sutures), brachycephaly (shortened face), and narrow eyes with a small upper jaw.It is characterized by scoliosis (curvature of the spine), joint contractures, and intellectual disability.Other features may include scoliosis, joint contracture, andintellectual disability."}
{"qid": "5ac24f7595d0062724000003", "original_text": "Yes, transcription of eRNA (extracellular RNA) is bidirectional. During the process of extracellular RNA (eRNA) biogenesis, the reverse transcription of eRNA occurs by binding of a reverse transcriptase enzyme to the eRNA molecule, followed by the synthesis of complementary DNA (cDNA) strand. This process is the opposite direction of the transcription of DNA to mRNA. The bidirectional nature of eRNA transcription allows for the generation of both sense and antisense RNA molecules, which can be involved in various cellular processes, including gene regulation and RNA silencing.", "label": 0, "is_selected": 0, "text": "Yes, transcription of eRNA (extracellular RNA) is bidirectional. During the process of extracellular RNA (eRNA) biogenesis, the reverse transcription of eRNA occurs by binding of a reverse transcriptase enzyme to the eRNA molecule, followed by the synthesis of complementary DNA (cDNA) strand. This process is the opposite direction of the transcription of DNA to mRNA. The bidirectional nature of eRNA transcription allows for the generation of both sense and antisense RNA molecules, which can be involved in various cellular processes, including gene regulation and RNA silencing."}
{"qid": "5a88370c61bb38fb24000014", "original_text": "Retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), including melanoma differentiation-associated gene 5 (MDA5) and RIG-I, are crucial for host recognition of non-self RNAs, especially viral RNA. Thus, the expression and activation of RLRs play fundamental roles in eliminating the invading RNA viruses and maintaining immune homeostasis. However, how RLR expression is tightly regulated remains to be further investigated.", "label": 1, "is_selected": 0, "text": "Retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), including melanoma differentiation-associated gene 5 (MDA5) and RIG-I, are crucial for host recognition of non-self RNAs, especially viral RNA. Thus, the expression and activation of RLRs play fundamental roles in eliminating the invading RNA viruses and maintaining immune homeostasis. However, how RLR expression is tightly regulated remains to be further investigated."}
{"qid": "6032866a1cb411341a000142", "original_text": "Maintenance of the commensal bacteria that comprise the gut microbiome is essential to both gut and systemic health. Traumatic injury, such as burn, elicits a number of changes in the gut, including a shift in the composition of the microbiome (dysbiosis), increased gut leakiness, and bacterial translocation into the lymphatic system and bloodstream. These effects are believed to contribute to devastating secondary complications following burn, including pneumonia, acute respiratory distress syndrome, multi-organ failure, and septic shock.", "label": 1, "is_selected": 0, "text": "Maintenance of the commensal bacteria that comprise the gut microbiome is essential to both gut and systemic health. Traumatic injury, such as burn, elicits a number of changes in the gut, including a shift in the composition of the microbiome (dysbiosis), increased gut leakiness, and bacterial translocation into the lymphatic system and bloodstream. These effects are believed to contribute to devastating secondary complications following burn, including pneumonia, acute respiratory distress syndrome, multi-organ failure, and septic shock."}
{"qid": "58eb984aeda5a57672000008", "original_text": "In eukaryotes transcriptional regulation often involves multiple long-range elements and is influenced by the genomic environment. A prime example of this concerns the mouse X-inactivation centre (Xic), which orchestrates the initiation of X-chromosome inactivation (XCI) by controlling the expression of the non-protein-coding Xist transcript. The extent of Xic sequences required for the proper regulation of Xist remains unknown. Here we use chromosome conformation capture carbon-copy (5C) and super-resolution microscopy to analyse the spatial organization of a 4.5-megabases (Mb) region including Xist. We discover a series of discrete 200-kilobase to 1 Mb topologically associating domains (TADs), present both before and after cell differentiation and on the active and inactive X. TADs align with, but do not rely on, several domain-wide features of the epigenome, such as H3K27me3 or H3K9me2 blocks and lamina-associated domains.", "label": 1, "is_selected": 0, "text": "In eukaryotes transcriptional regulation often involves multiple long-range elements and is influenced by the genomic environment. A prime example of this concerns the mouse X-inactivation centre (Xic), which orchestrates the initiation of X-chromosome inactivation (XCI) by controlling the expression of the non-protein-coding Xist transcript. The extent of Xic sequences required for the proper regulation of Xist remains unknown. Here we use chromosome conformation capture carbon-copy (5C) and super-resolution microscopy to analyse the spatial organization of a 4.5-megabases (Mb) region including Xist. We discover a series of discrete 200-kilobase to 1 Mb topologically associating domains (TADs), present both before and after cell differentiation and on the active and inactive X. TADs align with, but do not rely on, several domain-wide features of the epigenome, such as H3K27me3 or H3K9me2 blocks and lamina-associated domains."}
{"qid": "58a341eb60087bc10a000018", "original_text": "Statins, a popular class of cholesterol-lowering medications, have been associated with a potential link to an increased risk of developing type 2 diabetes. Several large observational studies have suggested a possible connection between statin use and diabetes incidence, including the JUPITER trial and the U.K. Clinical Practice Research Datalink (CPRD) study. However, these findings have been controversial and have not been consistently confirmed in all studies. The exact mechanism by which statins may increase diabetes risk is not fully understood, but possible contributing factors include: 1. Insulin resistance: Statins can increase liver enzymes, which can lead to insulin resistance and glucose intolerance. 2. Beta-cell dysfunction: Statins may affect beta-cell function and glucose-stimulated insulin secretion, potentially leading to impaired glucose tolerance. 3. Inflammation: Statins have anti-inflammatory properties, which may help reduce inflammation in the body. However, some studies suggest that chronic inflammation may contribute to the development of insulin resistance and type 2 diabetes. While the evidence is still inconclusive, some major medical organizations, such as the American College of Cardiology (ACC) and the American Diabetes Association (ADA), suggest that the benefits of statin therapy for reducing cardiovascular disease risks may outweigh the potential risks for diabetes. However, patients should be monitored closely for signs of diabetes while taking statins. In summary, while there is some evidence to suggest a potential link between statins and an increased risk of diabetes, the evidence is not yet conclusive, and more research is needed to fully understand the relationship between the two. As with any medication, it is important to weigh the potential benefits and risks when determining treatment options.", "label": 0, "is_selected": 1, "text": "The American College of Cardiology (ACC) and the American Diabetes Association (ADA) suggest that the benefits of statin therapy for reducing cardiovascular disease risks may outweigh the potential risks for diabetes. While the evidence is still inconclusive, some major medical organizations, such as the American Cancer Society (ACS), suggest that a potential link between statin use and diabetes incidence, including the JUPITER trial, is not yet conclusive, and more research is needed to fully understand the relationship between the two. in summary, while there is some evidence to suggest a potentially link between statins and an increased risk of diabetes, the evidence isn't yet conclusive and further research is still needed."}
{"qid": "54d796f93706e8952800001e", "original_text": "Yes, protein citrullination has been implicated in rheumatoid arthritis (RA). Citrullination is the post-translational modification of protein surfaces by the addition of a nitrogen atom, which can lead to the activation of autoantibodies. In RA, anti-citrullinated protein antibodies (ACPA) are present in the majority of patients and are associated with joint damage. The most commonly citrullinated proteins in RA are fibrinogen, cytoplasmic components, and proteins in the joint. The citrullination of these proteins can lead to the formation of autoantibodies and activation of immune cells, which can contribute to the progression of RA.", "label": 0, "is_selected": 1, "text": "Can protein citrullination be implicated in rheumatoid arthritis (RA), a condition that causes the immune system to attack the joints of the feet, hands, and elbows, as well as other parts of the body, such as the brain and spinal cord?"}
{"qid": "56a7d32fa17756b72f000001", "original_text": "Pax6 is a transcription factor essential for the development of tissues including the eyes, central nervous system and endocrine glands of vertebrates and invertebrates. It regulates the expression of a broad range of molecules, including transcription factors, cell adhesion and short-range cell-cell signalling molecules, hormones and structural proteins. It has been implicated in a number of key biological processes including cell proliferation, migration, adhesion and signalling both in normal development and in oncogenesis.", "label": 1, "is_selected": 0, "text": "Pax6 is a transcription factor essential for the development of tissues including the eyes, central nervous system and endocrine glands of vertebrates and invertebrates. It regulates the expression of a broad range of molecules, including transcription factors, cell adhesion and short-range cell-cell signalling molecules, hormones and structural proteins. It has been implicated in a number of key biological processes including cell proliferation, migration, adhesion and signalling both in normal development and in oncogenesis."}
{"qid": "56a3bf0f496b62f23f00000a", "original_text": "We describe Bioconductor infrastructure for representing and computing on annotated genomic ranges and integrating genomic data with the statistical computing features of R and its extensions. At the core of the infrastructure are three packages: IRanges, GenomicRanges, and GenomicFeatures. These packages provide scalable data structures for representing annotated ranges on the genome, with special support for transcript structures, read alignments and coverage vectors. Computational facilities include efficient algorithms for overlap and nearest neighbor detection, coverage calculation and other range operations. This infrastructure directly supports more than 80 other Bioconductor packages, including those for sequence analysis, differential expression analysis and visualization.", "label": 1, "is_selected": 0, "text": "We describe Bioconductor infrastructure for representing and computing on annotated genomic ranges and integrating genomic data with the statistical computing features of R and its extensions. At the core of the infrastructure are three packages: IRanges, GenomicRanges, and GenomicFeatures. These packages provide scalable data structures for representing annotated ranges on the genome, with special support for transcript structures, read alignments and coverage vectors. Computational facilities include efficient algorithms for overlap and nearest neighbor detection, coverage calculation and other range operations. This infrastructure directly supports more than 80 other Bioconductor packages, including those for sequence analysis, differential expression analysis and visualization."}
{"qid": "5c76d0417c78d694710000a8", "original_text": "Cystinosin, a lysosomal transporter is involved in the efflux of cystine from the lysosome to the cytosol. Mutations in the human cystinosin gene (CTNS) cause cystinosis, a recessive autosomal disorder. Studies on cystinosin have been limited by the absence of a robust genetic screen. In the present study we have developed a dual strategy for evaluating cystinosin function that is amenable to rapid genetic analysis.", "label": 1, "is_selected": 0, "text": "Cystinosin, a lysosomal transporter is involved in the efflux of cystine from the lysosome to the cytosol. Mutations in the human cystinosin gene (CTNS) cause cystinosis, a recessive autosomal disorder. Studies on cystinosin have been limited by the absence of a robust genetic screen. In the present study we have developed a dual strategy for evaluating cystinosin function that is amenable to rapid genetic analysis."}
{"qid": "5a7486a90384be9551000003", "original_text": "Prostate cancer (PCa) remains the second-leading cause of cancer-related deaths in American men with an estimated mortality of more than 26,000 in 2016 alone. Aggressive and metastatic tumors are treated with androgen deprivation therapies (ADT); however, the tumors acquire resistance and develop into lethal castration resistant prostate cancer (CRPC). With the advent of better therapeutics, the incidences of a more aggressive neuroendocrine prostate cancer (NEPC) variant continue to emerge. Although de novo occurrences of NEPC are rare, more than 25% of the therapy-resistant patients on highly potent new-generation anti-androgen therapies end up with NEPC.", "label": 1, "is_selected": 0, "text": "Prostate cancer (PCa) remains the second-leading cause of cancer-related deaths in American men with an estimated mortality of more than 26,000 in 2016 alone. Aggressive and metastatic tumors are treated with androgen deprivation therapies (ADT); however, the tumors acquire resistance and develop into lethal castration resistant prostate cancer (CRPC). With the advent of better therapeutics, the incidences of a more aggressive neuroendocrine prostate cancer (NEPC) variant continue to emerge. Although de novo occurrences of NEPC are rare, more than 25% of the therapy-resistant patients on highly potent new-generation anti-androgen therapies end up with NEPC."}
{"qid": "516e5f4e298dcd4e51000080", "original_text": "Huntington's disease (HD) is an inherited, progressive neurological disorder that is caused by a CAG/polyglutamine repeat expansion and for which there is no effective therapy. Recent evidence indicates that transcriptional dysregulation may contribute to the molecular pathogenesis of this disease. Supporting this view, administration of histone deacetylase (HDAC) inhibitors has been shown to rescue lethality and photoreceptor neurodegeneration in a Drosophila model of polyglutamine disease. To further explore the therapeutic potential of HDAC inhibitors, we have conducted preclinical trials with suberoylanilide hydroxamic acid (SAHA), a potent HDAC inhibitor, in the R6/2 HD mouse model. We show that SAHA crosses the blood-brain barrier and increases histone acetylation in the brain. We found that SAHA could be administered orally in drinking water when complexed with cyclodextrins.", "label": 1, "is_selected": 0, "text": "Huntington's disease (HD) is an inherited, progressive neurological disorder that is caused by a CAG/polyglutamine repeat expansion and for which there is no effective therapy. Recent evidence indicates that transcriptional dysregulation may contribute to the molecular pathogenesis of this disease. Supporting this view, administration of histone deacetylase (HDAC) inhibitors has been shown to rescue lethality and photoreceptor neurodegeneration in a Drosophila model of polyglutamine disease. To further explore the therapeutic potential of HDAC inhibitors, we have conducted preclinical trials with suberoylanilide hydroxamic acid (SAHA), a potent HDAC inhibitor, in the R6/2 HD mouse model. We show that SAHA crosses the blood-brain barrier and increases histone acetylation in the brain. We found that SAHA could be administered orally in drinking water when complexed with cyclodextrins."}
{"qid": "5173a8b48ed59a060a00001d", "original_text": "The generation of mature mRNAs involves interconnected processes, including transcription by RNA polymerase II (Pol II), modification of histones, and processing of pre-mRNAs through capping, intron splicing, and polyadenylation. These processes are thought to be integrated, both spatially and temporally, but it is unclear how these connections manifest at a global level with respect to chromatin patterns and transcription kinetics. We sought to clarify the relationships between chromatin, transcription and splicing using multiple genome-wide approaches in fission yeast. To investigate these functional interdependencies, we determined Pol II occupancy across all genes using high-density tiling arrays. We also performed ChIP-chip on the same array platform to globally map histone H3 and its H3K36me3 modification, complemented by formaldehyde-assisted isolation of regulatory elements (FAIRE).", "label": 1, "is_selected": 0, "text": "The generation of mature mRNAs involves interconnected processes, including transcription by RNA polymerase II (Pol II), modification of histones, and processing of pre-mRNAs through capping, intron splicing, and polyadenylation. These processes are thought to be integrated, both spatially and temporally, but it is unclear how these connections manifest at a global level with respect to chromatin patterns and transcription kinetics. We sought to clarify the relationships between chromatin, transcription and splicing using multiple genome-wide approaches in fission yeast. To investigate these functional interdependencies, we determined Pol II occupancy across all genes using high-density tiling arrays. We also performed ChIP-chip on the same array platform to globally map histone H3 and its H3K36me3 modification, complemented by formaldehyde-assisted isolation of regulatory elements (FAIRE)."}
{"qid": "6020a9f11cb411341a000080", "original_text": "Dog bites are the most common animal bite injuries occurring in the United States. Estimated infection rates range between 15% and 20%. Polymicrobial infections are most common. Capnocytophaga canimorsus (C. canimorsus) is a Gram-negative rod strongly associated with dog bites, and is known to cause life-threatening infection in humans. 1) Outline epidemiology of dog bites in the United States; 2) Identify host factors associated with infection, and common pathogens; 3) Discuss microbiology of C. canimorsus; 4) Discuss common clinical manifestations of C. canimorsus infection; 5) Outline treatment options.", "label": 1, "is_selected": 0, "text": "Dog bites are the most common animal bite injuries occurring in the United States. Estimated infection rates range between 15% and 20%. Polymicrobial infections are most common. Capnocytophaga canimorsus (C. canimorsus) is a Gram-negative rod strongly associated with dog bites, and is known to cause life-threatening infection in humans. 1) Outline epidemiology of dog bites in the United States; 2) Identify host factors associated with infection, and common pathogens; 3) Discuss microbiology of C. canimorsus; 4) Discuss common clinical manifestations of C. canimorsus infection; 5) Outline treatment options."}
{"qid": "5c58b26386df2b9174000011", "original_text": "Ibalizumab is a monoclonal antibody that works by blocking the CD4 receptor on immune cells, which is essential for the entry of HIV into these cells. By inhibiting the CD4 receptor, ibalizumab prevents HIV from infecting and replicating within immune cells, such as T cells and macrophages. This reduces the amount of HIV in the body and slows down the progression of the disease. Additionally, ibalizumab can also help to increase the number of immune cells that are able to recognize and fight off HIV, leading to a stronger immune response against the virus. Overall, the mechanism of action of ibalizumab is to prevent HIV from infecting and replicating within immune cells, and to enhance the immune response against the virus.", "label": 0, "is_selected": 0, "text": "Ibalizumab is a monoclonal antibody that works by blocking the CD4 receptor on immune cells, which is essential for the entry of HIV into these cells. By inhibiting the CD4 receptor, ibalizumab prevents HIV from infecting and replicating within immune cells, such as T cells and macrophages. This reduces the amount of HIV in the body and slows down the progression of the disease. Additionally, ibalizumab can also help to increase the number of immune cells that are able to recognize and fight off HIV, leading to a stronger immune response against the virus. Overall, the mechanism of action of ibalizumab is to prevent HIV from infecting and replicating within immune cells, and to enhance the immune response against the virus."}
{"qid": "601f105e1cb411341a000071", "original_text": "Herpesviruses are large double stranded DNA animal viruses with the distinguishing ability to establish latent, life-long infections. To date, eight human herpesviruses that exhibit distinct biological and corresponding pathological/clinical properties have been identified. During their life cycles, herpesviruses execute an intricate chain of events geared towards optimizing their replication. This sets an interesting paradigm to study fundamental biological processes. This review summarizes recent developments in herpesvirus research with emphasis on genome transactions, particularly with respect to the prototypic herpes simplex virus type-1.", "label": 1, "is_selected": 0, "text": "Herpesviruses are large double stranded DNA animal viruses with the distinguishing ability to establish latent, life-long infections. To date, eight human herpesviruses that exhibit distinct biological and corresponding pathological/clinical properties have been identified. During their life cycles, herpesviruses execute an intricate chain of events geared towards optimizing their replication. This sets an interesting paradigm to study fundamental biological processes. This review summarizes recent developments in herpesvirus research with emphasis on genome transactions, particularly with respect to the prototypic herpes simplex virus type-1."}
{"qid": "58f8a08370f9fc6f0f00001b", "original_text": "Ohdo syndrome is characterized by a range of symptoms that can vary in severity and presentation. The main manifestations of Ohdo syndrome include: 1. Cognitive impairment: Difficulty with concentration, memory, and problem-solving. 2. Sleep disturbances: Insomnia, sleepwalking, and parasomnia. 3. Mood disorder: Anxiety, depression, and irritability. 4. Autonomic dysfunction: Difficulty with regulation of blood pressure, heart rate, and digestion. 5. Motor dysfunction: Muscle weakness, tremors, and coordination difficulties. 6. Sensory disturbances: Hearing and vision loss, as well as tactile and proprioceptive deficits. It is important to note that Ohdo syndrome is a rare condition, and the specific symptoms can vary in severity and presentation from person to person.", "label": 0, "is_selected": 0, "text": "Ohdo syndrome is characterized by a range of symptoms that can vary in severity and presentation. The main manifestations of Ohdo syndrome include: 1. Cognitive impairment: Difficulty with concentration, memory, and problem-solving. 2. Sleep disturbances: Insomnia, sleepwalking, and parasomnia. 3. Mood disorder: Anxiety, depression, and irritability. 4. Autonomic dysfunction: Difficulty with regulation of blood pressure, heart rate, and digestion. 5. Motor dysfunction: Muscle weakness, tremors, and coordination difficulties. 6. Sensory disturbances: Hearing and vision loss, as well as tactile and proprioceptive deficits. It is important to note that Ohdo syndrome is a rare condition, and the specific symptoms can vary in severity and presentation from person to person."}
{"qid": "5710a592cf1c32585100002a", "original_text": "Transcription of the major Bacillus anthracis virulence genes is triggered by CO2, a signal mimicking the host environment. A 182-kb plasmid, pXO1, carries the anthrax toxin genes and the genes responsible for their regulation of transcription, namely atxA and, pagR, the second gene of the pag operon. AtxA has major effects on the physiology of B. anthracis. It coordinates the transcription activation of the toxin genes with that of the capsule biosynthetic enzyme operon, located on the second virulence plasmid, pXO2. In rich medium, B. anthracis synthesises alternatively two S-layer proteins (Sap and EA1). An exponential phase \"Sap-layer\" is subsequently replaced by a stationary phase \"EA1-layer\". S-layer gene transcription is controlled by alternative sigma factors and by Sap acting as a transcriptional repressor of eag.", "label": 1, "is_selected": 0, "text": "Transcription of the major Bacillus anthracis virulence genes is triggered by CO2, a signal mimicking the host environment. A 182-kb plasmid, pXO1, carries the anthrax toxin genes and the genes responsible for their regulation of transcription, namely atxA and, pagR, the second gene of the pag operon. AtxA has major effects on the physiology of B. anthracis. It coordinates the transcription activation of the toxin genes with that of the capsule biosynthetic enzyme operon, located on the second virulence plasmid, pXO2. In rich medium, B. anthracis synthesises alternatively two S-layer proteins (Sap and EA1). An exponential phase \"Sap-layer\" is subsequently replaced by a stationary phase \"EA1-layer\". S-layer gene transcription is controlled by alternative sigma factors and by Sap acting as a transcriptional repressor of eag."}
{"qid": "5a6a2dcab750ff4455000023", "original_text": "A Genomic Regulatory Block (GRB) is a complex structure that consists of multiple constitutive parts. These parts include: 1. Transcriptional regulatory elements (TREs): These are the regions on the DNA where transcription factors bind to regulate gene expression. TREs can be enhancer Elements, silencer elements, or promoter elements. 2. Transcriptional activator proteins: These are the proteins that bind to TREs and recruit RNA polymerase to initiate transcription. 3. Transcriptional repressor proteins: These are the proteins that bind to TREs and inhibit the recruitment of RNA polymerase, thereby repressing transcription. 4. Non-coding RNA molecules: These are RNA molecules that do not code for proteins but instead regulate gene expression by binding to TREs or other regulatory elements. Examples include microRNAs, siRNAs, and long non-coding RNAs. 5. Chromatin-modifying enzymes: These are enzymes that alter the structure of chromatin, thereby affecting the accessibility of transcription factors and other regulatory proteins to the DNA. Examples include histone-modifying enzymes and DNA-binding proteins. 6. Co-regulatory proteins: These are proteins that bind to TREs and other regulatory elements and modulate their activity. Examples include coactivator proteins, corepressor proteins, and modulators of transcriptional activators and repressors. 7. Signal transduction pathways: These are signaling pathways that transmit signals from outside the nucleus to the nucleus, where they regulate gene expression. Examples include signal transduction pathways involving cytokines, growth factors, or hormones. 8. Spacers: These are the intervening DNA sequences that separate TREs from each other or from the promoter or terminator regions. Spacers can affect the stability of the GRB structure and the accessibility of transcription factors to the regulatory elements. By understanding the constitutive parts of a GRB, researchers can gain insights into how gene regulation works and how to manipulate it for therapeutic purposes.", "label": 0, "is_selected": 0, "text": "A Genomic Regulatory Block (GRB) is a complex structure that consists of multiple constitutive parts. These parts include: 1. Transcriptional regulatory elements (TREs): These are the regions on the DNA where transcription factors bind to regulate gene expression. TREs can be enhancer Elements, silencer elements, or promoter elements. 2. Transcriptional activator proteins: These are the proteins that bind to TREs and recruit RNA polymerase to initiate transcription. 3. Transcriptional repressor proteins: These are the proteins that bind to TREs and inhibit the recruitment of RNA polymerase, thereby repressing transcription. 4. Non-coding RNA molecules: These are RNA molecules that do not code for proteins but instead regulate gene expression by binding to TREs or other regulatory elements. Examples include microRNAs, siRNAs, and long non-coding RNAs. 5. Chromatin-modifying enzymes: These are enzymes that alter the structure of chromatin, thereby affecting the accessibility of transcription factors and other regulatory proteins to the DNA. Examples include histone-modifying enzymes and DNA-binding proteins. 6. Co-regulatory proteins: These are proteins that bind to TREs and other regulatory elements and modulate their activity. Examples include coactivator proteins, corepressor proteins, and modulators of transcriptional activators and repressors. 7. Signal transduction pathways: These are signaling pathways that transmit signals from outside the nucleus to the nucleus, where they regulate gene expression. Examples include signal transduction pathways involving cytokines, growth factors, or hormones. 8. Spacers: These are the intervening DNA sequences that separate TREs from each other or from the promoter or terminator regions. Spacers can affect the stability of the GRB structure and the accessibility of transcription factors to the regulatory elements. By understanding the constitutive parts of a GRB, researchers can gain insights into how gene regulation works and how to manipulate it for therapeutic purposes."}
{"qid": "571f30c40fd6f91b68000002", "original_text": "Sotos syndrome is an overgrowth syndrome with characteristic facial gestalt and mental retardation of variable severity. Haploinsufficiency of the NSD1 gene has been implicated as the major cause of Sotos syndrome, with a predominance of microdeletions reported in Japanese patients. This study was conducted to investigate into the spectrum of NSD1 gene mutations in southern Chinese patients with Sotos syndrome. Thirty-six Chinese patients with Sotos syndrome and two patients with Weaver syndrome were subject to molecular testing. NSD1 gene mutations were detected in 26 (72%) Sotos patients.", "label": 1, "is_selected": 0, "text": "Sotos syndrome is an overgrowth syndrome with characteristic facial gestalt and mental retardation of variable severity. Haploinsufficiency of the NSD1 gene has been implicated as the major cause of Sotos syndrome, with a predominance of microdeletions reported in Japanese patients. This study was conducted to investigate into the spectrum of NSD1 gene mutations in southern Chinese patients with Sotos syndrome. Thirty-six Chinese patients with Sotos syndrome and two patients with Weaver syndrome were subject to molecular testing. NSD1 gene mutations were detected in 26 (72%) Sotos patients."}
{"qid": "5a8712af61bb38fb24000002", "original_text": "Psoriasis is a common, chronic and inflammatory disease of the skin, which has been associated with depression in cross-sectional studies with limited adjustment for confounders. In this prospective cohort study, we investigated the risk of incident depression among individuals with psoriasis and psoriatic arthritis (PsA). We included 50 750 US female nurses from the Nurses' Health Study who were free of depression at baseline in 2000. Those participants who had ever self-reported clinician-diagnosed depression or regular use of antidepressants, or had a Mental Health Inventory score of \u2264 52 were excluded. In 2008, we retrospectively asked participants if they had ever received a physician's diagnosis of psoriasis or PsA. We defined depression as self-report of clinician-diagnosed depression or regular use of antidepressant medication. Time-dependent Cox proportional hazard models were used to estimate age and multivariate-adjusted relative risks (RRs) of clinical depression. After adjusting for covariates including body mass index, physical activity, smoking and the presence of major chronic conditions, the multivariate-adjusted RRs of clinical depression were 1\u00b729 [95% confidence interval (CI) 1\u00b710-1\u00b752] for women with psoriasis and 1\u00b752 (95% CI 1\u00b706-2\u00b719) for women with psoriasis and concomitant PsA, compared with women without psoriasis. We found an increased risk of depression in US women with psoriasis compared with those without psoriasis. This risk was higher in those who reported concomitant PsA. Future studies are needed to confirm these findings in other populations and to identify pathophysiological mechanisms linking psoriasis to depression.", "label": 1, "is_selected": 0, "text": "Psoriasis is a common, chronic and inflammatory disease of the skin, which has been associated with depression in cross-sectional studies with limited adjustment for confounders. In this prospective cohort study, we investigated the risk of incident depression among individuals with psoriasis and psoriatic arthritis (PsA). We included 50 750 US female nurses from the Nurses' Health Study who were free of depression at baseline in 2000. Those participants who had ever self-reported clinician-diagnosed depression or regular use of antidepressants, or had a Mental Health Inventory score of \u2264 52 were excluded. In 2008, we retrospectively asked participants if they had ever received a physician's diagnosis of psoriasis or PsA. We defined depression as self-report of clinician-diagnosed depression or regular use of antidepressant medication. Time-dependent Cox proportional hazard models were used to estimate age and multivariate-adjusted relative risks (RRs) of clinical depression. After adjusting for covariates including body mass index, physical activity, smoking and the presence of major chronic conditions, the multivariate-adjusted RRs of clinical depression were 1\u00b729 [95% confidence interval (CI) 1\u00b710-1\u00b752] for women with psoriasis and 1\u00b752 (95% CI 1\u00b706-2\u00b719) for women with psoriasis and concomitant PsA, compared with women without psoriasis. We found an increased risk of depression in US women with psoriasis compared with those without psoriasis. This risk was higher in those who reported concomitant PsA. Future studies are needed to confirm these findings in other populations and to identify pathophysiological mechanisms linking psoriasis to depression."}
{"qid": "58a5d7ef60087bc10a000026", "original_text": "Krokodil is an informal term for a cheap injectable illicit drug domestically prepared from codeine-containing medication (CCM). The method of krokodil preparation may produce desomorphine as well as toxic reactants that cause extensive tissue necrosis. The first confirmed report of krokodil use in Russia took place in 2004. In 2012, reports of krokodil-related injection injuries began to appear beyond Russia in Western Europe and the United States. This exploratory study had two main objectives: (1) to determine if Internet search patterns could detect regularities in behavioral responses to Russian CCM policy at the population level, and (2) to determine if complementary data sources could explain the regularities we observed. First, we obtained krokodil-related search pattern data for each Russia subregion (oblast) between 2011 and 2012. Second, we analyzed several complementary data sources included krokodil-related court cases, and related search terms on both Google and Yandex to evaluate the characteristics of terms accompanying krokodil-related search queries. In the 6 months preceding CCM sales restrictions, 21 of Russia's 83 oblasts had search rates higher than the national average (mean) of 16.67 searches per 100,000 population for terms associated with krokodil. In the 6 months following restrictions, mean national searches dropped to 9.65 per 100,000. Further, the number of oblasts recording a higher than average search rate dropped from 30 to 16.", "label": 1, "is_selected": 0, "text": "Krokodil is an informal term for a cheap injectable illicit drug domestically prepared from codeine-containing medication (CCM). The method of krokodil preparation may produce desomorphine as well as toxic reactants that cause extensive tissue necrosis. The first confirmed report of krokodil use in Russia took place in 2004. In 2012, reports of krokodil-related injection injuries began to appear beyond Russia in Western Europe and the United States. This exploratory study had two main objectives: (1) to determine if Internet search patterns could detect regularities in behavioral responses to Russian CCM policy at the population level, and (2) to determine if complementary data sources could explain the regularities we observed. First, we obtained krokodil-related search pattern data for each Russia subregion (oblast) between 2011 and 2012. Second, we analyzed several complementary data sources included krokodil-related court cases, and related search terms on both Google and Yandex to evaluate the characteristics of terms accompanying krokodil-related search queries. In the 6 months preceding CCM sales restrictions, 21 of Russia's 83 oblasts had search rates higher than the national average (mean) of 16.67 searches per 100,000 population for terms associated with krokodil. In the 6 months following restrictions, mean national searches dropped to 9.65 per 100,000. Further, the number of oblasts recording a higher than average search rate dropped from 30 to 16."}
{"qid": "5c6b7fb27c78d6947100002d", "original_text": "Burosumab (Crysvita\u00ae; Kyowa Hakko Kirin Co., Ltd. and Ultragenyx Pharmaceutical Inc.) is a fully human monoclonal antibody directed at fibroblast growth factor 23 (FGF23). Excessive FGF23 production has been implicated in various hypophosphataemic diseases. Inhibition of FGF23 by burosumab results in increased renal phosphate reabsorption and increased serum levels of phosphorus and active vitamin D.", "label": 1, "is_selected": 0, "text": "Burosumab (Crysvita\u00ae; Kyowa Hakko Kirin Co., Ltd. and Ultragenyx Pharmaceutical Inc.) is a fully human monoclonal antibody directed at fibroblast growth factor 23 (FGF23). Excessive FGF23 production has been implicated in various hypophosphataemic diseases. Inhibition of FGF23 by burosumab results in increased renal phosphate reabsorption and increased serum levels of phosphorus and active vitamin D."}
{"qid": "5c307474133db5eb78000033", "original_text": "Esrrb (estrogen-related receptor \u03b2) is a nuclear receptor that is bound by several complexes, including: 1. Estrogen ligands: Esrrb is activated by estrogenic ligands, such as estradiol, and forms a complex with the ligand to regulate gene expression. 2. Coactivators: Esrrb forms a complex with coactivators, such as p300 and CBP (creb-binding protein), to enhance the transcriptional activity of the receptor. 3. Corepressors: Esrrb also forms a complex with corepressors, such as N-CoR (nuclear receptor corepressor) and SMRT (silencing mediator for retinoid and thyroid hormone receptors), to repress gene transcription. 4. Signaltransducer and activator of transcription (STAT) proteins: Esrrb can also interact with STAT proteins, such as STAT3 and STAT5, to modulate the expression of target genes involved in inflammation and immune responses. 5. Other transcription factors: Esrrb can also interact with other transcription factors, such as c-Jun and c-Fos, to regulate gene expression in response to hormonal signals. It is important to note that the specific complexes formed by Esrrb can vary depending on the cell type, the ligand present, and the context of the cellular response.", "label": 0, "is_selected": 0, "text": "Esrrb (estrogen-related receptor \u03b2) is a nuclear receptor that is bound by several complexes, including: 1. Estrogen ligands: Esrrb is activated by estrogenic ligands, such as estradiol, and forms a complex with the ligand to regulate gene expression. 2. Coactivators: Esrrb forms a complex with coactivators, such as p300 and CBP (creb-binding protein), to enhance the transcriptional activity of the receptor. 3. Corepressors: Esrrb also forms a complex with corepressors, such as N-CoR (nuclear receptor corepressor) and SMRT (silencing mediator for retinoid and thyroid hormone receptors), to repress gene transcription. 4. Signaltransducer and activator of transcription (STAT) proteins: Esrrb can also interact with STAT proteins, such as STAT3 and STAT5, to modulate the expression of target genes involved in inflammation and immune responses. 5. Other transcription factors: Esrrb can also interact with other transcription factors, such as c-Jun and c-Fos, to regulate gene expression in response to hormonal signals. It is important to note that the specific complexes formed by Esrrb can vary depending on the cell type, the ligand present, and the context of the cellular response."}
{"qid": "5a8980d2fcd1d6a10c00000d", "original_text": "Non-shivering thermogenesis in adipose tissue can be activated by excessive energy intake or following cold exposure. The molecular mechanisms regulating this activation have not been fully elucidated. The Janus kinase (JAK) - signal transducer and activator of transcription (STAT) pathway mediates the signal transduction of numerous hormones and growth factors that regulate adipose tissue development and function, and may play a role in adaptive thermogenesis. We analysed mRNA and protein levels of uncoupling protein 1 (UCP1) and JAK2 in different adipose depots in response to metabolic and thermal stress.", "label": 1, "is_selected": 0, "text": "Non-shivering thermogenesis in adipose tissue can be activated by excessive energy intake or following cold exposure. The molecular mechanisms regulating this activation have not been fully elucidated. The Janus kinase (JAK) - signal transducer and activator of transcription (STAT) pathway mediates the signal transduction of numerous hormones and growth factors that regulate adipose tissue development and function, and may play a role in adaptive thermogenesis. We analysed mRNA and protein levels of uncoupling protein 1 (UCP1) and JAK2 in different adipose depots in response to metabolic and thermal stress."}
{"qid": "52f89fc62059c6d71c000050", "original_text": "This study investigates the anticancer effect of dehydrocostuslactone (DHE), a medicinal plant-derived sesquiterpene lactone, on human non-small cell lung cancer cell lines, A549, NCI-H460 and NCI-H520. Our results show that DHE inhibits the proliferation of A549, NCI-H460 and NCI-H520 cells. DHE-induced apoptosis in both A549 and NCI-H460 cells. DHE triggered endoplasmic reticulum (ER) stress, as indicated by changes in cytosol-calcium levels, PKR-like ER kinase (PERK) phosphorylation, inositol requiring protein 1 (IRE1) and CHOP/GADD153 upregulation, X-box transcription factor-1", "label": 1, "is_selected": 0, "text": "This study investigates the anticancer effect of dehydrocostuslactone (DHE), a medicinal plant-derived sesquiterpene lactone, on human non-small cell lung cancer cell lines, A549, NCI-H460 and NCI-H520. Our results show that DHE inhibits the proliferation of A549, NCI-H460 and NCI-H520 cells. DHE-induced apoptosis in both A549 and NCI-H460 cells. DHE triggered endoplasmic reticulum (ER) stress, as indicated by changes in cytosol-calcium levels, PKR-like ER kinase (PERK) phosphorylation, inositol requiring protein 1 (IRE1) and CHOP/GADD153 upregulation, X-box transcription factor-1"}
{"qid": "52b2f1724003448f5500000b", "original_text": "JTV519 (K201) is a novel drug that has shown potential in preventing arrhythmias, particularly in patients with heart failure. Studies have shown that JTV519 can improve cardiac function, reduce inflammation, and slow the progression of heart failure. It has also been shown to reduce the incidence of arrhythmias in animals and humans with heart failure. However, it is important to note that the clinical trials for JTV519 are still ongoing, and more research is needed to fully understand its safety and efficacy in preventing arrhythmias in humans.", "label": 0, "is_selected": 0, "text": "JTV519 (K201) is a novel drug that has shown potential in preventing arrhythmias, particularly in patients with heart failure. Studies have shown that JTV519 can improve cardiac function, reduce inflammation, and slow the progression of heart failure. It has also been shown to reduce the incidence of arrhythmias in animals and humans with heart failure. However, it is important to note that the clinical trials for JTV519 are still ongoing, and more research is needed to fully understand its safety and efficacy in preventing arrhythmias in humans."}
{"qid": "5a6e18d8b750ff4455000038", "original_text": "Conserved Nonexonic Elements (CNEEs) are genomic regions that are highly conserved across different species, often containing functional elements such as genes, regulatory elements, or other molecular features. These elements are significant in phylogenomics research for several reasons: 1. Comparative genomics: CNEEs are highly conserved across different species, indicating their functional importance. Researchers can use CNEEs to identify and compare functional elements between species, which is crucial for understanding the evolutionary relationships between organisms. 2. Ancestral gene prediction: CNEEs are often enriched with functional genes, which were likely present in the ancestral genome of a particular clade. By identifying these elements, researchers can infer the presence of ancestral genes and reconstruct the evolutionary history of genes and genomes. 3. Identification of functional elements: CNEEs may contain regulatory elements, such as promoters, enhancers, or silencers, which are important for gene expression and function. Identifying these elements can provide insights into the molecular mechanisms underlying different biological processes. 4. Molecular evolution: CNEEs can provide insights into the evolutionary mechanisms that shape genomes. For example, studying the evolution of CNEEs can reveal how genes and regulatory elements change over time, providing a glimpse into the evolutionary history of organisms. In summary, CNEEs are important in phylogenomics research because they provide a means to identify and compare functional elements between species, predict the presence of ancestral genes, identify functional regulatory elements, and study molecular evolution.", "label": 0, "is_selected": 0, "text": "Conserved Nonexonic Elements (CNEEs) are genomic regions that are highly conserved across different species, often containing functional elements such as genes, regulatory elements, or other molecular features. These elements are significant in phylogenomics research for several reasons: 1. Comparative genomics: CNEEs are highly conserved across different species, indicating their functional importance. Researchers can use CNEEs to identify and compare functional elements between species, which is crucial for understanding the evolutionary relationships between organisms. 2. Ancestral gene prediction: CNEEs are often enriched with functional genes, which were likely present in the ancestral genome of a particular clade. By identifying these elements, researchers can infer the presence of ancestral genes and reconstruct the evolutionary history of genes and genomes. 3. Identification of functional elements: CNEEs may contain regulatory elements, such as promoters, enhancers, or silencers, which are important for gene expression and function. Identifying these elements can provide insights into the molecular mechanisms underlying different biological processes. 4. Molecular evolution: CNEEs can provide insights into the evolutionary mechanisms that shape genomes. For example, studying the evolution of CNEEs can reveal how genes and regulatory elements change over time, providing a glimpse into the evolutionary history of organisms. In summary, CNEEs are important in phylogenomics research because they provide a means to identify and compare functional elements between species, predict the presence of ancestral genes, identify functional regulatory elements, and study molecular evolution."}
{"qid": "553e1aa5a3cf796f71000003", "original_text": "The coexistence effects of multiple kinds of oxidized deoxyribonucleotides were examined using an SV40 origin-dependent in vitro replication system with a HeLa extract. Oxidized dGTP and dATP, 8-hydroxy-2'-deoxyguanosine 5'-triphosphate (8-OH-dGTP) and 2-hydroxy-2'-deoxyadenosine 5'-triphosphate (2-OH-dATP), were used in this study. The mutation frequency synergistically increased when the two oxidized deoxyribonucleotides were together in the reaction. 2-OH-dATP enhanced the mutagenicity of 8-OH-dGTP, since the induced mutations were A.T --> C.G transversions.", "label": 1, "is_selected": 0, "text": "The coexistence effects of multiple kinds of oxidized deoxyribonucleotides were examined using an SV40 origin-dependent in vitro replication system with a HeLa extract. Oxidized dGTP and dATP, 8-hydroxy-2'-deoxyguanosine 5'-triphosphate (8-OH-dGTP) and 2-hydroxy-2'-deoxyadenosine 5'-triphosphate (2-OH-dATP), were used in this study. The mutation frequency synergistically increased when the two oxidized deoxyribonucleotides were together in the reaction. 2-OH-dATP enhanced the mutagenicity of 8-OH-dGTP, since the induced mutations were A.T --> C.G transversions."}
{"qid": "5507fc114b2a315d41000003", "original_text": "The proteasome, which identifies and destroys unwanted proteins rapidly, plays a vital role in maintaining cellular protein homeostasis. Proteins that are destined for proteasome-mediated degradation are usually tagged with a chain of ubiquitin linked via lysine (K) 48 that targets them to the proteolytic machinery. However, when the proteasome becomes compromised in its function, it is attractive to think that the cell may switch to an alternative, non-proteolytic form of ubiquitination that could help divert cargo proteins away from an otherwise overloaded proteasome. Of the several types of ubiquitin chain topologies, K63-linked ubiquitination is the only one known to fulfil diverse proteasome-independent roles, including DNA repair, endocytosis and NF\u03baB signaling. By virtue of its apparent dissociation from the proteasome, we have originally proposed that K63-linked ubiquitination may be involved in cargo diversion during proteasomal stress and accordingly, in the biogenesis of inclusion bodies associated with neurodegenerative diseases. Here, we provide an overview of this non-classic form of ubiquitin modification, and discuss current evidence and controversies surrounding our proposed role for K63 polyubiquitin as a key regulator of inclusion dynamics that is relevant to neurodegeneration.", "label": 1, "is_selected": 0, "text": "The proteasome, which identifies and destroys unwanted proteins rapidly, plays a vital role in maintaining cellular protein homeostasis. Proteins that are destined for proteasome-mediated degradation are usually tagged with a chain of ubiquitin linked via lysine (K) 48 that targets them to the proteolytic machinery. However, when the proteasome becomes compromised in its function, it is attractive to think that the cell may switch to an alternative, non-proteolytic form of ubiquitination that could help divert cargo proteins away from an otherwise overloaded proteasome. Of the several types of ubiquitin chain topologies, K63-linked ubiquitination is the only one known to fulfil diverse proteasome-independent roles, including DNA repair, endocytosis and NF\u03baB signaling. By virtue of its apparent dissociation from the proteasome, we have originally proposed that K63-linked ubiquitination may be involved in cargo diversion during proteasomal stress and accordingly, in the biogenesis of inclusion bodies associated with neurodegenerative diseases. Here, we provide an overview of this non-classic form of ubiquitin modification, and discuss current evidence and controversies surrounding our proposed role for K63 polyubiquitin as a key regulator of inclusion dynamics that is relevant to neurodegeneration."}
{"qid": "5c9a6693ecadf2e73f000031", "original_text": "The apicomplexan parasite Cryptosporidium parvum possesses a mitosome, a relict mitochondrion with a greatly reduced metabolic capability. This mitosome houses a mitochondrial-type protein import apparatus, but elements of the protein import pathway have been reduced, and even lost, through evolution. The small Tim protein family is a case in point. The genomes of C. parvum and related species of Cryptosporidium each encode just one small Tim protein, CpTimS. This observation challenged the tenet that small Tim proteins are always found in pairs as \u03b13\u03b23 hexamers. We show that the atypical CpTimS exists as a relatively unstable homohexamer, shedding light both on the early evolution of the small Tim protein family and on small Tim hexamer formation in contemporary eukaryotes.", "label": 1, "is_selected": 0, "text": "The apicomplexan parasite Cryptosporidium parvum possesses a mitosome, a relict mitochondrion with a greatly reduced metabolic capability. This mitosome houses a mitochondrial-type protein import apparatus, but elements of the protein import pathway have been reduced, and even lost, through evolution. The small Tim protein family is a case in point. The genomes of C. parvum and related species of Cryptosporidium each encode just one small Tim protein, CpTimS. This observation challenged the tenet that small Tim proteins are always found in pairs as \u03b13\u03b23 hexamers. We show that the atypical CpTimS exists as a relatively unstable homohexamer, shedding light both on the early evolution of the small Tim protein family and on small Tim hexamer formation in contemporary eukaryotes."}
{"qid": "602753951cb411341a0000e9", "original_text": "A combination of a Wilms' tumor (WT) and renal cell carcinoma (RCC) is an extremely rare pediatric renal neoplasm. Its prognosis and clinicopathological features remain unclarified. Herein, we describe a case of the coexistence of a WT and an RCC in a male child aged 5 years and 10 months. The child had symptoms of hematuria for more than 1 month. Although his irises were clear, medical imaging revealed a potential malignant tumor in the left kidney. The patient underwent resection of the left kidney. The pathological diagnosis was the coexistence of a WT and papillary RCC. Negative surgical margins were examined. One month following the resection, chemotherapy with vincristine plus dactinomycin (EE-4A regimen) was commenced. At the 69-month follow-up, there was no recurrence or metastasis. The coexistence of a WT and an RCC in the pediatric population is considered a rare pathological event. At present, there is no standard treatment for these renal neoplasms. In this study, the RCC treatment, which was the same as that applied in cases of WTs, was reasonable.", "label": 1, "is_selected": 0, "text": "A combination of a Wilms' tumor (WT) and renal cell carcinoma (RCC) is an extremely rare pediatric renal neoplasm. Its prognosis and clinicopathological features remain unclarified. Herein, we describe a case of the coexistence of a WT and an RCC in a male child aged 5 years and 10 months. The child had symptoms of hematuria for more than 1 month. Although his irises were clear, medical imaging revealed a potential malignant tumor in the left kidney. The patient underwent resection of the left kidney. The pathological diagnosis was the coexistence of a WT and papillary RCC. Negative surgical margins were examined. One month following the resection, chemotherapy with vincristine plus dactinomycin (EE-4A regimen) was commenced. At the 69-month follow-up, there was no recurrence or metastasis. The coexistence of a WT and an RCC in the pediatric population is considered a rare pathological event. At present, there is no standard treatment for these renal neoplasms. In this study, the RCC treatment, which was the same as that applied in cases of WTs, was reasonable."}
{"qid": "5c6ffde47c78d69471000059", "original_text": "Not all breast cancer patients benefit from neoadjuvant or adjuvant therapy, resulting in considerable undertreatment or overtreatment. New insights into the role of tumor-infiltrating immune cells suggest that their composition, as well as their functionality, might serve as a biomarker to enable optimal patient selection for current systemic therapies and upcoming treatment options such as immunotherapy. We performed several complementary unbiased in silico analyses on gene expression profiles of 7270 unrelated tumor samples of nonmetastatic breast cancer patients with known clinical follow-up. CIBERSORT was used to estimate the fraction of 22 immune cell types to study their relations with pathological complete response (pCR), disease-free survival (DFS), and overall survival (OS).", "label": 1, "is_selected": 0, "text": "Not all breast cancer patients benefit from neoadjuvant or adjuvant therapy, resulting in considerable undertreatment or overtreatment. New insights into the role of tumor-infiltrating immune cells suggest that their composition, as well as their functionality, might serve as a biomarker to enable optimal patient selection for current systemic therapies and upcoming treatment options such as immunotherapy. We performed several complementary unbiased in silico analyses on gene expression profiles of 7270 unrelated tumor samples of nonmetastatic breast cancer patients with known clinical follow-up. CIBERSORT was used to estimate the fraction of 22 immune cell types to study their relations with pathological complete response (pCR), disease-free survival (DFS), and overall survival (OS)."}
{"qid": "5895b9ae7d9090f35300000a", "original_text": "Athelia syndrome, also known as congenital athelia, is a rare genetic disorder characterized by a lack of sweat glands, hypodense or absent sweat glands on the skin, and an increased risk of developing skin infections. It is caused by mutations in the gene encoding the glycoprotein apolipoprotein A-1 (APOA1), which plays a critical role in the formation and function of sweat glands. Symptoms typically appear at birth or in early childhood and may include skin fragility, easy bruising, and recurrent skin infections. Treatment primarily focuses on managing associated skin infections and preventing complications.", "label": 0, "is_selected": 1, "text": "The Athelia Syndrome - Pipeline Review, H2 2017, outlays comprehensive information on the ATHELIA syndrome (Congenital athelia syndrome) epidemiology, acquirers, antigens, potential inhibitors, antibacterials, synthases, and related neurobiology."}
{"qid": "602356b81cb411341a000099", "original_text": "Tofersen is an antisense oligonucleotide that mediates the degradation of superoxide dismutase 1 (SOD1) messenger RNA to reduce SOD1 protein synthesis. Intrathecal administration of tofersen is being studied for the treatment of amyotrophic lateral sclerosis (ALS) due to SOD1 mutations. We conducted a phase 1-2 ascending-dose trial evaluating tofersen in adults with ALS due to SOD1 mutations. In each dose cohort (20, 40, 60, or 100 mg), participants were randomly assigned in a 3:1 ratio to receive five doses of tofersen or placebo, administered intrathecally for 12 weeks. The primary outcomes were safety and pharmacokinetics.", "label": 1, "is_selected": 0, "text": "Tofersen is an antisense oligonucleotide that mediates the degradation of superoxide dismutase 1 (SOD1) messenger RNA to reduce SOD1 protein synthesis. Intrathecal administration of tofersen is being studied for the treatment of amyotrophic lateral sclerosis (ALS) due to SOD1 mutations. We conducted a phase 1-2 ascending-dose trial evaluating tofersen in adults with ALS due to SOD1 mutations. In each dose cohort (20, 40, 60, or 100 mg), participants were randomly assigned in a 3:1 ratio to receive five doses of tofersen or placebo, administered intrathecally for 12 weeks. The primary outcomes were safety and pharmacokinetics."}
{"qid": "5e639a0a1af46fc130000010", "original_text": "Herceptin is a humanized monoclonal antibody that selectively binds to the extracellular domain of human epidermal growth factor receptor 2 (HER2). Herceptin has an important role in the treatment of HER2-positive breast cancer when used in the neoadjuvant, adjuvant, and metastatic settings, and in the treatment of HER2-positive metastatic gastric cancer, and gastroesophageal junction adenocarcinoma. Prior to intravenous infusion, Herceptin must be reconstituted with sterile water for injection and then diluted in intravenous bags with normal saline.", "label": 1, "is_selected": 0, "text": "Herceptin is a humanized monoclonal antibody that selectively binds to the extracellular domain of human epidermal growth factor receptor 2 (HER2). Herceptin has an important role in the treatment of HER2-positive breast cancer when used in the neoadjuvant, adjuvant, and metastatic settings, and in the treatment of HER2-positive metastatic gastric cancer, and gastroesophageal junction adenocarcinoma. Prior to intravenous infusion, Herceptin must be reconstituted with sterile water for injection and then diluted in intravenous bags with normal saline."}
{"qid": "601c1a271cb411341a000011", "original_text": "SMAD6 variants have been associated with craniosynostosis, a condition characterized by the premature fusion of skull sutures. Studies have identified SMAD6 mutations in approximately 10% of patients with craniosynostosis, particularly those with a coronal craniosynostosis type. SMAD6 is a key regulator of TGF-\u03b2 signaling, which plays a crucial role in the development and maintenance of the skull. Mutations in SMAD6 can lead to altered TGF-\u03b2 signaling, potentially disrupting skull suture development and leading to premature fusion. However, it's essential to note that not all patients with SMAD6 variants will develop craniosynostosis, and other genetic and environmental factors can also contribute to the condition.", "label": 0, "is_selected": 1, "text": "The SMAD6 gene has been implicated in a number of disorders, including Graves' disease, a condition that causes Graves'' disease-like symptoms in the head and neck, as well as a condition called craniosynostosis, which causes premature fusion of skull sutures."}
{"qid": "569e7e99ceceede94d000003", "original_text": "DeepCAGE is a machine learning-based framework used for predicting clinical deterioration in hospitalized patients. It utilizes a complex algorithm to analyze various physiological and clinical parameters, such as vital signs, lab results, and medication use, to identify patients at high risk of clinical deterioration. By providing early detection and intervention, DeepCAGE aims to reduce the likelihood of adverse events and improve patient outcomes.", "label": 0, "is_selected": 0, "text": "DeepCAGE is a machine learning-based framework used for predicting clinical deterioration in hospitalized patients. It utilizes a complex algorithm to analyze various physiological and clinical parameters, such as vital signs, lab results, and medication use, to identify patients at high risk of clinical deterioration. By providing early detection and intervention, DeepCAGE aims to reduce the likelihood of adverse events and improve patient outcomes."}
{"qid": "5e2dbc55fbd6abf43b000016", "original_text": "To summarize the US Food and Drug Administration's (FDA's) review of the safety and effectiveness for pimavanserin, an atypical antipsychotic, for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. We describe the regulatory and clinical issues important to the FDA's approval of this New Drug Application, with special focus on the risk-benefit balance. We also describe a new labeling feature that presents additional efficacy data to clinicians. Data sets for all relevant clinical trials of pimavanserin and the Applicant's and FDA's analyses of these data were considered in this review.", "label": 1, "is_selected": 0, "text": "To summarize the US Food and Drug Administration's (FDA's) review of the safety and effectiveness for pimavanserin, an atypical antipsychotic, for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. We describe the regulatory and clinical issues important to the FDA's approval of this New Drug Application, with special focus on the risk-benefit balance. We also describe a new labeling feature that presents additional efficacy data to clinicians. Data sets for all relevant clinical trials of pimavanserin and the Applicant's and FDA's analyses of these data were considered in this review."}
{"qid": "56f112932ac5ed145900000d", "original_text": "RNA sponges are a type of non-coding RNA (ncRNA) that play a crucial role in regulating gene expression by binding to messenger RNA (mRNA) and preventing its translation into protein. They do this by acting as a \"sponge\" that soaks up mRNA molecules, neutralizing their ability to initiate protein synthesis. This process is important for regulating cellular processes, such as cell proliferation and differentiation, and for responding to environmental stimuli.", "label": 0, "is_selected": 0, "text": "RNA sponges are a type of non-coding RNA (ncRNA) that play a crucial role in regulating gene expression by binding to messenger RNA (mRNA) and preventing its translation into protein. They do this by acting as a \"sponge\" that soaks up mRNA molecules, neutralizing their ability to initiate protein synthesis. This process is important for regulating cellular processes, such as cell proliferation and differentiation, and for responding to environmental stimuli."}
{"qid": "6026af5e1cb411341a0000c9", "original_text": "Triple negative breast cancer (TNBC) is a aggressive and difficult to treat type of breast cancer, and CYLD (cytohesin D) is a key regulator of cellular processes involved in TNBC progression. MicroRNAs (miRNAs) are small non-coding RNAs that play critical roles in post-transcriptional gene regulation by binding to messenger RNAs (mRNAs) and preventing their translation into proteins. Several miRNAs have been shown to target CYLD in TNBC, including miR-141, miR-155, miR-200a, miR-205, and miR-375. These microRNAs can bind to specific sequences in the 3' untranslated region (UTR) of the CYLD mRNA, leading to its degradation and inhibiting its protein expression. By targeting CYLD, these miRNAs can inhibit the epithelial-to-mesenchymal transition (EMT), invasion, and metastasis of TNBC cells. Additionally, some of these miRNAs have been found to be aberrantly expressed in TNBC, suggesting that they may contribute to the development and progression of the disease. Further studies are needed to fully understand the mechanisms by which these miRNAs target CYLD in TNBC and to identify potential therapeutic strategies for targeting these microRNAs.", "label": 0, "is_selected": 1, "text": "The aim of this study is to identify microRNAs that target CYLD in triple negative breast cancer and to identify potential therapeutic strategies for targeting these microRNAs, as well as to understand the mechanisms by which theses contribute to the development and progression of the disease. Further studies are needed to fully understand the Mechanisms by whichtheses target CYLDA in TNBC and toidentify potential therapeutic Strategies for Targeting These microRNAs."}
{"qid": "61f5bef2882a024a10000011", "original_text": "Lumasiran is an investigational RNA interference (RNAi) therapy that targets and reduces the levels of the enzyme acid ceramidase (AC) in the body. AC is responsible for breaking down a molecule called ceramide, which is involved in various cellular processes, including cell signaling, proliferation, and differentiation. In certain tissues, such as the liver, AC is overactive, leading to an imbalance in ceramide levels. This imbalance has been implicated in several diseases, including progressive familial intrahepatic cholestasis (PFIC), a group of rare genetic disorders characterized by severe liver disease and cholestasis. Lumasiran works by selectively binding to AC mRNA and degrading it, leading to a reduction in AC protein levels. This inhibition of AC activity results in an increase in ceramide levels, which can help restore the balance of cellular signaling pathways and improve liver function. By reducing AC levels, lumasiran also inhibits the activity of other enzymes that are involved in the synthesis of toxic compounds, such as bile acids, which are produced in excess in PFIC patients. Overall, the mechanism of action of lumasiran involves the selective degradation of AC mRNA, leading to a decrease in AC protein levels and an increase in ceramide levels, which can help improve liver function and reduce the symptoms of PFIC.", "label": 0, "is_selected": 0, "text": "Lumasiran is an investigational RNA interference (RNAi) therapy that targets and reduces the levels of the enzyme acid ceramidase (AC) in the body. AC is responsible for breaking down a molecule called ceramide, which is involved in various cellular processes, including cell signaling, proliferation, and differentiation. In certain tissues, such as the liver, AC is overactive, leading to an imbalance in ceramide levels. This imbalance has been implicated in several diseases, including progressive familial intrahepatic cholestasis (PFIC), a group of rare genetic disorders characterized by severe liver disease and cholestasis. Lumasiran works by selectively binding to AC mRNA and degrading it, leading to a reduction in AC protein levels. This inhibition of AC activity results in an increase in ceramide levels, which can help restore the balance of cellular signaling pathways and improve liver function. By reducing AC levels, lumasiran also inhibits the activity of other enzymes that are involved in the synthesis of toxic compounds, such as bile acids, which are produced in excess in PFIC patients. Overall, the mechanism of action of lumasiran involves the selective degradation of AC mRNA, leading to a decrease in AC protein levels and an increase in ceramide levels, which can help improve liver function and reduce the symptoms of PFIC."}
{"qid": "571e1e11bb137a4b0c000004", "original_text": "SGLT2 inhibitors, a class of medications used to treat type 2 diabetes, have been shown to have several potential side effects. Some of the common side effects of SGLT2 inhibitors include: 1. Increased urination: SGLT2 inhibitors work by increasing the amount of glucose that is excreted in the urine, which can lead to an increase in urination. 2. Diarrhea: SGLT2 inhibitors can cause gastrointestinal side effects such as diarrhea, which can be mild to moderate in severity. 3. Abdominal pain: Some people may experience abdominal pain, cramping, or discomfort while taking SGLT2 inhibitors. 4. Nausea and vomiting: Nausea and vomiting are common side effects of SGLT2 inhibitors, especially when first starting the medication. 5. Headache: Headaches are a common side effect of SGLT2 inhibitors, and can range from mild to severe in intensity. 6. Fatigue: Some people may experience fatigue or weakness while taking SGLT2 inhibitors. 7. Increased thirst: SGLT2 inhibitors can cause an increase in thirst, which can be due to the increase in glucose excretion in the urine. 8. Erectile dysfunction: SGLT2 inhibitors may cause erectile dysfunction in some men, as the medication can decrease blood flow to the penis. 9. Increased blood pressure: SGLT2 inhibitors can increase blood pressure in some individuals, particularly those who have pre-existing hypertension. 10. Kidney problems: SGLT2 inhibitors may increase the risk of kidney problems in people with pre-existing kidney disease. It is important to note that not everyone who takes SGLT2 inhibitors will experience side effects, and the severity of side effects can vary from person to person. If you are taking SGLT2 inhibitors and experience any of these side effects, it is important to speak with your healthcare provider.", "label": 0, "is_selected": 0, "text": "SGLT2 inhibitors, a class of medications used to treat type 2 diabetes, have been shown to have several potential side effects. Some of the common side effects of SGLT2 inhibitors include: 1. Increased urination: SGLT2 inhibitors work by increasing the amount of glucose that is excreted in the urine, which can lead to an increase in urination. 2. Diarrhea: SGLT2 inhibitors can cause gastrointestinal side effects such as diarrhea, which can be mild to moderate in severity. 3. Abdominal pain: Some people may experience abdominal pain, cramping, or discomfort while taking SGLT2 inhibitors. 4. Nausea and vomiting: Nausea and vomiting are common side effects of SGLT2 inhibitors, especially when first starting the medication. 5. Headache: Headaches are a common side effect of SGLT2 inhibitors, and can range from mild to severe in intensity. 6. Fatigue: Some people may experience fatigue or weakness while taking SGLT2 inhibitors. 7. Increased thirst: SGLT2 inhibitors can cause an increase in thirst, which can be due to the increase in glucose excretion in the urine. 8. Erectile dysfunction: SGLT2 inhibitors may cause erectile dysfunction in some men, as the medication can decrease blood flow to the penis. 9. Increased blood pressure: SGLT2 inhibitors can increase blood pressure in some individuals, particularly those who have pre-existing hypertension. 10. Kidney problems: SGLT2 inhibitors may increase the risk of kidney problems in people with pre-existing kidney disease. It is important to note that not everyone who takes SGLT2 inhibitors will experience side effects, and the severity of side effects can vary from person to person. If you are taking SGLT2 inhibitors and experience any of these side effects, it is important to speak with your healthcare provider."}
{"qid": "5e4be9496d0a27794100002a", "original_text": "Epidermal growth factor receptor (EGFR) is a known target in cancer therapy and targeting the receptor has proven to be extremely successful in treating cancers that are dependent on EGFR signaling. To that effect, targeted therapies to EGFR such as Cetuximab, Panitumumab-monoclonal antibodies and Gefitinib, Erlotinib-tyrosine kinase inhibitors have had success in therapeutic scenarios. However, the development of resistance to these drugs makes it necessary to combine anti- EGFR therapies with other inhibitors, so that resistance can be overcome by the targeting of alternate signaling pathways. On the other hand, components of the inflammatory pathway, within and around a tumor, provide a conducive environment for tumor growth by supplying numerous cytokines and chemokines that foster carcinogenesis. Interleukin 6 (IL-6) is one such cytokine that is found to be associated with inflammation-driven cancers and which also plays a crucial role in acquired resistance to anti-EGFR drugs.", "label": 1, "is_selected": 0, "text": "Epidermal growth factor receptor (EGFR) is a known target in cancer therapy and targeting the receptor has proven to be extremely successful in treating cancers that are dependent on EGFR signaling. To that effect, targeted therapies to EGFR such as Cetuximab, Panitumumab-monoclonal antibodies and Gefitinib, Erlotinib-tyrosine kinase inhibitors have had success in therapeutic scenarios. However, the development of resistance to these drugs makes it necessary to combine anti- EGFR therapies with other inhibitors, so that resistance can be overcome by the targeting of alternate signaling pathways. On the other hand, components of the inflammatory pathway, within and around a tumor, provide a conducive environment for tumor growth by supplying numerous cytokines and chemokines that foster carcinogenesis. Interleukin 6 (IL-6) is one such cytokine that is found to be associated with inflammation-driven cancers and which also plays a crucial role in acquired resistance to anti-EGFR drugs."}
{"qid": "54f1e781c409818c32000003", "original_text": "Armodafinil is the R-enantiomer of racemic modafinil and has a significantly longer half-life than the S-enantiomer. This study evaluated armodafinil 150 mg/day as an adjunct treatment for residual excessive sleepiness in patients with obstructive sleep apnea/hypopnea syndrome (OSA/HS) who were otherwise well controlled with nasal continuous positive airway pressure (nCPAP). We assessed the ability of armodafinil to improve wakefulness and cognition and reduce fatigue in this population. In this 12-week, randomized, double-blind study, patients (n=259) received armodafinil (150 mg) or placebo once daily. Efficacy assessments at baseline and weeks 4, 8, and 12 included the Maintenance of Wakefulness Test (MWT), Clinical Global Impression of Change (CGI-C),", "label": 1, "is_selected": 0, "text": "Armodafinil is the R-enantiomer of racemic modafinil and has a significantly longer half-life than the S-enantiomer. This study evaluated armodafinil 150 mg/day as an adjunct treatment for residual excessive sleepiness in patients with obstructive sleep apnea/hypopnea syndrome (OSA/HS) who were otherwise well controlled with nasal continuous positive airway pressure (nCPAP). We assessed the ability of armodafinil to improve wakefulness and cognition and reduce fatigue in this population. In this 12-week, randomized, double-blind study, patients (n=259) received armodafinil (150 mg) or placebo once daily. Efficacy assessments at baseline and weeks 4, 8, and 12 included the Maintenance of Wakefulness Test (MWT), Clinical Global Impression of Change (CGI-C),"}
{"qid": "5c73ace67c78d69471000083", "original_text": "The DOOR syndrome, also known as Developmental Delay, Organic Brain Dysfunction, and Orthopedic Abnormalities, is a rare genetic disorder characterized by several distinct features. These include developmental delay or intellectual disability, organic brain dysfunction, such as seizures, cerebral atrophy, or abnormalities on MRI, and orthopedic abnormalities, such as clubfoot, congenital hip dislocation, or other skeletal defects.", "label": 0, "is_selected": 1, "text": "A new study suggests that a single dose of a drug commonly used to treat HIV may also be effective in treating a condition known as Ehlers-Danlos syndrome, which affects the brain and other parts of the body, including the legs and arms."}
{"qid": "5c6ad2997c78d69471000020", "original_text": "We present pyNBS: a modularized Python 2.7 implementation of the network-based stratification (NBS) algorithm for stratifying tumor somatic mutation profiles into molecularly and clinically relevant subtypes. In addition to release of the software, we benchmark its key parameters and provide a compact cancer reference network that increases the significance of tumor stratification using the NBS algorithm.", "label": 1, "is_selected": 0, "text": "We present pyNBS: a modularized Python 2.7 implementation of the network-based stratification (NBS) algorithm for stratifying tumor somatic mutation profiles into molecularly and clinically relevant subtypes. In addition to release of the software, we benchmark its key parameters and provide a compact cancer reference network that increases the significance of tumor stratification using the NBS algorithm."}
{"qid": "5cf4eb6aa49efeb44c00000e", "original_text": "The basis of the DamID experimental protocol is the use of dUTP (difluoro-UTP) nucleotides instead of thymine nucleotides in the PCR reaction. dUTP is incorporated into the DNA template during PCR amplification, leading to the formation of UTP (uridine-5'-triphosphate) residues at the 5' end of the amplified DNA fragments. The resulting UTP residues are then used as probes to detect the presence of certain DNA sequences in the sample.", "label": 0, "is_selected": 1, "text": "The aim of this project is to develop a method for the detection of DNA sequences in blood samples using a novel approach to amplification and analysis of single-stranded DNA (Sd DNA) in the blood of patients with HIV and other blood-borne diseases."}
{"qid": "517138b68ed59a060a000002", "original_text": "Hypertrophic cardiomyopathy (HCM), the most common mendelian heart disorder, remains an orphan of disease-specific pharmacological treatment because of the limited understanding of cellular mechanisms underlying arrhythmogenicity and diastolic dysfunction. We assessed the electromechanical profile of cardiomyocytes from 26 HCM patients undergoing myectomy compared with those from nonfailing nonhypertrophic surgical patients by performing patch-clamp and intracellular Ca(2+) (Ca(2+)(i)) studies. Compared with controls, HCM cardiomyocytes showed prolonged action potential related to increased late Na(+) (I(NaL)) and Ca(2+) (I(CaL)) currents and decreased repolarizing K(+) currents, increased occurrence of cellular arrhythmias, prolonged Ca(2+)(i) transients, and higher diastolic Ca(2+)(i). Such changes were related to enhanced Ca(2+)/calmodulin kinase II (CaMKII) activity and increased phosphorylation of its targets. Ranolazine at therapeutic concentrations partially reversed the HCM-related cellular abnormalities via I(NaL) inhibition, with negligible effects in controls.", "label": 1, "is_selected": 0, "text": "Hypertrophic cardiomyopathy (HCM), the most common mendelian heart disorder, remains an orphan of disease-specific pharmacological treatment because of the limited understanding of cellular mechanisms underlying arrhythmogenicity and diastolic dysfunction. We assessed the electromechanical profile of cardiomyocytes from 26 HCM patients undergoing myectomy compared with those from nonfailing nonhypertrophic surgical patients by performing patch-clamp and intracellular Ca(2+) (Ca(2+)(i)) studies. Compared with controls, HCM cardiomyocytes showed prolonged action potential related to increased late Na(+) (I(NaL)) and Ca(2+) (I(CaL)) currents and decreased repolarizing K(+) currents, increased occurrence of cellular arrhythmias, prolonged Ca(2+)(i) transients, and higher diastolic Ca(2+)(i). Such changes were related to enhanced Ca(2+)/calmodulin kinase II (CaMKII) activity and increased phosphorylation of its targets. Ranolazine at therapeutic concentrations partially reversed the HCM-related cellular abnormalities via I(NaL) inhibition, with negligible effects in controls."}
{"qid": "5a87145861bb38fb24000004", "original_text": "Coal workers' pneumoconiosis is a preventable occupational disorder of the respiratory system resulting from exposure to and retention of respirable coal dust. It exists in two distinguishable forms: simple, which is seldom if ever disabling, and complicated, also known as progressive massive fibrosis (PMF), which is sometimes totally disabling and is associated with a high mortality rate. The disease affects a small proportion of active U.S. miners, and only a very small number develop PMF. In its more advanced stages, the disorder is characterized by shortness of breath.", "label": 1, "is_selected": 0, "text": "Coal workers' pneumoconiosis is a preventable occupational disorder of the respiratory system resulting from exposure to and retention of respirable coal dust. It exists in two distinguishable forms: simple, which is seldom if ever disabling, and complicated, also known as progressive massive fibrosis (PMF), which is sometimes totally disabling and is associated with a high mortality rate. The disease affects a small proportion of active U.S. miners, and only a very small number develop PMF. In its more advanced stages, the disorder is characterized by shortness of breath."}
{"qid": "56b8ed4b156496395c000004", "original_text": "In vertebrates, conserved noncoding elements (CNEs) are functionally constrained sequences that can show striking conservation over >400 million years of evolutionary distance and frequently are located megabases away from target developmental genes. Conserved noncoding sequences (CNSs) in plants are much shorter, and it has been difficult to detect conservation among distantly related genomes. In this article, we show not only that CNS sequences can be detected throughout the eudicot clade of flowering plants, but also that a subset of 37 CNSs can be found in all flowering plants (diverging \u223c170 million years ago). These CNSs are functionally similar to vertebrate CNEs, being highly associated with transcription factor and development genes and enriched in transcription factor binding sites.", "label": 1, "is_selected": 0, "text": "In vertebrates, conserved noncoding elements (CNEs) are functionally constrained sequences that can show striking conservation over >400 million years of evolutionary distance and frequently are located megabases away from target developmental genes. Conserved noncoding sequences (CNSs) in plants are much shorter, and it has been difficult to detect conservation among distantly related genomes. In this article, we show not only that CNS sequences can be detected throughout the eudicot clade of flowering plants, but also that a subset of 37 CNSs can be found in all flowering plants (diverging \u223c170 million years ago). These CNSs are functionally similar to vertebrate CNEs, being highly associated with transcription factor and development genes and enriched in transcription factor binding sites."}
{"qid": "51485a4dd24251bc0500002a", "original_text": "Atrial fibrillation (AF) affects more than 3 million Americans and is expected to reach epidemic proportions as the US population ages. The presence of AF increases lifetime stroke risk nearly 5-fold. Conventionally, patients at moderate or high risk of stroke have been prescribed antiplatelet agents or vitamin K antagonists to reduce the risk, but each has significant limitations. Accordingly, the development of new oral anticoagulants (direct thrombin inhibitors [DTIs] and factor Xa inhibitors) has attracted significant interest. The DTI dabigatran etexilate was recently shown to provide superior risk reduction to warfarin for stroke and systemic embolism for patients with nonvalvular AF and recently gained US Food and Drug Administration approval for this indication.", "label": 1, "is_selected": 0, "text": "Atrial fibrillation (AF) affects more than 3 million Americans and is expected to reach epidemic proportions as the US population ages. The presence of AF increases lifetime stroke risk nearly 5-fold. Conventionally, patients at moderate or high risk of stroke have been prescribed antiplatelet agents or vitamin K antagonists to reduce the risk, but each has significant limitations. Accordingly, the development of new oral anticoagulants (direct thrombin inhibitors [DTIs] and factor Xa inhibitors) has attracted significant interest. The DTI dabigatran etexilate was recently shown to provide superior risk reduction to warfarin for stroke and systemic embolism for patients with nonvalvular AF and recently gained US Food and Drug Administration approval for this indication."}
{"qid": "58a71bb960087bc10a00002d", "original_text": "Ultraconserved elements (UCEs), stretches of DNA that are identical between distantly related species, are enigmatic genomic features whose function is not well understood. First identified and characterized in mammals, UCEs have been proposed to play important roles in gene regulation, RNA processing, and maintaining genome integrity. However, because all of these functions can tolerate some sequence variation, their ultraconserved and ultraselected nature is not explained. We investigated whether there are highly conserved DNA elements without genic function in distantly related plant genomes. We compared the genomes of Arabidopsis thaliana and Vitis vinifera; species that diverged \u223c115 million years ago (Mya). We identified 36 highly conserved elements with at least 85% similarity that are longer than 55 bp. Interestingly, these elements exhibit properties similar to mammalian UCEs, such that we named them UCE-like elements (ULEs). ULEs are located in intergenic or intronic regions and are depleted from segmental duplications. Like UCEs, ULEs are under strong purifying selection, suggesting a functional role for these elements. As their mammalian counterparts, ULEs show a sharp drop of A+T content at their borders and are enriched close to genes encoding transcription factors and genes involved in development, the latter showing preferential expression in undifferentiated tissues. By comparing the genomes of Brachypodium distachyon and Oryza sativa, species that diverged \u223c50 Mya, we identified a different set of ULEs with similar properties in monocots.", "label": 1, "is_selected": 0, "text": "Ultraconserved elements (UCEs), stretches of DNA that are identical between distantly related species, are enigmatic genomic features whose function is not well understood. First identified and characterized in mammals, UCEs have been proposed to play important roles in gene regulation, RNA processing, and maintaining genome integrity. However, because all of these functions can tolerate some sequence variation, their ultraconserved and ultraselected nature is not explained. We investigated whether there are highly conserved DNA elements without genic function in distantly related plant genomes. We compared the genomes of Arabidopsis thaliana and Vitis vinifera; species that diverged \u223c115 million years ago (Mya). We identified 36 highly conserved elements with at least 85% similarity that are longer than 55 bp. Interestingly, these elements exhibit properties similar to mammalian UCEs, such that we named them UCE-like elements (ULEs). ULEs are located in intergenic or intronic regions and are depleted from segmental duplications. Like UCEs, ULEs are under strong purifying selection, suggesting a functional role for these elements. As their mammalian counterparts, ULEs show a sharp drop of A+T content at their borders and are enriched close to genes encoding transcription factors and genes involved in development, the latter showing preferential expression in undifferentiated tissues. By comparing the genomes of Brachypodium distachyon and Oryza sativa, species that diverged \u223c50 Mya, we identified a different set of ULEs with similar properties in monocots."}
{"qid": "5e49c2356d0a277941000010", "original_text": "SNP2TFBS is a computational resource intended to support researchers investigating the molecular mechanisms underlying regulatory variation in the human genome. The database essentially consists of a collection of text files providing specific annotations for human single nucleotide polymorphisms (SNPs), namely whether they are predicted to abolish, create or change the affinity of one or several transcription factor (TF) binding sites. A SNP's effect on TF binding is estimated based on a position weight matrix (PWM) model for the binding specificity of the corresponding factor. These data files are regenerated at regular intervals by an automatic procedure that takes as input a reference genome, a comprehensive SNP catalogue and a collection of PWMs. SNP2TFBS is also accessible over a web interface, enabling users to view the information provided for an individual SNP, to extract SNPs based on various search criteria, to annotate uploaded sets of SNPs or to display statistics about the frequencies of binding sites affected by selected SNPs. Homepage: http://ccg.vital-it.ch/snp2tfbs/.", "label": 1, "is_selected": 0, "text": "SNP2TFBS is a computational resource intended to support researchers investigating the molecular mechanisms underlying regulatory variation in the human genome. The database essentially consists of a collection of text files providing specific annotations for human single nucleotide polymorphisms (SNPs), namely whether they are predicted to abolish, create or change the affinity of one or several transcription factor (TF) binding sites. A SNP's effect on TF binding is estimated based on a position weight matrix (PWM) model for the binding specificity of the corresponding factor. These data files are regenerated at regular intervals by an automatic procedure that takes as input a reference genome, a comprehensive SNP catalogue and a collection of PWMs. SNP2TFBS is also accessible over a web interface, enabling users to view the information provided for an individual SNP, to extract SNPs based on various search criteria, to annotate uploaded sets of SNPs or to display statistics about the frequencies of binding sites affected by selected SNPs. Homepage: http://ccg.vital-it.ch/snp2tfbs/."}
{"qid": "5e92015b2d3121100d000004", "original_text": "To date, there have been a limited number of useful biomarkers for the screening and monitoring of B-cell non-Hodgkin's lymphoma (B-NHL), which leads to the impetus to discover novel biomarkers for the disease. In the present study, gas chromatography-mass spectrometry (GC-MS) combined with head-space solid-phase micro-extraction (HS-SPME) was employed to analyze the volatile metabolites in the urine samples of 131 subjects. The subjects were divided into 4 main groups: Aggressive B-NHL, indolent B-NHL, benign lymphatic diseases patients and healthy volunteers. The differences of the concentrations of the potential biomarkers among the groups were assessed by non-parametric Wilcoxon's test. The ability of the potential biomarkers to discriminate between the four aforementioned groups was evaluated by receiver operating characteristic curves (ROC). The present study indicated that 4-heptanone, 2-methylpyrazine, 2-methylbutanal, 2,6-dimethyl-7-octen-2-ol and decanoic acid may serve as potential biomarkers for B-NHL. The area under the curve (AUC) values of single potential biomarker ranged from 0.634 to 0.901. The diagnostic models established with combined biomarkers exhibited higher diagnostic values (AUC, 0.824-0.968) compared with the models established with single biomarkers. The present study indicated that urinary volatile metabolites might be potential biomarkers for screening and monitoring of B-NHL.", "label": 1, "is_selected": 0, "text": "To date, there have been a limited number of useful biomarkers for the screening and monitoring of B-cell non-Hodgkin's lymphoma (B-NHL), which leads to the impetus to discover novel biomarkers for the disease. In the present study, gas chromatography-mass spectrometry (GC-MS) combined with head-space solid-phase micro-extraction (HS-SPME) was employed to analyze the volatile metabolites in the urine samples of 131 subjects. The subjects were divided into 4 main groups: Aggressive B-NHL, indolent B-NHL, benign lymphatic diseases patients and healthy volunteers. The differences of the concentrations of the potential biomarkers among the groups were assessed by non-parametric Wilcoxon's test. The ability of the potential biomarkers to discriminate between the four aforementioned groups was evaluated by receiver operating characteristic curves (ROC). The present study indicated that 4-heptanone, 2-methylpyrazine, 2-methylbutanal, 2,6-dimethyl-7-octen-2-ol and decanoic acid may serve as potential biomarkers for B-NHL. The area under the curve (AUC) values of single potential biomarker ranged from 0.634 to 0.901. The diagnostic models established with combined biomarkers exhibited higher diagnostic values (AUC, 0.824-0.968) compared with the models established with single biomarkers. The present study indicated that urinary volatile metabolites might be potential biomarkers for screening and monitoring of B-NHL."}
{"qid": "5acf74460340b9f058000013", "original_text": "The gene that controls the consistency of cerumen (earwax) is the keratin gene. The keratin gene encodes for the production of keratin proteins, which are the primary components of earwax. The type and amount of keratin proteins produced are influenced by genetic factors, which can affect the consistency and texture of earwax. For example, people with a certain variant of the keratin gene may produce earwax that is more lubricating and easier to remove, while others may produce earwax that is more brittle and harder to remove.", "label": 0, "is_selected": 1, "text": "The texture and consistency of earwax can be influenced by a number of genetic factors, such as whether the earwax is made of keratin, a type of connective tissue, or another type of hair follicle, known as adenoids, which are part of the hair follicle."}
{"qid": "5718bbb37de986d80d00000b", "original_text": "Autosomal recessive progressive external ophthalmoplegia (PEO) is one clinical disorder associated with multiple mitochondrial DNA deletions and can be caused by missense mutations in POLG, the gene encoding the mitochondrial DNA polymerase gamma. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is another autosomal recessive disorder associated with PEO and multiple deletions of mitochondrial DNA in skeletal muscle. In several patients this disorder is caused by loss of function mutations in the gene encoding thymidine phosphorylase (TP). We report a recessive family with features of MNGIE but no leukoencephalopathy in which two patients carry three missense mutations in POLG, of which two are novel mutations (N846S and P587L). The third mutation was previously reported as a recessive POLG mutation (T251I). This finding indicates the need for POLG sequencing in patients with features of MNGIE without TP mutations.", "label": 1, "is_selected": 0, "text": "Autosomal recessive progressive external ophthalmoplegia (PEO) is one clinical disorder associated with multiple mitochondrial DNA deletions and can be caused by missense mutations in POLG, the gene encoding the mitochondrial DNA polymerase gamma. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is another autosomal recessive disorder associated with PEO and multiple deletions of mitochondrial DNA in skeletal muscle. In several patients this disorder is caused by loss of function mutations in the gene encoding thymidine phosphorylase (TP). We report a recessive family with features of MNGIE but no leukoencephalopathy in which two patients carry three missense mutations in POLG, of which two are novel mutations (N846S and P587L). The third mutation was previously reported as a recessive POLG mutation (T251I). This finding indicates the need for POLG sequencing in patients with features of MNGIE without TP mutations."}
{"qid": "60274a2a1cb411341a0000e2", "original_text": "Narcolepsy is a chronic sleep disorder characterized by a pentad of excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed nocturnal sleep. Treatment of narcolepsy remains challenging and current therapy is strictly symptomatically based. The present manuscript is based on an extensive Internet and PubMed search from 1990 to 2020. It is focused on the clinical and pharmacological properties of pitolisant in the treatment of narcolepsy. Currently there is no cure for narcolepsy. Although efforts have been made, current treatments do not always allow to obtain an optimal control of symptoms. Pitolisant is an antagonist/inverse agonist of the histamine H3 autoreceptor. Its mechanism of action is novel and distinctive compared to the other available therapies for narcolepsy. Clinical trials suggest that pitolisant administered at a dose of \u226436 mg/day is an effective treatment option for narcolepsy, reducing EDS and cataplexy. Pitolisant is available as oral tablets and offers a convenient once-daily regimen. Pitolisant is generally well tolerated and showed minimal abuse potential in animals and humans. Long-term studies comparing the effectiveness and tolerability of pitolisant with active drugs (e.g. modafinil, sodium oxybate) are needed.", "label": 1, "is_selected": 0, "text": "Narcolepsy is a chronic sleep disorder characterized by a pentad of excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations, and disturbed nocturnal sleep. Treatment of narcolepsy remains challenging and current therapy is strictly symptomatically based. The present manuscript is based on an extensive Internet and PubMed search from 1990 to 2020. It is focused on the clinical and pharmacological properties of pitolisant in the treatment of narcolepsy. Currently there is no cure for narcolepsy. Although efforts have been made, current treatments do not always allow to obtain an optimal control of symptoms. Pitolisant is an antagonist/inverse agonist of the histamine H3 autoreceptor. Its mechanism of action is novel and distinctive compared to the other available therapies for narcolepsy. Clinical trials suggest that pitolisant administered at a dose of \u226436 mg/day is an effective treatment option for narcolepsy, reducing EDS and cataplexy. Pitolisant is available as oral tablets and offers a convenient once-daily regimen. Pitolisant is generally well tolerated and showed minimal abuse potential in animals and humans. Long-term studies comparing the effectiveness and tolerability of pitolisant with active drugs (e.g. modafinil, sodium oxybate) are needed."}
{"qid": "5fdb4253a43ad31278000022", "original_text": "Conserved noncoding elements (CNEs) constitute the majority of sequences under purifying selection in the human genome, yet their function remains largely unknown. Experimental evidence suggests that many of these elements play regulatory roles, but little is known about regulatory motifs contained within them. Here we describe a systematic approach to discover and characterize regulatory motifs within mammalian CNEs by searching for long motifs (12-22 nt) with significant enrichment in CNEs and studying their biochemical and genomic properties. Our analysis identifies 233 long motifs (LMs), matching a total of approximately 60,000 conserved instances across the human genome. These motifs include 16 previously known regulatory elements, such as the histone 3'-UTR motif and the neuron-restrictive silencer element, as well as striking examples of novel functional elements. The most highly enriched motif (LM1) corresponds to the X-box motif known from yeast and nematode. We show that it is bound by the RFX1 protein and identify thousands of conserved motif instances, suggesting a broad role for the RFX family in gene regulation.", "label": 1, "is_selected": 0, "text": "Conserved noncoding elements (CNEs) constitute the majority of sequences under purifying selection in the human genome, yet their function remains largely unknown. Experimental evidence suggests that many of these elements play regulatory roles, but little is known about regulatory motifs contained within them. Here we describe a systematic approach to discover and characterize regulatory motifs within mammalian CNEs by searching for long motifs (12-22 nt) with significant enrichment in CNEs and studying their biochemical and genomic properties. Our analysis identifies 233 long motifs (LMs), matching a total of approximately 60,000 conserved instances across the human genome. These motifs include 16 previously known regulatory elements, such as the histone 3'-UTR motif and the neuron-restrictive silencer element, as well as striking examples of novel functional elements. The most highly enriched motif (LM1) corresponds to the X-box motif known from yeast and nematode. We show that it is bound by the RFX1 protein and identify thousands of conserved motif instances, suggesting a broad role for the RFX family in gene regulation."}
{"qid": "626ae803e764a5320400003c", "original_text": "Volanesorsen (Waylivra\u00ae), an antisense oligonucleotide inhibitor of apolipoprotein CIII (apoCIII) mRNA, is being developed by Ionis Pharmaceuticals through its subsidiary company, Akcea Therapeutics, to treat familial chylomicronemia syndrome (FCS), hypertriglyceridemia and familial partial lipodystrophy (FPL). In May 2019, volanesorsen was approved in the EU for the treatment of adult patients with FCS based on positive results from the multinational, phase III APPROACH and COMPASS studies. Other clinical trials are ongoing to assess its utility in hypertriglyceridemia, FPL and partial lipodystrophy.", "label": 1, "is_selected": 0, "text": "Volanesorsen (Waylivra\u00ae), an antisense oligonucleotide inhibitor of apolipoprotein CIII (apoCIII) mRNA, is being developed by Ionis Pharmaceuticals through its subsidiary company, Akcea Therapeutics, to treat familial chylomicronemia syndrome (FCS), hypertriglyceridemia and familial partial lipodystrophy (FPL). In May 2019, volanesorsen was approved in the EU for the treatment of adult patients with FCS based on positive results from the multinational, phase III APPROACH and COMPASS studies. Other clinical trials are ongoing to assess its utility in hypertriglyceridemia, FPL and partial lipodystrophy."}
{"qid": "532f06e6d6d3ac6a34000028", "original_text": "The distribution of activated partial thromboplastin time (APTT) in nonvalvular atrial fibrillation (NVAF) patients under dabigatran therapy remains to be clarified. The study population was 196 NVAF patients who were treated with dabigatran in 2011 (126 with 220 mg/day). The APTT values showed a wide distribution among the patients, especially in those with a reduced dose, who seemed to show a high value even in patients without contraindications. We found a wide distribution of APTT in NVAF patients under dabigatran treatment. High APTT might help screen for bleeding risks among patients under dabigatran, but requires future investigation.", "label": 1, "is_selected": 0, "text": "The distribution of activated partial thromboplastin time (APTT) in nonvalvular atrial fibrillation (NVAF) patients under dabigatran therapy remains to be clarified. The study population was 196 NVAF patients who were treated with dabigatran in 2011 (126 with 220 mg/day). The APTT values showed a wide distribution among the patients, especially in those with a reduced dose, who seemed to show a high value even in patients without contraindications. We found a wide distribution of APTT in NVAF patients under dabigatran treatment. High APTT might help screen for bleeding risks among patients under dabigatran, but requires future investigation."}
{"qid": "5e41620648dab47f2600000e", "original_text": "No, poliosis circumscripta is not another term for a white or unpigmented patch of hair or skin. Poliosis circumscripta is a specific condition characterized by patches of hair that are either entirely white or have a distinctive whitish hue. It is a rare inherited disorder that affects the hair follicles, resulting in the unusual hair color.", "label": 0, "is_selected": 1, "text": "Have you ever wondered what it means to have a rare genetic condition that causes your hair to be white or unpigmented for a length of time, or is it just a matter of time before you have to have it shaved off or have your eyebrows shaved off?"}
{"qid": "5aad547efcf456587200000b", "original_text": "Protein inference is an important issue in proteomics research. Its main objective is to select a proper subset of candidate proteins that best explain the observed peptides. Although many methods have been proposed for solving this problem, several issues such as peptide degeneracy and one-hit wonders still remain unsolved. Therefore, the accurate identification of proteins that are truly present in the sample continues to be a challenging task. Based on the concept of peptide detectability, we formulate the protein inference problem as a constrained Lasso regression problem, which can be solved very efficiently through a coordinate descent procedure. The new inference algorithm is named as ProteinLasso, which explores an ensemble learning strategy to address the sparsity parameter selection problem in Lasso model. We test the performance of ProteinLasso on three datasets. As shown in the experimental results, ProteinLasso outperforms those state-of-the-art protein inference algorithms in terms of both identification accuracy and running efficiency. In addition, we show that ProteinLasso is stable under different parameter specifications. The source code of our algorithm is available at: http://sourceforge.net/projects/proteinlasso.", "label": 1, "is_selected": 0, "text": "Protein inference is an important issue in proteomics research. Its main objective is to select a proper subset of candidate proteins that best explain the observed peptides. Although many methods have been proposed for solving this problem, several issues such as peptide degeneracy and one-hit wonders still remain unsolved. Therefore, the accurate identification of proteins that are truly present in the sample continues to be a challenging task. Based on the concept of peptide detectability, we formulate the protein inference problem as a constrained Lasso regression problem, which can be solved very efficiently through a coordinate descent procedure. The new inference algorithm is named as ProteinLasso, which explores an ensemble learning strategy to address the sparsity parameter selection problem in Lasso model. We test the performance of ProteinLasso on three datasets. As shown in the experimental results, ProteinLasso outperforms those state-of-the-art protein inference algorithms in terms of both identification accuracy and running efficiency. In addition, we show that ProteinLasso is stable under different parameter specifications. The source code of our algorithm is available at: http://sourceforge.net/projects/proteinlasso."}
{"qid": "61f5fb64882a024a1000001a", "original_text": "Tebentafusp is used to treat metastatic uveal melanoma, a type of cancer that affects the eye. It is administered through intravenous infusion and works by targeting and destroying cancer cells. Tebentafusp is approved for patients whose tumors have progressed or returned after previous treatment with a BRAF inhibitor.", "label": 0, "is_selected": 0, "text": "Tebentafusp is used to treat metastatic uveal melanoma, a type of cancer that affects the eye. It is administered through intravenous infusion and works by targeting and destroying cancer cells. Tebentafusp is approved for patients whose tumors have progressed or returned after previous treatment with a BRAF inhibitor."}
{"qid": "621b4a223a8413c65300003a", "original_text": "Alphafold is a machine learning model developed by Google DeepMind that predicts the 3D structure of proteins from their amino acid sequence. It uses a technique called \"physics-informed neural networks\" (PINNs), which combines the power of deep learning with the laws of physics to generate accurate predictions of protein structure. Alphafold has been shown to be highly effective in predicting the structures of proteins, including those with high levels of complexity and flexibility. This technology has the potential to revolutionize the field of protein engineering and design, and could lead to breakthroughs in the development of new drugs and therapies.", "label": 0, "is_selected": 0, "text": "Alphafold is a machine learning model developed by Google DeepMind that predicts the 3D structure of proteins from their amino acid sequence. It uses a technique called \"physics-informed neural networks\" (PINNs), which combines the power of deep learning with the laws of physics to generate accurate predictions of protein structure. Alphafold has been shown to be highly effective in predicting the structures of proteins, including those with high levels of complexity and flexibility. This technology has the potential to revolutionize the field of protein engineering and design, and could lead to breakthroughs in the development of new drugs and therapies."}
{"qid": "5e35dc26158f994d3a000006", "original_text": "Proteins perform essential cellular functions as part of protein complexes, often in conjunction with RNA, DNA, metabolites and other small molecules. The genome encodes thousands of proteins but not all of them are expressed in every cell type; and expressed proteins are not active at all times. Such diversity of protein expression and function accounts for the level of biological intricacy seen in nature.", "label": 1, "is_selected": 0, "text": "Proteins perform essential cellular functions as part of protein complexes, often in conjunction with RNA, DNA, metabolites and other small molecules. The genome encodes thousands of proteins but not all of them are expressed in every cell type; and expressed proteins are not active at all times. Such diversity of protein expression and function accounts for the level of biological intricacy seen in nature."}
{"qid": "5c960d88ecadf2e73f00001f", "original_text": "Yes, tocilizumab is an anti-TNF (tumor necrosis factor) antibody. It works by blocking the activity of TNF-alpha, a pro-inflammatory cytokine that is involved in the pathogenesis of various inflammatory diseases, including rheumatoid arthritis, psoriatic arthritis, and Castleman disease.", "label": 0, "is_selected": 1, "text": "Tocilizumab is a drug that has been approved for the treatment of rheumatoid arthritis and psoriatic arthritis, two conditions in which the body's immune system attacks its own tissue and synovial fluid, a fluid that forms in the joints."}
{"qid": "5506a7a48e1671127b000008", "original_text": "The phosphorylation of rat cardiac microsomal proteins was investigated with special attention to the effects of okadaic acid (an inhibitor of protein phosphatases), inhibitor 2 of protein phosphatase 1 and inhibitor of cyclic AMP-dependent protein kinase (protein kinase A). The results showed that okadaic acid (5 microM) modestly but reproducibly augmented the protein kinase A-catalyzed phospholamban (PLN) phosphorylation, although exerted little effect on the calcium/calmodulin kinase-catalyzed PLN phosphorylation. Microsomes contained three other substrates (M(r) 23, 19 and 17 kDa) that were phosphorylated by protein kinase A but not by calcium/calmodulin kinase. The protein kinase A-catalyzed phosphorylation of these three substrates was markedly (2-3 fold) increased by 5 microM okadaic acid. Calmodulin was found to antagonize the action of okadaic acid on such phosphorylation. Protein kinase A inhibitor was found to decrease the protein kinase A-catalyzed phosphorylation of microsomal polypeptides. Unexpectedly, inhibitor 2 was also found to markedly decrease protein kinase A-catalyzed phosphorylation of phospholamban as well these other microsomal substrates. These results are consistent with the views that protein phosphatase 1 is capable of dephosphorylating membrane-associated phospholamban when it is phosphorylated by protein kinase A, but not by calcium/calmodulin kinase, and that under certain conditions, calcium/calmodulin-stimulated protein phosphatase (protein phosphatase 2B) is also able to dephosphorylate PLN phosphorylated by protein kinase A. Additionally, the observations show that protein phosphatase 1 is extremely active against the three protein kinase A substrates (M(r) 23, 19 and 17 kDa)", "label": 1, "is_selected": 0, "text": "The phosphorylation of rat cardiac microsomal proteins was investigated with special attention to the effects of okadaic acid (an inhibitor of protein phosphatases), inhibitor 2 of protein phosphatase 1 and inhibitor of cyclic AMP-dependent protein kinase (protein kinase A). The results showed that okadaic acid (5 microM) modestly but reproducibly augmented the protein kinase A-catalyzed phospholamban (PLN) phosphorylation, although exerted little effect on the calcium/calmodulin kinase-catalyzed PLN phosphorylation. Microsomes contained three other substrates (M(r) 23, 19 and 17 kDa) that were phosphorylated by protein kinase A but not by calcium/calmodulin kinase. The protein kinase A-catalyzed phosphorylation of these three substrates was markedly (2-3 fold) increased by 5 microM okadaic acid. Calmodulin was found to antagonize the action of okadaic acid on such phosphorylation. Protein kinase A inhibitor was found to decrease the protein kinase A-catalyzed phosphorylation of microsomal polypeptides. Unexpectedly, inhibitor 2 was also found to markedly decrease protein kinase A-catalyzed phosphorylation of phospholamban as well these other microsomal substrates. These results are consistent with the views that protein phosphatase 1 is capable of dephosphorylating membrane-associated phospholamban when it is phosphorylated by protein kinase A, but not by calcium/calmodulin kinase, and that under certain conditions, calcium/calmodulin-stimulated protein phosphatase (protein phosphatase 2B) is also able to dephosphorylate PLN phosphorylated by protein kinase A. Additionally, the observations show that protein phosphatase 1 is extremely active against the three protein kinase A substrates (M(r) 23, 19 and 17 kDa)"}
{"qid": "51600ca2298dcd4e51000037", "original_text": "A pathogen such as C. albicans needs an efficient mechanism of iron uptake in an iron-restricted environment such as is the human body. A ferric-reductase activity regulated by iron and copper, and analogous to that in S. cerevisiae, has been described in C. albicans. We have developed an in-plate protocol for the isolation of clones that complement an aft1 mutation in S. cerevisiae that makes cells dependent on iron for growth. After transformation of S. cerevisiae aft1 with a C. albicans library, we have selected clones that grow in conditions of iron deficiency and share an identical plasmid, pIRO1, with a 4500 bp insert containing the URA3 gene and an ORF (IRO1) responsible for the suppression of the iron dependency.", "label": 1, "is_selected": 0, "text": "A pathogen such as C. albicans needs an efficient mechanism of iron uptake in an iron-restricted environment such as is the human body. A ferric-reductase activity regulated by iron and copper, and analogous to that in S. cerevisiae, has been described in C. albicans. We have developed an in-plate protocol for the isolation of clones that complement an aft1 mutation in S. cerevisiae that makes cells dependent on iron for growth. After transformation of S. cerevisiae aft1 with a C. albicans library, we have selected clones that grow in conditions of iron deficiency and share an identical plasmid, pIRO1, with a 4500 bp insert containing the URA3 gene and an ORF (IRO1) responsible for the suppression of the iron dependency."}
{"qid": "516e5f10298dcd4e5100007c", "original_text": "Hypomethylation of CpG dinucleotides in genomic DNA was one of the first somatic epigenetic alterations discovered in human cancers. DNA hypomethylation is postulated to occur very early in almost all human cancers, perhaps facilitating genetic instability and cancer initiation and progression. We therefore examined the nature, extent, and timing of DNA hypomethylation changes in human prostate cancer. Contrary to the prevailing view that global DNA hypomethylation changes occur extremely early in all human cancers, we show that reductions in (5me)C content in the genome occur very late in prostate cancer progression, appearing at a significant extent only at the stage of metastatic disease. Furthermore, we found that, whereas some LINE1 promoter hypomethylation does occur in primary prostate cancers compared with normal tissues, this LINE1 hypomethylation is significantly more pronounced in metastatic prostate cancer. Next, we carried out a tiered gene expression microarray and bisulfite genomic sequencing-based approach to identify genes that are silenced by CpG island methylation in normal prostate cells but become overexpressed in prostate cancer cells as a result of CpG island hypomethylation.", "label": 1, "is_selected": 0, "text": "Hypomethylation of CpG dinucleotides in genomic DNA was one of the first somatic epigenetic alterations discovered in human cancers. DNA hypomethylation is postulated to occur very early in almost all human cancers, perhaps facilitating genetic instability and cancer initiation and progression. We therefore examined the nature, extent, and timing of DNA hypomethylation changes in human prostate cancer. Contrary to the prevailing view that global DNA hypomethylation changes occur extremely early in all human cancers, we show that reductions in (5me)C content in the genome occur very late in prostate cancer progression, appearing at a significant extent only at the stage of metastatic disease. Furthermore, we found that, whereas some LINE1 promoter hypomethylation does occur in primary prostate cancers compared with normal tissues, this LINE1 hypomethylation is significantly more pronounced in metastatic prostate cancer. Next, we carried out a tiered gene expression microarray and bisulfite genomic sequencing-based approach to identify genes that are silenced by CpG island methylation in normal prostate cells but become overexpressed in prostate cancer cells as a result of CpG island hypomethylation."}
{"qid": "5a69031bb750ff445500001e", "original_text": "Data regarding the treatment of nonsexually acquired genital ulceration (NSAGU) are limited. We sought to provide evidence for the safety and efficacy of topical and systemic corticosteroids followed by doxycycline prophylaxis for acute and recurrent NSAGU. A retrospective chart review was conducted of patients with NSAGU treated in a private dermogynecology practice. A total of 26 girls and women with NSAGU were identified and divided into 2 groups: group A = 17 patients with moderate to severe ulceration treated in the acute stage with oral corticosteroid; and group B = 9 patients with mild ulceration treated in the acute stage with topical corticosteroid. Patients in group A, with a mean age of 27.9 years (range, 11-62 years), were treated with oral prednisolone commencing with 15 to 50 mg per day depending on severity. Sixteen (94%) achieved rapid pain relief and complete healing of ulcers within 16 days. Eight (47%) commenced doxycycline prophylaxis. Women in group B, with a mean age of 42.5 years (range, 26-67 years) were treated with topical corticosteroids. Eight (89%) had a history of recurrent ulcers and 6 (66%) commenced doxycycline prophylaxis. Of all 14 patients on doxycycline prophylaxis, none reported any recurrences during a mean follow-up of 18.3 months. There were no adverse effects caused by prednisolone. One patient experienced mild photosensitivity from doxycycline but continued to take it. This was a retrospective case series from a single private practice-based population. Topical or oral corticosteroids followed by prophylactic doxycycline can be effective in rapidly resolving acute flareups and preventing recurrences of NSAGU.", "label": 1, "is_selected": 0, "text": "Data regarding the treatment of nonsexually acquired genital ulceration (NSAGU) are limited. We sought to provide evidence for the safety and efficacy of topical and systemic corticosteroids followed by doxycycline prophylaxis for acute and recurrent NSAGU. A retrospective chart review was conducted of patients with NSAGU treated in a private dermogynecology practice. A total of 26 girls and women with NSAGU were identified and divided into 2 groups: group A = 17 patients with moderate to severe ulceration treated in the acute stage with oral corticosteroid; and group B = 9 patients with mild ulceration treated in the acute stage with topical corticosteroid. Patients in group A, with a mean age of 27.9 years (range, 11-62 years), were treated with oral prednisolone commencing with 15 to 50 mg per day depending on severity. Sixteen (94%) achieved rapid pain relief and complete healing of ulcers within 16 days. Eight (47%) commenced doxycycline prophylaxis. Women in group B, with a mean age of 42.5 years (range, 26-67 years) were treated with topical corticosteroids. Eight (89%) had a history of recurrent ulcers and 6 (66%) commenced doxycycline prophylaxis. Of all 14 patients on doxycycline prophylaxis, none reported any recurrences during a mean follow-up of 18.3 months. There were no adverse effects caused by prednisolone. One patient experienced mild photosensitivity from doxycycline but continued to take it. This was a retrospective case series from a single private practice-based population. Topical or oral corticosteroids followed by prophylactic doxycycline can be effective in rapidly resolving acute flareups and preventing recurrences of NSAGU."}
{"qid": "587d30fb31b33e8760000001", "original_text": "Gene expression is mediated by specialized cis-regulatory modules (CRMs), the most prominent of which are called enhancers. Early experiments indicated that enhancers located far from the gene promoters are often responsible for mediating gene transcription. Knowing their properties, regulatory activity, and genomic targets is crucial to the functional understanding of cellular events, ranging from cellular homeostasis to differentiation. Recent genome-wide investigation of epigenomic marks has indicated that enhancer elements could be enriched for certain epigenomic marks, such as, combinatorial patterns of histone modifications. Our efforts in this paper are motivated by these recent advances in epigenomic profiling methods, which have uncovered enhancer-associated chromatin features in different cell types and organisms. Specifically, in this paper, we use recent state-of-the-art Deep Learning methods and develop a deep neural network (DNN)-based architecture, called EP-DNN, to predict the presence and types of enhancers in the human genome. It uses as features, the expression levels of the histone modifications at the peaks of the functional sites as well as in its adjacent regions. We apply EP-DNN to four different cell types: H1, IMR90, HepG2, and HeLa S3. We train EP-DNN using p300 binding sites as enhancers, and TSS and random non-DHS sites as non-enhancers.", "label": 1, "is_selected": 0, "text": "Gene expression is mediated by specialized cis-regulatory modules (CRMs), the most prominent of which are called enhancers. Early experiments indicated that enhancers located far from the gene promoters are often responsible for mediating gene transcription. Knowing their properties, regulatory activity, and genomic targets is crucial to the functional understanding of cellular events, ranging from cellular homeostasis to differentiation. Recent genome-wide investigation of epigenomic marks has indicated that enhancer elements could be enriched for certain epigenomic marks, such as, combinatorial patterns of histone modifications. Our efforts in this paper are motivated by these recent advances in epigenomic profiling methods, which have uncovered enhancer-associated chromatin features in different cell types and organisms. Specifically, in this paper, we use recent state-of-the-art Deep Learning methods and develop a deep neural network (DNN)-based architecture, called EP-DNN, to predict the presence and types of enhancers in the human genome. It uses as features, the expression levels of the histone modifications at the peaks of the functional sites as well as in its adjacent regions. We apply EP-DNN to four different cell types: H1, IMR90, HepG2, and HeLa S3. We train EP-DNN using p300 binding sites as enhancers, and TSS and random non-DHS sites as non-enhancers."}
{"qid": "531b2fc3b166e2b80600003c", "original_text": "Both low free triiodothyronine (fT3) and high brain natriuretic peptide (BNP) have been separately described as prognostic predictors for mortality in heart failure (HF). We investigated whether their prognostic value is independent. From January of 2001 to December of 2006, we prospectively evaluated 442 consecutive patients with systolic HF and no thyroid disease or treatment with drugs affecting thyroid function (age 65+/-12 years, mean +/- standard deviation, 75% were male, left ventricular ejection fraction 33% +/- 10%, New York Heart Association (NYHA) class I and II: 63%, NYHA class III and IV: 37%). All patients underwent full clinical and echocardiographic evaluation and assessment of BNP and thyroid function. Both cardiac and all-cause mortality (cumulative) were considered as end points.", "label": 1, "is_selected": 0, "text": "Both low free triiodothyronine (fT3) and high brain natriuretic peptide (BNP) have been separately described as prognostic predictors for mortality in heart failure (HF). We investigated whether their prognostic value is independent. From January of 2001 to December of 2006, we prospectively evaluated 442 consecutive patients with systolic HF and no thyroid disease or treatment with drugs affecting thyroid function (age 65+/-12 years, mean +/- standard deviation, 75% were male, left ventricular ejection fraction 33% +/- 10%, New York Heart Association (NYHA) class I and II: 63%, NYHA class III and IV: 37%). All patients underwent full clinical and echocardiographic evaluation and assessment of BNP and thyroid function. Both cardiac and all-cause mortality (cumulative) were considered as end points."}
{"qid": "58861f8b3b87a8a738000003", "original_text": "The Orpington Prognostic Scale is a tool used to predict the outcome or prognosis of patients with acute heart failure (AHF). The scale was developed by a multidisciplinary group of physicians and researchers in 2000, and its purpose is to stratify patients into different risk categories based on their clinical and laboratory data. This allows clinicians to identify patients at high risk of mortality or hospitalization, and to target interventions accordingly. The scale takes into account various factors such as age, sex, left ventricular ejection fraction, serum creatinine, and clinical symptoms. The purpose of the Orpington Prognostic Scale is to improve the accuracy of prognosis in AHF patients, and to ultimately improve patient outcomes.", "label": 0, "is_selected": 1, "text": "The Orpington Prognostic Scale is a tool used to predict the outcome or prognosis of patients with acute heart failure, and to ultimately improve patient outcomes. The purpose of the OrpingtonPrognosticScale is to improve the accuracy of prognosis in AHF patients, and ultimately to improve patient Outcomes."}
{"qid": "58f3d85170f9fc6f0f00000f", "original_text": "The association of Down's syndrome and leukemia has been documented for over 50 years. Multiple studies have established the incidence of leukemia in Down's syndrome patients to be 10- to 20-fold higher than that in the general population. The age of onset for leukemia in these children is bimodal, peaking first in the newborn period and again at 3-6 years. This increased risk extends into adulthood. All cytogenetic types of Down's syndrome apparently predispose to leukemia. The proportion of acute lymphoblastic leukemia and acute nonlymphoblastic leukemia in patients with Down's syndrome is similar to non-Down's syndrome leukemia patients matched for age. There are case reports in which leukemia, Down's syndrome, and other chromosomal aberrations cluster within a family.", "label": 1, "is_selected": 0, "text": "The association of Down's syndrome and leukemia has been documented for over 50 years. Multiple studies have established the incidence of leukemia in Down's syndrome patients to be 10- to 20-fold higher than that in the general population. The age of onset for leukemia in these children is bimodal, peaking first in the newborn period and again at 3-6 years. This increased risk extends into adulthood. All cytogenetic types of Down's syndrome apparently predispose to leukemia. The proportion of acute lymphoblastic leukemia and acute nonlymphoblastic leukemia in patients with Down's syndrome is similar to non-Down's syndrome leukemia patients matched for age. There are case reports in which leukemia, Down's syndrome, and other chromosomal aberrations cluster within a family."}
{"qid": "5c51f9dd07ef653866000005", "original_text": "Simultaneous detection of small copy number variations (CNVs) (<0.5 kb) and single-nucleotide variants in clinically significant genes is of great interest for clinical laboratories. The analytical variability in next-generation sequencing (NGS) and artifacts in coverage data because of issues with mappability along with lack of robust bioinformatics tools for CNV detection have limited the utility of targeted NGS data to identify CNVs. We describe the development and implementation of a bioinformatics algorithm, copy number variation-random forest (CNV-RF), that incorporates a machine learning component to identify CNVs from targeted NGS data. Using CNV-RF, we identified 12 of 13 deletions in samples with known CNVs, two cases with duplications, and identified novel deletions in 22 additional cases. Furthermore, no CNVs were identified among 60 genes in 14 cases with normal copy number and no CNVs were identified in another 104 patients with clinical suspicion of CNVs. All positive deletions and duplications were confirmed using a quantitative PCR method. CNV-RF also detected heterozygous deletions and duplications with a specificity of 50% across 4813 genes. The ability of CNV-RF to detect clinically relevant CNVs with a high degree of sensitivity along with confirmation using a low-cost quantitative PCR method provides a framework for providing comprehensive NGS-based CNV/single-nucleotide variant detection in a clinical molecular diagnostics laboratory.", "label": 1, "is_selected": 0, "text": "Simultaneous detection of small copy number variations (CNVs) (<0.5 kb) and single-nucleotide variants in clinically significant genes is of great interest for clinical laboratories. The analytical variability in next-generation sequencing (NGS) and artifacts in coverage data because of issues with mappability along with lack of robust bioinformatics tools for CNV detection have limited the utility of targeted NGS data to identify CNVs. We describe the development and implementation of a bioinformatics algorithm, copy number variation-random forest (CNV-RF), that incorporates a machine learning component to identify CNVs from targeted NGS data. Using CNV-RF, we identified 12 of 13 deletions in samples with known CNVs, two cases with duplications, and identified novel deletions in 22 additional cases. Furthermore, no CNVs were identified among 60 genes in 14 cases with normal copy number and no CNVs were identified in another 104 patients with clinical suspicion of CNVs. All positive deletions and duplications were confirmed using a quantitative PCR method. CNV-RF also detected heterozygous deletions and duplications with a specificity of 50% across 4813 genes. The ability of CNV-RF to detect clinically relevant CNVs with a high degree of sensitivity along with confirmation using a low-cost quantitative PCR method provides a framework for providing comprehensive NGS-based CNV/single-nucleotide variant detection in a clinical molecular diagnostics laboratory."}
{"qid": "58d90f228acda3452900000f", "original_text": "Yes, diphosphatidylglycerol (cardiolipin) is a phospholipid that is specifically associated with the inner mitochondrial membrane. It is a major component of the inner mitochondrial membrane and plays a crucial role in maintaining the structure and function of the mitochondria.", "label": 0, "is_selected": 0, "text": "Yes, diphosphatidylglycerol (cardiolipin) is a phospholipid that is specifically associated with the inner mitochondrial membrane. It is a major component of the inner mitochondrial membrane and plays a crucial role in maintaining the structure and function of the mitochondria."}
{"qid": "5a9d96564e03427e73000001", "original_text": "The incidence of Alzheimer's disease (AD) is increasing. Major risk factors for AD are advancing age and diabetes. Lately, obesity has been associated with an increased risk of dementia. Obese and diabetic individuals are prone to decreased circulating levels of zinc, reducing the amount of zinc available for crucial intracellular processes. In the brain, zinc co-localizes with glutamate in synaptic vesicles, and modulates NMDA receptor activity. Intracellular zinc is involved in apoptosis and fluctuations in cytoplasmic Zn(2+) affect modulation of intracellular signaling. The ZNT and ZIP proteins participate in intracellular zinc homeostasis. Altered expression of zinc-regulatory proteins has been described in AD patients. Using microarray data from human frontal cortex (BrainCloud), this study investigates expression of the SCLA30A (ZNT) and SCLA39A (ZIP) families of genes in a Caucasian and African-American sample of 145 neurologically and psychiatrically normal individuals.", "label": 1, "is_selected": 0, "text": "The incidence of Alzheimer's disease (AD) is increasing. Major risk factors for AD are advancing age and diabetes. Lately, obesity has been associated with an increased risk of dementia. Obese and diabetic individuals are prone to decreased circulating levels of zinc, reducing the amount of zinc available for crucial intracellular processes. In the brain, zinc co-localizes with glutamate in synaptic vesicles, and modulates NMDA receptor activity. Intracellular zinc is involved in apoptosis and fluctuations in cytoplasmic Zn(2+) affect modulation of intracellular signaling. The ZNT and ZIP proteins participate in intracellular zinc homeostasis. Altered expression of zinc-regulatory proteins has been described in AD patients. Using microarray data from human frontal cortex (BrainCloud), this study investigates expression of the SCLA30A (ZNT) and SCLA39A (ZIP) families of genes in a Caucasian and African-American sample of 145 neurologically and psychiatrically normal individuals."}
{"qid": "530cefaaad0bf1360c00000f", "original_text": "The aims were to analyze whether the levels of self-reported bruxism and anxiety associate among otherwise healthy subjects, and to investigate the independent effects of anxiety and stress experience on the probability of self-reported bruxism. As part of a study on irregular shift work, a questionnaire was mailed to all employees of the Finnish Broadcasting Company with irregular shift work (number of subjects: n=750) and to an equal number of randomly selected employees in the same company with regular eight-hour daytime work. The response rates were 82.3% (56.6 % men) and 34.3 % (46.7 % men), respectively. Among the 874 respondents, those aware of more frequent bruxism reported significantly more severe anxiety (p<0.001).", "label": 1, "is_selected": 0, "text": "The aims were to analyze whether the levels of self-reported bruxism and anxiety associate among otherwise healthy subjects, and to investigate the independent effects of anxiety and stress experience on the probability of self-reported bruxism. As part of a study on irregular shift work, a questionnaire was mailed to all employees of the Finnish Broadcasting Company with irregular shift work (number of subjects: n=750) and to an equal number of randomly selected employees in the same company with regular eight-hour daytime work. The response rates were 82.3% (56.6 % men) and 34.3 % (46.7 % men), respectively. Among the 874 respondents, those aware of more frequent bruxism reported significantly more severe anxiety (p<0.001)."}
{"qid": "54de15f91388e8454a000002", "original_text": "The APOBEC3 (A3) protein family includes several members that have been shown to inhibit Vif-deficient HIV-1 replication. Specifically, A3B, A3C, A3F, A3G, and A3H have been identified as Vif-inhibitors. These proteins, particularly A3B and A3F, have been shown to restrict Vif-deficient HIV-1 replication by blocking the activity of the viral protein Vif, which is essential for HIV-1 replication. Additionally, some studies have suggested that A3G and A3H may also inhibit Vif-deficient HIV-1 replication, although the mechanism by which they do so is less clear. Overall, the APOBEC3 proteins play an important role in restricting HIV-1 replication by inhibiting the activity of Vif-deficient virus.", "label": 0, "is_selected": 1, "text": "The APOBEC3 family of proteins has been implicated in the regulation of HIV-1 replication and has been identified as an important target for the development of new drugs to treat HIV-1 infection and its associated diseases.<n> Overall, the APOBEC 3 proteins play an important role in restricting HIV-1 replicating by inhibiting the activity of Vif-deficient virus."}
{"qid": "53636e727d100faa0900000d", "original_text": "Epigenetics refers to the study of heritable changes in the pattern of gene expression that is controlled by a mechanism specifically not due to changes the primary DNA sequence. Well-known epigenetic mechanisms include DNA methylation, post-translational histone modifications and RNA-based mechanisms including those controlled by small non-coding RNAs (miRNAs). Recent studies have shown that epigenetic modifications orchestrate the hepatic stellate cell (HSC) activation and liver fibrosis. In this review we focus on the aberrant methylation of CpG island promoters of select genes is the prominent epigenetic mechanism to effectively silence gene transcription facilitating HSC activation and liver fibrosis.", "label": 1, "is_selected": 0, "text": "Epigenetics refers to the study of heritable changes in the pattern of gene expression that is controlled by a mechanism specifically not due to changes the primary DNA sequence. Well-known epigenetic mechanisms include DNA methylation, post-translational histone modifications and RNA-based mechanisms including those controlled by small non-coding RNAs (miRNAs). Recent studies have shown that epigenetic modifications orchestrate the hepatic stellate cell (HSC) activation and liver fibrosis. In this review we focus on the aberrant methylation of CpG island promoters of select genes is the prominent epigenetic mechanism to effectively silence gene transcription facilitating HSC activation and liver fibrosis."}
{"qid": "602494cf1cb411341a00009c", "original_text": "RNA-based therapies, including RNA molecules as drugs and RNA-targeted small molecules, offer unique opportunities to expand the range of therapeutic targets. Various forms of RNAs may be used to selectively act on proteins, transcripts, and genes that cannot be targeted by conventional small molecules or proteins. Although development of RNA drugs faces unparalleled challenges, many strategies have been developed to improve RNA metabolic stability and intracellular delivery. A number of RNA drugs have been approved for medical use, including aptamers (e.g., pegaptanib) that mechanistically act on protein target and small interfering RNAs (e.g., patisiran and givosiran) and antisense oligonucleotides (e.g., inotersen and golodirsen) that directly interfere with RNA targets. Furthermore, guide RNAs are essential components of novel gene editing modalities, and mRNA therapeutics are under development for protein replacement therapy or vaccination, including those against unprecedented severe acute respiratory syndrome coronavirus pandemic. Moreover, functional RNAs or RNA motifs are highly structured to form binding pockets or clefts that are accessible by small molecules. Many natural, semisynthetic, or synthetic antibiotics (e.g., aminoglycosides, tetracyclines, macrolides, oxazolidinones, and phenicols) can directly bind to ribosomal RNAs to achieve the inhibition of bacterial infections. Therefore, there is growing interest in developing RNA-targeted small-molecule drugs amenable to oral administration, and some (e.g., risdiplam and branaplam) have entered clinical trials.", "label": 1, "is_selected": 0, "text": "RNA-based therapies, including RNA molecules as drugs and RNA-targeted small molecules, offer unique opportunities to expand the range of therapeutic targets. Various forms of RNAs may be used to selectively act on proteins, transcripts, and genes that cannot be targeted by conventional small molecules or proteins. Although development of RNA drugs faces unparalleled challenges, many strategies have been developed to improve RNA metabolic stability and intracellular delivery. A number of RNA drugs have been approved for medical use, including aptamers (e.g., pegaptanib) that mechanistically act on protein target and small interfering RNAs (e.g., patisiran and givosiran) and antisense oligonucleotides (e.g., inotersen and golodirsen) that directly interfere with RNA targets. Furthermore, guide RNAs are essential components of novel gene editing modalities, and mRNA therapeutics are under development for protein replacement therapy or vaccination, including those against unprecedented severe acute respiratory syndrome coronavirus pandemic. Moreover, functional RNAs or RNA motifs are highly structured to form binding pockets or clefts that are accessible by small molecules. Many natural, semisynthetic, or synthetic antibiotics (e.g., aminoglycosides, tetracyclines, macrolides, oxazolidinones, and phenicols) can directly bind to ribosomal RNAs to achieve the inhibition of bacterial infections. Therefore, there is growing interest in developing RNA-targeted small-molecule drugs amenable to oral administration, and some (e.g., risdiplam and branaplam) have entered clinical trials."}
{"qid": "516c220e298dcd4e51000071", "original_text": "Cucumber has been studied for its potential role in lowering blood sugar levels in diabetics. While some studies suggest that cucumber may have a beneficial effect on blood sugar control, the evidence is limited and inconclusive. A 2013 study published in the Journal of Ethnopharmacology found that cucumber extract reduced blood glucose levels in diabetic rats. Another study published in 2018 in the Journal of Medicinal Food found that cucumber juice increased insulin sensitivity in healthy adults. However, other studies have found little to no effect of cucumber on blood sugar levels. A 2015 review of 19 studies on the potential health benefits of cucumber found that the evidence was inconsistent and inconclusive. In summary, while some studies suggest that cucumber may have a beneficial effect on blood sugar levels in diabetics, more research is needed to confirm these findings and to establish a clear recommendation for its use in diabetes management.", "label": 0, "is_selected": 1, "text": "This article looks at the evidence on the potential health benefits of cucumber for people with diabetes and the evidence so far on its use in the management of the disease and its possible side effects. in summary, while some studies suggest that cucumber may have a beneficial effect on blood sugar levels in diabetics, more research is needed to confirm these findings and to establish a clear recommendation for its use as diabetes management."}
{"qid": "516ec97f298dcd4e51000087", "original_text": "There are several methods that can be used to evaluate the reliability of a phylogenetic tree. These include: 1. Node support: Assessing the support for each branch in the tree through statistical methods, such as bootstrap resampling or jackknife sampling, can help evaluate the reliability of the tree. 2. Retention of bootstrap replicate trees: Evaluating the proportion ofbootstrap replicate trees that retain a given branch in the original tree can provide an estimate of the support for that branch. 3. Distance-based methods: Measuring the distance between the tree and a reference tree can help determine the reliability of the tree. 4. Supermatrix methods: Using a supermatrix that combines data from multiple genes or loci can help to estimate the reliability of the tree by incorporating more data and reducing the impact of gene tree incongruence. 5. Molecular dating: Using molecular dating methods, such as Bayesian or maximum parsimony, to estimate the timing of evolutionary events can help evaluate the reliability of the tree by providing an estimate of the time scale of the evolutionary process. By using these methods, researchers can evaluate the reliability of a phylogenetic tree and increase confidence in its accuracy. However, it is important to note that no method can guarantee the absolute reliability of a tree, and multiple methods should be used in combination to provide a comprehensive assessment of tree reliability.", "label": 0, "is_selected": 1, "text": "A phylogenetic tree is a collection of trees that represent the evolutionary process of a single species, such as a bacterium, a mammal, or a bird, all of which have the same genetic code and are related by at least one branch to each other. by Daniel D'Alessandro, et al., The reliability of a phylogenetic tree: a literature review, Journal of Evolutionary Biology, doi: 10.1021/jhb.2011.015.x.doi: 10.1371/jheb.2011-01.014.x, hooplaExTRACT."}
{"qid": "626aab13e764a5320400003b", "original_text": "The rate of epimitations in Caenorhabditis elegans (C. elegans) has been widely studied and reported in the scientific literature. The rate of epimitations in C. elegans is estimated to be around 1-2% per generation, or approximately 10-20 epimitations per 100 cells per generation (Kurahashi et al., 2017). However, it is important to note that the rate of epimitations can vary depending on several factors, such as the age of the worm, the genetic background, and the environment.", "label": 0, "is_selected": 0, "text": "The rate of epimitations in Caenorhabditis elegans (C. elegans) has been widely studied and reported in the scientific literature. The rate of epimitations in C. elegans is estimated to be around 1-2% per generation, or approximately 10-20 epimitations per 100 cells per generation (Kurahashi et al., 2017). However, it is important to note that the rate of epimitations can vary depending on several factors, such as the age of the worm, the genetic background, and the environment."}
{"qid": "515dc066298dcd4e5100001a", "original_text": "Induced hypothermia, also known as therapeutic hypothermia or cooling therapy, has been shown to have a significant impact on the health and development of premature babies. Multiple studies have demonstrated that cooling the body of a premature baby within the first few hours of life can help reduce the risk of mortality, as well as the risk of long-term complications such as cerebral palsy and intellectual disability. For example, a 2017 meta-analysis published in the New England Journal of Medicine found that cooling therapy significantly reduced the risk of death or disability in premature babies, with the risk reduced by about 20% compared to standard care. Another study published in 2019 in the Journal of the American Medical Association found that cooling therapy reduced the risk of cerebral palsy in premature babies by about 40%. Overall, the evidence suggests that induced hypothermia can be an effective intervention for reducing morbidity and mortality in premature babies, and it is now widely recommended by medical organizations as a best practice for these babies.", "label": 0, "is_selected": 1, "text": "Premature babies who are treated with induced hypothermia are less likely to die and are more likely to have long-term complications, according to a new study published in the British Journal of Obstetricians and Gynaecologists (BJOG) and presented at the annual meeting of the American College of Obstetrics and Gynecology (ACOG) in Atlanta, Georgia, on Sunday, April 7.<n> Another study published on 2019 in the Journal of theAmerican Medical Association found that cooling therapy reduced the risk of cerebral palsy in premature babies by about 40%."}
{"qid": "5357a6d0f1005d6b58000004", "original_text": "The branch site consensus sequence in U12-dependent introns is \"AGGAAGACCT\". This sequence is recognized by the RNA splicing factors U12 and U4atac, which are responsible for excision of the intron and inclusion of the exon. The presence of this consensus sequence in the intron branch site is important for proper splicing of the RNA molecule.", "label": 0, "is_selected": 0, "text": "The branch site consensus sequence in U12-dependent introns is \"AGGAAGACCT\". This sequence is recognized by the RNA splicing factors U12 and U4atac, which are responsible for excision of the intron and inclusion of the exon. The presence of this consensus sequence in the intron branch site is important for proper splicing of the RNA molecule."}
{"qid": "530cf57efe2466f70c000001", "original_text": "Yes, depression has been shown to be a predictor of frailty. Multiple studies have found a significant association between depression and frailty in older adults. In a systematic review and meta-analysis of 32 observational studies, Li et al. (2019) found that depression was independently associated with an increased risk of frailty in older adults, with an odds ratio of 2.29 (95% CI: 1.61-3.56). Similarly, a meta-analysis of 16 studies by Zhang et al. (2020) found a pooled odds ratio of 1.71 (95% CI: 1.24-2.36) for the association between depression and frailty. These findings suggest that depression may be a useful predictor of frailty in older adults, and that addressing depression through interventions such as cognitive-behavioral therapy or antidepressant medication may help prevent or delay the onset of frailty.", "label": 0, "is_selected": 0, "text": "Yes, depression has been shown to be a predictor of frailty. Multiple studies have found a significant association between depression and frailty in older adults. In a systematic review and meta-analysis of 32 observational studies, Li et al. (2019) found that depression was independently associated with an increased risk of frailty in older adults, with an odds ratio of 2.29 (95% CI: 1.61-3.56). Similarly, a meta-analysis of 16 studies by Zhang et al. (2020) found a pooled odds ratio of 1.71 (95% CI: 1.24-2.36) for the association between depression and frailty. These findings suggest that depression may be a useful predictor of frailty in older adults, and that addressing depression through interventions such as cognitive-behavioral therapy or antidepressant medication may help prevent or delay the onset of frailty."}
{"qid": "532bf822d6d3ac6a34000016", "original_text": "Missense mutations in the PRESENILIN1 (PSEN1) gene frequently underlie familial Alzheimer's disease (FAD). Nonsense and most splicing mutations result in the synthesis of truncated peptides, and it has been assumed that truncated PSEN1 protein is functionless so that heterozygotes for these mutations are unaffected. Some FAD mutations affecting PSEN1 mRNA splicing cause loss of exon 8 or 9 sequences while maintaining the reading frame. We attempted to model these exon-loss mutations in zebrafish embryos by injecting morpholino antisense oligonucleotides (morpholinos) directed against splice acceptor sites in zebrafish psen1 transcripts. However, this produced cryptic changes in splicing potentially forming mRNAs encoding truncated presenilin proteins. Aberrant splicing in the region between exons 6 and 8 produces potent dominant negative effects on Psen1 protein activity, including Notch signalling, and causes a hydrocephalus phenotype. Reductions in Psen1 activity feedback positively to increase psen1 transcription through a mechanism apparently independent of gamma-secretase. We present evidence that the dominant negative effects are mediated through production of truncated Psen1 peptides that interfere with the normal activity of both Psen1 and Psen2.", "label": 1, "is_selected": 0, "text": "Missense mutations in the PRESENILIN1 (PSEN1) gene frequently underlie familial Alzheimer's disease (FAD). Nonsense and most splicing mutations result in the synthesis of truncated peptides, and it has been assumed that truncated PSEN1 protein is functionless so that heterozygotes for these mutations are unaffected. Some FAD mutations affecting PSEN1 mRNA splicing cause loss of exon 8 or 9 sequences while maintaining the reading frame. We attempted to model these exon-loss mutations in zebrafish embryos by injecting morpholino antisense oligonucleotides (morpholinos) directed against splice acceptor sites in zebrafish psen1 transcripts. However, this produced cryptic changes in splicing potentially forming mRNAs encoding truncated presenilin proteins. Aberrant splicing in the region between exons 6 and 8 produces potent dominant negative effects on Psen1 protein activity, including Notch signalling, and causes a hydrocephalus phenotype. Reductions in Psen1 activity feedback positively to increase psen1 transcription through a mechanism apparently independent of gamma-secretase. We present evidence that the dominant negative effects are mediated through production of truncated Psen1 peptides that interfere with the normal activity of both Psen1 and Psen2."}
{"qid": "5c72d4c77c78d6947100007c", "original_text": "Nup133 belongs to the Y-complex, a key component of the nuclear pore complex (NPC) scaffold. Studies on a null mutation in mice previously revealed that Nup133 is essential for embryonic development but not for mouse embryonic stem cell (mESC) proliferation. Using single-pore detection and average NE-fluorescence intensity, we find that Nup133 is dispensable for interphase and postmitotic NPC scaffold assembly in pluripotent mESCs. However, loss of Nup133 specifically perturbs the formation of the nuclear basket as manifested by the absence of Tpr in about half of the NPCs combined with altered dynamics of Nup153. We further demonstrate that its central domain mediates Nup133's role in assembling Tpr and Nup153 into a properly configured nuclear basket. Our findings thus revisit the role of the Y-complex in pore biogenesis and provide insights into the interplay between NPC scaffold architecture, nuclear basket assembly, and the generation of heterogeneity among NPCs.", "label": 1, "is_selected": 0, "text": "Nup133 belongs to the Y-complex, a key component of the nuclear pore complex (NPC) scaffold. Studies on a null mutation in mice previously revealed that Nup133 is essential for embryonic development but not for mouse embryonic stem cell (mESC) proliferation. Using single-pore detection and average NE-fluorescence intensity, we find that Nup133 is dispensable for interphase and postmitotic NPC scaffold assembly in pluripotent mESCs. However, loss of Nup133 specifically perturbs the formation of the nuclear basket as manifested by the absence of Tpr in about half of the NPCs combined with altered dynamics of Nup153. We further demonstrate that its central domain mediates Nup133's role in assembling Tpr and Nup153 into a properly configured nuclear basket. Our findings thus revisit the role of the Y-complex in pore biogenesis and provide insights into the interplay between NPC scaffold architecture, nuclear basket assembly, and the generation of heterogeneity among NPCs."}
{"qid": "517a8a718ed59a060a00003e", "original_text": "In patients suffering from hyperthyroidism dependent on Graves' disease, a reduction in Na+,K+ATPase activity has been demonstrated in red blood cells (RBCs), as well as an inverse correlation between this enzymatic action and free triiodothyronine (FT3) levels. The restoration of normal FT3 values also brings about a normalization of Na+,K+ATPase activity in erythrocytes. These results have made it possible to hypothesize that the thyroid hormones control Na+,K+ATPase activity and that this control is manifested by means of variations in the number of ouabain-binding sites. For this reason, the measurement of the activity of the Na/K pump can be considered as a further indicator of the peripheral effects of thyroid hormones. With a view to assess the relation between the course of treated hyperthyroidism and Na+,K+ATPase activity during antithyroid therapy and after surgical thyroidectomy followed by replacement therapy, we studied 24 patients affected by Graves' disease (group Graves [GG]). They were compared with 24 female Graves' patients who underwent total thyroidectomy for nontoxic and diffuse nodular goiter (NDNG) (group control [GC]) and with 24 normal healthy women (group normal [GN]).", "label": 1, "is_selected": 0, "text": "In patients suffering from hyperthyroidism dependent on Graves' disease, a reduction in Na+,K+ATPase activity has been demonstrated in red blood cells (RBCs), as well as an inverse correlation between this enzymatic action and free triiodothyronine (FT3) levels. The restoration of normal FT3 values also brings about a normalization of Na+,K+ATPase activity in erythrocytes. These results have made it possible to hypothesize that the thyroid hormones control Na+,K+ATPase activity and that this control is manifested by means of variations in the number of ouabain-binding sites. For this reason, the measurement of the activity of the Na/K pump can be considered as a further indicator of the peripheral effects of thyroid hormones. With a view to assess the relation between the course of treated hyperthyroidism and Na+,K+ATPase activity during antithyroid therapy and after surgical thyroidectomy followed by replacement therapy, we studied 24 patients affected by Graves' disease (group Graves [GG]). They were compared with 24 female Graves' patients who underwent total thyroidectomy for nontoxic and diffuse nodular goiter (NDNG) (group control [GC]) and with 24 normal healthy women (group normal [GN])."}
{"qid": "5c56033607647bbc4b00000c", "original_text": "On August 30, 2017, the U.S. Food and Drug Administration (FDA) approved Novartis' tisagenlecleucel (CTL-019, Kymriah), which is a synthetic bioimmune product of anti-CD19 chimeric antigen receptor (CAR) T cells, for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL). This was a milestone in tumor immunology on account of the significant antitumor effect of tisagenlecleucel for the treatment of relapsed/refractory B-ALL patients. Conventional standard therapies for B-ALL have high failure rates, thus developing new therapies is crucial for patients with B-ALL. Results from clinical trials indicate that anti-CD19 CAR T-cell therapies could successfully induce high response rates in B-ALL patients.", "label": 1, "is_selected": 0, "text": "On August 30, 2017, the U.S. Food and Drug Administration (FDA) approved Novartis' tisagenlecleucel (CTL-019, Kymriah), which is a synthetic bioimmune product of anti-CD19 chimeric antigen receptor (CAR) T cells, for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL). This was a milestone in tumor immunology on account of the significant antitumor effect of tisagenlecleucel for the treatment of relapsed/refractory B-ALL patients. Conventional standard therapies for B-ALL have high failure rates, thus developing new therapies is crucial for patients with B-ALL. Results from clinical trials indicate that anti-CD19 CAR T-cell therapies could successfully induce high response rates in B-ALL patients."}
{"qid": "5a6d022ab750ff445500002a", "original_text": "The deviation of the observed frequency of a word w from its expected frequency in a given sequence x is used to determine whether or not the word is avoided. This concept is particularly useful in DNA linguistic analysis. The value of the deviation of w, denoted by [Formula: see text], effectively characterises the extent of a word by its edge contrast in the context in which it occurs. A word w of length [Formula: see text] is a [Formula: see text]-avoided word in x if [Formula: see text], for a given threshold [Formula: see text]. Notice that such a word may be completely absent from x. Hence, computing all such words na\u00efvely can be a very time-consuming procedure, in particular for large k. In this article, we propose an [Formula: see text]-time and [Formula: see text]-space algorithm to compute all [Formula: see text]-avoided words of length k in a given sequence of length n over a fixed-sized alphabet. We also present a time-optimal [Formula: see text]-time algorithm to compute all [Formula: see text]-avoided words (of any length) in a sequence of length n over an integer alphabet of size [Formula: see text]. In addition, we provide a tight asymptotic upper bound for the number of [Formula: see text]-avoided words over an integer alphabet and the expected length of the longest one. We make available an implementation of our algorithm. Experimental results, using both real and synthetic data, show the efficiency and applicability of our implementation in biological sequence analysis. The systematic search for avoided words is particularly useful for biological sequence analysis. We present a linear-time and linear-space algorithm for the computation of avoided words of length k in a given sequence x. We suggest a modification to this algorithm so that it computes all avoided words of x, irrespective of their length, within the same time complexity.", "label": 1, "is_selected": 0, "text": "The deviation of the observed frequency of a word w from its expected frequency in a given sequence x is used to determine whether or not the word is avoided. This concept is particularly useful in DNA linguistic analysis. The value of the deviation of w, denoted by [Formula: see text], effectively characterises the extent of a word by its edge contrast in the context in which it occurs. A word w of length [Formula: see text] is a [Formula: see text]-avoided word in x if [Formula: see text], for a given threshold [Formula: see text]. Notice that such a word may be completely absent from x. Hence, computing all such words na\u00efvely can be a very time-consuming procedure, in particular for large k. In this article, we propose an [Formula: see text]-time and [Formula: see text]-space algorithm to compute all [Formula: see text]-avoided words of length k in a given sequence of length n over a fixed-sized alphabet. We also present a time-optimal [Formula: see text]-time algorithm to compute all [Formula: see text]-avoided words (of any length) in a sequence of length n over an integer alphabet of size [Formula: see text]. In addition, we provide a tight asymptotic upper bound for the number of [Formula: see text]-avoided words over an integer alphabet and the expected length of the longest one. We make available an implementation of our algorithm. Experimental results, using both real and synthetic data, show the efficiency and applicability of our implementation in biological sequence analysis. The systematic search for avoided words is particularly useful for biological sequence analysis. We present a linear-time and linear-space algorithm for the computation of avoided words of length k in a given sequence x. We suggest a modification to this algorithm so that it computes all avoided words of x, irrespective of their length, within the same time complexity."}
{"qid": "58a342e760087bc10a00001c", "original_text": "Iatrogenic disease refers to any medical condition or illness that is caused or contributed to by medical treatment or intervention itself. This can include adverse reactions to medications, injuries or complications resulting from medical procedures, or any other negative health consequences arising from medical care. Iatrogenic diseases can occur due to errors in diagnosis, mismanagement of medications, or any other medical mistake, and can have significant consequences for the patient's health and well-being. Examples of iatrogenic diseases include medication-induced side effects, surgical complications, and infections acquired during medical treatment. It is important for healthcare providers to be aware of the potential for iatrogenic disease and take steps to minimize its occurrence, such as carefully evaluating patients before treatment, using appropriate medications and procedures, and closely monitoring patients for any signs of complications.", "label": 0, "is_selected": 0, "text": "Iatrogenic disease refers to any medical condition or illness that is caused or contributed to by medical treatment or intervention itself. This can include adverse reactions to medications, injuries or complications resulting from medical procedures, or any other negative health consequences arising from medical care. Iatrogenic diseases can occur due to errors in diagnosis, mismanagement of medications, or any other medical mistake, and can have significant consequences for the patient's health and well-being. Examples of iatrogenic diseases include medication-induced side effects, surgical complications, and infections acquired during medical treatment. It is important for healthcare providers to be aware of the potential for iatrogenic disease and take steps to minimize its occurrence, such as carefully evaluating patients before treatment, using appropriate medications and procedures, and closely monitoring patients for any signs of complications."}
{"qid": "530cf4d5e2bfff940c000004", "original_text": "Finding a genetic disease-related gene is not a trivial task. Therefore, computational methods are needed to present clues to the biomedical community to explore genes that are more likely to be related to a specific disease as biomarker. We present biomarker identification problem using gene prioritization method called gene prioritization from microarray data based on shortest paths, extended with structural and biological properties and edge flux using voting scheme (GP-MIDAS-VXEF). The method is based on finding relevant interactions on protein interaction networks, then scoring the genes using shortest paths and topological analysis, integrating the results using a voting scheme and a biological boosting. We applied two experiments, one is prostate primary and normal samples and the other is prostate primary tumor with and without lymph nodes metastasis. We used 137 truly prostate cancer genes as benchmark.", "label": 1, "is_selected": 0, "text": "Finding a genetic disease-related gene is not a trivial task. Therefore, computational methods are needed to present clues to the biomedical community to explore genes that are more likely to be related to a specific disease as biomarker. We present biomarker identification problem using gene prioritization method called gene prioritization from microarray data based on shortest paths, extended with structural and biological properties and edge flux using voting scheme (GP-MIDAS-VXEF). The method is based on finding relevant interactions on protein interaction networks, then scoring the genes using shortest paths and topological analysis, integrating the results using a voting scheme and a biological boosting. We applied two experiments, one is prostate primary and normal samples and the other is prostate primary tumor with and without lymph nodes metastasis. We used 137 truly prostate cancer genes as benchmark."}
{"qid": "5cb39707ecadf2e73f000060", "original_text": "Autoimmune polyendocrine syndrome type 1 (APS-1; OMIM #240300), also referred to as autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), is a rare monogenic autoimmune disorder caused by mutations in the autoimmune regulator (AIRE) gene. APS-1 is classically characterized by a triad of chronic mucocutaneous candidiasis, autoimmune hypoparathyroidism, and autoimmune adrenocortical insufficiency. We report a 5-yr-old female who presented with symptoms of tetany due to hypocalcemia and was subsequently found to be secondary to hypoparathyroidism.", "label": 1, "is_selected": 0, "text": "Autoimmune polyendocrine syndrome type 1 (APS-1; OMIM #240300), also referred to as autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), is a rare monogenic autoimmune disorder caused by mutations in the autoimmune regulator (AIRE) gene. APS-1 is classically characterized by a triad of chronic mucocutaneous candidiasis, autoimmune hypoparathyroidism, and autoimmune adrenocortical insufficiency. We report a 5-yr-old female who presented with symptoms of tetany due to hypocalcemia and was subsequently found to be secondary to hypoparathyroidism."}
{"qid": "5ad303970340b9f05800001a", "original_text": "The cancer-anorexia-cachexia syndrome (CACS) negatively affects survival and therapy success in cancer patients. Inflammatory mediators and tumour-derived factors are thought to play an important role in the aetiology of CACS. However, the central and peripheral mechanisms contributing to CACS are insufficiently understood. The area postrema (AP) and the nucleus tractus solitarii are two important brainstem centres for the control of eating during acute sickness conditions. Recently, the tumour-derived macrophage inhibitory cytokine-1 (MIC-1) emerged as a possible mediator of cancer anorexia because lesions of these brainstem areas attenuated the anorectic effect of exogenous MIC-1 in mice. Using a rat hepatoma tumour model, we examined the roles of the AP and of vagal afferents in the mediation of CACS. Specifically, we investigated whether a lesion of the AP (APX) or subdiaphragmatic vagal deafferentation (SDA) attenuate anorexia, body weight, muscle, and fat loss. Moreover, we analysed MIC-1 levels in this tumour model and their correlation with tumour size and the severity of the anorectic response. In tumour-bearing sham-operated animals mean daily food intake significantly decreased.", "label": 1, "is_selected": 0, "text": "The cancer-anorexia-cachexia syndrome (CACS) negatively affects survival and therapy success in cancer patients. Inflammatory mediators and tumour-derived factors are thought to play an important role in the aetiology of CACS. However, the central and peripheral mechanisms contributing to CACS are insufficiently understood. The area postrema (AP) and the nucleus tractus solitarii are two important brainstem centres for the control of eating during acute sickness conditions. Recently, the tumour-derived macrophage inhibitory cytokine-1 (MIC-1) emerged as a possible mediator of cancer anorexia because lesions of these brainstem areas attenuated the anorectic effect of exogenous MIC-1 in mice. Using a rat hepatoma tumour model, we examined the roles of the AP and of vagal afferents in the mediation of CACS. Specifically, we investigated whether a lesion of the AP (APX) or subdiaphragmatic vagal deafferentation (SDA) attenuate anorexia, body weight, muscle, and fat loss. Moreover, we analysed MIC-1 levels in this tumour model and their correlation with tumour size and the severity of the anorectic response. In tumour-bearing sham-operated animals mean daily food intake significantly decreased."}
{"qid": "53355714d6d3ac6a34000045", "original_text": "We investigate the potential in using of using a graphics processor unit (GPU) for Monte-Carlo (MC)-based radiation dose calculations. The percent depth dose (PDD) of photons in a medium with known absorption and scattering coefficients is computed using a MC simulation running on both a standard CPU and a GPU. We demonstrate that the GPU's capability for massive parallel processing provides a significant acceleration in the MC calculation, and offers a significant advantage for distributed stochastic simulations on a single computer. Harnessing this potential of GPUs will help in the early adoption of MC for routine planning in a clinical environment.", "label": 1, "is_selected": 0, "text": "We investigate the potential in using of using a graphics processor unit (GPU) for Monte-Carlo (MC)-based radiation dose calculations. The percent depth dose (PDD) of photons in a medium with known absorption and scattering coefficients is computed using a MC simulation running on both a standard CPU and a GPU. We demonstrate that the GPU's capability for massive parallel processing provides a significant acceleration in the MC calculation, and offers a significant advantage for distributed stochastic simulations on a single computer. Harnessing this potential of GPUs will help in the early adoption of MC for routine planning in a clinical environment."}
{"qid": "587e1e57fc7e8dd84f000003", "original_text": "The development of colorectal cancer (CRC) is characterized by multiple genetic alterations. Transcribed ultraconserved regions (T-UCRs) are a subset of 481 sequences longer than 200 bp, which are absolutely conserved between orthologous regions of human, rat and mouse genomes, and are actively transcribed. It has recently been proven in cancer systems that differentially expressed T-UCRs could alter the functional characteristics of malignant cells. Genome-wide profiling revealed that T-UCRs have distinct signatures in human leukemia and carcinoma. In our study, we examined the expression levels of uc.43, uc.73, uc.134, uc.230, uc.339, uc.388 and uc.399 in 54 samples of primary colorectal carcinomas and 15 samples of non-tumoral adjacent tissues by real-time PCR. T-UCR expression levels were also correlated with commonly used clinicopathological features of CRC. Expression levels of uc.73 (p = 0.0139) and uc.388 (p = 0.0325) were significantly decreased in CRC tissue, and uc.73 indicated a positive correlation with overall survival (p = 0.0315). The lower expression of uc.388 was associated with the distal location of CRC (p = 0.0183), but no correlation of any evaluated T-UCR with clinical stage, grade and tumor diameter was observed. Our preliminary results suggest that uc.73 and uc.388 could be potential diagnostic and prognostic biomarkers in CRC patients.", "label": 1, "is_selected": 0, "text": "The development of colorectal cancer (CRC) is characterized by multiple genetic alterations. Transcribed ultraconserved regions (T-UCRs) are a subset of 481 sequences longer than 200 bp, which are absolutely conserved between orthologous regions of human, rat and mouse genomes, and are actively transcribed. It has recently been proven in cancer systems that differentially expressed T-UCRs could alter the functional characteristics of malignant cells. Genome-wide profiling revealed that T-UCRs have distinct signatures in human leukemia and carcinoma. In our study, we examined the expression levels of uc.43, uc.73, uc.134, uc.230, uc.339, uc.388 and uc.399 in 54 samples of primary colorectal carcinomas and 15 samples of non-tumoral adjacent tissues by real-time PCR. T-UCR expression levels were also correlated with commonly used clinicopathological features of CRC. Expression levels of uc.73 (p = 0.0139) and uc.388 (p = 0.0325) were significantly decreased in CRC tissue, and uc.73 indicated a positive correlation with overall survival (p = 0.0315). The lower expression of uc.388 was associated with the distal location of CRC (p = 0.0183), but no correlation of any evaluated T-UCR with clinical stage, grade and tumor diameter was observed. Our preliminary results suggest that uc.73 and uc.388 could be potential diagnostic and prognostic biomarkers in CRC patients."}
{"qid": "5fdb4176a43ad3127800001a", "original_text": "The co-occupancy of Tcf3 with Oct4, Sox2 and Nanog on embryonic stem cell (ESC) chromatin indicated that Tcf3 has been suggested to play an integral role in a poorly understood mechanism underlying Wnt-dependent stimulation of mouse ESC self-renewal of mouse ESCs. Although the conventional view of Tcf proteins as the \u03b2-catenin-binding effectors of Wnt signalling suggested Tcf3-\u03b2-catenin activation of target genes would stimulate self-renewal, here we show that an antagonistic relationship between Wnt3a and Tcf3 on gene expression regulates ESC self-renewal. Genetic ablation of Tcf3 replaced the requirement for exogenous Wnt3a or GSK3 inhibition for ESC self-renewal, demonstrating that inhibition of Tcf3 repressor is the necessary downstream effect of Wnt signalling. Interestingly, both Tcf3-\u03b2-catenin and Tcf1-\u03b2-catenin interactions contributed to Wnt stimulation of self-renewal and gene expression, and the combination of Tcf3 and Tcf1 recruited Wnt-stabilized \u03b2-catenin to Oct4 binding sites on ESC chromatin. This work elucidates the molecular link between the effects of Wnt and the regulation of the Oct4/Sox2/Nanog network.", "label": 1, "is_selected": 0, "text": "The co-occupancy of Tcf3 with Oct4, Sox2 and Nanog on embryonic stem cell (ESC) chromatin indicated that Tcf3 has been suggested to play an integral role in a poorly understood mechanism underlying Wnt-dependent stimulation of mouse ESC self-renewal of mouse ESCs. Although the conventional view of Tcf proteins as the \u03b2-catenin-binding effectors of Wnt signalling suggested Tcf3-\u03b2-catenin activation of target genes would stimulate self-renewal, here we show that an antagonistic relationship between Wnt3a and Tcf3 on gene expression regulates ESC self-renewal. Genetic ablation of Tcf3 replaced the requirement for exogenous Wnt3a or GSK3 inhibition for ESC self-renewal, demonstrating that inhibition of Tcf3 repressor is the necessary downstream effect of Wnt signalling. Interestingly, both Tcf3-\u03b2-catenin and Tcf1-\u03b2-catenin interactions contributed to Wnt stimulation of self-renewal and gene expression, and the combination of Tcf3 and Tcf1 recruited Wnt-stabilized \u03b2-catenin to Oct4 binding sites on ESC chromatin. This work elucidates the molecular link between the effects of Wnt and the regulation of the Oct4/Sox2/Nanog network."}
{"qid": "5319a7f2b166e2b80600002a", "original_text": "The interaction between TSC1 (tuberous sclerosis complex 1) and PLK1 (polo-like kinase 1) plays a crucial role in regulating the cellular processes of cell growth, proliferation, and survival. TSC1 is a tumor suppressor gene that regulates the mTOR (mechanistic target of rapamycin) pathway, while PLK1 is a serine/threonine kinase that is involved in the regulation of mitosis and cell division. Studies have shown that TSC1 and PLK1 interact with each other through their respective protein products, leading to the inhibition of the mTOR pathway and the induction of cell cycle arrest or apoptosis (programmed cell death) in response to various cellular stresses. This interaction is important in maintaining the integrity of the cellular genetic material and preventing the development of cancer.", "label": 0, "is_selected": 1, "text": "The aim of this study is to understand the role of TSC1 and PLK1 in the regulation of cancer cell growth and death and to identify novel targets for the treatment of this disease and other types of cancer., based on the discovery of two new cancer-related genes, TSC1 (tuberous sclerosis complex 1) and PLk1 (polo-like kinase 1)."}
{"qid": "606074ab94d57fd87900003e", "original_text": "Rtpca is an R package implementing methods for inferring protein-protein interactions (PPIs) based on thermal proteome profiling experiments of a single condition or in a differential setting via an approach called thermal proximity coaggregation.", "label": 1, "is_selected": 0, "text": "Rtpca is an R package implementing methods for inferring protein-protein interactions (PPIs) based on thermal proteome profiling experiments of a single condition or in a differential setting via an approach called thermal proximity coaggregation."}
{"qid": "52fe58f82059c6d71c00007a", "original_text": "Deviations from Chargaff's 2nd parity rule, according to which A approximately T and G approximately C in single stranded DNA, have been associated with replication as well as with transcription in prokaryotes. Based on observations regarding mainly the transcription-replication co-linearity in a large number of prokaryotic species, we formulate the hypothesis that the replication procedure may follow different modes between genomes throughout which the skews clearly follow different patterns.", "label": 1, "is_selected": 0, "text": "Deviations from Chargaff's 2nd parity rule, according to which A approximately T and G approximately C in single stranded DNA, have been associated with replication as well as with transcription in prokaryotes. Based on observations regarding mainly the transcription-replication co-linearity in a large number of prokaryotic species, we formulate the hypothesis that the replication procedure may follow different modes between genomes throughout which the skews clearly follow different patterns."}
{"qid": "5cf0f567a49efeb44c00000b", "original_text": "To understand how commitment to cell division in late G1 phase (Start) is controlled by growth and nutrients in budding yeast, we determined the absolute concentrations of the G1/S transcription factors SBF (composed of Swi4 and Swi6) and MBF (composed of Mbp1 and Swi6), the transcriptional repressor Whi5, and the G1 cyclins, Cln1 and Cln2, in single live yeast cells using scanning number and brightness (sN&B) microscopy.", "label": 1, "is_selected": 0, "text": "To understand how commitment to cell division in late G1 phase (Start) is controlled by growth and nutrients in budding yeast, we determined the absolute concentrations of the G1/S transcription factors SBF (composed of Swi4 and Swi6) and MBF (composed of Mbp1 and Swi6), the transcriptional repressor Whi5, and the G1 cyclins, Cln1 and Cln2, in single live yeast cells using scanning number and brightness (sN&B) microscopy."}
{"qid": "58bc640002b8c60953000003", "original_text": "The HSP70-HSP110 disaggregase machinery refers to a complex of proteins that facilitates the dissociation of protein aggregates, also known as amyloid fibrils, which are hallmarks of various neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. The machinery is composed of two proteins, heat shock protein 70 (HSP70) and heat shock protein 110 (HSP110), which work together to disaggregate protein aggregates by promoting their unfolding and solubilization. This process is crucial for maintaining the proper functioning of cells and preventing the progression of neurodegenerative diseases.", "label": 0, "is_selected": 1, "text": "Researchers at the University of California, Los Angeles (UCLA) have developed a new class of machinery that could help in the fight against neurodegenerative diseases such as Alzheimer's disease and Parkinson's diseases, by breaking downamyloid fibrils."}
{"qid": "61fbc3d5c9dfcb9c0900000e", "original_text": "The Qtern pill is a fixed-dose combination medication that contains three drugs: azelsenic acid, furosemide, and hydrochlorothiazide. Azelsenic acid is a diuretic that helps increase urine production, while furosemide is a loop diuretic that works faster and has a longer duration of action than azelsenic acid. Hydrochlorothiazide is a thiazide diuretic that helps reduce fluid buildup in the body by increasing urine production. Together, these three drugs help manage hypertension, edema, and hyperlipidemia.", "label": 0, "is_selected": 1, "text": "The Qtern pill is a medication used to treat high blood pressure, or hypertension, in patients who have not responded to diuretics or who have a history of kidney disease or other conditions that make it difficult to control their blood pressure through diet and exercise."}
{"qid": "56e844c442442bac75000002", "original_text": "In light of our previous observation of higher levels of cerebrospinal fluid (CSF) amyloid beta-42 (Abeta42) and CSF/serum albumin ratio in major depressive disorder (MDD), we analyzed two additional CSF biomarkers reflecting neurodegeneration-neurofilament protein light (NFL) and glial fibrillary acidic protein (GFAp)-in relationship to prevalent geriatric depression. Neuropsychiatric, physical, and lumbar puncture examinations, with DSM-III-R-based depression diagnoses and measurement of CSF levels of NFL and GFAp, were evaluated among a population-based sample of 78 elderly women (mean age, 73.9+/-3.2 years) without dementia for at least 10 years after CSF collection. Eleven (13.1%) women had MDD, and higher levels of NFL compared with women without depression. A multivariate model including age, NFL, Abeta42 and the CSF/serum albumin ratio showed that each biomarker was independently and positively associated with MDD, and that this biomarker profile explained more variation in the model compared with single or combined biomarkers. A CSF profile with higher levels of NFL, Abeta42, and CSF/serum albumin ratio may indicate neuropathological and vascular events in depression etiology. This contrasts with the well-characterized pattern of low Abeta42, higher CSF/serum albumin ratio, and higher NFL in Alzheimer's disease.", "label": 1, "is_selected": 0, "text": "In light of our previous observation of higher levels of cerebrospinal fluid (CSF) amyloid beta-42 (Abeta42) and CSF/serum albumin ratio in major depressive disorder (MDD), we analyzed two additional CSF biomarkers reflecting neurodegeneration-neurofilament protein light (NFL) and glial fibrillary acidic protein (GFAp)-in relationship to prevalent geriatric depression. Neuropsychiatric, physical, and lumbar puncture examinations, with DSM-III-R-based depression diagnoses and measurement of CSF levels of NFL and GFAp, were evaluated among a population-based sample of 78 elderly women (mean age, 73.9+/-3.2 years) without dementia for at least 10 years after CSF collection. Eleven (13.1%) women had MDD, and higher levels of NFL compared with women without depression. A multivariate model including age, NFL, Abeta42 and the CSF/serum albumin ratio showed that each biomarker was independently and positively associated with MDD, and that this biomarker profile explained more variation in the model compared with single or combined biomarkers. A CSF profile with higher levels of NFL, Abeta42, and CSF/serum albumin ratio may indicate neuropathological and vascular events in depression etiology. This contrasts with the well-characterized pattern of low Abeta42, higher CSF/serum albumin ratio, and higher NFL in Alzheimer's disease."}
{"qid": "58a1da4e78275d0c4a000059", "original_text": "Yes, smallpox has been eradicated from the world. The World Health Organization (WHO) declared smallpox free in 1980 through a global vaccination campaign led by the Centers for Disease Control and Prevention (CDC) and the WHO. The campaign involved mass vaccination of populations in Africa and Asia, where smallpox was most prevalent, and the virus was eventually wiped out through a combination of vaccination and herd immunity. Since then, smallpox has not reappeared in any part of the world, making it the only disease to have been completely eradicated from the planet.", "label": 0, "is_selected": 0, "text": "Yes, smallpox has been eradicated from the world. The World Health Organization (WHO) declared smallpox free in 1980 through a global vaccination campaign led by the Centers for Disease Control and Prevention (CDC) and the WHO. The campaign involved mass vaccination of populations in Africa and Asia, where smallpox was most prevalent, and the virus was eventually wiped out through a combination of vaccination and herd immunity. Since then, smallpox has not reappeared in any part of the world, making it the only disease to have been completely eradicated from the planet."}
{"qid": "5c74266a7c78d694710000a2", "original_text": "Intestinal epithelial cells are constantly stimulated by reactive oxidant metabolites (ROMs) in inflamed mucosa. Monochloramine (NH2Cl), a cell-permeant ROM, is particularly relevant to the pathogenesis of inflammation in the gastrointestinal tract. Nuclear speckles, a unique nuclear subcompartment, accumulate a family of proteins, namely, serine- and arginine-rich (SR) proteins. They play important roles in regulation of pre-mRNA splicing. Currently, little is known about the link between inflammatory stimulation and the pre-mRNA splicing process, although gene expression is changed in inflamed tissues. The present study was designed to investigate whether stimulation of human colonic epithelial cells (HT-29 and Caco-2 cell lines) with NH2Cl affects nuclear speckles and their components.", "label": 1, "is_selected": 0, "text": "Intestinal epithelial cells are constantly stimulated by reactive oxidant metabolites (ROMs) in inflamed mucosa. Monochloramine (NH2Cl), a cell-permeant ROM, is particularly relevant to the pathogenesis of inflammation in the gastrointestinal tract. Nuclear speckles, a unique nuclear subcompartment, accumulate a family of proteins, namely, serine- and arginine-rich (SR) proteins. They play important roles in regulation of pre-mRNA splicing. Currently, little is known about the link between inflammatory stimulation and the pre-mRNA splicing process, although gene expression is changed in inflamed tissues. The present study was designed to investigate whether stimulation of human colonic epithelial cells (HT-29 and Caco-2 cell lines) with NH2Cl affects nuclear speckles and their components."}
{"qid": "588fa4b9ed9bbee70d000006", "original_text": "Ocrelizumab is a monoclonal antibody that is effective for the treatment of primary progressive multiple sclerosis (PPMS) and relapsing-remitting multiple sclerosis (RRMS). Studies have shown that ocrelizumab can reduce the number of relapses and slow the progression of disability in patients with MS. Ocrelizumab works by binding to the CD20 protein on the surface of B cells, which are a type of immune cell that is involved in the autoimmune response in MS. By reducing the number of B cells, ocrelizumab can help to reduce inflammation and slow the progression of the disease. In clinical trials, ocrelizumab has been shown to be effective in reducing the number of relapses in patients with RRMS, with a reduction in the annualized relapse rate (ARR) of up to 86%. Ocrelizumab has also been shown to slow the progression of disability in patients with RRMS, as measured by the Expanded Disability Status Scale (EDSS). In patients with PPMS, ocrelizumab has been shown to reduce the number of relapses and slow the progression of disability, but the results have not been as robust as in RRMS. It is important to note that ocrelizumab is only approved for the treatment of MS and has not been studied for the treatment of other conditions. If you have MS, it is important to discuss the potential benefits and risks of ocrelizumab with your healthcare provider to determine if it is the right treatment option for you.", "label": 0, "is_selected": 0, "text": "Ocrelizumab is a monoclonal antibody that is effective for the treatment of primary progressive multiple sclerosis (PPMS) and relapsing-remitting multiple sclerosis (RRMS). Studies have shown that ocrelizumab can reduce the number of relapses and slow the progression of disability in patients with MS. Ocrelizumab works by binding to the CD20 protein on the surface of B cells, which are a type of immune cell that is involved in the autoimmune response in MS. By reducing the number of B cells, ocrelizumab can help to reduce inflammation and slow the progression of the disease. In clinical trials, ocrelizumab has been shown to be effective in reducing the number of relapses in patients with RRMS, with a reduction in the annualized relapse rate (ARR) of up to 86%. Ocrelizumab has also been shown to slow the progression of disability in patients with RRMS, as measured by the Expanded Disability Status Scale (EDSS). In patients with PPMS, ocrelizumab has been shown to reduce the number of relapses and slow the progression of disability, but the results have not been as robust as in RRMS. It is important to note that ocrelizumab is only approved for the treatment of MS and has not been studied for the treatment of other conditions. If you have MS, it is important to discuss the potential benefits and risks of ocrelizumab with your healthcare provider to determine if it is the right treatment option for you."}
{"qid": "5c58282e07647bbc4b00001e", "original_text": "RNA-Seq is currently used routinely, and it provides accurate information on gene transcription. However, the method cannot accurately estimate duplicated genes expression. Several strategies have been previously used (drop duplicated genes, distribute uniformly the reads, or estimate expression), but all of them provide biased results. We provide here a tool, called mmquant, for computing gene expression, included duplicated genes. If a read maps at different positions, the tool detects that the corresponding genes are duplicated; it merges the genes and creates a merged gene. The counts of ambiguous reads is then based on the input genes and the merged genes. mmquant is a drop-in replacement of the widely used tools htseq-count and featureCounts that handles multi-mapping reads in an unabiased way.", "label": 1, "is_selected": 0, "text": "RNA-Seq is currently used routinely, and it provides accurate information on gene transcription. However, the method cannot accurately estimate duplicated genes expression. Several strategies have been previously used (drop duplicated genes, distribute uniformly the reads, or estimate expression), but all of them provide biased results. We provide here a tool, called mmquant, for computing gene expression, included duplicated genes. If a read maps at different positions, the tool detects that the corresponding genes are duplicated; it merges the genes and creates a merged gene. The counts of ambiguous reads is then based on the input genes and the merged genes. mmquant is a drop-in replacement of the widely used tools htseq-count and featureCounts that handles multi-mapping reads in an unabiased way."}
{"qid": "5314d0e4dae131f84700000e", "original_text": "Fatigue in cancer patients is highly prevalent, predominantly idiopathic, difficult to manage, and has a significant negative impact on quality of life. Thyrotropin-releasing hormone (TRH) exerts normotrophic, state-dependent therapeutic effects in a variety of experimental and clinical situations. To evaluate TRH as a treatment for cancer-related fatigue, an ongoing randomized, placebo-controlled, crossover pilot study of breast cancer patients has been initiated and this report presents preliminary observations conducted with three of these patients over 4 consecutive weeks, thereby involving a total of six TRH treatments and six saline controls. Global assessment using both subjective and objective parameters showed that TRH exerted clear anti-fatigue effects in four of the six TRH treatments. These responses were rapid in onset and persisted through the 24 h observation period. No anti-fatigue responses were seen in five of the six saline controls. No unexpected side-effects were seen with TRH administration. These initial findings support the proposal that TRH can ameliorate cancer-related fatigue.", "label": 1, "is_selected": 0, "text": "Fatigue in cancer patients is highly prevalent, predominantly idiopathic, difficult to manage, and has a significant negative impact on quality of life. Thyrotropin-releasing hormone (TRH) exerts normotrophic, state-dependent therapeutic effects in a variety of experimental and clinical situations. To evaluate TRH as a treatment for cancer-related fatigue, an ongoing randomized, placebo-controlled, crossover pilot study of breast cancer patients has been initiated and this report presents preliminary observations conducted with three of these patients over 4 consecutive weeks, thereby involving a total of six TRH treatments and six saline controls. Global assessment using both subjective and objective parameters showed that TRH exerted clear anti-fatigue effects in four of the six TRH treatments. These responses were rapid in onset and persisted through the 24 h observation period. No anti-fatigue responses were seen in five of the six saline controls. No unexpected side-effects were seen with TRH administration. These initial findings support the proposal that TRH can ameliorate cancer-related fatigue."}
{"qid": "56c1f00cef6e39474100003e", "original_text": "Aleglitazar is a partial agonist of the peroxisome proliferator-activated receptor gamma (PPAR\u03b3). PPAR\u03b3 is a nuclear receptor that plays a key role in glucose and lipid metabolism, and is activated by ligands such as glitazones, which include alogliptin and pioglitazone. Aleglitazar is a novel, investigational drug that selectively activates PPAR\u03b3 in the liver, adipose tissue, and muscle, leading to improved insulin sensitivity and glucose tolerance. By selectively activating PPAR\u03b3 in these tissues, aleglitazar may offer improved efficacy and safety compared to traditional glitazones, which can have systemic effects.", "label": 0, "is_selected": 0, "text": "Aleglitazar is a partial agonist of the peroxisome proliferator-activated receptor gamma (PPAR\u03b3). PPAR\u03b3 is a nuclear receptor that plays a key role in glucose and lipid metabolism, and is activated by ligands such as glitazones, which include alogliptin and pioglitazone. Aleglitazar is a novel, investigational drug that selectively activates PPAR\u03b3 in the liver, adipose tissue, and muscle, leading to improved insulin sensitivity and glucose tolerance. By selectively activating PPAR\u03b3 in these tissues, aleglitazar may offer improved efficacy and safety compared to traditional glitazones, which can have systemic effects."}
{"qid": "56cdf4675795f9a73e00003f", "original_text": "The kinase that regulates stress granule biogenesis is the protein kinase B (PKB). PKB, also known as Akt, is a key regulator of cellular stress responses, including the formation of stress granules. PKB phosphorylates and activates the RNA-binding protein TIA-1, which is involved in the formation of stress granules. Additionally, PKB can also phosphorylate and activate other proteins involved in stress granule biogenesis, such as the RNA-binding protein TARDBP. Therefore, PKB plays a crucial role in regulating stress granule formation and the response to cellular stress.", "label": 0, "is_selected": 0, "text": "The kinase that regulates stress granule biogenesis is the protein kinase B (PKB). PKB, also known as Akt, is a key regulator of cellular stress responses, including the formation of stress granules. PKB phosphorylates and activates the RNA-binding protein TIA-1, which is involved in the formation of stress granules. Additionally, PKB can also phosphorylate and activate other proteins involved in stress granule biogenesis, such as the RNA-binding protein TARDBP. Therefore, PKB plays a crucial role in regulating stress granule formation and the response to cellular stress."}
{"qid": "56c5ade15795f9a73e000003", "original_text": "The Ten-Eleven-Translocation 2 (TET2) gene encodes a member of TET family enzymes that alters the epigenetic status of DNA by oxidizing 5-methylcytosine to 5-hydroxymethylcytosine (5hmC). Somatic loss-of-function mutations of TET2 are frequently observed in patients with diverse myeloid malignancies, including myelodysplastic syndromes, myeloproliferative neoplasms, and chronic myelomonocytic leukemia. By analyzing mice with targeted disruption of the Tet2 catalytic domain, we show here that Tet2 is a critical regulator of self-renewal and differentiation of hematopoietic stem cells (HSCs). Tet2 deficiency led to decreased genomic levels of 5hmC and augmented the size of the hematopoietic stem/progenitor cell pool in a cell-autonomous manner.", "label": 1, "is_selected": 0, "text": "The Ten-Eleven-Translocation 2 (TET2) gene encodes a member of TET family enzymes that alters the epigenetic status of DNA by oxidizing 5-methylcytosine to 5-hydroxymethylcytosine (5hmC). Somatic loss-of-function mutations of TET2 are frequently observed in patients with diverse myeloid malignancies, including myelodysplastic syndromes, myeloproliferative neoplasms, and chronic myelomonocytic leukemia. By analyzing mice with targeted disruption of the Tet2 catalytic domain, we show here that Tet2 is a critical regulator of self-renewal and differentiation of hematopoietic stem cells (HSCs). Tet2 deficiency led to decreased genomic levels of 5hmC and augmented the size of the hematopoietic stem/progenitor cell pool in a cell-autonomous manner."}
{"qid": "5896e4d478275d0c4a000015", "original_text": "Ulcerative colitis is a chronic inflammatory disease of the colon of unknown cause that is characterized by alternating intervals of active and inactive disease in 80-90% of patients. The primary goal of treatment is to induce and maintain remission using therapy tailored to the individual patient. The purpose of this review was to describe the management of ulcerative colitis with emphasis on the use of anti-tumor necrosis factor (TNF) agents. Recent research has shown that new anti-TNF agents, adalimumab (ADA) and golimumab, are effective in induction of remission and maintenance of remission in patients with extensive ulcerative colitis. In a recent study, infliximab was found to have comparable efficacy to cyclosporine in treatment of acute severe refractory to corticosteroids ulcerative colitis. Anti-TNF therapy should be initiated in patients with acute severe refractory to corticosteroids ulcerative colitis and in patients with moderate-to-severe ulcerative colitis who are not responsive to conventional treatment with aminosalicylates, corticosteroids and immune modulators. Alternatives to infliximab are ADA and golimumab. Future research is needed to further assess the long-term efficacy and safety of ADA and golimumab in ulcerative colitis.", "label": 1, "is_selected": 0, "text": "Ulcerative colitis is a chronic inflammatory disease of the colon of unknown cause that is characterized by alternating intervals of active and inactive disease in 80-90% of patients. The primary goal of treatment is to induce and maintain remission using therapy tailored to the individual patient. The purpose of this review was to describe the management of ulcerative colitis with emphasis on the use of anti-tumor necrosis factor (TNF) agents. Recent research has shown that new anti-TNF agents, adalimumab (ADA) and golimumab, are effective in induction of remission and maintenance of remission in patients with extensive ulcerative colitis. In a recent study, infliximab was found to have comparable efficacy to cyclosporine in treatment of acute severe refractory to corticosteroids ulcerative colitis. Anti-TNF therapy should be initiated in patients with acute severe refractory to corticosteroids ulcerative colitis and in patients with moderate-to-severe ulcerative colitis who are not responsive to conventional treatment with aminosalicylates, corticosteroids and immune modulators. Alternatives to infliximab are ADA and golimumab. Future research is needed to further assess the long-term efficacy and safety of ADA and golimumab in ulcerative colitis."}
{"qid": "5156be04d24251bc05000085", "original_text": "This study sought to evaluate the influence of single nucleotide polymorphisms (SNPs) on the pharmacodynamic effect of high- or standard-dose clopidogrel after percutaneous coronary intervention (PCI). There is a lack of prospective, multicenter data regarding the effect of different genetic variants on clopidogrel pharmacodynamics over time in patients undergoing PCI. The GRAVITAS (Gauging Responsiveness with A VerifyNow assay-Impact on Thrombosis And Safety) trial screened patients with platelet function testing after PCI and randomly assigned those with high on-treatment reactivity (OTR) to either high- or standard-dose clopidogrel; a cohort of patients without high OTR were also followed. DNA samples obtained from 1,028 patients were genotyped for 41 SNPs in 17 genes related to platelet reactivity. After adjusting for clinical characteristics, the associations between the SNPs and OTR using linear regression were evaluated.", "label": 1, "is_selected": 0, "text": "This study sought to evaluate the influence of single nucleotide polymorphisms (SNPs) on the pharmacodynamic effect of high- or standard-dose clopidogrel after percutaneous coronary intervention (PCI). There is a lack of prospective, multicenter data regarding the effect of different genetic variants on clopidogrel pharmacodynamics over time in patients undergoing PCI. The GRAVITAS (Gauging Responsiveness with A VerifyNow assay-Impact on Thrombosis And Safety) trial screened patients with platelet function testing after PCI and randomly assigned those with high on-treatment reactivity (OTR) to either high- or standard-dose clopidogrel; a cohort of patients without high OTR were also followed. DNA samples obtained from 1,028 patients were genotyped for 41 SNPs in 17 genes related to platelet reactivity. After adjusting for clinical characteristics, the associations between the SNPs and OTR using linear regression were evaluated."}
{"qid": "5a86bf2efaa1ab7d2e000033", "original_text": "Fusion of inducible degradation signals, so-called degrons, to cellular proteins is an elegant method of controlling protein levels in vivo. Recently, a degron system relying on the plant hormone auxin has been described for use in yeast and vertebrate cells. We now report the construction of a series of vectors that significantly enhance the versatility of this auxin-inducible degron (AID) system in Saccharomyces cerevisiae. We have minimized the size of the degron and appended a series of additional epitope tags, allowing detection by commercial antibodies or fluorescence microscopy.", "label": 1, "is_selected": 0, "text": "Fusion of inducible degradation signals, so-called degrons, to cellular proteins is an elegant method of controlling protein levels in vivo. Recently, a degron system relying on the plant hormone auxin has been described for use in yeast and vertebrate cells. We now report the construction of a series of vectors that significantly enhance the versatility of this auxin-inducible degron (AID) system in Saccharomyces cerevisiae. We have minimized the size of the degron and appended a series of additional epitope tags, allowing detection by commercial antibodies or fluorescence microscopy."}
{"qid": "58f0b0c070f9fc6f0f000006", "original_text": "The chronic use and high dosing of typical neuroleptics or centrally acting dopamine receptor blocking antiemetics predispose patients to the onset of tardive syndromes. One particular subtype, tardive dyskinesia, is characterized by rapid, repetitive, stereotypic, involuntary movements of the face, limbs or trunk. The inhibition of the vesicular monoamine transporter system, using tetrabenazine therapy, improves the severity of tardive dyskinesia. But there are also drawbacks to tetrabenazine treatment, such as a fluctuating response and the need for frequent intake due to its rapid metabolism. Clinical research on the potentially more efficacious and easier to use tetrabenazine analogs is already under way. One of them is valbenazine, the purified parent drug of the (+)-\u03b1-isomer of tetrabenazine.", "label": 1, "is_selected": 0, "text": "The chronic use and high dosing of typical neuroleptics or centrally acting dopamine receptor blocking antiemetics predispose patients to the onset of tardive syndromes. One particular subtype, tardive dyskinesia, is characterized by rapid, repetitive, stereotypic, involuntary movements of the face, limbs or trunk. The inhibition of the vesicular monoamine transporter system, using tetrabenazine therapy, improves the severity of tardive dyskinesia. But there are also drawbacks to tetrabenazine treatment, such as a fluctuating response and the need for frequent intake due to its rapid metabolism. Clinical research on the potentially more efficacious and easier to use tetrabenazine analogs is already under way. One of them is valbenazine, the purified parent drug of the (+)-\u03b1-isomer of tetrabenazine."}
{"qid": "56ebfac12ac5ed1459000001", "original_text": "The spatial organization of the genome is intimately linked to its biological function, yet our understanding of higher order genomic structure is coarse, fragmented and incomplete. In the nucleus of eukaryotic cells, interphase chromosomes occupy distinct chromosome territories, and numerous models have been proposed for how chromosomes fold within chromosome territories. These models, however, provide only few mechanistic details about the relationship between higher order chromatin structure and genome function.", "label": 1, "is_selected": 0, "text": "The spatial organization of the genome is intimately linked to its biological function, yet our understanding of higher order genomic structure is coarse, fragmented and incomplete. In the nucleus of eukaryotic cells, interphase chromosomes occupy distinct chromosome territories, and numerous models have been proposed for how chromosomes fold within chromosome territories. These models, however, provide only few mechanistic details about the relationship between higher order chromatin structure and genome function."}
{"qid": "5c6585097c78d69471000003", "original_text": "The Nup153 protein is a nuclear pore complex protein that plays a critical role in regulating various cellular processes, including gene expression, cell signaling, and protein transport. It belongs to the nucleoporin family of proteins and is specifically expressed in the central region of the nuclear envelope, where it interacts with other proteins to form the nuclear pore complex (NPC). The NPC is a large protein structure that spans the double membrane of the nucleus and serves as a selective barrier for the transport of molecules between the nucleus and the cytoplasm. Nup153 helps to regulate the transport of RNA and other nucleic acids across the NPC, ensuring proper gene expression and cellular function. Additionally, Nup153 has been shown to play a role in the regulation of cell division and the maintenance of genome stability.", "label": 0, "is_selected": 1, "text": "The Nup153 protein is a nuclear pore complex protein that plays a critical role in regulating various cellular processes, including gene expression, cell signaling, and protein transport. TheNup153Protein is a member of the nucleoporin family of proteins and plays a role in the regulation of cell division and the maintenance of genome stability."}
{"qid": "55411d9f379ddf3f47000001", "original_text": "The secretory pathway of eukaryotic cells consists of a number of distinct membrane-bound compartments interconnected by vesicular traffic. Each compartment has a characteristic content of proteins and lipids, which must be maintained. This is achieved in most cases by active sorting-proteins may reach the wrong compartment but are continually retrieved. A good example is the retrieval system for lumenal ER proteins. These proteins carry a specific sorting signal, typically the tetrapeptide KDEL, which is bound by a receptor in the Golgi apparatus. The receptor-ligand complex, together with escaped ER membrane proteins, returns to the ER.", "label": 1, "is_selected": 0, "text": "The secretory pathway of eukaryotic cells consists of a number of distinct membrane-bound compartments interconnected by vesicular traffic. Each compartment has a characteristic content of proteins and lipids, which must be maintained. This is achieved in most cases by active sorting-proteins may reach the wrong compartment but are continually retrieved. A good example is the retrieval system for lumenal ER proteins. These proteins carry a specific sorting signal, typically the tetrapeptide KDEL, which is bound by a receptor in the Golgi apparatus. The receptor-ligand complex, together with escaped ER membrane proteins, returns to the ER."}
{"qid": "515d9a42298dcd4e5100000d", "original_text": "Assessing feasibility and physiological effects of sedation with sevoflurane, administered with the anesthetic conserving device (AnaConDa), in comparison with propofol and remifentanil. Seventeen patients undergoing mechanical ventilation underwent sedation with sevoflurane delivered with AnaConDa (phase SevAn), preceded and followed by sedation with propofol and remifentanil (phases ProRe(1), ProRe(2)), with the same sedation targets. With both strategies it was possible to achieve the sedation targets. Time required to sedate and awake patients was greater during SevAn than ProRe(1): respectively, 3.3 +/- 3.0 versus 8.9 +/- 6.1 and 7.47 +/- 5.05 versus 16.3 +/- 11.4 min. During SevAn the PaCO(2) and minute ventilation increased.", "label": 1, "is_selected": 0, "text": "Assessing feasibility and physiological effects of sedation with sevoflurane, administered with the anesthetic conserving device (AnaConDa), in comparison with propofol and remifentanil. Seventeen patients undergoing mechanical ventilation underwent sedation with sevoflurane delivered with AnaConDa (phase SevAn), preceded and followed by sedation with propofol and remifentanil (phases ProRe(1), ProRe(2)), with the same sedation targets. With both strategies it was possible to achieve the sedation targets. Time required to sedate and awake patients was greater during SevAn than ProRe(1): respectively, 3.3 +/- 3.0 versus 8.9 +/- 6.1 and 7.47 +/- 5.05 versus 16.3 +/- 11.4 min. During SevAn the PaCO(2) and minute ventilation increased."}
{"qid": "58f6295a70f9fc6f0f000019", "original_text": "CLAST (Comprehensive Least-Squares Automatic Tree Search) is generally faster than BLAST (Basic Local Alignment Search Tool) for several reasons: 1. Algorithm: CLAST uses a different algorithm than BLAST, which makes it faster for large datasets. BLAST relies on the fast Fourier transform (FFT) to accelerate the search process, while CLAST uses the Comprehensive Least-Squares Automatic Tree Search (CLASST) algorithm, which is more optimized for modern computational hardware. 2. Parallelization: CLAST is designed to be highly parallelizable, which means that it can take advantage of multiple CPU cores or GPUs to accelerate the search process. BLAST, on the other hand, is less parallelizable, which can limit its performance on large datasets. 3. Database size: CLAST is designed to handle larger datasets than BLAST, thanks to its ability to handle non-coding regions of the genome. This means that CLAST can identify more potential gene variants than BLAST, which can lead to faster search times for complex genomes. Based on these factors, it's difficult to give a specific number of how many times CLAST is faster than BLAST, as it depends on the size and complexity of the dataset being searched. However, in general, CLAST is expected to be faster than BLAST for large-scale genome analysis tasks, particularly those that involve non-coding regions of the genome.", "label": 0, "is_selected": 1, "text": "The CLAST genome search tool has been developed by scientists at the University of Cambridge and the Massachusetts Institute of Technology (MIT) to speed up the analysis of large-scale genetic datasets, such as those from the Human Genome Project (HGP) and the Single Molecule Biophysics (SMB) project, as well as from other research projects such as the Wellcome Trust Sanger Institute (HTI) project and the National Human Genome Research Institute (NHRI)'s (NHI) Broad Institute of MIT and Harvard (BMRI) project."}
{"qid": "5a67b48cb750ff4455000010", "original_text": "Palamneus gravimanus envenomated rats showed dose-dependent alterations in serum biochemical parameters.", "label": 1, "is_selected": 0, "text": "Palamneus gravimanus envenomated rats showed dose-dependent alterations in serum biochemical parameters."}
{"qid": "601d73261cb411341a00003a", "original_text": "A suckling baby with microcephaly, craniostenosis, downward slanting palpebral fissues, malformed ears, cerebral, cardiac and intestinal malformation, and partial 6q25 leads to 6qter trisomy is presented. The baby is the second child of a mother with balanced translocation : 46,XX,t(2;6)(q37,q25). The first child with a similar phenotype and cardiac malformation did not undergo cytogenetic investigation and died at 4 months.", "label": 1, "is_selected": 0, "text": "A suckling baby with microcephaly, craniostenosis, downward slanting palpebral fissues, malformed ears, cerebral, cardiac and intestinal malformation, and partial 6q25 leads to 6qter trisomy is presented. The baby is the second child of a mother with balanced translocation : 46,XX,t(2;6)(q37,q25). The first child with a similar phenotype and cardiac malformation did not undergo cytogenetic investigation and died at 4 months."}
{"qid": "516ec97f298dcd4e51000087", "original_text": "Assessment of the reliability of a given phylogenetic hypothesis is an important step in phylogenetic analysis. Historically, the nonparametric bootstrap procedure has been the most frequently used method for assessing the support for specific phylogenetic relationships. The recent employment of Bayesian methods for phylogenetic inference problems has resulted in clade support being expressed in terms of posterior probabilities. We used simulated data and the four-taxon case to explore the relationship between nonparametric bootstrap values (as inferred by maximum likelihood) and posterior probabilities (as inferred by Bayesian analysis). The results suggest a complex association between the two measures. Three general regions of tree space can be identified: (1) the neutral zone, where differences between mean bootstrap and mean posterior probability values are not significant, (2) near the two-branch corner, and (3) deep in the two-branch corner. In the last two regions, significant differences occur between mean bootstrap and mean posterior probability values. Whether bootstrap or posterior probability values are higher depends on the data in support of alternative topologies. Examination of star topologies revealed that both bootstrap and posterior probability values differ significantly from theoretical expectations; in particular, there are more posterior probability values in the range 0.85-1 than expected by theory. Therefore, our results corroborate the findings of others that posterior probability values are excessively high.", "label": 1, "is_selected": 0, "text": "Assessment of the reliability of a given phylogenetic hypothesis is an important step in phylogenetic analysis. Historically, the nonparametric bootstrap procedure has been the most frequently used method for assessing the support for specific phylogenetic relationships. The recent employment of Bayesian methods for phylogenetic inference problems has resulted in clade support being expressed in terms of posterior probabilities. We used simulated data and the four-taxon case to explore the relationship between nonparametric bootstrap values (as inferred by maximum likelihood) and posterior probabilities (as inferred by Bayesian analysis). The results suggest a complex association between the two measures. Three general regions of tree space can be identified: (1) the neutral zone, where differences between mean bootstrap and mean posterior probability values are not significant, (2) near the two-branch corner, and (3) deep in the two-branch corner. In the last two regions, significant differences occur between mean bootstrap and mean posterior probability values. Whether bootstrap or posterior probability values are higher depends on the data in support of alternative topologies. Examination of star topologies revealed that both bootstrap and posterior probability values differ significantly from theoretical expectations; in particular, there are more posterior probability values in the range 0.85-1 than expected by theory. Therefore, our results corroborate the findings of others that posterior probability values are excessively high."}
{"qid": "5a75eb6483b0d9ea66000004", "original_text": "Blount's disease, also known as congenital blount's disease, is a rare genetic disorder that affects the growth anddevelopment of the long bones in the legs. It is characterized by a delay in the normal growth of the bones, which can lead to a variety of symptoms including limb length discrepancy, muscle weakness, and joint deformities. The exact cause of Blount's disease is not fully understood, but it is thought to be related to genetic mutations that affect the expression of genes involved in bone growth and development. Treatment for Blount's disease typically involves a combination of non-surgical and surgical interventions, such as braces, casts, or osteotomies, depending on the severity of the condition. Early detection and treatment can help to improve the outcome for children with Blount's disease.", "label": 0, "is_selected": 1, "text": "Children with Blount's disease should be screened for this condition at an early age, according to the American College of Obstetricians and Gynaecologists (ACOG) and the American Academy of Orthopaedic Surgeons (AAOS) in a joint statement released on Wednesday, April 5, 2016.<n> Filmed at the ACOG and AAOS annual meetings in Atlanta, Georgia, this video highlights the importance of early detection and treatment for children with Blount\u2019s disease."}
{"qid": "54da21bf4b1fd0d33c00000d", "original_text": "The western blot is a very useful and widely adopted lab technique, but its execution is challenging. The workflow is often characterized as a \"black box\" because an experimentalist does not know if it has been performed successfully until the last of several steps. Moreover, the quality of western blot data is sometimes challenged due to a lack of effective quality control tools in place throughout the western blotting process. Here we describe the V3 western workflow, which applies stain-free technology to address the major concerns associated with the traditional western blot protocol.", "label": 1, "is_selected": 0, "text": "The western blot is a very useful and widely adopted lab technique, but its execution is challenging. The workflow is often characterized as a \"black box\" because an experimentalist does not know if it has been performed successfully until the last of several steps. Moreover, the quality of western blot data is sometimes challenged due to a lack of effective quality control tools in place throughout the western blotting process. Here we describe the V3 western workflow, which applies stain-free technology to address the major concerns associated with the traditional western blot protocol."}
{"qid": "5ac37afc0340b9f058000002", "original_text": "Enhancers evolve from cis-acting regulatory elements called insulators, which are located far away from the promoter and gene they regulate. Insulators are thought to have arisen from the condensation of DNA into compact structures that can interact with proteins to regulate chromatin folding and gene expression. Over time, these insulators may have evolved into enhancers through a process of iterative selection, leading to the development of complex enhancer-promoter interactions that play a crucial role in regulating gene expression.", "label": 0, "is_selected": 0, "text": "Enhancers evolve from cis-acting regulatory elements called insulators, which are located far away from the promoter and gene they regulate. Insulators are thought to have arisen from the condensation of DNA into compact structures that can interact with proteins to regulate chromatin folding and gene expression. Over time, these insulators may have evolved into enhancers through a process of iterative selection, leading to the development of complex enhancer-promoter interactions that play a crucial role in regulating gene expression."}
{"qid": "5c851c2675a4a5d219000006", "original_text": "Clostridium difficile infection is a significant cause of infectious diarrhoea and is associated with considerable morbidity and mortality.1,2 Management of Clostridium difficile infection often requires treatment with antibiotics (metronidazole, vancomycin or fidaxomicin) alongside supportive care to manage hydration, electrolytes and nutrition. However, the risk of recurrence is approximately 20%.2 Here, we review the evidence for bezlotoxumab (\u25bc Zinplava - Merck Sharp & Dohme Limited), a monoclonal antibody licensed for the prevention of recurrence of Clostridium difficile in adults who are at high risk of recurrence.", "label": 1, "is_selected": 0, "text": "Clostridium difficile infection is a significant cause of infectious diarrhoea and is associated with considerable morbidity and mortality.1,2 Management of Clostridium difficile infection often requires treatment with antibiotics (metronidazole, vancomycin or fidaxomicin) alongside supportive care to manage hydration, electrolytes and nutrition. However, the risk of recurrence is approximately 20%.2 Here, we review the evidence for bezlotoxumab (\u25bc Zinplava - Merck Sharp & Dohme Limited), a monoclonal antibody licensed for the prevention of recurrence of Clostridium difficile in adults who are at high risk of recurrence."}
{"qid": "5a87e95461bb38fb2400000c", "original_text": "RNA polymerase III (Pol III) transcribes small untranslated RNAs, such as tRNAs. To define the Pol III transcriptome in Saccharomyces cerevisiae, we performed genome-wide chromatin immunoprecipitation using subunits of Pol III, TFIIIB and TFIIIC. Virtually all of the predicted targets of Pol III, as well as several novel candidates, were occupied by Pol III machinery. Interestingly, TATA box-binding protein occupancy was greater at Pol III targets than virtually all Pol II targets, and the highly occupied Pol II targets are generally strongly transcribed.", "label": 1, "is_selected": 0, "text": "RNA polymerase III (Pol III) transcribes small untranslated RNAs, such as tRNAs. To define the Pol III transcriptome in Saccharomyces cerevisiae, we performed genome-wide chromatin immunoprecipitation using subunits of Pol III, TFIIIB and TFIIIC. Virtually all of the predicted targets of Pol III, as well as several novel candidates, were occupied by Pol III machinery. Interestingly, TATA box-binding protein occupancy was greater at Pol III targets than virtually all Pol II targets, and the highly occupied Pol II targets are generally strongly transcribed."}
{"qid": "621b806c3a8413c653000040", "original_text": "Salt-inducible kinases (SIKs) are calcium/calmodulin-dependent protein kinase (CAMK)-like (CAMKL) family members implicated in insulin signal transduction, metabolic regulation, inflammatory response, and other processes. Here, we focused on SIK2, which is a target of the Food and Drug Administration (FDA)-approved pan inhibitor N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (dasatinib), and constructed four representative SIK2 structures by homology modeling. We investigated the interactions between dasatinib and SIK2 via molecular docking, molecular dynamics simulation, and binding free energy calculation and found that dasatinib showed strong binding affinity for SIK2. Binding free energy calculations suggested that the modification of various dasatinib regions may provide useful information for drug design and to guide the discovery of novel dasatinib-based SIK2 inhibitors.", "label": 1, "is_selected": 0, "text": "Salt-inducible kinases (SIKs) are calcium/calmodulin-dependent protein kinase (CAMK)-like (CAMKL) family members implicated in insulin signal transduction, metabolic regulation, inflammatory response, and other processes. Here, we focused on SIK2, which is a target of the Food and Drug Administration (FDA)-approved pan inhibitor N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (dasatinib), and constructed four representative SIK2 structures by homology modeling. We investigated the interactions between dasatinib and SIK2 via molecular docking, molecular dynamics simulation, and binding free energy calculation and found that dasatinib showed strong binding affinity for SIK2. Binding free energy calculations suggested that the modification of various dasatinib regions may provide useful information for drug design and to guide the discovery of novel dasatinib-based SIK2 inhibitors."}
{"qid": "5709e947cf1c32585100001d", "original_text": "Yes, Sidekick proteins are members of the immunoglobulin (Ig) superfamily. The Ig superfamily includes a group of proteins that share structural and functional similarities with immunoglobulins, including Sidekick proteins. These proteins are characterized by the presence of one or more immunoreceptor tyrosine-based activation motifs (ITAMs) or immunoreceptor tyrosine-based inhibition motifs (ITIMs) in their structure, which enables them to interact with the adaptor protein Lymphocyte-activation gene 3 (LAG-3). LAG-3 is important for the regulation of T cell activation and differentiation, and Sidekick proteins have been shown to modulate T cell responses by interacting with LAG-3.", "label": 0, "is_selected": 1, "text": "The Sidekick protein is a member of the Ig superfamily and has been shown to modulate T cell responses by interacting with the adaptor protein Lymphocyte-Activating Gene 3 (LAG-3), which is important for the regulation of T cell activation and differentiation."}
{"qid": "5e5b5c6fb761aafe0900000a", "original_text": "ABCG2 (ATP-Binding Cassette, subfamily G, member 2, transporter) is a protein that is involved in the transport of various substrates across cellular membranes, including pharmaceuticals, toxins, and xenobiotics. However, ABCG2 does not play a role in the excretion of uric acid. Uric acid is typically excreted by the kidneys through the glomerular filtration mechanism, followed by reabsorption and secretion into the tubular fluid. The excretion of uric acid is an important function of the kidneys, and abnormalities in this process can lead to various kidney disorders, such as hyperuricemia and gout.", "label": 0, "is_selected": 1, "text": "The mechanism by which ABCG2 is involved in the excretion of uric acid has been elucidated by researchers at the University of California, Los Angeles (UCLA) and the Keck School of Medicine of the Keck Hospital of Los Angeles, in collaboration with colleagues at Harvard Medical School."}
{"qid": "5c73acf57c78d6947100008c", "original_text": "Only rather few data on the validity of screening questionnaires to detect problem drinking in adolescents exist. The aim of this study was to compare the performance of the Alcohol Use Disorders Identification Test (AUDIT), its short form AUDIT-C, the Substance Module of the Problem Oriented Screening Instrument for Teenagers (POSIT), and CRAFFT (acronym for car, relax, alone, forget, family, and friends). The questionnaires were filled in by 9th and 10th graders from two comprehensive schools. All students received an interview using the alcohol section of the Composite International Diagnostic Interview. Alcohol abuse and alcohol dependence according to DSM-IV as well as episodic heavy drinking served as criteria to validate the screening instruments. All 9th and 10th graders (n=225) of both schools participated. No significant differences were found for areas under the receiver operating characteristic curves ranging from 0.810 to 0.872. Cronbach's alpha was satisfactory (0.77-0.80) but poor for CRAFFT (0.64). Different cut-offs are discussed.", "label": 1, "is_selected": 0, "text": "Only rather few data on the validity of screening questionnaires to detect problem drinking in adolescents exist. The aim of this study was to compare the performance of the Alcohol Use Disorders Identification Test (AUDIT), its short form AUDIT-C, the Substance Module of the Problem Oriented Screening Instrument for Teenagers (POSIT), and CRAFFT (acronym for car, relax, alone, forget, family, and friends). The questionnaires were filled in by 9th and 10th graders from two comprehensive schools. All students received an interview using the alcohol section of the Composite International Diagnostic Interview. Alcohol abuse and alcohol dependence according to DSM-IV as well as episodic heavy drinking served as criteria to validate the screening instruments. All 9th and 10th graders (n=225) of both schools participated. No significant differences were found for areas under the receiver operating characteristic curves ranging from 0.810 to 0.872. Cronbach's alpha was satisfactory (0.77-0.80) but poor for CRAFFT (0.64). Different cut-offs are discussed."}
{"qid": "604f632494d57fd879000007", "original_text": "The venom of the cone snail, Conus tulipa, contains a unique combination of compounds that can have varied effects on the body, depending on the species and the individual being envenomed. The venom contains a variety of peptides, including conotoxins, which can act on various ion channels, receptors, and enzymes in the body. These peptides can cause a range of effects, including: * Pain relief: Some conotoxins can act on pain receptors, producing analgesic effects. * Muscle paralysis: Conotoxins can also inhibit muscle contractions, leading to paralysis. * Respiratory depression: The venom can slow down breathing, leading to respiratory depression. * Cardiovascular effects: Conotoxins can affect the heart and blood vessels, causing changes in blood pressure, heart rate, and cardiac output. It is important to note that the effects of the venom of Conus tulipa can vary depending on the dose and the individual's sensitivity, and can be severe and even life-threatening in some cases.", "label": 0, "is_selected": 1, "text": "The venom of the cone snail, Conus tulipa, contains a unique combination of compounds that can have varied effects on the body, depending on the species and the individual being envenomed.The venom contains a variety of peptides, including conotoxins, which can act on various ion channels, receptors, and enzymes in the body.It is important to note that the effects of the venom of Conus tulipsa can vary Depending on the dose and an individual's sensitivity, and can be severe and even life-threatening in some cases."}
{"qid": "5548da00f35db7552600000b", "original_text": "The pericuticular necklace of the hair cell is composed of myosin isozymes, including myosin light chain kinase (MLCK) and non-muscle myosin (NMII). MLCK is primarily localized to the outer wall of the hair cell's synapse, while NMII is found along the length of the hair cell's process. Both isozymes play crucial roles in the formation and maintenance of the hair cell's structure, as well as the regulation of the hair cell's mechanical properties. MLCK regulates the contraction of the hair cell's mechanosensitive structure, while NMII is involved in the cytoskeletal organization of the hair cell's internal structures.", "label": 0, "is_selected": 0, "text": "The pericuticular necklace of the hair cell is composed of myosin isozymes, including myosin light chain kinase (MLCK) and non-muscle myosin (NMII). MLCK is primarily localized to the outer wall of the hair cell's synapse, while NMII is found along the length of the hair cell's process. Both isozymes play crucial roles in the formation and maintenance of the hair cell's structure, as well as the regulation of the hair cell's mechanical properties. MLCK regulates the contraction of the hair cell's mechanosensitive structure, while NMII is involved in the cytoskeletal organization of the hair cell's internal structures."}
{"qid": "54fc97b86ad7dcbc12000002", "original_text": "There is limited research on the clinical efficacy of ceftriaxone for the treatment of amyotrophic lateral sclerosis (ALS). Ceftriaxone is an antibiotic that has been used off-label to treat ALS, as some studies have suggested that it may have neuroprotective effects. However, the evidence for its efficacy in ALS is largely anecdotal and based on small, uncontrolled studies. A 2013 review of 16 studies on the use of ceftriaxone in ALS found that while some patients reported improved motor function, the evidence was inconsistent and the studies had many limitations. The review concluded that more research was needed to determine the safety and efficacy of ceftriaxone in ALS. A 2017 study published in the Journal of Neurology, Neurosurgery, and Psychiatry found that ceftriaxone treatment was associated with improved motor function in a small group of ALS patients, but the study was hampered by its small size and the fact that it was conducted at a single center. Overall, while there is some evidence to suggest that ceftriaxone may have potential as a treatment for ALS, further research is needed to fully understand its safety and efficacy in this condition. I don't have an answer to the question \"What is known about the clinical efficacy of ceftriaxone for the treatment of amyotrophic lateral sclerosis?\"", "label": 0, "is_selected": 0, "text": "There is limited research on the clinical efficacy of ceftriaxone for the treatment of amyotrophic lateral sclerosis (ALS). Ceftriaxone is an antibiotic that has been used off-label to treat ALS, as some studies have suggested that it may have neuroprotective effects. However, the evidence for its efficacy in ALS is largely anecdotal and based on small, uncontrolled studies. A 2013 review of 16 studies on the use of ceftriaxone in ALS found that while some patients reported improved motor function, the evidence was inconsistent and the studies had many limitations. The review concluded that more research was needed to determine the safety and efficacy of ceftriaxone in ALS. A 2017 study published in the Journal of Neurology, Neurosurgery, and Psychiatry found that ceftriaxone treatment was associated with improved motor function in a small group of ALS patients, but the study was hampered by its small size and the fact that it was conducted at a single center. Overall, while there is some evidence to suggest that ceftriaxone may have potential as a treatment for ALS, further research is needed to fully understand its safety and efficacy in this condition. I don't have an answer to the question \"What is known about the clinical efficacy of ceftriaxone for the treatment of amyotrophic lateral sclerosis?\""}
{"qid": "58a3423e60087bc10a000019", "original_text": "Creutzfeldt-Jakob disease (CJD) is a rare, rapidly progressive, and fatal neurodegenerative disease affecting the central nervous system. Brain lipid homeostasis and oxidative stress seem to play an important role in the disease pathogenesis. But little was known whether serum lipids and uric acid (a natural antioxidant) levels changed in patients with prion disease. Here we retrospectively reviewed and compared the serum lipids and uric acid levels of 19 probable sporadic CJD patients and 26 healthy control subjects. We found that the serum uric acid levels in sporadic CJD patients were significantly lower than that in controls (P=0.01). Serum triglycerides, cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and apolipoprotein A1 (ApoA1) were similar in sporadic CJD patients and controls.", "label": 1, "is_selected": 0, "text": "Creutzfeldt-Jakob disease (CJD) is a rare, rapidly progressive, and fatal neurodegenerative disease affecting the central nervous system. Brain lipid homeostasis and oxidative stress seem to play an important role in the disease pathogenesis. But little was known whether serum lipids and uric acid (a natural antioxidant) levels changed in patients with prion disease. Here we retrospectively reviewed and compared the serum lipids and uric acid levels of 19 probable sporadic CJD patients and 26 healthy control subjects. We found that the serum uric acid levels in sporadic CJD patients were significantly lower than that in controls (P=0.01). Serum triglycerides, cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and apolipoprotein A1 (ApoA1) were similar in sporadic CJD patients and controls."}
{"qid": "5c73acef7c78d69471000088", "original_text": "Erenumab is a monoclonal antibody that targets the calcitonin gene-related peptide (CGRP) receptor. The CGRP receptor is a G protein-coupled receptor that is involved in the transmission of pain signals in the body. By blocking the CGRP receptor, erenumab can help to reduce the transmission of pain signals and alleviate migraine symptoms. Erenumab is specifically designed to bind to the CGRP receptor and prevent it from being activated by CGRP, a neurotransmitter that is involved in the transmission of pain signals.", "label": 0, "is_selected": 1, "text": "The US Food and Drug Administration (FDA) has granted orphan drug status to erenumab for the treatment of acute migraine attacks in patients who have had at least two migraines in the past 12 months, as well as for the prevention of future migraines."}
{"qid": "5e80e449835f4e477700002c", "original_text": "ACE2 (angiotensin converting enzyme 2) plays a critical role in the local tissue RAS (renin-angiotensin system) by hydrolysing the potent hypertensive and mitogenic peptide AngII (angiotensin II). Changes in the levels of ACE2 have been observed in a number of pathologies, including cardiovascular disease, but little is known of the mechanisms regulating its expression. In the present study, therefore, the potential role of miRNAs in the regulation of ACE2 expression in primary human cardiac myofibroblasts was examined. Putative miRNA-binding sites were identified in the 3'-UTR of the ACE2 transcript using online prediction algorithms. Two of these, miR-200b and miR-421, were selected for further analysis. A reporter system using the 3'-UTR of ACE2 fused to the coding region of firefly luciferase was used to determine the functionality of the identified binding sites in vitro. This identified miR-421, but not miR-200b, as a potential regulator of ACE2. The ability of miR-421, an miRNA implicated in the development of thrombosis, to down-regulate ACE2 expression was subsequently confirmed by Western blot analysis of both primary cardiac myofibroblasts and transformed cells transfected with a synthetic miR-421 precursor.", "label": 1, "is_selected": 0, "text": "ACE2 (angiotensin converting enzyme 2) plays a critical role in the local tissue RAS (renin-angiotensin system) by hydrolysing the potent hypertensive and mitogenic peptide AngII (angiotensin II). Changes in the levels of ACE2 have been observed in a number of pathologies, including cardiovascular disease, but little is known of the mechanisms regulating its expression. In the present study, therefore, the potential role of miRNAs in the regulation of ACE2 expression in primary human cardiac myofibroblasts was examined. Putative miRNA-binding sites were identified in the 3'-UTR of the ACE2 transcript using online prediction algorithms. Two of these, miR-200b and miR-421, were selected for further analysis. A reporter system using the 3'-UTR of ACE2 fused to the coding region of firefly luciferase was used to determine the functionality of the identified binding sites in vitro. This identified miR-421, but not miR-200b, as a potential regulator of ACE2. The ability of miR-421, an miRNA implicated in the development of thrombosis, to down-regulate ACE2 expression was subsequently confirmed by Western blot analysis of both primary cardiac myofibroblasts and transformed cells transfected with a synthetic miR-421 precursor."}
{"qid": "5a9da8df4e03427e73000006", "original_text": "Emicizumab is a medication used to treat Hemophilia A, a genetic disorder that affects the blood's ability to clot. It is a bispecific antibody, meaning it binds to two different targets on the surface of blood cells, specifically the factor IX protein and the ADAM12 protein. This binding causes the factor IX protein to be delivered to the site of injury, where it can help to restore normal blood clotting. Emicizumab is given by injection and can be used to treat bleeding episodes in people with Hemophilia A. It was approved by the FDA in 2019 and is marketed under the brand name Hemlibra.", "label": 0, "is_selected": 1, "text": "The US Food and Drug Administration (FDA) has approved a new drug called Emicizumab for the treatment of bleeding episodes in people with a genetic disorder that affects the blood's ability to clot, according to the company that developed the drug, Bristol-Myers Squibb."}
{"qid": "55030a6ce9bde6963400000f", "original_text": "Titin, is definitely the largest protein in the body, with a molecular weight of 3 million Dalton and composed of 27,000 amino acids. Paradoxically, this huge structure was elusive until the last decade but, since it was described in muscle tissue, its importance has rapidly emerged. Titin constitutes about 10% of muscle mass, to represent the third most abundant protein in the muscle following actin and myosin. It is estimated that titin acts like a \"ruler\" that controls the relative positioning of the latter 2 muscle proteins, and regulates the flexibility and \"springiness\" of the contracting muscle.", "label": 1, "is_selected": 0, "text": "Titin, is definitely the largest protein in the body, with a molecular weight of 3 million Dalton and composed of 27,000 amino acids. Paradoxically, this huge structure was elusive until the last decade but, since it was described in muscle tissue, its importance has rapidly emerged. Titin constitutes about 10% of muscle mass, to represent the third most abundant protein in the muscle following actin and myosin. It is estimated that titin acts like a \"ruler\" that controls the relative positioning of the latter 2 muscle proteins, and regulates the flexibility and \"springiness\" of the contracting muscle."}
{"qid": "5fe3131ba43ad31278000047", "original_text": "RNA polymerase II (RNA Pol II) is the primary RNA polymerase that transcribes enhancer RNAs. Enhancer RNAs are non-coding RNAs that are transcribed from gene regulatory elements, such as enhancers, and play a crucial role in regulating gene expression. RNA Pol II is responsible for transcribing the majority of gene-specific and enhancer RNAs in eukaryotic cells. It reads the DNA template strand and synthesizes a complementary RNA molecule, which is then processed and transported to the cytoplasm for translation or further modification.", "label": 0, "is_selected": 1, "text": "This report studies the RNA II (RNA Pol II) market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report dissects the top players in global and important regions, and splits theRNA II ( RNA Pol II ) market by product and Application/end industries."}
{"qid": "5884c72fe56acf517600000f", "original_text": "Avelumab is a monoclonal antibody that targets the protein PD-L1 (programmed death-ligand 1). PD-L1 is a cell surface protein that is overexpressed in many types of cancer, including non-small cell lung cancer, renal cell carcinoma, and Merkel cell carcinoma. By binding to PD-L1, avelumab can block the interaction between PD-L1 and its receptor, PD-1 (programmed death-1), which is found on the surface of immune cells. This can help to restore the immune system's ability to recognize and attack cancer cells.", "label": 0, "is_selected": 0, "text": "Avelumab is a monoclonal antibody that targets the protein PD-L1 (programmed death-ligand 1). PD-L1 is a cell surface protein that is overexpressed in many types of cancer, including non-small cell lung cancer, renal cell carcinoma, and Merkel cell carcinoma. By binding to PD-L1, avelumab can block the interaction between PD-L1 and its receptor, PD-1 (programmed death-1), which is found on the surface of immune cells. This can help to restore the immune system's ability to recognize and attack cancer cells."}
{"qid": "601f1bbd1cb411341a000074", "original_text": "There are several small molecule CGRP-receptor antagonists that have been developed as potential treatments for migraine. Here are three examples: 1. Eptinezumab: This is a monoclonal antibody that binds to CGRP and prevents it from binding to the CGRP receptor. Studies have shown that eptinezumab is effective in reducing the frequency and severity of migraine attacks. 2. Galcanezumab: This is another monoclonal antibody that targets CGRP and has been shown to reduce the frequency and severity of migraine attacks in clinical trials. 3. Fremanezumab: This is a small molecule CGRP-receptor antagonist that has been shown to be effective in reducing the frequency and severity of migraine attacks. It has been approved by the FDA for the preventive treatment of migraine. It is important to note that these medications are not available yet for commercial use, they are still in clinical trials. Also, it's important to consult a doctor before starting any new medication, as they will be able to assess your individual needs and determine if these medications are appropriate for you.", "label": 0, "is_selected": 1, "text": "Migraines are caused by a protein called CGRP, which is found on the surface of the brain and has been shown to be a risk factor for Alzheimer's disease and stroke. Fremanezumab: This is a small molecule CGRP-receptor antagonist that has been shows to be effective in reducing the frequency and severity of migraine attacks, they have been approved by the FDA for the preventive treatment of migraine. It is important to note that these medications are not available yet for commercial use, they are still in clinical trials."}
{"qid": "533c394ec45e13371400000c", "original_text": "The RNA-binding protein, HuR, associates with the HuR mRNA, but the consequences of this interaction are unknown. Here, we use human diploid fibroblasts (HDFs) and cervical carcinoma cells to study this regulatory paradigm. Ectopic overexpression of HuR potently enhanced the translation and cytoplasmic levels of endogenous HuR, but did not affect HuR mRNA levels. Inhibition of CRM1 function by Lemptomycin B or by knockdown of CRM1 greatly diminished the cytoplasmic levels of endogenous HuR mRNA and hence blocked the induction of endogenous HuR by exogenous HuR. Further studies showed that HuR interacted with the 3'-untranslated region (UTR) of HuR and that overexpression of HuR increased the cytoplasmic levels of a chimeric luciferase-HuR 3'-UTR reporter transcript, as well as luciferase activity; conversely, HuR knockdown reduced both parameters.", "label": 1, "is_selected": 0, "text": "The RNA-binding protein, HuR, associates with the HuR mRNA, but the consequences of this interaction are unknown. Here, we use human diploid fibroblasts (HDFs) and cervical carcinoma cells to study this regulatory paradigm. Ectopic overexpression of HuR potently enhanced the translation and cytoplasmic levels of endogenous HuR, but did not affect HuR mRNA levels. Inhibition of CRM1 function by Lemptomycin B or by knockdown of CRM1 greatly diminished the cytoplasmic levels of endogenous HuR mRNA and hence blocked the induction of endogenous HuR by exogenous HuR. Further studies showed that HuR interacted with the 3'-untranslated region (UTR) of HuR and that overexpression of HuR increased the cytoplasmic levels of a chimeric luciferase-HuR 3'-UTR reporter transcript, as well as luciferase activity; conversely, HuR knockdown reduced both parameters."}
{"qid": "5a87124561bb38fb24000001", "original_text": "Cebocephaly, also known as cerebrofacial dysostosis, is a rare genetic disorder characterized by abnormalities in the growth and development of the brain and face. The term \"cebocephaly\" is derived from the Greek words \"kephale\" meaning \"head\" and \"cebus\" meaning \"wolf.\" The condition is caused by mutations in genes involved in neurocranium development, leading to various malformations in the head and face, including craniosynostosis (abnormal fusion of skull bones), microcephaly (small head size), and facial dysmorphism (e.g., narrow eyes, thin lips, and short nose). I don't have information on the prevalence or treatment options for cebocephaly.", "label": 0, "is_selected": 1, "text": "What is cebocephaly and what are the signs and symptoms of the condition?., What are the most common symptoms and causes of this condition?, What is the name of the disease and what is the difference between it and other conditions?"}
{"qid": "571f33f10fd6f91b68000004", "original_text": "Loss-of-function mutations of NSD1 and 5q35 microdeletions encompassing NSD1 are a major cause of Sotos syndrome (Sos), which is characterized by overgrowth, macrocephaly, characteristic facies, and variable intellectual disability (ID). Microduplications of 5q35.2-q35.3 including NSD1 have been reported in only five patients so far and described clinically as a reversed Sos resulting from a hypothetical gene dosage effect of NSD1. Here, we report on nine patients from five families with interstitial duplication 5q35 including NSD1 detected by molecular karyotyping. The clinical features of all 14 individuals are reviewed. Patients with microduplications including NSD1 appear to have a consistent phenotype consisting of short stature, microcephaly, learning disability or mild to moderate ID, and distinctive facial features comprising periorbital fullness, short palpebral fissures, a long nose with broad or long nasal tip, a smooth philtrum and a thin upper lip vermilion. Behavioral problems, ocular and minor hand anomalies may be associated. Based on our findings, we discuss the possible etiology and conclude that it is possible, but so far unproven, that a gene dosage effect of NSD1 may be the major cause.", "label": 1, "is_selected": 0, "text": "Loss-of-function mutations of NSD1 and 5q35 microdeletions encompassing NSD1 are a major cause of Sotos syndrome (Sos), which is characterized by overgrowth, macrocephaly, characteristic facies, and variable intellectual disability (ID). Microduplications of 5q35.2-q35.3 including NSD1 have been reported in only five patients so far and described clinically as a reversed Sos resulting from a hypothetical gene dosage effect of NSD1. Here, we report on nine patients from five families with interstitial duplication 5q35 including NSD1 detected by molecular karyotyping. The clinical features of all 14 individuals are reviewed. Patients with microduplications including NSD1 appear to have a consistent phenotype consisting of short stature, microcephaly, learning disability or mild to moderate ID, and distinctive facial features comprising periorbital fullness, short palpebral fissures, a long nose with broad or long nasal tip, a smooth philtrum and a thin upper lip vermilion. Behavioral problems, ocular and minor hand anomalies may be associated. Based on our findings, we discuss the possible etiology and conclude that it is possible, but so far unproven, that a gene dosage effect of NSD1 may be the major cause."}
{"qid": "54f2f81664850a5854000003", "original_text": "Fanconi anemia (FA) is a heterogeneous disease characterized by spontaneous chromosomal breaks and abnormal DNA repair. Major clinical problems in FA include congenital abnormalities, endocrinopathies, early onset bone marrow failure and increased risk of myelodysplastic syndrome, acute leukemia and solid tumors. To date, 15 different genes have been shown to cause FA, all of which have some role in DNA double-strand break repair. Very few strict genotype-phenotype associations have been identified and clinical manifestations vary widely from patient to patient, most likely due to modifier genes, environment and chance effects. Hematopoietic stem cell transplantation is the only proven cure for the hematopoietic manifestations of FA and aggressive lifelong surveillance for solid tumors is essential.", "label": 1, "is_selected": 0, "text": "Fanconi anemia (FA) is a heterogeneous disease characterized by spontaneous chromosomal breaks and abnormal DNA repair. Major clinical problems in FA include congenital abnormalities, endocrinopathies, early onset bone marrow failure and increased risk of myelodysplastic syndrome, acute leukemia and solid tumors. To date, 15 different genes have been shown to cause FA, all of which have some role in DNA double-strand break repair. Very few strict genotype-phenotype associations have been identified and clinical manifestations vary widely from patient to patient, most likely due to modifier genes, environment and chance effects. Hematopoietic stem cell transplantation is the only proven cure for the hematopoietic manifestations of FA and aggressive lifelong surveillance for solid tumors is essential."}
{"qid": "5709ee36cf1c32585100001e", "original_text": "DVL1 (Dishevelled Wnt signaling pathway protein 1) is a gene that has been associated with several syndromes, including: * Axenfeld-Rieger syndrome: This rare genetic disorder is characterized by distinctive facial features, such as microphthalmia (small eyes), coloboma (a hole in one of the structures of the eye), and facial dysostosis (abnormal development of the face). It is also associated with intellectual disability, delayed speech, and other health problems. * Riley-Day syndrome: This rare genetic disorder is characterized by distinctive facial features, such as widely spaced eyes, a small jaw, and a flat nasal bridge. It is also associated with intellectual disability, delayed speech, and other health problems. * Wnt-related neurodevelopmental disorder: This is a rare and severe neurodevelopmental disorder that is caused by mutations in genes involved in the Wnt signaling pathway, including DVL1. It is characterized by delayed or absent cognitive and motor skill development, intellectual disability, and other health problems. It's important to note that these syndromes are rare and the prevalence of DVL1 mutations causing these disorders is not well established. Additionally, the full spectrum of features associated with these syndromes may not be present in every individual with a DVL1 mutation, and other genetic and environmental factors may also contribute to the development of these disorders.", "label": 0, "is_selected": 0, "text": "DVL1 (Dishevelled Wnt signaling pathway protein 1) is a gene that has been associated with several syndromes, including: * Axenfeld-Rieger syndrome: This rare genetic disorder is characterized by distinctive facial features, such as microphthalmia (small eyes), coloboma (a hole in one of the structures of the eye), and facial dysostosis (abnormal development of the face). It is also associated with intellectual disability, delayed speech, and other health problems. * Riley-Day syndrome: This rare genetic disorder is characterized by distinctive facial features, such as widely spaced eyes, a small jaw, and a flat nasal bridge. It is also associated with intellectual disability, delayed speech, and other health problems. * Wnt-related neurodevelopmental disorder: This is a rare and severe neurodevelopmental disorder that is caused by mutations in genes involved in the Wnt signaling pathway, including DVL1. It is characterized by delayed or absent cognitive and motor skill development, intellectual disability, and other health problems. It's important to note that these syndromes are rare and the prevalence of DVL1 mutations causing these disorders is not well established. Additionally, the full spectrum of features associated with these syndromes may not be present in every individual with a DVL1 mutation, and other genetic and environmental factors may also contribute to the development of these disorders."}
{"qid": "54c12fd1f693c3b16b000001", "original_text": "A direct binding of HRC (histidine-rich Ca(2+)-binding protein) to triadin, the main transmembrane protein of the junctional sarcoplasmic reticulum (SR) of skeletal muscle, seems well supported. Opinions are still divided, however, concerning the triadin domain involved, either the cytoplasmic or the lumenal domain, and the exact role played by Ca(2+), in the protein-to-protein interaction. Further support for colocalization of HRC with triadin cytoplasmic domain is provided here by experiments of mild tryptic digestion of tightly sealed TC vesicles. Accordingly, we show that HRC is preferentially phosphorylated by endogenous CaM K II, anchored to SR membrane on the cytoplasmic side, and not by lumenally located casein kinase 2.", "label": 1, "is_selected": 0, "text": "A direct binding of HRC (histidine-rich Ca(2+)-binding protein) to triadin, the main transmembrane protein of the junctional sarcoplasmic reticulum (SR) of skeletal muscle, seems well supported. Opinions are still divided, however, concerning the triadin domain involved, either the cytoplasmic or the lumenal domain, and the exact role played by Ca(2+), in the protein-to-protein interaction. Further support for colocalization of HRC with triadin cytoplasmic domain is provided here by experiments of mild tryptic digestion of tightly sealed TC vesicles. Accordingly, we show that HRC is preferentially phosphorylated by endogenous CaM K II, anchored to SR membrane on the cytoplasmic side, and not by lumenally located casein kinase 2."}
{"qid": "5e52add36d0a277941000047", "original_text": "The cloud-based platform that has been developed for comparing Genome-Wide Association Studies (GWAS) iscalled \"GWAS Platform\" (GWP). GWP is an open-source, web-based platform that allows researchers to perform meta-analyses of GWAS data from various studies. It enables users to compare and combine results from multiple GWAS, identify replicating signals, and perform joint analysis of multiple studies. GWP also provides tools for quality control, imputation, and statistical analysis, and supports the integration of additional genomic data types, such as epigenomics and transcriptomics.", "label": 0, "is_selected": 0, "text": "The cloud-based platform that has been developed for comparing Genome-Wide Association Studies (GWAS) iscalled \"GWAS Platform\" (GWP). GWP is an open-source, web-based platform that allows researchers to perform meta-analyses of GWAS data from various studies. It enables users to compare and combine results from multiple GWAS, identify replicating signals, and perform joint analysis of multiple studies. GWP also provides tools for quality control, imputation, and statistical analysis, and supports the integration of additional genomic data types, such as epigenomics and transcriptomics."}
{"qid": "53358cd2d6d3ac6a3400004e", "original_text": "A profound knowledge of specific genetically determined anomalies of the hair may be of considerable value in the diagnosis of genetic syndromes. We give a review of a few recent developments in the field of genetic hair diseases.", "label": 1, "is_selected": 0, "text": "A profound knowledge of specific genetically determined anomalies of the hair may be of considerable value in the diagnosis of genetic syndromes. We give a review of a few recent developments in the field of genetic hair diseases."}
{"qid": "60292d311cb411341a00010f", "original_text": "Bow Hunter's syndrome, also known as hypothyroidism-related cretinism, is caused by a deficiency in thyroid hormone during fetal development. This can occur due to maternal hypothyroidism, which can be caused by several factors such as autoimmune disorders, thyroid cancer, or drugs that affect the thyroid gland. The syndrome is characterized by mental retardation, growth retardation, and congenital anomalies. Without proper treatment, children with Bow Hunter's syndrome may have significant neurological and cognitive impairments, and some may require lifelong care and support.", "label": 0, "is_selected": 1, "text": "Bow Hunter's syndrome is a rare genetic disorder that affects about one in every 10,000 babies born in the United States each year, according to the National Institutes of Health (NIH) and the US Centers for Disease Control and Prevention (CDC), both of which are part of the Department of Health and Human Services (HHS)."}
{"qid": "5e3247f1fbd6abf43b00005b", "original_text": "Low-grade extraskeletal osteosarcoma is a rare tumor that may arise de novo or following radiation therapy. Because of the low-grade histology, it may be misdiagnosed as a benign lesion. We present a case of a 59-year-old man with a past history of radiotherapy for papillary carcinoma of the thyroid, presenting 16 years later with a low-grade extraskeletal osteosarcoma of the neck. The patient was treated with surgical excision and is disease free after 12 months of follow-up. The prognosis for patients with low-grade extraskeletal osteosarcoma is relatively good when compared with high-grade sarcomas. While there is a report of a low-grade extraskeletal osteosarcoma arising following radiotherapy for a benign condition, to the best of our knowledge this is the first reported case of a low-grade extraskeletal osteosarcoma occurring following radiotherapy for thyroid cancer, and the only case reported in the soft tissue of the head and neck region.", "label": 1, "is_selected": 0, "text": "Low-grade extraskeletal osteosarcoma is a rare tumor that may arise de novo or following radiation therapy. Because of the low-grade histology, it may be misdiagnosed as a benign lesion. We present a case of a 59-year-old man with a past history of radiotherapy for papillary carcinoma of the thyroid, presenting 16 years later with a low-grade extraskeletal osteosarcoma of the neck. The patient was treated with surgical excision and is disease free after 12 months of follow-up. The prognosis for patients with low-grade extraskeletal osteosarcoma is relatively good when compared with high-grade sarcomas. While there is a report of a low-grade extraskeletal osteosarcoma arising following radiotherapy for a benign condition, to the best of our knowledge this is the first reported case of a low-grade extraskeletal osteosarcoma occurring following radiotherapy for thyroid cancer, and the only case reported in the soft tissue of the head and neck region."}
{"qid": "52f89fd32059c6d71c000051", "original_text": "Previous work has demonstrated that lineage-specific transcription factors play essential roles in red blood cell development. More recent studies have shown that these factors participate in critical protein-protein interactions in addition to binding DNA. The zinc finger transcription factor GATA-1, a central mediator of erythroid gene expression, interacts with multiple proteins including FOG-1, EKLF, SP1, CBP/p300 and PU.1. The mechanisms by which these interactions influence GATA-1 function, as well as any possible relationships between these seemingly disparate complexes, remain incompletely understood. However, several new findings have provided further insight into the functional significance of some of these interactions. Studies involving point mutants of GATA-1 have shown that a direct physical interaction between GATA-1 and FOG-1 is essential for normal human erythroid and megakaryocyte maturation in vivo. In addition, evidence has emerged that physical interaction between GATA-1 and the myeloid/lymphoid specific factor PU.1, an oncogene implicated in murine erythroleukemia, acts to functionally cross-antagonize one another.", "label": 1, "is_selected": 0, "text": "Previous work has demonstrated that lineage-specific transcription factors play essential roles in red blood cell development. More recent studies have shown that these factors participate in critical protein-protein interactions in addition to binding DNA. The zinc finger transcription factor GATA-1, a central mediator of erythroid gene expression, interacts with multiple proteins including FOG-1, EKLF, SP1, CBP/p300 and PU.1. The mechanisms by which these interactions influence GATA-1 function, as well as any possible relationships between these seemingly disparate complexes, remain incompletely understood. However, several new findings have provided further insight into the functional significance of some of these interactions. Studies involving point mutants of GATA-1 have shown that a direct physical interaction between GATA-1 and FOG-1 is essential for normal human erythroid and megakaryocyte maturation in vivo. In addition, evidence has emerged that physical interaction between GATA-1 and the myeloid/lymphoid specific factor PU.1, an oncogene implicated in murine erythroleukemia, acts to functionally cross-antagonize one another."}
{"qid": "5a9d9ab94e03427e73000003", "original_text": "Yes, Cystatin D is a biomarker for various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Elevated levels of Cystatin D in cerebrospinal fluid (CSF) have been found to be associated with these diseases, and can potentially serve as a diagnostic marker for early detection and monitoring of disease progression. Additionally, Cystatin D has been shown to have a protective effect against neurodegeneration, and may be a potential therapeutic target for the treatment of these diseases.", "label": 0, "is_selected": 1, "text": "Can I use this test to diagnose neurodegenerative diseases such as Alzheimer's disease and Parkinson's Disease?<n> The Cystatin D test can be used as a blood test or as a urine test for the early detection and monitoring of neurodegenerative disease."}
{"qid": "58a0a28a78275d0c4a000051", "original_text": "Diffuse congenital hyperinsulinism in infancy (CHI-D) arises from mutations inactivating the KATP channel; however, the phenotype is difficult to explain from electrophysiology alone. Here we studied wider abnormalities in the \u03b2-cell and other pancreatic lineages. Islets were disorganized in CHI-D compared with controls. PAX4 and ARX expression was decreased.", "label": 1, "is_selected": 0, "text": "Diffuse congenital hyperinsulinism in infancy (CHI-D) arises from mutations inactivating the KATP channel; however, the phenotype is difficult to explain from electrophysiology alone. Here we studied wider abnormalities in the \u03b2-cell and other pancreatic lineages. Islets were disorganized in CHI-D compared with controls. PAX4 and ARX expression was decreased."}
{"qid": "620bedb13a8413c653000004", "original_text": "Evidence regarding the influence of coffee on appetite and weight control is equivocal and the influence of covariates, such as genetic variation in caffeine metabolism, remains unknown. Herein, we addressed the novel hypothesis that genetic variation in CYP1A2, a gene responsible for more than 95% of caffeine metabolism, differentially impacts the association of coffee consumption with appetite and BMI among individuals with different genetic predispositions to obesity. A cross-over randomized intervention study involving 18 volunteers assessed the effects of coffee consumption on dietary intake, appetite, and levels of the appetite-controlling hormones asprosin and leptin. Data on habitual coffee intake, BMI, and perceived appetite were obtained from an observational cohort of 284 volunteers using validated questionnaires. Participants were stratified according to a validated genetic risk score (GRS) for obesity and to the -163C > A (rs762551) polymorphism of CYP1A2 as rapid (AA), intermediate (AC), or slow (CC) caffeine metabolizers. Coffee consumption led to lower energy and dietary fat intake and circulating asprosin levels (P for interaction of rs762551 genotype*coffee consumption=0.056, 0.039, and 0.043, respectively) as compared to slow/intermediate metabolizers. High coffee consumption was more prevalent in rapid compared to slow metabolizers (P = 0.008 after adjustment for age, sex, and BMI) and was associated with lower appetite perception and lower BMI only in rapid metabolizers (P for interaction of rs762551 genotype*coffee consumption = 0.002 and 0.048, respectively).", "label": 1, "is_selected": 0, "text": "Evidence regarding the influence of coffee on appetite and weight control is equivocal and the influence of covariates, such as genetic variation in caffeine metabolism, remains unknown. Herein, we addressed the novel hypothesis that genetic variation in CYP1A2, a gene responsible for more than 95% of caffeine metabolism, differentially impacts the association of coffee consumption with appetite and BMI among individuals with different genetic predispositions to obesity. A cross-over randomized intervention study involving 18 volunteers assessed the effects of coffee consumption on dietary intake, appetite, and levels of the appetite-controlling hormones asprosin and leptin. Data on habitual coffee intake, BMI, and perceived appetite were obtained from an observational cohort of 284 volunteers using validated questionnaires. Participants were stratified according to a validated genetic risk score (GRS) for obesity and to the -163C > A (rs762551) polymorphism of CYP1A2 as rapid (AA), intermediate (AC), or slow (CC) caffeine metabolizers. Coffee consumption led to lower energy and dietary fat intake and circulating asprosin levels (P for interaction of rs762551 genotype*coffee consumption=0.056, 0.039, and 0.043, respectively) as compared to slow/intermediate metabolizers. High coffee consumption was more prevalent in rapid compared to slow metabolizers (P = 0.008 after adjustment for age, sex, and BMI) and was associated with lower appetite perception and lower BMI only in rapid metabolizers (P for interaction of rs762551 genotype*coffee consumption = 0.002 and 0.048, respectively)."}
{"qid": "605e3c8294d57fd879000037", "original_text": "The study aimed to investigate the clinical adherence to drug label recommendations on important drug-drug interactions (DDIs). Dispensing data on drug combinations involving selective serotonin reuptake inhibitor (SSRI) antidepressants could help to identify areas for intensified medical education. This was a retrospective, cross-sectional analysis of individual dispensing data regarding all individuals > or =15 years old in Sweden.", "label": 1, "is_selected": 0, "text": "The study aimed to investigate the clinical adherence to drug label recommendations on important drug-drug interactions (DDIs). Dispensing data on drug combinations involving selective serotonin reuptake inhibitor (SSRI) antidepressants could help to identify areas for intensified medical education. This was a retrospective, cross-sectional analysis of individual dispensing data regarding all individuals > or =15 years old in Sweden."}
{"qid": "601c33f81cb411341a000017", "original_text": "Lipid-lowering therapy is one major cornerstone of medical treatment of cardiovascular disease in order to modulate atherosclerosis. Statins, ezetimibe and novel PCSK9-inhibitors are already recommended in current guidelines and were shown to improve lipid profiles and have positive effects on the rate of ischemic events and cardiovascular mortality. Recent studies suggest that the concept of \"The lower the better\" might be valid at least regarding low density lipoproteins. In addition, lowering lipoprotein (a) still displays a major challenge in lipid therapy. Furthermore, also lowering triglycerides seems to improve cardiovascular outcome. Regarding triglycerides, icosapent ethyl, a polyunsaturated fatty acid recently attracted attention showing cardiovascular risk reduction due to triglyceride lowering. Therefore, new therapeutic strategies and drug classes are eagerly awaited. Targeting LDL, bempedoic acid and the siRNA inclisiran provide promising results.", "label": 1, "is_selected": 0, "text": "Lipid-lowering therapy is one major cornerstone of medical treatment of cardiovascular disease in order to modulate atherosclerosis. Statins, ezetimibe and novel PCSK9-inhibitors are already recommended in current guidelines and were shown to improve lipid profiles and have positive effects on the rate of ischemic events and cardiovascular mortality. Recent studies suggest that the concept of \"The lower the better\" might be valid at least regarding low density lipoproteins. In addition, lowering lipoprotein (a) still displays a major challenge in lipid therapy. Furthermore, also lowering triglycerides seems to improve cardiovascular outcome. Regarding triglycerides, icosapent ethyl, a polyunsaturated fatty acid recently attracted attention showing cardiovascular risk reduction due to triglyceride lowering. Therefore, new therapeutic strategies and drug classes are eagerly awaited. Targeting LDL, bempedoic acid and the siRNA inclisiran provide promising results."}
{"qid": "5a77072c9e632bc06600000a", "original_text": "Craniosynostosis, or premature fusion of the cranial sutures, occurs in approximately 1 in 2500 live births. The genetic causes and molecular basis of these disorders have greatly expanded over the last 2 decades, with numerous causative and contributory mutations having been identified. The role of fibroblast growth factor receptor (FGFR) mutations in the etiology of certain eponymous forms of craniosynostosis is now well elucidated; the most common syndromes associated with craniosynostosis are Pfeifer (FGFR1, FGFR2), Apert (FGFR2), Crouzon (FGFR2), Saethre-Chotzen (TWIST1), Jackson-Weiss (FGFR2), Greig (GL13), and Muenke (FGFR3) syndromes. Although pathological expression of these mutations often results in bilateral coronal craniosynostosis, single suture fusions (typically unilateral coronal synostosis) or multiple suture craniosynostosis are possible. The majority of patients diagnosed with craniosynostosis lack an identifiable syndrome or genetic mutation. The etiopathogenesis of these \"nonsyndromic\" forms of craniosynostosis is believed to involve a complex interplay of genetics, epigenetics, and environmental factors. Evaluation of genes implicated in nonsyndromic craniosynostosis has been conflicting; some evidence demonstrates an interplay between genetic and epigenetic influences while others do not.", "label": 1, "is_selected": 0, "text": "Craniosynostosis, or premature fusion of the cranial sutures, occurs in approximately 1 in 2500 live births. The genetic causes and molecular basis of these disorders have greatly expanded over the last 2 decades, with numerous causative and contributory mutations having been identified. The role of fibroblast growth factor receptor (FGFR) mutations in the etiology of certain eponymous forms of craniosynostosis is now well elucidated; the most common syndromes associated with craniosynostosis are Pfeifer (FGFR1, FGFR2), Apert (FGFR2), Crouzon (FGFR2), Saethre-Chotzen (TWIST1), Jackson-Weiss (FGFR2), Greig (GL13), and Muenke (FGFR3) syndromes. Although pathological expression of these mutations often results in bilateral coronal craniosynostosis, single suture fusions (typically unilateral coronal synostosis) or multiple suture craniosynostosis are possible. The majority of patients diagnosed with craniosynostosis lack an identifiable syndrome or genetic mutation. The etiopathogenesis of these \"nonsyndromic\" forms of craniosynostosis is believed to involve a complex interplay of genetics, epigenetics, and environmental factors. Evaluation of genes implicated in nonsyndromic craniosynostosis has been conflicting; some evidence demonstrates an interplay between genetic and epigenetic influences while others do not."}
{"qid": "513711055274a5fb0700000e", "original_text": "Yes, some viruses have been implicated in the etiology of human subacute thyroiditis. The virus most commonly associated with this condition is the Epstein-Barr virus (EBV), which is a common herpesvirus that affects B cells and is known to cause various infectious mononucleosis. Other viruses that have been linked to subacute thyroiditis include human herpesvirus 6 (HHV-6), human adenovirus, and enteroviruses. The exact mechanisms by which these viruses trigger the inflammation and thyroid dysfunction in subacute thyroiditis are not fully understood and require further research.", "label": 0, "is_selected": 0, "text": "Yes, some viruses have been implicated in the etiology of human subacute thyroiditis. The virus most commonly associated with this condition is the Epstein-Barr virus (EBV), which is a common herpesvirus that affects B cells and is known to cause various infectious mononucleosis. Other viruses that have been linked to subacute thyroiditis include human herpesvirus 6 (HHV-6), human adenovirus, and enteroviruses. The exact mechanisms by which these viruses trigger the inflammation and thyroid dysfunction in subacute thyroiditis are not fully understood and require further research."}
{"qid": "58bbc0fc22d300530900001c", "original_text": "The present study aims to investigate the correlation of polymorphisms of SLCO1B1 gene with the toxicity during therapy with the high-dose methotrexate (MTX) chemotherapy in childhood acute lymphoblastic leukemia. We analyzed 2 polymorphisms (rs4149081 and rs11045897) in SLCO1B1 gene in 280 Chinese pediatric B-ALL patients, using MTX plasma concentration as an objective and quantifiable marker of toxicity. We utilized Enzyme-multiplied immunoassay technique (EMIT) to measure the plasma concentration of MTX. The polymerase chain reaction-allele specific (PCR-AS) method was utilized to perform the genotyping. We found there was a statistically significant association between MTX plasma concentration and the SLCO1B1 rs11045879 CC genotype (P<0.05). We also found the rs4149081 AA genotype was associated with high-MTX plasma concentrations.", "label": 1, "is_selected": 0, "text": "The present study aims to investigate the correlation of polymorphisms of SLCO1B1 gene with the toxicity during therapy with the high-dose methotrexate (MTX) chemotherapy in childhood acute lymphoblastic leukemia. We analyzed 2 polymorphisms (rs4149081 and rs11045897) in SLCO1B1 gene in 280 Chinese pediatric B-ALL patients, using MTX plasma concentration as an objective and quantifiable marker of toxicity. We utilized Enzyme-multiplied immunoassay technique (EMIT) to measure the plasma concentration of MTX. The polymerase chain reaction-allele specific (PCR-AS) method was utilized to perform the genotyping. We found there was a statistically significant association between MTX plasma concentration and the SLCO1B1 rs11045879 CC genotype (P<0.05). We also found the rs4149081 AA genotype was associated with high-MTX plasma concentrations."}
{"qid": "623345bf3a8413c6530000ab", "original_text": "LINC00339 is a circulating microRNA (miRNA) that has been identified as a potential biomarker for various diseases, including cancer, cardiovascular disease, and neurological disorders. Specifically, studies have shown that levels of LINC00339 are elevated in certain types of cancer, such as breast, lung, and colorectal cancer, and may serve as a prognostic marker for cancer progression and treatment response. Additionally, LINC00339 has been shown to be involved in the regulation of cellular processes such as cell proliferation, migration, and apoptosis, which makes it a potential therapeutic target for cancer treatment. However, more research is needed to fully understand the role of LINC00339 in cancer and other diseases, and to determine its clinical utility as a biomarker and therapeutictarget.", "label": 0, "is_selected": 0, "text": "LINC00339 is a circulating microRNA (miRNA) that has been identified as a potential biomarker for various diseases, including cancer, cardiovascular disease, and neurological disorders. Specifically, studies have shown that levels of LINC00339 are elevated in certain types of cancer, such as breast, lung, and colorectal cancer, and may serve as a prognostic marker for cancer progression and treatment response. Additionally, LINC00339 has been shown to be involved in the regulation of cellular processes such as cell proliferation, migration, and apoptosis, which makes it a potential therapeutic target for cancer treatment. However, more research is needed to fully understand the role of LINC00339 in cancer and other diseases, and to determine its clinical utility as a biomarker and therapeutictarget."}
{"qid": "5c34b45eda8336e21a000008", "original_text": "Genomic enhancers regulate spatio-temporal gene expression by recruiting specific combinations of transcription factors (TFs). When TFs are bound to active regulatory regions, they displace canonical nucleosomes, making these regions biochemically detectable as nucleosome-depleted regions or accessible/open chromatin.", "label": 1, "is_selected": 0, "text": "Genomic enhancers regulate spatio-temporal gene expression by recruiting specific combinations of transcription factors (TFs). When TFs are bound to active regulatory regions, they displace canonical nucleosomes, making these regions biochemically detectable as nucleosome-depleted regions or accessible/open chromatin."}
{"qid": "61f7d15d882a024a10000031", "original_text": "Oral naltrexone extended-release/bupropion extended-release (naltrexone ER/bupropion ER; Contrave(\u00ae), Mysimba(\u2122)) is available as an adjunct to a reduced-calorie diet and increased physical activity in adults with an initial body mass index (BMI) of \u2265 30 kg/m(2) (i.e. obese) or a BMI of \u2265 27 kg/m(2) (i.e. overweight) in the presence of at least one bodyweight-related comorbidity, such as type 2 diabetes mellitus, hypertension or dyslipidaemia. In 56-week phase III trials in these patient populations, oral naltrexone ER/bupropion ER 32/360 mg/day was significantly more effective than placebo with regard to percentage bodyweight reductions from baseline and the proportion of patients who achieved bodyweight reductions of \u2265 5 and \u2265 10%.", "label": 1, "is_selected": 0, "text": "Oral naltrexone extended-release/bupropion extended-release (naltrexone ER/bupropion ER; Contrave(\u00ae), Mysimba(\u2122)) is available as an adjunct to a reduced-calorie diet and increased physical activity in adults with an initial body mass index (BMI) of \u2265 30 kg/m(2) (i.e. obese) or a BMI of \u2265 27 kg/m(2) (i.e. overweight) in the presence of at least one bodyweight-related comorbidity, such as type 2 diabetes mellitus, hypertension or dyslipidaemia. In 56-week phase III trials in these patient populations, oral naltrexone ER/bupropion ER 32/360 mg/day was significantly more effective than placebo with regard to percentage bodyweight reductions from baseline and the proportion of patients who achieved bodyweight reductions of \u2265 5 and \u2265 10%."}
{"qid": "56bcd422d36b5da378000005", "original_text": "Assessing the prognosis before treatment for metastatic spine tumor is extremely important in therapy selection. Therefore, we review some prognostic scoring systems and their outcomes. Articles with combinations of two keywords among \"metastatic spine tumor\" and \"prognosis\", \"score\", \"scoring system\", \"predicting\", or \"life expectancy\" were searched for in PubMed. As a result, 236 articles were extracted. Those referring to representative scoring systems about predicting the survival of patients with metastatic spine tumors were used. The significance and limits of these scoring systems, and the future perspectives were described. Tokuhashi score, Tomita score, Baur score, Linden score, Rades score, and Katagiri score were introduced. They are all scoring systems prepared by combining factors that affect prognosis. The primary site of cancer and visceral metastasis were common factors in all of these scoring systems. Other factors selected to influence the prognosis varied. They were useful to roughly predict the survival period, such as, \"more than one year or not\" or \"more than six months or not\". In particular, they were utilized for decision-making about operative indications and avoidance of excessive medical treatment. Because the function depended on the survival period in the patients with metastatic spine tumor, it was also utilized in assessing functional prognosis. However, no scoring system had more than 90% consistency between the predicted and actual survival periods.", "label": 1, "is_selected": 0, "text": "Assessing the prognosis before treatment for metastatic spine tumor is extremely important in therapy selection. Therefore, we review some prognostic scoring systems and their outcomes. Articles with combinations of two keywords among \"metastatic spine tumor\" and \"prognosis\", \"score\", \"scoring system\", \"predicting\", or \"life expectancy\" were searched for in PubMed. As a result, 236 articles were extracted. Those referring to representative scoring systems about predicting the survival of patients with metastatic spine tumors were used. The significance and limits of these scoring systems, and the future perspectives were described. Tokuhashi score, Tomita score, Baur score, Linden score, Rades score, and Katagiri score were introduced. They are all scoring systems prepared by combining factors that affect prognosis. The primary site of cancer and visceral metastasis were common factors in all of these scoring systems. Other factors selected to influence the prognosis varied. They were useful to roughly predict the survival period, such as, \"more than one year or not\" or \"more than six months or not\". In particular, they were utilized for decision-making about operative indications and avoidance of excessive medical treatment. Because the function depended on the survival period in the patients with metastatic spine tumor, it was also utilized in assessing functional prognosis. However, no scoring system had more than 90% consistency between the predicted and actual survival periods."}
{"qid": "5c5f1f371a4c55d80b00001a", "original_text": "The normal function of the p53 protein is to act as a tumor suppressor by regulating various cellular processes, including cell growth, DNA repair, and apoptosis (programmed cell death). p53 is a transcription factor that binds to specific DNA sequences and regulates the expression of target genes involved in these cellular processes. In response to DNA damage or other cellular stress, p53 can induce cell cycle arrest, apoptosis, or senescence (a state of permanent cell cycle arrest) to prevent the proliferation of potentially cancerous cells. The dysfunction or loss of p53 can lead to the development of cancer, as it can no longer regulate cell growth and prevent the proliferation of damaged cells.", "label": 0, "is_selected": 0, "text": "The normal function of the p53 protein is to act as a tumor suppressor by regulating various cellular processes, including cell growth, DNA repair, and apoptosis (programmed cell death). p53 is a transcription factor that binds to specific DNA sequences and regulates the expression of target genes involved in these cellular processes. In response to DNA damage or other cellular stress, p53 can induce cell cycle arrest, apoptosis, or senescence (a state of permanent cell cycle arrest) to prevent the proliferation of potentially cancerous cells. The dysfunction or loss of p53 can lead to the development of cancer, as it can no longer regulate cell growth and prevent the proliferation of damaged cells."}
{"qid": "5fe31301a43ad31278000039", "original_text": "Condensin is a structural protein complex that plays a crucial role in compacting chromatin during mitosis and meiosis. In yeast, there are three genes that encode for condensin proteins: CDC6, CDC16, and SMC1. The CDC6 gene encodes for the core histone chaperone subunit of the condensin complex, which is responsible for the binding and remodeling of histones during chromatin compaction. The CDC16 gene encodes for a subunit of the condensin complex that is involved in the interaction with histones and the formation of the chromatin barrier. Finally, the SMC1 gene encodes for a subunit of the condensin complex that is involved in the formation of the chromatin fiber and the regulation of chromatin structure. All three of these genes are essential for cell division in yeast, and mutations in these genes can lead to defects in chromatin condensation and mitotic arrest. Understanding the role of these genes in yeast can provide valuable insights into the mechanisms of chromatin condensation and its importance in cell division.", "label": 0, "is_selected": 1, "text": "In this study, we show that mutations in three genes that encode for condensin proteins can lead to defects in cell division in yeast, and that these genes are essential for the formation and arrest of condensation in the cell, as well as for the regulation of the structure of allin during mitosis and meiosis, and in the formation of the barrier that keeps the cell from breaking down and dividing."}
{"qid": "56e45bc651531f7e33000018", "original_text": "BMAL1 deficiency, also known as blepharophimosis, ptosis, and epicanthus inversus (BPES), is a rare genetic disorder caused by mutations in the BMAL1 gene. The effects of BMAL1 deficiency can vary in severity and may include: * Eye abnormalities: Droopy eyelids (ptosis), excess skin on the eyelids (blepharophimosis), and a fold of skin on the inner corners of the eyes (epicanthus inversus) * Sleep apnea: BMAL1 deficiency can lead to obstructive sleep apnea due to the collapse of the nasal airways during sleep * Respiratory infections: Increased risk of respiratory infections due to the narrowing of the airways * Poor feeding: Newborns with BMAL1 deficiency may have difficulty feeding due to the narrow nasal passages. It is important to note that BMAL1 deficiency is a rare disorder, and the effects may vary in severity and presentation in different individuals. If you suspect you or your child may have BMAL1 deficiency, consult with a healthcare professional for an accurate diagnosis and appropriate treatment.", "label": 0, "is_selected": 1, "text": "BMAL1 deficiency is a genetic disorder that affects the eyelids, nasal passages, and respiratory system, and can cause eye and respiratory problems in newborn children, as well as increased risk of respiratory infections, infections, and sleep problems in older children, adults, and adults with other inherited disorders, including cystic fibrosis, multiple sclerosis, and Huntington's disease, all of which can be caused by BMAL1, according to the National Institutes of Health (NIH)."}
{"qid": "5c5f10791a4c55d80b000014", "original_text": "PolyA polymerase (PAP) adds a polyA tail onto the 3'-end of RNAs without a nucleic acid template, using adenosine-5'-triphosphate (ATP) as a substrate. The mechanism for the substrate selection by eubacterial PAP remains obscure. Structural and biochemical studies of Escherichia coli PAP (EcPAP) revealed that the shape and size of the nucleobase-interacting pocket of EcPAP are maintained by an intra-molecular hydrogen-network, making it suitable for the accommodation of only ATP, using a single amino acid, Arg(197).", "label": 1, "is_selected": 0, "text": "PolyA polymerase (PAP) adds a polyA tail onto the 3'-end of RNAs without a nucleic acid template, using adenosine-5'-triphosphate (ATP) as a substrate. The mechanism for the substrate selection by eubacterial PAP remains obscure. Structural and biochemical studies of Escherichia coli PAP (EcPAP) revealed that the shape and size of the nucleobase-interacting pocket of EcPAP are maintained by an intra-molecular hydrogen-network, making it suitable for the accommodation of only ATP, using a single amino acid, Arg(197)."}
{"qid": "54f35ad864850a5854000004", "original_text": "Alzheimer's disease (AD) is associated with deposition of amyloid-\u03b2 (A\u03b2) in the brain, which is reflected by low concentration of the A\u03b2(1-42) peptide in the cerebrospinal fluid (CSF). The \u03b3-secretase inhibitor LY450139 (semagacestat) lowers plasma A\u03b2(1-40) and A\u03b2(1-42) in a dose-dependent manner but has no clear effect on the CSF level of these isoforms. Less is known about the potent \u03b3-secretase modulator E2012.", "label": 1, "is_selected": 0, "text": "Alzheimer's disease (AD) is associated with deposition of amyloid-\u03b2 (A\u03b2) in the brain, which is reflected by low concentration of the A\u03b2(1-42) peptide in the cerebrospinal fluid (CSF). The \u03b3-secretase inhibitor LY450139 (semagacestat) lowers plasma A\u03b2(1-40) and A\u03b2(1-42) in a dose-dependent manner but has no clear effect on the CSF level of these isoforms. Less is known about the potent \u03b3-secretase modulator E2012."}
{"qid": "61f7cc0c882a024a1000002a", "original_text": "Sutimlimab is an investigational drug targeting glycoprotein A (Glycoprotein A, GPA) and is being developed for the treatment of nephrotic syndrome. Glycoprotein A is a proteoglycan found on the surfaces of many immune cells, including those involved in the kidney's filtration process. In people with nephrotic syndrome, Glycoprotein A is overexpressed on the surfaces of immune cells in the kidneys, leading to inflammation and damage to the kidneys. Sutimlimab works by targeting Glycoprotein A and inhibiting its activity, which can help reduce inflammation and slow the progression of kidney damage.", "label": 0, "is_selected": 1, "text": "The European Medicines Agency (EMA) has granted orphan drug status to Sutimlimab for the treatment of people with a rare form of kidney disease, known as nephrotic syndrome, for which there is no approved treatment or alternative to surgery."}
{"qid": "5a7a44b4faa1ab7d2e000010", "original_text": "According to semiotics, which may be defined as the doctrine of the essential nature and fundamental varieties of signs, objects, and interpretants, pain is considered to be a sign (significant) with very different meanings (significance) either as a naturalistic symptom (of disease) or as a symbol used in a metaphorical context.", "label": 1, "is_selected": 0, "text": "According to semiotics, which may be defined as the doctrine of the essential nature and fundamental varieties of signs, objects, and interpretants, pain is considered to be a sign (significant) with very different meanings (significance) either as a naturalistic symptom (of disease) or as a symbol used in a metaphorical context."}
{"qid": "55032785e9bde69634000031", "original_text": "To study the relation between N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, used as a marker of heart failure in clinical practice, blood pressure (BP), and cognitive decline in the oldest old. In 560 participants of the Leiden 85-plus Study, we measured NT-proBNP levels and BP at age 85 years, at baseline, and global cognitive function (Mini-Mental State Examination [MMSE]) annually during the follow-up of 5 years. Subjects in the highest tertile of NT-proBNP levels scored 1.7 points lower on the MMSE at age 85 years than subjects in the lowest tertile (p = 0.004), and had a 0.24-point-steeper decline in MMSE score per year (p = 0.021). The longitudinal association disappeared after full adjustment for possible confounders (0.14-point-steeper decline, p = 0.187).", "label": 1, "is_selected": 0, "text": "To study the relation between N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, used as a marker of heart failure in clinical practice, blood pressure (BP), and cognitive decline in the oldest old. In 560 participants of the Leiden 85-plus Study, we measured NT-proBNP levels and BP at age 85 years, at baseline, and global cognitive function (Mini-Mental State Examination [MMSE]) annually during the follow-up of 5 years. Subjects in the highest tertile of NT-proBNP levels scored 1.7 points lower on the MMSE at age 85 years than subjects in the lowest tertile (p = 0.004), and had a 0.24-point-steeper decline in MMSE score per year (p = 0.021). The longitudinal association disappeared after full adjustment for possible confounders (0.14-point-steeper decline, p = 0.187)."}
{"qid": "571e469bbb137a4b0c00000d", "original_text": "Recently, Christianson syndrome (CS) has been determined to be caused by mutations in the X-linked Na(+) /H(+) exchanger 6 (NHE6). We aimed to determine the diagnostic criteria and mutational spectrum for CS. Twelve independent pedigrees (14 boys, age = 4-19 years) with mutations in NHE6 were administered standardized research assessments, and mutations were characterized. The mutational spectrum was composed of 9 single nucleotide variants, 2 indels, and 1 copy number variation deletion. All mutations were protein-truncating or splicing mutations. We identified 2 recurrent mutations (c.1498 c>t, p.R500X; and c.1710 g>a, p.W570X). Otherwise, all mutations were unique.", "label": 1, "is_selected": 0, "text": "Recently, Christianson syndrome (CS) has been determined to be caused by mutations in the X-linked Na(+) /H(+) exchanger 6 (NHE6). We aimed to determine the diagnostic criteria and mutational spectrum for CS. Twelve independent pedigrees (14 boys, age = 4-19 years) with mutations in NHE6 were administered standardized research assessments, and mutations were characterized. The mutational spectrum was composed of 9 single nucleotide variants, 2 indels, and 1 copy number variation deletion. All mutations were protein-truncating or splicing mutations. We identified 2 recurrent mutations (c.1498 c>t, p.R500X; and c.1710 g>a, p.W570X). Otherwise, all mutations were unique."}
{"qid": "58a95c711978bbde22000001", "original_text": "Aducanumab is a drug that targets beta-amyloid plaques, which are a hallmark of Alzheimer's disease. The drug is designed to bind to beta-amyloid peptides and reduce their concentration in the brain, which is believed to be one of the underlying causes of Alzheimer's disease. By targeting beta-amyloid plaques, aducanumab aims to slow down or halt the progression of cognitive decline associated with Alzheimer's disease.", "label": 0, "is_selected": 0, "text": "Aducanumab is a drug that targets beta-amyloid plaques, which are a hallmark of Alzheimer's disease. The drug is designed to bind to beta-amyloid peptides and reduce their concentration in the brain, which is believed to be one of the underlying causes of Alzheimer's disease. By targeting beta-amyloid plaques, aducanumab aims to slow down or halt the progression of cognitive decline associated with Alzheimer's disease."}
{"qid": "58b6bd2622d300530900000c", "original_text": "Type III hyperlipoproteinemia (HLP), a disorder associated with a high incidence of premature cardiovascular diseases, is characterized by the accumulation of remnant lipoproteins in the plasma. The primary genetic defect in patients with type III HLP is the presence of apolipoprotein E2 (apoE2), an isoform of apoE, and accumulation of remnant lipoproteins in the plasma has been thought to be attributable to the presence of apoE2, which bind poorly to low density lipoprotein receptors, resulting in defective remnant lipoprotein clearance.", "label": 1, "is_selected": 0, "text": "Type III hyperlipoproteinemia (HLP), a disorder associated with a high incidence of premature cardiovascular diseases, is characterized by the accumulation of remnant lipoproteins in the plasma. The primary genetic defect in patients with type III HLP is the presence of apolipoprotein E2 (apoE2), an isoform of apoE, and accumulation of remnant lipoproteins in the plasma has been thought to be attributable to the presence of apoE2, which bind poorly to low density lipoprotein receptors, resulting in defective remnant lipoprotein clearance."}
{"qid": "603e43d51cb411341a00015e", "original_text": "Four members of the Ixodes ricinus species complex, Ixodes pacificus, Ixodes persulcatus, Ixodes ricinus and Ixodes scapularis, have, between them, a worldwide distribution within the northern hemisphere. They are responsible for the transmission of several animal and human pathogens, including the causal agents of Lyme borreliosis, tick-borne encephalitis, human granulocytic anaplasmosis and human babesiosis. Despite the importance of these ticks as vectors, the knowledge and understanding of the role that diapause plays in their complex life cycles are confused and incomplete.", "label": 1, "is_selected": 0, "text": "Four members of the Ixodes ricinus species complex, Ixodes pacificus, Ixodes persulcatus, Ixodes ricinus and Ixodes scapularis, have, between them, a worldwide distribution within the northern hemisphere. They are responsible for the transmission of several animal and human pathogens, including the causal agents of Lyme borreliosis, tick-borne encephalitis, human granulocytic anaplasmosis and human babesiosis. Despite the importance of these ticks as vectors, the knowledge and understanding of the role that diapause plays in their complex life cycles are confused and incomplete."}
{"qid": "54f49e56d0d681a040000004", "original_text": "This systematic review examines the economic and human costs of depression and the potential savings associated with improvement in patient adherence to treatment with antidepressants through the use of enhanced-care programs. A MEDLINE search was conducted for papers published on the health economics and costs of depression and compliance, adherence, and persistence. Compliance data collected through the online antidepressant compliance support website iCAN (www.ican.co.uk) were compared with data for patients with depression from the IMS Disease Analyzer UK database. Depression frequently causes unemployment, absenteeism, and presenteeism, which results in significantly reduced productivity. Indirect costs of depression accounted for more than $50 billion, whereas direct costs resulted in expenditure of $26 billion, in the US in 2000. Improving patients' compliance with their antidepressant medication results in improved outcomes and prolongs remission from depression, increasing work productivity, and thus reducing overall costs. The implementation of remote enhanced-care programs may improve compliance and reduce overall costs. Novel methods for delivering enhanced-care programs to assist in maintaining compliance have the potential to further reduce costs and should be a focus of future research. In conclusion, depression is a common disorder with a high economic impact. Enhanced-care programs may lower costs associated with depression and improve patients' lives.", "label": 1, "is_selected": 0, "text": "This systematic review examines the economic and human costs of depression and the potential savings associated with improvement in patient adherence to treatment with antidepressants through the use of enhanced-care programs. A MEDLINE search was conducted for papers published on the health economics and costs of depression and compliance, adherence, and persistence. Compliance data collected through the online antidepressant compliance support website iCAN (www.ican.co.uk) were compared with data for patients with depression from the IMS Disease Analyzer UK database. Depression frequently causes unemployment, absenteeism, and presenteeism, which results in significantly reduced productivity. Indirect costs of depression accounted for more than $50 billion, whereas direct costs resulted in expenditure of $26 billion, in the US in 2000. Improving patients' compliance with their antidepressant medication results in improved outcomes and prolongs remission from depression, increasing work productivity, and thus reducing overall costs. The implementation of remote enhanced-care programs may improve compliance and reduce overall costs. Novel methods for delivering enhanced-care programs to assist in maintaining compliance have the potential to further reduce costs and should be a focus of future research. In conclusion, depression is a common disorder with a high economic impact. Enhanced-care programs may lower costs associated with depression and improve patients' lives."}
{"qid": "5a6fa31ab750ff445500005e", "original_text": "Transcriptional enhancers regulate spatio-temporal gene expression. While genomic assays can identify putative enhancers en masse, assigning target genes is a complex challenge. We devised a machine learning approach, McEnhancer, which links target genes to putative enhancers via a semi-supervised learning algorithm that predicts gene expression patterns based on enriched sequence features.", "label": 1, "is_selected": 0, "text": "Transcriptional enhancers regulate spatio-temporal gene expression. While genomic assays can identify putative enhancers en masse, assigning target genes is a complex challenge. We devised a machine learning approach, McEnhancer, which links target genes to putative enhancers via a semi-supervised learning algorithm that predicts gene expression patterns based on enriched sequence features."}
{"qid": "533c3af6c45e13371400000d", "original_text": "Mutations in the CYLD gene have been associated with several pathological conditions, including: 1. Noonan syndrome: A rare genetic disorder characterized by short stature, congenital heart defects, and other physical abnormalities. 2. Costello syndrome: A rare genetic disorder that affects growth and development, and can cause a range of physical abnormalities, including short stature, facial dysmorphism, and cardiovascular problems. 3. Down syndrome: A genetic disorder that occurs when there is an extra copy of chromosome 21, which can cause delays in physical and cognitive development, as well as a range of medical problems. 4. Autism spectrum disorder: Some mutations in the CYLD gene have been linked to an increased risk of autism spectrum disorder. 5. Neuroblastoma: A type of cancer that develops in immature nerve cells, and can cause a range of symptoms including abdominal pain, fever, and weight loss. I hope this information is helpful. If you have any further questions, please don't hesitate to ask.", "label": 0, "is_selected": 0, "text": "Mutations in the CYLD gene have been associated with several pathological conditions, including: 1. Noonan syndrome: A rare genetic disorder characterized by short stature, congenital heart defects, and other physical abnormalities. 2. Costello syndrome: A rare genetic disorder that affects growth and development, and can cause a range of physical abnormalities, including short stature, facial dysmorphism, and cardiovascular problems. 3. Down syndrome: A genetic disorder that occurs when there is an extra copy of chromosome 21, which can cause delays in physical and cognitive development, as well as a range of medical problems. 4. Autism spectrum disorder: Some mutations in the CYLD gene have been linked to an increased risk of autism spectrum disorder. 5. Neuroblastoma: A type of cancer that develops in immature nerve cells, and can cause a range of symptoms including abdominal pain, fever, and weight loss. I hope this information is helpful. If you have any further questions, please don't hesitate to ask."}
{"qid": "58b5320e22d3005309000002", "original_text": "We present four cases of ocular melanosis. Choroidal melanoma was detected in all of them. Three eyes had decreased visual acuity and were enucleated because of their large, active tumours. In the fourth case the melanoma was detected in a routine examination and we were able to apply a preserving treatment with I125 brachytherapy. Melanosis oculi is often underestimated as a risk factor for uveal melanoma and glaucoma. Ophthalmic surveillance, every 6 or 12 months is important, in patients with ocular melanocytosis for early detection of high risk diseases.", "label": 1, "is_selected": 0, "text": "We present four cases of ocular melanosis. Choroidal melanoma was detected in all of them. Three eyes had decreased visual acuity and were enucleated because of their large, active tumours. In the fourth case the melanoma was detected in a routine examination and we were able to apply a preserving treatment with I125 brachytherapy. Melanosis oculi is often underestimated as a risk factor for uveal melanoma and glaucoma. Ophthalmic surveillance, every 6 or 12 months is important, in patients with ocular melanocytosis for early detection of high risk diseases."}
{"qid": "5a6f960fb750ff445500005c", "original_text": "Rapid antigen detection testing (RADT) is often performed for diagnosis of group A beta-hemolytic streptococcal (GABHS) pharyngitis among children. Among adults, the sensitivity of this test varies on the basis of disease severity (spectrum bias). A similar phenomenon may occur when this test is used in a pediatric population, which may affect the need for culture confirmation of all negative RADT results. To assess the performance of a clinical scoring system and to determine whether RADT spectrum bias is present among children who are evaluated for GABHS pharyngitis.", "label": 1, "is_selected": 0, "text": "Rapid antigen detection testing (RADT) is often performed for diagnosis of group A beta-hemolytic streptococcal (GABHS) pharyngitis among children. Among adults, the sensitivity of this test varies on the basis of disease severity (spectrum bias). A similar phenomenon may occur when this test is used in a pediatric population, which may affect the need for culture confirmation of all negative RADT results. To assess the performance of a clinical scoring system and to determine whether RADT spectrum bias is present among children who are evaluated for GABHS pharyngitis."}
{"qid": "5542644fed966d112c000004", "original_text": "The annotated genomes of two closely related strains of the intracellular bacterium Wolbachia pipientis have been reported without the identifications of the putative origin of replication (ori). Identifying the ori of these bacteria and related alpha-Proteobacteria as well as their patterns of sequence evolution will aid studies of cell replication and cell density, as well as the potential genetic manipulation of these widespread intracellular bacteria. Using features that have been previously experimentally verified in the alpha-Proteobacterium Caulobacter crescentus, the origin of DNA replication (ori) regions were identified in silico for Wolbachia strains and eleven other related bacteria belonging to Ehrlichia, Anaplasma, and Rickettsia genera. These features include DnaA-, CtrA- and IHF-binding sites as well as the flanking genes in C. crescentus. The Wolbachia ori boundary genes were found to be hemE and COG1253 protein (CBS domain protein). Comparisons of the putative ori region among related Wolbachia strains showed higher conservation of bases within binding sites. The sequences of the ori regions described here are only similar among closely related bacteria while fundamental characteristics like presence of DnaA and IHF binding sites as well as the boundary genes are more widely conserved. The relative paucity of CtrA binding sites in the ori regions, as well as the absence of key enzymes associated with DNA replication in the respective genomes, suggest that several of these obligate intracellular bacteria may have altered replication mechanisms. Based on these analyses, criteria are set forth for identifying the ori region in genome sequencing projects.", "label": 1, "is_selected": 0, "text": "The annotated genomes of two closely related strains of the intracellular bacterium Wolbachia pipientis have been reported without the identifications of the putative origin of replication (ori). Identifying the ori of these bacteria and related alpha-Proteobacteria as well as their patterns of sequence evolution will aid studies of cell replication and cell density, as well as the potential genetic manipulation of these widespread intracellular bacteria. Using features that have been previously experimentally verified in the alpha-Proteobacterium Caulobacter crescentus, the origin of DNA replication (ori) regions were identified in silico for Wolbachia strains and eleven other related bacteria belonging to Ehrlichia, Anaplasma, and Rickettsia genera. These features include DnaA-, CtrA- and IHF-binding sites as well as the flanking genes in C. crescentus. The Wolbachia ori boundary genes were found to be hemE and COG1253 protein (CBS domain protein). Comparisons of the putative ori region among related Wolbachia strains showed higher conservation of bases within binding sites. The sequences of the ori regions described here are only similar among closely related bacteria while fundamental characteristics like presence of DnaA and IHF binding sites as well as the boundary genes are more widely conserved. The relative paucity of CtrA binding sites in the ori regions, as well as the absence of key enzymes associated with DNA replication in the respective genomes, suggest that several of these obligate intracellular bacteria may have altered replication mechanisms. Based on these analyses, criteria are set forth for identifying the ori region in genome sequencing projects."}
{"qid": "56c1f02cef6e39474100004c", "original_text": "The GV1001 vaccine targets the enzyme glycoprotein B (GPB) of the Neisseria meningitidis bacteria. GPB is a key component of the bacterial membrane and plays a critical role in the invasion and colonization of host cells. By targeting GPB, the GV1001 vaccine aims to prevent the bacteria from entering and multiplying within host cells, thereby providing protection against meningococcal disease.", "label": 0, "is_selected": 1, "text": "A new vaccine for the prevention and treatment of meningococcal disease has been developed by the University of British Columbia (UBC) and the Canadian Institutes of Health Research (CIHR). By targeting GPB, the GV1001 vaccine aims to prevent the bacteria from entering and multiplying within host cells, thereby providing protection against meningitis disease."}
{"qid": "56f82f9acf1c325851000002", "original_text": "Single-cell prokaryotes represent a simple and primitive cellular life form. The identification of the essential genes of bacteria and the minimal genome for the free-living cellular life could provide insights into the origin, evolution, and essence of life forms. The principles, methodology, and recent progresses in the identification of essential genes and minimal genome and the creation of synthetic cells are reviewed and particularly the strategies for creating the minimal genome and the potential applications are introduced.", "label": 1, "is_selected": 0, "text": "Single-cell prokaryotes represent a simple and primitive cellular life form. The identification of the essential genes of bacteria and the minimal genome for the free-living cellular life could provide insights into the origin, evolution, and essence of life forms. The principles, methodology, and recent progresses in the identification of essential genes and minimal genome and the creation of synthetic cells are reviewed and particularly the strategies for creating the minimal genome and the potential applications are introduced."}
{"qid": "61f7c60c882a024a10000025", "original_text": "The FDA has approved the first KRAS-targeted therapy, sotorasib, for patients with previously treated non-small cell lung cancer with KRASG12C mutations. In a phase II trial, the drug yielded a median progression-free survival of 6.8 months in patients whose disease had advanced despite treatment with standard therapies, namely platinum-based chemotherapy and PD-1-PD-L1 inhibitors.", "label": 1, "is_selected": 0, "text": "The FDA has approved the first KRAS-targeted therapy, sotorasib, for patients with previously treated non-small cell lung cancer with KRASG12C mutations. In a phase II trial, the drug yielded a median progression-free survival of 6.8 months in patients whose disease had advanced despite treatment with standard therapies, namely platinum-based chemotherapy and PD-1-PD-L1 inhibitors."}
{"qid": "5518e817622b194345000006", "original_text": "There are three isoforms of the Ras oncogenes: HRas, KRas, and NRas. HRas and KRas are the most well-known isoforms and are expressed in nearly all tissues, while NRas is primarily expressed in neural tissues. HRas and KRas are synthesized as precursor proteins, HRasPro and KRasPro, respectively, and are processed to generate the active HRas and KRas proteins. NRas is synthesized as a full-length protein and does not undergo processing. The activation of Ras oncogenes is regulated by GTP binding and hydrolysis, and they play a crucial role in signaling pathways involved in cell proliferation, differentiation, and survival.", "label": 0, "is_selected": 0, "text": "There are three isoforms of the Ras oncogenes: HRas, KRas, and NRas. HRas and KRas are the most well-known isoforms and are expressed in nearly all tissues, while NRas is primarily expressed in neural tissues. HRas and KRas are synthesized as precursor proteins, HRasPro and KRasPro, respectively, and are processed to generate the active HRas and KRas proteins. NRas is synthesized as a full-length protein and does not undergo processing. The activation of Ras oncogenes is regulated by GTP binding and hydrolysis, and they play a crucial role in signaling pathways involved in cell proliferation, differentiation, and survival."}
{"qid": "601d6fe11cb411341a000033", "original_text": "We evaluated the safety, efficacy, pharmacokinetics, pharmacodynamics and predictive biomarkers of tirabrutinib, a second-generation, enhanced-selectivity Bruton's tyrosine kinase inhibitor in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma (B-cell NHL) and chronic lymphocytic leukemia (CLL). This was an open-label, multicenter, phase I study. Seventeen patients (male N = 8) with a median age of 70 years were enrolled in 4 dose cohorts (160 mg once daily [N = 3], 320 mg once daily [N = 3], 480 mg once daily [N = 4] and 300 mg twice daily [N = 7]); 4 patients had continued tirabrutinib administration as of 4 January 2018. The maximum tolerated dose was not reached. Pneumonitis (N = 1) was the dose-limiting toxicity for 300 mg twice daily. Common adverse events (AEs) were rash (35.3%) and vomiting (29.4%). Eight patients (47.1%) developed grade \u22653 AEs: neutropenia (23.5%), anemia (11.8%) and leukopenia (11.8%) were frequent. The overall response rate (\u2265PR) was 76.5% (13/17 patients), including 4 DLBCL patients with no CD79A/B or MYD88 mutations, and 1 CLL patient with a TP53 mutation, providing promising data for future developments. Of 16 patients with measurable lesions during the screening period, 12 showed \u226550% reductions in tumor diameter. In many patients, the tumor size decreased soon after beginning treatment.", "label": 1, "is_selected": 0, "text": "We evaluated the safety, efficacy, pharmacokinetics, pharmacodynamics and predictive biomarkers of tirabrutinib, a second-generation, enhanced-selectivity Bruton's tyrosine kinase inhibitor in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma (B-cell NHL) and chronic lymphocytic leukemia (CLL). This was an open-label, multicenter, phase I study. Seventeen patients (male N = 8) with a median age of 70 years were enrolled in 4 dose cohorts (160 mg once daily [N = 3], 320 mg once daily [N = 3], 480 mg once daily [N = 4] and 300 mg twice daily [N = 7]); 4 patients had continued tirabrutinib administration as of 4 January 2018. The maximum tolerated dose was not reached. Pneumonitis (N = 1) was the dose-limiting toxicity for 300 mg twice daily. Common adverse events (AEs) were rash (35.3%) and vomiting (29.4%). Eight patients (47.1%) developed grade \u22653 AEs: neutropenia (23.5%), anemia (11.8%) and leukopenia (11.8%) were frequent. The overall response rate (\u2265PR) was 76.5% (13/17 patients), including 4 DLBCL patients with no CD79A/B or MYD88 mutations, and 1 CLL patient with a TP53 mutation, providing promising data for future developments. Of 16 patients with measurable lesions during the screening period, 12 showed \u226550% reductions in tumor diameter. In many patients, the tumor size decreased soon after beginning treatment."}
{"qid": "55001420e9bde69634000005", "original_text": "Mowat-Wilson syndrome is a mental retardation-multiple congenital anomaly syndrome characterized by a typical facies, developmental delay, epilepsy, and variable congenital malformations, including Hirschsprung disease, urogenital anomalies, congenital heart disease, and agenesis of the corpus callosum. This disorder is sporadic and is caused by heterozygous mutations or deletions of the ZFHX1B gene located in the 2q22 region. We report here the first Moroccan patient, born to consanguineous parents, with Mowat-Wilson syndrome, due to a de novo, unreported mutation of the ZFHX1B gene.", "label": 1, "is_selected": 0, "text": "Mowat-Wilson syndrome is a mental retardation-multiple congenital anomaly syndrome characterized by a typical facies, developmental delay, epilepsy, and variable congenital malformations, including Hirschsprung disease, urogenital anomalies, congenital heart disease, and agenesis of the corpus callosum. This disorder is sporadic and is caused by heterozygous mutations or deletions of the ZFHX1B gene located in the 2q22 region. We report here the first Moroccan patient, born to consanguineous parents, with Mowat-Wilson syndrome, due to a de novo, unreported mutation of the ZFHX1B gene."}
{"qid": "5a760a4183b0d9ea66000016", "original_text": "Filgotinib is an oral, small molecule inhibitor of the enzyme Janus kinase 1 (JAK1) and Janus kinase 2 (JAK2), which are key regulators of the JAK-signal transducer and activator of transcription (STAT) signaling pathway. This pathway is involved in the regulation of immune cells and inflammation. Filgotinib is being developed for the treatment of various inflammatory and autoimmune diseases, including rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD). It has shown potent and selective activity against JAK1 and JAK2, with a high affinity for these enzymes. In preclinical studies, filgotinib has been shown to inhibit the activation of T cells and dendritic cells, and reduce the production of pro-inflammatory cytokines. In clinical trials, filgotinib has been studied in patients with moderate-to-severe RA, psoriasis, and IBD. In these studies, filgotinib has been shown to be well-tolerated and has demonstrated significant improvements in disease activity scores, including reductions in tender joint counts, swollen joint counts, and psoriasis area and severity index (PASI) scores. While filgotinib has shown promise as a potential treatment for inflammatory and autoimmune diseases, it is important to note that it is still an investigational drug and has not yet been approved by regulatory authorities for commercial use. Further research is needed to fully understand the safety and efficacy of filgotinib in humans.", "label": 0, "is_selected": 0, "text": "Filgotinib is an oral, small molecule inhibitor of the enzyme Janus kinase 1 (JAK1) and Janus kinase 2 (JAK2), which are key regulators of the JAK-signal transducer and activator of transcription (STAT) signaling pathway. This pathway is involved in the regulation of immune cells and inflammation. Filgotinib is being developed for the treatment of various inflammatory and autoimmune diseases, including rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD). It has shown potent and selective activity against JAK1 and JAK2, with a high affinity for these enzymes. In preclinical studies, filgotinib has been shown to inhibit the activation of T cells and dendritic cells, and reduce the production of pro-inflammatory cytokines. In clinical trials, filgotinib has been studied in patients with moderate-to-severe RA, psoriasis, and IBD. In these studies, filgotinib has been shown to be well-tolerated and has demonstrated significant improvements in disease activity scores, including reductions in tender joint counts, swollen joint counts, and psoriasis area and severity index (PASI) scores. While filgotinib has shown promise as a potential treatment for inflammatory and autoimmune diseases, it is important to note that it is still an investigational drug and has not yet been approved by regulatory authorities for commercial use. Further research is needed to fully understand the safety and efficacy of filgotinib in humans."}
{"qid": "58ca746d02b8c6095300002d", "original_text": "The cell death-inducing DNA fragmentation factor alpha-like effector c (CIDEC; also known in rodents as FSP27 or fat-specific protein 27) is a lipid droplet-associated protein that promotes intracellular triglyceride (TAG) storage. CIDEC/Fsp27 is highly expressed in adipose tissue, but undetectable in normal liver. However, its hepatic expression rises during fasting or under genetic or diet-induced hepatosteatosis in both mice and patients. Herein, we demonstrate that CIDEC/Fsp27 is a direct transcriptional target of the nuclear receptor PPAR\u03b1 (peroxisome proliferator-activated receptor alpha) in both mouse and human hepatocytes, and that preventing Fsp27 induction accelerates PPAR\u03b1-stimulated fatty acid oxidation. We show that adenoviral-mediated silencing of hepatic Fsp27 abolishes fasting-induced liver steatosis in the absence of changes in plasma lipids. Finally, we report that anti-Fsp27 short hairpin RNA and PPAR\u03b1 agonists synergize to ameliorate hepatosteatosis in mice fed a high fat diet. Together, our data highlight the physiological importance of CIDEC/Fsp27 in TAG homeostasis under both physiological and pathological liver steatosis.", "label": 1, "is_selected": 0, "text": "The cell death-inducing DNA fragmentation factor alpha-like effector c (CIDEC; also known in rodents as FSP27 or fat-specific protein 27) is a lipid droplet-associated protein that promotes intracellular triglyceride (TAG) storage. CIDEC/Fsp27 is highly expressed in adipose tissue, but undetectable in normal liver. However, its hepatic expression rises during fasting or under genetic or diet-induced hepatosteatosis in both mice and patients. Herein, we demonstrate that CIDEC/Fsp27 is a direct transcriptional target of the nuclear receptor PPAR\u03b1 (peroxisome proliferator-activated receptor alpha) in both mouse and human hepatocytes, and that preventing Fsp27 induction accelerates PPAR\u03b1-stimulated fatty acid oxidation. We show that adenoviral-mediated silencing of hepatic Fsp27 abolishes fasting-induced liver steatosis in the absence of changes in plasma lipids. Finally, we report that anti-Fsp27 short hairpin RNA and PPAR\u03b1 agonists synergize to ameliorate hepatosteatosis in mice fed a high fat diet. Together, our data highlight the physiological importance of CIDEC/Fsp27 in TAG homeostasis under both physiological and pathological liver steatosis."}
{"qid": "5e5e50751af46fc13000000b", "original_text": "Retapamulin belongs to the class of drugs called aminoglycoside antibiotics. These drugs work by interfering with the synthesis of bacterial proteins, which are essential for bacterial growth and survival. Aminoglycoside antibiotics are commonly used to treat bacterial infections such as pneumonia, meningitis, and sepsis. Retapamulin is specifically classified as a lysozyme-stable antibiotic, which means it is resistant to degradation by lysozyme, an enzyme found in human tears and mucus. This makes it effective in treating bacterial infections in the eye and respiratory tract.", "label": 0, "is_selected": 0, "text": "Retapamulin belongs to the class of drugs called aminoglycoside antibiotics. These drugs work by interfering with the synthesis of bacterial proteins, which are essential for bacterial growth and survival. Aminoglycoside antibiotics are commonly used to treat bacterial infections such as pneumonia, meningitis, and sepsis. Retapamulin is specifically classified as a lysozyme-stable antibiotic, which means it is resistant to degradation by lysozyme, an enzyme found in human tears and mucus. This makes it effective in treating bacterial infections in the eye and respiratory tract."}
{"qid": "5171393e8ed59a060a000005", "original_text": "To investigate the influence of trimetazidine, which is known to be an antioxidant and modulator of metabolism, on cardiac function and the development of diabetic cardiomyopathy in db/db mouse. Trimetazidine was administered to db/db mice for eight weeks. Cardiac function was measured by inserting a Millar catheter into the left ventricle, and oxidative stress and AMP-activated protein kinase (AMPK) activity in the myocardium were evaluated. Untreated db/db mice exhibited a significant decrease in cardiac function compared to normal C57 mice. Oxidative stress and lipid deposition were markedly increased in the myocardium, concomitant with inactivation of AMPK and increased expression of peroxisome proliferator-activated receptor coactivator-1 alpha (PGC-1 alpha). Trimetazidine significantly improved systolic and diastolic function in hearts of db/db mice and led to reduced production of reactive oxygen species and deposition of fatty acid in cardiomyocytes.", "label": 1, "is_selected": 0, "text": "To investigate the influence of trimetazidine, which is known to be an antioxidant and modulator of metabolism, on cardiac function and the development of diabetic cardiomyopathy in db/db mouse. Trimetazidine was administered to db/db mice for eight weeks. Cardiac function was measured by inserting a Millar catheter into the left ventricle, and oxidative stress and AMP-activated protein kinase (AMPK) activity in the myocardium were evaluated. Untreated db/db mice exhibited a significant decrease in cardiac function compared to normal C57 mice. Oxidative stress and lipid deposition were markedly increased in the myocardium, concomitant with inactivation of AMPK and increased expression of peroxisome proliferator-activated receptor coactivator-1 alpha (PGC-1 alpha). Trimetazidine significantly improved systolic and diastolic function in hearts of db/db mice and led to reduced production of reactive oxygen species and deposition of fatty acid in cardiomyocytes."}
{"qid": "5fdb42b7a43ad31278000025", "original_text": "Super enhancers are typically located in close proximity to the gene they regulate, and are structurally embedded within chromatin loops. Chromatin loops are three-dimensional structures that bring distant regulatory elements and gene promoters into close proximity, allowing for more efficient gene regulation. Super enhancers are thought to be insulated from the surrounding chromatin by specialized structural features, such as histone modifications and nucleosome depletion, which create a protected environment for gene expression.", "label": 0, "is_selected": 0, "text": "Super enhancers are typically located in close proximity to the gene they regulate, and are structurally embedded within chromatin loops. Chromatin loops are three-dimensional structures that bring distant regulatory elements and gene promoters into close proximity, allowing for more efficient gene regulation. Super enhancers are thought to be insulated from the surrounding chromatin by specialized structural features, such as histone modifications and nucleosome depletion, which create a protected environment for gene expression."}
{"qid": "5c56033607647bbc4b00000c", "original_text": "Yes, tisagenlecleucel is effective for B-cell lymphoma. Tisagenlecleucel, also known as Kymriah, is a CD19-targeted chimeric antigen receptor (CAR) T cell therapy that has shown promising results in treating B-cell acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL). Studies have shown that tisagenlecleucel can induce complete remissions in patients with relapsed or refractory B-cell malignancies, with response rates of up to 90% in ALL and 50% in DLBCL. However, it's important to note that tisagenlecleucel can also cause severe side effects, including cytokine release syndrome (CRS) and neurotoxicity, and patients may require close monitoring and supportive care to manage these adverse events.", "label": 0, "is_selected": 1, "text": "What is tisagenlecleucel and is it effective for B-cell lymphoma, and can I take it with me on my next trip to the dentist, or is it only for relapsed or refractory B- cell lymphoma?., asked by a Reddit user."}
{"qid": "6025912a1cb411341a0000aa", "original_text": "Approximately 30% of patients with rheumatoid arthritis (RA) respond inadequately to conventional-synthetic disease-modifying anti-rheumatic drugs (csDMARDs). However, widespread use of biologic DMARDs (bDMARDs) and targeted-synthetic (tsDMARDs) is limited by cost. We formulated updated recommendations for eligibility criteria for government-assisted funding of bDMARDs/tsDMARDs for RA patients in Singapore. Published guidelines regarding use of bDMARD and tsDMARDs were reviewed. We excluded those without a systematic literature review, formal consensus process or evidence grading. Separately, unpublished national reimbursement guidelines were included.", "label": 1, "is_selected": 0, "text": "Approximately 30% of patients with rheumatoid arthritis (RA) respond inadequately to conventional-synthetic disease-modifying anti-rheumatic drugs (csDMARDs). However, widespread use of biologic DMARDs (bDMARDs) and targeted-synthetic (tsDMARDs) is limited by cost. We formulated updated recommendations for eligibility criteria for government-assisted funding of bDMARDs/tsDMARDs for RA patients in Singapore. Published guidelines regarding use of bDMARD and tsDMARDs were reviewed. We excluded those without a systematic literature review, formal consensus process or evidence grading. Separately, unpublished national reimbursement guidelines were included."}
{"qid": "5abc974bfcf456587200001f", "original_text": "It is generally believed that splicing removes introns as single units from precursor messenger RNA transcripts. However, some long Drosophila melanogaster introns contain a cryptic site, known as a recursive splice site (RS-site), that enables a multi-step process of intron removal termed recursive splicing. The extent to which recursive splicing occurs in other species and its mechanistic basis have not been examined. Here we identify highly conserved RS-sites in genes expressed in the mammalian brain that encode proteins functioning in neuronal development. Moreover, the RS-sites are found in some of the longest introns across vertebrates. We find that vertebrate recursive splicing requires initial definition of an 'RS-exon' that follows the RS-site. The RS-exon is then excluded from the dominant mRNA isoform owing to competition with a reconstituted 5' splice site formed at the RS-site after the first splicing step. Conversely, the RS-exon is included when preceded by cryptic promoters or exons that fail to reconstitute an efficient 5' splice site.", "label": 1, "is_selected": 0, "text": "It is generally believed that splicing removes introns as single units from precursor messenger RNA transcripts. However, some long Drosophila melanogaster introns contain a cryptic site, known as a recursive splice site (RS-site), that enables a multi-step process of intron removal termed recursive splicing. The extent to which recursive splicing occurs in other species and its mechanistic basis have not been examined. Here we identify highly conserved RS-sites in genes expressed in the mammalian brain that encode proteins functioning in neuronal development. Moreover, the RS-sites are found in some of the longest introns across vertebrates. We find that vertebrate recursive splicing requires initial definition of an 'RS-exon' that follows the RS-site. The RS-exon is then excluded from the dominant mRNA isoform owing to competition with a reconstituted 5' splice site formed at the RS-site after the first splicing step. Conversely, the RS-exon is included when preceded by cryptic promoters or exons that fail to reconstitute an efficient 5' splice site."}
{"qid": "534ab91eaeec6fbd07000012", "original_text": "Bladder cancer cells illustrate major disruptions in their DNA methylation patterns as compared with normal ones. Authors aimed to identify epigenetic molecular markers in urine for early detection of bladder cancer. We retrospectively analyzed the methylation status of RAR\u03b2(2) and APC genes in urine samples from 210 bladder cancer patients, 61 patients with benign urological diseases, and 49 healthy volunteers by using methylation-specific PCR. Methylated RAR\u03b2(2) and APC were significantly higher in bladder cancer patients (62.8%, 59.5%) than benign (16.4%, 5%) but not detected in healthy volunteers (0%) at (P < 0.0001). Both methylated genes showed no significant difference among clinicopathologic factors; however, they were detected in all grades and stages. Among the 128 patients with bilharzial bladder cancer, 94 (73.4%) showed methylated RAR\u03b2(2) and 86 (67.2%) showed methylated APC. Homoplasmic methylation pattern of both genes were only detected in bilharzial bladder cancer cases. Both sensitivities and specificities of the methylated genes for bladder cancer detection were superior to urine cytology and when altogether combined, the sensitivities improved to (91.8%), (93.5%), (91.9%), and (80.9%) in detection of: bladder cancer, non-muscle invasive bladder cancer, low-grade tumors, and bilharzial associated bladder cancer, respectively. Thus, methylated RAR\u03b2(2) and APC genes might be valuable urinary molecular markers for early detection of bilharzial and nonbilharzial bladder cancer.", "label": 1, "is_selected": 0, "text": "Bladder cancer cells illustrate major disruptions in their DNA methylation patterns as compared with normal ones. Authors aimed to identify epigenetic molecular markers in urine for early detection of bladder cancer. We retrospectively analyzed the methylation status of RAR\u03b2(2) and APC genes in urine samples from 210 bladder cancer patients, 61 patients with benign urological diseases, and 49 healthy volunteers by using methylation-specific PCR. Methylated RAR\u03b2(2) and APC were significantly higher in bladder cancer patients (62.8%, 59.5%) than benign (16.4%, 5%) but not detected in healthy volunteers (0%) at (P < 0.0001). Both methylated genes showed no significant difference among clinicopathologic factors; however, they were detected in all grades and stages. Among the 128 patients with bilharzial bladder cancer, 94 (73.4%) showed methylated RAR\u03b2(2) and 86 (67.2%) showed methylated APC. Homoplasmic methylation pattern of both genes were only detected in bilharzial bladder cancer cases. Both sensitivities and specificities of the methylated genes for bladder cancer detection were superior to urine cytology and when altogether combined, the sensitivities improved to (91.8%), (93.5%), (91.9%), and (80.9%) in detection of: bladder cancer, non-muscle invasive bladder cancer, low-grade tumors, and bilharzial associated bladder cancer, respectively. Thus, methylated RAR\u03b2(2) and APC genes might be valuable urinary molecular markers for early detection of bilharzial and nonbilharzial bladder cancer."}
{"qid": "589a246a78275d0c4a000031", "original_text": "Verubecestat, also known as GSK'872, is an oral BET (bromodomain and extraterminal) inhibitor that targets the bromodomain proteins BRD2, BRD3, and BRDT. These proteins play a critical role in the regulation of gene expression by binding to acetylated histone proteins. By inhibiting BET proteins, verubecestat disrupts the gene regulation process, leading to the activation of pro-apoptotic genes and the inhibition of anti-apoptotic genes, ultimately resulting in the death of cancer cells.", "label": 0, "is_selected": 1, "text": "The following is a list of some of the key therapeutic proteins that are involved in the development of verubecestat: therapeutic proteins under Development by Companies /Universities /Institutes descriptive of all the products under development by Companies/Universities/Institutes Isis Pharmaceuticals, Inc, Bristol-Myers Squibb Company, bluebird bio, Inc., Eisai Co., Ltd, Galapagos NV, Millennium Pharmaceuticals, Plc, Merck KGaA, Novartis AG, Pfizer"}
{"qid": "58db9aa28acda34529000018", "original_text": "Type 2 diabetes mellitus (T2DM) is associated with elevated plasma apolipoprotein B and triglycerides levels, reduced HDL cholesterol and the presence of small-dense LDL particles. The present study was conducted to investigate the role of plasma proprotein convertase subtilisin kexin type 9 (PCSK9) levels, a regulator of LDL-receptor expression, in the occurrence of diabetic dyslipidemia.", "label": 1, "is_selected": 0, "text": "Type 2 diabetes mellitus (T2DM) is associated with elevated plasma apolipoprotein B and triglycerides levels, reduced HDL cholesterol and the presence of small-dense LDL particles. The present study was conducted to investigate the role of plasma proprotein convertase subtilisin kexin type 9 (PCSK9) levels, a regulator of LDL-receptor expression, in the occurrence of diabetic dyslipidemia."}
{"qid": "626aab13e764a5320400003b", "original_text": "Epigenetic regulation involves changes in gene expression independent of DNA sequence variation that are inherited through cell division. In addition to a fundamental role in cell differentiation, some epigenetic changes can also be transmitted transgenerationally through meiosis. Epigenetic alterations (epimutations) could thus contribute to heritable variation within populations and be subject to evolutionary processes such as natural selection and drift. However, the rate at which epimutations arise and their typical persistence are unknown, making it difficult to evaluate their potential for evolutionary adaptation.", "label": 1, "is_selected": 0, "text": "Epigenetic regulation involves changes in gene expression independent of DNA sequence variation that are inherited through cell division. In addition to a fundamental role in cell differentiation, some epigenetic changes can also be transmitted transgenerationally through meiosis. Epigenetic alterations (epimutations) could thus contribute to heritable variation within populations and be subject to evolutionary processes such as natural selection and drift. However, the rate at which epimutations arise and their typical persistence are unknown, making it difficult to evaluate their potential for evolutionary adaptation."}
{"qid": "5e4f2aeb6d0a277941000032", "original_text": "Protein kinases are known primarily for their ability to phosphorylate protein substrates, which constitutes an essential biological process. Recently, compelling evidence has accumulated that the functions of many protein kinases extend beyond phosphorylation and include an impressive spectrum of non-catalytic roles, such as scaffolding, allosteric regulation, or even protein-DNA interactions. How the conserved kinase fold shared by all metazoan protein kinases can accomplish these diverse tasks in a specific and regulated manner is poorly understood. In this review, we analyze the molecular mechanisms supporting phosphorylation-independent signaling by kinases and attempt to identify common and unique structural characteristics that enable kinases to perform non-catalytic functions. We also discuss how post-translational modifications, protein-protein interactions, and small molecules modulate these non-canonical kinase functions. Finally, we highlight current efforts in the targeted design of small-molecule modulators of non-catalytic kinase functions, a new pharmacological challenge for which structural considerations are more important than ever.", "label": 1, "is_selected": 0, "text": "Protein kinases are known primarily for their ability to phosphorylate protein substrates, which constitutes an essential biological process. Recently, compelling evidence has accumulated that the functions of many protein kinases extend beyond phosphorylation and include an impressive spectrum of non-catalytic roles, such as scaffolding, allosteric regulation, or even protein-DNA interactions. How the conserved kinase fold shared by all metazoan protein kinases can accomplish these diverse tasks in a specific and regulated manner is poorly understood. In this review, we analyze the molecular mechanisms supporting phosphorylation-independent signaling by kinases and attempt to identify common and unique structural characteristics that enable kinases to perform non-catalytic functions. We also discuss how post-translational modifications, protein-protein interactions, and small molecules modulate these non-canonical kinase functions. Finally, we highlight current efforts in the targeted design of small-molecule modulators of non-catalytic kinase functions, a new pharmacological challenge for which structural considerations are more important than ever."}
{"qid": "601d6ec61cb411341a000032", "original_text": "Mutations in the TRIM8 gene have been described in patients with severe developmental delay, intellectual disability and epilepsy. Only six patients have been described to date. All the previous mutations were truncating variants clustered in the C-terminus of the protein. A previous patient with TRIM8-related epileptic encephalopathy was reported to have nephrotic syndrome. Here we describe the clinical, radiological and histological features of an 8-year-old male patient with a TRIM8 mutation who, in contrast to previous patients, had only mild intellectual disability and well-controlled epilepsy. The patient was found to have proteinuria at 2 years of age. Renal biopsy findings were suggestive of focal segmental glomerulosclerosis. His kidney function declined and peritoneal dialysis was started at 5 years of age. He underwent renal transplant at 7 years of age. Trio-based whole genome sequencing identified a novel de novo heterozygous frameshift mutation in TRIM8 (NM_030912.2) c.1198_1220del, p.(Tyr400ArgfsTer2). This patient is further evidence that TRIM8 mutations cause a syndrome with both neurological and renal features. Our findings suggest the spectrum of TRIM8-related disease may be wider than previously thought with the possibility of milder neurodevelopmental problems and/or a more severe, progressive renal phenotype.", "label": 1, "is_selected": 0, "text": "Mutations in the TRIM8 gene have been described in patients with severe developmental delay, intellectual disability and epilepsy. Only six patients have been described to date. All the previous mutations were truncating variants clustered in the C-terminus of the protein. A previous patient with TRIM8-related epileptic encephalopathy was reported to have nephrotic syndrome. Here we describe the clinical, radiological and histological features of an 8-year-old male patient with a TRIM8 mutation who, in contrast to previous patients, had only mild intellectual disability and well-controlled epilepsy. The patient was found to have proteinuria at 2 years of age. Renal biopsy findings were suggestive of focal segmental glomerulosclerosis. His kidney function declined and peritoneal dialysis was started at 5 years of age. He underwent renal transplant at 7 years of age. Trio-based whole genome sequencing identified a novel de novo heterozygous frameshift mutation in TRIM8 (NM_030912.2) c.1198_1220del, p.(Tyr400ArgfsTer2). This patient is further evidence that TRIM8 mutations cause a syndrome with both neurological and renal features. Our findings suggest the spectrum of TRIM8-related disease may be wider than previously thought with the possibility of milder neurodevelopmental problems and/or a more severe, progressive renal phenotype."}
{"qid": "5e31cc22fbd6abf43b000050", "original_text": "Genetic hemochromatosis is classified into four subtypes of which only type 1 is of clinical importance in Caucasians. Type 1 is due to an autosomal recessive inborn error of metabolism; the homozygous C282Y mutation of the HFE gene on chromosome 6 accounts for more than 90% of the clinical phenotype in populations of Celtic origin. The mutation leads to an inadequately high intestinal iron absorption which may finally cause iron overload in and damage to various organs. Type 2 is the juvenile form of iron overload which leads to a severe phenotype prior to age 30 with cardiomyopathy and hypogonadism. The corresponding mutations are located in the hemojuveline and hepcidin genes. Typ 3 has mainly been described in Italian families and refers to mutations in transferrin receptor 2 gene. Histopathologic and clinical consequences of type 3 hemochromatosis are similar to those seen in type 1. Types 2 and 3 are autosomal recessive traits.", "label": 1, "is_selected": 0, "text": "Genetic hemochromatosis is classified into four subtypes of which only type 1 is of clinical importance in Caucasians. Type 1 is due to an autosomal recessive inborn error of metabolism; the homozygous C282Y mutation of the HFE gene on chromosome 6 accounts for more than 90% of the clinical phenotype in populations of Celtic origin. The mutation leads to an inadequately high intestinal iron absorption which may finally cause iron overload in and damage to various organs. Type 2 is the juvenile form of iron overload which leads to a severe phenotype prior to age 30 with cardiomyopathy and hypogonadism. The corresponding mutations are located in the hemojuveline and hepcidin genes. Typ 3 has mainly been described in Italian families and refers to mutations in transferrin receptor 2 gene. Histopathologic and clinical consequences of type 3 hemochromatosis are similar to those seen in type 1. Types 2 and 3 are autosomal recessive traits."}
{"qid": "5c72f9847c78d69471000081", "original_text": "Visual snow syndrome (VSS) is a relatively rare condition characterized by the presence of a persistent, static, or moving snow-like visual disturbance in the visual field. The symptoms of VSS can vary in severity and may include: * A persistent, flickering, or pulsing sensation in the visual field, often described as a \"snow\" or \"static\" pattern * Difficulty focusing or maintaining gaze, often leading to eye strain or fatigue * Blurred or distorted vision, particularly in the periphery of the visual field * Sensitivity to light and glare * Eye movements that are abnormal or uncoordinated * Headaches or migraines, often associated with visual disturbances * Difficulty reading, driving, or performing other visually demanding tasks It is important to note that the symptoms of VSS can vary in severity and may be accompanied by other neurological symptoms such as seizures, tremors, or difficulty with coordination and balance. If you suspect you or someone you know may be experiencing visual snow syndrome, it is important to consult with a qualified medical professional for proper diagnosis and treatment.", "label": 0, "is_selected": 1, "text": "If you or someone you know is experiencing any of the symptoms of visual snow syndrome, it is important to consult with a qualified medical professional for proper diagnosis and treatment. If you suspect you or anyone you know may be experiencing visual snow Syndrome, it's important to Consult with a Qualified Medical Professional for Proper diagnosis and Treatment. If You Suspect You Or Someone You Know Is Having Visual Snow Syndrome, It's Important to Consult With a qualified Medical Professional For Proper diagnosis And treatment."}
{"qid": "621ecc3e3a8413c653000060", "original_text": "Drug repositioning identifies new indications for known drugs. Here we report repositioning of the malaria drug amodiaquine as a potential anti-cancer agent. While most repositioning efforts emerge through serendipity, we have devised a computational approach, which exploits interaction patterns shared between compounds. As a test case, we took the anti-viral drug brivudine (BVDU), which also has anti-cancer activity, and defined ten interaction patterns using our tool PLIP. These patterns characterise BVDU's interaction with its target s. Using PLIP we performed an in silico screen of all structural data currently available and identified the FDA approved malaria drug amodiaquine as a promising repositioning candidate. We validated our prediction by showing that amodiaquine suppresses chemoresistance in a multiple myeloma cancer cell line by inhibiting the chaperone function of the cancer target Hsp27.", "label": 1, "is_selected": 0, "text": "Drug repositioning identifies new indications for known drugs. Here we report repositioning of the malaria drug amodiaquine as a potential anti-cancer agent. While most repositioning efforts emerge through serendipity, we have devised a computational approach, which exploits interaction patterns shared between compounds. As a test case, we took the anti-viral drug brivudine (BVDU), which also has anti-cancer activity, and defined ten interaction patterns using our tool PLIP. These patterns characterise BVDU's interaction with its target s. Using PLIP we performed an in silico screen of all structural data currently available and identified the FDA approved malaria drug amodiaquine as a promising repositioning candidate. We validated our prediction by showing that amodiaquine suppresses chemoresistance in a multiple myeloma cancer cell line by inhibiting the chaperone function of the cancer target Hsp27."}
{"qid": "58cdbaf302b8c60953000044", "original_text": "The N-end rule pathway is a proteolytic system in which destabilizing N-terminal residues of short-lived proteins act as degradation determinants (N-degrons). Substrates carrying N-degrons are recognized by N-recognins that mediate ubiquitylation-dependent selective proteolysis through the proteasome. Our previous studies identified the mammalian N-recognin family consisting of UBR1/E3\u03b1, UBR2, UBR4/p600, and UBR5, which recognize destabilizing N-terminal residues through the UBR box. In the current study, we addressed the physiological function of a poorly characterized N-recognin, 570-kDa UBR4, in mammalian development. UBR4-deficient mice die during embryogenesis and exhibit pleiotropic abnormalities, including impaired vascular development in the yolk sac (YS). Vascular development in UBR4-deficient YS normally advances through vasculogenesis but is arrested during angiogenic remodeling of primary capillary plexus associated with accumulation of autophagic vacuoles.", "label": 1, "is_selected": 0, "text": "The N-end rule pathway is a proteolytic system in which destabilizing N-terminal residues of short-lived proteins act as degradation determinants (N-degrons). Substrates carrying N-degrons are recognized by N-recognins that mediate ubiquitylation-dependent selective proteolysis through the proteasome. Our previous studies identified the mammalian N-recognin family consisting of UBR1/E3\u03b1, UBR2, UBR4/p600, and UBR5, which recognize destabilizing N-terminal residues through the UBR box. In the current study, we addressed the physiological function of a poorly characterized N-recognin, 570-kDa UBR4, in mammalian development. UBR4-deficient mice die during embryogenesis and exhibit pleiotropic abnormalities, including impaired vascular development in the yolk sac (YS). Vascular development in UBR4-deficient YS normally advances through vasculogenesis but is arrested during angiogenic remodeling of primary capillary plexus associated with accumulation of autophagic vacuoles."}
{"qid": "58e75d483e8b6dc87c000005", "original_text": "The expression of GATA-1 isoforms is controlled by the GATA-1 gene. Specifically, the promoter region of the GATA-1 gene contains specific regulatory elements that control the expression of different isoforms of the protein. The most well-studied of these isoforms are GATA-1alpha and GATA-1beta, which are produced through alternative splicing of the GATA-1 gene transcript. The ratio of GATA-1alpha to GATA-1beta isoforms can be modulated by various factors, including transcriptional regulators, signaling pathways, and environmental cues.", "label": 0, "is_selected": 0, "text": "The expression of GATA-1 isoforms is controlled by the GATA-1 gene. Specifically, the promoter region of the GATA-1 gene contains specific regulatory elements that control the expression of different isoforms of the protein. The most well-studied of these isoforms are GATA-1alpha and GATA-1beta, which are produced through alternative splicing of the GATA-1 gene transcript. The ratio of GATA-1alpha to GATA-1beta isoforms can be modulated by various factors, including transcriptional regulators, signaling pathways, and environmental cues."}
{"qid": "58a2e5f760087bc10a000007", "original_text": "Mutations in the alpha-synuclein gene have been linked to rare cases of familial Parkinson's disease (PD). Alpha-synuclein is a major component of Lewy bodies (LB), a pathological hallmark of PD. Transgenic mice and Drosophila expressing either wild-type or mutant human alpha-synuclein develop motor deficits, LB-like inclusions in some neurons, and neuronal degeneration. However, the relationship between abnormal aggregates of alpha-synuclein and human dopamine (DA) neuron degeneration remains unclear. In this report, we have investigated the influence of alpha-synuclein expression on DA neurons in primary culture of embryonic human mesencephalon. Two days after culture, human DA cells were transduced with wild-type or mutant human (Ala(53)Thr) alpha-synuclein adenoviruses and maintained for 5 days.", "label": 1, "is_selected": 0, "text": "Mutations in the alpha-synuclein gene have been linked to rare cases of familial Parkinson's disease (PD). Alpha-synuclein is a major component of Lewy bodies (LB), a pathological hallmark of PD. Transgenic mice and Drosophila expressing either wild-type or mutant human alpha-synuclein develop motor deficits, LB-like inclusions in some neurons, and neuronal degeneration. However, the relationship between abnormal aggregates of alpha-synuclein and human dopamine (DA) neuron degeneration remains unclear. In this report, we have investigated the influence of alpha-synuclein expression on DA neurons in primary culture of embryonic human mesencephalon. Two days after culture, human DA cells were transduced with wild-type or mutant human (Ala(53)Thr) alpha-synuclein adenoviruses and maintained for 5 days."}
{"qid": "532673c4d6d3ac6a34000009", "original_text": "Although triiodothyronine deficiency has been described after cardiopulmonary bypass, data supporting its use have been conflicting. A double-blind, randomized, placebo-controlled study was undertaken to further define the effect of triiodothyronine on hemodynamics and outcome after coronary artery bypass grafting. A total of 170 patients undergoing elective coronary artery bypass grafting were enrolled and completed the study from November 1996 through March 1998. On removal of the aortic crossclamp, patients were randomized to receive either intravenous triiodothyronine (0.4 microgram/kg bolus plus 0.1 microgram/kg infusion administered over a 6-hour period, n = 81) or placebo (n = 89). Outcome variables included hemodynamic profile and inotropic drug/pressor requirements at several time points (mean +/- standard error of the mean), perioperative morbidity (arrhythmia/ischemia/infarction), and mortality. Despite similar baseline characteristics, patients randomized to triiodothyronine had a higher cardiac index and lower inotropic requirements after the operation. Subjects receiving triiodothyronine demonstrated a significantly lower incidence of postoperative myocardial ischemia (4% vs 18%, P =.007) and pacemaker dependence (14% vs 25%, P =.013).", "label": 1, "is_selected": 0, "text": "Although triiodothyronine deficiency has been described after cardiopulmonary bypass, data supporting its use have been conflicting. A double-blind, randomized, placebo-controlled study was undertaken to further define the effect of triiodothyronine on hemodynamics and outcome after coronary artery bypass grafting. A total of 170 patients undergoing elective coronary artery bypass grafting were enrolled and completed the study from November 1996 through March 1998. On removal of the aortic crossclamp, patients were randomized to receive either intravenous triiodothyronine (0.4 microgram/kg bolus plus 0.1 microgram/kg infusion administered over a 6-hour period, n = 81) or placebo (n = 89). Outcome variables included hemodynamic profile and inotropic drug/pressor requirements at several time points (mean +/- standard error of the mean), perioperative morbidity (arrhythmia/ischemia/infarction), and mortality. Despite similar baseline characteristics, patients randomized to triiodothyronine had a higher cardiac index and lower inotropic requirements after the operation. Subjects receiving triiodothyronine demonstrated a significantly lower incidence of postoperative myocardial ischemia (4% vs 18%, P =.007) and pacemaker dependence (14% vs 25%, P =.013)."}
{"qid": "54fc4e2e6ea36a810c000003", "original_text": "Piebaldism is an uncommon autosomal dominantly inherited pigment anomaly characterized by a congenital white forelock and leukoderma on the frontal scalp, forehead, ventral trunk and extremities. It is caused by a loss-of-function mutation in the KIT gene. Genetic analyses reveal a consistent genotype-phenotype relationship in piebaldism. However, recently reported cases of piebaldism that are milder or severer than genetically expected indicate that other factors, such as a modifier gene of MC1R, influence skin and hair color.", "label": 1, "is_selected": 0, "text": "Piebaldism is an uncommon autosomal dominantly inherited pigment anomaly characterized by a congenital white forelock and leukoderma on the frontal scalp, forehead, ventral trunk and extremities. It is caused by a loss-of-function mutation in the KIT gene. Genetic analyses reveal a consistent genotype-phenotype relationship in piebaldism. However, recently reported cases of piebaldism that are milder or severer than genetically expected indicate that other factors, such as a modifier gene of MC1R, influence skin and hair color."}
{"qid": "56af5abb0a360a5e45000012", "original_text": "We combine immunofluorescence and single-molecule fluorescence in situ hybridization (smFISH), followed by automated image analysis, to quantify the concentration of nuclear transcription factors, number of transcription factors bound, and number of nascent mRNAs synthesized at individual gene loci. A theoretical model is used to decipher how transcription factor binding modulates the stochastic kinetics of mRNA production. We demonstrate this approach by examining the regulation of hunchback in the early Drosophila embryo.", "label": 1, "is_selected": 0, "text": "We combine immunofluorescence and single-molecule fluorescence in situ hybridization (smFISH), followed by automated image analysis, to quantify the concentration of nuclear transcription factors, number of transcription factors bound, and number of nascent mRNAs synthesized at individual gene loci. A theoretical model is used to decipher how transcription factor binding modulates the stochastic kinetics of mRNA production. We demonstrate this approach by examining the regulation of hunchback in the early Drosophila embryo."}
{"qid": "58da1aa08acda34529000012", "original_text": "To determine the relative importance of thyroid hormones and human chorionic gonadotropin in the etiology of hyperemesis gravidarum. A prospective study comparing the hormonal status in women with hyperemesis gravidarum (5-18 weeks), with healthy pregnant controls, matched for gestational age. Sensitive thyroid stimulating hormone, free thyroxine, free triiodothyronine and total beta human chorionic gonadotropin were measured by immunoassays. The hormone results for hyperemesis gravidarum group (n=58) were compared with pregnant control women (n=58) using the Mann Whitney test. Stepwise logistic regression analysis was performed to determine which variables were significantly associated with hyperemesis gravidarum and to estimate the probability of each woman having hyperemesis gravidarum.", "label": 1, "is_selected": 0, "text": "To determine the relative importance of thyroid hormones and human chorionic gonadotropin in the etiology of hyperemesis gravidarum. A prospective study comparing the hormonal status in women with hyperemesis gravidarum (5-18 weeks), with healthy pregnant controls, matched for gestational age. Sensitive thyroid stimulating hormone, free thyroxine, free triiodothyronine and total beta human chorionic gonadotropin were measured by immunoassays. The hormone results for hyperemesis gravidarum group (n=58) were compared with pregnant control women (n=58) using the Mann Whitney test. Stepwise logistic regression analysis was performed to determine which variables were significantly associated with hyperemesis gravidarum and to estimate the probability of each woman having hyperemesis gravidarum."}
{"qid": "61f9cc19c9dfcb9c09000003", "original_text": "We present SPar-K (Signal Partitioning with K-means), a method to search for archetypical chromatin architectures by partitioning a set of genomic regions characterized by chromatin signal profiles around ChIP-seq peaks and other kinds of functional sites. This method efficiently deals with problems of data heterogeneity, limited misalignment of anchor points and unknown orientation of asymmetric patterns. SPar-K is a C++ program available on GitHub https://github.com/romaingroux/SPar-K and Docker Hub https://hub.docker.com/r/rgroux/spar-k. Supplementary data are available at Bioinformatics online.", "label": 1, "is_selected": 0, "text": "We present SPar-K (Signal Partitioning with K-means), a method to search for archetypical chromatin architectures by partitioning a set of genomic regions characterized by chromatin signal profiles around ChIP-seq peaks and other kinds of functional sites. This method efficiently deals with problems of data heterogeneity, limited misalignment of anchor points and unknown orientation of asymmetric patterns. SPar-K is a C++ program available on GitHub https://github.com/romaingroux/SPar-K and Docker Hub https://hub.docker.com/r/rgroux/spar-k. Supplementary data are available at Bioinformatics online."}
{"qid": "5522fadb7b523f2123000001", "original_text": "NOTCH proteins (NOTCH1, NOTCH2, NOTCH3 and NOTCH4) play crucial roles in embryonic development. Also, mounting evidence indicates that NOTCH contributes to the pathogenesis of hematopoietic and solid malignancies. Recent studies reported a high incidence of gain-of-function mutations of the NOTCH1 gene in T-cell acute lymphoblastic leukemias (ALL). To see whether NOTCH1 mutation occurs in other malignancies, we analyzed NOTCH1 for the detection of somatic mutations in 334 malignancies, including 48 lung, 48 breast, 48 colorectal and 48 gastric carcinomas, and 142 acute leukemias (105 acute myelogenous leukemias, 32 B-ALLs and 4 T-ALLs) by single-strand conformation polymorphism assay. Also, to see whether other NOTCH genes harbor somatic mutations, we analyzed NOTCH2, NOTCH3 and NOTCH4 genes in the same tissue samples.", "label": 1, "is_selected": 0, "text": "NOTCH proteins (NOTCH1, NOTCH2, NOTCH3 and NOTCH4) play crucial roles in embryonic development. Also, mounting evidence indicates that NOTCH contributes to the pathogenesis of hematopoietic and solid malignancies. Recent studies reported a high incidence of gain-of-function mutations of the NOTCH1 gene in T-cell acute lymphoblastic leukemias (ALL). To see whether NOTCH1 mutation occurs in other malignancies, we analyzed NOTCH1 for the detection of somatic mutations in 334 malignancies, including 48 lung, 48 breast, 48 colorectal and 48 gastric carcinomas, and 142 acute leukemias (105 acute myelogenous leukemias, 32 B-ALLs and 4 T-ALLs) by single-strand conformation polymorphism assay. Also, to see whether other NOTCH genes harbor somatic mutations, we analyzed NOTCH2, NOTCH3 and NOTCH4 genes in the same tissue samples."}
{"qid": "5e3a6a4eb5b409ea53000016", "original_text": "One-and-a-half syndrome is characterized by combination of the clinical features of unilateral horizontal gaze palsy and internuclear ophthalmoplegia. The common symptoms are double vision and oscillopsia. The lesion is located in the paramedian pontine reticular formation, involving the centre of horizontal gaze and medial longitudinal fasciculus. More extensive brainstem damage may result in additional neurological signs. The most frequent underlying diseases are vascular insults, multiple sclerosis, and brainstem tumor.", "label": 1, "is_selected": 0, "text": "One-and-a-half syndrome is characterized by combination of the clinical features of unilateral horizontal gaze palsy and internuclear ophthalmoplegia. The common symptoms are double vision and oscillopsia. The lesion is located in the paramedian pontine reticular formation, involving the centre of horizontal gaze and medial longitudinal fasciculus. More extensive brainstem damage may result in additional neurological signs. The most frequent underlying diseases are vascular insults, multiple sclerosis, and brainstem tumor."}
{"qid": "601c3fc21cb411341a000019", "original_text": "Finerenone is a selective, non-steroidal mineralocorticoid receptor antagonist. In vivo and in vitro studies were performed to assess absolute bioavailability of finerenone, the effect of metabolic enzyme inhibitors on the pharmacokinetics of finerenone and its metabolites, the quantitative contribution of the involved enzymes cytochrome P450 (CYP) 3A4 and CYP2C8 and the relevance of gut wall versus liver metabolism. The pharmacokinetics, safety and tolerability of finerenone (1.25-10 mg orally or 0.25-1.0 mg intravenously) were evaluated in healthy male volunteers in four crossover studies. Absolute bioavailability was assessed in volunteers receiving finerenone orally and by intravenous infusion (n = 15) and the effects of erythromycin (n = 15), verapamil (n = 13) and gemfibrozil (n = 16) on finerenone pharmacokinetics were investigated. Finerenone was also incubated with cryopreserved human hepatocytes in vitro in the presence of erythromycin, verapamil or gemfibrozil.", "label": 1, "is_selected": 0, "text": "Finerenone is a selective, non-steroidal mineralocorticoid receptor antagonist. In vivo and in vitro studies were performed to assess absolute bioavailability of finerenone, the effect of metabolic enzyme inhibitors on the pharmacokinetics of finerenone and its metabolites, the quantitative contribution of the involved enzymes cytochrome P450 (CYP) 3A4 and CYP2C8 and the relevance of gut wall versus liver metabolism. The pharmacokinetics, safety and tolerability of finerenone (1.25-10 mg orally or 0.25-1.0 mg intravenously) were evaluated in healthy male volunteers in four crossover studies. Absolute bioavailability was assessed in volunteers receiving finerenone orally and by intravenous infusion (n = 15) and the effects of erythromycin (n = 15), verapamil (n = 13) and gemfibrozil (n = 16) on finerenone pharmacokinetics were investigated. Finerenone was also incubated with cryopreserved human hepatocytes in vitro in the presence of erythromycin, verapamil or gemfibrozil."}
{"qid": "52b2ecd34003448f55000003", "original_text": "We describe clinical, electrophysiological, histopathological and molecular features of a unique disease caused by mutations in the glycyl-tRNA synthetase (GARS) gene. Sixty patients from five multigenerational families have been evaluated. The disease is characterized by adolescent onset of weakness, and atrophy of thenar and first dorsal interosseus muscles progressing to involve foot and peroneal muscles in most but not all cases. Mild to moderate sensory deficits develop in a minority of patients. Neurophysiologically confirmed chronic denervation in distal muscles with reduced compound motor action potentials were features consistent with both motor neuronal and axonal pathology. Sural nerve biopsy showed mild to moderate selective loss of small- and medium-sized myelinated and small unmyelinated axons, although sensory nerve action potentials were not significantly decreased.", "label": 1, "is_selected": 0, "text": "We describe clinical, electrophysiological, histopathological and molecular features of a unique disease caused by mutations in the glycyl-tRNA synthetase (GARS) gene. Sixty patients from five multigenerational families have been evaluated. The disease is characterized by adolescent onset of weakness, and atrophy of thenar and first dorsal interosseus muscles progressing to involve foot and peroneal muscles in most but not all cases. Mild to moderate sensory deficits develop in a minority of patients. Neurophysiologically confirmed chronic denervation in distal muscles with reduced compound motor action potentials were features consistent with both motor neuronal and axonal pathology. Sural nerve biopsy showed mild to moderate selective loss of small- and medium-sized myelinated and small unmyelinated axons, although sensory nerve action potentials were not significantly decreased."}
{"qid": "5c910ae0ecadf2e73f000007", "original_text": "As part of its single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufacturer (Bristol-Myers Squibb) of nivolumab (Opdivo\u00ae) to submit evidence of its clinical and cost effectiveness for metastatic or unresectable urothelial cancer. Kleijnen Systematic Reviews Ltd, in collaboration with Maastricht University Medical Centre+, was commissioned to act as the independent Evidence Review Group (ERG), which produced a detailed review of the evidence for the clinical and cost effectiveness of the technology, based on the company's submission to NICE.", "label": 1, "is_selected": 0, "text": "As part of its single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufacturer (Bristol-Myers Squibb) of nivolumab (Opdivo\u00ae) to submit evidence of its clinical and cost effectiveness for metastatic or unresectable urothelial cancer. Kleijnen Systematic Reviews Ltd, in collaboration with Maastricht University Medical Centre+, was commissioned to act as the independent Evidence Review Group (ERG), which produced a detailed review of the evidence for the clinical and cost effectiveness of the technology, based on the company's submission to NICE."}
{"qid": "5aa825b1fcf4565872000003", "original_text": "Liquid-liquid phase separation (LLPS) of RNA-binding proteins plays an important role in the formation of multiple membrane-less organelles involved in RNA metabolism, including stress granules. Defects in stress granule homeostasis constitute a cornerstone of ALS/FTLD pathogenesis. Polar residues (tyrosine and glutamine) have been previously demonstrated to be critical for phase separation of ALS-linked stress granule proteins.", "label": 1, "is_selected": 0, "text": "Liquid-liquid phase separation (LLPS) of RNA-binding proteins plays an important role in the formation of multiple membrane-less organelles involved in RNA metabolism, including stress granules. Defects in stress granule homeostasis constitute a cornerstone of ALS/FTLD pathogenesis. Polar residues (tyrosine and glutamine) have been previously demonstrated to be critical for phase separation of ALS-linked stress granule proteins."}
{"qid": "5c5f18501a4c55d80b000017", "original_text": "The Leucosporidium ice-binding protein, also known as LIG, is a key component of the Leucosporidium genus of protists, which are eukaryotic microorganisms that are found in a variety of aquatic environments. The LIG protein is responsible for the organism's ability to survive and thrive in cold environments, such as glaciers and ice masses. The LIG protein is a small, globular protein that is highly hydrophilic and contains a number of hydrophobic amino acids. This unique arrangement allows the protein to bind to ice crystals and protect them from melting, allowing the protist to survive in environments that would otherwise be inhospitable. The protein also plays a role in the organism's nutrient uptake and metabolism, as it can interact with the cell membrane and facilitate the transport of essential nutrients. Studies have shown that the LIG protein is highly conserved across the Leucosporidium genus, indicating its importance for the organism's survival and adaptation to cold environments. Understanding the structure and function of the LIG protein has implications for the development of novel antifreeze agents and the study of the evolutionary mechanisms that enable organisms to adapt to extreme environments.", "label": 0, "is_selected": 1, "text": "The structure and function of an ice-binding protein have been unravelled by researchers at the University of Cambridge and King's College London, as part of a study published in Plos One on 7 March 2016.<n> Studies have shown that the LIG protein is highly conserved across the Leucosporidium genus, indicating its importance for the organism's survival and adaptation to cold environments.<n> The structure of the protein has implications for the development of novel antifreeze agents and the study of the evolutionary mechanisms that enable organisms to adapt to extreme environments."}
{"qid": "5c588d0986df2b9174000003", "original_text": "Treatment of brain tumors remains challenging. Cytoreductive surgery is used as the first line treatment for most brain tumors. However complete, curative, resection is not achievable in many tumors leading to the need for adjuvant chemotherapy and radiation therapy. Laser interstitial thermal therapy (LITT) is a minimally invasive cytoreductive treatment. A low voltage laser is used to induce hyperthermia and to kill tumor cells. The extent of thermal damage is controlled through use of real-time MR-thermography guidance. Initial results have shown the feasibility of LITT for a variety of brain pathologies. LITT can be considered as an alternative type of surgery for difficult to access brain tumors and also for tumors in patients who are deemed high risk for more traditional surgery. Randomized trials are currently planned to continue assessing the efficacy of LITT and long-term follow-up data are awaited.", "label": 1, "is_selected": 0, "text": "Treatment of brain tumors remains challenging. Cytoreductive surgery is used as the first line treatment for most brain tumors. However complete, curative, resection is not achievable in many tumors leading to the need for adjuvant chemotherapy and radiation therapy. Laser interstitial thermal therapy (LITT) is a minimally invasive cytoreductive treatment. A low voltage laser is used to induce hyperthermia and to kill tumor cells. The extent of thermal damage is controlled through use of real-time MR-thermography guidance. Initial results have shown the feasibility of LITT for a variety of brain pathologies. LITT can be considered as an alternative type of surgery for difficult to access brain tumors and also for tumors in patients who are deemed high risk for more traditional surgery. Randomized trials are currently planned to continue assessing the efficacy of LITT and long-term follow-up data are awaited."}
{"qid": "5a981e66fcd1d6a10c00002f", "original_text": "Metabolic Syndrome X is a clinical entity which comprises the following factors: diabetes mellitus, arterial hypertension, high levels of triglyceride and/or low levels of HDL cholesterol, central obesity and microalbuminuria (by WHO criteria). The first goal of this study was to determine the frequency of the Metabolic Syndrome X (MSX) in patients with acute myocardial infarction compared with the general population. The second goal of the study was to examine the frequency of heart failure and reinfarction rate in the patients with myocardial infarction, with and without MSX. Furthermore, the relationship between gender and MSX was analyzed. A total of 101 patients with acute myocardial infarction took part in randomized trial (32 women and 69 men).", "label": 1, "is_selected": 0, "text": "Metabolic Syndrome X is a clinical entity which comprises the following factors: diabetes mellitus, arterial hypertension, high levels of triglyceride and/or low levels of HDL cholesterol, central obesity and microalbuminuria (by WHO criteria). The first goal of this study was to determine the frequency of the Metabolic Syndrome X (MSX) in patients with acute myocardial infarction compared with the general population. The second goal of the study was to examine the frequency of heart failure and reinfarction rate in the patients with myocardial infarction, with and without MSX. Furthermore, the relationship between gender and MSX was analyzed. A total of 101 patients with acute myocardial infarction took part in randomized trial (32 women and 69 men)."}
{"qid": "569e731cca240fa209000003", "original_text": "Enhancers control the correct temporal and cell-type-specific activation of gene expression in multicellular eukaryotes. Knowing their properties, regulatory activity and targets is crucial to understand the regulation of differentiation and homeostasis. Here we use the FANTOM5 panel of samples, covering the majority of human tissues and cell types, to produce an atlas of active, in vivo-transcribed enhancers. We show that enhancers share properties with CpG-poor messenger RNA promoters but produce bidirectional, exosome-sensitive, relatively short unspliced RNAs, the generation of which is strongly related to enhancer activity. The atlas is used to compare regulatory programs between different cells at unprecedented depth, to identify disease-associated regulatory single nucleotide polymorphisms, and to classify cell-type-specific and ubiquitous enhancers.", "label": 1, "is_selected": 0, "text": "Enhancers control the correct temporal and cell-type-specific activation of gene expression in multicellular eukaryotes. Knowing their properties, regulatory activity and targets is crucial to understand the regulation of differentiation and homeostasis. Here we use the FANTOM5 panel of samples, covering the majority of human tissues and cell types, to produce an atlas of active, in vivo-transcribed enhancers. We show that enhancers share properties with CpG-poor messenger RNA promoters but produce bidirectional, exosome-sensitive, relatively short unspliced RNAs, the generation of which is strongly related to enhancer activity. The atlas is used to compare regulatory programs between different cells at unprecedented depth, to identify disease-associated regulatory single nucleotide polymorphisms, and to classify cell-type-specific and ubiquitous enhancers."}
{"qid": "6201a85cc9dfcb9c0900002a", "original_text": "The relationship between chromatin organization and gene regulation remains unclear. While disruption of chromatin domains and domain boundaries can lead to misexpression of developmental genes, acute depletion of regulators of genome organization has a relatively small effect on gene expression. It is therefore uncertain whether gene expression and chromatin state drive chromatin organization or whether changes in chromatin organization facilitate cell-type-specific activation of gene expression. Here, using the dorsoventral patterning of the Drosophila melanogaster embryo as a model system, we provide evidence for the independence of chromatin organization and dorsoventral gene expression. We define tissue-specific enhancers and link them to expression patterns using single-cell RNA-seq. Surprisingly, despite tissue-specific chromatin states and gene expression, chromatin organization is largely maintained across tissues.", "label": 1, "is_selected": 0, "text": "The relationship between chromatin organization and gene regulation remains unclear. While disruption of chromatin domains and domain boundaries can lead to misexpression of developmental genes, acute depletion of regulators of genome organization has a relatively small effect on gene expression. It is therefore uncertain whether gene expression and chromatin state drive chromatin organization or whether changes in chromatin organization facilitate cell-type-specific activation of gene expression. Here, using the dorsoventral patterning of the Drosophila melanogaster embryo as a model system, we provide evidence for the independence of chromatin organization and dorsoventral gene expression. We define tissue-specific enhancers and link them to expression patterns using single-cell RNA-seq. Surprisingly, despite tissue-specific chromatin states and gene expression, chromatin organization is largely maintained across tissues."}
{"qid": "5e7745ea835f4e4777000006", "original_text": "We evaluated the efficacy and tolerability of 3- and 6-month leuprorelin acetate (LA) depot formulations (Eligard\u00ae, Astellas Pharma GmbH) in patients with advanced prostate cancer treated in routine clinical practice in Germany. Data was pooled from 2 prospective, open-label, non-interventional studies in which 1,906 patients were treated for 12 months with either the 3-month (n = 633) or 6-month (n = 1,273) LA formulation.", "label": 1, "is_selected": 0, "text": "We evaluated the efficacy and tolerability of 3- and 6-month leuprorelin acetate (LA) depot formulations (Eligard\u00ae, Astellas Pharma GmbH) in patients with advanced prostate cancer treated in routine clinical practice in Germany. Data was pooled from 2 prospective, open-label, non-interventional studies in which 1,906 patients were treated for 12 months with either the 3-month (n = 633) or 6-month (n = 1,273) LA formulation."}
{"qid": "623648723a8413c6530000af", "original_text": "IDD stands for Infectious Disease Development. In the context of organ transplantation, IDD refers to the risk of developing an infectious disease after the transplant. This can occur due to various factors, including the immunosuppressive drugs used to prevent rejection of the transplanted organ, the patient's underlying health conditions, and the source of the transplanted organ. IDD can lead to serious complications and even death, therefore it is important for transplant recipients to receive regular monitoring and treatment to prevent and manage any infectious complications.", "label": 0, "is_selected": 0, "text": "IDD stands for Infectious Disease Development. In the context of organ transplantation, IDD refers to the risk of developing an infectious disease after the transplant. This can occur due to various factors, including the immunosuppressive drugs used to prevent rejection of the transplanted organ, the patient's underlying health conditions, and the source of the transplanted organ. IDD can lead to serious complications and even death, therefore it is important for transplant recipients to receive regular monitoring and treatment to prevent and manage any infectious complications."}
{"qid": "5162af0f298dcd4e51000045", "original_text": "Deadenylation is the major step in triggering mRNA decay and results in mRNA translation inhibition in eukaryotic cells. Therefore, it is plausible that deadenylation also induces the mRNP remodeling required for formation of GW bodies or RNA processing bodies (P-bodies), which harbor translationally silenced mRNPs. In this chapter, we discuss several examples to illustrate the roles of deadenylation in regulating gene expression. We highlight several lines of evidence indicating that even though non-translatable mRNPs may be prepared and/or assembled into P-bodies in different ways, deadenylation is always a necessary, and perhaps the earliest, step in mRNA decay pathways that enable mRNP remodeling required for P-body formation.", "label": 1, "is_selected": 0, "text": "Deadenylation is the major step in triggering mRNA decay and results in mRNA translation inhibition in eukaryotic cells. Therefore, it is plausible that deadenylation also induces the mRNP remodeling required for formation of GW bodies or RNA processing bodies (P-bodies), which harbor translationally silenced mRNPs. In this chapter, we discuss several examples to illustrate the roles of deadenylation in regulating gene expression. We highlight several lines of evidence indicating that even though non-translatable mRNPs may be prepared and/or assembled into P-bodies in different ways, deadenylation is always a necessary, and perhaps the earliest, step in mRNA decay pathways that enable mRNP remodeling required for P-body formation."}
{"qid": "52f89fd32059c6d71c000051", "original_text": "Ldb1, a ubiquitously expressed LIM domain binding protein, is essential in a number of tissues during development. It interacts with Gata1, Tal1, E2A and Lmo2 to form a transcription factor complex regulating late erythroid genes. We identify a number of novel Ldb1 interacting proteins in erythroleukaemic cells, in particular the repressor protein Eto-2 (and its family member Mtgr1), the cyclin-dependent kinase Cdk9, and the bridging factor Lmo4. MO-mediated knockdowns in zebrafish show these factors to be essential for definitive haematopoiesis. In accordance with the zebrafish results these factors are coexpressed in prehaematopoietic cells of the early mouse embryo, although we originally identified the complex in late erythroid cells. Based on the change in subcellullar localisation of Eto-2 we postulate that it plays a central role in the transition from the migration and expansion phase of the prehaematopoietic cells to the establishment of definitive haematopoietic stem cells.", "label": 1, "is_selected": 0, "text": "Ldb1, a ubiquitously expressed LIM domain binding protein, is essential in a number of tissues during development. It interacts with Gata1, Tal1, E2A and Lmo2 to form a transcription factor complex regulating late erythroid genes. We identify a number of novel Ldb1 interacting proteins in erythroleukaemic cells, in particular the repressor protein Eto-2 (and its family member Mtgr1), the cyclin-dependent kinase Cdk9, and the bridging factor Lmo4. MO-mediated knockdowns in zebrafish show these factors to be essential for definitive haematopoiesis. In accordance with the zebrafish results these factors are coexpressed in prehaematopoietic cells of the early mouse embryo, although we originally identified the complex in late erythroid cells. Based on the change in subcellullar localisation of Eto-2 we postulate that it plays a central role in the transition from the migration and expansion phase of the prehaematopoietic cells to the establishment of definitive haematopoietic stem cells."}
{"qid": "54ede95c94afd6150400000a", "original_text": "Fanconi anemia is an autosomal recessive syndrome characterized by diverse clinical symptoms, hypersensitivity to DNA crosslinking agents, chromosomal instability and susceptibility to cancer. Fanconi anemia has at least 11 complementation groups (A, B, C, D1, D2, E, F, G, I, J, L); the genes mutated in 8 of these have been identified. The gene BRCA2 was suggested to underlie complementation group B, but the evidence is inconclusive.", "label": 1, "is_selected": 0, "text": "Fanconi anemia is an autosomal recessive syndrome characterized by diverse clinical symptoms, hypersensitivity to DNA crosslinking agents, chromosomal instability and susceptibility to cancer. Fanconi anemia has at least 11 complementation groups (A, B, C, D1, D2, E, F, G, I, J, L); the genes mutated in 8 of these have been identified. The gene BRCA2 was suggested to underlie complementation group B, but the evidence is inconclusive."}
{"qid": "56e5aeec0c19e5451d000002", "original_text": "Axon regeneration in the mature central nervous system is limited by extrinsic inhibitory signals and a postnatal decline in neurons' intrinsic growth capacity. Neuronal levels of the second messenger cAMP are important in regulating both intrinsic growth capacity and neurons' responses to extrinsic factors. Approaches which increase intracellular cAMP in neurons enhance neurite outgrowth and facilitate regeneration after injury. Thus, understanding the factors which affect cAMP in neurons is of potential therapeutic importance. Recently, soluble adenylyl cyclase (sAC, ADCY10), the ubiquitous, non-transmembrane adenylyl cyclase, was found to play a key role in neuronal survival and axon growth. sAC is activated by bicarbonate and cations and may translate physiologic signals from metabolism and electrical activity into a neuron's decision to survive or regenerate.", "label": 1, "is_selected": 0, "text": "Axon regeneration in the mature central nervous system is limited by extrinsic inhibitory signals and a postnatal decline in neurons' intrinsic growth capacity. Neuronal levels of the second messenger cAMP are important in regulating both intrinsic growth capacity and neurons' responses to extrinsic factors. Approaches which increase intracellular cAMP in neurons enhance neurite outgrowth and facilitate regeneration after injury. Thus, understanding the factors which affect cAMP in neurons is of potential therapeutic importance. Recently, soluble adenylyl cyclase (sAC, ADCY10), the ubiquitous, non-transmembrane adenylyl cyclase, was found to play a key role in neuronal survival and axon growth. sAC is activated by bicarbonate and cations and may translate physiologic signals from metabolism and electrical activity into a neuron's decision to survive or regenerate."}
{"qid": "621e5cf53a8413c65300004e", "original_text": "Dimensionality reduction of high-dimensional data is crucial for single-cell RNA sequencing (scRNA-seq) visualization and clustering. One prominent challenge in scRNA-seq studies comes from the dropout events, which lead to zero-inflated data. To address this issue, in this paper, we propose a scRNA-seq data dimensionality reduction algorithm based on a hierarchical autoencoder, termed SCDRHA. The proposed SCDRHA consists of two core modules, where the first module is a deep count autoencoder (DCA) that is used to denoise data, and the second module is a graph autoencoder that projects the data into a low-dimensional space. Experimental results demonstrate that SCDRHA has better performance than existing state-of-the-art algorithms on dimension reduction and noise reduction in five real scRNA-seq datasets. Besides, SCDRHA can also dramatically improve the performance of data visualization and cell clustering.", "label": 1, "is_selected": 0, "text": "Dimensionality reduction of high-dimensional data is crucial for single-cell RNA sequencing (scRNA-seq) visualization and clustering. One prominent challenge in scRNA-seq studies comes from the dropout events, which lead to zero-inflated data. To address this issue, in this paper, we propose a scRNA-seq data dimensionality reduction algorithm based on a hierarchical autoencoder, termed SCDRHA. The proposed SCDRHA consists of two core modules, where the first module is a deep count autoencoder (DCA) that is used to denoise data, and the second module is a graph autoencoder that projects the data into a low-dimensional space. Experimental results demonstrate that SCDRHA has better performance than existing state-of-the-art algorithms on dimension reduction and noise reduction in five real scRNA-seq datasets. Besides, SCDRHA can also dramatically improve the performance of data visualization and cell clustering."}
{"qid": "530c7f52970c65fa6b000010", "original_text": "Oxantel is an antibiotic used to treat periodontitis, a gum infection. It works by killing the bacteria that cause the infection, specifically Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, and Tannerella forsythia. By reducing the number of these harmful bacteria in the mouth, Oxantel helps to reduce the inflammation and promote healing of the periodontal tissues. It is typically used in combination with other antibiotics and may be administered as a single dose or over a prolonged period of time, depending on the severity of the infection.", "label": 0, "is_selected": 1, "text": "Oxantel is an antibiotic used to treat periodontitis, a gum infection, and has been approved for use in the United States by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of gum disease."}
{"qid": "58d8e6818acda3452900000a", "original_text": "Marfan syndrome is an autosomal dominant connective tissue disorder caused by mutations in the fibrillin gene FBN1, which encodes an extracellular matrix glycoprotein. Major features of Marfan syndrome occur in the ocular, cardiovascular, and skeletal systems as well as in the dura mater. Approximately 60% of known disease-causing mutations are missense mutations of single amino acid residues. Effects on the cardiovascular system are classically associated with mutations in exons 24-32 of the 65 FBN1 exons and many, though not all, reports associate missense mutations in exons 59-65 with a mild cardiovascular phenotype.", "label": 1, "is_selected": 0, "text": "Marfan syndrome is an autosomal dominant connective tissue disorder caused by mutations in the fibrillin gene FBN1, which encodes an extracellular matrix glycoprotein. Major features of Marfan syndrome occur in the ocular, cardiovascular, and skeletal systems as well as in the dura mater. Approximately 60% of known disease-causing mutations are missense mutations of single amino acid residues. Effects on the cardiovascular system are classically associated with mutations in exons 24-32 of the 65 FBN1 exons and many, though not all, reports associate missense mutations in exons 59-65 with a mild cardiovascular phenotype."}
{"qid": "5d35f07b7bc3fee31f000003", "original_text": "As a member of the bromodomain and extraterminal (BET) family, BRD4 (bromodomain containing 4) can bind to acetylated histones and transcription factors, and is also able to recruit various transcriptional regulators. Previous studies have shown that BRD4 mainly plays a positive role in cell growth and cell cycle progression. In a recent study conducted by Sakamaki et al., the authors found that BRD4 acts as a transcriptional repressor in regulating macroautophagy/autophagy and lysosome gene expression, via binding to the histone lysine methyltransferase EHMT2/G9a.", "label": 1, "is_selected": 0, "text": "As a member of the bromodomain and extraterminal (BET) family, BRD4 (bromodomain containing 4) can bind to acetylated histones and transcription factors, and is also able to recruit various transcriptional regulators. Previous studies have shown that BRD4 mainly plays a positive role in cell growth and cell cycle progression. In a recent study conducted by Sakamaki et al., the authors found that BRD4 acts as a transcriptional repressor in regulating macroautophagy/autophagy and lysosome gene expression, via binding to the histone lysine methyltransferase EHMT2/G9a."}
{"qid": "55391b2cbc4f83e828000017", "original_text": "Platelet-derived growth factor (PDGF) receptor (PDGFR) expression correlates with metastatic medulloblastoma. PDGF stimulation of medulloblastoma cells phosphorylates extracellular signal-regulated kinase (ERK) and promotes migration. We sought to determine whether blocking PDGFR activity effectively inhibits signaling required for medulloblastoma cell migration and invasion. DAOY and D556 human medulloblastoma cells were treated with imatinib mesylate (Gleevec), a PDGFR tyrosine kinase inhibitor, or transfected with small interfering RNA (siRNA) to PDGFRB to test the effects of blocking PDGFR phosphorylation and expression, respectively. PDGFR cell signaling, migration, invasion, survival, and proliferation following PDGF-BB stimulation, with and without PDGFR inhibition, were measured. PDGF-BB treatment of cells increased PDGFRB, Akt and ERK phosphorylation, and transactivated epidermal growth factor receptor (EGFR), which correlated with enhanced migration, survival, and proliferation. Imatinib (1 \u03bcmol/L) treatment of DAOY and D556 cells inhibited PDGF-BB- and serum-mediated migration and invasion at 24 and 48 h, respectively, and concomitantly inhibited PDGF-BB activation of PDGFRB, Akt, and ERK but increased PTEN expression and activity.", "label": 1, "is_selected": 0, "text": "Platelet-derived growth factor (PDGF) receptor (PDGFR) expression correlates with metastatic medulloblastoma. PDGF stimulation of medulloblastoma cells phosphorylates extracellular signal-regulated kinase (ERK) and promotes migration. We sought to determine whether blocking PDGFR activity effectively inhibits signaling required for medulloblastoma cell migration and invasion. DAOY and D556 human medulloblastoma cells were treated with imatinib mesylate (Gleevec), a PDGFR tyrosine kinase inhibitor, or transfected with small interfering RNA (siRNA) to PDGFRB to test the effects of blocking PDGFR phosphorylation and expression, respectively. PDGFR cell signaling, migration, invasion, survival, and proliferation following PDGF-BB stimulation, with and without PDGFR inhibition, were measured. PDGF-BB treatment of cells increased PDGFRB, Akt and ERK phosphorylation, and transactivated epidermal growth factor receptor (EGFR), which correlated with enhanced migration, survival, and proliferation. Imatinib (1 \u03bcmol/L) treatment of DAOY and D556 cells inhibited PDGF-BB- and serum-mediated migration and invasion at 24 and 48 h, respectively, and concomitantly inhibited PDGF-BB activation of PDGFRB, Akt, and ERK but increased PTEN expression and activity."}
{"qid": "532f06e6d6d3ac6a34000028", "original_text": "Dabigatran therapy, a direct oral anticoagulant (DOAC), significantly prolongs activated partial thromboplastin time (aPTT) in patients with nonvalvular atrial fibrillation (AF). Studies have shown that dabigatran can increase aPTT by up to 2-3 times the normal range, indicating enhanced coagulant activity. This is thought to be due to dabigatran's ability to inhibit free thrombin, which is a critical component of the coagulation cascade. The prolongation of aPTT by dabigatran therapy is clinically significant, as it may lead to an increased risk of bleeding, particularly in patients with a history of bleeding or at high risk of bleeding. Therefore, patients with AF should be closely monitored for signs of bleeding during dabigatran therapy, and the dose may need to be adjusted in certain cases to minimize this risk.", "label": 0, "is_selected": 0, "text": "Dabigatran therapy, a direct oral anticoagulant (DOAC), significantly prolongs activated partial thromboplastin time (aPTT) in patients with nonvalvular atrial fibrillation (AF). Studies have shown that dabigatran can increase aPTT by up to 2-3 times the normal range, indicating enhanced coagulant activity. This is thought to be due to dabigatran's ability to inhibit free thrombin, which is a critical component of the coagulation cascade. The prolongation of aPTT by dabigatran therapy is clinically significant, as it may lead to an increased risk of bleeding, particularly in patients with a history of bleeding or at high risk of bleeding. Therefore, patients with AF should be closely monitored for signs of bleeding during dabigatran therapy, and the dose may need to be adjusted in certain cases to minimize this risk."}
{"qid": "58adc1ff9ef3c34033000006", "original_text": "The protein that mediates gene loop formation in the yeast Saccharomyces cerevisiae is called SBF (Swi6-Brm-Fis). SBF is a transcriptional regulator that binds to specific DNA sequences and recruits chromatin remodeling complexes to modulate gene expression. In the context of gene loop formation, SBF works by looping back to the promoter region of a gene, bringing the gene into proximity with the transcriptional activators and enhancers, and thereby enhancing the expression of the gene. This process is an important mechanism for regulating gene expression in yeast and has been implicated in various biological processes, including cellular differentiation and stress response.", "label": 0, "is_selected": 0, "text": "The protein that mediates gene loop formation in the yeast Saccharomyces cerevisiae is called SBF (Swi6-Brm-Fis). SBF is a transcriptional regulator that binds to specific DNA sequences and recruits chromatin remodeling complexes to modulate gene expression. In the context of gene loop formation, SBF works by looping back to the promoter region of a gene, bringing the gene into proximity with the transcriptional activators and enhancers, and thereby enhancing the expression of the gene. This process is an important mechanism for regulating gene expression in yeast and has been implicated in various biological processes, including cellular differentiation and stress response."}
{"qid": "5e44c18648dab47f2600001f", "original_text": "Gavestinel is a medication that has been investigated for its potential to improve outcomes in stroke patients. The drug works by inhibiting the breakdown of a protein called brain-derived neurotrophic factor (BDNF), which is important for neuronal survival and function. Studies have suggested that BDNF levels are reduced in the hours and days following a stroke, and that gavestinel may help to restore these levels and promote neural recovery. One study published in the journal Neuropharmacology found that gavestinel treatment in the hour after stroke significantly improved functional outcomes in mice. The treatment was found to increase BDNF levels and improve behavioral recovery, as measured by tests of motor function and cognitive ability. Another study published in the journal Stroke found that gavestinel treatment in patients who experienced an ischemic stroke (the most common type of stroke) improved functional outcomes at the one-month follow-up. The study found that patients who received gavestinel had better scores on a test of physical function compared to those who received a placebo. While these findings are promising, it's important to note that the research in this area is still in its early stages, and more studies are needed to confirm these results and establish the safety and efficacy of gavestinel for stroke treatment. In summary, while there is some evidence to suggest that gavestinel may improve outcomes in stroke patients, more research is needed to fully understand its potential.", "label": 0, "is_selected": 1, "text": "There is some evidence to suggest that gavestinel may improve outcomes in stroke patients, but more research is needed to establish its safety and efficacy, as well as to establish the timing and dosage of the drug's use in stroke treatment, according to a recent article in the Journal of the American Medical Association (JAMA). in summary, while there is some Evidence to Suggest that Gavestinel May Improve Outcomes in Stroke patients, more research are needed to fully understand its potential. in conclusion, while There is Some Evidence to suggest That Gavestiner may improve Outcomes inStroke patients, More Research are needed in this area, to Establishing the Safety and efficacy of Gavestined for stroke treatment."}
{"qid": "5e6e767e51b80c9423000006", "original_text": "Many medical diagnostic studies involve three ordinal diagnostic populations in which the diagnostic accuracy can be summarized by the volume or partial volume under the receiver operating characteristic surface for a diagnostic marker. When the diagnostic populations are clustered, e.g. by families, we propose to model the diagnostic marker by a general linear mixed model that takes into account of the correlation on the diagnostic marker from members of the same clusters. This model then facilitates the maximum likelihood estimation and statistical inferences of the diagnostic accuracy for the diagnostic marker. This approach naturally allows the incorporation of covariates as well as missing data when some clusters do not have subjects on all diagnostic groups in the estimation of, and the subsequent inferences on the diagnostic accuracy. We further study the performance of the proposed methods in a large simulation study with clustered data. Finally, we apply the proposed methodology to the data of several biomarkers collected by the Dominantly Inherited Alzheimer Network, an international family-clustered registry to study autosomal dominant Alzheimer disease which is a rare form of Alzheimer disease caused by mutations in any of the three genes including the amyloid precursor protein, presenilin 1 and presenilin 2.", "label": 1, "is_selected": 0, "text": "Many medical diagnostic studies involve three ordinal diagnostic populations in which the diagnostic accuracy can be summarized by the volume or partial volume under the receiver operating characteristic surface for a diagnostic marker. When the diagnostic populations are clustered, e.g. by families, we propose to model the diagnostic marker by a general linear mixed model that takes into account of the correlation on the diagnostic marker from members of the same clusters. This model then facilitates the maximum likelihood estimation and statistical inferences of the diagnostic accuracy for the diagnostic marker. This approach naturally allows the incorporation of covariates as well as missing data when some clusters do not have subjects on all diagnostic groups in the estimation of, and the subsequent inferences on the diagnostic accuracy. We further study the performance of the proposed methods in a large simulation study with clustered data. Finally, we apply the proposed methodology to the data of several biomarkers collected by the Dominantly Inherited Alzheimer Network, an international family-clustered registry to study autosomal dominant Alzheimer disease which is a rare form of Alzheimer disease caused by mutations in any of the three genes including the amyloid precursor protein, presenilin 1 and presenilin 2."}
{"qid": "5c7836dad774d04240000002", "original_text": "Mesenchymal stem cells (MSCs) can differentiate into multiple mesodermal cell types in vitro; however, their differentiation capacity is influenced by their tissue of origin. To what extent epigenetic information on promoters of lineage-specification genes in human progenitors influences transcriptional activation and differentiation potential remains unclear. We produced bisulfite sequencing maps of DNA methylation in adipogenic, myogenic, and endothelial promoters in relation to gene expression and differentiation capacity, and unravel a similarity in DNA methylation profiles between MSCs isolated from human adipose tissue, bone marrow (BM), and muscle. This similarity is irrespective of promoter CpG content.", "label": 1, "is_selected": 0, "text": "Mesenchymal stem cells (MSCs) can differentiate into multiple mesodermal cell types in vitro; however, their differentiation capacity is influenced by their tissue of origin. To what extent epigenetic information on promoters of lineage-specification genes in human progenitors influences transcriptional activation and differentiation potential remains unclear. We produced bisulfite sequencing maps of DNA methylation in adipogenic, myogenic, and endothelial promoters in relation to gene expression and differentiation capacity, and unravel a similarity in DNA methylation profiles between MSCs isolated from human adipose tissue, bone marrow (BM), and muscle. This similarity is irrespective of promoter CpG content."}
{"qid": "530d7e8a38c1322806000001", "original_text": "SUV39H1, a human homologue of the Drosophila position effect variegation modifier Su(var)3-9 and of the Schizosaccharomyces pombe silencing factor clr4, encodes a novel heterochromatic protein that transiently accumulates at centromeric positions during mitosis. Using a detailed structure-function analysis of SUV39H1 mutant proteins in transfected cells, we now show that deregulated SUV39H1 interferes at multiple levels with mammalian higher-order chromatin organization. First, forced expression of full-length SUV39H1 (412 amino acids) redistributes endogenous M31 (HP1beta) and induces abundant associations with inter- and metaphase chromatin. These properties depend on the C-terminal SET domain, although the major portion of the SUV39H1 protein (amino acids 89 to 412) does not display affinity for nuclear chromatin.", "label": 1, "is_selected": 0, "text": "SUV39H1, a human homologue of the Drosophila position effect variegation modifier Su(var)3-9 and of the Schizosaccharomyces pombe silencing factor clr4, encodes a novel heterochromatic protein that transiently accumulates at centromeric positions during mitosis. Using a detailed structure-function analysis of SUV39H1 mutant proteins in transfected cells, we now show that deregulated SUV39H1 interferes at multiple levels with mammalian higher-order chromatin organization. First, forced expression of full-length SUV39H1 (412 amino acids) redistributes endogenous M31 (HP1beta) and induces abundant associations with inter- and metaphase chromatin. These properties depend on the C-terminal SET domain, although the major portion of the SUV39H1 protein (amino acids 89 to 412) does not display affinity for nuclear chromatin."}
{"qid": "61f602a3882a024a1000001f", "original_text": "Cabotegravir (CAB) and rilpivirine (RPV) is the first long-acting injectable antiretroviral therapy (ART) option approved for virologically suppressed adults with HIV-1. In addition, long-acting CAB is a promising agent for HIV preexposure prophylaxis (PrEP). This review focuses on phase 3 clinical trial results and implementation considerations for these long-acting ART and PrEP strategies. Long-acting CAB and RPV administered every 4 weeks demonstrated noninferiority to oral ART through week 96 in both the ATLAS and FLAIR studies, whereas ATLAS-2M found similar efficacy through 96 weeks when the long-acting injectable ART was administered every 8 weeks instead of every 4 weeks.", "label": 1, "is_selected": 0, "text": "Cabotegravir (CAB) and rilpivirine (RPV) is the first long-acting injectable antiretroviral therapy (ART) option approved for virologically suppressed adults with HIV-1. In addition, long-acting CAB is a promising agent for HIV preexposure prophylaxis (PrEP). This review focuses on phase 3 clinical trial results and implementation considerations for these long-acting ART and PrEP strategies. Long-acting CAB and RPV administered every 4 weeks demonstrated noninferiority to oral ART through week 96 in both the ATLAS and FLAIR studies, whereas ATLAS-2M found similar efficacy through 96 weeks when the long-acting injectable ART was administered every 8 weeks instead of every 4 weeks."}
{"qid": "56cf32e23975bb303a000006", "original_text": "Venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI), does not appear to have a significant effect on the activity of norepinephrine transporter (NET). A study published in the Journal of Pharmacology and Experimental Therapeutics found that venlafaxine did not alter NET activity in rat synaptosomes, suggesting that it does not block NET. On the other hand, venlafaxine has been shown to interact with the serotonin transporter (SERT). SERT is responsible for reuptaking serotonin from the synaptic cleft back into the presynaptic neuron. Venlafaxine has been demonstrated to inhibit SERT, with a Ki value of around 10 \u03bcM, which suggests that it can bind to SERT with moderate affinity. This suggests that venlafaxine may have some effect on the activity of serotonin neurons, which could contribute to its therapeutic effects in depression and anxiety disorders. In summary, while venlafaxine does not appear to block NET, it does interact with SERT, which could contribute to its therapeutic effects in certain psychiatric disorders.", "label": 0, "is_selected": 1, "text": "A drug has been shown to interact with two serotonin transporters, which could contribute to its therapeutic effects in certain psychiatric disorders. in summary, while venlafaxine does not appear to block NET, it does interact with SERT, which Could contribute to Its Therapeutic Effects in Certain Psychiatric Disorders., published in the Journal of Pharmacology and Experimental Therapeutics., doi: 10.1371/journal.pone.00476."}
{"qid": "550342a8f8aee20f27000002", "original_text": "We reported a 7-year-old girl with myoclonic-astatic epilepsy of early childhood (Doose syndrome). She had minor seizures (i. e. absence, atonic and myoclonic seizures) refractory to treatment with many kinds of anti-epileptic drugs as well as thyrotropin releasing hormone. Though she had suffered from long-lasting clusters of minor seizures, the treatment with continuous intravenous lidocaine successfully brought a case of prolonged remission of both clinical seizures and EEG abnormalities. It has been reported that lidocaine is effective mainly for partial seizures.", "label": 1, "is_selected": 0, "text": "We reported a 7-year-old girl with myoclonic-astatic epilepsy of early childhood (Doose syndrome). She had minor seizures (i. e. absence, atonic and myoclonic seizures) refractory to treatment with many kinds of anti-epileptic drugs as well as thyrotropin releasing hormone. Though she had suffered from long-lasting clusters of minor seizures, the treatment with continuous intravenous lidocaine successfully brought a case of prolonged remission of both clinical seizures and EEG abnormalities. It has been reported that lidocaine is effective mainly for partial seizures."}
{"qid": "5c54224807647bbc4b000001", "original_text": "Faithful chromosome segregation and genome maintenance requires the removal of all DNA bridges that physically link chromosomes before cells divide. Using C. elegans embryos we show that the LEM-3/Ankle1 nuclease defines a previously undescribed genome integrity mechanism by processing DNA bridges right before cells divide. LEM-3 acts at the midbody, the structure where abscission occurs at the end of cytokinesis. LEM-3 localization depends on factors needed for midbody assembly, and LEM-3 accumulation is increased and prolonged when chromatin bridges are trapped at the cleavage plane. LEM-3 locally processes chromatin bridges that arise from incomplete DNA replication, unresolved recombination intermediates, or the perturbance of chromosome structure. Proper LEM-3 midbody localization and function is regulated by AIR-2/Aurora B kinase. Strikingly, LEM-3 acts cooperatively with the BRC-1/BRCA1 homologous recombination factor to promote genome integrity. These findings provide a molecular basis for the suspected role of the LEM-3 orthologue Ankle1 in human breast cancer.", "label": 1, "is_selected": 0, "text": "Faithful chromosome segregation and genome maintenance requires the removal of all DNA bridges that physically link chromosomes before cells divide. Using C. elegans embryos we show that the LEM-3/Ankle1 nuclease defines a previously undescribed genome integrity mechanism by processing DNA bridges right before cells divide. LEM-3 acts at the midbody, the structure where abscission occurs at the end of cytokinesis. LEM-3 localization depends on factors needed for midbody assembly, and LEM-3 accumulation is increased and prolonged when chromatin bridges are trapped at the cleavage plane. LEM-3 locally processes chromatin bridges that arise from incomplete DNA replication, unresolved recombination intermediates, or the perturbance of chromosome structure. Proper LEM-3 midbody localization and function is regulated by AIR-2/Aurora B kinase. Strikingly, LEM-3 acts cooperatively with the BRC-1/BRCA1 homologous recombination factor to promote genome integrity. These findings provide a molecular basis for the suspected role of the LEM-3 orthologue Ankle1 in human breast cancer."}
{"qid": "5a68f005b750ff4455000016", "original_text": "Borderline personality disorder is the most common personality disorder, with a global prevalence rate between 1.6% and 6%. It is characterized by affective disturbance and impulsivity, which lead to a high number of self-harm behaviors and great amount of health services use. International guidelines recommend psychotherapy as the primary treatment for borderline personality disorder. This paper reviews evidence about the effects and efficacy of cognitive-behavioral oriented psychological treatments for borderline personality disorder.", "label": 1, "is_selected": 0, "text": "Borderline personality disorder is the most common personality disorder, with a global prevalence rate between 1.6% and 6%. It is characterized by affective disturbance and impulsivity, which lead to a high number of self-harm behaviors and great amount of health services use. International guidelines recommend psychotherapy as the primary treatment for borderline personality disorder. This paper reviews evidence about the effects and efficacy of cognitive-behavioral oriented psychological treatments for borderline personality disorder."}
{"qid": "5133b15e5274a5fb0700000b", "original_text": "CpG islands are located near housekeeping genes in the human genome. Housekeeping genes are genes that are expressed at constant levels throughout the cell cycle and are involved in basic cellular processes such as RNA splicing, DNA repair, and protein synthesis. CpG islands, which are found near the promoter regions of many housekeeping genes, are regions of DNA that are rich in the base cytosine and contain a high percentage of methylated CpG dinucleotides. The proximity of CpG islands to housekeeping genes suggests that these regions may play a role in the regulation of gene expression, perhaps by influencing the binding of transcription factors or other regulatory proteins. However, the exact mechanisms by which CpG islands regulate gene expression are not yet fully understood.", "label": 0, "is_selected": 1, "text": "Researchers at the University of California, Los Angeles, have identified a new class of regions of DNA known as cytosine-rich G-protein-coupled receptors (CpG islands) in Drosophila melanogaster and have shown that these islands regulate gene expression in a manner similar to that of transcription factors and other regulatory proteins."}
{"qid": "5a690487b750ff445500001f", "original_text": "The monospot test is used to diagnose certain viral infections, including: Measles (rubeola) Rubella (German measles) The monospot test detects the presence of antibodies against these viruses in the blood. It can confirm a suspected infection and check for immunity against these viruses. However, it is not a perfect test and may not always provide accurate results, especially in cases of weakened immune systems or if the infection is not recent.", "label": 0, "is_selected": 0, "text": "The monospot test is used to diagnose certain viral infections, including: Measles (rubeola) Rubella (German measles) The monospot test detects the presence of antibodies against these viruses in the blood. It can confirm a suspected infection and check for immunity against these viruses. However, it is not a perfect test and may not always provide accurate results, especially in cases of weakened immune systems or if the infection is not recent."}
{"qid": "52fc94572059c6d71c000070", "original_text": "Yes, apixaban has been shown to be effective for the treatment of acute venous thromboembolism (VTE). Multiple randomized controlled trials have demonstrated that apixaban significantly reduces the risk of recurrent VTE and bleeding complications compared to standard anticoagulation therapy with vitamin K antagonists. Apixaban's efficacy has been demonstrated in various patient populations, including those with pulmonary embolism and those at high risk of bleeding. The latest American College of Chest Physicians (ACCP) guidelines recommend apixaban as a preferred anticoagulant for the treatment of non-valvular VTE.", "label": 0, "is_selected": 1, "text": "Can apixaban be used for the treatment of non-valvular venous thromboembolism (VTE) in patients who are at high risk of bleeding and who have failed to respond to other anticoagulation therapy?, according to the latest American College of Chest Physicians (ACCP) guidelines."}
{"qid": "553653a5bc4f83e828000007", "original_text": "More than 90% of Ewing's sarcomas (ES) contain a fusion of the EWS and FLI1 genes, due to the t(11;22)(q24;q12) translocation. At the molecular level, the EWS-FLI1 rearrangements show great diversity. Specifically, many different combinations of exons from EWS and FLI1 encode in-frame fusion transcripts and result in differences in the length and composition of the chimeric protein, which functions as an oncogenic aberrant transcription factor. In the most common fusion type (type 1), EWS exon 7 is linked in frame with exon 6 of FLI1. As the fundamental pathogenetic lesion in ES, the molecular heterogeneity of these fusion transcripts may have functional and clinical significance.", "label": 1, "is_selected": 0, "text": "More than 90% of Ewing's sarcomas (ES) contain a fusion of the EWS and FLI1 genes, due to the t(11;22)(q24;q12) translocation. At the molecular level, the EWS-FLI1 rearrangements show great diversity. Specifically, many different combinations of exons from EWS and FLI1 encode in-frame fusion transcripts and result in differences in the length and composition of the chimeric protein, which functions as an oncogenic aberrant transcription factor. In the most common fusion type (type 1), EWS exon 7 is linked in frame with exon 6 of FLI1. As the fundamental pathogenetic lesion in ES, the molecular heterogeneity of these fusion transcripts may have functional and clinical significance."}
{"qid": "554140ad182542114d000003", "original_text": "Molecular recognition features (MoRFs) are small, intrinsically disordered regions in proteins that undergo a disorder-to-order transition on binding to their partners. MoRFs are involved in protein-protein interactions and may function as the initial step in molecular recognition. The aim of this work was to collect, organize and store all membrane proteins that contain MoRFs. Membrane proteins constitute \u223c30% of fully sequenced proteomes and are responsible for a wide variety of cellular functions. MoRFs were classified according to their secondary structure, after interacting with their partners. We identified MoRFs in transmembrane and peripheral membrane proteins.", "label": 1, "is_selected": 0, "text": "Molecular recognition features (MoRFs) are small, intrinsically disordered regions in proteins that undergo a disorder-to-order transition on binding to their partners. MoRFs are involved in protein-protein interactions and may function as the initial step in molecular recognition. The aim of this work was to collect, organize and store all membrane proteins that contain MoRFs. Membrane proteins constitute \u223c30% of fully sequenced proteomes and are responsible for a wide variety of cellular functions. MoRFs were classified according to their secondary structure, after interacting with their partners. We identified MoRFs in transmembrane and peripheral membrane proteins."}
{"qid": "51682382298dcd4e51000066", "original_text": "Thyroid hormones reduce glucose tolerance in humans and animals. This effect is related to a decrease of glucose-induced insulin secretion following a reduction of pancreatic beta cell mass due to beta cell loss. The aim of this study was to analyze in vitro the mechanisms underlying the effects of triiodothyronine (T(3)) on the cell viability and cell cycle caused by changes of cell death or proliferation rate of insulin-producing INS-1 cells. 72-h Exposure of INS-1 cells to increasing T(3) concentrations up to 500 microM resulted in a significant viability reduction. This T(3) toxicity was caused by an increased apoptotic cell death rate, which was accompanied by a decreased proliferation rate. Inhibitory effects of T(3) on glucose-induced insulin secretion were already seen after 24 h of incubation, indicating that the deleterious effects of T(3) were time-dependent, changing from specific cellular dysfunctions to a severe and extended disturbance of the cellular survival program.", "label": 1, "is_selected": 0, "text": "Thyroid hormones reduce glucose tolerance in humans and animals. This effect is related to a decrease of glucose-induced insulin secretion following a reduction of pancreatic beta cell mass due to beta cell loss. The aim of this study was to analyze in vitro the mechanisms underlying the effects of triiodothyronine (T(3)) on the cell viability and cell cycle caused by changes of cell death or proliferation rate of insulin-producing INS-1 cells. 72-h Exposure of INS-1 cells to increasing T(3) concentrations up to 500 microM resulted in a significant viability reduction. This T(3) toxicity was caused by an increased apoptotic cell death rate, which was accompanied by a decreased proliferation rate. Inhibitory effects of T(3) on glucose-induced insulin secretion were already seen after 24 h of incubation, indicating that the deleterious effects of T(3) were time-dependent, changing from specific cellular dysfunctions to a severe and extended disturbance of the cellular survival program."}
{"qid": "60292e661cb411341a000112", "original_text": "The sphincter of Oddi is a circular muscle that encircles the proximal duodenum and is associated with three organs: the liver, the pancreas, and the duodenum. The sphincter of Oddi regulates the flow of bile and pancreatic juice from these organs into the duodenum, aiding in digestion. The sphincter is also involved in the regulation of gut motility and inflammation in the digestive system.", "label": 0, "is_selected": 1, "text": "The sphincter of Oddi is the most important sphincter muscle in the gut, controlling the flow of bile and pancreatic juice into the duodenum, and regulating gut motility and inflammation in the digestive system, according to researchers at the University of California, Los Angeles."}
{"qid": "6277e4ee56bf9aee6f000008", "original_text": "Fever has been reported as a common symptom occurring in COVID-19 illness. Over the counter antipyretics such as ibuprofen and acetaminophen are often taken by individuals to reduce the discomfort of fever. Recently, the safety of ibuprofen in COVID-19 patients has been questioned due to anecdotal reports of worsening symptoms in previously healthy young adults. Studies show that ibuprofen demonstrates superior efficacy in fever reduction compared to acetaminophen. As fever may have benefit in shortening the duration of viral illness, it is plausible to hypothesize that the antipyretic efficacy of ibuprofen may be hindering the benefits of a fever response when taken during the early stages of COVID-19 illness.", "label": 1, "is_selected": 0, "text": "Fever has been reported as a common symptom occurring in COVID-19 illness. Over the counter antipyretics such as ibuprofen and acetaminophen are often taken by individuals to reduce the discomfort of fever. Recently, the safety of ibuprofen in COVID-19 patients has been questioned due to anecdotal reports of worsening symptoms in previously healthy young adults. Studies show that ibuprofen demonstrates superior efficacy in fever reduction compared to acetaminophen. As fever may have benefit in shortening the duration of viral illness, it is plausible to hypothesize that the antipyretic efficacy of ibuprofen may be hindering the benefits of a fever response when taken during the early stages of COVID-19 illness."}
{"qid": "52e0c9a298d0239505000010", "original_text": "Histone methylation was first described more than 35 years ago, but its role has remained enigmatic. Proposed functions range from transcriptional regulation to the higher-order packaging of chromatin in preparation for mitotic condensation. Histone methylation can occur on Arg or Lys residues, with an exquisite site selectivity for Lys methylation at specific positions in the N-termini of histones H3 and H4. Thus, Lys methylation joins acetylation and phosphorylation as a third component of a 'histone code' that modifies the underlying chromatin structure of the genetic information. Notably, in contrast to acetylation and phosphorylation, Lys methylation appears to be a relatively stable histone modification, thereby providing an ideal epigenetic mark for more long-term maintenance of chromatin states. The recent discovery of the first histone Lys methyltransferase has allowed the identification of a molecular mechanism in which the specific methylation of histone H3 at Lys9 generates a binding site for heterochromatin-associated proteins. These findings have broad implications for the overall functional organization of chromosome structure at constitutive heterochromatin (e.g. centromeres) and for chromatin-dependent inheritance of gene expression patterns. This review discusses how understanding this methylation system should address some of the long-standing mysteries of heterochromatin.", "label": 1, "is_selected": 0, "text": "Histone methylation was first described more than 35 years ago, but its role has remained enigmatic. Proposed functions range from transcriptional regulation to the higher-order packaging of chromatin in preparation for mitotic condensation. Histone methylation can occur on Arg or Lys residues, with an exquisite site selectivity for Lys methylation at specific positions in the N-termini of histones H3 and H4. Thus, Lys methylation joins acetylation and phosphorylation as a third component of a 'histone code' that modifies the underlying chromatin structure of the genetic information. Notably, in contrast to acetylation and phosphorylation, Lys methylation appears to be a relatively stable histone modification, thereby providing an ideal epigenetic mark for more long-term maintenance of chromatin states. The recent discovery of the first histone Lys methyltransferase has allowed the identification of a molecular mechanism in which the specific methylation of histone H3 at Lys9 generates a binding site for heterochromatin-associated proteins. These findings have broad implications for the overall functional organization of chromosome structure at constitutive heterochromatin (e.g. centromeres) and for chromatin-dependent inheritance of gene expression patterns. This review discusses how understanding this methylation system should address some of the long-standing mysteries of heterochromatin."}
{"qid": "5a8056a2faa1ab7d2e00001f", "original_text": "Atg8-family proteins are the best-studied proteins of the core autophagic machinery. They are essential for the elongation and closure of the phagophore into a proper autophagosome. Moreover, Atg8-family proteins are associated with the phagophore from the initiation of the autophagic process to, or just prior to, the fusion between autophagosomes with lysosomes. In addition to their implication in autophagosome biogenesis, they are crucial for selective autophagy through their ability to interact with selective autophagy receptor proteins necessary for the specific targeting of substrates for autophagic degradation.", "label": 1, "is_selected": 0, "text": "Atg8-family proteins are the best-studied proteins of the core autophagic machinery. They are essential for the elongation and closure of the phagophore into a proper autophagosome. Moreover, Atg8-family proteins are associated with the phagophore from the initiation of the autophagic process to, or just prior to, the fusion between autophagosomes with lysosomes. In addition to their implication in autophagosome biogenesis, they are crucial for selective autophagy through their ability to interact with selective autophagy receptor proteins necessary for the specific targeting of substrates for autophagic degradation."}
{"qid": "62507602e764a5320400000d", "original_text": "Temsirolimus is a mTOR inhibitor approved for the first-line treatment of advanced or metastatic renal cell carcinoma (a/mRCC) with poor prognosis. In treatment of a/mRCC several prognostic scoring systems are used. We assessed the prognostic value of these scores in a large temsirolimus treated cohort and compared the results with the physician's prognosis. A German multicenter registry (STAR-TOR) for a/mRCC patients (NCT00700258) was established to evaluate the efficacy and safety of temsirolimus 25 mg weekly in a routine clinical setting. These prospective data were systematically analyzed and followed-up by an independent clinical research organization to compare established prognostic scores (MSKCC, IMDC and Hudes) with the risk assessment by treating physicians based on their medical expertise and match them with survival outcomes. This interim analysis included 547 patients between 02/2008 and 05/2015 in 87 centers. Either prognostic tool resulted in significant and clinically meaningful differentiation between good, intermediate and poor prognosis. However, physician's prognosis identified more patients with good prognosis (9.1% vs. 1.3%). In patients with good physician's prognosis and intermediate prognosis by MSKCC, overall survival was nearly doubled compared to consensual intermediate prognosis (26.6 vs. 13.6 months), albeit without reaching statistical significance (P=0.09).", "label": 1, "is_selected": 0, "text": "Temsirolimus is a mTOR inhibitor approved for the first-line treatment of advanced or metastatic renal cell carcinoma (a/mRCC) with poor prognosis. In treatment of a/mRCC several prognostic scoring systems are used. We assessed the prognostic value of these scores in a large temsirolimus treated cohort and compared the results with the physician's prognosis. A German multicenter registry (STAR-TOR) for a/mRCC patients (NCT00700258) was established to evaluate the efficacy and safety of temsirolimus 25 mg weekly in a routine clinical setting. These prospective data were systematically analyzed and followed-up by an independent clinical research organization to compare established prognostic scores (MSKCC, IMDC and Hudes) with the risk assessment by treating physicians based on their medical expertise and match them with survival outcomes. This interim analysis included 547 patients between 02/2008 and 05/2015 in 87 centers. Either prognostic tool resulted in significant and clinically meaningful differentiation between good, intermediate and poor prognosis. However, physician's prognosis identified more patients with good prognosis (9.1% vs. 1.3%). In patients with good physician's prognosis and intermediate prognosis by MSKCC, overall survival was nearly doubled compared to consensual intermediate prognosis (26.6 vs. 13.6 months), albeit without reaching statistical significance (P=0.09)."}
{"qid": "58a87bd338c171fb5b000005", "original_text": "Dynamic changes to the epigenome play a critical role in establishing and maintaining cellular phenotype during differentiation, but little is known about the normal methylomic differences that occur between functionally distinct areas of the brain. We characterized intra- and inter-individual methylomic variation across whole blood and multiple regions of the brain from multiple donors.", "label": 1, "is_selected": 0, "text": "Dynamic changes to the epigenome play a critical role in establishing and maintaining cellular phenotype during differentiation, but little is known about the normal methylomic differences that occur between functionally distinct areas of the brain. We characterized intra- and inter-individual methylomic variation across whole blood and multiple regions of the brain from multiple donors."}
{"qid": "5fdb1023a43ad31278000009", "original_text": "The Liebenberg syndrome was first described in 1973 in a five- generation family. A sixth generation was added in 2001, and in 2009 a hitherto unknown branch of the same family with similar anomalies extended the family tree significantly. This article describes the clinical findings and illustrates the abnormalities with radiographs and three-dimensional computed tomography scans.", "label": 1, "is_selected": 0, "text": "The Liebenberg syndrome was first described in 1973 in a five- generation family. A sixth generation was added in 2001, and in 2009 a hitherto unknown branch of the same family with similar anomalies extended the family tree significantly. This article describes the clinical findings and illustrates the abnormalities with radiographs and three-dimensional computed tomography scans."}
{"qid": "58add1d79ef3c34033000008", "original_text": "Diffuse Intrinsic Pontine Glioma (DIPG) is a devastating brain tumor that primarily affects children. Several driver mutations have been identified in DIPG, including: 1. H3 K27M mutation: This is the most common driver mutation in DIPG, found in approximately 70% of cases. It results in the activation of the H3K27 demethylase complex, leading to the misregulation of gene expression. 2. IDH1/IDH2 mutations: These mutations are found in approximately 20% of DIPG cases and lead to the production of 2-hydroxyglutarate (2HG), which can alter the epigenetic landscape of the brain. 3. P53 mutations: These mutations are found in approximately 10% of DIPG cases and can lead to the loss of tumor suppressor function. 4. MTOR pathway mutations: These mutations, particularly in the PI3K and AKT signaling pathways, have been identified in a subset of DIPG cases. 5. KRAS/NRAS mutations: These mutations have been identified in some DIPG cases and may contribute to the development and progression of the disease. It is important to note that DIPG is a complex disease, and no single mutation is present in all cases. The specific mutational landscape may vary between individuals, and additional driver mutations may be identified in the future. I don't have answer for the question \"What are the common driver mutations in Diffuse Intrinsic Pontine Glioma (DIPG)?\".", "label": 0, "is_selected": 1, "text": "What are the common driver mutations in Diffuse Intrinsic Pontine Glioma (DIPG) and how do they contribute to the development and progression of the disease? I don't have answer for the question \"What are the Common Driver Mutations in Diffused Intrinsic  Pontine glioma ( DIPG)?\".'' I would like to ask you a question about what are the drivers mutations in DIPG, and how are they contributing to the disease's development and Progression?, but I have no answer for that question."}
{"qid": "56e68967edfc094c1f000002", "original_text": "Yes, protein CXCR4 has been investigated as a prognostic marker for various types of cancer, including breast, lung, and pancreatic cancer. CXCR4 is a chemokine receptor that is overexpressed in many cancers, and it has been shown to promote cancer cell migration, invasion, and metastasis. Studies have found that high levels of CXCR4 expression are associated with poor prognosis in cancer patients, including lower overall survival, increased risk of disease recurrence, and reduced response to chemotherapy. Additionally, CXCR4 has been identified as a potential therapeutic target for cancer treatment, and several CXCR4 inhibitors are currently being developed as anti-cancer drugs.", "label": 0, "is_selected": 1, "text": "What is CXCR4 and what is its potential use in cancer diagnosis and treatment and how is it different from other markers of cancer such as Gleason score or HER2 score?<n> Additionally, CXCR 4 has been identified as a potential therapeutic target for cancer treatment, and several CXCR5 inhibitors are currently being developed as anti-cancer drugs."}
{"qid": "514b335dd24251bc05000061", "original_text": "Yes, cortical spreading depression (CSD) can occur in the ischemic penumbra following ischemic stroke. CSD is a transient, widespread wave of depolarization that occurs in the cerebral cortex after ischemic injury and is characterized by a gradual spreading of the depolarization wave from the site of injury towards the periphery. The penumbra, which is the region of the brain where there is a decreased blood supply but not complete loss of blood supply, is particularly susceptible to CSD following ischemic stroke. CSD can lead to further neuronal damage and worsen the outcome in stroke patients.", "label": 0, "is_selected": 0, "text": "Yes, cortical spreading depression (CSD) can occur in the ischemic penumbra following ischemic stroke. CSD is a transient, widespread wave of depolarization that occurs in the cerebral cortex after ischemic injury and is characterized by a gradual spreading of the depolarization wave from the site of injury towards the periphery. The penumbra, which is the region of the brain where there is a decreased blood supply but not complete loss of blood supply, is particularly susceptible to CSD following ischemic stroke. CSD can lead to further neuronal damage and worsen the outcome in stroke patients."}
{"qid": "5e2db15cfbd6abf43b000014", "original_text": "Although levodopa is considered the most effective pharmacotherapy for motor symptoms of Parkinson's disease (PD), chronic use is associated with motor complications, including fluctuating response and unpredictable, involuntary movements called dyskinesia. ADS-5102 (amantadine) extended-release (ER) capsules (GOCOVRITM) is a recent US FDA-approved treatment for dyskinesia in PD patients. ADS-5102 is a high-dose, ER formulation of amantadine, administered orally once daily at bedtime, that achieves high plasma drug concentrations throughout the day. In this study, we present pooled results from two randomized, double-blind, placebo-controlled, phase III ADS-5102 trials. The two studies in PD patients with dyskinesia shared design and eligibility criteria, differing only in treatment duration. Results from common assessment time points were pooled. At 12 weeks, the least squares (LS) mean change in total score on the Unified Dyskinesia Rating Scale among 100 patients randomized to ADS-5102 and 96 patients randomized to placebo was - 17.7 (standard error [SE] 1.3) vs. - 7.6 (1.3) points, respectively (- 10.1 points, 95% confidence interval", "label": 1, "is_selected": 0, "text": "Although levodopa is considered the most effective pharmacotherapy for motor symptoms of Parkinson's disease (PD), chronic use is associated with motor complications, including fluctuating response and unpredictable, involuntary movements called dyskinesia. ADS-5102 (amantadine) extended-release (ER) capsules (GOCOVRITM) is a recent US FDA-approved treatment for dyskinesia in PD patients. ADS-5102 is a high-dose, ER formulation of amantadine, administered orally once daily at bedtime, that achieves high plasma drug concentrations throughout the day. In this study, we present pooled results from two randomized, double-blind, placebo-controlled, phase III ADS-5102 trials. The two studies in PD patients with dyskinesia shared design and eligibility criteria, differing only in treatment duration. Results from common assessment time points were pooled. At 12 weeks, the least squares (LS) mean change in total score on the Unified Dyskinesia Rating Scale among 100 patients randomized to ADS-5102 and 96 patients randomized to placebo was - 17.7 (standard error [SE] 1.3) vs. - 7.6 (1.3) points, respectively (- 10.1 points, 95% confidence interval"}
{"qid": "5e7744c3835f4e4777000005", "original_text": "Leuprorelin acetate is a synthetic version of the hormone leuprolide, which is used as an androgen deprivation therapy (ADT) for the treatment of prostate cancer. ADT works by reducing the levels of testosterone in the body, which can slow the growth of cancer cells. Leuprorelin acetate is given as an injection every 3-4 months and can be used in combination with other therapies, such as surgery or radiation, to treat prostate cancer. It is important to note that leuprorelin acetate can cause a range of side effects, including hot flashes, fatigue, and changes in mood, and patients should be closely monitored by their healthcare provider while taking this medication.", "label": 0, "is_selected": 1, "text": "Leuprorelin acetate is a medication used to treat men with advanced prostate cancer who have not had any other treatment options available, such as surgery, radiation, or hormone replacement therapy, or who have had their cancer spread to other parts of the body, including the bone."}
{"qid": "54fc99f36ad7dcbc12000004", "original_text": "Neurostimulation of the anterior cingulate nucleus (ACN) is used for the treatment of dystonia, a movement disorder characterized by sustained or intermittent muscle contractions that can cause abnormal postures or movements. Deep brain stimulation (DBS) of the ACN has been shown to significantly improve dystonia symptoms in patients who have not responded to other treatments. DBS of the ACN works by delivering electrical impulses to the brain, which can help regulate abnormal brain activity and reduce dystonia symptoms. Other nuclei, such as the subthalamic nucleus, have also been targeted for DBS in the treatment of dystonia, but the ACN is the most commonly targeted nucleus for this purpose.", "label": 0, "is_selected": 1, "text": "This article describes the use of deep brain stimulation (DBS) of a specific part of the brain for the treatment of dystonia, and how this therapy can be used in a variety of other neurological conditions, including Parkinson's disease and spinal muscular atrophy (SMA)."}
{"qid": "602354e41cb411341a000098", "original_text": "Prurigo nodularis is a chronic pruritic skin disease with multiple nodular skin lesions. Nemolizumab is a monoclonal antibody targeting the interleukin-31 receptor, which is involved in the pathogenesis of prurigo nodularis. We conducted a 12-week, randomized, double-blind, phase 2 trial of nemolizumab (at a dose of 0.5 mg per kilogram of body weight) administered subcutaneously at baseline, week 4, and week 8, as compared with placebo, in patients with moderate-to-severe prurigo nodularis and severe pruritus. Moderate-to-severe prurigo nodularis was defined as 20 or more nodules, and severe pruritus was defined as a mean score of at least 7 for the worst daily intensity of pruritus on the numerical rating scale (scores range from 0 [no itch] to 10 [worst itch imaginable]).", "label": 1, "is_selected": 0, "text": "Prurigo nodularis is a chronic pruritic skin disease with multiple nodular skin lesions. Nemolizumab is a monoclonal antibody targeting the interleukin-31 receptor, which is involved in the pathogenesis of prurigo nodularis. We conducted a 12-week, randomized, double-blind, phase 2 trial of nemolizumab (at a dose of 0.5 mg per kilogram of body weight) administered subcutaneously at baseline, week 4, and week 8, as compared with placebo, in patients with moderate-to-severe prurigo nodularis and severe pruritus. Moderate-to-severe prurigo nodularis was defined as 20 or more nodules, and severe pruritus was defined as a mean score of at least 7 for the worst daily intensity of pruritus on the numerical rating scale (scores range from 0 [no itch] to 10 [worst itch imaginable])."}
{"qid": "5c76e6d27c78d694710000ac", "original_text": "Histophilus somni is capable of intracellular survival within professional phagocytic cells, but the mechanism of survival is not understood. The Fic motif within the direct repeat (DR1)/DR2 domains of the IbpA fibrillary network protein of H. somni is cytotoxic to epithelial and phagocytic cells, which may interfere with the bactericidal activity of these cells. To determine the contribution of IbpA and Fic to resistance to host defenses, H. somni strains and mutants that lacked all or a region of ibpA (including the DR1/DR2 regions) were tested for survival in bovine monocytic cells and for serum susceptibility. An H. somni mutant lacking IbpA, but not the DR1/DR2 region within ibpA, was more susceptible to killing by antiserum than the parent, indicating that the entire protein was associated with serum resistance. H. somni strains expressing IbpA replicated in bovine monocytes for at least 72 h and were toxic for these cells. Virulent strain 2336 mutants lacking the entire ibpA gene or both DR1 and DR2 were not toxic to the monocytes but still survived within the monocytes for at least 72 h. Monitoring of intracellular trafficking of H. somni with monoclonal antibodies to phagosomal markers indicated that the early phagosomal marker early endosome antigen 1 colocalized with all isolates tested, but only strains that could survive intracellularly did not colocalize with the late lysosomal marker lysosome-associated membrane protein 2 and prevented the acidification of phagosomes.", "label": 1, "is_selected": 0, "text": "Histophilus somni is capable of intracellular survival within professional phagocytic cells, but the mechanism of survival is not understood. The Fic motif within the direct repeat (DR1)/DR2 domains of the IbpA fibrillary network protein of H. somni is cytotoxic to epithelial and phagocytic cells, which may interfere with the bactericidal activity of these cells. To determine the contribution of IbpA and Fic to resistance to host defenses, H. somni strains and mutants that lacked all or a region of ibpA (including the DR1/DR2 regions) were tested for survival in bovine monocytic cells and for serum susceptibility. An H. somni mutant lacking IbpA, but not the DR1/DR2 region within ibpA, was more susceptible to killing by antiserum than the parent, indicating that the entire protein was associated with serum resistance. H. somni strains expressing IbpA replicated in bovine monocytes for at least 72 h and were toxic for these cells. Virulent strain 2336 mutants lacking the entire ibpA gene or both DR1 and DR2 were not toxic to the monocytes but still survived within the monocytes for at least 72 h. Monitoring of intracellular trafficking of H. somni with monoclonal antibodies to phagosomal markers indicated that the early phagosomal marker early endosome antigen 1 colocalized with all isolates tested, but only strains that could survive intracellularly did not colocalize with the late lysosomal marker lysosome-associated membrane protein 2 and prevented the acidification of phagosomes."}
{"qid": "5c7d520ed774d0424000000f", "original_text": "Adipokines are a class of proteins produced by adipose tissue (fat cells) that play a key role in regulating metabolic processes such as energy homeostasis and glucose tolerance. There are several adipokines, including: 1. Leptin: a hormone produced by white adipose tissue that helps regulate energy balance and metabolism. 2. Resistin: a hormone produced by white and brown adipose tissue that has been linked to insulin resistance and type 2 diabetes. 3. Adiponectin: a protein produced by white and brown adipose tissue that promotes glucose tolerance, insulin sensitivity, and inflammation reduction. 4. PAI-1: a protein produced by fat cells that inhibits the activity of the protein lipase, leading to increased triglyceride levels. 5. TNF-alpha: a cytokine produced by immune cells that induces inflammation in adipose tissue and contributes to insulin resistance and metabolic disorders. These are some of the most well-known adipokines, but there are many others that have been identified and are being studied for their potential role in metabolic disorders.", "label": 0, "is_selected": 0, "text": "Adipokines are a class of proteins produced by adipose tissue (fat cells) that play a key role in regulating metabolic processes such as energy homeostasis and glucose tolerance. There are several adipokines, including: 1. Leptin: a hormone produced by white adipose tissue that helps regulate energy balance and metabolism. 2. Resistin: a hormone produced by white and brown adipose tissue that has been linked to insulin resistance and type 2 diabetes. 3. Adiponectin: a protein produced by white and brown adipose tissue that promotes glucose tolerance, insulin sensitivity, and inflammation reduction. 4. PAI-1: a protein produced by fat cells that inhibits the activity of the protein lipase, leading to increased triglyceride levels. 5. TNF-alpha: a cytokine produced by immune cells that induces inflammation in adipose tissue and contributes to insulin resistance and metabolic disorders. These are some of the most well-known adipokines, but there are many others that have been identified and are being studied for their potential role in metabolic disorders."}
{"qid": "5a76196faacfb9cd4c000001", "original_text": "Primary Evans syndrome (ES) is defined by the concurrent or sequential occurrence of immune thrombocytopenia and autoimmune hemolytic anemia in the absence of an underlying etiology. The syndrome is characterized by a chronic, relapsing, and potentially fatal course requiring long-term immunosuppressive therapy. Treatment of ES is hardly evidence-based. Corticosteroids are the mainstay of therapy.", "label": 1, "is_selected": 0, "text": "Primary Evans syndrome (ES) is defined by the concurrent or sequential occurrence of immune thrombocytopenia and autoimmune hemolytic anemia in the absence of an underlying etiology. The syndrome is characterized by a chronic, relapsing, and potentially fatal course requiring long-term immunosuppressive therapy. Treatment of ES is hardly evidence-based. Corticosteroids are the mainstay of therapy."}
{"qid": "5e290a268b3851296d00000d", "original_text": "Alterations in the CDK4/6-RB signaling pathway are common causes of cell cycle dysregulation in many cancers, including glioblastoma. Palbociclib is an oral inhibitor of CDK4/6, which leads to phosphorylation of RB1 and cell-cycle arrest. We conducted a two-arm study evaluating efficacy and tissue pharmacokinetics/pharmacodynamics of palbociclib in patients with recurrent glioblastoma. Eligibility criteria included confirmation of RB1 proficiency by IHC; \u2264 3 relapses; KPS \u2265 60; no limit on prior treatments. Arm 1 received palbociclib for 7 days prior to indicated resection followed by adjuvant palbociclib. Arm 2 received palbociclib without resection. Primary objective was PFS6; secondary included toxicity, OS, and ORR. Exploratory aims included biomarker assessment and pharmacokinetic/pharmacodynamic effects in surgical patients. Total of 22 patients were enrolled; 6 on Arm 1 and 16 on Arm 2. Trial was stopped early secondary to lack of efficacy, with 95% of evaluable patients progressing within 6 months. Median PFS was 5.14 weeks (range 5 days-142 weeks) and median OS was 15.4 weeks (range 2-274 weeks). Two patients (10%) had related grade \u2265 3 AEs.", "label": 1, "is_selected": 0, "text": "Alterations in the CDK4/6-RB signaling pathway are common causes of cell cycle dysregulation in many cancers, including glioblastoma. Palbociclib is an oral inhibitor of CDK4/6, which leads to phosphorylation of RB1 and cell-cycle arrest. We conducted a two-arm study evaluating efficacy and tissue pharmacokinetics/pharmacodynamics of palbociclib in patients with recurrent glioblastoma. Eligibility criteria included confirmation of RB1 proficiency by IHC; \u2264 3 relapses; KPS \u2265 60; no limit on prior treatments. Arm 1 received palbociclib for 7 days prior to indicated resection followed by adjuvant palbociclib. Arm 2 received palbociclib without resection. Primary objective was PFS6; secondary included toxicity, OS, and ORR. Exploratory aims included biomarker assessment and pharmacokinetic/pharmacodynamic effects in surgical patients. Total of 22 patients were enrolled; 6 on Arm 1 and 16 on Arm 2. Trial was stopped early secondary to lack of efficacy, with 95% of evaluable patients progressing within 6 months. Median PFS was 5.14 weeks (range 5 days-142 weeks) and median OS was 15.4 weeks (range 2-274 weeks). Two patients (10%) had related grade \u2265 3 AEs."}
{"qid": "58d131218acda34529000005", "original_text": "We demonstrate the use of surface-immobilized, oriented peptide aptamers for the detection of specific target proteins from complex biological solutions. These peptide aptamers are target-specific peptides expressed within a protein scaffold engineered from the human protease inhibitor stefin A. The scaffold provides stability to the inserted peptides and increases their binding affinity owing to the resulting three-dimensional constraints. A unique cysteine residue was introduced into the protein scaffold to allow orientation-specific surface immobilization of the peptide aptamer and to ensure exposure of the binding site to the target solution. Using dual-polarization interferometry, we demonstrate a strong relationship between binding affinity and aptamer orientation and determine the affinity constant KD for the interaction between an oriented peptide aptamer ST(cys+)_(pep9) and the target protein CDK2. Further, we demonstrate the high selectivity of the peptide aptamer STM_(pep9) by exposing surface-immobilized ST(cys+)_(pep9) to a complex biological solution containing small concentrations of the target protein CDK2.", "label": 1, "is_selected": 0, "text": "We demonstrate the use of surface-immobilized, oriented peptide aptamers for the detection of specific target proteins from complex biological solutions. These peptide aptamers are target-specific peptides expressed within a protein scaffold engineered from the human protease inhibitor stefin A. The scaffold provides stability to the inserted peptides and increases their binding affinity owing to the resulting three-dimensional constraints. A unique cysteine residue was introduced into the protein scaffold to allow orientation-specific surface immobilization of the peptide aptamer and to ensure exposure of the binding site to the target solution. Using dual-polarization interferometry, we demonstrate a strong relationship between binding affinity and aptamer orientation and determine the affinity constant KD for the interaction between an oriented peptide aptamer ST(cys+)_(pep9) and the target protein CDK2. Further, we demonstrate the high selectivity of the peptide aptamer STM_(pep9) by exposing surface-immobilized ST(cys+)_(pep9) to a complex biological solution containing small concentrations of the target protein CDK2."}
{"qid": "5880be1dc872c95565000007", "original_text": "Poly(ADP-ribose) polymerases(PARP) synthesize the ADP-ribose polymers onto proteins and play a role in DNA repair. PARP inhibitors block the repair of single-strand breaks, which in turn gives rise to double-strand breaks during DNA replication. Thus, PARP inhibitors elicit synthetic lethality in cancer with BRCA1/2 loss-of-function mutations that hamper homologous recombination repair of double-strand breaks. Olaparib, the first-in-class PARP inhibitor, was approved for treatment of BRCA-mutated ovarian cancer in Europe and the United States in 2014. Other PARP inhibitors under clinical trials include rucaparib, niraparib, veliparib, and the \"PARP-trapping\" BMN-673.", "label": 1, "is_selected": 0, "text": "Poly(ADP-ribose) polymerases(PARP) synthesize the ADP-ribose polymers onto proteins and play a role in DNA repair. PARP inhibitors block the repair of single-strand breaks, which in turn gives rise to double-strand breaks during DNA replication. Thus, PARP inhibitors elicit synthetic lethality in cancer with BRCA1/2 loss-of-function mutations that hamper homologous recombination repair of double-strand breaks. Olaparib, the first-in-class PARP inhibitor, was approved for treatment of BRCA-mutated ovarian cancer in Europe and the United States in 2014. Other PARP inhibitors under clinical trials include rucaparib, niraparib, veliparib, and the \"PARP-trapping\" BMN-673."}
{"qid": "58a5723c60087bc10a00001e", "original_text": "Benserazide, also known as benzodiazepine, is a medication that is commonly used in the treatment of Parkinson's disease (PD) when co-administered with L-DOPA (levodopa). The mechanism of function of benserazide in this context is thought to involve the inhibition of an enzyme in the brain called catechol-O-methyltransferase (COMT). This enzyme is responsible for breaking down L-DOPA, which can lead to a more rapid decline in the effectiveness of the medication over time. By inhibiting COMT, benserazide increases the levels of L-DOPA in the brain, which can help to improve the symptoms of PD, such as tremors, rigidity, and bradykinesia. However, it is important to note that benserazide can also have side effects, such as drowsiness, confusion, and fatigue, and its use in PD patients should be carefully monitored and managed by a healthcare professional.", "label": 0, "is_selected": 1, "text": "Benserazide is a prescription medication used in the treatment of Parkinson's disease when co-administered with L-DOPA (levodopa) and in the palliative care setting when used in combination with other medications, such as anti-seizure drugs or anti-anxiety drugs.<n> However, it is important to note that benserazide can also have side effects,such as confusion, and drowsiness, and its use in PD patients should be carefully monitored and managed by a healthcare professional."}
{"qid": "5713bc991174fb1755000010", "original_text": "Charcot-Marie-Tooth (CMT) disease caused by mutations in the GDAP1 gene has been shown to be inherited via traits that may be either autosomal recessive (in the majority of cases) [CMT4A] or autosomal dominant [CMT2K]. CMT4A disease is characterized by an early onset, and a severe clinical course often leading to a loss of ambulation, whereas CMT2K is characterized by a mild clinical course of benign axonal neuropathy beginning even in the 6th decade of life. Clinical data from a GDAP1 mutated patient suggests that the presence of a particular mutation is associated with a certain trait of inheritance. The association of a particular GDAP1 gene mutation and a dominant or recessive trait of inheritance is of special importance for genetic counseling and the prenatal diagnostics as regards severe forms of CMT. In the present study we report on two CMT families in which a newly identified Glu222Lys mutation within the GDAP1 gene segregates both in autosomal dominant and recessive traits. Our study shows that at least some GDAP1 gene mutations may segregate with the CMT phenotype as both dominant and recessive traits. Thus, genetic counseling for CMT4A/CMT2K families requires more extensive data on GDAP1 phenotype-genotype correlations.", "label": 1, "is_selected": 0, "text": "Charcot-Marie-Tooth (CMT) disease caused by mutations in the GDAP1 gene has been shown to be inherited via traits that may be either autosomal recessive (in the majority of cases) [CMT4A] or autosomal dominant [CMT2K]. CMT4A disease is characterized by an early onset, and a severe clinical course often leading to a loss of ambulation, whereas CMT2K is characterized by a mild clinical course of benign axonal neuropathy beginning even in the 6th decade of life. Clinical data from a GDAP1 mutated patient suggests that the presence of a particular mutation is associated with a certain trait of inheritance. The association of a particular GDAP1 gene mutation and a dominant or recessive trait of inheritance is of special importance for genetic counseling and the prenatal diagnostics as regards severe forms of CMT. In the present study we report on two CMT families in which a newly identified Glu222Lys mutation within the GDAP1 gene segregates both in autosomal dominant and recessive traits. Our study shows that at least some GDAP1 gene mutations may segregate with the CMT phenotype as both dominant and recessive traits. Thus, genetic counseling for CMT4A/CMT2K families requires more extensive data on GDAP1 phenotype-genotype correlations."}
{"qid": "5e2dbd72fbd6abf43b000018", "original_text": "To summarize the US Food and Drug Administration's (FDA's) review of the safety and effectiveness for pimavanserin, an atypical antipsychotic, for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. We describe the regulatory and clinical issues important to the FDA's approval of this New Drug Application, with special focus on the risk-benefit balance. We also describe a new labeling feature that presents additional efficacy data to clinicians. Data sets for all relevant clinical trials of pimavanserin and the Applicant's and FDA's analyses of these data were considered in this review. Data were available from 616 patients with Parkinson's disease with hallucinations and delusions who received at least 1 dose of pimavanserin, with a total exposure of 825 patient-years in the Parkinson's disease psychosis population.", "label": 1, "is_selected": 0, "text": "To summarize the US Food and Drug Administration's (FDA's) review of the safety and effectiveness for pimavanserin, an atypical antipsychotic, for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. We describe the regulatory and clinical issues important to the FDA's approval of this New Drug Application, with special focus on the risk-benefit balance. We also describe a new labeling feature that presents additional efficacy data to clinicians. Data sets for all relevant clinical trials of pimavanserin and the Applicant's and FDA's analyses of these data were considered in this review. Data were available from 616 patients with Parkinson's disease with hallucinations and delusions who received at least 1 dose of pimavanserin, with a total exposure of 825 patient-years in the Parkinson's disease psychosis population."}
{"qid": "58bfcb8702b8c60953000016", "original_text": "Two patients with unusual skin stimuli causing koebner phenomenon in psoriasis are reported. First patient, a 33-year-old man, had psoriasis and multiple keloids for the last 26-years. At few places, the lesions of psoriasis and multiple keloids for the last 26-years. At few places, the lesions of psoriasis healed with keloid formation, and psoriatic plaques appeared selectively on the top of the keloids in addition to palms, soles and scalp.", "label": 1, "is_selected": 0, "text": "Two patients with unusual skin stimuli causing koebner phenomenon in psoriasis are reported. First patient, a 33-year-old man, had psoriasis and multiple keloids for the last 26-years. At few places, the lesions of psoriasis and multiple keloids for the last 26-years. At few places, the lesions of psoriasis healed with keloid formation, and psoriatic plaques appeared selectively on the top of the keloids in addition to palms, soles and scalp."}
{"qid": "5a9eb008d6d6b54f79000001", "original_text": "The brown marmorated stink bug, Halyomorpha halys (St\u00e5l), is native to eastern Asia and is presently invading North America. Little is known about the exposure to and effects of winter temperatures in newly invaded regions on H. halys The overwintering habitats that this species utilizes vary greatly in their thermal buffering capacity. They naturally overwinter in aggregations beneath loose bark on trees and in cliff outcroppings, but will also commonly aggregate in buildings.", "label": 1, "is_selected": 0, "text": "The brown marmorated stink bug, Halyomorpha halys (St\u00e5l), is native to eastern Asia and is presently invading North America. Little is known about the exposure to and effects of winter temperatures in newly invaded regions on H. halys The overwintering habitats that this species utilizes vary greatly in their thermal buffering capacity. They naturally overwinter in aggregations beneath loose bark on trees and in cliff outcroppings, but will also commonly aggregate in buildings."}
{"qid": "56a292ae496b62f23f000001", "original_text": "Yes, shadow enhancers are associated with fetal development. Shadow enhancers are structures in the fetal brain that are visible on ultrasound images and are used to assess fetal growth and development. These structures include the anterior and posterior horns, the lateral ventricles, and the third ventricle. The size and shape of these structures can provide information about the fetal brain's development, including the maturation of the cerebral cortex, the growth of the cerebral white matter, and the development of the basal ganglia. Studies have shown that abnormalities in the size and shape of shadow enhancers can be associated with various developmental disorders, such as autism, Down syndrome, and intellectual disability. For example, a smaller anterior horn size has been found to be associated with an increased risk of autism. Therefore, measuring shadow enhancers on ultrasound images can provide valuable information about fetal development and can help identify potential developmental disorders early on.", "label": 0, "is_selected": 1, "text": "Can shadow enhancers on ultrasound images be used to identify potential developmental disorders early on in the baby's life?<n> Therefore, measuring shadow enhancerS on ultrasound Images can provide valuable information about fetal development and can help identify potential development disorders Early on in a baby''s Life..Continued below..Please follow our Frequently Asked Questions section for more information on this topic."}
{"qid": "60367f5e1cb411341a000157", "original_text": "HbA1c is a biomarker with a central role in the diagnosis and follow-up of patients with diabetes, although not a perfect one. Common comorbidities encountered in patients with diabetes mellitus, such as renal insufficiency, high output states (iron deficiency anaemia, haemolytic anaemia, haemoglobinopathies and pregnancy) and intake of specific drugs could compromise the sensitivity and specificity of the biomarker. COVID-19 pandemic poses a pressing challenge for the diabetic population, since maintaining optimal blood glucose control is key to reduce morbidity and mortality rates.", "label": 1, "is_selected": 0, "text": "HbA1c is a biomarker with a central role in the diagnosis and follow-up of patients with diabetes, although not a perfect one. Common comorbidities encountered in patients with diabetes mellitus, such as renal insufficiency, high output states (iron deficiency anaemia, haemolytic anaemia, haemoglobinopathies and pregnancy) and intake of specific drugs could compromise the sensitivity and specificity of the biomarker. COVID-19 pandemic poses a pressing challenge for the diabetic population, since maintaining optimal blood glucose control is key to reduce morbidity and mortality rates."}
{"qid": "5a6d23ccb750ff4455000035", "original_text": "TUC-338, also known as tubulysin B, is a marine-derived compound that has shown promise in inhibiting the growth of colorectal cancer cells. Studies have shown that TUC-338 can induce cell cycle arrest and apoptosis (programmed cell death) in colorectal cancer cells, leading to inhibition of cancer growth. The mechanistic actions of TUC-338 include the alteration of microtubule dynamics, leading to the inhibition of cancer cell migration and invasion. Additionally, TUC-338 has been shown to modulate the PI3K/Akt signaling pathway, which is commonly activated in colorectal cancer. While TUC-338 has shown promise as a potential cancer treatment, further research is needed to fully understand its efficacy and safety in humans.", "label": 0, "is_selected": 0, "text": "TUC-338, also known as tubulysin B, is a marine-derived compound that has shown promise in inhibiting the growth of colorectal cancer cells. Studies have shown that TUC-338 can induce cell cycle arrest and apoptosis (programmed cell death) in colorectal cancer cells, leading to inhibition of cancer growth. The mechanistic actions of TUC-338 include the alteration of microtubule dynamics, leading to the inhibition of cancer cell migration and invasion. Additionally, TUC-338 has been shown to modulate the PI3K/Akt signaling pathway, which is commonly activated in colorectal cancer. While TUC-338 has shown promise as a potential cancer treatment, further research is needed to fully understand its efficacy and safety in humans."}
{"qid": "58ca746d02b8c6095300002d", "original_text": "White adipose tissue (WAT) functions as an energy reservoir where excess circulating fatty acids are transported to WAT, converted to triglycerides, and stored as unilocular lipid droplets. Fat-specific protein 27 (FSP27, CIDEC in humans) is a lipid-coating protein highly expressed in mature white adipocytes that contributes to unilocular lipid droplet formation. However, the influence of FSP27 in adipose tissue on whole-body energy homeostasis remains unclear. Mice with adipocyte-specific disruption of the Fsp27 gene (Fsp27(\u0394Ad)) were generated using an aP2-Cre transgene with the Cre/LoxP system. Upon high-fat diet feeding, Fsp27(\u0394Ad) mice were resistant to weight gain. In the small WAT of these mice, small adipocytes containing multilocular lipid droplets were dispersed. The expression levels of the genes associated with mitochondrial abundance and brown adipocyte identity were increased, and basal lipolytic activities were significantly augmented in adipocytes isolated from Fsp27(\u0394Ad) mice compared with the Fsp27(F/F) counterparts.", "label": 1, "is_selected": 0, "text": "White adipose tissue (WAT) functions as an energy reservoir where excess circulating fatty acids are transported to WAT, converted to triglycerides, and stored as unilocular lipid droplets. Fat-specific protein 27 (FSP27, CIDEC in humans) is a lipid-coating protein highly expressed in mature white adipocytes that contributes to unilocular lipid droplet formation. However, the influence of FSP27 in adipose tissue on whole-body energy homeostasis remains unclear. Mice with adipocyte-specific disruption of the Fsp27 gene (Fsp27(\u0394Ad)) were generated using an aP2-Cre transgene with the Cre/LoxP system. Upon high-fat diet feeding, Fsp27(\u0394Ad) mice were resistant to weight gain. In the small WAT of these mice, small adipocytes containing multilocular lipid droplets were dispersed. The expression levels of the genes associated with mitochondrial abundance and brown adipocyte identity were increased, and basal lipolytic activities were significantly augmented in adipocytes isolated from Fsp27(\u0394Ad) mice compared with the Fsp27(F/F) counterparts."}
{"qid": "56f4011709dd18d46b000003", "original_text": "The main symptom of Marfan syndrome patients is tall stature with a disproportionately long torso and limbs. Individuals with Marfan syndrome typically have a tall, lanky build, with arms and legs that are longer than average. This is caused by a mutation in the FBN1 gene, which encodes a protein called fibrillin-1, which plays a crucial role in the structure and function of connective tissue. Other common symptoms of Marfan syndrome include cardiovascular problems, such as aortic aneurysm or dilated aorta, as well as eye problems, such as myopia, hyperopia, or cataracts. Some individuals with Marfan syndrome may also experience joint hypermobility, scoliosis, or other skeletal abnormalities.", "label": 0, "is_selected": 0, "text": "The main symptom of Marfan syndrome patients is tall stature with a disproportionately long torso and limbs. Individuals with Marfan syndrome typically have a tall, lanky build, with arms and legs that are longer than average. This is caused by a mutation in the FBN1 gene, which encodes a protein called fibrillin-1, which plays a crucial role in the structure and function of connective tissue. Other common symptoms of Marfan syndrome include cardiovascular problems, such as aortic aneurysm or dilated aorta, as well as eye problems, such as myopia, hyperopia, or cataracts. Some individuals with Marfan syndrome may also experience joint hypermobility, scoliosis, or other skeletal abnormalities."}
{"qid": "5c641179e842deac67000012", "original_text": "The second messenger cAMP plays a pivotal role in neurite/axon growth and guidance, but its downstream pathways leading to the regulation of Rho GTPases, centrally implicated in neuronal morphogenesis, remain elusive. We examined spatiotemporal changes in Rac1 and Cdc42 activity and phosphatidylinositol 3,4,5-triphosphate (PIP(3)) concentration in dibutyryl cAMP (dbcAMP)-treated PC12D cells using F\u00f6rster resonance energy transfer-based biosensors. During a 30-min incubation with dbcAMP, Rac1 activity gradually increased throughout the cells and remained at its maximal level. There was no change in PIP(3) concentration. After a 5-h incubation with dbcAMP, Rac1 and Cdc42 were activated at the protruding tips of neurites without PIP(3) accumulation. dbcAMP-induced Rac1 activation was principally mediated by protein kinase A (PKA) and Sif- and Tiam1-like exchange factor (STEF)/Tiam2.", "label": 1, "is_selected": 0, "text": "The second messenger cAMP plays a pivotal role in neurite/axon growth and guidance, but its downstream pathways leading to the regulation of Rho GTPases, centrally implicated in neuronal morphogenesis, remain elusive. We examined spatiotemporal changes in Rac1 and Cdc42 activity and phosphatidylinositol 3,4,5-triphosphate (PIP(3)) concentration in dibutyryl cAMP (dbcAMP)-treated PC12D cells using F\u00f6rster resonance energy transfer-based biosensors. During a 30-min incubation with dbcAMP, Rac1 activity gradually increased throughout the cells and remained at its maximal level. There was no change in PIP(3) concentration. After a 5-h incubation with dbcAMP, Rac1 and Cdc42 were activated at the protruding tips of neurites without PIP(3) accumulation. dbcAMP-induced Rac1 activation was principally mediated by protein kinase A (PKA) and Sif- and Tiam1-like exchange factor (STEF)/Tiam2."}
{"qid": "53267871d6d3ac6a3400000a", "original_text": "The treatment of hypothyroidism in patients undergoing coronary artery bypass surgery is a difficult clinical problem. To determine perioperative thyroid replacement therapy in patients with hypothyroidism, plasma total thyroxine (T4), total triiodothyroxine (T3), free T4, free T3 and thyroid-stimulating hormone levels were measured preoperatively and at 1, 2, 3, 7, and 14 days after operation in 9 patients with hypothyroidism and were compared with levels in 14 patients with normal thyroid function who underwent coronary bypass surgery. In the normal control group, total T4 decreased to its lowest level on the 1st postoperative day and then increased gradually to the preoperative level at 7 days. Total T4 remained within the normal range throughout the entire postoperative course. In 6 patients with hypothyroidism who were treated with thyroid hormone before surgery, total T4 decreased immediately after operation and only increased after starting thyroid replacement therapy. In 3 hypothyroid patients without prior thyroid replacement, total T4 showed a change similar to patients in the control group but remained below the normal range until starting thyroid replacement therapy. Coronary bypass surgery was performed safely in patients with hypothyroidism. Preoperative thyroid replacement with suboptimal doses was safe in patients with severe hypothyroidism. Adequate postoperative thyroid replacement was achieved in all patients without complications.", "label": 1, "is_selected": 0, "text": "The treatment of hypothyroidism in patients undergoing coronary artery bypass surgery is a difficult clinical problem. To determine perioperative thyroid replacement therapy in patients with hypothyroidism, plasma total thyroxine (T4), total triiodothyroxine (T3), free T4, free T3 and thyroid-stimulating hormone levels were measured preoperatively and at 1, 2, 3, 7, and 14 days after operation in 9 patients with hypothyroidism and were compared with levels in 14 patients with normal thyroid function who underwent coronary bypass surgery. In the normal control group, total T4 decreased to its lowest level on the 1st postoperative day and then increased gradually to the preoperative level at 7 days. Total T4 remained within the normal range throughout the entire postoperative course. In 6 patients with hypothyroidism who were treated with thyroid hormone before surgery, total T4 decreased immediately after operation and only increased after starting thyroid replacement therapy. In 3 hypothyroid patients without prior thyroid replacement, total T4 showed a change similar to patients in the control group but remained below the normal range until starting thyroid replacement therapy. Coronary bypass surgery was performed safely in patients with hypothyroidism. Preoperative thyroid replacement with suboptimal doses was safe in patients with severe hypothyroidism. Adequate postoperative thyroid replacement was achieved in all patients without complications."}
{"qid": "530e42e65937551c09000007", "original_text": "Yes, fatigue is a common symptom experienced by patients receiving treatment for glioblastoma, which is a type of aggressive brain cancer. According to a study published in the Journal of Clinical Oncology, approximately 70% of patients with glioblastoma experience fatigue during treatment. The fatigue is often severe and can interfere with daily activities, including work, social activities, and exercise. The exact cause of fatigue in glioblastoma patients is not fully understood, but it is believed to be multifactorial, involving physical, psychological, and cancer-related factors. The treatment itself, including surgery, radiation, and chemotherapy, can cause fatigue due to the alteration of brain function and the metabolic demands of the cancer. Additionally, the stress of dealing with a life-threatening illness and the emotional toll of treatment can also contribute to fatigue. Managing fatigue in glioblastoma patients is important, as it can significantly impact their quality of life. Conservative management strategies, such as pacing activities, taking regular breaks, and maintaining a regular sleep schedule, can be effective in managing fatigue. In addition, medications, such as stimulants and corticosteroids, may be prescribed to help manage fatigue. In some cases, alternative therapies, such as acupuncture and massage, may also be recommended to help manage cancer-related fatigue.", "label": 0, "is_selected": 1, "text": "How common is fatigue among patients receiving treatment for brain cancer, and what are the best ways to deal with it?<n> The treatment itself, including surgery, radiation, and chemotherapy, can cause fatigue due to the alteration of brain function and the metabolic demands of the cancer. In some cases, alternative therapies, such as acupuncture and massage, may also be recommended to help manage cancer-related fatigue., according to a study published in the Journal of Clinical Oncology., but it is important to note that these therapies are not a substitute for professional medical care."}
{"qid": "587f857b8ce3255b64000001", "original_text": "Raxibacumab is a monoclonal antibody that works by neutralizing the activity of the bacterial toxin botulinum neurotoxin (BoNT). It does this by binding to the heavy chain of BoNT and blocking its activity. BoNT is a powerful neurotoxin that can cause botulism, a serious and potentially life-threatening illness. By blocking the activity of BoNT, raxibacumab helps to prevent the symptoms of botulism, such as muscle weakness, paralysis, and difficulty breathing. Raxibacumab is given through an intravenous (IV) infusion and is typically used to treat botulism in adults and children who are experiencing severe symptoms.", "label": 0, "is_selected": 0, "text": "Raxibacumab is a monoclonal antibody that works by neutralizing the activity of the bacterial toxin botulinum neurotoxin (BoNT). It does this by binding to the heavy chain of BoNT and blocking its activity. BoNT is a powerful neurotoxin that can cause botulism, a serious and potentially life-threatening illness. By blocking the activity of BoNT, raxibacumab helps to prevent the symptoms of botulism, such as muscle weakness, paralysis, and difficulty breathing. Raxibacumab is given through an intravenous (IV) infusion and is typically used to treat botulism in adults and children who are experiencing severe symptoms."}
{"qid": "5c73ad347c78d69471000098", "original_text": "Axitinib is a potent, selective inhibitor of vascular endothelial growth factor (VEGF) receptors 1, 2, and 3. A randomised phase 2 trial of gemcitabine with or without axitinib in advanced pancreatic cancer suggested increased overall survival in axitinib-treated patients. On the basis of these results, we aimed to assess the effect of treatment with gemcitabine plus axitinib on overall survival in a phase 3 trial. In this double-blind, placebo-controlled, phase 3 study, eligible patients had metastatic or locally advanced pancreatic adenocarcinoma, no uncontrolled hypertension or venous thrombosis, and Eastern Cooperative Oncology Group performance status 0 or 1. Patients, stratified by disease extent (metastatic vs locally advanced), were randomly assigned (1:1) to receive gemcitabine 1000 mg/m(2) intravenously on days 1, 8, and 15 every 28 days plus either axitinib or placebo. Axitinib or placebo were administered orally with food at a starting dose of 5 mg twice a day, which could be dose-titrated up to 10 mg twice daily if well tolerated. A centralised randomisation procedure was used to assign patients to each treatment group, with randomised permuted blocks within strata. Patients, investigators, and the trial sponsor were masked to treatment assignments. The primary endpoint was overall survival. All efficacy analyses were done in all patients assigned to treatment groups for whom data were available; safety and treatment administration and compliance assessments were based on treatment received.", "label": 1, "is_selected": 0, "text": "Axitinib is a potent, selective inhibitor of vascular endothelial growth factor (VEGF) receptors 1, 2, and 3. A randomised phase 2 trial of gemcitabine with or without axitinib in advanced pancreatic cancer suggested increased overall survival in axitinib-treated patients. On the basis of these results, we aimed to assess the effect of treatment with gemcitabine plus axitinib on overall survival in a phase 3 trial. In this double-blind, placebo-controlled, phase 3 study, eligible patients had metastatic or locally advanced pancreatic adenocarcinoma, no uncontrolled hypertension or venous thrombosis, and Eastern Cooperative Oncology Group performance status 0 or 1. Patients, stratified by disease extent (metastatic vs locally advanced), were randomly assigned (1:1) to receive gemcitabine 1000 mg/m(2) intravenously on days 1, 8, and 15 every 28 days plus either axitinib or placebo. Axitinib or placebo were administered orally with food at a starting dose of 5 mg twice a day, which could be dose-titrated up to 10 mg twice daily if well tolerated. A centralised randomisation procedure was used to assign patients to each treatment group, with randomised permuted blocks within strata. Patients, investigators, and the trial sponsor were masked to treatment assignments. The primary endpoint was overall survival. All efficacy analyses were done in all patients assigned to treatment groups for whom data were available; safety and treatment administration and compliance assessments were based on treatment received."}
{"qid": "5c62a276e842deac6700000a", "original_text": "De novo mutations in novel genes have been implicated in the development of systemic lupus erythematosus (SLE). SLE is a complex and multifactorial autoimmune disease that can affect multiple organs and systems in the body. Recent genetic studies have identified several novel genes that may contribute to the development of SLE, including: 1. TNFSF4: This gene encodes for a cytokine called TL1A, which is involved in the activation of autoreactive T cells and the development of autoimmune responses. Variants in TNFSF4 have been associated with an increased risk of SLE. 2. CD226: This gene encodes for a cell surface protein called CD226, which is involved in the regulation of immune responses. Variants in CD226 have been associated with an increased risk of SLE and its complications. 3. CLEC16A: This gene encodes for a cell surface protein called CLEC16A, which is involved in the recognition of autophagosomes and the regulation of immune responses. Variants in CLEC16A have been associated with an increased risk of SLE. 4. BLK: This gene encodes for a protein called BLK, which is involved in the regulation of T cell activation and differentiation. Variants in BLK have been associated with an increased risk of SLE. 5. STAT4: This gene encodes for a protein called STAT4, which is involved in the regulation of immune responses. Variants in STAT4 have been associated with an increased risk of SLE and its complications. While these findings are promising, it is important to note that the genetic background of SLE is complex and multifactorial, and further research is needed to fully understand the role of these genes in the development of the disease.", "label": 0, "is_selected": 0, "text": "De novo mutations in novel genes have been implicated in the development of systemic lupus erythematosus (SLE). SLE is a complex and multifactorial autoimmune disease that can affect multiple organs and systems in the body. Recent genetic studies have identified several novel genes that may contribute to the development of SLE, including: 1. TNFSF4: This gene encodes for a cytokine called TL1A, which is involved in the activation of autoreactive T cells and the development of autoimmune responses. Variants in TNFSF4 have been associated with an increased risk of SLE. 2. CD226: This gene encodes for a cell surface protein called CD226, which is involved in the regulation of immune responses. Variants in CD226 have been associated with an increased risk of SLE and its complications. 3. CLEC16A: This gene encodes for a cell surface protein called CLEC16A, which is involved in the recognition of autophagosomes and the regulation of immune responses. Variants in CLEC16A have been associated with an increased risk of SLE. 4. BLK: This gene encodes for a protein called BLK, which is involved in the regulation of T cell activation and differentiation. Variants in BLK have been associated with an increased risk of SLE. 5. STAT4: This gene encodes for a protein called STAT4, which is involved in the regulation of immune responses. Variants in STAT4 have been associated with an increased risk of SLE and its complications. While these findings are promising, it is important to note that the genetic background of SLE is complex and multifactorial, and further research is needed to fully understand the role of these genes in the development of the disease."}
{"qid": "601d76131cb411341a000044", "original_text": "Introduction: Urothelial carcinoma (UC) has a poor prognosis, with the only standard first-line metastatic treatment being platinum-based chemotherapy. Until 2018, there was no Food and Drug Administration (FDA)-approved drug for second-line setting, and only vinflunine was approved by the European Medicines Agency (EMEA) in Europe. However, targeting the programmed cell-death 1 (PD-1)/PD-ligand 1 (PD-L1) pathway with immune checkpoint inhibitor (ICI) agents has shown encouraging results. Avelumab is a human anti-PD-L1 antibody that is currently being investigated in several trials. Areas covered: In this review article, we summarise preclinical, clinical, and safety data on avelumab for UC, and describeongoing trials that are evaluating avelumab for local or advanced diseases. We also compare its place in the management of UC. Expert opinion: Avelumab has shown clinical efficacy for metastatic and advanced UC in phase I studies after the failure of platinum-based therapy with a well-tolerated safety profile. This anti-PD-L1 targeting agent has the capacity to induce antibody-dependant cellular cytotoxicity (ADCC)-mediated tumor cell lysis compared to other ICI.", "label": 1, "is_selected": 0, "text": "Introduction: Urothelial carcinoma (UC) has a poor prognosis, with the only standard first-line metastatic treatment being platinum-based chemotherapy. Until 2018, there was no Food and Drug Administration (FDA)-approved drug for second-line setting, and only vinflunine was approved by the European Medicines Agency (EMEA) in Europe. However, targeting the programmed cell-death 1 (PD-1)/PD-ligand 1 (PD-L1) pathway with immune checkpoint inhibitor (ICI) agents has shown encouraging results. Avelumab is a human anti-PD-L1 antibody that is currently being investigated in several trials. Areas covered: In this review article, we summarise preclinical, clinical, and safety data on avelumab for UC, and describeongoing trials that are evaluating avelumab for local or advanced diseases. We also compare its place in the management of UC. Expert opinion: Avelumab has shown clinical efficacy for metastatic and advanced UC in phase I studies after the failure of platinum-based therapy with a well-tolerated safety profile. This anti-PD-L1 targeting agent has the capacity to induce antibody-dependant cellular cytotoxicity (ADCC)-mediated tumor cell lysis compared to other ICI."}
{"qid": "5175b97a8ed59a060a00002f", "original_text": "DNA damage induces apoptosis and many apoptotic genes are regulated via alternative splicing (AS), but little is known about the control mechanisms. Here we show that ultraviolet irradiation (UV) affects cotranscriptional AS in a p53-independent way, through the hyperphosphorylation of RNA polymerase II carboxy-terminal domain (CTD) and a subsequent inhibition of transcriptional elongation, estimated in vivo and in real time. Phosphomimetic CTD mutants not only display lower elongation but also duplicate the UV effect on AS. Consistently, nonphosphorylatable mutants prevent the UV effect. Apoptosis promoted by UV in cells lacking p53 is prevented when the change in AS of the apoptotic gene bcl-x is reverted, confirming the relevance of this mechanism. Splicing-sensitive microarrays revealed a significant overlap of the subsets of genes that have changed AS with UV and those that have reduced expression, suggesting that transcriptional coupling to AS is a key feature of the DNA-damage response.", "label": 1, "is_selected": 0, "text": "DNA damage induces apoptosis and many apoptotic genes are regulated via alternative splicing (AS), but little is known about the control mechanisms. Here we show that ultraviolet irradiation (UV) affects cotranscriptional AS in a p53-independent way, through the hyperphosphorylation of RNA polymerase II carboxy-terminal domain (CTD) and a subsequent inhibition of transcriptional elongation, estimated in vivo and in real time. Phosphomimetic CTD mutants not only display lower elongation but also duplicate the UV effect on AS. Consistently, nonphosphorylatable mutants prevent the UV effect. Apoptosis promoted by UV in cells lacking p53 is prevented when the change in AS of the apoptotic gene bcl-x is reverted, confirming the relevance of this mechanism. Splicing-sensitive microarrays revealed a significant overlap of the subsets of genes that have changed AS with UV and those that have reduced expression, suggesting that transcriptional coupling to AS is a key feature of the DNA-damage response."}
{"qid": "570a7594cf1c325851000026", "original_text": "The scission of biological membranes is facilitated by a variety of protein complexes that bind and manipulate lipid bilayers. ESCRT-III (endosomal sorting complex required for transport III) filaments mediate membrane scission during the ostensibly disparate processes of multivesicular endosome biogenesis, cytokinesis, and retroviral budding. However, mechanisms by which ESCRT-III subunits assemble into a polymer remain unknown. Using cryogenic electron microscopy (cryo-EM), we found that the full-length ESCRT-III subunit Vps32/CHMP4B spontaneously forms single-stranded spiral filaments.", "label": 1, "is_selected": 0, "text": "The scission of biological membranes is facilitated by a variety of protein complexes that bind and manipulate lipid bilayers. ESCRT-III (endosomal sorting complex required for transport III) filaments mediate membrane scission during the ostensibly disparate processes of multivesicular endosome biogenesis, cytokinesis, and retroviral budding. However, mechanisms by which ESCRT-III subunits assemble into a polymer remain unknown. Using cryogenic electron microscopy (cryo-EM), we found that the full-length ESCRT-III subunit Vps32/CHMP4B spontaneously forms single-stranded spiral filaments."}
{"qid": "52fc94ae2059c6d71c000073", "original_text": "Alzheimer's disease is characterized by the accumulation of amyloid deposits in the brain and the progressive loss of cognitive functions. Although the precise role of amyloid-\u03b2 in disease progression remains somewhat controversial, many efforts to halt or reverse disease progression have focussed on reducing its synthesis or enhancing its removal. It is believed that brain and peripheral soluble amyloid-\u03b2 are in equilibrium and it has previously been hypothesized that a reduction in peripheral amyloid-\u03b2 can lower brain amyloid-\u03b2, thereby reducing formation of plaques predominantly composed of insoluble amyloid-\u03b2; the so-called peripheral sink hypothesis.", "label": 1, "is_selected": 0, "text": "Alzheimer's disease is characterized by the accumulation of amyloid deposits in the brain and the progressive loss of cognitive functions. Although the precise role of amyloid-\u03b2 in disease progression remains somewhat controversial, many efforts to halt or reverse disease progression have focussed on reducing its synthesis or enhancing its removal. It is believed that brain and peripheral soluble amyloid-\u03b2 are in equilibrium and it has previously been hypothesized that a reduction in peripheral amyloid-\u03b2 can lower brain amyloid-\u03b2, thereby reducing formation of plaques predominantly composed of insoluble amyloid-\u03b2; the so-called peripheral sink hypothesis."}
{"qid": "5be48282133db5eb7800001b", "original_text": "At the intersection between neuroscience, microbiology, and psychiatry, the enteric microbiome has potential to become a novel paradigm for studying the psychobiological underpinnings of mental illness. Several studies provide support for the view that the enteric microbiome influences behavior through the microbiota-gut-brain axis. Moreover, recent findings are suggestive of the possibility that dysregulation of the enteric microbiota (i.e., dysbiosis) and associated bacterial translocation across the intestinal epithelium may be involved in the pathophysiology of stress-related psychiatric disorders, particularly depression. The current article reviews preliminary evidence linking the enteric microbiota and its metabolites to psychiatric illness, along with separate lines of empirical inquiry on the potential involvement of psychosocial stressors, proinflammatory cytokines and neuroinflammation, the hypothalamic-pituitary-adrenal axis, and vagal nerve activation, respectively, in this relationship.", "label": 1, "is_selected": 0, "text": "At the intersection between neuroscience, microbiology, and psychiatry, the enteric microbiome has potential to become a novel paradigm for studying the psychobiological underpinnings of mental illness. Several studies provide support for the view that the enteric microbiome influences behavior through the microbiota-gut-brain axis. Moreover, recent findings are suggestive of the possibility that dysregulation of the enteric microbiota (i.e., dysbiosis) and associated bacterial translocation across the intestinal epithelium may be involved in the pathophysiology of stress-related psychiatric disorders, particularly depression. The current article reviews preliminary evidence linking the enteric microbiota and its metabolites to psychiatric illness, along with separate lines of empirical inquiry on the potential involvement of psychosocial stressors, proinflammatory cytokines and neuroinflammation, the hypothalamic-pituitary-adrenal axis, and vagal nerve activation, respectively, in this relationship."}
{"qid": "587d3873ae41fa4569000002", "original_text": "Mammalian genomes encode numerous natural antisense long noncoding RNAs (lncRNAs) that regulate gene expression. Recently, an antisense lncRNA to mouse Ubiquitin carboxyl-terminal hydrolase L1 (Uchl1) was reported to increase UCHL1 protein synthesis, representing a new functional class of lncRNAs, designated as SINEUPs, for SINE element-containing translation UP-regulators. Here, we show that an antisense lncRNA to the human protein phosphatase 1 regulatory subunit 12A (PPP1R12A), named as R12A-AS1, which overlaps with the 5' UTR and first coding exon of the PPP1R12A mRNA, functions as a SINEUP, increasing PPP1R12A protein translation in human cells.", "label": 1, "is_selected": 0, "text": "Mammalian genomes encode numerous natural antisense long noncoding RNAs (lncRNAs) that regulate gene expression. Recently, an antisense lncRNA to mouse Ubiquitin carboxyl-terminal hydrolase L1 (Uchl1) was reported to increase UCHL1 protein synthesis, representing a new functional class of lncRNAs, designated as SINEUPs, for SINE element-containing translation UP-regulators. Here, we show that an antisense lncRNA to the human protein phosphatase 1 regulatory subunit 12A (PPP1R12A), named as R12A-AS1, which overlaps with the 5' UTR and first coding exon of the PPP1R12A mRNA, functions as a SINEUP, increasing PPP1R12A protein translation in human cells."}
{"qid": "571f30c40fd6f91b68000002", "original_text": "Sotos syndrome, also known as NSHD (Norman-Shine-Hall-Dubowitz) syndrome, is a rare genetic disorder caused by a mutation in the NSD1 gene on chromosome 5. It is characterized by delayed development, intellectual disability, and a distinctive face with a prominent forehead, large eyes, and a long, narrow head. Other features may include seizures, behavioral problems, and delayed speech and language development. Sotos syndrome is usually diagnosed in early childhood and can affect an individual's quality of life and cognitive functioning. Treatment options are primarily focused on managing associated symptoms and improving overall health.", "label": 0, "is_selected": 0, "text": "Sotos syndrome, also known as NSHD (Norman-Shine-Hall-Dubowitz) syndrome, is a rare genetic disorder caused by a mutation in the NSD1 gene on chromosome 5. It is characterized by delayed development, intellectual disability, and a distinctive face with a prominent forehead, large eyes, and a long, narrow head. Other features may include seizures, behavioral problems, and delayed speech and language development. Sotos syndrome is usually diagnosed in early childhood and can affect an individual's quality of life and cognitive functioning. Treatment options are primarily focused on managing associated symptoms and improving overall health."}
{"qid": "5ad247720340b9f058000017", "original_text": "A fibrocyte is a type of mesenchymal stem cell that is found in the bone marrow. It is characterized by its ability to differentiate into a variety of cell types, including osteoblasts, chondrocytes, and adipocytes. Fibrocytes are known to play a role in the repair and maintenance of connective tissue, including bone, cartilage, and fat. They can also differentiate into immune cells, such as T cells and macrophages, and have been implicated in the regulation of inflammation. Fibrocytes are thought to be involved in a variety of diseases, including bone and cartilage disorders, as well as certain immune disorders.", "label": 0, "is_selected": 1, "text": "A new study suggests that a type of bone marrow stem cell, the fibrocyte, may be involved in a variety of diseases, including bone and cartilage disorders, as well as certain immune disorders. The study, by researchers at the University of California, San Diego, and the Children's Hospital of Los Angeles, suggests that fibroocytes may play a role in the repair and maintenance of connective tissue, including cartilage, and fat."}
{"qid": "5a8dc57ffcd1d6a10c000025", "original_text": "Gastrin-releasing peptide (GRP), a member of the bombesin family of peptides, has been shown to have mitogenic activity in small cell lung carcinoma (SCLC), and to be produced by SCLC in an autocrine fashion. In this report, we demonstrate that both GRP and another member of the bombesin family of peptides, neuromedin B (NMB), are also autocrine growth factors for non-small cell lung carcinoma (NSCLC). Using the reverse transcription-polymerase chain reaction (RT-PCR), we have detected mRNA for the neuromedin B receptor (NMBR) in all 14 of the NSCLC cell lines examined. GRP receptor (GRPR) mRNA was also expressed in the majority of NSCLC cell lines (nine of 14). By immunoblotting using SDS-PAGE gradient gels fixed in trichloroacetic acid, GRP and NMB were found in fractions of culture medium that had been purified by high pressure liquid chromatography (HPLC) from NSCLC cell lines. NMB was detected in the conditioned medium of seven of nine cell lines and GRP in seven of nine cell lines; both peptides were produced in six cell lines.", "label": 1, "is_selected": 0, "text": "Gastrin-releasing peptide (GRP), a member of the bombesin family of peptides, has been shown to have mitogenic activity in small cell lung carcinoma (SCLC), and to be produced by SCLC in an autocrine fashion. In this report, we demonstrate that both GRP and another member of the bombesin family of peptides, neuromedin B (NMB), are also autocrine growth factors for non-small cell lung carcinoma (NSCLC). Using the reverse transcription-polymerase chain reaction (RT-PCR), we have detected mRNA for the neuromedin B receptor (NMBR) in all 14 of the NSCLC cell lines examined. GRP receptor (GRPR) mRNA was also expressed in the majority of NSCLC cell lines (nine of 14). By immunoblotting using SDS-PAGE gradient gels fixed in trichloroacetic acid, GRP and NMB were found in fractions of culture medium that had been purified by high pressure liquid chromatography (HPLC) from NSCLC cell lines. NMB was detected in the conditioned medium of seven of nine cell lines and GRP in seven of nine cell lines; both peptides were produced in six cell lines."}
{"qid": "57092635cf1c325851000019", "original_text": "The CpG island methylator phenotype (CIMP), characterized by an exceptionally high frequency of methylation of discrete CpG islands, is observed in 18% to 25% of sporadic colorectal cancers. Another hypermethylation pattern found in colorectal cancers, termed long-range epigenetic silencing, is associated with DNA/histone methylation in three distinct gene clusters at chromosome 2q14.2, showing that DNA hypermethylation can span larger chromosomal domains and lead to the silencing of flanking, unmethylated genes. We investigated whether these two phenotypes are interrelated in colorectal cancers. The CIMP status of 148 sporadic colorectal cancers was determined by methylation-specific PCR. We determined the BRAF V600E mutation by mutant allele-specific PCR amplification. The methylation status of the MLH1 gene and of three CpG islands (EN1, SCTR, and INHBB), corresponding to three distinct clusters along 2q14.2, was determined by methylation-specific PCR. The average number of sites showing methylation in CIMP+ tumors was 2.21, compared with 1.22 for CIMP- individuals, and this difference was highly significant (P = 3.6 x 10(-8), Mann-Whitney test).", "label": 1, "is_selected": 0, "text": "The CpG island methylator phenotype (CIMP), characterized by an exceptionally high frequency of methylation of discrete CpG islands, is observed in 18% to 25% of sporadic colorectal cancers. Another hypermethylation pattern found in colorectal cancers, termed long-range epigenetic silencing, is associated with DNA/histone methylation in three distinct gene clusters at chromosome 2q14.2, showing that DNA hypermethylation can span larger chromosomal domains and lead to the silencing of flanking, unmethylated genes. We investigated whether these two phenotypes are interrelated in colorectal cancers. The CIMP status of 148 sporadic colorectal cancers was determined by methylation-specific PCR. We determined the BRAF V600E mutation by mutant allele-specific PCR amplification. The methylation status of the MLH1 gene and of three CpG islands (EN1, SCTR, and INHBB), corresponding to three distinct clusters along 2q14.2, was determined by methylation-specific PCR. The average number of sites showing methylation in CIMP+ tumors was 2.21, compared with 1.22 for CIMP- individuals, and this difference was highly significant (P = 3.6 x 10(-8), Mann-Whitney test)."}
{"qid": "531d744c267d7dd053000009", "original_text": "C-reactive protein (CRP) is a heritable marker of chronic inflammation that is strongly associated with cardiovascular disease. We sought to identify genetic variants that are associated with CRP levels. We performed a genome-wide association analysis of CRP in 66 185 participants from 15 population-based studies. We sought replication for the genome-wide significant and suggestive loci in a replication panel comprising 16 540 individuals from 10 independent studies. We found 18 genome-wide significant loci, and we provided evidence of replication for 8 of them. Our results confirm 7 previously known loci and introduce 11 novel loci that are implicated in pathways related to the metabolic syndrome (APOC1, HNF1A, LEPR, GCKR, HNF4A, and PTPN2) or the immune system (CRP, IL6R, NLRP3, IL1F10, and IRF1) or that reside in regions previously not known to play a role in chronic inflammation (PPP1R3B, SALL1, PABPC4, ASCL1, RORA, and BCL7B).", "label": 1, "is_selected": 0, "text": "C-reactive protein (CRP) is a heritable marker of chronic inflammation that is strongly associated with cardiovascular disease. We sought to identify genetic variants that are associated with CRP levels. We performed a genome-wide association analysis of CRP in 66 185 participants from 15 population-based studies. We sought replication for the genome-wide significant and suggestive loci in a replication panel comprising 16 540 individuals from 10 independent studies. We found 18 genome-wide significant loci, and we provided evidence of replication for 8 of them. Our results confirm 7 previously known loci and introduce 11 novel loci that are implicated in pathways related to the metabolic syndrome (APOC1, HNF1A, LEPR, GCKR, HNF4A, and PTPN2) or the immune system (CRP, IL6R, NLRP3, IL1F10, and IRF1) or that reside in regions previously not known to play a role in chronic inflammation (PPP1R3B, SALL1, PABPC4, ASCL1, RORA, and BCL7B)."}
{"qid": "5fd0d880a43ad31278000002", "original_text": "Otx2 is associated with neural pluripotency. Neural pluripotency refers to the ability of a cell to differentiate into various cell types of the nervous system, including neurons, glial cells, and brain structures. Otx2 is a transcription factor that regulates the expression of genes involved in neural development and plasticity, and is essential for the proper formation and function of the nervous system.", "label": 0, "is_selected": 0, "text": "Otx2 is associated with neural pluripotency. Neural pluripotency refers to the ability of a cell to differentiate into various cell types of the nervous system, including neurons, glial cells, and brain structures. Otx2 is a transcription factor that regulates the expression of genes involved in neural development and plasticity, and is essential for the proper formation and function of the nervous system."}
{"qid": "5e81d6c6835f4e4777000030", "original_text": "EphA2 is a protein that plays a significant role in cellular signaling and has been implicated in various diseases, including cancer. Recent studies have shown that EphA2 is involved in the development of drug resistance in cancer cells. EphA2 activation can promote the survival of cancer cells exposed to chemotherapy drugs, making them more resistant to treatment. Additionally, EphA2 has been shown to enhance the epithelial-to-mesenchymal transition (EMT), a process that confers drug resistance on cancer cells. Overexpression of EphA2 has been detected in many types of cancer, including breast, lung, and ovarian cancer, and has been associated with poor prognosis. Understanding the role of EphA2 in drug resistance may lead to the development of new therapies that target this protein and improve cancer treatment outcomes.", "label": 0, "is_selected": 0, "text": "EphA2 is a protein that plays a significant role in cellular signaling and has been implicated in various diseases, including cancer. Recent studies have shown that EphA2 is involved in the development of drug resistance in cancer cells. EphA2 activation can promote the survival of cancer cells exposed to chemotherapy drugs, making them more resistant to treatment. Additionally, EphA2 has been shown to enhance the epithelial-to-mesenchymal transition (EMT), a process that confers drug resistance on cancer cells. Overexpression of EphA2 has been detected in many types of cancer, including breast, lung, and ovarian cancer, and has been associated with poor prognosis. Understanding the role of EphA2 in drug resistance may lead to the development of new therapies that target this protein and improve cancer treatment outcomes."}
{"qid": "61fbc1acc9dfcb9c0900000d", "original_text": "Within the past several years, no chemotherapy has been sufficient to increase the overall survival of patients with chemorefractory colorectal cancer. TAS-102 (Lonsurf) is an oral fluoropyrimidine that is formed by the combination of 2 active drugs: trifluridine (a nucleoside analog) and tipiracil hydrochloride (a thymidine phosphorylase inhibitor). This drug extended the median overall survival by approximately 2 months compared with placebo in a randomized phase III trial composed of Asian and non-Asian patients with refractory (or intolerant) metastatic colorectal cancer.", "label": 1, "is_selected": 0, "text": "Within the past several years, no chemotherapy has been sufficient to increase the overall survival of patients with chemorefractory colorectal cancer. TAS-102 (Lonsurf) is an oral fluoropyrimidine that is formed by the combination of 2 active drugs: trifluridine (a nucleoside analog) and tipiracil hydrochloride (a thymidine phosphorylase inhibitor). This drug extended the median overall survival by approximately 2 months compared with placebo in a randomized phase III trial composed of Asian and non-Asian patients with refractory (or intolerant) metastatic colorectal cancer."}
{"qid": "61f5ee57882a024a10000012", "original_text": "We discuss a case of a 20-year-old woman presenting with chest pain found to have a Hampton's hump on chest x-ray and corresponding wedge infarct on computed tomographic scan.", "label": 1, "is_selected": 0, "text": "We discuss a case of a 20-year-old woman presenting with chest pain found to have a Hampton's hump on chest x-ray and corresponding wedge infarct on computed tomographic scan."}
{"qid": "517539af8ed59a060a000026", "original_text": "MEF-2 (Myocyte-specific enhancer factor 2) is a transcription factor that plays a crucial role in regulating gene expression in the heart. MEF-2 regulates a variety of genes involved in cardiac development, growth, and function. Some of the genes known to be regulated by MEF-2 in the heart include: 1. Cardiac troponin I (TNNI): MEF-2 regulates the expression of TNNI, a protein that plays a critical role in the regulation of muscle contraction in the heart. 2. \u03b1-Myosin heavy chain (MYH7): MEF-2 regulates the expression of MYH7, a protein that is essential for cardiac muscle contraction. 3. \u03b2-Myosin heavy chain (MYH6): MEF-2 regulates the expression of MYH6, which is also important for cardiac muscle contraction. 4. Tropomyosin (TPM1): MEF-2 regulates the expression of TPM1, a protein that plays a role in the regulation of muscle contraction and cell adhesion in the heart. 5. GATA4: MEF-2 regulates the expression of GATA4, a transcription factor that is essential for the development and maintenance of the heart. 6. GATA6: MEF-2 also regulates the expression of GATA6, which is involved in the development and maintenance of the heart. 7. Kr\u00fcppel-like factor 1 (KLF1): MEF-2 regulates the expression of KLF1, a transcription factor that is involved in the regulation of cardiac gene expression. 8. Brain natriuretic peptide (BNP): MEF-2 regulates the expression of BNP, a hormone that is involved in the regulation of cardiac function and blood pressure. These genes are among the many that are regulated by MEF-2 in the heart, and their dysregulation can lead to various cardiovascular diseases and disorders.", "label": 0, "is_selected": 1, "text": "MEF-2 is a transcription factor that plays a crucial role in regulating gene expression in the heart, and its dysregulation can lead to various cardiovascular diseases and disorders. These genes are among the many that are regulated by MEF-2, and their dysregulation could lead to Various cardiovascular diseases (CVDs) and disorders such as heart attack, stroke, congestive heart failure (CHF), and congenital heart disease (CHD), as well as other diseases such as Alzheimer's disease, diabetes, and Parkinson's diseases, according to the American Heart Association (AHA) and the National Institutes of Health (NIH) in the United States."}
{"qid": "5c65abd17c78d69471000009", "original_text": "The predicted function for the TMEM132 family of proteins is primarily involved in the regulation of cellular signaling pathways, particularly in the context of cancer. TMEM132A and TMEM132B have been shown to interact with the epidermal growth factor receptor (EGFR) and the downstream signaling proteins, suggesting a role in modulating EGFR-mediated signaling pathways. Additionally, TMEM132A has been implicated in the regulation of cell migration and invasion, which are key features of cancer progression. Overall, the TMEM132 family of proteins is predicted to play a crucial role in the development and progression of cancer.", "label": 0, "is_selected": 1, "text": "The T132 family of proteins has been implicated in a number of cellular processes, including the regulation of signaling pathways and cell migration and invasion, as well as in the development and progression of cancer. Overall, the T132 Family of proteins is predicted to play a crucial role in thedevelopment and progression in cancer."}
{"qid": "5c6db9917c78d69471000043", "original_text": "The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) are basically characterized by obsessive-compulsive symptoms and/or tics triggered by group-A beta-hemolytic Streptococcus infections. Poor data are available about the clear definition of PANDAS's autoimmune origin. The aim of our study was to evaluate the prevalence of autoimmune phenomena, including thyroid function abnormalities, specific celiac disease antibodies, and positivity of organ- or nonorgan-specific autoantibodies in a large cohort of Caucasian children and adolescents with PANDAS. Seventy-seven consecutive patients (59 males, 18 females; mean age 6.3\u00b12.5 years, range 2.0-14.5 years) strictly fulfilling the clinical criteria for PANDAS diagnosis were recruited. In all subjects we evaluated serum concentrations of free-T3, free-T4, thyrotropin, and the following auto-antibodies: anti-thyroperoxidase, anti-thyroglobulin, anti-thyrotropin receptor, anti-gliadin, anti-endomysium, anti-tissue transglutaminase, anti-nuclear, anti-smooth muscle, anti-extractable nuclear antigens, anti-phospholipid, plus lupus-like anticoagulant. The results were compared with those obtained from 197 age- and sex-matched healthy controls (130 males, 67 females; mean age 6.8\u00b12.9 years, range 2.3-14.8 years). The frequencies of subclinical (3.8% vs 3.6%) and overt hypothyroidism (1.2% vs 0%), autoimmune thyroiditis (2.46% vs 1.14%), celiac disease (1.2% vs 0.05%), and positivity of organ- and nonorgan-specific autoantibodies (5.1% vs 4.8%) were not statistically significant between patients with PANDAS and controls. Evaluating the overall disease duration, we did not observe any significant difference between patients with (3.4\u00b12.15 years) and without (3.4\u00b12.89 years) autoimmune abnormalities.", "label": 1, "is_selected": 0, "text": "The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) are basically characterized by obsessive-compulsive symptoms and/or tics triggered by group-A beta-hemolytic Streptococcus infections. Poor data are available about the clear definition of PANDAS's autoimmune origin. The aim of our study was to evaluate the prevalence of autoimmune phenomena, including thyroid function abnormalities, specific celiac disease antibodies, and positivity of organ- or nonorgan-specific autoantibodies in a large cohort of Caucasian children and adolescents with PANDAS. Seventy-seven consecutive patients (59 males, 18 females; mean age 6.3\u00b12.5 years, range 2.0-14.5 years) strictly fulfilling the clinical criteria for PANDAS diagnosis were recruited. In all subjects we evaluated serum concentrations of free-T3, free-T4, thyrotropin, and the following auto-antibodies: anti-thyroperoxidase, anti-thyroglobulin, anti-thyrotropin receptor, anti-gliadin, anti-endomysium, anti-tissue transglutaminase, anti-nuclear, anti-smooth muscle, anti-extractable nuclear antigens, anti-phospholipid, plus lupus-like anticoagulant. The results were compared with those obtained from 197 age- and sex-matched healthy controls (130 males, 67 females; mean age 6.8\u00b12.9 years, range 2.3-14.8 years). The frequencies of subclinical (3.8% vs 3.6%) and overt hypothyroidism (1.2% vs 0%), autoimmune thyroiditis (2.46% vs 1.14%), celiac disease (1.2% vs 0.05%), and positivity of organ- and nonorgan-specific autoantibodies (5.1% vs 4.8%) were not statistically significant between patients with PANDAS and controls. Evaluating the overall disease duration, we did not observe any significant difference between patients with (3.4\u00b12.15 years) and without (3.4\u00b12.89 years) autoimmune abnormalities."}
{"qid": "5a774431faa1ab7d2e000004", "original_text": "The past decade has brought tremendous progress in unraveling the pathophysiology of Alzheimer's disease (AD). While increasingly sophisticated immunotherapy targeting soluble and aggregated brain amyloid-beta (A\u03b2) continues to dominate clinical research in AD, a deeper understanding of A\u03b2 physiology has led to the recognition of distinct neuronal signaling pathways linking A\u03b2 to synaptotoxicity and neurodegeneration and to new targets for therapeutic intervention. Identifying specific signaling pathways involving A\u03b2 has allowed for the development of more precise therapeutic interventions targeting the most relevant molecular mechanisms leading to AD. In this review, I highlight the discovery of cellular prion protein as a high-affinity receptor for A\u03b2 oligomers, and the downstream signaling pathway elucidated to date, converging on nonreceptor tyrosine kinase Fyn. I discuss preclinical studies targeting Fyn as a therapeutic intervention in AD and our recent experience with the safety, tolerability, and cerebrospinal fluid penetration of the Src family kinase inhibitor saracatinib in patients with AD. Fyn is an attractive target for AD therapeutics, not only based on its activation by A\u03b2 via cellular prion protein but also due to its known interaction with tau, uniquely linking the two key pathologies in AD.", "label": 1, "is_selected": 0, "text": "The past decade has brought tremendous progress in unraveling the pathophysiology of Alzheimer's disease (AD). While increasingly sophisticated immunotherapy targeting soluble and aggregated brain amyloid-beta (A\u03b2) continues to dominate clinical research in AD, a deeper understanding of A\u03b2 physiology has led to the recognition of distinct neuronal signaling pathways linking A\u03b2 to synaptotoxicity and neurodegeneration and to new targets for therapeutic intervention. Identifying specific signaling pathways involving A\u03b2 has allowed for the development of more precise therapeutic interventions targeting the most relevant molecular mechanisms leading to AD. In this review, I highlight the discovery of cellular prion protein as a high-affinity receptor for A\u03b2 oligomers, and the downstream signaling pathway elucidated to date, converging on nonreceptor tyrosine kinase Fyn. I discuss preclinical studies targeting Fyn as a therapeutic intervention in AD and our recent experience with the safety, tolerability, and cerebrospinal fluid penetration of the Src family kinase inhibitor saracatinib in patients with AD. Fyn is an attractive target for AD therapeutics, not only based on its activation by A\u03b2 via cellular prion protein but also due to its known interaction with tau, uniquely linking the two key pathologies in AD."}
{"qid": "56bdc79bef6e394741000001", "original_text": "The Athens Protocol is a set of guidelines for the management of retinal vein occlusion (RVO), a common eye condition that occurs when the vein that carries blood away from the retina becomes blocked. The protocol was developed by the Athens Retinal Vein Occlusion Study Group in 1995 and has since become the standard of care for the management of RVO. The protocol recommends a stepped care approach, starting with observational therapy and progressing to intravenous (IV) corticosteroids, oral anti-vascular endothelial growth factor (VEGF) medications, and laser photocoagulation, depending on the severity and location of the occlusion. The goal of the protocol is to reduce visual acuity loss and improve quality of life for patients with RVO.", "label": 0, "is_selected": 0, "text": "The Athens Protocol is a set of guidelines for the management of retinal vein occlusion (RVO), a common eye condition that occurs when the vein that carries blood away from the retina becomes blocked. The protocol was developed by the Athens Retinal Vein Occlusion Study Group in 1995 and has since become the standard of care for the management of RVO. The protocol recommends a stepped care approach, starting with observational therapy and progressing to intravenous (IV) corticosteroids, oral anti-vascular endothelial growth factor (VEGF) medications, and laser photocoagulation, depending on the severity and location of the occlusion. The goal of the protocol is to reduce visual acuity loss and improve quality of life for patients with RVO."}
{"qid": "51bdf045047fa84d1d000003", "original_text": "GABARAPL1 belongs to the small family of GABARAP proteins (including GABARAP, GABARAPL1 and GABARAPL2/GATE-16), one of the two subfamilies of the yeast Atg8 orthologue. GABARAPL1 is involved in the intracellular transport of receptors, via an interaction with tubulin and GABA(A) or kappa opioid receptors, and also participates in autophagy and cell proliferation. In the present study, we identify the HSP90 protein as a novel interaction partner for GABARAPL1 using GST pull-down, mass spectrometry and coimmunoprecipitation experiments. GABARAPL1 and HSP90 partially colocalize in MCF-7 breast cancer cells overexpressed Dsred-GABARAPL1 and in rat brain. Moreover, treatment of MCF-7 cells overexpressed FLAG-GABARAPL1-6HIS with the HSP90 inhibitor 17-AAG promotes the GABARAPL1 degradation, a process that is blocked by proteasome inhibitors such as MG132, bortezomib and lactacystin.", "label": 1, "is_selected": 0, "text": "GABARAPL1 belongs to the small family of GABARAP proteins (including GABARAP, GABARAPL1 and GABARAPL2/GATE-16), one of the two subfamilies of the yeast Atg8 orthologue. GABARAPL1 is involved in the intracellular transport of receptors, via an interaction with tubulin and GABA(A) or kappa opioid receptors, and also participates in autophagy and cell proliferation. In the present study, we identify the HSP90 protein as a novel interaction partner for GABARAPL1 using GST pull-down, mass spectrometry and coimmunoprecipitation experiments. GABARAPL1 and HSP90 partially colocalize in MCF-7 breast cancer cells overexpressed Dsred-GABARAPL1 and in rat brain. Moreover, treatment of MCF-7 cells overexpressed FLAG-GABARAPL1-6HIS with the HSP90 inhibitor 17-AAG promotes the GABARAPL1 degradation, a process that is blocked by proteasome inhibitors such as MG132, bortezomib and lactacystin."}
{"qid": "5151b8efd24251bc0500007a", "original_text": "Although muscle metabolism and exercise capacity seem to be affected in patients with subclinical hypothyroidism, there is little evidence indicating improvement of the exercise tolerance due to levothyroxine (L-T(4)) replacement. The aim of the present study was to verify possible cardiopulmonary changes during exercise in patients with subclinical hypothyroidism on L-T(4) replacement with a normal serum TSH for six months. Twenty-three patients with subclinical hypothyroidism were randomized into treated (no.=11) and untreated (no.=12) patients. A cardiopulmonary test was performed with a treadmill, using the modified Balke protocol. Heart rate, oxygen uptake, minute ventilation and other cardiopulmonary parameters were assessed at the 5th minute of exercise. FT4 levels increased while TSH normalized after hormone replacement. Oxygen uptake decreased significantly after hormone replacement (24.1+/-6.3 vs 17.1+/-4.2 ml x kg x min(-1); p=0.03).Minute ventilation also showed an enhanced performance in treated patients (28.0+/-8.1 vs 23.5+/-5.6 l x min(-1); p=0.03), as did the heart rate (128+/-17 vs 121+/-17 bpm; p=0.03). There were no changes in the untreated group. The results demonstrate that submaximal cardiopulmonary exercise performance improved after six months of TSH normalization and this improvement can help enhance the ability to carry out daily life activities in patients with subclinical hypothyroidism.", "label": 1, "is_selected": 0, "text": "Although muscle metabolism and exercise capacity seem to be affected in patients with subclinical hypothyroidism, there is little evidence indicating improvement of the exercise tolerance due to levothyroxine (L-T(4)) replacement. The aim of the present study was to verify possible cardiopulmonary changes during exercise in patients with subclinical hypothyroidism on L-T(4) replacement with a normal serum TSH for six months. Twenty-three patients with subclinical hypothyroidism were randomized into treated (no.=11) and untreated (no.=12) patients. A cardiopulmonary test was performed with a treadmill, using the modified Balke protocol. Heart rate, oxygen uptake, minute ventilation and other cardiopulmonary parameters were assessed at the 5th minute of exercise. FT4 levels increased while TSH normalized after hormone replacement. Oxygen uptake decreased significantly after hormone replacement (24.1+/-6.3 vs 17.1+/-4.2 ml x kg x min(-1); p=0.03).Minute ventilation also showed an enhanced performance in treated patients (28.0+/-8.1 vs 23.5+/-5.6 l x min(-1); p=0.03), as did the heart rate (128+/-17 vs 121+/-17 bpm; p=0.03). There were no changes in the untreated group. The results demonstrate that submaximal cardiopulmonary exercise performance improved after six months of TSH normalization and this improvement can help enhance the ability to carry out daily life activities in patients with subclinical hypothyroidism."}
{"qid": "5c6636c57c78d69471000011", "original_text": "Arimoclomol is a medication used to treat neuromuscular disorders, including spinal muscular atrophy (SMA) and other conditions caused by deficient or absent SMN protein. The mechanism of action of arimoclomol involves increasing the production of full-length surviving motor neuron (SMN) protein, which is deficient in individuals with SMA. Arimoclomol achieves this by inhibiting the degradation of SMN protein and increasing its transport and localization within motor neurons. This results in increased levels of functional SMN protein, which can lead to improved motor neuron survival and function. Arimoclomol also has neuroprotective effects, reducing oxidative stress and inflammation in motor neurons. By targeting multiple steps in the degradation pathway of SMN protein, arimoclomol has been shown to be more effective than other treatments that target a single step in the pathway.", "label": 0, "is_selected": 0, "text": "Arimoclomol is a medication used to treat neuromuscular disorders, including spinal muscular atrophy (SMA) and other conditions caused by deficient or absent SMN protein. The mechanism of action of arimoclomol involves increasing the production of full-length surviving motor neuron (SMN) protein, which is deficient in individuals with SMA. Arimoclomol achieves this by inhibiting the degradation of SMN protein and increasing its transport and localization within motor neurons. This results in increased levels of functional SMN protein, which can lead to improved motor neuron survival and function. Arimoclomol also has neuroprotective effects, reducing oxidative stress and inflammation in motor neurons. By targeting multiple steps in the degradation pathway of SMN protein, arimoclomol has been shown to be more effective than other treatments that target a single step in the pathway."}
{"qid": "5c61f767e842deac67000007", "original_text": "Telomere length is a risk factor in disease and the dynamics of telomere length are crucial to our understanding of cell replication and vitality. The proliferation of whole genome sequencing represents an unprecedented opportunity to glean new insights into telomere biology on a previously unimaginable scale. To this end, a number of approaches for estimating telomere length from whole-genome sequencing data have been proposed. Here we present Telomerecat, a novel approach to the estimation of telomere length. Previous methods have been dependent on the number of telomeres present in a cell being known, which may be problematic when analysing aneuploid cancer data and non-human samples. Telomerecat is designed to be agnostic to the number of telomeres present, making it suited for the purpose of estimating telomere length in cancer studies. Telomerecat also accounts for interstitial telomeric reads and presents a novel approach to dealing with sequencing errors.", "label": 1, "is_selected": 0, "text": "Telomere length is a risk factor in disease and the dynamics of telomere length are crucial to our understanding of cell replication and vitality. The proliferation of whole genome sequencing represents an unprecedented opportunity to glean new insights into telomere biology on a previously unimaginable scale. To this end, a number of approaches for estimating telomere length from whole-genome sequencing data have been proposed. Here we present Telomerecat, a novel approach to the estimation of telomere length. Previous methods have been dependent on the number of telomeres present in a cell being known, which may be problematic when analysing aneuploid cancer data and non-human samples. Telomerecat is designed to be agnostic to the number of telomeres present, making it suited for the purpose of estimating telomere length in cancer studies. Telomerecat also accounts for interstitial telomeric reads and presents a novel approach to dealing with sequencing errors."}
{"qid": "5e7f5b43835f4e4777000014", "original_text": "The Fluzone intradermal quadrivalent vaccine contains four attenuated live viruses: * Influenza A/H1N1 (A/California/7/2009) * Influenza A/H3N2 (A/Perth/16/2009) * Influenza B/Victoria (B/Brisbane/10/2018) * Influenza B/Yamagata (B/Phuket/30/2013) These viruses are inactivated with formaldehyde to ensure they cannot cause infection, but can still stimulate an immune response.", "label": 0, "is_selected": 1, "text": "This vaccine is designed to protect against four strains of influenza, including the 2009 H1N1 pandemic strain, which is circulating in the United States and Australia at the time of this year's World Health Organization (WHO) influenza pandemic alert."}
{"qid": "53261e79600967d132000003", "original_text": "The derangement of neuro-endocrine control of circulation influences both disease evolution and response to treatment in patients with heart failure, but little data are available about the complex relationships between the degree of neuro-hormonal activation and clinical severity. We studied the relationships between cardiac natriuretic hormones (CNHs) and several neuro-hormones and immunological markers in a prospective cohort of 105 consecutive patients with cardiomyopathy (77 men and 28 women, mean age 66.7+/-12.4 years, range 33-89 years). We assayed the circulating levels of CNHs (atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP)), plasma renin activity (PRA), aldosterone, cortisol, adrenaline, noradrenaline, thyroid hormones and thyroid stimulating hormone (TSH), tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). The concentrations of all CNHs and neurohormones were higher in patients with heart failure compared to normal subjects, except for free triiodothyronine (FT3), which was below normal values.", "label": 1, "is_selected": 0, "text": "The derangement of neuro-endocrine control of circulation influences both disease evolution and response to treatment in patients with heart failure, but little data are available about the complex relationships between the degree of neuro-hormonal activation and clinical severity. We studied the relationships between cardiac natriuretic hormones (CNHs) and several neuro-hormones and immunological markers in a prospective cohort of 105 consecutive patients with cardiomyopathy (77 men and 28 women, mean age 66.7+/-12.4 years, range 33-89 years). We assayed the circulating levels of CNHs (atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP)), plasma renin activity (PRA), aldosterone, cortisol, adrenaline, noradrenaline, thyroid hormones and thyroid stimulating hormone (TSH), tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). The concentrations of all CNHs and neurohormones were higher in patients with heart failure compared to normal subjects, except for free triiodothyronine (FT3), which was below normal values."}
{"qid": "60314c361cb411341a00012e", "original_text": "Aortitis is a pathological term designating inflammation of the aortic wall, regardless of its cause. The clinical presentation of aortitis is nonspecific and variable. Symptoms include abdominal pain, fever, and weight loss; acute phase reactants may also be elevated. Aortitis can be caused by a wide spectrum of entities, including from infectious processes to autoimmune diseases (Takayasu arteritis and giant cell arteritis are among the most common of these causing aortitis), and the prognosis and treatment of these entities vary widely.", "label": 1, "is_selected": 0, "text": "Aortitis is a pathological term designating inflammation of the aortic wall, regardless of its cause. The clinical presentation of aortitis is nonspecific and variable. Symptoms include abdominal pain, fever, and weight loss; acute phase reactants may also be elevated. Aortitis can be caused by a wide spectrum of entities, including from infectious processes to autoimmune diseases (Takayasu arteritis and giant cell arteritis are among the most common of these causing aortitis), and the prognosis and treatment of these entities vary widely."}
{"qid": "5fe31319a43ad31278000046", "original_text": "Yes, ATAC-Seq can be employed in single-cell mode. This is done by isolating single cells using techniques such as microfluidics, Drop-Seq, or FACS, and then performing the ATAC-Seq assay on each cell individually. This allows for the analysis of gene regulatory elements at the level of individual cells, which can provide valuable insights into cell-to-cell variation and heterogeneity.", "label": 0, "is_selected": 0, "text": "Yes, ATAC-Seq can be employed in single-cell mode. This is done by isolating single cells using techniques such as microfluidics, Drop-Seq, or FACS, and then performing the ATAC-Seq assay on each cell individually. This allows for the analysis of gene regulatory elements at the level of individual cells, which can provide valuable insights into cell-to-cell variation and heterogeneity."}
{"qid": "553a8d78f321868558000003", "original_text": "The development of colorectal cancer (CRC) is characterized by multiple genetic alterations. Transcribed ultraconserved regions (T-UCRs) are a subset of 481 sequences longer than 200 bp, which are absolutely conserved between orthologous regions of human, rat and mouse genomes, and are actively transcribed. It has recently been proven in cancer systems that differentially expressed T-UCRs could alter the functional characteristics of malignant cells. Genome-wide profiling revealed that T-UCRs have distinct signatures in human leukemia and carcinoma. In our study, we examined the expression levels of uc.43, uc.73, uc.134, uc.230, uc.339, uc.388 and uc.399 in 54 samples of primary colorectal carcinomas and 15 samples of non-tumoral adjacent tissues by real-time PCR. T-UCR expression levels were also correlated with commonly used clinicopathological features of CRC. Expression levels of uc.73 (p = 0.0139) and uc.388 (p = 0.0325) were significantly decreased in CRC tissue, and uc.73 indicated a positive correlation with overall survival (p = 0.0315). The lower expression of uc.388 was associated with the distal location of CRC (p = 0.0183), but no correlation of any evaluated T-UCR with clinical stage, grade and tumor diameter was observed. Our preliminary results suggest that uc.73 and uc.388 could be potential diagnostic and prognostic biomarkers in CRC patients.", "label": 1, "is_selected": 0, "text": "The development of colorectal cancer (CRC) is characterized by multiple genetic alterations. Transcribed ultraconserved regions (T-UCRs) are a subset of 481 sequences longer than 200 bp, which are absolutely conserved between orthologous regions of human, rat and mouse genomes, and are actively transcribed. It has recently been proven in cancer systems that differentially expressed T-UCRs could alter the functional characteristics of malignant cells. Genome-wide profiling revealed that T-UCRs have distinct signatures in human leukemia and carcinoma. In our study, we examined the expression levels of uc.43, uc.73, uc.134, uc.230, uc.339, uc.388 and uc.399 in 54 samples of primary colorectal carcinomas and 15 samples of non-tumoral adjacent tissues by real-time PCR. T-UCR expression levels were also correlated with commonly used clinicopathological features of CRC. Expression levels of uc.73 (p = 0.0139) and uc.388 (p = 0.0325) were significantly decreased in CRC tissue, and uc.73 indicated a positive correlation with overall survival (p = 0.0315). The lower expression of uc.388 was associated with the distal location of CRC (p = 0.0183), but no correlation of any evaluated T-UCR with clinical stage, grade and tumor diameter was observed. Our preliminary results suggest that uc.73 and uc.388 could be potential diagnostic and prognostic biomarkers in CRC patients."}
{"qid": "5925227670f9fc6f0f000020", "original_text": "Genomic DNA of African trypanosomes contains a hypermodified thymidine residue termed base J (beta-d-glucosyl-HOMedU). This modified base is localized primarily to repetitive DNA, namely the telomeres, and is implicated in the regulation of antigenic variation. The base is synthesized in a two-step pathway. Initially, a thymidine residue in DNA is hydroxylated by a thymidine hydroxylase (TH).", "label": 1, "is_selected": 0, "text": "Genomic DNA of African trypanosomes contains a hypermodified thymidine residue termed base J (beta-d-glucosyl-HOMedU). This modified base is localized primarily to repetitive DNA, namely the telomeres, and is implicated in the regulation of antigenic variation. The base is synthesized in a two-step pathway. Initially, a thymidine residue in DNA is hydroxylated by a thymidine hydroxylase (TH)."}
{"qid": "54cf4bc3f693c3b16b00000d", "original_text": "Yes, there is an association between serum interleukin-6 (IL-6) concentrations and outcomes of stroke patients. Studies have shown that elevated levels of IL-6 in the blood are associated with increased risk of poor outcomes in stroke patients, including higher rates of mortality, severe disability, and longer hospital stays. IL-6 is a cytokine that plays a key role in the inflammatory response and is produced by various cell types in the body, including immune cells and endothelial cells, in response to stroke injury. Elevated levels of IL-6 in the blood have been shown to correlate with larger infarction volumes, worse neurological outcomes, and increased risk of hemorrhagic transformation in stroke patients. Additionally, IL-6 levels have been shown to be associated with the development of post-stroke complications, such as sepsis and pneumonia, which are leading causes of morbidity and mortality in stroke patients. Overall, the association between IL-6 concentrations and outcomes of stroke patients highlights the importance of inflammation in the acute phase of stroke and the potential benefits of targeting inflammatory mechanisms in stroke treatment. Note: The above answer is based on a combination of published studies and current medical knowledge, but it's not exhaustive.", "label": 0, "is_selected": 0, "text": "Yes, there is an association between serum interleukin-6 (IL-6) concentrations and outcomes of stroke patients. Studies have shown that elevated levels of IL-6 in the blood are associated with increased risk of poor outcomes in stroke patients, including higher rates of mortality, severe disability, and longer hospital stays. IL-6 is a cytokine that plays a key role in the inflammatory response and is produced by various cell types in the body, including immune cells and endothelial cells, in response to stroke injury. Elevated levels of IL-6 in the blood have been shown to correlate with larger infarction volumes, worse neurological outcomes, and increased risk of hemorrhagic transformation in stroke patients. Additionally, IL-6 levels have been shown to be associated with the development of post-stroke complications, such as sepsis and pneumonia, which are leading causes of morbidity and mortality in stroke patients. Overall, the association between IL-6 concentrations and outcomes of stroke patients highlights the importance of inflammation in the acute phase of stroke and the potential benefits of targeting inflammatory mechanisms in stroke treatment. Note: The above answer is based on a combination of published studies and current medical knowledge, but it's not exhaustive."}
{"qid": "5e6e8f92c6a8763d23000004", "original_text": "Long non-coding RNAs (lncRNAs) are RNA molecules that are longer than 200 nucleotides in length but do not code for proteins. The size of lncRNAs can vary greatly, ranging from a few hundred nucleotides to several kilobases (kb). Some lncRNAs have been reported to be as long as 100 kb or more. It is important to note that the size of lncRNAs can affect their function, as larger lncRNAs may be more stable and have a longer half-life than smaller ones. The exact size of an lncRNA can also depend on the location of the transcript, as well as the specific cellular or tissue context in which it is expressed.", "label": 0, "is_selected": 0, "text": "Long non-coding RNAs (lncRNAs) are RNA molecules that are longer than 200 nucleotides in length but do not code for proteins. The size of lncRNAs can vary greatly, ranging from a few hundred nucleotides to several kilobases (kb). Some lncRNAs have been reported to be as long as 100 kb or more. It is important to note that the size of lncRNAs can affect their function, as larger lncRNAs may be more stable and have a longer half-life than smaller ones. The exact size of an lncRNA can also depend on the location of the transcript, as well as the specific cellular or tissue context in which it is expressed."}
{"qid": "593ff22b70f9fc6f0f000023", "original_text": "The Grg gene encodes a 197-amino-acid protein homologous to the amino-terminal domain of the product of the groucho gene of the Drosophila Enhancer of split complex. We describe here the genomic organization of the mouse Grg gene. It spans approximately 7 kb on chromosome 10 and consists of seven exons.", "label": 1, "is_selected": 0, "text": "The Grg gene encodes a 197-amino-acid protein homologous to the amino-terminal domain of the product of the groucho gene of the Drosophila Enhancer of split complex. We describe here the genomic organization of the mouse Grg gene. It spans approximately 7 kb on chromosome 10 and consists of seven exons."}
{"qid": "5141bcd423fec9037500000d", "original_text": "We determined how CXC-chemokine signalling and necrosis factor-kappaB (NF-kappaB) activity affected heat-shock protein 90 (Hsp90) inhibitor (geldanamycin (GA) and 17-allylamino-demethoxygeldanamycin (17-AAG)) cytotoxicity in castrate-resistant prostate cancer (CRPC). Geldanamycin and 17-AAG toxicity, together with the CXCR2 antagonist AZ10397767 or NF-kappaB inhibitor BAY11-7082, was assessed by 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide assay in two CRPC lines, DU145 and PC3. Flow cytometry quantified apoptotic or necrosis profiles. Necrosis factor-kappaB activity was determined by luciferase readouts or indirectly by quantitative PCR and ELISA-based determination of CXCL8 expression. Geldanamycin and 17-AAG reduced PC3 and DU145 cell viability, although PC3 cells were less sensitive. Addition of AZ10397767 increased GA (e.g., PC3 IC(20): from 1.67+/-0.4 to 0.18+/-0.2 nM) and 17-AAG (PC3 IC(20): 43.7+/-7.8 to 0.64+/-1.8 nM) potency in PC3 but not DU145 cells. Similarly, BAY11-7082 increased the potency of 17-AAG in PC3 but not in DU145 cells, correlating with the elevated constitutive NF-kappaB activity in PC3 cells. AZ10397767 increased 17-AAG-induced apoptosis and necrosis and decreased NF-kappaB activity/CXCL8 expression in 17-AAG-treated PC3 cells. Ansamycin cytotoxicity is enhanced by inhibiting NF-kappaB activity and/or CXC-chemokine signalling in CRPC cells.", "label": 1, "is_selected": 0, "text": "We determined how CXC-chemokine signalling and necrosis factor-kappaB (NF-kappaB) activity affected heat-shock protein 90 (Hsp90) inhibitor (geldanamycin (GA) and 17-allylamino-demethoxygeldanamycin (17-AAG)) cytotoxicity in castrate-resistant prostate cancer (CRPC). Geldanamycin and 17-AAG toxicity, together with the CXCR2 antagonist AZ10397767 or NF-kappaB inhibitor BAY11-7082, was assessed by 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide assay in two CRPC lines, DU145 and PC3. Flow cytometry quantified apoptotic or necrosis profiles. Necrosis factor-kappaB activity was determined by luciferase readouts or indirectly by quantitative PCR and ELISA-based determination of CXCL8 expression. Geldanamycin and 17-AAG reduced PC3 and DU145 cell viability, although PC3 cells were less sensitive. Addition of AZ10397767 increased GA (e.g., PC3 IC(20): from 1.67+/-0.4 to 0.18+/-0.2 nM) and 17-AAG (PC3 IC(20): 43.7+/-7.8 to 0.64+/-1.8 nM) potency in PC3 but not DU145 cells. Similarly, BAY11-7082 increased the potency of 17-AAG in PC3 but not in DU145 cells, correlating with the elevated constitutive NF-kappaB activity in PC3 cells. AZ10397767 increased 17-AAG-induced apoptosis and necrosis and decreased NF-kappaB activity/CXCL8 expression in 17-AAG-treated PC3 cells. Ansamycin cytotoxicity is enhanced by inhibiting NF-kappaB activity and/or CXC-chemokine signalling in CRPC cells."}
{"qid": "515bd543298dcd4e51000001", "original_text": "We investigated the genomic distribution of mouse and human repeated sequences by assessing their relative amounts in the four major components into which these genomes can be resolved by density gradient centrifugation techniques. These components are families of fragments that account for most or all of main-band DNAs, range in dG + dC content from 37% to 49%, and are derived by preparative breakage from long DNA segments (greater than 300 kb) of fairly homogeneous composition, the isochores.", "label": 1, "is_selected": 0, "text": "We investigated the genomic distribution of mouse and human repeated sequences by assessing their relative amounts in the four major components into which these genomes can be resolved by density gradient centrifugation techniques. These components are families of fragments that account for most or all of main-band DNAs, range in dG + dC content from 37% to 49%, and are derived by preparative breakage from long DNA segments (greater than 300 kb) of fairly homogeneous composition, the isochores."}
{"qid": "56cca4da5795f9a73e000034", "original_text": "How multisite posttranslational modification coordinates dynamic regulation of protein function is an issue fundamental to many biological processes. Related to this, a composite sequence motif has recently been identified that couples phosphorylation, sumoylation, and perhaps also deacetylation to control transcriptional repression in stress response, mitogen and nuclear hormone signaling, myogenesis, and neuronal differentiation. This motif is present in many proteins, integrates cellular signals from diverse pathways, and serves as a valuable signature for in silico identification of proteins regulated by adjacent phosphorylation and sumoylation.", "label": 1, "is_selected": 0, "text": "How multisite posttranslational modification coordinates dynamic regulation of protein function is an issue fundamental to many biological processes. Related to this, a composite sequence motif has recently been identified that couples phosphorylation, sumoylation, and perhaps also deacetylation to control transcriptional repression in stress response, mitogen and nuclear hormone signaling, myogenesis, and neuronal differentiation. This motif is present in many proteins, integrates cellular signals from diverse pathways, and serves as a valuable signature for in silico identification of proteins regulated by adjacent phosphorylation and sumoylation."}
{"qid": "61f56284882a024a10000005", "original_text": "The reported prevalence of Alport syndrome varies from one in 5000 to one in 53,000 individuals. This study estimated the frequencies of predicted pathogenic COL4A3-COL4A5 variants in sequencing databases of populations without known kidney disease. Predicted pathogenic variants were identified using filtering steps based on the ACMG/AMP criteria, which considered collagen IV \u03b13-\u03b15 position 1 Gly to be critical domains. The population frequencies of predicted pathogenic COL4A3-COL4A5 variants were then determined per mean number of sequenced alleles. Population frequencies for compound heterozygous and digenic combinations were calculated from the results for heterozygous variants. COL4A3-COL4A5 variants resulting in position 1 Gly substitutions were confirmed to be associated with hematuria (for each, P<0.001).", "label": 1, "is_selected": 0, "text": "The reported prevalence of Alport syndrome varies from one in 5000 to one in 53,000 individuals. This study estimated the frequencies of predicted pathogenic COL4A3-COL4A5 variants in sequencing databases of populations without known kidney disease. Predicted pathogenic variants were identified using filtering steps based on the ACMG/AMP criteria, which considered collagen IV \u03b13-\u03b15 position 1 Gly to be critical domains. The population frequencies of predicted pathogenic COL4A3-COL4A5 variants were then determined per mean number of sequenced alleles. Population frequencies for compound heterozygous and digenic combinations were calculated from the results for heterozygous variants. COL4A3-COL4A5 variants resulting in position 1 Gly substitutions were confirmed to be associated with hematuria (for each, P<0.001)."}
{"qid": "54d796f93706e8952800001e", "original_text": "Autoantibodies have been associated with human pathologies for a long time, particularly with autoimmune diseases (AIDs). Rheumatoid factor (RF) is known since the late 1930s to be associated with rheumatoid arthritis (RA). The discovery of anticitrullinated protein antibodies in the last century has changed this and other posttranslational modifications (PTM) relevant to RA have since been described. Such PTM introduce neoepitopes in proteins that can generate novel autoantibody specificities. The recent recognition of these novel specificities in RA provides a unique opportunity to understand human B-cell development in vivo.", "label": 1, "is_selected": 0, "text": "Autoantibodies have been associated with human pathologies for a long time, particularly with autoimmune diseases (AIDs). Rheumatoid factor (RF) is known since the late 1930s to be associated with rheumatoid arthritis (RA). The discovery of anticitrullinated protein antibodies in the last century has changed this and other posttranslational modifications (PTM) relevant to RA have since been described. Such PTM introduce neoepitopes in proteins that can generate novel autoantibody specificities. The recent recognition of these novel specificities in RA provides a unique opportunity to understand human B-cell development in vivo."}
{"qid": "58cbd0d502b8c60953000035", "original_text": "Ch\u00e9diak-Higashi Syndrome (CHS) is caused by mutations in the gene encoding the protein lysosomal-associated membrane protein 2 (LAMP2). This gene is located on chromosome 1q44 in humans. CHS is a rare genetic disorder characterized by a combination of neurodegeneration, immunodeficiency, and cancer predisposition. Mutations in the LAMP2 gene lead to impaired lysosomal function and the accumulation of autophagosomes, which is thought to contribute to the development of the disease. The specific mutations that cause CHS can vary, but the majority of cases are caused by missense mutations in the LAMP2 gene.", "label": 0, "is_selected": 1, "text": "The purpose of this review is to provide an overview of the current understanding of Ch\u00e9diak-Higashi Syndrome and to provide a basis for future research into the genetic cause of the disease.<n> The specific mutations that cause vary, but the majority of cases are caused by missense mutations in the2 gene."}
{"qid": "51680b05298dcd4e51000064", "original_text": "Yes, Serca2a (sarcoplasmic/endoplasmic reticulum calcium ATPase 2a) has been shown to bind to the proteolipid protein (PLP) in the heart. PLP is a major component of the sarcoplasmic reticulum (SR) in cardiac muscle cells, and it plays a crucial role in regulating calcium (Ca2+) storage and release in the heart. Serca2a is one of the key enzymes involved in the Ca2+ transport system in the SR, and it is responsible for pumping Ca2+ back into the SR from the cytosol. Studies have shown that Serca2a binds to PLP in the heart, and this interaction is important for maintaining proper Ca2+ homeostasis in the cardiomyocyte. The binding of Serca2a to PLP creates a stable complex that can sequester Ca2+ ions and prevent them from entering the cytosol. This helps to maintain a stable intracellular Ca2+ concentration, which is essential for proper cardiac function. In summary, Serca2a does bind to PLN in the heart, and this interaction plays a critical role in regulating Ca2+ homeostasis in the cardiac muscle cell.", "label": 0, "is_selected": 1, "text": "Is it true that Serca2a binds to the proteolipid protein (PLP) in the heart, and this interaction plays a critical role in regulating Ca2+ in the cardiac cell, and is it possible that this interaction could be used as a potential drug target for the treatment of coronary heart disease (CHD) and congestive heart failure (CHF) and possibly other heart diseases, such as stroke?"}
{"qid": "5acf74460340b9f058000013", "original_text": "We report here the initial examination of volatile organic compounds (VOCs) emanating from human earwax (cerumen). Recent studies link a single nucleotide polymorphism (SNP) in the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11) to the production of different types of axillary odorants and cerumen. ABCC11 encodes an ATP-driven efflux pump protein that plays an important function in ceruminous apocrine glands of the auditory canal and the secretion of axillary odor precursors. The type of cerumen and underarm odor produced by East Asians differ markedly from that produced by non-Asians.", "label": 1, "is_selected": 0, "text": "We report here the initial examination of volatile organic compounds (VOCs) emanating from human earwax (cerumen). Recent studies link a single nucleotide polymorphism (SNP) in the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11) to the production of different types of axillary odorants and cerumen. ABCC11 encodes an ATP-driven efflux pump protein that plays an important function in ceruminous apocrine glands of the auditory canal and the secretion of axillary odor precursors. The type of cerumen and underarm odor produced by East Asians differ markedly from that produced by non-Asians."}
{"qid": "58bfe70e02b8c60953000019", "original_text": "PUVA (psoralen ultraviolet A) therapy is not typically indicated for the treatment of eczema. While PUVA can be effective for certain skin conditions, such as vitiligo and psoriasis, it is not commonly used for eczema. Eczema, also known as atopic dermatitis, is typically treated with topical corticosteroids, immunomodulators, and moisturizers. In severe cases, systemic corticosteroids or immunosuppressants may be prescribed. It is important to consult a dermatologist or healthcare provider for proper evaluation and treatment of eczema.", "label": 0, "is_selected": 0, "text": "PUVA (psoralen ultraviolet A) therapy is not typically indicated for the treatment of eczema. While PUVA can be effective for certain skin conditions, such as vitiligo and psoriasis, it is not commonly used for eczema. Eczema, also known as atopic dermatitis, is typically treated with topical corticosteroids, immunomodulators, and moisturizers. In severe cases, systemic corticosteroids or immunosuppressants may be prescribed. It is important to consult a dermatologist or healthcare provider for proper evaluation and treatment of eczema."}
{"qid": "56c58ceeb04e159d0e000004", "original_text": "It is now clear that there is a diversity of circular RNAs in biological systems. Circular RNAs can be produced by the direct ligation of 5' and 3' ends of linear RNAs, as intermediates in RNA processing reactions, or by \"backsplicing,\" wherein a downstream 5' splice site (splice donor) is joined to an upstream 3' splice site (splice acceptor). Circular RNAs have unique properties including the potential for rolling circle amplification of RNA, the ability to rearrange the order of genomic information, protection from exonucleases, and constraints on RNA folding. Circular RNAs can function as templates for viroid and viral replication, as intermediates in RNA processing reactions, as regulators of transcription in cis, as snoRNAs, and as miRNA sponges.", "label": 1, "is_selected": 0, "text": "It is now clear that there is a diversity of circular RNAs in biological systems. Circular RNAs can be produced by the direct ligation of 5' and 3' ends of linear RNAs, as intermediates in RNA processing reactions, or by \"backsplicing,\" wherein a downstream 5' splice site (splice donor) is joined to an upstream 3' splice site (splice acceptor). Circular RNAs have unique properties including the potential for rolling circle amplification of RNA, the ability to rearrange the order of genomic information, protection from exonucleases, and constraints on RNA folding. Circular RNAs can function as templates for viroid and viral replication, as intermediates in RNA processing reactions, as regulators of transcription in cis, as snoRNAs, and as miRNA sponges."}
{"qid": "56c830635795f9a73e00000e", "original_text": "Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized by the progressive loss of motor neurons. The stress granules, which are cytoplasmic structures formed in response to cellular stress, have been implicated in the pathogenesis of ALS. Specifically, several components of the stress granules have been identified as potential contributors to motor neuron degeneration in ALS. One of the key components of stress granules is the RNA-binding protein TIA-1. TIA-1 has been shown to interact with the ALS-associated protein FUS (Fetal Protein 1) and promote its aggregation, which is a hallmark of ALS. Additionally, TIA-1 has been implicated in the regulation of the unfolded protein response (UPR), which is activated in response to stress and can contribute to motor neuron degeneration in ALS. Another component of stress granules is the protein G3BP1. G3BP1 has been shown to interact with FUS and promote its aggregation, and has also been implicated in the regulation of the UPR. Finally, the RNA-binding protein TARDBP, which is mutated in some cases of ALS, has been shown to interact with the stress granule component G3BP1 and promote its accumulation in motor neurons. Overall, the stress granules are emerging as an important player in the pathogenesis of ALS, and the components of these structures are likely to be key players in the degeneration of motor neurons in this disease.", "label": 0, "is_selected": 0, "text": "Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized by the progressive loss of motor neurons. The stress granules, which are cytoplasmic structures formed in response to cellular stress, have been implicated in the pathogenesis of ALS. Specifically, several components of the stress granules have been identified as potential contributors to motor neuron degeneration in ALS. One of the key components of stress granules is the RNA-binding protein TIA-1. TIA-1 has been shown to interact with the ALS-associated protein FUS (Fetal Protein 1) and promote its aggregation, which is a hallmark of ALS. Additionally, TIA-1 has been implicated in the regulation of the unfolded protein response (UPR), which is activated in response to stress and can contribute to motor neuron degeneration in ALS. Another component of stress granules is the protein G3BP1. G3BP1 has been shown to interact with FUS and promote its aggregation, and has also been implicated in the regulation of the UPR. Finally, the RNA-binding protein TARDBP, which is mutated in some cases of ALS, has been shown to interact with the stress granule component G3BP1 and promote its accumulation in motor neurons. Overall, the stress granules are emerging as an important player in the pathogenesis of ALS, and the components of these structures are likely to be key players in the degeneration of motor neurons in this disease."}
{"qid": "56b8ccc5156496395c000003", "original_text": "Genomic enhancers are important regulators of gene expression, but their identification is a challenge, and methods depend on indirect measures of activity. We developed a method termed STARR-seq to directly and quantitatively assess enhancer activity for millions of candidates from arbitrary sources of DNA, which enables screens across entire genomes. When applied to the Drosophila genome, STARR-seq identifies thousands of cell type-specific enhancers across a broad continuum of strengths, links differential gene expression to differences in enhancer activity, and creates a genome-wide quantitative enhancer map. This map reveals the highly complex regulation of transcription, with several independent enhancers for both developmental regulators and ubiquitously expressed genes.", "label": 1, "is_selected": 0, "text": "Genomic enhancers are important regulators of gene expression, but their identification is a challenge, and methods depend on indirect measures of activity. We developed a method termed STARR-seq to directly and quantitatively assess enhancer activity for millions of candidates from arbitrary sources of DNA, which enables screens across entire genomes. When applied to the Drosophila genome, STARR-seq identifies thousands of cell type-specific enhancers across a broad continuum of strengths, links differential gene expression to differences in enhancer activity, and creates a genome-wide quantitative enhancer map. This map reveals the highly complex regulation of transcription, with several independent enhancers for both developmental regulators and ubiquitously expressed genes."}
{"qid": "51630226298dcd4e5100004d", "original_text": "Top-down mass spectrometric analysis of histones offers several advantages over other approaches. Firstly, it allows for the simultaneous analysis of multiple histone modifications, which can provide a comprehensive view of the epigenetic landscape. Secondly, it can resolve individual histone variants and their post-translational modifications with high accuracy, enabling the identification of specific histone modifications associated with particular cellular processes or diseases. Thirdly, the high mass accuracy of top-down MS enables the detection of histone modifications with high sensitivity and specificity, even at low abundance levels. Finally, the ability to link histone modifications to specific genomic locations through ChIP-seq data provides a powerful tool for understanding the functional implications of epigenetic modifications.", "label": 0, "is_selected": 0, "text": "Top-down mass spectrometric analysis of histones offers several advantages over other approaches. Firstly, it allows for the simultaneous analysis of multiple histone modifications, which can provide a comprehensive view of the epigenetic landscape. Secondly, it can resolve individual histone variants and their post-translational modifications with high accuracy, enabling the identification of specific histone modifications associated with particular cellular processes or diseases. Thirdly, the high mass accuracy of top-down MS enables the detection of histone modifications with high sensitivity and specificity, even at low abundance levels. Finally, the ability to link histone modifications to specific genomic locations through ChIP-seq data provides a powerful tool for understanding the functional implications of epigenetic modifications."}
{"qid": "52ed27c098d0239505000030", "original_text": "Chondrogenic differentiating mesenchymal stem cells (MSCs) express markers of hypertrophic growth plate chondrocytes. As hypertrophic cartilage undergoes ossification, this is a concern for the application of MSCs in articular cartilage tissue engineering. To identify mechanisms that elicit this phenomenon, we used an in vitro hypertrophy model of chondrifying MSCs for differential gene expression analysis and functional experiments with the focus on bone morphogenetic protein (BMP) signaling. Hypertrophy was induced in chondrogenic MSC pellet cultures by transforming growth factor \u03b2 (TGF\u03b2) and dexamethasone withdrawal and addition of triiodothyronine. Differential gene expression analysis of BMPs and their receptors was performed. Based on these results, the in vitro hypertrophy model was used to investigate the effect of recombinant BMP4 and the BMP inhibitor Noggin. The enhancement of hypertrophy could be shown clearly by an increased cell size, alkaline phosphatase activity, and collagen type X deposition. Upon induction of hypertrophy, BMP4 and the BMP receptor 1B were upregulated. Addition of BMP4 further enhanced hypertrophy in the absence, but not in the presence of TGF\u03b2 and dexamethasone. Thyroid hormone induced hypertrophy by upregulation of BMP4 and this induced enhancement of hypertrophy could be blocked by the BMP antagonist Noggin. BMP signaling is an important modulator of the late differentiation stages in MSC chondrogenesis and the thyroid hormone induces this pathway. As cartilage tissue engineering constructs will be exposed to this factor in vivo, this study provides important insight into the biology of MSC-based cartilage.", "label": 1, "is_selected": 0, "text": "Chondrogenic differentiating mesenchymal stem cells (MSCs) express markers of hypertrophic growth plate chondrocytes. As hypertrophic cartilage undergoes ossification, this is a concern for the application of MSCs in articular cartilage tissue engineering. To identify mechanisms that elicit this phenomenon, we used an in vitro hypertrophy model of chondrifying MSCs for differential gene expression analysis and functional experiments with the focus on bone morphogenetic protein (BMP) signaling. Hypertrophy was induced in chondrogenic MSC pellet cultures by transforming growth factor \u03b2 (TGF\u03b2) and dexamethasone withdrawal and addition of triiodothyronine. Differential gene expression analysis of BMPs and their receptors was performed. Based on these results, the in vitro hypertrophy model was used to investigate the effect of recombinant BMP4 and the BMP inhibitor Noggin. The enhancement of hypertrophy could be shown clearly by an increased cell size, alkaline phosphatase activity, and collagen type X deposition. Upon induction of hypertrophy, BMP4 and the BMP receptor 1B were upregulated. Addition of BMP4 further enhanced hypertrophy in the absence, but not in the presence of TGF\u03b2 and dexamethasone. Thyroid hormone induced hypertrophy by upregulation of BMP4 and this induced enhancement of hypertrophy could be blocked by the BMP antagonist Noggin. BMP signaling is an important modulator of the late differentiation stages in MSC chondrogenesis and the thyroid hormone induces this pathway. As cartilage tissue engineering constructs will be exposed to this factor in vivo, this study provides important insight into the biology of MSC-based cartilage."}
{"qid": "532ad4b4d6d3ac6a34000012", "original_text": "The sequence variability of antibodies refers to the degree of variation in the amino acid sequence of the antibody molecule. Antibodies are composed of four polypeptide chains: two heavy chains and two light chains. These chains are made up of various amino acids that are linked together through peptide bonds. The sequence of these amino acids determines the structure and function of the antibody. There are several types of sequence variability in antibodies, including: * Somatic mutations: These are random mutations that occur in the antibody genes during B cell development. They can result in small changes in the amino acid sequence of the antibody molecule. * Antibody diversity: This refers to the range of possible amino acid sequences that can occur in the antibody molecule. Antibodies are produced by a process called somatic hypermutation, which involves the random mutation of the antibody genes. This process generates a large pool of possible antibody sequences, allowing the immune system to produce a diverse repertoire of antibodies that can recognize a wide range of pathogens. * Antibody repertoire: This refers to the collection of all the possible antibody sequences that are produced by an individual's immune system. The size and diversity of an individual's antibody repertoire can affect their immune response to infection. I hope this information is helpful. If you have any more questions, please feel free to ask.", "label": 0, "is_selected": 1, "text": "The structure and function of antibodies are determined by the degree of variability in the sequence of the molecules that make up the antibody molecule, as well as by the size and diversity of an individual's antibody repertoire. The sequence variability of antibodies refers to the Degree ofVariation in the Amino Acid Sequence of the Antibody Molecule., which is the largest and most important variable in the structure and Function of an Antibody., the structure of an antibody molecule., The size and Diversity of an Individual's Antibody repertoire.,The Antibody Sequence variability of Antibody Molecules, is the Largest and Most Important Variable in the Structure andFunction of an Antibodies.,"}
{"qid": "5324d0429b2d7acc7e000023", "original_text": "Topical minoxidil has been associated with several adverse effects, including: irritation, itching, redness, dryness, and flaking of the skin at the application site. More severe reactions such as bullous pemphigus, anaphylaxis, and fixed drug eruption have also been reported. Rarely, minoxidil can cause sexual dysfunction, such as erectile dysfunction or decreased libido, due to its effects on the blood vessels. It is important to use minoxidil as directed and to discontinue use if any adverse effects occur. I don't have the answer to your next question.", "label": 0, "is_selected": 1, "text": "minoxidil is a prescription drug used for the treatment of a number of skin conditions, including acne, eczema, psoriasis, and Sonoran Desert dermatitis (SMDs) in adults and children under the age of 18 years.Rarely, it can cause sexual dysfunction, such as erectile dysfunction or decreased libido, due to its effects on the blood vessels."}
{"qid": "52fb78572059c6d71c000067", "original_text": "Short QT syndrome (SQTS) is a rare cardiac arrhythmia disorder that affects approximately 1 in 2,500 to 1 in 10,000 individuals worldwide. The prevalence of SQTS varies depending on the population being studied and the diagnostic criteria used. According to a study published in the Journal of the American College of Cardiology, the prevalence of SQTS in the general population is estimated to be around 0.3% to 0.5%. Another study published in the European Heart Journal estimated the prevalence of SQTS in a pediatric population to be around 0.17%. It is important to note that SQTS can be underdiagnosed or misdiagnosed, as the symptoms are nonspecific and can resemble other cardiac arrhythmia disorders. Therefore, the actual prevalence of SQTS may be higher than the estimated prevalence.", "label": 0, "is_selected": 1, "text": "Short QT syndrome (SQTS) is a rare cardiac arrhythmia disorder that affects approximately 1 in 2,500 to 1 in 10,000 individuals worldwide, according to a study published in the Journal of the American College of Cardiology, and is estimated to be around 0.3% to 0.5% in the general population and 0.17% in a pediatric population."}
{"qid": "5c8974bcd558e5f232000008", "original_text": "Glybera is a genetically modified adeno-associated viral (AAV) gene therapy developed by uniQure, a Dutch biotechnology company. It was the first gene therapy to be approved by the European Medicines Agency (EMA) in 2012 for the treatment of limb-girdle muscular dystrophy (LGMD) type 2A. uniQure has since developed other AAV gene therapies for different genetic diseases, including hemophilia B and huntington's disease.", "label": 0, "is_selected": 1, "text": "The US Food and Drug Administration (FDA) has approved Glybera (adalimumab) for the treatment of adult patients with a form of muscular dystrophy who do not respond to currently available therapies, or who are intolerant to existing therapies."}
{"qid": "56e46ad951531f7e3300001a", "original_text": "Recent findings have shown that the blood vessels of different organs exert an active role in regulating organ function. In detail, the endothelium that aligns the vasculature of most organs is fundamental in maintaining organ homeostasis and in promoting organ recovery following injury. Mechanistically, endothelial cells (EC) of tissues such as the liver, lungs or the bone marrow (BM) have been shown to produce \"angiocrine\" factors that promote organ recovery and restore normal organ function. Controlled production of angiocrine factors following organ injury is therefore essential to promote organ regeneration and to restore organ function. However, the molecular mechanisms underlying the coordinated production and function of such \"angiocrine\" factors are largely undisclosed and were the subject of the present study. In detail, we identified for the first time a microRNA (miRNA) expressed by BM EC that regulates the expression of angiocrine genes involved in BM recovery following irradiation. Using a microarray-based approach, we identified several miRNA expressed by irradiated BMEC. After validating the variations in miRNA expression by semi-quantitative PCR, we chose to study further the ones showing consistent variations between experiments, and those predicted to regulate (directly or indirectly) angiogenic and angiocrine factors. Of the mi-RNA that were chosen, miR-363-5p (previously termed miR-363*) was subsequently shown to modulate the expression of numerous EC-specific genes including some angiocrine factors. By luciferase reporter assays, miR-363-5p is shown to regulate the expression of angiocrine factors tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3 (THBS3) at post-transcriptional level. Moreover, miR-363-5p reduction using anti-miR is shown to affect EC angiogenic properties (such as the response to angiogenic factors stimulation) and the interaction between EC and hematopoietic precursors (particularly relevant in a BM setting). miR-363-5p reduction resulted in a significant decrease in EC tube formation on matrigel, but increased hematopoietic precursor cells adhesion onto EC, a mechanism that is shown to involve kit ligand-mediated cell adhesion.", "label": 1, "is_selected": 0, "text": "Recent findings have shown that the blood vessels of different organs exert an active role in regulating organ function. In detail, the endothelium that aligns the vasculature of most organs is fundamental in maintaining organ homeostasis and in promoting organ recovery following injury. Mechanistically, endothelial cells (EC) of tissues such as the liver, lungs or the bone marrow (BM) have been shown to produce \"angiocrine\" factors that promote organ recovery and restore normal organ function. Controlled production of angiocrine factors following organ injury is therefore essential to promote organ regeneration and to restore organ function. However, the molecular mechanisms underlying the coordinated production and function of such \"angiocrine\" factors are largely undisclosed and were the subject of the present study. In detail, we identified for the first time a microRNA (miRNA) expressed by BM EC that regulates the expression of angiocrine genes involved in BM recovery following irradiation. Using a microarray-based approach, we identified several miRNA expressed by irradiated BMEC. After validating the variations in miRNA expression by semi-quantitative PCR, we chose to study further the ones showing consistent variations between experiments, and those predicted to regulate (directly or indirectly) angiogenic and angiocrine factors. Of the mi-RNA that were chosen, miR-363-5p (previously termed miR-363*) was subsequently shown to modulate the expression of numerous EC-specific genes including some angiocrine factors. By luciferase reporter assays, miR-363-5p is shown to regulate the expression of angiocrine factors tissue inhibitor of metalloproteinases-1 (Timp-1) and thrombospondin 3 (THBS3) at post-transcriptional level. Moreover, miR-363-5p reduction using anti-miR is shown to affect EC angiogenic properties (such as the response to angiogenic factors stimulation) and the interaction between EC and hematopoietic precursors (particularly relevant in a BM setting). miR-363-5p reduction resulted in a significant decrease in EC tube formation on matrigel, but increased hematopoietic precursor cells adhesion onto EC, a mechanism that is shown to involve kit ligand-mediated cell adhesion."}
{"qid": "5502fe13e9bde69634000009", "original_text": "Methods that measure energy balance accurately in real time represent promising avenues to address the obesity epidemic. We developed an electronic food diary on a mobile phone that includes an energy balance visualization and computes and displays the difference between energy intake from food entries and energy expenditure from a multiple-sensor device that provides objective estimates of energy expenditure in real time. A geographic information system dataset containing locations associated with activity and eating episodes is integrated with an ArcPad mapping application on the phone to provide users with a visual display of food sources and locations associated with physical activity within their proximal environment. This innovative tool captures peoples' movement through space and time under free-living conditions and could potentially have many health-related applications in the future.", "label": 1, "is_selected": 0, "text": "Methods that measure energy balance accurately in real time represent promising avenues to address the obesity epidemic. We developed an electronic food diary on a mobile phone that includes an energy balance visualization and computes and displays the difference between energy intake from food entries and energy expenditure from a multiple-sensor device that provides objective estimates of energy expenditure in real time. A geographic information system dataset containing locations associated with activity and eating episodes is integrated with an ArcPad mapping application on the phone to provide users with a visual display of food sources and locations associated with physical activity within their proximal environment. This innovative tool captures peoples' movement through space and time under free-living conditions and could potentially have many health-related applications in the future."}
{"qid": "5a9d8a651d1251d03b00001f", "original_text": "The performance of a small-scale automated cryopreservation and storage system (Mini-BioArchive system) used in the banking of umbilical cord blood (UCB) units was evaluated. After thawing the units, the viability and recovery of cells, as well as the recovery rate of hematopoietic progenitor cells (HPCs) such as CD34+ cells, colony-forming unit-granulocyte-macrophage (CFU-GM), and total CFU were analyzed. Twenty UCB units cryopreserved using the automated system and stored for a median of 34 days were analyzed. Mean CD34+ cell viabilities before freezing were 99.8+/-0.5% and after thawing were 99.8+/-0.4% in the large bag compartments and 99.7+/-0.5% in the small compartments. The mean recovery values for total nucleated cells, CD34+ cells, CFU-GM, and total CFU were 94.8+/-16.0%, 99.3+/-18.6%, 103.9+/-20.6%, and 94.3+/-12.5%, respectively in the large compartments, and 95.8+/-25.9%, 106.8+/-23.9%, 101.3+/-23.3%, and 93.8+/-19.2%, respectively in the small compartments. A small-scale automated cryopreservation and storage system did not impair the clonogenic capacity of UCB HPCs. This cryopreservation system could provide cellular products adequate for UCB banking and HPC transplantation.", "label": 1, "is_selected": 0, "text": "The performance of a small-scale automated cryopreservation and storage system (Mini-BioArchive system) used in the banking of umbilical cord blood (UCB) units was evaluated. After thawing the units, the viability and recovery of cells, as well as the recovery rate of hematopoietic progenitor cells (HPCs) such as CD34+ cells, colony-forming unit-granulocyte-macrophage (CFU-GM), and total CFU were analyzed. Twenty UCB units cryopreserved using the automated system and stored for a median of 34 days were analyzed. Mean CD34+ cell viabilities before freezing were 99.8+/-0.5% and after thawing were 99.8+/-0.4% in the large bag compartments and 99.7+/-0.5% in the small compartments. The mean recovery values for total nucleated cells, CD34+ cells, CFU-GM, and total CFU were 94.8+/-16.0%, 99.3+/-18.6%, 103.9+/-20.6%, and 94.3+/-12.5%, respectively in the large compartments, and 95.8+/-25.9%, 106.8+/-23.9%, 101.3+/-23.3%, and 93.8+/-19.2%, respectively in the small compartments. A small-scale automated cryopreservation and storage system did not impair the clonogenic capacity of UCB HPCs. This cryopreservation system could provide cellular products adequate for UCB banking and HPC transplantation."}
{"qid": "5e499e0a6d0a27794100000b", "original_text": "The National Institutes of Health (US NIH, 2018) estimates that in the US approximately 50 million men and 30 million women suffer from AGA (also known as pattern hair loss). Minoxidil is the only topical drug for the treatment of both female and male pattern hair loss. In the US, minoxidil is approved over-the-counter (OTC) at a maximum concentration of 5%.", "label": 1, "is_selected": 0, "text": "The National Institutes of Health (US NIH, 2018) estimates that in the US approximately 50 million men and 30 million women suffer from AGA (also known as pattern hair loss). Minoxidil is the only topical drug for the treatment of both female and male pattern hair loss. In the US, minoxidil is approved over-the-counter (OTC) at a maximum concentration of 5%."}
{"qid": "5c851a8175a4a5d219000005", "original_text": "The exotoxins toxin A (TcdA) and toxin B (TcdB) are produced by the bacterial pathogen Clostridium difficile and are responsible for the pathology associated with C. difficile infection (CDI). The antitoxin antibodies actoxumab and bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. Bezlotoxumab was recently approved by the FDA for reducing the recurrence of CDI. We have previously shown that a single molecule of bezlotoxumab binds to two distinct epitopes within the TcdB combined repetitive oligopeptide (CROP) domain, preventing toxin binding to host cells. In this study, we characterize the binding of actoxumab to TcdA and examine its mechanism of toxin neutralization. Using a combination of approaches including a number of biophysical techniques, we show that there are two distinct actoxumab binding sites within the CROP domain of TcdA centered on identical amino acid sequences at residues 2162-2189 and 2410-2437. Actoxumab binding caused the aggregation of TcdA especially at higher antibody:toxin concentration ratios.", "label": 1, "is_selected": 0, "text": "The exotoxins toxin A (TcdA) and toxin B (TcdB) are produced by the bacterial pathogen Clostridium difficile and are responsible for the pathology associated with C. difficile infection (CDI). The antitoxin antibodies actoxumab and bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. Bezlotoxumab was recently approved by the FDA for reducing the recurrence of CDI. We have previously shown that a single molecule of bezlotoxumab binds to two distinct epitopes within the TcdB combined repetitive oligopeptide (CROP) domain, preventing toxin binding to host cells. In this study, we characterize the binding of actoxumab to TcdA and examine its mechanism of toxin neutralization. Using a combination of approaches including a number of biophysical techniques, we show that there are two distinct actoxumab binding sites within the CROP domain of TcdA centered on identical amino acid sequences at residues 2162-2189 and 2410-2437. Actoxumab binding caused the aggregation of TcdA especially at higher antibody:toxin concentration ratios."}
{"qid": "5ca64b5becadf2e73f000051", "original_text": "This review deals with recent advances in studies on P-glycoprotein (P-gp) and its expression regulators, focusing especially on our own research. Firstly, we describe findings demonstrating that the distribution of P-gp along the small intestine is heterogeneous, which explains why orally administered P-gp substrate drugs often show bimodal changes of plasma concentration. Secondly, we discuss the post-translational regulation of P-gp localization and function by the scaffold proteins ezrin, radixin and moesin (ERM proteins), together with recent reports indicating that tissue-specific differences in regulation by ERM proteins in normal tissues might be retained in corresponding cancerous tissues. Thirdly, we review evidence that P-gp activity is enhanced in the process of epithelial-to-mesenchymal transition (EMT), which is associated with cancer progression, without any increase in expression of P-gp mRNA.", "label": 1, "is_selected": 0, "text": "This review deals with recent advances in studies on P-glycoprotein (P-gp) and its expression regulators, focusing especially on our own research. Firstly, we describe findings demonstrating that the distribution of P-gp along the small intestine is heterogeneous, which explains why orally administered P-gp substrate drugs often show bimodal changes of plasma concentration. Secondly, we discuss the post-translational regulation of P-gp localization and function by the scaffold proteins ezrin, radixin and moesin (ERM proteins), together with recent reports indicating that tissue-specific differences in regulation by ERM proteins in normal tissues might be retained in corresponding cancerous tissues. Thirdly, we review evidence that P-gp activity is enhanced in the process of epithelial-to-mesenchymal transition (EMT), which is associated with cancer progression, without any increase in expression of P-gp mRNA."}
{"qid": "5a8941c5bc7bade53a000002", "original_text": "The ability to adequately measure the phosphorylation state of a protein has major biological as well as clinical relevance. Due to its variable nature, reversible protein phosphorylations are sensitive to changes in the tissue environment.", "label": 1, "is_selected": 0, "text": "The ability to adequately measure the phosphorylation state of a protein has major biological as well as clinical relevance. Due to its variable nature, reversible protein phosphorylations are sensitive to changes in the tissue environment."}
{"qid": "61f80c37882a024a1000003b", "original_text": "KCNT2 variants resulting in substitutions affecting the Arg190 residue have been shown to cause epileptic encephalopathy and a recognizable facial gestalt. We report two additional individuals with intellectual disability, dysmorphic features, hypertrichosis, macrocephaly and the same de novo KCNT2 missense variants affecting the Arg190 residue as previously described. Notably, neither patient has epilepsy.", "label": 1, "is_selected": 0, "text": "KCNT2 variants resulting in substitutions affecting the Arg190 residue have been shown to cause epileptic encephalopathy and a recognizable facial gestalt. We report two additional individuals with intellectual disability, dysmorphic features, hypertrichosis, macrocephaly and the same de novo KCNT2 missense variants affecting the Arg190 residue as previously described. Notably, neither patient has epilepsy."}
{"qid": "5c9158a5ecadf2e73f000008", "original_text": "Prior to 2017, Keytruda (pembrolizumab) was approved for the treatment of several malignancies, including: 1. Melanoma: Keytruda was first approved in 2014 for the treatment of patients with advanced melanoma, regardless of BRAF status. 2. Head and neck squamous cell carcinoma (HNSCC): In 2015, Keytruda was approved for the treatment of patients with recurrent or metastatic HNSCC. 3. classical Hodgkin lymphoma (cHL): In 2015, Keytruda was approved for the treatment of patients with cHL who had relapsed or were refractory to previous treatments. 4. Non-small cell lung cancer (NSCLC): In 2015, Keytruda was approved for the treatment of patients with metastatic NSCLC whose tumors express PD-L1, regardless of histology. Please note that this list only includes the approvals from the US Food and Drug Administration (FDA) and may not reflect other regulatory agencies' approvals.", "label": 0, "is_selected": 1, "text": "Keytruda has been approved for the treatment of a number of different types of cancer over the past three years. Non-small cell lung cancer (NSCLC)): In 2015, Keytrude was approved for patients with metastatic NSCLC whose PD-L1 expression is higher than that of the human epidermal growth factor receptor 2 (HER2)expressing cancer."}
{"qid": "5325a1a69b2d7acc7e000025", "original_text": "Microneedling with dermaroller is a new treatment modality for the treatment of scars, especially acne scars, stretch marks, wrinkles, and for facial rejuvenation. It is a simple and relatively cheap modality that also can be used for transdermal drug delivery.", "label": 1, "is_selected": 0, "text": "Microneedling with dermaroller is a new treatment modality for the treatment of scars, especially acne scars, stretch marks, wrinkles, and for facial rejuvenation. It is a simple and relatively cheap modality that also can be used for transdermal drug delivery."}
{"qid": "5524562387ecba3764000001", "original_text": "Hedgehog (Hh) signaling proteins stimulate cell proliferation, differentiation, and tissue patterning at multiple points in animal development. A single Hh homolog is present in Drosophila, but three Hh homologs, Sonic Hh, Indian Hh, and Desert Hh, are present in mammals. Distribution, movement, and reception of Hh signals are tightly regulated, and abnormal Hh signaling is associated with developmental defects and cancer. In addition to the integral membrane proteins Patched and Smoothened, members of the Drosophila Ihog family of adhesion-like molecules have recently been shown to bind Hh proteins with micromolar affinity and positively regulate Hh signaling. Cell adhesion molecule-related, down-regulated by oncogenes (CDO) and Brother of CDO (BOC) are the closest mammalian relatives of Drosophila Ihog, and CDO binds Sonic Hh with micromolar affinity and positively regulates Hh signaling. Despite these similarities, structural and biochemical studies have shown that Ihog and CDO utilize nonorthologous domains and completely different binding modes to interact with cognate Hh proteins. We report here biochemical and x-ray structural studies of Sonic, Indian, and Desert Hh proteins both alone and complexed with active domains of CDO and BOC.", "label": 1, "is_selected": 0, "text": "Hedgehog (Hh) signaling proteins stimulate cell proliferation, differentiation, and tissue patterning at multiple points in animal development. A single Hh homolog is present in Drosophila, but three Hh homologs, Sonic Hh, Indian Hh, and Desert Hh, are present in mammals. Distribution, movement, and reception of Hh signals are tightly regulated, and abnormal Hh signaling is associated with developmental defects and cancer. In addition to the integral membrane proteins Patched and Smoothened, members of the Drosophila Ihog family of adhesion-like molecules have recently been shown to bind Hh proteins with micromolar affinity and positively regulate Hh signaling. Cell adhesion molecule-related, down-regulated by oncogenes (CDO) and Brother of CDO (BOC) are the closest mammalian relatives of Drosophila Ihog, and CDO binds Sonic Hh with micromolar affinity and positively regulates Hh signaling. Despite these similarities, structural and biochemical studies have shown that Ihog and CDO utilize nonorthologous domains and completely different binding modes to interact with cognate Hh proteins. We report here biochemical and x-ray structural studies of Sonic, Indian, and Desert Hh proteins both alone and complexed with active domains of CDO and BOC."}
{"qid": "60571d4294d57fd879000028", "original_text": "Research into Alzheimer's disease pathology and treatment has often focused on presenilin proteins. These proteins provide the key catalytic activity of the \u03b3-secretase complex in the cleavage of amyloid-\u03b2 precursor protein and resultant amyloid tangle deposition. Over the last 25 years, screening novel drugs to control this aberrant proteolytic activity has yet to identify effective treatments for the disease. In the search for other mechanisms of presenilin pathology, several studies have demonstrated that mammalian presenilin proteins also act in a non-proteolytic role as a scaffold to co-localize key signaling proteins. This role is likely to represent an ancestral presenilin function, as it has been described in genetically distant species including non-mammalian animals, plants, and a simple eukaryotic amoeba Dictyostelium that diverged from the human lineage over a billion years ago.", "label": 1, "is_selected": 0, "text": "Research into Alzheimer's disease pathology and treatment has often focused on presenilin proteins. These proteins provide the key catalytic activity of the \u03b3-secretase complex in the cleavage of amyloid-\u03b2 precursor protein and resultant amyloid tangle deposition. Over the last 25 years, screening novel drugs to control this aberrant proteolytic activity has yet to identify effective treatments for the disease. In the search for other mechanisms of presenilin pathology, several studies have demonstrated that mammalian presenilin proteins also act in a non-proteolytic role as a scaffold to co-localize key signaling proteins. This role is likely to represent an ancestral presenilin function, as it has been described in genetically distant species including non-mammalian animals, plants, and a simple eukaryotic amoeba Dictyostelium that diverged from the human lineage over a billion years ago."}
{"qid": "5e323e93fbd6abf43b000059", "original_text": "Advanced diagnostic imaging has provided tremendous benefits; however, increased use of ionizing radiation modalities such as cranial computed tomography (CT) may be associated with an increased risk of developing central nervous system tumors. A literature review identified studies published for more than the last 50 years from 1968 to 2018 that explored the association between head CT scans and developing central nervous system tumors in pediatrics. We reviewed seven studies that described and analyzed the risk of brain tumors. A positive correlation between exposure to CT scans and developing central nervous system tumors was evident in all cohorts. The strength of the association varied across the studies. Exclusion of patients with predisposing factors to central nervous system tumors was examined in four studies with a decreased risk to develop central nervous system tumors noted in three studies. Two studies reported nonsignificant reduction in the excess relative risk per milliGray of brain dose after adjusting for predisposing factors, whereas the reduction was significant in one study. The frequency of CT exposure was proportional to the risk of developing tumors in two studies although not significantly maintained in two other studies. Gender had no significant effect on the central nervous system tumor risk.", "label": 1, "is_selected": 0, "text": "Advanced diagnostic imaging has provided tremendous benefits; however, increased use of ionizing radiation modalities such as cranial computed tomography (CT) may be associated with an increased risk of developing central nervous system tumors. A literature review identified studies published for more than the last 50 years from 1968 to 2018 that explored the association between head CT scans and developing central nervous system tumors in pediatrics. We reviewed seven studies that described and analyzed the risk of brain tumors. A positive correlation between exposure to CT scans and developing central nervous system tumors was evident in all cohorts. The strength of the association varied across the studies. Exclusion of patients with predisposing factors to central nervous system tumors was examined in four studies with a decreased risk to develop central nervous system tumors noted in three studies. Two studies reported nonsignificant reduction in the excess relative risk per milliGray of brain dose after adjusting for predisposing factors, whereas the reduction was significant in one study. The frequency of CT exposure was proportional to the risk of developing tumors in two studies although not significantly maintained in two other studies. Gender had no significant effect on the central nervous system tumor risk."}
{"qid": "5318929fb166e2b80600001b", "original_text": "Li-Fraumeni syndrome (LFS) is a rare genetic disorder that increases the risk of developing certain types of cancer, including breast cancer. Her2 status, also known as Human Epidermal Growth Factor Receptor 2 (HER2), refers to the presence and expression of a protein on the surface of cancer cells. In LFS, the Her2 status is often tested to determine the best course of treatment for breast cancer. Studies have shown that approximately 30-50% of individuals with LFS will develop breast cancer, with a higher risk of developing the disease at a younger age. Her2-positive breast cancer is more common in individuals with LFS compared to the general population, with a higher frequency of Her2-positive tumors in those under the age of 40. However, the Her2 status can vary widely among individuals with LFS, and some may have no detectable Her2 protein expression. Therefore, it is essential to test the Her2 status of breast cancer cells in individuals with LFS to determine the most appropriate treatment options, which may include Her2-targeted therapies such as trastuzumab (Herceptin) or lapatinib (Tykerb). In summary, the Her2 status in Li-Fraumeni syndrome is an important factor to consider in the management of breast cancer, as it can help guide treatment decisions and improve outcomes for individuals with this rare genetic disorder.", "label": 0, "is_selected": 1, "text": "The Her2 status of breast cancer cells in individuals with Li-Fraumeni syndrome is an important factor to consider in the management of the disease, as it can help guide treatment decisions and improve outcomes for individuals with this rare genetic disorder. in summary, the Her2Status of Breast Cancer Cells in Individuals with LFS is an Important Factor to Consider in the Management of Breast cancer, As It Can Help Guide Treatment Decisions and Improve Outcomes for Individuals with this Rare Genetic disorder., published in the British Journal of Cancer, doi: 10.1038/bjc."}
{"qid": "5aa4f47cd6d6b54f7900000a", "original_text": "The different pipelines that may be used in 16S rRNA gene profiling of bacterial communities are known to have a significant impact on alpha and beta diversity measures and this may prevent direct comparison of results obtained in studies using different bioinformatic approaches to analyse raw sequences. To evaluate the feasibility of meta-studies on food bacterial communities, we compared four analysis procedures, varying in OTU picking and taxonomy assignment strategies. A closed reference OTU picking resulted in the most divergent results in terms of both alpha and beta diversity, compared to open reference methods. Nevertheless, when OTUs were collapsed at the genus level, a high correlation was obtained among the estimated abundances of taxa for most studies. Aggregation of samples by their nature and occurrence of food spoilage or fermentation resulted in a very similar classification using two beta diversity analysis methods. We conclude that comparisons of data obtained from different studies are feasible at the genus level, when the same OTU picking strategy is used. Finally, we provide a new version of FoodMicrobionet (Parente et al., 2016), including data from 26 recent studies on food bacterial communities, together with R scripts allowing both the extraction of data in formats which can be used in several analysis tools (including the R package phyloseq and the Cytoscape app CoNet) and the statistical and graphical analysis using common alpha- and beta-diversity analysis methods.", "label": 1, "is_selected": 0, "text": "The different pipelines that may be used in 16S rRNA gene profiling of bacterial communities are known to have a significant impact on alpha and beta diversity measures and this may prevent direct comparison of results obtained in studies using different bioinformatic approaches to analyse raw sequences. To evaluate the feasibility of meta-studies on food bacterial communities, we compared four analysis procedures, varying in OTU picking and taxonomy assignment strategies. A closed reference OTU picking resulted in the most divergent results in terms of both alpha and beta diversity, compared to open reference methods. Nevertheless, when OTUs were collapsed at the genus level, a high correlation was obtained among the estimated abundances of taxa for most studies. Aggregation of samples by their nature and occurrence of food spoilage or fermentation resulted in a very similar classification using two beta diversity analysis methods. We conclude that comparisons of data obtained from different studies are feasible at the genus level, when the same OTU picking strategy is used. Finally, we provide a new version of FoodMicrobionet (Parente et al., 2016), including data from 26 recent studies on food bacterial communities, together with R scripts allowing both the extraction of data in formats which can be used in several analysis tools (including the R package phyloseq and the Cytoscape app CoNet) and the statistical and graphical analysis using common alpha- and beta-diversity analysis methods."}
{"qid": "589c8e5e78275d0c4a000041", "original_text": "The aims of this study were to determine if statins reduce adhesion formation in vivo and to identify the mechanism of action in vitro. : Intraperitoneal adhesions develop in up to 95% of patients following laparotomy. Adhesions are reduced by mechanisms that up-regulate fibrinolysis within the peritoneum. Statins promote fibrinolysis in the cardiovascular system and may play a role in the prevention of adhesions. Adhesions were induced in rats (n = 102) using our previously described ischemic button model. Rats received vehicle (controls), lovastatin (30 mg/kg), or atorvastatin (30 mg/kg) as a single intraperitoneal dose at the time of laparotomy. Animals were killed and adhesions were quantified at day 7. Peritoneal fluid and tissue were collected at day 1 to measure tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) by real-time PCR and ELISA. To assess the effects of statins on wound healing, burst pressures were measured in anastomoses of the colon. The effects of lovastatin on tPA and PAI-1 production were measured in vitro in human mesothelial cells (HMC) in the presence or absence of mevalonate (MVA), geranylgeranyl-pyrophosphate (GGPP) and farnesyl-pyrophosphate (FPP), all intermediates in the cholesterol pathway downstream of HMG-CoA. The effect of a Rho protein inhibitor, exoenzyme C3 transferase, on tPA production was also determined.", "label": 1, "is_selected": 0, "text": "The aims of this study were to determine if statins reduce adhesion formation in vivo and to identify the mechanism of action in vitro. : Intraperitoneal adhesions develop in up to 95% of patients following laparotomy. Adhesions are reduced by mechanisms that up-regulate fibrinolysis within the peritoneum. Statins promote fibrinolysis in the cardiovascular system and may play a role in the prevention of adhesions. Adhesions were induced in rats (n = 102) using our previously described ischemic button model. Rats received vehicle (controls), lovastatin (30 mg/kg), or atorvastatin (30 mg/kg) as a single intraperitoneal dose at the time of laparotomy. Animals were killed and adhesions were quantified at day 7. Peritoneal fluid and tissue were collected at day 1 to measure tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) by real-time PCR and ELISA. To assess the effects of statins on wound healing, burst pressures were measured in anastomoses of the colon. The effects of lovastatin on tPA and PAI-1 production were measured in vitro in human mesothelial cells (HMC) in the presence or absence of mevalonate (MVA), geranylgeranyl-pyrophosphate (GGPP) and farnesyl-pyrophosphate (FPP), all intermediates in the cholesterol pathway downstream of HMG-CoA. The effect of a Rho protein inhibitor, exoenzyme C3 transferase, on tPA production was also determined."}
{"qid": "57092f9bcf1c32585100001b", "original_text": "The Foxa subfamily of winged helix/forkhead box (Fox) transcription factors has been the subject of genetic and biochemical study for over 15 years. During this time its three members, Foxa1, Foxa2 and Foxa3, have been found to play important roles in multiple stages of mammalian life, beginning with early development, continuing during organogenesis, and finally in metabolism and homeostasis in the adult. Foxa2 is required for the formation of the node and notochord, and in its absence severe defects in gastrulation, neural tube patterning, and gut morphogenesis result in embryonic lethality. Foxa1 and Foxa2 cooperate to establish competence in foregut endoderm and are required for normal development of endoderm-derived organs such as the liver, pancreas, lungs, and prostate.", "label": 1, "is_selected": 0, "text": "The Foxa subfamily of winged helix/forkhead box (Fox) transcription factors has been the subject of genetic and biochemical study for over 15 years. During this time its three members, Foxa1, Foxa2 and Foxa3, have been found to play important roles in multiple stages of mammalian life, beginning with early development, continuing during organogenesis, and finally in metabolism and homeostasis in the adult. Foxa2 is required for the formation of the node and notochord, and in its absence severe defects in gastrulation, neural tube patterning, and gut morphogenesis result in embryonic lethality. Foxa1 and Foxa2 cooperate to establish competence in foregut endoderm and are required for normal development of endoderm-derived organs such as the liver, pancreas, lungs, and prostate."}
{"qid": "604cda2f94d57fd879000004", "original_text": "Bisphenol A (BPA) is a synthetic chemical that has been widely used in various consumer products, including food packaging materials, medical devices, and dental materials. Once ingested, BPA can enter the body and disrupt the endocrine system, which is responsible for regulating hormones. Research has shown that BPA can have numerous effects on the body, including: 1. Hormone disruption: BPA can mimic or interfere with the body's natural hormones, leading to changes in the levels of various hormones, including estrogen and testosterone. 2. Reproductive problems: Exposure to BPA has been linked to infertility, miscarriage, and birth defects. 3. Cancer risk: Some studies suggest that exposure to BPA may increase the risk of certain types of cancer, such as breast cancer and prostate cancer. 4. Neurological problems: BPA has been linked to problems with brain development and cognitive function, as well as increased risk of neurological disorders such as autism and ADHD. 5. Immune system problems: BPA has been shown to suppress the immune system, making it more difficult for the body to fight off infections. It is important to note that the effects of BPA on the human body are still being researched and debated, and some studies have found no link between BPA exposure and adverse health effects. However, many medical organizations and regulatory agencies, including the World Health Organization and the U.S. Food and Drug Administration, have expressed concerns about the potential health risks of BPA exposure.", "label": 0, "is_selected": 0, "text": "Bisphenol A (BPA) is a synthetic chemical that has been widely used in various consumer products, including food packaging materials, medical devices, and dental materials. Once ingested, BPA can enter the body and disrupt the endocrine system, which is responsible for regulating hormones. Research has shown that BPA can have numerous effects on the body, including: 1. Hormone disruption: BPA can mimic or interfere with the body's natural hormones, leading to changes in the levels of various hormones, including estrogen and testosterone. 2. Reproductive problems: Exposure to BPA has been linked to infertility, miscarriage, and birth defects. 3. Cancer risk: Some studies suggest that exposure to BPA may increase the risk of certain types of cancer, such as breast cancer and prostate cancer. 4. Neurological problems: BPA has been linked to problems with brain development and cognitive function, as well as increased risk of neurological disorders such as autism and ADHD. 5. Immune system problems: BPA has been shown to suppress the immune system, making it more difficult for the body to fight off infections. It is important to note that the effects of BPA on the human body are still being researched and debated, and some studies have found no link between BPA exposure and adverse health effects. However, many medical organizations and regulatory agencies, including the World Health Organization and the U.S. Food and Drug Administration, have expressed concerns about the potential health risks of BPA exposure."}
{"qid": "58a6b98860087bc10a000028", "original_text": "Yes, SUMOylation (protein arginine methyltransferase activation domain-containing protein 1, or PAM1) is a post-translational modification in eukaryotes. It is a covalent attachment of a small molecule called SUMO (short for small ubiquitin-related modifier) to a target protein. This modification plays a role in various cellular processes, including protein degradation, nuclear-cytoplasmic shuttling, and protein-protein interactions. In eukaryotes, SUMOylation is primarily mediated by the enzyme PAM1, which recognizes a specific target protein and attaches the SUMO molecule to it in a processive manner.", "label": 0, "is_selected": 1, "text": "SUMOylation is a post-translational modification in eukaryotes that plays a role in various cellular processes, including protein degradation, nuclear-cytoplasmic interactions and protein-protein interactions, according to researchers at the University of California, Los Angeles."}
{"qid": "5895e4637d9090f353000012", "original_text": "CDKN1C (also known as P57 (kip2) ) is a cyclin-dependent kinase inhibitor that functions as a negative regulator of cell proliferation through G1 phase cell cycle arrest. Recently, our group described gain-of-function mutations in the PCNA-binding site of CDKN1C that result in an undergrowth syndrome called IMAGe Syndrome (Intrauterine Growth Restriction, Metaphyseal dysplasia, Adrenal hypoplasia, and Genital anomalies), with life-threatening consequences. Loss-of-function mutations in CDKN1C have been identified in 5-10% of individuals with Beckwith-Wiedemann syndrome (BWS), an overgrowth disorder with features that are the opposite of IMAGe syndrome. Here, we investigate the effects of IMAGe-associated mutations on protein stability, cell cycle progression and cell proliferation.", "label": 1, "is_selected": 0, "text": "CDKN1C (also known as P57 (kip2) ) is a cyclin-dependent kinase inhibitor that functions as a negative regulator of cell proliferation through G1 phase cell cycle arrest. Recently, our group described gain-of-function mutations in the PCNA-binding site of CDKN1C that result in an undergrowth syndrome called IMAGe Syndrome (Intrauterine Growth Restriction, Metaphyseal dysplasia, Adrenal hypoplasia, and Genital anomalies), with life-threatening consequences. Loss-of-function mutations in CDKN1C have been identified in 5-10% of individuals with Beckwith-Wiedemann syndrome (BWS), an overgrowth disorder with features that are the opposite of IMAGe syndrome. Here, we investigate the effects of IMAGe-associated mutations on protein stability, cell cycle progression and cell proliferation."}
{"qid": "621d19cc3a8413c65300004a", "original_text": "We aimed to develop a novel method for orthotopic colon cancer model, using tissue adhesive in place of conventional surgical method. RFP HCT 116 cell line were used to establish the colon cancer model. Fresh tumor tissue harvested from a subcutaneous injection was grafted into twenty nude mice, divided into group A (suture method) and group B (tissue adhesive method). For the group A, we fixed the tissue on the serosa layer of proximal colon by 8-0 surgical suture. For the group B, tissue adhesive (10 \u03bcL) was used to fix the tumor. The mortality, tumor implantation success, tumor metastasis, primary tumor size, and operation time were compared between the two groups.", "label": 1, "is_selected": 0, "text": "We aimed to develop a novel method for orthotopic colon cancer model, using tissue adhesive in place of conventional surgical method. RFP HCT 116 cell line were used to establish the colon cancer model. Fresh tumor tissue harvested from a subcutaneous injection was grafted into twenty nude mice, divided into group A (suture method) and group B (tissue adhesive method). For the group A, we fixed the tissue on the serosa layer of proximal colon by 8-0 surgical suture. For the group B, tissue adhesive (10 \u03bcL) was used to fix the tumor. The mortality, tumor implantation success, tumor metastasis, primary tumor size, and operation time were compared between the two groups."}
{"qid": "621e5cf53a8413c65300004e", "original_text": "Graph attention networks (GATs) are a type of neural network architecture that have shown promise in analyzing graph-structured data, such as transcriptomics data. In the context of single-cell RNA sequencing (scRNA-seq), GATs have been used in various workflows to analyze the expression patterns of genes at the single-cell level. Here are some examples of scRNA-seq workflows that harness GATs: 1. Graph Convolutional Networks (GCNs): GCNs are a type of GAT that have been widely used in scRNA-seq analysis. They use a spectral-based approach to learn a graph convolutional filter that captures the structural information in the graph. 2. Graph Attention Networks (GATs): GATs are a type of GCN that use attention mechanisms to learn the importance of different nodes in the graph. They have been used to analyze the expression patterns of genes in scRNA-seq data. 3. Graph Autoencoders (GAEs): GAEs are a type of GNN that use an autoencoder architecture to learn a compact representation of the graph. They have been used to identify robust gene markers in scRNA-seq data. 4. Spatially-aware Graph Attention Networks (SA-GATs): SA-GATs are a type of GAT that incorporate spatial information into the graph attention mechanism. They have been used to analyze the expression patterns of genes in scRNA-seq data with a focus on spatially-resolved information. In summary, GATs have been widely used in scRNA-seq analysis, and various workflows have been proposed to harness the power of GATs in analyzing graph-structured data.", "label": 0, "is_selected": 0, "text": "Graph attention networks (GATs) are a type of neural network architecture that have shown promise in analyzing graph-structured data, such as transcriptomics data. In the context of single-cell RNA sequencing (scRNA-seq), GATs have been used in various workflows to analyze the expression patterns of genes at the single-cell level. Here are some examples of scRNA-seq workflows that harness GATs: 1. Graph Convolutional Networks (GCNs): GCNs are a type of GAT that have been widely used in scRNA-seq analysis. They use a spectral-based approach to learn a graph convolutional filter that captures the structural information in the graph. 2. Graph Attention Networks (GATs): GATs are a type of GCN that use attention mechanisms to learn the importance of different nodes in the graph. They have been used to analyze the expression patterns of genes in scRNA-seq data. 3. Graph Autoencoders (GAEs): GAEs are a type of GNN that use an autoencoder architecture to learn a compact representation of the graph. They have been used to identify robust gene markers in scRNA-seq data. 4. Spatially-aware Graph Attention Networks (SA-GATs): SA-GATs are a type of GAT that incorporate spatial information into the graph attention mechanism. They have been used to analyze the expression patterns of genes in scRNA-seq data with a focus on spatially-resolved information. In summary, GATs have been widely used in scRNA-seq analysis, and various workflows have been proposed to harness the power of GATs in analyzing graph-structured data."}
{"qid": "603bc16b1cb411341a000158", "original_text": "Erabutoxin B is a toxin found in certain plants, including members of the Eupatorium genus. These plants are commonly found in wetlands and can be found throughout the world, including North America, South America, Africa, and Asia. Erabutoxin B is a type of cyclic heptadepsipeptide toxin, which is produced by the plant as a defense mechanism against herbivores and other predators. It has been shown to have a variety of biological activities, including anti-inflammatory, antimicrobial, and anticancer properties. However, it is important to note that the toxicity of erabutoxin B can vary depending on the plant species and the individual's sensitivity to the toxin, and it should be handled with caution.", "label": 0, "is_selected": 0, "text": "Erabutoxin B is a toxin found in certain plants, including members of the Eupatorium genus. These plants are commonly found in wetlands and can be found throughout the world, including North America, South America, Africa, and Asia. Erabutoxin B is a type of cyclic heptadepsipeptide toxin, which is produced by the plant as a defense mechanism against herbivores and other predators. It has been shown to have a variety of biological activities, including anti-inflammatory, antimicrobial, and anticancer properties. However, it is important to note that the toxicity of erabutoxin B can vary depending on the plant species and the individual's sensitivity to the toxin, and it should be handled with caution."}
{"qid": "58932cd87d9090f353000001", "original_text": "Fluorescence in situ hybridization (FISH) is a powerful molecular diagnostic technique that has been used to detect various human syndromes, including: 1. Down syndrome: FISH is commonly used to diagnose Down syndrome, a genetic disorder caused by an extra copy of chromosome 21. 2. Turner syndrome: FISH can diagnose Turner syndrome, a genetic disorder caused by a monosomy of chromosome 4. 3. Klinefelter syndrome: FISH can detect Klinefelter syndrome, a genetic disorder caused by an extra X chromosome in males. 4. Wolf-Parkinson-White syndrome: FISH can identify mutations in the PRKAG2 gene, which causes Wolf-Parkinson-White syndrome, a heart rhythm disorder. 5. Noonan syndrome: FISH can diagnose Noonan syndrome, a rare genetic disorder characterized by short stature, congenital heart defects, and other physical abnormalities. 6. Cri du chat syndrome: FISH can detect the characteristic deletion of chromosome 5p in Cri du chat syndrome, a rare genetic disorder characterized by a high-pitched cry and developmental delays. 7. Patau syndrome: FISH can identify the characteristic deletion of chromosome 13 in Patau syndrome, a rare genetic disorder characterized by developmental delays and intellectual disability. These are just a few examples of the many human syndromes that can be detected with FISH. The technique has revolutionized the diagnosis of genetic disorders and has helped to improve patient care and management.", "label": 0, "is_selected": 1, "text": "A new technique has been developed that can detect a wide range of human genetic disorders, including Down syndrome, Turner syndrome, Klinefelter syndrome, Noonan syndrome, Patau syndrome, Wolf-Parkinson-White syndrome, Cri du chat syndrome, and Turner syndrome. Cri du chats syndrome: FISH can detect the characteristic deletion of chromosome 5p in Cri du Chat syndrome, a rare genetic disorder characterized by a high-pitched cry and developmental delays, as well as brain and heart defects. Patau Syndrome:  Fish can identify the deletion of chromosomes 13 and 14 in Patau syndromes, a genetic disorder that can be detected with FISH."}
{"qid": "587d30fb31b33e8760000001", "original_text": "There are several deep learning-based algorithms that have been used for enhancer prediction, including: 1. DeepSEA: This algorithm uses a deep convolutional neural network (CNN) to predict enhancers from chromatin accessibility data. It takes into account the spatial proximity of enhancers and other genomic features. 2. DeepEnhancer: This algorithm uses a deep neural network to predict enhancers from a combination of chromatin accessibility, DNA sequence, and other genomic features. It can identify both proximal and distal enhancers. 3. EnhancerNet: This algorithm uses a deep neural network to predict enhancers from chromatin accessibility data. It incorporates features such as histone modifications and DNA sequence. 4. HI-Enhancer: This algorithm uses a deep neural network to predict enhancers from a combination of chromatin accessibility, DNA sequence, and other genomic features. It can identify both proximal and distal enhancers. 5. Enhancer-DNN: This algorithm uses a deep neural network to predict enhancers from a combination of chromatin accessibility, DNA sequence, and other genomic features. It can identify both proximal and distal enhancers. Note: These algorithms are constantly evolving, and new algorithms with improved performance are being developed regularly. It's essential to consult the most recent literature and assessments to get the most precise and up-to-date information on the best algorithms for enhancer prediction.", "label": 0, "is_selected": 0, "text": "There are several deep learning-based algorithms that have been used for enhancer prediction, including: 1. DeepSEA: This algorithm uses a deep convolutional neural network (CNN) to predict enhancers from chromatin accessibility data. It takes into account the spatial proximity of enhancers and other genomic features. 2. DeepEnhancer: This algorithm uses a deep neural network to predict enhancers from a combination of chromatin accessibility, DNA sequence, and other genomic features. It can identify both proximal and distal enhancers. 3. EnhancerNet: This algorithm uses a deep neural network to predict enhancers from chromatin accessibility data. It incorporates features such as histone modifications and DNA sequence. 4. HI-Enhancer: This algorithm uses a deep neural network to predict enhancers from a combination of chromatin accessibility, DNA sequence, and other genomic features. It can identify both proximal and distal enhancers. 5. Enhancer-DNN: This algorithm uses a deep neural network to predict enhancers from a combination of chromatin accessibility, DNA sequence, and other genomic features. It can identify both proximal and distal enhancers. Note: These algorithms are constantly evolving, and new algorithms with improved performance are being developed regularly. It's essential to consult the most recent literature and assessments to get the most precise and up-to-date information on the best algorithms for enhancer prediction."}
{"qid": "588800f43b87a8a738000009", "original_text": "The endoplasmic reticulum aminopeptidases (ERAP)1 and ERAP2 play a critical role in the production of final epitopes presented by MHC class I molecules. Formation of heterodimers by ERAP1 and ERAP2 has been proposed to facilitate trimming of epitope precursor peptides, but the effects of dimerization on ERAP function remain unknown.", "label": 1, "is_selected": 0, "text": "The endoplasmic reticulum aminopeptidases (ERAP)1 and ERAP2 play a critical role in the production of final epitopes presented by MHC class I molecules. Formation of heterodimers by ERAP1 and ERAP2 has been proposed to facilitate trimming of epitope precursor peptides, but the effects of dimerization on ERAP function remain unknown."}
{"qid": "5fe31316a43ad31278000043", "original_text": "DoG readthrough transcription is induced by several factors, including: 1. Upstream open reading frames (uORFs): These are sequences located upstream of the main coding region of a gene, and they can act as enhancers of DoG readthrough transcription by providing a binding site for RNA polymerase II (RNAPII) and other transcription factors. 2. Downstream enhancers: These are sequences located downstream of the gene and can also bind to RNAPII and other transcription factors, enhancing DoG readthrough transcription by increasing the recruitment of these factors to the coding region. 3. Chromatin structure: The chromatin structure of the gene can also influence DoG readthrough transcription, with more accessible chromatin structures leading to increased transcription. 4. Transcription factors: Certain transcription factors, such as the Kr\u00fcppel-like factor 1 (KLF1), can bind to specific sequences upstream of the DoG and enhance its readthrough transcription. 5. Small molecules: Certain small molecules, such as the drugs rapamycin and dexamethasone, have been shown to induce DoG readthrough transcription in certain contexts.", "label": 0, "is_selected": 1, "text": "The DoG readsthrough gene (DoG) has been shown to be involved in a number of diseases, including lung cancer, breast cancer, and Alzheimer's disease, as well as in the development and maintenance of many autoimmune diseases., DoG readthrough transcription is an important step in the translation of RNA into DNA, and plays a key role in the regulation of many of the genes involved in RNAi."}
{"qid": "61f7d4da882a024a10000033", "original_text": "As part of postauthorization safety surveillance, the US Food and Drug Administration (FDA) has identified a potential safety concern for Guillain-Barr\u00e9 syndrome (GBS) following receipt of the Ad26.COV2.S (Janssen/Johnson & Johnson) COVID-19 vaccine. To assess reports of GBS received in the Vaccine Adverse Event Reporting System (VAERS) following Ad26.COV2.S vaccination. Reports of presumptive GBS were identified in a US passive reporting system (VAERS) February-July 2021 and characterized, including demographics, clinical characteristics, and relevant medical history.", "label": 1, "is_selected": 0, "text": "As part of postauthorization safety surveillance, the US Food and Drug Administration (FDA) has identified a potential safety concern for Guillain-Barr\u00e9 syndrome (GBS) following receipt of the Ad26.COV2.S (Janssen/Johnson & Johnson) COVID-19 vaccine. To assess reports of GBS received in the Vaccine Adverse Event Reporting System (VAERS) following Ad26.COV2.S vaccination. Reports of presumptive GBS were identified in a US passive reporting system (VAERS) February-July 2021 and characterized, including demographics, clinical characteristics, and relevant medical history."}
{"qid": "58b9585c22d3005309000010", "original_text": "Bone mineralization is possible via complex interactions among fibroblast growth factor 23 (FGF23), phosphate-regulating gene with homologies to endopeptidases on the X-chromosome (PHEX), and matrix extracellular phosphoglycoprotein. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets. X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets, and there have been reports linking XLH rickets to craniosynostosis. A clinical report of a patient with XLH rickets and craniosynostosis is presented with a review of literature.", "label": 1, "is_selected": 0, "text": "Bone mineralization is possible via complex interactions among fibroblast growth factor 23 (FGF23), phosphate-regulating gene with homologies to endopeptidases on the X-chromosome (PHEX), and matrix extracellular phosphoglycoprotein. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets. X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets, and there have been reports linking XLH rickets to craniosynostosis. A clinical report of a patient with XLH rickets and craniosynostosis is presented with a review of literature."}
{"qid": "532f03e6d6d3ac6a34000022", "original_text": "Placement of an elastic biodegradable patch onto a subacute myocardial infarct (MI) provides temporary elastic support that may act to effectively alter adverse left ventricular (LV) remodeling processes. Two weeks after permanent left coronary ligation in Lewis rats, the infarcted anterior wall was covered with polyester urethane urea (MI + PEUU; n = 15) or expanded polytetrafluoroethylene (MI + ePTFE; n = 15) patches, or had no implantation (MI + sham; n = 12). Eight weeks after surgery, cardiac function and histology were assessed.", "label": 1, "is_selected": 0, "text": "Placement of an elastic biodegradable patch onto a subacute myocardial infarct (MI) provides temporary elastic support that may act to effectively alter adverse left ventricular (LV) remodeling processes. Two weeks after permanent left coronary ligation in Lewis rats, the infarcted anterior wall was covered with polyester urethane urea (MI + PEUU; n = 15) or expanded polytetrafluoroethylene (MI + ePTFE; n = 15) patches, or had no implantation (MI + sham; n = 12). Eight weeks after surgery, cardiac function and histology were assessed."}
{"qid": "6278c73756bf9aee6f00000b", "original_text": "Adequate bioavailability is one of the essential properties for an orally administered drug. Lipinski and others have formulated simplified rules in which compounds that satisfy selected physiochemical properties, for example, molecular weight (MW) \u2264 500 or the logarithm of the octanol-water partition coefficient, log P(o/w) < 5, are anticipated to likely have pharmacokinetic properties appropriate for oral administration. However, these schemes do not simultaneously consider the combination of the physiochemical properties, complicating their application in a more automated fashion. To overcome this, we present a novel method to select compounds with a combination of physicochemical properties that maximize bioavailability and druglikeness based on compounds in the World Drug Index database. In the study four properties, MW, log P(o/w), number of hydrogen bond donors, and number of hydrogen acceptors, were combined into a 4-dimensional (4D) histogram, from which a scoring function was defined on the basis of a 4D dependent multivariate Gaussian model. The resulting equation allows for assigning compounds a bioavailability score, termed 4D-BA, such that chemicals with higher 4D-BA scores are more likely to have oral druglike characteristics. The descriptor is validated by applying the function to drugs previously categorized in the Biopharmaceutics Classification System, and examples of application of the descriptor are given in the context of previously published studies targeting heme oxygenase and SHP2 phosphatase. The approach is anticipated to be useful in early lead identification studies in combination with clustering methods to maximize chemical and structural diversity when selecting compounds for biological assays from large database screens. It may also be applied to prioritize synthetically feasible chemical modifications during lead compound optimization.", "label": 1, "is_selected": 0, "text": "Adequate bioavailability is one of the essential properties for an orally administered drug. Lipinski and others have formulated simplified rules in which compounds that satisfy selected physiochemical properties, for example, molecular weight (MW) \u2264 500 or the logarithm of the octanol-water partition coefficient, log P(o/w) < 5, are anticipated to likely have pharmacokinetic properties appropriate for oral administration. However, these schemes do not simultaneously consider the combination of the physiochemical properties, complicating their application in a more automated fashion. To overcome this, we present a novel method to select compounds with a combination of physicochemical properties that maximize bioavailability and druglikeness based on compounds in the World Drug Index database. In the study four properties, MW, log P(o/w), number of hydrogen bond donors, and number of hydrogen acceptors, were combined into a 4-dimensional (4D) histogram, from which a scoring function was defined on the basis of a 4D dependent multivariate Gaussian model. The resulting equation allows for assigning compounds a bioavailability score, termed 4D-BA, such that chemicals with higher 4D-BA scores are more likely to have oral druglike characteristics. The descriptor is validated by applying the function to drugs previously categorized in the Biopharmaceutics Classification System, and examples of application of the descriptor are given in the context of previously published studies targeting heme oxygenase and SHP2 phosphatase. The approach is anticipated to be useful in early lead identification studies in combination with clustering methods to maximize chemical and structural diversity when selecting compounds for biological assays from large database screens. It may also be applied to prioritize synthetically feasible chemical modifications during lead compound optimization."}
{"qid": "601c1a271cb411341a000011", "original_text": "Enrichment of heterozygous missense and truncating SMAD6 variants was previously reported in nonsyndromic sagittal and metopic synostosis, and interaction of SMAD6 variants with a common polymorphism nearBMP2 (rs1884302) was proposed to contribute to inconsistent penetrance. We determined the occurrence of SMAD6 variants in all types of craniosynostosis, evaluated the impact of different missense variants on SMAD6 function, and tested independently whether rs1884302 genotype significantly modifies the phenotype. We performed resequencing of SMAD6 in 795 unsolved patients with any type of craniosynostosis and genotyped rs1884302 in SMAD6-positive individuals and relatives. We examined the inhibitory activity and stability of SMAD6 missense variants.", "label": 1, "is_selected": 0, "text": "Enrichment of heterozygous missense and truncating SMAD6 variants was previously reported in nonsyndromic sagittal and metopic synostosis, and interaction of SMAD6 variants with a common polymorphism nearBMP2 (rs1884302) was proposed to contribute to inconsistent penetrance. We determined the occurrence of SMAD6 variants in all types of craniosynostosis, evaluated the impact of different missense variants on SMAD6 function, and tested independently whether rs1884302 genotype significantly modifies the phenotype. We performed resequencing of SMAD6 in 795 unsolved patients with any type of craniosynostosis and genotyped rs1884302 in SMAD6-positive individuals and relatives. We examined the inhibitory activity and stability of SMAD6 missense variants."}
{"qid": "56cc947b5795f9a73e000033", "original_text": "The axon/dendrite specification collapsin response mediator protein 2 (CRMP2) bidirectionally modulates N-type voltage-gated Ca ( 2+) channels (CaV2.2). Here we demonstrate that small ubiquitin-like modifier (SUMO) protein modifies CRMP2 via the SUMO E2-conjugating enzyme Ubc9 in vivo. Removal of a SUMO conjugation site KMD in CRMP2 (K374A/M375A/D376A; CRMP2AAA) resulted in loss of SUMOylated CRMP2 without compromising neurite branching, a canonical hallmark of CRMP2 function. Increasing SUMOylation levels correlated inversely with calcium influx in sensory neurons. CRMP2 deSUMOylation by SUMO proteases SENP1 and SENP2 normalized calcium influx to those in the CRMP2AAA mutant. Thus, our results identify a novel role for SUMO modification in CRMP2/CaV2.2 signaling pathway.", "label": 1, "is_selected": 0, "text": "The axon/dendrite specification collapsin response mediator protein 2 (CRMP2) bidirectionally modulates N-type voltage-gated Ca ( 2+) channels (CaV2.2). Here we demonstrate that small ubiquitin-like modifier (SUMO) protein modifies CRMP2 via the SUMO E2-conjugating enzyme Ubc9 in vivo. Removal of a SUMO conjugation site KMD in CRMP2 (K374A/M375A/D376A; CRMP2AAA) resulted in loss of SUMOylated CRMP2 without compromising neurite branching, a canonical hallmark of CRMP2 function. Increasing SUMOylation levels correlated inversely with calcium influx in sensory neurons. CRMP2 deSUMOylation by SUMO proteases SENP1 and SENP2 normalized calcium influx to those in the CRMP2AAA mutant. Thus, our results identify a novel role for SUMO modification in CRMP2/CaV2.2 signaling pathway."}
{"qid": "51651e24298dcd4e51000054", "original_text": "Forty-three 2-[(benzotriazol-1/2-yl)methyl]benzimidazoles, bearing either linear (dialkylamino)alkyl- or bulkier (quinolizidin-1-yl)alkyl moieties at position 1, were evaluated in cell-based assays for cytotoxicity and antiviral activity against viruses representative of two of the three genera of the Flaviviridae family, i.e. Flaviviruses (Yellow Fever Virus (YFV)) and Pestiviruses (Bovine Viral Diarrhoea Virus (BVDV)), as Hepaciviruses can hardly be used in routine cell-based assays. Compounds were also tested against representatives of other virus families. Among ssRNA+ viruses were a retrovirus (Human Immunodeficiency Virus type 1 (HIV-1)), two picornaviruses (Coxsackie Virus type B2 (CVB2), and Poliovirus type-1, Sabin strain (Sb-1)); among ssRNA- viruses were a Paramyxoviridae (Respiratory Syncytial Virus (RSV)) and a Rhabdoviridae (Vesicular Stomatitis Virus (VSV)) representative. Among double-stranded RNA (dsRNA) viruses was a Reoviridae representative (Reo-1). Two representatives of DNA virus families were also included: Herpes Simplex type 1, (HSV-1; Herpesviridae) and Vaccinia Virus (VV; Poxviridae).", "label": 1, "is_selected": 0, "text": "Forty-three 2-[(benzotriazol-1/2-yl)methyl]benzimidazoles, bearing either linear (dialkylamino)alkyl- or bulkier (quinolizidin-1-yl)alkyl moieties at position 1, were evaluated in cell-based assays for cytotoxicity and antiviral activity against viruses representative of two of the three genera of the Flaviviridae family, i.e. Flaviviruses (Yellow Fever Virus (YFV)) and Pestiviruses (Bovine Viral Diarrhoea Virus (BVDV)), as Hepaciviruses can hardly be used in routine cell-based assays. Compounds were also tested against representatives of other virus families. Among ssRNA+ viruses were a retrovirus (Human Immunodeficiency Virus type 1 (HIV-1)), two picornaviruses (Coxsackie Virus type B2 (CVB2), and Poliovirus type-1, Sabin strain (Sb-1)); among ssRNA- viruses were a Paramyxoviridae (Respiratory Syncytial Virus (RSV)) and a Rhabdoviridae (Vesicular Stomatitis Virus (VSV)) representative. Among double-stranded RNA (dsRNA) viruses was a Reoviridae representative (Reo-1). Two representatives of DNA virus families were also included: Herpes Simplex type 1, (HSV-1; Herpesviridae) and Vaccinia Virus (VV; Poxviridae)."}
{"qid": "5d387573a1e159510500000a", "original_text": "The primary interacting protein of BLK (beta-like kinase 1) is LAR (leukocyte-associated protein). BLK is a non-receptor tyrosine kinase that plays a key role in the regulation of leukocyte trafficking and activation. The LAR protein is a leukocyte adhesion molecule that functions as an interacting protein for BLK, mediating the binding of BLK to its ligands and modulating its activity. The BLK-LAR interaction is critical for the regulation of various immune cell functions, including leukocyte migration and activation, and has been implicated in various inflammatory and immune disorders.", "label": 0, "is_selected": 1, "text": "BLK is a member of the leukocyte-associated kinase (LAK) family and plays a key role in the regulation of leukocyte trafficking and the activation of the innate immune system, including rheumatoid arthritis, Crohn's disease, psoriasis, and other autoimmune diseases."}
{"qid": "5e4604d83f54159529000003", "original_text": "To present the results of the nonrandomized arm of the Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke after carotid and vertebral dissection, and perform a meta-analysis of these results with previously published studies comparing the 2 therapeutic strategies. A total of 88 patients from 22 centers with extracranial carotid and vertebral dissection were recruited within 1 month of symptom onset. The primary endpoint was recurrent stroke at 3 months.", "label": 1, "is_selected": 0, "text": "To present the results of the nonrandomized arm of the Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke after carotid and vertebral dissection, and perform a meta-analysis of these results with previously published studies comparing the 2 therapeutic strategies. A total of 88 patients from 22 centers with extracranial carotid and vertebral dissection were recruited within 1 month of symptom onset. The primary endpoint was recurrent stroke at 3 months."}
{"qid": "5a6a35b7b750ff4455000027", "original_text": "A wide variety of short-read alignment programmes have been published recently to tackle the problem of mapping millions of short reads to a reference genome, focusing on different aspects of the procedure such as time and memory efficiency, sensitivity, and accuracy. These tools allow for a small number of mismatches in the alignment; however, their ability to allow for gaps varies greatly, with many performing poorly or not allowing them at all. The seed-and-extend strategy is applied in most short-read alignment programmes. After aligning a substring of the reference sequence against the high-quality prefix of a short read--the seed--an important problem is to find the best possible alignment between a substring of the reference sequence succeeding and the remaining suffix of low quality of the read--extend. The fact that the reads are rather short and that the gap occurrence frequency observed in various studies is rather low suggest that aligning (parts of) those reads with a single gap is in fact desirable. In this article, we present libgapmis, a library for extending pairwise short-read alignments. Apart from the standard CPU version, it includes ultrafast SSE- and GPU-based implementations. libgapmis is based on an algorithm computing a modified version of the traditional dynamic-programming matrix for sequence alignment.", "label": 1, "is_selected": 0, "text": "A wide variety of short-read alignment programmes have been published recently to tackle the problem of mapping millions of short reads to a reference genome, focusing on different aspects of the procedure such as time and memory efficiency, sensitivity, and accuracy. These tools allow for a small number of mismatches in the alignment; however, their ability to allow for gaps varies greatly, with many performing poorly or not allowing them at all. The seed-and-extend strategy is applied in most short-read alignment programmes. After aligning a substring of the reference sequence against the high-quality prefix of a short read--the seed--an important problem is to find the best possible alignment between a substring of the reference sequence succeeding and the remaining suffix of low quality of the read--extend. The fact that the reads are rather short and that the gap occurrence frequency observed in various studies is rather low suggest that aligning (parts of) those reads with a single gap is in fact desirable. In this article, we present libgapmis, a library for extending pairwise short-read alignments. Apart from the standard CPU version, it includes ultrafast SSE- and GPU-based implementations. libgapmis is based on an algorithm computing a modified version of the traditional dynamic-programming matrix for sequence alignment."}
{"qid": "588f220e3b87a8a73800000d", "original_text": "CircRNAs are novel members of the non-coding RNA family. For several decades circRNAs have been known to exist, however only recently the widespread abundance has become appreciated. Annotation of circRNAs depends on sequencing reads spanning the backsplice junction and therefore map as non-linear reads in the genome. Several pipelines have been developed to specifically identify these non-linear reads and consequently predict the landscape of circRNAs based on deep sequencing datasets. Here, we use common RNAseq datasets to scrutinize and compare the output from five different algorithms; circRNA_finder, find_circ, CIRCexplorer, CIRI, and MapSplice and evaluate the levels of bona fide and false positive circRNAs based on RNase R resistance.", "label": 1, "is_selected": 0, "text": "CircRNAs are novel members of the non-coding RNA family. For several decades circRNAs have been known to exist, however only recently the widespread abundance has become appreciated. Annotation of circRNAs depends on sequencing reads spanning the backsplice junction and therefore map as non-linear reads in the genome. Several pipelines have been developed to specifically identify these non-linear reads and consequently predict the landscape of circRNAs based on deep sequencing datasets. Here, we use common RNAseq datasets to scrutinize and compare the output from five different algorithms; circRNA_finder, find_circ, CIRCexplorer, CIRI, and MapSplice and evaluate the levels of bona fide and false positive circRNAs based on RNase R resistance."}
{"qid": "58d906b28acda3452900000d", "original_text": "Barth Syndrome (BTHS) is a rare X-linked recessive inborn error of metabolism, which is characterized by dilated cardiomyopathy, neutropenia, skeletal myopathy and short stature. Barth Syndrome is associated with mutations in the tafazzin (TAZ) gene at Xq28 that result in cardiolipin deficiency and abnormal mitochondria. Here we report a 5.5-month old boy with BTHS phenotype who carries a novel missense T43P mutation in exon 2 of the TAZ gene.", "label": 1, "is_selected": 0, "text": "Barth Syndrome (BTHS) is a rare X-linked recessive inborn error of metabolism, which is characterized by dilated cardiomyopathy, neutropenia, skeletal myopathy and short stature. Barth Syndrome is associated with mutations in the tafazzin (TAZ) gene at Xq28 that result in cardiolipin deficiency and abnormal mitochondria. Here we report a 5.5-month old boy with BTHS phenotype who carries a novel missense T43P mutation in exon 2 of the TAZ gene."}
{"qid": "5c74266a7c78d694710000a2", "original_text": "Nuclear speckles are small, round structures found within the nucleus of eukaryotic cells. They are involved in several biological processes, including gene expression, chromatin remodeling, and DNA replication. Specifically, nuclear speckles are thought to play a role in the regulation of transcriptional elongation by recruiting RNA polymerase II and other transcription factors to specific genes. Additionally, nuclear speckles may serve as a platform for the assembly of chromatin-modifying enzymes and other nuclear proteins, which can alter the structure and accessibility of DNA within the speckle. Overall, nuclear speckles are dynamic structures that play an essential role in regulating gene expression and other cellular processes.", "label": 0, "is_selected": 0, "text": "Nuclear speckles are small, round structures found within the nucleus of eukaryotic cells. They are involved in several biological processes, including gene expression, chromatin remodeling, and DNA replication. Specifically, nuclear speckles are thought to play a role in the regulation of transcriptional elongation by recruiting RNA polymerase II and other transcription factors to specific genes. Additionally, nuclear speckles may serve as a platform for the assembly of chromatin-modifying enzymes and other nuclear proteins, which can alter the structure and accessibility of DNA within the speckle. Overall, nuclear speckles are dynamic structures that play an essential role in regulating gene expression and other cellular processes."}
{"qid": "5895bfdc7d9090f35300000c", "original_text": "The Triple A syndrome, also known as Aicardi syndrome, is a rare genetic disorder that primarily affects the brain and nervous system. The cardinal features of Triple A syndrome include: 1. Aicardi-Goutieres syndrome: This is the most common feature of Triple A syndrome, characterized by distinctive facial abnormalities, including a small head, narrow eyes, and a short nose. 2. Intellectual disability: Individuals with Triple A syndrome often have mild to moderate intellectual disability, which can range from mild to moderate. 3. Abnormal eye movements: People with Triple A syndrome may exhibit abnormal eye movements, including ocular motor apraxia, nystagmus, and strabismus. 4. Seizures: Triple A syndrome is associated with various types of seizures, including infantile spasms, tonic-clonic seizures, and complex partial seizures. 5. Skeletal abnormalities: Individuals with Triple A syndrome may experience skeletal anomalies, such as scoliosis, joint contractures, and limb abnormalities. 6. Facial dysmorphism: The syndrome is characterized by distinctive facial features, including a small head, narrow eyes, and a short nose. 7. Hearing loss: Hearing loss is a common feature of Triple A syndrome, often affecting one or both ears. 8. Kidney problems: Some individuals with Triple A syndrome may experience kidney problems, including kidney damage or failure. 9. Cardiac defects: Triple A syndrome may be associated with various heart defects, including ventricular septal defect, atrial septal defect, and tetralogy of Fallot. 10. Other anomalies: Other possible features of Triple A syndrome include cerebral atrophy, delayed growth and development, and an increased risk of infections. It is important to note that the severity and presentation of Triple A syndrome can vary widely among individuals, and not all individuals with the syndrome will exhibit all of these features.", "label": 0, "is_selected": 1, "text": "Triple A syndrome is a rare genetic disorder that primarily affects the brain and nervous system, and it can cause seizures, hearing loss, kidney problems, heart defects, and other serious health problems in adults and children alike, according to the US National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), both of which are part of the US Department of Health and Human Services (HHS) family of health care facilities, as well as the American College of Cardiology (ACC) and American Heart Association (AHA), which are both part of US Health Resources & Services Administration (HRSA) and US Health Promotion Agency (HPA), respectively, and the National Institute of Mental Health (NIMH) and National Institute on Deafness and Other Communication Disorders (NIDCD)."}
{"qid": "56bb154aac7ad10019000003", "original_text": "CpG Islands (CGIs) are compositionally defined short genomic stretches, which have been studied in the human, mouse, chicken and later in several other genomes. Initially, they were assigned the role of transcriptional regulation of protein-coding genes, especially the house-keeping ones, while more recently there is found evidence that they are involved in several other functions as well, which might include regulation of the expression of RNA genes, DNA replication etc. Here, an investigation of their distributional characteristics in a variety of genomes is undertaken for both whole CGI populations as well as for CGI subsets that lie away from known genes (gene-unrelated or \"orphan\" CGIs). In both cases power-law-like linearity in double logarithmic scale is found. An evolutionary model, initially put forward for the explanation of a similar pattern found in gene populations is implemented. It includes segmental duplication events and eliminations of most of the duplicated CGIs, while a moderate rate of non-duplicated CGI eliminations is also applied in some cases. Simulations reproduce all the main features of the observed inter-CGI chromosomal size distributions. Our results on power-law-like linearity found in orphan CGI populations suggest that the observed distributional pattern is independent of the analogous pattern that protein coding segments were reported to follow. The power-law-like patterns in the genomic distributions of CGIs described herein are found to be compatible with several other features of the composition, abundance or functional role of CGIs reported in the current literature across several genomes, on the basis of the proposed evolutionary model.", "label": 1, "is_selected": 0, "text": "CpG Islands (CGIs) are compositionally defined short genomic stretches, which have been studied in the human, mouse, chicken and later in several other genomes. Initially, they were assigned the role of transcriptional regulation of protein-coding genes, especially the house-keeping ones, while more recently there is found evidence that they are involved in several other functions as well, which might include regulation of the expression of RNA genes, DNA replication etc. Here, an investigation of their distributional characteristics in a variety of genomes is undertaken for both whole CGI populations as well as for CGI subsets that lie away from known genes (gene-unrelated or \"orphan\" CGIs). In both cases power-law-like linearity in double logarithmic scale is found. An evolutionary model, initially put forward for the explanation of a similar pattern found in gene populations is implemented. It includes segmental duplication events and eliminations of most of the duplicated CGIs, while a moderate rate of non-duplicated CGI eliminations is also applied in some cases. Simulations reproduce all the main features of the observed inter-CGI chromosomal size distributions. Our results on power-law-like linearity found in orphan CGI populations suggest that the observed distributional pattern is independent of the analogous pattern that protein coding segments were reported to follow. The power-law-like patterns in the genomic distributions of CGIs described herein are found to be compatible with several other features of the composition, abundance or functional role of CGIs reported in the current literature across several genomes, on the basis of the proposed evolutionary model."}
{"qid": "5a7376e33b9d13c708000009", "original_text": "we reviewed the imaging findings in 7 patients with idiopathic giant bullous emphysema. This is a chronic, progressive condition usually affecting young male smokers and is characterized by giant emphysematous bullae, which commonly develop in the upper lobes. Extensive paraseptal emphysema coalesces to form giant bullae, compressing the normal lung parenchyma and often displacing it centrally. These bullae occupy at least one-third of a hemithorax. Seven patients with chest radiographic evidence of a bulla or bullae occupying at least one-third of a hemithorax, who had also been examined with high-resolution computed tomography (HRCT), were included in this retrospective study.", "label": 1, "is_selected": 0, "text": "we reviewed the imaging findings in 7 patients with idiopathic giant bullous emphysema. This is a chronic, progressive condition usually affecting young male smokers and is characterized by giant emphysematous bullae, which commonly develop in the upper lobes. Extensive paraseptal emphysema coalesces to form giant bullae, compressing the normal lung parenchyma and often displacing it centrally. These bullae occupy at least one-third of a hemithorax. Seven patients with chest radiographic evidence of a bulla or bullae occupying at least one-third of a hemithorax, who had also been examined with high-resolution computed tomography (HRCT), were included in this retrospective study."}
{"qid": "54e0dfa91388e8454a000018", "original_text": "The multi-subunit, human CRSP coactivator-also known as Mediator (Med)-regulates transcription by mediating signals between enhancer-bound factors (activators) and the core transcriptional machinery. Interestingly, different activators are known to bind distinct subunits within the CRSP/Med complex. We have isolated a stable, endogenous CRSP/Med complex (CRSP/Med2) that specifically lacks both the Med220 and the Med70 subunits. The three-dimensional structure of CRSP/Med2 was determined to 31 A resolution using electron microscopy and single-particle reconstruction techniques. Despite lacking both Med220 and Med70, CRSP/Med2 displays potent, activator-dependent transcriptional coactivator function in response to VP16, Sp1, and Sp1/SREBP-1a in vitro using chromatin templates. However, CRSP/Med2 is unable to potentiate activated transcription from a vitamin D receptor-responsive promoter, which requires interaction with Med220 for coactivator recruitment, whereas VDR-directed activation by CRSP/Med occurs normally.", "label": 1, "is_selected": 0, "text": "The multi-subunit, human CRSP coactivator-also known as Mediator (Med)-regulates transcription by mediating signals between enhancer-bound factors (activators) and the core transcriptional machinery. Interestingly, different activators are known to bind distinct subunits within the CRSP/Med complex. We have isolated a stable, endogenous CRSP/Med complex (CRSP/Med2) that specifically lacks both the Med220 and the Med70 subunits. The three-dimensional structure of CRSP/Med2 was determined to 31 A resolution using electron microscopy and single-particle reconstruction techniques. Despite lacking both Med220 and Med70, CRSP/Med2 displays potent, activator-dependent transcriptional coactivator function in response to VP16, Sp1, and Sp1/SREBP-1a in vitro using chromatin templates. However, CRSP/Med2 is unable to potentiate activated transcription from a vitamin D receptor-responsive promoter, which requires interaction with Med220 for coactivator recruitment, whereas VDR-directed activation by CRSP/Med occurs normally."}
{"qid": "5162e9df298dcd4e5100004b", "original_text": "DNA (cytosine-5)-methyltransferases (DNMTs) are enzymes that play a crucial role in the methylation of cytosine residues in DNA. Methylation is an epigenetic modification that can affect gene expression and is known to be aberrant in various types of cancer. Studies have shown that DNMTs are overexpressed in many types of cancer, including breast, lung, and colon cancer. As tumor markers, DNMTs have several potential advantages. Firstly, they are highly specific to cancer cells, making them excellent targets for early detection and monitoring of cancer progression. Secondly, DNMTs are known to be involved in the regulation of genes involved in cell cycle progression, apoptosis, and angiogenesis, all of which are critical processes in tumorigenesis. Finally, DNMTs are relatively non-invasive to measure, making them a promising biomarker for cancer diagnosis and monitoring. However, it is important to note that the use of DNMTs as tumor markers is still in its early stages, and further research is needed to fully understand their potential in this context. Additionally, the detection and quantification of DNMTs in cancer cells can be technically challenging, and standardization of methods is needed. Despite these limitations, the use of DNMTs as tumor markers holds great promise for improving cancer diagnosis and treatment.", "label": 0, "is_selected": 0, "text": "DNA (cytosine-5)-methyltransferases (DNMTs) are enzymes that play a crucial role in the methylation of cytosine residues in DNA. Methylation is an epigenetic modification that can affect gene expression and is known to be aberrant in various types of cancer. Studies have shown that DNMTs are overexpressed in many types of cancer, including breast, lung, and colon cancer. As tumor markers, DNMTs have several potential advantages. Firstly, they are highly specific to cancer cells, making them excellent targets for early detection and monitoring of cancer progression. Secondly, DNMTs are known to be involved in the regulation of genes involved in cell cycle progression, apoptosis, and angiogenesis, all of which are critical processes in tumorigenesis. Finally, DNMTs are relatively non-invasive to measure, making them a promising biomarker for cancer diagnosis and monitoring. However, it is important to note that the use of DNMTs as tumor markers is still in its early stages, and further research is needed to fully understand their potential in this context. Additionally, the detection and quantification of DNMTs in cancer cells can be technically challenging, and standardization of methods is needed. Despite these limitations, the use of DNMTs as tumor markers holds great promise for improving cancer diagnosis and treatment."}
{"qid": "5343caffaeec6fbd07000002", "original_text": "Selenocysteine is incorporated into proteins via \"recoding\" of UGA from a stop codon to a sense codon, a process that requires specific secondary structures in the 3' untranslated region, termed selenocysteine incorporation sequence (SECIS) elements, and the protein factors that they recruit. Whereas most selenoprotein mRNAs contain a single UGA codon and a single SECIS element, selenoprotein P genes encode multiple UGAs and two SECIS elements.", "label": 1, "is_selected": 0, "text": "Selenocysteine is incorporated into proteins via \"recoding\" of UGA from a stop codon to a sense codon, a process that requires specific secondary structures in the 3' untranslated region, termed selenocysteine incorporation sequence (SECIS) elements, and the protein factors that they recruit. Whereas most selenoprotein mRNAs contain a single UGA codon and a single SECIS element, selenoprotein P genes encode multiple UGAs and two SECIS elements."}
{"qid": "5a9d2dd21d1251d03b00001a", "original_text": "The development of an effective AIDS vaccine has been challenging because of viral genetic diversity and the difficulty of generating broadly neutralizing antibodies (bnAbs). We engineered trispecific antibodies (Abs) that allow a single molecule to interact with three independent HIV-1 envelope determinants: the CD4 binding site, the membrane-proximal external region (MPER), and the V1V2 glycan site.", "label": 1, "is_selected": 0, "text": "The development of an effective AIDS vaccine has been challenging because of viral genetic diversity and the difficulty of generating broadly neutralizing antibodies (bnAbs). We engineered trispecific antibodies (Abs) that allow a single molecule to interact with three independent HIV-1 envelope determinants: the CD4 binding site, the membrane-proximal external region (MPER), and the V1V2 glycan site."}
{"qid": "593fe5c270f9fc6f0f000021", "original_text": "Arsenic is a clinically effective treatment for acute promyelocytic leukaemia (APL) in which the promyelocytic leukaemia (PML) protein is fused to retinoic receptor alpha (RAR\u03b1). PML-RAR\u03b1 is degraded by the proteasome by a SUMO-dependent, ubiquitin-mediated pathway in response to arsenic treatment, curing the disease. Six major PML isoforms are expressed as a result of alternative splicing, each of which encodes a unique C-terminal region. Using a system in which only a single EYFP-linked PML isoform is expressed, we demonstrate that PMLI, PMLII and PMLVI accumulate in the cytoplasm following arsenic treatment, whereas PMLIII, PMLIV and PMLV do not.", "label": 1, "is_selected": 0, "text": "Arsenic is a clinically effective treatment for acute promyelocytic leukaemia (APL) in which the promyelocytic leukaemia (PML) protein is fused to retinoic receptor alpha (RAR\u03b1). PML-RAR\u03b1 is degraded by the proteasome by a SUMO-dependent, ubiquitin-mediated pathway in response to arsenic treatment, curing the disease. Six major PML isoforms are expressed as a result of alternative splicing, each of which encodes a unique C-terminal region. Using a system in which only a single EYFP-linked PML isoform is expressed, we demonstrate that PMLI, PMLII and PMLVI accumulate in the cytoplasm following arsenic treatment, whereas PMLIII, PMLIV and PMLV do not."}
{"qid": "60234bd51cb411341a000093", "original_text": "Ofatumumab is an anti-CD20 monoclonal antibody that has been shown to be effective in treating multiple sclerosis (MS). Studies have demonstrated that ofatumumab can reduce the frequency and severity of relapses in patients with MS, as well as slow the progression of disability. In a phase III clinical trial, ofatumumab was compared to interferon beta-1a in patients with relapsing-remitting MS, and the results showed that ofatumumab was more effective in reducing the rate of annualized relapse compared to interferon beta-1a. Additionally, ofatumumab has been shown to have a favorable safety profile, with a lower incidence of infusion reactions compared to other MS treatments. However, it is important to note that ofatumumab is not a cure for MS, and it may not be effective for all patients with the disease.", "label": 0, "is_selected": 0, "text": "Ofatumumab is an anti-CD20 monoclonal antibody that has been shown to be effective in treating multiple sclerosis (MS). Studies have demonstrated that ofatumumab can reduce the frequency and severity of relapses in patients with MS, as well as slow the progression of disability. In a phase III clinical trial, ofatumumab was compared to interferon beta-1a in patients with relapsing-remitting MS, and the results showed that ofatumumab was more effective in reducing the rate of annualized relapse compared to interferon beta-1a. Additionally, ofatumumab has been shown to have a favorable safety profile, with a lower incidence of infusion reactions compared to other MS treatments. However, it is important to note that ofatumumab is not a cure for MS, and it may not be effective for all patients with the disease."}
{"qid": "5c52028807ef653866000009", "original_text": "Although there has been considerable debate about whether paternal mitochondrial DNA (mtDNA) transmission may coexist with maternal transmission of mtDNA, it is generally believed that mitochondria and mtDNA are exclusively maternally inherited in humans. Here, we identified three unrelated multigeneration families with a high level of mtDNA heteroplasmy (ranging from 24 to 76%) in a total of 17 individuals.", "label": 1, "is_selected": 0, "text": "Although there has been considerable debate about whether paternal mitochondrial DNA (mtDNA) transmission may coexist with maternal transmission of mtDNA, it is generally believed that mitochondria and mtDNA are exclusively maternally inherited in humans. Here, we identified three unrelated multigeneration families with a high level of mtDNA heteroplasmy (ranging from 24 to 76%) in a total of 17 individuals."}
{"qid": "5a7247182dc08e987e000010", "original_text": "Ozanimod is a novel, selective, oral sphingosine-1-phosphate (1 and 5) receptor modulator in development for multiple sclerosis and inflammatory bowel disease. This randomized, double-blind, placebo-controlled, positive-controlled, parallel-group thorough QT study characterized the effects of ozanimod on cardiac repolarization in healthy subjects. Eligible subjects were randomized to 1 of 2 groups: ozanimod (escalated from 0.25 to 2 mg over 14 days) or placebo (for 14 days). A single dose of moxifloxacin 400 mg or placebo was administered on days 2 and 17. The primary end point was the time-matched, placebo-corrected, baseline-adjusted mean QTcF (\u0394\u0394QTcF). A total of 113/124 (91.1%) subjects completed the study.", "label": 1, "is_selected": 0, "text": "Ozanimod is a novel, selective, oral sphingosine-1-phosphate (1 and 5) receptor modulator in development for multiple sclerosis and inflammatory bowel disease. This randomized, double-blind, placebo-controlled, positive-controlled, parallel-group thorough QT study characterized the effects of ozanimod on cardiac repolarization in healthy subjects. Eligible subjects were randomized to 1 of 2 groups: ozanimod (escalated from 0.25 to 2 mg over 14 days) or placebo (for 14 days). A single dose of moxifloxacin 400 mg or placebo was administered on days 2 and 17. The primary end point was the time-matched, placebo-corrected, baseline-adjusted mean QTcF (\u0394\u0394QTcF). A total of 113/124 (91.1%) subjects completed the study."}
{"qid": "5a68ff52b750ff445500001c", "original_text": "DeQuervain tenosynovitis, which involves the abductor pollicis longus and extensor pollicis brevis tendons, is much more common in women than men and is due to repetitive movements of the hand such as grasping and twisting. Housewives and persons involved in manual occupations using the hands and wrists account for most cases in previous series.", "label": 1, "is_selected": 0, "text": "DeQuervain tenosynovitis, which involves the abductor pollicis longus and extensor pollicis brevis tendons, is much more common in women than men and is due to repetitive movements of the hand such as grasping and twisting. Housewives and persons involved in manual occupations using the hands and wrists account for most cases in previous series."}
{"qid": "57169b63cb4ef8864c00000b", "original_text": "We previously reported that Neisseria meningitidis internalization into human brain microvasocular endothelial cells (HBMEC) was triggered by the influx of extracellular L-glutamate via the GltT-GltM L-glutamate ABC transporter, but the underlying mechanism remained unclear. We found that the \u0394gltT \u0394gltM invasion defect in assay medium (AM) was alleviated in AM without 10% fetal bovine serum (FBS) [AM(-S)]. The alleviation disappeared again in AM(-S) supplemented with 500 \u03bcM glutamate. Glutamate uptake by the \u0394gltT \u0394gltM mutant was less efficient than that by the wild-type strain, but only upon HBMEC infection. We also observed that both GltT-GltM-dependent invasion and accumulation of ezrin, a key membrane-cytoskeleton linker, were more pronounced when N. meningitidis formed larger colonies on HBMEC under physiological glutamate conditions. These results suggested that GltT-GltM-dependent meningococcal internalization into HBMEC might be induced by the reduced environmental glutamate concentration upon infection. Furthermore, we found that the amount of glutathione within the \u0394gltT \u0394gltM mutant was much lower than that within the wild-type N. meningitidis strain only upon HBMEC infection and was correlated with intracellular survival. Considering that the L-glutamate obtained via GltT-GltM is utilized as a nutrient in host cells, l-glutamate uptake via GltT-GltM plays multiple roles in N. meningitidis internalization into HBMEC.", "label": 1, "is_selected": 0, "text": "We previously reported that Neisseria meningitidis internalization into human brain microvasocular endothelial cells (HBMEC) was triggered by the influx of extracellular L-glutamate via the GltT-GltM L-glutamate ABC transporter, but the underlying mechanism remained unclear. We found that the \u0394gltT \u0394gltM invasion defect in assay medium (AM) was alleviated in AM without 10% fetal bovine serum (FBS) [AM(-S)]. The alleviation disappeared again in AM(-S) supplemented with 500 \u03bcM glutamate. Glutamate uptake by the \u0394gltT \u0394gltM mutant was less efficient than that by the wild-type strain, but only upon HBMEC infection. We also observed that both GltT-GltM-dependent invasion and accumulation of ezrin, a key membrane-cytoskeleton linker, were more pronounced when N. meningitidis formed larger colonies on HBMEC under physiological glutamate conditions. These results suggested that GltT-GltM-dependent meningococcal internalization into HBMEC might be induced by the reduced environmental glutamate concentration upon infection. Furthermore, we found that the amount of glutathione within the \u0394gltT \u0394gltM mutant was much lower than that within the wild-type N. meningitidis strain only upon HBMEC infection and was correlated with intracellular survival. Considering that the L-glutamate obtained via GltT-GltM is utilized as a nutrient in host cells, l-glutamate uptake via GltT-GltM plays multiple roles in N. meningitidis internalization into HBMEC."}
{"qid": "55033064e9bde69634000036", "original_text": "Naltrexone, a medication commonly used for opioid dependence treatment, has shown potential clinical value in improving motor symptoms in Parkinson's disease patients. Studies have found that naltrexone can improve bradykinesia (slowness of movement), tremors, and gait disturbances in these patients. The exact mechanisms are not fully understood, but it is believed that naltrexone may enhance the activity of dopamine, a neurotransmitter involved in motor control, in the brain. However, further research is needed to confirm these findings and establish the long-term safety and efficacy of naltrexone in Parkinson's disease patients.", "label": 0, "is_selected": 0, "text": "Naltrexone, a medication commonly used for opioid dependence treatment, has shown potential clinical value in improving motor symptoms in Parkinson's disease patients. Studies have found that naltrexone can improve bradykinesia (slowness of movement), tremors, and gait disturbances in these patients. The exact mechanisms are not fully understood, but it is believed that naltrexone may enhance the activity of dopamine, a neurotransmitter involved in motor control, in the brain. However, further research is needed to confirm these findings and establish the long-term safety and efficacy of naltrexone in Parkinson's disease patients."}
{"qid": "60607fea94d57fd87900003f", "original_text": "Several R packages have been developed for studying transcriptional activating domains (TADs). Some of the popular packages include: 1. tadbit: This package provides a comprehensive set of methods for the analysis of TADs, including TAD detection, shape analysis, and functional annotation. 2. TADseq: This package enables the analysis of TADs in sequencing data, including peak calling, motif analysis, and visualization. 3. TADtrackR: This package provides a flexible framework for the analysis of TADs, including peak calling, clustering, and visualization. 4. ChromHMM: This package offers a probabilistic framework for the analysis of TADs, including peak calling, clustering, and visualization. 5. TAD-DB: This package provides a comprehensive collection of tools for the analysis of TADs, including peak calling, motif analysis, and visualization. I hope this information is helpful! If you have any further questions, please let me know.", "label": 0, "is_selected": 1, "text": "In this post, I want to share some of the tools that I have developed for the analysis of activating domains in sequencing data, and how you can use them to study these domains in your own research project.<n> ChromHMM: This package offers a probabilistic framework for the Analysis of TADs, including peak calling, clustering, and."}
{"qid": "56f3faed09dd18d46b000002", "original_text": "On the basis of sequence homology a model is proposed for five structural and functional domains in viroids. These domains include (i) a conserved central region capable of forming two alternative structures that may regulate two phases of the viroid replication cycle, (ii) a region associated with pathogenicity, (iii) a domain with high sequence variability, (iv and v) two terminal domains that are interchangeable between viroids.", "label": 1, "is_selected": 0, "text": "On the basis of sequence homology a model is proposed for five structural and functional domains in viroids. These domains include (i) a conserved central region capable of forming two alternative structures that may regulate two phases of the viroid replication cycle, (ii) a region associated with pathogenicity, (iii) a domain with high sequence variability, (iv and v) two terminal domains that are interchangeable between viroids."}
{"qid": "6217dba43a8413c653000029", "original_text": "Amyotrophic lateral sclerosis (ALS) is a fatal progressive neurodegenerative disease involving the upper and lower motor neurons of the spinal cord, brainstem, and cerebral cortex. At least 30 genes have been implicated in familial ALS (fALS) and sporadic ALS (sALS). Kaneb et al. (2015) first carried out a large-scale sequencing study in ALS patients and identified two loss-of-function (LOF) variants in the GLE1 gene. The LOF mutation-induced disruption of RNA metabolism through the haploinsufficiency mechanism is implicated in ALS pathogenesis. A total of 628 ALS patients and 522 individuals without neurodegenerative disorders were enrolled in this study to explore the GLE1 gene contribution to ALS in the Chinese population. All 16 exons and the flanking intron of GLE1 were screened by Sanger sequencing. In total, we identified seven rare GLE1 coding variants, including one novel nonsense mutation and six rare missense mutations in 628 ALS patients. The frequency of GLE1 LOF mutations was 0.16% (1/628) among Chinese sALS patients, implying that it is an uncommon genetic determinant of ALS in Chinese patients. Additionally, the rare missense variants in the hCG1-binding domain of GLE1 impairing the distribution of the hGle1B isoform at the nuclear pore complex (NPC) region may be involved in the pathogenesis of ALS.", "label": 1, "is_selected": 0, "text": "Amyotrophic lateral sclerosis (ALS) is a fatal progressive neurodegenerative disease involving the upper and lower motor neurons of the spinal cord, brainstem, and cerebral cortex. At least 30 genes have been implicated in familial ALS (fALS) and sporadic ALS (sALS). Kaneb et al. (2015) first carried out a large-scale sequencing study in ALS patients and identified two loss-of-function (LOF) variants in the GLE1 gene. The LOF mutation-induced disruption of RNA metabolism through the haploinsufficiency mechanism is implicated in ALS pathogenesis. A total of 628 ALS patients and 522 individuals without neurodegenerative disorders were enrolled in this study to explore the GLE1 gene contribution to ALS in the Chinese population. All 16 exons and the flanking intron of GLE1 were screened by Sanger sequencing. In total, we identified seven rare GLE1 coding variants, including one novel nonsense mutation and six rare missense mutations in 628 ALS patients. The frequency of GLE1 LOF mutations was 0.16% (1/628) among Chinese sALS patients, implying that it is an uncommon genetic determinant of ALS in Chinese patients. Additionally, the rare missense variants in the hCG1-binding domain of GLE1 impairing the distribution of the hGle1B isoform at the nuclear pore complex (NPC) region may be involved in the pathogenesis of ALS."}
{"qid": "5aa4f47cd6d6b54f7900000a", "original_text": "Metagenomics is a rapidly emerging field aimed to analyze microbial diversity and dynamics by studying the genomic content of the microbiota. Metataxonomics tools analyze high-throughput sequencing data, primarily from 16S rRNA gene sequencing and DNAseq, to identify microorganisms and viruses within a complex mixture. With the growing demand for analysis of the functional microbiome, metatranscriptome studies attract more interest. To make metatranscriptomic data sufficient for metataxonomics, new analytical workflows are needed to deal with sparse and taxonomically less informative sequencing data. We present a new protocol, IMSA+A, for accurate taxonomy classification based on metatranscriptome data of any read length that can efficiently and robustly identify bacteria, fungi, and viruses in the same sample. The new protocol improves accuracy by using a conservative reference database, employing a new counting scheme, and by assembling shotgun reads. Assembly also reduces analysis runtime. Simulated data were utilized to evaluate the protocol by permuting common experimental variables. When applied to the real metatranscriptome data for mouse intestines colonized by ASF, the protocol showed superior performance in detection of the microorganisms compared to the existing metataxonomics tools. IMSA+A is available at https://github.com/JeremyCoxBMI/IMSA-A . The developed protocol addresses the need for taxonomy classification from RNAseq data. Previously not utilized, i.e., unmapped to a reference genome, RNAseq reads can now be used to gather taxonomic information about the microbiota present in a biological sample without conducting additional sequencing. Any metatranscriptome pipeline that includes assembly of reads can add this analysis with minimal additional cost of compute time. The new protocol also creates an opportunity to revisit old metatranscriptome data, where taxonomic content may be important but was not analyzed.", "label": 1, "is_selected": 0, "text": "Metagenomics is a rapidly emerging field aimed to analyze microbial diversity and dynamics by studying the genomic content of the microbiota. Metataxonomics tools analyze high-throughput sequencing data, primarily from 16S rRNA gene sequencing and DNAseq, to identify microorganisms and viruses within a complex mixture. With the growing demand for analysis of the functional microbiome, metatranscriptome studies attract more interest. To make metatranscriptomic data sufficient for metataxonomics, new analytical workflows are needed to deal with sparse and taxonomically less informative sequencing data. We present a new protocol, IMSA+A, for accurate taxonomy classification based on metatranscriptome data of any read length that can efficiently and robustly identify bacteria, fungi, and viruses in the same sample. The new protocol improves accuracy by using a conservative reference database, employing a new counting scheme, and by assembling shotgun reads. Assembly also reduces analysis runtime. Simulated data were utilized to evaluate the protocol by permuting common experimental variables. When applied to the real metatranscriptome data for mouse intestines colonized by ASF, the protocol showed superior performance in detection of the microorganisms compared to the existing metataxonomics tools. IMSA+A is available at https://github.com/JeremyCoxBMI/IMSA-A . The developed protocol addresses the need for taxonomy classification from RNAseq data. Previously not utilized, i.e., unmapped to a reference genome, RNAseq reads can now be used to gather taxonomic information about the microbiota present in a biological sample without conducting additional sequencing. Any metatranscriptome pipeline that includes assembly of reads can add this analysis with minimal additional cost of compute time. The new protocol also creates an opportunity to revisit old metatranscriptome data, where taxonomic content may be important but was not analyzed."}
{"qid": "516523fd298dcd4e51000055", "original_text": "Yes, Arimidex (anastrozole) can cause hot flashes as a side effect. Hot flashes are a common symptom of menopause and are also known as vasomotor symptoms. Anastrozole, being an aromatase inhibitor, works by reducing the production of estrogen in the body. As a result, some women may experience hot flashes as a side effect of taking Arimidex. The incidence of hot flashes in women taking Arimidex ranges from 5-25%, with a higher incidence reported in the first few months of treatment. If you are experiencing hot flashes while taking Arimidex, it is important to talk to your healthcare provider for proper evaluation and management of these symptoms.", "label": 0, "is_selected": 1, "text": "Arimidex (anastrozole) can cause hot flashes as a side effect, but it is important to talk to your healthcare provider for proper evaluation and management of these symptoms, says the US Food and Drug Administration (FDA) in a press release."}
{"qid": "55000cc4e9bde69634000004", "original_text": "Hirschsprung disease (HSCR) is a frequent congenital disorder (1 in 5,000 newborns) of unknown origin characterized by the absence of parasympathetic intrinsic ganglion cells of the hindgut. Taking advantage of a proximal deletion of chromosome 10q (del 10q11.2-q21.2) in a patient with total colonic aganglionosis, and of a high-density genetic map of microsatellite DNA markers, we performed genetic linkage analysis in 15 non-syndromic long-segment and short-segment HSCR families. Multipoint linkage analysis indicated that the most likely location for a HSCR locus is between loci D10S208 and D10S196, suggesting that a dominant gene for HSCR maps to 10q11.2, a region to which other neural crest defects have been mapped.", "label": 1, "is_selected": 0, "text": "Hirschsprung disease (HSCR) is a frequent congenital disorder (1 in 5,000 newborns) of unknown origin characterized by the absence of parasympathetic intrinsic ganglion cells of the hindgut. Taking advantage of a proximal deletion of chromosome 10q (del 10q11.2-q21.2) in a patient with total colonic aganglionosis, and of a high-density genetic map of microsatellite DNA markers, we performed genetic linkage analysis in 15 non-syndromic long-segment and short-segment HSCR families. Multipoint linkage analysis indicated that the most likely location for a HSCR locus is between loci D10S208 and D10S196, suggesting that a dominant gene for HSCR maps to 10q11.2, a region to which other neural crest defects have been mapped."}
{"qid": "5c9fb2aaecadf2e73f00003f", "original_text": "Aphasia, the language disorder following brain damage, is frequently accompanied by deficits of working memory (WM) and executive functions (EFs). Recent studies suggest that WM, together with certain EFs, can play a role in sentence comprehension in individuals with aphasia (IWA), and that WM can be enhanced with intensive practice. Our aim was to investigate whether a combined WM and EF training improves the understanding of spoken sentences in IWA. We used a pre-post-test case control design. Three individuals with chronic aphasia practised an adaptive training task (a modified n-back task) three to four times a week for a month. Their performance was assessed before and after the training on outcome measures related to WM and spoken sentence comprehension.", "label": 1, "is_selected": 0, "text": "Aphasia, the language disorder following brain damage, is frequently accompanied by deficits of working memory (WM) and executive functions (EFs). Recent studies suggest that WM, together with certain EFs, can play a role in sentence comprehension in individuals with aphasia (IWA), and that WM can be enhanced with intensive practice. Our aim was to investigate whether a combined WM and EF training improves the understanding of spoken sentences in IWA. We used a pre-post-test case control design. Three individuals with chronic aphasia practised an adaptive training task (a modified n-back task) three to four times a week for a month. Their performance was assessed before and after the training on outcome measures related to WM and spoken sentence comprehension."}
{"qid": "5cf4eb6aa49efeb44c00000e", "original_text": "Determining how genes are normally expressed throughout development and how they are mis-regulated in cancer is challenging. The availability of complete genome sequences, the advances in microarray technologies, and the development of novel functional genomic techniques such as 'chromatin profiling' facilitate dissection of the interplay among transcriptional networks and reveals chromosome organization in vivo.", "label": 1, "is_selected": 0, "text": "Determining how genes are normally expressed throughout development and how they are mis-regulated in cancer is challenging. The availability of complete genome sequences, the advances in microarray technologies, and the development of novel functional genomic techniques such as 'chromatin profiling' facilitate dissection of the interplay among transcriptional networks and reveals chromosome organization in vivo."}
{"qid": "52fe52702059c6d71c000078", "original_text": "Histone variant CENPA is preferentially localized to the centromere region of chromosomes. The centromere is a specialized region of DNA that plays a critical role in the separation of chromosomes during cell division. CENPA is one of the histones that make up the kinetochore, a protein complex that forms at the centromere and is responsible for the attachment of chromosomes to the spindle fibers during mitosis.", "label": 0, "is_selected": 0, "text": "Histone variant CENPA is preferentially localized to the centromere region of chromosomes. The centromere is a specialized region of DNA that plays a critical role in the separation of chromosomes during cell division. CENPA is one of the histones that make up the kinetochore, a protein complex that forms at the centromere and is responsible for the attachment of chromosomes to the spindle fibers during mitosis."}
{"qid": "603bc2b61cb411341a00015b", "original_text": "An accumulating body of evidence indicates a tight relationship between the endocrine system and abnormal social behavior. Two evolutionarily conserved hypothalamic peptides, oxytocin and arginine-vasopressin, because of their extensively documented function in supporting and regulating affiliative and socio-emotional responses, have attracted great interest for their critical implications for autism spectrum disorders (ASD). A large number of controlled trials demonstrated that exogenous oxytocin or arginine-vasopressin administration can mitigate social behavior impairment in ASD. Furthermore, there exists long-standing evidence of severe socioemotional dysfunctions after hypothalamic lesions in animals and humans. However, despite the major role of the hypothalamus for the synthesis and release of oxytocin and vasopressin, and the evident hypothalamic implication in affiliative behavior in animals and humans, a rather small number of neuroimaging studies showed an association between this region and socioemotional responses in ASD.", "label": 1, "is_selected": 0, "text": "An accumulating body of evidence indicates a tight relationship between the endocrine system and abnormal social behavior. Two evolutionarily conserved hypothalamic peptides, oxytocin and arginine-vasopressin, because of their extensively documented function in supporting and regulating affiliative and socio-emotional responses, have attracted great interest for their critical implications for autism spectrum disorders (ASD). A large number of controlled trials demonstrated that exogenous oxytocin or arginine-vasopressin administration can mitigate social behavior impairment in ASD. Furthermore, there exists long-standing evidence of severe socioemotional dysfunctions after hypothalamic lesions in animals and humans. However, despite the major role of the hypothalamus for the synthesis and release of oxytocin and vasopressin, and the evident hypothalamic implication in affiliative behavior in animals and humans, a rather small number of neuroimaging studies showed an association between this region and socioemotional responses in ASD."}
{"qid": "5e30f12afbd6abf43b000041", "original_text": "The CheckMate 227 clinical trial, also known as NCT02795387, is a phase 3, randomized, double-blind, placebo-controlled study conducted to evaluate the efficacy and safety of nivolumab (Opdivo) plus ipilimumab (Yervoy) in patients with advanced melanoma. In this trial, the following drugs were tested: * Nivolumab (Opdivo): an anti-programmed death-1 (PD-1) monoclonal antibody * Ipilimumab (Yervoy): an anti-CTLA-4 monoclonal antibody The study found that the combination of nivolumab and ipilimumab significantly improved overall survival, durable response rate, and progression-free survival compared to placebo in patients with advanced melanoma.", "label": 0, "is_selected": 0, "text": "The CheckMate 227 clinical trial, also known as NCT02795387, is a phase 3, randomized, double-blind, placebo-controlled study conducted to evaluate the efficacy and safety of nivolumab (Opdivo) plus ipilimumab (Yervoy) in patients with advanced melanoma. In this trial, the following drugs were tested: * Nivolumab (Opdivo): an anti-programmed death-1 (PD-1) monoclonal antibody * Ipilimumab (Yervoy): an anti-CTLA-4 monoclonal antibody The study found that the combination of nivolumab and ipilimumab significantly improved overall survival, durable response rate, and progression-free survival compared to placebo in patients with advanced melanoma."}
{"qid": "5e4b639c6d0a277941000027", "original_text": "Most smokers are aware of the dangers of smoking and want to quit, yet few are successful owing to the highly addictive properties of nicotine. Available smoking cessation tools include pharmacotherapies that act in the CNS and show modest long-term efficacy. Additionally, there are emerging concerns that they may cause adverse neuropsychiatric events. Antinicotine vaccines have been used experimentally as aids to smoking cessation. It is hypothesized that antibody capture of nicotine in the bloodstream would prevent it from crossing the blood-brain barrier and reaching the nicotinic receptors. The advantage of the approach includes the relatively gradual rise of antibody levels, which may reduce nicotine withdrawal symptoms, and the possible persistence of the antibodies potentially provides long-term protection, possibly preventing relapse. Proof-of-concept studies of at least two vaccine candidates have shown correlations between antinicotine antibody exposure and smoking abstinence. Unfortunately, the only vaccine tested in two large, randomized Phase III trials, 3'-amino-methyl-nicotine r-exoprotein A conjugate vaccine (NicVAX(\u00ae), Nabi Biopharmaceuticals, MD, USA), did not demonstrate efficacy. However, despite the lack of efficacy, there is good reason for continued optimism. This review will summarize the current status of the development of nicotine vaccines, discuss possible causes for the mixed results and review future scientific directions.", "label": 1, "is_selected": 0, "text": "Most smokers are aware of the dangers of smoking and want to quit, yet few are successful owing to the highly addictive properties of nicotine. Available smoking cessation tools include pharmacotherapies that act in the CNS and show modest long-term efficacy. Additionally, there are emerging concerns that they may cause adverse neuropsychiatric events. Antinicotine vaccines have been used experimentally as aids to smoking cessation. It is hypothesized that antibody capture of nicotine in the bloodstream would prevent it from crossing the blood-brain barrier and reaching the nicotinic receptors. The advantage of the approach includes the relatively gradual rise of antibody levels, which may reduce nicotine withdrawal symptoms, and the possible persistence of the antibodies potentially provides long-term protection, possibly preventing relapse. Proof-of-concept studies of at least two vaccine candidates have shown correlations between antinicotine antibody exposure and smoking abstinence. Unfortunately, the only vaccine tested in two large, randomized Phase III trials, 3'-amino-methyl-nicotine r-exoprotein A conjugate vaccine (NicVAX(\u00ae), Nabi Biopharmaceuticals, MD, USA), did not demonstrate efficacy. However, despite the lack of efficacy, there is good reason for continued optimism. This review will summarize the current status of the development of nicotine vaccines, discuss possible causes for the mixed results and review future scientific directions."}
{"qid": "58a8045860087bc10a000035", "original_text": "No neurocognitive examinations of pediatric trichotillomania (hair pulling disorder; HPD) have taken place. As a result, science's understanding of the underlying pathophysiology associated with HPD in youths is greatly lacking. The present study seeks to begin to address this gap in the literature via examination of executive functioning in a stimulant-free sample of children with HPD. Sixteen and 23 children between 9 and 17 years of age meeting DSM-5", "label": 1, "is_selected": 0, "text": "No neurocognitive examinations of pediatric trichotillomania (hair pulling disorder; HPD) have taken place. As a result, science's understanding of the underlying pathophysiology associated with HPD in youths is greatly lacking. The present study seeks to begin to address this gap in the literature via examination of executive functioning in a stimulant-free sample of children with HPD. Sixteen and 23 children between 9 and 17 years of age meeting DSM-5"}
{"qid": "5c928303ecadf2e73f000014", "original_text": "Cas13a and C2c2 are two different RNA-guided nucleases that are derived from the CRISPR-Cas13 system. While both enzymes are capable of cleaving RNA, they have distinct differences in their mechanisms of action and specificities. Cas13a is a single-stranded RNA nuclease that is activated by the recognition of a specific 20-nt protospacer adjacent motif (PAM) in the RNA substrate. Once activated, Cas13a cleaves the RNA through a double-stranded break, leading to degradation of the targeted RNA molecule. Cas13a has been shown to be highly specific and efficient in cleaving a wide range of RNA substrates, including messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). In contrast, C2c2 is a double-stranded RNA nuclease that is also activated by a specific PAM sequence. However, unlike Cas13a, C2c2 requires a longer PAM sequence (typically around 30-40 nt) for activation. Once activated, C2c2 cleaves the RNA through a mechanism involving the formation of a double-stranded break followed by 3' phosphodiester bond formation. C2c2 has been shown to have a broader substrate specificity than Cas13a, with a preference for cleaving longer RNA substrates. In summary, while both Cas13a and C2c2 are RNA-guided nucleases, they differ in their mechanisms of action, specificities, and requirements for PAM sequences. Cas13a is more specific and efficient, while C2c2 has a broader substrate specificity but lower efficiency.", "label": 0, "is_selected": 1, "text": "Here we describe the mechanisms of action and specificities of Cas13a and C2c2 RNA nucleases, as well as their potential use in the development of new human therapeutics and gene editing tools and techniques for CRISPR/CasCas13-based gene therapy and CRISPR-Cas14-based chimeric antigen receptors (CARs) for the treatment of autoimmune diseases and Huntington's disease (HD) in humans and animals, respectively, and in chimeric RNA-editing systems for the development and production of chimeric oligonucleotides for use in regenerative medicine and tissue engineering."}
{"qid": "5e48a916d14c9f295d00000f", "original_text": "Siponimod is a drug that modulates the sphingosine 1-phosphate (S1P) receptor subtype 1 (S1P1). S1P1 is a G-protein coupled receptor that plays a crucial role in the regulation of immune cell trafficking, inflammation, and neuroprotection. Siponimod binds to S1P1 and selectively inhibits its activity, leading to the reduction of immune cell infiltration into the central nervous system (CNS) and the alleviation of neurodegeneration in multiple sclerosis (MS) patients. Therefore, Siponimod is used to treat secondary progressive MS and clinically isolated syndrome (CIS) with active inflammation.", "label": 0, "is_selected": 0, "text": "Siponimod is a drug that modulates the sphingosine 1-phosphate (S1P) receptor subtype 1 (S1P1). S1P1 is a G-protein coupled receptor that plays a crucial role in the regulation of immune cell trafficking, inflammation, and neuroprotection. Siponimod binds to S1P1 and selectively inhibits its activity, leading to the reduction of immune cell infiltration into the central nervous system (CNS) and the alleviation of neurodegeneration in multiple sclerosis (MS) patients. Therefore, Siponimod is used to treat secondary progressive MS and clinically isolated syndrome (CIS) with active inflammation."}
{"qid": "55262a9787ecba3764000009", "original_text": "The pathogenic mechanisms of bone loss caused by Brucella species have not been completely deciphered. Although T lymphocytes (LTs) are considered important to control infection, the mechanism of Brucella-induced T-cell responses to immunopathological features is not known. We present in vitro and in vivo evidence showing that Brucella abortus-induced inflammatory response leads to the activation of LTs, which further promote osteoclastogenesis. Pre-activated murine LTs treated with culture supernatant from macrophages infected with B. abortus induced bone marrow-derived monocytes (BMMs) to undergo osteoclastogenesis. Furthermore, osteoclastogenesis was mediated by CD4(+)", "label": 1, "is_selected": 0, "text": "The pathogenic mechanisms of bone loss caused by Brucella species have not been completely deciphered. Although T lymphocytes (LTs) are considered important to control infection, the mechanism of Brucella-induced T-cell responses to immunopathological features is not known. We present in vitro and in vivo evidence showing that Brucella abortus-induced inflammatory response leads to the activation of LTs, which further promote osteoclastogenesis. Pre-activated murine LTs treated with culture supernatant from macrophages infected with B. abortus induced bone marrow-derived monocytes (BMMs) to undergo osteoclastogenesis. Furthermore, osteoclastogenesis was mediated by CD4(+)"}
{"qid": "58a6c94860087bc10a00002a", "original_text": "Histone mutations associated with pediatric gliomas include H3K27M (histone H3 lysine 27 mutation), HIST1H3B (histone H1 family member H3B), and HIST1H3C (histone H1 family member H3C). These mutations are commonly found in diffuse intrinsic pontine gliomas (DIPGs) and other pediatric gliomas. H3K27M is the most commonly identified histone mutation in pediatric gliomas, occurring in approximately 70% of cases.", "label": 0, "is_selected": 0, "text": "Histone mutations associated with pediatric gliomas include H3K27M (histone H3 lysine 27 mutation), HIST1H3B (histone H1 family member H3B), and HIST1H3C (histone H1 family member H3C). These mutations are commonly found in diffuse intrinsic pontine gliomas (DIPGs) and other pediatric gliomas. H3K27M is the most commonly identified histone mutation in pediatric gliomas, occurring in approximately 70% of cases."}
{"qid": "5e5d24811af46fc130000006", "original_text": "Thrombocytopenia is frequent among sick neonates. While most cases are transient, some neonates experience prolonged and severe thrombocytopenia. These infants often pose diagnostic and therapeutic challenges, and may receive large numbers of platelet transfusions. Romiplostim (ROM) is a thrombopoietin (TPO)-receptor-agonist approved for treatment of adults with chronic immune thrombocytopenia (ITP). The immature platelet fraction (IPF) is a novel measure of newly produced platelets, which could aid with the diagnostic evaluation of thrombocytopenic neonates. This study had the following two objectives: (1) compare the response of newborn and adult mice to escalating doses of ROM in vivo and (2) assess the correlation between IPF and megakaryocyte (MK) mass in newborn and adult treated and untreated mice.", "label": 1, "is_selected": 0, "text": "Thrombocytopenia is frequent among sick neonates. While most cases are transient, some neonates experience prolonged and severe thrombocytopenia. These infants often pose diagnostic and therapeutic challenges, and may receive large numbers of platelet transfusions. Romiplostim (ROM) is a thrombopoietin (TPO)-receptor-agonist approved for treatment of adults with chronic immune thrombocytopenia (ITP). The immature platelet fraction (IPF) is a novel measure of newly produced platelets, which could aid with the diagnostic evaluation of thrombocytopenic neonates. This study had the following two objectives: (1) compare the response of newborn and adult mice to escalating doses of ROM in vivo and (2) assess the correlation between IPF and megakaryocyte (MK) mass in newborn and adult treated and untreated mice."}
{"qid": "56bdcc4cef6e394741000002", "original_text": "The R/Bioconductor package \"HilbertSpace\" utilizes the Hilbert curve for visualizing genomic data. HilbertSpace provides a variety of visualization tools, including interactive visualizations of high-dimensional data, to help researchers better understand complex genomic structures and relationships.", "label": 0, "is_selected": 1, "text": "Researchers at the University of California, Los Angeles (UCLA) have developed a new tool for studying the structure and function of DNA, RNA, and proteins, as well as their interactions with each other and with the environment"}
{"qid": "621215ec3a8413c653000012", "original_text": "The intact antibody of human immunoglobulin (IgG) is composed of the fragment for antigen binding (Fab) and the crystallizable fragment (Fc) for binding of Fc\u03b3 receptors. Among the four subclasses of human IgG (IgG1, IgG2, IgG3, IgG4), which differ in their constant regions, particularly in their hinges and CH2 domains, IgG1 has the highest Fc\u03b3R-binding affinity, followed by IgG3, IgG2, and IgG4. As a result, different subclasses have different effector functions such as antibody-dependent cell-mediated cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP). Fc\u03b3 receptors include six subtypes (Fc\u03b3RI, Fc\u03b3RIIA, Fc\u03b3RIIB, Fc\u03b3RIIC, Fc\u03b3RIIIA, Fc\u03b3RIIIB) which differ in cellular distribution, binding affinity to Fc, and the resulting biological activity. Therefore, when developing anti-tumor therapeutic antibodies, including single-targeted antibodies, bi-specific antibodies (BsAbs), and antibody-drug conjugates (ADCs), many factors, such as target biology, cellular distribution of the targets, the environments of particular tumor types, as well as the proposed mechanism of action (MOA), must be taken into consideration.", "label": 1, "is_selected": 0, "text": "The intact antibody of human immunoglobulin (IgG) is composed of the fragment for antigen binding (Fab) and the crystallizable fragment (Fc) for binding of Fc\u03b3 receptors. Among the four subclasses of human IgG (IgG1, IgG2, IgG3, IgG4), which differ in their constant regions, particularly in their hinges and CH2 domains, IgG1 has the highest Fc\u03b3R-binding affinity, followed by IgG3, IgG2, and IgG4. As a result, different subclasses have different effector functions such as antibody-dependent cell-mediated cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP). Fc\u03b3 receptors include six subtypes (Fc\u03b3RI, Fc\u03b3RIIA, Fc\u03b3RIIB, Fc\u03b3RIIC, Fc\u03b3RIIIA, Fc\u03b3RIIIB) which differ in cellular distribution, binding affinity to Fc, and the resulting biological activity. Therefore, when developing anti-tumor therapeutic antibodies, including single-targeted antibodies, bi-specific antibodies (BsAbs), and antibody-drug conjugates (ADCs), many factors, such as target biology, cellular distribution of the targets, the environments of particular tumor types, as well as the proposed mechanism of action (MOA), must be taken into consideration."}
{"qid": "5e3356c0fbd6abf43b00005c", "original_text": "The Match BAM to VCF (MegaBase Alignment Matrix to Variant Call Format) method is a tool used to convert BAM (Bases Alignment Matrix) files into VCF (Variant Call Format) format. BAM is a binary format that stores genomic read data, and VCF is a text-based format that describes genetic variants found in the data. The Match BAM to VCF tool aligns the BAM reads with a reference genome and creates a VCF file that contains information on the variants identified.", "label": 0, "is_selected": 1, "text": "The Match BAM to VCF method is a tool used to convert BAM (Bases Alignment Matrix) files into VCF (Variant Call Format) format. The match BAM toVCF tool aligns the BAM reads with a reference genome and creates a VCF file that contains information on the variants identified."}
{"qid": "60355c0f1cb411341a000156", "original_text": "Here, we present further characterization of cryptococcal CUF1 in copper homeostasis. We demonstrated that CUF1 was involved both in copper acquisition and in copper detoxification in response to copper variation. This was verified by direct measurement of the quantity of intracellular copper with flame atomic absorption spectrometry (FAAS) and molecular evidence. In copper-limited growth, the mutant cuf1\u0394 exhibited copper deficiency, growth defect on glycerol and sensitivity to hydrogen peroxide and methionine. A novel function of cryptococcal CUF1 is revealed in copper detoxification when copper is in excess. The mutant cuf1\u0394 showed severe hypersensitivity to exogenous copper, while a high level of copper was accumulated shown by FAAS, suggesting that CUF1 may be required in copper export events.", "label": 1, "is_selected": 0, "text": "Here, we present further characterization of cryptococcal CUF1 in copper homeostasis. We demonstrated that CUF1 was involved both in copper acquisition and in copper detoxification in response to copper variation. This was verified by direct measurement of the quantity of intracellular copper with flame atomic absorption spectrometry (FAAS) and molecular evidence. In copper-limited growth, the mutant cuf1\u0394 exhibited copper deficiency, growth defect on glycerol and sensitivity to hydrogen peroxide and methionine. A novel function of cryptococcal CUF1 is revealed in copper detoxification when copper is in excess. The mutant cuf1\u0394 showed severe hypersensitivity to exogenous copper, while a high level of copper was accumulated shown by FAAS, suggesting that CUF1 may be required in copper export events."}
{"qid": "6023598a1cb411341a00009b", "original_text": "Trastuzumab deruxtecan (DS-8201a) is an antibody-drug conjugate (ADC) composed of a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) conjugated to a topoisomerase I inhibitor (DXd) at a drug-to-antibody ratio (DAR) of 7-8. Here, we examined the pharmacokinetic (PK) profiles of DS-8201a and DXd in cynomolgus monkeys, a cross-reactive species. Following intravenous (iv) administration of DS-8201a, the linker was stable in plasma, and systemic DXd exposure was low. DXd was rapidly cleared following iv dosing.", "label": 1, "is_selected": 0, "text": "Trastuzumab deruxtecan (DS-8201a) is an antibody-drug conjugate (ADC) composed of a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) conjugated to a topoisomerase I inhibitor (DXd) at a drug-to-antibody ratio (DAR) of 7-8. Here, we examined the pharmacokinetic (PK) profiles of DS-8201a and DXd in cynomolgus monkeys, a cross-reactive species. Following intravenous (iv) administration of DS-8201a, the linker was stable in plasma, and systemic DXd exposure was low. DXd was rapidly cleared following iv dosing."}
{"qid": "5e44c76f48dab47f26000022", "original_text": "Glutamate N-methyl-D-aspartate (NMDA) receptor antagonists (competitive receptor antagonists, ion channel blockers, and glycine antagonists)--such as selfotel, aptiganel, eliprodil, licostinel and gavestinel--failed to show efficacy in clinical trials of stroke or traumatic brain injury. This failure has been attributed to the deficient properties of the molecules that entered human trials and to inappropriate design of clinical studies. In this article we hypothesise that glutamate may be involved in the acute neurodestructive phase that occurs immediately after traumatic or ischaemic injury (excitotoxicity), but that, after this period, it assumes its normal physiological functions, which include promotion of neuronal survival. We propose that NMDA receptor antagonists failed stroke and traumatic brain injury trials in human beings because blockade of synaptic transmission mediated by NMDA receptors hinders neuronal survival.", "label": 1, "is_selected": 0, "text": "Glutamate N-methyl-D-aspartate (NMDA) receptor antagonists (competitive receptor antagonists, ion channel blockers, and glycine antagonists)--such as selfotel, aptiganel, eliprodil, licostinel and gavestinel--failed to show efficacy in clinical trials of stroke or traumatic brain injury. This failure has been attributed to the deficient properties of the molecules that entered human trials and to inappropriate design of clinical studies. In this article we hypothesise that glutamate may be involved in the acute neurodestructive phase that occurs immediately after traumatic or ischaemic injury (excitotoxicity), but that, after this period, it assumes its normal physiological functions, which include promotion of neuronal survival. We propose that NMDA receptor antagonists failed stroke and traumatic brain injury trials in human beings because blockade of synaptic transmission mediated by NMDA receptors hinders neuronal survival."}
{"qid": "5aa0495bd6d6b54f79000002", "original_text": "The physical barrier between blood and the CNS (the blood-brain barrier, the blood-spinal cord barrier and the blood-CSF barrier) protects the CNS from both toxic and pathogenic agents in the blood. It is now clear that disruption of the blood-CNS barrier plays a key role in a number of CNS disorders, particularly those associated with neurodegeneration. Such disruption is inevitably accompanied by inflammatory change, as immune cells and immune mediators gain access to the brain or spinal cord. The blood-CNS barrier also presents a major obstacle for potential CNS medicines. Robust methods to assess CNS permeation are therefore essential for CNS drug discovery, particularly when brain pharmacokinetics are taken into account and especially when such measures are linked to neurochemical, physiological, behavioural or neuroimaging readouts of drug action. Drug candidates can be successfully designed to cross the blood-CNS barrier, but for those that can't there is the possibility of entry with a delivery system that facilitates the movement of drug candidate across the blood-CNS barrier.", "label": 1, "is_selected": 0, "text": "The physical barrier between blood and the CNS (the blood-brain barrier, the blood-spinal cord barrier and the blood-CSF barrier) protects the CNS from both toxic and pathogenic agents in the blood. It is now clear that disruption of the blood-CNS barrier plays a key role in a number of CNS disorders, particularly those associated with neurodegeneration. Such disruption is inevitably accompanied by inflammatory change, as immune cells and immune mediators gain access to the brain or spinal cord. The blood-CNS barrier also presents a major obstacle for potential CNS medicines. Robust methods to assess CNS permeation are therefore essential for CNS drug discovery, particularly when brain pharmacokinetics are taken into account and especially when such measures are linked to neurochemical, physiological, behavioural or neuroimaging readouts of drug action. Drug candidates can be successfully designed to cross the blood-CNS barrier, but for those that can't there is the possibility of entry with a delivery system that facilitates the movement of drug candidate across the blood-CNS barrier."}
{"qid": "5c531d8f7e3cb0e231000017", "original_text": "Bathing suit Ichthyosis (BSI) is caused by mutations in the Filaggrin gene (FLG), which codes for the filaggrin protein. Filaggrin is a key component of the skin's natural barrier function, and mutations in the FLG gene can lead to a deficiency in filaggrin production. This deficiency can cause the skin to become excessively dry and itchy, leading to the characteristic thick, scaly skin flakes that occur in BSI. The condition is usually inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition.", "label": 0, "is_selected": 1, "text": "Scientists at the University of Bristol have discovered a gene defect that causes people to have thick, scaly skin flakes on their arms, legs, and backs, known as \"bathing suit Ichthyosis\" or \"dry itchy skin\", as well as a number of other skin conditions."}
{"qid": "5e48ab8dd14c9f295d000010", "original_text": "Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS). The modern treatment era for MS witnessed a growing pool of drugs now available for use in clinical practice. These therapies work at different levels, however there is a lack of treatments acting on the neurodegenerative component or improving mechanism of repair. Areas covered: The latest knowledge about the pathophysiological changes occurring in MS have translated into novel treatments at different stages of development. Drugs for MS work mainly through modulating the inflammatory factors of the disease, but enhancing remyelination may be more successful in reducing long-term disability. Anti-LINGO-1 (opicinumab) is the first investigational product that achieved phase I trial with the aim of remyelination and axonal protection and/or repair in MS.", "label": 1, "is_selected": 0, "text": "Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS). The modern treatment era for MS witnessed a growing pool of drugs now available for use in clinical practice. These therapies work at different levels, however there is a lack of treatments acting on the neurodegenerative component or improving mechanism of repair. Areas covered: The latest knowledge about the pathophysiological changes occurring in MS have translated into novel treatments at different stages of development. Drugs for MS work mainly through modulating the inflammatory factors of the disease, but enhancing remyelination may be more successful in reducing long-term disability. Anti-LINGO-1 (opicinumab) is the first investigational product that achieved phase I trial with the aim of remyelination and axonal protection and/or repair in MS."}
{"qid": "6027dc011cb411341a0000eb", "original_text": "Inactivation of CYLD, a protein that regulates inflammation and cancer development, has been shown to have a potential therapeutic role in colorectal cancer. CYLD is overexpressed in many colorectal cancer tumors, and its inactivation can lead to the suppression of cancer cell growth and invasion. Studies have shown that inactivating CYLD can inhibit the proliferation of colorectal cancer cells and reduce their ability to form tumors in mice. Additionally, CYLD inactivation has been shown to increase the sensitivity of colorectal cancer cells to chemotherapy, suggesting that it may be a useful strategy for improving the effectiveness of cancer treatment. Overall, the inactivation of CYLD may be a promising therapeutic approach for colorectal cancer, and further research is needed to fully understand its potential benefits and limitations.", "label": 0, "is_selected": 0, "text": "Inactivation of CYLD, a protein that regulates inflammation and cancer development, has been shown to have a potential therapeutic role in colorectal cancer. CYLD is overexpressed in many colorectal cancer tumors, and its inactivation can lead to the suppression of cancer cell growth and invasion. Studies have shown that inactivating CYLD can inhibit the proliferation of colorectal cancer cells and reduce their ability to form tumors in mice. Additionally, CYLD inactivation has been shown to increase the sensitivity of colorectal cancer cells to chemotherapy, suggesting that it may be a useful strategy for improving the effectiveness of cancer treatment. Overall, the inactivation of CYLD may be a promising therapeutic approach for colorectal cancer, and further research is needed to fully understand its potential benefits and limitations."}
{"qid": "6025d9e41cb411341a0000b7", "original_text": "To study the efficacy and tolerability of valproic acid (VPA) and radiation, followed by VPA and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG) or high-grade glioma (HGG). Children 3 to 21 years of age received radiation therapy and VPA at 15 mg/kg/day and dose adjusted to maintain a trough range of 85 to 115 \u03bcg/mL. VPA was continued post-radiation, and bevacizumab was started at 10 mg/kg intravenously biweekly, four weeks after completing radiation therapy. From September 2009 through August 2015, 20 DIPG and 18 HGG patients were enrolled (NCT00879437). During radiation and VPA, grade 3 or higher toxicities requiring discontinuation or modification of VPA dosing included grade 3 thrombocytopenia (1), grade 3 weight gain (1), and grade 3 pancreatitis (1). During VPA and bevacizumab, the most common grade 3 or higher toxicities were grade 3 neutropenia (3), grade 3 thrombocytopenia (3), grade 3 fatigue (3), and grade 3 hypertension (4). Two patients discontinued protocol therapy prior to disease progression (one grade 4 thrombosis and one grade 1 intratumoral hemorrhage). Median event-free survival (EFS) and overall survival (OS) for DIPG were 7.8 (95% CI 5.6-8.2) and 10.3 (7.4-13.4) months, and estimated one-year EFS was 12% (2%-31%). Median EFS and OS for HGG were 9.1 (6.4-11) and 12.1 (10-22.1) months, and estimated one-year EFS was 24% (7%-45%).", "label": 1, "is_selected": 0, "text": "To study the efficacy and tolerability of valproic acid (VPA) and radiation, followed by VPA and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG) or high-grade glioma (HGG). Children 3 to 21 years of age received radiation therapy and VPA at 15 mg/kg/day and dose adjusted to maintain a trough range of 85 to 115 \u03bcg/mL. VPA was continued post-radiation, and bevacizumab was started at 10 mg/kg intravenously biweekly, four weeks after completing radiation therapy. From September 2009 through August 2015, 20 DIPG and 18 HGG patients were enrolled (NCT00879437). During radiation and VPA, grade 3 or higher toxicities requiring discontinuation or modification of VPA dosing included grade 3 thrombocytopenia (1), grade 3 weight gain (1), and grade 3 pancreatitis (1). During VPA and bevacizumab, the most common grade 3 or higher toxicities were grade 3 neutropenia (3), grade 3 thrombocytopenia (3), grade 3 fatigue (3), and grade 3 hypertension (4). Two patients discontinued protocol therapy prior to disease progression (one grade 4 thrombosis and one grade 1 intratumoral hemorrhage). Median event-free survival (EFS) and overall survival (OS) for DIPG were 7.8 (95% CI 5.6-8.2) and 10.3 (7.4-13.4) months, and estimated one-year EFS was 12% (2%-31%). Median EFS and OS for HGG were 9.1 (6.4-11) and 12.1 (10-22.1) months, and estimated one-year EFS was 24% (7%-45%)."}
{"qid": "53442ca9aeec6fbd0700000b", "original_text": "Epithelial cell adhesion molecule (EpCAM) is an epithelial and cancer cell \"marker\" and there is a cumulative and growing evidence of its signaling role. Its importance has been recognized as part of the breast cancer stem cell phenotype, the tumorigenic breast cancer stem cell is EpCAM(+). In spite of its complex functions in normal cell development and cancer, relatively little is known about EpCAM-interacting proteins.", "label": 1, "is_selected": 0, "text": "Epithelial cell adhesion molecule (EpCAM) is an epithelial and cancer cell \"marker\" and there is a cumulative and growing evidence of its signaling role. Its importance has been recognized as part of the breast cancer stem cell phenotype, the tumorigenic breast cancer stem cell is EpCAM(+). In spite of its complex functions in normal cell development and cancer, relatively little is known about EpCAM-interacting proteins."}
{"qid": "56c1f03bef6e394741000053", "original_text": "Brain-lung-thyroid syndrome (BLTS) characterized by congenital hypothyroidism, respiratory distress syndrome, and benign hereditary chorea is caused by thyroid transcription factor 1 (NKX2-1/TTF1) mutations. We report the clinical and molecular characteristics of four cases presenting with primary hypothyroidism, respiratory distress, and neurological disorder. Two of the four patients presenting with the triad of BLTS had NKX2-1 mutations, and one of these NKX2-1 [c.890_896del (p.Ala327Glyfs*52)] is a novel variant. The third patient without any identified NKX2-1 mutations was a carrier of mitochondrial mutation; this raises the possibility of mitochondrial mutations contributing to thyroid dysgenesis. Although rare, the triad of congenital hypothyroidism, neurological, and respiratory signs is highly suggestive of NKX2-1 anomalies.", "label": 1, "is_selected": 0, "text": "Brain-lung-thyroid syndrome (BLTS) characterized by congenital hypothyroidism, respiratory distress syndrome, and benign hereditary chorea is caused by thyroid transcription factor 1 (NKX2-1/TTF1) mutations. We report the clinical and molecular characteristics of four cases presenting with primary hypothyroidism, respiratory distress, and neurological disorder. Two of the four patients presenting with the triad of BLTS had NKX2-1 mutations, and one of these NKX2-1 [c.890_896del (p.Ala327Glyfs*52)] is a novel variant. The third patient without any identified NKX2-1 mutations was a carrier of mitochondrial mutation; this raises the possibility of mitochondrial mutations contributing to thyroid dysgenesis. Although rare, the triad of congenital hypothyroidism, neurological, and respiratory signs is highly suggestive of NKX2-1 anomalies."}
{"qid": "56b3efc38525abca1e000006", "original_text": "Comparative genomics remains a pivotal strategy to study the evolution of gene organization, and this primacy is reinforced by the growing number of full genome sequences available in public repositories. Despite this growth, bioinformatic tools available to visualize and compare genomes and to infer evolutionary events remain restricted to two or three genomes at a time, thus limiting the breadth and the nature of the question that can be investigated.", "label": 1, "is_selected": 0, "text": "Comparative genomics remains a pivotal strategy to study the evolution of gene organization, and this primacy is reinforced by the growing number of full genome sequences available in public repositories. Despite this growth, bioinformatic tools available to visualize and compare genomes and to infer evolutionary events remain restricted to two or three genomes at a time, thus limiting the breadth and the nature of the question that can be investigated."}
{"qid": "5c7aae9dd774d0424000000a", "original_text": "The production of cytokines in response to DNA-damage events may be an important host defense response to help prevent the escape of pre-cancerous cells. The innate immune pathways involved in these events are known to be regulated by cellular molecules such as stimulator of interferon genes (STING), which controls type I interferon and pro-inflammatory cytokine production in response to the presence of microbial DNA or cytosolic DNA that has escaped from the nucleus. STING signaling has been shown to be defective in a variety of cancers, such as colon cancer and melanoma, actions that may enable damaged cells to escape the immunosurveillance system.", "label": 1, "is_selected": 0, "text": "The production of cytokines in response to DNA-damage events may be an important host defense response to help prevent the escape of pre-cancerous cells. The innate immune pathways involved in these events are known to be regulated by cellular molecules such as stimulator of interferon genes (STING), which controls type I interferon and pro-inflammatory cytokine production in response to the presence of microbial DNA or cytosolic DNA that has escaped from the nucleus. STING signaling has been shown to be defective in a variety of cancers, such as colon cancer and melanoma, actions that may enable damaged cells to escape the immunosurveillance system."}
{"qid": "5c990241ecadf2e73f00002d", "original_text": "The transcriptional co-activator p300 is a histone acetyltransferase (HAT) that is typically recruited to transcriptional enhancers and regulates gene expression by acetylating chromatin. Here we show that the activation of p300 directly depends on the activation and oligomerization status of transcription factor ligands. Using two model transcription factors, IRF3 and STAT1, we demonstrate that transcription factor dimerization enables the trans-autoacetylation of p300 in a highly conserved and intrinsically disordered autoinhibitory lysine-rich loop, resulting in p300 activation. We describe a crystal structure of p300 in which the autoinhibitory loop invades the active site of a neighbouring HAT domain, revealing a snapshot of a trans-autoacetylation reaction intermediate. Substrate access to the active site involves the rearrangement of an autoinhibitory RING domain.", "label": 1, "is_selected": 0, "text": "The transcriptional co-activator p300 is a histone acetyltransferase (HAT) that is typically recruited to transcriptional enhancers and regulates gene expression by acetylating chromatin. Here we show that the activation of p300 directly depends on the activation and oligomerization status of transcription factor ligands. Using two model transcription factors, IRF3 and STAT1, we demonstrate that transcription factor dimerization enables the trans-autoacetylation of p300 in a highly conserved and intrinsically disordered autoinhibitory lysine-rich loop, resulting in p300 activation. We describe a crystal structure of p300 in which the autoinhibitory loop invades the active site of a neighbouring HAT domain, revealing a snapshot of a trans-autoacetylation reaction intermediate. Substrate access to the active site involves the rearrangement of an autoinhibitory RING domain."}
{"qid": "5a787544faa1ab7d2e00000b", "original_text": "Kummell's disease is a spinal disorder characterized by delayed post-traumatic collapse of a vertebral body with avascular necrosis. Although definitive treatment for Kummell's disease has not been established, it has been reported that percutaneous vertebroplasty or kyphoplasty has shown good results. However, these procedures are not recommended for severely collapsed vertebral bodies because of the risk of cement leakage or technical difficulties. Authors report a rare case of spontaneous reduction in vertebral height by the insertion of a working cannula into the vertebral body in Kummell's disease.", "label": 1, "is_selected": 0, "text": "Kummell's disease is a spinal disorder characterized by delayed post-traumatic collapse of a vertebral body with avascular necrosis. Although definitive treatment for Kummell's disease has not been established, it has been reported that percutaneous vertebroplasty or kyphoplasty has shown good results. However, these procedures are not recommended for severely collapsed vertebral bodies because of the risk of cement leakage or technical difficulties. Authors report a rare case of spontaneous reduction in vertebral height by the insertion of a working cannula into the vertebral body in Kummell's disease."}
{"qid": "52ee9f55c8da898910000009", "original_text": "Romano-Ward long QT syndrome is an inherited cardiac disorder that affects the electrical conduction system of the heart. The mode of inheritance is autosomal dominant, meaning that a single copy of the mutated gene is enough to cause the condition. This means that if one parent has the mutation, each child has a 50% chance of inheriting the mutated gene and developing the condition. However, some individuals with a mutation in the gene may not exhibit any symptoms, making it difficult to predict who will develop the condition.", "label": 0, "is_selected": 1, "text": "Researchers at the University of California, Los Angeles (UCLA) have identified a gene mutation that causes a heart condition called Romano-Ward long QT syndrome, according to a report in the New England Journal of Medicine, which was published online on 17 March."}
{"qid": "5fdb2e3ea43ad3127800000b", "original_text": "About 70% of C. elegans mRNAs are trans-spliced to one of two 22 nucleotide spliced leaders. SL1 is used to trim off the 5' ends of pre-mRNAs and replace them with the SL1 sequence. This processing event is very closely related to cis-splicing, or intron removal. The SL1 sequence is donated by a 100 nt small nuclear ribonucleoprotein particle (snRNP), the SL1 snRNP. This snRNP is structurally and functionally similar to the U snRNAs (U1, U2, U4, U5 and U6) that play key roles in intron removal and trans-splicing, except that the SL1 snRNP is consumed in the process. More than half of C. elegans pre-mRNAs are subject to SL1 trans-splicing, whereas ~30% are not trans-spliced. The remaining genes are trans-spliced by SL2, which is donated by a similar snRNP, the SL2 snRNP. SL2 recipients are all downstream genes in closely spaced gene clusters similar to bacterial operons. They are transcribed from a promoter at the 5' end of the cluster of between 2 and 8 genes. This transcription makes a polycistronic pre-mRNA that is co-transcriptionally processed by cleavage and polyadenylation at the 3' end of each gene, and this event is closely coupled to the SL2 trans-splicing event that occurs only ~100 nt further downstream.", "label": 1, "is_selected": 0, "text": "About 70% of C. elegans mRNAs are trans-spliced to one of two 22 nucleotide spliced leaders. SL1 is used to trim off the 5' ends of pre-mRNAs and replace them with the SL1 sequence. This processing event is very closely related to cis-splicing, or intron removal. The SL1 sequence is donated by a 100 nt small nuclear ribonucleoprotein particle (snRNP), the SL1 snRNP. This snRNP is structurally and functionally similar to the U snRNAs (U1, U2, U4, U5 and U6) that play key roles in intron removal and trans-splicing, except that the SL1 snRNP is consumed in the process. More than half of C. elegans pre-mRNAs are subject to SL1 trans-splicing, whereas ~30% are not trans-spliced. The remaining genes are trans-spliced by SL2, which is donated by a similar snRNP, the SL2 snRNP. SL2 recipients are all downstream genes in closely spaced gene clusters similar to bacterial operons. They are transcribed from a promoter at the 5' end of the cluster of between 2 and 8 genes. This transcription makes a polycistronic pre-mRNA that is co-transcriptionally processed by cleavage and polyadenylation at the 3' end of each gene, and this event is closely coupled to the SL2 trans-splicing event that occurs only ~100 nt further downstream."}
{"qid": "5d2f3a5db3a6380763000001", "original_text": "There are no specific drugs that target granulocytes in the treatment of Systemic Lupus Erythematosus (SLE). Granulocytes are a type of white blood cell that plays a role in the immune system, but they are not directly involved in the pathogenesis of SLE. Treatment of SLE typically focuses on managing inflammation and preventing flares, rather than targeting specific immune cells. Common treatment options for SLE include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, immunosuppressants, and antimalarials.", "label": 0, "is_selected": 0, "text": "There are no specific drugs that target granulocytes in the treatment of Systemic Lupus Erythematosus (SLE). Granulocytes are a type of white blood cell that plays a role in the immune system, but they are not directly involved in the pathogenesis of SLE. Treatment of SLE typically focuses on managing inflammation and preventing flares, rather than targeting specific immune cells. Common treatment options for SLE include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, immunosuppressants, and antimalarials."}
{"qid": "5ac0a82d19833b0d7b000003", "original_text": "Antisense therapy with both chemistries of phosphorodiamidate morpholino oligomers (PMOs) and 2'-O-methyl phosphorothioate has demonstrated the capability to induce dystrophin expression in Duchenne muscular dystrophy (DMD) patients in phase II-III clinical trials with benefit in muscle functions. However, potential of the therapy for DMD at different stages of the disease progression is not understood. In this study, we examined the effect of peptide-conjugated PMO (PPMO)-mediated exon skipping on disease progression of utrophin-dystrophin-deficient mice (dko) of four age groups (21-29, 30-39, 40-49 and 50+ days), representing diseases from early stage to advanced stage with severe kyphosis. Biweekly intravenous (i.v.) administration of the PPMO restored the dystrophin expression in nearly 100% skeletal muscle fibers in all age groups. This was associated with the restoration of dystrophin-associated proteins including functional glycosylated dystroglycan and neuronal nitric synthase. However, therapeutic outcomes clearly depended on severity of the disease at the time the treatment started. The PPMO treatment alleviated the disease pathology and significantly prolonged the life span of the mice receiving treatment at younger age with mild phenotype. However, restoration of high levels of dystrophin expression failed to prevent disease progression to the mice receiving treatment when disease was already at advanced stage.", "label": 1, "is_selected": 0, "text": "Antisense therapy with both chemistries of phosphorodiamidate morpholino oligomers (PMOs) and 2'-O-methyl phosphorothioate has demonstrated the capability to induce dystrophin expression in Duchenne muscular dystrophy (DMD) patients in phase II-III clinical trials with benefit in muscle functions. However, potential of the therapy for DMD at different stages of the disease progression is not understood. In this study, we examined the effect of peptide-conjugated PMO (PPMO)-mediated exon skipping on disease progression of utrophin-dystrophin-deficient mice (dko) of four age groups (21-29, 30-39, 40-49 and 50+ days), representing diseases from early stage to advanced stage with severe kyphosis. Biweekly intravenous (i.v.) administration of the PPMO restored the dystrophin expression in nearly 100% skeletal muscle fibers in all age groups. This was associated with the restoration of dystrophin-associated proteins including functional glycosylated dystroglycan and neuronal nitric synthase. However, therapeutic outcomes clearly depended on severity of the disease at the time the treatment started. The PPMO treatment alleviated the disease pathology and significantly prolonged the life span of the mice receiving treatment at younger age with mild phenotype. However, restoration of high levels of dystrophin expression failed to prevent disease progression to the mice receiving treatment when disease was already at advanced stage."}
{"qid": "5c6545bae842deac6700001d", "original_text": "Natural killer (NK) cell-based immunotherapy is a promising novel approach to treat cancer. However, NK cell function has been shown to be potentially diminished by factors common in the tumor microenvironment (TME). In this study, we assessed the synergistic potential of antibody-dependent cell-mediated cytotoxicity (ADCC) and killer immunoglobin-like receptor (KIR)-ligand mismatched NK cells to potentiate NK cell antitumor reactivity in multiple myeloma (MM). Hypoxia, lactate, prostaglandin E2 (PGE2) or combinations were selected to mimic the TME.", "label": 1, "is_selected": 0, "text": "Natural killer (NK) cell-based immunotherapy is a promising novel approach to treat cancer. However, NK cell function has been shown to be potentially diminished by factors common in the tumor microenvironment (TME). In this study, we assessed the synergistic potential of antibody-dependent cell-mediated cytotoxicity (ADCC) and killer immunoglobin-like receptor (KIR)-ligand mismatched NK cells to potentiate NK cell antitumor reactivity in multiple myeloma (MM). Hypoxia, lactate, prostaglandin E2 (PGE2) or combinations were selected to mimic the TME."}
{"qid": "5a68fd01b750ff445500001b", "original_text": "We describe the overall accuracy and performance of a serial rapid HIV testing algorithm used in community-based HIV testing in the context of a population-based household survey conducted in two sub-districts of uMgungundlovu district, KwaZulu-Natal, South Africa, against reference fourth-generation HIV-1/2 antibody and p24 antigen combination immunoassays. We discuss implications of the findings on rapid HIV testing programmes. Cross-sectional design: Following enrolment into the survey, questionnaires were administered to eligible and consenting participants in order to obtain demographic and HIV-related data. Peripheral blood samples were collected for HIV-related testing. Participants were offered community-based HIV testing in the home by trained field workers using a serial algorithm with two rapid diagnostic tests (RDTs) in series. In the laboratory, reference HIV testing was conducted using two fourth-generation immunoassays with all positives in the confirmatory test considered true positives. Accuracy, sensitivity, specificity, positive predictive value, negative predictive value and false-positive and false-negative rates were determined. Of 10,236 individuals enrolled in the survey, 3740 were tested in the home (median age 24 years (interquartile range 19-31 years), 42.1% males and HIV positivity on RDT algorithm 8.0%). From those tested, 3729 (99.7%) had a definitive RDT result as well as a laboratory immunoassay result.", "label": 1, "is_selected": 0, "text": "We describe the overall accuracy and performance of a serial rapid HIV testing algorithm used in community-based HIV testing in the context of a population-based household survey conducted in two sub-districts of uMgungundlovu district, KwaZulu-Natal, South Africa, against reference fourth-generation HIV-1/2 antibody and p24 antigen combination immunoassays. We discuss implications of the findings on rapid HIV testing programmes. Cross-sectional design: Following enrolment into the survey, questionnaires were administered to eligible and consenting participants in order to obtain demographic and HIV-related data. Peripheral blood samples were collected for HIV-related testing. Participants were offered community-based HIV testing in the home by trained field workers using a serial algorithm with two rapid diagnostic tests (RDTs) in series. In the laboratory, reference HIV testing was conducted using two fourth-generation immunoassays with all positives in the confirmatory test considered true positives. Accuracy, sensitivity, specificity, positive predictive value, negative predictive value and false-positive and false-negative rates were determined. Of 10,236 individuals enrolled in the survey, 3740 were tested in the home (median age 24 years (interquartile range 19-31 years), 42.1% males and HIV positivity on RDT algorithm 8.0%). From those tested, 3729 (99.7%) had a definitive RDT result as well as a laboratory immunoassay result."}
{"qid": "56c1d857ef6e394741000033", "original_text": "Opicapone (OPC) is a novel catechol-O-methyltransferase (COMT) inhibitor to be used as adjunctive therapy in levodopa-treated patients with Parkinson's disease. The purpose of this study was to evaluate the effect of moderate liver impairment on the pharmacokinetics (PK) and pharmacodynamics (PD; effect on COMT activity) of OPC. An open-label, parallel-group study in patients (n = 8) with moderate liver impairment (Child-Pugh category B, score of 7 to 9) and matched healthy subjects (n = 8, control) with normal liver function. All subjects received a single 50-mg oral dose of OPC, with plasma and urine concentrations of opicapone and its metabolites measured up to 72 h post-dose, including soluble COMT (S-COMT) activity. A one-way analysis of variance (ANOVA) was used to compare the main PK and PD parameters between groups. Point estimates (PE) of geometric mean ratios (GMR) and corresponding 90 % confidence intervals (90%CI) for the ratio hepatic/control subjects of each parameter were calculated and compared with the reference interval (80-125 %). Exposure to opicapone (AUC and Cmax) increased significantly in patients with moderate hepatic impairment (PE", "label": 1, "is_selected": 0, "text": "Opicapone (OPC) is a novel catechol-O-methyltransferase (COMT) inhibitor to be used as adjunctive therapy in levodopa-treated patients with Parkinson's disease. The purpose of this study was to evaluate the effect of moderate liver impairment on the pharmacokinetics (PK) and pharmacodynamics (PD; effect on COMT activity) of OPC. An open-label, parallel-group study in patients (n = 8) with moderate liver impairment (Child-Pugh category B, score of 7 to 9) and matched healthy subjects (n = 8, control) with normal liver function. All subjects received a single 50-mg oral dose of OPC, with plasma and urine concentrations of opicapone and its metabolites measured up to 72 h post-dose, including soluble COMT (S-COMT) activity. A one-way analysis of variance (ANOVA) was used to compare the main PK and PD parameters between groups. Point estimates (PE) of geometric mean ratios (GMR) and corresponding 90 % confidence intervals (90%CI) for the ratio hepatic/control subjects of each parameter were calculated and compared with the reference interval (80-125 %). Exposure to opicapone (AUC and Cmax) increased significantly in patients with moderate hepatic impairment (PE"}
{"qid": "587d13c0d673c3eb14000004", "original_text": "Chromatin immunoprecipitation (ChIP) followed by high-throughput sequencing (ChIP-seq) or ChIP followed by genome tiling array analysis (ChIP-chip) have become standard technologies for genome-wide identification of DNA-binding protein target sites. A number of algorithms have been developed in parallel that allow identification of binding sites from ChIP-seq or ChIP-chip datasets and subsequent visualization in the University of California Santa Cruz (UCSC) Genome Browser as custom annotation tracks. However, summarizing these tracks can be a daunting task, particularly if there are a large number of binding sites or the binding sites are distributed widely across the genome. We have developed ChIPpeakAnno as a Bioconductor package within the statistical programming environment R to facilitate batch annotation of enriched peaks identified from ChIP-seq, ChIP-chip, cap analysis of gene expression (CAGE) or any experiments resulting in a large number of enriched genomic regions. The binding sites annotated with ChIPpeakAnno can be viewed easily as a table, a pie chart or plotted in histogram form, i.e., the distribution of distances to the nearest genes for each set of peaks. In addition, we have implemented functionalities for determining the significance of overlap between replicates or binding sites among transcription factors within a complex, and for drawing Venn diagrams to visualize the extent of the overlap between replicates. Furthermore, the package includes functionalities to retrieve sequences flanking putative binding sites for PCR amplification, cloning, or motif discovery, and to identify Gene Ontology (GO) terms associated with adjacent genes.", "label": 1, "is_selected": 0, "text": "Chromatin immunoprecipitation (ChIP) followed by high-throughput sequencing (ChIP-seq) or ChIP followed by genome tiling array analysis (ChIP-chip) have become standard technologies for genome-wide identification of DNA-binding protein target sites. A number of algorithms have been developed in parallel that allow identification of binding sites from ChIP-seq or ChIP-chip datasets and subsequent visualization in the University of California Santa Cruz (UCSC) Genome Browser as custom annotation tracks. However, summarizing these tracks can be a daunting task, particularly if there are a large number of binding sites or the binding sites are distributed widely across the genome. We have developed ChIPpeakAnno as a Bioconductor package within the statistical programming environment R to facilitate batch annotation of enriched peaks identified from ChIP-seq, ChIP-chip, cap analysis of gene expression (CAGE) or any experiments resulting in a large number of enriched genomic regions. The binding sites annotated with ChIPpeakAnno can be viewed easily as a table, a pie chart or plotted in histogram form, i.e., the distribution of distances to the nearest genes for each set of peaks. In addition, we have implemented functionalities for determining the significance of overlap between replicates or binding sites among transcription factors within a complex, and for drawing Venn diagrams to visualize the extent of the overlap between replicates. Furthermore, the package includes functionalities to retrieve sequences flanking putative binding sites for PCR amplification, cloning, or motif discovery, and to identify Gene Ontology (GO) terms associated with adjacent genes."}
{"qid": "5c6aef167c78d69471000023", "original_text": "The tool developed for GPU-accelerated alignment of bisulfite-treated DNA sequences is called Bismark. Bismark is a widely used tool for bisulfite sequencing data analysis, including the alignment of bisulfite-treated DNA sequences. It utilizes the GPU acceleration provided by NVIDIA to significantly reduce the computational time required for alignment, making it a powerful tool for analyzing large-scale bisulfite sequencing data. Bismark can be downloaded from the official website and is compatible with various operating systems, including Linux, macOS, and Windows.", "label": 0, "is_selected": 0, "text": "The tool developed for GPU-accelerated alignment of bisulfite-treated DNA sequences is called Bismark. Bismark is a widely used tool for bisulfite sequencing data analysis, including the alignment of bisulfite-treated DNA sequences. It utilizes the GPU acceleration provided by NVIDIA to significantly reduce the computational time required for alignment, making it a powerful tool for analyzing large-scale bisulfite sequencing data. Bismark can be downloaded from the official website and is compatible with various operating systems, including Linux, macOS, and Windows."}
{"qid": "62005c68c9dfcb9c09000017", "original_text": "The tool developed for annotation of G\u03b1, G\u03b2, and G\u03b3 subunits of G-proteins is called GammaAnnotator. It is a web-based tool that provides a user-friendly interface for annotating and predicting the functional roles of G-protein subunits in protein-protein interactions. GammaAnnotator uses a combination of machine learning algorithms and bioinformatics tools to identify potential binding sites and functional domains in G-protein subunits, including G\u03b1, G\u03b2, and G\u03b3. The tool also provides a comprehensive database of G-protein subunit annotations, allowing users to access and analyze large amounts of data related to G-protein function and regulation.", "label": 0, "is_selected": 0, "text": "The tool developed for annotation of G\u03b1, G\u03b2, and G\u03b3 subunits of G-proteins is called GammaAnnotator. It is a web-based tool that provides a user-friendly interface for annotating and predicting the functional roles of G-protein subunits in protein-protein interactions. GammaAnnotator uses a combination of machine learning algorithms and bioinformatics tools to identify potential binding sites and functional domains in G-protein subunits, including G\u03b1, G\u03b2, and G\u03b3. The tool also provides a comprehensive database of G-protein subunit annotations, allowing users to access and analyze large amounts of data related to G-protein function and regulation."}
{"qid": "54ede95c94afd6150400000a", "original_text": "Fanconi anemia is a rare genetic disorder that is inherited in an autosomal recessive manner. This means that a person must inherit two copies of a mutated gene, one from each parent, to develop the condition. There are currently 16 identified genes associated with Fanconi anemia, and each gene mutation can lead to a different combination of clinical features. The inheritance pattern of Fanconi anemia is complex and can involve both genetic and epigenetic factors.", "label": 0, "is_selected": 0, "text": "Fanconi anemia is a rare genetic disorder that is inherited in an autosomal recessive manner. This means that a person must inherit two copies of a mutated gene, one from each parent, to develop the condition. There are currently 16 identified genes associated with Fanconi anemia, and each gene mutation can lead to a different combination of clinical features. The inheritance pattern of Fanconi anemia is complex and can involve both genetic and epigenetic factors."}
{"qid": "58f3c62970f9fc6f0f00000b", "original_text": "Phalanges refer to the bones of the fingers and toes. In the human body, there are 14 phalanges in each hand and 14 in each foot. The proximal phalanges are the bones at the base of the fingers and toes, while the distal phalanges are the bones at the tips of the fingers and toes.", "label": 0, "is_selected": 0, "text": "Phalanges refer to the bones of the fingers and toes. In the human body, there are 14 phalanges in each hand and 14 in each foot. The proximal phalanges are the bones at the base of the fingers and toes, while the distal phalanges are the bones at the tips of the fingers and toes."}
{"qid": "5e46da9c3f5415952900000a", "original_text": "The UV-damaged DNA-binding protein (UV-DDB) complex is a sensor of UV-damaged DNA. It is composed of the proteins UV-DDB1 and UV-DDB2 and is responsible for detecting and responding to UV-induced DNA damage. The UV-DDB complex detects the presence of abasic sites, which are non-canonical base pairs that are formed in response to UV damage. These base pairs are recognized by the UV-DDB complex, which then recruits other repair proteins to initiate the repair process. The UV-DDB complex also plays a role in the repair of other types of DNA damage, such as oxidized bases and DNA crosslinks. In summary, the UV-DDB complex detects UV-induced DNA damage, including abasic sites, and initiates the repair process to maintain genome stability.", "label": 0, "is_selected": 1, "text": "The UV-damaged DNA-binding protein (UV-DDB complex) complex is a sensor of UV-induced DNA damage, which is responsible for detecting and responding to UV damage, and for initiating the repair process to maintain genome stability, in this article we report on the structure and function of the complex."}
{"qid": "5149e23dd24251bc0500004b", "original_text": "We have recorded blood flow velocity in the anterior and middle cerebral arteries by transcranial Doppler sonography in abstinent marijuana abusers (n = 16) and control subjects (n = 19) to assess the effects of prolonged marijuana use of the cerebrovascular system. The pulsatility index, a measure of cerebrovascular resistance, and systolic velocity were significantly (p < 0.005) increased in marijuana abusers compared to the control subjects. These findings suggest that cerebral perfusion observed in 18-30 year old marijuana abusers is comparable to that of normal 60 year-olds.", "label": 1, "is_selected": 0, "text": "We have recorded blood flow velocity in the anterior and middle cerebral arteries by transcranial Doppler sonography in abstinent marijuana abusers (n = 16) and control subjects (n = 19) to assess the effects of prolonged marijuana use of the cerebrovascular system. The pulsatility index, a measure of cerebrovascular resistance, and systolic velocity were significantly (p < 0.005) increased in marijuana abusers compared to the control subjects. These findings suggest that cerebral perfusion observed in 18-30 year old marijuana abusers is comparable to that of normal 60 year-olds."}
{"qid": "5e2f972bfbd6abf43b000030", "original_text": "Alkaptonuria is a rare disorder of metabolism caused by deficiency of homogentisic acid oxidase enzyme and characterized by triad of homogentisic aciduria (dark urine), relentlessly progressive arthritis and ochronosis. We have documented a case with typical features of alkaptonuria along with intramedullary calcification which has not been reported in the literature before.", "label": 1, "is_selected": 0, "text": "Alkaptonuria is a rare disorder of metabolism caused by deficiency of homogentisic acid oxidase enzyme and characterized by triad of homogentisic aciduria (dark urine), relentlessly progressive arthritis and ochronosis. We have documented a case with typical features of alkaptonuria along with intramedullary calcification which has not been reported in the literature before."}
{"qid": "515aa0abd24251bc050000a8", "original_text": "The aim of the Human Chromosome-centric Proteome Project (C-HPP) is to provide a comprehensive understanding of the protein complement of each human chromosome. The project aims to identify and characterize all proteins encoded by the human genome, with a focus on the specific proteins present on each chromosome. This will enable researchers to gain insights into the functional organization and evolution of the human genome, and to develop new approaches for diagnosing and treating genetic diseases. The C-HPP will also provide a resource for identifying potential drug targets and developing new therapies. By characterizing the protein complement of each chromosome, the project will help to advance our understanding of human health and disease.", "label": 0, "is_selected": 1, "text": "The Wellcome Trust has awarded a \u00a31.2m grant to the University of Oxford for the development of aProteome of the human chromosome system, which will be the first of its kind in the world, and one of the largest ever undertaken by a UK research institute.<n>"}
{"qid": "56c1f011ef6e394741000042", "original_text": "Biogen Idec Inc, Genentech Inc, Roche Holding AG and Chugai Pharmaceutical Co Ltd are developing ocrelizumab, a humanized mAb against CD20, for the potential treatment of inflammatory disorders and B-cell malignancies. Ocrelizumab is undergoing phase III clinical trials for rheumatoid arthritis and lupus nephritis, and phase II trials for multiple sclerosis and hematological cancer. Previously, ocrelizumab was also being developed for the treatment of systemic lupus erythematosus (SLE) and neuromyelitis optica; however, development for SLE has been discontinued. No development has been reported for neuromyelitis optica and as of January 2007, this indication had been removed from the company pipeline.", "label": 1, "is_selected": 0, "text": "Biogen Idec Inc, Genentech Inc, Roche Holding AG and Chugai Pharmaceutical Co Ltd are developing ocrelizumab, a humanized mAb against CD20, for the potential treatment of inflammatory disorders and B-cell malignancies. Ocrelizumab is undergoing phase III clinical trials for rheumatoid arthritis and lupus nephritis, and phase II trials for multiple sclerosis and hematological cancer. Previously, ocrelizumab was also being developed for the treatment of systemic lupus erythematosus (SLE) and neuromyelitis optica; however, development for SLE has been discontinued. No development has been reported for neuromyelitis optica and as of January 2007, this indication had been removed from the company pipeline."}
{"qid": "5721f4b30fd6f91b68000011", "original_text": "Incontinentia pigmenti (IP) is a rare X-linked dominant disorder that affects ectodermal tissues. In IP, mutations in NEMO lead to the complete loss of NF-kB activation creating a susceptibility to cellular apoptosis in response to TNF-alpha. Recently, a second nonfunctional copy of the gene, Delta NEMO was identified, opposite in direction to NEMO. Almost 90% of IP whose gene mutation type had been recognized have a recurrent genomic deletion of exons 4-10 of the NEMO (IKK gamma) gene, called NEMO Delta 4-10, which is necessary to activate the NF-kB pathway. Therefore, PCR-based detection of the NEMO deletion is a diagnostic measurement for IP.", "label": 1, "is_selected": 0, "text": "Incontinentia pigmenti (IP) is a rare X-linked dominant disorder that affects ectodermal tissues. In IP, mutations in NEMO lead to the complete loss of NF-kB activation creating a susceptibility to cellular apoptosis in response to TNF-alpha. Recently, a second nonfunctional copy of the gene, Delta NEMO was identified, opposite in direction to NEMO. Almost 90% of IP whose gene mutation type had been recognized have a recurrent genomic deletion of exons 4-10 of the NEMO (IKK gamma) gene, called NEMO Delta 4-10, which is necessary to activate the NF-kB pathway. Therefore, PCR-based detection of the NEMO deletion is a diagnostic measurement for IP."}
{"qid": "56f15c5a2ac5ed1459000012", "original_text": "Zinc Finger nucleases (ZFNs) have been used to create precise genome modifications at frequencies that might be therapeutically useful in gene therapy. We created a mouse model of a generic recessive genetic disease to establish a preclinical system to develop the use of ZFN-mediated gene correction for gene therapy. We knocked a mutated GFP gene into the ROSA26 locus in murine embryonic stem (ES) cells and used these cells to create a transgenic mouse. We used ZFNs to determine the frequency of gene correction by gene targeting in different primary cells from this model.", "label": 1, "is_selected": 0, "text": "Zinc Finger nucleases (ZFNs) have been used to create precise genome modifications at frequencies that might be therapeutically useful in gene therapy. We created a mouse model of a generic recessive genetic disease to establish a preclinical system to develop the use of ZFN-mediated gene correction for gene therapy. We knocked a mutated GFP gene into the ROSA26 locus in murine embryonic stem (ES) cells and used these cells to create a transgenic mouse. We used ZFNs to determine the frequency of gene correction by gene targeting in different primary cells from this model."}
{"qid": "58cf5c5a8acda34529000003", "original_text": "Base J is a specialized DNA base found in the genome of Leishmania tarentolae, a species of protozoan parasite that causes leishmaniasis. Specifically, base J is located in the intronic region of the Leishmania tarentolae gene encoding the protein LTAR108. The intronic region is a non-coding DNA sequence located within a gene, and base J is present in a specific location within this region. The exact location of base J in the L. tarentolae genome is not well understood, as it is a relatively rare base pairing event compared to other base pairs. However, recent studies have identified specific sequences that are enriched for base J in the L. tarentolae genome.", "label": 0, "is_selected": 0, "text": "Base J is a specialized DNA base found in the genome of Leishmania tarentolae, a species of protozoan parasite that causes leishmaniasis. Specifically, base J is located in the intronic region of the Leishmania tarentolae gene encoding the protein LTAR108. The intronic region is a non-coding DNA sequence located within a gene, and base J is present in a specific location within this region. The exact location of base J in the L. tarentolae genome is not well understood, as it is a relatively rare base pairing event compared to other base pairs. However, recent studies have identified specific sequences that are enriched for base J in the L. tarentolae genome."}
{"qid": "5311bf53e3eabad021000006", "original_text": "There are several biotracers that are used for the detection of Alzheimer's disease using positron emission tomography (PET). The most commonly used biotracers are: 1. Pittsburgh Compound-B (PiB): This tracer binds to beta-amyloid plaques, a hallmark of Alzheimer's disease. 2. Florbetapir (Amyvid): This tracer binds to beta-amyloid plaques and is FDA-approved for clinical diagnostic imaging of Alzheimer's disease. 3. florbetapir (Avanafil): This tracer also binds to beta-amyloid plaques. 4. T807 (GE-068): This tracer is a novel PET radioligand that selectively binds to alpha-synuclein, a protein that is implicated in Parkinson's disease and dementia with Lewy bodies. 5. NE-100: This tracer is a novel PET radioligand that selectively binds to tau protein, which is a hallmark of various neurodegenerative diseases, including Alzheimer's disease. It's important to note that these biotracers are only available for research purposes and are not yet approved for clinical use. Additionally, the diagnosis of Alzheimer's disease should be made by a qualified healthcare professional based on a comprehensive medical evaluation, including a combination of clinical, cognitive, and laboratory tests.", "label": 0, "is_selected": 1, "text": "The diagnosis of Alzheimer's disease can be made using positron emission tomography (PET), but it is important to note that these biotracers are only available for research purposes and are not yet approved for clinical use, as well as that a qualified healthcare professional should be made aware of a comprehensive medical evaluation, including a combination of clinical, cognitive, and laboratory tests. Additionally, the diagnosis ofAlzheimer's Disease should be given to a qualified medical professional based on a comprehensive clinical, Cognitive, and Laboratory tests."}
{"qid": "61fbc51ec9dfcb9c0900000f", "original_text": "The Segluromet combination pill is a fixed-dose combination of two drugs: semaglutide and metformin. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps to increase insulin secretion, improve insulin sensitivity, and reduce glucagon secretion. Metformin is a biguanide anti-diabetic medication that works by decreasing glucose production in the liver and increasing insulin sensitivity. This combination pill is used to treat type 2 diabetes mellitus.", "label": 0, "is_selected": 1, "text": "The US Food and Drug Administration (FDA) has granted approval for the Segluromet combination pill for the treatment of type 2 diabetes in patients who have failed or are intolerant to other anti-diabetic treatments.This combination pill is a fixed-dose combination of two drugs, semaglutide and metformin, that helps to increase insulin secretion, improve insulin sensitivity, and reduce glucagon secretion."}
{"qid": "5898500478275d0c4a000017", "original_text": "Obsessive-compulsive disorder (OCD) is a common, often debilitating disorder characterized by the presence of obsessions and compulsions. Obsessions are repetitive thoughts or images which are experienced as intrusive and unwanted; they cause marked anxiety and distress. Compulsions (also known as rituals) are repetitive behaviors or mental acts that individuals with OCD perform in an attempt to decrease their anxiety. Patients tend to hide their symptoms due to shame; the amount of time between onset of symptoms and appropriate treatment is often many years. The disorder likely results from several etiological variables; functional imaging studies have consistently shown hyperactivity in the orbitofrontal cortex, anterior cingulate, thalamus, and striatum. The mainstays of treatment include cognitive-behavioral therapy in the form of exposure and response prevention (ERP) and serotonin reuptake inhibiting medications. Several pharmacological augmentation strategies exist for treatment-resistant OCD, with addition of antipsychotics being most commonly employed. Radio and neurosurgical procedures, including gamma knife radiation and deep brain stimulation, are reserved for severe, treatment-refractory disease that has not responded to multiple treatments, and some patients may benefit from transcranial magnetic stimulation.", "label": 1, "is_selected": 0, "text": "Obsessive-compulsive disorder (OCD) is a common, often debilitating disorder characterized by the presence of obsessions and compulsions. Obsessions are repetitive thoughts or images which are experienced as intrusive and unwanted; they cause marked anxiety and distress. Compulsions (also known as rituals) are repetitive behaviors or mental acts that individuals with OCD perform in an attempt to decrease their anxiety. Patients tend to hide their symptoms due to shame; the amount of time between onset of symptoms and appropriate treatment is often many years. The disorder likely results from several etiological variables; functional imaging studies have consistently shown hyperactivity in the orbitofrontal cortex, anterior cingulate, thalamus, and striatum. The mainstays of treatment include cognitive-behavioral therapy in the form of exposure and response prevention (ERP) and serotonin reuptake inhibiting medications. Several pharmacological augmentation strategies exist for treatment-resistant OCD, with addition of antipsychotics being most commonly employed. Radio and neurosurgical procedures, including gamma knife radiation and deep brain stimulation, are reserved for severe, treatment-refractory disease that has not responded to multiple treatments, and some patients may benefit from transcranial magnetic stimulation."}
{"qid": "55046d5ff8aee20f27000007", "original_text": "Intrahepatic cholangiocarcinoma (CCA) is characterized by an abundant desmoplastic environment. Poor prognosis of CCA has been associated with the presence of alpha-smooth muscle actin (\u03b1-SMA)-positive myofibroblasts (MFs) in the stroma and with the sustained activation of the epidermal growth factor receptor (EGFR) in tumor cells. Among EGFR ligands, heparin-binding epidermal growth factor (HB-EGF) has emerged as a paracrine factor that contributes to intercellular communications between MFs and tumor cells in several cancers. This study was designed to test whether hepatic MFs contributed to CCA progression through EGFR signaling. The interplay between CCA cells and hepatic MFs was examined first in vivo, using subcutaneous xenografts into immunocompromised mice. In these experiments, cotransplantation of CCA cells with human liver myofibroblasts (HLMFs) increased tumor incidence, size, and metastatic dissemination of tumors. These effects were abolished by gefitinib, an EGFR tyrosine kinase inhibitor. Immunohistochemical analyses of human CCA tissues showed that stromal MFs expressed HB-EGF, whereas EGFR was detected in cancer cells. In vitro, HLMFs produced HB-EGF and their conditioned media induced EGFR activation and promoted disruption of adherens junctions, migratory and invasive properties in CCA cells. These effects were abolished in the presence of gefitinib or HB-EGF-neutralizing antibody. We also showed that CCA cells produced transforming growth factor beta 1, which, in turn, induced HB-EGF expression in HLMFs. A reciprocal cross-talk between CCA cells and myofibroblasts through the HB-EGF/EGFR axis contributes to CCA progression.", "label": 1, "is_selected": 0, "text": "Intrahepatic cholangiocarcinoma (CCA) is characterized by an abundant desmoplastic environment. Poor prognosis of CCA has been associated with the presence of alpha-smooth muscle actin (\u03b1-SMA)-positive myofibroblasts (MFs) in the stroma and with the sustained activation of the epidermal growth factor receptor (EGFR) in tumor cells. Among EGFR ligands, heparin-binding epidermal growth factor (HB-EGF) has emerged as a paracrine factor that contributes to intercellular communications between MFs and tumor cells in several cancers. This study was designed to test whether hepatic MFs contributed to CCA progression through EGFR signaling. The interplay between CCA cells and hepatic MFs was examined first in vivo, using subcutaneous xenografts into immunocompromised mice. In these experiments, cotransplantation of CCA cells with human liver myofibroblasts (HLMFs) increased tumor incidence, size, and metastatic dissemination of tumors. These effects were abolished by gefitinib, an EGFR tyrosine kinase inhibitor. Immunohistochemical analyses of human CCA tissues showed that stromal MFs expressed HB-EGF, whereas EGFR was detected in cancer cells. In vitro, HLMFs produced HB-EGF and their conditioned media induced EGFR activation and promoted disruption of adherens junctions, migratory and invasive properties in CCA cells. These effects were abolished in the presence of gefitinib or HB-EGF-neutralizing antibody. We also showed that CCA cells produced transforming growth factor beta 1, which, in turn, induced HB-EGF expression in HLMFs. A reciprocal cross-talk between CCA cells and myofibroblasts through the HB-EGF/EGFR axis contributes to CCA progression."}
{"qid": "58aa0c6f396a458e50000008", "original_text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and pair bonding. More recent research indicates that oxytocin may have broader pro-social effects on behavior and cognition, which points towards oxytocin's potential as an agent to help improve social cognition and functioning in psychiatric disorders such as schizophrenia and autism.", "label": 1, "is_selected": 0, "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and pair bonding. More recent research indicates that oxytocin may have broader pro-social effects on behavior and cognition, which points towards oxytocin's potential as an agent to help improve social cognition and functioning in psychiatric disorders such as schizophrenia and autism."}
{"qid": "5c5f0c5a1a4c55d80b00000f", "original_text": "Yes, LRP1 (Low-density lipoprotein receptor-related protein 1) has been shown to interact with the urokinase receptor (uKPA/uKPB1). LRP1 and uKPA/uKPB1 are both members of the extracellular matrix protein superfamily and have been implicated in various cellular processes, including cell adhesion, migration, and signaling. Studies have demonstrated that LRP1 and uKPA/uKPB1 interact through their extracellular domains, leading to the activation of downstream signaling pathways involved in cellular processes such as cell proliferation, differentiation, and survival. These interactions have important implications for various diseases, including cancer and neurodegenerative disorders.", "label": 0, "is_selected": 1, "text": "What is the relationship between LRP1 and the urokinase receptor (uKPA/uKPB1) and what are the implications for cancer and neurodegenerative diseases?...what is the mechanism by which LRP 1 interacts with uKPA and uKPB1 and what is the implication for diseases such as cancer, neurodegenerative disorders and Parkinson's disease?"}
{"qid": "5e481b2cd14c9f295d00000a", "original_text": "ROS (Reactive Oxygen Species) production in relation to UVR (Ultraviolet Radiation) is a well-established area of research in the field of photobiology. UVR exposure can induce the formation of ROS in various biological systems, including cells, tissues, and organs. ROS are highly reactive molecules that can damage cellular components, including DNA, proteins, and lipids, leading to various adverse effects. The most common ROS produced in response to UVR are superoxide anions (O2\u2022-), hydrogen peroxide (H2O2), and singlet oxygen (1O2). These ROS can also react with other molecules, such as endogenous antioxidants, resulting in the depletion of cellular antioxidant defenses. Studies have shown that UVR can increase ROS production in various tissues, including the skin, eyes, and immune system. For example, UVR exposure can increase intracellular O2\u2022- levels in keratinocytes, leading to DNA damage and mutations. Similarly, UVR can induce H2O2 production in immune cells, which can activate pro-inflammatory signaling pathways and promote inflammation. The production of ROS in response to UVR can also impact the immune system, leading to the activation of immune cells and the production of pro-inflammatory cytokines. For example, UVR can activate the NF-\u03baB pathway in immune cells, leading to the production of pro-inflammatory cytokines such as TNF-\u03b1 and IL-6. Overall, the production of ROS in response to UVR is a complex process that can impact various cellular pathways and contribute to the development of various UVR-induced diseases, including photoaging, photodermatitis, and cancer. Understanding the mechanisms of ROS production in response to UVR can provide valuable insights into the development of effective prevention and treatment strategies for these diseases.", "label": 0, "is_selected": 1, "text": "The aim of this project is to investigate the mechanisms by which the production of reactive oxygen species (ROS) in response to UVR can contribute to the development of various UVR-induced diseases, including photoaging, photodermatitis, and cancer, and to develop effective prevention and treatment strategies for these diseases.Overall, this project will be carried out at the University of California, Los Angeles (UCLA), and will be funded by the National Institute of Environmental Health Sciences (NIEHS), part of the US Department of Health and Human Services (HHS), and the National Institutes of Health (NIH), with support from the National Science Foundation (NSF)."}
{"qid": "56c1f029ef6e39474100004a", "original_text": "Valproic acid (VPA) is an antiepileptic agent with histone deacetylase inhibitor (HDACi) activity shown to sensitize glioblastoma (GBM) cells to radiation in preclinical models. We evaluated the addition of VPA to standard radiation therapy (RT) plus temozolomide (TMZ) in patients with newly diagnosed GBM. Thirty-seven patients with newly diagnosed GBM were enrolled between July 2006 and April 2013. Patients received VPA, 25 mg/kg orally, divided into 2 daily doses concurrent with RT and TMZ. The first dose of VPA was given 1 week before the first day of RT at 10 to 15 mg/kg/day and subsequently increased up to 25 mg/kg/day over the week prior to radiation. VPA- and TMZ-related acute toxicities were evaluated using Common Toxicity Criteria version 3.0 (National Cancer Institute Cancer Therapy Evaluation Program) and Cancer Radiation Morbidity Scoring Scheme for toxicity and adverse event reporting (Radiation Therapy Oncology Group/European Organization for Research and Treatment). A total of 81% of patients took VPA according to protocol. Median overall survival (OS) was 29.6 months (range: 21-63.8 months), and median progression-free survival (PFS) was 10.5 months (range: 6.8-51.2 months). OS at 6, 12, and 24 months was 97%, 86%, and 56%, respectively.", "label": 1, "is_selected": 0, "text": "Valproic acid (VPA) is an antiepileptic agent with histone deacetylase inhibitor (HDACi) activity shown to sensitize glioblastoma (GBM) cells to radiation in preclinical models. We evaluated the addition of VPA to standard radiation therapy (RT) plus temozolomide (TMZ) in patients with newly diagnosed GBM. Thirty-seven patients with newly diagnosed GBM were enrolled between July 2006 and April 2013. Patients received VPA, 25 mg/kg orally, divided into 2 daily doses concurrent with RT and TMZ. The first dose of VPA was given 1 week before the first day of RT at 10 to 15 mg/kg/day and subsequently increased up to 25 mg/kg/day over the week prior to radiation. VPA- and TMZ-related acute toxicities were evaluated using Common Toxicity Criteria version 3.0 (National Cancer Institute Cancer Therapy Evaluation Program) and Cancer Radiation Morbidity Scoring Scheme for toxicity and adverse event reporting (Radiation Therapy Oncology Group/European Organization for Research and Treatment). A total of 81% of patients took VPA according to protocol. Median overall survival (OS) was 29.6 months (range: 21-63.8 months), and median progression-free survival (PFS) was 10.5 months (range: 6.8-51.2 months). OS at 6, 12, and 24 months was 97%, 86%, and 56%, respectively."}
{"qid": "5a76039b83b0d9ea66000010", "original_text": "Treatment of autoimmune diseases, such as rheumatoid arthritis (RA), has advanced substantially over the past decade with the development of biologics targeting inflammatory cytokines. Recent progress in treating RA has been achieved with janus kinase (JAK) inhibitors (Jakinibs), an orally available disease-modifying anti-rheumatic drug targeting the intracellular kinase JAK and with similar efficacy to biologics. The first Jakinib approved for RA was tofacitinib, which exerted superiority to methotrexate and non-inferiority to tumor necrosis factor (TNF) inhibitors.", "label": 1, "is_selected": 0, "text": "Treatment of autoimmune diseases, such as rheumatoid arthritis (RA), has advanced substantially over the past decade with the development of biologics targeting inflammatory cytokines. Recent progress in treating RA has been achieved with janus kinase (JAK) inhibitors (Jakinibs), an orally available disease-modifying anti-rheumatic drug targeting the intracellular kinase JAK and with similar efficacy to biologics. The first Jakinib approved for RA was tofacitinib, which exerted superiority to methotrexate and non-inferiority to tumor necrosis factor (TNF) inhibitors."}
{"qid": "55200c606b348bb82c000013", "original_text": "Betrixaban is a novel oral anticoagulant that inhibits factor Xa, which is a clotting factor in the blood coagulation cascade. It is used to treat and prevent venous thromboembolism (VTE) in patients at high risk for VTE, including those with cancer, surgery, or immobility. By inhibiting factor Xa, betrixaban prevents the formation of thrombin, which is essential for clot formation, and reduces the risk of VTE.", "label": 0, "is_selected": 0, "text": "Betrixaban is a novel oral anticoagulant that inhibits factor Xa, which is a clotting factor in the blood coagulation cascade. It is used to treat and prevent venous thromboembolism (VTE) in patients at high risk for VTE, including those with cancer, surgery, or immobility. By inhibiting factor Xa, betrixaban prevents the formation of thrombin, which is essential for clot formation, and reduces the risk of VTE."}
{"qid": "51588c34d24251bc05000095", "original_text": "Two recent studies have reported the association of rs75932628-T in the TREM2 gene with the risk for Alzheimer's disease (AD). Rs75932628-T is a rare nonsynonymous variant (p.R47H) that confers a high risk of AD with an effect size similar to that of the APOE \u025b4 allele. However, this association has not been replicated in any independent studies to date. The allelic frequency of rs75932628 varies according to the population from 0.02% to 0.63% among healthy controls.", "label": 1, "is_selected": 0, "text": "Two recent studies have reported the association of rs75932628-T in the TREM2 gene with the risk for Alzheimer's disease (AD). Rs75932628-T is a rare nonsynonymous variant (p.R47H) that confers a high risk of AD with an effect size similar to that of the APOE \u025b4 allele. However, this association has not been replicated in any independent studies to date. The allelic frequency of rs75932628 varies according to the population from 0.02% to 0.63% among healthy controls."}
{"qid": "5c5897c786df2b9174000008", "original_text": "The purpose of this study was to report recurrent hemolacria, or \"bloody tears,\" as a sign of scleral buckle (SB) infection. This is an interventional case series of three eyes of three patients with hemolacria after SB placement. Two men and one woman were treated for recurrent hemolacria after SB placement for a rhegmatogenous retinal detachment. Two patients had an encircling silicone sponge placed, one 6 years and the other 3 years before presentation.", "label": 1, "is_selected": 0, "text": "The purpose of this study was to report recurrent hemolacria, or \"bloody tears,\" as a sign of scleral buckle (SB) infection. This is an interventional case series of three eyes of three patients with hemolacria after SB placement. Two men and one woman were treated for recurrent hemolacria after SB placement for a rhegmatogenous retinal detachment. Two patients had an encircling silicone sponge placed, one 6 years and the other 3 years before presentation."}
{"qid": "535d69177d100faa09000003", "original_text": "SCENAR therapy is used to treat a variety of medical conditions, including pain management, inflammation, and immune system disorders. It involves the application of a gentle electrical current to specific points on the body to stimulate the body's natural healing processes. SCENAR therapy has been shown to be effective in reducing pain, improving circulation, and promoting overall wellness.", "label": 0, "is_selected": 0, "text": "SCENAR therapy is used to treat a variety of medical conditions, including pain management, inflammation, and immune system disorders. It involves the application of a gentle electrical current to specific points on the body to stimulate the body's natural healing processes. SCENAR therapy has been shown to be effective in reducing pain, improving circulation, and promoting overall wellness."}
{"qid": "602343051cb411341a00008d", "original_text": "The prevalence of hypertriglyceridemia (HTG) is increasing. Elevated triglyceride (TG) levels are associated with an increased cardiovascular disease (CVD) risk. Moreover, severe HTG results in an elevated risk of pancreatitis, especially in severe HTG with an up to 350-fold increased risk. Both problems emphasize the clinical need for effective TG lowering. The purpose of this review is to discuss the currently available therapies and to elaborate the most promising novel therapeutics for TG lowering. Conventional lipid lowering strategies do not efficiently lower plasma TG levels, leaving a residual CVD and pancreatitis risk.", "label": 1, "is_selected": 0, "text": "The prevalence of hypertriglyceridemia (HTG) is increasing. Elevated triglyceride (TG) levels are associated with an increased cardiovascular disease (CVD) risk. Moreover, severe HTG results in an elevated risk of pancreatitis, especially in severe HTG with an up to 350-fold increased risk. Both problems emphasize the clinical need for effective TG lowering. The purpose of this review is to discuss the currently available therapies and to elaborate the most promising novel therapeutics for TG lowering. Conventional lipid lowering strategies do not efficiently lower plasma TG levels, leaving a residual CVD and pancreatitis risk."}
{"qid": "61f93c38882a024a1000004b", "original_text": "The loss of dopamine (DA)-producing neurons in the substantia nigra pars compacta (SN) underlies the core motor symptoms of the progressive movement disorder Parkinson's disease (PD). To date, no treatment to prevent or slow SN DA neurodegeneration exists; thus, the identification of the underlying factors contributing to the high vulnerability of these neurons represents the basis for the development of novel therapies. Disrupted Ca2+ homeostasis and mitochondrial dysfunction seem to be key players in the pathophysiology of PD. The autonomous pacemaker activity of SN DA neurons, in combination with low cytosolic Ca2+ buffering, leads to large somatodendritic fluctuations of intracellular Ca2+ levels that are linked to elevated mitochondrial oxidant stress. L-type voltage-gated Ca2+ channels (LTCCs) contribute to these Ca2+ oscillations in dendrites, and LTCC inhibition was beneficial in cellular and in vivo animal models of PD. However, in a recently completed phase 3 clinical trial, the dihydropyridine (DHP) LTCC inhibitor isradipine failed to slow disease progression in early PD patients, questioning the feasibility of DHPs for PD therapy. Novel evidence also suggests that R- and T-type Ca2+ channels (RTCCs and TTCCs, respectively) represent potential PD drug targets.", "label": 1, "is_selected": 0, "text": "The loss of dopamine (DA)-producing neurons in the substantia nigra pars compacta (SN) underlies the core motor symptoms of the progressive movement disorder Parkinson's disease (PD). To date, no treatment to prevent or slow SN DA neurodegeneration exists; thus, the identification of the underlying factors contributing to the high vulnerability of these neurons represents the basis for the development of novel therapies. Disrupted Ca2+ homeostasis and mitochondrial dysfunction seem to be key players in the pathophysiology of PD. The autonomous pacemaker activity of SN DA neurons, in combination with low cytosolic Ca2+ buffering, leads to large somatodendritic fluctuations of intracellular Ca2+ levels that are linked to elevated mitochondrial oxidant stress. L-type voltage-gated Ca2+ channels (LTCCs) contribute to these Ca2+ oscillations in dendrites, and LTCC inhibition was beneficial in cellular and in vivo animal models of PD. However, in a recently completed phase 3 clinical trial, the dihydropyridine (DHP) LTCC inhibitor isradipine failed to slow disease progression in early PD patients, questioning the feasibility of DHPs for PD therapy. Novel evidence also suggests that R- and T-type Ca2+ channels (RTCCs and TTCCs, respectively) represent potential PD drug targets."}
{"qid": "518cb5ab310faafe08000008", "original_text": "Because of the decrease in the Helicobacter pylori eradication rate after standard triple therapy with a proton pump inhibitor and two antibiotics, bismuth-based therapy has recently been recommended as alternate first-line regimen in children. To comprehensively review the clinical, pharmacologic and microbiologic properties of bismuth salts, and to summarise the evidence for the therapeutic efficacy of bismuth-based therapy for H. pylori eradication in children. Bibliographical searches were performed in MEDLINE. Results on the efficacy of bismuth-containing regimens on H. pylori eradication were combined using the inverse variance method. Bismuth monotherapy showed a very low efficacy. Overall, the mean eradication rate with bismuth-based dual therapy was 68% (95% CI, 60-76%) (intention-to-treat analysis-ITT) and 73% (95% CI, 64-81%) (per protocol-PP).", "label": 1, "is_selected": 0, "text": "Because of the decrease in the Helicobacter pylori eradication rate after standard triple therapy with a proton pump inhibitor and two antibiotics, bismuth-based therapy has recently been recommended as alternate first-line regimen in children. To comprehensively review the clinical, pharmacologic and microbiologic properties of bismuth salts, and to summarise the evidence for the therapeutic efficacy of bismuth-based therapy for H. pylori eradication in children. Bibliographical searches were performed in MEDLINE. Results on the efficacy of bismuth-containing regimens on H. pylori eradication were combined using the inverse variance method. Bismuth monotherapy showed a very low efficacy. Overall, the mean eradication rate with bismuth-based dual therapy was 68% (95% CI, 60-76%) (intention-to-treat analysis-ITT) and 73% (95% CI, 64-81%) (per protocol-PP)."}
{"qid": "53215fca9b2d7acc7e000005", "original_text": "Mitochondria contain two membranes, the outer membrane and the inner membrane with folded cristae. The mitochondrial inner membrane organizing system (MINOS) is a large protein complex required for maintaining inner membrane architecture. MINOS interacts with both preprotein transport machineries of the outer membrane, the translocase of the outer membrane (TOM) and the sorting and assembly machinery (SAM). It is unknown, however, whether MINOS plays a role in the biogenesis of outer membrane proteins. We have dissected the interaction of MINOS with TOM and SAM and report that MINOS binds to both translocases independently. MINOS binds to the SAM complex via the conserved polypeptide transport-associated domain of Sam50.", "label": 1, "is_selected": 0, "text": "Mitochondria contain two membranes, the outer membrane and the inner membrane with folded cristae. The mitochondrial inner membrane organizing system (MINOS) is a large protein complex required for maintaining inner membrane architecture. MINOS interacts with both preprotein transport machineries of the outer membrane, the translocase of the outer membrane (TOM) and the sorting and assembly machinery (SAM). It is unknown, however, whether MINOS plays a role in the biogenesis of outer membrane proteins. We have dissected the interaction of MINOS with TOM and SAM and report that MINOS binds to both translocases independently. MINOS binds to the SAM complex via the conserved polypeptide transport-associated domain of Sam50."}
{"qid": "56f3f2072ac5ed1459000018", "original_text": "3H-1,2-dithiole-3-thione (D3T), an inducer of antioxidant and phase 2 genes, is known to enhance the detoxification of environmental carcinogens, prevent neoplasia, and elicit other protective effects. However, a comprehensive view of the regulatory pathways induced by this compound has not yet been elaborated. Fischer F344 rats were gavaged daily for 5 days with vehicle or D3T (0.3 mmol/kg). The global changes of gene expression in liver were measured with Affymetrix RG-U34A chips. With the use of functional class scoring, a semi-supervised method exploring both the expression pattern and the functional annotation of the genes, the Gene Ontology classes were ranked according to the significance of the impact of D3T treatment. Two unexpected functional classes were identified for the D3T treatment, cytosolic ribosome constituents with 90% of those genes increased, and cholesterol biosynthesis with 91% of the genes repressed.", "label": 1, "is_selected": 0, "text": "3H-1,2-dithiole-3-thione (D3T), an inducer of antioxidant and phase 2 genes, is known to enhance the detoxification of environmental carcinogens, prevent neoplasia, and elicit other protective effects. However, a comprehensive view of the regulatory pathways induced by this compound has not yet been elaborated. Fischer F344 rats were gavaged daily for 5 days with vehicle or D3T (0.3 mmol/kg). The global changes of gene expression in liver were measured with Affymetrix RG-U34A chips. With the use of functional class scoring, a semi-supervised method exploring both the expression pattern and the functional annotation of the genes, the Gene Ontology classes were ranked according to the significance of the impact of D3T treatment. Two unexpected functional classes were identified for the D3T treatment, cytosolic ribosome constituents with 90% of those genes increased, and cholesterol biosynthesis with 91% of the genes repressed."}
{"qid": "51716a438ed59a060a00000a", "original_text": "Since the early 1980s of the twentieth century, there has been great progress in the development of computational gene-finding algorithms. Some problems, however, have not yet been solved currently. Recognizing short genes in prokaryotes and short exons in eukaryotes is one of such problems. The paper is devoted to assessing various algorithms, including those currently available and the new ones proposed here, in order to find the best algorithm to solve the issue. The databases consisting of phase-specific coding and non-coding sequences of human genes with length of 192, 162, 129, 108, 87, 63 and 42 bp, respectively, have been established. Based on the databases and a standard benchmark, 19 algorithms were evaluated, which include the methods of Markov models with orders of 1 through 5, codon usage, hexamer usage, codon preference, amino acid usage, codon prototype, Fourier transform and 8 Z curve methods with various numbers of parameters. Consequently, the Z curve methods with 69 and 189 parameters are the best ones among them, based on the databases constructed here. In addition to the highest recognition accuracy confirmed by 10-fold cross-validation tests, the Z curve methods are much simpler computationally than the second best one, the fifth-order Markov chain model, in which 12 288 parameters are used. We hope that the Z curve methods presented in this paper would be beneficial to the further development of gene-finding algorithms.", "label": 1, "is_selected": 0, "text": "Since the early 1980s of the twentieth century, there has been great progress in the development of computational gene-finding algorithms. Some problems, however, have not yet been solved currently. Recognizing short genes in prokaryotes and short exons in eukaryotes is one of such problems. The paper is devoted to assessing various algorithms, including those currently available and the new ones proposed here, in order to find the best algorithm to solve the issue. The databases consisting of phase-specific coding and non-coding sequences of human genes with length of 192, 162, 129, 108, 87, 63 and 42 bp, respectively, have been established. Based on the databases and a standard benchmark, 19 algorithms were evaluated, which include the methods of Markov models with orders of 1 through 5, codon usage, hexamer usage, codon preference, amino acid usage, codon prototype, Fourier transform and 8 Z curve methods with various numbers of parameters. Consequently, the Z curve methods with 69 and 189 parameters are the best ones among them, based on the databases constructed here. In addition to the highest recognition accuracy confirmed by 10-fold cross-validation tests, the Z curve methods are much simpler computationally than the second best one, the fifth-order Markov chain model, in which 12 288 parameters are used. We hope that the Z curve methods presented in this paper would be beneficial to the further development of gene-finding algorithms."}
{"qid": "5323640b9b2d7acc7e000014", "original_text": "CADASIL (Cerebral Autosomal Dominant Arteriopathy with Amyloid Deposits) is caused by mutations in the Notch3 gene (also known as NOTCH3). The Notch3 gene is located on chromosome 12q24.1 and encodes for a protein called presenilin 1 (PS1), which plays a crucial role in the regulation of \u03b2-secretase-mediated proteolysis of the amyloid precursor protein (APP). Mutations in the Notch3 gene lead to the formation of amyloid plaques and neurofibrillary tangles, resulting in cognitive decline and vascular dementia. Therefore, the identification of mutations in the Notch3 gene is crucial for the diagnosis and genetic counseling of CADASIL.", "label": 0, "is_selected": 0, "text": "CADASIL (Cerebral Autosomal Dominant Arteriopathy with Amyloid Deposits) is caused by mutations in the Notch3 gene (also known as NOTCH3). The Notch3 gene is located on chromosome 12q24.1 and encodes for a protein called presenilin 1 (PS1), which plays a crucial role in the regulation of \u03b2-secretase-mediated proteolysis of the amyloid precursor protein (APP). Mutations in the Notch3 gene lead to the formation of amyloid plaques and neurofibrillary tangles, resulting in cognitive decline and vascular dementia. Therefore, the identification of mutations in the Notch3 gene is crucial for the diagnosis and genetic counseling of CADASIL."}
{"qid": "601c48c11cb411341a00001e", "original_text": "A Couvaier uterus is a rare congenital uterine abnormality characterized by a uterus with a duplicated or mirrored configuration, resulting in a total of three or more uterine cavities. It is estimated to occur in fewer than 1 in 10,000 births. The condition can lead to complications during pregnancy and childbirth, such as placenta previa, abnormal fetal development, and increased risk of miscarriage. Surgical correction may be considered in some cases.", "label": 0, "is_selected": 0, "text": "A Couvaier uterus is a rare congenital uterine abnormality characterized by a uterus with a duplicated or mirrored configuration, resulting in a total of three or more uterine cavities. It is estimated to occur in fewer than 1 in 10,000 births. The condition can lead to complications during pregnancy and childbirth, such as placenta previa, abnormal fetal development, and increased risk of miscarriage. Surgical correction may be considered in some cases."}
{"qid": "532f05bdd6d3ac6a34000026", "original_text": "An increasing body of evidence indicates that oxidative stress and damage play a role in the pathogenesis of a number of diseases associated with neurodegeneration, including Down syndrome (DS), Alzheimer's disease (AD) and Pick's disease (PD). Although oxidative stress is a common element in these diseases, specific clinico-pathological phenotypes have been described for each disorder. Development of these phenotypes might be linked, among others, to differences in antioxidant response. The present study is designed to investigate expression of peroxiredoxins (Prxs), the newly characterized family of highly conserved antioxidant enzymes, and other antioxidant enzymes in frontal cortex and cerebellum of DS, AD and PD patients using the technique of proteomics. Levels of Prx I, Mn superoxide dismutase (SOD2) and glutathione-S-transferase omega1 in DS, AD and PD were not significantly different from that of controls in both brain regions investigated.", "label": 1, "is_selected": 0, "text": "An increasing body of evidence indicates that oxidative stress and damage play a role in the pathogenesis of a number of diseases associated with neurodegeneration, including Down syndrome (DS), Alzheimer's disease (AD) and Pick's disease (PD). Although oxidative stress is a common element in these diseases, specific clinico-pathological phenotypes have been described for each disorder. Development of these phenotypes might be linked, among others, to differences in antioxidant response. The present study is designed to investigate expression of peroxiredoxins (Prxs), the newly characterized family of highly conserved antioxidant enzymes, and other antioxidant enzymes in frontal cortex and cerebellum of DS, AD and PD patients using the technique of proteomics. Levels of Prx I, Mn superoxide dismutase (SOD2) and glutathione-S-transferase omega1 in DS, AD and PD were not significantly different from that of controls in both brain regions investigated."}
{"qid": "571cdd227de986d80d00000f", "original_text": "Protein tyrosine phosphatases (PTPases) and kinases coregulate the critical levels of phosphorylation necessary for intracellular signalling, cell growth and differentiation. Yersinia, the causative bacteria of the bubonic plague and other enteric diseases, secrete an active PTPase, Yop51, that enters and suppresses host immune cells. Though the catalytic domain is only approximately 20% identical to human PTP1B, the Yersinia PTPase contains all of the invariant residues present in eukaryotic PTPases, including the nucleophilic Cys 403 which forms a phosphocysteine intermediate during catalysis.", "label": 1, "is_selected": 0, "text": "Protein tyrosine phosphatases (PTPases) and kinases coregulate the critical levels of phosphorylation necessary for intracellular signalling, cell growth and differentiation. Yersinia, the causative bacteria of the bubonic plague and other enteric diseases, secrete an active PTPase, Yop51, that enters and suppresses host immune cells. Though the catalytic domain is only approximately 20% identical to human PTP1B, the Yersinia PTPase contains all of the invariant residues present in eukaryotic PTPases, including the nucleophilic Cys 403 which forms a phosphocysteine intermediate during catalysis."}
{"qid": "5c990afbecadf2e73f000030", "original_text": "Missense mutations that disrupt the RING domain of the tumor suppressor gene BRCA1 lead to increased risk of breast and ovarian cancer. The BRCA1 RING domain is a ubiquitin ligase, whose structure and function rely critically on forming a heterodimer with BARD1, which also harbors a RING domain. The function of the BARD1 RING domain is unknown. In families severely affected with breast cancer, we identified inherited BARD1 missense mutations Cys53Trp, Cys71Tyr, and Cys83Arg that alter three zinc-binding residues of the BARD1 RING domain. Each of these mutant BARD1 proteins retained the ability to form heterodimeric complexes with BRCA1 to make an active ubiquitin ligase, but the mutant BRCA1/BARD1 complexes were deficient in binding to nucleosomes and in ubiquitylating histone H2A. The BARD1 mutations also caused loss of transcriptional repression of BRCA1-regulated estrogen metabolism genes CYP1A1 and CYP3A4; breast epithelial cells edited to create heterozygous loss of BARD1 showed significantly higher expression of CYP1A1 and CYP3A4 Reintroduction of wild-type BARD1 into these cells restored CYP1A1 and CYP3A4 transcription to normal levels, but introduction of the cancer-predisposing BARD1 RING mutants failed to do so.", "label": 1, "is_selected": 0, "text": "Missense mutations that disrupt the RING domain of the tumor suppressor gene BRCA1 lead to increased risk of breast and ovarian cancer. The BRCA1 RING domain is a ubiquitin ligase, whose structure and function rely critically on forming a heterodimer with BARD1, which also harbors a RING domain. The function of the BARD1 RING domain is unknown. In families severely affected with breast cancer, we identified inherited BARD1 missense mutations Cys53Trp, Cys71Tyr, and Cys83Arg that alter three zinc-binding residues of the BARD1 RING domain. Each of these mutant BARD1 proteins retained the ability to form heterodimeric complexes with BRCA1 to make an active ubiquitin ligase, but the mutant BRCA1/BARD1 complexes were deficient in binding to nucleosomes and in ubiquitylating histone H2A. The BARD1 mutations also caused loss of transcriptional repression of BRCA1-regulated estrogen metabolism genes CYP1A1 and CYP3A4; breast epithelial cells edited to create heterozygous loss of BARD1 showed significantly higher expression of CYP1A1 and CYP3A4 Reintroduction of wild-type BARD1 into these cells restored CYP1A1 and CYP3A4 transcription to normal levels, but introduction of the cancer-predisposing BARD1 RING mutants failed to do so."}
{"qid": "5156be04d24251bc05000085", "original_text": "The cytochrome P450 (CYP) 2C19*2 loss-of-function allele has been associated with impaired clopidogrel response and worse prognosis in clopidogrel-treated patients. The benefit of tailored therapy according to platelet function test results remains unclear, and the potential effect of genotypes on this benefit has not been addressed in unstable patients. The present study was designed to evaluate the benefit of tailored therapy with a higher maintenance dose according to CYP2C19 genotypes in patients identified as nonresponders who underwent percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes. Three hundred forty-six consecutive patients were enrolled and received a loading dose of 600 mg, including 86 *2 carriers (13 homozygotes and 73 heterozygotes) and 260 *2 noncarriers. Clopidogrel response, assessed with platelet reactivity index vasoactive-stimulated phosphoprotein, was significantly affected by genotype, with lower clopidogrel response in CYP2C19*2 allele carriers (p = 0.01). Accordingly, the rate of clopidogrel nonresponse was higher in CYP2C19*2 allele carriers (53% vs 41%, p = 0.04).", "label": 1, "is_selected": 0, "text": "The cytochrome P450 (CYP) 2C19*2 loss-of-function allele has been associated with impaired clopidogrel response and worse prognosis in clopidogrel-treated patients. The benefit of tailored therapy according to platelet function test results remains unclear, and the potential effect of genotypes on this benefit has not been addressed in unstable patients. The present study was designed to evaluate the benefit of tailored therapy with a higher maintenance dose according to CYP2C19 genotypes in patients identified as nonresponders who underwent percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes. Three hundred forty-six consecutive patients were enrolled and received a loading dose of 600 mg, including 86 *2 carriers (13 homozygotes and 73 heterozygotes) and 260 *2 noncarriers. Clopidogrel response, assessed with platelet reactivity index vasoactive-stimulated phosphoprotein, was significantly affected by genotype, with lower clopidogrel response in CYP2C19*2 allele carriers (p = 0.01). Accordingly, the rate of clopidogrel nonresponse was higher in CYP2C19*2 allele carriers (53% vs 41%, p = 0.04)."}
{"qid": "5fdb42e7a43ad31278000026", "original_text": "There is increased expression of type I interferon (IFN)-regulated proteins in the blood and target tissues of patients with cutaneous lupus erythematosus (CLE) and systemic lupus erythematosus (SLE). Patients with SLE have increased IFN-regulated gene expression pointing towards a possible underlying genetic defect. To determine expression levels of five type I IFN-regulated genes that are highly expressed in SLE in the peripheral blood of patients with CLE and to correlate the expression levels with cutaneous disease activity. Peripheral blood was obtained from 10 healthy controls and 30 patients with CLE, including eight with concomitant SLE. Total RNA was extracted and reverse transcribed into complementary DNA.", "label": 1, "is_selected": 0, "text": "There is increased expression of type I interferon (IFN)-regulated proteins in the blood and target tissues of patients with cutaneous lupus erythematosus (CLE) and systemic lupus erythematosus (SLE). Patients with SLE have increased IFN-regulated gene expression pointing towards a possible underlying genetic defect. To determine expression levels of five type I IFN-regulated genes that are highly expressed in SLE in the peripheral blood of patients with CLE and to correlate the expression levels with cutaneous disease activity. Peripheral blood was obtained from 10 healthy controls and 30 patients with CLE, including eight with concomitant SLE. Total RNA was extracted and reverse transcribed into complementary DNA."}
{"qid": "61f609d3882a024a10000024", "original_text": "Psoriasis is a chronic inflammatory skin disease with significant psychological and physical impact. Over the last few decades, several highly effective target therapies have been developed, leading to a major paradigm shift in the way psoriatic disease is managed. Despite this, a proportion of patients still do not respond or lose response over time.", "label": 1, "is_selected": 0, "text": "Psoriasis is a chronic inflammatory skin disease with significant psychological and physical impact. Over the last few decades, several highly effective target therapies have been developed, leading to a major paradigm shift in the way psoriatic disease is managed. Despite this, a proportion of patients still do not respond or lose response over time."}
{"qid": "5a89537cfcd1d6a10c000002", "original_text": "Genome mapping in the dog is in its early stages. Here we illustrate an approach to combined physical and linkage mapping of type 1 anchor (gene) loci in the dog using information on syntenic homology from human and mouse, an interbreed cross/backcross, and a strategy for isolation of dog genomic clones containing both gene-specific sequences and simple sequence repeat polymorphisms.", "label": 1, "is_selected": 0, "text": "Genome mapping in the dog is in its early stages. Here we illustrate an approach to combined physical and linkage mapping of type 1 anchor (gene) loci in the dog using information on syntenic homology from human and mouse, an interbreed cross/backcross, and a strategy for isolation of dog genomic clones containing both gene-specific sequences and simple sequence repeat polymorphisms."}
{"qid": "5fdb2e91a43ad3127800000e", "original_text": "In all animals, the initial events of embryogenesis are controlled by maternal gene products that are deposited into the developing oocyte. At some point after fertilization, control of embryogenesis is transferred to the zygotic genome in a process called the maternal-to-zygotic transition. During this time, many maternal RNAs are degraded and transcription of zygotic RNAs ensues. There is a long-standing question as to which factors regulate these events. The recent findings that microRNAs and Smaug mediate maternal transcript degradation have shed new light on this aspect of the problem. However, the transcription factor(s) that activate the zygotic genome remain elusive. The discovery that many of the early transcribed genes in Drosophila share a cis-regulatory heptamer motif, CAGGTAG and related sequences, collectively referred to as TAGteam sites raised the possibility that a dedicated transcription factor could interact with these sites to activate transcription.", "label": 1, "is_selected": 0, "text": "In all animals, the initial events of embryogenesis are controlled by maternal gene products that are deposited into the developing oocyte. At some point after fertilization, control of embryogenesis is transferred to the zygotic genome in a process called the maternal-to-zygotic transition. During this time, many maternal RNAs are degraded and transcription of zygotic RNAs ensues. There is a long-standing question as to which factors regulate these events. The recent findings that microRNAs and Smaug mediate maternal transcript degradation have shed new light on this aspect of the problem. However, the transcription factor(s) that activate the zygotic genome remain elusive. The discovery that many of the early transcribed genes in Drosophila share a cis-regulatory heptamer motif, CAGGTAG and related sequences, collectively referred to as TAGteam sites raised the possibility that a dedicated transcription factor could interact with these sites to activate transcription."}
{"qid": "54d8e59f4b1fd0d33c000001", "original_text": "The mammalian target of rapamycin complex 1 (mTORC1) is involved in the cellular transcription and translation processes. The undertaken study characterized the enhancer of mRNA decapping protein 4 (Edc4) as mTORC1 interacting protein. Human T lymphoblast (CCRF-CEM) cells were used for mTORC1 purification. Co-immunoprecipitation coupled with immunoblotting analysis was used to confirm the interaction of Edc4 in mTORC1 specific purifications. Further assays were incorporated to conclude the role of mTORC1 in mRNA decapping via Edc4.", "label": 1, "is_selected": 0, "text": "The mammalian target of rapamycin complex 1 (mTORC1) is involved in the cellular transcription and translation processes. The undertaken study characterized the enhancer of mRNA decapping protein 4 (Edc4) as mTORC1 interacting protein. Human T lymphoblast (CCRF-CEM) cells were used for mTORC1 purification. Co-immunoprecipitation coupled with immunoblotting analysis was used to confirm the interaction of Edc4 in mTORC1 specific purifications. Further assays were incorporated to conclude the role of mTORC1 in mRNA decapping via Edc4."}
{"qid": "60274aca1cb411341a0000e3", "original_text": "The Thrombotic Thrombocytopenic Purpura (TTP) pentad is a clinical syndrome characterized by the following features: 1) Microangiopathic hemolytic anemia, 2) Thrombocytopenia, 3) Renal involvement (acute kidney injury or hematuria), 4) Neurological symptoms (seizures, confusion, or loss of consciousness), and 5) Cardiac dysfunction (heart failure or arrhythmias). These features are typically seen in patients with TTP, a rare blood clotting disorder caused by deficiency of the enzyme ADAMTS13.", "label": 0, "is_selected": 0, "text": "The Thrombotic Thrombocytopenic Purpura (TTP) pentad is a clinical syndrome characterized by the following features: 1) Microangiopathic hemolytic anemia, 2) Thrombocytopenia, 3) Renal involvement (acute kidney injury or hematuria), 4) Neurological symptoms (seizures, confusion, or loss of consciousness), and 5) Cardiac dysfunction (heart failure or arrhythmias). These features are typically seen in patients with TTP, a rare blood clotting disorder caused by deficiency of the enzyme ADAMTS13."}
{"qid": "54e0d7471388e8454a000015", "original_text": "Secukinumab is a monoclonal antibody that targets the molecule interleukin-17A (IL-17A). IL-17A is a cytokine that plays a central role in the inflammatory response and is involved in the pathogenesis of various inflammatory diseases, including psoriasis. Secukinumab binds to IL-17A and inhibits its activity, reducing the production of pro-inflammatory cytokines and promoting the differentiation of anti-inflammatory cytokines. This helps to alleviate symptoms of psoriasis, such as redness, itching, and scaling of the skin.", "label": 0, "is_selected": 1, "text": "Secukinumab is an anti-inflammatory drug that is being developed by Radius Health for the treatment of patients with moderate to severe plaque psoriasis, who have failed to respond to treatment with peginterferon alfa and/or peg-agony kinase inhibitors."}
{"qid": "602828b11cb411341a0000fc", "original_text": "Camrelizumab is a monoclonal antibody that targets the molecule Mucin 16 (MUC16) on cancer cells. MUC16 is a cell surface glycoprotein that is overexpressed in many cancer types, including breast, lung, and gastrointestinal cancers. Camrelizumab works by binding to MUC16 and triggering an immune response that leads to the death of cancer cells.", "label": 0, "is_selected": 1, "text": "The European Medicines Agency (EMA) has granted conditional approval for Camrelizumab (natalizumab) for the treatment of patients with advanced breast cancer who have failed at least one other treatment option and whose disease has spread to other parts of the body."}
{"qid": "54d8f37b4b1fd0d33c000004", "original_text": "The histidine-rich calcium binding protein (HRC) Ser96Ala polymorphism was shown to correlate with ventricular arrhythmias and sudden death only in dilated cardiomyopathy patients but not in healthy human carriers. In the present study, we assessed the molecular and cellular mechanisms underlying human arrhythmias by adenoviral expression of the human wild-type (HRC(WT)) or mutant HRC (HRC(S96A)) in adult rat ventricular cardiomyocytes. Total HRC protein was increased by \u223c50% in both HRC(WT)- and HRC(S96A)-infected cells. The HRC(S96A) mutant exacerbated the inhibitory effects of HRC(WT) on the amplitude of Ca(2+) transients, prolongation of Ca(2+) decay time, and caffeine-induced sarcoplasmic reticulum Ca(2+) release. Consistent with these findings, HRC(S96A) reduced maximal sarcoplasmic reticulum calcium uptake rate to a higher extent than HRC(WT). Furthermore, the frequency of spontaneous Ca(2+) sparks, which was reduced by HRC(WT), was increased by mutant HRC(S96A) under resting conditions although there were no spontaneous Ca(2+) waves under stress conditions. However, expression of the HRC(S96A) genetic variant in cardiomyocytes from a rat model of postmyocardial infarction heart failure induced dramatic disturbances of rhythmic Ca(2+) transients. These findings indicate that the HRC Ser96Ala variant increases the propensity of arrhythmogenic Ca(2+) waves in the stressed failing heart, suggesting a link between this genetic variant and life-threatening ventricular arrhythmias in human carriers.", "label": 1, "is_selected": 0, "text": "The histidine-rich calcium binding protein (HRC) Ser96Ala polymorphism was shown to correlate with ventricular arrhythmias and sudden death only in dilated cardiomyopathy patients but not in healthy human carriers. In the present study, we assessed the molecular and cellular mechanisms underlying human arrhythmias by adenoviral expression of the human wild-type (HRC(WT)) or mutant HRC (HRC(S96A)) in adult rat ventricular cardiomyocytes. Total HRC protein was increased by \u223c50% in both HRC(WT)- and HRC(S96A)-infected cells. The HRC(S96A) mutant exacerbated the inhibitory effects of HRC(WT) on the amplitude of Ca(2+) transients, prolongation of Ca(2+) decay time, and caffeine-induced sarcoplasmic reticulum Ca(2+) release. Consistent with these findings, HRC(S96A) reduced maximal sarcoplasmic reticulum calcium uptake rate to a higher extent than HRC(WT). Furthermore, the frequency of spontaneous Ca(2+) sparks, which was reduced by HRC(WT), was increased by mutant HRC(S96A) under resting conditions although there were no spontaneous Ca(2+) waves under stress conditions. However, expression of the HRC(S96A) genetic variant in cardiomyocytes from a rat model of postmyocardial infarction heart failure induced dramatic disturbances of rhythmic Ca(2+) transients. These findings indicate that the HRC Ser96Ala variant increases the propensity of arrhythmogenic Ca(2+) waves in the stressed failing heart, suggesting a link between this genetic variant and life-threatening ventricular arrhythmias in human carriers."}
{"qid": "51680a6d298dcd4e51000063", "original_text": "It has been reported that disruption of the circadian clock may lead to increased risk of breast cancer in humans and to a high rate or ionizing radiation-induced tumors and mortality in mice. Cryptochrome 1 and cryptochrome 2 proteins are core components of the mammalian circadian clock and mice mutated in both genes are arrhythmic. We tested Cry1-/- Cry2-/- mice and fibroblasts derived from these mice for radiation-induced cancer and killing and DNA damage checkpoints and killing, respectively. We find that the mutant mice are indistinguishable from the wild-type controls with respect to radiation-induced morbidity and mortality.", "label": 1, "is_selected": 0, "text": "It has been reported that disruption of the circadian clock may lead to increased risk of breast cancer in humans and to a high rate or ionizing radiation-induced tumors and mortality in mice. Cryptochrome 1 and cryptochrome 2 proteins are core components of the mammalian circadian clock and mice mutated in both genes are arrhythmic. We tested Cry1-/- Cry2-/- mice and fibroblasts derived from these mice for radiation-induced cancer and killing and DNA damage checkpoints and killing, respectively. We find that the mutant mice are indistinguishable from the wild-type controls with respect to radiation-induced morbidity and mortality."}
{"qid": "5160193d298dcd4e51000039", "original_text": "Thyrotropin-releasing hormone (TRH) improved mean arterial pressure (MAP) and myocardial contractility (dp/dtmax, -dp/dtmax, Vpm, and Vmax) and increased plasma epinephrine levels significantly at 10 min after TRH treatment in rabbits following shock, but the effects of TRH on MAP and myocardial contractility disappeared in reserpinized rabbits (4 mg/kg, 24 hr pre-treatment, iv). TRH had no effect on myocardial contractility and MAP at 20 and 30 min post-treatment in rabbits pre-treated with the beta adrenergic blocker propranolol (1 mg/kg, 1 hr before TRH treatment, iv), but the alpha adrenergic blocker phenoxybenzamine did not affect these responses to TRH.", "label": 1, "is_selected": 0, "text": "Thyrotropin-releasing hormone (TRH) improved mean arterial pressure (MAP) and myocardial contractility (dp/dtmax, -dp/dtmax, Vpm, and Vmax) and increased plasma epinephrine levels significantly at 10 min after TRH treatment in rabbits following shock, but the effects of TRH on MAP and myocardial contractility disappeared in reserpinized rabbits (4 mg/kg, 24 hr pre-treatment, iv). TRH had no effect on myocardial contractility and MAP at 20 and 30 min post-treatment in rabbits pre-treated with the beta adrenergic blocker propranolol (1 mg/kg, 1 hr before TRH treatment, iv), but the alpha adrenergic blocker phenoxybenzamine did not affect these responses to TRH."}
{"qid": "5a87e95461bb38fb2400000c", "original_text": "RNA polymerase III (Pol III) transcribes a limited set of short genes in eukaryotes producing abundant small RNAs, mostly tRNA. The originally defined yeast Pol III transcriptome appears to be expanding owing to the application of new methods. Also, several factors required for assembly and nuclear import of Pol III complex have been identified recently. Models of Pol III based on cryo-electron microscopy reconstructions of distinct Pol III conformations reveal unique features distinguishing Pol III from other polymerases.", "label": 1, "is_selected": 0, "text": "RNA polymerase III (Pol III) transcribes a limited set of short genes in eukaryotes producing abundant small RNAs, mostly tRNA. The originally defined yeast Pol III transcriptome appears to be expanding owing to the application of new methods. Also, several factors required for assembly and nuclear import of Pol III complex have been identified recently. Models of Pol III based on cryo-electron microscopy reconstructions of distinct Pol III conformations reveal unique features distinguishing Pol III from other polymerases."}
{"qid": "6026af5e1cb411341a0000c9", "original_text": "Aberrant expression of microRNAs (miRNAs) plays important roles in carcinogenesis and tumor progression. However, the expression and biological role of miR-301b in triple-negative breast cancer (TNBC) remains unclear. Here we aimed to evaluate the roles and mechanisms of miR-301b in TNBC cells. miR-301b expression was assessed in TNBC specimens and cell lines by quantitative Real-Time PCR (qRT-PCR). TNBC cells were transfected with miR-301b mimics, inhibitors or Cylindromatosis (CYLD) small interfering RNA (siRNA) using Lipofectamine 2000. The functional roles of miR-301b were determined by cell proliferation, colony formation, and apoptosis assays. Western blots and qRT-PCR were used to measure the expression of mRNAs and proteins in the cells. We found that miR-301b was upregulated in TNBC specimens and cell lines. Overexpression of miR-301b promoted cell proliferation in TNBC cells, while inhibited the apoptosis induced by 5-FU. CYLD was downregulated by miR-301b at both mRNA and protein levels in TNBC cells. Dual-luciferase report assay confirmed that miR-301b downregulated CYLD by direct interaction with the 3'-untranslated region(3'-UTR) of CYLD mRNA.", "label": 1, "is_selected": 0, "text": "Aberrant expression of microRNAs (miRNAs) plays important roles in carcinogenesis and tumor progression. However, the expression and biological role of miR-301b in triple-negative breast cancer (TNBC) remains unclear. Here we aimed to evaluate the roles and mechanisms of miR-301b in TNBC cells. miR-301b expression was assessed in TNBC specimens and cell lines by quantitative Real-Time PCR (qRT-PCR). TNBC cells were transfected with miR-301b mimics, inhibitors or Cylindromatosis (CYLD) small interfering RNA (siRNA) using Lipofectamine 2000. The functional roles of miR-301b were determined by cell proliferation, colony formation, and apoptosis assays. Western blots and qRT-PCR were used to measure the expression of mRNAs and proteins in the cells. We found that miR-301b was upregulated in TNBC specimens and cell lines. Overexpression of miR-301b promoted cell proliferation in TNBC cells, while inhibited the apoptosis induced by 5-FU. CYLD was downregulated by miR-301b at both mRNA and protein levels in TNBC cells. Dual-luciferase report assay confirmed that miR-301b downregulated CYLD by direct interaction with the 3'-untranslated region(3'-UTR) of CYLD mRNA."}
{"qid": "571529efcb4ef8864c000001", "original_text": "Ramoplanin, a new lipoglycopeptide antibiotic, inhibits cell wall peptidoglycan biosynthesis in gram-positive bacteria. In both Staphylococcus aureus and Bacillus megaterium, UDP-N-acetylmuramyl-pentapeptides (UDP-MurNAc-pentapeptides) accumulated at concentrations of ramoplanin close to the MIC, indicating that inhibition of peptidoglycan biosynthesis occurred after formation of cytoplasmic precursors. Susceptible bacteria bound or accumulated approximately 5 x 10(4) molecules of ramoplanin per cell, only 1/100th of the amount of vancomycin which binds to groups within peptidoglycan conforming to the pattern L-alpha alpha (amino acid)-D-alpha alpha-D-alpha alpha, suggesting that ramoplanin has a different target site.", "label": 1, "is_selected": 0, "text": "Ramoplanin, a new lipoglycopeptide antibiotic, inhibits cell wall peptidoglycan biosynthesis in gram-positive bacteria. In both Staphylococcus aureus and Bacillus megaterium, UDP-N-acetylmuramyl-pentapeptides (UDP-MurNAc-pentapeptides) accumulated at concentrations of ramoplanin close to the MIC, indicating that inhibition of peptidoglycan biosynthesis occurred after formation of cytoplasmic precursors. Susceptible bacteria bound or accumulated approximately 5 x 10(4) molecules of ramoplanin per cell, only 1/100th of the amount of vancomycin which binds to groups within peptidoglycan conforming to the pattern L-alpha alpha (amino acid)-D-alpha alpha-D-alpha alpha, suggesting that ramoplanin has a different target site."}
{"qid": "5c7f806d617e120c34000001", "original_text": "Early investigations into the immune surveillance of chemically-induced sarcomas led to two important concepts in tumour immunobiology: one, tumour rejection can be elicited by immune recognition of tumour antigens; and two, tumours express unique sets of antigens, which are known as tumour-specific antigens. The pioneering studies of Srivastava and colleagues led to the proposal that heat-shock proteins (HSPs) function as ubiquitous tumour-specific antigens, with the specificity residing in a population of bound peptides that identify the tissue of origin of the HSP. However, recent findings, including new data on the cell biology of peptide generation and trafficking, have called into question the specificity of tumour rejection that is induced by HSPs.", "label": 1, "is_selected": 0, "text": "Early investigations into the immune surveillance of chemically-induced sarcomas led to two important concepts in tumour immunobiology: one, tumour rejection can be elicited by immune recognition of tumour antigens; and two, tumours express unique sets of antigens, which are known as tumour-specific antigens. The pioneering studies of Srivastava and colleagues led to the proposal that heat-shock proteins (HSPs) function as ubiquitous tumour-specific antigens, with the specificity residing in a population of bound peptides that identify the tissue of origin of the HSP. However, recent findings, including new data on the cell biology of peptide generation and trafficking, have called into question the specificity of tumour rejection that is induced by HSPs."}
{"qid": "5e49c5ee6d0a277941000012", "original_text": "PWMScan is a medical device used to detect and monitor neurodegenerative disorders, such as Parkinson's disease, through a non-invasive scan of the brain. It uses advanced MRI technology to measure brain structure and function, providing accurate and early diagnosis of neurological conditions.", "label": 0, "is_selected": 0, "text": "PWMScan is a medical device used to detect and monitor neurodegenerative disorders, such as Parkinson's disease, through a non-invasive scan of the brain. It uses advanced MRI technology to measure brain structure and function, providing accurate and early diagnosis of neurological conditions."}
{"qid": "5c979383ecadf2e73f000027", "original_text": "The genomes of many bacteria that participate in nitrogen cycling through the process of nitrification contain putative genes associated with acyl-homoserine lactone (AHL) quorum sensing (QS). AHL QS or bacterial cell-cell signaling is a method of bacterial communication and gene regulation and may be involved in nitrogen oxide fluxes or other important phenotypes in nitrifying bacteria. Here, we carried out a broad survey of AHL production in nitrifying bacteria in three steps. First, we analyzed the evolutionary history of AHL synthase and AHL receptor homologs in sequenced genomes and metagenomes of nitrifying bacteria to identify AHL synthase homologs in ammonia-oxidizing bacteria (AOB) of the genus Nitrosospira and nitrite-oxidizing bacteria (NOB) of the genera Nitrococcus, Nitrobacter, and Nitrospira Next, we screened cultures of both AOB and NOB with uncharacterized AHL synthase genes and AHL synthase-negative nitrifiers by a bioassay.", "label": 1, "is_selected": 0, "text": "The genomes of many bacteria that participate in nitrogen cycling through the process of nitrification contain putative genes associated with acyl-homoserine lactone (AHL) quorum sensing (QS). AHL QS or bacterial cell-cell signaling is a method of bacterial communication and gene regulation and may be involved in nitrogen oxide fluxes or other important phenotypes in nitrifying bacteria. Here, we carried out a broad survey of AHL production in nitrifying bacteria in three steps. First, we analyzed the evolutionary history of AHL synthase and AHL receptor homologs in sequenced genomes and metagenomes of nitrifying bacteria to identify AHL synthase homologs in ammonia-oxidizing bacteria (AOB) of the genus Nitrosospira and nitrite-oxidizing bacteria (NOB) of the genera Nitrococcus, Nitrobacter, and Nitrospira Next, we screened cultures of both AOB and NOB with uncharacterized AHL synthase genes and AHL synthase-negative nitrifiers by a bioassay."}
{"qid": "58a71bb960087bc10a00002d", "original_text": "Ultraconserved elements (UCEs) are strongly depleted from segmental duplications and copy number variations (CNVs) in the human genome, suggesting that deletion or duplication of a UCE can be deleterious to the mammalian cell. Here we address the process by which CNVs become depleted of UCEs. We begin by showing that depletion for UCEs characterizes the most recent large-scale human CNV datasets and then find that even newly formed de novo CNVs, which have passed through meiosis at most once, are significantly depleted for UCEs. In striking contrast, CNVs arising specifically in cancer cells are, as a rule, not depleted for UCEs and can even become significantly enriched. This observation raises the possibility that CNVs that arise somatically and are relatively newly formed are less likely to have established a CNV profile that is depleted for UCEs. Alternatively, lack of depletion for UCEs from cancer CNVs may reflect the diseased state. In support of this latter explanation, somatic CNVs that are not associated with disease are depleted for UCEs. Finally, we show that it is possible to observe the CNVs of induced pluripotent stem (iPS) cells become depleted of UCEs over time, suggesting that depletion may be established through selection against UCE-disrupting CNVs without the requirement for meiotic divisions.", "label": 1, "is_selected": 0, "text": "Ultraconserved elements (UCEs) are strongly depleted from segmental duplications and copy number variations (CNVs) in the human genome, suggesting that deletion or duplication of a UCE can be deleterious to the mammalian cell. Here we address the process by which CNVs become depleted of UCEs. We begin by showing that depletion for UCEs characterizes the most recent large-scale human CNV datasets and then find that even newly formed de novo CNVs, which have passed through meiosis at most once, are significantly depleted for UCEs. In striking contrast, CNVs arising specifically in cancer cells are, as a rule, not depleted for UCEs and can even become significantly enriched. This observation raises the possibility that CNVs that arise somatically and are relatively newly formed are less likely to have established a CNV profile that is depleted for UCEs. Alternatively, lack of depletion for UCEs from cancer CNVs may reflect the diseased state. In support of this latter explanation, somatic CNVs that are not associated with disease are depleted for UCEs. Finally, we show that it is possible to observe the CNVs of induced pluripotent stem (iPS) cells become depleted of UCEs over time, suggesting that depletion may be established through selection against UCE-disrupting CNVs without the requirement for meiotic divisions."}
{"qid": "62211d6f3a8413c65300006f", "original_text": "Circular RNA(circRNA)is a novel type of endogenous non-coding RNA.Most circRNAs act as microRNA(miRNA)sponges to regulate the expression of functional genes. In addition,some circRNAs can be translated and interact with RNA-binding proteins to perform biological functions. The expression of circRNAs is prevalent in tissues and body fluids,and their abnormal expression is related to tumor progression.circRNAs are stable even under the treatment of RNase R because of their circular conformation. As circRNAs have construct stability,wide variety,specific regulation of tumor progression and high expression in body fluids,it is potential for circRNAs to serve as candidate diagnostic,prognostic and therapeutic targets. However,the knowledge about circRNAs remains poor. In addition to the not completely resolved functions and generation mechanisms of circRNAs,the annotations of circRNAs are also waiting for expanding.", "label": 1, "is_selected": 0, "text": "Circular RNA(circRNA)is a novel type of endogenous non-coding RNA.Most circRNAs act as microRNA(miRNA)sponges to regulate the expression of functional genes. In addition,some circRNAs can be translated and interact with RNA-binding proteins to perform biological functions. The expression of circRNAs is prevalent in tissues and body fluids,and their abnormal expression is related to tumor progression.circRNAs are stable even under the treatment of RNase R because of their circular conformation. As circRNAs have construct stability,wide variety,specific regulation of tumor progression and high expression in body fluids,it is potential for circRNAs to serve as candidate diagnostic,prognostic and therapeutic targets. However,the knowledge about circRNAs remains poor. In addition to the not completely resolved functions and generation mechanisms of circRNAs,the annotations of circRNAs are also waiting for expanding."}
{"qid": "516c220e298dcd4e51000071", "original_text": "Much attention has been focused on food components that may be beneficial in preventing lifestyle-related diseases. In this study, we investigated the effects of saponins of sea cucumber (SSC) on high-fat diet-induced obesity, insulin resistance, and fatty liver in mice. C57/BL6 mice were fed a high-fat diet, containing 0.03% SSC, or 0.1% SSC for 8 weeks. Both doses of SSC exhibited a weight-loss effect and significantly decreased adipose tissue weight, in both visceral and subcutaneous depots. Furthermore, 0.1% SSC treatment dramatically decreased the hepatic triglyceride and total cholesterol accumulation. Mice administrated with 0.1% SSC had significantly decreased serum glucose and insulin levels, lower homeostatic model assessment for insulin resistance index, and area under the blood glucose curve, suggesting that insulin sensitivity is enhanced by dietary SSC. Dietary SSC also prevented adipokine imbalance, by increasing adiponectin production and decreasing tumor necrosis factor alpha level caused by high-fat diet.", "label": 1, "is_selected": 0, "text": "Much attention has been focused on food components that may be beneficial in preventing lifestyle-related diseases. In this study, we investigated the effects of saponins of sea cucumber (SSC) on high-fat diet-induced obesity, insulin resistance, and fatty liver in mice. C57/BL6 mice were fed a high-fat diet, containing 0.03% SSC, or 0.1% SSC for 8 weeks. Both doses of SSC exhibited a weight-loss effect and significantly decreased adipose tissue weight, in both visceral and subcutaneous depots. Furthermore, 0.1% SSC treatment dramatically decreased the hepatic triglyceride and total cholesterol accumulation. Mice administrated with 0.1% SSC had significantly decreased serum glucose and insulin levels, lower homeostatic model assessment for insulin resistance index, and area under the blood glucose curve, suggesting that insulin sensitivity is enhanced by dietary SSC. Dietary SSC also prevented adipokine imbalance, by increasing adiponectin production and decreasing tumor necrosis factor alpha level caused by high-fat diet."}
{"qid": "623dfd2ef0baec9a1b000004", "original_text": "Calreticulin is a protein that plays a crucial role in various cellular processes, including protein folding, quality control, and cell signaling. It is primarily localized in the endoplasmic reticulum (ER) and is involved in the maturation and folding of newly synthesized proteins. Calreticulin acts as a molecular chaperone, helping proteins to fold into their correct three-dimensional structure, and aids in the removal of misfolded or damaged proteins from the ER. Additionally, calreticulin has been shown to mediate cellular responses to inflammation and stress, and is implicated in various diseases, including cancer and neurodegenerative disorders.", "label": 0, "is_selected": 1, "text": "The report 'Calreticulin - Pipeline Review, H2 2017' outlays comprehensive information on the calreticlin-targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type."}
{"qid": "58a2df9c60087bc10a000006", "original_text": "The frequency of beta-thalassaemia trait was estimated in 209 consecutive patients hospitalized for acute myocardial infarction in order to answer the question of the possible protective effect of heterozygosity for beta-thalassaemia on the incidence of the disease. 212 patients hospitalized during the same period for various accidental bone fractures served as controls.", "label": 1, "is_selected": 0, "text": "The frequency of beta-thalassaemia trait was estimated in 209 consecutive patients hospitalized for acute myocardial infarction in order to answer the question of the possible protective effect of heterozygosity for beta-thalassaemia on the incidence of the disease. 212 patients hospitalized during the same period for various accidental bone fractures served as controls."}
{"qid": "5e67bc121af46fc13000001c", "original_text": "Yes, Spinal Intradural Primary Malignant Peripheral Nerve Sheath Tumors (MPNST) are rare in neurofibromatosis patients. According to a study published in the Journal of Clinical Oncology, MPNSTs account for only 1-2% of all central nervous system (CNS) tumors in patients with neurofibromatosis type 1 (NF1). The incidence of spinal MPNSTs in NF1 patients is estimated to be less than 1%. It is important to note that while MPNSTs are rare, they are the most common type of malignant tumor to arise in the peripheral nervous system in patients with NF1.", "label": 0, "is_selected": 1, "text": "What is the most common type of malignant tumor to arise in the peripheral nervous system in patients with neurofibromatosis and what are the risks and benefits of this treatment?<n> It is important to note that while MPNSTs are rare, they are the mostcommon type of cancerous tumor to originate in the Peripheral Nervous System in patients who have NF1."}
{"qid": "5c6db9917c78d69471000043", "original_text": "'Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections' (PANDAS) identified a unique subgroup of patients with abrupt onset of obsessive compulsive disorder (OCD) symptoms clinically related to Streptococcus infection and accompanied by neuropsychological and motor symptoms. After almost 20 years, PANDAS has not been accepted as distinct disorder and new criteria for paediatric acute-onset neuropsychiatric syndrome (PANS) have been replaced it, highlighting the fact that several agents rather than only Streptococcus might be involved. Extensive review of the PANDAS/PANS literature was performed on PubMed. Although antibiotics have been reported to be effective for acute and prophylactic phases in several uncontrolled studies and non-steroidal anti-inflammatory drugs (NSAID) are used during exacerbations, clinical multicenter trials are still missing. Selective serotonin reuptake inhibitors (SSRIs) and cognitive behavioural therapy (CBT) are still the first line of recommendation for acute onset OCD spectrum. Immunological therapies should be restricted to a few cases. While PANDAS has found no confirmation as a distinct syndrome, and it is not presented in DSM-5, patients with acute onset OCD spectrum, neurocognitive and motor symptoms should be evaluated for inflammatory, infective, immunological and metabolic abnormalities with a comprehensive diagnostic algorithm.", "label": 1, "is_selected": 0, "text": "'Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections' (PANDAS) identified a unique subgroup of patients with abrupt onset of obsessive compulsive disorder (OCD) symptoms clinically related to Streptococcus infection and accompanied by neuropsychological and motor symptoms. After almost 20 years, PANDAS has not been accepted as distinct disorder and new criteria for paediatric acute-onset neuropsychiatric syndrome (PANS) have been replaced it, highlighting the fact that several agents rather than only Streptococcus might be involved. Extensive review of the PANDAS/PANS literature was performed on PubMed. Although antibiotics have been reported to be effective for acute and prophylactic phases in several uncontrolled studies and non-steroidal anti-inflammatory drugs (NSAID) are used during exacerbations, clinical multicenter trials are still missing. Selective serotonin reuptake inhibitors (SSRIs) and cognitive behavioural therapy (CBT) are still the first line of recommendation for acute onset OCD spectrum. Immunological therapies should be restricted to a few cases. While PANDAS has found no confirmation as a distinct syndrome, and it is not presented in DSM-5, patients with acute onset OCD spectrum, neurocognitive and motor symptoms should be evaluated for inflammatory, infective, immunological and metabolic abnormalities with a comprehensive diagnostic algorithm."}
{"qid": "5a894f6abc7bade53a000004", "original_text": "ALDH2 deficiency is associated with a range of effects, including: 1. Alcohol intolerance: Individuals with ALDH2 deficiency may experience severe adverse reactions to alcohol, such as flushing, vomiting, and headaches, even at low levels of alcohol consumption. 2. Increased risk of liver disease: ALDH2 plays a crucial role in the metabolism of ethanol in the liver, and its deficiency can lead to increased levels of circulating ethanol, which can damage liver cells and increase the risk of liver disease. 3. Cancer risk: Some studies have suggested that ALDH2 deficiency may be associated with an increased risk of certain types of cancer, such as liver cancer and breast cancer. 4. Neurological effects: ALDH2 deficiency has been linked to cognitive impairment, memory loss, and other neurological effects. 5. Cardiovascular problems: Individuals with ALDH2 deficiency may be at higher risk of cardiovascular disease, including high blood pressure, heart attack, and stroke. It is important to note that the severity of these effects can vary depending on the level of ALDH2 deficiency and other individual factors. If you suspect you may have ALDH2 deficiency, it is essential to consult with a medical professional for proper diagnosis and treatment.", "label": 0, "is_selected": 1, "text": "ALDH2 deficiency is a genetic disorder that affects the body's ability to make adenosine triphosphate (ATP), a molecule that is important in the synthesis of adenosine, as well as in the production of norepinephrine, a norepinephrine-like molecule, and other hormones andneurotransmitters, among other functions, in the brain and other parts of the nervous system and in the body, including the liver and cardiovascular system, and in some animals, such as dogs and horses. Cardiovascular problems: Individuals with ALDH2] deficiency may be at higher risk of cardiovascular disease, including high blood pressure, heart attack, and stroke."}
{"qid": "5a75fbf383b0d9ea6600000a", "original_text": "Tofacitinib, an oral, small-molecule Janus kinase inhibitor, was shown to have potential efficacy as induction therapy for ulcerative colitis in a phase 2 trial. We further evaluated the efficacy of tofacitinib as induction and maintenance therapy. We conducted three phase 3, randomized, double-blind, placebo-controlled trials of tofacitinib therapy in adults with ulcerative colitis. In the OCTAVE Induction 1 and 2 trials, 598 and 541 patients, respectively, who had moderately to severely active ulcerative colitis despite previous conventional therapy or therapy with a tumor necrosis factor antagonist were randomly assigned to receive induction therapy with tofacitinib (10 mg twice daily) or placebo for 8 weeks. The primary end point was remission at 8 weeks. In the OCTAVE Sustain trial, 593 patients who had a clinical response to induction therapy were randomly assigned to receive maintenance therapy with tofacitinib (either 5 mg or 10 mg twice daily) or placebo for 52 weeks. The primary end point was remission at 52 weeks. In the OCTAVE Induction 1 trial, remission at 8 weeks occurred in 18.5% of the patients in the tofacitinib group versus 8.2% in the placebo group (P=0.007); in the OCTAVE Induction 2 trial, remission occurred in 16.6% versus 3.6% (P<0.001). In the OCTAVE Sustain trial, remission at 52 weeks occurred in 34.3% of the patients in the 5-mg tofacitinib group and 40.6% in the 10-mg tofacitinib group versus 11.1% in the placebo group (P<0.001 for both comparisons with placebo). In the OCTAVE Induction 1 and 2 trials, the rates of overall infection and serious infection were higher with tofacitinib than with placebo.", "label": 1, "is_selected": 0, "text": "Tofacitinib, an oral, small-molecule Janus kinase inhibitor, was shown to have potential efficacy as induction therapy for ulcerative colitis in a phase 2 trial. We further evaluated the efficacy of tofacitinib as induction and maintenance therapy. We conducted three phase 3, randomized, double-blind, placebo-controlled trials of tofacitinib therapy in adults with ulcerative colitis. In the OCTAVE Induction 1 and 2 trials, 598 and 541 patients, respectively, who had moderately to severely active ulcerative colitis despite previous conventional therapy or therapy with a tumor necrosis factor antagonist were randomly assigned to receive induction therapy with tofacitinib (10 mg twice daily) or placebo for 8 weeks. The primary end point was remission at 8 weeks. In the OCTAVE Sustain trial, 593 patients who had a clinical response to induction therapy were randomly assigned to receive maintenance therapy with tofacitinib (either 5 mg or 10 mg twice daily) or placebo for 52 weeks. The primary end point was remission at 52 weeks. In the OCTAVE Induction 1 trial, remission at 8 weeks occurred in 18.5% of the patients in the tofacitinib group versus 8.2% in the placebo group (P=0.007); in the OCTAVE Induction 2 trial, remission occurred in 16.6% versus 3.6% (P<0.001). In the OCTAVE Sustain trial, remission at 52 weeks occurred in 34.3% of the patients in the 5-mg tofacitinib group and 40.6% in the 10-mg tofacitinib group versus 11.1% in the placebo group (P<0.001 for both comparisons with placebo). In the OCTAVE Induction 1 and 2 trials, the rates of overall infection and serious infection were higher with tofacitinib than with placebo."}
{"qid": "5fdb43c2a43ad3127800002c", "original_text": "The concept of unidirectional differentiation of the haematopoietic stem cell has been challenged after recent findings that human B cell progenitors and even mature B cells can be reprogrammed into histiocytic/dendritic cells by altering expression of lineage-associated transcription factors. The conversion of mature B cell lymphomas to Langerhans cell neoplasms is not well documented. Three previous reports have described clonally related follicular lymphoma and Langerhans cell tumours, whereas no case has been published of clonally related marginal zone lymphoma and Langerhans cell sarcoma.", "label": 1, "is_selected": 0, "text": "The concept of unidirectional differentiation of the haematopoietic stem cell has been challenged after recent findings that human B cell progenitors and even mature B cells can be reprogrammed into histiocytic/dendritic cells by altering expression of lineage-associated transcription factors. The conversion of mature B cell lymphomas to Langerhans cell neoplasms is not well documented. Three previous reports have described clonally related follicular lymphoma and Langerhans cell tumours, whereas no case has been published of clonally related marginal zone lymphoma and Langerhans cell sarcoma."}
{"qid": "52bf19f703868f1b06000002", "original_text": "Previously, autosomal dominant catecholaminergic polymorphic ventricular tachycardia (CPVT [1]) was mapped to chromosome 1q42-43 with identification of pathogenic mutations in RYR2. Autosomal recessive CPVT (2) was mapped to chromosome 1p13-21, leading to the identification of mutations in CASQ2. In this study, we aimed to elucidate clinical phenotypes of a new variant of CPVT (3) in an inbred Arab family and also delineate the chromosomal location of the gene causing CPVT (3). In a highly inbred family, clinical symptoms of CPVT appeared early in childhood (7-12 years) and in three of the four cases, the first appearance of symptoms turned into a fatal outcome. Parents of the affected children were first-degree cousins and without any symptoms.", "label": 1, "is_selected": 0, "text": "Previously, autosomal dominant catecholaminergic polymorphic ventricular tachycardia (CPVT [1]) was mapped to chromosome 1q42-43 with identification of pathogenic mutations in RYR2. Autosomal recessive CPVT (2) was mapped to chromosome 1p13-21, leading to the identification of mutations in CASQ2. In this study, we aimed to elucidate clinical phenotypes of a new variant of CPVT (3) in an inbred Arab family and also delineate the chromosomal location of the gene causing CPVT (3). In a highly inbred family, clinical symptoms of CPVT appeared early in childhood (7-12 years) and in three of the four cases, the first appearance of symptoms turned into a fatal outcome. Parents of the affected children were first-degree cousins and without any symptoms."}
{"qid": "5abc9ecffcf4565872000021", "original_text": "The large majority of mitochondrial DNA (mtDNA) deletions analyzed from mitochondrial myopathies and aging humans have been found to be flanked by direct repeats, a finding which has led to the slip-replication hypothesis of deletion formation. In this study, we have characterized 13 mtDNA deletion breakpoints from skeletal muscle harvested from 9- to 27-year-old rhesus monkeys. Seven of the deletions, five of which were unique to a particular animal, did not have direct repeats at the deletion breakpoints. In contrast, two of the three deletions common to several animals had direct repeats flanking the breakpoints.", "label": 1, "is_selected": 0, "text": "The large majority of mitochondrial DNA (mtDNA) deletions analyzed from mitochondrial myopathies and aging humans have been found to be flanked by direct repeats, a finding which has led to the slip-replication hypothesis of deletion formation. In this study, we have characterized 13 mtDNA deletion breakpoints from skeletal muscle harvested from 9- to 27-year-old rhesus monkeys. Seven of the deletions, five of which were unique to a particular animal, did not have direct repeats at the deletion breakpoints. In contrast, two of the three deletions common to several animals had direct repeats flanking the breakpoints."}
{"qid": "5be2a070133db5eb78000013", "original_text": "LincRNA Xist is expressed in various tissues throughout the body, including embryonic stem cells, placenta, brain, heart, liver, and pancreas. In these tissues, Xist regulates gene expression by acting as a competing endogenous RNA (ceRNA) and binding to the miRNA-induced silencing complex (miRISC). Xist is also expressed in cancer cells, where it can promote tumor progression and resistance to chemotherapy. In breast cancer, for instance, Xist is overexpressed in the majority of tumors and is associated with aggressive disease and poor prognosis. Therefore, understanding the tissue-specific expression and function of Xist is crucial for developing therapeutic strategies to target this molecule in cancer treatment.", "label": 0, "is_selected": 0, "text": "LincRNA Xist is expressed in various tissues throughout the body, including embryonic stem cells, placenta, brain, heart, liver, and pancreas. In these tissues, Xist regulates gene expression by acting as a competing endogenous RNA (ceRNA) and binding to the miRNA-induced silencing complex (miRISC). Xist is also expressed in cancer cells, where it can promote tumor progression and resistance to chemotherapy. In breast cancer, for instance, Xist is overexpressed in the majority of tumors and is associated with aggressive disease and poor prognosis. Therefore, understanding the tissue-specific expression and function of Xist is crucial for developing therapeutic strategies to target this molecule in cancer treatment."}
{"qid": "5c55de1607647bbc4b00000a", "original_text": "WHIM syndrome is a rare, autosomal dominant, immunodeficiency disorder so-named because it is characterized by warts, hypogammaglobulinemia, infections, and myelokathexis (defective neutrophil egress from the BM). Gain-of-function mutations that truncate the C-terminus of the chemokine receptor CXCR4 by 10-19 amino acids cause WHIM syndrome. We have identified a family with autosomal dominant inheritance of WHIM syndrome that is caused by a missense mutation in CXCR4, E343K (1027G \u2192 A). This mutation is also located in the C-terminal domain, a region responsible for negative regulation of the receptor. Accordingly, like CXCR4(R334X), the most common truncation mutation in WHIM syndrome, CXCR4(E343K) mediated approximately 2-fold increased signaling in calcium flux and chemotaxis assays relative to wild-type CXCR4; however, CXCR4(E343K) had a reduced effect on blocking normal receptor down-regulation from the cell surface.", "label": 1, "is_selected": 0, "text": "WHIM syndrome is a rare, autosomal dominant, immunodeficiency disorder so-named because it is characterized by warts, hypogammaglobulinemia, infections, and myelokathexis (defective neutrophil egress from the BM). Gain-of-function mutations that truncate the C-terminus of the chemokine receptor CXCR4 by 10-19 amino acids cause WHIM syndrome. We have identified a family with autosomal dominant inheritance of WHIM syndrome that is caused by a missense mutation in CXCR4, E343K (1027G \u2192 A). This mutation is also located in the C-terminal domain, a region responsible for negative regulation of the receptor. Accordingly, like CXCR4(R334X), the most common truncation mutation in WHIM syndrome, CXCR4(E343K) mediated approximately 2-fold increased signaling in calcium flux and chemotaxis assays relative to wild-type CXCR4; however, CXCR4(E343K) had a reduced effect on blocking normal receptor down-regulation from the cell surface."}
{"qid": "52f129d92059c6d71c000009", "original_text": "Myotonic dystrophy type 2 (DM2) is a subtype of the myotonic dystrophies, caused by expansion of a tetranucleotide CCTG repeat in intron 1 of the zinc finger protein 9 (ZNF9) gene. The expansions are extremely unstable and variable, ranging from 75-11,000 CCTG repeats. This unprecedented repeat size and somatic heterogeneity make molecular diagnosis of DM2 difficult, and yield variable clinical phenotypes. To better understand the mutational origin and instability of the ZNF9 CCTG repeat, we analyzed the repeat configuration and flanking regions in 26 primate species. The 3'-end of an AluSx element, flanked by target site duplications (5'-ACTRCCAR-3'or 5'-ACTRCCARTTA-3'), followed the CCTG repeat, suggesting that the repeat was originally derived from the Alu element insertion. In addition, our results revealed lineage-specific repetitive motifs: pyrimidine (CT)-rich repeat motifs in New World monkeys, dinucleotide (TG) repeat motifs in Old World monkeys and gibbons, and dinucleotide (TG) and tetranucleotide (TCTG and/or CCTG) repeat motifs in great apes and humans.", "label": 1, "is_selected": 0, "text": "Myotonic dystrophy type 2 (DM2) is a subtype of the myotonic dystrophies, caused by expansion of a tetranucleotide CCTG repeat in intron 1 of the zinc finger protein 9 (ZNF9) gene. The expansions are extremely unstable and variable, ranging from 75-11,000 CCTG repeats. This unprecedented repeat size and somatic heterogeneity make molecular diagnosis of DM2 difficult, and yield variable clinical phenotypes. To better understand the mutational origin and instability of the ZNF9 CCTG repeat, we analyzed the repeat configuration and flanking regions in 26 primate species. The 3'-end of an AluSx element, flanked by target site duplications (5'-ACTRCCAR-3'or 5'-ACTRCCARTTA-3'), followed the CCTG repeat, suggesting that the repeat was originally derived from the Alu element insertion. In addition, our results revealed lineage-specific repetitive motifs: pyrimidine (CT)-rich repeat motifs in New World monkeys, dinucleotide (TG) repeat motifs in Old World monkeys and gibbons, and dinucleotide (TG) and tetranucleotide (TCTG and/or CCTG) repeat motifs in great apes and humans."}
{"qid": "60579cb394d57fd87900002e", "original_text": "miRNAs regulate the expression of several genes with one miRNA able to target multiple genes and with one gene able to be simultaneously targeted by more than one miRNA. Therefore, it has become indispensable to shorten the long list of miRNA-target interactions to put in the spotlight in order to gain insight into understanding the regulatory mechanism orchestrated by miRNAs in various cellular processes. A reasonable solution is certainly to prioritize miRNA-target interactions to maximize the effectiveness of the downstream analysis.", "label": 1, "is_selected": 0, "text": "miRNAs regulate the expression of several genes with one miRNA able to target multiple genes and with one gene able to be simultaneously targeted by more than one miRNA. Therefore, it has become indispensable to shorten the long list of miRNA-target interactions to put in the spotlight in order to gain insight into understanding the regulatory mechanism orchestrated by miRNAs in various cellular processes. A reasonable solution is certainly to prioritize miRNA-target interactions to maximize the effectiveness of the downstream analysis."}
{"qid": "5a43b2d7966455904c00000c", "original_text": "The pervasive expression of circular RNAs (circRNAs) is a recently discovered feature of gene expression in highly diverged eukaryotes. Numerous algorithms that are used to detect genome-wide circRNA expression from RNA sequencing (RNA-seq) data have been developed in the past few years, but there is little overlap in their predictions and no clear gold-standard method to assess the accuracy of these algorithms. We review sources of experimental and bioinformatic biases that complicate the accurate discovery of circRNAs and discuss statistical approaches to address these biases. We conclude with a discussion of the current experimental progress on the topic.", "label": 1, "is_selected": 0, "text": "The pervasive expression of circular RNAs (circRNAs) is a recently discovered feature of gene expression in highly diverged eukaryotes. Numerous algorithms that are used to detect genome-wide circRNA expression from RNA sequencing (RNA-seq) data have been developed in the past few years, but there is little overlap in their predictions and no clear gold-standard method to assess the accuracy of these algorithms. We review sources of experimental and bioinformatic biases that complicate the accurate discovery of circRNAs and discuss statistical approaches to address these biases. We conclude with a discussion of the current experimental progress on the topic."}
{"qid": "5a7727f39e632bc06600000d", "original_text": "To evaluate clinical outcomes and steroid side effects in a cohort of patients with Duchenne muscular dystrophy (DMD) treated with long-term daily glucocorticoid therapy. Although daily glucocorticoid therapy has been shown to extend ambulatory function in DMD, less frequent dosing is often used because of side effect concerns. Retrospective study of 97 patients with DMD aged 10 to <16 years treated with daily glucocorticoid (89% on deflazacort) for a mean of 8.5 years. Outcome measures were motor, pulmonary, and cardiac function, and scoliosis. Side effects were growth failure and weight gain, facial fullness, blood pressure, bone health, cataracts, gastrointestinal symptoms, behavior, hypertrichosis, and need for medication interventions. For 13- to 16-year-old patients, 40% could rise from the floor and 50% could perform the 30-foot run test. Forced vital capacity for the entire cohort was well preserved. Thirteen percent of younger (10- to <13-year-old) and 21% of older patients had findings of left ventricle systolic dysfunction. Six percent (all aged 16 years) developed scoliosis (Cobb angle >20 degrees). Eighty-six percent had normal weight velocities; 30% had no increased facial fullness; 72% had short stature; and 19% had asymptomatic cataracts. Asymptomatic spine compression deformities were noted in 76% and long bone fractures in 30%. One patient stopped glucocorticoid because of behavioral concerns. With evidence for improved outcomes and manageable side effects, we recommend use of daily glucocorticoid therapy for patients with DMD with anticipatory management of side effects and a coordinated interdisciplinary care approach.", "label": 1, "is_selected": 0, "text": "To evaluate clinical outcomes and steroid side effects in a cohort of patients with Duchenne muscular dystrophy (DMD) treated with long-term daily glucocorticoid therapy. Although daily glucocorticoid therapy has been shown to extend ambulatory function in DMD, less frequent dosing is often used because of side effect concerns. Retrospective study of 97 patients with DMD aged 10 to <16 years treated with daily glucocorticoid (89% on deflazacort) for a mean of 8.5 years. Outcome measures were motor, pulmonary, and cardiac function, and scoliosis. Side effects were growth failure and weight gain, facial fullness, blood pressure, bone health, cataracts, gastrointestinal symptoms, behavior, hypertrichosis, and need for medication interventions. For 13- to 16-year-old patients, 40% could rise from the floor and 50% could perform the 30-foot run test. Forced vital capacity for the entire cohort was well preserved. Thirteen percent of younger (10- to <13-year-old) and 21% of older patients had findings of left ventricle systolic dysfunction. Six percent (all aged 16 years) developed scoliosis (Cobb angle >20 degrees). Eighty-six percent had normal weight velocities; 30% had no increased facial fullness; 72% had short stature; and 19% had asymptomatic cataracts. Asymptomatic spine compression deformities were noted in 76% and long bone fractures in 30%. One patient stopped glucocorticoid because of behavioral concerns. With evidence for improved outcomes and manageable side effects, we recommend use of daily glucocorticoid therapy for patients with DMD with anticipatory management of side effects and a coordinated interdisciplinary care approach."}
{"qid": "53130a77e3eabad02100000f", "original_text": "Costello syndrome is associated with a deficiency in the hormone cortisol, which is produced by the adrenal glands. This hormone deficiency can lead to a broad range of symptoms, including short stature, skin abnormalities, and developmental delays. Without adequate cortisol production, the body's ability to respond to stress and regulate blood sugar levels can be impaired, leading to a variety of health problems.", "label": 0, "is_selected": 0, "text": "Costello syndrome is associated with a deficiency in the hormone cortisol, which is produced by the adrenal glands. This hormone deficiency can lead to a broad range of symptoms, including short stature, skin abnormalities, and developmental delays. Without adequate cortisol production, the body's ability to respond to stress and regulate blood sugar levels can be impaired, leading to a variety of health problems."}
{"qid": "552440452c8b63434a00000b", "original_text": "Yes, ACTA1 (alpha actin) and NEB (nebulin) genes have been associated with nemaline myopathy, a type of congenital muscular dystrophy. Nemaline myopathy is caused by mutations in the ACTA1 gene, which codes for the alpha-actin protein, and the NEB gene, which codes for nebulin. These proteins play important roles in muscle function and structure, and mutations in these genes can lead to muscle weakness, wasting, and disability.", "label": 0, "is_selected": 1, "text": "Two genes have been linked to a type of muscular dystrophy, according to a new study by researchers at the University of California, Los Angeles (UCLA) and the Children's Hospital of Philadelphia (CHOP) in Philadelphia, Pennsylvania, USA."}
{"qid": "5c73ad347c78d69471000098", "original_text": "Axitinib is an orally available tyrosine kinase inhibitor that has been investigated for the treatment of various types of cancer, including pancreatic cancer. While there is some evidence to suggest that axitinib may have anti-tumor activity in pancreatic cancer, the current evidence does not demonstrate a significant prolongation of survival in these patients. A phase Ib/II clinical trial published in the journal Lancet Oncology in 2018 evaluated the safety and efficacy of axitinib in patients with advanced pancreatic cancer. The study found that axitinib was associated with a response rate of 14% and a median progression-free survival of 2.8 months in these patients. However, the trial did not meet its primary endpoint of improving overall survival. A more recent study published in the Journal of Clinical Oncology in 2020 also evaluated the use of axitinib in pancreatic cancer, but this study was limited to patients with non-resectable disease. The study found that axitinib was associated with a response rate of 11% and a median progression-free survival of 3.5 months in these patients. In summary, while there is some evidence to suggest that axitinib may have activity in pancreatic cancer, the current evidence does not demonstrate a significant prolongation of survival in these patients. Further research is needed to determine the optimal use of axitinib in the treatment of pancreatic cancer.", "label": 0, "is_selected": 1, "text": "The use of axitinib in the treatment of pancreatic cancer has been investigated in a number of clinical trials, but the current evidence does not support the use of this drug in pancreatic cancer.<n> A phase Ib/II clinical trial published in the journal Lancet Oncology in 2018 evaluated the safety and efficacy of axitinib in patients with advanced pancreatic cancer, and the trial did not meet its primary endpoint of improving overall survival.<n> The study found that axtinib was associated with a response rate of 14% and a median progression-free survival of 2.8 months in these patients."}
{"qid": "51542e84d24251bc05000083", "original_text": "The biological behavior and prognosis of gliomas depend largely on cellular proliferation, resistance to chemotherapy, and metastatic potential. Proliferative propensity has significant implications on patient management but its assessment requires tissue sampling; the non-invasive estimation of brain tumor proliferation represents therefore a major goal. Pentavalent technetium-99 m dimercapto-succinic acid [99m Tc-(V)DMSA] is a tumor-seeking radiotracer displaying affinity for gliomas; its intracellular accumulation is directly linked to cell proliferation. We performed a tomographic 99m Tc-(V)DMSA brain scan in a 35-year-old male baring a recurrent glioblastoma multiforme, to depict its proliferative disposition. The patient had been diagnosed 14 months earlier and had been submitted to surgery, followed by adjuvant radiotherapy and temozolomide-based chemotherapy.", "label": 1, "is_selected": 0, "text": "The biological behavior and prognosis of gliomas depend largely on cellular proliferation, resistance to chemotherapy, and metastatic potential. Proliferative propensity has significant implications on patient management but its assessment requires tissue sampling; the non-invasive estimation of brain tumor proliferation represents therefore a major goal. Pentavalent technetium-99 m dimercapto-succinic acid [99m Tc-(V)DMSA] is a tumor-seeking radiotracer displaying affinity for gliomas; its intracellular accumulation is directly linked to cell proliferation. We performed a tomographic 99m Tc-(V)DMSA brain scan in a 35-year-old male baring a recurrent glioblastoma multiforme, to depict its proliferative disposition. The patient had been diagnosed 14 months earlier and had been submitted to surgery, followed by adjuvant radiotherapy and temozolomide-based chemotherapy."}
{"qid": "51682c52298dcd4e51000067", "original_text": "Thyroid hormones play a crucial role in regulating metabolic rate and cardiovascular function. Thyroid hormone excess (hyperthyroidism) or deficiency (hypothyroidism) can lead to changes in insulin sensitivity and contribute to the development of insulin resistance in the heart. In hyperthyroidism, increased levels of thyroid hormones stimulate the heart, leading to an increase in heart rate, contractility, and oxygen demand. This can lead to cardiac remodeling, including hypertrophy and fibrosis, which can contribute to insulin resistance in the heart. Additionally, thyroid hormones can decrease the expression of insulin receptors on cardiac myocytes, leading to decreased insulin signaling and increased insulin resistance. On the other hand, hypothyroidism is associated with decreased cardiac function, including decreased heart rate, reduced contractility, and a decrease in cardiac output. This can lead to decreased insulin sensitivity in the heart, contributing to the development of insulin resistance. Overall, thyroid hormones play a significant role in regulating insulin sensitivity in the heart, and alterations in thyroid hormone levels can contribute to the development of insulin resistance and cardiac dysfunction.", "label": 0, "is_selected": 0, "text": "Thyroid hormones play a crucial role in regulating metabolic rate and cardiovascular function. Thyroid hormone excess (hyperthyroidism) or deficiency (hypothyroidism) can lead to changes in insulin sensitivity and contribute to the development of insulin resistance in the heart. In hyperthyroidism, increased levels of thyroid hormones stimulate the heart, leading to an increase in heart rate, contractility, and oxygen demand. This can lead to cardiac remodeling, including hypertrophy and fibrosis, which can contribute to insulin resistance in the heart. Additionally, thyroid hormones can decrease the expression of insulin receptors on cardiac myocytes, leading to decreased insulin signaling and increased insulin resistance. On the other hand, hypothyroidism is associated with decreased cardiac function, including decreased heart rate, reduced contractility, and a decrease in cardiac output. This can lead to decreased insulin sensitivity in the heart, contributing to the development of insulin resistance. Overall, thyroid hormones play a significant role in regulating insulin sensitivity in the heart, and alterations in thyroid hormone levels can contribute to the development of insulin resistance and cardiac dysfunction."}
{"qid": "58a5add260087bc10a000022", "original_text": "Nox5 belongs to the calcium-regulated subfamily of NADPH oxidases (Nox). Like other calcium-regulated Noxes, Nox5 has an EF-hand-containing calcium-binding domain at its N-terminus, a transmembrane heme-containing region, and a C-terminal dehydrogenase (DH) domain that binds FAD and NADPH. While Nox1-4 require regulatory subunits, including p22phox, Nox5 activity does not depend on any subunits. We found that inactive point mutants and truncated forms of Nox5 (including the naturally expressed splice form, Nox5S) inhibit full-length Nox5, consistent with formation of a dominant negative complex. Oligomerization of full-length Nox5 was demonstrated using co-immunoprecipitation of coexpressed, differentially tagged forms of Nox5 and occurred in a manner independent of calcium ion. Several approaches were used to show that the DH domain mediates oligomerization: Nox5 could be isolated as a multimer when the calcium-binding domain and/or the N-terminal polybasic region (PBR-N) was deleted, but deletion of the DH domain eliminated oligomerization. Further, a chimera containing the transmembrane domain of Ciona intestinalis voltage sensor-containing phosphatase (CiVSP) fused to the Nox5 DH domain formed a co-immunoprecipitating complex with, and functioned as a dominant inhibitor of, full-length Nox5. Radiation inactivation of Nox5 overexpressed in HEK293 cells and endogenously expressed in human aortic smooth muscle cells indicated molecular masses of \u223c350 and \u223c300 kDa, respectively, consistent with a tetramer being the functionally active unit. Thus, Nox5 forms a catalytically active oligomer in the membrane that is mediated by its dehydrogenase domain.", "label": 1, "is_selected": 0, "text": "Nox5 belongs to the calcium-regulated subfamily of NADPH oxidases (Nox). Like other calcium-regulated Noxes, Nox5 has an EF-hand-containing calcium-binding domain at its N-terminus, a transmembrane heme-containing region, and a C-terminal dehydrogenase (DH) domain that binds FAD and NADPH. While Nox1-4 require regulatory subunits, including p22phox, Nox5 activity does not depend on any subunits. We found that inactive point mutants and truncated forms of Nox5 (including the naturally expressed splice form, Nox5S) inhibit full-length Nox5, consistent with formation of a dominant negative complex. Oligomerization of full-length Nox5 was demonstrated using co-immunoprecipitation of coexpressed, differentially tagged forms of Nox5 and occurred in a manner independent of calcium ion. Several approaches were used to show that the DH domain mediates oligomerization: Nox5 could be isolated as a multimer when the calcium-binding domain and/or the N-terminal polybasic region (PBR-N) was deleted, but deletion of the DH domain eliminated oligomerization. Further, a chimera containing the transmembrane domain of Ciona intestinalis voltage sensor-containing phosphatase (CiVSP) fused to the Nox5 DH domain formed a co-immunoprecipitating complex with, and functioned as a dominant inhibitor of, full-length Nox5. Radiation inactivation of Nox5 overexpressed in HEK293 cells and endogenously expressed in human aortic smooth muscle cells indicated molecular masses of \u223c350 and \u223c300 kDa, respectively, consistent with a tetramer being the functionally active unit. Thus, Nox5 forms a catalytically active oligomer in the membrane that is mediated by its dehydrogenase domain."}
{"qid": "52bf209303868f1b0600001a", "original_text": "(1) Alteplase is the first thrombolytic drug to be approved in France for the treatment of ischaemic stroke within three hours of symptom onset. (2) The clinical evaluation dossier contains nine placebo-controlled trials, of which six were relatively large. In the two NINDS trials (624 patients in total), treatment was started within the first three hours and it showed no survival benefit. Near-complete functional recovery was more frequent in the alteplase group than in the placebo group. In the two ECASS trials (620 and 800 patients) and the ATLANTIS trials (142 patients and 613 patients), treatment was started within the first six hours and it showed no significant benefit in terms of survival or functional recovery. (3) There are two meta-analyses of these trials. They confirm the lack of a survival benefit with alteplase. Using a combined endpoint, one meta-analysis showed that treating 1000 patients with alteplase prevented death or major disability (dependency) in 55 patients. The other meta-analysis underlined the importance of a short interval between the onset of symptoms and the beginning of treatment.", "label": 1, "is_selected": 0, "text": "(1) Alteplase is the first thrombolytic drug to be approved in France for the treatment of ischaemic stroke within three hours of symptom onset. (2) The clinical evaluation dossier contains nine placebo-controlled trials, of which six were relatively large. In the two NINDS trials (624 patients in total), treatment was started within the first three hours and it showed no survival benefit. Near-complete functional recovery was more frequent in the alteplase group than in the placebo group. In the two ECASS trials (620 and 800 patients) and the ATLANTIS trials (142 patients and 613 patients), treatment was started within the first six hours and it showed no significant benefit in terms of survival or functional recovery. (3) There are two meta-analyses of these trials. They confirm the lack of a survival benefit with alteplase. Using a combined endpoint, one meta-analysis showed that treating 1000 patients with alteplase prevented death or major disability (dependency) in 55 patients. The other meta-analysis underlined the importance of a short interval between the onset of symptoms and the beginning of treatment."}
{"qid": "5c7161f47c78d69471000066", "original_text": "Vintafolide (EC145) is a folic acid-desacetylvinblastine conjugate that binds to the folate receptor (FR), which is expressed on the majority of epithelial ovarian cancers. This randomized phase II trial evaluated vintafolide combined with pegylated liposomal doxorubicin (PLD) compared with PLD alone. The utility of an FR-targeted imaging agent, (99m)Tc-etarfolatide (EC20), in selecting patients likely to benefit from vintafolide was also examined. Women with recurrent platinum-resistant ovarian cancer who had undergone \u2264 two prior cytotoxic regimens were randomly assigned at a 2:1 ratio to PLD (50 mg/m(2) intravenously [IV] once every 28 days) with or without vintafolide (2.5 mg IV three times per week during weeks 1 and 3). Etarfolatide scanning was optional. The primary objective was to compare progression-free survival (PFS) between the groups.", "label": 1, "is_selected": 0, "text": "Vintafolide (EC145) is a folic acid-desacetylvinblastine conjugate that binds to the folate receptor (FR), which is expressed on the majority of epithelial ovarian cancers. This randomized phase II trial evaluated vintafolide combined with pegylated liposomal doxorubicin (PLD) compared with PLD alone. The utility of an FR-targeted imaging agent, (99m)Tc-etarfolatide (EC20), in selecting patients likely to benefit from vintafolide was also examined. Women with recurrent platinum-resistant ovarian cancer who had undergone \u2264 two prior cytotoxic regimens were randomly assigned at a 2:1 ratio to PLD (50 mg/m(2) intravenously [IV] once every 28 days) with or without vintafolide (2.5 mg IV three times per week during weeks 1 and 3). Etarfolatide scanning was optional. The primary objective was to compare progression-free survival (PFS) between the groups."}
{"qid": "5a8a9abdfcd1d6a10c000019", "original_text": "Research over the past decade has revealed how NF-\u03baB essential modulator (NEMO; also known as IKK\u03b3) regulates the IKK\u03b1-IKK\u03b2 signalling axis in the innate immune system. The discovery that NEMO is a polyubiquitin-binding protein and that the IKK complex is modulated by other protein kinases that are themselves controlled by polyubiquitin chains has provided a deeper molecular understanding of the non-degradative roles of ubiquitylation. New mechanistic insights of NEMO and related polyubiquitin-binding proteins have become a paradigm for how the interplay between phosphorylation and ubiquitylation controls cell signalling networks in health and disease.", "label": 1, "is_selected": 0, "text": "Research over the past decade has revealed how NF-\u03baB essential modulator (NEMO; also known as IKK\u03b3) regulates the IKK\u03b1-IKK\u03b2 signalling axis in the innate immune system. The discovery that NEMO is a polyubiquitin-binding protein and that the IKK complex is modulated by other protein kinases that are themselves controlled by polyubiquitin chains has provided a deeper molecular understanding of the non-degradative roles of ubiquitylation. New mechanistic insights of NEMO and related polyubiquitin-binding proteins have become a paradigm for how the interplay between phosphorylation and ubiquitylation controls cell signalling networks in health and disease."}
{"qid": "58a71bb960087bc10a00002d", "original_text": "Yes, ultra-conserved elements (UCEs) are often enriched in segmental duplications. Segmental duplications are genomic regions that are duplicated within a short segment of the genome, often resulting in the amplification of nearby genes or regulatory elements. UCEs, on the other hand, are short, highly conserved sequence elements scattered throughout the genome that are thought to be responsible for controlling gene expression and other cellular processes. Studies have shown that many UCEs are located in regions of the genome that are enriched in segmental duplications, particularly in the vicinity of coding genes. This is thought to be due to the fact that segmental duplications can lead to the amplification of nearby genes and regulatory elements, including UCEs, which can result in the evolution of new gene functions and the regulation of gene expression. For example, a study published in the journal Nature in 2018 found that over 50% of UCEs in the human genome are located in regions of the genome that are enriched in segmental duplications. The study also found that UCEs in these regions are more likely to be conserved across species than UCEs in other regions of the genome. In summary, while not all UCEs are enriched in segmental duplications, many are, and this association is thought to reflect the role of segmental duplications in the evolution of new gene functions and the regulation of gene expression.", "label": 0, "is_selected": 0, "text": "Yes, ultra-conserved elements (UCEs) are often enriched in segmental duplications. Segmental duplications are genomic regions that are duplicated within a short segment of the genome, often resulting in the amplification of nearby genes or regulatory elements. UCEs, on the other hand, are short, highly conserved sequence elements scattered throughout the genome that are thought to be responsible for controlling gene expression and other cellular processes. Studies have shown that many UCEs are located in regions of the genome that are enriched in segmental duplications, particularly in the vicinity of coding genes. This is thought to be due to the fact that segmental duplications can lead to the amplification of nearby genes and regulatory elements, including UCEs, which can result in the evolution of new gene functions and the regulation of gene expression. For example, a study published in the journal Nature in 2018 found that over 50% of UCEs in the human genome are located in regions of the genome that are enriched in segmental duplications. The study also found that UCEs in these regions are more likely to be conserved across species than UCEs in other regions of the genome. In summary, while not all UCEs are enriched in segmental duplications, many are, and this association is thought to reflect the role of segmental duplications in the evolution of new gene functions and the regulation of gene expression."}
{"qid": "513711055274a5fb0700000e", "original_text": "Chronic hepatitis C virus infection may be associated with extrahepatic manifestations. Thyroid disease related to chronic hepatitis C virus infection has been associated with interferon-alpha treatment. We present the case of a 40-year-old woman with chronic hepatitis C virus infection, who developed subacute thyroiditis during treatment with pegylated interferon-alpha plus ribavirin.", "label": 1, "is_selected": 0, "text": "Chronic hepatitis C virus infection may be associated with extrahepatic manifestations. Thyroid disease related to chronic hepatitis C virus infection has been associated with interferon-alpha treatment. We present the case of a 40-year-old woman with chronic hepatitis C virus infection, who developed subacute thyroiditis during treatment with pegylated interferon-alpha plus ribavirin."}
{"qid": "56c8605b5795f9a73e000014", "original_text": "Alopecia areata (AA) is an autoimmune disease resulting in hair loss with devastating psychosocial consequences. Despite its high prevalence, there are no FDA-approved treatments for AA. Prior studies have identified a prominent interferon signature in AA, which signals through JAK molecules. A patient with AA was enrolled in a clinical trial to examine the efficacy of baricitinib, a JAK1/2 inhibitor, to treat concomitant CANDLE syndrome. In vivo, preclinical studies were conducted using the C3H/HeJ AA mouse model to assess the mechanism of clinical improvement by baricitinib. The patient exhibited a striking improvement of his AA on baricitinib over several months.", "label": 1, "is_selected": 0, "text": "Alopecia areata (AA) is an autoimmune disease resulting in hair loss with devastating psychosocial consequences. Despite its high prevalence, there are no FDA-approved treatments for AA. Prior studies have identified a prominent interferon signature in AA, which signals through JAK molecules. A patient with AA was enrolled in a clinical trial to examine the efficacy of baricitinib, a JAK1/2 inhibitor, to treat concomitant CANDLE syndrome. In vivo, preclinical studies were conducted using the C3H/HeJ AA mouse model to assess the mechanism of clinical improvement by baricitinib. The patient exhibited a striking improvement of his AA on baricitinib over several months."}
{"qid": "532ff558d6d3ac6a34000037", "original_text": "Nucleosomes, the basic organizational units of chromatin, package and regulate eukaryotic genomes. ATP-dependent nucleosome-remodeling factors endow chromatin with structural flexibility by promoting assembly or disruption of nucleosomes and the exchange of histone variants. Furthermore, most remodeling factors induce nucleosome movements through sliding of histone octamers on DNA. We summarize recent progress toward unraveling the basic nucleosome sliding mechanism and the interplay of the remodelers' DNA translocases with accessory domains.", "label": 1, "is_selected": 0, "text": "Nucleosomes, the basic organizational units of chromatin, package and regulate eukaryotic genomes. ATP-dependent nucleosome-remodeling factors endow chromatin with structural flexibility by promoting assembly or disruption of nucleosomes and the exchange of histone variants. Furthermore, most remodeling factors induce nucleosome movements through sliding of histone octamers on DNA. We summarize recent progress toward unraveling the basic nucleosome sliding mechanism and the interplay of the remodelers' DNA translocases with accessory domains."}
{"qid": "606a296394d57fd87900004e", "original_text": "Studies on the effect of cytochrome P450 2C9 (CYP2C9), vitamin K epoxide reductase complex subunit 1 (VKORC1), and cytochrome P450 4F2 (CYP4F2) polymorphisms on warfarin maintenance dose in children are conflicting. We conducted a systematic review and meta-analysis to evaluate the effect of these polymorphisms on warfarin maintenance dose in children. We searched relevant literature using the MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trial libraries without any language restrictions from their inception to 23 July 2017. Dose differences are expressed as standardized mean difference (SMD) or mean difference (MD) with 95% confidence intervals (CI). This review was registered in the PROSPERO prospective register of systematic reviews (CRD42015016172). We included a total of nine studies (745 participants) in the meta-analysis. Patients with CYP2C9 *1/*2, *1/*3, *2/*2, *2/*3, or *3/*3 required a lower warfarin maintenance dose compared with patients with CYP2C9 *1/*1 (SMD = -0.610, 95% CI: -0.802 to -0.419, I2 = 0%).", "label": 1, "is_selected": 0, "text": "Studies on the effect of cytochrome P450 2C9 (CYP2C9), vitamin K epoxide reductase complex subunit 1 (VKORC1), and cytochrome P450 4F2 (CYP4F2) polymorphisms on warfarin maintenance dose in children are conflicting. We conducted a systematic review and meta-analysis to evaluate the effect of these polymorphisms on warfarin maintenance dose in children. We searched relevant literature using the MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trial libraries without any language restrictions from their inception to 23 July 2017. Dose differences are expressed as standardized mean difference (SMD) or mean difference (MD) with 95% confidence intervals (CI). This review was registered in the PROSPERO prospective register of systematic reviews (CRD42015016172). We included a total of nine studies (745 participants) in the meta-analysis. Patients with CYP2C9 *1/*2, *1/*3, *2/*2, *2/*3, or *3/*3 required a lower warfarin maintenance dose compared with patients with CYP2C9 *1/*1 (SMD = -0.610, 95% CI: -0.802 to -0.419, I2 = 0%)."}
{"qid": "58da5dc58acda34529000016", "original_text": "To include the vast array of interrelated derangements and to stress the bidirectional nature of the heart-kidney interactions, the classification of the cardiorenal syndrome today includes 5 subtypes whose terminology reflects their primary and secondary pathology, time frame, and the presence of concomitant cardiac and renal dysfunction. Cardiorenal syndromes (CRSs) are pathophysiologic disorders of the heart and kidneys whereby acute or chronic dysfunction of one organ may induce acute or chronic dysfunction of the other. Type 1 CRS reflects an abrupt worsening of cardiac function leading to acute kidney injury. Type 2 CRS describes chronic abnormalities in cardiac function causing progressive chronic kidney disease. Type 3 CRS consists in an abrupt worsening of renal function causing acute cardiac disorder. Type 4 CRS describes a state of chronic kidney disease contributing to decreased cardiac function, cardiac hypertrophy, and/or increased risk of adverse cardiovascular events.", "label": 1, "is_selected": 0, "text": "To include the vast array of interrelated derangements and to stress the bidirectional nature of the heart-kidney interactions, the classification of the cardiorenal syndrome today includes 5 subtypes whose terminology reflects their primary and secondary pathology, time frame, and the presence of concomitant cardiac and renal dysfunction. Cardiorenal syndromes (CRSs) are pathophysiologic disorders of the heart and kidneys whereby acute or chronic dysfunction of one organ may induce acute or chronic dysfunction of the other. Type 1 CRS reflects an abrupt worsening of cardiac function leading to acute kidney injury. Type 2 CRS describes chronic abnormalities in cardiac function causing progressive chronic kidney disease. Type 3 CRS consists in an abrupt worsening of renal function causing acute cardiac disorder. Type 4 CRS describes a state of chronic kidney disease contributing to decreased cardiac function, cardiac hypertrophy, and/or increased risk of adverse cardiovascular events."}
{"qid": "5710a51bcf1c325851000029", "original_text": "Upon infection of a mammalian host, Bacillus anthracis responds to host cues, and particularly to elevated temperature (37\u00b0C) and bicarbonate/CO2 concentrations, with increased expression of virulence factors that include the anthrax toxins and extracellular capsular layer. This response requires the presence of the pXO1 virulence plasmid-encoded pleiotropic regulator AtxA. To better understand the genetic basis of this response, we utilized a controlled in vitro system and Next Generation sequencing to determine and compare RNA expression profiles of the parental strain and an isogenic AtxA-deficient strain in a 2 \u00d7 2 factorial design with growth environments containing or lacking carbon dioxide. We found 15 pXO1-encoded genes and 3 chromosomal genes that were strongly regulated by the separate or synergistic actions of AtxA and carbon dioxide.", "label": 1, "is_selected": 0, "text": "Upon infection of a mammalian host, Bacillus anthracis responds to host cues, and particularly to elevated temperature (37\u00b0C) and bicarbonate/CO2 concentrations, with increased expression of virulence factors that include the anthrax toxins and extracellular capsular layer. This response requires the presence of the pXO1 virulence plasmid-encoded pleiotropic regulator AtxA. To better understand the genetic basis of this response, we utilized a controlled in vitro system and Next Generation sequencing to determine and compare RNA expression profiles of the parental strain and an isogenic AtxA-deficient strain in a 2 \u00d7 2 factorial design with growth environments containing or lacking carbon dioxide. We found 15 pXO1-encoded genes and 3 chromosomal genes that were strongly regulated by the separate or synergistic actions of AtxA and carbon dioxide."}
{"qid": "56e0813651531f7e33000010", "original_text": "Classically, temporally precise excitation of membrane potential in neurons within intact tissue can be achieved by direct electrical stimulation or indirect electrical stimulation induced by changing magnetic fields. Both of these approaches have a predetermined selectivity based on the biophysical properties of the nervous tissue and membrane in the region of the stimulation. A recent advance in selective excitation of neurons is the \"optogenetic\" approach utilizing channelrhodopsins (ChRs). By expressing the light-responsive ChR in neurons using cell-type selective promoters or other methods, specific neurons can be depolarized by light in a temporally precise manner with millisecond resolution even if their membrane biophysical properties are less favorable for electrical stimulation. In addition, ChRs can be used to depolarize nonneuronal cells in the nervous tissue, and to sustain depolarization over a prolonged period of time, both of which cannot be achieved with electrical or magnetic stimulations.", "label": 1, "is_selected": 0, "text": "Classically, temporally precise excitation of membrane potential in neurons within intact tissue can be achieved by direct electrical stimulation or indirect electrical stimulation induced by changing magnetic fields. Both of these approaches have a predetermined selectivity based on the biophysical properties of the nervous tissue and membrane in the region of the stimulation. A recent advance in selective excitation of neurons is the \"optogenetic\" approach utilizing channelrhodopsins (ChRs). By expressing the light-responsive ChR in neurons using cell-type selective promoters or other methods, specific neurons can be depolarized by light in a temporally precise manner with millisecond resolution even if their membrane biophysical properties are less favorable for electrical stimulation. In addition, ChRs can be used to depolarize nonneuronal cells in the nervous tissue, and to sustain depolarization over a prolonged period of time, both of which cannot be achieved with electrical or magnetic stimulations."}
{"qid": "536e46f27d100faa09000012", "original_text": "The gene most commonly mutated in Tay-Sachs disease is the hexosaminidase A (HEXA) gene, which is located on chromosome 15q21. The HEXA gene encodes for the enzyme hexosaminidase A, which is responsible for breaking down the lipid substance GM2 ganglioside in the cells. The mutation of the HEXA gene leads to the accumulation of GM2 ganglioside in the cells, particularly in the brain and nervous system, resulting in the characteristic signs and symptoms of Tay-Sachs disease. The majority of cases of Tay-Sachs disease are caused by a point mutation in the HEXA gene, resulting in the complete deficiency of hexosaminidase A enzyme activity.", "label": 0, "is_selected": 1, "text": "Tay-Sachs disease is a rare genetic disease that is caused by a single mutation in one of the genes involved in the metabolism of fatty acids in the brain and nervous system, as well as in the liver and bone marrow, resulting in the accumulation of a substance known as GM2 ganglioside in the cells, particularly in the nervous system and brain."}
{"qid": "54c12fd1f693c3b16b000001", "original_text": "The present study documents the binding interaction of skeletal muscle sarcoplasmic reticulum (SR) transmembrane protein triadin with peripheral histidine-rich, Ca(2+)-binding protein (HCP). In addition to providing further evidence that HCP coenriches with RyR1, FKBP-12, triadin and calsequestrin (CS) in sucrose-density-purified TC vesicles, using specific polyclonal antibody, we show it to be expressed as a single protein species, both in fast-twitch and slow-twitch fibers, and to identically localize to the I-band. Colocalization of HCP and triadin at junctional triads is supported by the overlapping staining pattern using monoclonal antibodies to triadin. We show a specific binding interaction between digoxigenin-HCP and triadin, using ligand blot techniques.", "label": 1, "is_selected": 0, "text": "The present study documents the binding interaction of skeletal muscle sarcoplasmic reticulum (SR) transmembrane protein triadin with peripheral histidine-rich, Ca(2+)-binding protein (HCP). In addition to providing further evidence that HCP coenriches with RyR1, FKBP-12, triadin and calsequestrin (CS) in sucrose-density-purified TC vesicles, using specific polyclonal antibody, we show it to be expressed as a single protein species, both in fast-twitch and slow-twitch fibers, and to identically localize to the I-band. Colocalization of HCP and triadin at junctional triads is supported by the overlapping staining pattern using monoclonal antibodies to triadin. We show a specific binding interaction between digoxigenin-HCP and triadin, using ligand blot techniques."}
{"qid": "5fdb43aea43ad3127800002b", "original_text": "During 'emergency' situations such as infections, host defense requires rapid mobilization of bone marrow granulocyte progenitors. 'Steady-state' granulopoiesis is absolutely dependent on the C/EBPalpha transcription factor, but the transcriptional mechanisms underlying emergency granulopoiesis remain unclear. Here we show that large numbers of granulocytes were generated from C/EBPalpha-deficient progenitors after cytokine stimulation in vivo. Cytokine treatment or fungal infection induced upregulation of C/EBPbeta but not C/EBPalpha or C/EBPepsilon transcripts in granulocyte progenitors, and C/EBPbeta-deficient progenitors showed decreased emergency-induced granulopoiesis in vitro and in vivo.", "label": 1, "is_selected": 0, "text": "During 'emergency' situations such as infections, host defense requires rapid mobilization of bone marrow granulocyte progenitors. 'Steady-state' granulopoiesis is absolutely dependent on the C/EBPalpha transcription factor, but the transcriptional mechanisms underlying emergency granulopoiesis remain unclear. Here we show that large numbers of granulocytes were generated from C/EBPalpha-deficient progenitors after cytokine stimulation in vivo. Cytokine treatment or fungal infection induced upregulation of C/EBPbeta but not C/EBPalpha or C/EBPepsilon transcripts in granulocyte progenitors, and C/EBPbeta-deficient progenitors showed decreased emergency-induced granulopoiesis in vitro and in vivo."}
{"qid": "5179602c8ed59a060a00003d", "original_text": "Hepatocyte differentiation and proliferation are greatly affected by extracellular matrix (ECM). Primary hepatocytes cultured without matrix dedifferentiate over time, but matrix overlay quickly restores differentiation. ECM also is critical in liver regeneration where ECM degradation and reconstitution are steps in the regenerative process. Integrin-linked kinase (ILK) is a cell-ECM-adhesion component implicated in cell-ECM signaling by means of integrins. We investigated the role of ILK in whole liver by using the LoxP/Cre model system. ILK was eliminated from the liver by mating homozygous ILK-floxed animals with mice expressing Cre-recombinase under control of the alpha fetoprotein enhancer and albumin promoter. After ablation of ILK, animals are born normal.", "label": 1, "is_selected": 0, "text": "Hepatocyte differentiation and proliferation are greatly affected by extracellular matrix (ECM). Primary hepatocytes cultured without matrix dedifferentiate over time, but matrix overlay quickly restores differentiation. ECM also is critical in liver regeneration where ECM degradation and reconstitution are steps in the regenerative process. Integrin-linked kinase (ILK) is a cell-ECM-adhesion component implicated in cell-ECM signaling by means of integrins. We investigated the role of ILK in whole liver by using the LoxP/Cre model system. ILK was eliminated from the liver by mating homozygous ILK-floxed animals with mice expressing Cre-recombinase under control of the alpha fetoprotein enhancer and albumin promoter. After ablation of ILK, animals are born normal."}
{"qid": "6024a6871cb411341a0000a4", "original_text": "Recent evidence demonstrates a rising epidemic of unintentional brodifacoum poisoning associated with synthetic cannabinoid use. Synthetic cannabinoid use is on the rise because of its inexpensiveness as well as difficulty to screen and regulate. We present a rare case of severe coagulopathy and cardiac arrest secondary to synthetic cannabinoid use complicated by brodifacoum toxicity.", "label": 1, "is_selected": 0, "text": "Recent evidence demonstrates a rising epidemic of unintentional brodifacoum poisoning associated with synthetic cannabinoid use. Synthetic cannabinoid use is on the rise because of its inexpensiveness as well as difficulty to screen and regulate. We present a rare case of severe coagulopathy and cardiac arrest secondary to synthetic cannabinoid use complicated by brodifacoum toxicity."}
{"qid": "60354a7b1cb411341a000154", "original_text": "Honey does not contain diastases or amylases. Diastases are enzymes that breaks down starches into simple sugars, while amylases are enzymes that break down carbohydrates into simple sugars. Honey is a supersaturated sugar solution produced by bees, and it does not contain these types of enzymes.", "label": 0, "is_selected": 0, "text": "Honey does not contain diastases or amylases. Diastases are enzymes that breaks down starches into simple sugars, while amylases are enzymes that break down carbohydrates into simple sugars. Honey is a supersaturated sugar solution produced by bees, and it does not contain these types of enzymes."}
{"qid": "621b806c3a8413c653000040", "original_text": "Hypertrophy of chondrocytes is a crucial step in the endochondral bone formation process that drives bone lengthening and the transition to endochondral bone formation. Both Parathyroid hormone-related protein (PTHrP) and Histone deacetylase 4 (HDAC4) inhibit chondrocyte hypertrophy. Use of multiple mouse genetics models reveals how PTHrP and HDAC4 participate in a pathway that regulates chondrocyte hypertrophy. PTHrP/cAMP/protein kinase A (PKA) signaling pathway phosphorylates the PKA-target sites on salt-inducible kinase 3 (Sik3), which leads to inhibition of Sik3 kinase activity. Inhibition of Sik3 kinase activity decreases phosphorylation of HDAC4 by Sik3 at binding sites for 14-3-3; lower levels of HDAC4 phosphorylation then allow HDAC4 nuclear translocation. In the nucleus, the transcription factor, Myocyte Enhancer Factor 2 (Mef2), activates Runt-related transcription factor 2 (Runx2), and together these two transcription factors drive the hypertrophic process. HDAC4 binds both Mef2 and Runx2 and blocks their activities. There are genetic redundancies in this pathway. Sik1 and Sik2 also mediate PTHrP/cAMP/PKA signaling when Sik3 activity is low. HDAC5 also mediates PTHrP signaling when HDAC4 expression is low. Thus, PTHrP triggers a kinase cascade that leads to inhibition of the key transcription factors (Mef2 and Runx2) that promote chondrocyte hypertrophy.", "label": 1, "is_selected": 0, "text": "Hypertrophy of chondrocytes is a crucial step in the endochondral bone formation process that drives bone lengthening and the transition to endochondral bone formation. Both Parathyroid hormone-related protein (PTHrP) and Histone deacetylase 4 (HDAC4) inhibit chondrocyte hypertrophy. Use of multiple mouse genetics models reveals how PTHrP and HDAC4 participate in a pathway that regulates chondrocyte hypertrophy. PTHrP/cAMP/protein kinase A (PKA) signaling pathway phosphorylates the PKA-target sites on salt-inducible kinase 3 (Sik3), which leads to inhibition of Sik3 kinase activity. Inhibition of Sik3 kinase activity decreases phosphorylation of HDAC4 by Sik3 at binding sites for 14-3-3; lower levels of HDAC4 phosphorylation then allow HDAC4 nuclear translocation. In the nucleus, the transcription factor, Myocyte Enhancer Factor 2 (Mef2), activates Runt-related transcription factor 2 (Runx2), and together these two transcription factors drive the hypertrophic process. HDAC4 binds both Mef2 and Runx2 and blocks their activities. There are genetic redundancies in this pathway. Sik1 and Sik2 also mediate PTHrP/cAMP/PKA signaling when Sik3 activity is low. HDAC5 also mediates PTHrP signaling when HDAC4 expression is low. Thus, PTHrP triggers a kinase cascade that leads to inhibition of the key transcription factors (Mef2 and Runx2) that promote chondrocyte hypertrophy."}
{"qid": "5fd779b4a43ad31278000004", "original_text": "Inactivating mutations of the 5\u03b1-steroid reductase type-2 (SRD5A2) gene result in a broad spectrum of masculinization defects, ranging from a male phenotype with hypospadias to a female phenotype with Wolffian structures. Molecular studies of the SRD5A2 revealed a new heterozygous gene variant within the coding region that results in phenotypic expression. A c.92C>T transition changing serine to phenylalanine at codon 31 of exon 1 (p.Ser31Phe) was identified in a patient with 46,XY disorder of sexual development who displayed glandular hypospadias with micropenis and bilateral cryptorchidism. The restoration of the p.Ser31Phe mutation by site-directed mutagenesis and transient expression assays using cultured HEK-293 cells showed that this novel substitution does not abolish but does deregulate the catalytic efficiency of the enzyme.", "label": 1, "is_selected": 0, "text": "Inactivating mutations of the 5\u03b1-steroid reductase type-2 (SRD5A2) gene result in a broad spectrum of masculinization defects, ranging from a male phenotype with hypospadias to a female phenotype with Wolffian structures. Molecular studies of the SRD5A2 revealed a new heterozygous gene variant within the coding region that results in phenotypic expression. A c.92C>T transition changing serine to phenylalanine at codon 31 of exon 1 (p.Ser31Phe) was identified in a patient with 46,XY disorder of sexual development who displayed glandular hypospadias with micropenis and bilateral cryptorchidism. The restoration of the p.Ser31Phe mutation by site-directed mutagenesis and transient expression assays using cultured HEK-293 cells showed that this novel substitution does not abolish but does deregulate the catalytic efficiency of the enzyme."}
{"qid": "58846be0e56acf5176000005", "original_text": "Focused ultrasound thalamotomy is a non-invasive, image-guided treatment that uses ultrasound waves to ablate a specific area of the brain, known as the thalamus, for the treatment of various neurological disorders. Some of the diseases that can be treated using focused ultrasound thalamotomy include: - Essential tremor: Focused ultrasound thalamotomy has been approved by the FDA for the treatment of medication-resistant essential tremor, a common movement disorder that affects the hands, head, or voice. - Parkinson's disease: Focused ultrasound thalamotomy can be used to reduce motor symptoms such as tremors, rigidity, and bradykinesia in patients with advanced Parkinson's disease who have not responded to other treatments. - Dystonia: Focused ultrasound thalamotomy can be used to treat dystonia, a movement disorder characterized by sustained or intermittent muscle contractions that can cause twisting, repetitive movements, or abnormal postures. - Obsessive-compulsive disorder (OCD): Focused ultrasound thalamotomy has been used to treat severe, medication-resistant OCD in some cases, with promising results. It is important to note that focused ultrasound thalamotomy is typically reserved for patients who have not responded to other treatments or who have significant functional impairment due to their condition. As with any medical treatment, the potential risks and benefits of focused ultrasound thalamotomy should be carefully evaluated on a case-by-case basis.", "label": 0, "is_selected": 0, "text": "Focused ultrasound thalamotomy is a non-invasive, image-guided treatment that uses ultrasound waves to ablate a specific area of the brain, known as the thalamus, for the treatment of various neurological disorders. Some of the diseases that can be treated using focused ultrasound thalamotomy include: - Essential tremor: Focused ultrasound thalamotomy has been approved by the FDA for the treatment of medication-resistant essential tremor, a common movement disorder that affects the hands, head, or voice. - Parkinson's disease: Focused ultrasound thalamotomy can be used to reduce motor symptoms such as tremors, rigidity, and bradykinesia in patients with advanced Parkinson's disease who have not responded to other treatments. - Dystonia: Focused ultrasound thalamotomy can be used to treat dystonia, a movement disorder characterized by sustained or intermittent muscle contractions that can cause twisting, repetitive movements, or abnormal postures. - Obsessive-compulsive disorder (OCD): Focused ultrasound thalamotomy has been used to treat severe, medication-resistant OCD in some cases, with promising results. It is important to note that focused ultrasound thalamotomy is typically reserved for patients who have not responded to other treatments or who have significant functional impairment due to their condition. As with any medical treatment, the potential risks and benefits of focused ultrasound thalamotomy should be carefully evaluated on a case-by-case basis."}
{"qid": "5a9d96564e03427e73000001", "original_text": "Cardiovascular risk factors, especially hypertension, are also major risk factors for Alzheimer's disease (AD). To elucidate the underlying vascular origin of neurodegenerative processes in AD, we investigated the relation between systolic blood pressure (SBP) cerebral blood flow (CBF) and vasoreactivity with brain structure and function in a 16-18 months old double transgenic A\u03b2PPswe/PS1dE9 (A\u03b2PP/PS1) mouse model for AD. These aging A\u03b2PP/PS1 mice showed an increased SBP linked to a declined regional CBF. Furthermore, using advanced MRI techniques, decline of functional and structural connectivity was revealed in the AD-like mice coupled to impaired cognition, increased locomotor activity, and anxiety-related behavior. Post mortem analyses demonstrated also increased neuroinflammation, and both decreased synaptogenesis and neurogenesis in the A\u03b2PP/PS1 mice. Additionally, deviant levels of fatty acids and sterols were present in the brain tissue of the A\u03b2PP/PS1 mice indicating maladapted brain fatty acid metabolism.", "label": 1, "is_selected": 0, "text": "Cardiovascular risk factors, especially hypertension, are also major risk factors for Alzheimer's disease (AD). To elucidate the underlying vascular origin of neurodegenerative processes in AD, we investigated the relation between systolic blood pressure (SBP) cerebral blood flow (CBF) and vasoreactivity with brain structure and function in a 16-18 months old double transgenic A\u03b2PPswe/PS1dE9 (A\u03b2PP/PS1) mouse model for AD. These aging A\u03b2PP/PS1 mice showed an increased SBP linked to a declined regional CBF. Furthermore, using advanced MRI techniques, decline of functional and structural connectivity was revealed in the AD-like mice coupled to impaired cognition, increased locomotor activity, and anxiety-related behavior. Post mortem analyses demonstrated also increased neuroinflammation, and both decreased synaptogenesis and neurogenesis in the A\u03b2PP/PS1 mice. Additionally, deviant levels of fatty acids and sterols were present in the brain tissue of the A\u03b2PP/PS1 mice indicating maladapted brain fatty acid metabolism."}
{"qid": "5aacd38efcf4565872000006", "original_text": "DNA polymerase \u03b8 protects against genomic instability via an alternative end-joining repair pathway for DNA double-strand breaks. Polymerase \u03b8 is overexpressed in breast, lung and oral cancers, and reduction of its activity in mammalian cells increases sensitivity to double-strand break-inducing agents, including ionizing radiation. Reported here are crystal structures of the C-terminal polymerase domain from human polymerase \u03b8, illustrating two potential modes of dimerization.", "label": 1, "is_selected": 0, "text": "DNA polymerase \u03b8 protects against genomic instability via an alternative end-joining repair pathway for DNA double-strand breaks. Polymerase \u03b8 is overexpressed in breast, lung and oral cancers, and reduction of its activity in mammalian cells increases sensitivity to double-strand break-inducing agents, including ionizing radiation. Reported here are crystal structures of the C-terminal polymerase domain from human polymerase \u03b8, illustrating two potential modes of dimerization."}
{"qid": "51585b28d24251bc0500008d", "original_text": "The enzyme involved in the maintenance of DNA (cytosine-5)-methylation is DNA methyltransferase (DNMT). DNMT is responsible for adding a methyl group to the cytosine residue of CpG dinucleotides in DNA, leading to the repression of gene transcription. There are two main types of DNMTs: DNMT1, which maintains DNA methylation patterns during DNA replication, and DNMT3, which methylates DNA in a non-recombinatorial manner. Both DNMT1 and DNMT3 are essential for the maintenance of DNA (cytosine-5)-methylation in various tissues, including the brain, and their dysregulation has been implicated in various diseases, including cancer and neurological disorders.", "label": 0, "is_selected": 1, "text": "DNA methyltransferase is an enzyme involved in the maintenance of DNA (cytosine-5)-methylation in various tissues, including the brain, and their dysregulation has been implicated in various diseases, including cancer and neurological disorders.<n> Both DNMT1 and DNMT3 are Essential for the Maintenance of DNA in Various Tissues, Including the Brain, and Their Dysregulation has be implicated in Various Diseases, including Cancer and Neurological disorders."}
{"qid": "57152ebbcb4ef8864c000002", "original_text": "Human heterophile antibodies that agglutinate animal erythrocytes are known to detect the nonhuman sialic acid N-glycolylneuraminic acid (Neu5Gc). This monosaccharide cannot by itself fill the binding site (paratope) of an antibody and can also be modified and presented in various linkages, on diverse underlying glycans. Thus, we hypothesized that the human anti-Neu5Gc antibody response is diverse and polyclonal. Here, we use a novel set of natural and chemoenzymatically synthesized glycans to show that normal humans have an abundant and diverse spectrum of such anti-Neu5Gc antibodies, directed against a variety of Neu5Gc-containing epitopes. High sensitivity and specificity assays were achieved by using N-acetylneuraminic acid (Neu5Ac)-containing probes (differing from Neu5Gc by one less oxygen atom) as optimal background controls. The commonest anti-Neu5Gc antibodies are of the IgG class. Moreover, the range of reactivity and Ig classes of antibodies vary greatly amongst normal humans, with some individuals having remarkably large amounts, even surpassing levels of some well-known natural blood group and xenoreactive antibodies.", "label": 1, "is_selected": 0, "text": "Human heterophile antibodies that agglutinate animal erythrocytes are known to detect the nonhuman sialic acid N-glycolylneuraminic acid (Neu5Gc). This monosaccharide cannot by itself fill the binding site (paratope) of an antibody and can also be modified and presented in various linkages, on diverse underlying glycans. Thus, we hypothesized that the human anti-Neu5Gc antibody response is diverse and polyclonal. Here, we use a novel set of natural and chemoenzymatically synthesized glycans to show that normal humans have an abundant and diverse spectrum of such anti-Neu5Gc antibodies, directed against a variety of Neu5Gc-containing epitopes. High sensitivity and specificity assays were achieved by using N-acetylneuraminic acid (Neu5Ac)-containing probes (differing from Neu5Gc by one less oxygen atom) as optimal background controls. The commonest anti-Neu5Gc antibodies are of the IgG class. Moreover, the range of reactivity and Ig classes of antibodies vary greatly amongst normal humans, with some individuals having remarkably large amounts, even surpassing levels of some well-known natural blood group and xenoreactive antibodies."}
{"qid": "5e4bf7876d0a27794100002c", "original_text": "In the adult mammalian brain niches for neural stem cells are maintained, which enable a steady-state neurogenesis. This process is tightly regulated by multiple niche factors, including Notch and NF-\u03baB signaling. The NF-\u03baB-activating-protein (NKAP) has previously been shown to act as Notch co-repressor component by binding CIR and recruiting HDAC3 in T-cell development and furthermore to regulate NF-\u03baB-dependent transcription. Here, we provide first evidence for the expression of NKAP in neurogenic cells of the adult mammalian brain.", "label": 1, "is_selected": 0, "text": "In the adult mammalian brain niches for neural stem cells are maintained, which enable a steady-state neurogenesis. This process is tightly regulated by multiple niche factors, including Notch and NF-\u03baB signaling. The NF-\u03baB-activating-protein (NKAP) has previously been shown to act as Notch co-repressor component by binding CIR and recruiting HDAC3 in T-cell development and furthermore to regulate NF-\u03baB-dependent transcription. Here, we provide first evidence for the expression of NKAP in neurogenic cells of the adult mammalian brain."}
{"qid": "56c1f00cef6e39474100003e", "original_text": "Aleglitazar is a new, balanced dual peroxisome proliferator-activated receptor (PPAR)\u03b1/\u03b3 agonist designed to optimize lipid and glycemic benefits and minimize PPAR-related adverse effects. SESTA R was a 26-week, randomized, double-blind, multicenter study comparing the effects of a supratherapeutic dosage of aleglitazar (600 \u03bcg/day) with pioglitazone (45 mg/day) on change in measured GFR (mGFR) in 174 patients with type 2 diabetes and normal to mildly impaired renal function (estimated GFR [eGFR] 60 to 120 ml/min/1.73 m(2)).", "label": 1, "is_selected": 0, "text": "Aleglitazar is a new, balanced dual peroxisome proliferator-activated receptor (PPAR)\u03b1/\u03b3 agonist designed to optimize lipid and glycemic benefits and minimize PPAR-related adverse effects. SESTA R was a 26-week, randomized, double-blind, multicenter study comparing the effects of a supratherapeutic dosage of aleglitazar (600 \u03bcg/day) with pioglitazone (45 mg/day) on change in measured GFR (mGFR) in 174 patients with type 2 diabetes and normal to mildly impaired renal function (estimated GFR [eGFR] 60 to 120 ml/min/1.73 m(2))."}
{"qid": "5e764440c6a8763d23000013", "original_text": "Vaxchora is an oral vaccine approved for the prevention of cholera in adults 18 years and older. The recommended dosage is 2 doses given 2-4 weeks apart. The Centers for Disease Control and Prevention (CDC) recommend that travelers to areas with a high risk of cholera infection receive 1 dose of vaxchora at least 10 days before travel and an additional dose at least 1 month after the first dose. Therefore, a total of 2 doses of vaxchora are required for full protection.", "label": 0, "is_selected": 1, "text": "Vaxchora is a vaccine that protects against cholera, a bacterial infection that can cause severe diarrhoea, vomiting, and death in people who have not had any contact with contaminated water or contaminated food or contaminated faeces, or who have recently travelled to areas with a high risk of cholera infection."}
{"qid": "54e12c30ae9738404b000005", "original_text": "The COL5A2 gene has been associated with an increased risk of ischemic heart disease (IHD). IHD is a condition where the heart muscle does not receive enough oxygen-rich blood, leading to chest pain, fatigue, and increased risk of heart failure. Research has shown that mutations in the COL5A2 gene can lead to changes in the structure and function of the cardiac collagen network, which can increase the risk of IHD. These changes can result in the development of atherosclerosis, the buildup of plaque in the arteries that can block blood flow to the heart, leading to IHD. Additionally, the COL5A2 gene has been found to be associated with other cardiovascular diseases, such as hypertension and atrial fibrillation. In conclusion, the COL5A2 gene has been linked to an increased risk of ischemic heart disease, and further research is needed to fully understand the relationship between this gene and cardiovascular disease. I don't have answer to the question.", "label": 0, "is_selected": 0, "text": "The COL5A2 gene has been associated with an increased risk of ischemic heart disease (IHD). IHD is a condition where the heart muscle does not receive enough oxygen-rich blood, leading to chest pain, fatigue, and increased risk of heart failure. Research has shown that mutations in the COL5A2 gene can lead to changes in the structure and function of the cardiac collagen network, which can increase the risk of IHD. These changes can result in the development of atherosclerosis, the buildup of plaque in the arteries that can block blood flow to the heart, leading to IHD. Additionally, the COL5A2 gene has been found to be associated with other cardiovascular diseases, such as hypertension and atrial fibrillation. In conclusion, the COL5A2 gene has been linked to an increased risk of ischemic heart disease, and further research is needed to fully understand the relationship between this gene and cardiovascular disease. I don't have answer to the question."}
{"qid": "5a551a8fb750ff4455000002", "original_text": "Prolonged treatment with human parathyroid hormone (hPTH) in rats results in development of bone tumors, though this finding has not been supported by clinical experience. The PTH type 1 receptor agonist abaloparatide, selected for its bone anabolic activity, is under clinical development to treat postmenopausal women with osteoporosis. To determine the carcinogenic potential of abaloparatide, Fischer (F344) rats were administered SC daily abaloparatide at doses of 0, 10, 25, and 50 \u03bcg/kg or 30 \u03bcg/kg hPTH(1-34) as a positive control for up to 2 years.", "label": 1, "is_selected": 0, "text": "Prolonged treatment with human parathyroid hormone (hPTH) in rats results in development of bone tumors, though this finding has not been supported by clinical experience. The PTH type 1 receptor agonist abaloparatide, selected for its bone anabolic activity, is under clinical development to treat postmenopausal women with osteoporosis. To determine the carcinogenic potential of abaloparatide, Fischer (F344) rats were administered SC daily abaloparatide at doses of 0, 10, 25, and 50 \u03bcg/kg or 30 \u03bcg/kg hPTH(1-34) as a positive control for up to 2 years."}
{"qid": "54f4c382d0d681a040000006", "original_text": "Yes, FAK (Focal Adhesion Kinase) is phosphorylated. Phosphorylation of FAK is a crucial signaling event that regulates various cellular processes, including cell adhesion, migration, and survival. FAK is a non-receptor tyrosine kinase that is primarily involved in integrin-mediated adhesion and signaling. Upon integrin activation, FAK is phosphorylated on specific tyrosine residues, leading to the activation of downstream signaling pathways, including the MAPK/ERK, PI3K/AKT, and NF-\u03baB pathways. The phosphorylation of FAK can also regulate the stability and localization of FAK, and impact the interactions between FAK and other signaling proteins. In summary, FAK phosphorylation is a dynamic process that plays a critical role in regulating cellular responses to integrin activation and other signaling events.", "label": 0, "is_selected": 1, "text": "How does FAK work and why is it so important in the development and maintenance of human tissues?...what does it do and how does it work?...does it bind to integrin or not?...how does it affect cell migration and survival?...is it involved in MAPK/ERK and NF-B signaling?"}
{"qid": "531778ddb166e2b80600000f", "original_text": "A clinical testing cohort was used to gain a broader understanding of the spectrum of tumors associated with germline p53 mutations to aid clinicians in identifying high-risk families. Full sequencing of the coding exons (2 to 11) and associated splice junctions of the p53 gene was performed on 525 consecutive patients whose blood samples were submitted for diagnostic testing. Clinical features of p53 germline carriers in this cohort were characterized, clinical referral schemes based on reported p53-associated family phenotypes were evaluated, and practical mutation prevalence tables were generated. Mutations were identified in 91 (17%) of 525 patients submitted for testing. All families with a p53 mutation had at least one family member with a sarcoma, breast, brain, or adrenocortical carcinoma (ACC). Every individual with a choroid plexus tumor (eight of eight) and 14 of 21 individuals with a childhood ACC had a mutation regardless of family history. Based on reported personal and family history, 95% of patients (71 of 75) with a mutation met either classic Li Fraumeni syndrome (LFS) or Chompret criteria. A simplified prevalence table provides a concise summary of individual and family characteristics associated with p53 mutations.", "label": 1, "is_selected": 0, "text": "A clinical testing cohort was used to gain a broader understanding of the spectrum of tumors associated with germline p53 mutations to aid clinicians in identifying high-risk families. Full sequencing of the coding exons (2 to 11) and associated splice junctions of the p53 gene was performed on 525 consecutive patients whose blood samples were submitted for diagnostic testing. Clinical features of p53 germline carriers in this cohort were characterized, clinical referral schemes based on reported p53-associated family phenotypes were evaluated, and practical mutation prevalence tables were generated. Mutations were identified in 91 (17%) of 525 patients submitted for testing. All families with a p53 mutation had at least one family member with a sarcoma, breast, brain, or adrenocortical carcinoma (ACC). Every individual with a choroid plexus tumor (eight of eight) and 14 of 21 individuals with a childhood ACC had a mutation regardless of family history. Based on reported personal and family history, 95% of patients (71 of 75) with a mutation met either classic Li Fraumeni syndrome (LFS) or Chompret criteria. A simplified prevalence table provides a concise summary of individual and family characteristics associated with p53 mutations."}
{"qid": "56c1f03bef6e394741000053", "original_text": "The gene mutation implicated in Brain-Lung-Thyroid (BLT) syndrome is typically found in the RET gene. This gene encodes for a protein called retinoid-related protein receptor alpha (RPR-alpha), which is involved in the development and function of the nervous system, lung, and thyroid gland. Mutations in the RET gene can lead to the development of multiple endocrine neoplasia type 2 (MEN2), which is characterized by the formation of tumors in the thyroid gland, lung, and other endocrine glands. BLT syndrome is a rare genetic disorder that is caused by mutations in the RET gene, and it is characterized by the simultaneous development of brain, lung, and thyroid tumors.", "label": 0, "is_selected": 1, "text": "The study of Brain-Lung-Thyroid syndrome has been published in Plos One by researchers at the University of California, Los Angeles (UCLA), and the Children's Hospital of Philadelphia (CHOP) in the United States, and funded by the National Institutes of Health (NIH)."}
{"qid": "5c5f0f581a4c55d80b000012", "original_text": "A flow cytometer is a medical device used to analyze the properties of cells, including lymphocytes. The following are the main types of lymphocytes that can be analyzed by a flow cytometer: 1. T cells (CD3+): These cells are responsible for cell-mediated immunity and play a crucial role in protecting against viral infections and cancer. There are several subtypes of T cells, including CD4+ and CD8+ T cells, which can be distinguished based on their surface proteins. 2. B cells (CD19+): B cells are responsible for humoral immunity and produce antibodies to fight infections. 3. Natural killer (NK) cells (CD16/56+): These cells are a type of white blood cell that can recognize and kill infected cells or tumor cells without prior exposure. 4. T follicular helper (Tfh) cells (CD40+): Tfh cells are a subset of T cells that play a role in the activation of B cells and the production of antibodies. 5. Regulatory T cells (CD4+/CD25+/FOXP3+): These cells are involved in maintaining immune homeostasis and preventing autoimmune diseases. 6. Memory T cells (CD45RA+/CD27+/CD38-): These cells are a type of T cell that can quickly respond to infections without needing to mature first. 7. Memory B cells (CD20+): These cells are a type of B cell that can quickly produce antibodies in response to infections. Please note that the subtypes of lymphocytes may vary depending on the specific assay and the laboratory performing the analysis.", "label": 0, "is_selected": 0, "text": "A flow cytometer is a medical device used to analyze the properties of cells, including lymphocytes. The following are the main types of lymphocytes that can be analyzed by a flow cytometer: 1. T cells (CD3+): These cells are responsible for cell-mediated immunity and play a crucial role in protecting against viral infections and cancer. There are several subtypes of T cells, including CD4+ and CD8+ T cells, which can be distinguished based on their surface proteins. 2. B cells (CD19+): B cells are responsible for humoral immunity and produce antibodies to fight infections. 3. Natural killer (NK) cells (CD16/56+): These cells are a type of white blood cell that can recognize and kill infected cells or tumor cells without prior exposure. 4. T follicular helper (Tfh) cells (CD40+): Tfh cells are a subset of T cells that play a role in the activation of B cells and the production of antibodies. 5. Regulatory T cells (CD4+/CD25+/FOXP3+): These cells are involved in maintaining immune homeostasis and preventing autoimmune diseases. 6. Memory T cells (CD45RA+/CD27+/CD38-): These cells are a type of T cell that can quickly respond to infections without needing to mature first. 7. Memory B cells (CD20+): These cells are a type of B cell that can quickly produce antibodies in response to infections. Please note that the subtypes of lymphocytes may vary depending on the specific assay and the laboratory performing the analysis."}
{"qid": "530cf4e0c8a0b4a00c000007", "original_text": "The commotio cordis literature has largely focused on events occurring in the United States. However, with enhanced public awareness, commotio cordis has been increasingly recognized internationally as a cause of cardiac arrest and sudden death due to blunt nonpenetrating chest blows. This study sought to characterize the demographics of commotio cordis globally in comparison to the U.S. experience. This study used interrogation of the Commotio Cordis Registry (Minneapolis, Minnesota). We report 60 cases of commotio cordis occurring outside the United States from 19 countries (most commonly the United Kingdom and Canada) on 5 continents and compared these events to 2:3 occuring in the U.S. In the 2 groups, events were largely similar demographically, including frequency of survival (26% in U.S. vs 25%; P = .84), and the striking male predominance evident in both groups (i.e., 95%), although non-U.S. victims were somewhat older (19 \u00b1 13 vs 15 \u00b1 9; P = .002). Not unexpectedly, the groups differed with baseball/softball and football predominant in the United States (55% of events) and soccer, cricket, and hockey most common internationally (47% of events). Notably, the frequency with which soccer participation caused commotio cordis was much more common than expected, particularly in non-U.S. athletes (20% vs 3% U.S.; P < .001). Commotio cordis demonstrates a global occurrence, very similar demographically in the United States and internationally. However, the frequency with which chest blows from soccer balls caused commotio cordis events (particularly during sports played internationally) seems to contradict the prevailing notion that air-filled projectiles convey less risk for ventricular fibrillation than do those with solid cores (e.g., baseball or lacrosse balls).", "label": 1, "is_selected": 0, "text": "The commotio cordis literature has largely focused on events occurring in the United States. However, with enhanced public awareness, commotio cordis has been increasingly recognized internationally as a cause of cardiac arrest and sudden death due to blunt nonpenetrating chest blows. This study sought to characterize the demographics of commotio cordis globally in comparison to the U.S. experience. This study used interrogation of the Commotio Cordis Registry (Minneapolis, Minnesota). We report 60 cases of commotio cordis occurring outside the United States from 19 countries (most commonly the United Kingdom and Canada) on 5 continents and compared these events to 2:3 occuring in the U.S. In the 2 groups, events were largely similar demographically, including frequency of survival (26% in U.S. vs 25%; P = .84), and the striking male predominance evident in both groups (i.e., 95%), although non-U.S. victims were somewhat older (19 \u00b1 13 vs 15 \u00b1 9; P = .002). Not unexpectedly, the groups differed with baseball/softball and football predominant in the United States (55% of events) and soccer, cricket, and hockey most common internationally (47% of events). Notably, the frequency with which soccer participation caused commotio cordis was much more common than expected, particularly in non-U.S. athletes (20% vs 3% U.S.; P < .001). Commotio cordis demonstrates a global occurrence, very similar demographically in the United States and internationally. However, the frequency with which chest blows from soccer balls caused commotio cordis events (particularly during sports played internationally) seems to contradict the prevailing notion that air-filled projectiles convey less risk for ventricular fibrillation than do those with solid cores (e.g., baseball or lacrosse balls)."}
{"qid": "5c928958ecadf2e73f000017", "original_text": "Rapid detection of nucleic acids is integral for clinical diagnostics and biotechnological applications. We recently developed a platform termed SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) that combines isothermal preamplification with Cas13 to detect single molecules of RNA or DNA.", "label": 1, "is_selected": 0, "text": "Rapid detection of nucleic acids is integral for clinical diagnostics and biotechnological applications. We recently developed a platform termed SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) that combines isothermal preamplification with Cas13 to detect single molecules of RNA or DNA."}
{"qid": "59bf823b542ba3824b000001", "original_text": "The aim of our study was to investigate the short- and long-term effects of tonsillectomy on voice performance in adults. Prospective cohort study. This study was conducted between January 2013 and June 2015. A total of 26 adults who had tonsillectomy due to chronic tonsillitis or recurrent acute tonsillitis were included in the study. The voice performances of the participants were analyzed with objective and subjective methods before surgery, and 1 and 3 months after surgery. An acoustic voice analysis (fundamental frequency [F0], jitter %, shimmer %) was performed for objective analysis, and Voice Handicap Index survey was used for subjective analysis of the voice. Preoperative F0, jitter %, shimmer %, and Voice Handicap Index values were compared with the values obtained 1 and 3 months after surgery. Impairment of voice performance was determined when preoperative and postoperative first month F0, jitter %, and shimmer % values were compared. Three months after surgery, those values were found similar to the preoperative values. Tonsillectomy affects voice performance negatively in adults in short term; however, it does not affect voice performance in long term after surgery.", "label": 1, "is_selected": 0, "text": "The aim of our study was to investigate the short- and long-term effects of tonsillectomy on voice performance in adults. Prospective cohort study. This study was conducted between January 2013 and June 2015. A total of 26 adults who had tonsillectomy due to chronic tonsillitis or recurrent acute tonsillitis were included in the study. The voice performances of the participants were analyzed with objective and subjective methods before surgery, and 1 and 3 months after surgery. An acoustic voice analysis (fundamental frequency [F0], jitter %, shimmer %) was performed for objective analysis, and Voice Handicap Index survey was used for subjective analysis of the voice. Preoperative F0, jitter %, shimmer %, and Voice Handicap Index values were compared with the values obtained 1 and 3 months after surgery. Impairment of voice performance was determined when preoperative and postoperative first month F0, jitter %, and shimmer % values were compared. Three months after surgery, those values were found similar to the preoperative values. Tonsillectomy affects voice performance negatively in adults in short term; however, it does not affect voice performance in long term after surgery."}
{"qid": "5c6e01af7c78d69471000048", "original_text": "Letermovir (Prevymis\u2122) is an orally or intravenously administered cytomegalovirus (CMV) DNA terminase complex inhibitor being developed by Merck & Co., Inc., under a global license from AiCuris Anti-infective Cures GmbH. Letermovir has been approved in Canada and the USA for the prophylaxis of CMV infection and disease in adult CMV-seropositive recipients of an allogeneic haematopoietic stem cell transplant (HSCT).", "label": 1, "is_selected": 0, "text": "Letermovir (Prevymis\u2122) is an orally or intravenously administered cytomegalovirus (CMV) DNA terminase complex inhibitor being developed by Merck & Co., Inc., under a global license from AiCuris Anti-infective Cures GmbH. Letermovir has been approved in Canada and the USA for the prophylaxis of CMV infection and disease in adult CMV-seropositive recipients of an allogeneic haematopoietic stem cell transplant (HSCT)."}
{"qid": "606b718994d57fd87900006b", "original_text": "Dupilumab is a fully human monoclonal IgG4 antibody directed against the alpha subunit of the IL-4 receptor and prevents the signaling of IL-4 and IL-13, two type 2 cytokines known to be important drivers of atopic diseases. In March of 2017, the United States Food and Drug Administration (FDA) approved dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults that is uncontrolled with topical medications, becoming the first biologic agent approved to treat this chronic skin condition.", "label": 1, "is_selected": 0, "text": "Dupilumab is a fully human monoclonal IgG4 antibody directed against the alpha subunit of the IL-4 receptor and prevents the signaling of IL-4 and IL-13, two type 2 cytokines known to be important drivers of atopic diseases. In March of 2017, the United States Food and Drug Administration (FDA) approved dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults that is uncontrolled with topical medications, becoming the first biologic agent approved to treat this chronic skin condition."}
{"qid": "61f5fe43882a024a1000001c", "original_text": "Background Although Zika virus (ZIKV) infection is typically self-limiting, other associated complications such as congenital birth defects and the Guillain-Barr\u00e9 syndrome are well described. There are no approved vaccines against ZIKV infection. Methods In this phase 1, open-label clinical trial, we evaluated the safety and immunogenicity of a synthetic, consensus DNA vaccine (GLS-5700) encoding the ZIKV premembrane and envelope proteins in two groups of 20 participants each. The participants received either 1 mg or 2 mg of vaccine intradermally, with each injection followed by electroporation (the use of a pulsed electric field to introduce the DNA sequence into cells) at baseline, 4 weeks, and 12 weeks. Results The median age of the participants was 38 years, and 60% were women; 78% were white, and 22% black; in addition, 30% were Hispanic. At the interim analysis at 14 weeks (i.e., after the third dose of vaccine), no serious adverse events were reported.", "label": 1, "is_selected": 0, "text": "Background Although Zika virus (ZIKV) infection is typically self-limiting, other associated complications such as congenital birth defects and the Guillain-Barr\u00e9 syndrome are well described. There are no approved vaccines against ZIKV infection. Methods In this phase 1, open-label clinical trial, we evaluated the safety and immunogenicity of a synthetic, consensus DNA vaccine (GLS-5700) encoding the ZIKV premembrane and envelope proteins in two groups of 20 participants each. The participants received either 1 mg or 2 mg of vaccine intradermally, with each injection followed by electroporation (the use of a pulsed electric field to introduce the DNA sequence into cells) at baseline, 4 weeks, and 12 weeks. Results The median age of the participants was 38 years, and 60% were women; 78% were white, and 22% black; in addition, 30% were Hispanic. At the interim analysis at 14 weeks (i.e., after the third dose of vaccine), no serious adverse events were reported."}
{"qid": "5abce6acfcf4565872000022", "original_text": "To determine the rates of concomitant use of drugs known to interact with warfarin by increasing the prothrombin time expressed as the international normalized ratio (INR), decreasing the INR, or increasing bleeding risk without apparent changes in INR in a cohort of patients receiving long-term warfarin therapy. Retrospective, longitudinal cohort study. Large pharmacy benefits manager database. A total of 134,833 patients who were prescribed long-term warfarin from June 1, 1999-May 31, 2000. Longitudinal pharmacy claims from the pharmacy benefits manager database were reviewed to identify coprescription of warfarin and drugs associated with significant interactions with warfarin. Of the 134,833 patients receiving long-term warfarin therapy, 109,998 (81.6%) were prescribed a concurrent prescription for at least one potentially interacting drug, including 87,346 (64.8%) who were prescribed one or more concomitant drugs associated with interactions known to increase the INR. Acetaminophen-containing products, prescribed for 22.7% of patients receiving concomitant prescriptions, and thyroid hormones, prescribed for 17.5%, were the most commonly prescribed concurrent drugs associated with an increased INR response.", "label": 1, "is_selected": 0, "text": "To determine the rates of concomitant use of drugs known to interact with warfarin by increasing the prothrombin time expressed as the international normalized ratio (INR), decreasing the INR, or increasing bleeding risk without apparent changes in INR in a cohort of patients receiving long-term warfarin therapy. Retrospective, longitudinal cohort study. Large pharmacy benefits manager database. A total of 134,833 patients who were prescribed long-term warfarin from June 1, 1999-May 31, 2000. Longitudinal pharmacy claims from the pharmacy benefits manager database were reviewed to identify coprescription of warfarin and drugs associated with significant interactions with warfarin. Of the 134,833 patients receiving long-term warfarin therapy, 109,998 (81.6%) were prescribed a concurrent prescription for at least one potentially interacting drug, including 87,346 (64.8%) who were prescribed one or more concomitant drugs associated with interactions known to increase the INR. Acetaminophen-containing products, prescribed for 22.7% of patients receiving concomitant prescriptions, and thyroid hormones, prescribed for 17.5%, were the most commonly prescribed concurrent drugs associated with an increased INR response."}
{"qid": "5c5f0d071a4c55d80b000010", "original_text": "Endothelial cells (ECs) play an important role in neovascularisation, but are too limited in number for adequate therapeutic applications. Mesenchymal stem cells (MSCs) have the potential to differentiate into endothelial lineage cells, which makes them attractive candidates for therapeutic angiogenesis. The aim of this study was to investigate efficient differentiation of MSCs into ECs by inducing medium in vitro. MSCs were isolated from bone marrow by density gradient centrifugation. The characterisation of the MSCs was determined by their cluster of differentiation (CD) marker profile. Inducing medium containing vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), insulin like growth factor (IGF), epidermal growth factor (EGF), ascorbic acid, and heparin was applied to differentiate the MSCs into ECs. Endothelial differentiation was quantitatively evaluated using flow cytometry. Real time quantitative PCR (qRT-PCR) was used to analyse mRNA expression of endothelial markers. Tube formation assay was further performed to examine the functional status of the differentiated MSCs. Flow cytometry analysis demonstrated that CD31+ and CD34+ cells increased steadily from 12% at 3 days, to 40% at 7 days, and to 60% at 14 days. Immunofluorescence staining further confirmed the expression of CD31 and CD34. qRT-PCR showed that expression of von Willebrand factor (vWF), vascular endothelial cadherin (VE-cadherin) and vascular endothelial growth factor receptor-2 (VEGFR-2) were significantly higher in the induced MSCs group compared with the uninduced MSCs group.", "label": 1, "is_selected": 0, "text": "Endothelial cells (ECs) play an important role in neovascularisation, but are too limited in number for adequate therapeutic applications. Mesenchymal stem cells (MSCs) have the potential to differentiate into endothelial lineage cells, which makes them attractive candidates for therapeutic angiogenesis. The aim of this study was to investigate efficient differentiation of MSCs into ECs by inducing medium in vitro. MSCs were isolated from bone marrow by density gradient centrifugation. The characterisation of the MSCs was determined by their cluster of differentiation (CD) marker profile. Inducing medium containing vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), insulin like growth factor (IGF), epidermal growth factor (EGF), ascorbic acid, and heparin was applied to differentiate the MSCs into ECs. Endothelial differentiation was quantitatively evaluated using flow cytometry. Real time quantitative PCR (qRT-PCR) was used to analyse mRNA expression of endothelial markers. Tube formation assay was further performed to examine the functional status of the differentiated MSCs. Flow cytometry analysis demonstrated that CD31+ and CD34+ cells increased steadily from 12% at 3 days, to 40% at 7 days, and to 60% at 14 days. Immunofluorescence staining further confirmed the expression of CD31 and CD34. qRT-PCR showed that expression of von Willebrand factor (vWF), vascular endothelial cadherin (VE-cadherin) and vascular endothelial growth factor receptor-2 (VEGFR-2) were significantly higher in the induced MSCs group compared with the uninduced MSCs group."}
{"qid": "5e36de90b5b409ea5300000e", "original_text": "The Hof1-Cyk3 interaction plays a crucial role in the regulation of the cell cycle progression in yeast. Hof1 (Heterochromatin-Associated Factor 1) is a chromatin-associated protein that is involved in the formation of constitutive heterochromatin, while Cyk3 (Cyclin-Dependent Kinase 3) is a key regulator of the cell cycle. Studies have shown that the interaction between Hof1 and Cyk3 is essential for the proper progression of the cell cycle, particularly during the G1 phase. Hof1-Cyk3 interaction leads to the phosphorylation and inactivation of the cell cycle regulator SBF (Swi6-Brm1-Fis2), which is required for the transition from the G1 phase to the S phase. This indicates that the Hof1-Cyk3 interaction is critical for the proper coordination of the cell cycle progression in yeast.", "label": 0, "is_selected": 1, "text": "The interactions between two key regulators of the cell cycle in yeast have been explained in detail in a new paper published in Plos One on Friday, 20 February.<n> This indicates that the Hof1-Cyk3 interaction is critical for the proper coordination of the Cell Cycle progression in yeast., et al."}
{"qid": "61f97372882a024a10000051", "original_text": "KMT2B-related disorders are a group of rare genetic conditions caused by mutations in the KMT2B gene. The KMT2B gene provides instructions for making a protein called lysine (K) modifier of transmembrane 2B (KMT2B), which plays a crucial role in the development and function of neurological and muscular systems. Here are the clinical phenotypes and molecular genetic features of patients with KMT2B-related disorders: Clinical Phenotypes: 1. Neurological Manifestations: KMT2B-related disorders are characterized by a wide range of neurological symptoms, including developmental delay, intellectual disability, epilepsy, ataxia, and autism spectrum disorder. 2. Muscular Disease: Patients with KMT2B-related disorders often experience muscle weakness, wasting, and distal limb weakness, which can progressively worsen over time. 3. Cardiac Disease: Some individuals with KMT2B-related disorders may experience cardiac problems, such as hypertrophic cardiomyopathy, arrhythmias, and conduction disturbance. 4. Dysmorphic Features: Patients with KMT2B-related disorders may display distinctive facial features, such as a prominent forehead, wide set eyes, and a thin upper lip. 5. Growth and Development: KMT2B-related disorders can affect growth and development, leading to short stature, delayed puberty, and reduced muscle mass. Molecular Genetic Features: 1. Mutation Spectrum: KMT2B mutations can occur in the entire gene, including the coding region, splice sites, and intron-exon boundaries. The most common mutations are missense mutations, which result in a change in the protein sequence. 2. Mutation Distribution: KMT2B mutations are found in approximately 25% of patients with Angelman syndrome, a neurodevelopmental disorder characterized by developmental delay, intellectual disability, and hyperactivity. KMT2B mutations are also found in approximately 10% of patients with autism spectrum disorder. 3. Mutation Type: KMT2B mutations can be classified into several categories, including missense, nonsense, frameshift, and splice site mutations. Missense mutations are the most common type of KMT2B mutation and can result in the production of a dysfunctional KMT2B protein. 4. Mutation Frequency: The frequency of KMT2B mutations varies depending on the disease subtype. For example, KMT2B mutations are found in approximately 90% of patients with Angelman syndrome and in approximately 30% of patients with autism spectrum disorder. 5. Penetrance: The penetrance of KMT2B-related disorders varies depending on the type of mutation and the expressivity of the disease. Some mutations may be fully penetrant, meaning that all individuals with the mutation will develop symptoms, while others may be partially penetrant, meaning that only some individuals with the mutation will develop symptoms. In conclusion, KMT2B-related disorders are characterized by a range of neurological, muscular, and cardiac symptoms, as well as distinctive dysmorphic features. Molecular genetic analysis can reveal a spectrum of mutations, including missense, nonsense, frameshift, and splice site mutations, with varying frequencies and penetrances depending on the disease subtype. Further research is needed to understand the mechanisms underlying KMT2", "label": 0, "is_selected": 1, "text": "Patients with KMT2B-related disorders face a wide range of neurological symptoms, including developmental delay, intellectual disability, epilepsy, ataxia, and autism spectrum disorder, as well as cardiac problems, such as hypertrophic cardiomyopathy, and conduction disturbance, which can progressively worsen over time, according to a study published in the journal Nature Communications on 5 November, 2014. The clinical phenotypes and molecular genetic features of patients with K MT2B disorders vary depending on the subtype of the disease, including Angelman syndrome, autism spectrum disorders, and cardiac disease, which is why it is important to understand the clinical and molecular features of these patients before they are referred to a specialist for treatment, the study suggests. The study suggests that patients with Angelman Syndrome and autismspectrum disorder are more likely to have a form of KMT 2B mutation than those with other forms of the disorder, suggesting that the two groups may be more closely related than previously thought, and that the prevalence of these disorders may be higher in these patients than in the general population, which may lead to more accurate diagnosis and treatment of the patients with these disorders."}
{"qid": "5c6e01af7c78d69471000048", "original_text": "Letermovir is an orally administered antifungal drug that is used to treat certain types of fungal infections. Two indications of letermovir are: 1. Prevention of invasive fungal infections in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) who are at risk of developing invasive fungal infections. 2. Treatment of invasive pulmonary aspergillosis (IPA) in patients with acquired immunodeficiency syndrome (AIDS).", "label": 0, "is_selected": 0, "text": "Letermovir is an orally administered antifungal drug that is used to treat certain types of fungal infections. Two indications of letermovir are: 1. Prevention of invasive fungal infections in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) who are at risk of developing invasive fungal infections. 2. Treatment of invasive pulmonary aspergillosis (IPA) in patients with acquired immunodeficiency syndrome (AIDS)."}
{"qid": "5159502dd24251bc0500009b", "original_text": "The levels of secreted frizzled-related protein 3 (sFPR3) have been found to decrease in various human cancers, including pancreatic, breast, and lung cancers. This decrease in sFPR3 levels is associated with the progression of cancer and is thought to contribute to the development and progression of cancer by promoting tumor cell growth and survival. Specifically, sFPR3 has been shown to inhibit the epithelial-to-mesenchymal transition (EMT), a process that is important for cancer cell migration and invasion. Additionally, sFPR3 has been found to suppress the expression of pro-inflammatory cytokines and chemokines, which are involved in the immune response to cancer. Overall, the decreased expression of sFPR3 in cancer is thought to contribute to the development and progression of cancer by promoting tumor cell growth, survival, and immune evasion.", "label": 0, "is_selected": 0, "text": "The levels of secreted frizzled-related protein 3 (sFPR3) have been found to decrease in various human cancers, including pancreatic, breast, and lung cancers. This decrease in sFPR3 levels is associated with the progression of cancer and is thought to contribute to the development and progression of cancer by promoting tumor cell growth and survival. Specifically, sFPR3 has been shown to inhibit the epithelial-to-mesenchymal transition (EMT), a process that is important for cancer cell migration and invasion. Additionally, sFPR3 has been found to suppress the expression of pro-inflammatory cytokines and chemokines, which are involved in the immune response to cancer. Overall, the decreased expression of sFPR3 in cancer is thought to contribute to the development and progression of cancer by promoting tumor cell growth, survival, and immune evasion."}
{"qid": "6020b8811cb411341a000089", "original_text": "Selpercatinib (RETEVMO\u2122) is a receptor tyrosine kinase RET (rearranged during transfection) inhibitor being developed by Loxo Oncology for the treatment of cancers harbouring RET alterations. Based on results from the phase I/II LIBRETTO-001 trial, selpercatinib was recently approved by the US FDA for the treatment of RET fusion-positive non-small-cell lung cancer, RET fusion-positive thyroid cancer and RET-mutant medullary thyroid cancer. This article summarizes the milestones in the development of selpercatinib leading to this first approval.", "label": 1, "is_selected": 0, "text": "Selpercatinib (RETEVMO\u2122) is a receptor tyrosine kinase RET (rearranged during transfection) inhibitor being developed by Loxo Oncology for the treatment of cancers harbouring RET alterations. Based on results from the phase I/II LIBRETTO-001 trial, selpercatinib was recently approved by the US FDA for the treatment of RET fusion-positive non-small-cell lung cancer, RET fusion-positive thyroid cancer and RET-mutant medullary thyroid cancer. This article summarizes the milestones in the development of selpercatinib leading to this first approval."}
{"qid": "5fe31323a43ad3127800004d", "original_text": "The compaction of chromatin that occurs when cells enter mitosis is probably the most iconic process of dividing cells. Mitotic chromosomal compaction or 'condensation' is functionally linked to resolution of chromosomal intertwines, transcriptional shut-off and complete segregation of chromosomes. At present, understanding of the molecular events required to convert interphase chromatin into mitotic chromosomes is limited. Here, we review recent advances in the field, focusing on potential chromosomal compaction mechanisms and their importance to chromosome segregation. We propose a model of how metaphase chromosomes could be shaped based on the enzymatic activities of condensin and topoisomerase II in overwinding and relaxation of the DNA fiber during mitosis.", "label": 1, "is_selected": 0, "text": "The compaction of chromatin that occurs when cells enter mitosis is probably the most iconic process of dividing cells. Mitotic chromosomal compaction or 'condensation' is functionally linked to resolution of chromosomal intertwines, transcriptional shut-off and complete segregation of chromosomes. At present, understanding of the molecular events required to convert interphase chromatin into mitotic chromosomes is limited. Here, we review recent advances in the field, focusing on potential chromosomal compaction mechanisms and their importance to chromosome segregation. We propose a model of how metaphase chromosomes could be shaped based on the enzymatic activities of condensin and topoisomerase II in overwinding and relaxation of the DNA fiber during mitosis."}
{"qid": "5c5839e707647bbc4b00001f", "original_text": "BCL11B haploinsufficiency has been identified as a risk factor for several neurodevelopmental disorders, including syndromic neurodevelopmental delay (SND). Haploinsufficiency refers to the condition where an individual has one functionally normal copy of a gene, but the other copy is mutated, leading to reduced gene function. Studies have shown that BCL11B haploinsufficiency is associated with a range of neurodevelopmental features, including intellectual disability, autism spectrum disorder, attention deficit hyperactivity disorder, and seizures. The exact mechanisms by which BCL11B haploinsufficiency leads to these neurodevelopmental disorders are not fully understood, but it is thought to disrupt the normal regulation of gene expression in the brai, resulting in changes to brain structure and function. In addition, there is evidence to suggest that BCL11B haploinsufficiency may be a contributing factor to syndromic neurodevelopmental delay, a group of disorders characterized by cognitive and behavioral impairments in addition to other physical features. For example, studies have found that individuals with BCL11B haploinsufficiency are more likely to have co-occurring SND than those without the mutation. Overall, while the link between BCL11B haploinsufficiency and syndromic neurodevelopmental delay is still being investigated, there is evidence to suggest that the two are related. Further research is needed to clarify the mechanisms underlying this association and to identify the most effective strategies for managing these disorders.", "label": 0, "is_selected": 1, "text": "A gene known as BCL11B haploinsufficiency has been linked to a range of neurodevelopmental disorders, including intellectual disability, autism spectrum disorder, attention deficit hyperactivity disorder, and seizures.Studies have shown that BCL 11B hacloinsufficiency is associated with a range or neurodevelopmental features, including Intellectual disability, Autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), and seizures, and may be a contributing factor to syndromic neurodevelopmental delay, a group of disorders characterized by cognitive and behavioral impairments in addition to other physical features."}
{"qid": "6026dc481cb411341a0000d0", "original_text": "Here are 4 monoclonal antibodies currently in development for the prevention of migraine: 1. Fremanezumab: This antibody targets calcitonin gene-related peptide (CGRP), a molecule involved in migraine pathophysiology. Phase III clinical trials are ongoing. 2. Galcanezumab: Similar to fremanezumab, galcanezumab targets CGRP and is in Phase III clinical trials. 3. Eptinezumab: This monoclonal antibody targets CGRP and has shown promise in Phase II clinical trials. 4. Ubrogepant: Ubrogepant is an oral calcitonin gene-related peptide receptor antagonist in Phase III clinical trials for the prevention of migraine.", "label": 0, "is_selected": 0, "text": "Here are 4 monoclonal antibodies currently in development for the prevention of migraine: 1. Fremanezumab: This antibody targets calcitonin gene-related peptide (CGRP), a molecule involved in migraine pathophysiology. Phase III clinical trials are ongoing. 2. Galcanezumab: Similar to fremanezumab, galcanezumab targets CGRP and is in Phase III clinical trials. 3. Eptinezumab: This monoclonal antibody targets CGRP and has shown promise in Phase II clinical trials. 4. Ubrogepant: Ubrogepant is an oral calcitonin gene-related peptide receptor antagonist in Phase III clinical trials for the prevention of migraine."}
{"qid": "5e2f93bbfbd6abf43b00002e", "original_text": "Rupture of an abdominal aortic aneurysm is readily diagnosed when the triad of abdominal or back pain, shock and a pulsatile abdominal mass are present. Clinical diagnosis can be difficult, however, when patients present with chronic pain and an aneurysm which is not readily palpable. In these patients with confusing abdominal symptoms, CT scan provides a rapid, noninvasive diagnosis.", "label": 1, "is_selected": 0, "text": "Rupture of an abdominal aortic aneurysm is readily diagnosed when the triad of abdominal or back pain, shock and a pulsatile abdominal mass are present. Clinical diagnosis can be difficult, however, when patients present with chronic pain and an aneurysm which is not readily palpable. In these patients with confusing abdominal symptoms, CT scan provides a rapid, noninvasive diagnosis."}
{"qid": "5cebe41ea49efeb44c000006", "original_text": "Cohesin is a chromosome-bound, multisubunit adenosine triphosphatase complex. After loading onto chromosomes, it generates loops to regulate chromosome functions. It has been suggested that cohesin organizes the genome through loop extrusion, but direct evidence is lacking. Here, we used single-molecule imaging to show that the recombinant human cohesin-NIPBL complex compacts both naked and nucleosome-bound DNA by extruding DNA loops. DNA compaction by cohesin requires adenosine triphosphate (ATP) hydrolysis and is force sensitive. This compaction is processive over tens of kilobases at an average rate of 0.5 kilobases per second.", "label": 1, "is_selected": 0, "text": "Cohesin is a chromosome-bound, multisubunit adenosine triphosphatase complex. After loading onto chromosomes, it generates loops to regulate chromosome functions. It has been suggested that cohesin organizes the genome through loop extrusion, but direct evidence is lacking. Here, we used single-molecule imaging to show that the recombinant human cohesin-NIPBL complex compacts both naked and nucleosome-bound DNA by extruding DNA loops. DNA compaction by cohesin requires adenosine triphosphate (ATP) hydrolysis and is force sensitive. This compaction is processive over tens of kilobases at an average rate of 0.5 kilobases per second."}
{"qid": "58861d413b87a8a738000002", "original_text": "The aim of this study was to evaluate brain-derived neurotrophic factor levels in two patients, one with posttraumatic stress disorder and one with acute stress disorder, before and after treatment, and to compare those levels to those of healthy controls. Brain-derived neurotrophic factor level, Davidson Trauma Scale, Beck Depression Inventory, Global Assessment of Functioning, and Clinical Global Impression were assessed before and after 6 weeks of treatment. Brain-derived neurotrophic factor levels were higher in patients than in matched controls before treatment. After 6 weeks, there was a reduction in symptoms and an improvement in functioning in both cases. At the same time, brain-derived neurotrophic factor levels decreased after treatment, even in case 2, treated with psychotherapy only. These results suggest that serum levels of brain-derived neurotrophic factor, as opposed to what has been described in mood disorders, are increased in posttraumatic stress disorder as well as in acute stress disorder.", "label": 1, "is_selected": 0, "text": "The aim of this study was to evaluate brain-derived neurotrophic factor levels in two patients, one with posttraumatic stress disorder and one with acute stress disorder, before and after treatment, and to compare those levels to those of healthy controls. Brain-derived neurotrophic factor level, Davidson Trauma Scale, Beck Depression Inventory, Global Assessment of Functioning, and Clinical Global Impression were assessed before and after 6 weeks of treatment. Brain-derived neurotrophic factor levels were higher in patients than in matched controls before treatment. After 6 weeks, there was a reduction in symptoms and an improvement in functioning in both cases. At the same time, brain-derived neurotrophic factor levels decreased after treatment, even in case 2, treated with psychotherapy only. These results suggest that serum levels of brain-derived neurotrophic factor, as opposed to what has been described in mood disorders, are increased in posttraumatic stress disorder as well as in acute stress disorder."}
{"qid": "605cc21d94d57fd879000036", "original_text": "The IRE1a-XBP1 pathway is a conserved adaptive mediator of the unfolded protein response. The pathway is indispensable for the development of secretory cells by facilitating protein folding and enhancing secretory capacity. In the immune system, it is known to function in dendritic cells, plasma cells, and eosinophil development and differentiation, while its role in T helper cell is unexplored. Here, we investigated the role of the IRE1a-XBP1 pathway in regulating activation and differentiation of type-2 T helper cell (Th2), a major T helper cell type involved in allergy, asthma, helminth infection, pregnancy, and tumor immunosuppression. We perturbed the IRE1a-XBP1 pathway and interrogated its role in Th2 cell differentiation. We performed genome-wide transcriptomic analysis of differential gene expression to reveal IRE1a-XBP1 pathway-regulated genes and predict their biological role. To identify direct target genes of XBP1 and define XBP1's regulatory network, we performed XBP1 ChIPmentation (ChIP-seq). We validated our predictions by flow cytometry, ELISA, and qPCR. We also used a fluorescent ubiquitin cell cycle indicator mouse to demonstrate the role of XBP1 in the cell cycle. We show that Th2 lymphocytes induce the IRE1a-XBP1 pathway during in vitro and in vivo activation. Genome-wide transcriptomic analysis of differential gene expression by perturbing the IRE1a-XBP1 pathway reveals XBP1-controlled genes and biological pathways. Performing XBP1 ChIPmentation (ChIP-seq) and integrating with transcriptomic data, we identify XBP1-controlled direct target genes and its transcriptional regulatory network.", "label": 1, "is_selected": 0, "text": "The IRE1a-XBP1 pathway is a conserved adaptive mediator of the unfolded protein response. The pathway is indispensable for the development of secretory cells by facilitating protein folding and enhancing secretory capacity. In the immune system, it is known to function in dendritic cells, plasma cells, and eosinophil development and differentiation, while its role in T helper cell is unexplored. Here, we investigated the role of the IRE1a-XBP1 pathway in regulating activation and differentiation of type-2 T helper cell (Th2), a major T helper cell type involved in allergy, asthma, helminth infection, pregnancy, and tumor immunosuppression. We perturbed the IRE1a-XBP1 pathway and interrogated its role in Th2 cell differentiation. We performed genome-wide transcriptomic analysis of differential gene expression to reveal IRE1a-XBP1 pathway-regulated genes and predict their biological role. To identify direct target genes of XBP1 and define XBP1's regulatory network, we performed XBP1 ChIPmentation (ChIP-seq). We validated our predictions by flow cytometry, ELISA, and qPCR. We also used a fluorescent ubiquitin cell cycle indicator mouse to demonstrate the role of XBP1 in the cell cycle. We show that Th2 lymphocytes induce the IRE1a-XBP1 pathway during in vitro and in vivo activation. Genome-wide transcriptomic analysis of differential gene expression by perturbing the IRE1a-XBP1 pathway reveals XBP1-controlled genes and biological pathways. Performing XBP1 ChIPmentation (ChIP-seq) and integrating with transcriptomic data, we identify XBP1-controlled direct target genes and its transcriptional regulatory network."}
{"qid": "5a9ac7ba1d1251d03b000013", "original_text": "Intepirdine is a dopamine D1 receptor agonist that targets the dopamine D1 receptor in the brain. It activates the receptor by binding to it, leading to an increase in dopamine signaling in certain brain regions. The dopamine D1 receptor is involved in various physiological processes, including movement, emotion, and cognitive function. Intepirdine has been investigated for the potential treatment of various neurological and psychiatric disorders, including Parkinson's disease, dystonia, and schizophrenia. However, its development was discontinued due to safety concerns related to extrapyramidal side effects.", "label": 0, "is_selected": 0, "text": "Intepirdine is a dopamine D1 receptor agonist that targets the dopamine D1 receptor in the brain. It activates the receptor by binding to it, leading to an increase in dopamine signaling in certain brain regions. The dopamine D1 receptor is involved in various physiological processes, including movement, emotion, and cognitive function. Intepirdine has been investigated for the potential treatment of various neurological and psychiatric disorders, including Parkinson's disease, dystonia, and schizophrenia. However, its development was discontinued due to safety concerns related to extrapyramidal side effects."}
{"qid": "5c54d1a207647bbc4b000007", "original_text": "The chemical aspects of the circadian leaf movement known as \"nyctinasty\" are discussed in this paper. Each of the nyctinastic plants of five different genera so far examined contained a pair of factors, one of which induced leaf closure and another induced leaf opening. The relative contents of the closing and opening factors changed correlating with the nyctinastic leaf movement.", "label": 1, "is_selected": 0, "text": "The chemical aspects of the circadian leaf movement known as \"nyctinasty\" are discussed in this paper. Each of the nyctinastic plants of five different genera so far examined contained a pair of factors, one of which induced leaf closure and another induced leaf opening. The relative contents of the closing and opening factors changed correlating with the nyctinastic leaf movement."}
{"qid": "61f86f58882a024a10000046", "original_text": "The underrepresentation of non-Europeans in human genetic studies so far has limited the diversity of individuals in genomic datasets and led to reduced medical relevance for a large proportion of the world's population. Population-specific reference genome datasets as well as genome-wide association studies in diverse populations are needed to address this issue. Here we describe the pilot phase of the GenomeAsia 100K Project. This includes a whole-genome sequencing reference dataset from 1,739 individuals of 219 population groups and 64 countries across Asia. We catalogue genetic variation, population structure, disease associations and founder effects. We also explore the use of this dataset in imputation, to facilitate genetic studies in populations across Asia and worldwide.", "label": 1, "is_selected": 0, "text": "The underrepresentation of non-Europeans in human genetic studies so far has limited the diversity of individuals in genomic datasets and led to reduced medical relevance for a large proportion of the world's population. Population-specific reference genome datasets as well as genome-wide association studies in diverse populations are needed to address this issue. Here we describe the pilot phase of the GenomeAsia 100K Project. This includes a whole-genome sequencing reference dataset from 1,739 individuals of 219 population groups and 64 countries across Asia. We catalogue genetic variation, population structure, disease associations and founder effects. We also explore the use of this dataset in imputation, to facilitate genetic studies in populations across Asia and worldwide."}
{"qid": "56bc8d65ac7ad1001900001a", "original_text": "Reduced-nicotine cigarettes, also known as \"mini\" or \"light\" cigarettes, are cigarettes that have lower nicotine levels than traditional cigarettes. While these cigarettes may be helpful in reducing nicotine intake and associated withdrawal symptoms, there is limited scientific evidence to support their effectiveness in aiding smoking cessation. Studies have shown that reduced-nicotine cigarettes can reduce nicotine dependence and withdrawal symptoms, but they have not been shown to increase the likelihood of quitting smoking. In fact, some studies have suggested that these cigarettes may actually make it more difficult to quit, as the reduced nicotine levels can lead to an increased desire to smoke. As a helpful assistant, I must inform you that the most effective way to quit smoking is through the use of evidence-based treatments, such as nicotine replacement therapy (NRT), bupropion, or varenicline. These medications have been shown to significantly increase the chances of quitting smoking when used in combination with counseling and support. In summary, while reduced-nicotine cigarettes may be helpful in reducing nicotine intake, they have not been shown to be effective in aiding smoking cessation. Evidence-based treatments, such as NRT, bupropion, or varenicline, are the most effective way to quit smoking.", "label": 0, "is_selected": 1, "text": "If you are trying to quit smoking, I would like to share with you some information about reduced-nicotine cigarettes and the most effective way to quit Smoking, as well as some helpful hints on how to go about it, such as how to light up, how to stop, and what to do if you smoke all day and don't get any sleep at night, and how to know when it's time to quit, so that you can make the best decision for you and your family."}
{"qid": "533c2230c45e133714000002", "original_text": "Proteins containing the SPRY domain have been implicated in various biological roles. These proteins are primarily involved in protein-protein interactions and modulation of signaling pathways. They are also known to play a role in regulating actin cytoskeleton organization, cell adhesion, and cell migration. Additionally, some SPRY domain-containing proteins have been shown to be involved in immune cell function and regulation of inflammation. Further research has revealed that these proteins play critical roles in embryonic development and tissue homeostasis.", "label": 0, "is_selected": 0, "text": "Proteins containing the SPRY domain have been implicated in various biological roles. These proteins are primarily involved in protein-protein interactions and modulation of signaling pathways. They are also known to play a role in regulating actin cytoskeleton organization, cell adhesion, and cell migration. Additionally, some SPRY domain-containing proteins have been shown to be involved in immune cell function and regulation of inflammation. Further research has revealed that these proteins play critical roles in embryonic development and tissue homeostasis."}
{"qid": "532366f09b2d7acc7e000015", "original_text": "Cadasil syndrome is a rare genetic disorder caused by mutations in the NOTCH3 gene. The NOTCH3 gene encodes for the protein neuroserpin, which is involved in blood coagulation and inflammation. The most common mutation in Cadasil syndrome is a missense mutation in the R185H residue of the neuroserpin protein. This mutation leads to the production of a dysfunctional neuroserpin protein that accumulates in the brain and leads to progressive neurodegeneration and stroke. Therefore, the answer is R185H residue in the NOTCH3 gene.", "label": 0, "is_selected": 1, "text": "The Cadasil syndrome gene is involved in blood clotting and inflammation, and has been implicated in the development of neurodegenerative diseases such as Alzheimer's and Parkinson's, among others, in recent years. The most common mutation in CadaSIL syndrome is a missense mutation in the R185H residue of the neuroserpin protein."}
{"qid": "5c700c607c78d6947100005e", "original_text": "The Lupus Severity Index (LSI) is a patient-reported outcomes measure that assesses the severity of systemic lupus erythematosus (SLE) symptoms and impact on daily life. It was developed by the Lupus Foundation of America and is widely used in clinical practice and research. The LSI includes 20 items that evaluate various organ systems affected in SLE, such as joint pain, fatigue, and cognitive impairment. Each item is rated on a 7-point scale, with higher scores indicating greater severity. The total score ranges from 0 to 140, with higher scores indicating greater overall severity of SLE symptoms. The LSI is a reliable and valid measure of SLE severity and can help clinicians monitor disease activity and evaluate treatment effectiveness.", "label": 0, "is_selected": 1, "text": "The Lupus Severity Index (LSI) is a patient-reported outcomes measure that assesses the severity of systemic lupustosus (SLE) symptoms and impact on daily life.The LSI is a reliable and valid measure of SLE severity and can help clinicians monitor disease activity and evaluate treatment effectiveness."}
{"qid": "54f5f8925f206a0c06000003", "original_text": "Transposons have contributed protein coding sequences to a unexpectedly large number of human genes. Except for the V(D)J recombinase and telomerase, all remain of unknown function. Here we investigate the activity of the human SETMAR protein, a highly expressed fusion between a histone H3 methylase and a mariner family transposase. Although SETMAR has demonstrated methylase activity and a DNA repair phenotype, its mode of action and the role of the transposase domain remain obscure.", "label": 1, "is_selected": 0, "text": "Transposons have contributed protein coding sequences to a unexpectedly large number of human genes. Except for the V(D)J recombinase and telomerase, all remain of unknown function. Here we investigate the activity of the human SETMAR protein, a highly expressed fusion between a histone H3 methylase and a mariner family transposase. Although SETMAR has demonstrated methylase activity and a DNA repair phenotype, its mode of action and the role of the transposase domain remain obscure."}
{"qid": "58bca3eb02b8c6095300000d", "original_text": "Adhesive capsulitis of the shoulder is an idiopathic condition characterized clinically by pain and limitation of movement. The characteristic arthrographic features are those of limited capacity of the joint, pain during injection, and retracted recesses. Progressive distension of the capsule with 1% lidocaine and 40 mg of triamcinolone acetonide (Kenalog) is a recommended form of treatment for this condition. Twenty-five patients treated by this method were reviewed retrospectively. Eleven (44%) were completely relieved of their symptoms, 6 (24%) had a 50% improvement, and 8 (32%) had no relief. Patients with idiopathic adhesive capsulitis responded more favorably to the treatment than those with a traumatic etiology. The duration of symptoms had no correlation with the results of therapy. There were no complications from the treatment.", "label": 1, "is_selected": 0, "text": "Adhesive capsulitis of the shoulder is an idiopathic condition characterized clinically by pain and limitation of movement. The characteristic arthrographic features are those of limited capacity of the joint, pain during injection, and retracted recesses. Progressive distension of the capsule with 1% lidocaine and 40 mg of triamcinolone acetonide (Kenalog) is a recommended form of treatment for this condition. Twenty-five patients treated by this method were reviewed retrospectively. Eleven (44%) were completely relieved of their symptoms, 6 (24%) had a 50% improvement, and 8 (32%) had no relief. Patients with idiopathic adhesive capsulitis responded more favorably to the treatment than those with a traumatic etiology. The duration of symptoms had no correlation with the results of therapy. There were no complications from the treatment."}
{"qid": "601ef7cf1cb411341a000068", "original_text": "Morton's Neuroma is a common condition that affects the nerves in the foot, usually between the third and fourth toes. It occurs when the nerve that runs from the foot to the toes becomes inflamed and irritated, leading to symptoms such as pain, numbness, and tingling. The exact cause of Morton's Neuroma is not known, but it is more likely to occur in people who wear tight or pointed shoes that put pressure on the toes. Treatment options for Morton's Neuroma include conservative measures such as rest, ice, and physical therapy, as well as surgical interventions in severe cases. It's important to seek medical attention if symptoms persist or worsen over time to prevent further damage and promote proper healing.", "label": 0, "is_selected": 0, "text": "Morton's Neuroma is a common condition that affects the nerves in the foot, usually between the third and fourth toes. It occurs when the nerve that runs from the foot to the toes becomes inflamed and irritated, leading to symptoms such as pain, numbness, and tingling. The exact cause of Morton's Neuroma is not known, but it is more likely to occur in people who wear tight or pointed shoes that put pressure on the toes. Treatment options for Morton's Neuroma include conservative measures such as rest, ice, and physical therapy, as well as surgical interventions in severe cases. It's important to seek medical attention if symptoms persist or worsen over time to prevent further damage and promote proper healing."}
{"qid": "55088e412e93f0133a000001", "original_text": "The p50 subunit of NF-kappa B is derived from the amino terminus of a 105 kilodalton precursor. The p105 carboxyl terminus, which contains ankyrin-like repeats, a feature of I kappa B molecules, regulates the cytoplasmic retention of p105 and inhibits DNA binding by the precursor. Here, we describe an I kappa B protein identical to the carboxyl-terminal region of p105. Probes spanning the COOH terminus but not the rel homology domain of p105 hybridize to a distinct 2.6-kilobase mRNA expressed in a wide range of murine tissues.", "label": 1, "is_selected": 0, "text": "The p50 subunit of NF-kappa B is derived from the amino terminus of a 105 kilodalton precursor. The p105 carboxyl terminus, which contains ankyrin-like repeats, a feature of I kappa B molecules, regulates the cytoplasmic retention of p105 and inhibits DNA binding by the precursor. Here, we describe an I kappa B protein identical to the carboxyl-terminal region of p105. Probes spanning the COOH terminus but not the rel homology domain of p105 hybridize to a distinct 2.6-kilobase mRNA expressed in a wide range of murine tissues."}
{"qid": "6237ac143a8413c6530000b7", "original_text": "Epiregulin promotes leptin secretion through the EP4 pathway. Leptin, a hormone produced by adipocytes, plays a crucial role in regulating energy balance and metabolism. Upon binding to the EP4 receptor, epiregulin activates downstream signaling pathways that stimulate leptin secretion from adipocytes. Specifically, the activation of the EP4 receptor by epiregulin leads to the phosphorylation and activation of the protein kinase A (PKA) pathway, which finally induces the release of leptin from adipocytes. This pathway is important in regulating energy homeostasis and metabolism, as leptin plays a key role in suppressing hunger and promoting satiety.", "label": 0, "is_selected": 1, "text": "Epiregulin is a secreted protein that has been implicated in a number of metabolic disorders, including obesity, diabetes, and metabolic syndrome, as well as obesity-related heart disease, stroke, and Parkinson's disease, all of which have been linked to obesity."}
{"qid": "5c6638717c78d69471000012", "original_text": "To determine whether chronic treatment with celecoxib, a cyclooxygenase-2 inhibitor that has been shown to be beneficial in preclinical testing, is safe and effective in amyotrophic lateral sclerosis (ALS). A double-blind, placebo-controlled, clinical trial was conducted. Three hundred research subjects with ALS were randomized (2:1) to receive celecoxib (800 mg/day) or placebo for 12 months. The primary outcome measure was the rate of change in upper extremity motor function measured by the maximum voluntary isometric contraction strength. Secondary end points included safety, survival, change in cerebrospinal fluid prostaglandin E(2) levels, and changes in the rate of decline of leg and grip strength, vital capacity, ALS Functional Rating Scale-Revised, and motor unit number estimates. Celecoxib did not slow the decline in muscle strength, vital capacity, motor unit number estimates, ALS Functional Rating Scale-Revised, or affect survival. Celecoxib was well tolerated and was not associated with an increased frequency of adverse events.", "label": 1, "is_selected": 0, "text": "To determine whether chronic treatment with celecoxib, a cyclooxygenase-2 inhibitor that has been shown to be beneficial in preclinical testing, is safe and effective in amyotrophic lateral sclerosis (ALS). A double-blind, placebo-controlled, clinical trial was conducted. Three hundred research subjects with ALS were randomized (2:1) to receive celecoxib (800 mg/day) or placebo for 12 months. The primary outcome measure was the rate of change in upper extremity motor function measured by the maximum voluntary isometric contraction strength. Secondary end points included safety, survival, change in cerebrospinal fluid prostaglandin E(2) levels, and changes in the rate of decline of leg and grip strength, vital capacity, ALS Functional Rating Scale-Revised, and motor unit number estimates. Celecoxib did not slow the decline in muscle strength, vital capacity, motor unit number estimates, ALS Functional Rating Scale-Revised, or affect survival. Celecoxib was well tolerated and was not associated with an increased frequency of adverse events."}
{"qid": "5e6e8897c6a8763d23000003", "original_text": "There are number of studies which report that BCL-2 anti-apoptotic proteins (e.g. BCL-2, BCL-XL, and MCL-1) are highly expressed in cervical cancer tissues compared to the normal cervical epithelia. Despite these reports, targeting these proteins for cervical cancer treatment has not been explored extensively. BH3-mimetics that inhibit specific BCL-2 anti-apoptotic proteins may hold encouraging treatment outcomes for cervical cancer management. Hence, the aim of this pilot study is to investigate the sensitivity of cervical cancer cell lines to combination of two BH3-mimetics namely ABT-263 which selectively inhibits BCL-2, BCL-XL and BCL-w and A-1210477, a selective MCL-1 inhibitor. We report that combination of A-1210477 and ABT-263 exhibited synergistic effects on all cervical cancer cell lines tested. Drug sensitization studies revealed that A-1210477 sensitised the cervical cancer cell lines SiHa and CaSki to ABT-263 by 11- and fivefold, respectively. Sensitization also occurred in the opposite direction whereby ABT-263 sensitised SiHa and CaSki to A-1210477 by eightfold. This report shows that combination of ABT-263 and A-1210477 could be a potential treatment strategy for cervical cancer. Extensive drug mechanistic studies and drug sensitivity studies in physiological models are necessary to unleash the prospect of this combination for cervical cancer therapy.", "label": 1, "is_selected": 0, "text": "There are number of studies which report that BCL-2 anti-apoptotic proteins (e.g. BCL-2, BCL-XL, and MCL-1) are highly expressed in cervical cancer tissues compared to the normal cervical epithelia. Despite these reports, targeting these proteins for cervical cancer treatment has not been explored extensively. BH3-mimetics that inhibit specific BCL-2 anti-apoptotic proteins may hold encouraging treatment outcomes for cervical cancer management. Hence, the aim of this pilot study is to investigate the sensitivity of cervical cancer cell lines to combination of two BH3-mimetics namely ABT-263 which selectively inhibits BCL-2, BCL-XL and BCL-w and A-1210477, a selective MCL-1 inhibitor. We report that combination of A-1210477 and ABT-263 exhibited synergistic effects on all cervical cancer cell lines tested. Drug sensitization studies revealed that A-1210477 sensitised the cervical cancer cell lines SiHa and CaSki to ABT-263 by 11- and fivefold, respectively. Sensitization also occurred in the opposite direction whereby ABT-263 sensitised SiHa and CaSki to A-1210477 by eightfold. This report shows that combination of ABT-263 and A-1210477 could be a potential treatment strategy for cervical cancer. Extensive drug mechanistic studies and drug sensitivity studies in physiological models are necessary to unleash the prospect of this combination for cervical cancer therapy."}
{"qid": "6025e2641cb411341a0000bb", "original_text": "Introduction. Osteosarcoma relapse has a poor prognosis, with less than 25% survival at 5 years. We describe the experience of the French Society of Paediatric Oncology (SFCE) with high dose (HD) thiotepa and autologous stem cell transplantation (ASCT) in 45 children with relapsed osteosarcoma. Patients and Methods. Between 1992 and 2004, 53 patients received HD thiotepa (900 mg/m(2)) followed by ASCT in 6 centres. Eight patients were excluded from analysis, and we retrospectively reviewed the clinical radiological and anatomopathological patterns of the 45 remaining patients. Results. Sixteen girls and 29 boys (median age, 15.9 years) received HD thiotepa after initial progression of metastatic disease (2), first relapse (26), and second or third relapse (17). We report 12 radiological partial responses and 9 of 31 histological complete responses. Thirty-two patients experienced further relapses, and 13 continued in complete remission after surgical resection of the residual disease. Three-year overall survival was 40%, and 3-year progression-free survival was 24%. Delay of relapse (+/- 2 years from diagnosis) was a prognostic factor (P = 0.011). No acute toxic serious adverse event occurred. Conclusion. The use of HD thiotepa and ASCT is feasible in patients with relapsed osteosarcoma. A randomized study for recurrent osteosarcoma between standard salvage chemotherapy and high dose thiotepa with stem cell rescue is ongoing.", "label": 1, "is_selected": 0, "text": "Introduction. Osteosarcoma relapse has a poor prognosis, with less than 25% survival at 5 years. We describe the experience of the French Society of Paediatric Oncology (SFCE) with high dose (HD) thiotepa and autologous stem cell transplantation (ASCT) in 45 children with relapsed osteosarcoma. Patients and Methods. Between 1992 and 2004, 53 patients received HD thiotepa (900 mg/m(2)) followed by ASCT in 6 centres. Eight patients were excluded from analysis, and we retrospectively reviewed the clinical radiological and anatomopathological patterns of the 45 remaining patients. Results. Sixteen girls and 29 boys (median age, 15.9 years) received HD thiotepa after initial progression of metastatic disease (2), first relapse (26), and second or third relapse (17). We report 12 radiological partial responses and 9 of 31 histological complete responses. Thirty-two patients experienced further relapses, and 13 continued in complete remission after surgical resection of the residual disease. Three-year overall survival was 40%, and 3-year progression-free survival was 24%. Delay of relapse (+/- 2 years from diagnosis) was a prognostic factor (P = 0.011). No acute toxic serious adverse event occurred. Conclusion. The use of HD thiotepa and ASCT is feasible in patients with relapsed osteosarcoma. A randomized study for recurrent osteosarcoma between standard salvage chemotherapy and high dose thiotepa with stem cell rescue is ongoing."}
{"qid": "5c9ff25eecadf2e73f000043", "original_text": "The Cobb-Stansby excision arthroplasty is a surgical procedure that is typically performed in the knee joint. The procedure involves removing a portion of the cartilage and bone in the knee joint, and replacing it with an implant made of polyethylene or metal. The goal of the procedure is to reduce pain and improve joint mobility in individuals with advanced knee osteoarthritis. The excision arthroplasty is usually performed through a surgical incision on the front of the knee, and the implant is secured to the bone using bone cement or a mechanical fixation device.", "label": 0, "is_selected": 1, "text": "The Cobb-Stansby excision is a surgical procedure that is typically performed in the knee joint, and the goal of the procedure is to reduce pain and improve joint mobility in individuals with advanced knee osteoarthritis.The procedure is usually performed through a surgical incision on the front of the knee, and is secured to the bone using bone cement or a mechanical fixation device."}
{"qid": "5e7667b1835f4e4777000004", "original_text": "IntroductionRotavirus vaccination with the live-attenuated monovalent (a G1P[8] human rotavirus strain) two-dose Rotarix vaccine was introduced in England in July 2013. Since then, there have been significant reductions in rotavirus gastroenteritis incidence. AimWe assessed the vaccine's impact on rotavirus genotype distribution and diversity 3 years post-vaccine introduction. MethodsEpidemiological and microbiological data on genotyped rotavirus-positive samples between September 2006 and August 2016 were supplied by EuroRotaNet and Public Health England. Multinomial multivariable logistic regression adjusting for year, season and age was used to quantify changes in genotype prevalence in the vaccine period.", "label": 1, "is_selected": 0, "text": "IntroductionRotavirus vaccination with the live-attenuated monovalent (a G1P[8] human rotavirus strain) two-dose Rotarix vaccine was introduced in England in July 2013. Since then, there have been significant reductions in rotavirus gastroenteritis incidence. AimWe assessed the vaccine's impact on rotavirus genotype distribution and diversity 3 years post-vaccine introduction. MethodsEpidemiological and microbiological data on genotyped rotavirus-positive samples between September 2006 and August 2016 were supplied by EuroRotaNet and Public Health England. Multinomial multivariable logistic regression adjusting for year, season and age was used to quantify changes in genotype prevalence in the vaccine period."}
{"qid": "58a3160d60087bc10a00000a", "original_text": "FFI, or fatal familial insomnia, is a rare and inherited neurodegenerative disorder that primarily affects the brain's sleep-wake cycle. It is caused by mutations in the PRNP gene, which codes for the prion protein. The disorder leads to progressive degeneration of the brain, resulting in insomnia, confusion, and eventually death, usually within 1-3 years of symptom onset. There is currently no treatment or cure for FFI, and diagnosis is based on a combination of clinical evaluation and genetic testing.", "label": 0, "is_selected": 1, "text": "The US Food and Drug Administration (FDA) has approved a new drug for the treatment of FFI, known as prion encephalopathy (PEO), which is caused by a specific type of brain disease known as motor neurone disease (MND)."}
{"qid": "5a68f448b750ff4455000018", "original_text": "Erythrasma is a superficial skin disease caused by Gram-positive Corynebacterium species. Coral-red fluorescence under Wood's light, strongly suggestive of erythrasma, can be attributed to the presence of porphyrins. Fractionated porphyrin analysis in erythrasma lesions is yet to be reported. We attempted to investigate erythrasma lesions by isolating the responsible bacteria and determining their exogenous porphyrin production by HPLC analysis. We observed a 78-year-old woman with erythrasma who had a well-demarcated slightly scaling patch on her left foot, between the fourth and fifth toes.", "label": 1, "is_selected": 0, "text": "Erythrasma is a superficial skin disease caused by Gram-positive Corynebacterium species. Coral-red fluorescence under Wood's light, strongly suggestive of erythrasma, can be attributed to the presence of porphyrins. Fractionated porphyrin analysis in erythrasma lesions is yet to be reported. We attempted to investigate erythrasma lesions by isolating the responsible bacteria and determining their exogenous porphyrin production by HPLC analysis. We observed a 78-year-old woman with erythrasma who had a well-demarcated slightly scaling patch on her left foot, between the fourth and fifth toes."}
{"qid": "54f09a5894afd6150400001c", "original_text": "Mindfulness interventions have shown promise in improving the quality of life and psychological well-being of prostate cancer patients. Several studies have demonstrated that mindfulness-based interventions, such as mindfulness-based stress reduction (MBSR) and mindfulness-based cognitive therapy (MBCT), can reduce symptoms of depression, anxiety, and distress in these patients. Mindfulness practices have also been found to enhance communication and decision-making skills in prostate cancer patients, leading to improved patient-provider communication and adherence to treatment plans. Additionally, mindfulness interventions have been shown to reduce cancer-related fatigue and improve overall physical functioning in prostate cancer patients. While the exact mechanisms of mindfulness interventions in prostate cancer patients are not yet fully understood, it is believed that they may modulate the body's stress response and promote a more positive psychological outlook. Further research is needed to fully elucidate the benefits of mindfulness interventions in prostate cancer patients and to determine their potential as a complementary treatment approach.", "label": 0, "is_selected": 1, "text": "Prostate cancer is one of the most common types of cancer in men and is the second leading cause of cancer-related deaths in men in the United States, according to the National Institutes of Health (NIH) and the American Urological Association (AUA). Further research is needed to fully elucidate the benefits of mindfulness interventions in prostate cancer patients and to determine their potential as a complementary treatment approach."}
{"qid": "5abd13e1fcf4565872000029", "original_text": "A 16-year-old boy developed left foot pain of unknown cause that was unresponsive to conservative treatment, associated with fever and difficulty walking. He was admitted to our hospital with osteomyelitis of the accessory and body of the navicular bone. Surgery could not be performed because the patient had been diagnosed with Wiskott-Aldrich syndrome. After antibiotic therapy, laboratory abnormalities and pain had resolved. One year after treatment, the patient had returned to his original level of sports activity.", "label": 1, "is_selected": 0, "text": "A 16-year-old boy developed left foot pain of unknown cause that was unresponsive to conservative treatment, associated with fever and difficulty walking. He was admitted to our hospital with osteomyelitis of the accessory and body of the navicular bone. Surgery could not be performed because the patient had been diagnosed with Wiskott-Aldrich syndrome. After antibiotic therapy, laboratory abnormalities and pain had resolved. One year after treatment, the patient had returned to his original level of sports activity."}
{"qid": "5e2deb35fbd6abf43b00001c", "original_text": "The FISH-seq method has been developed for mapping Transcription Start Sites (TSS) starting from nanograms of RNA. FISH-seq uses fluorescence in situ hybridization (FISH) to map RNA molecules in cells, followed by sequencing of the hybridized RNA. This approach allows for the identification of TSSs from low-input RNA samples, including those with nanogram quantities of RNA. The method has been shown to be highly efficient and accurate for TSS mapping, enabling researchers to study the regulation of gene expression at a genomic scale.", "label": 0, "is_selected": 0, "text": "The FISH-seq method has been developed for mapping Transcription Start Sites (TSS) starting from nanograms of RNA. FISH-seq uses fluorescence in situ hybridization (FISH) to map RNA molecules in cells, followed by sequencing of the hybridized RNA. This approach allows for the identification of TSSs from low-input RNA samples, including those with nanogram quantities of RNA. The method has been shown to be highly efficient and accurate for TSS mapping, enabling researchers to study the regulation of gene expression at a genomic scale."}
{"qid": "52bf1db603868f1b06000011", "original_text": "Fully human monoclonal antibodies (mAbs) are a promising and rapidly growing category of targeted therapeutic agents. The first such agents were developed during the 1980s, but none achieved clinical or commercial success. Advances in technology to generate the molecules for study - in particular, transgenic mice and yeast or phage display - renewed interest in the development of human mAbs during the 1990s. In 2002, adalimumab became the first human mAb to be approved by the US Food and Drug Administration (FDA).", "label": 1, "is_selected": 0, "text": "Fully human monoclonal antibodies (mAbs) are a promising and rapidly growing category of targeted therapeutic agents. The first such agents were developed during the 1980s, but none achieved clinical or commercial success. Advances in technology to generate the molecules for study - in particular, transgenic mice and yeast or phage display - renewed interest in the development of human mAbs during the 1990s. In 2002, adalimumab became the first human mAb to be approved by the US Food and Drug Administration (FDA)."}
{"qid": "5713c4a11174fb1755000013", "original_text": "Dominant mutations in GARS, encoding the essential enzyme glycyl-tRNA synthetase (GlyRS), result in a form of Charcot-Marie-Tooth disease, type 2D (CMT2D), predominantly characterized by lower motor nerve degeneration. GlyRS charges the amino acid glycine with its cognate tRNA and is therefore essential for protein translation. However, the underlying mechanisms linking toxic gain-of-function GARS mutations to lower motor neuron degeneration remain unidentified.", "label": 1, "is_selected": 0, "text": "Dominant mutations in GARS, encoding the essential enzyme glycyl-tRNA synthetase (GlyRS), result in a form of Charcot-Marie-Tooth disease, type 2D (CMT2D), predominantly characterized by lower motor nerve degeneration. GlyRS charges the amino acid glycine with its cognate tRNA and is therefore essential for protein translation. However, the underlying mechanisms linking toxic gain-of-function GARS mutations to lower motor neuron degeneration remain unidentified."}
{"qid": "5505c9008e1671127b000002", "original_text": "mTORC2 is a complex protein comprised of several subunits, including: (1) mTOR (also known as proteins of unknown function 1 or rapamycin-insensitive protein 1) (2) Raptor (also known as AMP-activated protein kinase-activated protein kinase interacting protein 1) (3) Del Rivero (also known as DJ-1BP1 or DJ-1-binding protein 1) (4) Proliferator-activated receptor gamma coactivator 1 alpha (PGC-1\u03b1) (5) Sestrin 1 and 2 (6) GTPase-activating protein (GAP) for Ras These subunits work together to regulate cell growth, metabolism, and autophagy in response to various signaling pathways, including the PI3K/AKT and mTORC1 pathways.", "label": 0, "is_selected": 1, "text": "mTORC2 is a member of the mTOR family of proteins and plays a key role in the regulation of cell growth, metabolism, and autophagy, as well as in the formation of new cell membranes and in the production of new mitochondria."}
{"qid": "5c9f1b0cecadf2e73f00003c", "original_text": "Protamines are proteins that are involved in the regulation of chromatin dynamics and are known to be ubiquitously expressed in eukaryotic cells. They are found in various organisms, including humans, and play a crucial role in the modulation of gene expression, cell cycle progression, and DNA damage response. Research has shown that protamines are expressed in all somatic cells, including stem cells, and are particularly enriched in the nucleus. Their expression levels can vary depending on the cell type and the specific stage of the cell cycle.", "label": 0, "is_selected": 0, "text": "Protamines are proteins that are involved in the regulation of chromatin dynamics and are known to be ubiquitously expressed in eukaryotic cells. They are found in various organisms, including humans, and play a crucial role in the modulation of gene expression, cell cycle progression, and DNA damage response. Research has shown that protamines are expressed in all somatic cells, including stem cells, and are particularly enriched in the nucleus. Their expression levels can vary depending on the cell type and the specific stage of the cell cycle."}
{"qid": "5ac07b67dd95b2cd42000001", "original_text": "Extracellular matrix (ECM) composition and stiffness are major driving forces for the development and persistence of fibrotic diseases. Lysyl oxidase (LOX) and LOX-like (LOXL) proteins play crucial roles in ECM remodeling due to their collagen crosslinking and intracellular functions. Here, we systematically investigated LOX/L expression in primary fibroblasts and epithelial cells under fibrotic conditions, Bleomycin (BLM) induced lung fibrosis and in human IPF tissue. Basal expression of all LOX/L family members was detected in epithelial cells and at higher levels in fibroblasts.", "label": 1, "is_selected": 0, "text": "Extracellular matrix (ECM) composition and stiffness are major driving forces for the development and persistence of fibrotic diseases. Lysyl oxidase (LOX) and LOX-like (LOXL) proteins play crucial roles in ECM remodeling due to their collagen crosslinking and intracellular functions. Here, we systematically investigated LOX/L expression in primary fibroblasts and epithelial cells under fibrotic conditions, Bleomycin (BLM) induced lung fibrosis and in human IPF tissue. Basal expression of all LOX/L family members was detected in epithelial cells and at higher levels in fibroblasts."}
{"qid": "5321bb019b2d7acc7e00000b", "original_text": "Pericardial effusion has recently been reported as a complication of anorexia nervosa. A distinct pathophysiological cause of it could not be revealed. In some reports, there was a probable correlation between weight gain and reduction of pericardial effusion in anorexia nervosa cases. We encountered a case in which pericardial effusion remitted completely along with body weight increase and normalization of low T3 syndrome. These findings suggest that the reduction of pericardial effusion may correlate with both weight gain and low T3 normalization. Plasma brain natriuretic peptide (BNP) levels were increased in this case despite heart failure, and plasma BNP decreased as pericardial effusion remitted.", "label": 1, "is_selected": 0, "text": "Pericardial effusion has recently been reported as a complication of anorexia nervosa. A distinct pathophysiological cause of it could not be revealed. In some reports, there was a probable correlation between weight gain and reduction of pericardial effusion in anorexia nervosa cases. We encountered a case in which pericardial effusion remitted completely along with body weight increase and normalization of low T3 syndrome. These findings suggest that the reduction of pericardial effusion may correlate with both weight gain and low T3 normalization. Plasma brain natriuretic peptide (BNP) levels were increased in this case despite heart failure, and plasma BNP decreased as pericardial effusion remitted."}
{"qid": "5fe31307a43ad3127800003d", "original_text": "According to the latest research, approximately 40-50% of patients with Rheumatoid Arthritis (RA) do not respond to anti-Tumor Necrosis Factor (TNF) therapy. This includes both biologic and small molecule TNF inhibitors, which are commonly used to treat RA. The lack of response to anti-TNF therapy can be attributed to various factors, such as insufficient dosing, inadequate duration of treatment, or the presence of concurrent comorbidities. Additionally, some patients may have a genetic predisposition to resistance to anti-TNF therapy. It is important to closely monitor patients who are not responding to anti-TNF therapy and consider alternative treatments, such as different TNF inhibitors or other disease-modifying anti-rheumatic drugs (DMARDs), to manage their RA effectively.", "label": 0, "is_selected": 1, "text": "The lack of response to anti-TNF therapy is a major concern for patients with Rheumatoid Arthritis, and it is important to closely monitor patients who are not responding to alternative treatments, such as different anti-rheumatic drugs (DMARDs) and other disease-modifying drugs."}
{"qid": "56c5c7915795f9a73e000004", "original_text": "Cohesins, which mediate sister chromatin cohesion, and CTCF, which functions at chromatin boundaries, play key roles in the structural and functional organization of chromosomes. We examined the binding of these two factors on the Kaposi's sarcoma-associated herpesvirus (KSHV) episome during latent infection and found a striking colocalization within the control region of the major latency transcript responsible for expressing LANA (ORF73), vCyclin (ORF72), vFLIP (ORF71), and vmiRNAs. Deletion of the CTCF-binding site from the viral genome disrupted cohesin binding, and crippled colony formation in 293 cells.", "label": 1, "is_selected": 0, "text": "Cohesins, which mediate sister chromatin cohesion, and CTCF, which functions at chromatin boundaries, play key roles in the structural and functional organization of chromosomes. We examined the binding of these two factors on the Kaposi's sarcoma-associated herpesvirus (KSHV) episome during latent infection and found a striking colocalization within the control region of the major latency transcript responsible for expressing LANA (ORF73), vCyclin (ORF72), vFLIP (ORF71), and vmiRNAs. Deletion of the CTCF-binding site from the viral genome disrupted cohesin binding, and crippled colony formation in 293 cells."}
{"qid": "58ea6c3eeda5a57672000001", "original_text": "Magnetoreception is essential for magnetic orientation in animal migration. The molecular basis for magnetoreception has recently been elucidated in fruitfly as complexes between the magnetic receptor magnetoreceptor (MagR) and its ligand cryptochrome (Cry). MagR and Cry are present in the animal kingdom. However, it is unknown whether they perform a conserved role in diverse animals. Here we report the identification and expression of zebrafish MagR and Cry homologs towards understanding their roles in lower vertebrates. A single magr gene and 7 cry genes are present in the zebrafish genome. Zebrafish has four cry1 genes (cry1aa, cry1ab, cry1ba and cry1bb) homologous to human CRY1 and a single ortholog of human CRY2 as well as 2 cry-like genes (cry4 and cry5).", "label": 1, "is_selected": 0, "text": "Magnetoreception is essential for magnetic orientation in animal migration. The molecular basis for magnetoreception has recently been elucidated in fruitfly as complexes between the magnetic receptor magnetoreceptor (MagR) and its ligand cryptochrome (Cry). MagR and Cry are present in the animal kingdom. However, it is unknown whether they perform a conserved role in diverse animals. Here we report the identification and expression of zebrafish MagR and Cry homologs towards understanding their roles in lower vertebrates. A single magr gene and 7 cry genes are present in the zebrafish genome. Zebrafish has four cry1 genes (cry1aa, cry1ab, cry1ba and cry1bb) homologous to human CRY1 and a single ortholog of human CRY2 as well as 2 cry-like genes (cry4 and cry5)."}
{"qid": "5a6e4d22b750ff445500004d", "original_text": "Schimke immuno-osseous dysplasia is an autosomal recessive multisystem disorder caused by defects in SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1 gene (SMARCAL1). SMARCAL1 product is a helicase that has role in selective cellular proliferation. The disorder is characterized by spondyloepiphyseal dysplasia with short stature, nephropathy, T cell deficiency, neurologic and cutaneous signs. Patients may have hyperpigmented skin lesions similar to caf\u00e9 au lait spots. Symptoms and disease severity in Schimke immuno-osseous dysplasia varies from patient to patient.", "label": 1, "is_selected": 0, "text": "Schimke immuno-osseous dysplasia is an autosomal recessive multisystem disorder caused by defects in SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1 gene (SMARCAL1). SMARCAL1 product is a helicase that has role in selective cellular proliferation. The disorder is characterized by spondyloepiphyseal dysplasia with short stature, nephropathy, T cell deficiency, neurologic and cutaneous signs. Patients may have hyperpigmented skin lesions similar to caf\u00e9 au lait spots. Symptoms and disease severity in Schimke immuno-osseous dysplasia varies from patient to patient."}
{"qid": "515bf6d6298dcd4e51000004", "original_text": "The Tpl2 gene is associated with several forms of cancer, including: 1. Melanoma: The Tpl2 gene is mutated in many melanoma tumors, and the mutations are often found in the exon 16 region. 2. Pancreatic cancer: Research has shown that Tpl2 mutations are present in approximately 30% of pancreatic cancer tumors. 3. Colorectal cancer: Tpl2 mutations have been identified in approximately 15% of colorectal cancer tumors. 4. Lung cancer: Tpl2 mutations have been detected in some non-small cell lung cancer (NSCLC) tumors, particularly in adenocarcinoma subtype. 5. Gastrointestinal stromal tumors (GISTs): Tpl2 mutations are found in approximately 50% of GISTs, particularly in the exon 16 region. It's worth noting that the prevalence of Tpl2 mutations in different cancers can vary depending on the population and the specific study being referenced. Additionally, Tpl2 mutations can also be found in other types of cancer, such as breast cancer and ovarian cancer, but the frequency may be lower than in the above mentioned cancers.", "label": 0, "is_selected": 0, "text": "The Tpl2 gene is associated with several forms of cancer, including: 1. Melanoma: The Tpl2 gene is mutated in many melanoma tumors, and the mutations are often found in the exon 16 region. 2. Pancreatic cancer: Research has shown that Tpl2 mutations are present in approximately 30% of pancreatic cancer tumors. 3. Colorectal cancer: Tpl2 mutations have been identified in approximately 15% of colorectal cancer tumors. 4. Lung cancer: Tpl2 mutations have been detected in some non-small cell lung cancer (NSCLC) tumors, particularly in adenocarcinoma subtype. 5. Gastrointestinal stromal tumors (GISTs): Tpl2 mutations are found in approximately 50% of GISTs, particularly in the exon 16 region. It's worth noting that the prevalence of Tpl2 mutations in different cancers can vary depending on the population and the specific study being referenced. Additionally, Tpl2 mutations can also be found in other types of cancer, such as breast cancer and ovarian cancer, but the frequency may be lower than in the above mentioned cancers."}
{"qid": "6025a1e91cb411341a0000b4", "original_text": "Sure, here are three conventional synthetic DMARDs: 1. Methotrexate: This is a folate inhibitor that works by reducing inflammation and slowing down the growth of immune cells. It is commonly used to treat rheumatoid arthritis, psoriasis, and inflammatory bowel disease. 2. Hydroxyurea: This drug works by inhibiting the production of white blood cells, which are responsible for inflammation. It is used to treat conditions such as polycythemia vera, essential thrombocythemia, and primary myelofibrosis. 3. Leflunomide: This drug works by reducing the activity of immune cells and inhibiting the production of prostaglandins, which are pro-inflammatory molecules. It is used to treat rheumatoid arthritis and psoriasis. Please note that this is not an exhaustive list, and there are many other synthetic DMARDs available. Additionally, the use of these drugs may have side effects and should only be used under the guidance of a healthcare professional.", "label": 0, "is_selected": 1, "text": "Is there a synthetic DMARD out there that works as well as a real DMARD? Leflunomide: This drug works by reducing the activity of immune cells and inhibiting the production of prostaglandins, which are pro-inflammatory molecules., and is commonly used to treat rheumatoid arthritis and psoriasis., but is it safe?, and if so, what is it?"}
{"qid": "587f60f892a5b8ad44000004", "original_text": "More than 90% of common variants associated with complex traits do not affect proteins directly, but instead the circuits that control gene expression. This has increased the urgency of understanding the regulatory genome as a key component for translating genetic results into mechanistic insights and ultimately therapeutics. To address this challenge, we developed HaploReg (http://compbio.mit.edu/HaploReg) to aid the functional dissection of genome-wide association study (GWAS) results, the prediction of putative causal variants in haplotype blocks, the prediction of likely cell types of action, and the prediction of candidate target genes by systematic mining of comparative, epigenomic and regulatory annotations. Since first launching the website in 2011, we have greatly expanded HaploReg, increasing the number of chromatin state maps to 127 reference epigenomes from ENCODE 2012 and Roadmap Epigenomics, incorporating regulator binding data, expanding regulatory motif disruption annotations, and integrating expression quantitative trait locus (eQTL) variants and their tissue-specific target genes from GTEx, Geuvadis, and other recent studies.", "label": 1, "is_selected": 0, "text": "More than 90% of common variants associated with complex traits do not affect proteins directly, but instead the circuits that control gene expression. This has increased the urgency of understanding the regulatory genome as a key component for translating genetic results into mechanistic insights and ultimately therapeutics. To address this challenge, we developed HaploReg (http://compbio.mit.edu/HaploReg) to aid the functional dissection of genome-wide association study (GWAS) results, the prediction of putative causal variants in haplotype blocks, the prediction of likely cell types of action, and the prediction of candidate target genes by systematic mining of comparative, epigenomic and regulatory annotations. Since first launching the website in 2011, we have greatly expanded HaploReg, increasing the number of chromatin state maps to 127 reference epigenomes from ENCODE 2012 and Roadmap Epigenomics, incorporating regulator binding data, expanding regulatory motif disruption annotations, and integrating expression quantitative trait locus (eQTL) variants and their tissue-specific target genes from GTEx, Geuvadis, and other recent studies."}
{"qid": "601bcb5d1cb411341a000003", "original_text": "GRK1 associated Oguchi disease is caused by missense mutations in the GRK1 gene, which encodes the G-protein receptor kinase 1. These mutations result in an abnormal function of the GRK1 protein, leading to the progressive degeneration of neurons in the brain and spinal cord. The mutations can be inherited in an autosomal dominant or recessive manner, depending on the type of mutation. Common mutations include those that result in the premature termination of protein synthesis, alter the protein's structure, or disrupt its normal signaling pathways.", "label": 0, "is_selected": 1, "text": "The GRK1 associated Oguchi disease is caused by missense mutations in the GRK 1 gene, which encodes the G-protein receptor kinase 1 and is known to cause progressive degeneration of neurons in the brain and spinal cord, leading to the progressive loss of function."}
{"qid": "5a79d25dfaa1ab7d2e00000f", "original_text": "The genus Avena consists of at least 23 species composed of three ploidy levels. Cytogenetic analysis has characterised four distinct karyotypes. These are the A, B, C and D genomes.", "label": 1, "is_selected": 0, "text": "The genus Avena consists of at least 23 species composed of three ploidy levels. Cytogenetic analysis has characterised four distinct karyotypes. These are the A, B, C and D genomes."}
{"qid": "5e339202fbd6abf43b000062", "original_text": "Proton beam therapy (PBT) is a type of radiation therapy that uses positively charged protons to destroy cancer cells. While PBT is generally considered a safe and effective treatment option, there is a risk of secondary cancer following the therapy. Studies have shown that the risk of secondary cancer after PBT varies depending on several factors, including the type of cancer being treated, the dose of radiation used, and the location of the tumor. For example, a study published in the Journal of Clinical Oncology found that the risk of secondary cancer was higher in patients with brain tumors who received PBT compared to those with other types of cancer. According to the National Cancer Institute, the risk of secondary cancer after PBT is generally low, with estimates suggesting that the risk ranges from 0.2% to 2.2% for patients who receive PBT for brain tumors. However, the risk may be higher for certain types of cancer, such as breast cancer, which has been associated with a 1.4% to 3.2% risk of secondary cancer after PBT. It is important to note that the risk of secondary cancer after PBT is still lower than the risk associated with other types of radiation therapy, such as photon therapy. Additionally, PBT has been shown to have a lower risk of toxicity to healthy tissues compared to photon therapy, which may reduce the overall risk of secondary cancer. In summary, while the risk of secondary cancer after PBT is still a concern, the evidence suggests that the risk is generally low. Patients should discuss their individual risk factors and concerns with their radiation oncologist to determine the appropriate course of treatment.", "label": 0, "is_selected": 1, "text": "The risk of secondary cancer after proton beam therapy is still a concern, but the evidence suggests that the risk is generally low, and patients should discuss their individual risk factors and concerns with their radiation oncologist, according to the American Society for Radiation Oncology (ASTRO) and the National Cancer Institute (NCTI).Patients with breast cancer who have received proton beam treatment should discuss the risks and benefits of this type of therapy with their Radiation Oncologist, says the American Cancer Society (ACS) in a press release, but it is important to note that there is no known cure for breast cancer, so it is best to wait until the disease has spread to other parts of the body before proceeding with this treatment."}
{"qid": "516beae9298dcd4e5100006b", "original_text": "Failure of the functional pancreatic beta-cell mass to expand in response to increased metabolic demand is a hallmark of type 2 diabetes. Lineage tracing studies indicate that replication of existing beta-cells is important for beta-cell proliferation in adult animals. In rat pancreatic beta-cell lines (RIN5F), treatment with 100 nM thyroid hormone (triiodothyronine, T(3)) enhances cell proliferation. This result suggests that T(3) is required for beta-cell proliferation or replication. To identify the role of thyroid hormone receptor alpha (TR(alpha)) in the processes of beta-cell growth and cell cycle regulation, we constructed a recombinant adenovirus vector, AdTR(alpha). Infection with AdTR(alpha) to RIN5F cells increased the expression of cyclin D1 mRNA and protein. Overexpression of the cyclin D1 protein in AdTR(alpha)-infected cells led to activation of the cyclin D1/cyclin-dependent kinase/retinoblastoma protein/E2F pathway, along with cell cycle progression and cell proliferation following treatment with 100 nM T(3). Conversely, lowering cellular cyclin D1 by small interfering RNA knockdown in AdTR(alpha)-infected cells led to down-regulation of the cyclin D1/CDK/Rb/E2F pathway and inhibited cell proliferation. Furthermore, in immunodeficient mice with streptozotocin-induced diabetes, intrapancreatic injection of AdTR(alpha) led to the restoration of islet function and to an increase in the beta-cell mass.", "label": 1, "is_selected": 0, "text": "Failure of the functional pancreatic beta-cell mass to expand in response to increased metabolic demand is a hallmark of type 2 diabetes. Lineage tracing studies indicate that replication of existing beta-cells is important for beta-cell proliferation in adult animals. In rat pancreatic beta-cell lines (RIN5F), treatment with 100 nM thyroid hormone (triiodothyronine, T(3)) enhances cell proliferation. This result suggests that T(3) is required for beta-cell proliferation or replication. To identify the role of thyroid hormone receptor alpha (TR(alpha)) in the processes of beta-cell growth and cell cycle regulation, we constructed a recombinant adenovirus vector, AdTR(alpha). Infection with AdTR(alpha) to RIN5F cells increased the expression of cyclin D1 mRNA and protein. Overexpression of the cyclin D1 protein in AdTR(alpha)-infected cells led to activation of the cyclin D1/cyclin-dependent kinase/retinoblastoma protein/E2F pathway, along with cell cycle progression and cell proliferation following treatment with 100 nM T(3). Conversely, lowering cellular cyclin D1 by small interfering RNA knockdown in AdTR(alpha)-infected cells led to down-regulation of the cyclin D1/CDK/Rb/E2F pathway and inhibited cell proliferation. Furthermore, in immunodeficient mice with streptozotocin-induced diabetes, intrapancreatic injection of AdTR(alpha) led to the restoration of islet function and to an increase in the beta-cell mass."}
{"qid": "52fa6ac72059c6d71c000055", "original_text": "Bach1 is a transcriptional repressor which modulates several critical transcriptional responses, such as the expression of the heme oxygenase-1 (HO-1) gene in response to oxidative stress. In our recent study, we found that Bach1 possesses a novel role in mitotic chromosome alignment during metaphase. Upon BACH1 depletion in HeLa cells, mitotic chromosomes become unstable. This defect was efficiently rescued by expressing Bach1 fragments that lack the DNA binding domain, indicating that its function in mitosis involves a transcription-independent mechanism. The nuclear export signal (NES/CLS) of Bach1 is required for the mitotic function. Bach1 is excluded from the mitotic chromosomes depending on its NES/CLS and the nuclear exporter Crm1. Our findings suggest that Bach1 might mediate the regulation of mitotic chromosomes under conditions of cellular stress.", "label": 1, "is_selected": 0, "text": "Bach1 is a transcriptional repressor which modulates several critical transcriptional responses, such as the expression of the heme oxygenase-1 (HO-1) gene in response to oxidative stress. In our recent study, we found that Bach1 possesses a novel role in mitotic chromosome alignment during metaphase. Upon BACH1 depletion in HeLa cells, mitotic chromosomes become unstable. This defect was efficiently rescued by expressing Bach1 fragments that lack the DNA binding domain, indicating that its function in mitosis involves a transcription-independent mechanism. The nuclear export signal (NES/CLS) of Bach1 is required for the mitotic function. Bach1 is excluded from the mitotic chromosomes depending on its NES/CLS and the nuclear exporter Crm1. Our findings suggest that Bach1 might mediate the regulation of mitotic chromosomes under conditions of cellular stress."}
{"qid": "6226317a3a8413c653000080", "original_text": "Ameloblastoma is the most common aggressive benign odontogenic tumor of the jaws. Ameloblastoma is a benign epithelial odontogenic tumor that typically arises in the mandible or maxilla or, rarely, in the immediate adjacent soft tissues. A clinical, radiographic and histopathological report is presented of a case of acanthomatous ameloblastoma in relation to molar in the left mandible of a 30-year-old healthy male. The histopathological examination of the removed specimen revealed the histopathological pattern of an acanthomatous ameloblastoma.", "label": 1, "is_selected": 0, "text": "Ameloblastoma is the most common aggressive benign odontogenic tumor of the jaws. Ameloblastoma is a benign epithelial odontogenic tumor that typically arises in the mandible or maxilla or, rarely, in the immediate adjacent soft tissues. A clinical, radiographic and histopathological report is presented of a case of acanthomatous ameloblastoma in relation to molar in the left mandible of a 30-year-old healthy male. The histopathological examination of the removed specimen revealed the histopathological pattern of an acanthomatous ameloblastoma."}
{"qid": "6027fcd31cb411341a0000ef", "original_text": "Elementary flux modes (EFMs) analysis constitutes a fundamental tool in systems biology. However, the efficient calculation of EFMs in genome-scale metabolic networks (GSMNs) is still a challenge. We present a novel algorithm that uses a linear programming-based tree search and efficiently enumerates a subset of EFMs in GSMNs. Our approach is compared with the EFMEvolver approach, demonstrating a significant improvement in computation time. We also validate the usefulness of our new approach by studying the acetate overflow metabolism in the Escherichia coli bacteria. To do so, we computed 1 million EFMs for each energetic amino acid and then analysed the relevance of each energetic amino acid based on gene/protein expression data and the obtained EFMs.", "label": 1, "is_selected": 0, "text": "Elementary flux modes (EFMs) analysis constitutes a fundamental tool in systems biology. However, the efficient calculation of EFMs in genome-scale metabolic networks (GSMNs) is still a challenge. We present a novel algorithm that uses a linear programming-based tree search and efficiently enumerates a subset of EFMs in GSMNs. Our approach is compared with the EFMEvolver approach, demonstrating a significant improvement in computation time. We also validate the usefulness of our new approach by studying the acetate overflow metabolism in the Escherichia coli bacteria. To do so, we computed 1 million EFMs for each energetic amino acid and then analysed the relevance of each energetic amino acid based on gene/protein expression data and the obtained EFMs."}
{"qid": "58a5d54860087bc10a000025", "original_text": "In modern times scurvy is a rarely encountered disease caused by ascorbic acid (vitamin C) deficiency. However, sporadic cases of scurvy persist, particularly within the pediatric population. Recent individual case reports highlight an increased incidence of scurvy among patients with autism or developmental delay, with isolated case reports detailing the magnetic resonance imaging (MRI) findings of scurvy in these pediatric populations. We present the MRI findings of scurvy in four patients with autism or developmental delay, and review the literature on MRI findings in pediatric patients with scurvy. Despite its rarity, the radiologist must consider scurvy in a pediatric patient with a restricted diet presenting with arthralgia or myalgia.", "label": 1, "is_selected": 0, "text": "In modern times scurvy is a rarely encountered disease caused by ascorbic acid (vitamin C) deficiency. However, sporadic cases of scurvy persist, particularly within the pediatric population. Recent individual case reports highlight an increased incidence of scurvy among patients with autism or developmental delay, with isolated case reports detailing the magnetic resonance imaging (MRI) findings of scurvy in these pediatric populations. We present the MRI findings of scurvy in four patients with autism or developmental delay, and review the literature on MRI findings in pediatric patients with scurvy. Despite its rarity, the radiologist must consider scurvy in a pediatric patient with a restricted diet presenting with arthralgia or myalgia."}
{"qid": "5a67a550b750ff4455000009", "original_text": "A case of carcinoid syndrome, stemming from a tumor of the large intestine with hepatic metastases, is reported. Clinical features included cardiac disease with triple valvular lesion: tricuspid insufficiency with stenosis, pulmonary artery stenosis and mitral insufficiency. More recent views about the pathogenesis of the cardiac involvement in the carcinoid syndrome are reported, and the cardiac therapy is discussed.", "label": 1, "is_selected": 0, "text": "A case of carcinoid syndrome, stemming from a tumor of the large intestine with hepatic metastases, is reported. Clinical features included cardiac disease with triple valvular lesion: tricuspid insufficiency with stenosis, pulmonary artery stenosis and mitral insufficiency. More recent views about the pathogenesis of the cardiac involvement in the carcinoid syndrome are reported, and the cardiac therapy is discussed."}
{"qid": "56f7c44109dd18d46b000013", "original_text": "alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency is a rare hereditary lysosomal storage disease, and only three alpha-NAGA-deficient patients with angiokeratoma corporis diffusum (Kanzaki) have been described. We report a further case in a 47-year-old Japanese woman, the product of a consanguineous marriage. The remarkable findings in this patient were her normal intelligence, M\u00e9ni\u00e8re's syndrome, disturbance of peripheral sensory nerves, hearing loss and cardiac hypertrophy.", "label": 1, "is_selected": 0, "text": "alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency is a rare hereditary lysosomal storage disease, and only three alpha-NAGA-deficient patients with angiokeratoma corporis diffusum (Kanzaki) have been described. We report a further case in a 47-year-old Japanese woman, the product of a consanguineous marriage. The remarkable findings in this patient were her normal intelligence, M\u00e9ni\u00e8re's syndrome, disturbance of peripheral sensory nerves, hearing loss and cardiac hypertrophy."}
{"qid": "589d965a78275d0c4a000049", "original_text": "MicroRNAs (miRNAs) constitute a large family of noncoding RNAs that function as guide molecules in diverse gene silencing pathways. Current efforts are focused on the regulatory function of miRNAs, while little is known about how these unusual genes themselves are regulated. Here we present the first direct evidence that miRNA genes are transcribed by RNA polymerase II (pol II).", "label": 1, "is_selected": 0, "text": "MicroRNAs (miRNAs) constitute a large family of noncoding RNAs that function as guide molecules in diverse gene silencing pathways. Current efforts are focused on the regulatory function of miRNAs, while little is known about how these unusual genes themselves are regulated. Here we present the first direct evidence that miRNA genes are transcribed by RNA polymerase II (pol II)."}
{"qid": "5c6b15467c78d69471000024", "original_text": "3'-untranslated regions (UTRs) can vary through the use of alternative polyadenylation sites during pre-mRNA processing. Multiple publically available pipelines combining high profiling technologies and bioinformatics tools have been developed to catalog changes in 3'-UTR lengths. In our recent RNA-seq experiments using cells with hyper-activated mammalian target of rapamycin (mTOR), we found that cellular mTOR activation leads to transcriptome-wide alternative polyadenylation (APA), resulting in the activation of multiple cellular pathways. Here, we developed a novel bioinformatics algorithm, IntMAP, which integrates RNA-Seq and PolyA Site (PAS)-Seq data for a comprehensive characterization of APA events. By applying IntMAP to the datasets from cells with hyper-activated mTOR, we identified novel APA events that could otherwise not be identified by either profiling method alone. Several transcription factors including Cebpg (CCAAT/enhancer binding protein gamma) were among the newly discovered APA transcripts, indicating that diverse transcriptional networks may be regulated by mTOR-coordinated APA. The prevention of APA in Cebpg using the CRISPR/cas9-mediated genome editing tool showed that mTOR-driven 3'-UTR shortening in Cebpg is critical in protecting cells from endoplasmic reticulum (ER) stress. Taken together, we present IntMAP as a new bioinformatics algorithm for APA analysis by which we expand our understanding of the physiological role of mTOR-coordinated APA events to ER stress response. IntMAP toolbox is available at http://compbio.cs.umn.edu/IntMAP/.", "label": 1, "is_selected": 0, "text": "3'-untranslated regions (UTRs) can vary through the use of alternative polyadenylation sites during pre-mRNA processing. Multiple publically available pipelines combining high profiling technologies and bioinformatics tools have been developed to catalog changes in 3'-UTR lengths. In our recent RNA-seq experiments using cells with hyper-activated mammalian target of rapamycin (mTOR), we found that cellular mTOR activation leads to transcriptome-wide alternative polyadenylation (APA), resulting in the activation of multiple cellular pathways. Here, we developed a novel bioinformatics algorithm, IntMAP, which integrates RNA-Seq and PolyA Site (PAS)-Seq data for a comprehensive characterization of APA events. By applying IntMAP to the datasets from cells with hyper-activated mTOR, we identified novel APA events that could otherwise not be identified by either profiling method alone. Several transcription factors including Cebpg (CCAAT/enhancer binding protein gamma) were among the newly discovered APA transcripts, indicating that diverse transcriptional networks may be regulated by mTOR-coordinated APA. The prevention of APA in Cebpg using the CRISPR/cas9-mediated genome editing tool showed that mTOR-driven 3'-UTR shortening in Cebpg is critical in protecting cells from endoplasmic reticulum (ER) stress. Taken together, we present IntMAP as a new bioinformatics algorithm for APA analysis by which we expand our understanding of the physiological role of mTOR-coordinated APA events to ER stress response. IntMAP toolbox is available at http://compbio.cs.umn.edu/IntMAP/."}
{"qid": "532f05bdd6d3ac6a34000026", "original_text": "Yes, proteomics has been used in the study of Pick's disease, a rare and progressive neurodegenerative disorder characterized by cognitive decline, dementia, and motor dysfunction. Proteomics is the study of the complete set of proteins produced by an organism, and it has been applied to the study of Pick's disease with the aim of identifying biomarkers for early diagnosis and monitoring of the disease. Research has shown that proteomics can help distinguish Pick's disease from other neurodegenerative disorders and may provide insights into the molecular mechanisms underlying the disease. For example, one study identified a panel of plasma proteins that could distinguish Pick's disease from Alzheimer's disease with an accuracy rate of 90%. However, more research is needed to validate these findings and to determine the clinical utility of proteomics in the diagnosis and management of Pick's disease.", "label": 0, "is_selected": 0, "text": "Yes, proteomics has been used in the study of Pick's disease, a rare and progressive neurodegenerative disorder characterized by cognitive decline, dementia, and motor dysfunction. Proteomics is the study of the complete set of proteins produced by an organism, and it has been applied to the study of Pick's disease with the aim of identifying biomarkers for early diagnosis and monitoring of the disease. Research has shown that proteomics can help distinguish Pick's disease from other neurodegenerative disorders and may provide insights into the molecular mechanisms underlying the disease. For example, one study identified a panel of plasma proteins that could distinguish Pick's disease from Alzheimer's disease with an accuracy rate of 90%. However, more research is needed to validate these findings and to determine the clinical utility of proteomics in the diagnosis and management of Pick's disease."}
{"qid": "58e23ec66fddd3e83e000010", "original_text": "The common European honey bee is part of the genus Apis. There are seven species within the Apis genus, with Apis mellifera being the most widely known and distributed species, which is the European honey bee.", "label": 0, "is_selected": 1, "text": "The European honey bee (Apis mellifera) is one of the world's most common honey bees and is native to most of the European Union and parts of North America, South America, and Asia.<n>"}
{"qid": "58bdc76102b8c60953000013", "original_text": "Yes, the hERG gene (Hyperpolarization-activated cyclic nucleotide-gated channel, subfamily H, member 4) encodes a protein that forms a sodium channel. The hERG protein is a voltage-gated sodium channel that is primarily expressed in the cardiac ventricles and plays a crucial role in the regulation of the cardiac action potential duration and refractoriness. The hERG channel is gated by both hyperpolarization and cyclic nucleotides, and it has been shown to be involved in the development of cardiac arrhythmias, such as long QT syndrome and atrioventricular block. Mutations in the hERG gene have been associated with an increased risk of ventricular arrhythmias and sudden cardiac death.", "label": 0, "is_selected": 0, "text": "Yes, the hERG gene (Hyperpolarization-activated cyclic nucleotide-gated channel, subfamily H, member 4) encodes a protein that forms a sodium channel. The hERG protein is a voltage-gated sodium channel that is primarily expressed in the cardiac ventricles and plays a crucial role in the regulation of the cardiac action potential duration and refractoriness. The hERG channel is gated by both hyperpolarization and cyclic nucleotides, and it has been shown to be involved in the development of cardiac arrhythmias, such as long QT syndrome and atrioventricular block. Mutations in the hERG gene have been associated with an increased risk of ventricular arrhythmias and sudden cardiac death."}
{"qid": "533ba218fd9a95ea0d000007", "original_text": "Cardiac magnetic resonance (CMR) imaging is a well-established noninvasive imaging modality in clinical cardiology. Its unsurpassed accuracy in defining cardiac morphology and function and its ability to provide tissue characterization make it well suited for the study of patients with cardiac diseases. Late gadolinium enhancement was a major advancement in the development of tissue characterization techniques, allowing the unique ability of CMR to differentiate ischemic heart disease from nonischemic cardiomyopathies. Using T2-weighted techniques, areas of edema and inflammation can be identified in the myocardium. A new generation of myocardial mapping techniques are emerging, enabling direct quantitative assessment of myocardial tissue properties in absolute terms. This review will summarize recent developments involving T1-mapping and T2-mapping techniques and focus on the clinical applications and future potential of these evolving CMR methodologies.", "label": 1, "is_selected": 0, "text": "Cardiac magnetic resonance (CMR) imaging is a well-established noninvasive imaging modality in clinical cardiology. Its unsurpassed accuracy in defining cardiac morphology and function and its ability to provide tissue characterization make it well suited for the study of patients with cardiac diseases. Late gadolinium enhancement was a major advancement in the development of tissue characterization techniques, allowing the unique ability of CMR to differentiate ischemic heart disease from nonischemic cardiomyopathies. Using T2-weighted techniques, areas of edema and inflammation can be identified in the myocardium. A new generation of myocardial mapping techniques are emerging, enabling direct quantitative assessment of myocardial tissue properties in absolute terms. This review will summarize recent developments involving T1-mapping and T2-mapping techniques and focus on the clinical applications and future potential of these evolving CMR methodologies."}
{"qid": "621ecac13a8413c65300005f", "original_text": "The lysosomotropic amine primaquine has previously been shown to inhibit both secretory and recycling processes of cells in culture. We have used a cell-free assay that reconstitutes glycoprotein transport through the Golgi apparatus to investigate the mechanism of action of primaquine. In this assay, primaquine inhibits protein transport at a half-maximal concentration of 50 microM, similar to the concentration previously reported to disrupt protein secretion in cultured cells. Kinetic analysis of primaquine inhibition indicates that its point of action is at an early step in the vesicular transport mechanism.", "label": 1, "is_selected": 0, "text": "The lysosomotropic amine primaquine has previously been shown to inhibit both secretory and recycling processes of cells in culture. We have used a cell-free assay that reconstitutes glycoprotein transport through the Golgi apparatus to investigate the mechanism of action of primaquine. In this assay, primaquine inhibits protein transport at a half-maximal concentration of 50 microM, similar to the concentration previously reported to disrupt protein secretion in cultured cells. Kinetic analysis of primaquine inhibition indicates that its point of action is at an early step in the vesicular transport mechanism."}
{"qid": "5d35ef8a7bc3fee31f000002", "original_text": "It is almost ten years since senescence associated heterochromatic foci (SAHFs) were first described in human diploid fibroblasts (HDFs). Since then, a number of factors have been identified that affect SAHF formation, including HMGA proteins, structural components of SAHFs. However, the involvement of epigenetic marks in SAHF formation remains unclear. Our recent study, combining microscopy and ChIP-seq approaches, revealed that SAHFs are formed through spatial repositioning of the genome. This occurs according to certain chromatin features that are correlated with, but do not require, the repressive marks histone H3 trimethylated on lysine 9 (H3K9me3) and H3K27me3.", "label": 1, "is_selected": 0, "text": "It is almost ten years since senescence associated heterochromatic foci (SAHFs) were first described in human diploid fibroblasts (HDFs). Since then, a number of factors have been identified that affect SAHF formation, including HMGA proteins, structural components of SAHFs. However, the involvement of epigenetic marks in SAHF formation remains unclear. Our recent study, combining microscopy and ChIP-seq approaches, revealed that SAHFs are formed through spatial repositioning of the genome. This occurs according to certain chromatin features that are correlated with, but do not require, the repressive marks histone H3 trimethylated on lysine 9 (H3K9me3) and H3K27me3."}
{"qid": "54e061ee1388e8454a00000c", "original_text": "Tuberous sclerosis complex is a genetic disorder leading to constitutive activation of mammalian target of rapamycin (mTOR) and growth of benign tumours in several organs. In the brain, growth of subependymal giant cell astrocytomas can cause life-threatening symptoms--eg, hydrocephalus, requiring surgery. In an open-label, phase 1/2 study, the mTOR inhibitor everolimus substantially and significantly reduced the volume of subependymal giant cell astrocytomas. We assessed the efficacy and safety of everolimus in patients with subependymal giant cell astrocytomas associated with tuberous sclerosis complex. In this double-blind, placebo-controlled, phase 3 trial, patients (aged 0-65 years) in 24 centres in Australia, Belgium, Canada, Germany, the UK, Italy, the Netherlands, Poland, Russian Federation, and the USA were randomly assigned, with an interactive internet-response system, in a 2:1 ratio to oral everolimus 4\u00b75 mg/m(2) per day (titrated to achieve blood trough concentrations of 5-15 ng/mL) or placebo.", "label": 1, "is_selected": 0, "text": "Tuberous sclerosis complex is a genetic disorder leading to constitutive activation of mammalian target of rapamycin (mTOR) and growth of benign tumours in several organs. In the brain, growth of subependymal giant cell astrocytomas can cause life-threatening symptoms--eg, hydrocephalus, requiring surgery. In an open-label, phase 1/2 study, the mTOR inhibitor everolimus substantially and significantly reduced the volume of subependymal giant cell astrocytomas. We assessed the efficacy and safety of everolimus in patients with subependymal giant cell astrocytomas associated with tuberous sclerosis complex. In this double-blind, placebo-controlled, phase 3 trial, patients (aged 0-65 years) in 24 centres in Australia, Belgium, Canada, Germany, the UK, Italy, the Netherlands, Poland, Russian Federation, and the USA were randomly assigned, with an interactive internet-response system, in a 2:1 ratio to oral everolimus 4\u00b75 mg/m(2) per day (titrated to achieve blood trough concentrations of 5-15 ng/mL) or placebo."}
{"qid": "5c6585287c78d69471000004", "original_text": "Midostaurin (PKC412, Rydapt\u00ae) is an oral multiple tyrosine kinase inhibitor. Main targets are the kinase domain receptor, vascular endothelial-, platelet derived-, and fibroblast growth factor receptor, stem cell factor receptor c-KIT, as well as mutated and wild-type FLT3 kinases.", "label": 1, "is_selected": 0, "text": "Midostaurin (PKC412, Rydapt\u00ae) is an oral multiple tyrosine kinase inhibitor. Main targets are the kinase domain receptor, vascular endothelial-, platelet derived-, and fibroblast growth factor receptor, stem cell factor receptor c-KIT, as well as mutated and wild-type FLT3 kinases."}
{"qid": "5fe31317a43ad31278000044", "original_text": "MAP3K8 (TPL2) regulates the formation of the inflammatory molecule TNF-alpha (Tumor Necrosis Factor-alpha). TNF-alpha is a pro-inflammatory cytokine that plays a crucial role in the regulation of immune responses, inflammation, and tissue repair. MAP3K8 (TPL2) activates the p38 mitogen-activated protein kinase (MAPK) pathway, which ultimately leads to the activation and release of TNF-alpha from cells. The dysregulation of MAP3K8 (TPL2) and TNF-alpha has been implicated in various inflammatory disorders, including arthritis, autoimmune diseases, and cancer.", "label": 0, "is_selected": 1, "text": "The protein MAP3K8 (TPL2) is encoded by the TPL2 gene, which is a member of the cytokine-regulating kinase family of molecules, the mitogen-activated protein kinase (MAPK) family, and has been implicated in a number of inflammatory diseases."}
{"qid": "5891f9e549702f2e01000002", "original_text": "Both restless legs syndrome ([RLS], also known as Willis-Ekbom Disease [WED]) and depression are common during pregnancy. However, no prior studies have assessed if pregnant women with RLS have an elevated risk of depression during and/or after pregnancy. 1,428 women who were pregnant in gestational week 16-17 were asked to participate in a longitudinal survey. They were followed by web-based questionnaires in gestational week 17 and 32, and 6 weeks after delivery.", "label": 1, "is_selected": 0, "text": "Both restless legs syndrome ([RLS], also known as Willis-Ekbom Disease [WED]) and depression are common during pregnancy. However, no prior studies have assessed if pregnant women with RLS have an elevated risk of depression during and/or after pregnancy. 1,428 women who were pregnant in gestational week 16-17 were asked to participate in a longitudinal survey. They were followed by web-based questionnaires in gestational week 17 and 32, and 6 weeks after delivery."}
{"qid": "6275199fe764a5320400004d", "original_text": "Pancreatic ductal adenocarcinoma (PDA) is frequently driven by oncogenic KRAS(KRAS*) mutations. We developed a mouse model of KRAS*-induced PDA and, based on genetic results demonstrating that KRAS* tumorigenicity depends on Myc activity, we evaluated the therapeutic potential of an orally administered anti-Myc drug. We tested the efficacy of Mycro3, a small-molecule inhibitor of Myc-Max dimerization, in the treatment of mouse PDA (n = 9) and also of xenografts of human pancreatic cancer cell lines (NOD/SCID mice, n = 3-12). Tumor responses to the drug were evaluated by PET/CT imaging, and histological, immunohistochemical, molecular and microarray analyses. The Student's t test was used for differences between groups. All statistical tests were two-sided. Transgenic overexpression of KRAS* in the pancreas resulted in pancreatic intraepithelial neoplasia in two-week old mice, which developed invasive PDA a week later and became moribund at one month. However, this aggressive form of pancreatic tumorigenesis was effectively prevented by genetic ablation of Myc specifically in the pancreas. We then treated moribund, PDA-bearing mice daily with the Mycro3 Myc-inhibitor. The mice survived until killed at two months.", "label": 1, "is_selected": 0, "text": "Pancreatic ductal adenocarcinoma (PDA) is frequently driven by oncogenic KRAS(KRAS*) mutations. We developed a mouse model of KRAS*-induced PDA and, based on genetic results demonstrating that KRAS* tumorigenicity depends on Myc activity, we evaluated the therapeutic potential of an orally administered anti-Myc drug. We tested the efficacy of Mycro3, a small-molecule inhibitor of Myc-Max dimerization, in the treatment of mouse PDA (n = 9) and also of xenografts of human pancreatic cancer cell lines (NOD/SCID mice, n = 3-12). Tumor responses to the drug were evaluated by PET/CT imaging, and histological, immunohistochemical, molecular and microarray analyses. The Student's t test was used for differences between groups. All statistical tests were two-sided. Transgenic overexpression of KRAS* in the pancreas resulted in pancreatic intraepithelial neoplasia in two-week old mice, which developed invasive PDA a week later and became moribund at one month. However, this aggressive form of pancreatic tumorigenesis was effectively prevented by genetic ablation of Myc specifically in the pancreas. We then treated moribund, PDA-bearing mice daily with the Mycro3 Myc-inhibitor. The mice survived until killed at two months."}
{"qid": "5144bc8fd24251bc0500000e", "original_text": "For this special issue of J. R. Soc. Interface we present an overview of the driving forces behind technological advances in the field of single-cell analysis. These range from increasing our understanding of cellular heterogeneity through to the study of rare cells, areas of research that cannot be tackled effectively using current high-throughput population-based averaging techniques.", "label": 1, "is_selected": 0, "text": "For this special issue of J. R. Soc. Interface we present an overview of the driving forces behind technological advances in the field of single-cell analysis. These range from increasing our understanding of cellular heterogeneity through to the study of rare cells, areas of research that cannot be tackled effectively using current high-throughput population-based averaging techniques."}
{"qid": "6081b64d4e6a4cf63000000a", "original_text": "HSJ1 (Heterochromatin Protein 1) is a multi-functional protein that plays a crucial role in various cellular processes, including chromatin remodeling, transcriptional regulation, and DNA damage response. HSJ1 is primarily located in the heterochromatin region of the chromosome, where it helps to maintain the compact structure of the chromatin fibers by recruiting and positioning histone modifications. HSJ1 can bind to specific sequences of DNA and remodel the chromatin structure by Sliding Clamp Loops and translocating DNA loops. It also interacts with various transcription factors and co-regulators to modulate the expression of target genes. In response to DNA damage, HSJ1 helps to repair damaged DNA by recruiting repair proteins and promoting the repair process. Additionally, HSJ1 regulates the expression of genes involved in cell cycle progression and apoptosis. In summary, the function of HSJ1 protein is to maintain the structural integrity of chromatin, regulate gene expression, and participate in the DNA damage response.", "label": 0, "is_selected": 1, "text": "The report provides comprehensive information on the HSJ1 (Heterochromatin Protein 1),targeted therapeutics,drugs,latest developments, and key players operating in the global HSJ 1 market,capecitabine,ubiquitin,trimonium chloride,diglyceryl triphosphate,tyrosine triphosphate (Trp),zirconium chloride (Zirconium chloride), thalidomide, methotrexate, cyclosporine, doxorubicin, human chorionic gonadotropintropin (hCG) and all other proteins involved in the development and regulation of the cell."}
{"qid": "5541297f182542114d000001", "original_text": "Oxaliplatin, a platinum compound, has been commonly used around the world for treating advanced colorectal cancer. The generally recommended dose and schedule of oxaliplatin monotherapy is 130 mg/m(2) every 3 weeks. This trial was conducted to evaluate the safety and pharmacokinetics of oxaliplatin monotherapy in Japanese patients with solid tumors. Oxaliplatin was administered as a 2-h intravenous infusion every 3 weeks at a dose of 90 and 130 mg/m(2). Blood was collected to determine the total platinum and the ultrafiltrate platinum concentrations in plasma in all cycles. Nine patients were enrolled; three were given oxaliplatin monotherapy at 90 mg/m(2) and six received 130 mg/m(2). All tumors were colorectal cancer. The major adverse reactions included myelosuppressive, neurological and gastrointestinal toxicities, although most were grades 1 and 2 at both dose levels. Peripheral sensory neuropathy of without movement disturbance (grade 1 or 2) was observed in all patients at both dose levels. The 130 mg/m(2) dose level was not found to be the maximum tolerated dose, but was judged to be the recommended dose.", "label": 1, "is_selected": 0, "text": "Oxaliplatin, a platinum compound, has been commonly used around the world for treating advanced colorectal cancer. The generally recommended dose and schedule of oxaliplatin monotherapy is 130 mg/m(2) every 3 weeks. This trial was conducted to evaluate the safety and pharmacokinetics of oxaliplatin monotherapy in Japanese patients with solid tumors. Oxaliplatin was administered as a 2-h intravenous infusion every 3 weeks at a dose of 90 and 130 mg/m(2). Blood was collected to determine the total platinum and the ultrafiltrate platinum concentrations in plasma in all cycles. Nine patients were enrolled; three were given oxaliplatin monotherapy at 90 mg/m(2) and six received 130 mg/m(2). All tumors were colorectal cancer. The major adverse reactions included myelosuppressive, neurological and gastrointestinal toxicities, although most were grades 1 and 2 at both dose levels. Peripheral sensory neuropathy of without movement disturbance (grade 1 or 2) was observed in all patients at both dose levels. The 130 mg/m(2) dose level was not found to be the maximum tolerated dose, but was judged to be the recommended dose."}
{"qid": "5e67cd6b1af46fc13000001e", "original_text": "Since the discovery of sensitizing EGFR mutations as a predictive marker of sensitivity to EGFR tyrosine kinase inhibitors (TKIs), the field of targeted therapy in non-small cell lung cancer (NSCLC) has been revolutionized. Patients harbouring these sensitizing mutations treated with EGFR TKI have derived significant clinical outcome when compared with standard platinum based chemotherapy doublets. However disease progression invariably occurs at a median of about 9-13 months from initiation treatment, if acquired resistance commonly due to the development of EGFR T790M mutation. A novel class of \"third generation\" EGFR TKIs have been developed that is sensitising and T790M mutant-specific whilst sparing WT EGFR, representing a significant breakthrough in the treatment in NSCLC patients with acquired resistance harboring these genotypes. Early phase clinical data suggest the third generation EGFR TKIs such as osimertinib, rociletinib, and HM61713 are highly efficacious and well tolerated. Another promising class of EGFR TKI such as AZD3759 has been designed to penetrate blood brain barrier to treat brain metastases and leptomeningeal disease and has showed promising responses in patients with brain metastases.", "label": 1, "is_selected": 0, "text": "Since the discovery of sensitizing EGFR mutations as a predictive marker of sensitivity to EGFR tyrosine kinase inhibitors (TKIs), the field of targeted therapy in non-small cell lung cancer (NSCLC) has been revolutionized. Patients harbouring these sensitizing mutations treated with EGFR TKI have derived significant clinical outcome when compared with standard platinum based chemotherapy doublets. However disease progression invariably occurs at a median of about 9-13 months from initiation treatment, if acquired resistance commonly due to the development of EGFR T790M mutation. A novel class of \"third generation\" EGFR TKIs have been developed that is sensitising and T790M mutant-specific whilst sparing WT EGFR, representing a significant breakthrough in the treatment in NSCLC patients with acquired resistance harboring these genotypes. Early phase clinical data suggest the third generation EGFR TKIs such as osimertinib, rociletinib, and HM61713 are highly efficacious and well tolerated. Another promising class of EGFR TKI such as AZD3759 has been designed to penetrate blood brain barrier to treat brain metastases and leptomeningeal disease and has showed promising responses in patients with brain metastases."}
{"qid": "5e3a6e70b5b409ea53000018", "original_text": "The programmed death-1 (PD-1) immune checkpoint pathway is an emerging target in the treatment of hematologic malignancies. Pidilizumab is an mAb that binds to PD-1 and is a safe and well-tolerated therapy. Recent data have shown clinical activity utilizing this strategy in diffuse large B-cell lymphoma (DLBCL). The role of PD-1 expression in hematologic malignancies is explored. Recent clinical trials including the results of a Phase I trial in hematologic malignancies and a Phase II trial of pidilizumab following autologous hematopoietic stem-cell transplant (AHSCT) are reviewed.", "label": 1, "is_selected": 0, "text": "The programmed death-1 (PD-1) immune checkpoint pathway is an emerging target in the treatment of hematologic malignancies. Pidilizumab is an mAb that binds to PD-1 and is a safe and well-tolerated therapy. Recent data have shown clinical activity utilizing this strategy in diffuse large B-cell lymphoma (DLBCL). The role of PD-1 expression in hematologic malignancies is explored. Recent clinical trials including the results of a Phase I trial in hematologic malignancies and a Phase II trial of pidilizumab following autologous hematopoietic stem-cell transplant (AHSCT) are reviewed."}
{"qid": "5c7a4a31d774d04240000006", "original_text": "Immunotherapy with monoclonal antibodies targeting programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) has become a standard of care treatment for patients with advanced or metastatic non-small cell lung cancer (NSCLC) in first and later treatment lines with durable responses seen in approximately 10-20% of patients treated. However, the optimal selection of eligible patients who will benefit most, is far from being clear and the best biomarker has not yet been established. PD-L1 expression as a predictive biomarker for immunotherapy in NSCLC patients has shown some value for predicting response to immune checkpoint inhibitors in some studies, but not in others, and its use has been complicated by a number of factors which has prompted many researchers to establish better predictive biomarkers for immunotherapy of NSCLC. Most recently, two phase III first-line NSCLC studies have provided evidence that tumour mutational burden (TMB) correlates with the clinical response to the combination of nivolumab and ipilimumab (CheckMate-227; NCT02477826), whereas atezolizumab response was correlated with T effector gene signature expression (IMPower 150; NCT02366143). Both studies demonstrated a significant primary endpoint [progression-free survival (PFS)] benefit in the TMB group and in the group of patients expressing a T effector cell signature, respectively.", "label": 1, "is_selected": 0, "text": "Immunotherapy with monoclonal antibodies targeting programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) has become a standard of care treatment for patients with advanced or metastatic non-small cell lung cancer (NSCLC) in first and later treatment lines with durable responses seen in approximately 10-20% of patients treated. However, the optimal selection of eligible patients who will benefit most, is far from being clear and the best biomarker has not yet been established. PD-L1 expression as a predictive biomarker for immunotherapy in NSCLC patients has shown some value for predicting response to immune checkpoint inhibitors in some studies, but not in others, and its use has been complicated by a number of factors which has prompted many researchers to establish better predictive biomarkers for immunotherapy of NSCLC. Most recently, two phase III first-line NSCLC studies have provided evidence that tumour mutational burden (TMB) correlates with the clinical response to the combination of nivolumab and ipilimumab (CheckMate-227; NCT02477826), whereas atezolizumab response was correlated with T effector gene signature expression (IMPower 150; NCT02366143). Both studies demonstrated a significant primary endpoint [progression-free survival (PFS)] benefit in the TMB group and in the group of patients expressing a T effector cell signature, respectively."}
{"qid": "5eb9a7f60d431b5f7300000c", "original_text": "Cas9-based technologies have transformed genome engineering and the interrogation of genomic functions, but methods to control such technologies across numerous dimensions-including dose, time, specificity, and mutually exclusive modulation of multiple genes-are still lacking. We conferred such multidimensional controls to diverse Cas9 systems by leveraging small-molecule-regulated protein degron domains. Application of our strategy to both Cas9-mediated genome editing and transcriptional activities opens new avenues for systematic genome interrogation.", "label": 1, "is_selected": 0, "text": "Cas9-based technologies have transformed genome engineering and the interrogation of genomic functions, but methods to control such technologies across numerous dimensions-including dose, time, specificity, and mutually exclusive modulation of multiple genes-are still lacking. We conferred such multidimensional controls to diverse Cas9 systems by leveraging small-molecule-regulated protein degron domains. Application of our strategy to both Cas9-mediated genome editing and transcriptional activities opens new avenues for systematic genome interrogation."}
{"qid": "56c1f003ef6e394741000039", "original_text": "Orexins/hypocretins are key neuropeptides responsible for regulating central arousal and reward circuits. Two receptors respond to orexin signaling, orexin 1 receptor (OX(1)R) and orexin 2 receptor (OX(2)R) with partially overlapping nervous system distributions. Genetic studies suggest orexin receptor antagonists could be therapeutic for insomnia and other disorders with disruptions of sleep and wake.", "label": 1, "is_selected": 0, "text": "Orexins/hypocretins are key neuropeptides responsible for regulating central arousal and reward circuits. Two receptors respond to orexin signaling, orexin 1 receptor (OX(1)R) and orexin 2 receptor (OX(2)R) with partially overlapping nervous system distributions. Genetic studies suggest orexin receptor antagonists could be therapeutic for insomnia and other disorders with disruptions of sleep and wake."}
{"qid": "52bf1d9e03868f1b06000010", "original_text": "Denosumab (Prolia) is an antibody that binds to two different receptors: the receptor activator of nuclear factor kappa-B ligand (RANKL) and the osteoprotogerin (OPG). RANKL is a key regulator of bone metabolism and is involved in the activation and proliferation of osteoclasts, the cells responsible for bone resorption. OPG, on the other hand, is a decoy receptor that inhibits the activity of RANKL and prevents excessive bone resorption. By binding to these receptors, Denosumab (Prolia) helps to regulate bone metabolism and prevent bone loss, which can occur in conditions such as osteoporosis.", "label": 0, "is_selected": 1, "text": "The European Medicines Agency (EMA) has approved Denosumab (Pro) for the treatment of osteoporosis in post-menopausal women with a history of bone loss. By binding to these receptors, Denoslizumab ( Pro) helps to regulate bone metabolism and prevent bone loss, which can occur in conditions such as osteoporosis."}
{"qid": "606ad2ab94d57fd879000053", "original_text": "HLA-B\u221715:02 is known as a biomarker for carbamazepine (CBZ) induced Steven-Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN) in some Asian populations. Hence United States Federal Drug Administration (USFDA) recommends HLA-B\u221715:02 screening for Asian and other populations with a high prevalence of HLA-B\u221715:02, prior to the administration of carbamazepine. This study was conducted to estimate the prevalence of HLA-B\u221715:02 in a cohort of Sri Lankans.", "label": 1, "is_selected": 0, "text": "HLA-B\u221715:02 is known as a biomarker for carbamazepine (CBZ) induced Steven-Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN) in some Asian populations. Hence United States Federal Drug Administration (USFDA) recommends HLA-B\u221715:02 screening for Asian and other populations with a high prevalence of HLA-B\u221715:02, prior to the administration of carbamazepine. This study was conducted to estimate the prevalence of HLA-B\u221715:02 in a cohort of Sri Lankans."}
{"qid": "5c74266a7c78d694710000a2", "original_text": "The human genetic disorders caused by CAG repeat expansions in the translated sequences of various genes are called polyglutamine (polyQ) diseases because of the cellular \"toxicity\" of the mutant proteins. The contribution of mutant transcripts to the pathogenesis of these diseases is supported by several observations obtained from cellular models of these disorders. Here, we show that the common feature of cell lines modeling polyQ diseases is the formation of nuclear CAG RNA foci. We performed qualitative and quantitative analyses of these foci in numerous cellular models endogenously and exogenously expressing mutant transcripts by fluorescence in situ hybridization (FISH).", "label": 1, "is_selected": 0, "text": "The human genetic disorders caused by CAG repeat expansions in the translated sequences of various genes are called polyglutamine (polyQ) diseases because of the cellular \"toxicity\" of the mutant proteins. The contribution of mutant transcripts to the pathogenesis of these diseases is supported by several observations obtained from cellular models of these disorders. Here, we show that the common feature of cell lines modeling polyQ diseases is the formation of nuclear CAG RNA foci. We performed qualitative and quantitative analyses of these foci in numerous cellular models endogenously and exogenously expressing mutant transcripts by fluorescence in situ hybridization (FISH)."}
{"qid": "622669363a8413c653000089", "original_text": "LncRNAs are involved in the occurrence and progressions of multiple cancers. Emerging evidence has shown that PCAT6, a newly discovered carcinogenic lncRNA, is abnormally elevated in various human malignant tumors. Until now, PCAT6 has been found to sponge various miRNAs to activate the signaling pathways, which further affects tumor cell proliferation, migration, invasion, cycle, apoptosis, radioresistance, and chemoresistance. Moreover, PCAT6 has been shown to exert biological functions beyond ceRNAs. In this review, we summarize the biological characteristics of PCAT6 in a variety of human malignancies and describe the biological mechanisms by which PCAT6 can facilitate tumor progression.", "label": 1, "is_selected": 0, "text": "LncRNAs are involved in the occurrence and progressions of multiple cancers. Emerging evidence has shown that PCAT6, a newly discovered carcinogenic lncRNA, is abnormally elevated in various human malignant tumors. Until now, PCAT6 has been found to sponge various miRNAs to activate the signaling pathways, which further affects tumor cell proliferation, migration, invasion, cycle, apoptosis, radioresistance, and chemoresistance. Moreover, PCAT6 has been shown to exert biological functions beyond ceRNAs. In this review, we summarize the biological characteristics of PCAT6 in a variety of human malignancies and describe the biological mechanisms by which PCAT6 can facilitate tumor progression."}
{"qid": "6254340ae764a53204000028", "original_text": "Febrifugine, a compound extracted from the roots of the Asian plant Picrorhiza kurroa, has potential in the treatment of various diseases. Research suggests that it could be repurposed for the management of: 1. Viral infections: Febrifugine has been shown to inhibit the replication of dengue virus, a mosquito-borne pathogen that causes dengue fever. 2. Cancer: Studies suggest that febrifugine may have anticancer properties, particularly in the treatment of breast, colon, and skin cancers. 3. Neurodegenerative diseases: Febrifugine has been investigated as a potential treatment for diseases such as Alzheimer's and Parkinson's, as it may help reduce inflammation and oxidative stress in the brain. 4. Autoimmune disorders: Febrifugine may have immunomodulatory effects, making it a potential treatment for autoimmune diseases such as rheumatoid arthritis, lupus, and multiple sclerosis. I hope this information is helpful! Let me know if you have any further questions.", "label": 0, "is_selected": 0, "text": "Febrifugine, a compound extracted from the roots of the Asian plant Picrorhiza kurroa, has potential in the treatment of various diseases. Research suggests that it could be repurposed for the management of: 1. Viral infections: Febrifugine has been shown to inhibit the replication of dengue virus, a mosquito-borne pathogen that causes dengue fever. 2. Cancer: Studies suggest that febrifugine may have anticancer properties, particularly in the treatment of breast, colon, and skin cancers. 3. Neurodegenerative diseases: Febrifugine has been investigated as a potential treatment for diseases such as Alzheimer's and Parkinson's, as it may help reduce inflammation and oxidative stress in the brain. 4. Autoimmune disorders: Febrifugine may have immunomodulatory effects, making it a potential treatment for autoimmune diseases such as rheumatoid arthritis, lupus, and multiple sclerosis. I hope this information is helpful! Let me know if you have any further questions."}
{"qid": "58a9c152396a458e50000001", "original_text": "Alpha defensin 5 is secreted by a type of immune cell called neutrophils, which are a subtype of white blood cells. Specifically, alpha defensin 5 is produced by a protein called neutrophil elastase, which is released from the cytoplasm of neutrophils upon activation. Neutrophils are important components of the innate immune system and play a key role in fighting off bacterial infections. Alpha defensin 5 is one of the many antimicrobial peptides produced by neutrophils, and it has been shown to have broad-spectrum antimicrobial activity against a variety of bacterial pathogens.", "label": 0, "is_selected": 0, "text": "Alpha defensin 5 is secreted by a type of immune cell called neutrophils, which are a subtype of white blood cells. Specifically, alpha defensin 5 is produced by a protein called neutrophil elastase, which is released from the cytoplasm of neutrophils upon activation. Neutrophils are important components of the innate immune system and play a key role in fighting off bacterial infections. Alpha defensin 5 is one of the many antimicrobial peptides produced by neutrophils, and it has been shown to have broad-spectrum antimicrobial activity against a variety of bacterial pathogens."}
{"qid": "5318985eb166e2b80600001d", "original_text": "Arnold-Chiari Syndrome I is a malformation of the cervicomedullary junction, manifesting usually with downbeat nystagmus, palsy of the caudal cerebral nerves, headache, and vertigo. We present three patients with unusual symptomatology. A two-year-old child with isolated non-ocular torticollis, a 52-year-old male patient, and a 42-year-old female patient, both with gaze-evoked nystagmus, underwent a cerebral MRI examination. The findings of the first two patients were typical for an Arnold-Chiari syndrome. The malformation in the third patient was found only by reviewing the initial MRI. Arnold-Chiari malformation may manifest atypically.", "label": 1, "is_selected": 0, "text": "Arnold-Chiari Syndrome I is a malformation of the cervicomedullary junction, manifesting usually with downbeat nystagmus, palsy of the caudal cerebral nerves, headache, and vertigo. We present three patients with unusual symptomatology. A two-year-old child with isolated non-ocular torticollis, a 52-year-old male patient, and a 42-year-old female patient, both with gaze-evoked nystagmus, underwent a cerebral MRI examination. The findings of the first two patients were typical for an Arnold-Chiari syndrome. The malformation in the third patient was found only by reviewing the initial MRI. Arnold-Chiari malformation may manifest atypically."}
{"qid": "589d965a78275d0c4a000049", "original_text": "The polymerase that transcribes pri-miRNAs is RNA polymerase II (RNAPII). RNAPII is the primary enzyme responsible for transcribing long messenger RNAs (mRNAs) and other non-coding RNAs, including pri-miRNAs. Pri-miRNAs are the precursor molecules that give rise to mature miRNAs through a process known as processing. During this process, the pri-miRNA is cleaved by the Drosha ribonuclease and then further processed by the Dicer ribonuclease to produce the mature miRNA.", "label": 0, "is_selected": 0, "text": "The polymerase that transcribes pri-miRNAs is RNA polymerase II (RNAPII). RNAPII is the primary enzyme responsible for transcribing long messenger RNAs (mRNAs) and other non-coding RNAs, including pri-miRNAs. Pri-miRNAs are the precursor molecules that give rise to mature miRNAs through a process known as processing. During this process, the pri-miRNA is cleaved by the Drosha ribonuclease and then further processed by the Dicer ribonuclease to produce the mature miRNA."}
{"qid": "621fd6083a8413c653000066", "original_text": "No. RNA (ribonucleic acid) is methylated in certain contexts, such as in the form of N6-methyladenosine (m6A), which is a common modification found in messenger RNA (mRNA) and other types of RNA molecules. Methylation of RNA can play a role in various cellular processes, including gene regulation and RNA stability.", "label": 0, "is_selected": 1, "text": "Methylation of RNA is one of the most common chemical reactions in the eukaryotic cell.<n> Methylated RNA can play a role in various cellular processes, including gene regulation and RNA stability., and is a common modification found in messenger RNA (mRNA) and other types of RNA molecules."}
{"qid": "62266c353a8413c65300008a", "original_text": "Autophagy-related long non-coding RNAs (lncRNAs) have been increasingly implicated in colorectal cancer (CRC) prognosis. LncRNAs are RNA molecules that perform regulatory functions without coding for proteins, and they have been shown to play a crucial role in various cellular processes, including cell proliferation, differentiation, and apoptosis. Several studies have investigated the prognostic value of autophagy-related lncRNAs in CRC. For example, one study found that high levels of lncRNA ATG2 were associated with poor prognosis in CRC patients. Another study found that lncRNA LHX2 was significantly upregulated in CRC tissues compared to normal tissues and was associated with poor overall survival in CRC patients. These findings suggest that autophagy-related lncRNAs may serve as potential prognostic markers for CRC. However, further studies are needed to confirm these results and to investigate the underlying mechanisms. In summary, while the prognostic value of autophagy-related lncRNAs in colorectal cancer is still a developing area of research, the available evidence suggests that these RNAs may be useful for predicting disease prognosis and identifying potential therapeutic targets.", "label": 0, "is_selected": 1, "text": "The aim of this study was to investigate the prognostic value of autophagy-related lncRNAs in colorectal cancer and to identify potential therapeutic targets for this disease. in summary, while the prognosis value of autophagy-related RNAs is still a developing area of research, the available evidence suggests that these RNAs may be useful for predicting disease prognosis and identifying potential Therapeutic Targets., and to explore the underlying mechanisms."}
{"qid": "58cd522902b8c60953000038", "original_text": "The gamma interferon (IFN-\u03b3)-activated inhibitor of translation (GAIT) complex in human myeloid cells is heterotetrameric, consisting of glutamyl-prolyl-tRNA synthetase (EPRS), NS1-associated protein 1 (NSAP1), ribosomal protein L13a, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The complex binds a structural GAIT element in the 3' untranslated region of VEGF-A and other inflammation-related transcripts and inhibits their translation. EPRS is dually phosphorylated by cyclin-dependent kinase 5 (Cdk5) at Ser(886) and then by a Cdk5-dependent-AGC kinase at Ser(999); L13a is phosphorylated at Ser(77) by death-associated protein kinases DAPK and ZIPK.", "label": 1, "is_selected": 0, "text": "The gamma interferon (IFN-\u03b3)-activated inhibitor of translation (GAIT) complex in human myeloid cells is heterotetrameric, consisting of glutamyl-prolyl-tRNA synthetase (EPRS), NS1-associated protein 1 (NSAP1), ribosomal protein L13a, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The complex binds a structural GAIT element in the 3' untranslated region of VEGF-A and other inflammation-related transcripts and inhibits their translation. EPRS is dually phosphorylated by cyclin-dependent kinase 5 (Cdk5) at Ser(886) and then by a Cdk5-dependent-AGC kinase at Ser(999); L13a is phosphorylated at Ser(77) by death-associated protein kinases DAPK and ZIPK."}
{"qid": "5ca61176ecadf2e73f00004e", "original_text": "Mammalian genomes are organized into megabase-scale topologically associated domains (TADs). We demonstrate that disruption of TADs can rewire long-range regulatory architecture and result in pathogenic phenotypes. We show that distinct human limb malformations are caused by deletions, inversions, or duplications altering the structure of the TAD-spanning WNT6/IHH/EPHA4/PAX3 locus. Using CRISPR/ Cas genome editing, we generated mice with corresponding rearrangements.", "label": 1, "is_selected": 0, "text": "Mammalian genomes are organized into megabase-scale topologically associated domains (TADs). We demonstrate that disruption of TADs can rewire long-range regulatory architecture and result in pathogenic phenotypes. We show that distinct human limb malformations are caused by deletions, inversions, or duplications altering the structure of the TAD-spanning WNT6/IHH/EPHA4/PAX3 locus. Using CRISPR/ Cas genome editing, we generated mice with corresponding rearrangements."}
{"qid": "56e47e0051531f7e3300001c", "original_text": "Orexigenic peptides, also known as hunger-stimulating peptides, are synthesized in the brain. Specifically, they are produced in the arcuate nucleus of the hypothalamus, a region that plays a critical role in regulating feeding behavior and energy homeostasis. Within the arcuate nucleus, the orexigenic peptides are synthesized in neurons located in the ventromedial hypothalamus (VMH) and the paraventricular hypothalamus (PVH). These peptides include neuropeptide Y (NPY), agouti-related peptide (AGRP), and cocaine- and amphetamine-regulated transmission (CART). Once synthesized, these peptides are released into the hypophyseal portal system and transported to the anterior pituitary gland, where they exert their orexigenic effects.", "label": 0, "is_selected": 1, "text": "Scientists at the University of California, Los Angeles (UCLA) have discovered a new class of peptides that stimulate hunger and energy production in the hypothalamus, a region of the brain responsible for regulating food intake and energy expenditure, as well as the transmission of amphetamines."}
{"qid": "54f1e4d0c409818c32000002", "original_text": "The concept of thyroid hormone (TH) analogs that retain the beneficial effects of TH excess on lipid lowering and fat metabolism, while avoiding any harmful effects on the heart, muscle, bone and other tissues, has interested scientists and physicians for several decades. While there have been many attempts to develop selective TH receptor (TR) modulators (STRMs) for safe lipid lowering, these approaches have failed consistently. This review details recent advances in the development of TR\u03b2 subtype- and liver-selective STRM analogs, and presents the results of preliminary clinical trials with one of these compounds, eprotirome (KB-2115; Karo Bio AB).", "label": 1, "is_selected": 0, "text": "The concept of thyroid hormone (TH) analogs that retain the beneficial effects of TH excess on lipid lowering and fat metabolism, while avoiding any harmful effects on the heart, muscle, bone and other tissues, has interested scientists and physicians for several decades. While there have been many attempts to develop selective TH receptor (TR) modulators (STRMs) for safe lipid lowering, these approaches have failed consistently. This review details recent advances in the development of TR\u03b2 subtype- and liver-selective STRM analogs, and presents the results of preliminary clinical trials with one of these compounds, eprotirome (KB-2115; Karo Bio AB)."}
{"qid": "5324a8ac9b2d7acc7e000018", "original_text": "Chronic myeloid leukemia (CML) is characterized by the presence of a BCR-ABL fusion gene, which is the result of a reciprocal translocation between chromosomes 9 and 22, and is cytogenetically visible as a shortened chromosome 22 (Philadelphia). Research during the past two decades has established that BCR-ABL is probably the pathogenetic pathway leading to CML, and that constitutive tyrosine kinase activity is central to BCR-ABL capacity to transform hematopoietic cells in vitro and in vivo.", "label": 1, "is_selected": 0, "text": "Chronic myeloid leukemia (CML) is characterized by the presence of a BCR-ABL fusion gene, which is the result of a reciprocal translocation between chromosomes 9 and 22, and is cytogenetically visible as a shortened chromosome 22 (Philadelphia). Research during the past two decades has established that BCR-ABL is probably the pathogenetic pathway leading to CML, and that constitutive tyrosine kinase activity is central to BCR-ABL capacity to transform hematopoietic cells in vitro and in vivo."}
{"qid": "5c5217fd7e3cb0e231000005", "original_text": "Suicide is a major problem in Western society. However we have very little understanding of suicidal behaviour among individuals with autism spectrum disorders. The purpose of this review is to synthesise primary research on suicidal behaviour among adolescents and young adults with autism spectrum disorders in order to estimate prevalence and to identify and critically evaluate risk factors for suicidal behaviour in this population. Four primary research studies were identified for this review following a comprehensive literature search. The available research provides little empirical evidence for the processes underlying suicidal behaviour in adolescents and young adults with autism.", "label": 1, "is_selected": 0, "text": "Suicide is a major problem in Western society. However we have very little understanding of suicidal behaviour among individuals with autism spectrum disorders. The purpose of this review is to synthesise primary research on suicidal behaviour among adolescents and young adults with autism spectrum disorders in order to estimate prevalence and to identify and critically evaluate risk factors for suicidal behaviour in this population. Four primary research studies were identified for this review following a comprehensive literature search. The available research provides little empirical evidence for the processes underlying suicidal behaviour in adolescents and young adults with autism."}
{"qid": "530c844e970c65fa6b000014", "original_text": "The mitochondrial MTND6 gene plays a critical role in the structure and function of mitochondria, the cellular organelles responsible for energy production. Mutations in the MTND6 gene have been associated with several rare genetic disorders, including: 1. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): A rare genetic disorder characterized by recurrent stroke-like episodes, muscle weakness, seizures, and cognitive impairment. 2. Kearns-Sayre syndrome: A rare genetic disorder that affects the nervous system, causing symptoms such as weakness, paralysis, seizures, and cognitive impairment. 3. Chronic progressive external ophthalmoplegia (CPEO): A rare disorder that affects the muscles responsible for eye movements, leading to droopy eyelids and difficultymoving the eyes. 4. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes (MELAS): A rare disorder characterized by recurrent stroke-like episodes, muscle weakness, seizures, and cognitive impairment. These disorders are caused by mutations in the MTND6 gene, which affect the structure and function of mitochondria, leading to impaired energy production and oxidative phosphorylation. Further research and medical evaluation are necessary to determine the underlying cause of these disorders and to develop appropriate treatment and management strategies.", "label": 0, "is_selected": 0, "text": "The mitochondrial MTND6 gene plays a critical role in the structure and function of mitochondria, the cellular organelles responsible for energy production. Mutations in the MTND6 gene have been associated with several rare genetic disorders, including: 1. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): A rare genetic disorder characterized by recurrent stroke-like episodes, muscle weakness, seizures, and cognitive impairment. 2. Kearns-Sayre syndrome: A rare genetic disorder that affects the nervous system, causing symptoms such as weakness, paralysis, seizures, and cognitive impairment. 3. Chronic progressive external ophthalmoplegia (CPEO): A rare disorder that affects the muscles responsible for eye movements, leading to droopy eyelids and difficultymoving the eyes. 4. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes (MELAS): A rare disorder characterized by recurrent stroke-like episodes, muscle weakness, seizures, and cognitive impairment. These disorders are caused by mutations in the MTND6 gene, which affect the structure and function of mitochondria, leading to impaired energy production and oxidative phosphorylation. Further research and medical evaluation are necessary to determine the underlying cause of these disorders and to develop appropriate treatment and management strategies."}
{"qid": "6206cfd5c9dfcb9c09000040", "original_text": "The chromones are a class of chemical compounds characterised by the presence of the structure 5:6 benz-1:4-pyrone in their chemical make-up. The first chromone in clinical use, khellin, was extracted from the seeds of the plant Ammi visnaga, and had been used for centuries as a diuretic and as a smooth muscle relaxant. Its use in bronchial asthma was reported in 1947. In the 1950s, Benger's Laboratories embarked on a research programme to synthesise and develop modifications of khellin for the treatment of asthma.", "label": 1, "is_selected": 0, "text": "The chromones are a class of chemical compounds characterised by the presence of the structure 5:6 benz-1:4-pyrone in their chemical make-up. The first chromone in clinical use, khellin, was extracted from the seeds of the plant Ammi visnaga, and had been used for centuries as a diuretic and as a smooth muscle relaxant. Its use in bronchial asthma was reported in 1947. In the 1950s, Benger's Laboratories embarked on a research programme to synthesise and develop modifications of khellin for the treatment of asthma."}
{"qid": "5c6c46677c78d69471000035", "original_text": "There are several R packages available for processing NanoString data, including: * Nanostring: This package provides a comprehensive set of tools for analyzing NanoString data, including data preprocessing, feature extraction, and statistical analysis. * NanoStringTools: This package provides a set of functions for processing NanoString data, including feature extraction, data normalization, and visualization. * NSArray: This package provides a simple and easy-to-use interface for processing NanoString data, including data preprocessing, feature extraction, and statistical analysis. I hope this information is helpful! Let me know if you have any other questions.", "label": 0, "is_selected": 1, "text": "If you have any questions about processing NanoString data in R, please feel free to contact me via the contact page of this blog.<n> * NS: This package provides a simple and easy-to-use interface for processing Nano String data, including data preprocessing, feature extraction, and statistical analysis."}
{"qid": "56cab4c75795f9a73e00001f", "original_text": "Yes, Lsm4 and Lsm6, which are associated with the U6 small nuclear ribonucleoprotein (snRNP), have been shown to interact with survival motor neuron (SMN), a crucial protein in the survival of motor neurons in patients with spinal muscular atrophy (SMA). Studies have demonstrated that Lsm4 and Lsm6 are essential for the proper assembly and function of the U6 snRNP, and that they play a role in the regulation of SMN mRNA splicing. In particular, Lsm4 has been shown to interact directly with SMN and facilitate its association with the U6 snRNP, while Lsm6 has been implicated in the regulation of SMN splicing and localization. These findings suggest that the U6-associated proteins Lsm4 and Lsm6 play important roles in the regulation of SMN activity and may be potential therapeutic targets for the treatment of SMA.", "label": 0, "is_selected": 0, "text": "Yes, Lsm4 and Lsm6, which are associated with the U6 small nuclear ribonucleoprotein (snRNP), have been shown to interact with survival motor neuron (SMN), a crucial protein in the survival of motor neurons in patients with spinal muscular atrophy (SMA). Studies have demonstrated that Lsm4 and Lsm6 are essential for the proper assembly and function of the U6 snRNP, and that they play a role in the regulation of SMN mRNA splicing. In particular, Lsm4 has been shown to interact directly with SMN and facilitate its association with the U6 snRNP, while Lsm6 has been implicated in the regulation of SMN splicing and localization. These findings suggest that the U6-associated proteins Lsm4 and Lsm6 play important roles in the regulation of SMN activity and may be potential therapeutic targets for the treatment of SMA."}
{"qid": "58eb99f3eda5a57672000009", "original_text": "We isolated mutants of Saccharomyces cerevisiae that lose a 100 kb linear yeast artificial chromosome (YAC) at elevated rates. Mutations in two of these LCS (linear chromosome stability) genes had little or no effect on the loss rate of a circular YAC that had the same centromere and origin of replication as present on the linear YAC. Moreover, mutations in these LCS genes also increased the loss rate of an authentic linear yeast chromosome, chromosome III, but had only small effects on the loss rate of a circular derivative of chromosome III. As these mutants preferentially destabilize linear chromosomes, they may affect chromosome stability through interactions at telomeres. Telomeres are thought to be essential for the protection and complete replication of chromosome ends. The cytological properties of telomeres suggest that these structures may play additional roles in chromosome function. The lengths of the terminal C1-3A repeats at the ends of yeast chromosomes were unaltered in the linear preferential lcs mutants, suggesting that these mutants do not affect the replication or protection of telomeric DNA. Thus, the linear-preferential lcs mutants may identify a role for telomeres in chromosome stability that is distinct from their function in the replication and protection of chromosomal termini.", "label": 1, "is_selected": 0, "text": "We isolated mutants of Saccharomyces cerevisiae that lose a 100 kb linear yeast artificial chromosome (YAC) at elevated rates. Mutations in two of these LCS (linear chromosome stability) genes had little or no effect on the loss rate of a circular YAC that had the same centromere and origin of replication as present on the linear YAC. Moreover, mutations in these LCS genes also increased the loss rate of an authentic linear yeast chromosome, chromosome III, but had only small effects on the loss rate of a circular derivative of chromosome III. As these mutants preferentially destabilize linear chromosomes, they may affect chromosome stability through interactions at telomeres. Telomeres are thought to be essential for the protection and complete replication of chromosome ends. The cytological properties of telomeres suggest that these structures may play additional roles in chromosome function. The lengths of the terminal C1-3A repeats at the ends of yeast chromosomes were unaltered in the linear preferential lcs mutants, suggesting that these mutants do not affect the replication or protection of telomeric DNA. Thus, the linear-preferential lcs mutants may identify a role for telomeres in chromosome stability that is distinct from their function in the replication and protection of chromosomal termini."}
{"qid": "5c928afeecadf2e73f000018", "original_text": "Cardiospheres represent a more effective cell-based therapy for treatment of myocardial infarction than stem cells of non-cardiac origin. Unfortunately, their therapeutic application is limited by low yield of cell harvesting, declining quality and quantity during the aging process, and the need for highly invasive heart biopsy. Therefore, there is an emerging interest in generating cardiosphere-like stem cells from somatic cells via somatic reprogramming. This novel approach would provide an unlimited source of stem cells with cardiac differentiation potential.", "label": 1, "is_selected": 0, "text": "Cardiospheres represent a more effective cell-based therapy for treatment of myocardial infarction than stem cells of non-cardiac origin. Unfortunately, their therapeutic application is limited by low yield of cell harvesting, declining quality and quantity during the aging process, and the need for highly invasive heart biopsy. Therefore, there is an emerging interest in generating cardiosphere-like stem cells from somatic cells via somatic reprogramming. This novel approach would provide an unlimited source of stem cells with cardiac differentiation potential."}
{"qid": "52bf1f4503868f1b06000016", "original_text": "At first, this article comprises the innovative programme of the international \"Early Detection and Intervention\" research and then shows results of the \"Cologne/Bonn Early Recognition - CER\" project on schizophrenia, the first longterm prospective study on patients in potentially initial prodromal stages prior to the first psychotic manifestation. At re-examination at an average of 9.6 years later, 79 of 160 patients had subsequently developed a schizophrenic psychosis according to DSM-IV criteria. Prediction values for the complete range of prodromal symptoms, for 5 subsyndromes and for individual symptoms were assessed. Best prediction values with a high positive predictive power (71 - 91 %) and a low rate of false-positive predictions (7.5 - 1.9 %) were achieved for 10 symptoms and symptom complexes mainly out of the group of thought, speech and perception disturbances.", "label": 1, "is_selected": 0, "text": "At first, this article comprises the innovative programme of the international \"Early Detection and Intervention\" research and then shows results of the \"Cologne/Bonn Early Recognition - CER\" project on schizophrenia, the first longterm prospective study on patients in potentially initial prodromal stages prior to the first psychotic manifestation. At re-examination at an average of 9.6 years later, 79 of 160 patients had subsequently developed a schizophrenic psychosis according to DSM-IV criteria. Prediction values for the complete range of prodromal symptoms, for 5 subsyndromes and for individual symptoms were assessed. Best prediction values with a high positive predictive power (71 - 91 %) and a low rate of false-positive predictions (7.5 - 1.9 %) were achieved for 10 symptoms and symptom complexes mainly out of the group of thought, speech and perception disturbances."}
{"qid": "56afe6d40a360a5e45000017", "original_text": "For promoterome mining using CAGE (CAGE is a high-throughput sequencing technology that identifies transcriptional activity) data, the tool \"CAGE-Miner\" is commonly used. CAGE-Miner is a computational pipeline that takes CAGE data as input and generates detailed information about the transcriptional activity of the genome. It can identify active promoters, measure the strength of promoter activity, and identify potential regulatory elements.", "label": 0, "is_selected": 0, "text": "For promoterome mining using CAGE (CAGE is a high-throughput sequencing technology that identifies transcriptional activity) data, the tool \"CAGE-Miner\" is commonly used. CAGE-Miner is a computational pipeline that takes CAGE data as input and generates detailed information about the transcriptional activity of the genome. It can identify active promoters, measure the strength of promoter activity, and identify potential regulatory elements."}
{"qid": "5c5b52731a4c55d80b000003", "original_text": "Standard treatments for advanced high-grade serous ovarian carcinomas (HGSOCs) show significant side-effects and provide only short-term survival benefits due to disease recurrence. Thus, identification of novel prognostic and predictive biomarkers is urgently needed. We have used 42 paraffin-embedded HGSOCs, to evaluate the utility of DNA copy number alterations, as potential predictors of clinical outcome. Copy number-based unsupervised clustering stratified HGSOCs into two clusters of different immunohistopathological features and survival outcome (HR = 0.15, 95%CI = 0.03-0.81; Padj = 0.03). We found that loss at 6q24.2-26 was significantly associated with the cluster of longer survival independently from other confounding factors (HR = 0.06, 95%CI = 0.01-0.43, Padj = 0.005).", "label": 1, "is_selected": 0, "text": "Standard treatments for advanced high-grade serous ovarian carcinomas (HGSOCs) show significant side-effects and provide only short-term survival benefits due to disease recurrence. Thus, identification of novel prognostic and predictive biomarkers is urgently needed. We have used 42 paraffin-embedded HGSOCs, to evaluate the utility of DNA copy number alterations, as potential predictors of clinical outcome. Copy number-based unsupervised clustering stratified HGSOCs into two clusters of different immunohistopathological features and survival outcome (HR = 0.15, 95%CI = 0.03-0.81; Padj = 0.03). We found that loss at 6q24.2-26 was significantly associated with the cluster of longer survival independently from other confounding factors (HR = 0.06, 95%CI = 0.01-0.43, Padj = 0.005)."}
{"qid": "553cf397f321868558000010", "original_text": "Comparative genetic studies of non-model organisms are transforming rapidly due to major advances in sequencing technology. A limiting factor in these studies has been the identification and screening of orthologous loci across an evolutionarily distant set of taxa. Here, we evaluate the efficacy of genomic markers targeting ultraconserved DNA elements (UCEs) for analyses at shallow evolutionary timescales. Using sequence capture and massively parallel sequencing to generate UCE data for five co-distributed Neotropical rainforest bird species, we recovered 776-1516 UCE loci across the five species. Across species, 53-77% of the loci were polymorphic, containing between 2.0 and 3.2 variable sites per polymorphic locus, on average. We performed species tree construction, coalescent modeling, and species delimitation, and we found that the five co-distributed species exhibited discordant phylogeographic histories. We also found that species trees and divergence times estimated from UCEs were similar to the parameters obtained from mtDNA. The species that inhabit the understory had older divergence times across barriers, contained a higher number of cryptic species, and exhibited larger effective population sizes relative to the species inhabiting the canopy. Because orthologous UCEs can be obtained from a wide array of taxa, are polymorphic at shallow evolutionary timescales, and can be generated rapidly at low cost, they are an effective genetic marker for studies investigating evolutionary patterns and processes at shallow timescales.", "label": 1, "is_selected": 0, "text": "Comparative genetic studies of non-model organisms are transforming rapidly due to major advances in sequencing technology. A limiting factor in these studies has been the identification and screening of orthologous loci across an evolutionarily distant set of taxa. Here, we evaluate the efficacy of genomic markers targeting ultraconserved DNA elements (UCEs) for analyses at shallow evolutionary timescales. Using sequence capture and massively parallel sequencing to generate UCE data for five co-distributed Neotropical rainforest bird species, we recovered 776-1516 UCE loci across the five species. Across species, 53-77% of the loci were polymorphic, containing between 2.0 and 3.2 variable sites per polymorphic locus, on average. We performed species tree construction, coalescent modeling, and species delimitation, and we found that the five co-distributed species exhibited discordant phylogeographic histories. We also found that species trees and divergence times estimated from UCEs were similar to the parameters obtained from mtDNA. The species that inhabit the understory had older divergence times across barriers, contained a higher number of cryptic species, and exhibited larger effective population sizes relative to the species inhabiting the canopy. Because orthologous UCEs can be obtained from a wide array of taxa, are polymorphic at shallow evolutionary timescales, and can be generated rapidly at low cost, they are an effective genetic marker for studies investigating evolutionary patterns and processes at shallow timescales."}
{"qid": "5ad83cd6133db5eb78000010", "original_text": "Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne disease. Haemophysalis longicornis ticks have been considered the vector of severe fever with thrombocytopenia syndrome virus (SFTSV). However, clear data on the transmission of SFTS from ticks to humans are limited. We report an 84-year-old woman who presented with fever and altered mentality, which was confirmed as SFTS with encephalopathy by reverse-transcription polymerase chain reaction in blood and cerebrospinal fluid.", "label": 1, "is_selected": 0, "text": "Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne disease. Haemophysalis longicornis ticks have been considered the vector of severe fever with thrombocytopenia syndrome virus (SFTSV). However, clear data on the transmission of SFTS from ticks to humans are limited. We report an 84-year-old woman who presented with fever and altered mentality, which was confirmed as SFTS with encephalopathy by reverse-transcription polymerase chain reaction in blood and cerebrospinal fluid."}
{"qid": "5e669e0e1af46fc130000019", "original_text": "Klinefelter Syndrome is a chromosomal abnormality that occurs in males, characterized by an extra copy of the X chromosome. This results in a total of 47 or 48 chromosomes instead of the normal 46 in males. The extra X chromosome leads to a variety of medical problems, including infertility, small testes, and learning disabilities. The chromosomal abnormality associated with Klinefelter Syndrome is called XXY or 47,XXY.", "label": 0, "is_selected": 0, "text": "Klinefelter Syndrome is a chromosomal abnormality that occurs in males, characterized by an extra copy of the X chromosome. This results in a total of 47 or 48 chromosomes instead of the normal 46 in males. The extra X chromosome leads to a variety of medical problems, including infertility, small testes, and learning disabilities. The chromosomal abnormality associated with Klinefelter Syndrome is called XXY or 47,XXY."}
{"qid": "54f0920f94afd61504000018", "original_text": "The DHAP-R chemotherapy regiment typically includes a combination of drugs to treat various types of cancer, including breast cancer, ovarian cancer, and lung cancer. The specific drugs included in the DHAP-R regime may vary depending on the type of cancer and the individual patient's needs, but some common drugs used in this regime include: 1. Doxorubicin (Adriamycin): an anthracycline drug that kills cancer cells by interfering with DNA replication. 2. Cyclophosphamide (Cytoxan): an alkylating agent that kills cancer cells by breaking down their DNA. 3. Epirubicin (Ellence): an anthracycline drug similar to doxorubicin. 4. Paclitaxel (Taxol): a plant alkaloid that interferes with the ability of cancer cells to divide and grow. 5. Cisplatin (Platinol): a platinum-based chemotherapy drug that kills cancer cells by damaging their DNA. 6. 5-Fluorouracil (5-FU): a drug that interferes with the DNA replication process in cancer cells. 7. Vinorelbine (Navelbine): a vinca alkaloid that kills cancer cells by interfering with their ability to divide and grow. It is important to note that the specific drugs used in the DHAP-R regime and the duration of treatment may vary depending on the individual patient and the type of cancer being treated. Patients should consult their oncologist for personalized information on their cancer treatment plan.", "label": 0, "is_selected": 1, "text": "The Department of Health and Social Care (DHSC) at the University of California, San Francisco (UCSD) has developed a new chemotherapy regime, known as the Dual Anti-cancer Regimen (DAP-R), to treat patients with cancer who have received prior platinum-based chemotherapy or who are intolerant to other chemotherapy drugs, such as paclitaxel and rituximab (Rituxan). The specific drugs included in the DHAP-R regime may vary depending on the type of cancer and the individual patient's needs, but some common drugs used in this regime include: 1."}
{"qid": "61fa904fc9dfcb9c09000004", "original_text": "High-dose erythropoietin has been shown to have a neuroprotective effect in preclinical models of neonatal brain injury, and phase 2 trials have suggested possible efficacy; however, the benefits and safety of this therapy in extremely preterm infants have not been established. In this multicenter, randomized, double-blind trial of high-dose erythropoietin, we assigned 941 infants who were born at 24 weeks 0 days to 27 weeks 6 days of gestation to receive erythropoietin or placebo within 24 hours after birth. Erythropoietin was administered intravenously at a dose of 1000 U per kilogram of body weight every 48 hours for a total of six doses, followed by a maintenance dose of 400 U per kilogram three times per week by subcutaneous injection through 32 completed weeks of postmenstrual age. Placebo was administered as intravenous saline followed by sham injections. The primary outcome was death or severe neurodevelopmental impairment at 22 to 26 months of postmenstrual age. Severe neurodevelopmental impairment was defined as severe cerebral palsy or a composite motor or composite cognitive score of less than 70 (which corresponds to 2 SD below the mean, with higher scores indicating better performance) on the Bayley Scales of Infant and Toddler Development, third edition. A total of 741 infants were included in the per-protocol efficacy analysis: 376 received erythropoietin and 365 received placebo. There was no significant difference between the erythropoietin group and the placebo group in the incidence of death or severe neurodevelopmental impairment at 2 years of age (97 children [26%] vs. 94 children [26%]; relative risk, 1.03; 95% confidence interval, 0.81 to 1.32; P = 0.80).", "label": 1, "is_selected": 0, "text": "High-dose erythropoietin has been shown to have a neuroprotective effect in preclinical models of neonatal brain injury, and phase 2 trials have suggested possible efficacy; however, the benefits and safety of this therapy in extremely preterm infants have not been established. In this multicenter, randomized, double-blind trial of high-dose erythropoietin, we assigned 941 infants who were born at 24 weeks 0 days to 27 weeks 6 days of gestation to receive erythropoietin or placebo within 24 hours after birth. Erythropoietin was administered intravenously at a dose of 1000 U per kilogram of body weight every 48 hours for a total of six doses, followed by a maintenance dose of 400 U per kilogram three times per week by subcutaneous injection through 32 completed weeks of postmenstrual age. Placebo was administered as intravenous saline followed by sham injections. The primary outcome was death or severe neurodevelopmental impairment at 22 to 26 months of postmenstrual age. Severe neurodevelopmental impairment was defined as severe cerebral palsy or a composite motor or composite cognitive score of less than 70 (which corresponds to 2 SD below the mean, with higher scores indicating better performance) on the Bayley Scales of Infant and Toddler Development, third edition. A total of 741 infants were included in the per-protocol efficacy analysis: 376 received erythropoietin and 365 received placebo. There was no significant difference between the erythropoietin group and the placebo group in the incidence of death or severe neurodevelopmental impairment at 2 years of age (97 children [26%] vs. 94 children [26%]; relative risk, 1.03; 95% confidence interval, 0.81 to 1.32; P = 0.80)."}
{"qid": "56b0eb3b0a360a5e45000019", "original_text": "Curcuma longa (Zingiberaceae) is known for its uses in medicine, cosmetics, food flavouring and textile industries. The secondary metabolites of turmeric like essential oil, oleoresin and curcumin are important for its multipurpose uses. These traits of turmeric vary from place to place due to the influence of environment, soil and agro-climatic conditions. Here, we analyzed turmeric from different agroclimatic regions for influence of various factors on its growth and yield of important phytochemicals.", "label": 1, "is_selected": 0, "text": "Curcuma longa (Zingiberaceae) is known for its uses in medicine, cosmetics, food flavouring and textile industries. The secondary metabolites of turmeric like essential oil, oleoresin and curcumin are important for its multipurpose uses. These traits of turmeric vary from place to place due to the influence of environment, soil and agro-climatic conditions. Here, we analyzed turmeric from different agroclimatic regions for influence of various factors on its growth and yield of important phytochemicals."}
{"qid": "56c1f029ef6e39474100004a", "original_text": "Glioblastoma multiforme (GBM) is the most lethal type of primary brain tumor, and patients that undergo the maximum tumor resection that is safely possible and standard radiochemotherapy only achieve a median survival time of 14.6 months. Several clinical studies have reported that valproic acid could prolong survival of GBM patients. However, the results of these studies are inconsistent. We examined relevant studies and conducted a meta-analysis to assess the effects of VPA on survival times and recurrence. A bibliographic search was performed in the EMBASE, MEDLINE, ClinicalTrials.gov and Cochrane Central Register of the Controlled Trials databases to identify potentially relevant articles or conference abstracts that investigated the effects of VPA on the outcome of glioma patients. Five observational studies were included. Pooled estimates of the hazard ratio (HR) and 95% confidence intervals (CI) were calculated. Our meta-analysis confirmed the benefit of using VPA (HR, 0.56; 95% CI, 0.44-0.71). Sub-group analysis shows that patients treated with VPA had a hazard ratio of 0.74 with a 95% confidence interval of 0.59-0.94 vs. patients treated by other-AEDs and a hazard ratio of 0.66 with a 95% confidence interval of 0.52-0.84 vs. patients treated by administration of non-AEDs.", "label": 1, "is_selected": 0, "text": "Glioblastoma multiforme (GBM) is the most lethal type of primary brain tumor, and patients that undergo the maximum tumor resection that is safely possible and standard radiochemotherapy only achieve a median survival time of 14.6 months. Several clinical studies have reported that valproic acid could prolong survival of GBM patients. However, the results of these studies are inconsistent. We examined relevant studies and conducted a meta-analysis to assess the effects of VPA on survival times and recurrence. A bibliographic search was performed in the EMBASE, MEDLINE, ClinicalTrials.gov and Cochrane Central Register of the Controlled Trials databases to identify potentially relevant articles or conference abstracts that investigated the effects of VPA on the outcome of glioma patients. Five observational studies were included. Pooled estimates of the hazard ratio (HR) and 95% confidence intervals (CI) were calculated. Our meta-analysis confirmed the benefit of using VPA (HR, 0.56; 95% CI, 0.44-0.71). Sub-group analysis shows that patients treated with VPA had a hazard ratio of 0.74 with a 95% confidence interval of 0.59-0.94 vs. patients treated by other-AEDs and a hazard ratio of 0.66 with a 95% confidence interval of 0.52-0.84 vs. patients treated by administration of non-AEDs."}
{"qid": "5e2902e48b3851296d000006", "original_text": "This post hoc analysis compared anifrolumab 300 mg every 4 weeks with placebo on rash and arthritis measures with different stringency in patients with moderate to severe SLE (phase IIb; MUSE; NCT01438489). Subgroups were analysed by type I interferon gene signature (IFNGS test-high or test-low). Rash was measured with the SLE Disease Activity Index 2000 (SLEDAI-2K), British Isles Lupus Assessment Group (BILAG) Index and modified Cutaneous Lupus Erythematosus Disease Area and Severity Index (mCLASI). Arthritis was evaluated using SLEDAI-2K, BILAG and swollen and tender joint counts. Outcomes were measured at week 52.", "label": 1, "is_selected": 0, "text": "This post hoc analysis compared anifrolumab 300 mg every 4 weeks with placebo on rash and arthritis measures with different stringency in patients with moderate to severe SLE (phase IIb; MUSE; NCT01438489). Subgroups were analysed by type I interferon gene signature (IFNGS test-high or test-low). Rash was measured with the SLE Disease Activity Index 2000 (SLEDAI-2K), British Isles Lupus Assessment Group (BILAG) Index and modified Cutaneous Lupus Erythematosus Disease Area and Severity Index (mCLASI). Arthritis was evaluated using SLEDAI-2K, BILAG and swollen and tender joint counts. Outcomes were measured at week 52."}
{"qid": "5159502dd24251bc0500009b", "original_text": "Wnt signaling pathway is important for development and carcinogenesis. Alterations of this pathway, such as mutations in adenomatous polyposis coli (APC) gene and activation mutations of beta-catenin, would result in stabilization of beta-catenin and subsequent translocation to nucleus where genes are transcribed. Recently, a receptor of Wnt, FzE3 was found to be up-regulated in esophageal carcinoma while a non-receptor antagonist of Wnt, secreted frizzled related protein (hsFRP) was found to be down-regulated in some cancer. These findings suggested that FzE3 is a potential oncogene while hsFRP is a potential tumor suppressor gene. We aimed to investigate whether FzE3 and hsFRP were altered in gastric cancer. Twelve cases of gastric cancer, including 7 cases of intestinal type, 4 cases of diffuse type and I case of mixed type, were studied.", "label": 1, "is_selected": 0, "text": "Wnt signaling pathway is important for development and carcinogenesis. Alterations of this pathway, such as mutations in adenomatous polyposis coli (APC) gene and activation mutations of beta-catenin, would result in stabilization of beta-catenin and subsequent translocation to nucleus where genes are transcribed. Recently, a receptor of Wnt, FzE3 was found to be up-regulated in esophageal carcinoma while a non-receptor antagonist of Wnt, secreted frizzled related protein (hsFRP) was found to be down-regulated in some cancer. These findings suggested that FzE3 is a potential oncogene while hsFRP is a potential tumor suppressor gene. We aimed to investigate whether FzE3 and hsFRP were altered in gastric cancer. Twelve cases of gastric cancer, including 7 cases of intestinal type, 4 cases of diffuse type and I case of mixed type, were studied."}
{"qid": "61f60157882a024a1000001e", "original_text": "Atogepant is a newly approved drug for the treatment of migraine. It is an oral calcitonin gene-related peptide receptor antagonist, which works by blocking the transmission of pain signals in the body. Specifically, atogepant binds to the calcitonin gene-related peptide receptor, which is involved in the transmission of pain signals during a migraine attack. By blocking this receptor, atogepant can help to reduce the severity and frequency of migraine episodes. Atogepant is taken orally, once daily, and can be used as monotherapy or in combination with other medications. It has been shown to be effective in reducing the frequency and severity of migraine attacks, as well as improving other symptoms such as sensory sensitivity and nausea. Atogepant has also been shown to have a low risk of side effects compared to other migraine treatments, making it a potential option for patients who have difficulty tolerating other medications.", "label": 0, "is_selected": 1, "text": "The United States Food and Drug Administration (FDA) has approved atogepant for the treatment of migraine attacks in adults, as well as for the prophylaxis of future migraine attacks. Specifically, atogePant binds to the calcitonin gene-related peptide receptor, which is involved in the transmission of pain signals during a migraine attack. it is taken orally, once daily, and can be used as monotherapy or in combination with other medications. It has been shown to be effective in reducing the frequency and severity of migraines attacks, and improving other symptoms such as sensory sensitivity and nausea."}
{"qid": "5fe3130ca43ad3127800003e", "original_text": "The BIOCURA cohort is a large-scale study that monitors the disease spectrum of bacterial and fungal infections in immunocompromised patients, particularly those with HIV infection. The primary objectives of the BIOCURA cohort are to: 1. Determine the incidence, etiology, and outcomes of bacterial and fungal infections in immunocompromised patients. 2. Evaluate the impact of antimicrobial resistance on the management and outcome of infections in this population. 3. Identify risk factors and host-factor determinants of infection susceptibility and resistance. 4. Develop and validate novel diagnostic markers and therapeutic targets for bacterial and fungal infections in immunocompromised patients. 5. Investigate the potential role of the gut microbiome in the pathogenesis and treatment of infections in this population. 6. Explore the use of novel antimicrobial therapies, such as phage therapy and bacteriophage cocktails, in the management of antibiotic-resistant infections in immunocompromised patients. Overall, the BIOCURA cohort is focused on improving our understanding of the complex interactions between the host, pathogens, and the microbiome in the context of immunocompromised hosts, with the goal of developing novel diagnostic and therapeutic strategies to address the growing problem of antimicrobial resistance.", "label": 0, "is_selected": 1, "text": "The Centre for Infection and Immunity (CURA) at the University of Glasgow is investigating the role of the gut microbiome in the management and treatment of infections in immunocompromised patients, particularly those with HIV infection, with the goal of developing novel diagnostic and therapeutic strategies to address the growing problem of antimicrobial resistance. Overall, theCURA cohort is focused on improving our understanding of the complex interactions between the host, pathogens, and the microbiomes in the context of immunoCOMpromised hosts, with a goal of Developing novel diagnostic markers and Therapeutic strategies to Address the Growing Problem of Antimicrobial Resistance."}
{"qid": "54d907c84b1fd0d33c000008", "original_text": "We examined levels of hyaluronan, a matrix glycosaminoglycan and versican, a matrix proteoglycan, in the sputum of asthmatics treated with mepolizumab (anti-IL-5 monoclonal antibody) versus placebo to evaluate the utility of these measurements as possible biomarkers of asthma control and airway remodeling. Patients with severe, prednisone-dependent asthma received either mepolizumab or placebo as described in a previously published randomized, double-blind, placebo-controlled study.", "label": 1, "is_selected": 0, "text": "We examined levels of hyaluronan, a matrix glycosaminoglycan and versican, a matrix proteoglycan, in the sputum of asthmatics treated with mepolizumab (anti-IL-5 monoclonal antibody) versus placebo to evaluate the utility of these measurements as possible biomarkers of asthma control and airway remodeling. Patients with severe, prednisone-dependent asthma received either mepolizumab or placebo as described in a previously published randomized, double-blind, placebo-controlled study."}
{"qid": "5fdb43f6a43ad3127800002e", "original_text": "In the yeast species Saccharomyces cerevisiae, there are two types of duplicated genes: 1. Homologous genes: These are duplicated genes that have the same function and are located on different chromosomes. For example, the ADH1 and ADH2 genes are homologous genes that encode alcohol dehydrogenase enzymes involved in fermentation. 2. Non-homologous genes: These are duplicated genes that have different functions and are located on the same chromosome. For example, the FLO11 and FLO12 genes are non-homologous genes that encode proteins involved in filamentous growth and cell wall biosynthesis.", "label": 0, "is_selected": 1, "text": "duplicated genes have been shown to be important in the development of new cell types and in the maintenance of healthy tissues and organs. For example, the FLO11 and FLO12 genes are non-homologous genes that encode proteins involved in filamentous growth and cell wall dehydrogenase."}
{"qid": "56c1d848ef6e39474100002f", "original_text": "Tarlov or perineurial cysts are lesions of the nerve root most often found in the sacral region. Although there is agreement that asymptomatic Tarlov cysts should be followed, it is still debated whether patients with symptomatic Tarlov cysts should be treated surgically. The authors assessed the outcome and efficacy of cyst wall resection in 10 patients with symptomatic Tarlov cysts. The medical literature is reviewed, theories of origin are evaluated, and suggestions as to their cause and pathogenesis are offered. Ten consecutive patients harboring symptomatic Tarlov cysts were treated by the senior author between 1989 and 1999.", "label": 1, "is_selected": 0, "text": "Tarlov or perineurial cysts are lesions of the nerve root most often found in the sacral region. Although there is agreement that asymptomatic Tarlov cysts should be followed, it is still debated whether patients with symptomatic Tarlov cysts should be treated surgically. The authors assessed the outcome and efficacy of cyst wall resection in 10 patients with symptomatic Tarlov cysts. The medical literature is reviewed, theories of origin are evaluated, and suggestions as to their cause and pathogenesis are offered. Ten consecutive patients harboring symptomatic Tarlov cysts were treated by the senior author between 1989 and 1999."}
{"qid": "5e7744c3835f4e4777000005", "original_text": "We investigated the health-related quality of life (HRQoL) of long-term prostate cancer patients who received leuprorelin acetate in microcapsules (LAM) for androgen-deprivation therapy (ADT). The observational study was carried out by 30 office-based German urologists in 536 prostate cancer (PCa) patients treated for \u22655 years with LAM and in 116 patients of an age-matched control group (CG). Data on HRQoL and health status was collected prospectively using validated questionnaires QLQ-C30, QLQ-PR25 and Karnofsky Index. Data on effectiveness (clinical response, prostate specific antigen [PSA], testosterone) and safety was collected retrospectively from patients' health records. We used descriptive statistics to analyze the data. The mean treatment duration was 8.6 years (range 4.5-19.8 years).", "label": 1, "is_selected": 0, "text": "We investigated the health-related quality of life (HRQoL) of long-term prostate cancer patients who received leuprorelin acetate in microcapsules (LAM) for androgen-deprivation therapy (ADT). The observational study was carried out by 30 office-based German urologists in 536 prostate cancer (PCa) patients treated for \u22655 years with LAM and in 116 patients of an age-matched control group (CG). Data on HRQoL and health status was collected prospectively using validated questionnaires QLQ-C30, QLQ-PR25 and Karnofsky Index. Data on effectiveness (clinical response, prostate specific antigen [PSA], testosterone) and safety was collected retrospectively from patients' health records. We used descriptive statistics to analyze the data. The mean treatment duration was 8.6 years (range 4.5-19.8 years)."}
{"qid": "535d3c069a4572de6f000006", "original_text": "Although the Human Genome Project was completed 4 years ago, the catalog of human protein-coding genes remains a matter of controversy. Current catalogs list a total of approximately 24,500 putative protein-coding genes. It is broadly suspected that a large fraction of these entries are functionally meaningless ORFs present by chance in RNA transcripts, because they show no evidence of evolutionary conservation with mouse or dog.", "label": 1, "is_selected": 0, "text": "Although the Human Genome Project was completed 4 years ago, the catalog of human protein-coding genes remains a matter of controversy. Current catalogs list a total of approximately 24,500 putative protein-coding genes. It is broadly suspected that a large fraction of these entries are functionally meaningless ORFs present by chance in RNA transcripts, because they show no evidence of evolutionary conservation with mouse or dog."}
{"qid": "62005c68c9dfcb9c09000017", "original_text": "Heterotrimeric G-proteins form a major protein family, which participates in signal transduction. They are composed of three subunits, G\u03b1, G\u03b2 and G\u03b3. The G\u03b1 subunit is further divided in four distinct families Gs, Gi/o, Gq/11 and G12/13. The goal of this work was to detect and classify members of the four distinct families, plus the G\u03b2 and the G\u03b3 subunits of G-proteins from sequence alone. To achieve this purpose, six specific profile Hidden Markov Models (pHMMs) were built and checked for their credibility.", "label": 1, "is_selected": 0, "text": "Heterotrimeric G-proteins form a major protein family, which participates in signal transduction. They are composed of three subunits, G\u03b1, G\u03b2 and G\u03b3. The G\u03b1 subunit is further divided in four distinct families Gs, Gi/o, Gq/11 and G12/13. The goal of this work was to detect and classify members of the four distinct families, plus the G\u03b2 and the G\u03b3 subunits of G-proteins from sequence alone. To achieve this purpose, six specific profile Hidden Markov Models (pHMMs) were built and checked for their credibility."}
{"qid": "56e0447a51531f7e3300000b", "original_text": "Contrary to earlier beliefs, viruses are not the smallest causative agents of infectious diseases. Single-stranded RNAs as small as 246 nucleotides exist in certain higher plants and cause more than a dozen crop diseases. These RNAs have been termed viroids. Despite their extremely limited information content, viroids replicate autonomously in susceptible cells--that is, they do not require helper functions from simultaneously replicating conventional viruses.", "label": 1, "is_selected": 0, "text": "Contrary to earlier beliefs, viruses are not the smallest causative agents of infectious diseases. Single-stranded RNAs as small as 246 nucleotides exist in certain higher plants and cause more than a dozen crop diseases. These RNAs have been termed viroids. Despite their extremely limited information content, viroids replicate autonomously in susceptible cells--that is, they do not require helper functions from simultaneously replicating conventional viruses."}
{"qid": "55451e53bf90a13052000003", "original_text": "Transcription-coupled DNA repair (TCR) is a subpathway of nucleotide excision repair (NER) that is triggered when RNA polymerase is stalled by DNA damage. Lesions targeted by TCR are repaired more quickly than lesions repaired by the transcription-independent \"global\" NER pathway, but the mechanism underlying this rate enhancement is not understood. Damage recognition during bacterial NER depends upon UvrA, which binds to the damage and loads UvrB onto the DNA. Bacterial TCR additionally requires the Mfd protein, a DNA translocase that removes the stalled transcription complexes. We have determined the properties of Mfd, UvrA, and UvrB that are required for the elevated rate of repair observed during TCR.", "label": 1, "is_selected": 0, "text": "Transcription-coupled DNA repair (TCR) is a subpathway of nucleotide excision repair (NER) that is triggered when RNA polymerase is stalled by DNA damage. Lesions targeted by TCR are repaired more quickly than lesions repaired by the transcription-independent \"global\" NER pathway, but the mechanism underlying this rate enhancement is not understood. Damage recognition during bacterial NER depends upon UvrA, which binds to the damage and loads UvrB onto the DNA. Bacterial TCR additionally requires the Mfd protein, a DNA translocase that removes the stalled transcription complexes. We have determined the properties of Mfd, UvrA, and UvrB that are required for the elevated rate of repair observed during TCR."}
{"qid": "5e6e35b07fc1ee872b000004", "original_text": "The blood-brain barrier (BBB) is a tight boundary formed between endothelial cells and astrocytes, which separates and protects brain from most pathogens as well as neural toxins in circulation. However, detailed molecular players involved in formation of BBB are not completely known. Dentin matrix protein 1 (DMP1)-proteoglycan (PG), which is known to be involved in mineralization of bones and dentin, is also expressed in soft tissues including brain with unknown functions. In the present study, we reported that DMP1-PG was expressed in brain astrocytes and enriched in BBB units. The only glycosylation site of DMP1 is serine89 (S89) in the N-terminal domain of the protein in mouse.", "label": 1, "is_selected": 0, "text": "The blood-brain barrier (BBB) is a tight boundary formed between endothelial cells and astrocytes, which separates and protects brain from most pathogens as well as neural toxins in circulation. However, detailed molecular players involved in formation of BBB are not completely known. Dentin matrix protein 1 (DMP1)-proteoglycan (PG), which is known to be involved in mineralization of bones and dentin, is also expressed in soft tissues including brain with unknown functions. In the present study, we reported that DMP1-PG was expressed in brain astrocytes and enriched in BBB units. The only glycosylation site of DMP1 is serine89 (S89) in the N-terminal domain of the protein in mouse."}
{"qid": "5e480da0d14c9f295d000006", "original_text": "The Cyberknife, also known as stereotactic body radiation therapy (SBRT), is a non-invasive, painless treatment that delivers highly precise radiation beams to targets in the body, such as tumors. It is used to treat a variety of cancers, including brain, spine, liver, lung, prostate, and pancreatic cancer, as well as metastases to these organs. The Cyberknife works by using a linear accelerator to deliver radiation beams that are shaped and focused using a sophisticated robotic arm, allowing for precise targeting of the tumor while minimizing damage to surrounding healthy tissue. treatment is typically completed in 1-5 sessions, depending on the location and size of the tumor.", "label": 0, "is_selected": 0, "text": "The Cyberknife, also known as stereotactic body radiation therapy (SBRT), is a non-invasive, painless treatment that delivers highly precise radiation beams to targets in the body, such as tumors. It is used to treat a variety of cancers, including brain, spine, liver, lung, prostate, and pancreatic cancer, as well as metastases to these organs. The Cyberknife works by using a linear accelerator to deliver radiation beams that are shaped and focused using a sophisticated robotic arm, allowing for precise targeting of the tumor while minimizing damage to surrounding healthy tissue. treatment is typically completed in 1-5 sessions, depending on the location and size of the tumor."}
{"qid": "5aa13fd3d6d6b54f79000003", "original_text": "Certainly! Here are 4 drugs commonly used to treat opioid addiction or overdose: 1. Methadone: A long-acting opioid agonist, methadone is used for maintenance treatment of opioid addiction. It is often used to manage withdrawal symptoms and reduce cravings. 2. Buprenorphine: A partial opioid agonist, buprenorphine is used to treat opioid addiction, including withdrawal symptoms and cravings. It is available in both injection and tablet forms. 3. Naltrexone: An opioid antagonist, naltrexone is used to treat opioid addiction by blocking the effects of opioids, including euphoria and withdrawal symptoms. It is often used in combination with counseling and support. 4. Narcan (Naloxone): An opioid antagonist, narcan is used to reverse the effects of opioid overdose. It works by binding to opioid receptors, reversing the effects of the overdose and restoring breathing. It is often administered via injection or auto-injector.", "label": 0, "is_selected": 1, "text": "Is it possible to treat opioid addiction with a drug that is not a prescription opioid, such as buprenorphine or naltrexone, but is prescribed by a health care provider or by a friend or family member who has been prescribed an opioid for medical reasons, like methadone?, or is it just a matter of time before someone dies from an overdose of an opioid?"}
{"qid": "532f0b2cd6d3ac6a3400002c", "original_text": "Marfan syndrome is a genetic disorder that affects the body's connective tissue, which provides support and structure to various organs, including the musculoskeletal system. The musculoskeletal manifestations of Marfan syndrome include: * Tall stature and long limbs * Proportionate limbs with a relatively short torso * Extremely flexible joints, resulting in hypermobile joints * Ectopic breast development in males * Scoliosis (sideways curvature of the spine) * Kyphosis (forward curvature of the spine) * Neck instability and poor muscle tone in the neck muscles * Shoulder instability * Torn or stretched tendons, particularly in the hands and feet. It's important to note that the severity and specific musculoskeletal manifestations of Marfan syndrome can vary widely between individuals.", "label": 0, "is_selected": 0, "text": "Marfan syndrome is a genetic disorder that affects the body's connective tissue, which provides support and structure to various organs, including the musculoskeletal system. The musculoskeletal manifestations of Marfan syndrome include: * Tall stature and long limbs * Proportionate limbs with a relatively short torso * Extremely flexible joints, resulting in hypermobile joints * Ectopic breast development in males * Scoliosis (sideways curvature of the spine) * Kyphosis (forward curvature of the spine) * Neck instability and poor muscle tone in the neck muscles * Shoulder instability * Torn or stretched tendons, particularly in the hands and feet. It's important to note that the severity and specific musculoskeletal manifestations of Marfan syndrome can vary widely between individuals."}
{"qid": "5c56fd7407647bbc4b000013", "original_text": "Hydroxyethyl starch (HES) is widely used to prevent and treat spinal anesthesia-induced hypotension during cesarean section. However, the use of saline-based HES may lead to hyperchloremia. This study aimed to clarify the effects of saline-based HES on umbilical cord chloride level at delivery. We retrospectively analyzed 93 consecutive single-pregnancy patients who underwent cesarean section with combined spinal-epidural anesthesia. The patients were divided into two groups, depending on the use of 6% HES 130/0.4: group A (461 \u00b1 167 ml of saline-based HES was administered; 43 patients) and group B (HES not administered; 50 patients). The major outcome was umbilical cord chloride level at delivery.", "label": 1, "is_selected": 0, "text": "Hydroxyethyl starch (HES) is widely used to prevent and treat spinal anesthesia-induced hypotension during cesarean section. However, the use of saline-based HES may lead to hyperchloremia. This study aimed to clarify the effects of saline-based HES on umbilical cord chloride level at delivery. We retrospectively analyzed 93 consecutive single-pregnancy patients who underwent cesarean section with combined spinal-epidural anesthesia. The patients were divided into two groups, depending on the use of 6% HES 130/0.4: group A (461 \u00b1 167 ml of saline-based HES was administered; 43 patients) and group B (HES not administered; 50 patients). The major outcome was umbilical cord chloride level at delivery."}
{"qid": "5e9202c52d3121100d000006", "original_text": "The soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex is composed of three neuronal proteins VAMP2, Syntaxin and SNAP25, which plays a core role during the process of membrane fusion. The zipping assembly of the SNARE complex releases energies and drives the vesicle and cell membrane into close proximity. In this study, we use all-atom molecular dynamics simulations to probe the dynamics of SNARE and its unzipping process in the context of membrane at the atomistic details. Our results indicated that the NTD of SNARE core domain is relatively more stable than CTD, which is in agreement with previous experiments. More importantly, possible interactions between the linker loop (LL) region of SNAP25 and VAMP2 are observed, suggests that the LL region may facilitate VAMP2 binding and SNARE initiation.", "label": 1, "is_selected": 0, "text": "The soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex is composed of three neuronal proteins VAMP2, Syntaxin and SNAP25, which plays a core role during the process of membrane fusion. The zipping assembly of the SNARE complex releases energies and drives the vesicle and cell membrane into close proximity. In this study, we use all-atom molecular dynamics simulations to probe the dynamics of SNARE and its unzipping process in the context of membrane at the atomistic details. Our results indicated that the NTD of SNARE core domain is relatively more stable than CTD, which is in agreement with previous experiments. More importantly, possible interactions between the linker loop (LL) region of SNAP25 and VAMP2 are observed, suggests that the LL region may facilitate VAMP2 binding and SNARE initiation."}
{"qid": "5d36b4817bc3fee31f000007", "original_text": "SATB1 is a transcriptional regulator controlling the gene expression that is essential in the maturation of the immune T-cell. SATB1 binds to the nuclear matrix attachment regions of DNA, where it recruits histone deacetylase and represses transcription through a local chromatin remodeling. Here we determined the solution structure of the matrix attachment region-binding domain, possessing similarity to the CUT DNA-binding domain, of human SATB1 by NMR spectroscopy. The structure consists of five alpha-helices, in which the N-terminal four are arranged similarly to the four-helix structure of the CUT domain of hepatocyte nuclear factor 6alpha.", "label": 1, "is_selected": 0, "text": "SATB1 is a transcriptional regulator controlling the gene expression that is essential in the maturation of the immune T-cell. SATB1 binds to the nuclear matrix attachment regions of DNA, where it recruits histone deacetylase and represses transcription through a local chromatin remodeling. Here we determined the solution structure of the matrix attachment region-binding domain, possessing similarity to the CUT DNA-binding domain, of human SATB1 by NMR spectroscopy. The structure consists of five alpha-helices, in which the N-terminal four are arranged similarly to the four-helix structure of the CUT domain of hepatocyte nuclear factor 6alpha."}
{"qid": "58e186fd6fddd3e83e00000f", "original_text": "Pulmonary hypertension (PHT) is associated with tricuspid annular dilatation, but the effect of acute increase of pulmonary pressure on three-dimensional (3D) tricuspid annular dynamics and shape is unknown. Better understanding of tricuspid annular dynamics may lead to improved and more durable surgical reparative techniques. In nine open-chest anaesthetized sheep nine sonomicrometry crystals were implanted on the right ventricle while on cardiopulmonary bypass.", "label": 1, "is_selected": 0, "text": "Pulmonary hypertension (PHT) is associated with tricuspid annular dilatation, but the effect of acute increase of pulmonary pressure on three-dimensional (3D) tricuspid annular dynamics and shape is unknown. Better understanding of tricuspid annular dynamics may lead to improved and more durable surgical reparative techniques. In nine open-chest anaesthetized sheep nine sonomicrometry crystals were implanted on the right ventricle while on cardiopulmonary bypass."}
{"qid": "601c13a91cb411341a00000a", "original_text": "In recent years, immunotherapies have been clinically investigated in AML and other myeloid malignancies. While most of these are focused on stimulating the adaptive immune system (including T cell checkpoint inhibitors), several key approaches targeting the innate immune system have been identified. Macrophages are a key cell type in the innate immune response with CD47 being identified as a dominant macrophage checkpoint. CD47 is a \"do not eat me\" signal, overexpressed in myeloid malignancies that leads to tumor evasion of phagocytosis by macrophages.", "label": 1, "is_selected": 0, "text": "In recent years, immunotherapies have been clinically investigated in AML and other myeloid malignancies. While most of these are focused on stimulating the adaptive immune system (including T cell checkpoint inhibitors), several key approaches targeting the innate immune system have been identified. Macrophages are a key cell type in the innate immune response with CD47 being identified as a dominant macrophage checkpoint. CD47 is a \"do not eat me\" signal, overexpressed in myeloid malignancies that leads to tumor evasion of phagocytosis by macrophages."}
{"qid": "517a8b768ed59a060a00003f", "original_text": "The deiodinase enzyme present in the liver is type 2 iodothyronine deiodinase (D2). D2 is the primary deiodinase enzyme responsible for the conversion of triiodothyronine (T3) to reverse T3 (rT3) in the liver. This enzyme is essential for the regulation of thyroid hormone metabolism and is found in high levels in the liver, where it plays a critical role in the regulation of thyroid hormone activity. The liver D2 enzyme is also involved in the inactivation of T4 to rT3, which helps to regulate the amount of free T3 and T4 in the bloodstream.", "label": 0, "is_selected": 0, "text": "The deiodinase enzyme present in the liver is type 2 iodothyronine deiodinase (D2). D2 is the primary deiodinase enzyme responsible for the conversion of triiodothyronine (T3) to reverse T3 (rT3) in the liver. This enzyme is essential for the regulation of thyroid hormone metabolism and is found in high levels in the liver, where it plays a critical role in the regulation of thyroid hormone activity. The liver D2 enzyme is also involved in the inactivation of T4 to rT3, which helps to regulate the amount of free T3 and T4 in the bloodstream."}
{"qid": "515b1eccd24251bc050000af", "original_text": "Long nano columns (LNCs) in proteomics offer several advantages over traditional shorter columns. One of the primary benefits is their ability to separate proteins based on their hydrodynamic volume, rather than their molecular weight. This allows for the detection of low-abundance proteins that may be missed using traditional shorter columns. Additionally, LNCs can accommodate larger protein complexes and post-translational modifications, enabling the analysis of protein structures and interactions. The increased separation power of LNCs also allows for the detection of protein isoforms and the quantification of protein expression levels with higher accuracy. Furthermore, LNCs can be easily coupled with other analytical techniques, such as mass spectrometry, to provide a comprehensive view of the proteome.", "label": 0, "is_selected": 1, "text": "Long nano columns in proteomics offer several advantages over traditional shorter columns, such as their ability to separate proteins based on their hydrodynamic volume, rather than their molecular weight. Long nanotubes (LNCs) in proteomics have been used to study the structure and function of proteins in the human proteome."}
{"qid": "5e91ffc22d3121100d000002", "original_text": "There are several types of mutations that can occur in the human genome, including: 1. Point mutations: These are the most common type of mutation and involve a change in a single nucleotide base. There are several types of point mutations, including substitutions, deletions, and insertions. 2. Frameshift mutations: These mutations involve the insertion or deletion of one or more nucleotides in the genome, leading to a change in the reading frame of the genetic code. 3. Chromosomalmutations: These involve changes in the number or structure of the chromosomes, such as chromosomal deletions, duplications, or translocations. 4. Genomic mutations: These involve changes in the overall structure or organization of the genome, such as the loss or gain of genetic material. 5. Epigenetic mutations: These involve changes in the way genes are expressed, rather than changes in the DNA sequence itself. Epigenetic mutations can be influenced by a variety of factors, including aging, environmental exposures, and lifestyle choices. I hope this information is helpful! Let me know if you have any other questions.", "label": 0, "is_selected": 1, "text": "A mutation is a change in the genetic code that takes place in a person's body, such as the loss or gain of a gene or part of a chromosome. Genomic mutations: These involve changes in the overall structure or 888-276-5932 888-276-5932 of the human genome, including the loss, gain, or loss of a DNA sequence, or the insertion or deletion of nucleotides, or a sequence of letters or numbers, in the genome."}
{"qid": "6277d7f356bf9aee6f000004", "original_text": "The literature was reviewed to abstract items which were claimed to distinguish organic dementia from pseudodementia. Their discriminating powers were tested in a prospective study. Eighteen of these items were selected to create a questionnaire which should distinguish organic dementia from pseudodementia. The gold standard was the final diagnosis given by a consultant psychiatrist 12-14 months later.", "label": 1, "is_selected": 0, "text": "The literature was reviewed to abstract items which were claimed to distinguish organic dementia from pseudodementia. Their discriminating powers were tested in a prospective study. Eighteen of these items were selected to create a questionnaire which should distinguish organic dementia from pseudodementia. The gold standard was the final diagnosis given by a consultant psychiatrist 12-14 months later."}
{"qid": "511a16f9df1ebcce7d000005", "original_text": "Eukaryotic DNA cytosine methylation can be used to transcriptionally silence repetitive sequences, including transposons and retroviruses. This silencing is stable between cell generations as cytosine methylation is maintained epigenetically through DNA replication. The Arabidopsis thaliana Dnmt3 cytosine methyltransferase ortholog DOMAINS rearranged methyltransferase2 (DRM2) is required for establishment of small interfering RNA (siRNA) directed DNA methylation. In mammals PIWI proteins and piRNA act in a convergently evolved RNA-directed DNA methylation system that is required to repress transposon expression in the germ line. De novo methylation may also be independent of RNA interference and small RNAs, as in Neurospora crassa. Here we identify a clade of catalytically mutated DRM2 paralogs in flowering plant genomes, which in A.thaliana we term domains rearranged methyltransferase3 (DRM3).", "label": 1, "is_selected": 0, "text": "Eukaryotic DNA cytosine methylation can be used to transcriptionally silence repetitive sequences, including transposons and retroviruses. This silencing is stable between cell generations as cytosine methylation is maintained epigenetically through DNA replication. The Arabidopsis thaliana Dnmt3 cytosine methyltransferase ortholog DOMAINS rearranged methyltransferase2 (DRM2) is required for establishment of small interfering RNA (siRNA) directed DNA methylation. In mammals PIWI proteins and piRNA act in a convergently evolved RNA-directed DNA methylation system that is required to repress transposon expression in the germ line. De novo methylation may also be independent of RNA interference and small RNAs, as in Neurospora crassa. Here we identify a clade of catalytically mutated DRM2 paralogs in flowering plant genomes, which in A.thaliana we term domains rearranged methyltransferase3 (DRM3)."}
{"qid": "54f5f8925f206a0c06000003", "original_text": "The emergence of new genes and functions is of central importance to the evolution of species. The contribution of various types of duplications to genetic innovation has been extensively investigated. Less understood is the creation of new genes by recycling of coding material from selfish mobile genetic elements. To investigate this process, we reconstructed the evolutionary history of SETMAR, a new primate chimeric gene resulting from fusion of a SET histone methyltransferase gene to the transposase gene of a mobile element.", "label": 1, "is_selected": 0, "text": "The emergence of new genes and functions is of central importance to the evolution of species. The contribution of various types of duplications to genetic innovation has been extensively investigated. Less understood is the creation of new genes by recycling of coding material from selfish mobile genetic elements. To investigate this process, we reconstructed the evolutionary history of SETMAR, a new primate chimeric gene resulting from fusion of a SET histone methyltransferase gene to the transposase gene of a mobile element."}
{"qid": "5335d4e8d6d3ac6a34000053", "original_text": "Macitentan is a drug that targets specific receptors in the vasculature to treat pulmonary arterial hypertension (PAH). It specifically targets the endothelin receptor B (ETBR), which is overexpressed in the vascular smooth muscle cells of the pulmonary arteries in PAH. By blocking ETBR, macitentan reduces the production of endothelin-1, a vasoconstrictor that contributes to the development and progression of PAH. Additionally, macitentan also targets the soluble guanylyl cyclase (sGC) and increases the levels of cyclic guanosine monophosphate (cGMP), which can help to relax the blood vessels and improve blood flow.", "label": 0, "is_selected": 1, "text": "Macitentan is a drug that targets specific receptors in the vasculature to treat pulmonary arterial hypertension (PAH) and is being developed by Radius Health, a subsidiary of Radius Health (formerly Radius Health), a Radius Health company."}
{"qid": "532f55fed6d3ac6a34000036", "original_text": "The frequency of nine different mutated alleles known to occur in the glucocerebrosidase gene was determined in 247 Gaucher patients, of whom 176 were of Jewish extraction, 2 were Jewish with one converted parent, and 69 were of non-Jewish origin. DNA was prepared from peripheral blood, active glucocerebrosidase sequences were amplified by using the PCR technique, and the mutations were identified by using the allele-specific oligonucleotide hybridization method. The N37OS mutation appeared in 69.77% of the mutated alleles in Jewish patients and in 22.86% of the mutated alleles in non-Jews. The 84GG mutation, which has not been found so far among non-Jewish patients, existed in 10.17% of the disease alleles among Jewish patients.", "label": 1, "is_selected": 0, "text": "The frequency of nine different mutated alleles known to occur in the glucocerebrosidase gene was determined in 247 Gaucher patients, of whom 176 were of Jewish extraction, 2 were Jewish with one converted parent, and 69 were of non-Jewish origin. DNA was prepared from peripheral blood, active glucocerebrosidase sequences were amplified by using the PCR technique, and the mutations were identified by using the allele-specific oligonucleotide hybridization method. The N37OS mutation appeared in 69.77% of the mutated alleles in Jewish patients and in 22.86% of the mutated alleles in non-Jews. The 84GG mutation, which has not been found so far among non-Jewish patients, existed in 10.17% of the disease alleles among Jewish patients."}
{"qid": "56bc7d71ac7ad10019000018", "original_text": "Tuberculosis (Tb) continues to be a dreadful infection worldwide with nearly 1.5 million deaths in 2013. Furthermore multi/extensively drug-resistant Tb (MDR/XDR-Tb) worsens the condition. Recently approved anti-Tb drugs (bedaquiline and delamanid) have the potential to induce arrhythmia and are recommended in patients with MDR-Tb when other alternatives fail. The goal of elimination of Tb by 2050 will not be achieved without an effective new vaccine. The recent advancement in the development of Tb vaccines is the keen focus of this review. To date, Bacille Calmette Guerin (BCG) is the only licensed Tb vaccine in use, however its efficacy in pulmonary Tb is variable in adolescents and adults.", "label": 1, "is_selected": 0, "text": "Tuberculosis (Tb) continues to be a dreadful infection worldwide with nearly 1.5 million deaths in 2013. Furthermore multi/extensively drug-resistant Tb (MDR/XDR-Tb) worsens the condition. Recently approved anti-Tb drugs (bedaquiline and delamanid) have the potential to induce arrhythmia and are recommended in patients with MDR-Tb when other alternatives fail. The goal of elimination of Tb by 2050 will not be achieved without an effective new vaccine. The recent advancement in the development of Tb vaccines is the keen focus of this review. To date, Bacille Calmette Guerin (BCG) is the only licensed Tb vaccine in use, however its efficacy in pulmonary Tb is variable in adolescents and adults."}
{"qid": "5e6e9a2fc6a8763d23000007", "original_text": "Anticitrullinated protein/peptide antibodies (ACPA) are implicated in rheumatoid arthritis (RA) pathogenesis and linked to the shared epitope (SE). Citrulline modification is very similar to a different modified amino acid, homocitrulline. We investigated antihomocitrullinated protein/ peptide antibody (AHCPA) specificity for RA, whether ACPA were also able to bind homocitrullinated targets, and whether the SE could accommodate homocitrullinated peptide. Homocitrullinated fibrinogen was used to screen sera from patients with RA, psoriatic arthritis, and systemic lupus erythematosus, and healthy subjects for AHCPA using ELISA. Homocitrullination sites on fibrinogen were identified by mass spectrometry.", "label": 1, "is_selected": 0, "text": "Anticitrullinated protein/peptide antibodies (ACPA) are implicated in rheumatoid arthritis (RA) pathogenesis and linked to the shared epitope (SE). Citrulline modification is very similar to a different modified amino acid, homocitrulline. We investigated antihomocitrullinated protein/ peptide antibody (AHCPA) specificity for RA, whether ACPA were also able to bind homocitrullinated targets, and whether the SE could accommodate homocitrullinated peptide. Homocitrullinated fibrinogen was used to screen sera from patients with RA, psoriatic arthritis, and systemic lupus erythematosus, and healthy subjects for AHCPA using ELISA. Homocitrullination sites on fibrinogen were identified by mass spectrometry."}
{"qid": "62265c953a8413c653000084", "original_text": "METTL3 is an m6A eraser. It is a member of the METTL protein family, which are involved in the regulation of N6-methyladenosine (m6A) levels in RNA. METTL3 specifically recognizes and removes m6A from RNA, leading to changes in RNA fate and function.", "label": 0, "is_selected": 1, "text": "METTL3 is a member of the METTL protein family, which is involved in the regulation of N6-methyladenosine (m6A) levels in RNA, leading to changes in RNA fate and function, and has been described as a key player in"}
{"qid": "5895f18ce370baff39000001", "original_text": "The majority of existing computational tools rely on sequence homology and/or structural similarity to identify novel microRNA (miRNA) genes. Recently supervised algorithms are utilized to address this problem, taking into account sequence, structure and comparative genomics information. In most of these studies miRNA gene predictions are rarely supported by experimental evidence and prediction accuracy remains uncertain. In this work we present a new computational tool (SSCprofiler) utilizing a probabilistic method based on Profile Hidden Markov Models to predict novel miRNA precursors. Via the simultaneous integration of biological features such as sequence, structure and conservation, SSCprofiler achieves a performance accuracy of 88.95% sensitivity and 84.16% specificity on a large set of human miRNA genes. The trained classifier is used to identify novel miRNA gene candidates located within cancer-associated genomic regions and rank the resulting predictions using expression information from a full genome tiling array. Finally, four of the top scoring predictions are verified experimentally using northern blot analysis. Our work combines both analytical and experimental techniques to show that SSCprofiler is a highly accurate tool which can be used to identify novel miRNA gene candidates in the human genome. SSCprofiler is freely available as a web service at http://www.imbb.forth.gr/SSCprofiler.html.", "label": 1, "is_selected": 0, "text": "The majority of existing computational tools rely on sequence homology and/or structural similarity to identify novel microRNA (miRNA) genes. Recently supervised algorithms are utilized to address this problem, taking into account sequence, structure and comparative genomics information. In most of these studies miRNA gene predictions are rarely supported by experimental evidence and prediction accuracy remains uncertain. In this work we present a new computational tool (SSCprofiler) utilizing a probabilistic method based on Profile Hidden Markov Models to predict novel miRNA precursors. Via the simultaneous integration of biological features such as sequence, structure and conservation, SSCprofiler achieves a performance accuracy of 88.95% sensitivity and 84.16% specificity on a large set of human miRNA genes. The trained classifier is used to identify novel miRNA gene candidates located within cancer-associated genomic regions and rank the resulting predictions using expression information from a full genome tiling array. Finally, four of the top scoring predictions are verified experimentally using northern blot analysis. Our work combines both analytical and experimental techniques to show that SSCprofiler is a highly accurate tool which can be used to identify novel miRNA gene candidates in the human genome. SSCprofiler is freely available as a web service at http://www.imbb.forth.gr/SSCprofiler.html."}
{"qid": "5d35be1cb3a6380763000005", "original_text": "Wapl protein regulates binding of the cohesin complex to chromosomes during interphase and helps remove cohesin from chromosomes at mitosis. We isolated a dominant mutation in wapl (wapl(AG)) in a screen for mutations that counteract silencing mediated by an engrailed Polycomb-group response element. wapl(AG) hemizygotes die as pharate adults and have an extra sex combs phenotype characteristic of males with mutations in Polycomb-group (PcG) genes. The wapl gene encodes two proteins, a long form and a short form.", "label": 1, "is_selected": 0, "text": "Wapl protein regulates binding of the cohesin complex to chromosomes during interphase and helps remove cohesin from chromosomes at mitosis. We isolated a dominant mutation in wapl (wapl(AG)) in a screen for mutations that counteract silencing mediated by an engrailed Polycomb-group response element. wapl(AG) hemizygotes die as pharate adults and have an extra sex combs phenotype characteristic of males with mutations in Polycomb-group (PcG) genes. The wapl gene encodes two proteins, a long form and a short form."}
{"qid": "54fb6fb5d176fff445000004", "original_text": "The Notch transcriptional activation complex is composed of several proteins, including Notch itself, the transcriptional coactivator CSL (CBF1 in humans), and various other coactivators and corepressors. The specific proteins involved in the activation complex can vary depending on the cellular context and the specific Notch signaling pathway. In general, the complex includes the following proteins: Notch, CSL, the coactivator p300, the corepressor HDAC1, and the transcriptional adaptor proteins Suppressor of Hairless (Shh) and Mastermind (Mam).", "label": 0, "is_selected": 0, "text": "The Notch transcriptional activation complex is composed of several proteins, including Notch itself, the transcriptional coactivator CSL (CBF1 in humans), and various other coactivators and corepressors. The specific proteins involved in the activation complex can vary depending on the cellular context and the specific Notch signaling pathway. In general, the complex includes the following proteins: Notch, CSL, the coactivator p300, the corepressor HDAC1, and the transcriptional adaptor proteins Suppressor of Hairless (Shh) and Mastermind (Mam)."}
{"qid": "52fc8b772059c6d71c00006e", "original_text": "Known inhibitors of the TPL2/MAP3K8 protein include the small molecule inhibitors, such as: 1. GDC-0980 2. R5218 3. BMS-911571 4. ONO-9229 5. LB-100 6. GSK2801 It is important to note that the above list may not be exhaustive and new inhibitors may be discovered or developed in the future. Additionally, the effectiveness and specificity of these inhibitors may vary depending on the context and experimental conditions.", "label": 0, "is_selected": 1, "text": "The following is a list of inhibitors of the TPL2/MAP3K8 protein that have been discovered or developed in the past few years.Additionally, the effectiveness and specificity of these inhibitors may vary depending on the context and experimental conditions.Moreover, the above list may not be exhaustive and new inhibitors may be discovered or development in the future."}
{"qid": "6082e2254e6a4cf63000000d", "original_text": "There are several proteins that have been implicated in the promotion of calcification. These include: 1. Osteoprotogerin (OPG): OPG is a protein produced by osteoclasts, which are the cells responsible for bone resorption. OPG promotes the activation of osteoclasts and inhibits the formation of new bone. 2. RANKL (Receptor Activator of NF-\u03baB Ligand): RANKL is a protein produced by osteoclasts and other cells in the bone microenvironment. RANKL binds to the receptor RANK on the surface of osteoclasts, triggering their activation and the process of bone resorption. 3. Tumor Necrosis Factor-alpha (TNF-\u03b1): TNF-\u03b1 is a cytokine that can promote the production of OPG and RANKL, leading to increased bone resorption. 4. Interleukin-1 beta (IL-1\u03b2): IL-1\u03b2 is another cytokine that can promote inflammation in the bone microenvironment, leading to increased bone resorption. It is important to note that the expression of these proteins can be regulated by a variety of factors, including the presence of hormones, growth factors, and inflammatory cytokines. Understanding the regulation of these proteins can provide valuable insights into the development of osteoporosis and other bone disorders.", "label": 0, "is_selected": 1, "text": "Osteoporosis is a disease of the bone that is caused by increased bone resorption, which results in the loss of bone tissue and reduces the strength of the spine and other bones in the patient's neck, wrist, and hands, as well as bone loss in the feet, ankles, and other extremities, and is a major cause of disability in older people.<n> This article will focus on proteins that have been implicated in the promotion of calcification in the bone microenvironment, and how these proteins may be regulated by factors such as hormones, growth factors, and inflammatory cytokines."}
{"qid": "58b95ea222d3005309000011", "original_text": "We investigated the regulation of Sox9, a transcription factor known to play a role in chondrogenesis, by bone morphogenetic protein-2 (BMP-2) and hedgehog proteins in order to better understand their signaling function in endochondral bone formation. The mesenchymal progenitor cell line C3H10T1/2 was stimulated with BMP-2. Sox9 expression levels were measured by quantitative reverse transcriptase-polymerase chain reaction and Northern analysis. We found that Sox9 was up-regulated by BMP-2 in a dose-dependent manner. The expression of Col2a1, a downstream response gene of Sox9, was also significantly increased upon BMP-2 addition. We also monitored Sox9 expression after the addition of BMP-2 to osteosarcoma cell lines; BMP-2 treatment increased Sox9 mRNA levels in MG63, considered to be early osteoblast-like, but not in human osteogenic sarcoma (HOS) cells, which are thought to be more advanced in the osteoblastic lineage.", "label": 1, "is_selected": 0, "text": "We investigated the regulation of Sox9, a transcription factor known to play a role in chondrogenesis, by bone morphogenetic protein-2 (BMP-2) and hedgehog proteins in order to better understand their signaling function in endochondral bone formation. The mesenchymal progenitor cell line C3H10T1/2 was stimulated with BMP-2. Sox9 expression levels were measured by quantitative reverse transcriptase-polymerase chain reaction and Northern analysis. We found that Sox9 was up-regulated by BMP-2 in a dose-dependent manner. The expression of Col2a1, a downstream response gene of Sox9, was also significantly increased upon BMP-2 addition. We also monitored Sox9 expression after the addition of BMP-2 to osteosarcoma cell lines; BMP-2 treatment increased Sox9 mRNA levels in MG63, considered to be early osteoblast-like, but not in human osteogenic sarcoma (HOS) cells, which are thought to be more advanced in the osteoblastic lineage."}
{"qid": "62260afb3a8413c65300007b", "original_text": "The rs34269950 SNP (single nucleotide polymorphism) is located in the X-linked motif of the RUNX1T1 protein. Specifically, it is located at position 24697 in the human genome, which corresponds to the amino acid residue Gly1307 in the RUNX1T1 protein. This motif is important for the regulation of gene expression and is known to be associated with various diseases, including cancer and developmental disorders.", "label": 0, "is_selected": 1, "text": "A single-letter polymorphism in the human RUNX1T1 gene has been identified by scientists at the University of California, Los Angeles.<n> The rs34269950 SNP (single nucleotide polymorphism) is located in the X-linked motif of the RUNX2T1 protein."}
{"qid": "58a57f9460087bc10a00001f", "original_text": "Waardenburg and Tietz syndromes are caused by mutations in the MITF gene, which is responsible for producing the microphthalmia-associated transcription factor (MITF) protein. MITF plays a critical role in regulating pigmentation and melanocyte development, and mutations in the MITF gene can lead to the characteristic clinical features of these syndromes, including hypopigmentation, congenital cataracts, and other ocular abnormalities.", "label": 0, "is_selected": 1, "text": "The purpose of this study is to describe the genetic basis of two inherited eye diseases, Waardenburg-Tietz syndrome and Tietz-Wahrdenburg syndrome, and to shed light on the clinical features of these diseases.<n> The aim of the study was to identify the genetic cause of these eye diseases and to develop a treatment strategy for patients with these diseases"}
{"qid": "5c571f7607647bbc4b000017", "original_text": "Exposure to heavy metals such as lead (Pb) or cadmium (Cd) can potentially cause changes in DNA methylation patterns in Isoetes sinensis. DNA methylation is a crucial epigenetic mechanism that regulates gene expression by adding a methyl group to the cytosine residue of CpG dinucleotides. Heavy metal exposure has been shown to alter DNA methylation patterns in various organisms, including plants. Studies have demonstrated that exposure to heavy metals can result in the demethylation or methylation of specific genes or genomic regions, leading to changes in gene expression and cellular behavior. For instance, lead exposure has been shown to demethylate the promoter region of the human aryl hydrocarbon receptor (AhR) gene, leading to its activation and the subsequent induction of cytochrome P450 enzymes involved in xenobiotic metabolism. Similarly, cadmium exposure has been shown to cause methylation of specific genes involved in stress response and antioxidant pathways. In the case of Isoetes sinensis, exposure to heavy metals may also affect its DNA methylation patterns, potentially leading to changes in its growth and development. However, further research is needed to fully understand the impact of heavy metal exposure on DNA methylation patterns in this species. In summary, while there is evidence to suggest that heavy metal exposure can affect DNA methylation patterns in various organisms, the specific effects of heavy metal exposure on DNA methylation in Isoetes sinensis are not well understood and require further investigation.", "label": 0, "is_selected": 1, "text": "The effects of heavy metal exposure on DNA in Isoetes sinensis are not well understood, and further research is needed to fully understand the impact of heavy metals on DNA patterns in this species. in summary, while there is evidence to suggest that heavy metal exposed organisms can affect DNA patterns, the specific Effects of Heavy Metal Exposure On DNA In Isoete's sinensis Are Not Well understood and require further investigation, further studies are needed to understand the specific effects ofHeavy Metal Exposure on DNA In this species, there is not well understanding of the effects of Heavy Metals on DNA and further investigation is needed."}
{"qid": "5ac7185f0340b9f058000004", "original_text": "Calcific aortic valve disease is characterized by an abnormal mineralization of the aortic valve. Osteogenic activity in the aortic valve is under the control of NOTCH1, which regulates the expression of key pro-osteogenic genes such as RUNX2 and BMP2. Long noncoding RNAs (lncRNAs) may reprogram cells by altering the gene expression pattern. Multidimensional genomic profiling was performed in human aortic valves to document the expression of lncRNAs and the DNA methylation pattern in calcific aortic valve disease. In-depth functional assays were carried out to document the impact of lncRNA on the mineralization of the aortic valve. We documented that lncRNA H19 (H19) was increased in calcific aortic valve disease. Hypomethylation of the promoter region was observed in mineralized aortic valves and was inversely associated with H19 expression. Knockdown and overexpression experiments showed that H19 induces a strong osteogenic phenotype by altering the NOTCH1 pathway. Gene promoter analyses showed that H19 silenced NOTCH1 by preventing the recruitment of p53 to its promoter.", "label": 1, "is_selected": 0, "text": "Calcific aortic valve disease is characterized by an abnormal mineralization of the aortic valve. Osteogenic activity in the aortic valve is under the control of NOTCH1, which regulates the expression of key pro-osteogenic genes such as RUNX2 and BMP2. Long noncoding RNAs (lncRNAs) may reprogram cells by altering the gene expression pattern. Multidimensional genomic profiling was performed in human aortic valves to document the expression of lncRNAs and the DNA methylation pattern in calcific aortic valve disease. In-depth functional assays were carried out to document the impact of lncRNA on the mineralization of the aortic valve. We documented that lncRNA H19 (H19) was increased in calcific aortic valve disease. Hypomethylation of the promoter region was observed in mineralized aortic valves and was inversely associated with H19 expression. Knockdown and overexpression experiments showed that H19 induces a strong osteogenic phenotype by altering the NOTCH1 pathway. Gene promoter analyses showed that H19 silenced NOTCH1 by preventing the recruitment of p53 to its promoter."}
{"qid": "58ea659c3e8b6dc87c000013", "original_text": "The marine cyanobacterium Prochlorococcus is the smallest and most abundant photosynthetic organism on Earth. In this Review, we summarize our understanding of the diversity of this remarkable phototroph and describe its role in ocean ecosystems. We discuss the importance of interactions of Prochlorococcus with the physical environment, with phages and with heterotrophs in shaping the ecology and evolution of this group.", "label": 1, "is_selected": 0, "text": "The marine cyanobacterium Prochlorococcus is the smallest and most abundant photosynthetic organism on Earth. In this Review, we summarize our understanding of the diversity of this remarkable phototroph and describe its role in ocean ecosystems. We discuss the importance of interactions of Prochlorococcus with the physical environment, with phages and with heterotrophs in shaping the ecology and evolution of this group."}
{"qid": "624c88a1e764a53204000002", "original_text": "Yes, Satb1 (Special AT-rich Sequence Binding Protein 1) is a transcription factor. Transcription factors are proteins that regulate gene expression by binding to specific DNA sequences near gene promoters and either activating or repressing transcription. Satb1 is a multifunctional transcription factor that plays a crucial role in the regulation of various cellular processes, including cell proliferation, differentiation, and survival. It is known to bind to and regulate the expression of various genes involved in these processes, and its dysregulation has been implicated in various diseases, including cancer.", "label": 0, "is_selected": 1, "text": "Satb1 is a transcription factor that plays a crucial role in the regulation of various cellular processes, including cell proliferation, differentiation, and survival, and has been implicated in various diseases, including cancer, as well as being a potential target for drug development."}
{"qid": "622662e13a8413c653000085", "original_text": "This study aimed to explore the regulatory mechanism of methyltransferase3 (METTL3) -mediated long non-coding RNA (lncRNA) N6-methyladenosine (m6A) modification in the osteogenic differentiation of human adipose-derived stem cells (hASCs) induced by NEL-like 1 protein (NELL-1). Methylated RNA immunoprecipitation sequencing (MeRIP-seq) and high- throughput sequencing for RNA (RNA-seq) were performed on hASCs. Osteogenic ability was detected by alkaline phosphatase (ALP) staining, Alizarin Red S(ARS) staining, ALP quantification and Quantitative real-time polymerase chain reaction analysis (qRT-PCR). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis predicted the osteogenesis-related pathways enriched for the lncRNAs and identified the target lncRNAs. After overexpression and knockdown of METTL3, methylated RNA immunoprecipitation-qPCR (MeRIP-qPCR) and qRT-PCR were used to detect the levels of m6A modification and the expression of the target lncRNA, and the binding of both was confirmed by RNA binding protein immunoprecipitation (RIP) assay.", "label": 1, "is_selected": 0, "text": "This study aimed to explore the regulatory mechanism of methyltransferase3 (METTL3) -mediated long non-coding RNA (lncRNA) N6-methyladenosine (m6A) modification in the osteogenic differentiation of human adipose-derived stem cells (hASCs) induced by NEL-like 1 protein (NELL-1). Methylated RNA immunoprecipitation sequencing (MeRIP-seq) and high- throughput sequencing for RNA (RNA-seq) were performed on hASCs. Osteogenic ability was detected by alkaline phosphatase (ALP) staining, Alizarin Red S(ARS) staining, ALP quantification and Quantitative real-time polymerase chain reaction analysis (qRT-PCR). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis predicted the osteogenesis-related pathways enriched for the lncRNAs and identified the target lncRNAs. After overexpression and knockdown of METTL3, methylated RNA immunoprecipitation-qPCR (MeRIP-qPCR) and qRT-PCR were used to detect the levels of m6A modification and the expression of the target lncRNA, and the binding of both was confirmed by RNA binding protein immunoprecipitation (RIP) assay."}
{"qid": "53386282d6d3ac6a3400005a", "original_text": "Transforming growth factor-beta (TGF-beta) plays an important role during the period of developmental cell death in the nervous system. Using the oligodendroglial precursor cell line OLI-neu, we have previously established an in vitro system to analyze TGF-beta-mediated cell death on the molecular level. We could show that the Kr\u00fcppel-like Zn-finger transcription factor TIEG1 was up-regulated after TGF-beta stimulation of OLI-neu cells and mimicked TGF-beta effects in these cells; i.e., overexpression of TIEG1 in OLI-neu cells induced apoptosis as shown by apoptosis ELISA, DNA fragmentation, and caspases-3 activation. The apoptotic pathway seemed to be initiated by repressing the expression of the antiapoptotic protein Bcl-XL.", "label": 1, "is_selected": 0, "text": "Transforming growth factor-beta (TGF-beta) plays an important role during the period of developmental cell death in the nervous system. Using the oligodendroglial precursor cell line OLI-neu, we have previously established an in vitro system to analyze TGF-beta-mediated cell death on the molecular level. We could show that the Kr\u00fcppel-like Zn-finger transcription factor TIEG1 was up-regulated after TGF-beta stimulation of OLI-neu cells and mimicked TGF-beta effects in these cells; i.e., overexpression of TIEG1 in OLI-neu cells induced apoptosis as shown by apoptosis ELISA, DNA fragmentation, and caspases-3 activation. The apoptotic pathway seemed to be initiated by repressing the expression of the antiapoptotic protein Bcl-XL."}
{"qid": "52f89fd32059c6d71c000051", "original_text": "GATA1 is a transcription factor that plays a crucial role in regulating the expression of genes involved in red blood cell development and function. Its interaction partners include: * DNA: GATA1 binds to specific DNA sequences in the promoter regions of target genes to regulate their transcription. * Other transcription factors: GATA1 interacts with other transcription factors, such as NF-E2, to modulate their activity and regulate gene expression. * Co-repressors and co-activators: GATA1 associates with co-repressors and co-activators, such as CBX3 and PC4, to modulate its transcriptional activity. * Chromatin-modifying enzymes: GATA1 interacts with chromatin-modifying enzymes, such as histone acetyltransferases and histone deacetylases, to regulate gene expression by modifying chromatin structure. * Protein kinases and phosphatases: GATA1 is phosphorylated by protein kinases and dephosphorylated by phosphatases, which can affect its transcriptional activity and stability. * Other proteins: GATA1 also interacts with other proteins, such as HIF1A, KLF1, and GATA2, to regulate red blood cell development and function.", "label": 0, "is_selected": 0, "text": "GATA1 is a transcription factor that plays a crucial role in regulating the expression of genes involved in red blood cell development and function. Its interaction partners include: * DNA: GATA1 binds to specific DNA sequences in the promoter regions of target genes to regulate their transcription. * Other transcription factors: GATA1 interacts with other transcription factors, such as NF-E2, to modulate their activity and regulate gene expression. * Co-repressors and co-activators: GATA1 associates with co-repressors and co-activators, such as CBX3 and PC4, to modulate its transcriptional activity. * Chromatin-modifying enzymes: GATA1 interacts with chromatin-modifying enzymes, such as histone acetyltransferases and histone deacetylases, to regulate gene expression by modifying chromatin structure. * Protein kinases and phosphatases: GATA1 is phosphorylated by protein kinases and dephosphorylated by phosphatases, which can affect its transcriptional activity and stability. * Other proteins: GATA1 also interacts with other proteins, such as HIF1A, KLF1, and GATA2, to regulate red blood cell development and function."}
{"qid": "5895e4637d9090f353000012", "original_text": "IMAGe syndrome, also known as Inflammatory Mucopolysaccharidosis and Gastritis, is a rare genetic disorder characterized by inflammation in the mucous membranes and gastrointestinal tract, as well as a range of other clinical features. These may include short stature, joint stiffness, corneal clouding, and hearing loss. Respiratory problems, such as bronchiectasis and cystic fibrosis, are also common. Skin rashes, particularly on the palms and soles, are a characteristic feature of IMAGe syndrome. In addition, individuals with this condition may experience gastrointestinal symptoms, including abdominal pain, nausea, and diarrhea. IMAGe syndrome is caused by a mutation in the IDUA gene, which codes for the enzyme alpha-L-iduronidase, and is inherited in an autosomal recessive pattern.", "label": 0, "is_selected": 1, "text": "IMAGe syndrome is a rare genetic disorder characterized by inflammation in the mucous membranes and gastrointestinal tract, as well as a range of other clinical features, including skin rashes, respiratory problems, and hearing loss. IMAGa syndrome is caused by a mutation in the IDUA gene, which codes for the enzyme alpha-L-iduron, and is inherited in an recessive pattern."}
{"qid": "601d725d1cb411341a000036", "original_text": "Progeria is a rare segmental premature aging disease with significant skeletal abnormalities. Defining the full scope of radiologic abnormalities requires examination of a large proportion of the world's progeria population (estimated at 1 in 4 million). There has been no comprehensive prospective study describing the skeletal abnormalities associated with progeria. To define characteristic radiographic features of this syndrome. Thirty-nine children with classic progeria, ages 2-17 years, from 29 countries were studied at a single site. Comprehensive radiographic imaging studies were performed. Sample included 23 girls and 16 boys-the largest number of patients with progeria evaluated prospectively to date. Eight new and two little known progeria-associated radiologic findings were identified (frequencies of 3-36%).", "label": 1, "is_selected": 0, "text": "Progeria is a rare segmental premature aging disease with significant skeletal abnormalities. Defining the full scope of radiologic abnormalities requires examination of a large proportion of the world's progeria population (estimated at 1 in 4 million). There has been no comprehensive prospective study describing the skeletal abnormalities associated with progeria. To define characteristic radiographic features of this syndrome. Thirty-nine children with classic progeria, ages 2-17 years, from 29 countries were studied at a single site. Comprehensive radiographic imaging studies were performed. Sample included 23 girls and 16 boys-the largest number of patients with progeria evaluated prospectively to date. Eight new and two little known progeria-associated radiologic findings were identified (frequencies of 3-36%)."}
{"qid": "56cf413f3975bb303a000009", "original_text": "Subjective Wellbeing (SWB) can be assessed with distinct measures that have been hypothesized to represent different domains of SWB. The current study assessed SWB with four different measures in a genetically informative sample of adolescent twins and their siblings aged 13-28 years (N = 5,024 subjects from 2,157 families). Multivariate genetic modeling was applied to the data to explore the etiology of individual differences in SWB measures and the association among them. Developmental trends and sex differences were examined for mean levels and the variance-covariance structure. Mean SWB levels were equal in men and women.", "label": 1, "is_selected": 0, "text": "Subjective Wellbeing (SWB) can be assessed with distinct measures that have been hypothesized to represent different domains of SWB. The current study assessed SWB with four different measures in a genetically informative sample of adolescent twins and their siblings aged 13-28 years (N = 5,024 subjects from 2,157 families). Multivariate genetic modeling was applied to the data to explore the etiology of individual differences in SWB measures and the association among them. Developmental trends and sex differences were examined for mean levels and the variance-covariance structure. Mean SWB levels were equal in men and women."}
{"qid": "511979b04eab811676000003", "original_text": "Phydbac (phylogenomic display of bacterial genes) implemented a method of phylogenomic profiling using a distance measure based on normalized BLAST scores. This method was able to increase the predictive power of phylogenomic profiling by about 25% when compared to the classical approach based on Hamming distances. Here we present a major extension of Phydbac (named here Phydbac2), that extends both the concept and the functionality of the original web-service. While phylogenomic profiles remain the central focus of Phydbac2, it now integrates chromosomal proximity and gene fusion analyses as two additional non-similarity-based indicators for inferring pairwise gene functional relationships. Moreover, all presently available (January 2004) fully sequenced bacterial genomes and those of three lower eukaryotes are now included in the profiling process, thus increasing the initial number of reference genomes (71 in Phydbac) to 150 in Phydbac2.", "label": 1, "is_selected": 0, "text": "Phydbac (phylogenomic display of bacterial genes) implemented a method of phylogenomic profiling using a distance measure based on normalized BLAST scores. This method was able to increase the predictive power of phylogenomic profiling by about 25% when compared to the classical approach based on Hamming distances. Here we present a major extension of Phydbac (named here Phydbac2), that extends both the concept and the functionality of the original web-service. While phylogenomic profiles remain the central focus of Phydbac2, it now integrates chromosomal proximity and gene fusion analyses as two additional non-similarity-based indicators for inferring pairwise gene functional relationships. Moreover, all presently available (January 2004) fully sequenced bacterial genomes and those of three lower eukaryotes are now included in the profiling process, thus increasing the initial number of reference genomes (71 in Phydbac) to 150 in Phydbac2."}
{"qid": "517179718ed59a060a00000e", "original_text": "The proteasome was validated as an oncology target following the clinical success of VELCADE (bortezomib) for injection for the treatment of multiple myeloma and recurring mantle cell lymphoma. Consequently, several groups are pursuing the development of additional small-molecule proteasome inhibitors for both hematologic and solid tumor indications. Here, we describe MLN9708, a selective, orally bioavailable, second-generation proteasome inhibitor that is in phase I clinical development. MLN9708 has a shorter proteasome dissociation half-life and improved pharmacokinetics, pharmacodynamics, and antitumor activity compared with bortezomib. MLN9708 has a larger blood volume distribution at steady state, and analysis of 20S proteasome inhibition and markers of the unfolded protein response confirmed that MLN9708 has greater pharmacodynamic effects in tissues than bortezomib. MLN9708 showed activity in both solid tumor and hematologic preclinical xenograft models, and we found a correlation between greater pharmacodynamic responses and improved antitumor activity. Moreover, antitumor activity was shown via multiple dosing routes, including oral gavage. Taken together, these data support the clinical development of MLN9708 for both hematologic and solid tumor indications.", "label": 1, "is_selected": 0, "text": "The proteasome was validated as an oncology target following the clinical success of VELCADE (bortezomib) for injection for the treatment of multiple myeloma and recurring mantle cell lymphoma. Consequently, several groups are pursuing the development of additional small-molecule proteasome inhibitors for both hematologic and solid tumor indications. Here, we describe MLN9708, a selective, orally bioavailable, second-generation proteasome inhibitor that is in phase I clinical development. MLN9708 has a shorter proteasome dissociation half-life and improved pharmacokinetics, pharmacodynamics, and antitumor activity compared with bortezomib. MLN9708 has a larger blood volume distribution at steady state, and analysis of 20S proteasome inhibition and markers of the unfolded protein response confirmed that MLN9708 has greater pharmacodynamic effects in tissues than bortezomib. MLN9708 showed activity in both solid tumor and hematologic preclinical xenograft models, and we found a correlation between greater pharmacodynamic responses and improved antitumor activity. Moreover, antitumor activity was shown via multiple dosing routes, including oral gavage. Taken together, these data support the clinical development of MLN9708 for both hematologic and solid tumor indications."}
{"qid": "5fe31301a43ad31278000039", "original_text": "Structural maintenance of chromosomes (SMC) protein complexes, including cohesin and condensin, play key roles in the regulation of higher-order chromosome organization. Even though SMC proteins are thought to mechanistically determine the function of the complexes, their native conformations and dynamics have remained unclear. Here, we probe the topology of Smc2-Smc4 dimers of the S. cerevisiae condensin complex with high-speed atomic force microscopy (AFM) in liquid. We show that the Smc2-Smc4 coiled coils are highly flexible polymers with a persistence length of only \u223c 4 nm. Moreover, we demonstrate that the SMC dimers can adopt various architectures that interconvert dynamically over time, and we find that the SMC head domains engage not only with each other, but also with the hinge domain situated at the other end of the \u223c 45-nm-long coiled coil. Our findings reveal structural properties that provide insights into the molecular mechanics of condensin complexes.", "label": 1, "is_selected": 0, "text": "Structural maintenance of chromosomes (SMC) protein complexes, including cohesin and condensin, play key roles in the regulation of higher-order chromosome organization. Even though SMC proteins are thought to mechanistically determine the function of the complexes, their native conformations and dynamics have remained unclear. Here, we probe the topology of Smc2-Smc4 dimers of the S. cerevisiae condensin complex with high-speed atomic force microscopy (AFM) in liquid. We show that the Smc2-Smc4 coiled coils are highly flexible polymers with a persistence length of only \u223c 4 nm. Moreover, we demonstrate that the SMC dimers can adopt various architectures that interconvert dynamically over time, and we find that the SMC head domains engage not only with each other, but also with the hinge domain situated at the other end of the \u223c 45-nm-long coiled coil. Our findings reveal structural properties that provide insights into the molecular mechanics of condensin complexes."}
{"qid": "533d0f44c45e13371400000e", "original_text": "Signal transducer and activator of transcription 3 (Stat3) is one of a family of cytoplasmic proteins that participate in normal cellular responses to cytokines and growth factors as transcription factors. Stat3 modulates various physiological functions including cell survival, cell-cycle regulation, and angiogenesis through regulation of gene expression, and its constitutive activation is associated with a number of human epithelial cancers. Recent studies with skin-specific gain and loss of Stat3 function transgenic mice have shown that Stat3 plays critical roles in skin carcinogenesis. Multistage skin carcinogenesis bioassays performed with these transgenic mice clearly demonstrate that Stat3 is required for both tumor initiation and promotion through regulation of genes involved in survival and proliferation, respectively. Stat3 also plays a role in malignant progression of skin tumors by regulating genes that are involved in angiogenesis and invasion. Further studies have revealed that Stat3 plays a critical role in epidermal cell proliferation and survival following exposure to ultraviolet B (UVB) irradiation.", "label": 1, "is_selected": 0, "text": "Signal transducer and activator of transcription 3 (Stat3) is one of a family of cytoplasmic proteins that participate in normal cellular responses to cytokines and growth factors as transcription factors. Stat3 modulates various physiological functions including cell survival, cell-cycle regulation, and angiogenesis through regulation of gene expression, and its constitutive activation is associated with a number of human epithelial cancers. Recent studies with skin-specific gain and loss of Stat3 function transgenic mice have shown that Stat3 plays critical roles in skin carcinogenesis. Multistage skin carcinogenesis bioassays performed with these transgenic mice clearly demonstrate that Stat3 is required for both tumor initiation and promotion through regulation of genes involved in survival and proliferation, respectively. Stat3 also plays a role in malignant progression of skin tumors by regulating genes that are involved in angiogenesis and invasion. Further studies have revealed that Stat3 plays a critical role in epidermal cell proliferation and survival following exposure to ultraviolet B (UVB) irradiation."}
{"qid": "601ef0571cb411341a000067", "original_text": "Keratomileusis, also known as laser keratomileusis or LASIK, is another name for laser-assisted in situ keratomileusis. This is a type of refractive surgery that uses a laser to reshape the cornea and improve vision in individuals with mild to severe nearsightedness, farsightedness, or astigmatism. The term \"keratomileusis\" refers to the surgical removal of a thin layer of the cornea to reshape it and improve vision.", "label": 0, "is_selected": 0, "text": "Keratomileusis, also known as laser keratomileusis or LASIK, is another name for laser-assisted in situ keratomileusis. This is a type of refractive surgery that uses a laser to reshape the cornea and improve vision in individuals with mild to severe nearsightedness, farsightedness, or astigmatism. The term \"keratomileusis\" refers to the surgical removal of a thin layer of the cornea to reshape it and improve vision."}
{"qid": "54fc48bb6ea36a810c000002", "original_text": "The development of induced pluripotent stem cell (iPSC) technology has led to many advances in the areas of directed cell differentiation and characterization. New methods for generating iPSC-derived cardiomyocytes provide an invaluable resource for the study of certain cardiovascular disorders. This review highlights the current technology in this field, its application thus far to the study of genetic disorders of the RAS/MAPK pathway and long-QT syndrome (LQTS), and future directions for the field. Enhanced methods increase the efficiency of generating and stringently purifying iPSC-derived cardiomyocytes. The use of cardiomyocytes derived from patients with LEOPARD syndrome and LQTS has shed light on the molecular mechanisms of disease and validated their use as reliable human disease models. The use of iPSC-derived cardiomyocytes to study genetic cardiovascular disorders will enable a deeper and more applicable understanding of the molecular mechanisms of human disease, as well as improving our ability to achieve successful cell-based therapies.", "label": 1, "is_selected": 0, "text": "The development of induced pluripotent stem cell (iPSC) technology has led to many advances in the areas of directed cell differentiation and characterization. New methods for generating iPSC-derived cardiomyocytes provide an invaluable resource for the study of certain cardiovascular disorders. This review highlights the current technology in this field, its application thus far to the study of genetic disorders of the RAS/MAPK pathway and long-QT syndrome (LQTS), and future directions for the field. Enhanced methods increase the efficiency of generating and stringently purifying iPSC-derived cardiomyocytes. The use of cardiomyocytes derived from patients with LEOPARD syndrome and LQTS has shed light on the molecular mechanisms of disease and validated their use as reliable human disease models. The use of iPSC-derived cardiomyocytes to study genetic cardiovascular disorders will enable a deeper and more applicable understanding of the molecular mechanisms of human disease, as well as improving our ability to achieve successful cell-based therapies."}
{"qid": "58e79e703e8b6dc87c00000a", "original_text": "Treatment strategies blocking tumor necrosis factor (anti-TNF) have proven very successful in patients with rheumatoid arthritis (RA), showing beneficial effects in approximately 50-60% of the patients. However, a significant subset of patients does not respond to anti-TNF agents, for reasons that are still unknown. The aim of this study was to validate five single nucleotide polymorphisms (SNPs) of PTPRC, CD226, AFF3, MyD88 and CHUK gene loci that have previously been reported to predict anti-TNF outcome.", "label": 1, "is_selected": 0, "text": "Treatment strategies blocking tumor necrosis factor (anti-TNF) have proven very successful in patients with rheumatoid arthritis (RA), showing beneficial effects in approximately 50-60% of the patients. However, a significant subset of patients does not respond to anti-TNF agents, for reasons that are still unknown. The aim of this study was to validate five single nucleotide polymorphisms (SNPs) of PTPRC, CD226, AFF3, MyD88 and CHUK gene loci that have previously been reported to predict anti-TNF outcome."}
{"qid": "5cb37f76ecadf2e73f00005c", "original_text": "The Pim1 serine/threonine kinase is associated with multiple cellular functions including proliferation, survival, differentiation, apoptosis, tumorigenesis, immune regulation and inflammation in vertebrates. However, little is known about the role of Pim1 in invertebrate immunity. In this study, we identified and characterized for the first time, a Pim1 (LvPim1) gene in Litopenaeus vannamei, with a full-length cDNA of 2352 bp and a 1119 bp open reading frame (ORF) encoding a putative protein of 372 amino acids, which contains a typical serine/threonine kinase domain.", "label": 1, "is_selected": 0, "text": "The Pim1 serine/threonine kinase is associated with multiple cellular functions including proliferation, survival, differentiation, apoptosis, tumorigenesis, immune regulation and inflammation in vertebrates. However, little is known about the role of Pim1 in invertebrate immunity. In this study, we identified and characterized for the first time, a Pim1 (LvPim1) gene in Litopenaeus vannamei, with a full-length cDNA of 2352 bp and a 1119 bp open reading frame (ORF) encoding a putative protein of 372 amino acids, which contains a typical serine/threonine kinase domain."}
{"qid": "5e51dab06d0a27794100003d", "original_text": "We aimed to evaluate the prognostic and predictive value of the nucleotide excision repair-related gene GTF2H5, which is localized at the 6q24.2-26 deletion previously reported by our group to predict longer survival of high-grade serous ovarian cancer patients. In order to test if protein levels of GTF2H5 are associated with patients' outcome, we performed GTF2H5 immunohistochemical staining in 139 high-grade serous ovarian carcinomas included in tissue microarrays. Upon stratification of cases into high- and low-GTF2H5 staining categories (> and \u2264 median staining, respectively) Kaplan-Meier and log-rank test were used to estimate patients' survival and assess statistical differences. We also evaluated the association of GTF2H5 with survival at the transcriptional level by using the on-line Kaplan-Meier plotter tool, which includes gene expression and survival data of 855 high-grade serous ovarian cancer patients from 13 different datasets. Finally, we determined whether stable short hairpin RNA-mediated GTF2H5 downregulation modulates cisplatin sensitivity in the SKOV3 and COV504 cell lines by using cytotoxicity assays. Low expression of GTF2H5 was associated with longer 5-year survival of patients at the protein (hazard ratio [HR], 0.52; 95% CI, 0.29 to 0.93; p=0.024) and transcriptional level (HR, 0.80; 95% CI, 0.65 to 0.97; p=0.023) in high-grade serous ovarian cancer patients.", "label": 1, "is_selected": 0, "text": "We aimed to evaluate the prognostic and predictive value of the nucleotide excision repair-related gene GTF2H5, which is localized at the 6q24.2-26 deletion previously reported by our group to predict longer survival of high-grade serous ovarian cancer patients. In order to test if protein levels of GTF2H5 are associated with patients' outcome, we performed GTF2H5 immunohistochemical staining in 139 high-grade serous ovarian carcinomas included in tissue microarrays. Upon stratification of cases into high- and low-GTF2H5 staining categories (> and \u2264 median staining, respectively) Kaplan-Meier and log-rank test were used to estimate patients' survival and assess statistical differences. We also evaluated the association of GTF2H5 with survival at the transcriptional level by using the on-line Kaplan-Meier plotter tool, which includes gene expression and survival data of 855 high-grade serous ovarian cancer patients from 13 different datasets. Finally, we determined whether stable short hairpin RNA-mediated GTF2H5 downregulation modulates cisplatin sensitivity in the SKOV3 and COV504 cell lines by using cytotoxicity assays. Low expression of GTF2H5 was associated with longer 5-year survival of patients at the protein (hazard ratio [HR], 0.52; 95% CI, 0.29 to 0.93; p=0.024) and transcriptional level (HR, 0.80; 95% CI, 0.65 to 0.97; p=0.023) in high-grade serous ovarian cancer patients."}
{"qid": "5895db407d9090f35300000e", "original_text": "Harlequin syndrome is a curious phenomenon in which one half of the face fails to flush during thermal or emotional stress as a result of damage to vasodilator sympathetic fibers. Anecdotal reports suggest that some of these patients have abnormal pupils. In this study we set out to systematically investigate autonomic pupil disturbances in an unselected cohort of patients with harlequin syndrome. A consecutive series of 39 patients with harlequin syndrome who were referred to a tertiary autonomic function laboratory underwent slit-lamp examinations, testing of deep tendon reflexes, infrared video pupillography and, where needed, additional pharmacologic pupillary testing.", "label": 1, "is_selected": 0, "text": "Harlequin syndrome is a curious phenomenon in which one half of the face fails to flush during thermal or emotional stress as a result of damage to vasodilator sympathetic fibers. Anecdotal reports suggest that some of these patients have abnormal pupils. In this study we set out to systematically investigate autonomic pupil disturbances in an unselected cohort of patients with harlequin syndrome. A consecutive series of 39 patients with harlequin syndrome who were referred to a tertiary autonomic function laboratory underwent slit-lamp examinations, testing of deep tendon reflexes, infrared video pupillography and, where needed, additional pharmacologic pupillary testing."}
{"qid": "5519113b622b19434500000f", "original_text": "Mowat-Wilson syndrome (MWS) is a genetic disease caused by heterozygous mutations or deletions of the ZEB2 gene rarely diagnosed prenatally and with little fetal description reported. It is mainly characterized by moderate-to-severe intellectual disability, epilepsy, facial dysmorphism and various malformations including Hirschsprung disease and corpus callosum anomalies. Here we report a fetal case of MWS well described, suspected at standard autopsy.", "label": 1, "is_selected": 0, "text": "Mowat-Wilson syndrome (MWS) is a genetic disease caused by heterozygous mutations or deletions of the ZEB2 gene rarely diagnosed prenatally and with little fetal description reported. It is mainly characterized by moderate-to-severe intellectual disability, epilepsy, facial dysmorphism and various malformations including Hirschsprung disease and corpus callosum anomalies. Here we report a fetal case of MWS well described, suspected at standard autopsy."}
{"qid": "51406e6223fec90375000009", "original_text": "Levothyroxine (LT4) absorption is affected by concomitant ingestion of certain minerals, medications, and foods. It has been hypothesized that metformin may suppress serum thyrotropin (TSH) concentrations by enhancing LT4 absorption or by directly affecting the hypothalamic-pituitary axis. This study examined the effect of metformin ingestion on LT4 absorption, as assessed by serum total thyroxine (TT4) concentrations. A modified Food and Drug Administration LT4 bioequivalence protocol was applied to healthy, metformin-na\u00efve, euthyroid adult volunteers. Following an overnight fast, 600 \u03bcg LT4 was administered orally. Serum TT4 concentrations were measured at baseline and at 0.5, 1, 1.5, 2, 4, and 6 h following LT4 administration. Measurements were performed before and after one week of metformin ingestion (850 mg three times daily). Peak serum TT4 concentrations, time to peak TT4 concentrations, and area under the concentration-time curve (AUC) were calculated. Twenty-six subjects (54% men, 27% white, age 33 \u00b1 10 years) were studied.", "label": 1, "is_selected": 0, "text": "Levothyroxine (LT4) absorption is affected by concomitant ingestion of certain minerals, medications, and foods. It has been hypothesized that metformin may suppress serum thyrotropin (TSH) concentrations by enhancing LT4 absorption or by directly affecting the hypothalamic-pituitary axis. This study examined the effect of metformin ingestion on LT4 absorption, as assessed by serum total thyroxine (TT4) concentrations. A modified Food and Drug Administration LT4 bioequivalence protocol was applied to healthy, metformin-na\u00efve, euthyroid adult volunteers. Following an overnight fast, 600 \u03bcg LT4 was administered orally. Serum TT4 concentrations were measured at baseline and at 0.5, 1, 1.5, 2, 4, and 6 h following LT4 administration. Measurements were performed before and after one week of metformin ingestion (850 mg three times daily). Peak serum TT4 concentrations, time to peak TT4 concentrations, and area under the concentration-time curve (AUC) were calculated. Twenty-six subjects (54% men, 27% white, age 33 \u00b1 10 years) were studied."}
{"qid": "5a70dfd599e2c3af26000006", "original_text": "Dysphoric milk ejection reflex (D-MER) results in waves of negative emotions that last from shortly before initial milk ejection until baby starts to feed vigorously Symptoms may decrease by 3 months or they may continue throughout the breastfeeding period. This report is a case study of an Australian mother who experienced D-MER with her fourth child.", "label": 1, "is_selected": 0, "text": "Dysphoric milk ejection reflex (D-MER) results in waves of negative emotions that last from shortly before initial milk ejection until baby starts to feed vigorously Symptoms may decrease by 3 months or they may continue throughout the breastfeeding period. This report is a case study of an Australian mother who experienced D-MER with her fourth child."}
{"qid": "5a86ecc7faa1ab7d2e000039", "original_text": "Parent-of-origin-specific expression at imprinted genes is regulated by allele-specific DNA methylation at imprinting control regions (ICRs). This mechanism of gene regulation, where one element controls allelic expression of multiple genes, is not fully understood. Furthermore, the mechanism of gene dysregulation through ICR epimutations, such as loss or gain of DNA methylation, remains a mystery. We have used genetic mouse models to dissect ICR-mediated genetic and epigenetic regulation of imprinted gene expression. The H19/insulin-like growth factor 2 (Igf2) ICR has a multifunctional role including insulation, activation and repression. Microdeletions at the human H19/IGF2 ICR (IC1) are proposed to be responsible for IC1 epimutations associated with imprinting disorders such as Beckwith-Wiedemann syndrome (BWS). Here, we have generated and characterized a mouse model that mimics BWS microdeletions to define the role of the deleted sequence in establishing and maintaining epigenetic marks and imprinted expression at the H19/IGF2 locus. These mice carry a 1.3 kb deletion at the H19/Igf2 ICR [\u03942,3] removing two of four CCCTC-binding factor (CTCF) sites and the intervening sequence, \u223c75% of the ICR. Surprisingly, the \u03942,3 deletion does not perturb DNA methylation at the ICR; however, it does disrupt imprinted expression. While repressive functions of the ICR are compromised by the deletion regardless of tissue type, insulator function is only disrupted in tissues of mesodermal origin where a significant amount of CTCF is poly(ADP-ribosyl)ated.", "label": 1, "is_selected": 0, "text": "Parent-of-origin-specific expression at imprinted genes is regulated by allele-specific DNA methylation at imprinting control regions (ICRs). This mechanism of gene regulation, where one element controls allelic expression of multiple genes, is not fully understood. Furthermore, the mechanism of gene dysregulation through ICR epimutations, such as loss or gain of DNA methylation, remains a mystery. We have used genetic mouse models to dissect ICR-mediated genetic and epigenetic regulation of imprinted gene expression. The H19/insulin-like growth factor 2 (Igf2) ICR has a multifunctional role including insulation, activation and repression. Microdeletions at the human H19/IGF2 ICR (IC1) are proposed to be responsible for IC1 epimutations associated with imprinting disorders such as Beckwith-Wiedemann syndrome (BWS). Here, we have generated and characterized a mouse model that mimics BWS microdeletions to define the role of the deleted sequence in establishing and maintaining epigenetic marks and imprinted expression at the H19/IGF2 locus. These mice carry a 1.3 kb deletion at the H19/Igf2 ICR [\u03942,3] removing two of four CCCTC-binding factor (CTCF) sites and the intervening sequence, \u223c75% of the ICR. Surprisingly, the \u03942,3 deletion does not perturb DNA methylation at the ICR; however, it does disrupt imprinted expression. While repressive functions of the ICR are compromised by the deletion regardless of tissue type, insulator function is only disrupted in tissues of mesodermal origin where a significant amount of CTCF is poly(ADP-ribosyl)ated."}
{"qid": "5c54600207647bbc4b000004", "original_text": "Large-scale sequencing studies discovered substantial genetic variants occurring in enhancers which regulate genes via long range chromatin interactions. Importantly, such variants could affect enhancer regulation by changing transcription factor bindings or enhancer hijacking, and in turn, make an essential contribution to disease progression. To facilitate better usage of published data and exploring enhancer deregulation in various human diseases, we created DiseaseEnhancer (http://biocc.hrbmu.edu.cn/DiseaseEnhancer/), a manually curated database for disease-associated enhancers. As of July 2017, DiseaseEnhancer includes 847 disease-associated enhancers in 143 human diseases.", "label": 1, "is_selected": 0, "text": "Large-scale sequencing studies discovered substantial genetic variants occurring in enhancers which regulate genes via long range chromatin interactions. Importantly, such variants could affect enhancer regulation by changing transcription factor bindings or enhancer hijacking, and in turn, make an essential contribution to disease progression. To facilitate better usage of published data and exploring enhancer deregulation in various human diseases, we created DiseaseEnhancer (http://biocc.hrbmu.edu.cn/DiseaseEnhancer/), a manually curated database for disease-associated enhancers. As of July 2017, DiseaseEnhancer includes 847 disease-associated enhancers in 143 human diseases."}
{"qid": "5e36d924b5b409ea5300000b", "original_text": "AND-1/CTF4 is a transcriptional coactivator that plays a crucial role in the proliferation of various cell types, including cancer cells. AND-1/CTF4 is essential for the maintenance of proliferative state by regulating key cell cycle checkpoints and promoting the expression of proliferation-associated genes. Studies have shown that AND-1/CTF4 knockdown or inhibition leads to a decrease in cell proliferation, suggesting that it is essential for cell proliferation. Therefore, AND-1/CTF4 can be considered as an essential factor for proliferation.", "label": 0, "is_selected": 1, "text": "We have shown that inhibition of AND-1/CTF4 has been shown to be an effective treatment for a number of cancer types, including lung, breast, and pancreatic cancers, as well as for prophylaxis of leukaemia and prophylaxis of HIV infection."}
{"qid": "56f7c44109dd18d46b000013", "original_text": "alpha-N-acetylgalactosaminidase (alpha-NAGAL; E.C. 3.2.1.49) is a lysosomal exoglycosidase that cleaves terminal alpha-N-acetylgalactosamine residues from glycopeptides and glycolipids. In humans, a deficiency of alpha-NAGAL activity results in the lysosomal storage disorders Schindler disease and Kanzaki disease. To better understand the molecular defects in the diseases, we determined the crystal structure of human alpha-NAGAL after expressing wild-type and glycosylation-deficient glycoproteins in recombinant insect cell expression systems.", "label": 1, "is_selected": 0, "text": "alpha-N-acetylgalactosaminidase (alpha-NAGAL; E.C. 3.2.1.49) is a lysosomal exoglycosidase that cleaves terminal alpha-N-acetylgalactosamine residues from glycopeptides and glycolipids. In humans, a deficiency of alpha-NAGAL activity results in the lysosomal storage disorders Schindler disease and Kanzaki disease. To better understand the molecular defects in the diseases, we determined the crystal structure of human alpha-NAGAL after expressing wild-type and glycosylation-deficient glycoproteins in recombinant insect cell expression systems."}
{"qid": "552440452c8b63434a00000b", "original_text": "Nemaline myopathy is a heterogenous form of congenital myopathy characterised by a variable spectrum of clinical features, predominated in the severe form by profound muscle hypotonia and weakness accompanied by respiratory insufficiency. The clinical variability, with differing age of onset and severity of symptoms makes the diagnosis of nemaline myopathy difficult in some cases.", "label": 1, "is_selected": 0, "text": "Nemaline myopathy is a heterogenous form of congenital myopathy characterised by a variable spectrum of clinical features, predominated in the severe form by profound muscle hypotonia and weakness accompanied by respiratory insufficiency. The clinical variability, with differing age of onset and severity of symptoms makes the diagnosis of nemaline myopathy difficult in some cases."}
{"qid": "5e494b0e6d0a277941000007", "original_text": "Lung cancer is the leading cause of cancer death in France with low response rates to conventional chemotherapy. Nevertheless, new therapies have emerged recently, among which PD1 immune checkpoint inhibitors (ICI), such as nivolumab (OPDIVO\u00ae, Bristol-Myers Squibb) and pembrolizumab (KEYTRUDA\u00ae, Merck & Co), or PD-L1 ICI, such as atezolizumab (TECENTRIQ\u00ae, Genentech), durvalumab (IMFINZI\u00ae, Astra-Zeneca), and avelumab (BAVENCIO\u00ae, EMD Serono). The prescription of pembrolizumab for advanced stage non-small cell lung carcinoma (NSCLC) patients requires the demonstration of PD-L1 expression by tumor cells by immunohistochemistry (IHC) (minimum of 50% of positive tumor cells is required for first-line setting, and of 1% for second-line and beyond) and PD-L1 assay is now considered as a companion diagnostic tool for this drug. Numerous standardized PD-L1 assays performed on dedicated platforms have been validated in clinical trials, each antibody being associated to one specific PD1 or PD-L1 inhibitor. However, not all pathologists have access to the dedicated platforms and the high cost of these assays is still a limitation to their implementation; in addition, the small size of the NSCLC tumor samples does not allow to perform at the same time multiple assays for multiple drugs.", "label": 1, "is_selected": 0, "text": "Lung cancer is the leading cause of cancer death in France with low response rates to conventional chemotherapy. Nevertheless, new therapies have emerged recently, among which PD1 immune checkpoint inhibitors (ICI), such as nivolumab (OPDIVO\u00ae, Bristol-Myers Squibb) and pembrolizumab (KEYTRUDA\u00ae, Merck & Co), or PD-L1 ICI, such as atezolizumab (TECENTRIQ\u00ae, Genentech), durvalumab (IMFINZI\u00ae, Astra-Zeneca), and avelumab (BAVENCIO\u00ae, EMD Serono). The prescription of pembrolizumab for advanced stage non-small cell lung carcinoma (NSCLC) patients requires the demonstration of PD-L1 expression by tumor cells by immunohistochemistry (IHC) (minimum of 50% of positive tumor cells is required for first-line setting, and of 1% for second-line and beyond) and PD-L1 assay is now considered as a companion diagnostic tool for this drug. Numerous standardized PD-L1 assays performed on dedicated platforms have been validated in clinical trials, each antibody being associated to one specific PD1 or PD-L1 inhibitor. However, not all pathologists have access to the dedicated platforms and the high cost of these assays is still a limitation to their implementation; in addition, the small size of the NSCLC tumor samples does not allow to perform at the same time multiple assays for multiple drugs."}
{"qid": "56cf2be73975bb303a000005", "original_text": "Elevated numbers of blood and tissue eosinophils are present in allergic diseases and experimental evidence suggests that eosinophils play an important pathogenic role in these conditions. Regulation of eosinophil maturation, recruitment, and survival is under the control of a small group of factors, including interleukin-5 (IL-5). Given the probable importance of eosinophils to allergy and other associated disorders, IL-5 has been proposed as a potential molecular target in the treatment of these diseases. IL-5 antagonist therapies in current development include two monoclonal anti-IL-5 antibodies (mepolizumab, reslizumab), a monoclonal antibody directed at the IL-5 receptor (benralizumab), and anti-sense oligonucleotide therapy (TPI ASM8).", "label": 1, "is_selected": 0, "text": "Elevated numbers of blood and tissue eosinophils are present in allergic diseases and experimental evidence suggests that eosinophils play an important pathogenic role in these conditions. Regulation of eosinophil maturation, recruitment, and survival is under the control of a small group of factors, including interleukin-5 (IL-5). Given the probable importance of eosinophils to allergy and other associated disorders, IL-5 has been proposed as a potential molecular target in the treatment of these diseases. IL-5 antagonist therapies in current development include two monoclonal anti-IL-5 antibodies (mepolizumab, reslizumab), a monoclonal antibody directed at the IL-5 receptor (benralizumab), and anti-sense oligonucleotide therapy (TPI ASM8)."}
{"qid": "5a6f98e6b750ff445500005d", "original_text": "Dislocations of the knee are relatively uncommon injuries. However, the incidence of this injury appears to be increasing. Knee dislocations are most often high velocity blunt injuries, with motor vehicle accidents being a frequent etiology. Other causes include falls from height, athletic injuries, farming and industrial accidents, and even low velocity mechanisms such as a misstep into a hole. Likewise, minor trauma in the morbidly obese is increasingly recognized as a mechanism of knee dislocation.", "label": 1, "is_selected": 0, "text": "Dislocations of the knee are relatively uncommon injuries. However, the incidence of this injury appears to be increasing. Knee dislocations are most often high velocity blunt injuries, with motor vehicle accidents being a frequent etiology. Other causes include falls from height, athletic injuries, farming and industrial accidents, and even low velocity mechanisms such as a misstep into a hole. Likewise, minor trauma in the morbidly obese is increasingly recognized as a mechanism of knee dislocation."}
{"qid": "5cf4ea83a49efeb44c00000d", "original_text": "Multiple regulatory elements distant from their targets on the linear genome can influence the expression of a single gene through chromatin looping. Chromosome conformation capture implemented in Hi-C allows for genome-wide agnostic characterization of chromatin contacts. However, detection of functional enhancer-promoter interactions is precluded by its effective resolution that is determined by both restriction fragmentation and sensitivity of the experiment. Here we develop a capture Hi-C (cHi-C) approach to allow an agnostic characterization of these physical interactions on a genome-wide scale.", "label": 1, "is_selected": 0, "text": "Multiple regulatory elements distant from their targets on the linear genome can influence the expression of a single gene through chromatin looping. Chromosome conformation capture implemented in Hi-C allows for genome-wide agnostic characterization of chromatin contacts. However, detection of functional enhancer-promoter interactions is precluded by its effective resolution that is determined by both restriction fragmentation and sensitivity of the experiment. Here we develop a capture Hi-C (cHi-C) approach to allow an agnostic characterization of these physical interactions on a genome-wide scale."}
{"qid": "5e4700e03f54159529000015", "original_text": "RiboTag profiling is a method used to analyze the translational landscape of cells, tissues, or organisms. It involves the labeling of ribosomes with a unique tag, which allows for the visualization and quantification of protein synthesis in real-time. The tag is incorporated into the growing polypeptide chain during translation, allowing researchers to track the dynamics of protein synthesis and identify specific ribosomes. RiboTag profiling can be used to study various biological processes, including cellular stress responses, protein synthesis dynamics, and cancer development. It has also been used to investigate the effects of drugs and small molecules on protein synthesis. The technique has advantages over traditional methods of protein analysis, such as Western blotting, as it provides a more comprehensive picture of protein synthesis in a given sample. RiboTag profiling typically involves the following steps: 1. Ribosome labeling: The ribosomes are labeled with a unique tag, such as a fluorescent dye or a radioactive molecule. 2. Cell or tissue preparation: The cells or tissues of interest are prepared for analysis. 3. Imaging: The labeled ribosomes are visualized using imaging techniques such as fluorescence microscopy or mass spectrometry. 4. Data analysis: The resulting images are analyzed using bioinformatic tools to quantify protein synthesis dynamics. In summary, RiboTag profiling is a powerful tool for analyzing protein synthesis dynamics in cells, tissues, or organisms, providing valuable insights into the translational landscape of the cell.", "label": 0, "is_selected": 1, "text": "RiboTag profiling is a novel method of protein analysis, which has the potential to transform our understanding of the biological world, and has been used to study the effects of drugs and small molecules on protein synthesis in cell and tissue samples, as well as to investigate cancer development and stress responses. The technique has advantages over traditional methods of protein synthesis analysis, such as Western blotting, as it provides a more comprehensive picture of protein in a sample given the following steps: 1. In summary Ribo Tag profiling is powerful tool for studying protein synthesis, providing insights into the translational landscape of the cell."}
{"qid": "53440d2caeec6fbd07000004", "original_text": "Recent studies with tiling arrays have revealed more genomic transcription than previously anticipated. Whole new groups of non-coding transcripts (NCTs) have been detected. Some of these NCTs, including miRNAs, can regulate gene expression. To date, most known NCTs studied have been relatively short, but several important regulatory NCTs, including XIST, MALAT-1, BC1 and BC200, are considerably larger in length and represent a novel class of long, non-coding RNA species. Whole-genome tiling arrays were utilized to identify novel long NCTs across the entire human genome. Our results have identified a new group of long (>400 nt), abundantly expressed NCTs and have found that a subset of these are also highly evolutionarily conserved.", "label": 1, "is_selected": 0, "text": "Recent studies with tiling arrays have revealed more genomic transcription than previously anticipated. Whole new groups of non-coding transcripts (NCTs) have been detected. Some of these NCTs, including miRNAs, can regulate gene expression. To date, most known NCTs studied have been relatively short, but several important regulatory NCTs, including XIST, MALAT-1, BC1 and BC200, are considerably larger in length and represent a novel class of long, non-coding RNA species. Whole-genome tiling arrays were utilized to identify novel long NCTs across the entire human genome. Our results have identified a new group of long (>400 nt), abundantly expressed NCTs and have found that a subset of these are also highly evolutionarily conserved."}
{"qid": "58a6db8660087bc10a00002c", "original_text": "H2A.Z is a highly conserved variant of histone H2A with well-characterized roles in transcriptional regulation. We previously reported that H2A.Z and Mcd1, a subunit of the cohesin complex, regulate the establishment of transcriptional silencing at telomeres in Saccharomyces cerevisiae and that H2A.Z broadly dissociated from chromatin during the anaphase-to-telophase transition, coincident with the dissociation of Mcd1 from chromosomes and dissolution of cohesion.", "label": 1, "is_selected": 0, "text": "H2A.Z is a highly conserved variant of histone H2A with well-characterized roles in transcriptional regulation. We previously reported that H2A.Z and Mcd1, a subunit of the cohesin complex, regulate the establishment of transcriptional silencing at telomeres in Saccharomyces cerevisiae and that H2A.Z broadly dissociated from chromatin during the anaphase-to-telophase transition, coincident with the dissociation of Mcd1 from chromosomes and dissolution of cohesion."}
{"qid": "5314a7a4dae131f847000003", "original_text": "Recently four new hypertrophic cardiomyopathy mutations in cardiac troponin C (cTnC) (A8V, C84Y, E134D, and D145E) were reported, and their effects on the Ca(2+) sensitivity of force development were evaluated (Landstrom, A. P., Parvatiyar, M. S., Pinto, J. R., Marquardt, M. L., Bos, J. M., Tester, D. J., Ommen, S. R., Potter, J. D., and Ackerman, M. J. (2008) J. Mol. Cell. Cardiol. 45, 281-288). We performed actomyosin ATPase and spectroscopic solution studies to investigate the molecular properties of these mutations. Actomyosin ATPase activity was measured as a function of [Ca(2+)] utilizing reconstituted thin filaments (TFs) with 50% mutant and 50% wild type (WT) and 100% mutant cardiac troponin (cTn) complexes: A8V, C84Y, and D145E increased the Ca(2+) sensitivity with only A8V demonstrating lowered Ca(2+) sensitization at the 50% ratio when compared with 100%; E134D was the same as WT at both ratios. Of these four mutants, only D145E showed increased ATPase activation in the presence of Ca(2+). None of the mutants affected ATPase inhibition or the binding of cTn to the TF measured by co-sedimentation. Only D145E increased the Ca(2+) affinity of site II measured by 2-(4'-(2''-iodoacetamido)phenyl)aminonaphthalene-6-sulfonic acid fluorescence in isolated cTnC or the cTn complex. In the presence of the TF, only A8V was further sensitized to Ca(2+). Circular dichroism measurements in different metal-bound states of the isolated cTnCs showed changes in the secondary structure of A8V, C84Y, and D145E, whereas E134D was the same as WT.", "label": 1, "is_selected": 0, "text": "Recently four new hypertrophic cardiomyopathy mutations in cardiac troponin C (cTnC) (A8V, C84Y, E134D, and D145E) were reported, and their effects on the Ca(2+) sensitivity of force development were evaluated (Landstrom, A. P., Parvatiyar, M. S., Pinto, J. R., Marquardt, M. L., Bos, J. M., Tester, D. J., Ommen, S. R., Potter, J. D., and Ackerman, M. J. (2008) J. Mol. Cell. Cardiol. 45, 281-288). We performed actomyosin ATPase and spectroscopic solution studies to investigate the molecular properties of these mutations. Actomyosin ATPase activity was measured as a function of [Ca(2+)] utilizing reconstituted thin filaments (TFs) with 50% mutant and 50% wild type (WT) and 100% mutant cardiac troponin (cTn) complexes: A8V, C84Y, and D145E increased the Ca(2+) sensitivity with only A8V demonstrating lowered Ca(2+) sensitization at the 50% ratio when compared with 100%; E134D was the same as WT at both ratios. Of these four mutants, only D145E showed increased ATPase activation in the presence of Ca(2+). None of the mutants affected ATPase inhibition or the binding of cTn to the TF measured by co-sedimentation. Only D145E increased the Ca(2+) affinity of site II measured by 2-(4'-(2''-iodoacetamido)phenyl)aminonaphthalene-6-sulfonic acid fluorescence in isolated cTnC or the cTn complex. In the presence of the TF, only A8V was further sensitized to Ca(2+). Circular dichroism measurements in different metal-bound states of the isolated cTnCs showed changes in the secondary structure of A8V, C84Y, and D145E, whereas E134D was the same as WT."}
{"qid": "58f4b2f070f9fc6f0f000012", "original_text": "Mirabegron (YM-178), currently in development by Astellas Pharma Inc, is an orally active \u03b2\u2083-adrenoceptor (AR) agonist for the potential symptomatic treatment of overactive bladder (OAB). Mirabegron demonstrates nanomolar EC50 values against the human \u03b2\u2083-AR in biochemical assays with potent selectivity over the \u03b2\u2081- and \u03b2\u2082-ARs. Originally developed as a treatment for diabetes, the development of mirabegron was later refocused to OAB. Cystometric experiments in rats reported a reduction in resting intravesical pressure and contraction frequency in anesthetized rats, without any effect on the amplitude of micturition contraction. Mirabegron also reduced non-micturition bladder contractions in an awake rat model of bladder outlet obstruction. Top-line results from clinical trials to date indicate that mirabegron has been well tolerated with significant efficacy in reducing the number of incontinence episodes and mean micturition frequency in patients.", "label": 1, "is_selected": 0, "text": "Mirabegron (YM-178), currently in development by Astellas Pharma Inc, is an orally active \u03b2\u2083-adrenoceptor (AR) agonist for the potential symptomatic treatment of overactive bladder (OAB). Mirabegron demonstrates nanomolar EC50 values against the human \u03b2\u2083-AR in biochemical assays with potent selectivity over the \u03b2\u2081- and \u03b2\u2082-ARs. Originally developed as a treatment for diabetes, the development of mirabegron was later refocused to OAB. Cystometric experiments in rats reported a reduction in resting intravesical pressure and contraction frequency in anesthetized rats, without any effect on the amplitude of micturition contraction. Mirabegron also reduced non-micturition bladder contractions in an awake rat model of bladder outlet obstruction. Top-line results from clinical trials to date indicate that mirabegron has been well tolerated with significant efficacy in reducing the number of incontinence episodes and mean micturition frequency in patients."}
{"qid": "56cf236f3975bb303a000002", "original_text": "Ethosuximide, a medication used to treat absence seizures, targets several types of calcium channels in the brain. specifically, it acts on calcium channels of the T-type (Cav3.1 and Cav3.2) and P/Q-type (Cav2.1, Cav2.2, and Cav2.3). These channels are involved in the regulation of neuronal excitability and play a crucial role in the transmission of electrical signals in the brain. By targeting these channels, ethosuximide can reduce the excessive activity of neurons that occurs in absence seizures, leading to a decrease in seizure frequency and severity.", "label": 0, "is_selected": 1, "text": "A new treatment for seizures has been developed by researchers at the University of California, Los Angeles (UCLA) and the Children's Hospital of Los Angeles in Los Angeles, United States, and the University Hospital of Hong Kong in Shenzhen, China."}
{"qid": "530cf57efe2466f70c000001", "original_text": "In this chapter we have reviewed the evidence for physiological anorexia of aging and stressed that its pathophysiology involves both central and peripheral mechanisms. Early satiation in the older person appears to involve signals predominantly arising in the stomach. The increased feeling of satiety in older persons is mainly related to changes in the central feeding drive, in particular a decrease in the opioid rewarding properties for fatty foods. Increased cytokines, secondary to inflammatory conditions which are common in old age, may further increase the anorexia seen in older persons. Leptin, the fat hormone, is an excellent indicator of fat mass in women, in whom leptin concentrations correlate with the MNA. In men, testosterone inhibits leptin, and the fall in testosterone with age results in an increase in leptin concentrations.", "label": 1, "is_selected": 0, "text": "In this chapter we have reviewed the evidence for physiological anorexia of aging and stressed that its pathophysiology involves both central and peripheral mechanisms. Early satiation in the older person appears to involve signals predominantly arising in the stomach. The increased feeling of satiety in older persons is mainly related to changes in the central feeding drive, in particular a decrease in the opioid rewarding properties for fatty foods. Increased cytokines, secondary to inflammatory conditions which are common in old age, may further increase the anorexia seen in older persons. Leptin, the fat hormone, is an excellent indicator of fat mass in women, in whom leptin concentrations correlate with the MNA. In men, testosterone inhibits leptin, and the fall in testosterone with age results in an increase in leptin concentrations."}
{"qid": "56bc7d71ac7ad10019000018", "original_text": "Delamanid (OPC-67683), a nitro-dihydro-imidazooxazole derivative, is a new antituberculosis medication that inhibits mycolic acid synthesis and has shown potent in vitro and in vivo activity against drug-resistant strains of Mycobacterium tuberculosis. In this randomized, placebo-controlled, multinational clinical trial, we assigned 481 patients (nearly all of whom were negative for the human immunodeficiency virus) with pulmonary multidrug-resistant tuberculosis to receive delamanid, at a dose of 100 mg twice daily (161 patients) or 200 mg twice daily (160 patients), or placebo (160 patients) for 2 months in combination with a background drug regimen developed according to World Health Organization guidelines.", "label": 1, "is_selected": 0, "text": "Delamanid (OPC-67683), a nitro-dihydro-imidazooxazole derivative, is a new antituberculosis medication that inhibits mycolic acid synthesis and has shown potent in vitro and in vivo activity against drug-resistant strains of Mycobacterium tuberculosis. In this randomized, placebo-controlled, multinational clinical trial, we assigned 481 patients (nearly all of whom were negative for the human immunodeficiency virus) with pulmonary multidrug-resistant tuberculosis to receive delamanid, at a dose of 100 mg twice daily (161 patients) or 200 mg twice daily (160 patients), or placebo (160 patients) for 2 months in combination with a background drug regimen developed according to World Health Organization guidelines."}
{"qid": "6020a7391cb411341a00007e", "original_text": "Chronic urticaria (CU) is a common, heterogeneous, and debilitating disease. Antihistamines and omalizumab are the mainstay therapies of CU. Additional treatment options are needed. Here, we review the off and beyond label use of licensed drugs, novel treatments that are currently under development, and promising new targets. MEDLINE was searched for recent reports of the successful use of treatments in CU and promising targets for the development of novel treatment options. We also searched ClinicalTrials.gov for recent and ongoing randomized clinical trials in CU. Relevant articles were selected and reviewed. Omalizumab, the treatment of choice in patients with antihistamine-resistant chronic spontaneous urticaria (CSU), should be explored for use in chronic inducible urticaria in children younger than 12 years with CSU and at higher doses. The off-label use of dupilumab, reslizumab, mepolizumab, and benralizumab can be effective in CU. Ligelizumab and UB-221, 2 novel anti-IgE monoclonal antibodies, are in clinical trials for CU. Other promising drugs that are currently under development for CU are a chemoattractant receptor-homologous molecule expressed on TH2 cell antagonist, a monoclonal antibody to Siglec-8 (AK002), Bruton tyrosine kinase inhibitors (fenebrutinib and Lou064), a spleen tyrosine kinase inhibitor, and dupilumab.", "label": 1, "is_selected": 0, "text": "Chronic urticaria (CU) is a common, heterogeneous, and debilitating disease. Antihistamines and omalizumab are the mainstay therapies of CU. Additional treatment options are needed. Here, we review the off and beyond label use of licensed drugs, novel treatments that are currently under development, and promising new targets. MEDLINE was searched for recent reports of the successful use of treatments in CU and promising targets for the development of novel treatment options. We also searched ClinicalTrials.gov for recent and ongoing randomized clinical trials in CU. Relevant articles were selected and reviewed. Omalizumab, the treatment of choice in patients with antihistamine-resistant chronic spontaneous urticaria (CSU), should be explored for use in chronic inducible urticaria in children younger than 12 years with CSU and at higher doses. The off-label use of dupilumab, reslizumab, mepolizumab, and benralizumab can be effective in CU. Ligelizumab and UB-221, 2 novel anti-IgE monoclonal antibodies, are in clinical trials for CU. Other promising drugs that are currently under development for CU are a chemoattractant receptor-homologous molecule expressed on TH2 cell antagonist, a monoclonal antibody to Siglec-8 (AK002), Bruton tyrosine kinase inhibitors (fenebrutinib and Lou064), a spleen tyrosine kinase inhibitor, and dupilumab."}
{"qid": "605271d994d57fd87900000f", "original_text": "Fingolimod (Gilenya; FTY720), a synthetic compound based on the fungal secondary metabolite myriocin (ISP-I), is a potent immunosuppressant that was approved (September 2010) by the U.S. FDA as a new treatment for multiple sclerosis (MS). Fingolimod was synthesized by the research group of Tetsuro Fujita at Kyoto University in 1992 while investigating structure-activity relationships of derivatives of the fungal metabolite ISP-I, isolated from Isaria sinclairii.", "label": 1, "is_selected": 0, "text": "Fingolimod (Gilenya; FTY720), a synthetic compound based on the fungal secondary metabolite myriocin (ISP-I), is a potent immunosuppressant that was approved (September 2010) by the U.S. FDA as a new treatment for multiple sclerosis (MS). Fingolimod was synthesized by the research group of Tetsuro Fujita at Kyoto University in 1992 while investigating structure-activity relationships of derivatives of the fungal metabolite ISP-I, isolated from Isaria sinclairii."}
{"qid": "532bfd15d6d3ac6a34000017", "original_text": "Interferons (IFNs) are cytokines with powerful immunomodulatory and antiviral properties, but less is known about how they induce cell death. Here, we show that both type I (\u03b1/\u03b2) and type II (\u03b3) IFNs induce precipitous receptor-interacting protein (RIP)1/RIP3 kinase-mediated necrosis when the adaptor protein Fas-associated death domain (FADD) is lost or disabled by phosphorylation, or when caspases (e.g., caspase 8) are inactivated. IFN-induced necrosis proceeds via progressive assembly of a RIP1-RIP3 \"necrosome\" complex that requires Jak1/STAT1-dependent transcription, but does not need the kinase activity of RIP1. Instead, IFNs transcriptionally activate the RNA-responsive protein kinase PKR, which then interacts with RIP1 to initiate necrosome formation and trigger necrosis.", "label": 1, "is_selected": 0, "text": "Interferons (IFNs) are cytokines with powerful immunomodulatory and antiviral properties, but less is known about how they induce cell death. Here, we show that both type I (\u03b1/\u03b2) and type II (\u03b3) IFNs induce precipitous receptor-interacting protein (RIP)1/RIP3 kinase-mediated necrosis when the adaptor protein Fas-associated death domain (FADD) is lost or disabled by phosphorylation, or when caspases (e.g., caspase 8) are inactivated. IFN-induced necrosis proceeds via progressive assembly of a RIP1-RIP3 \"necrosome\" complex that requires Jak1/STAT1-dependent transcription, but does not need the kinase activity of RIP1. Instead, IFNs transcriptionally activate the RNA-responsive protein kinase PKR, which then interacts with RIP1 to initiate necrosome formation and trigger necrosis."}
{"qid": "5353aedb288f4dae47000006", "original_text": "Mammalian dosage compensation requires silencing of one of the two X chromosomes in females and is controlled by the X inactivation center (Xic). Xic contains many of the regulatory elements for the mutual interplay of X-inactive specific transcript (Xist) and Tsix, the antisense counterpart of Xist. The regulatory elements control X chromosome inactivation (XCI) via the formation of DNA-DNA and DNA-protein complexes with cis- and trans-acting factors. However, the process-dependent regulation of Xist/Tsix by these elements in each XCI process remains largely unknown. In this study, a 6-thioguanine-resistant female F(1) hybrid mouse cell line (designated HOBMSKI2) was constructed from a cross between a female HPRT-deficient transgenic mouse (designated BM3) and a male wild type Mus spretus mouse (designated MS), which enabled the direct discrimination of both allele-specific expression of X-linked genes and allele-specific binding of proteins associated with XCI due to DNA polymorphisms between BM3 and MS.", "label": 1, "is_selected": 0, "text": "Mammalian dosage compensation requires silencing of one of the two X chromosomes in females and is controlled by the X inactivation center (Xic). Xic contains many of the regulatory elements for the mutual interplay of X-inactive specific transcript (Xist) and Tsix, the antisense counterpart of Xist. The regulatory elements control X chromosome inactivation (XCI) via the formation of DNA-DNA and DNA-protein complexes with cis- and trans-acting factors. However, the process-dependent regulation of Xist/Tsix by these elements in each XCI process remains largely unknown. In this study, a 6-thioguanine-resistant female F(1) hybrid mouse cell line (designated HOBMSKI2) was constructed from a cross between a female HPRT-deficient transgenic mouse (designated BM3) and a male wild type Mus spretus mouse (designated MS), which enabled the direct discrimination of both allele-specific expression of X-linked genes and allele-specific binding of proteins associated with XCI due to DNA polymorphisms between BM3 and MS."}
{"qid": "62058198c9dfcb9c09000030", "original_text": "Grapefruit juice has been shown to have a significant effect on CYP3A4, an enzyme responsible for metabolizing many drugs. Research has demonstrated that grapefruit juice can inhibit CYP3A4 activity, leading to increased drug concentrations and potentially altering the efficacy and toxicity of certain medications. The extent of this inhibition varies depending on the type and amount of grapefruit juice consumed, as well as the specific drug being metabolized. It is important for individuals to inform their healthcare providers about any grapefruit juice consumption to avoid potential drug-food interactions.", "label": 0, "is_selected": 0, "text": "Grapefruit juice has been shown to have a significant effect on CYP3A4, an enzyme responsible for metabolizing many drugs. Research has demonstrated that grapefruit juice can inhibit CYP3A4 activity, leading to increased drug concentrations and potentially altering the efficacy and toxicity of certain medications. The extent of this inhibition varies depending on the type and amount of grapefruit juice consumed, as well as the specific drug being metabolized. It is important for individuals to inform their healthcare providers about any grapefruit juice consumption to avoid potential drug-food interactions."}
{"qid": "601d724a1cb411341a000035", "original_text": "Fusobacterium necrophorum is a gram-negative anaerobic bacterium that is the causative agent of the invasive disease Lemierre's syndrome. In addition, it is also associated with peritonsillar abscess formation and otitis media in small children. Recent research has shown that F. necrophorum may be involved in pharyngotonsillitis especially in adolescent and young adults and that it may be the second most common bacterial cause of pharyngotonsillitis after Streptococcus pyogenes (Group A streptococci).", "label": 1, "is_selected": 0, "text": "Fusobacterium necrophorum is a gram-negative anaerobic bacterium that is the causative agent of the invasive disease Lemierre's syndrome. In addition, it is also associated with peritonsillar abscess formation and otitis media in small children. Recent research has shown that F. necrophorum may be involved in pharyngotonsillitis especially in adolescent and young adults and that it may be the second most common bacterial cause of pharyngotonsillitis after Streptococcus pyogenes (Group A streptococci)."}
{"qid": "5aa0495bd6d6b54f79000002", "original_text": "The blood-brain barrier (BBB) is a specialized barrier that separates the brain from the bloodstream. Its primary function is to protect the brain from harmful substances, such as toxins and pathogens, by preventing them from entering the brain tissue. The BBB is composed of a layer of cells called endothelial cells, which form tight junctions to prevent the passage of large molecules. The BBB also contains a variety of transport proteins and receptors that regulate the movement of molecules across the barrier. In addition to its protective function, the BBB also plays a critical role in maintaining the proper environment for brain function. It helps to regulate the concentration of ions and neurotransmitters in the brain, and it participates in the immune response by preventing the entry of immune cells into the brain. The BBB also plays a role in the transport of nutrients and waste products across the brain. Dysfunction of the BBB has been implicated in a variety of neurological disorders, including stroke, cerebral edema, and neurodegenerative diseases such as Alzheimer's and Parkinson's. In these disorders, the BBB may be unable to effectively regulate the movement of molecules into and out of the brain, leading to cellular damage and tissue degeneration. In summary, the BBB plays a critical role in protecting the brain from harmful substances and maintaining proper brain function. Its dysfunction may contribute to a range of neurological disorders.", "label": 0, "is_selected": 1, "text": "The blood-brain barrier (BBB) is a specialized barrier that separates the brain from the bloodstream, and its dysfunction may contribute to a variety of neurological disorders, including stroke, neurodegenerative diseases such as Alzheimer's and Parkinson's, and edema, a build-up of waste products across the brain, which can lead to cellular damage and tissue degeneration. In these disorders, the BBB may be unable to effectively regulate the movement of molecules into and out of the Brain, leading to Cellular Damage and Tissue degeneration. in summary, theBBB plays a critical role in protecting the brains from harmful substances and maintaining proper brain function."}
{"qid": "5abd2ce0fcf456587200002a", "original_text": "The two main bacterial phyla in the human gut are Firmicutes and Bacteroidetes. Firmicutes is the most abundant phylum, comprising approximately 60% of the gut microbiome, and includes bacteria such as Streptococcus and Lactobacillus. Bacteroidetes is the second most abundant phylum, making up around 30% of the gut microbiome, and includes bacteria such as Bacteroides and Parabacteroides.", "label": 0, "is_selected": 0, "text": "The two main bacterial phyla in the human gut are Firmicutes and Bacteroidetes. Firmicutes is the most abundant phylum, comprising approximately 60% of the gut microbiome, and includes bacteria such as Streptococcus and Lactobacillus. Bacteroidetes is the second most abundant phylum, making up around 30% of the gut microbiome, and includes bacteria such as Bacteroides and Parabacteroides."}
{"qid": "517539ca8ed59a060a000027", "original_text": "Alterations in TR [thyroid hormone (TH) receptor]1 isoform expression have been reported in models of both physiologic and pathologic cardiac hypertrophy as well as in patients with heart failure. In this report, we demonstrate that TH induces hypertrophy as a direct result of binding to the TRalpha1 isoform and, moreover, that overexpression of TRalpha1 alone is also associated with a hypertrophic phenotype, even in the absence of ligand. The mechanism of TH and TRalpha1-specific hypertrophy is novel for a nuclear hormone receptor and involves the transforming growth factor beta-activated kinase (TAK1) and p38. Mitigating TRalpha1 effects, both TRalpha2 and TRbeta1 attenuate TRalpha1-induced myocardial growth and gene expression by diminishing TAK1 and p38 activities, respectively. These findings refine our previous observations on TR expression in the hypertrophied and failing heart and suggest that manipulation of thyroid hormone signaling in an isoform-specific manner may be a relevant therapeutic target for altering the pathologic myocardial program.", "label": 1, "is_selected": 0, "text": "Alterations in TR [thyroid hormone (TH) receptor]1 isoform expression have been reported in models of both physiologic and pathologic cardiac hypertrophy as well as in patients with heart failure. In this report, we demonstrate that TH induces hypertrophy as a direct result of binding to the TRalpha1 isoform and, moreover, that overexpression of TRalpha1 alone is also associated with a hypertrophic phenotype, even in the absence of ligand. The mechanism of TH and TRalpha1-specific hypertrophy is novel for a nuclear hormone receptor and involves the transforming growth factor beta-activated kinase (TAK1) and p38. Mitigating TRalpha1 effects, both TRalpha2 and TRbeta1 attenuate TRalpha1-induced myocardial growth and gene expression by diminishing TAK1 and p38 activities, respectively. These findings refine our previous observations on TR expression in the hypertrophied and failing heart and suggest that manipulation of thyroid hormone signaling in an isoform-specific manner may be a relevant therapeutic target for altering the pathologic myocardial program."}
{"qid": "5709f646cf1c325851000021", "original_text": "DUF (Disease Undiagnosed in Family) families are groups of individuals who are affected by an unidentified genetic disorder with no clear diagnosis despite thorough clinical evaluation and genetic testing. Deciphering DUF families requires a multidisciplinary approach involving geneticists, clinical geneticists, molecular geneticists, and other healthcare professionals. Here are some steps involved in deciphering DUF families: 1. Extensive clinical evaluation: Conduct a thorough clinical evaluation of all family members to identify the signs, symptoms, and medical history of the disorder. 2. Genetic testing: Perform genetic testing on affected family members to identify genetic mutations or variations that may be responsible for the disorder. 3. Literature review: Review medical literature and scientific papers to identify similar cases and potential genetic causes of the disorder. 4. Whole-genome sequencing: Use whole-genome sequencing to identify novel genetic mutations or variations that may be responsible for the disorder. 5. Candidate gene analysis: Analyze specific genes that have been identified as potential causes of the disorder. 6. Functional studies: Use functional studies to determine the impact of identified genetic mutations or variations on gene function and protein structure. 7. Collaboration with other experts: Collaborate with experts in related fields, such as bioinformatics, computational biology, and biostatistics, to provide additional insights and perspectives. By following these steps, healthcare professionals can work together to decipher DUF families and provide accurate diagnoses and appropriate treatments for affected individuals.", "label": 0, "is_selected": 1, "text": "The National Institutes of Health's (NIH) National Human Genome Research Institute (NHGRI) has launched a new initiative to help healthcare professionals identify and treat DUF families, and to provide accurate diagnoses and appropriate treatments for individuals affected by these genetic disorders, including cystic fibrosis (CF), multiple sclerosis (MS), Huntington's disease (HD), and other genetic disorders.., according to a press release from the NHGRI, which is part of the NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in Washington, DC."}
{"qid": "5e3daf7648dab47f26000005", "original_text": "A J pouch, also known as a J-pouch or ileal pouch-anal anastomosis (IPAA), is a type of surgical procedure used to create a pouch from the small intestine to serve as a replacement for the rectum and anus in individuals with chronic inflammatory bowel disease (IBD) or other conditions that cause bowel dysfunction. During the procedure, the surgeon removes the damaged or diseased portions of the rectum and anus and creates a pouch from the proximal part of the small intestine. This pouch is then attached to the anus, allowing stool to pass through the anus as usual. The J pouch is named after the surgeon who first described the procedure, Dr. John Poucher. The J pouch is a complex surgical procedure that can take several hours to complete and may require a hospital stay of several days. It can be performed through a traditional open incision or through laparoscopic surgery, which involves several small incisions and the use of a camera and specialized instruments. While the J pouch can provide significant relief from symptoms such as abdominal pain, diarrhea, and rectal bleeding, it is not without risks and complications. These may include infection, narrowing or blockage of the pouch, and changes in bowel movements. It is important to discuss the potential benefits and risks of the J pouch with a qualified healthcare provider to determine if it is the best course of treatment for your individual needs.", "label": 0, "is_selected": 0, "text": "A J pouch, also known as a J-pouch or ileal pouch-anal anastomosis (IPAA), is a type of surgical procedure used to create a pouch from the small intestine to serve as a replacement for the rectum and anus in individuals with chronic inflammatory bowel disease (IBD) or other conditions that cause bowel dysfunction. During the procedure, the surgeon removes the damaged or diseased portions of the rectum and anus and creates a pouch from the proximal part of the small intestine. This pouch is then attached to the anus, allowing stool to pass through the anus as usual. The J pouch is named after the surgeon who first described the procedure, Dr. John Poucher. The J pouch is a complex surgical procedure that can take several hours to complete and may require a hospital stay of several days. It can be performed through a traditional open incision or through laparoscopic surgery, which involves several small incisions and the use of a camera and specialized instruments. While the J pouch can provide significant relief from symptoms such as abdominal pain, diarrhea, and rectal bleeding, it is not without risks and complications. These may include infection, narrowing or blockage of the pouch, and changes in bowel movements. It is important to discuss the potential benefits and risks of the J pouch with a qualified healthcare provider to determine if it is the best course of treatment for your individual needs."}
{"qid": "54f9d3eedd3fc62544000004", "original_text": "Catecholaminergic polymorphic ventricular tachycardia is an inherited disease that predisposes to cardiac arrest and sudden death. The disease is associated with mutations in the genes encoding for the cardiac ryanodine receptor (RyR2) and cardiac calsequestrin (CASQ2). CASQ2 mutations lead to a major loss of CASQ2 monomers, possibly because of enhanced degradation of the mutant protein. The decrease of CASQ2 is associated with a reduction in the levels of Triadin (TrD) and Junctin (JnC), two proteins that form, with CASQ2 and RyR2, a macromolecular complex devoted to control of calcium release from the sarcoplasmic reticulum. We intended to evaluate whether viral gene transfer of wild-type CASQ2 may rescue the broad spectrum of abnormalities caused by mutant CASQ2. We used an adeno-associated serotype 9 viral vector to express a green fluorescent protein-tagged CASQ2 construct. Twenty weeks after intraperitoneal injection of the vector in neonate CASQ2 KO mice, we observed normalization of the levels of calsequestrin, triadin, and junctin, rescue of electrophysiological and ultrastructural abnormalities caused by CASQ2 ablation, and lack of life-threatening arrhythmias. We have proven the concept that induction of CASQ2 expression in knockout mice reverts the molecular, structural, and electric abnormalities and prevents life-threatening arrhythmias in CASQ2-defective catecholaminergic polymorphic ventricular tachycardia mice. These data support the view that development of CASQ2 viral gene transfer could have clinical application.", "label": 1, "is_selected": 0, "text": "Catecholaminergic polymorphic ventricular tachycardia is an inherited disease that predisposes to cardiac arrest and sudden death. The disease is associated with mutations in the genes encoding for the cardiac ryanodine receptor (RyR2) and cardiac calsequestrin (CASQ2). CASQ2 mutations lead to a major loss of CASQ2 monomers, possibly because of enhanced degradation of the mutant protein. The decrease of CASQ2 is associated with a reduction in the levels of Triadin (TrD) and Junctin (JnC), two proteins that form, with CASQ2 and RyR2, a macromolecular complex devoted to control of calcium release from the sarcoplasmic reticulum. We intended to evaluate whether viral gene transfer of wild-type CASQ2 may rescue the broad spectrum of abnormalities caused by mutant CASQ2. We used an adeno-associated serotype 9 viral vector to express a green fluorescent protein-tagged CASQ2 construct. Twenty weeks after intraperitoneal injection of the vector in neonate CASQ2 KO mice, we observed normalization of the levels of calsequestrin, triadin, and junctin, rescue of electrophysiological and ultrastructural abnormalities caused by CASQ2 ablation, and lack of life-threatening arrhythmias. We have proven the concept that induction of CASQ2 expression in knockout mice reverts the molecular, structural, and electric abnormalities and prevents life-threatening arrhythmias in CASQ2-defective catecholaminergic polymorphic ventricular tachycardia mice. These data support the view that development of CASQ2 viral gene transfer could have clinical application."}
{"qid": "531375a6e3eabad021000011", "original_text": "Myocardial late gadolinium enhancement (LGE) on contrast-enhanced magnetic resonance imaging (CE-MRI) of patients with hypertrophic cardiomyopathy (HCM) has been suggested to represent intramyocardial fibrosis and, as such, an adverse prognostic risk factor. We evaluated the characteristics of LGE on CE-MRI and explored whether LGE among patients with HCM was associated with genetic testing, severe symptoms, ventricular arrhythmias, or sudden cardiac death (SCD). Four hundred twenty-four patients with HCM (age=55+/-16 years [range 2 to 90], 41% females), without a history of septal ablation/myectomy, underwent CE-MRI (GE 1.5 Tesla). We evaluated the relation between LGE and HCM genes status, severity of symptoms, and the degree of ventricular ectopy on Holter ECG. Subsequent SCD and appropriate implanted cardioverter defibrillator (ICD) therapies were recorded during a mean follow-up of 43+/-14 months (range 16 to 94). Two hundred thirty-nine patients (56%) had LGE on CE-MRI, ranging from 0.4% to 65% of the left ventricle. Gene-positive patients were more likely to have LGE (P<0.001). The frequencies of New York Heart Association class >or=3 dyspnea and angina class >or=3 were similar in patients with and without LGE (125 of 239 [52%] versus 94 of 185 [51%] and 24 of 239 [10%] versus 18 of 185 [10%], respectively, P=NS). LGE-positive patients were more likely to have episodes of nonsustained ventricular tachycardia (34 of 126 [27%] versus 8 of 94 [8.5%], P<0.001), had more episodes of nonsustained ventricular tachycardia per patient (4.5+/-12 versus 1.1+/-0.3, P=0.04), and had higher frequency of ventricular extrasystoles/24 hours (700+/-2080 versus 103+/-460, P=0.003). During follow-up, SCD occurred in 4 patients, and additional 4 patients received appropriate ICD discharges. All 8 patients were LGE positive (event rate of 0.94%/y, P=0.01 versus LGE negative).", "label": 1, "is_selected": 0, "text": "Myocardial late gadolinium enhancement (LGE) on contrast-enhanced magnetic resonance imaging (CE-MRI) of patients with hypertrophic cardiomyopathy (HCM) has been suggested to represent intramyocardial fibrosis and, as such, an adverse prognostic risk factor. We evaluated the characteristics of LGE on CE-MRI and explored whether LGE among patients with HCM was associated with genetic testing, severe symptoms, ventricular arrhythmias, or sudden cardiac death (SCD). Four hundred twenty-four patients with HCM (age=55+/-16 years [range 2 to 90], 41% females), without a history of septal ablation/myectomy, underwent CE-MRI (GE 1.5 Tesla). We evaluated the relation between LGE and HCM genes status, severity of symptoms, and the degree of ventricular ectopy on Holter ECG. Subsequent SCD and appropriate implanted cardioverter defibrillator (ICD) therapies were recorded during a mean follow-up of 43+/-14 months (range 16 to 94). Two hundred thirty-nine patients (56%) had LGE on CE-MRI, ranging from 0.4% to 65% of the left ventricle. Gene-positive patients were more likely to have LGE (P<0.001). The frequencies of New York Heart Association class >or=3 dyspnea and angina class >or=3 were similar in patients with and without LGE (125 of 239 [52%] versus 94 of 185 [51%] and 24 of 239 [10%] versus 18 of 185 [10%], respectively, P=NS). LGE-positive patients were more likely to have episodes of nonsustained ventricular tachycardia (34 of 126 [27%] versus 8 of 94 [8.5%], P<0.001), had more episodes of nonsustained ventricular tachycardia per patient (4.5+/-12 versus 1.1+/-0.3, P=0.04), and had higher frequency of ventricular extrasystoles/24 hours (700+/-2080 versus 103+/-460, P=0.003). During follow-up, SCD occurred in 4 patients, and additional 4 patients received appropriate ICD discharges. All 8 patients were LGE positive (event rate of 0.94%/y, P=0.01 versus LGE negative)."}
{"qid": "5c9e738decadf2e73f000037", "original_text": "Despite the high cure rate of T cell acute lymphoblastic leukemia (T-ALL), drug resistance to chemotherapy remains a significant clinical problem. Bone marrow mesenchymal stem cells (MSCs) protect leukemic cells from chemotherapy, but the underlying mechanisms are poorly understood. In this study, we aimed to uncover the mechanism of MSC-induced chemoresistance in T-ALL cells, thus providing a promising clinical therapy target. Cell viability was determined using the viability assay kit CCK-8. The mitochondrial ROS levels were detected using the fluorescent probe MitoSOX\u2122 Red, and fluorescence intensity was measured by flow cytometry. In vitro, MSCs and Jurkat cells were cocultured. MSCs were labeled with green fluorescent protein (GFP), and Jurkat cells were labeled with the mitochondria-specific dye MitoTracker Red. Bidirectional mitochondrial transfer was detected by flow cytometry and confocal microscopy. The mechanism of mitochondria transfer was analyzed by inhibitor assays. Transcripts related to Jurkat cell/MSC adhesion in the coculture system were assessed by qRT-PCR. After treatment with a neutralizing antibody against a key adhesion molecule, mitochondria transfer from Jurkat cells to MSCs was again detected by flow cytometry and confocal microscopy.", "label": 1, "is_selected": 0, "text": "Despite the high cure rate of T cell acute lymphoblastic leukemia (T-ALL), drug resistance to chemotherapy remains a significant clinical problem. Bone marrow mesenchymal stem cells (MSCs) protect leukemic cells from chemotherapy, but the underlying mechanisms are poorly understood. In this study, we aimed to uncover the mechanism of MSC-induced chemoresistance in T-ALL cells, thus providing a promising clinical therapy target. Cell viability was determined using the viability assay kit CCK-8. The mitochondrial ROS levels were detected using the fluorescent probe MitoSOX\u2122 Red, and fluorescence intensity was measured by flow cytometry. In vitro, MSCs and Jurkat cells were cocultured. MSCs were labeled with green fluorescent protein (GFP), and Jurkat cells were labeled with the mitochondria-specific dye MitoTracker Red. Bidirectional mitochondrial transfer was detected by flow cytometry and confocal microscopy. The mechanism of mitochondria transfer was analyzed by inhibitor assays. Transcripts related to Jurkat cell/MSC adhesion in the coculture system were assessed by qRT-PCR. After treatment with a neutralizing antibody against a key adhesion molecule, mitochondria transfer from Jurkat cells to MSCs was again detected by flow cytometry and confocal microscopy."}
{"qid": "5aaef38dfcf456587200000f", "original_text": "Acute atrial fibrillation is rapid, irregular, and chaotic atrial activity of less than 48 hours' duration. Risk factors for acute atrial fibrillation include increasing age, cardiovascular disease, alcohol, diabetes, and lung disease. Acute atrial fibrillation increases the risk of stroke and heart failure. The condition resolves spontaneously within 24 to 48 hours in over 50% of people; however, many people will require interventions to control heart rate or restore sinus rhythm. We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions to prevent embolism, for conversion to sinus rhythm, and to control heart rate in people with recent-onset atrial fibrillation (within 7 days) who are haemodynamically stable? We searched: Medline, Embase, The Cochrane Library, and other important databases up to April 2010 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). We found 30 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.", "label": 1, "is_selected": 0, "text": "Acute atrial fibrillation is rapid, irregular, and chaotic atrial activity of less than 48 hours' duration. Risk factors for acute atrial fibrillation include increasing age, cardiovascular disease, alcohol, diabetes, and lung disease. Acute atrial fibrillation increases the risk of stroke and heart failure. The condition resolves spontaneously within 24 to 48 hours in over 50% of people; however, many people will require interventions to control heart rate or restore sinus rhythm. We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions to prevent embolism, for conversion to sinus rhythm, and to control heart rate in people with recent-onset atrial fibrillation (within 7 days) who are haemodynamically stable? We searched: Medline, Embase, The Cochrane Library, and other important databases up to April 2010 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). We found 30 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions."}
{"qid": "6028196e1cb411341a0000f2", "original_text": "Big data initiatives such as the Enhancing NeuroImaging Genetics through Meta-Analysis consortium (ENIGMA), combine data collected by independent studies worldwide to achieve more generalizable estimates of effect sizes and more reliable and reproducible outcomes. Such efforts require harmonized image analyses protocols to extract phenotypes consistently. This harmonization is particularly challenging for resting state fMRI due to the wide variability of acquisition protocols and scanner platforms; this leads to site-to-site variance in quality, resolution and temporal signal-to-noise ratio (tSNR). An effective harmonization should provide optimal measures for data of different qualities. We developed a multi-site rsfMRI analysis pipeline to allow research groups around the world to process rsfMRI scans in a harmonized way, to extract consistent and quantitative measurements of connectivity and to perform coordinated statistical tests. We used the single-modality ENIGMA rsfMRI preprocessing pipeline based on modelfree Marchenko-Pastur PCA based denoising to verify and replicate resting state network heritability estimates. We analyzed two independent cohorts, GOBS (Genetics of Brain Structure) and HCP (the Human Connectome Project), which collected data using conventional and connectomics oriented fMRI protocols, respectively. We used seed-based connectivity and dual-regression approaches to show that the rsfMRI signal is consistently heritable across twenty major functional network measures.", "label": 1, "is_selected": 0, "text": "Big data initiatives such as the Enhancing NeuroImaging Genetics through Meta-Analysis consortium (ENIGMA), combine data collected by independent studies worldwide to achieve more generalizable estimates of effect sizes and more reliable and reproducible outcomes. Such efforts require harmonized image analyses protocols to extract phenotypes consistently. This harmonization is particularly challenging for resting state fMRI due to the wide variability of acquisition protocols and scanner platforms; this leads to site-to-site variance in quality, resolution and temporal signal-to-noise ratio (tSNR). An effective harmonization should provide optimal measures for data of different qualities. We developed a multi-site rsfMRI analysis pipeline to allow research groups around the world to process rsfMRI scans in a harmonized way, to extract consistent and quantitative measurements of connectivity and to perform coordinated statistical tests. We used the single-modality ENIGMA rsfMRI preprocessing pipeline based on modelfree Marchenko-Pastur PCA based denoising to verify and replicate resting state network heritability estimates. We analyzed two independent cohorts, GOBS (Genetics of Brain Structure) and HCP (the Human Connectome Project), which collected data using conventional and connectomics oriented fMRI protocols, respectively. We used seed-based connectivity and dual-regression approaches to show that the rsfMRI signal is consistently heritable across twenty major functional network measures."}
{"qid": "56af573b0a360a5e45000011", "original_text": "Knowledge of RNA structure is critical to understanding both the important functional roles of RNA in biology and the engineering of RNA to control biological systems. This article contains a protocol for selective 2'-hydroxyl acylation analyzed by primer extension and sequencing (SHAPE-Seq) that, through a combination of structure-dependent chemical probing and next-generation sequencing technologies, achieves structural characterization of hundreds of RNAs in a single experiment. This protocol is applicable in a variety of conditions, and represents an important tool for understanding RNA biology.", "label": 1, "is_selected": 0, "text": "Knowledge of RNA structure is critical to understanding both the important functional roles of RNA in biology and the engineering of RNA to control biological systems. This article contains a protocol for selective 2'-hydroxyl acylation analyzed by primer extension and sequencing (SHAPE-Seq) that, through a combination of structure-dependent chemical probing and next-generation sequencing technologies, achieves structural characterization of hundreds of RNAs in a single experiment. This protocol is applicable in a variety of conditions, and represents an important tool for understanding RNA biology."}
{"qid": "62792bb156bf9aee6f00001c", "original_text": "COVID-19, caused by SARS-CoV-2, can involve sequelae and other medical complications that last weeks to months after initial recovery, which has come to be called Long-COVID or COVID long-haulers. This systematic review and meta-analysis aims to identify studies assessing long-term effects of COVID-19 and estimates the prevalence of each symptom, sign, or laboratory parameter of patients at a post-COVID-19 stage. LitCOVID (PubMed and Medline) and Embase were searched by two independent researchers. All articles with original data for detecting long-term COVID-19 published before 1st of January 2021 and with a minimum of 100 patients were included. For effects reported in two or more studies, meta-analyses using a random-effects model were performed using the MetaXL software to estimate the pooled prevalence with 95% CI. Heterogeneity was assessed using I2 statistics. The Preferred Reporting Items for Systematic Reviewers and Meta-analysis (PRISMA) reporting guideline was followed. A total of 18,251 publications were identified, of which 15 met the inclusion criteria. The prevalence of 55 long-term effects was estimated, 21 meta-analyses were performed, and 47,910 patients were included. The follow-up time ranged from 15 to 110 days post-viral infection. The age of the study participants ranged between 17 and 87 years. It was estimated that 80% (95% CI 65-92) of the patients that were infected with SARS-CoV-2 developed one or more long-term symptoms.", "label": 1, "is_selected": 0, "text": "COVID-19, caused by SARS-CoV-2, can involve sequelae and other medical complications that last weeks to months after initial recovery, which has come to be called Long-COVID or COVID long-haulers. This systematic review and meta-analysis aims to identify studies assessing long-term effects of COVID-19 and estimates the prevalence of each symptom, sign, or laboratory parameter of patients at a post-COVID-19 stage. LitCOVID (PubMed and Medline) and Embase were searched by two independent researchers. All articles with original data for detecting long-term COVID-19 published before 1st of January 2021 and with a minimum of 100 patients were included. For effects reported in two or more studies, meta-analyses using a random-effects model were performed using the MetaXL software to estimate the pooled prevalence with 95% CI. Heterogeneity was assessed using I2 statistics. The Preferred Reporting Items for Systematic Reviewers and Meta-analysis (PRISMA) reporting guideline was followed. A total of 18,251 publications were identified, of which 15 met the inclusion criteria. The prevalence of 55 long-term effects was estimated, 21 meta-analyses were performed, and 47,910 patients were included. The follow-up time ranged from 15 to 110 days post-viral infection. The age of the study participants ranged between 17 and 87 years. It was estimated that 80% (95% CI 65-92) of the patients that were infected with SARS-CoV-2 developed one or more long-term symptoms."}
{"qid": "532498959b2d7acc7e000017", "original_text": "Imetelstat is a telomerase inhibitor that targets the enzyme telomerase. Telomerase is responsible for maintaining the length of telomeres, which are repetitive DNA sequences located at the ends of chromosomes. Telomerase is overexpressed in many cancer types, and its inhibition has been shown to slow down or stop cancer cell growth. Imetelstat binds to the active site of telomerase, preventing it from cleaving and adding nucleotides to the telomere, leading to telomere shortening and eventual cell death. Therefore, Imetelstat is a specific inhibitor of telomerase.", "label": 0, "is_selected": 0, "text": "Imetelstat is a telomerase inhibitor that targets the enzyme telomerase. Telomerase is responsible for maintaining the length of telomeres, which are repetitive DNA sequences located at the ends of chromosomes. Telomerase is overexpressed in many cancer types, and its inhibition has been shown to slow down or stop cancer cell growth. Imetelstat binds to the active site of telomerase, preventing it from cleaving and adding nucleotides to the telomere, leading to telomere shortening and eventual cell death. Therefore, Imetelstat is a specific inhibitor of telomerase."}
{"qid": "52f348542059c6d71c00000f", "original_text": "Bradykinin and prostaglandins are established mediators of exudative and inflammatory phases of healing. Their contribution to the fibrogenic component of healing in the heart is less certain. We therefore undertook the present study in rats with acute myocardial infarction (MI) following left coronary artery ligation. Treatment with a bradykinin B2 receptor antagonist (Hoe140, 0.5 microgram/kg/min s.c.) or a cyclooxygenase inhibitor (indomethacin, 2 mg/kg p.o.), initiated 24 h after surgery, was examined for responses in MI topography (size and area), MI and nonMI tissue fibrosis (fibrillar collagen specific picrosirius red). Early (week 1) and late (week 4) phases of fibrogenesis postMI were examined. Compared to control, we found: (1) MI size at weeks 1 and 4 was comparable in untreated and treated rats: (2) infarct area, a measure of scar thickness, was reduced (P < 0.05) at week 4 by each intervention; and (3) densitometric collagen volume fraction did not reveal a reduction in collagen accumulation at the MI site, but this was evident remote to the MI (P < 0.05) at week 4 for each agent.", "label": 1, "is_selected": 0, "text": "Bradykinin and prostaglandins are established mediators of exudative and inflammatory phases of healing. Their contribution to the fibrogenic component of healing in the heart is less certain. We therefore undertook the present study in rats with acute myocardial infarction (MI) following left coronary artery ligation. Treatment with a bradykinin B2 receptor antagonist (Hoe140, 0.5 microgram/kg/min s.c.) or a cyclooxygenase inhibitor (indomethacin, 2 mg/kg p.o.), initiated 24 h after surgery, was examined for responses in MI topography (size and area), MI and nonMI tissue fibrosis (fibrillar collagen specific picrosirius red). Early (week 1) and late (week 4) phases of fibrogenesis postMI were examined. Compared to control, we found: (1) MI size at weeks 1 and 4 was comparable in untreated and treated rats: (2) infarct area, a measure of scar thickness, was reduced (P < 0.05) at week 4 by each intervention; and (3) densitometric collagen volume fraction did not reveal a reduction in collagen accumulation at the MI site, but this was evident remote to the MI (P < 0.05) at week 4 for each agent."}
{"qid": "5aa824a8fcf4565872000002", "original_text": "Dimethyl fumarate (Tecfidera\u2122) is an effective therapy for relapsing forms of multiple sclerosis (MS). Our study suggests that this drug may have immunosuppressive properties evidenced by significant sustained reduction in CD8 lymphocyte counts and, to a lesser extent, CD4 lymphocyte counts. This observation is relevant in light of the recent case of progressive multifocal leukoencephalopathy in a patient receiving this drug.", "label": 1, "is_selected": 0, "text": "Dimethyl fumarate (Tecfidera\u2122) is an effective therapy for relapsing forms of multiple sclerosis (MS). Our study suggests that this drug may have immunosuppressive properties evidenced by significant sustained reduction in CD8 lymphocyte counts and, to a lesser extent, CD4 lymphocyte counts. This observation is relevant in light of the recent case of progressive multifocal leukoencephalopathy in a patient receiving this drug."}
{"qid": "5c6445f0e842deac67000017", "original_text": "Yes, the National Library of Medicine's (NLM) Medical Text Indexer (MTI) is still useful and relevant in the medical field. MTI is a software tool that automatically processes and indexes biomedical literature, including journal articles, conference proceedings, and book chapters, to create a searchable database of medical terms and concepts. Despite the emergence of newer technologies and tools in the field of natural language processing (NLP), MTI remains a valuable resource for various applications. Here are some reasons why: 1. Comprehensive coverage: MTI indexes a wide range of biomedical literature, including articles from over 7,000 journals, conference proceedings, and book chapters. This comprehensive coverage makes it a valuable resource for researchers, clinicians, and students searching for relevant information. 2. Accurate indexing: MTI uses a sophisticated indexing algorithm to identify and index medical terms, including gene and protein names, disease names, and anatomical locations. This accuracy is crucial for effective search and retrieval of biomedical information. 3. Ease of use: MTI is user-friendly and can be accessed via a web-based interface, making it easy to use for researchers across different disciplines and institutions. 4. Integration with other tools: MTI can be integrated with other NLM tools, such as PubMed, to enhance the search experience and provide more comprehensive results. 5. Continuous updating: NLM continuously updates MTI to ensure that it remains relevant to the latest medical research and discoveries. This ensures that users have access to the most current and accurate information. In summary, MTI is still a useful and relevant tool in the medical field due to its comprehensive coverage, accurate indexing, ease of use, integration with other tools, and continuous updating. While newer technologies and tools may offer additional functionality, MTI remains a valuable resource for biomedical research and information retrieval.", "label": 0, "is_selected": 1, "text": "Is there a tool that searches and retrieves biomedical information from thousands of medical journal articles, conference proceedings, book chapters, and other sources? In summary, MTI is still a useful and relevant tool in the medical field due to its comprehensive coverage, accurate indexing, ease of use, integration with other tools, and continuous updating. while newer technologies and tools may offer additional functionality, MT I remains a valuable resource for biomedical research and information retrieval., says NLM's Head of Research and Development, Dr. Lee Swee-Kyung., in a recent interview with the BBC's science and technology news programme, HARDtalk, about the National Library of Medicine's Medical Text Indexer., which was launched in the 1970s."}
{"qid": "5c6d8f4c7c78d6947100003f", "original_text": "Whole genome sequencing is becoming a diagnostics of choice for the identification of rare inherited and de novo copy number variants in families with various pediatric and late-onset genetic diseases. However, joint variant calling in pedigrees is hampered by the complexity of consensus breakpoint alignment across samples within an arbitrary pedigree structure. We have developed a new tool, Canvas SPW, for the identification of inherited and de novo copy number variants from pedigree sequencing data. Canvas SPW supports a number of family structures and provides a wide range of scoring and filtering options to automate and streamline identification of de novo variants.", "label": 1, "is_selected": 0, "text": "Whole genome sequencing is becoming a diagnostics of choice for the identification of rare inherited and de novo copy number variants in families with various pediatric and late-onset genetic diseases. However, joint variant calling in pedigrees is hampered by the complexity of consensus breakpoint alignment across samples within an arbitrary pedigree structure. We have developed a new tool, Canvas SPW, for the identification of inherited and de novo copy number variants from pedigree sequencing data. Canvas SPW supports a number of family structures and provides a wide range of scoring and filtering options to automate and streamline identification of de novo variants."}
{"qid": "61f5f1ef882a024a10000015", "original_text": "Itepekimab is a monoclonal antibody that has been shown to be effective in treating various inflammatory and autoimmune diseases. Some of the diseases that can be treated with itepekimab include: 1. Rheumatoid Arthritis (RA): Itepekimab has been shown to reduce inflammation and improve joint damage in patients with moderate-to-severe RA. 2. Psoriatic Arthritis (PsA): Itepekimab has been demonstrated to improve joint inflammation and psoriasis symptoms in patients with PsA. 3. Ankylosing Spondylitis (AS): Itepekimab has been shown to reduce inflammation and improve function in patients with active AS. 4. Crohn's Disease (CD): Itepekimab has been shown to reduce inflammation and improve symptoms in patients with moderate-to-severe CD. 5. Ulcerative Colitis (UC): Itepekimab has been demonstrated to improve symptoms and reduce inflammation in patients with moderate-to-severe UC. 6. Non-alcoholic Steatohepatitis (NASH): Itepekimab has been shown to reduce liver inflammation and improve metabolic dysregulation in patients with NASH. 7. Vitiligo: Itepekimab has been demonstrated to improve skin repigmentation in patients with vitiligo. 8. Atopic Dermatitis (AD): Itepekimab has been shown to improve skin inflammation and itching in patients with moderate-to-severe AD. 9. Gastrointestinal (GI) diseases: Itepekimab has been shown to improve inflammation and symptoms in patients with GI diseases such as GI ulcers, GI infections, and inflammatory bowel disease. It is important to note that these are some of the diseases that have been shown to be treated with itepekimab, but the drug is still being studied for safety and efficacy in these conditions, and its use may be limited or restricted. Therefore, it is essential to consult a healthcare professional for more information and to discuss the potential benefits and risks of using itepekimab for a specific condition.", "label": 0, "is_selected": 1, "text": "The European Medicines Agency (EMA) has approved Itepekimab for the treatment of a number of inflammatory diseases, including rheumatoid arthritis (RA), psoriatic arthritis (PsA), Crohn's disease (CD), ulcerative colitis (UC) and skin diseases such as vitiligo and atopic dermatitis (Atopic Dermatitis), as well as GI diseases, such as ulcers and  GI diseases (Spondylitis) and non-alcoholic steatohepatitis (NASH), in patients with conditions such as rheumatoid arthritis, psoriatic arthritis, Crohn' s disease, Ulcerative Colitis, NASH, and skin conditions like vitiligo and Atopic dermatitis, in adults."}
{"qid": "5e44bc4c48dab47f2600001b", "original_text": "Rogaratinib is a tyrosine kinase inhibitor (TKI) that targets the Bruton's tyrosine kinase (BTK) protein. BTK is involved in the B-cell receptor (BCR) signaling pathway, which is important for B-cell survival and activation. By inhibiting BTK, rogaratinib reduces BCR signaling, leading to the inhibition of B-cell proliferation and survival. This can be helpful in treating certain B-cell malignancies, such as diffuse large B-cell lymphoma (DLBCL) and chronic lymphocytic leukemia (CLL). Additionally, rogaratinib can also inhibit the activation of the NF-\u03baB pathway, which is involved in inflammation and immune responses. By inhibiting BTK and NF-\u03baB, rogaratinib can reduce inflammation and immune activation in various conditions, including inflammatory bowel disease (IBD) and multiple sclerosis (MS).", "label": 0, "is_selected": 0, "text": "Rogaratinib is a tyrosine kinase inhibitor (TKI) that targets the Bruton's tyrosine kinase (BTK) protein. BTK is involved in the B-cell receptor (BCR) signaling pathway, which is important for B-cell survival and activation. By inhibiting BTK, rogaratinib reduces BCR signaling, leading to the inhibition of B-cell proliferation and survival. This can be helpful in treating certain B-cell malignancies, such as diffuse large B-cell lymphoma (DLBCL) and chronic lymphocytic leukemia (CLL). Additionally, rogaratinib can also inhibit the activation of the NF-\u03baB pathway, which is involved in inflammation and immune responses. By inhibiting BTK and NF-\u03baB, rogaratinib can reduce inflammation and immune activation in various conditions, including inflammatory bowel disease (IBD) and multiple sclerosis (MS)."}
{"qid": "6253307fe764a53204000024", "original_text": "Teleosts, a group of fish that includes over 30,000 species, have a varying number of long interspersed nuclear elements (L1) and long terminal repeats (LTR) retrotransposons, which are collectively known as LBX. The number of LBX elements varies greatly among teleost species, with some having as few as 10 copies, while others have over 100 copies. According to a study published in the journal \"Nucleic Acids Research\" in 2018, the average number of LBX elements per genome in 30 teleost species was found to be around 30-40 copies. However, the range of LBX copy numbers was quite large, with some species having as few as 10 copies (e.g., medaka, Oryzias latipes) and others having over 100 copies (e.g., stickleback, Gasterosteus aculeatus). It's worth noting that the number of LBX elements in a given teleost species can vary among different tissues and developmental stages, and can also be influenced by factors such as evolutionary history and environmental conditions. Therefore, the actual number of LBX elements in a given species may be different from the average value reported in the literature.", "label": 0, "is_selected": 1, "text": "The number of nuclear elements found in a fish's genome has been estimated to be about 30-40 copies per genome, according to a study published in the journal \"Nucleic Research\" in 2018, but the range of LBX copy numbers in a given teleost species is quite large, with some species having as few as 10 copies (e.g., medaka, Oryzias latipes, Gasterosteus aculeatus)."}
{"qid": "5c978924ecadf2e73f000023", "original_text": "In most bacteria, a global level of regulation, termed quorum sensing (QS), exists involving intercellular communication via the production and response to cell density-dependent signal molecules. QS has been associated with a number of important features in bacteria including virulence regulation and biofilm formation. Consequently, there is considerable interest in understanding, detecting, and inhibiting QS. N-acylated homoserine lactones (AHLs) are used as extracellular QS signals by a variety of Gram-negative bacteria. Chromobacterium violaceum, commonly found in soil and water, produces the characteristic purple pigment violacein, regulated by AHL-mediated QS. Based on this readily observed pigmentation phenotype, C. violaceum strains can be used to detect various aspects of AHL-mediated QS activity.", "label": 1, "is_selected": 0, "text": "In most bacteria, a global level of regulation, termed quorum sensing (QS), exists involving intercellular communication via the production and response to cell density-dependent signal molecules. QS has been associated with a number of important features in bacteria including virulence regulation and biofilm formation. Consequently, there is considerable interest in understanding, detecting, and inhibiting QS. N-acylated homoserine lactones (AHLs) are used as extracellular QS signals by a variety of Gram-negative bacteria. Chromobacterium violaceum, commonly found in soil and water, produces the characteristic purple pigment violacein, regulated by AHL-mediated QS. Based on this readily observed pigmentation phenotype, C. violaceum strains can be used to detect various aspects of AHL-mediated QS activity."}
{"qid": "61f80e22882a024a1000003d", "original_text": "BCAS3 microtubule-associated cell migration factor (BCAS3) is a large, highly conserved cytoskeletal protein previously proposed to be critical in angiogenesis and implicated in human embryogenesis and tumorigenesis. Here, we established BCAS3 loss-of-function variants as causative for a neurodevelopmental disorder. We report 15 individuals from eight unrelated families with germline bi-allelic loss-of-function variants in BCAS3. All probands share a global developmental delay accompanied by pyramidal tract involvement, microcephaly, short stature, strabismus, dysmorphic facial features, and seizures. The human phenotype is less severe compared with the Bcas3 knockout mouse model and cannot be explained by angiogenic defects alone.", "label": 1, "is_selected": 0, "text": "BCAS3 microtubule-associated cell migration factor (BCAS3) is a large, highly conserved cytoskeletal protein previously proposed to be critical in angiogenesis and implicated in human embryogenesis and tumorigenesis. Here, we established BCAS3 loss-of-function variants as causative for a neurodevelopmental disorder. We report 15 individuals from eight unrelated families with germline bi-allelic loss-of-function variants in BCAS3. All probands share a global developmental delay accompanied by pyramidal tract involvement, microcephaly, short stature, strabismus, dysmorphic facial features, and seizures. The human phenotype is less severe compared with the Bcas3 knockout mouse model and cannot be explained by angiogenic defects alone."}
{"qid": "513f3ab6bee46bd34c00000f", "original_text": "Food, dietary fibre and espresso coffee interfere with the absorption of levothyroxine. Malabsorptive disorders reported to affect the absorption of levothyroxine include coeliac disease, inflammatory bowel disease, lactose intolerance as well as Helicobacter pylori (H. pylori) infection and atrophic gastritis. Many commonly used drugs, such as bile acid sequestrants, ferrous sulphate, sucralfate, calcium carbonate, aluminium-containing antacids, phosphate binders, raloxifene and proton-pump inhibitors, have also been shown to interfere with the absorption of levothyroxine.", "label": 1, "is_selected": 0, "text": "Food, dietary fibre and espresso coffee interfere with the absorption of levothyroxine. Malabsorptive disorders reported to affect the absorption of levothyroxine include coeliac disease, inflammatory bowel disease, lactose intolerance as well as Helicobacter pylori (H. pylori) infection and atrophic gastritis. Many commonly used drugs, such as bile acid sequestrants, ferrous sulphate, sucralfate, calcium carbonate, aluminium-containing antacids, phosphate binders, raloxifene and proton-pump inhibitors, have also been shown to interfere with the absorption of levothyroxine."}
{"qid": "5e4703d13f54159529000016", "original_text": "Radioprotection agents, also known as radiation protectors or radioprotectors, are substances that can help protect living cells, tissues, and organs from the harmful effects of ionizing radiation. These agents can reduce the damage caused by radiation to normal tissues and organs, while sparing the tumor cells, allowing for more effective cancer treatment. Here are some examples of radioprotection agents: 1. Amifostine: Amifostine is a phosphate-based compound that has been shown to protect normal tissues from radiation damage. It is commonly used to reduce the risk of hearing loss and skin damage in patients undergoing radiation therapy for head and neck cancer. 2. Bleomycin: Bleomycin is an antibiotic that has been used as a radioprotector in radiation therapy. It can help reduce the risk of damage to normal tissues by inhibiting the production of reactive oxygen species (ROS), which are formed during radiation exposure. 3. Caffeine: Caffeine has been shown to have radioprotective effects in some studies. It is thought to work by reducing the formation of ROS, which can damage normal tissues. However, the evidence for its use as a radioprotector is not consistent. 4. Dextran: Dextran is a polymer that has been used as a radioprotector in radiation therapy. It can help reduce the risk of damage to normal tissues by absorbing ionizing radiation and preventing it from reaching the surrounding cells. 5. Mesna: Mesna is a sulfate-containing compound that has been used as a radioprotector in radiation therapy. It can help reduce the risk of damage to normal tissues by reducing the amount of ROS produced during radiation exposure. 6. Taurine: Taurine is an amino acid that has been shown to have radioprotective effects in some studies. It is thought to work by reducing the formation of ROS, which can damage normal tissues. However, the evidence for its use as a radioprotector is not consistent. 7. Vitamin C: Vitamin C is an antioxidant that has been shown to have radioprotective effects in some studies. It is thought to work by reducing the formation of ROS, which can damage normal tissues. However, the evidence for its use as a radioprotector is not consistent. It is important to note that while these agents can help reduce the risk of radiation damage, they are not a substitute for proper radiation protection measures, such as shielding and dose limitation.", "label": 0, "is_selected": 0, "text": "Radioprotection agents, also known as radiation protectors or radioprotectors, are substances that can help protect living cells, tissues, and organs from the harmful effects of ionizing radiation. These agents can reduce the damage caused by radiation to normal tissues and organs, while sparing the tumor cells, allowing for more effective cancer treatment. Here are some examples of radioprotection agents: 1. Amifostine: Amifostine is a phosphate-based compound that has been shown to protect normal tissues from radiation damage. It is commonly used to reduce the risk of hearing loss and skin damage in patients undergoing radiation therapy for head and neck cancer. 2. Bleomycin: Bleomycin is an antibiotic that has been used as a radioprotector in radiation therapy. It can help reduce the risk of damage to normal tissues by inhibiting the production of reactive oxygen species (ROS), which are formed during radiation exposure. 3. Caffeine: Caffeine has been shown to have radioprotective effects in some studies. It is thought to work by reducing the formation of ROS, which can damage normal tissues. However, the evidence for its use as a radioprotector is not consistent. 4. Dextran: Dextran is a polymer that has been used as a radioprotector in radiation therapy. It can help reduce the risk of damage to normal tissues by absorbing ionizing radiation and preventing it from reaching the surrounding cells. 5. Mesna: Mesna is a sulfate-containing compound that has been used as a radioprotector in radiation therapy. It can help reduce the risk of damage to normal tissues by reducing the amount of ROS produced during radiation exposure. 6. Taurine: Taurine is an amino acid that has been shown to have radioprotective effects in some studies. It is thought to work by reducing the formation of ROS, which can damage normal tissues. However, the evidence for its use as a radioprotector is not consistent. 7. Vitamin C: Vitamin C is an antioxidant that has been shown to have radioprotective effects in some studies. It is thought to work by reducing the formation of ROS, which can damage normal tissues. However, the evidence for its use as a radioprotector is not consistent. It is important to note that while these agents can help reduce the risk of radiation damage, they are not a substitute for proper radiation protection measures, such as shielding and dose limitation."}
{"qid": "516d4770298dcd4e51000076", "original_text": "The present study investigated the effects of dronedarone and amiodarone on plasma thyroid hormones and the possible consequences on the response of the heart to ischemia. Amiodarone (30 mg/kg/day per os) or dronedarone (30 mg/kg/day per os) were administered for 2 weeks in normal and thyroxine-treated animals (25 microg/100 g body weight od sc, for 2 weeks), while animals without amiodarone and dronedarone served as controls. Isolated rat hearts were perfused in a Langendorff mode and subjected to 20 and 30 min of zero-flow global ischemia followed by 45 min of reperfusion. Functional changes were assessed by measuring left ventricular developed pressure (LVDP) under resting conditions and in response to ischemia-reperfusion, LVDP%, as well as the severity of ischemic contracture. Amiodarone resulted in increased T4, T4/T3 and rT3, whereas dronedarone did not alter the thyroid hormone profile in normal animals. In thyroxine-treated animals, amiodarone increased T4/T3 ratio but T4, T3 and rT3 levels were not altered.", "label": 1, "is_selected": 0, "text": "The present study investigated the effects of dronedarone and amiodarone on plasma thyroid hormones and the possible consequences on the response of the heart to ischemia. Amiodarone (30 mg/kg/day per os) or dronedarone (30 mg/kg/day per os) were administered for 2 weeks in normal and thyroxine-treated animals (25 microg/100 g body weight od sc, for 2 weeks), while animals without amiodarone and dronedarone served as controls. Isolated rat hearts were perfused in a Langendorff mode and subjected to 20 and 30 min of zero-flow global ischemia followed by 45 min of reperfusion. Functional changes were assessed by measuring left ventricular developed pressure (LVDP) under resting conditions and in response to ischemia-reperfusion, LVDP%, as well as the severity of ischemic contracture. Amiodarone resulted in increased T4, T4/T3 and rT3, whereas dronedarone did not alter the thyroid hormone profile in normal animals. In thyroxine-treated animals, amiodarone increased T4/T3 ratio but T4, T3 and rT3 levels were not altered."}
{"qid": "56f3f0f02ac5ed1459000017", "original_text": "Eukaryotic gene control regions are known to be spread throughout non-coding DNA sequences which may appear distant from the gene promoter. Transcription factors are proteins that coordinately bind to these regions at transcription factor binding sites to regulate gene expression. Several tools allow to detect significant co-occurrences of closely located binding sites (cis-regulatory modules, CRMs). However, these tools present at least one of the following limitations: 1) scope limited to promoter or conserved regions of the genome; 2) do not allow to identify combinations involving more than two motifs; 3) require prior information about target motifs. In this work we present CisMiner, a novel methodology to detect putative CRMs by means of a fuzzy itemset mining approach able to operate at genome-wide scale. CisMiner allows to perform a blind search of CRMs without any prior information about target CRMs nor limitation in the number of motifs. CisMiner tackles the combinatorial complexity of genome-wide cis-regulatory module extraction using a natural representation of motif combinations as itemsets and applying the Top-Down Fuzzy Frequent- Pattern Tree algorithm to identify significant itemsets. Fuzzy technology allows CisMiner to better handle the imprecision and noise inherent to regulatory processes. Results obtained for a set of well-known binding sites in the S. cerevisiae genome show that our method yields highly reliable predictions. Furthermore, CisMiner was also applied to putative in-silico predicted transcription factor binding sites to identify significant combinations in S. cerevisiae and D. melanogaster, proving that our approach can be further applied genome-wide to more complex genomes.", "label": 1, "is_selected": 0, "text": "Eukaryotic gene control regions are known to be spread throughout non-coding DNA sequences which may appear distant from the gene promoter. Transcription factors are proteins that coordinately bind to these regions at transcription factor binding sites to regulate gene expression. Several tools allow to detect significant co-occurrences of closely located binding sites (cis-regulatory modules, CRMs). However, these tools present at least one of the following limitations: 1) scope limited to promoter or conserved regions of the genome; 2) do not allow to identify combinations involving more than two motifs; 3) require prior information about target motifs. In this work we present CisMiner, a novel methodology to detect putative CRMs by means of a fuzzy itemset mining approach able to operate at genome-wide scale. CisMiner allows to perform a blind search of CRMs without any prior information about target CRMs nor limitation in the number of motifs. CisMiner tackles the combinatorial complexity of genome-wide cis-regulatory module extraction using a natural representation of motif combinations as itemsets and applying the Top-Down Fuzzy Frequent- Pattern Tree algorithm to identify significant itemsets. Fuzzy technology allows CisMiner to better handle the imprecision and noise inherent to regulatory processes. Results obtained for a set of well-known binding sites in the S. cerevisiae genome show that our method yields highly reliable predictions. Furthermore, CisMiner was also applied to putative in-silico predicted transcription factor binding sites to identify significant combinations in S. cerevisiae and D. melanogaster, proving that our approach can be further applied genome-wide to more complex genomes."}
{"qid": "58e26ede6fddd3e83e000015", "original_text": "The number of known mutations in human nuclear genes, underlying or associated with human inherited disease, has now exceeded 100,000 in more than 3700 different genes (Human Gene Mutation Database). However, for a variety of reasons, this figure is likely to represent only a small proportion of the clinically relevant genetic variants that remain to be identified in the human genome (the 'mutome').", "label": 1, "is_selected": 0, "text": "The number of known mutations in human nuclear genes, underlying or associated with human inherited disease, has now exceeded 100,000 in more than 3700 different genes (Human Gene Mutation Database). However, for a variety of reasons, this figure is likely to represent only a small proportion of the clinically relevant genetic variants that remain to be identified in the human genome (the 'mutome')."}
{"qid": "58cbb55402b8c60953000033", "original_text": "Melanin biosynthesis is reduced in oculocutaneous albinism, an autosomal recessive disorder. Hermansky-Pudlak syndrome is associated with oculocutaneous albinism but also has systemic complications. The ocular and systemic phenotypes vary, depending, in part, on the genetic mutations. This report presents a case of a patient with Hermansky-Pudlak syndrome and the unique association of iris heterochromia.", "label": 1, "is_selected": 0, "text": "Melanin biosynthesis is reduced in oculocutaneous albinism, an autosomal recessive disorder. Hermansky-Pudlak syndrome is associated with oculocutaneous albinism but also has systemic complications. The ocular and systemic phenotypes vary, depending, in part, on the genetic mutations. This report presents a case of a patient with Hermansky-Pudlak syndrome and the unique association of iris heterochromia."}
{"qid": "602738ac1cb411341a0000d7", "original_text": "The approval of the novel long-acting HIV injection; Cabenuva\u00ae- Cabotegravir and Rilpivirine injectable formulation) and the recent call by the World Health Organization for promoting community-based ART management, underscore the remarkable progress towards meeting the Joint United Nations Programme on HIV/AIDS (UNAIDS) 95-95-95 targets by 2030.", "label": 1, "is_selected": 0, "text": "The approval of the novel long-acting HIV injection; Cabenuva\u00ae- Cabotegravir and Rilpivirine injectable formulation) and the recent call by the World Health Organization for promoting community-based ART management, underscore the remarkable progress towards meeting the Joint United Nations Programme on HIV/AIDS (UNAIDS) 95-95-95 targets by 2030."}
{"qid": "5c52028807ef653866000009", "original_text": "Mitochondria are inherited exclusively through the maternal line in humans. Mitochondrial DNA (mtDNA) is passed down from mother to child through the egg cell, and this DNA is different from the nuclear DNA found in the father's sperm. Therefore, the mtDNA inherited by a child is solely from their mother, and not from their father.", "label": 0, "is_selected": 1, "text": "A team of scientists at the University of California, Irvine, have created a baby using DNA from three people - a mother, a father, and an egg from a third person - to create a genetically-modified baby, called a \"three-parent\" baby."}
{"qid": "55033064e9bde69634000036", "original_text": "Ten patients with Parkinson's disease and levodopa induced dyskinesias (LIDs) took part in this randomised, placebo controlled, double blind, crossover trial to assess the efficacy and tolerability of high dose oral naltrexone for LIDs in Parkinson's disease. Patients received naltrexone (5 mg/kg/day) or placebo for 2.5 weeks with 1 week wash out in between. Dyskinesias and motor function were assessed with a levodopa challenge, unified Parkinson's disease rating scale (UPDRS), the unified dyskinesia rating scale (UDRS), and patient diaries. Eight patients completed the trial.", "label": 1, "is_selected": 0, "text": "Ten patients with Parkinson's disease and levodopa induced dyskinesias (LIDs) took part in this randomised, placebo controlled, double blind, crossover trial to assess the efficacy and tolerability of high dose oral naltrexone for LIDs in Parkinson's disease. Patients received naltrexone (5 mg/kg/day) or placebo for 2.5 weeks with 1 week wash out in between. Dyskinesias and motor function were assessed with a levodopa challenge, unified Parkinson's disease rating scale (UPDRS), the unified dyskinesia rating scale (UDRS), and patient diaries. Eight patients completed the trial."}
{"qid": "5713c4a11174fb1755000013", "original_text": "Yes, the glycyl-tRNA synthetase gene (GARS) has been implicated in the development of Charcot-Marie-Tooth disease (CMT), a group of inherited disorders affecting the peripheral nervous system. Mutations in the GARS gene can lead to a deficiency of the enzyme glycyl-tRNA synthetase, which plays a critical role in the synthesis of myelin, the protective covering of nerve fibers. This deficiency can contribute to the degeneration of peripheral nerves and the symptoms of CMT.", "label": 0, "is_selected": 1, "text": "A gene that has been implicated in the development of Charcot-Marie-Tooth disease (CMT) has been identified by scientists at the University of Oxford.... read more A genetic test has been developed to assess whether a person has a mutation in the GARS gene, which has been linked to the disease."}
{"qid": "534eb34b288f4dae47000002", "original_text": "Invadopodia are matrix-degrading membrane protrusions in invasive carcinoma cells. The mechanisms regulating invadopodium assembly and maturation are not understood. We have dissected the stages of invadopodium assembly and maturation and show that invadopodia use cortactin phosphorylation as a master switch during these processes. In particular, cortactin phosphorylation was found to regulate cofilin and Arp2/3 complex-dependent actin polymerization. Cortactin directly binds cofilin and inhibits its severing activity. Cortactin phosphorylation is required to release this inhibition so cofilin can sever actin filaments to create barbed ends at invadopodia to support Arp2/3-dependent actin polymerization. After barbed end formation, cortactin is dephosphorylated, which blocks cofilin severing activity thereby stabilizing invadopodia.", "label": 1, "is_selected": 0, "text": "Invadopodia are matrix-degrading membrane protrusions in invasive carcinoma cells. The mechanisms regulating invadopodium assembly and maturation are not understood. We have dissected the stages of invadopodium assembly and maturation and show that invadopodia use cortactin phosphorylation as a master switch during these processes. In particular, cortactin phosphorylation was found to regulate cofilin and Arp2/3 complex-dependent actin polymerization. Cortactin directly binds cofilin and inhibits its severing activity. Cortactin phosphorylation is required to release this inhibition so cofilin can sever actin filaments to create barbed ends at invadopodia to support Arp2/3-dependent actin polymerization. After barbed end formation, cortactin is dephosphorylated, which blocks cofilin severing activity thereby stabilizing invadopodia."}
{"qid": "56c1d85fef6e394741000036", "original_text": "Maternal smoking during pregnancy has been linked to an increased risk of brain tumors in offspring later in life. Several studies have found that children exposed to maternal smoking in utero have a higher risk of developing brain tumors, including gliomas, astrocytomas, and medulloblastomas. The increased risk is thought to be due to the exposure of fetal brain tissue to carcinogenic chemicals in tobacco smoke, such as polycyclic aromatic hydrocarbons (PAHs) and DNA-reactive compounds. The risk persists even after cessation of smoking during pregnancy, highlighting the importance of smoking cessation programs for pregnant women. However, it is important to note that the overall risk of brain tumors in offspring of smoking mothers is still relatively low compared to other environmental and genetic risk factors.", "label": 0, "is_selected": 1, "text": "This article looks at the possible link between smoking during pregnancy and the development of brain cancer in the child, and the importance of smoking cessation during pregnancy for the sake of the child and for the mother's own health., authored by researchers at the University of California, Los Angeles., and funded by the National Institute on Alcohol Abuse and Alcoholism., part of the US Department of Health and Human Services."}
{"qid": "58861f8b3b87a8a738000003", "original_text": "In the present study the potential for functional improvement in 103 stroke patients attending a geriatric day hospital was evaluated using the Orpington Prognostic Scale (OPS). This information may assist in coordinating the patients' and caregivers' expectations, allocating resources efficiently, and advance care planning. The Spearman correlation was used to calculate the association between OPS score and Functional Independent Measure (FIM), the Nottingham Extended ADL Index (NEAI), and the timed Get Up and Go test (TUG). The studied population was divided into two groups: patients with mild neurological impairment (OPS score<3.2) and those with moderate to severe neurological impairment (OPS score> or =3.2) and their performance on the above outcome measure were compared.", "label": 1, "is_selected": 0, "text": "In the present study the potential for functional improvement in 103 stroke patients attending a geriatric day hospital was evaluated using the Orpington Prognostic Scale (OPS). This information may assist in coordinating the patients' and caregivers' expectations, allocating resources efficiently, and advance care planning. The Spearman correlation was used to calculate the association between OPS score and Functional Independent Measure (FIM), the Nottingham Extended ADL Index (NEAI), and the timed Get Up and Go test (TUG). The studied population was divided into two groups: patients with mild neurological impairment (OPS score<3.2) and those with moderate to severe neurological impairment (OPS score> or =3.2) and their performance on the above outcome measure were compared."}
{"qid": "536787467d100faa09000010", "original_text": "We measured the aerobic capacity, sweat rate and fluid intake of trained athletes during outdoor exercise and examined the relationship between aerobic capacity and thermoregulatory responses at high ambient temperatures. The maximal aerobic capacity (VO2max) of the subjects, nine male baseball players of college age, was determined by maximal exercise tests on a cycle ergometer. The subjects practised baseball regularly without drinking fluids from 1330 to 1530 hours. After 30 min rest, they played a baseball game with free access to a sports drink at 15 degrees C from 1600 to 1830 hours. At a mean ambient temperature of 36.7 (SEM 0.2) degree C, the mean percentage of body mass loss (delta mb) and increase of oral temperature (delta To) from 1330 to 1530 hours was 3.47 (SEM 0.12)% and 0.81 (SEM 0.14) degree C, respectively. The sweat loss from 1330 to 1830 hours was 56.53 (SEM 1.56)ml.kg-1 of body mass (mb) while the mean fluid consumption was 44.78 (SEM 2.39)ml.kg-1 of mb, with recovery of 76.08 (SEM 2.81)% of sweat loss. The VO2max was significantly inversely correlated with delta mb, fluid intake and rehydration amount, but showed no correlation with delta To. These results would suggest that at a given exercise intensity in subjects with a higher aerobic capacity body temperature is maintained with a lower sweating rate than that in subjects with a lower aerobic capacity.", "label": 1, "is_selected": 0, "text": "We measured the aerobic capacity, sweat rate and fluid intake of trained athletes during outdoor exercise and examined the relationship between aerobic capacity and thermoregulatory responses at high ambient temperatures. The maximal aerobic capacity (VO2max) of the subjects, nine male baseball players of college age, was determined by maximal exercise tests on a cycle ergometer. The subjects practised baseball regularly without drinking fluids from 1330 to 1530 hours. After 30 min rest, they played a baseball game with free access to a sports drink at 15 degrees C from 1600 to 1830 hours. At a mean ambient temperature of 36.7 (SEM 0.2) degree C, the mean percentage of body mass loss (delta mb) and increase of oral temperature (delta To) from 1330 to 1530 hours was 3.47 (SEM 0.12)% and 0.81 (SEM 0.14) degree C, respectively. The sweat loss from 1330 to 1830 hours was 56.53 (SEM 1.56)ml.kg-1 of body mass (mb) while the mean fluid consumption was 44.78 (SEM 2.39)ml.kg-1 of mb, with recovery of 76.08 (SEM 2.81)% of sweat loss. The VO2max was significantly inversely correlated with delta mb, fluid intake and rehydration amount, but showed no correlation with delta To. These results would suggest that at a given exercise intensity in subjects with a higher aerobic capacity body temperature is maintained with a lower sweating rate than that in subjects with a lower aerobic capacity."}
{"qid": "532f08b8d6d3ac6a34000029", "original_text": "Rivaroxaban, a direct oral anticoagulant (DOAC), does not have a specific antidote. However, there are several strategies to reverse its anticoagulant effects in emergency situations, such as bleeding or surgery. These include: 1. Vitamin K: Administering vitamin K by injection can increase the anticoagulant protein, protein C, and protein S, which can help reverse rivaroxaban's anticoagulant effects. 2. Prothrombin complex concentrate (PCC): PCC contains factors II, VII, and X, which can help restore hemostasis in patients with rivaroxaban-induced bleeding. 3. Fresh frozen plasma (FFP): FFP contains factors II, VII, VIII, and IX, which can help replace coagulation factors that are deficient due to rivaroxaban use. It is important to note that these reversal strategies are not always effective and may not completely restore hemostasis. In some cases, discontinuing rivaroxaban and administering emergency treatment to control bleeding may be necessary. I hope this information helps. Let me know if you have any further questions.", "label": 0, "is_selected": 1, "text": "I have been asked how to reverse the anticoagulant effects of rivaroxaban in patients who are having surgery or who have had a recent bleed due to an injury or illness, such as a heart attack, stroke, or venous malformations (VMS) where bleeding is a common complication.<n> Fresh frozen plasma (FFP): FFP contains factors II, VII, VIII, and IX, which can help replace coagulation factors that are deficient due to riva Roxaban use."}
{"qid": "5a4e50b242878bf97d000001", "original_text": "In yeast, the essential topoisomerase is Top1. Top1 is a type II topoisomerase that plays a crucial role in regulating the topological state of DNA in yeast cells. It helps to relieve DNA supercoiling and maintains the integrity of the genome by resolving DNA tangles and knots. Without Top1, yeast cells are unable to repair DNA damage and undergo programmed cell death, leading to a shortened lifespan.", "label": 0, "is_selected": 0, "text": "In yeast, the essential topoisomerase is Top1. Top1 is a type II topoisomerase that plays a crucial role in regulating the topological state of DNA in yeast cells. It helps to relieve DNA supercoiling and maintains the integrity of the genome by resolving DNA tangles and knots. Without Top1, yeast cells are unable to repair DNA damage and undergo programmed cell death, leading to a shortened lifespan."}
{"qid": "5ac07b67dd95b2cd42000001", "original_text": "Yes, lysyl oxidase (LOX) is involved in collagen crosslinking. LOX is an enzyme that catalyzes the oxidation of lysine residues in collagen, leading to the formation of covalent crosslinks between collagen fibrils. These crosslinks are important for maintaining the structure and integrity of connective tissue, such as skin, bone, and blood vessels. Abnormalities in LOX activity or function have been implicated in a variety of diseases, including muscular dystrophy, skin fragility, and cardiovascular disease.", "label": 0, "is_selected": 0, "text": "Yes, lysyl oxidase (LOX) is involved in collagen crosslinking. LOX is an enzyme that catalyzes the oxidation of lysine residues in collagen, leading to the formation of covalent crosslinks between collagen fibrils. These crosslinks are important for maintaining the structure and integrity of connective tissue, such as skin, bone, and blood vessels. Abnormalities in LOX activity or function have been implicated in a variety of diseases, including muscular dystrophy, skin fragility, and cardiovascular disease."}
{"qid": "62587803e764a5320400002b", "original_text": "Transposable elements (TEs) are repetitive sequences of viral origin that compose almost half of the human genome. These elements are tightly controlled within cells, and if activated, they can cause changes in both gene regulation and immune viral responses that have been associated with several chronic inflammatory diseases in humans. As oxidants are potent activators of TEs, and because oxidative injury is a major risk factor in relation to idiopathic pulmonary fibrosis (IPF), we hypothesized that TEs might be involved in the regulation of gene expression and so contribute to inflammation in cases of IPF.", "label": 1, "is_selected": 0, "text": "Transposable elements (TEs) are repetitive sequences of viral origin that compose almost half of the human genome. These elements are tightly controlled within cells, and if activated, they can cause changes in both gene regulation and immune viral responses that have been associated with several chronic inflammatory diseases in humans. As oxidants are potent activators of TEs, and because oxidative injury is a major risk factor in relation to idiopathic pulmonary fibrosis (IPF), we hypothesized that TEs might be involved in the regulation of gene expression and so contribute to inflammation in cases of IPF."}
{"qid": "56f961b3cf1c325851000003", "original_text": "Ranasmurfin, a previously uncharacterized approximately 13 kDa blue protein found in the nests of the frog Polypedates leucomystax, has been purified and crystallized.", "label": 1, "is_selected": 0, "text": "Ranasmurfin, a previously uncharacterized approximately 13 kDa blue protein found in the nests of the frog Polypedates leucomystax, has been purified and crystallized."}
{"qid": "62211f453a8413c653000072", "original_text": "The GRN gene encodes glial cell line-derived neurotrophic factor (GDNF), which is a protein that plays a critical role in the survival and function of certain types of neurons in the central nervous system. GDNF is a member of the neurotrophin family of proteins, which also includes nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophin-3 (NT-3). These proteins are involved in the regulation of neural development, maintenance, and plasticity, and are implicated in a range of neurological disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.", "label": 0, "is_selected": 1, "text": "The GRN gene has been identified by scientists at the University of California, Los Angeles (UCLA) and the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH) in Washington, DC, USA."}
{"qid": "58efa1b870f9fc6f0f000003", "original_text": "Nowadays it has been established that metals and metal-induced oxidative stress act on signal transduction pathways, and are in association with cancer growth and spreading as well as in neurodegenerative disorders. In cases of several neurodegenerative diseases metals, especially Al, can be considered as a risk factor. Frequency of chemotherapy-related cognitive impairment or \"chemobrain\" is mentioned to be significant in literature, although very little is known about the chemotherapy-caused chemobrain and its connection with metal homeostasis alteration. Dysregulation of metal homeostasis can be assumed as one of the key factors in the progression of neurodegeneration. Therefore we were interested in studying metal element status of 27 adult patients in 3 years after their colectomy, 22 outpatients and 10 healthy volunteers in both genders. Tumour markers, laboratory parameters and metal element concentrations were determined. We found significant difference among the Al concentrations in operated patients compared with controls.", "label": 1, "is_selected": 0, "text": "Nowadays it has been established that metals and metal-induced oxidative stress act on signal transduction pathways, and are in association with cancer growth and spreading as well as in neurodegenerative disorders. In cases of several neurodegenerative diseases metals, especially Al, can be considered as a risk factor. Frequency of chemotherapy-related cognitive impairment or \"chemobrain\" is mentioned to be significant in literature, although very little is known about the chemotherapy-caused chemobrain and its connection with metal homeostasis alteration. Dysregulation of metal homeostasis can be assumed as one of the key factors in the progression of neurodegeneration. Therefore we were interested in studying metal element status of 27 adult patients in 3 years after their colectomy, 22 outpatients and 10 healthy volunteers in both genders. Tumour markers, laboratory parameters and metal element concentrations were determined. We found significant difference among the Al concentrations in operated patients compared with controls."}
{"qid": "54f1e781c409818c32000003", "original_text": "Armodafinil is a wakefulness-promoting drug that is used to treat conditions like narcolepsy, sleep apnea, and shift work sleep disorder. However, it is not specifically approved for the treatment of insomnia. While some studies have shown that armodafinil can improve sleep quality and reduce the time it takes to fall asleep, it is not a substitute for insomnia treatment. Insomnia is a complex sleep disorder that can have multiple underlying causes, and treatment typically involves a combination of behavioral modifications, relaxation techniques, and cognitive-behavioral therapy. If you are experiencing symptoms of insomnia, it is important to consult with a qualified healthcare professional for proper diagnosis and treatment.", "label": 0, "is_selected": 1, "text": "If you are experiencing symptoms of insomnia, it is important to know that armodafinil is not a substitute for insomnia treatment, according to the American College of Obstetricians and Gynaecologists (ACOG) and the American Academy of Sleep Medicine (AASM)."}
{"qid": "535917f3c95abccd6f000001", "original_text": "Bacteria can induce tumors in Arabidopsis through several mechanisms, including: 1. Rhizobacteria-mediated tumorigenesis: Certain rhizobacteria, such as Agrobacterium tumefaciens, can transfer their genetic material to plant cells through natural transformation, leading to the formation of tumors. 2. Induction of systemic acquired resistance (SAR): Some bacteria, like Pseudomonas syringae, can trigger SAR, a defense response in plants, which can lead to the formation of tumors. 3. Production of plant hormones: Bacteria like Streptomyces can produce plant hormones, such as auxins and cytokinins, that can promote tumor growth. It's important to note that the exact mechanism of bacterial tumor induction in Arabidopsis can vary depending on the bacterial species and the specific plant genotype.", "label": 0, "is_selected": 1, "text": "The bacterium Streptomyces excelsior has been implicated in the development and growth of many types of cancer, including breast, lung, pancreatic, and prostate cancers, as well as skin, ear, and brain cancers. It's important to note that the exact mechanism of bacterial tumor induction in Arabidopsis can vary depending on the bacterial species and the specific plant genotype."}
{"qid": "56cf2a153975bb303a000004", "original_text": "High-threshold voltage-sensitive calcium channels of the N-type, L-type, and P-type have been distinguished in the mammalian CNS predominantly on the basis of their sensitivity to selective antagonists. Matching them with genes identified by molecular cloning is an ongoing undertaking. Whereas L-type channels are characterized by their sensitivity to dihydropyridines and P-type channels by sensitivity to the funnel-web spider toxin AgaIVA, the N-type channel has been shown to be recognized by the omega-conopeptides GVIA and MVIIA. Recently, two new members of the family of omega-conopeptides--MVIIC from the marine snail Conus magus and SVIB from Conus striatus--have been described.", "label": 1, "is_selected": 0, "text": "High-threshold voltage-sensitive calcium channels of the N-type, L-type, and P-type have been distinguished in the mammalian CNS predominantly on the basis of their sensitivity to selective antagonists. Matching them with genes identified by molecular cloning is an ongoing undertaking. Whereas L-type channels are characterized by their sensitivity to dihydropyridines and P-type channels by sensitivity to the funnel-web spider toxin AgaIVA, the N-type channel has been shown to be recognized by the omega-conopeptides GVIA and MVIIA. Recently, two new members of the family of omega-conopeptides--MVIIC from the marine snail Conus magus and SVIB from Conus striatus--have been described."}
{"qid": "58a57f9460087bc10a00001f", "original_text": "Tietz syndrome and Waardenburg syndrome type 2A are allelic conditions caused by MITF mutations. Tietz syndrome is inherited in an autosomal dominant pattern and is characterized by congenital deafness and generalized skin, hair, and eye hypopigmentation, while Waardenburg syndrome type 2A typically includes variable degrees of sensorineural hearing loss and patches of de-pigmented skin, hair, and irides.", "label": 1, "is_selected": 0, "text": "Tietz syndrome and Waardenburg syndrome type 2A are allelic conditions caused by MITF mutations. Tietz syndrome is inherited in an autosomal dominant pattern and is characterized by congenital deafness and generalized skin, hair, and eye hypopigmentation, while Waardenburg syndrome type 2A typically includes variable degrees of sensorineural hearing loss and patches of de-pigmented skin, hair, and irides."}
{"qid": "6028183e1cb411341a0000f1", "original_text": "The subcortical brain structure that is influenced the most by common genetic variants is the amygdala. The amygdala is a small, almond-shaped structure located in the temporal lobe that plays a critical role in emotional processing and the regulation of fear and anxiety responses. Studies have found that common genetic variants in the amygdala region are associated with a wide range of psychiatric and neurological disorders, including anxiety disorders, depression, and autism spectrum disorder. These variants are thought to affect the functioning of the amygdala, leading to impaired emotional processing and an increased risk of developing these disorders. Other subcortical brain structures, such as the hippocampus and the striatum, are also influenced by genetic variants, but the amygdala is the most well-studied in this regard.", "label": 0, "is_selected": 1, "text": "The structure and function of the brain are influenced by a wide range of factors, including genetic variants and environmental influences, as well as by age, gender, and other risk factors, such as smoking, alcohol, and obesity. The amygdala is a small, almond-shaped structure located in the temporal lobe that plays a critical role in emotional processing and the regulation of fear and anxiety responses."}
{"qid": "5d3858a97bc3fee31f000018", "original_text": "Methylation-profiling-based next-generation sequencing (MPE-seq) is a novel method for assessing DNA methylation levels at a genomic scale. The method combines the principles of methylation-specific PCR (MSP) and next-generation sequencing (NGS). The basic strategy of MPE-seq involves: (1) bisulfite treatment to convert unmethylated cytosine to uracil, (2) PCR amplification of the bisulfite-treated DNA, (3) sequencing the amplified DNA using NGS, and (4) bioinformatic analysis to identify regions of differential methylation. Compared to other methylation analysis methods, MPE-seq offers several advantages, including high sensitivity, specificity, and throughput.", "label": 0, "is_selected": 0, "text": "Methylation-profiling-based next-generation sequencing (MPE-seq) is a novel method for assessing DNA methylation levels at a genomic scale. The method combines the principles of methylation-specific PCR (MSP) and next-generation sequencing (NGS). The basic strategy of MPE-seq involves: (1) bisulfite treatment to convert unmethylated cytosine to uracil, (2) PCR amplification of the bisulfite-treated DNA, (3) sequencing the amplified DNA using NGS, and (4) bioinformatic analysis to identify regions of differential methylation. Compared to other methylation analysis methods, MPE-seq offers several advantages, including high sensitivity, specificity, and throughput."}
{"qid": "52f5417b2059c6d71c000024", "original_text": "There are several mouse models that have been generated to study Autism Spectrum Disorder (ASD). These models are useful tools for understanding the underlying genetic and biological mechanisms of ASD, as well as for testing potential treatments. Here are some of the most commonly used mouse models for ASD: 1. BTBR mice: These mice have a mutation in the gene that codes for the protein tyrosine phosphatase, SAPAP3. They display behaviors similar to those seen in humans with ASD, including social avoidance and repetitive behaviors. 2. Cntnap2 knockout mice: Mice lacking the Cntnap2 gene, which is associated with ASD in humans, exhibit social and communication impairments, as well as repetitive behaviors. 3. Shank3 knockout mice: Mice lacking the Shank3 gene, which is involved in synaptic plasticity and neural circuit development, display deficits in social behavior and cognitive function, similar to those seen in ASD. 4. Neuroligin-2 knockout mice: Mice lacking the Neuroligin-2 gene, which is involved in synaptic adhesion and neural circuit development, display social and communication impairments, as well as repetitive behaviors. 5. FMRP knockout mice: Mice lacking the FMRP gene, which is associated with Fragile X syndrome, the most common genetic cause of ASD, display social and communication impairments, as well as repetitive behaviors. It's worth noting that while these mouse models can provide valuable insights into the mechanisms underlying ASD, they are not perfect representations of the human condition, and caution should be exercised when interpreting the results of studies using these models.", "label": 0, "is_selected": 0, "text": "There are several mouse models that have been generated to study Autism Spectrum Disorder (ASD). These models are useful tools for understanding the underlying genetic and biological mechanisms of ASD, as well as for testing potential treatments. Here are some of the most commonly used mouse models for ASD: 1. BTBR mice: These mice have a mutation in the gene that codes for the protein tyrosine phosphatase, SAPAP3. They display behaviors similar to those seen in humans with ASD, including social avoidance and repetitive behaviors. 2. Cntnap2 knockout mice: Mice lacking the Cntnap2 gene, which is associated with ASD in humans, exhibit social and communication impairments, as well as repetitive behaviors. 3. Shank3 knockout mice: Mice lacking the Shank3 gene, which is involved in synaptic plasticity and neural circuit development, display deficits in social behavior and cognitive function, similar to those seen in ASD. 4. Neuroligin-2 knockout mice: Mice lacking the Neuroligin-2 gene, which is involved in synaptic adhesion and neural circuit development, display social and communication impairments, as well as repetitive behaviors. 5. FMRP knockout mice: Mice lacking the FMRP gene, which is associated with Fragile X syndrome, the most common genetic cause of ASD, display social and communication impairments, as well as repetitive behaviors. It's worth noting that while these mouse models can provide valuable insights into the mechanisms underlying ASD, they are not perfect representations of the human condition, and caution should be exercised when interpreting the results of studies using these models."}
{"qid": "625ebf76e764a53204000033", "original_text": "Thoracic aortic dissection (AD) is one of the most common aortic emergencies. It can be fatal if not promptly diagnosed and treated. Intramural hematoma (IMH) of the aorta is recognized as distinct from classic (double-barreled) AD. IMH also frequently leads to aortic emergency, which can be fatal unless rapidly diagnosed and treated. Recently, thoracic endovascular aortic repair (TEVAR) has been used for the treatment of complications caused by AD. TEVAR is also a viable option for the treatment of complicated IHM. In this article, we review the details of TEVAR as treatment options for AD and IMH, including the indications for TEVAR, imaging, and follow-up.", "label": 1, "is_selected": 0, "text": "Thoracic aortic dissection (AD) is one of the most common aortic emergencies. It can be fatal if not promptly diagnosed and treated. Intramural hematoma (IMH) of the aorta is recognized as distinct from classic (double-barreled) AD. IMH also frequently leads to aortic emergency, which can be fatal unless rapidly diagnosed and treated. Recently, thoracic endovascular aortic repair (TEVAR) has been used for the treatment of complications caused by AD. TEVAR is also a viable option for the treatment of complicated IHM. In this article, we review the details of TEVAR as treatment options for AD and IMH, including the indications for TEVAR, imaging, and follow-up."}
{"qid": "58d0dc878acda34529000004", "original_text": "Although most eukaryotic genomes lack operons, they contain some physical clusters of genes that are related in function despite being unrelated in sequence. How these clusters are formed during evolution is unknown. The DAL cluster is the largest metabolic gene cluster in yeast and consists of six adjacent genes encoding proteins that enable Saccharomyces cerevisiae to use allantoin as a nitrogen source. We show here that the DAL cluster was assembled, quite recently in evolutionary terms, through a set of genomic rearrangements that happened almost simultaneously.", "label": 1, "is_selected": 0, "text": "Although most eukaryotic genomes lack operons, they contain some physical clusters of genes that are related in function despite being unrelated in sequence. How these clusters are formed during evolution is unknown. The DAL cluster is the largest metabolic gene cluster in yeast and consists of six adjacent genes encoding proteins that enable Saccharomyces cerevisiae to use allantoin as a nitrogen source. We show here that the DAL cluster was assembled, quite recently in evolutionary terms, through a set of genomic rearrangements that happened almost simultaneously."}
{"qid": "6025fd261cb411341a0000bf", "original_text": "Studies suggest that dihydropyridine calcium-channel blockers may be associated with reduced risk for Parkinson disease (PD). To assess the effect of isradipine, a dihydropyridine calcium-channel blocker, on the rate of clinical progression of PD. Multicenter, randomized, parallel-group, double-blind, placebo-controlled trial. (ClinicalTrials.gov: NCT02168842). 57 Parkinson Study Group sites in North America. Patients with early-stage PD (duration <3 years) who were not taking dopaminergic medications at enrollment. 5 mg of immediate-release isradipine twice daily or placebo for 36 months. The primary outcome was change in the Unified Parkinson's Disease Rating Scale (UPDRS) parts I to III score measured in the antiparkinson medication \"ON\" state between baseline and 36 months. Secondary outcomes included time to initiation and use of antiparkinson medications, time to onset of motor complications, change in nonmotor disability, and quality-of-life measures. 336 patients were randomly assigned (mean age, 62 years [SD, 9]; 68% men; disease duration, 0.9 year [SD, 0.7]; mean UPDRS part I to III score, 23.1 [SD, 8.6]); 95% of patients completed the study. Adjusted least-squares mean changes in total UPDRS score in the antiparkinson medication ON state over 36 months for isradipine and placebo recipients were 2.99 (95% CI, 0.95 to 5.03) points versus 3.26 (CI, 1.25 to 5.26) points, respectively, with a treatment effect of -0.27 (CI, -3.02 to 2.48) point (P = 0.85). Statistical adjustment for antiparkinson medication use did not change the findings. Secondary outcomes showed no effect of isradipine treatment. The most common adverse effects of isradipine were edema and dizziness. The isradipine dose may have been insufficient to engage the target calcium channels associated with neuroprotective effects. Long-term treatment with immediate-release isradipine did not slow the clinical progression of early-stage PD. National Institute of Neurological Disorders and Stroke.", "label": 1, "is_selected": 0, "text": "Studies suggest that dihydropyridine calcium-channel blockers may be associated with reduced risk for Parkinson disease (PD). To assess the effect of isradipine, a dihydropyridine calcium-channel blocker, on the rate of clinical progression of PD. Multicenter, randomized, parallel-group, double-blind, placebo-controlled trial. (ClinicalTrials.gov: NCT02168842). 57 Parkinson Study Group sites in North America. Patients with early-stage PD (duration <3 years) who were not taking dopaminergic medications at enrollment. 5 mg of immediate-release isradipine twice daily or placebo for 36 months. The primary outcome was change in the Unified Parkinson's Disease Rating Scale (UPDRS) parts I to III score measured in the antiparkinson medication \"ON\" state between baseline and 36 months. Secondary outcomes included time to initiation and use of antiparkinson medications, time to onset of motor complications, change in nonmotor disability, and quality-of-life measures. 336 patients were randomly assigned (mean age, 62 years [SD, 9]; 68% men; disease duration, 0.9 year [SD, 0.7]; mean UPDRS part I to III score, 23.1 [SD, 8.6]); 95% of patients completed the study. Adjusted least-squares mean changes in total UPDRS score in the antiparkinson medication ON state over 36 months for isradipine and placebo recipients were 2.99 (95% CI, 0.95 to 5.03) points versus 3.26 (CI, 1.25 to 5.26) points, respectively, with a treatment effect of -0.27 (CI, -3.02 to 2.48) point (P = 0.85). Statistical adjustment for antiparkinson medication use did not change the findings. Secondary outcomes showed no effect of isradipine treatment. The most common adverse effects of isradipine were edema and dizziness. The isradipine dose may have been insufficient to engage the target calcium channels associated with neuroprotective effects. Long-term treatment with immediate-release isradipine did not slow the clinical progression of early-stage PD. National Institute of Neurological Disorders and Stroke."}
{"qid": "515df5b2298dcd4e5100002c", "original_text": "Human multipotent mesenchymal stem cell (MSC) therapies are currently being tested in clinical trials for Crohn's disease, multiple sclerosis, graft-versus-host disease, type 1 diabetes, bone fractures, cartilage damage, and cardiac diseases. Despite remarkable progress in clinical trials, most applications still use traditional culture media containing fetal bovine serum or serum-free media that contain serum albumin, insulin, and transferrin. The ill-defined and variable nature of traditional culture media remains a challenge and has created a need for better defined xeno-free culture media to meet the regulatory and long-term safety requirements for cell-based therapies.", "label": 1, "is_selected": 0, "text": "Human multipotent mesenchymal stem cell (MSC) therapies are currently being tested in clinical trials for Crohn's disease, multiple sclerosis, graft-versus-host disease, type 1 diabetes, bone fractures, cartilage damage, and cardiac diseases. Despite remarkable progress in clinical trials, most applications still use traditional culture media containing fetal bovine serum or serum-free media that contain serum albumin, insulin, and transferrin. The ill-defined and variable nature of traditional culture media remains a challenge and has created a need for better defined xeno-free culture media to meet the regulatory and long-term safety requirements for cell-based therapies."}
{"qid": "58de34608acda3452900002b", "original_text": "One of the first questions asked about excavated human skeletal remains is the sex. As the morphological sex determination is complicated in cases involving fragmentary bones and in skeletons from infants and children, the development of DNA-based techniques has led to improvements in sex determination. This study is focused on sex determination from ancient DNA obtained from 25 skeletons found in Middle Aged burials in western Slovakia. We performed separate amplifications of DXZ4 repetitive satellite sequences on the X chromosome, and SRY gene - testis determined factor on the Y chromosome, using nested PCR. Our results showed that DXZ4 was amplified in the case of 23 individuals.", "label": 1, "is_selected": 0, "text": "One of the first questions asked about excavated human skeletal remains is the sex. As the morphological sex determination is complicated in cases involving fragmentary bones and in skeletons from infants and children, the development of DNA-based techniques has led to improvements in sex determination. This study is focused on sex determination from ancient DNA obtained from 25 skeletons found in Middle Aged burials in western Slovakia. We performed separate amplifications of DXZ4 repetitive satellite sequences on the X chromosome, and SRY gene - testis determined factor on the Y chromosome, using nested PCR. Our results showed that DXZ4 was amplified in the case of 23 individuals."}
{"qid": "57169a49cb4ef8864c00000a", "original_text": "Decitabine is a potent demethylating agent that exhibits clinical activity against myeloid malignancies. Numerous genes silenced by hypermethylation are reactivated by decitabine through a mechanism involving promoter demethylation with subsequent release of histone deacetylases (HDACs) and accumulation of acetylated histones. Recent studies indicating that decitabine also induces regional chromatin remodeling of some unmethylated genes suggest additional mechanisms of action. Decitabine reactivates unmethylated p21WAF1 in some AML cell lines but the possible occurrence of p21WAF1 methylation in AML in vivo has not been studied in detail and decitabine effects on p21WAF1 chromatin remodeling have not been reported. We found that p21WAF1 mRNA was undetectable in 6 of 24 AML patient samples and 4 of 5 AML cell lines but there was no evidence of p21WAF1 promoter methylation. However, decitabine induced p21WAF1 in AML cell lines KG-1 and KG-1a in association with release of HDAC1 and increased acetylated histone H3 at the unmethylated p21WAF1 promoter.", "label": 1, "is_selected": 0, "text": "Decitabine is a potent demethylating agent that exhibits clinical activity against myeloid malignancies. Numerous genes silenced by hypermethylation are reactivated by decitabine through a mechanism involving promoter demethylation with subsequent release of histone deacetylases (HDACs) and accumulation of acetylated histones. Recent studies indicating that decitabine also induces regional chromatin remodeling of some unmethylated genes suggest additional mechanisms of action. Decitabine reactivates unmethylated p21WAF1 in some AML cell lines but the possible occurrence of p21WAF1 methylation in AML in vivo has not been studied in detail and decitabine effects on p21WAF1 chromatin remodeling have not been reported. We found that p21WAF1 mRNA was undetectable in 6 of 24 AML patient samples and 4 of 5 AML cell lines but there was no evidence of p21WAF1 promoter methylation. However, decitabine induced p21WAF1 in AML cell lines KG-1 and KG-1a in association with release of HDAC1 and increased acetylated histone H3 at the unmethylated p21WAF1 promoter."}
{"qid": "5e639a0a1af46fc130000010", "original_text": "HER-2 (Human Epidermal Growth Factor Receptor 2) belongs to the ErbB (Epidermal Growth Factor Receptor) family of proteins. The ErbB family includes four members: ErbB-1 (Epidermal Growth Factor Receptor), ErbB-2 (Human Epidermal Growth Factor Receptor 2), ErbB-3 (Protein Tyrosine Kinase ErbB-3), and ErbB-4 (Protein Tyrosine Kinase ErbB-4). HER-2 is overexpressed in many types of cancer, including breast cancer, and is a key target for cancer therapy.", "label": 0, "is_selected": 0, "text": "HER-2 (Human Epidermal Growth Factor Receptor 2) belongs to the ErbB (Epidermal Growth Factor Receptor) family of proteins. The ErbB family includes four members: ErbB-1 (Epidermal Growth Factor Receptor), ErbB-2 (Human Epidermal Growth Factor Receptor 2), ErbB-3 (Protein Tyrosine Kinase ErbB-3), and ErbB-4 (Protein Tyrosine Kinase ErbB-4). HER-2 is overexpressed in many types of cancer, including breast cancer, and is a key target for cancer therapy."}
{"qid": "58a3428d60087bc10a00001b", "original_text": "Huntington's disease is caused by an expansion of a CAG repeat in the Huntingtin gene (also known as HTT). The mutated gene leads to a toxic protein that causes progressive degeneration of the brain, leading to the symptoms of Huntington's disease. Specifically, the CAG repeat expands from a normal length of 10-39 repeats to 30-79 repeats, resulting in a mutant Huntingtin protein that is aberrantly expressed and causes cellular toxicity. The exact mechanisms of how this leads to neurodegeneration are not yet fully understood, but research suggests that it may involve disruption of normal cellular processes, including transport of nutrients and waste products, as well as abnormal protein aggregation and inflammation.", "label": 0, "is_selected": 1, "text": "Scientists at the University of California, Los Angeles (UCLA) have identified a genetic defect that causes Huntington's disease, a neurodegenerative disease that affects people over the age of 40.<n> Specifically, the CAG repeat expands from a normal length of 10-39 repeats to 30-79 repeats, resulting in a mutant Huntingtin protein that is aberrantly expressed and causes cellular toxicity."}
{"qid": "5a737e233b9d13c70800000d", "original_text": "Enzastaurin, a phosphatidylinositol 3-kinase (PI3K) inhibitor, has been investigated as a potential treatment for glioblastoma, an aggressive and malignant brain cancer. While some early-stage clinical trials suggested a possible benefit of enzastaurin in glioblastoma patient survival, more recent and larger-scale studies have not found a significant improvement in overall survival with this treatment. A 2017 meta-analysis of six clinical trials involving a total of 1,071 glioblastoma patients found that enzastaurin did not significantly improve overall survival compared to standard treatments. Another study published in 2020 found that enzastaurin treatment was associated with a slight improvement in progression-free survival, but the difference was not statistically significant. Therefore, while some evidence suggests that enzastaurin may have a role in the management of glioblastoma, further research is needed to determine its full potential as a therapy for this disease. In summary, the current evidence does not support a conclusion that enzastaurin improves survival in glioblastoma patients.", "label": 0, "is_selected": 0, "text": "Enzastaurin, a phosphatidylinositol 3-kinase (PI3K) inhibitor, has been investigated as a potential treatment for glioblastoma, an aggressive and malignant brain cancer. While some early-stage clinical trials suggested a possible benefit of enzastaurin in glioblastoma patient survival, more recent and larger-scale studies have not found a significant improvement in overall survival with this treatment. A 2017 meta-analysis of six clinical trials involving a total of 1,071 glioblastoma patients found that enzastaurin did not significantly improve overall survival compared to standard treatments. Another study published in 2020 found that enzastaurin treatment was associated with a slight improvement in progression-free survival, but the difference was not statistically significant. Therefore, while some evidence suggests that enzastaurin may have a role in the management of glioblastoma, further research is needed to determine its full potential as a therapy for this disease. In summary, the current evidence does not support a conclusion that enzastaurin improves survival in glioblastoma patients."}
{"qid": "55203ae78e534a4535000001", "original_text": "Psoriasin (S100 A7) was discovered two decades ago as a protein abundantly expressed in psoriatic keratinocytes. Even though much scientific research has been carried out on the characterization of psoriasin, only recent studies point to an important role of psoriasin as an antimicrobial and immunomodulatory protein in skin and other epithelia.", "label": 1, "is_selected": 0, "text": "Psoriasin (S100 A7) was discovered two decades ago as a protein abundantly expressed in psoriatic keratinocytes. Even though much scientific research has been carried out on the characterization of psoriasin, only recent studies point to an important role of psoriasin as an antimicrobial and immunomodulatory protein in skin and other epithelia."}
{"qid": "5518e817622b194345000006", "original_text": "Ras proteins are proto-oncogenes that are frequently mutated in human cancers. Three closely related isoforms, HRAS, KRAS and NRAS, are expressed in all cells and have overlapping but distinctive functions. Recent work has revealed how differences between the Ras isoforms in their trafficking, localization and protein-membrane orientation enable signalling specificity to be determined. We review the various strategies used to characterize compartmentalized Ras localization and signalling. Localization is an important contextual modifier of signalling networks and insights from the Ras system are of widespread relevance for researchers interested in signalling initiated from membranes.", "label": 1, "is_selected": 0, "text": "Ras proteins are proto-oncogenes that are frequently mutated in human cancers. Three closely related isoforms, HRAS, KRAS and NRAS, are expressed in all cells and have overlapping but distinctive functions. Recent work has revealed how differences between the Ras isoforms in their trafficking, localization and protein-membrane orientation enable signalling specificity to be determined. We review the various strategies used to characterize compartmentalized Ras localization and signalling. Localization is an important contextual modifier of signalling networks and insights from the Ras system are of widespread relevance for researchers interested in signalling initiated from membranes."}
{"qid": "531a3a58b166e2b806000037", "original_text": "It will likely be more than 20 years before there is unequivocal evidence available that HPV vaccination decreases the incidence of invasive cervical cancer. However, existing data strongly suggests that as many as 440,000 cervical cancer cases and 220,000 deaths due to this malignancy will be prevented with the establishment of an effective worldwide HPV immunization program.", "label": 1, "is_selected": 0, "text": "It will likely be more than 20 years before there is unequivocal evidence available that HPV vaccination decreases the incidence of invasive cervical cancer. However, existing data strongly suggests that as many as 440,000 cervical cancer cases and 220,000 deaths due to this malignancy will be prevented with the establishment of an effective worldwide HPV immunization program."}
{"qid": "534abe8aaeec6fbd07000013", "original_text": "The heat shock protein (HSP) 90 chaperone machine involved in numerous oncogenic signaling pathways is overexpressed in cancer cells and is currently being evaluated for anticancer therapy. Neuroendocrine tumors (NETs) of the gastroenteropancreatic (GEP) system comprise a heterogeneous group of tumors with increasing incidence and poor prognosis. Here, we report the antiproliferative effects of the HSP90 inhibitors AUY922 and HSP990 in neuroendocrine tumor cells. Treatment of human pancreatic BON1, bronchopulmonary NCI-H727 and midgut carcinoid GOT1 neuroendocrine tumor cells with increasing concentrations of AUY922 and HSP990 dose-dependently suppressed cell viability.", "label": 1, "is_selected": 0, "text": "The heat shock protein (HSP) 90 chaperone machine involved in numerous oncogenic signaling pathways is overexpressed in cancer cells and is currently being evaluated for anticancer therapy. Neuroendocrine tumors (NETs) of the gastroenteropancreatic (GEP) system comprise a heterogeneous group of tumors with increasing incidence and poor prognosis. Here, we report the antiproliferative effects of the HSP90 inhibitors AUY922 and HSP990 in neuroendocrine tumor cells. Treatment of human pancreatic BON1, bronchopulmonary NCI-H727 and midgut carcinoid GOT1 neuroendocrine tumor cells with increasing concentrations of AUY922 and HSP990 dose-dependently suppressed cell viability."}
{"qid": "5c6dfba77c78d69471000046", "original_text": "Apalutamide (ARN-509) is an antiandrogen that binds selectively to androgen receptors (AR) and does not show antagonist-to-agonist switch like bicalutamide. We compared the activity of ARN versus bicalutamide on prostate cancer cell lines. The 22Rv1, PC3, and DU145 cell lines were used to study the effect of ARN and bicalutamide on the expression cytoplasmic/nuclear kinetics of AR, AR-V7 variant, phosphorylated AR, as well as the levels of the AR downstream proteins prostate-specific antigen and TMPRSS2, under exposure to testosterone and/or hypoxia. The effects on autophagic flux (LC3A, p62, TFEB, LAMP2a, cathepsin D) and cell metabolism-related enzymes (hypoxia-inducible factor 1\u03b1/2\u03b1, BNIP3, carbonic anhydrase 9, LDHA, PDH, PDH-kinase) were also studied.", "label": 1, "is_selected": 0, "text": "Apalutamide (ARN-509) is an antiandrogen that binds selectively to androgen receptors (AR) and does not show antagonist-to-agonist switch like bicalutamide. We compared the activity of ARN versus bicalutamide on prostate cancer cell lines. The 22Rv1, PC3, and DU145 cell lines were used to study the effect of ARN and bicalutamide on the expression cytoplasmic/nuclear kinetics of AR, AR-V7 variant, phosphorylated AR, as well as the levels of the AR downstream proteins prostate-specific antigen and TMPRSS2, under exposure to testosterone and/or hypoxia. The effects on autophagic flux (LC3A, p62, TFEB, LAMP2a, cathepsin D) and cell metabolism-related enzymes (hypoxia-inducible factor 1\u03b1/2\u03b1, BNIP3, carbonic anhydrase 9, LDHA, PDH, PDH-kinase) were also studied."}
{"qid": "5a774240faa1ab7d2e000003", "original_text": "The past decade has brought tremendous progress in unraveling the pathophysiology of Alzheimer's disease (AD). While increasingly sophisticated immunotherapy targeting soluble and aggregated brain amyloid-beta (A\u03b2) continues to dominate clinical research in AD, a deeper understanding of A\u03b2 physiology has led to the recognition of distinct neuronal signaling pathways linking A\u03b2 to synaptotoxicity and neurodegeneration and to new targets for therapeutic intervention. Identifying specific signaling pathways involving A\u03b2 has allowed for the development of more precise therapeutic interventions targeting the most relevant molecular mechanisms leading to AD. In this review, I highlight the discovery of cellular prion protein as a high-affinity receptor for A\u03b2 oligomers, and the downstream signaling pathway elucidated to date, converging on nonreceptor tyrosine kinase Fyn. I discuss preclinical studies targeting Fyn as a therapeutic intervention in AD and our recent experience with the safety, tolerability, and cerebrospinal fluid penetration of the Src family kinase inhibitor saracatinib in patients with AD. Fyn is an attractive target for AD therapeutics, not only based on its activation by A\u03b2 via cellular prion protein but also due to its known interaction with tau, uniquely linking the two key pathologies in AD.", "label": 1, "is_selected": 0, "text": "The past decade has brought tremendous progress in unraveling the pathophysiology of Alzheimer's disease (AD). While increasingly sophisticated immunotherapy targeting soluble and aggregated brain amyloid-beta (A\u03b2) continues to dominate clinical research in AD, a deeper understanding of A\u03b2 physiology has led to the recognition of distinct neuronal signaling pathways linking A\u03b2 to synaptotoxicity and neurodegeneration and to new targets for therapeutic intervention. Identifying specific signaling pathways involving A\u03b2 has allowed for the development of more precise therapeutic interventions targeting the most relevant molecular mechanisms leading to AD. In this review, I highlight the discovery of cellular prion protein as a high-affinity receptor for A\u03b2 oligomers, and the downstream signaling pathway elucidated to date, converging on nonreceptor tyrosine kinase Fyn. I discuss preclinical studies targeting Fyn as a therapeutic intervention in AD and our recent experience with the safety, tolerability, and cerebrospinal fluid penetration of the Src family kinase inhibitor saracatinib in patients with AD. Fyn is an attractive target for AD therapeutics, not only based on its activation by A\u03b2 via cellular prion protein but also due to its known interaction with tau, uniquely linking the two key pathologies in AD."}
{"qid": "5e52bc986d0a277941000049", "original_text": "To identify common variants contributing to normal variation in two specific domains of cognitive functioning, we conducted a genome-wide association study (GWAS) of executive functioning and information processing speed in non-demented older adults from the CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology) consortium. Neuropsychological testing was available for 5429-32,070 subjects of European ancestry aged 45 years or older, free of dementia and clinical stroke at the time of cognitive testing from 20 cohorts in the discovery phase. We analyzed performance on the Trail Making Test parts A and B, the Letter Digit Substitution Test (LDST), the Digit Symbol Substitution Task (DSST), semantic and phonemic fluency tests, and the Stroop Color and Word Test. Replication was sought in 1311-21860 subjects from 20 independent cohorts.", "label": 1, "is_selected": 0, "text": "To identify common variants contributing to normal variation in two specific domains of cognitive functioning, we conducted a genome-wide association study (GWAS) of executive functioning and information processing speed in non-demented older adults from the CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology) consortium. Neuropsychological testing was available for 5429-32,070 subjects of European ancestry aged 45 years or older, free of dementia and clinical stroke at the time of cognitive testing from 20 cohorts in the discovery phase. We analyzed performance on the Trail Making Test parts A and B, the Letter Digit Substitution Test (LDST), the Digit Symbol Substitution Task (DSST), semantic and phonemic fluency tests, and the Stroop Color and Word Test. Replication was sought in 1311-21860 subjects from 20 independent cohorts."}
{"qid": "5a6d23ccb750ff4455000035", "original_text": "Ultraconserved regions (UCRs) are non-protein coding gene sequences that are strictly conserved across among different species. Emerging evidence demonstrates that transcribed ultraconserved regions (TUCRs) encoding noncoding RNAs serve as regulators of gene expression. In recent decades, increasing evidence implicates the involvement of UCRs in carcinogenesis. The role of TUC.338 in cervical cancers was an oncogene in previous studies. Until now, the role of TUC.338 in colorectal cancers remains undefined. This study revealed that TUC.338 is significantly up-regulated in colorectal cancers (CRC) tissue and CRC cell lines, and the up-regulated TUC.338 is associated with lymph node metastasis. Transfection with small interfering RNA (siRNA) markedly inhibited cell migration and invasion in SW480 and HCT116 colorectal cancer cell lines.", "label": 1, "is_selected": 0, "text": "Ultraconserved regions (UCRs) are non-protein coding gene sequences that are strictly conserved across among different species. Emerging evidence demonstrates that transcribed ultraconserved regions (TUCRs) encoding noncoding RNAs serve as regulators of gene expression. In recent decades, increasing evidence implicates the involvement of UCRs in carcinogenesis. The role of TUC.338 in cervical cancers was an oncogene in previous studies. Until now, the role of TUC.338 in colorectal cancers remains undefined. This study revealed that TUC.338 is significantly up-regulated in colorectal cancers (CRC) tissue and CRC cell lines, and the up-regulated TUC.338 is associated with lymph node metastasis. Transfection with small interfering RNA (siRNA) markedly inhibited cell migration and invasion in SW480 and HCT116 colorectal cancer cell lines."}
{"qid": "550f0e4c6a8cde6b72000003", "original_text": "Facioscapulohumeral muscular dystrophy has been genetically linked to reduced numbers (\u2264 8) of D4Z4 repeats at 4q35 combined with 4A(159/161/168) DUX4 polyadenylation signal haplotype. However, we have recently reported that 1.3% of healthy individuals carry this molecular signature and 19% of subjects affected by facioscapulohumeral muscular dystrophy do not carry alleles with eight or fewer D4Z4 repeats. Therefore, prognosis for subjects carrying or at risk of carrying D4Z4 reduced alleles has become more complicated. To test for additional prognostic factors, we measured the degree of motor impairment in a large group of patients affected by facioscapulohumeral muscular dystrophy and their relatives who are carrying D4Z4 reduced alleles.", "label": 1, "is_selected": 0, "text": "Facioscapulohumeral muscular dystrophy has been genetically linked to reduced numbers (\u2264 8) of D4Z4 repeats at 4q35 combined with 4A(159/161/168) DUX4 polyadenylation signal haplotype. However, we have recently reported that 1.3% of healthy individuals carry this molecular signature and 19% of subjects affected by facioscapulohumeral muscular dystrophy do not carry alleles with eight or fewer D4Z4 repeats. Therefore, prognosis for subjects carrying or at risk of carrying D4Z4 reduced alleles has become more complicated. To test for additional prognostic factors, we measured the degree of motor impairment in a large group of patients affected by facioscapulohumeral muscular dystrophy and their relatives who are carrying D4Z4 reduced alleles."}
{"qid": "58aa0a62396a458e50000007", "original_text": "Yes, microtubules are known to be modified by glutamylation. Glutamylation of microtubules is a post-translational modification that involves the addition of a glutamic acid molecule to the tubulin subunits that make up the microtubule structure. This modification can play a role in regulating microtubule dynamics and stability, and has been implicated in various cellular processes including cell division, intracellular transport, and neurodegeneration.", "label": 0, "is_selected": 1, "text": "How does glutamylation of microtubules play a role in cell division and neurodegenerative diseases such as Parkinson's disease and motor neurone disease, and how does this have implications for our understanding of the mechanisms by which these diseases occur?"}
{"qid": "5148e1d6d24251bc0500003a", "original_text": "Neurofibromatosis type I (NF1) is caused by a mutation in the tumor suppressor gene von Hippel-Lindau (VHL) located on chromosome 3p25. The VHL gene encodes a protein involved in the oxygen-dependent degradation of hypoxia-inducible factor (HIF), which is a transcription factor that regulates the expression of genes involved in angiogenesis and glucose metabolism. Mutations in the VHL gene lead to the development of benign and malignant tumors, including neurofibromas, which are the hallmark of NF1.", "label": 0, "is_selected": 0, "text": "Neurofibromatosis type I (NF1) is caused by a mutation in the tumor suppressor gene von Hippel-Lindau (VHL) located on chromosome 3p25. The VHL gene encodes a protein involved in the oxygen-dependent degradation of hypoxia-inducible factor (HIF), which is a transcription factor that regulates the expression of genes involved in angiogenesis and glucose metabolism. Mutations in the VHL gene lead to the development of benign and malignant tumors, including neurofibromas, which are the hallmark of NF1."}
{"qid": "5a67afb7b750ff445500000d", "original_text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (POEMS) syndrome is a multisystem disorder arising from underlying plasma cell dyscrasia. Renal impairment and related pathological changes have been reported, but data on its prevalence, response to therapy and impact on survival are still lacking. We retrospectively reviewed 299 patients diagnosed with POEMS syndrome in a tertiary-care university hospital from 2000 until 2014. The estimated glomerular filtration rate (eGFR) was used to define renal impairment and response, according to International Myeloma Working Group criteria. We examined the impact of renal impairment and response on patient survival. Sixty-seven patients (22.4%) had renal impairment (eGFR < 60 mL/min/1.73 m(2)) at baseline. In a multivariate analysis, ascites was independently associated with renal impairment [odds ratio (OR) 12.366, P < 0.001].", "label": 1, "is_selected": 0, "text": "Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (POEMS) syndrome is a multisystem disorder arising from underlying plasma cell dyscrasia. Renal impairment and related pathological changes have been reported, but data on its prevalence, response to therapy and impact on survival are still lacking. We retrospectively reviewed 299 patients diagnosed with POEMS syndrome in a tertiary-care university hospital from 2000 until 2014. The estimated glomerular filtration rate (eGFR) was used to define renal impairment and response, according to International Myeloma Working Group criteria. We examined the impact of renal impairment and response on patient survival. Sixty-seven patients (22.4%) had renal impairment (eGFR < 60 mL/min/1.73 m(2)) at baseline. In a multivariate analysis, ascites was independently associated with renal impairment [odds ratio (OR) 12.366, P < 0.001]."}
{"qid": "622dc4b63a8413c6530000a4", "original_text": "As a crucial virulence factor of Porphyromonas gingivalis, gingipains play an important role in periodontal destruction. This study aimed to investigate the effect of gingipains on osteoclastogenesis. We used RAW264.7 cells as osteoclast precursors in our study. In experimental groups, cells were treated with gingipains and/or receptor activator of nuclear factor-\u03baB ligand (RANKL). Tartrate-resistant acid phosphatase (TRAP) activity staining assay showed osteoclast precursors and RANKL-induced mature osteoclasts were increased in a gingipains dose-dependent manner. Real-time reverse transcription polymerase chain reaction analysis demonstrated that gingipains upregulated osteoclastic genes including the protease cathepsin K (Ctsk), matrix metalloprotein 9 (Mmp9), nuclear factor of activated T cells 1 (Nfatc1) and acid phosphatase 5, tartrate resistant (Acp5) in a time-dependent manner. Western blotting assays presented upregulated expressions of TNF receptor-activating factor 6 (TRAF6) and integrin \u03b23 induced by gingipains and RANKL compared to RANKL alone.", "label": 1, "is_selected": 0, "text": "As a crucial virulence factor of Porphyromonas gingivalis, gingipains play an important role in periodontal destruction. This study aimed to investigate the effect of gingipains on osteoclastogenesis. We used RAW264.7 cells as osteoclast precursors in our study. In experimental groups, cells were treated with gingipains and/or receptor activator of nuclear factor-\u03baB ligand (RANKL). Tartrate-resistant acid phosphatase (TRAP) activity staining assay showed osteoclast precursors and RANKL-induced mature osteoclasts were increased in a gingipains dose-dependent manner. Real-time reverse transcription polymerase chain reaction analysis demonstrated that gingipains upregulated osteoclastic genes including the protease cathepsin K (Ctsk), matrix metalloprotein 9 (Mmp9), nuclear factor of activated T cells 1 (Nfatc1) and acid phosphatase 5, tartrate resistant (Acp5) in a time-dependent manner. Western blotting assays presented upregulated expressions of TNF receptor-activating factor 6 (TRAF6) and integrin \u03b23 induced by gingipains and RANKL compared to RANKL alone."}
{"qid": "54cf4a0ef693c3b16b00000c", "original_text": "Pregabalin is an anticonvulsant drug that has been found to be effective in reducing symptoms of restless leg syndrome (RLS) in some studies. A systematic review and meta-analysis of 13 randomized controlled trials found that pregabalin resulted in significant improvements in RLS symptoms compared to placebo. The review also found that pregabalin was generally well-tolerated, with the most common adverse events being dizziness, somnolence, and dry mouth. However, it is important to note that the evidence for pregabalin's effectiveness in RLS is not yet conclusive, and more research is needed to fully understand its efficacy and safety in this condition. I don't have answer.", "label": 0, "is_selected": 0, "text": "Pregabalin is an anticonvulsant drug that has been found to be effective in reducing symptoms of restless leg syndrome (RLS) in some studies. A systematic review and meta-analysis of 13 randomized controlled trials found that pregabalin resulted in significant improvements in RLS symptoms compared to placebo. The review also found that pregabalin was generally well-tolerated, with the most common adverse events being dizziness, somnolence, and dry mouth. However, it is important to note that the evidence for pregabalin's effectiveness in RLS is not yet conclusive, and more research is needed to fully understand its efficacy and safety in this condition. I don't have answer."}
{"qid": "621ed10f3a8413c653000062", "original_text": "CD4(+)CD25(+) regulatory T cells (Tregs) are critical for the peripheral immune tolerance. Understanding the signals for the generation of Tregs is important for the clinical immunotherapy, but only limited progress has been made on obtaining enough peripheral Tregs. The aim of this study was to evaluate the role of trichosanthin (Tk) extracted from Chinese medicinal herb Trichosanthes kirilowi on the function of Tregs in vitro and in vivo. We reported here that Tk is needed for the expansion of freshly isolated CD4(+)CD25(+)Tregs (nTregs) into Tk-expanded CD4(+)CD25(+)Tregs (Tk-Tregs) through up-regulating CD25 and Foxp3 expression. The dose-response analyses indicated that 100 ng/ml Tk was the most appropriate dose. The result of real-time PCR showed that Tk-Tregs expressed 1.5-fold higher levels of Foxp3 than those observed in nTregs.", "label": 1, "is_selected": 0, "text": "CD4(+)CD25(+) regulatory T cells (Tregs) are critical for the peripheral immune tolerance. Understanding the signals for the generation of Tregs is important for the clinical immunotherapy, but only limited progress has been made on obtaining enough peripheral Tregs. The aim of this study was to evaluate the role of trichosanthin (Tk) extracted from Chinese medicinal herb Trichosanthes kirilowi on the function of Tregs in vitro and in vivo. We reported here that Tk is needed for the expansion of freshly isolated CD4(+)CD25(+)Tregs (nTregs) into Tk-expanded CD4(+)CD25(+)Tregs (Tk-Tregs) through up-regulating CD25 and Foxp3 expression. The dose-response analyses indicated that 100 ng/ml Tk was the most appropriate dose. The result of real-time PCR showed that Tk-Tregs expressed 1.5-fold higher levels of Foxp3 than those observed in nTregs."}
{"qid": "5cb0856decadf2e73f000058", "original_text": "Human dihydroorotate dehydrogenase (DHODH) is a drug target involved in the biosynthetic pathway of pyrimidines, which are important molecules in nucleic acids and DNA synthesis. Specifically, DHODH is a key enzyme in the de novo pathway of pyrimidine biosynthesis, which involves the conversion of orotate to uracil. Inhibition of DHODH has been investigated as a potential therapeutic strategy for various cancer types, as well as for the treatment of diseases caused by pyrimidine biosynthesis defects.", "label": 0, "is_selected": 0, "text": "Human dihydroorotate dehydrogenase (DHODH) is a drug target involved in the biosynthetic pathway of pyrimidines, which are important molecules in nucleic acids and DNA synthesis. Specifically, DHODH is a key enzyme in the de novo pathway of pyrimidine biosynthesis, which involves the conversion of orotate to uracil. Inhibition of DHODH has been investigated as a potential therapeutic strategy for various cancer types, as well as for the treatment of diseases caused by pyrimidine biosynthesis defects."}
{"qid": "530a34eb970c65fa6b000004", "original_text": "Identification of ancient biological samples from the 1991-discovered and more than 5300-year-old Tyrolean mummy, also called iceman or Oetzi, is very difficult. The species of origins of four animal-hair-bearing samples of the accoutrement of the mummy not yet diagnosed were identified by a special proteomics method. Ha 43/91/130 and Ha 6/91, two samples from his coat, and Ha 5/91, a sample from his leggings, were assigned to sheep. The upper leather of his moccasins, Ha 2/91, was made from cattle. Despite the enormous age of these samples with partial (bio)chemical alterations, reliable identification was possible using a recently developed matrix-assisted laser desorption/ionization time-of-flight mass spectrometric ((MALDI-TOF MS)-based analytical method.", "label": 1, "is_selected": 0, "text": "Identification of ancient biological samples from the 1991-discovered and more than 5300-year-old Tyrolean mummy, also called iceman or Oetzi, is very difficult. The species of origins of four animal-hair-bearing samples of the accoutrement of the mummy not yet diagnosed were identified by a special proteomics method. Ha 43/91/130 and Ha 6/91, two samples from his coat, and Ha 5/91, a sample from his leggings, were assigned to sheep. The upper leather of his moccasins, Ha 2/91, was made from cattle. Despite the enormous age of these samples with partial (bio)chemical alterations, reliable identification was possible using a recently developed matrix-assisted laser desorption/ionization time-of-flight mass spectrometric ((MALDI-TOF MS)-based analytical method."}
{"qid": "52bf1df903868f1b06000013", "original_text": "Opioids that stimulate the \u03bc-opioid receptor (MOR1) are the most frequently prescribed and effective analgesics. Here we present a structural model of MOR1. Molecular dynamics simulations show a ligand-dependent increase in the conformational flexibility of the third intracellular loop that couples with the G protein complex. These simulations likewise identified residues that form frequent contacts with ligands. We validated the binding residues using site-directed mutagenesis coupled with radioligand binding and functional assays. The model was used to blindly screen a library of \u223c1.2 million compounds.", "label": 1, "is_selected": 0, "text": "Opioids that stimulate the \u03bc-opioid receptor (MOR1) are the most frequently prescribed and effective analgesics. Here we present a structural model of MOR1. Molecular dynamics simulations show a ligand-dependent increase in the conformational flexibility of the third intracellular loop that couples with the G protein complex. These simulations likewise identified residues that form frequent contacts with ligands. We validated the binding residues using site-directed mutagenesis coupled with radioligand binding and functional assays. The model was used to blindly screen a library of \u223c1.2 million compounds."}
{"qid": "56d03a4d3975bb303a00000c", "original_text": "The anaplastic lymphoma kinase (ALK) is chromosomally rearranged in a subset of certain cancers, including 2% to 7% of non-small cell lung cancers (NSCLC) and \u223c70% of anaplastic large cell lymphomas (ALCL). The ALK kinase inhibitors crizotinib and ceritinib are approved for relapsed ALK(+) NSCLC, but acquired resistance to these drugs limits median progression-free survival on average to \u223c10 months. Kinase domain mutations are detectable in 25% to 37% of resistant NSCLC samples, with activation of bypass signaling pathways detected frequently with or without concurrent ALK mutations. Here we report that, in contrast to NSCLC cells, drug-resistant ALCL cells show no evidence of bypassing ALK by activating alternate signaling pathways. Instead, drug resistance selected in this setting reflects upregulation of ALK itself. Notably, in the absence of crizotinib or ceritinib, we found that increased ALK signaling rapidly arrested or killed cells, allowing a prolonged control of drug-resistant tumors in vivo with the administration of discontinuous rather than continuous regimens of drug dosing. Furthermore, even when drug resistance mutations were detected in the kinase domain, overexpression of the mutant ALK was toxic to tumor cells.", "label": 1, "is_selected": 0, "text": "The anaplastic lymphoma kinase (ALK) is chromosomally rearranged in a subset of certain cancers, including 2% to 7% of non-small cell lung cancers (NSCLC) and \u223c70% of anaplastic large cell lymphomas (ALCL). The ALK kinase inhibitors crizotinib and ceritinib are approved for relapsed ALK(+) NSCLC, but acquired resistance to these drugs limits median progression-free survival on average to \u223c10 months. Kinase domain mutations are detectable in 25% to 37% of resistant NSCLC samples, with activation of bypass signaling pathways detected frequently with or without concurrent ALK mutations. Here we report that, in contrast to NSCLC cells, drug-resistant ALCL cells show no evidence of bypassing ALK by activating alternate signaling pathways. Instead, drug resistance selected in this setting reflects upregulation of ALK itself. Notably, in the absence of crizotinib or ceritinib, we found that increased ALK signaling rapidly arrested or killed cells, allowing a prolonged control of drug-resistant tumors in vivo with the administration of discontinuous rather than continuous regimens of drug dosing. Furthermore, even when drug resistance mutations were detected in the kinase domain, overexpression of the mutant ALK was toxic to tumor cells."}
{"qid": "5133b9455274a5fb0700000c", "original_text": "The most prominent consensus sequence for the polyadenylation site is the AU-rich element (ARE), which is found in the 3' untranslated region (UTR) of many mRNAs. The ARE sequence is conserved across different species and is recognized by the polyadenylation complex, which adds the poly(A) tail to the mRNA. The consensus sequence is: GCACAAGCAG/T, where the slash indicates the inverted repeat. This sequence is highly enriched in the 3' UTR of many mRNAs and is a key element for polyadenylation.", "label": 0, "is_selected": 0, "text": "The most prominent consensus sequence for the polyadenylation site is the AU-rich element (ARE), which is found in the 3' untranslated region (UTR) of many mRNAs. The ARE sequence is conserved across different species and is recognized by the polyadenylation complex, which adds the poly(A) tail to the mRNA. The consensus sequence is: GCACAAGCAG/T, where the slash indicates the inverted repeat. This sequence is highly enriched in the 3' UTR of many mRNAs and is a key element for polyadenylation."}
{"qid": "5c6e16eb7c78d6947100004e", "original_text": "The components of sweat provide an array of potential biomarkers for health and disease. Sweat chloride is of interest as a biomarker for cystic fibrosis, electrolyte metabolism disorders, electrolyte balance, and electrolyte loss during exercise. Developing wearable sensors for biomarkers in sweat is a major technological challenge. Potentiometric sensors provide a relatively simple technology for on-body sweat chloride measurement, however, equilibration between reference and test solutions has limited the time over which accurate measurements can be made. Here, we report on a wearable potentiometric chloride sweat sensor. We performed parametric studies to show how the salt bridge geometry determines equilibration between the reference and test solutions.", "label": 1, "is_selected": 0, "text": "The components of sweat provide an array of potential biomarkers for health and disease. Sweat chloride is of interest as a biomarker for cystic fibrosis, electrolyte metabolism disorders, electrolyte balance, and electrolyte loss during exercise. Developing wearable sensors for biomarkers in sweat is a major technological challenge. Potentiometric sensors provide a relatively simple technology for on-body sweat chloride measurement, however, equilibration between reference and test solutions has limited the time over which accurate measurements can be made. Here, we report on a wearable potentiometric chloride sweat sensor. We performed parametric studies to show how the salt bridge geometry determines equilibration between the reference and test solutions."}
{"qid": "5c8c05c70101eac870000001", "original_text": "Lactotransferrin (LTF) has been confirmed to act as a tumor suppressor in multiple cancers; however, its roles in oral squamous cell carcinoma (OSCC), one of malignant head and neck carcinomas, has not been explored. Here, the expression of LTF in OSCC tissues and TCA8113 cells was detected with RT-PCR, qPCR, and IHC. And the correlation between LTF expression and OSCC metastasis was assessed. MS-PCR was performed to reveal the methylation status in promoter regions of LTF both in OSCC tissue samples and cells. The influences of 5-Aza-Cdc treatment to the methylation status and expression levels of LTF were also analyzed. At last, the functions of LTF in OSCC progression were demonstrated by MTT analysis, clone formation assay, and cell cycle analysis in TCA8113 cells with forced ectopic expression of LTF. LTF showed a low or null expression pattern in OSCC tissues and cells, at least partially, due to the hypermethylated status in promoter regions for 5-Aza-Cdc, a methyltransferase inhibitor, could restore the expression of LTF in TCA8113 cells.", "label": 1, "is_selected": 0, "text": "Lactotransferrin (LTF) has been confirmed to act as a tumor suppressor in multiple cancers; however, its roles in oral squamous cell carcinoma (OSCC), one of malignant head and neck carcinomas, has not been explored. Here, the expression of LTF in OSCC tissues and TCA8113 cells was detected with RT-PCR, qPCR, and IHC. And the correlation between LTF expression and OSCC metastasis was assessed. MS-PCR was performed to reveal the methylation status in promoter regions of LTF both in OSCC tissue samples and cells. The influences of 5-Aza-Cdc treatment to the methylation status and expression levels of LTF were also analyzed. At last, the functions of LTF in OSCC progression were demonstrated by MTT analysis, clone formation assay, and cell cycle analysis in TCA8113 cells with forced ectopic expression of LTF. LTF showed a low or null expression pattern in OSCC tissues and cells, at least partially, due to the hypermethylated status in promoter regions for 5-Aza-Cdc, a methyltransferase inhibitor, could restore the expression of LTF in TCA8113 cells."}
{"qid": "51602609298dcd4e5100003a", "original_text": "1. The purpose of this study was to examine the contribution of the sympatho-adrenomedullary system to the blood pressure response to an intravenous bolus of thyrotropin-releasing hormone (TRH) in conscious medullectomized and sham-operated rats. 2. The peak pressor effect of 0.5 mg TRH was significantly increased in rats having no adrenal medulla (+24.2 +/- 1.6 mmHg, mean +/- s.e.m., P < 0.01) as compared to sham-operated animals (+12.2 +/- 3.0 mmHg). 3. Blockade of alpha-adrenergic receptors with phentolamine abolished the pressor effect of TRH in control rats (+2.1 +/- 1.9 mmHg) but did not attenuate the blood pressure response of medullectomized rats (+21.5 +/- 4.7 mmHg). In contrast, beta-blockade with propranolol blunted the blood pressure responsiveness of rats subjected to adrenal medullectomy (+12.4 +/- 2.6 mmHg) but did not modify the effect of TRH in sham-operated controls (+10.9 +/- 2.9 mmHg). 4. The direct in vitro effect of TRH on isolated mesenteric rat arteries was also evaluated. TRH did not induce contractions of isolated arteries. 5. These results suggest that in rats with intact adrenals, the pressor effect of intravenous TRH is mediated primarily by a stimulation of alpha-adrenergic receptors.", "label": 1, "is_selected": 0, "text": "1. The purpose of this study was to examine the contribution of the sympatho-adrenomedullary system to the blood pressure response to an intravenous bolus of thyrotropin-releasing hormone (TRH) in conscious medullectomized and sham-operated rats. 2. The peak pressor effect of 0.5 mg TRH was significantly increased in rats having no adrenal medulla (+24.2 +/- 1.6 mmHg, mean +/- s.e.m., P < 0.01) as compared to sham-operated animals (+12.2 +/- 3.0 mmHg). 3. Blockade of alpha-adrenergic receptors with phentolamine abolished the pressor effect of TRH in control rats (+2.1 +/- 1.9 mmHg) but did not attenuate the blood pressure response of medullectomized rats (+21.5 +/- 4.7 mmHg). In contrast, beta-blockade with propranolol blunted the blood pressure responsiveness of rats subjected to adrenal medullectomy (+12.4 +/- 2.6 mmHg) but did not modify the effect of TRH in sham-operated controls (+10.9 +/- 2.9 mmHg). 4. The direct in vitro effect of TRH on isolated mesenteric rat arteries was also evaluated. TRH did not induce contractions of isolated arteries. 5. These results suggest that in rats with intact adrenals, the pressor effect of intravenous TRH is mediated primarily by a stimulation of alpha-adrenergic receptors."}
{"qid": "53319653d6d3ac6a3400003e", "original_text": "Yes, a prudent diet can significantly reduce the risk of cardiovascular disease. A well-balanced diet that emphasizes whole, unprocessed foods such as vegetables, fruits, whole grains, lean proteins, and healthy fats can help lower blood pressure, cholesterol levels, and body weight, all of which are important risk factors for cardiovascular disease. The dietary recommendations for reducing cardiovascular risk include limiting intake of saturated and trans fats, added sugars, and refined carbohydrates, while increasing consumption of omega-3 fatty acids, fiber, and antioxidants. A diet rich in vitamins, minerals, and plant-based foods may also help reduce inflammation and improve overall cardiovascular health. According to the American Heart Association, a heart-healthy diet should include a variety of fruits, vegetables, whole grains, lean proteins, and low-fat dairy products. It is also recommended to limit intake of sodium, added sugars, and saturated and trans fats. By following these guidelines, individuals can significantly reduce their risk of developing cardiovascular disease.", "label": 0, "is_selected": 0, "text": "Yes, a prudent diet can significantly reduce the risk of cardiovascular disease. A well-balanced diet that emphasizes whole, unprocessed foods such as vegetables, fruits, whole grains, lean proteins, and healthy fats can help lower blood pressure, cholesterol levels, and body weight, all of which are important risk factors for cardiovascular disease. The dietary recommendations for reducing cardiovascular risk include limiting intake of saturated and trans fats, added sugars, and refined carbohydrates, while increasing consumption of omega-3 fatty acids, fiber, and antioxidants. A diet rich in vitamins, minerals, and plant-based foods may also help reduce inflammation and improve overall cardiovascular health. According to the American Heart Association, a heart-healthy diet should include a variety of fruits, vegetables, whole grains, lean proteins, and low-fat dairy products. It is also recommended to limit intake of sodium, added sugars, and saturated and trans fats. By following these guidelines, individuals can significantly reduce their risk of developing cardiovascular disease."}
{"qid": "5177def18ed59a060a000034", "original_text": "Mutations in the K-ras oncogene and in the p53 tumor suppressor gene are commonly identified in sporadic cases of pancreatic adenocarcinoma. Although these genes might serve as useful markers for early diagnosis of pancreatic carcinoma in patients at risk for the development of this disease, familial pancreatic carcinomas have not been studied for these mutations. We recently had the opportunity to examine a pancreas prophylactically removed from a patient with a strong family history of pancreatic carcinoma. This gave us the unique opportunity to study the early events in the development of familial adenocarcinoma of the pancreas. Histopathological examination of the pancreas revealed multifocal papillary and nonpapillary mucinous duct hyperplasia. Seven of these foci were microdissected and analyzed for K-ras and p53 mutations. The K-ras mutations were detected by combined mutant-enriched polymerase chain reaction-restriction fragment length polymorphism analysis and characterized further by allele-specific oligonucleotide hybridization. Five of the seven duct lesions harbored activating point mutations in codon 12 of K-ras; a G to A transition was found in four and a G to C transversion in one. In contrast, these lesions did not harbor detectable p53 mutations as determined by denaturing gradient gel electrophoresis of exons 5 to 8, nor was there overexpression of the p53 protein as determined by immunohistochemistry.", "label": 1, "is_selected": 0, "text": "Mutations in the K-ras oncogene and in the p53 tumor suppressor gene are commonly identified in sporadic cases of pancreatic adenocarcinoma. Although these genes might serve as useful markers for early diagnosis of pancreatic carcinoma in patients at risk for the development of this disease, familial pancreatic carcinomas have not been studied for these mutations. We recently had the opportunity to examine a pancreas prophylactically removed from a patient with a strong family history of pancreatic carcinoma. This gave us the unique opportunity to study the early events in the development of familial adenocarcinoma of the pancreas. Histopathological examination of the pancreas revealed multifocal papillary and nonpapillary mucinous duct hyperplasia. Seven of these foci were microdissected and analyzed for K-ras and p53 mutations. The K-ras mutations were detected by combined mutant-enriched polymerase chain reaction-restriction fragment length polymorphism analysis and characterized further by allele-specific oligonucleotide hybridization. Five of the seven duct lesions harbored activating point mutations in codon 12 of K-ras; a G to A transition was found in four and a G to C transversion in one. In contrast, these lesions did not harbor detectable p53 mutations as determined by denaturing gradient gel electrophoresis of exons 5 to 8, nor was there overexpression of the p53 protein as determined by immunohistochemistry."}
{"qid": "5fdb4148a43ad31278000018", "original_text": "Tcf3 (transcription factor 3) plays a crucial role in the maintenance of pluripotency in embryonic stem cells. Tcf3 functions as a transcriptional repressor and binds to specific DNA sequences called E-box elements in the promoter region of pluripotency genes, such as Nanog and Lin28. By recruiting histone-modifying enzymes, Tcf3 can alter chromatin structure and silence the expression of genes that are incompatible with pluripotency, thereby maintaining the stem cell state. In addition, Tcf3 also regulates the expression of self-renewal and survival factors, such as Bmi1, and promotes the proliferation of stem cells.", "label": 0, "is_selected": 1, "text": "Here we report on the role of Tcf3 in the regulation of pluripotency and stem cell proliferation in mouse embryonic stem cell lines and in human embryonic stem cells and induced pluripotent stem cells (iPSCs) in a mouse model of Parkinson's disease."}
{"qid": "571e2beabb137a4b0c000006", "original_text": "Murine basophils can contribute to the T(H)2 polarization of the immune response by providing rapidly large amounts of IL-4, which suggests that pharmacologic downregulation of this cytokine might provide a strategy to attenuate pathologies associated with excessive production. We examined a number of physiological and pharmacologic ligands of the organic cation transporter 3 (OCT3), a membrane carrier of biogenic amines, for their inhibitory effect on IL-4 production by basophils, selecting the most efficient compounds for in vivo evaluation in basophil-dependent experimental models. IL-4 production by basophils isolated ex vivo or from bone marrow cultures was assessed in response to various stimuli with or without biogenic monoamines or pharmacologic analogs. Selected compounds were administered in vivo to examine their effect on levels of circulating IgE generated during a basophil-dependent T(H)2 response and on basophil activation in mice receiving IL-33. We found a drastic decrease in IL-4 production by stimulated basophils on exposure to serotonin (5-hydroxytryptamine [5-HT]) that is taken up by basophils through the specific high-affinity transporters serotonin transporter and the polyspecific, high-capacity organic cation transporter 3 (OCT3; or Slc22a3) but inhibits their function exclusively through the latter.", "label": 1, "is_selected": 0, "text": "Murine basophils can contribute to the T(H)2 polarization of the immune response by providing rapidly large amounts of IL-4, which suggests that pharmacologic downregulation of this cytokine might provide a strategy to attenuate pathologies associated with excessive production. We examined a number of physiological and pharmacologic ligands of the organic cation transporter 3 (OCT3), a membrane carrier of biogenic amines, for their inhibitory effect on IL-4 production by basophils, selecting the most efficient compounds for in vivo evaluation in basophil-dependent experimental models. IL-4 production by basophils isolated ex vivo or from bone marrow cultures was assessed in response to various stimuli with or without biogenic monoamines or pharmacologic analogs. Selected compounds were administered in vivo to examine their effect on levels of circulating IgE generated during a basophil-dependent T(H)2 response and on basophil activation in mice receiving IL-33. We found a drastic decrease in IL-4 production by stimulated basophils on exposure to serotonin (5-hydroxytryptamine [5-HT]) that is taken up by basophils through the specific high-affinity transporters serotonin transporter and the polyspecific, high-capacity organic cation transporter 3 (OCT3; or Slc22a3) but inhibits their function exclusively through the latter."}
{"qid": "550899c92e93f0133a000003", "original_text": "Modification of proteins by the addition of lysine (K)-63-linked polyubiquitin (polyUb) chains is suggested to play important roles in a variety of cellular events, including DNA repair, signal transduction, and receptor endocytosis. However, identifying such modifications in living cells is complex and cumbersome. We have generated a monoclonal antibody (mAb) that specifically recognizes K63-linked polyUb, but not any other isopeptide-linked (K6, K11, K27, K29, K33, or K48) polyUb or monoubiquitin. We demonstrate the sensitivity and specificity of this K63Ub-specific mAb to detect K63Ub-modified proteins in cell lysates by Western blotting and in cells by immunofluorescence, and K63Ub-modified TRAF6 and MEKK1 in vitro and ex vivo.", "label": 1, "is_selected": 0, "text": "Modification of proteins by the addition of lysine (K)-63-linked polyubiquitin (polyUb) chains is suggested to play important roles in a variety of cellular events, including DNA repair, signal transduction, and receptor endocytosis. However, identifying such modifications in living cells is complex and cumbersome. We have generated a monoclonal antibody (mAb) that specifically recognizes K63-linked polyUb, but not any other isopeptide-linked (K6, K11, K27, K29, K33, or K48) polyUb or monoubiquitin. We demonstrate the sensitivity and specificity of this K63Ub-specific mAb to detect K63Ub-modified proteins in cell lysates by Western blotting and in cells by immunofluorescence, and K63Ub-modified TRAF6 and MEKK1 in vitro and ex vivo."}
{"qid": "5c6f15577c78d69471000053", "original_text": "Galcanezumab is an injectable drug used to treat migraine attacks. Multiple clinical trials have demonstrated its effectiveness in reducing the severity and frequency of migraine episodes. In a phase 3 clinical trial, galcanezumab was shown to significantly reduce the number of days with migraine-related symptoms compared to placebo. Additionally, a meta-analysis of three phase 3 trials found that galcanezumab was superior to placebo in reducing migraine frequency and severity. However, it's important to note that galcanezumab is not a cure for migraine and may not be effective for everyone. It's also important to consult a medical professional before starting any new medication for migraine treatment.", "label": 0, "is_selected": 0, "text": "Galcanezumab is an injectable drug used to treat migraine attacks. Multiple clinical trials have demonstrated its effectiveness in reducing the severity and frequency of migraine episodes. In a phase 3 clinical trial, galcanezumab was shown to significantly reduce the number of days with migraine-related symptoms compared to placebo. Additionally, a meta-analysis of three phase 3 trials found that galcanezumab was superior to placebo in reducing migraine frequency and severity. However, it's important to note that galcanezumab is not a cure for migraine and may not be effective for everyone. It's also important to consult a medical professional before starting any new medication for migraine treatment."}
{"qid": "5c34a029da8336e21a000003", "original_text": "Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with wide clinical features ranging from cutaneous manifestations to systemic disease. Skin is one of the most commonly affected organs in SLE. To determine whether there is any correlation between discoid lupus erythematosus (DLE) and the severity of SLE. In a prospective cross-sectional study, 60 consecutive patients with newly diagnosed SLE were enrolled. Skin biopsy was performed to establish the diagnosis of DLE. Disease activity was determined by the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K). A SLEDAI-2K score \u2265 10 was considered active and severe disease. Eleven SLE patients (9 females and 2 males) had DLE (18.3%) and 49 patients (46 females and 3 males) had SLE without DLE (81.7%). The mean age of patients with DLE was 30.18 \u00b1 11.07 years and in patients without it was 28.4 \u00b1 10.26 years (p = .6). Three of 11 patients with DLE (27.3%) and 14 of 49 patients without DLE (28.6%) had a SLEDAI-2K score \u2265 10 (p = 1).", "label": 1, "is_selected": 0, "text": "Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with wide clinical features ranging from cutaneous manifestations to systemic disease. Skin is one of the most commonly affected organs in SLE. To determine whether there is any correlation between discoid lupus erythematosus (DLE) and the severity of SLE. In a prospective cross-sectional study, 60 consecutive patients with newly diagnosed SLE were enrolled. Skin biopsy was performed to establish the diagnosis of DLE. Disease activity was determined by the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K). A SLEDAI-2K score \u2265 10 was considered active and severe disease. Eleven SLE patients (9 females and 2 males) had DLE (18.3%) and 49 patients (46 females and 3 males) had SLE without DLE (81.7%). The mean age of patients with DLE was 30.18 \u00b1 11.07 years and in patients without it was 28.4 \u00b1 10.26 years (p = .6). Three of 11 patients with DLE (27.3%) and 14 of 49 patients without DLE (28.6%) had a SLEDAI-2K score \u2265 10 (p = 1)."}
{"qid": "58dcbb8c8acda34529000021", "original_text": "Histone chaperones that escort histones during their overall lifetime from synthesis to sites of usage can participate in various tasks. Their requirement culminates in the dynamic processes of nucleosome assembly and disassembly. In this context, it is important to define the exact role of the histone chaperone Asf1. In mammals, Asf1 interacts with two other chaperones, CAF-1 and HIRA, which are critical in DNA synthesis-coupled and synthesis-uncoupled nucleosome assembly pathways, respectively. A key issue is whether Asf1 is able or not to deposit histones onto DNA by itself in both pathways.", "label": 1, "is_selected": 0, "text": "Histone chaperones that escort histones during their overall lifetime from synthesis to sites of usage can participate in various tasks. Their requirement culminates in the dynamic processes of nucleosome assembly and disassembly. In this context, it is important to define the exact role of the histone chaperone Asf1. In mammals, Asf1 interacts with two other chaperones, CAF-1 and HIRA, which are critical in DNA synthesis-coupled and synthesis-uncoupled nucleosome assembly pathways, respectively. A key issue is whether Asf1 is able or not to deposit histones onto DNA by itself in both pathways."}
{"qid": "5e48bf5ed14c9f295d000019", "original_text": "The Salzburg EEG criteria are used to diagnose and differentiate between various neurological disorders, particularly epilepsy and seizures. These criteria were developed at the University of Salzburg in Austria and have been widely used in clinical practice and research. The criteria are based on the analysis of electroencephalogram (EEG) recordings and are used to identify specific patterns of brain activity that are associated with different neurological disorders. The Salzburg EEG criteria are used to diagnose the following disorders: 1. Epilepsy: The criteria are used to diagnose and classify different types of epilepsy, such as partial onset seizures, generalized seizures, and tonic-clonic seizures. 2. Seizures: The criteria are used to diagnose and differentiate between different types of seizures, such as simple partial seizures, complex partial seizures, and secondarily generalized seizures. 3. Status epilepticus: The criteria are used to diagnose and manage status epilepticus, a condition characterized by continuous seizure activity lasting for more than 24 hours. 4. Absence epilepsy: The criteria are used to diagnose and manage absence epilepsy, a condition characterized by brief periods of absence or loss of consciousness. 5. Myoclonus epilepsy: The criteria are used to diagnose and manage myoclonus epilepsy, a condition characterized by muscle jerks or twitches that occur in association with seizures. 6. Lennox-Gastaut syndrome: The criteria are used to diagnose and manage Lennox-Gastaut syndrome, a rare and severe form of epilepsy that is characterized by multiple types of seizures, including tonic, atonic, and myoclonic seizures. It is important to note that the Salzburg EEG criteria are not a definitive diagnostic tool and may not be able to distinguish between all possible neurological disorders. Therefore, it is important to use the criteria in conjunction with other diagnostic tools and clinical evaluation to make an accurate diagnosis and develop an appropriate treatment plan.", "label": 0, "is_selected": 1, "text": "The American Academy of Neurology (AAN) has approved the Salzburg EEG criteria for the diagnosis and management of epilepsy, Lennox-Gastaut syndrome, status epilepticus, Absence epilepsy, and myoclonus epilepsy. The criteria are based on the analysis of electroencephalogram (EEG) recordings and are used to identify specific patterns of brain activity that are associated with different neurological disorders. Lennox- Gastaut Syndrome: The criteria were developed by researchers at the University of Salzburg in Austria and have been widely used in clinical practice and research by neurologists and other medical professionals in Europe and the United States to diagnose and manage epilepsy, epilepsy-related seizures, and other neurological disorders, such as Lennox-gastaut syndromes."}
{"qid": "602599251cb411341a0000b1", "original_text": "The use of biologic disease-modifying anti-rheumatic drugs (bDMARDs) during pregnancy may potentially impact neonatal development. Studies have shown that exposure to these medications during fetal development can result in various changes, including smaller size and lower birth weight. However, the magnitude of these effects can vary depending on the specific drug, dosage, and timing of exposure during pregnancy. It is essential for pregnant women with rheumatoid arthritis or other inflammatory conditions to discuss their treatment options with their healthcare provider, including the potential risks and benefits of bDMARDs during pregnancy.", "label": 0, "is_selected": 0, "text": "The use of biologic disease-modifying anti-rheumatic drugs (bDMARDs) during pregnancy may potentially impact neonatal development. Studies have shown that exposure to these medications during fetal development can result in various changes, including smaller size and lower birth weight. However, the magnitude of these effects can vary depending on the specific drug, dosage, and timing of exposure during pregnancy. It is essential for pregnant women with rheumatoid arthritis or other inflammatory conditions to discuss their treatment options with their healthcare provider, including the potential risks and benefits of bDMARDs during pregnancy."}
{"qid": "5a7d535ffaa1ab7d2e000018", "original_text": "IVIG (Intravenous Immunoglobulin) treatment for Alzheimer's disease typically contains a mixture of antibodies from donated blood plasma, which are derived from healthy donors. The main components of IVIG are: 1. Immunoglobulins: These are the primary active moieties in IVIG, which are made up of protein subunits called immunoglobulin light chains and heavy chains. Immunoglobulins provide a broad range of immune functions, including antibody production, complement activation, and cytokine regulation. 2. Antibodies: IVIG contains a variety of antibodies, including IgG, IgM, IgA, and IgD. These antibodies are present in different proportions depending on the specific donor and production process. Antibodies recognize and bind to specific antigens, triggering an immune response. 3. Complement proteins: IVIG contains complement proteins, such as C1q, C3, C4, and C5, which play a crucial role in the immune response. Complement proteins help to activate the immune system by marking pathogens for destruction, activating neutrophils and macrophages, and opsonizing immune complexes for phagocytosis. 4. Glycoproteins: IVIG contains glycoproteins, including transferrin, lactoferrin, and haptoglobin, which are involved in various cellular processes, including iron metabolism, cell adhesion, and immune function. 5. Cytokines: IVIG contains a range of cytokines, including interleukins (IL-1, IL-6, IL-8, and IL-10), tumor necrosis factor (TNF), and interferons (IFN-alpha, IFN-beta, and IFN-gamma). Cytokines are signalling molecules that help to coordinate the immune response. 6. Other components: IVIG may also contain other components, including albumin, globulins, and trace elements, such as zinc, copper, and selenium. These components provide a range of functions, including maintaining blood pressure, supporting cell growth and differentiation, and modulating the immune response. It's important to note that the exact components of IVIG may vary depending on the specific product and manufacturer. Additionally, the concentration and proportions of each component may differ between different batches of the same product. Therefore, it's important to consult with a healthcare professional to determine the appropriate IVIG product and dosing regimen for Alzheimer's disease treatment.", "label": 0, "is_selected": 0, "text": "IVIG (Intravenous Immunoglobulin) treatment for Alzheimer's disease typically contains a mixture of antibodies from donated blood plasma, which are derived from healthy donors. The main components of IVIG are: 1. Immunoglobulins: These are the primary active moieties in IVIG, which are made up of protein subunits called immunoglobulin light chains and heavy chains. Immunoglobulins provide a broad range of immune functions, including antibody production, complement activation, and cytokine regulation. 2. Antibodies: IVIG contains a variety of antibodies, including IgG, IgM, IgA, and IgD. These antibodies are present in different proportions depending on the specific donor and production process. Antibodies recognize and bind to specific antigens, triggering an immune response. 3. Complement proteins: IVIG contains complement proteins, such as C1q, C3, C4, and C5, which play a crucial role in the immune response. Complement proteins help to activate the immune system by marking pathogens for destruction, activating neutrophils and macrophages, and opsonizing immune complexes for phagocytosis. 4. Glycoproteins: IVIG contains glycoproteins, including transferrin, lactoferrin, and haptoglobin, which are involved in various cellular processes, including iron metabolism, cell adhesion, and immune function. 5. Cytokines: IVIG contains a range of cytokines, including interleukins (IL-1, IL-6, IL-8, and IL-10), tumor necrosis factor (TNF), and interferons (IFN-alpha, IFN-beta, and IFN-gamma). Cytokines are signalling molecules that help to coordinate the immune response. 6. Other components: IVIG may also contain other components, including albumin, globulins, and trace elements, such as zinc, copper, and selenium. These components provide a range of functions, including maintaining blood pressure, supporting cell growth and differentiation, and modulating the immune response. It's important to note that the exact components of IVIG may vary depending on the specific product and manufacturer. Additionally, the concentration and proportions of each component may differ between different batches of the same product. Therefore, it's important to consult with a healthcare professional to determine the appropriate IVIG product and dosing regimen for Alzheimer's disease treatment."}
{"qid": "58946d6e7d9090f353000005", "original_text": "The analysis of chromatin structure is essential for the understanding of transcriptional regulation in eukaryotes. Here we describe methidiumpropyl-EDTA sequencing (MPE-seq), a method for the genome-wide characterization of chromatin that involves the digestion of nuclei withMPE-Fe(II) followed by massively parallel sequencing. Like micrococcal nuclease (MNase), MPE-Fe(II) preferentially cleaves the linker DNA between nucleosomes. However, there are differences in the cleavage of nuclear chromatin by MPE-Fe(II) relative to MNase. Most notably, immediately upstream of the transcription start site of active promoters, we frequently observed nucleosome-sized (141-190 bp) and subnucleosome-sized (such as 101-140 bp) peaks of digested chromatin fragments with MPE-seq but not with MNase-seq. These peaks also correlate with the presence of core histones and could thus be due, at least in part, to noncanonical chromatin structures such as labile nucleosome-like particles that have been observed in other contexts.", "label": 1, "is_selected": 0, "text": "The analysis of chromatin structure is essential for the understanding of transcriptional regulation in eukaryotes. Here we describe methidiumpropyl-EDTA sequencing (MPE-seq), a method for the genome-wide characterization of chromatin that involves the digestion of nuclei withMPE-Fe(II) followed by massively parallel sequencing. Like micrococcal nuclease (MNase), MPE-Fe(II) preferentially cleaves the linker DNA between nucleosomes. However, there are differences in the cleavage of nuclear chromatin by MPE-Fe(II) relative to MNase. Most notably, immediately upstream of the transcription start site of active promoters, we frequently observed nucleosome-sized (141-190 bp) and subnucleosome-sized (such as 101-140 bp) peaks of digested chromatin fragments with MPE-seq but not with MNase-seq. These peaks also correlate with the presence of core histones and could thus be due, at least in part, to noncanonical chromatin structures such as labile nucleosome-like particles that have been observed in other contexts."}
{"qid": "56ffd08bcf1c325851000009", "original_text": "To get insight into the early evolution of the primate Alu elements, we characterized sequences of these repeats from the Malagasy prosimians, lemurs (Lemuridae) and sifakas (Indriidae), as well as from galagos (Lorisidae). These sequences were compared with the oldest Alu species known from the human genome: dimeric Alu J and S and free Alu monomers.", "label": 1, "is_selected": 0, "text": "To get insight into the early evolution of the primate Alu elements, we characterized sequences of these repeats from the Malagasy prosimians, lemurs (Lemuridae) and sifakas (Indriidae), as well as from galagos (Lorisidae). These sequences were compared with the oldest Alu species known from the human genome: dimeric Alu J and S and free Alu monomers."}
{"qid": "5c9d18f1ecadf2e73f000033", "original_text": "Patient phenotypes in pharmacological pain treatment varies between individuals, which could be partly assigned to their genotypes regarding the targets of classical analgesics (OPRM1, PTGS2) or associated signalling pathways (KCNJ6). Translational and genetic research have identified new targets, for which new analgesics are being developed. This addresses voltage-gated sodium, calcium and potassium channels, for which SCN9A, CACNA1B, KCNQ2 and KCNQ3, respectively, are primary gene candidates because they code for the subunits of the respective channels targeted by analgesics currently in clinical development. Mutations in voltage gated transient receptor potential (TRPV) channels are known from genetic pain research and may modulate the effects of analgesics under development targeting TRPV1 or TRPV3. To this add ligand-gated ion channels including nicotinic acetylcholine receptors, ionotropic glutamate-gated receptors and ATP-gated purinergic P2X receptors with most important subunits coded by CHRNA4, GRIN2B and P2RX7. Among G protein coupled receptors, \u03b4-opioid receptors (coded by OPRD1), cannabinoid receptors (CNR1 and CNR2), metabotropic glutamate receptors (mGluR5 coded by GRM5), bradykinin B(1) (BDKRB1) and 5-HT(1A) (HTR1A) receptors are targeted by new analgesic substances. Finally, nerve growth factor (NGFB), its tyrosine kinase receptor (NTRK1) and the fatty acid amide hydrolase (FAAH) have become targets of interest. For most of these genes, functional variants have been associated with neuro-psychiatric disorders and not yet with analgesia. However, research on the genetic modulation of pain has already identified variants in these genes, relative to pain, which may facilitate the pharmacogenetic assessments of new analgesics.", "label": 1, "is_selected": 0, "text": "Patient phenotypes in pharmacological pain treatment varies between individuals, which could be partly assigned to their genotypes regarding the targets of classical analgesics (OPRM1, PTGS2) or associated signalling pathways (KCNJ6). Translational and genetic research have identified new targets, for which new analgesics are being developed. This addresses voltage-gated sodium, calcium and potassium channels, for which SCN9A, CACNA1B, KCNQ2 and KCNQ3, respectively, are primary gene candidates because they code for the subunits of the respective channels targeted by analgesics currently in clinical development. Mutations in voltage gated transient receptor potential (TRPV) channels are known from genetic pain research and may modulate the effects of analgesics under development targeting TRPV1 or TRPV3. To this add ligand-gated ion channels including nicotinic acetylcholine receptors, ionotropic glutamate-gated receptors and ATP-gated purinergic P2X receptors with most important subunits coded by CHRNA4, GRIN2B and P2RX7. Among G protein coupled receptors, \u03b4-opioid receptors (coded by OPRD1), cannabinoid receptors (CNR1 and CNR2), metabotropic glutamate receptors (mGluR5 coded by GRM5), bradykinin B(1) (BDKRB1) and 5-HT(1A) (HTR1A) receptors are targeted by new analgesic substances. Finally, nerve growth factor (NGFB), its tyrosine kinase receptor (NTRK1) and the fatty acid amide hydrolase (FAAH) have become targets of interest. For most of these genes, functional variants have been associated with neuro-psychiatric disorders and not yet with analgesia. However, research on the genetic modulation of pain has already identified variants in these genes, relative to pain, which may facilitate the pharmacogenetic assessments of new analgesics."}
{"qid": "532670e7d6d3ac6a34000008", "original_text": "Early after coronary artery bypass graft surgery (CABG), there is a common alteration in thyroid profile metabolism, which includes: * Decreased levels of free triiodothyronine (FT3) and free thyroxine (FT4) in the blood. This is due to the administration of beta-blockers, which can suppress thyroid function. * Increased levels of thyroid-stimulating hormone (TSH) in the blood. This is a compensatory response to the decreased levels of FT3 and FT4, as the pituitary gland tries to stimulate the thyroid gland to produce more hormones. * Mild hypothyroidism is also common in the early post-operative period, especially in patients who have undergone a prolonged surgery or have developed hypopituitarism, a condition where the pituitary gland is damaged. It's important to monitor thyroid function closely in the early post-operative period to detect any changes and initiate appropriate treatment if necessary.", "label": 0, "is_selected": 1, "text": "Changes in thyroid function following coronary artery bypass graft surgery are common and should be monitored closely in the early post-operative period, according to a new study in the British Journal of Sports Medicine (BJSM) - the first of its kind to look at the effects of thyroid function after CABG surgery in patients who have undergone a prolonged operation."}
{"qid": "52f88a062059c6d71c000032", "original_text": "Making informed decisions about breast and prostate cancer screening requires knowledge of its benefits. However, country-specific information on public knowledge of the benefits of screening is lacking. Face-to-face computer-assisted personal interviews were conducted with 10,228 persons selected by a representative quota method in nine European countries (Austria, France, Germany, Italy, the Netherlands, Poland, Russia, Spain, and the United Kingdom) to assess perceptions of cancer-specific mortality reduction associated with mammography and prostate-specific antigen (PSA) screening. Participants were also queried on the extent to which they consulted 14 different sources of health information. Correlation coefficients between frequency of use of particular sources and the accuracy of estimates of screening benefit were calculated. Ninety-two percent of women overestimated the mortality reduction from mammography screening by at least one order of magnitude or reported that they did not know. Eighty-nine percent of men overestimated the benefits of PSA screening by a similar extent or did not know. Women and men aged 50-69 years, and thus targeted by screening programs, were not substantially better informed about the benefits of mammography and PSA screening, respectively, than men and women overall. Frequent consulting of physicians (r = .07, 95% confidence interval", "label": 1, "is_selected": 0, "text": "Making informed decisions about breast and prostate cancer screening requires knowledge of its benefits. However, country-specific information on public knowledge of the benefits of screening is lacking. Face-to-face computer-assisted personal interviews were conducted with 10,228 persons selected by a representative quota method in nine European countries (Austria, France, Germany, Italy, the Netherlands, Poland, Russia, Spain, and the United Kingdom) to assess perceptions of cancer-specific mortality reduction associated with mammography and prostate-specific antigen (PSA) screening. Participants were also queried on the extent to which they consulted 14 different sources of health information. Correlation coefficients between frequency of use of particular sources and the accuracy of estimates of screening benefit were calculated. Ninety-two percent of women overestimated the mortality reduction from mammography screening by at least one order of magnitude or reported that they did not know. Eighty-nine percent of men overestimated the benefits of PSA screening by a similar extent or did not know. Women and men aged 50-69 years, and thus targeted by screening programs, were not substantially better informed about the benefits of mammography and PSA screening, respectively, than men and women overall. Frequent consulting of physicians (r = .07, 95% confidence interval"}
{"qid": "61fbc613c9dfcb9c09000010", "original_text": "Avandamet is a prescription medication that contains two active ingredients: rosiglitazone and metformin. Rosiglitazone is a thiazolidinedione (TZD) that works by increasing the body's sensitivity to insulin, while metformin is a biguanide that helps reduce the amount of glucose produced by the liver and increases the body's ability to use insulin effectively. The Avandamet pill is used to treat type 2 diabetes by reducing blood sugar levels and improving insulin sensitivity.", "label": 0, "is_selected": 1, "text": "The European Medicines Agency (EMA) has approved Avandamet (rosiglitazone) tablets for the treatment of type 2 diabetes in combination with diet and exercise for adults aged 12 years and older, and for use in adults aged 18 years and over."}
{"qid": "60320ef51cb411341a000130", "original_text": "Immune evasion from NK surveillance related to inadequate NK-cell function has been suggested as an explanation of the high incidence of relapse and fatal outcome of many blood malignancies. In this report we have used Jurkat and Raji cell lines as a model for studies of the NKG2D receptor-ligand system in T-and B cell leukemia/lymphoma. Using real-time quantitative RT-PCR and immunoflow cytometry we show that Jurkat and Raji cells constitutively express mRNA and protein for the stress-inducible NKG2D ligands MICA/B and ULBP1 and 2, and up-regulate the expression in a cell-line specific and stress-specific manner. Furthermore, we revealed by electron microscopy, immunoflow cytometry and western blot that these ligands were expressed and secreted on exosomes, nanometer-sized microvesicles of endosomal origin.", "label": 1, "is_selected": 0, "text": "Immune evasion from NK surveillance related to inadequate NK-cell function has been suggested as an explanation of the high incidence of relapse and fatal outcome of many blood malignancies. In this report we have used Jurkat and Raji cell lines as a model for studies of the NKG2D receptor-ligand system in T-and B cell leukemia/lymphoma. Using real-time quantitative RT-PCR and immunoflow cytometry we show that Jurkat and Raji cells constitutively express mRNA and protein for the stress-inducible NKG2D ligands MICA/B and ULBP1 and 2, and up-regulate the expression in a cell-line specific and stress-specific manner. Furthermore, we revealed by electron microscopy, immunoflow cytometry and western blot that these ligands were expressed and secreted on exosomes, nanometer-sized microvesicles of endosomal origin."}
{"qid": "51740da48ed59a060a000024", "original_text": "Accurate gene structure annotation is a challenging computational problem in genomics. The best results are achieved with spliced alignment of full-length cDNAs or multiple expressed sequence tags (ESTs) with sufficient overlap to cover the entire gene. For most species, cDNA and EST collections are far from comprehensive. We sought to overcome this bottleneck by exploring the possibility of using combined EST resources from fairly diverged species that still share a common gene space. Previous spliced alignment tools were found inadequate for this task because they rely on very high sequence similarity between the ESTs and the genomic DNA. We have developed a computer program, GeneSeqer, which is capable of aligning thousands of ESTs with a long genomic sequence in a reasonable amount of time. The algorithm is uniquely designed to tolerate a high percentage of mismatches and insertions or deletions in the EST relative to the genomic template. This feature allows use of non-cognate ESTs for gene structure prediction, including ESTs derived from duplicated genes and homologous genes from related species. The increased gene prediction sensitivity results in part from novel splice site prediction models that are also available as a stand-alone splice site prediction tool. We assessed GeneSeqer performance relative to a standard Arabidopsis thaliana gene set and demonstrate its utility for plant genome annotation. In particular, we propose that this method provides a timely tool for the annotation of the rice genome, using abundant ESTs from other cereals and plants. The source code is available for download at http://bioinformatics.iastate.edu/bioinformatics2go/gs/download.html. Web servers for Arabidopsis and other plant species are accessible at http://www.plantgdb.org/cgi-bin/AtGeneSeqer.cgi and http://www.plantgdb.org/cgi-bin/GeneSeqer.cgi, respectively. For non-plant species, use http://bioinformatics.iastate.edu/cgi-bin/gs.cgi.", "label": 1, "is_selected": 0, "text": "Accurate gene structure annotation is a challenging computational problem in genomics. The best results are achieved with spliced alignment of full-length cDNAs or multiple expressed sequence tags (ESTs) with sufficient overlap to cover the entire gene. For most species, cDNA and EST collections are far from comprehensive. We sought to overcome this bottleneck by exploring the possibility of using combined EST resources from fairly diverged species that still share a common gene space. Previous spliced alignment tools were found inadequate for this task because they rely on very high sequence similarity between the ESTs and the genomic DNA. We have developed a computer program, GeneSeqer, which is capable of aligning thousands of ESTs with a long genomic sequence in a reasonable amount of time. The algorithm is uniquely designed to tolerate a high percentage of mismatches and insertions or deletions in the EST relative to the genomic template. This feature allows use of non-cognate ESTs for gene structure prediction, including ESTs derived from duplicated genes and homologous genes from related species. The increased gene prediction sensitivity results in part from novel splice site prediction models that are also available as a stand-alone splice site prediction tool. We assessed GeneSeqer performance relative to a standard Arabidopsis thaliana gene set and demonstrate its utility for plant genome annotation. In particular, we propose that this method provides a timely tool for the annotation of the rice genome, using abundant ESTs from other cereals and plants. The source code is available for download at http://bioinformatics.iastate.edu/bioinformatics2go/gs/download.html. Web servers for Arabidopsis and other plant species are accessible at http://www.plantgdb.org/cgi-bin/AtGeneSeqer.cgi and http://www.plantgdb.org/cgi-bin/GeneSeqer.cgi, respectively. For non-plant species, use http://bioinformatics.iastate.edu/cgi-bin/gs.cgi."}
{"qid": "58add7699ef3c34033000009", "original_text": "The yeast Cleavage and Polyadenylation Complex (CPC) contains several proteins, including: * Pcf11: A catalytic subunit that cleaves pre-mRNA * Pcf22: A subunit that binds and stabilizes the cleaved pre-mRNA * Pcf17: A subunit that mediates the polyadenylation reaction * Pcf226: A subunit that interacts with the Cleavage and Polyadenylation Factor (CPF) In addition, the CPC also contains other proteins such as Nab3, Nab20, and Srb7, which play roles in pre-mRNA splicing, polyadenylation, and mRNA export.", "label": 0, "is_selected": 1, "text": "The Cleavage and Polyadenylation Complex (CPC) is a complex of proteins that cleaves pre-mRNA, binds to it, and produces polyadenylating RNA, which is then exported to the host cell to be used as a scaffold for RNAi."}
{"qid": "530c844e970c65fa6b000014", "original_text": "The human mitochondrial genome (mtDNA) encodes polypeptides that are critical for coupling oxidative phosphorylation. Our detailed understanding of the molecular processes that mediate mitochondrial gene expression and the structure-function relationships of the OXPHOS components could be greatly improved if we were able to transfect mitochondria and manipulate mtDNA in vivo. Increasing our knowledge of this process is not merely of fundamental importance, as mutations of the mitochondrial genome are known to cause a spectrum of clinical disorders and have been implicated in more common neurodegenerative disease and the ageing process. In organellar or in vitro reconstitution studies have identified many factors central to the mechanisms of mitochondrial gene expression, but being able to investigate the molecular aetiology of a limited number of cell lines from patients harbouring mutated mtDNA has been enormously beneficial. In the absence of a mechanism for manipulating mtDNA, a much larger pool of pathogenic mtDNA mutations would increase our knowledge of mitochondrial gene expression. Colonic crypts from ageing individuals harbour mutated mtDNA.", "label": 1, "is_selected": 0, "text": "The human mitochondrial genome (mtDNA) encodes polypeptides that are critical for coupling oxidative phosphorylation. Our detailed understanding of the molecular processes that mediate mitochondrial gene expression and the structure-function relationships of the OXPHOS components could be greatly improved if we were able to transfect mitochondria and manipulate mtDNA in vivo. Increasing our knowledge of this process is not merely of fundamental importance, as mutations of the mitochondrial genome are known to cause a spectrum of clinical disorders and have been implicated in more common neurodegenerative disease and the ageing process. In organellar or in vitro reconstitution studies have identified many factors central to the mechanisms of mitochondrial gene expression, but being able to investigate the molecular aetiology of a limited number of cell lines from patients harbouring mutated mtDNA has been enormously beneficial. In the absence of a mechanism for manipulating mtDNA, a much larger pool of pathogenic mtDNA mutations would increase our knowledge of mitochondrial gene expression. Colonic crypts from ageing individuals harbour mutated mtDNA."}
{"qid": "60570fe494d57fd879000026", "original_text": "Hemoglobin is one of the most important molecules of the human body. Beyond its physiological activity, hemoglobins are able to inhibit the growth of several microorganisms. Since 1999, studies have reported that antimicrobial peptides can be produced by blood-feeding insects through hemoglobin digestion, and it has been reported that Triatoma infestans can generate an antimicrobial fragment from human fibrinopeptide. Thus T. infestans intestinal content was analyzed through Reverse Phase High-Performance Liquid Chromatography (RP-HPLC), the eluted fractions were tested against Micrococcus luteus, Escherichia coli and Staphylococcus aureus, and the active fractions submitted to mass spectrometry.", "label": 1, "is_selected": 0, "text": "Hemoglobin is one of the most important molecules of the human body. Beyond its physiological activity, hemoglobins are able to inhibit the growth of several microorganisms. Since 1999, studies have reported that antimicrobial peptides can be produced by blood-feeding insects through hemoglobin digestion, and it has been reported that Triatoma infestans can generate an antimicrobial fragment from human fibrinopeptide. Thus T. infestans intestinal content was analyzed through Reverse Phase High-Performance Liquid Chromatography (RP-HPLC), the eluted fractions were tested against Micrococcus luteus, Escherichia coli and Staphylococcus aureus, and the active fractions submitted to mass spectrometry."}
{"qid": "5c34ac49da8336e21a000006", "original_text": "Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease characterized by production of autoantibodies against a series of nuclear antigens. Although the exact cause of SLE is still unknown, the influence of environment, which is largely reflected by the epigenetic mechanisms, with DNA methylation changes in particular, are generally considered as key players in the pathogenesis of SLE. As an important post-translational modification, DNA methylation mainly suppresses the expression of relevant genes. Accumulating evidence has indicated that abnormal DNA hypomethylation in T cells is an important epigenetic hallmark in SLE.", "label": 1, "is_selected": 0, "text": "Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease characterized by production of autoantibodies against a series of nuclear antigens. Although the exact cause of SLE is still unknown, the influence of environment, which is largely reflected by the epigenetic mechanisms, with DNA methylation changes in particular, are generally considered as key players in the pathogenesis of SLE. As an important post-translational modification, DNA methylation mainly suppresses the expression of relevant genes. Accumulating evidence has indicated that abnormal DNA hypomethylation in T cells is an important epigenetic hallmark in SLE."}
{"qid": "6278d0a756bf9aee6f00000e", "original_text": "Yes, p85\u03b1 homodimerizes. The p85\u03b1 protein is composed of two identical subunits, p85\u03b11 and p85\u03b12, which are capable of forming homodimers through multiple interactions between their intracellular domains. These homodimers play a critical role in the activation of downstream signaling pathways, including the PI3K/Akt signaling pathway.", "label": 0, "is_selected": 0, "text": "Yes, p85\u03b1 homodimerizes. The p85\u03b1 protein is composed of two identical subunits, p85\u03b11 and p85\u03b12, which are capable of forming homodimers through multiple interactions between their intracellular domains. These homodimers play a critical role in the activation of downstream signaling pathways, including the PI3K/Akt signaling pathway."}
{"qid": "587e2300fc7e8dd84f000004", "original_text": "The R package \"brainTumor\" (https://CRAN.R-project.org/package=brainTumor) can be used for the identification of pediatric brain tumors. This package provides a set of tools for tumor segmentation, classification, and feature extraction from MRI images. It also includes a dataset of pediatric brain tumors for training and testing purposes.", "label": 0, "is_selected": 0, "text": "The R package \"brainTumor\" (https://CRAN.R-project.org/package=brainTumor) can be used for the identification of pediatric brain tumors. This package provides a set of tools for tumor segmentation, classification, and feature extraction from MRI images. It also includes a dataset of pediatric brain tumors for training and testing purposes."}
{"qid": "56f96333cf1c325851000004", "original_text": "X-rays interact strongly with biological organisms. Synchrotron radiation sources deliver very intense X-ray photon fluxes within micro- or submicro cross-section beams, resulting in doses larger than the MGy. The relevance of synchrotron radiation analyses of biological materials is therefore questionable since such doses, million times higher than the ones used in radiotherapy, can cause huge damages in tissues, with regard to not only DNA, but also proteic and lipid organizations. Very few data concerning the effect of very high X-ray doses in tissues are available in the literature.", "label": 1, "is_selected": 0, "text": "X-rays interact strongly with biological organisms. Synchrotron radiation sources deliver very intense X-ray photon fluxes within micro- or submicro cross-section beams, resulting in doses larger than the MGy. The relevance of synchrotron radiation analyses of biological materials is therefore questionable since such doses, million times higher than the ones used in radiotherapy, can cause huge damages in tissues, with regard to not only DNA, but also proteic and lipid organizations. Very few data concerning the effect of very high X-ray doses in tissues are available in the literature."}
{"qid": "5c840daf617e120c34000007", "original_text": "Rhamnose, a type of sugar, has been investigated for its potential anti-aging effects in some studies. It has been shown to increase the activity of an enzyme called SIRT1, which plays a role in maintaining cellular homeostasis and protecting against age-related diseases. Rhamnose may also activate other anti-aging pathways, such as the AMPK signaling pathway, which can help to promote cellular energy homeostasis and reduce the risk of age-related diseases. However, more research is needed to fully understand the anti-aging effects of rhamnose and its potential as an anti-aging therapy.", "label": 0, "is_selected": 0, "text": "Rhamnose, a type of sugar, has been investigated for its potential anti-aging effects in some studies. It has been shown to increase the activity of an enzyme called SIRT1, which plays a role in maintaining cellular homeostasis and protecting against age-related diseases. Rhamnose may also activate other anti-aging pathways, such as the AMPK signaling pathway, which can help to promote cellular energy homeostasis and reduce the risk of age-related diseases. However, more research is needed to fully understand the anti-aging effects of rhamnose and its potential as an anti-aging therapy."}
{"qid": "569e731cca240fa209000003", "original_text": "The FANTOM5 project was a large-scale effort to create a detailed and comprehensive Atlas of human gene expression, covering over 20,000 tissues and cell types across the human body. The project aimed to provide a resource for researchers to study the complex interplay between genetic and environmental factors and their impact on human health and disease. The FANTOM5 Atlas included gene expression profiling data, as well as other types of molecular data, such as DNA methylation and histone modification. The project was completed in 2018 and has been widely used by the research community to better understand the regulation of gene expression and its role in human disease.", "label": 0, "is_selected": 0, "text": "The FANTOM5 project was a large-scale effort to create a detailed and comprehensive Atlas of human gene expression, covering over 20,000 tissues and cell types across the human body. The project aimed to provide a resource for researchers to study the complex interplay between genetic and environmental factors and their impact on human health and disease. The FANTOM5 Atlas included gene expression profiling data, as well as other types of molecular data, such as DNA methylation and histone modification. The project was completed in 2018 and has been widely used by the research community to better understand the regulation of gene expression and its role in human disease."}
{"qid": "532f49f8d6d3ac6a34000035", "original_text": "The choice of parameter sets used to calculate Down's syndrome risks is important. This study details analysis of samples from affected and unaffected pregnancies and evaluates whether published population data is optimal. Screening efficiency realized with measurement procedure-specific population parameters is compared with selected population sets available in the literature. In a retrospective experiment, double and triple testing was performed on maternal serum samples from 286 randomly chosen unaffected singleton pregnancies and 95 Down's syndrome affected pregnancy samples. Using a risk cut-off of 1 in 250, detection rates and false positive rates were estimated for different population settings to select a model giving the best overall efficacy. Receiver operation characteristics curve analysis was performed and detection rates realized with the different population settings was estimated at a 5% fixed false positive rate.", "label": 1, "is_selected": 0, "text": "The choice of parameter sets used to calculate Down's syndrome risks is important. This study details analysis of samples from affected and unaffected pregnancies and evaluates whether published population data is optimal. Screening efficiency realized with measurement procedure-specific population parameters is compared with selected population sets available in the literature. In a retrospective experiment, double and triple testing was performed on maternal serum samples from 286 randomly chosen unaffected singleton pregnancies and 95 Down's syndrome affected pregnancy samples. Using a risk cut-off of 1 in 250, detection rates and false positive rates were estimated for different population settings to select a model giving the best overall efficacy. Receiver operation characteristics curve analysis was performed and detection rates realized with the different population settings was estimated at a 5% fixed false positive rate."}
{"qid": "6032899c1cb411341a000144", "original_text": "Integrins are transmembrane glycoproteins that are broadly distributed in living organisms. As a heterodimer, they contain an \u03b1 and a \u03b2 subunit, which are reported to be associated with various physiological and pathological processes. In the present study, a 2502 bp full-length cDNA sequence of Bmintegrin \u03b21 was obtained from the silkworm, Bombyx mori. Bmintegrin \u03b21 belongs to the \u03b2 subunit of the integrin family and contains several typical structures of integrins. Gene expression profile analysis demonstrated that Bmintegrin \u03b21 was ubiquitously expressed in all tested tissues and organs, with the maximum expression levels in fat body and hemocytes. The immunofluorescence results showed that Bmintegrin \u03b21 was located in the cell membrane and widely distributed in fat bodies and different types of hemocytes. Bmintegrin \u03b21 expression was remarkably increased after challenging with different kinds of bacteria and pathogen-associated molecular patterns (PAMPs). Further investigation revealed that Bmintegrin \u03b21 could participate in the agglutination of pathogenic bacteria possibly through direct binding with the relative bacteria and PAMPs. Altogether, this study provides a novel insight into the immune functional features of Bmintegrin \u03b21.", "label": 1, "is_selected": 0, "text": "Integrins are transmembrane glycoproteins that are broadly distributed in living organisms. As a heterodimer, they contain an \u03b1 and a \u03b2 subunit, which are reported to be associated with various physiological and pathological processes. In the present study, a 2502 bp full-length cDNA sequence of Bmintegrin \u03b21 was obtained from the silkworm, Bombyx mori. Bmintegrin \u03b21 belongs to the \u03b2 subunit of the integrin family and contains several typical structures of integrins. Gene expression profile analysis demonstrated that Bmintegrin \u03b21 was ubiquitously expressed in all tested tissues and organs, with the maximum expression levels in fat body and hemocytes. The immunofluorescence results showed that Bmintegrin \u03b21 was located in the cell membrane and widely distributed in fat bodies and different types of hemocytes. Bmintegrin \u03b21 expression was remarkably increased after challenging with different kinds of bacteria and pathogen-associated molecular patterns (PAMPs). Further investigation revealed that Bmintegrin \u03b21 could participate in the agglutination of pathogenic bacteria possibly through direct binding with the relative bacteria and PAMPs. Altogether, this study provides a novel insight into the immune functional features of Bmintegrin \u03b21."}
{"qid": "511979b04eab811676000003", "original_text": "The complete human genome sequences in the public database provide ways to understand the blue print of life. As of June 29, 2006, 27 archaeal, 326 bacterial and 21 eukaryotes is complete genomes are available and the sequencing for 316 bacterial, 24 archaeal, 126 eukaryotic genomes are in progress. The traditional biochemical/molecular experiments can assign accurate functions for genes in these genomes. However, the process is time-consuming and costly. Despite several efforts, only 50-60 % of genes have been annotated in most completely sequenced genomes. Automated genome sequence analysis and annotation may provide ways to understand genomes. Thus, determination of protein function is one of the challenging problems of the post-genome era. This demands bioinformatics to predict functions of un-annotated protein sequences by developing efficient tools. Here, we discuss some of the recent and popular approaches developed in Bioinformatics to predict functions for hypothetical proteins.", "label": 1, "is_selected": 0, "text": "The complete human genome sequences in the public database provide ways to understand the blue print of life. As of June 29, 2006, 27 archaeal, 326 bacterial and 21 eukaryotes is complete genomes are available and the sequencing for 316 bacterial, 24 archaeal, 126 eukaryotic genomes are in progress. The traditional biochemical/molecular experiments can assign accurate functions for genes in these genomes. However, the process is time-consuming and costly. Despite several efforts, only 50-60 % of genes have been annotated in most completely sequenced genomes. Automated genome sequence analysis and annotation may provide ways to understand genomes. Thus, determination of protein function is one of the challenging problems of the post-genome era. This demands bioinformatics to predict functions of un-annotated protein sequences by developing efficient tools. Here, we discuss some of the recent and popular approaches developed in Bioinformatics to predict functions for hypothetical proteins."}
{"qid": "602747921cb411341a0000e0", "original_text": "TransCon CNP is a C-type natriuretic peptide (CNP-38) conjugated via a cleavable linker to a polyethylene glycol carrier molecule, designed to provide sustained systemic CNP levels upon weekly subcutaneous administration. TransCon CNP is in clinical development for the treatment of comorbidities associated with achondroplasia. In both mice and cynomolgus monkeys, sustained exposure to CNP via TransCon CNP was more efficacious in stimulating bone growth than intermittent CNP exposure. TransCon CNP was well tolerated with no adverse cardiovascular effects observed at exposure levels exceeding the expected clinical therapeutic exposure. At equivalent dose levels, reductions in blood pressure and/or an increase in heart rate were seen following single subcutaneous injections of the unconjugated CNP-38 molecule or a daily CNP-39 molecule (same amino acid sequence as Vosoritide, USAN:INN). The half-life of the daily CNP-39 molecule in cynomolgus monkey was estimated to be 20 minutes, compared with 90 hours for CNP-38, released from TransCon CNP.", "label": 1, "is_selected": 0, "text": "TransCon CNP is a C-type natriuretic peptide (CNP-38) conjugated via a cleavable linker to a polyethylene glycol carrier molecule, designed to provide sustained systemic CNP levels upon weekly subcutaneous administration. TransCon CNP is in clinical development for the treatment of comorbidities associated with achondroplasia. In both mice and cynomolgus monkeys, sustained exposure to CNP via TransCon CNP was more efficacious in stimulating bone growth than intermittent CNP exposure. TransCon CNP was well tolerated with no adverse cardiovascular effects observed at exposure levels exceeding the expected clinical therapeutic exposure. At equivalent dose levels, reductions in blood pressure and/or an increase in heart rate were seen following single subcutaneous injections of the unconjugated CNP-38 molecule or a daily CNP-39 molecule (same amino acid sequence as Vosoritide, USAN:INN). The half-life of the daily CNP-39 molecule in cynomolgus monkey was estimated to be 20 minutes, compared with 90 hours for CNP-38, released from TransCon CNP."}
{"qid": "56d2ae19f22319765a000006", "original_text": "The lagging annotation of bacterial genomes and the inherent genetic complexity of many phenotypes is hindering the discovery of new drug targets and the development of new antimicrobials and vaccines. Here we present the method Tn-seq, with which it has become possible to quantitatively determine fitness for most genes in a microorganism and to screen for quantitative genetic interactions on a genome-wide scale and in a high-throughput fashion. Tn-seq can thus direct studies in the annotation of genes and untangle complex phenotypes. The method is based on the construction of a saturated Mariner transposon insertion library. After library selection, changes in frequency of each insertion mutant are determined by sequencing of the flanking regions en masse. These changes are used to calculate each mutant's fitness. The method has been developed for the Gram-positive bacterium Streptococcus pneumoniae, a causative agent of pneumonia and meningitis; however, due to the wide activity of the Mariner transposon, Tn-seq can be applied to many different microbial species.", "label": 1, "is_selected": 0, "text": "The lagging annotation of bacterial genomes and the inherent genetic complexity of many phenotypes is hindering the discovery of new drug targets and the development of new antimicrobials and vaccines. Here we present the method Tn-seq, with which it has become possible to quantitatively determine fitness for most genes in a microorganism and to screen for quantitative genetic interactions on a genome-wide scale and in a high-throughput fashion. Tn-seq can thus direct studies in the annotation of genes and untangle complex phenotypes. The method is based on the construction of a saturated Mariner transposon insertion library. After library selection, changes in frequency of each insertion mutant are determined by sequencing of the flanking regions en masse. These changes are used to calculate each mutant's fitness. The method has been developed for the Gram-positive bacterium Streptococcus pneumoniae, a causative agent of pneumonia and meningitis; however, due to the wide activity of the Mariner transposon, Tn-seq can be applied to many different microbial species."}
{"qid": "5895f9cf78275d0c4a000002", "original_text": "Hereditary intrahepatic cholestasis with lymph oedema is now a well defined autosomal recessive inherited syndrome. More than 75% of the known cases (about 40) are Norwegian, and most of these came from a few communities in the south-western part of Norway. Cholestasis is present prior to or shortly after birth. With modern treatment the cholestasis usually improves considerably during the first two years of life, but periods of recurrent cholestasis occur later.", "label": 1, "is_selected": 0, "text": "Hereditary intrahepatic cholestasis with lymph oedema is now a well defined autosomal recessive inherited syndrome. More than 75% of the known cases (about 40) are Norwegian, and most of these came from a few communities in the south-western part of Norway. Cholestasis is present prior to or shortly after birth. With modern treatment the cholestasis usually improves considerably during the first two years of life, but periods of recurrent cholestasis occur later."}
{"qid": "5e360b81158f994d3a000008", "original_text": "The Smith-Waterman algorithm is known to be a more sensitive approach than heuristic algorithms for local sequence alignment algorithms. Despite its sensitivity, a greater time complexity associated with the Smith-Waterman algorithm prevents its application to the all-pairs comparisons of base sequences, which aids in the construction of accurate phylogenetic trees. The aim of this study is to achieve greater acceleration using the Smith-Waterman algorithm (by realizing interpair block pruning and band optimization) compared with that achieved using a previous method that performs intrapair block pruning on graphics processing units (GPUs). We present an interpair optimization method for the Smith-Waterman algorithm with the aim of accelerating the all-pairs comparison of base sequences. Given the results of the pairs of sequences, our method realizes efficient block pruning by computing a lower bound for other pairs that have not yet been processed.", "label": 1, "is_selected": 0, "text": "The Smith-Waterman algorithm is known to be a more sensitive approach than heuristic algorithms for local sequence alignment algorithms. Despite its sensitivity, a greater time complexity associated with the Smith-Waterman algorithm prevents its application to the all-pairs comparisons of base sequences, which aids in the construction of accurate phylogenetic trees. The aim of this study is to achieve greater acceleration using the Smith-Waterman algorithm (by realizing interpair block pruning and band optimization) compared with that achieved using a previous method that performs intrapair block pruning on graphics processing units (GPUs). We present an interpair optimization method for the Smith-Waterman algorithm with the aim of accelerating the all-pairs comparison of base sequences. Given the results of the pairs of sequences, our method realizes efficient block pruning by computing a lower bound for other pairs that have not yet been processed."}
{"qid": "535917f3c95abccd6f000001", "original_text": "We show that among ecotypes of Arabidopsis, there is considerable variation in their susceptibility to crown gall disease. Differences in susceptibility are heritable and, in one ecotype, segregate as a single major contributing locus. In several ecotypes, recalcitrance to tumorigenesis results from decreased binding of Agrobacterium to inoculated root explants. The recalcitrance of another ecotype occurs at a late step in T-DNA transfer. Transient expression of a T-DNA-encoded beta-glucuronidase gusA gene is efficient, but the ecotype is deficient in crown gall tumorigenesis, transformation to kanamycin resistance, and stable GUS expression. This ecotype is also more sensitive to gamma radiation than is a susceptible ecotype.", "label": 1, "is_selected": 0, "text": "We show that among ecotypes of Arabidopsis, there is considerable variation in their susceptibility to crown gall disease. Differences in susceptibility are heritable and, in one ecotype, segregate as a single major contributing locus. In several ecotypes, recalcitrance to tumorigenesis results from decreased binding of Agrobacterium to inoculated root explants. The recalcitrance of another ecotype occurs at a late step in T-DNA transfer. Transient expression of a T-DNA-encoded beta-glucuronidase gusA gene is efficient, but the ecotype is deficient in crown gall tumorigenesis, transformation to kanamycin resistance, and stable GUS expression. This ecotype is also more sensitive to gamma radiation than is a susceptible ecotype."}
{"qid": "5c7813f57c78d694710000b0", "original_text": "The Cholera toxin (CT) enters a cell through a process called endocytosis, which involves the engulfment of the toxin by the cell membrane. CT is a large protein that cannot passively diffuse across the cell membrane, so it must be internalized by the cell through specific receptors on the membrane. The receptors bind the CT and form a complex that is pinched off from the membrane and internalized through a process called clathrin-mediated endocytosis. Once inside the cell, the CT is released from the endosome and enters the cytosol, where it can interact with the host cell proteins and initiate its toxic effects.", "label": 0, "is_selected": 0, "text": "The Cholera toxin (CT) enters a cell through a process called endocytosis, which involves the engulfment of the toxin by the cell membrane. CT is a large protein that cannot passively diffuse across the cell membrane, so it must be internalized by the cell through specific receptors on the membrane. The receptors bind the CT and form a complex that is pinched off from the membrane and internalized through a process called clathrin-mediated endocytosis. Once inside the cell, the CT is released from the endosome and enters the cytosol, where it can interact with the host cell proteins and initiate its toxic effects."}
{"qid": "5c58ac2286df2b917400000f", "original_text": "Management of progressive multiple sclerosis (MS) is one of the main challenges of the new century. Based on our knowledge of pathophysiology, three therapeutic strategies are proposed: anti-inflammatory (ocrelizumab, siponimod\u2026); remyelinating (opicinumab); and neuroprotective (high-dose biotin, ibudilast, simvastatin\u2026). Nevertheless, despite recent promising positive clinical trials, new methodological approaches for therapeutic protocols with adaptable outcomes to assess progression are still needed.", "label": 1, "is_selected": 0, "text": "Management of progressive multiple sclerosis (MS) is one of the main challenges of the new century. Based on our knowledge of pathophysiology, three therapeutic strategies are proposed: anti-inflammatory (ocrelizumab, siponimod\u2026); remyelinating (opicinumab); and neuroprotective (high-dose biotin, ibudilast, simvastatin\u2026). Nevertheless, despite recent promising positive clinical trials, new methodological approaches for therapeutic protocols with adaptable outcomes to assess progression are still needed."}
{"qid": "530cf54dab4de4de0c000009", "original_text": "There is currently no scientific evidence to support a direct causal link between H1N1 influenza vaccination and the development of narcolepsy. Multiple studies have been conducted to investigate this association, and all have found no significant increase in the risk of narcolepsy in individuals who received the H1N1 vaccine compared to those who did not. One of the largest and most comprehensive studies to date, conducted by the Norwegian Medicines Agency, found no increased risk of narcolepsy in over 750,000 individuals who received the H1N1 vaccine. Similarly, a meta-analysis of 14 observational studies involving over 1.3 million individuals found no evidence of a causal relationship between H1N1 vaccination and narcolepsy. It is important to note that narcolepsy is a rare genetic disorder that can occur spontaneously, and there may be other factors that contribute to its development. While the exact cause of narcolepsy is still not fully understood, it is clear that the H1N1 vaccine is not a causal factor.", "label": 0, "is_selected": 1, "text": "The World Health Organization (WHO) has confirmed that there is no link between the H1N1 influenza vaccine and the development of narcolepsy, a rare genetic disorder that can occur spontaneously, and there is currently no scientific evidence to support a direct causal link between H1 N1 influenza vaccination and the developing of the disorder. The exact cause of narcolepsy is still not fully understood, and it is clear that the H2N1 vaccine is not a causal factor."}
{"qid": "5c6548d4e842deac67000020", "original_text": "CPX351 is a fixed-dose combination of three drugs: cyclophosphamide, prednisone, and etoposide. It is used to treat patients with aggressive B-cell non-Hodgkin lymphoma (NHL) who have relapsed or are refractory to earlier treatment. CPX351 is typically administered as a 3-day continuous infusion, followed by a 10-day rest period, for a total of 2 cycles. The medication works by targeting cancer cells and stimulating the immune system to attack the tumor.", "label": 0, "is_selected": 0, "text": "CPX351 is a fixed-dose combination of three drugs: cyclophosphamide, prednisone, and etoposide. It is used to treat patients with aggressive B-cell non-Hodgkin lymphoma (NHL) who have relapsed or are refractory to earlier treatment. CPX351 is typically administered as a 3-day continuous infusion, followed by a 10-day rest period, for a total of 2 cycles. The medication works by targeting cancer cells and stimulating the immune system to attack the tumor."}
{"qid": "5a733efc2dc08e987e000016", "original_text": "Achenbach's syndrome is a rare genetic disorder characterized by congenital anomalies, including microcephaly, intellectual disability, and distinctive facial features, such as a wide, flat nose and widely spaced eyes. It is caused by mutations in the GDF6 gene and is often diagnosed during fetal life or in the first few years of life. Treatment is focused on managing symptoms and may include therapies such as occupational and speech therapy, as well as supportive care.", "label": 0, "is_selected": 1, "text": "BBC News takes a look at some of the key facts and figures behind Achenbach's syndrome, as compiled by the charity Sense, in partnership with the BBC News website and the BBC World Service, and with support from the UK's National Institute for Health and Care Excellence (NICE)."}
{"qid": "5e31af4bfbd6abf43b00004b", "original_text": "Fibroblast growth factor (FGF) signaling plays critical roles in key biological processes ranging from embryogenesis to wound healing and has strong links to several hallmarks of cancer. Genetic alterations in FGF receptor (FGFR) family members are associated with increased tumor growth, metastasis, angiogenesis, and decreased survival. JNJ-42756493, erdafitinib, is an orally active small molecule with potent tyrosine kinase inhibitory activity against all four FGFR family members and selectivity versus other highly related kinases. JNJ-42756493 shows rapid uptake into the lysosomal compartment of cells in culture, which is associated with prolonged inhibition of FGFR signaling, possibly due to sustained release of the inhibitor. In xenografts from human tumor cell lines or patient-derived tumor tissue with activating FGFR alterations, JNJ-42756493 administration results in potent and dose-dependent antitumor activity accompanied by pharmacodynamic modulation of phospho-FGFR and phospho-ERK in tumors.", "label": 1, "is_selected": 0, "text": "Fibroblast growth factor (FGF) signaling plays critical roles in key biological processes ranging from embryogenesis to wound healing and has strong links to several hallmarks of cancer. Genetic alterations in FGF receptor (FGFR) family members are associated with increased tumor growth, metastasis, angiogenesis, and decreased survival. JNJ-42756493, erdafitinib, is an orally active small molecule with potent tyrosine kinase inhibitory activity against all four FGFR family members and selectivity versus other highly related kinases. JNJ-42756493 shows rapid uptake into the lysosomal compartment of cells in culture, which is associated with prolonged inhibition of FGFR signaling, possibly due to sustained release of the inhibitor. In xenografts from human tumor cell lines or patient-derived tumor tissue with activating FGFR alterations, JNJ-42756493 administration results in potent and dose-dependent antitumor activity accompanied by pharmacodynamic modulation of phospho-FGFR and phospho-ERK in tumors."}
{"qid": "5aae651ffcf456587200000d", "original_text": "Penicillinase, also known as beta-lactamase, is an enzyme that breaks down penicillin and other beta-lactam antibiotics. These antibiotics are inactivated by the enzyme, which renders them ineffective against bacterial infections. Beta-lactamases are produced by certain bacteria, such as Staphylococcus aureus and Pseudomonas aeruginosa, as a defense mechanism against antibiotics. The function of penicillinase is to hydrolyze the beta-lactam ring in penicillin and other related antibiotics, such as cephalosporins and carbapenems. This results in the breakdown of the antibiotic molecule, rendering it unable to bind to the bacterial cell wall and inhibit bacterial growth. By producing beta-lactamase, bacteria can protect themselves against the lethal effects of beta-lactam antibiotics, making them inherently resistant to these drugs. In summary, the function of penicillinase is to break down penicillin and other beta-lactam antibiotics, rendering them ineffective against bacterial infections. This enzyme plays a crucial role in the development of antibiotic resistance in bacteria.", "label": 0, "is_selected": 0, "text": "Penicillinase, also known as beta-lactamase, is an enzyme that breaks down penicillin and other beta-lactam antibiotics. These antibiotics are inactivated by the enzyme, which renders them ineffective against bacterial infections. Beta-lactamases are produced by certain bacteria, such as Staphylococcus aureus and Pseudomonas aeruginosa, as a defense mechanism against antibiotics. The function of penicillinase is to hydrolyze the beta-lactam ring in penicillin and other related antibiotics, such as cephalosporins and carbapenems. This results in the breakdown of the antibiotic molecule, rendering it unable to bind to the bacterial cell wall and inhibit bacterial growth. By producing beta-lactamase, bacteria can protect themselves against the lethal effects of beta-lactam antibiotics, making them inherently resistant to these drugs. In summary, the function of penicillinase is to break down penicillin and other beta-lactam antibiotics, rendering them ineffective against bacterial infections. This enzyme plays a crucial role in the development of antibiotic resistance in bacteria."}
{"qid": "515db20e298dcd4e51000014", "original_text": "Family history studies in adults reveal strong familiality for the anxiety disorders with some specificity. The aim of the current study was to establish whether there was an elevated rate of anxiety disorders in the parents of children with anxiety disorders, and whether there was intergenerational specificity in the form of disorder. The mental state of a clinic sample of 85 children with anxiety disorder and their parents was systematically assessed, together with a comparison sample of 45 children with no current disorder and their parents. Compared to the rate of anxiety disorder amongst parents of comparison children, the rate of current anxiety disorder in mothers of anxious children was significantly raised, as was the lifetime rate of anxiety disorder for both mothers and fathers. The mothers of children with generalised anxiety disorder, social phobia, specific phobia and separation anxiety disorder all had raised lifetime rates of the corresponding disorder, but also raised rates of others disorders. Only 60% of the fathers of the anxious children were assessed. Strong familiality of anxiety disorders was confirmed, especially between child and maternal anxiety disorder. All child anxiety disorders were associated with several forms of anxiety disorder in the mother. Some specificity in the form of anxiety disorder in the child and the mother was apparent for social phobia and separation anxiety disorder.", "label": 1, "is_selected": 0, "text": "Family history studies in adults reveal strong familiality for the anxiety disorders with some specificity. The aim of the current study was to establish whether there was an elevated rate of anxiety disorders in the parents of children with anxiety disorders, and whether there was intergenerational specificity in the form of disorder. The mental state of a clinic sample of 85 children with anxiety disorder and their parents was systematically assessed, together with a comparison sample of 45 children with no current disorder and their parents. Compared to the rate of anxiety disorder amongst parents of comparison children, the rate of current anxiety disorder in mothers of anxious children was significantly raised, as was the lifetime rate of anxiety disorder for both mothers and fathers. The mothers of children with generalised anxiety disorder, social phobia, specific phobia and separation anxiety disorder all had raised lifetime rates of the corresponding disorder, but also raised rates of others disorders. Only 60% of the fathers of the anxious children were assessed. Strong familiality of anxiety disorders was confirmed, especially between child and maternal anxiety disorder. All child anxiety disorders were associated with several forms of anxiety disorder in the mother. Some specificity in the form of anxiety disorder in the child and the mother was apparent for social phobia and separation anxiety disorder."}
{"qid": "5cebe41ea49efeb44c000006", "original_text": "DNA loop-extrusion is an process that involves the unwinding of DNA and the formation of a replication bubble. While ATP is not directly involved in the process of DNA loop-extrusion, it is required for the movement of the replication fork, which is necessary for the formation of the loop. The movement of the replication fork is driven by the hydrolysis of ATP, which provides the energy for the process. Therefore, while ATP is not directly involved in DNA loop-extrusion, it is essential for the entire replication process.", "label": 0, "is_selected": 0, "text": "DNA loop-extrusion is an process that involves the unwinding of DNA and the formation of a replication bubble. While ATP is not directly involved in the process of DNA loop-extrusion, it is required for the movement of the replication fork, which is necessary for the formation of the loop. The movement of the replication fork is driven by the hydrolysis of ATP, which provides the energy for the process. Therefore, while ATP is not directly involved in DNA loop-extrusion, it is essential for the entire replication process."}
{"qid": "5a6f8dc6b750ff4455000058", "original_text": "Trastuzumab is a monoclonal antibody that targets the human epidermal growth factor receptor tyrosine kinase HER2/ErbB2. This agent has shown a highly significant antitumour effect for patients with HER2-positive breast cancer, and is now considered part of the standard regimens for the treatment of this disease in both the metastatic and adjuvant setting. Cardiotoxicity has been associated with trastuzumab, and this issue has now been studied and documented in a number of adjuvant trials for which data have now been released. Cardiotoxicity has been shown to be potentiated when the agent is used concurrently or sequentially with an anthracycline, and this has limited the use of trastuzumab in some patients. Determining the overall impact of trastuzumab is further complicated by the administration of other cardiotoxic agents such as the taxanes and cyclophosphamide as well as by pre-existing cardiac disease.", "label": 1, "is_selected": 0, "text": "Trastuzumab is a monoclonal antibody that targets the human epidermal growth factor receptor tyrosine kinase HER2/ErbB2. This agent has shown a highly significant antitumour effect for patients with HER2-positive breast cancer, and is now considered part of the standard regimens for the treatment of this disease in both the metastatic and adjuvant setting. Cardiotoxicity has been associated with trastuzumab, and this issue has now been studied and documented in a number of adjuvant trials for which data have now been released. Cardiotoxicity has been shown to be potentiated when the agent is used concurrently or sequentially with an anthracycline, and this has limited the use of trastuzumab in some patients. Determining the overall impact of trastuzumab is further complicated by the administration of other cardiotoxic agents such as the taxanes and cyclophosphamide as well as by pre-existing cardiac disease."}
{"qid": "5e2b0d167d50947c2f000002", "original_text": "Acromelic frontonasal dysostosis (AFND) is a distinctive and rare frontonasal malformation that presents in combination with brain and limb abnormalities. A single recurrent heterozygous missense substitution in ZSWIM6, encoding a protein of unknown function, was previously shown to underlie this disorder in four unrelated cases. Here we describe four additional individuals from three families, comprising two sporadic subjects (one of whom had no limb malformation) and a mildly affected female with a severely affected son. In the latter family we demonstrate parental mosaicism through deep sequencing of DNA isolated from a variety of tissues, which each contain different levels of mutation.", "label": 1, "is_selected": 0, "text": "Acromelic frontonasal dysostosis (AFND) is a distinctive and rare frontonasal malformation that presents in combination with brain and limb abnormalities. A single recurrent heterozygous missense substitution in ZSWIM6, encoding a protein of unknown function, was previously shown to underlie this disorder in four unrelated cases. Here we describe four additional individuals from three families, comprising two sporadic subjects (one of whom had no limb malformation) and a mildly affected female with a severely affected son. In the latter family we demonstrate parental mosaicism through deep sequencing of DNA isolated from a variety of tissues, which each contain different levels of mutation."}
{"qid": "56e6f027a12c1fc13b000001", "original_text": "Treatment for cancer can induce a series of secreted factors into the tumor microenvironment, which can affect cancer progression. Wingless-type MMTV (mouse mammary tumor virus) integration site 16B (WNT16B) is a new member of the WNT family and has been reported to play growth-related roles in previous studies.", "label": 1, "is_selected": 0, "text": "Treatment for cancer can induce a series of secreted factors into the tumor microenvironment, which can affect cancer progression. Wingless-type MMTV (mouse mammary tumor virus) integration site 16B (WNT16B) is a new member of the WNT family and has been reported to play growth-related roles in previous studies."}
{"qid": "58bca08702b8c6095300000a", "original_text": "Dravet syndrome, also known as severe myoclonic epilepsy of infancy (SMEI), is a rare genetic disorder that causes intractable epilepsy, developmental delays, and other neurological problems. It is caused by mutations in the SCN1A gene, which codes for the alpha-1 subunit of the voltage-gated sodium channel. The syndrome typically appears in infancy, with seizures occurring within the first year of life. Children with Dravet syndrome often have difficulty walking, speaking, and performing other daily tasks due to frequent and severe seizures. Other symptoms can include intellectual disability, autism, and behavioral problems. There is currently no cure for Dravet syndrome, but various medications and therapies can help manage seizures and improve quality of life.", "label": 0, "is_selected": 1, "text": "Researchers at the University of California, Los Angeles, have identified a gene defect that causes severe epilepsy in children with Dravet syndrome, according to a report in the Journal of the American Academy of Child and Adolescent Psychiatry (JAAACP.) The study, led by researchers at the university's Fielding School of Public Health, found that mutations in the gene were responsible for about one-half of all cases of the syndrome."}
{"qid": "56bcdf1ad36b5da378000009", "original_text": "Dracorhodin perchlorate has been investigated for the treatment of various cancer types, including: * Breast cancer: Dracorhodin perchlorate has shown cytotoxic activity against breast cancer cells and has been suggested as a potential candidate for breast cancer chemotherapy. * Lung cancer: Studies have shown that dracorhodin perchlorate can inhibit the growth of lung cancer cells and induce apoptosis (cell death). * Colorectal cancer: Dracorhodin perchlorate has been shown to have antitumor activity against colorectal cancer cells. It is important to note that while these findings are promising, further research is needed to fully understand the efficacy and safety of dracorhodin perchlorate as an anticancer agent.", "label": 0, "is_selected": 0, "text": "Dracorhodin perchlorate has been investigated for the treatment of various cancer types, including: * Breast cancer: Dracorhodin perchlorate has shown cytotoxic activity against breast cancer cells and has been suggested as a potential candidate for breast cancer chemotherapy. * Lung cancer: Studies have shown that dracorhodin perchlorate can inhibit the growth of lung cancer cells and induce apoptosis (cell death). * Colorectal cancer: Dracorhodin perchlorate has been shown to have antitumor activity against colorectal cancer cells. It is important to note that while these findings are promising, further research is needed to fully understand the efficacy and safety of dracorhodin perchlorate as an anticancer agent."}
{"qid": "6211557b3a8413c65300000f", "original_text": "CPX-351 (United States: Vyxeos\u00ae; Europe: Vyxeos\u00ae Liposomal), a dual-drug liposomal encapsulation of daunorubicin and cytarabine in a synergistic 1:5 molar ratio, is approved by the US FDA and the EMA for the treatment of adults with newly diagnosed therapy-related acute myeloid leukemia or acute myeloid leukemia with myelodysplasia-related changes. In a pivotal phase 3 study that evaluated 309 patients aged 60 to 75 years with newly diagnosed high-risk/secondary acute myeloid leukemia, CPX-351 significantly improved median overall survival versus conventional 7 + 3 chemotherapy (cytarabine continuous infusion for 7 days plus daunorubicin for 3 days), with a comparable safety profile. A Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of the phase 3 study was performed to compare survival quality between patients receiving CPX-351 versus conventional 7 + 3 after 5 years of follow-up. Patients were randomized 1:1 between December 20, 2012 and November 11, 2014 to receive induction with CPX-351 or 7 + 3. Survival time for each patient was partitioned into 3 health states: TOX (time with any grade 3 or 4 toxicity or prior to remission), TWiST (time in remission without relapse or grade 3 or 4 toxicity), and REL (time after relapse). Within each treatment arm, Q-TWiST was calculated by adding the mean time spent in each health state weighted by its respective quality-of-life, represented by health utility. The relative Q-TWiST gain, calculated as the difference in Q-TWiST between treatment arms divided by the mean survival of the 7 + 3 control arm, was determined in order to evaluate results in the context of other Q-TWiST analyses.", "label": 1, "is_selected": 0, "text": "CPX-351 (United States: Vyxeos\u00ae; Europe: Vyxeos\u00ae Liposomal), a dual-drug liposomal encapsulation of daunorubicin and cytarabine in a synergistic 1:5 molar ratio, is approved by the US FDA and the EMA for the treatment of adults with newly diagnosed therapy-related acute myeloid leukemia or acute myeloid leukemia with myelodysplasia-related changes. In a pivotal phase 3 study that evaluated 309 patients aged 60 to 75 years with newly diagnosed high-risk/secondary acute myeloid leukemia, CPX-351 significantly improved median overall survival versus conventional 7 + 3 chemotherapy (cytarabine continuous infusion for 7 days plus daunorubicin for 3 days), with a comparable safety profile. A Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of the phase 3 study was performed to compare survival quality between patients receiving CPX-351 versus conventional 7 + 3 after 5 years of follow-up. Patients were randomized 1:1 between December 20, 2012 and November 11, 2014 to receive induction with CPX-351 or 7 + 3. Survival time for each patient was partitioned into 3 health states: TOX (time with any grade 3 or 4 toxicity or prior to remission), TWiST (time in remission without relapse or grade 3 or 4 toxicity), and REL (time after relapse). Within each treatment arm, Q-TWiST was calculated by adding the mean time spent in each health state weighted by its respective quality-of-life, represented by health utility. The relative Q-TWiST gain, calculated as the difference in Q-TWiST between treatment arms divided by the mean survival of the 7 + 3 control arm, was determined in order to evaluate results in the context of other Q-TWiST analyses."}
{"qid": "52f21e8f2059c6d71c00000c", "original_text": "We have previously reported an array comparative genomic hybridization profile that identifies triple-negative breast cancers (TNBC), with BRCA1 dysfunction and a high sensitivity to intensified dose bifunctional alkylating agents. To determine the effect of conventional-dose chemotherapy in patients with this so-called BRCA1-like profile, clinical characteristics and survival were studied in a large group of TNBC patients. DNA was isolated and BRCA1-like status was assessed in 101 patients with early-stage TNBC receiving adjuvant cyclophosphamide-based chemotherapy. Clinical characteristics and survival were compared between BRCA1-like and non-BRCA1-like groups. Results Sixty-six tumors (65%) had a BRCA1-like profile. Patients with BRCA1-like tumors tended to be younger and had more often node-negative disease (P = 0.06 and P = 0.03, respectively). Five-year recurrence-free survival was 80% for the BRCA1-like group and 75% for the non-BRCA1-like group (P = 0.35). T stage was the only variable significantly associated with survival.", "label": 1, "is_selected": 0, "text": "We have previously reported an array comparative genomic hybridization profile that identifies triple-negative breast cancers (TNBC), with BRCA1 dysfunction and a high sensitivity to intensified dose bifunctional alkylating agents. To determine the effect of conventional-dose chemotherapy in patients with this so-called BRCA1-like profile, clinical characteristics and survival were studied in a large group of TNBC patients. DNA was isolated and BRCA1-like status was assessed in 101 patients with early-stage TNBC receiving adjuvant cyclophosphamide-based chemotherapy. Clinical characteristics and survival were compared between BRCA1-like and non-BRCA1-like groups. Results Sixty-six tumors (65%) had a BRCA1-like profile. Patients with BRCA1-like tumors tended to be younger and had more often node-negative disease (P = 0.06 and P = 0.03, respectively). Five-year recurrence-free survival was 80% for the BRCA1-like group and 75% for the non-BRCA1-like group (P = 0.35). T stage was the only variable significantly associated with survival."}
{"qid": "5c8fe71b0101eac87000000b", "original_text": "Yes, RUNX2 has been shown to inhibit astrocyte differentiation. In a study published in the journal Nature Communications in 2018, researchers found that RUNX2 regulates the expression of genes involved in astrocyte differentiation and inhibits the process of astrocyte maturation. This suggests that RUNX2 may play a role in the development and progression of various neurological disorders, including brain tumors.", "label": 0, "is_selected": 0, "text": "Yes, RUNX2 has been shown to inhibit astrocyte differentiation. In a study published in the journal Nature Communications in 2018, researchers found that RUNX2 regulates the expression of genes involved in astrocyte differentiation and inhibits the process of astrocyte maturation. This suggests that RUNX2 may play a role in the development and progression of various neurological disorders, including brain tumors."}
{"qid": "55376f19bc4f83e82800000c", "original_text": "Medulloblastoma is a malignant cerebellar tumor seen primarily in the pediatric age group that has a known ability to metastasize extraneurally. The skeleton is the most common site of extraneural metastases, but metastases to the bone marrow can also occur. Four cases of medulloblastoma metastatic to the marrow are reported. In addition, 31 cases from the medical literature are reviewed. Clinical features include bone tenderness, cytopenias and elevated serum alkaline phosphatase and lactic dehydrogenase levels. Skeletal involvement, especially of the pelvic bones, is frequently seen radiographically. Weight loss, soft tissue masses and a requirement for blood transfusion are also associated features.", "label": 1, "is_selected": 0, "text": "Medulloblastoma is a malignant cerebellar tumor seen primarily in the pediatric age group that has a known ability to metastasize extraneurally. The skeleton is the most common site of extraneural metastases, but metastases to the bone marrow can also occur. Four cases of medulloblastoma metastatic to the marrow are reported. In addition, 31 cases from the medical literature are reviewed. Clinical features include bone tenderness, cytopenias and elevated serum alkaline phosphatase and lactic dehydrogenase levels. Skeletal involvement, especially of the pelvic bones, is frequently seen radiographically. Weight loss, soft tissue masses and a requirement for blood transfusion are also associated features."}
{"qid": "62507520e764a5320400000c", "original_text": "Complexins are expressed in various regions of the body, including the brain, heart, and muscles. In the brain, complexins are primarily found in the cerebral cortex, hippocampus, and cerebellum. They are involved in regulating synaptic plasticity, learning, and memory. In the heart, complexins are primarily located in the cardiac myocytes, where they play a role in regulating the contraction and relaxation of the heart muscle. In muscles, complexins are found in the muscle fibers and are involved in the regulation of muscle contraction and relaxation. Additionally, complexins are also expressed in other tissues, such as the pancreas, where they are involved in regulating insulin secretion.", "label": 0, "is_selected": 1, "text": "Complexins are a class of proteins that are involved in a wide range of biological functions, including memory, learning, and regulation of muscle contraction and relaxation, as well as insulin production and cell death, among others. In the heart, complexins are primarily located in the cardiac myocytes, where they play a role in regulating the contraction and contraction of the heart muscle."}
{"qid": "515b1eccd24251bc050000af", "original_text": "An estimation of the performance and optimization of gradient HPLC conditions using various columns for maximum total peak capacity was studied for \"one-shot proteomics\" which involves one-dimensional gradient HPLC, connected to an electrospray ionization (ESI)-mass spectrometry (MS), using a monolithic silica-C\u2081\u2088 capillary column (350 cm long and 100 \u03bcm internal diameter) and an over 40 h shallow gradient elution with one injection. Optimization of such special one-dimensional HPLC has been a tedious task if carried out with a trial-and-error approach due to the extremely long analysis time for each run. Here, the optimized separation conditions including the column type, either particle-packed or monolithic, and the column length with a fixed gradient time are proposed by calculating the peak capacity obtainable using a long column and a long gradient time that may promote the \"one-shot proteomics\" approach.", "label": 1, "is_selected": 0, "text": "An estimation of the performance and optimization of gradient HPLC conditions using various columns for maximum total peak capacity was studied for \"one-shot proteomics\" which involves one-dimensional gradient HPLC, connected to an electrospray ionization (ESI)-mass spectrometry (MS), using a monolithic silica-C\u2081\u2088 capillary column (350 cm long and 100 \u03bcm internal diameter) and an over 40 h shallow gradient elution with one injection. Optimization of such special one-dimensional HPLC has been a tedious task if carried out with a trial-and-error approach due to the extremely long analysis time for each run. Here, the optimized separation conditions including the column type, either particle-packed or monolithic, and the column length with a fixed gradient time are proposed by calculating the peak capacity obtainable using a long column and a long gradient time that may promote the \"one-shot proteomics\" approach."}
{"qid": "5a9da59c4e03427e73000005", "original_text": "To study the impact of genetic and lifestyle factors on protein biomarkers and develop personally normalized plasma protein profiles (PNPPP) controlling for non-disease-related variance. Proximity extension assays were used to measure 145 proteins in 632 controls and 344 cases with non-communicable diseases. Genetic and lifestyle factors explained 20-88% of the variation in healthy controls.", "label": 1, "is_selected": 0, "text": "To study the impact of genetic and lifestyle factors on protein biomarkers and develop personally normalized plasma protein profiles (PNPPP) controlling for non-disease-related variance. Proximity extension assays were used to measure 145 proteins in 632 controls and 344 cases with non-communicable diseases. Genetic and lifestyle factors explained 20-88% of the variation in healthy controls."}
{"qid": "5c53143b7e3cb0e231000013", "original_text": "Prolactinomas are the most frequent functioning pituitary adenomas, and sex differences in tumor size, behavior and incidence have been described. These differences have been associated with earlier diagnosis in woman, as well as with serum estradiol levels. Experimental models of prolactinomas in rodents also show a higher incidence in females, and recent findings suggest that gender differences in the transforming growth factor beta 1 (TGF\u03b21) system might be involved in the sex-specific development of prolactinomas in these models. The aim of this review is to summarize the literature supporting the important role of TGF\u03b21 as a local modulator of pituitary lactotroph function and to provide recent evidence for TGF\u03b21 involvement in the sex differences found in prolactinoma development in animal models.", "label": 1, "is_selected": 0, "text": "Prolactinomas are the most frequent functioning pituitary adenomas, and sex differences in tumor size, behavior and incidence have been described. These differences have been associated with earlier diagnosis in woman, as well as with serum estradiol levels. Experimental models of prolactinomas in rodents also show a higher incidence in females, and recent findings suggest that gender differences in the transforming growth factor beta 1 (TGF\u03b21) system might be involved in the sex-specific development of prolactinomas in these models. The aim of this review is to summarize the literature supporting the important role of TGF\u03b21 as a local modulator of pituitary lactotroph function and to provide recent evidence for TGF\u03b21 involvement in the sex differences found in prolactinoma development in animal models."}
{"qid": "601d31df1cb411341a00002e", "original_text": "Multiple TREX mRNA export complex subunits (e.g., THOC1, THOC2, THOC5, THOC6, THOC7) have now been implicated in neurodevelopmental disorders (NDDs), neurodegeneration and cancer. We previously implicated missense and splicing-defective THOC2 variants in NDDs and a broad range of other clinical features. Here we report 10 individuals from nine families with rare missense THOC2 variants including the first case of a recurrent variant (p.Arg77Cys), and an additional individual with an intragenic THOC2 microdeletion (Del-Ex37-38). Ex vivo missense variant testing and patient-derived cell line data from current and published studies show 9 of the 14 missense THOC2 variants result in reduced protein stability. The splicing-defective and deletion variants result in a loss of small regions of the C-terminal THOC2 RNA binding domain (RBD).", "label": 1, "is_selected": 0, "text": "Multiple TREX mRNA export complex subunits (e.g., THOC1, THOC2, THOC5, THOC6, THOC7) have now been implicated in neurodevelopmental disorders (NDDs), neurodegeneration and cancer. We previously implicated missense and splicing-defective THOC2 variants in NDDs and a broad range of other clinical features. Here we report 10 individuals from nine families with rare missense THOC2 variants including the first case of a recurrent variant (p.Arg77Cys), and an additional individual with an intragenic THOC2 microdeletion (Del-Ex37-38). Ex vivo missense variant testing and patient-derived cell line data from current and published studies show 9 of the 14 missense THOC2 variants result in reduced protein stability. The splicing-defective and deletion variants result in a loss of small regions of the C-terminal THOC2 RNA binding domain (RBD)."}
{"qid": "5319ac36b166e2b806000031", "original_text": "Recent evidence suggests G-protein-coupled receptor-2-interacting protein-1 (GIT1) overexpression in several human metastatic tumors, including breast, lung, and prostate. Tumor metastasis is associated with an increase in angiogenesis. We have showed previously that GIT1 is required for postnatal angiogenesis during lung development. However, the functional role of GIT1 in pathological angiogenesis during tumor growth is unknown. In the present study, we show inhibition of angiogenesis in matrigel implants as well as reduced tumor angiogenesis and melanoma tumor growth in GIT1-knockout mice. We demonstrate that this is a result of impaired directional migration of GIT1-depleted endothelial cells toward a vascular endothelial growth factor gradient.", "label": 1, "is_selected": 0, "text": "Recent evidence suggests G-protein-coupled receptor-2-interacting protein-1 (GIT1) overexpression in several human metastatic tumors, including breast, lung, and prostate. Tumor metastasis is associated with an increase in angiogenesis. We have showed previously that GIT1 is required for postnatal angiogenesis during lung development. However, the functional role of GIT1 in pathological angiogenesis during tumor growth is unknown. In the present study, we show inhibition of angiogenesis in matrigel implants as well as reduced tumor angiogenesis and melanoma tumor growth in GIT1-knockout mice. We demonstrate that this is a result of impaired directional migration of GIT1-depleted endothelial cells toward a vascular endothelial growth factor gradient."}
{"qid": "571f609c0fd6f91b6800000c", "original_text": "GM1 gangliosidoses are a group of genetic disorders caused by deficiencies in the enzyme hexosaminidase A or hexosaminidase B. Hexosaminidase A deficiency is the most common cause of GM1 gangliosidoses, accounting for approximately 80% of cases. Hexosaminidase B deficiency is less common and accounts for the remaining 20% of cases. Both hexosaminidase A and B are necessary for the breakdown and recycling of GM1 gangliosides, which are important components of the myelin sheath surrounding nerve fibers. Without these enzymes, GM1 gangliosides accumulate and cause progressive nerve damage and degeneration.", "label": 0, "is_selected": 0, "text": "GM1 gangliosidoses are a group of genetic disorders caused by deficiencies in the enzyme hexosaminidase A or hexosaminidase B. Hexosaminidase A deficiency is the most common cause of GM1 gangliosidoses, accounting for approximately 80% of cases. Hexosaminidase B deficiency is less common and accounts for the remaining 20% of cases. Both hexosaminidase A and B are necessary for the breakdown and recycling of GM1 gangliosides, which are important components of the myelin sheath surrounding nerve fibers. Without these enzymes, GM1 gangliosides accumulate and cause progressive nerve damage and degeneration."}
{"qid": "58ef9ff170f9fc6f0f000002", "original_text": "South Asians exhibit extensive variation in skin melanin index (MI) which is observed across the broader region of South Asia as well as within restricted geographic regions. However, the genetic variants associated with variation in the skin pigmentation phenotype are poorly understood in these populations. The present study examines the association between MI measures and genetic variants from 5 candidate pigmentation genes among 533 individuals representing 6 populations of West Maharashtra. Associations between five single nucleotide polymorphisms (SNPs) known to play a role in pigmentation (rs1426654-SLC24A5, rs1042602-TYR, rs16891982-SLC45A2, rs6058017-ASIP, and rs642742-KITLG) and MI measures were tested using standard one-way analysis of variance (ANOVA) within each population.", "label": 1, "is_selected": 0, "text": "South Asians exhibit extensive variation in skin melanin index (MI) which is observed across the broader region of South Asia as well as within restricted geographic regions. However, the genetic variants associated with variation in the skin pigmentation phenotype are poorly understood in these populations. The present study examines the association between MI measures and genetic variants from 5 candidate pigmentation genes among 533 individuals representing 6 populations of West Maharashtra. Associations between five single nucleotide polymorphisms (SNPs) known to play a role in pigmentation (rs1426654-SLC24A5, rs1042602-TYR, rs16891982-SLC45A2, rs6058017-ASIP, and rs642742-KITLG) and MI measures were tested using standard one-way analysis of variance (ANOVA) within each population."}
{"qid": "605700d294d57fd879000021", "original_text": "Royal jelly proteins are the main components of royal jelly, which is a glandular secretion produced by worker bees of the genus Apis (Apis mellifera and Apis cerana) and are used to feed the larvae and the queen bee. The major royal jelly proteins in Apis mellifera include: 1. Royalactin: a cytoskeletal protein involved in cell signaling and division. 2. Vesharin: a calcium-binding protein that regulates calcium metabolism in bees. 3. Honeybee apolipoprotein 1 (HBAP1): a protein that plays a role in lipid transport and metabolism. 4. Honeybee apolipoprotein 2 (HBAP2): a protein involved in the transport of triglycerides and cholesterol in bees. 5. Royal jelly acid (RJA): a protein that is responsible for the antibacterial and antifungal properties of royal jelly. 6. Major royal jelly protein (MRJP): the most abundant protein in royal jelly, involved in the maintenance of bee health and immune function. 7. Glucotropic hormone (GtH): a protein that regulates carbohydrate metabolism in bees. 8. Phospholipase A2 (PLA2): an enzyme involved in lipid metabolism and cell signaling. Note: The composition of royal jelly proteins may vary depending on factors such as the age of the bee, the time of year, and the queen bee's presence or absence.", "label": 0, "is_selected": 1, "text": "The royal jelly proteins found in bees play a key role in the maintenance of the bees' health and function. Major royal jelly protein (MRJP): the most abundant protein in royal jelly, involved in themaintenance of bee health and Function.Moreover, royal jelly is a rich source of Omega-3 fatty acids, which are important for the health of the bee and the development of its immune system, as well as a source of Vitamin C, which is essential for the survival of the queen bee."}
{"qid": "5536554abc4f83e828000008", "original_text": "The recurrent translocation breakpoint on chromosome 22 of neuroepithelioma has been localized between two probes, D22S1 and D22S15, by both in situ hybridization and somatic cell hybrids.", "label": 1, "is_selected": 0, "text": "The recurrent translocation breakpoint on chromosome 22 of neuroepithelioma has been localized between two probes, D22S1 and D22S15, by both in situ hybridization and somatic cell hybrids."}
{"qid": "5ad255210340b9f058000018", "original_text": "Pancreatic ductal adenocarcinoma (PDAC) is lethal cancer whose primary tumor is characterized by dense composition of cancer cells, stromal cells, and extracellular matrix (ECM) composed largely of collagen. Within the PDAC tumor microenvironment, activated pancreatic stellate cells (PSC) are the dominant stromal cell type and responsible for collagen deposition. Lumican is a secreted proteoglycan that regulates collagen fibril assembly. We have previously identified that the presence of lumican in the ECM surrounding PDAC cells is associated with improved patient outcome after multimodal therapy and surgical removal of localized PDAC.", "label": 1, "is_selected": 0, "text": "Pancreatic ductal adenocarcinoma (PDAC) is lethal cancer whose primary tumor is characterized by dense composition of cancer cells, stromal cells, and extracellular matrix (ECM) composed largely of collagen. Within the PDAC tumor microenvironment, activated pancreatic stellate cells (PSC) are the dominant stromal cell type and responsible for collagen deposition. Lumican is a secreted proteoglycan that regulates collagen fibril assembly. We have previously identified that the presence of lumican in the ECM surrounding PDAC cells is associated with improved patient outcome after multimodal therapy and surgical removal of localized PDAC."}
{"qid": "61f5fe43882a024a1000001c", "original_text": "Zika virus (ZIKV) infection has been associated with prolonged viral excretion in human semen and causes testicular atrophy and infertility in 10-week-old immunodeficient mice. Male IFNAR-/- mice, knockout for type I interferon receptor, were immunized with GLS-5700, a deoxyribonucleic acid-based vaccine, before a subcutaneous ZIKV challenge with 6 \u00d7 105 plaque-forming units at 13 weeks of age. On day 28 postinfection, testes and epididymides were collected in some mice for histological and functional analyses, whereas others were mated with naive female wild-type C57BL/6J. Although all mice challenged with ZIKV developed viremia, most of them were asymptomatic, showed no weight loss, and survived infection. On day 28 postinfection, none of the unvaccinated, infected mice (9 of 9) exhibited abnormal spermatozoa counts or motility. However, 33% (3 of 9) and 36% (4 of 11) of mated males from this group were infertile, from 2 independent studies. Contrarily, males from the noninfected and the vaccinated, infected groups were all fertile.", "label": 1, "is_selected": 0, "text": "Zika virus (ZIKV) infection has been associated with prolonged viral excretion in human semen and causes testicular atrophy and infertility in 10-week-old immunodeficient mice. Male IFNAR-/- mice, knockout for type I interferon receptor, were immunized with GLS-5700, a deoxyribonucleic acid-based vaccine, before a subcutaneous ZIKV challenge with 6 \u00d7 105 plaque-forming units at 13 weeks of age. On day 28 postinfection, testes and epididymides were collected in some mice for histological and functional analyses, whereas others were mated with naive female wild-type C57BL/6J. Although all mice challenged with ZIKV developed viremia, most of them were asymptomatic, showed no weight loss, and survived infection. On day 28 postinfection, none of the unvaccinated, infected mice (9 of 9) exhibited abnormal spermatozoa counts or motility. However, 33% (3 of 9) and 36% (4 of 11) of mated males from this group were infertile, from 2 independent studies. Contrarily, males from the noninfected and the vaccinated, infected groups were all fertile."}
{"qid": "606b800994d57fd879000071", "original_text": "The FoundationOne CDx test uses a methodology called DNA sequencing to analyze tumor DNA from a blood sample. Specifically, it employs next-generation sequencing (NGS) technology, which allows for the simultaneous analysis of millions of DNA sequences in a single run. The test covers a wide range of genetic mutations that are commonly found in cancer, including those in the TP53, EGFR, BRCA1/2, and BRAF genes. The resulting data is then analyzed using advanced computational methods to identify potential mutations and guide treatment decisions.", "label": 0, "is_selected": 1, "text": "The FoundationOne CDx test has been approved by the US Food and Drug Administration (FDA) for the analysis of blood samples to help doctors select the best cancer treatment for a patient based on his or her genetic make-up and stage of the disease."}
{"qid": "553c9f96f32186855800000c", "original_text": "Genomic context analysis, also known as phylogenetic profiling, is widely used to infer functional interactions between proteins but rarely applied to non-coding cis-regulatory DNA elements. We were wondering whether this approach could provide insights about utlraconserved non-coding elements (UCNEs). These elements are organized as large clusters, so-called gene regulatory blocks (GRBs) around key developmental genes. Their molecular functions and the reasons for their high degree of conservation remain enigmatic. In a special setting of genomic context analysis, we analyzed the fate of GRBs after a whole-genome duplication event in five fish genomes.", "label": 1, "is_selected": 0, "text": "Genomic context analysis, also known as phylogenetic profiling, is widely used to infer functional interactions between proteins but rarely applied to non-coding cis-regulatory DNA elements. We were wondering whether this approach could provide insights about utlraconserved non-coding elements (UCNEs). These elements are organized as large clusters, so-called gene regulatory blocks (GRBs) around key developmental genes. Their molecular functions and the reasons for their high degree of conservation remain enigmatic. In a special setting of genomic context analysis, we analyzed the fate of GRBs after a whole-genome duplication event in five fish genomes."}
{"qid": "532f08dcd6d3ac6a3400002a", "original_text": "Yes, there are specific antidotes for dabigatran. Dabigatran is a direct oral anticoagulant (DOAC) that is used to prevent blood clots. The antidote for dabigatran is called idarucizumab, which is administered intravenously. Idarucizumab works by reversing the anticoagulant effects of dabigatran by binding to the drug and inhibiting its activity. The antidote should be administered as soon as possible after dabigatran use, ideally within 4 hours of the last dose. It's important to note that idarucizumab is only available in certain countries and its availability may vary depending on the specific regulations and guidelines in place.", "label": 0, "is_selected": 0, "text": "Yes, there are specific antidotes for dabigatran. Dabigatran is a direct oral anticoagulant (DOAC) that is used to prevent blood clots. The antidote for dabigatran is called idarucizumab, which is administered intravenously. Idarucizumab works by reversing the anticoagulant effects of dabigatran by binding to the drug and inhibiting its activity. The antidote should be administered as soon as possible after dabigatran use, ideally within 4 hours of the last dose. It's important to note that idarucizumab is only available in certain countries and its availability may vary depending on the specific regulations and guidelines in place."}
{"qid": "517295c18ed59a060a000016", "original_text": "Current methods for high throughput sequencing (HTS) for the first time offer the opportunity to investigate the entire transcriptome in an essentially unbiased way. In many species, small non-coding RNAs with specific secondary structures constitute a significant part of the transcriptome. Some of these RNA classes, in particular microRNAs and snoRNAs, undergo maturation processes that lead to the production of shorter RNAs. After mapping the sequences to the reference genome specific patterns of short reads can be observed. These read patterns seem to reflect the processing and thus are specific for the RNA transcripts of which they are derived from. We explore here the potential of short read sequence data in the classification and identification of non-coding RNAs.", "label": 1, "is_selected": 0, "text": "Current methods for high throughput sequencing (HTS) for the first time offer the opportunity to investigate the entire transcriptome in an essentially unbiased way. In many species, small non-coding RNAs with specific secondary structures constitute a significant part of the transcriptome. Some of these RNA classes, in particular microRNAs and snoRNAs, undergo maturation processes that lead to the production of shorter RNAs. After mapping the sequences to the reference genome specific patterns of short reads can be observed. These read patterns seem to reflect the processing and thus are specific for the RNA transcripts of which they are derived from. We explore here the potential of short read sequence data in the classification and identification of non-coding RNAs."}
{"qid": "601c4a0a1cb411341a00001f", "original_text": "Despite the common practice of upper gastrointestinal endoscopy, the unique phenomenon of punctate black pigmentation of the duodenal mucosa, now known as pseudomelanosis duodeni, still remains a rare entity. Four patients with normal renal function at presentation were found to have this pigment on endoscopy. One developed renal failure subsequently but the pigmentation persisted and this observation has not been reported before. Histochemical and ultrastructural studies were made. It is postulated that the pigment is heterogenous and represents a form of stored iron.", "label": 1, "is_selected": 0, "text": "Despite the common practice of upper gastrointestinal endoscopy, the unique phenomenon of punctate black pigmentation of the duodenal mucosa, now known as pseudomelanosis duodeni, still remains a rare entity. Four patients with normal renal function at presentation were found to have this pigment on endoscopy. One developed renal failure subsequently but the pigmentation persisted and this observation has not been reported before. Histochemical and ultrastructural studies were made. It is postulated that the pigment is heterogenous and represents a form of stored iron."}
{"qid": "58ce69cd1f5fb2b734000003", "original_text": "The 5' and 3' untranslated regions (UTRs) of messenger RNAs (mRNAs) function as platforms that can determine the fate of each mRNA individually and in aggregate. Multiple mRNAs that encode proteins that are functionally related often interact with RNA-binding proteins (RBPs) and noncoding RNAs (ncRNAs) that coordinate their expression in time and space as RNA regulons within the ribonucleoprotein (RNP) infrastructure we term the ribonome.", "label": 1, "is_selected": 0, "text": "The 5' and 3' untranslated regions (UTRs) of messenger RNAs (mRNAs) function as platforms that can determine the fate of each mRNA individually and in aggregate. Multiple mRNAs that encode proteins that are functionally related often interact with RNA-binding proteins (RBPs) and noncoding RNAs (ncRNAs) that coordinate their expression in time and space as RNA regulons within the ribonucleoprotein (RNP) infrastructure we term the ribonome."}
{"qid": "58bbb71f22d3005309000016", "original_text": "tRNA molecules contain numerous chemically altered nucleosides, which are formed by enzymatic modification of the primary transcripts during the complex tRNA maturation process. Some of the modifications are introduced by single reactions, while other require complex series of reactions carried out by several different enzymes. The location and distribution of various types of modifications vary greatly between different tRNA molecules, organisms and organelles. We have developed a computational method tRNAmodpred, for predicting modifications in tRNA sequences. Briefly, our method takes as an input one or more unmodified tRNA sequences and a set of protein sequences corresponding to a proteome of a cell. Subsequently it identifies homologs of known tRNA modification enzymes in the proteome, predicts tRNA modification activities and maps them onto known pathways of RNA modification from the MODOMICS database. Thereby, theoretically possible modification pathways are identified, and products of these modification reactions are proposed for query tRNAs. This method allows for predicting modification patterns for newly sequenced genomes as well as for checking tentative modification status of tRNAs from one species treated with enzymes from another source, e.g. to predict the possible modifications of eukaryotic tRNAs expressed in bacteria. tRNAmodpred is freely available as a web server at http://genesilico.pl/trnamodpred/.", "label": 1, "is_selected": 0, "text": "tRNA molecules contain numerous chemically altered nucleosides, which are formed by enzymatic modification of the primary transcripts during the complex tRNA maturation process. Some of the modifications are introduced by single reactions, while other require complex series of reactions carried out by several different enzymes. The location and distribution of various types of modifications vary greatly between different tRNA molecules, organisms and organelles. We have developed a computational method tRNAmodpred, for predicting modifications in tRNA sequences. Briefly, our method takes as an input one or more unmodified tRNA sequences and a set of protein sequences corresponding to a proteome of a cell. Subsequently it identifies homologs of known tRNA modification enzymes in the proteome, predicts tRNA modification activities and maps them onto known pathways of RNA modification from the MODOMICS database. Thereby, theoretically possible modification pathways are identified, and products of these modification reactions are proposed for query tRNAs. This method allows for predicting modification patterns for newly sequenced genomes as well as for checking tentative modification status of tRNAs from one species treated with enzymes from another source, e.g. to predict the possible modifications of eukaryotic tRNAs expressed in bacteria. tRNAmodpred is freely available as a web server at http://genesilico.pl/trnamodpred/."}
{"qid": "52b2ecd34003448f55000003", "original_text": "Yes, mutations in the GARS gene have been identified as a causative factor for Charcot-Marie-Tooth Disease Type 2D (CMT2D). The GARS gene encodes for the enzyme alpha-keto acid decarboxylase (KAD), which is involved in the biosynthesis of myelin, the protective covering of nerve fibers. Mutations in the GARS gene can lead to a deficiency in KAD activity, resulting in demyelination and axonal loss, hallmark symptoms of CMT2D. Studies have shown that mutations in the GARS gene are present in a significant proportion of CMT2D patients, and are often found in combination with mutations in other genes involved in myelin formation, such as the PMP22 gene. Therefore, mutations in the GARS gene are a critical component of the genetic etiology of CMT2D.", "label": 0, "is_selected": 0, "text": "Yes, mutations in the GARS gene have been identified as a causative factor for Charcot-Marie-Tooth Disease Type 2D (CMT2D). The GARS gene encodes for the enzyme alpha-keto acid decarboxylase (KAD), which is involved in the biosynthesis of myelin, the protective covering of nerve fibers. Mutations in the GARS gene can lead to a deficiency in KAD activity, resulting in demyelination and axonal loss, hallmark symptoms of CMT2D. Studies have shown that mutations in the GARS gene are present in a significant proportion of CMT2D patients, and are often found in combination with mutations in other genes involved in myelin formation, such as the PMP22 gene. Therefore, mutations in the GARS gene are a critical component of the genetic etiology of CMT2D."}
{"qid": "606b61f794d57fd879000068", "original_text": "Atrial natriuretic peptide (ANP) and its natriuretic peptide receptors A (NPR-A) and C (NPR-C) are involved in the regulation of physiological and pathophysiological process of blood pressure. The present study aimed to determine the role of NPR-C in the development of salt-sensitive hypertension. The Dahl salt-sensitive (DS) and salt-resistant (DR) rats were used in this study. Animals were matched according to their age and weight, and then placed on either a high-salt (HS, 8%) or a normal-salt (NS, 0.4%) diet for 6 weeks randomly using random number table. The systolic blood pressure (SBP), plasmatic sodium concentration (PLNa), urinary sodium excretion (UVNa), and serum creatinine concentration (Scr) were measured. The concentration of ANP in blood and tissues (heart and kidney) was detected by enzyme-linked immunosorbent assay. The expression of ANP, NPR-A, and NPR-C in kidney was evaluated with western blot analysis. Regarding renal redox state, the concentration changes in malondialdehyde (MDA), lipofuscin, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox), and nitric oxide synthase (NOS) in kidney were detected by a spectrophotometric method. The kidney damage was evaluated using pathological techniques and the succinodehydrogenase (SDHase) examination. Furthermore, after an intra-peritoneal injection of C-atrial natriuretic peptide (ANP)4-23 (C-ANP4-23), an NPR-C receptor agonist, the SBP, biochemical values in blood and urine, and renal redox state were evaluated. The paired Student's t test and analysis of variance followed by the Bonferroni test were performed for statistical analyses of the comparisons between two groups and multiple groups, respectively. The baseline SBP in all groups was within the normal range.", "label": 1, "is_selected": 0, "text": "Atrial natriuretic peptide (ANP) and its natriuretic peptide receptors A (NPR-A) and C (NPR-C) are involved in the regulation of physiological and pathophysiological process of blood pressure. The present study aimed to determine the role of NPR-C in the development of salt-sensitive hypertension. The Dahl salt-sensitive (DS) and salt-resistant (DR) rats were used in this study. Animals were matched according to their age and weight, and then placed on either a high-salt (HS, 8%) or a normal-salt (NS, 0.4%) diet for 6 weeks randomly using random number table. The systolic blood pressure (SBP), plasmatic sodium concentration (PLNa), urinary sodium excretion (UVNa), and serum creatinine concentration (Scr) were measured. The concentration of ANP in blood and tissues (heart and kidney) was detected by enzyme-linked immunosorbent assay. The expression of ANP, NPR-A, and NPR-C in kidney was evaluated with western blot analysis. Regarding renal redox state, the concentration changes in malondialdehyde (MDA), lipofuscin, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox), and nitric oxide synthase (NOS) in kidney were detected by a spectrophotometric method. The kidney damage was evaluated using pathological techniques and the succinodehydrogenase (SDHase) examination. Furthermore, after an intra-peritoneal injection of C-atrial natriuretic peptide (ANP)4-23 (C-ANP4-23), an NPR-C receptor agonist, the SBP, biochemical values in blood and urine, and renal redox state were evaluated. The paired Student's t test and analysis of variance followed by the Bonferroni test were performed for statistical analyses of the comparisons between two groups and multiple groups, respectively. The baseline SBP in all groups was within the normal range."}
{"qid": "5a6e21b4b750ff445500003a", "original_text": "MicroRNAs (miRNAs) are small non-coding RNA chains that can each interact with the 3'-untranslated region of multiple target transcripts in various organisms, humans included. MiRNAs tune entire biological pathways, spanning stress reactions, by regulating the stability and/or translation of their targets. MiRNA genes are often subject to co-evolutionary changes together with their target transcripts, which may be reflected by differences between paralog mouse and primate miRNA/mRNA pairs. However, whether such evolution occurred in stress-related miRNAs remained largely unknown. Here, we report that the stress-induced evolutionarily conserved miR-132-3p, its target transcripts and its regulated pathways provide an intriguing example to exceptionally robust conservation. Mice and human miR-132-3p share six experimentally validated targets and 18 predicted targets with a common miRNA response element. Enrichment analysis and mining in-house and web-available experimental data identified co-regulation by miR-132 in mice and humans of stress-related, inflammatory, metabolic, and neuronal growth pathways. Our findings demonstrate pan-mammalian preservation of miR-132's neuronal roles, and call for further exploring the corresponding stress-related implications.", "label": 1, "is_selected": 0, "text": "MicroRNAs (miRNAs) are small non-coding RNA chains that can each interact with the 3'-untranslated region of multiple target transcripts in various organisms, humans included. MiRNAs tune entire biological pathways, spanning stress reactions, by regulating the stability and/or translation of their targets. MiRNA genes are often subject to co-evolutionary changes together with their target transcripts, which may be reflected by differences between paralog mouse and primate miRNA/mRNA pairs. However, whether such evolution occurred in stress-related miRNAs remained largely unknown. Here, we report that the stress-induced evolutionarily conserved miR-132-3p, its target transcripts and its regulated pathways provide an intriguing example to exceptionally robust conservation. Mice and human miR-132-3p share six experimentally validated targets and 18 predicted targets with a common miRNA response element. Enrichment analysis and mining in-house and web-available experimental data identified co-regulation by miR-132 in mice and humans of stress-related, inflammatory, metabolic, and neuronal growth pathways. Our findings demonstrate pan-mammalian preservation of miR-132's neuronal roles, and call for further exploring the corresponding stress-related implications."}
{"qid": "56a375f8496b62f23f000002", "original_text": "Cancer germline (CG) genes are normally expressed in germ cells and aberrantly expressed in a variety of cancers; their immunogenicity has led to the widespread development of cancer vaccines targeting these antigens. BORIS/CTCFL is an autosomal CG antigen and promising cancer vaccine target. BORIS is the only known paralog of CTCF, a gene intimately involved in genomic imprinting, chromatin insulation, and nuclear regulation. We have previously shown that BORIS is expressed in epithelial ovarian cancer (EOC) and that its expression coincides with promoter and global DNA hypomethylation. Recently, 23 different BORIS mRNA variants have been described, and have been functionally grouped into six BORIS isoform families (sf1-sf6). In the present study, we have characterized the expression of BORIS isoform families in normal ovary (NO) and EOC, the latter of which were selected to include two groups with widely varying global DNA methylation status. We find selective expression of BORIS isoform families in NO, which becomes altered in EOC, primarily by the activation of BORIS sf1 in EOC. When comparing EOC samples based on methylation status, we find that BORIS sf1 and sf2 isoform families are selectively activated in globally hypomethylated tumors.", "label": 1, "is_selected": 0, "text": "Cancer germline (CG) genes are normally expressed in germ cells and aberrantly expressed in a variety of cancers; their immunogenicity has led to the widespread development of cancer vaccines targeting these antigens. BORIS/CTCFL is an autosomal CG antigen and promising cancer vaccine target. BORIS is the only known paralog of CTCF, a gene intimately involved in genomic imprinting, chromatin insulation, and nuclear regulation. We have previously shown that BORIS is expressed in epithelial ovarian cancer (EOC) and that its expression coincides with promoter and global DNA hypomethylation. Recently, 23 different BORIS mRNA variants have been described, and have been functionally grouped into six BORIS isoform families (sf1-sf6). In the present study, we have characterized the expression of BORIS isoform families in normal ovary (NO) and EOC, the latter of which were selected to include two groups with widely varying global DNA methylation status. We find selective expression of BORIS isoform families in NO, which becomes altered in EOC, primarily by the activation of BORIS sf1 in EOC. When comparing EOC samples based on methylation status, we find that BORIS sf1 and sf2 isoform families are selectively activated in globally hypomethylated tumors."}
{"qid": "62507520e764a5320400000c", "original_text": "Complexins play a critical role in the regulation of neurotransmission by regulating SNARE-mediated exocytosis of synaptic vesicles. Complexins can exert either a facilitatory or an inhibitory effect on neurotransmitter release, depending on the context, and different complexin domains contribute differently to these opposing roles. Structural characterization of the central helix domain of complexin bound to the assembled SNARE bundle provided key insights into the functional mechanism of this domain of complexin, which is critical for both complexin activities, but many questions remain, particularly regarding the roles and mechanisms of other complexin domains. Recent progress has clarified the structural properties of these additional domains, and has led to various proposals regarding how they contribute to complexin function.", "label": 1, "is_selected": 0, "text": "Complexins play a critical role in the regulation of neurotransmission by regulating SNARE-mediated exocytosis of synaptic vesicles. Complexins can exert either a facilitatory or an inhibitory effect on neurotransmitter release, depending on the context, and different complexin domains contribute differently to these opposing roles. Structural characterization of the central helix domain of complexin bound to the assembled SNARE bundle provided key insights into the functional mechanism of this domain of complexin, which is critical for both complexin activities, but many questions remain, particularly regarding the roles and mechanisms of other complexin domains. Recent progress has clarified the structural properties of these additional domains, and has led to various proposals regarding how they contribute to complexin function."}
{"qid": "62532ce6e764a53204000021", "original_text": "Facial musculature is divided into masticatory muscles, i.e. M. masseter and M. buccalis, with bony insertions and smaller facial muscles involved in facial expression, which insert into bone and skin. There are four fixed osteocutaneous points of the face, i.e. zygomatic (Mac Gregor), mandibular (Furnas), orbital (Psillakis), and masseteric with an antigravitational effect and functional role in facial expression (1,2).", "label": 1, "is_selected": 0, "text": "Facial musculature is divided into masticatory muscles, i.e. M. masseter and M. buccalis, with bony insertions and smaller facial muscles involved in facial expression, which insert into bone and skin. There are four fixed osteocutaneous points of the face, i.e. zygomatic (Mac Gregor), mandibular (Furnas), orbital (Psillakis), and masseteric with an antigravitational effect and functional role in facial expression (1,2)."}
{"qid": "5fdb2f54a43ad31278000012", "original_text": "Formative pluripotency refers to the capacity of a stem cell to differentiate into multiple cell types, including those that are not yet well-defined or established. This is in contrast to traditional pluripotency, which refers to the ability of a stem cell to differentiate into all cell types that are present in the body. Formative pluripotency is considered a more dynamic and flexible form of pluripotency, as it allows for the generation of new cell types and the adaptation to changing conditions.", "label": 0, "is_selected": 0, "text": "Formative pluripotency refers to the capacity of a stem cell to differentiate into multiple cell types, including those that are not yet well-defined or established. This is in contrast to traditional pluripotency, which refers to the ability of a stem cell to differentiate into all cell types that are present in the body. Formative pluripotency is considered a more dynamic and flexible form of pluripotency, as it allows for the generation of new cell types and the adaptation to changing conditions."}
{"qid": "5a99332a1d1251d03b00000e", "original_text": "Endometriosis, an estrogen-dependent disease, is believed to be influenced by multiple genetic and environmental factors. Here, we evaluated whether the risk and severity of endometriosis are associated with polymorphisms in estradiol-synthesizing enzyme genes: the Ser312Gly polymorphism in 17-beta-hydroxysteroid dehydrogenase type 1 (HSD17B1) and the Arg264Cys polymorphism in cytochrome P450, subfamily XIX (CYP19). All participants underwent diagnostic laparoscopy, and the stage of endometriosis was determined according to the Revised American Fertility Society classification. Of the 138 women enrolled, 59 had no endometriosis, 21 had stage I, 10 had stage II, 23 had stage III and 25 had stage IV.", "label": 1, "is_selected": 0, "text": "Endometriosis, an estrogen-dependent disease, is believed to be influenced by multiple genetic and environmental factors. Here, we evaluated whether the risk and severity of endometriosis are associated with polymorphisms in estradiol-synthesizing enzyme genes: the Ser312Gly polymorphism in 17-beta-hydroxysteroid dehydrogenase type 1 (HSD17B1) and the Arg264Cys polymorphism in cytochrome P450, subfamily XIX (CYP19). All participants underwent diagnostic laparoscopy, and the stage of endometriosis was determined according to the Revised American Fertility Society classification. Of the 138 women enrolled, 59 had no endometriosis, 21 had stage I, 10 had stage II, 23 had stage III and 25 had stage IV."}
{"qid": "5c3479dcda8336e21a000002", "original_text": "Most copy number variations are neutral, but some are deleterious and associated with various human diseases. Copy number variations are distributed non-randomly in vertebrate genomes, and it was recently reported that ohnologs, which are duplicated genes derived from whole genome duplication, are refractory to copy number variations. However, it is unclear what genomic factors affect the deleterious effects of copy number variations and the biological significance of the biased genomic distribution of copy number variations remains poorly understood. Here we show that non-ohnologs neighbouring ohnologs are unlikely to have copy number variations, resulting in ohnolog-rich regions in vertebrate genomes being copy number variation deserts.", "label": 1, "is_selected": 0, "text": "Most copy number variations are neutral, but some are deleterious and associated with various human diseases. Copy number variations are distributed non-randomly in vertebrate genomes, and it was recently reported that ohnologs, which are duplicated genes derived from whole genome duplication, are refractory to copy number variations. However, it is unclear what genomic factors affect the deleterious effects of copy number variations and the biological significance of the biased genomic distribution of copy number variations remains poorly understood. Here we show that non-ohnologs neighbouring ohnologs are unlikely to have copy number variations, resulting in ohnolog-rich regions in vertebrate genomes being copy number variation deserts."}
{"qid": "52e6c92598d0239505000019", "original_text": "The KRAS oncogene is a commonly mutated gene in various human cancers, including lung, colon, and pancreatic cancer. Mutational hotspots in the KRAS gene refer to specific regions within the gene that are more frequently mutated than other regions. Here are some of the known mutational hotspots in the human KRAS oncogene: 1. G12C: This is the most common hotspot mutation in KRAS, occurring in approximately 20% of all KRAS-mutated cancers. The G12C mutation occurs in the codons 12 of the KRAS gene and is associated with resistance to EGFR inhibitors. 2. G13D: This hotspot mutation occurs in approximately 5% of KRAS-mutated cancers and is associated with resistance to EGFR inhibitors. 3. G25M: This hotspot mutation occurs in approximately 5% of KRAS-mutated cancers and is associated with resistance to EGFR inhibitors. 4. Q61H: This hotspot mutation occurs in approximately 5% of KRAS-mutated cancers and is associated with resistance to EGFR inhibitors. 5. Exon 2 hotspots: Exon 2 of the KRAS gene is a common hotspot for mutations, occurring in approximately 10% of KRAS-mutated cancers. Mutations in this region can result in the production of an abnormally stable KRAS protein that promotes oncogenic signaling. 6. Exon 3 hotspots: Exon 3 of the KRAS gene is another common hotspot for mutations, occurring in approximately 5% of KRAS-mutated cancers. Mutations in this region can also result in the production of an abnormally stable KRAS protein that promotes oncogenic signaling. It is important to note that the specific mutational hotspots in the KRAS gene can vary depending on the type of cancer and the patient population. The most common hotspot mutations may not be present in all patients with KRAS-mutated cancers. I hope this information is helpful. If you have any further questions, please let me know.", "label": 0, "is_selected": 0, "text": "The KRAS oncogene is a commonly mutated gene in various human cancers, including lung, colon, and pancreatic cancer. Mutational hotspots in the KRAS gene refer to specific regions within the gene that are more frequently mutated than other regions. Here are some of the known mutational hotspots in the human KRAS oncogene: 1. G12C: This is the most common hotspot mutation in KRAS, occurring in approximately 20% of all KRAS-mutated cancers. The G12C mutation occurs in the codons 12 of the KRAS gene and is associated with resistance to EGFR inhibitors. 2. G13D: This hotspot mutation occurs in approximately 5% of KRAS-mutated cancers and is associated with resistance to EGFR inhibitors. 3. G25M: This hotspot mutation occurs in approximately 5% of KRAS-mutated cancers and is associated with resistance to EGFR inhibitors. 4. Q61H: This hotspot mutation occurs in approximately 5% of KRAS-mutated cancers and is associated with resistance to EGFR inhibitors. 5. Exon 2 hotspots: Exon 2 of the KRAS gene is a common hotspot for mutations, occurring in approximately 10% of KRAS-mutated cancers. Mutations in this region can result in the production of an abnormally stable KRAS protein that promotes oncogenic signaling. 6. Exon 3 hotspots: Exon 3 of the KRAS gene is another common hotspot for mutations, occurring in approximately 5% of KRAS-mutated cancers. Mutations in this region can also result in the production of an abnormally stable KRAS protein that promotes oncogenic signaling. It is important to note that the specific mutational hotspots in the KRAS gene can vary depending on the type of cancer and the patient population. The most common hotspot mutations may not be present in all patients with KRAS-mutated cancers. I hope this information is helpful. If you have any further questions, please let me know."}
{"qid": "56cafa845795f9a73e00002e", "original_text": "The mechanistic target of rapamycin (mTOR) functions as a component of two large complexes, mTORC1 and mTORC2, which play crucial roles in regulating cell growth and homeostasis. However, the molecular mechanisms by which mTOR controls cell proliferation remain elusive. Here we show that the FoxO3a transcription factor is coordinately regulated by mTORC1 and mTORC2, and plays a crucial role in controlling cell proliferation. To dissect mTOR signaling, mTORC1 was specifically inactivated by depleting p18, an essential anchor of mTORC1 on lysosomes. mTORC1 inactivation caused a marked retardation of cell proliferation, which was associated with upregulation of cyclin-dependent kinase inhibitors (CDKIs). Although Akt was activated by mTORC1 inactivation, FoxO3a was upregulated via an epigenetic mechanism and hypophosphorylated at Ser314, which resulted in its nuclear accumulation.", "label": 1, "is_selected": 0, "text": "The mechanistic target of rapamycin (mTOR) functions as a component of two large complexes, mTORC1 and mTORC2, which play crucial roles in regulating cell growth and homeostasis. However, the molecular mechanisms by which mTOR controls cell proliferation remain elusive. Here we show that the FoxO3a transcription factor is coordinately regulated by mTORC1 and mTORC2, and plays a crucial role in controlling cell proliferation. To dissect mTOR signaling, mTORC1 was specifically inactivated by depleting p18, an essential anchor of mTORC1 on lysosomes. mTORC1 inactivation caused a marked retardation of cell proliferation, which was associated with upregulation of cyclin-dependent kinase inhibitors (CDKIs). Although Akt was activated by mTORC1 inactivation, FoxO3a was upregulated via an epigenetic mechanism and hypophosphorylated at Ser314, which resulted in its nuclear accumulation."}
{"qid": "5ad3130c0340b9f05800001d", "original_text": "Yes, gut proteobacteria have been associated with inflammatory diseases. Proteobacteria are a diverse group of bacteria that inhabit the gut microbiome and play important roles in various physiological processes. However, an imbalance or altered composition of proteobacteria in the gut has been linked to various inflammatory diseases, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and inflammatory conditions such as arthritis and atherosclerosis. Studies have shown that certain species of proteobacteria, such as Clostridium and Desulfovibrio, are overrepresented in the gut microbiomes of individuals with IBD and IBS. These bacteria can produce pro-inflammatory molecules, such as lipopolysaccharides and bacterial toxins, which can trigger an immune response and promote inflammation in the gut. Additionally, proteobacteria have been shown to play a role in the modulation of the gut-brain axis, which can contribute to the development of psychological symptoms in conditions such as IBS. In summary, alterations in the composition of gut proteobacteria have been linked to the development of inflammatory diseases, highlighting the complex interplay between the gut microbiome and the immune system. Further research is needed to fully understand the mechanisms by which gut proteobacteria contribute to inflammation and to identify potential therapeutic targets for the prevention and treatment of these diseases.", "label": 0, "is_selected": 1, "text": "Can gut proteobacteria have been associated with inflammatory diseases, such as IBD and IBS, and what are the mechanisms by which they have been linked to the development of these diseases?<n> Importantly, further research is needed to fully understand the mechanisms and to identify potential therapeutic targets for the prevention and treatment of this diseases.Moreover, further studies are needed to understand the role of gut microbiomes in the development and progression of inflammatory diseases.Lastly, more research is needs to be carried out to better understand the gut microbiome's role in the maintenance of healthy gut health."}
{"qid": "62008456c9dfcb9c0900001e", "original_text": "The ASTRAL (Assessment of Sepsis Related Organ Dysfunction) score is a clinical score used to evaluate the severity of organ dysfunction in patients with suspected or confirmed sepsis. It was developed by the ACCM (American College of Critical Care Medicine) and is widely used in clinical practice. The ASTRAL score consists of six components: * Respiratory rate (RR): 1 point for each respiratory rate \u2265 22 breaths per minute * Heart rate (HR): 1 point for each heart rate \u2265 100 beats per minute * Mean arterial pressure (MAP): 1 point for each MAP \u2264 70 mmHg * Serum creatinine concentration: 1 point for each creatinine concentration \u2265 1.5 mg/dL * Blood urea nitrogen (BUN) concentration: 1 point for each BUN concentration \u2265 12 mg/dL * Arterial lactate level (ALact): 1 point for each ALact \u2265 2 mg/dL Each component is assigned a weight of 1, 2, or 3, and the total score ranges from 0 to 18. A higher score indicates more severe organ dysfunction. A score of 0-5 indicates mild dysfunction, 6-10 indicates moderate dysfunction, and 11-18 indicates severe dysfunction. The ASTRAL score has been shown to be a reliable and valid predictor of mortality in patients with sepsis, and it can help clinicians identify patients at high risk of mortality who may benefit from early intervention.", "label": 0, "is_selected": 1, "text": "The ASTRAL score has been shown to be a reliable and valid predictor of mortality in patients with sepsis, and it can help identify patients at high risk of who may benefit from early intervention, but it can also be used to assess organ dysfunction in patients who are not at risk of developing severe organ dysfunction, such as heart failure or kidney failure, as well as to assess the severity of organ dysfunction and its impact on the patient's survival. TheASTRAL score consists of six components: * Respiratory rate (RR): 1 point for each respiratory rate  22 breaths per minute * Heart rate (HR): 1 points for each heart rate ( 100 beats per minute) * Mean arterial pressure (MAP): 1 Point for each MAP score  70 mmHg * Serum concentration: 1point for each A concentration ( 1.5 mg/dL)"}
{"qid": "554a0cadf35db7552600000f", "original_text": "The accumulation of deleterious mutations is driven by rare fluctuations that lead to the loss of all mutation free individuals, a process known as Muller's ratchet. Even though Muller's ratchet is a paradigmatic process in population genetics, a quantitative understanding of its rate is still lacking. The difficulty lies in the nontrivial nature of fluctuations in the fitness distribution, which control the rate of extinction of the fittest genotype. We address this problem using the simple but classic model of mutation selection balance with deleterious mutations all having the same effect on fitness. We show analytically how fluctuations among the fittest individuals propagate to individuals of lower fitness and have dramatically amplified effects on the bulk of the population at a later time. If a reduction in the size of the fittest class reduces the mean fitness only after a delay, selection opposing this reduction is also delayed. This delayed restoring force speeds up Muller's ratchet. We show how the delayed response can be accounted for using a path-integral formulation of the stochastic dynamics and provide an expression for the rate of the ratchet that is accurate across a broad range of parameters.", "label": 1, "is_selected": 0, "text": "The accumulation of deleterious mutations is driven by rare fluctuations that lead to the loss of all mutation free individuals, a process known as Muller's ratchet. Even though Muller's ratchet is a paradigmatic process in population genetics, a quantitative understanding of its rate is still lacking. The difficulty lies in the nontrivial nature of fluctuations in the fitness distribution, which control the rate of extinction of the fittest genotype. We address this problem using the simple but classic model of mutation selection balance with deleterious mutations all having the same effect on fitness. We show analytically how fluctuations among the fittest individuals propagate to individuals of lower fitness and have dramatically amplified effects on the bulk of the population at a later time. If a reduction in the size of the fittest class reduces the mean fitness only after a delay, selection opposing this reduction is also delayed. This delayed restoring force speeds up Muller's ratchet. We show how the delayed response can be accounted for using a path-integral formulation of the stochastic dynamics and provide an expression for the rate of the ratchet that is accurate across a broad range of parameters."}
{"qid": "5a9acd921d1251d03b000016", "original_text": "Crenezumab is currently in Phase III clinical trials for the treatment of Alzheimer's disease, as of November 2017.", "label": 0, "is_selected": 0, "text": "Crenezumab is currently in Phase III clinical trials for the treatment of Alzheimer's disease, as of November 2017."}
{"qid": "5fe31322a43ad3127800004c", "original_text": "Using Reactome, a curated Internet database, noise-induced hearing loss studies were aggregated into cellular pathways for organization of the emerging genomic and epigenetic data in the literature. PubMed and Reactome.org, a relational data base program systematizing biological processes into interactive pathways and subpathways based on ontology, cellular constituents, gene expression, and molecular components. Peer-reviewed population and laboratory studies for the previous 15 years relating genomics and noise and hearing loss were identified in PubMed. Criteria included p values <0.05 with correction for multiple genes, a fold change of >1.5, or duplicated studies. One-hundred fifty-eight unique HGNC identifiers from 77 articles met the selection criteria, and were uploaded into the analysis program at http://reactome.org. These genes participated in a total of 621 cellular interactions in 21 of 23 pathways. Cellular response to stress with its attenuation phase, particularly in response to heat stress, detoxification of ROS, and specific areas of the immune system are predominant pathways identified as significantly 'overrepresented' (p values <0.1e-5 and false discovery rates <0.01). Twenty-one of 23 of the designated pathways in Reactome have significant influence on noise-induced hearing loss, signifying a confluence of molecular pathways in reaction to acoustic trauma; however, cellular response to stress, including heat shock response, and other small areas of immune response were highly overrepresented. Yet-to-be-explored genomics areas include miRNA, lncRNA, copy number variations, RNA sequencing, and human genome-wide association study.", "label": 1, "is_selected": 0, "text": "Using Reactome, a curated Internet database, noise-induced hearing loss studies were aggregated into cellular pathways for organization of the emerging genomic and epigenetic data in the literature. PubMed and Reactome.org, a relational data base program systematizing biological processes into interactive pathways and subpathways based on ontology, cellular constituents, gene expression, and molecular components. Peer-reviewed population and laboratory studies for the previous 15 years relating genomics and noise and hearing loss were identified in PubMed. Criteria included p values <0.05 with correction for multiple genes, a fold change of >1.5, or duplicated studies. One-hundred fifty-eight unique HGNC identifiers from 77 articles met the selection criteria, and were uploaded into the analysis program at http://reactome.org. These genes participated in a total of 621 cellular interactions in 21 of 23 pathways. Cellular response to stress with its attenuation phase, particularly in response to heat stress, detoxification of ROS, and specific areas of the immune system are predominant pathways identified as significantly 'overrepresented' (p values <0.1e-5 and false discovery rates <0.01). Twenty-one of 23 of the designated pathways in Reactome have significant influence on noise-induced hearing loss, signifying a confluence of molecular pathways in reaction to acoustic trauma; however, cellular response to stress, including heat shock response, and other small areas of immune response were highly overrepresented. Yet-to-be-explored genomics areas include miRNA, lncRNA, copy number variations, RNA sequencing, and human genome-wide association study."}
{"qid": "5a760ed883b0d9ea66000019", "original_text": "There is no effective treatment for recurrent glioblastoma (GBM) after bevacizumab failure. Putative mechanisms of resistance to bevacizumab include increased pericyte coverage, mediated partly by platelet-derived growth factor receptor (PDGFR) signaling, and an infiltrative tumor growth pattern potentially dependent on SRC. We explored the efficacy of dasatinib, a SRC, BCR-ABL, c-KIT, EPHA2, and PDGFR\u03b2 inhibitor, in patients with recurrent GBM after bevacizumab failure. Adult patients with histologically confirmed GBM who failed bevacizumab therapy were treated with dasatinib 70-100 mg twice daily in combination with bevacizumab (n = 14), until tumor progression or unacceptable toxicity. Fourteen patients were treated. Median age was 55 years (range 32-66) and median KPS was 80 (range 50-90). All patients (100%) had glioblastomas. The median number of prior regimens was 4 (range from 2 to 6). Of the thirteen evaluable patients, none had a complete or partial response. Only one patient had stable disease after an 8 week interval. Median progression-free survival (PFS) was 28 days (95% confidence interval [CI] 26-35 days). Six month progression-free survival (PFS6) was 0%. Median overall survival (OS) was 78 days (95% CI 41-137 days). Treatment was moderately well-tolerated, although one patient sustained a grade 4 intracerebral hemorrhage. Dasatinib in conjunction with bevacizumab does not appear to have activity in patients with recurrent, heavily pretreated GBM.", "label": 1, "is_selected": 0, "text": "There is no effective treatment for recurrent glioblastoma (GBM) after bevacizumab failure. Putative mechanisms of resistance to bevacizumab include increased pericyte coverage, mediated partly by platelet-derived growth factor receptor (PDGFR) signaling, and an infiltrative tumor growth pattern potentially dependent on SRC. We explored the efficacy of dasatinib, a SRC, BCR-ABL, c-KIT, EPHA2, and PDGFR\u03b2 inhibitor, in patients with recurrent GBM after bevacizumab failure. Adult patients with histologically confirmed GBM who failed bevacizumab therapy were treated with dasatinib 70-100 mg twice daily in combination with bevacizumab (n = 14), until tumor progression or unacceptable toxicity. Fourteen patients were treated. Median age was 55 years (range 32-66) and median KPS was 80 (range 50-90). All patients (100%) had glioblastomas. The median number of prior regimens was 4 (range from 2 to 6). Of the thirteen evaluable patients, none had a complete or partial response. Only one patient had stable disease after an 8 week interval. Median progression-free survival (PFS) was 28 days (95% confidence interval [CI] 26-35 days). Six month progression-free survival (PFS6) was 0%. Median overall survival (OS) was 78 days (95% CI 41-137 days). Treatment was moderately well-tolerated, although one patient sustained a grade 4 intracerebral hemorrhage. Dasatinib in conjunction with bevacizumab does not appear to have activity in patients with recurrent, heavily pretreated GBM."}
{"qid": "550718e9fd1abe1741000001", "original_text": "A signal sequence is a specific sequence of amino acids at the N-terminus of a protein that serves as a targeting signal for the protein to be membrane-associated or secreted from the cell. The signal sequence is typically found in the proximal region of the protein, i.e., the first 20-30 amino acids, and is rich in hydrophobic residues such as leucine, isoleucine, and valine. These hydrophobic residues interact with the lipid bilayer of the cell membrane, directing the protein to the extracellular space or to the membrane for protein-protein interactions. The presence of a signal sequence in a protein can determine its cellular localization, subcellular localization, and its function within the cell.", "label": 0, "is_selected": 0, "text": "A signal sequence is a specific sequence of amino acids at the N-terminus of a protein that serves as a targeting signal for the protein to be membrane-associated or secreted from the cell. The signal sequence is typically found in the proximal region of the protein, i.e., the first 20-30 amino acids, and is rich in hydrophobic residues such as leucine, isoleucine, and valine. These hydrophobic residues interact with the lipid bilayer of the cell membrane, directing the protein to the extracellular space or to the membrane for protein-protein interactions. The presence of a signal sequence in a protein can determine its cellular localization, subcellular localization, and its function within the cell."}
{"qid": "5721f4b30fd6f91b68000011", "original_text": "The inherited disorder known to be caused by mutations in the NEMO gene is Chronic Granulomatous Disease (CGD). CGD is a rare genetic disorder that affects the immune system's ability to fight infections, leading to recurrent and severe infections, especially of the lungs, sinuses, and skin. The NEMO gene provides instructions for making a protein called NF-\u03baB p50, which plays a critical role in the immune system's response to infection. Mutations in the NEMO gene can lead to the production of an abnormal or incomplete NF-\u03baB p50 protein, which disrupts the normal immune response and leads to the symptoms of CGD.", "label": 0, "is_selected": 1, "text": "A team of researchers at the University of California, Los Angeles (UCLA) has identified a gene defect that can lead to a rare genetic disorder that affects the body's ability to fight infections. The NEMO gene provides instructions for making a protein called NF-B p50, which plays a critical role in the immune system's response to infection."}
{"qid": "6032a0e21cb411341a000148", "original_text": "Bacteriocins, the ribosomally produced antimicrobial peptides of bacteria, represent an untapped source of promising antibiotic alternatives. However, bacteriocins display diverse mechanisms of action, a narrow spectrum of activity, and inherent challenges in natural product isolation making in vitro verification of putative bacteriocins difficult. A subset of bacteriocins exert their antimicrobial effects through favorable biophysical interactions with the bacterial membrane mediated by the charge, hydrophobicity, and conformation of the peptide. We have developed a pipeline for bacteriocin-derived compound design and testing that combines sequence-free prediction of bacteriocins using machine learning and a simple biophysical trait filter to generate 20 amino acid peptides that can be synthesized and evaluated for activity. We generated 28,895 total 20-mer candidate peptides and scored them for charge, \u03b1-helicity, and hydrophobic moment.", "label": 1, "is_selected": 0, "text": "Bacteriocins, the ribosomally produced antimicrobial peptides of bacteria, represent an untapped source of promising antibiotic alternatives. However, bacteriocins display diverse mechanisms of action, a narrow spectrum of activity, and inherent challenges in natural product isolation making in vitro verification of putative bacteriocins difficult. A subset of bacteriocins exert their antimicrobial effects through favorable biophysical interactions with the bacterial membrane mediated by the charge, hydrophobicity, and conformation of the peptide. We have developed a pipeline for bacteriocin-derived compound design and testing that combines sequence-free prediction of bacteriocins using machine learning and a simple biophysical trait filter to generate 20 amino acid peptides that can be synthesized and evaluated for activity. We generated 28,895 total 20-mer candidate peptides and scored them for charge, \u03b1-helicity, and hydrophobic moment."}
{"qid": "5149b575d24251bc05000047", "original_text": "Most proteins comprise one or several domains. New domain architectures can be created by combining previously existing domains. The elementary events that create new domain architectures may be categorized into three classes, namely domain(s) insertion or deletion (indel), exchange and repetition. Using 'DomainTeam', a tool dedicated to the search for microsyntenies of domains, we quantified the relative contribution of these events. This tool allowed us to collect homologous bacterial genes encoding proteins that have obviously evolved by modular assembly of domains. We show that indels are the most frequent elementary events and that they occur in most cases at either the N- or C-terminus of the proteins.", "label": 1, "is_selected": 0, "text": "Most proteins comprise one or several domains. New domain architectures can be created by combining previously existing domains. The elementary events that create new domain architectures may be categorized into three classes, namely domain(s) insertion or deletion (indel), exchange and repetition. Using 'DomainTeam', a tool dedicated to the search for microsyntenies of domains, we quantified the relative contribution of these events. This tool allowed us to collect homologous bacterial genes encoding proteins that have obviously evolved by modular assembly of domains. We show that indels are the most frequent elementary events and that they occur in most cases at either the N- or C-terminus of the proteins."}
{"qid": "5324cf869b2d7acc7e000020", "original_text": "Yes, there have been several clinical trials investigating the effectiveness of evening primrose oil (EPO) on postmenopausal symptoms. A 2010 systematic review and meta-analysis published in the Journal of the North American Menopause Society found that EPO supplementation was associated with significant improvements in hot flash frequency and severity in postmenopausal women. The review included five randomized controlled trials with a total of 367 participants. A more recent randomized controlled trial published in the Journal of Women's Health in 2019 found that EPO supplementation (1000 mg/day) for 8 weeks significantly reduced hot flash frequency and severity in postmenopausal women compared to placebo. The study included 85 participants. Another study published in Menopause in 2017 found that EPO supplementation (500 mg/day) for 6 months improved vaginal health and sexual function in postmenopausal women. The study included 81 participants. It is important to note that the quality of the evidence varies across the different studies, and the results may not be applicable to all postmenopausal women. More research is needed to confirm the efficacy and safety of EPO supplementation for postmenopausal symptoms. In summary, while the evidence is promising, more research is needed to fully understand the effects of EPO supplementation on postmenopausal symptoms. As with any supplement, it is important to consult with a healthcare provider before starting EPO supplementation.", "label": 0, "is_selected": 0, "text": "Yes, there have been several clinical trials investigating the effectiveness of evening primrose oil (EPO) on postmenopausal symptoms. A 2010 systematic review and meta-analysis published in the Journal of the North American Menopause Society found that EPO supplementation was associated with significant improvements in hot flash frequency and severity in postmenopausal women. The review included five randomized controlled trials with a total of 367 participants. A more recent randomized controlled trial published in the Journal of Women's Health in 2019 found that EPO supplementation (1000 mg/day) for 8 weeks significantly reduced hot flash frequency and severity in postmenopausal women compared to placebo. The study included 85 participants. Another study published in Menopause in 2017 found that EPO supplementation (500 mg/day) for 6 months improved vaginal health and sexual function in postmenopausal women. The study included 81 participants. It is important to note that the quality of the evidence varies across the different studies, and the results may not be applicable to all postmenopausal women. More research is needed to confirm the efficacy and safety of EPO supplementation for postmenopausal symptoms. In summary, while the evidence is promising, more research is needed to fully understand the effects of EPO supplementation on postmenopausal symptoms. As with any supplement, it is important to consult with a healthcare provider before starting EPO supplementation."}
{"qid": "5c896f60d558e5f232000003", "original_text": "Two autologous chimeric antigen receptor (CAR) T cell therapies (Kymriah\u2122 and Yescarta\u2122) were recently approved by the FDA. Kymriah\u2122 is for the treatment of pediatric patients and young adults with refractory or relapse (R/R) B cell precursor acute lymphoblastic leukemia and Yescarta\u2122 is for the treatment of adult patients with R/R large B cell lymphoma.", "label": 1, "is_selected": 0, "text": "Two autologous chimeric antigen receptor (CAR) T cell therapies (Kymriah\u2122 and Yescarta\u2122) were recently approved by the FDA. Kymriah\u2122 is for the treatment of pediatric patients and young adults with refractory or relapse (R/R) B cell precursor acute lymphoblastic leukemia and Yescarta\u2122 is for the treatment of adult patients with R/R large B cell lymphoma."}
{"qid": "589af57a78275d0c4a000038", "original_text": "The European Medicines Agency has approved a multicomponent serogroup B meningococcal vaccine (Bexsero\u00ae) for use in individuals of 2 months of age and older. A cost-effectiveness analysis (CEA) from the societal and Italian National Health Service perspectives was performed in order to evaluate the impact of vaccinating Italian infants less than 1 y of age with Bexsero\u00ae, as opposed to non-vaccination. The analysis was carried out by means of Excel Version 2011 and the TreeAge Pro\u00ae software Version 2012. Two basal scenarios that differed in terms of disease incidence (official and estimated data to correct for underreporting) were considered.", "label": 1, "is_selected": 0, "text": "The European Medicines Agency has approved a multicomponent serogroup B meningococcal vaccine (Bexsero\u00ae) for use in individuals of 2 months of age and older. A cost-effectiveness analysis (CEA) from the societal and Italian National Health Service perspectives was performed in order to evaluate the impact of vaccinating Italian infants less than 1 y of age with Bexsero\u00ae, as opposed to non-vaccination. The analysis was carried out by means of Excel Version 2011 and the TreeAge Pro\u00ae software Version 2012. Two basal scenarios that differed in terms of disease incidence (official and estimated data to correct for underreporting) were considered."}
{"qid": "6278dc0c56bf9aee6f000010", "original_text": "Circulating microRNAs (miRs/miRNAs) are being used as non-invasive biomarkers for diagnosis, prognosis and efficiency of clinical trials. However, to exploit their potential it is necessary to improve and standardize their detection. In a previous study, we identified two microRNAs, miR-30c and miR-181a, that appear to be key regulators of muscular dystrophy. We hypothesized that they could represent useful biomarkers of Duchenne and Becker muscular dystrophies (DMD and BMD). The objective of this study was to assess the absolute levels of miR-30c and miR-181a in sera of DMD and BMD patients using digital PCR (a robust technique for precise and direct quantification of small amounts of nucleic acids without standard curves and external references), and investigate the correlation between miR-30c and miR-181a expressions and several clinical parameters. Our results show that the serum levels of miR-30c and miR-181a increased 7- and 6-fold respectively in DMD patients (n = 21, 2-14 years, ambulant), and 7-fold in BMD patients (n = 5, 9-15 years) compared to controls (n = 22, 2-14 years). No association between miRNA levels and age or corticosteroid treatment was detected in DMD.", "label": 1, "is_selected": 0, "text": "Circulating microRNAs (miRs/miRNAs) are being used as non-invasive biomarkers for diagnosis, prognosis and efficiency of clinical trials. However, to exploit their potential it is necessary to improve and standardize their detection. In a previous study, we identified two microRNAs, miR-30c and miR-181a, that appear to be key regulators of muscular dystrophy. We hypothesized that they could represent useful biomarkers of Duchenne and Becker muscular dystrophies (DMD and BMD). The objective of this study was to assess the absolute levels of miR-30c and miR-181a in sera of DMD and BMD patients using digital PCR (a robust technique for precise and direct quantification of small amounts of nucleic acids without standard curves and external references), and investigate the correlation between miR-30c and miR-181a expressions and several clinical parameters. Our results show that the serum levels of miR-30c and miR-181a increased 7- and 6-fold respectively in DMD patients (n = 21, 2-14 years, ambulant), and 7-fold in BMD patients (n = 5, 9-15 years) compared to controls (n = 22, 2-14 years). No association between miRNA levels and age or corticosteroid treatment was detected in DMD."}
{"qid": "56ed03862ac5ed1459000004", "original_text": "Cerenkov luminescence imaging (CLI) is an emerging imaging technique that combines aspects of both optical and nuclear imaging fields. The ability to fully evaluate the correlation and sensitivity of CLI to PET is critical to progress this technique further for use in high-throughput screening of pharmaceutical compounds. To achieve this milestone, it must first be established that CLI data correlate to PET data in an in vivo preclinical antitumor study.", "label": 1, "is_selected": 0, "text": "Cerenkov luminescence imaging (CLI) is an emerging imaging technique that combines aspects of both optical and nuclear imaging fields. The ability to fully evaluate the correlation and sensitivity of CLI to PET is critical to progress this technique further for use in high-throughput screening of pharmaceutical compounds. To achieve this milestone, it must first be established that CLI data correlate to PET data in an in vivo preclinical antitumor study."}
{"qid": "55016397e9bde69634000006", "original_text": "The role of sarcolipin (SLN) in cardiac physiology was critically evaluated by generating a transgenic (TG) mouse model in which the SLN to sarco(endoplasmic)reticulum (SR) Ca(2+) ATPase (SERCA) ratio was increased in the ventricle. Overexpression of SLN decreases SR calcium transport function and results in decreased calcium transient amplitude and rate of relaxation. SLN TG hearts exhibit a significant decrease in rates of contraction and relaxation when assessed by ex vivo work-performing heart preparations. Similar results were also observed with muscle preparations and myocytes from SLN TG ventricles.", "label": 1, "is_selected": 0, "text": "The role of sarcolipin (SLN) in cardiac physiology was critically evaluated by generating a transgenic (TG) mouse model in which the SLN to sarco(endoplasmic)reticulum (SR) Ca(2+) ATPase (SERCA) ratio was increased in the ventricle. Overexpression of SLN decreases SR calcium transport function and results in decreased calcium transient amplitude and rate of relaxation. SLN TG hearts exhibit a significant decrease in rates of contraction and relaxation when assessed by ex vivo work-performing heart preparations. Similar results were also observed with muscle preparations and myocytes from SLN TG ventricles."}
{"qid": "54e25eaaae9738404b000017", "original_text": "The organs of animal embryos are typically covered with an extracellular matrix (ECM) that must be carefully remodeled as these organs enlarge during post-embryonic growth; otherwise, their shape and functions may be compromised. We previously described the twisting of the Caenorhabditis elegans pharynx (here called the Twp phenotype) as a quantitative mutant phenotype that worsens as that organ enlarges during growth.", "label": 1, "is_selected": 0, "text": "The organs of animal embryos are typically covered with an extracellular matrix (ECM) that must be carefully remodeled as these organs enlarge during post-embryonic growth; otherwise, their shape and functions may be compromised. We previously described the twisting of the Caenorhabditis elegans pharynx (here called the Twp phenotype) as a quantitative mutant phenotype that worsens as that organ enlarges during growth."}
{"qid": "622118a43a8413c65300006a", "original_text": "Telomestatin is derived from the bacterium Streptomyces telomastatin. It was first identified in 1995 and is a natural product with potent anticancer activity. Telomestatin inhibits the enzyme telomerase, which is involved in the maintenance of telomeres, the repetitive DNA sequences at the ends of chromosomes. Telomere shortening is a hallmark of cancer cells, and telomestatin has been shown to induce apoptosis (cell death) in cancer cells and inhibit tumor growth. Further research is being conducted to explore the potential of telomestatin as a cancer treatment.", "label": 0, "is_selected": 0, "text": "Telomestatin is derived from the bacterium Streptomyces telomastatin. It was first identified in 1995 and is a natural product with potent anticancer activity. Telomestatin inhibits the enzyme telomerase, which is involved in the maintenance of telomeres, the repetitive DNA sequences at the ends of chromosomes. Telomere shortening is a hallmark of cancer cells, and telomestatin has been shown to induce apoptosis (cell death) in cancer cells and inhibit tumor growth. Further research is being conducted to explore the potential of telomestatin as a cancer treatment."}
{"qid": "5318a6b2b166e2b80600001f", "original_text": "Human papillomavirus 16 (HPV16) is a high-risk DNA tumour virus, which is a major causative agent of cervical cancer. Cellular transformation is associated with deregulated expression of the E6 and E7 oncogenes. E7 has been shown to bind a number of cellular proteins, including the cell cycle control protein pRb. In this study, RNA aptamers (small, single-stranded oligonucleotides selected for high-affinity binding) to HPV16 E7 were employed as molecular tools to further investigate these protein-protein interactions. This study is focused on one aptamer (termed A2).", "label": 1, "is_selected": 0, "text": "Human papillomavirus 16 (HPV16) is a high-risk DNA tumour virus, which is a major causative agent of cervical cancer. Cellular transformation is associated with deregulated expression of the E6 and E7 oncogenes. E7 has been shown to bind a number of cellular proteins, including the cell cycle control protein pRb. In this study, RNA aptamers (small, single-stranded oligonucleotides selected for high-affinity binding) to HPV16 E7 were employed as molecular tools to further investigate these protein-protein interactions. This study is focused on one aptamer (termed A2)."}
{"qid": "5e4940f46d0a277941000004", "original_text": "Only a small portion of human long non-coding RNAs (lncRNAs) appear to be conserved outside of mammals, but the events underlying the birth of new lncRNAs in mammals remain largely unknown. One potential source is remnants of protein-coding genes that transitioned into lncRNAs. We systematically compare lncRNA and protein-coding loci across vertebrates, and estimate that up to 5% of conserved mammalian lncRNAs are derived from lost protein-coding genes. These lncRNAs have specific characteristics, such as broader expression domains, that set them apart from other lncRNAs. Fourteen lncRNAs have sequence similarity with the loci of the contemporary homologs of the lost protein-coding genes. We propose that selection acting on enhancer sequences is mostly responsible for retention of these regions.", "label": 1, "is_selected": 0, "text": "Only a small portion of human long non-coding RNAs (lncRNAs) appear to be conserved outside of mammals, but the events underlying the birth of new lncRNAs in mammals remain largely unknown. One potential source is remnants of protein-coding genes that transitioned into lncRNAs. We systematically compare lncRNA and protein-coding loci across vertebrates, and estimate that up to 5% of conserved mammalian lncRNAs are derived from lost protein-coding genes. These lncRNAs have specific characteristics, such as broader expression domains, that set them apart from other lncRNAs. Fourteen lncRNAs have sequence similarity with the loci of the contemporary homologs of the lost protein-coding genes. We propose that selection acting on enhancer sequences is mostly responsible for retention of these regions."}
{"qid": "5c780caf7c78d694710000af", "original_text": "The introduction of stem cell-based technologies for the derivation of three-dimensional retinal tissues, the so-called retinal organoids, offers many new possibilities for vision research: Organoids facilitate studies on retinal development and in vitro retinal disease modeling, as well as being valuable for drug testing. Further, retinal organoids also provide an unlimited cell source for cell replacement therapies. Here, we describe our protocol for efficiently differentiating large, stratified retinal organoids from mouse embryonic stem cells: unbiased manual dissection of the developing retinal organoid at an early stage into three evenly sized neuroepithelial portions (trisection step) doubles the yield of high-quality organoids. We also describe some useful applications of the protocol, e.g., generation of rod- or cone-enriched retinal organoids, AAV transfection, and cell birth dating.", "label": 1, "is_selected": 0, "text": "The introduction of stem cell-based technologies for the derivation of three-dimensional retinal tissues, the so-called retinal organoids, offers many new possibilities for vision research: Organoids facilitate studies on retinal development and in vitro retinal disease modeling, as well as being valuable for drug testing. Further, retinal organoids also provide an unlimited cell source for cell replacement therapies. Here, we describe our protocol for efficiently differentiating large, stratified retinal organoids from mouse embryonic stem cells: unbiased manual dissection of the developing retinal organoid at an early stage into three evenly sized neuroepithelial portions (trisection step) doubles the yield of high-quality organoids. We also describe some useful applications of the protocol, e.g., generation of rod- or cone-enriched retinal organoids, AAV transfection, and cell birth dating."}
{"qid": "5fe31301a43ad31278000039", "original_text": "The titan (ttn) mutants of Arabidopsis exhibit striking alterations in chromosome dynamics and cell division during seed development. Endosperm defects include aberrant mitoses and giant polyploid nuclei. Mutant embryos differ in cell size, morphology and viability, depending on the locus involved. Here we demonstrate that three TTN genes encode chromosome scaffold proteins of the condensin (SMC2) and cohesin (SMC1 and SMC3) classes. These proteins have been studied extensively in yeast and animal systems, where they modulate chromosome condensation, chromatid separation, and dosage compensation. Arabidopsis contains single copies of SMC1 and SMC3 cohesins. We used forward genetics to identify duplicate T-DNA insertions in each gene. These mutants (ttn7 and ttn8) have similar titan phenotypes: giant endosperm nuclei and arrested embryos with a few small cells. A single SMC2 knockout (ttn3) was identified and confirmed by molecular complementation. The weak embryo phenotype observed in this mutant may result from expression of a related gene (AtSMC2) with overlapping functions.", "label": 1, "is_selected": 0, "text": "The titan (ttn) mutants of Arabidopsis exhibit striking alterations in chromosome dynamics and cell division during seed development. Endosperm defects include aberrant mitoses and giant polyploid nuclei. Mutant embryos differ in cell size, morphology and viability, depending on the locus involved. Here we demonstrate that three TTN genes encode chromosome scaffold proteins of the condensin (SMC2) and cohesin (SMC1 and SMC3) classes. These proteins have been studied extensively in yeast and animal systems, where they modulate chromosome condensation, chromatid separation, and dosage compensation. Arabidopsis contains single copies of SMC1 and SMC3 cohesins. We used forward genetics to identify duplicate T-DNA insertions in each gene. These mutants (ttn7 and ttn8) have similar titan phenotypes: giant endosperm nuclei and arrested embryos with a few small cells. A single SMC2 knockout (ttn3) was identified and confirmed by molecular complementation. The weak embryo phenotype observed in this mutant may result from expression of a related gene (AtSMC2) with overlapping functions."}
{"qid": "535d69177d100faa09000003", "original_text": "Administration of artrofoon in combination with SCENAR therapy to patients with localized suppurative peritonitis in the postoperative period considerably reduced plasma MDA level, stabilized ceruloplasmin activity, and increased catalase activity in erythrocytes compared to the corresponding parameters in patients receiving standard treatment in combination with SCENAR therapy.", "label": 1, "is_selected": 0, "text": "Administration of artrofoon in combination with SCENAR therapy to patients with localized suppurative peritonitis in the postoperative period considerably reduced plasma MDA level, stabilized ceruloplasmin activity, and increased catalase activity in erythrocytes compared to the corresponding parameters in patients receiving standard treatment in combination with SCENAR therapy."}
{"qid": "601c3f041cb411341a000018", "original_text": "The color of urine in patients who receive anesthetic gives much medical information to a medical team. So, we must check the urine color and know the cause of discoloration of the urine from anesthetic patients. Green urine is rare indeed and it is a benign potential side effect of propofol; this phenomenon is related to the metabolism of propofol. We experienced green urine from a long-term anesthetized patient who received a continuous infusion of propofol. We report here on this unusual case and we review the relevant literature.", "label": 1, "is_selected": 0, "text": "The color of urine in patients who receive anesthetic gives much medical information to a medical team. So, we must check the urine color and know the cause of discoloration of the urine from anesthetic patients. Green urine is rare indeed and it is a benign potential side effect of propofol; this phenomenon is related to the metabolism of propofol. We experienced green urine from a long-term anesthetized patient who received a continuous infusion of propofol. We report here on this unusual case and we review the relevant literature."}
{"qid": "58df73bd38f7f3e93a000001", "original_text": "Sensory stimuli drive the maturation and function of the mammalian nervous system in part through the activation of gene expression networks that regulate synapse development and plasticity. These networks have primarily been studied in mice, and it is not known whether there are species- or clade-specific activity-regulated genes that control features of brain development and function. Here we use transcriptional profiling of human fetal brain cultures to identify an activity-dependent secreted factor, Osteocrin (OSTN), that is induced by membrane depolarization of human but not mouse neurons. We find that OSTN has been repurposed in primates through the evolutionary acquisition of DNA regulatory elements that bind the activity-regulated transcription factor MEF2. In addition, we demonstrate that OSTN is expressed in primate neocortex and restricts activity-dependent dendritic growth in human neurons. These findings suggest that, in response to sensory input, OSTN regulates features of neuronal structure and function that are unique to primates.", "label": 1, "is_selected": 0, "text": "Sensory stimuli drive the maturation and function of the mammalian nervous system in part through the activation of gene expression networks that regulate synapse development and plasticity. These networks have primarily been studied in mice, and it is not known whether there are species- or clade-specific activity-regulated genes that control features of brain development and function. Here we use transcriptional profiling of human fetal brain cultures to identify an activity-dependent secreted factor, Osteocrin (OSTN), that is induced by membrane depolarization of human but not mouse neurons. We find that OSTN has been repurposed in primates through the evolutionary acquisition of DNA regulatory elements that bind the activity-regulated transcription factor MEF2. In addition, we demonstrate that OSTN is expressed in primate neocortex and restricts activity-dependent dendritic growth in human neurons. These findings suggest that, in response to sensory input, OSTN regulates features of neuronal structure and function that are unique to primates."}
{"qid": "5a8881118cb19eca6b000006", "original_text": "Yes, the proteome of mouse hippocampus has been extensively analyzed. The hippocampus is a complex brain structure involved in memory formation, spatial navigation, and emotional processing, and alterations in its proteome have been implicated in various neurological disorders. Studies have used various proteomic techniques, including two-dimensional gel electrophoresis (2DGE), mass spectrometry (MS), and label-free methods, to identify and quantify proteins in the hippocampus of mice. Some of the key findings from these studies include the identification of proteins involved in neuronal synaptic plasticity, such as synaptotagmin and neuroligins, and proteins involved in inflammation and immune response, such as TNF-\u03b1 and IL-1\u03b2. Additionally, studies have identified proteins that are specifically regulated in the hippocampus of mice in response to various stimuli, such as exercise, stress, and aging. Overall, the proteome of mouse hippocampus has been found to be complex and dynamic, with many proteins involved in various cellular processes and functions. Further research on the proteome of the hippocampus can provide valuable insights into the molecular mechanisms underlying neural function and dysfunction, and may lead to the development of new therapeutic strategies for neurological disorders.", "label": 0, "is_selected": 1, "text": "The proteome of the hippocampus is a complex brain structure involved in memory formation, navigation, and emotional processing, and alterations in its Proteome have been implicated in various neurological disorders, such as Alzheimer's disease, autism, and Parkinson's diseases, to name just a few.Overall, the protesome of mouse hippocampus has been found to be complex and dynamic, with many proteins involved in various cellular processes and functions.Further research on the proteomicome of hippocampus can provide valuable insights into the molecular mechanisms underlying neural function and dysfunction, and may lead to the development of new therapeutic strategies for neurological disorders."}
{"qid": "54de15f91388e8454a000002", "original_text": "Human cytidine deaminases APOBEC3G (A3G) and APOBEC3F (A3F) inhibit replication of Vif-deficient human immunodeficiency virus type 1 (HIV-1). HIV-1 Vif overcomes these host restriction factors by binding to them and inducing their proteasomal degradation. The Vif-A3G and Vif-A3F interactions are attractive targets for antiviral drug development because inhibiting the interactions could allow the host defense mechanism to control HIV-1 replication. It was recently reported that the Vif amino acids D(14)RMR(17) are important for functional interaction and degradation of the previously identified Vif-resistant mutant of A3G (D128K-A3G). However, the Vif determinants important for functional interaction with A3G and A3F have not been fully characterized.", "label": 1, "is_selected": 0, "text": "Human cytidine deaminases APOBEC3G (A3G) and APOBEC3F (A3F) inhibit replication of Vif-deficient human immunodeficiency virus type 1 (HIV-1). HIV-1 Vif overcomes these host restriction factors by binding to them and inducing their proteasomal degradation. The Vif-A3G and Vif-A3F interactions are attractive targets for antiviral drug development because inhibiting the interactions could allow the host defense mechanism to control HIV-1 replication. It was recently reported that the Vif amino acids D(14)RMR(17) are important for functional interaction and degradation of the previously identified Vif-resistant mutant of A3G (D128K-A3G). However, the Vif determinants important for functional interaction with A3G and A3F have not been fully characterized."}
{"qid": "5a9ac4161d1251d03b000010", "original_text": "MC1R (melanocortin 1 receptor) palmitoylation, the covalent attachment of palmitate molecules to the receptor protein, has been shown to play a role in regulating pigmentation. Research suggests that MC1R palmitoylation can affect the receptor's activity and function, leading to changes in pigmentation. Specifically, palmitoylation of MC1R can modulate the binding of catecholamines, such as norepinephrine, to the receptor, which in turn can influence the production of melanin, a pigment responsible for skin and hair color. Studies have found that alterations in MC1R palmitoylation have been associated with various pigmentation disorders, including vitiligo, albinism, and melasmic hyperpigmentation. However, the exact mechanisms by which MC1R palmitoylation influences pigmentation are still not fully understood and require further investigation.", "label": 0, "is_selected": 1, "text": "The role of palmitoylation in the regulation of skin pigmentation has been investigated in a series of studies., published in Plos One, by researchers at the University of California, Los Angeles., and the National Institute of Health, Washington, DC., in the United States."}
{"qid": "5c6b810e7c78d6947100002e", "original_text": "Cerliponase alfa is approved for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that affects the central nervous system. It is used to treat acute attacks and reduce the frequency of relapses in NMOSD patients.", "label": 0, "is_selected": 0, "text": "Cerliponase alfa is approved for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that affects the central nervous system. It is used to treat acute attacks and reduce the frequency of relapses in NMOSD patients."}
{"qid": "5354f289288f4dae47000008", "original_text": "Certainly! Here are five popular programs for transcript quantification from RNA-seq experiments: 1. Cufflinks: Cufflinks is a widely used program for RNA-seq analysis, particularly for transcript quantification. It uses a probabilistic model to estimate the expression levels of genes and can handle multiple samples and different sequencing technologies. 2. featureCounts: featureCounts is another popular program for RNA-seq analysis that provides a straightforward and efficient way to quantify transcripts. It reads count data from the RNA-seq reads and outputs a list of genes along with their expression levels. 3. DESeq2: DESeq2 is a bioconductor package that is specifically designed for the analysis of RNA-seq data. It can perform statistical modeling of gene expression and estimate the significance of differences in expression between samples. 4. HISAT2: HISAT2 is an splicing-sensitive RNA-seq reader that can be used for transcript quantification. It can align RNA-seq reads to a reference genome or transcriptome and output the expression levels of genes. 5. STAR: STAR is a high-performance RNA-seq aligner that can handle large datasets and produce accurate transcript quantification results. It can also output various types of gene expression estimates, including counts per kilobase million (CPM) and FPKM.", "label": 0, "is_selected": 0, "text": "Certainly! Here are five popular programs for transcript quantification from RNA-seq experiments: 1. Cufflinks: Cufflinks is a widely used program for RNA-seq analysis, particularly for transcript quantification. It uses a probabilistic model to estimate the expression levels of genes and can handle multiple samples and different sequencing technologies. 2. featureCounts: featureCounts is another popular program for RNA-seq analysis that provides a straightforward and efficient way to quantify transcripts. It reads count data from the RNA-seq reads and outputs a list of genes along with their expression levels. 3. DESeq2: DESeq2 is a bioconductor package that is specifically designed for the analysis of RNA-seq data. It can perform statistical modeling of gene expression and estimate the significance of differences in expression between samples. 4. HISAT2: HISAT2 is an splicing-sensitive RNA-seq reader that can be used for transcript quantification. It can align RNA-seq reads to a reference genome or transcriptome and output the expression levels of genes. 5. STAR: STAR is a high-performance RNA-seq aligner that can handle large datasets and produce accurate transcript quantification results. It can also output various types of gene expression estimates, including counts per kilobase million (CPM) and FPKM."}
{"qid": "55391825bc4f83e828000016", "original_text": "Homozygosity of EDNRB mutations can result in additional health issues beyond Hirschsprung disease. These effects include: 1. Skeletal abnormalities: Homozygous EDNRB mutations can lead to various skeletal defects, such as scoliosis, kyphosis, and clubfoot. 2. Neurological problems: Homozygous mutations can result in seizures, intellectual disability, and ataxia (loss of coordination). 3. Vision problems: Individuals with homozygous EDNRB mutations may experience retinal degeneration, leading to vision loss or blindness. 4. Cardiac issues: Homozygous mutations can increase the risk of heart defects, such as atrial septal defects and ventricular septal defects. It is important to note that the severity and type of additional health issues can vary depending on the specific EDNRB mutation and the individual affected.", "label": 0, "is_selected": 0, "text": "Homozygosity of EDNRB mutations can result in additional health issues beyond Hirschsprung disease. These effects include: 1. Skeletal abnormalities: Homozygous EDNRB mutations can lead to various skeletal defects, such as scoliosis, kyphosis, and clubfoot. 2. Neurological problems: Homozygous mutations can result in seizures, intellectual disability, and ataxia (loss of coordination). 3. Vision problems: Individuals with homozygous EDNRB mutations may experience retinal degeneration, leading to vision loss or blindness. 4. Cardiac issues: Homozygous mutations can increase the risk of heart defects, such as atrial septal defects and ventricular septal defects. It is important to note that the severity and type of additional health issues can vary depending on the specific EDNRB mutation and the individual affected."}
{"qid": "5be2a070133db5eb78000013", "original_text": "We hypothesized that patients with Klinefelter's syndrome (KS) not only undergo X inactivation, but also that genes escape from inactivation. Their transcripts would constitute a significant difference, as male metabolism is not adapted to a 'female-like' gene dosage. We evaluated the expression of selected X-linked genes in our 41, XX(Y)* male mice to determine whether these genes escape inactivation and whether tissue-specific differences occur. Correct X inactivation was identified by Xist expression. Relative expression of X-linked genes was examined in liver, kidney and brain tissue by real-time PCR in adult XX(Y)* and XY* males and XX females. Expression of genes known to escape X inactivation was analysed.", "label": 1, "is_selected": 0, "text": "We hypothesized that patients with Klinefelter's syndrome (KS) not only undergo X inactivation, but also that genes escape from inactivation. Their transcripts would constitute a significant difference, as male metabolism is not adapted to a 'female-like' gene dosage. We evaluated the expression of selected X-linked genes in our 41, XX(Y)* male mice to determine whether these genes escape inactivation and whether tissue-specific differences occur. Correct X inactivation was identified by Xist expression. Relative expression of X-linked genes was examined in liver, kidney and brain tissue by real-time PCR in adult XX(Y)* and XY* males and XX females. Expression of genes known to escape X inactivation was analysed."}
{"qid": "622a5a483a8413c65300008f", "original_text": "Preterm, premature rupture of membranes (PPROM) is a dire pregnancy outcome that is frequently associated with infection by the genital mycoplasmas, Mycoplasma hominis, Ureaplasma parvum, and U. urealyticum. One potential mechanism by which these microorganisms may cause PPROM is by increasing the concentration of matrix metalloproteinases (MMPs) in the membranes and amniotic fluid. We tested this hypothesis in a well-defined model system of genital infection with M. pulmonis, a natural reproductive pathogen of rats. Timed-pregnant, specific pathogen-free, Sprague-Dawley rats were infected with 10(7) CFU M. pulmonis at gestation day (gd) 14. Controls received an equivalent volume (100 microL) of sterile medium. At gd 18, rats were euthanized, and membranes and amniotic fluids were harvested and stored at -70 degrees C until analysis. Proteinase activity of amniotic fluid and membranes was resolved on discontinuous 7.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gelatin zymography gels. Band intensity was determined using a digital gel documentation system and the manufacturer's software (Kodak). Gelatinolytic activity associated with a band similar in molecular weight to ProMMP-9 (92 kDa, the inactive precursor of MMP-9) was significantly increased in amniotic fluids and membranes harvested from M. pulmonis-treated pups at gd 18 when compared with tissues harvested from control pups. Both ProMMP-9 and ProMMP-2 (72 kDa, the inactive precursor of MMP-2) were increased in infected animals at gd 21.", "label": 1, "is_selected": 0, "text": "Preterm, premature rupture of membranes (PPROM) is a dire pregnancy outcome that is frequently associated with infection by the genital mycoplasmas, Mycoplasma hominis, Ureaplasma parvum, and U. urealyticum. One potential mechanism by which these microorganisms may cause PPROM is by increasing the concentration of matrix metalloproteinases (MMPs) in the membranes and amniotic fluid. We tested this hypothesis in a well-defined model system of genital infection with M. pulmonis, a natural reproductive pathogen of rats. Timed-pregnant, specific pathogen-free, Sprague-Dawley rats were infected with 10(7) CFU M. pulmonis at gestation day (gd) 14. Controls received an equivalent volume (100 microL) of sterile medium. At gd 18, rats were euthanized, and membranes and amniotic fluids were harvested and stored at -70 degrees C until analysis. Proteinase activity of amniotic fluid and membranes was resolved on discontinuous 7.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gelatin zymography gels. Band intensity was determined using a digital gel documentation system and the manufacturer's software (Kodak). Gelatinolytic activity associated with a band similar in molecular weight to ProMMP-9 (92 kDa, the inactive precursor of MMP-9) was significantly increased in amniotic fluids and membranes harvested from M. pulmonis-treated pups at gd 18 when compared with tissues harvested from control pups. Both ProMMP-9 and ProMMP-2 (72 kDa, the inactive precursor of MMP-2) were increased in infected animals at gd 21."}
{"qid": "54d63d873706e89528000006", "original_text": "Recent advances in the genetics of neurodevelopmental disorder (NDD) have demonstrated that rare mutations play a role not only in Mendelian syndromes, but in complex, common forms of NDDs as well. Strikingly, both common polymorphisms and rare variations in a single gene or genetic locus have been found to carry risk for conditions previously considered to be clinically and aetiologically distinct. Recent developments in the methods and tools available for studying complex NDDs have led to systematic and reliable genome-wide variant discovery. Both common as well as rare, and structural as well as sequence, genetic variations have been identified as contributing to NDDs. There are multiple examples in which the identical variant had been found to contribute to a wide range of formerly distinct diagnoses, including autism, schizophrenia, epilepsy, intellectual disability and language disorders. These include variations in chromosomal structure at 16p11.2, rare de novo point mutations at the gene SCN2A, and common single nucleotide polymorphisms (SNPs) mapping near loci encoding the genes ITIH3, AS3MT, CACNA1C and CACNB2. These selected examples point to the challenges to current diagnostic approaches. Widely used categorical schema have been adequate to provide an entr\u00e9 into molecular mechanisms of NDDs, but there is a need to develop an alternative, more biologically-relevant nosology. Thus recent advances in gene discovery in the area of NDDs are leading to a re-conceptualization of diagnostic boundaries.", "label": 1, "is_selected": 0, "text": "Recent advances in the genetics of neurodevelopmental disorder (NDD) have demonstrated that rare mutations play a role not only in Mendelian syndromes, but in complex, common forms of NDDs as well. Strikingly, both common polymorphisms and rare variations in a single gene or genetic locus have been found to carry risk for conditions previously considered to be clinically and aetiologically distinct. Recent developments in the methods and tools available for studying complex NDDs have led to systematic and reliable genome-wide variant discovery. Both common as well as rare, and structural as well as sequence, genetic variations have been identified as contributing to NDDs. There are multiple examples in which the identical variant had been found to contribute to a wide range of formerly distinct diagnoses, including autism, schizophrenia, epilepsy, intellectual disability and language disorders. These include variations in chromosomal structure at 16p11.2, rare de novo point mutations at the gene SCN2A, and common single nucleotide polymorphisms (SNPs) mapping near loci encoding the genes ITIH3, AS3MT, CACNA1C and CACNB2. These selected examples point to the challenges to current diagnostic approaches. Widely used categorical schema have been adequate to provide an entr\u00e9 into molecular mechanisms of NDDs, but there is a need to develop an alternative, more biologically-relevant nosology. Thus recent advances in gene discovery in the area of NDDs are leading to a re-conceptualization of diagnostic boundaries."}
{"qid": "5a722ccd2dc08e987e000003", "original_text": "Tezepelumab is a monoclonal antibody that targets the inflammatory cytokine IL-33. IL-33 is a protein produced by various cells in the body, including epithelial cells, endothelial cells, and fibroblasts, in response to cellular stress or inflammation. It plays a key role in the activation of Group 2 innate lymphoid cells (ILC2s), which are involved in the regulation of allergic inflammation and airway hyperresponsiveness. Tezepelumab binds to IL-33 and prevents its interaction with the ILC2s, thereby reducing the activation and proliferation of these cells. This leads to a decrease in the production of pro-inflammatory cytokines, such as interleukin-5 (IL-5) and interleukin-13 (IL-13), which are involved in the pathogenesis of asthma. Additionally, tezepelumab has been shown to reduce airway hyperresponsiveness and improve lung function in patients with severe asthma.", "label": 0, "is_selected": 0, "text": "Tezepelumab is a monoclonal antibody that targets the inflammatory cytokine IL-33. IL-33 is a protein produced by various cells in the body, including epithelial cells, endothelial cells, and fibroblasts, in response to cellular stress or inflammation. It plays a key role in the activation of Group 2 innate lymphoid cells (ILC2s), which are involved in the regulation of allergic inflammation and airway hyperresponsiveness. Tezepelumab binds to IL-33 and prevents its interaction with the ILC2s, thereby reducing the activation and proliferation of these cells. This leads to a decrease in the production of pro-inflammatory cytokines, such as interleukin-5 (IL-5) and interleukin-13 (IL-13), which are involved in the pathogenesis of asthma. Additionally, tezepelumab has been shown to reduce airway hyperresponsiveness and improve lung function in patients with severe asthma."}
{"qid": "5c74111f7c78d694710000a1", "original_text": "Alu repeats are a type of repetitive DNA element that are found throughout the human genome. These repeats are composed of short repetitive sequences of nucleotides, and they are known to form a variety of different structures, including hairpin loops, stem-loop structures, and longer repetitive sequences. One of the key features of Alu repeats is that they contain a specific transcription factor binding site, known as the Alu core element. This element is located within the repeat itself and is recognized by a specific transcription factor, known as the Alu bound factor (ABF). The ABF protein binds to the Alu core element and regulates the expression of genes that are located nearby. The Alu core element is a specific sequence of nucleotides that is found in all Alu repeats. It is typically located in the center of the repeat and is formed by the following sequence: 5'-GAGCAG-3'. This sequence is recognized by the ABF protein, which binds to it and regulates the expression of nearby genes. In summary, the Alu transcription factor binding site is contained within the Alu repeats in the human genome. This binding site is recognized by the Alu bound factor protein and regulates the expression of nearby genes.", "label": 0, "is_selected": 1, "text": "The Alu core element is a specific sequence of nucleotides that is found in all Alu repeats in the human genome, and it is recognized by a specific transcription factor, known as the Alu bound factor (ABF), which regulates the expression of genes that are located near the core of the repeat. This binding site is located within the repeat itself and is recognition by a Specific Transcription Factor (ABF) that regulates the Expression of Genes that are Located Near the Core of the Alu Repeats in the Human Genome."}
{"qid": "55058af6f73303d458000004", "original_text": "The E3-ubiquitin ligase that targets the tumor suppressor p53 for proteasomal degradation is MDM2 (mouse double minute 2). MDM2 is a ubiquitin ligase that is overexpressed in many types of cancer and plays a crucial role in the regulation of p53 stability and activity. MDM2 interacts with p53 and promotes its ubiquitination and degradation by the proteasome, leading to suppression of p53-mediated cell cycle arrest and apoptosis.", "label": 0, "is_selected": 0, "text": "The E3-ubiquitin ligase that targets the tumor suppressor p53 for proteasomal degradation is MDM2 (mouse double minute 2). MDM2 is a ubiquitin ligase that is overexpressed in many types of cancer and plays a crucial role in the regulation of p53 stability and activity. MDM2 interacts with p53 and promotes its ubiquitination and degradation by the proteasome, leading to suppression of p53-mediated cell cycle arrest and apoptosis."}
{"qid": "54f08d4a94afd61504000016", "original_text": "To examine the headache characteristics of women with migraine and endometriosis (EM), and differences in the prevalence of comorbid conditions between female migraineurs with EM, without EM and nonheadache controls. Migraine and EM are common conditions in women of reproductive age, and both are influenced by ovarian hormones. The comorbidity of migraine and EM is newly recognized, but reasons for the association are uncertain. This is a cross-sectional study of female headache outpatients and healthy controls conducted at University of Toledo and Duke University in 2005 and 2006. After a headache specialist determined headache frequency and diagnosis (based on criteria of the second International Classification of Headache Disorders), patients completed a self-administered electronic survey with information on demographics, headache-related disability, menstrual disorders, premenstrual dysphoric disorder (PMDD), vascular event risk, and comorbid conditions, including irritable bowel syndrome (IBS), fibromyalgia (FM), chronic fatigue syndrome (CFS), interstitial cystitis (IC), depression, and anxiety. Study enrolled 171 women with migraine and 104 controls. EM was reported more commonly in migraineurs than in controls (22% vs 9.6%, P < .01).", "label": 1, "is_selected": 0, "text": "To examine the headache characteristics of women with migraine and endometriosis (EM), and differences in the prevalence of comorbid conditions between female migraineurs with EM, without EM and nonheadache controls. Migraine and EM are common conditions in women of reproductive age, and both are influenced by ovarian hormones. The comorbidity of migraine and EM is newly recognized, but reasons for the association are uncertain. This is a cross-sectional study of female headache outpatients and healthy controls conducted at University of Toledo and Duke University in 2005 and 2006. After a headache specialist determined headache frequency and diagnosis (based on criteria of the second International Classification of Headache Disorders), patients completed a self-administered electronic survey with information on demographics, headache-related disability, menstrual disorders, premenstrual dysphoric disorder (PMDD), vascular event risk, and comorbid conditions, including irritable bowel syndrome (IBS), fibromyalgia (FM), chronic fatigue syndrome (CFS), interstitial cystitis (IC), depression, and anxiety. Study enrolled 171 women with migraine and 104 controls. EM was reported more commonly in migraineurs than in controls (22% vs 9.6%, P < .01)."}
{"qid": "59d09a0cbc32f93e6d000001", "original_text": "Ganglion mother cells (GMCs) and intermediate neural precursor cells (INPs) are two distinct types of neural cells found in the embryonic nervous system of Drosophila. While both cell types are involved in the generation and development of the nervous system, they have distinct roles and characteristics. GMCs are progenitor cells that give rise to sensory and motor neurons in the peripheral nervous system. They are characterized by the expression of the proneural gene complex and the ability to differentiate into neurons upon injury. INPs, on the other hand, are more general precursor cells that can give rise to a wide range of cell types in the nervous system, including neurons, glial cells, and vascular cells. INPs express the proneural gene complex but do not have the same level of commitment to neural differentiation as GMCs. In summary, GMCs are specialized progenitor cells that are dedicated to generating neurons in the peripheral nervous system, while INPs are more general precursor cells that have the ability to give rise to multiple cell types in the nervous system.", "label": 0, "is_selected": 0, "text": "Ganglion mother cells (GMCs) and intermediate neural precursor cells (INPs) are two distinct types of neural cells found in the embryonic nervous system of Drosophila. While both cell types are involved in the generation and development of the nervous system, they have distinct roles and characteristics. GMCs are progenitor cells that give rise to sensory and motor neurons in the peripheral nervous system. They are characterized by the expression of the proneural gene complex and the ability to differentiate into neurons upon injury. INPs, on the other hand, are more general precursor cells that can give rise to a wide range of cell types in the nervous system, including neurons, glial cells, and vascular cells. INPs express the proneural gene complex but do not have the same level of commitment to neural differentiation as GMCs. In summary, GMCs are specialized progenitor cells that are dedicated to generating neurons in the peripheral nervous system, while INPs are more general precursor cells that have the ability to give rise to multiple cell types in the nervous system."}
{"qid": "6206b8c2c9dfcb9c0900003c", "original_text": "rHDL-apoE3, or recombinant high-density lipoprotein-apolipoprotein E3, is a chimeric protein consisting of apolipoprotein E3 and the apolipoprotein E3 binding domain of the major facilitator superfamily protein 2 (MFSP2). It has been shown to modulate endothelial cell migration pathways at the gene expression level. Specifically, rHDL-apoE3 has been found to upregulate the expression of several genes involved in endothelial cell migration, including: 1. Vascular endothelial growth factor (VEGF): VEGF is a potent angiogenic factor that promotes endothelial cell migration and proliferation. rHDL-apoE3 has been shown to increase VEGF expression in endothelial cells, leading to enhanced endothelial cell migration. 2. Matrix metalloproteinase-2 (MMP-2): MMP-2 is an enzyme that degrades the extracellular matrix, contributing to endothelial cell migration and tissue invasion. rHDL-apoE3 has been found to upregulate MMP-2 expression in endothelial cells, thereby promoting endothelial cell migration. 3. Fibroblast growth factor receptor 2 (FGF-2): FGF-2 is a potent mitogen that regulates endothelial cell proliferation and migration. rHDL-apoE3 has been shown to increase FGF-2 expression in endothelial cells, leading to enhanced endothelial cell proliferation and migration. 4. Nuclear factor kappa B (NF-\u03baB): NF-\u03baB is a transcription factor that regulates the expression of genes involved in inflammation and immune responses. rHDL-apoE3 has been found to activate NF-\u03baB signaling in endothelial cells, leading to the upregulation of genes involved in endothelial cell migration and proliferation. 5. Hypoxia-inducible factor (HIF) 1\u03b1: HIF-1\u03b1 is a transcription factor that regulates the expression of genes involved in response to hypoxia. rHDL-apoE3 has been shown to increase HIF-1\u03b1 expression in endothelial cells, leading to the upregulation of genes involved in endothelial cell survival and migration. In summary, rHDL-apoE3 has been shown to modulate endothelial cell migration pathways at the gene expression level by upregulating the expression of several key genes involved in endothelial cell migration, inflammation, and survival. These findings suggest that rHDL-apoE3 may be a promising therapeutic agent for the treatment of endothelial-related diseases, such as atherosclerosis and cancer.", "label": 0, "is_selected": 1, "text": "The aim of this study is to describe the mechanism by which rHDL-apoE3 modulates endothelial cell migration and inflammation, as well as to describe its potential use in the treatment of endothelial-related diseases, such as atherosclerosis and cancer. In summary, rHDl-apo E3 has been shown to modulate endothelial cellmigration pathways at the gene expression level by upregulating the expression of several key genes involved in endothelial cells migration, inflammation, and survival., and may be a promising therapeutic agent for the treatment and prevention of atherosclerosis, cancer, and other endothelium-related disorders., as reported in the journal Science Translational Medicine., June 2013., 2010., 2014., 2015., 2014..., 2015.., 2015, Nature Communications, 21-24 June, 2015."}
{"qid": "601c13be1cb411341a00000d", "original_text": "Current available inotropic agents increase cardiac contractility, but are associated with myocardial ischemia, arrhythmias, and mortality. A novel selective cardiac myosin activator, omecamtiv mecarbil (CK-1827452/ AMG-423) is a small molecule that activates the sarcomere proteins directly, resulting in prolonged systolic ejection time and increased cardiac contractility. This paper discusses the chemistry, pharmacokinetics, clinical efficacy and safety of omecamtiv mecarbil. Omecamtiv mecarbil represents a novel therapeutic approach to directly improve cardiac function and is therefore proposed as a potential new treatment of patients with systolic heart failure. The authors review results of previous studies investigating the effect of omecamtiv mecarbil in heart failure animal models, healthy volunteers, and patients with acute and chronic systolic heart failure.", "label": 1, "is_selected": 0, "text": "Current available inotropic agents increase cardiac contractility, but are associated with myocardial ischemia, arrhythmias, and mortality. A novel selective cardiac myosin activator, omecamtiv mecarbil (CK-1827452/ AMG-423) is a small molecule that activates the sarcomere proteins directly, resulting in prolonged systolic ejection time and increased cardiac contractility. This paper discusses the chemistry, pharmacokinetics, clinical efficacy and safety of omecamtiv mecarbil. Omecamtiv mecarbil represents a novel therapeutic approach to directly improve cardiac function and is therefore proposed as a potential new treatment of patients with systolic heart failure. The authors review results of previous studies investigating the effect of omecamtiv mecarbil in heart failure animal models, healthy volunteers, and patients with acute and chronic systolic heart failure."}
{"qid": "5e920be42d3121100d00000c", "original_text": "Despite several clinical trials implemented, no antiviral drug could demonstrate efficacy against Ebola virus. In non-human primates, early initiation of polymerase inhibitors favipiravir and remdesivir improves survival, but whether they could be effective in patients is unknown. Here we analyze the impact of antiviral therapy by using a mathematical model that integrates virological and immunological data of 44 cynomolgus macaques, left untreated or treated with favipiravir. We estimate that favipiravir has a ~50% efficacy in blocking viral production, which results in reducing virus growth and cytokine storm while IFN\u03b1 reduces cell susceptibility to infection.", "label": 1, "is_selected": 0, "text": "Despite several clinical trials implemented, no antiviral drug could demonstrate efficacy against Ebola virus. In non-human primates, early initiation of polymerase inhibitors favipiravir and remdesivir improves survival, but whether they could be effective in patients is unknown. Here we analyze the impact of antiviral therapy by using a mathematical model that integrates virological and immunological data of 44 cynomolgus macaques, left untreated or treated with favipiravir. We estimate that favipiravir has a ~50% efficacy in blocking viral production, which results in reducing virus growth and cytokine storm while IFN\u03b1 reduces cell susceptibility to infection."}
{"qid": "5c521c8c7e3cb0e231000007", "original_text": "Brain-computer interface (BCI) technology is attracting increasing interest as a tool for enhancing recovery of motor function after stroke, yet the optimal way to apply this technology is unknown. Here, we studied the immediate and therapeutic effects of BCI-based training to control pre-movement sensorimotor rhythm (SMR) amplitude on robot-assisted finger extension in people with stroke. Eight people with moderate to severe hand impairment due to chronic stroke completed a four-week three-phase protocol during which they practiced finger extension with assistance from the FINGER robotic exoskeleton. In Phase 1, we identified spatiospectral SMR features for each person that correlated with the intent to extend the index and/or middle finger(s). In Phase 2, the participants learned to increase or decrease SMR features given visual feedback, without movement. In Phase 3, the participants were cued to increase or decrease their SMR features, and when successful, were then cued to immediately attempt to extend the finger(s) with robot assistance.", "label": 1, "is_selected": 0, "text": "Brain-computer interface (BCI) technology is attracting increasing interest as a tool for enhancing recovery of motor function after stroke, yet the optimal way to apply this technology is unknown. Here, we studied the immediate and therapeutic effects of BCI-based training to control pre-movement sensorimotor rhythm (SMR) amplitude on robot-assisted finger extension in people with stroke. Eight people with moderate to severe hand impairment due to chronic stroke completed a four-week three-phase protocol during which they practiced finger extension with assistance from the FINGER robotic exoskeleton. In Phase 1, we identified spatiospectral SMR features for each person that correlated with the intent to extend the index and/or middle finger(s). In Phase 2, the participants learned to increase or decrease SMR features given visual feedback, without movement. In Phase 3, the participants were cued to increase or decrease their SMR features, and when successful, were then cued to immediately attempt to extend the finger(s) with robot assistance."}
{"qid": "5322d3cb9b2d7acc7e000010", "original_text": "It has been shown that Wallerian degeneration, an anterograde degeneration of transected axons, is markedly delayed in a mutant mouse called slow Wallerian degeneration (Wld(S)). These mice also show resistance to axonal degeneration caused by microtubule depolymerizing drugs, suggesting that axonal microtubules are stabilized. Here, we have focused on tubulin acetylation, a post-translational modification associated with microtubule stability. We found that the basal level of microtubule acetylation was increased in cultured cerebellar granule cells from Wld(S) mice.", "label": 1, "is_selected": 0, "text": "It has been shown that Wallerian degeneration, an anterograde degeneration of transected axons, is markedly delayed in a mutant mouse called slow Wallerian degeneration (Wld(S)). These mice also show resistance to axonal degeneration caused by microtubule depolymerizing drugs, suggesting that axonal microtubules are stabilized. Here, we have focused on tubulin acetylation, a post-translational modification associated with microtubule stability. We found that the basal level of microtubule acetylation was increased in cultured cerebellar granule cells from Wld(S) mice."}
{"qid": "5540ca8a0083d1bf0e000003", "original_text": "The mature central nervous system contains precursor cells in the subventricular zone of the lateral ventricle. In this study we examined the possibility to affect fate of precursor cells through exogenous manipulations. The results indicate that administration of thyroid hormone and retinoic acid increases the expression of Ki67, a nuclear antigen associated with cell proliferation, and of nestin, a marker protein for precursor cells in the subventricular zone of adult male rats. Moreover, retinoic acid increases polysialated-neural cell adhesion molecules (PSA-NCAM)-immunoreactivity.", "label": 1, "is_selected": 0, "text": "The mature central nervous system contains precursor cells in the subventricular zone of the lateral ventricle. In this study we examined the possibility to affect fate of precursor cells through exogenous manipulations. The results indicate that administration of thyroid hormone and retinoic acid increases the expression of Ki67, a nuclear antigen associated with cell proliferation, and of nestin, a marker protein for precursor cells in the subventricular zone of adult male rats. Moreover, retinoic acid increases polysialated-neural cell adhesion molecules (PSA-NCAM)-immunoreactivity."}
{"qid": "6086f0ef4e6a4cf630000011", "original_text": "A foam cell is a type of immune cell that is filled with lipid droplets, which give it a foamy appearance under a microscope. Foam cells are typically seen in the context of atherosclerosis, a condition in which plaque builds up inside the arteries. In atherosclerosis, the inner lining of the artery becomes damaged, allowing immune cells called macrophages to enter the area and engulf lipids. However, in some cases, the macrophages become overloaded with lipids and begin to burst, releasing their contents into the surrounding tissue. The lipid droplets from these burst macrophages can then aggregate and form foam cells. The presence of foam cells in the artery wall is a hallmark of advanced atherosclerosis, as they are a sign of ongoing inflammation and tissue damage. Foam cells can also contribute to the progression of atherosclerosis by releasing pro-inflammatory cytokines and attracting more immune cells to the area, leading to an inflammatory cascade that can further damage the artery wall.", "label": 0, "is_selected": 0, "text": "A foam cell is a type of immune cell that is filled with lipid droplets, which give it a foamy appearance under a microscope. Foam cells are typically seen in the context of atherosclerosis, a condition in which plaque builds up inside the arteries. In atherosclerosis, the inner lining of the artery becomes damaged, allowing immune cells called macrophages to enter the area and engulf lipids. However, in some cases, the macrophages become overloaded with lipids and begin to burst, releasing their contents into the surrounding tissue. The lipid droplets from these burst macrophages can then aggregate and form foam cells. The presence of foam cells in the artery wall is a hallmark of advanced atherosclerosis, as they are a sign of ongoing inflammation and tissue damage. Foam cells can also contribute to the progression of atherosclerosis by releasing pro-inflammatory cytokines and attracting more immune cells to the area, leading to an inflammatory cascade that can further damage the artery wall."}
{"qid": "56e30dd551531f7e33000016", "original_text": "The circadian clock plays an integral role in the regulation of physiological processes, including the regulation of blood pressure. However, deregulation of the clock can lead to pathophysiological states including hypertension. Recent work has implicated the circadian clock genes in the regulation of processes in the heart, kidney, vasculature, and the metabolic organs, which are all critical in the regulation of the blood pressure. The goal of this review is to provide an introduction and general overview into the role of circadian clock genes in the regulation of blood pressure with a focus on their deregulation in the etiology of hypertension. This review will focus on the core circadian clock genes CLOCK, BMAL1, Per, and Cry.", "label": 1, "is_selected": 0, "text": "The circadian clock plays an integral role in the regulation of physiological processes, including the regulation of blood pressure. However, deregulation of the clock can lead to pathophysiological states including hypertension. Recent work has implicated the circadian clock genes in the regulation of processes in the heart, kidney, vasculature, and the metabolic organs, which are all critical in the regulation of the blood pressure. The goal of this review is to provide an introduction and general overview into the role of circadian clock genes in the regulation of blood pressure with a focus on their deregulation in the etiology of hypertension. This review will focus on the core circadian clock genes CLOCK, BMAL1, Per, and Cry."}
{"qid": "622dfb133a8413c6530000a8", "original_text": "Gantenerumab is a monoclonal antibody drug that targets beta-amyloid peptide, a hallmark of Alzheimer's disease. It works by binding to beta-amyloid peptide and preventing it from accumulating in the brain, which is believed to contribute to the progression of Alzheimer's disease. By targeting beta-amyloid peptide, gantenerumab aims to slow down or halt the progression of cognitive decline associated with Alzheimer's disease.", "label": 0, "is_selected": 0, "text": "Gantenerumab is a monoclonal antibody drug that targets beta-amyloid peptide, a hallmark of Alzheimer's disease. It works by binding to beta-amyloid peptide and preventing it from accumulating in the brain, which is believed to contribute to the progression of Alzheimer's disease. By targeting beta-amyloid peptide, gantenerumab aims to slow down or halt the progression of cognitive decline associated with Alzheimer's disease."}
{"qid": "5abcf0b0fcf4565872000024", "original_text": "Visceral leishmaniasis (VL) is caused by the protozoan parasite Leishmania donovani and transmitted by the bite of infected sandfly Phlebotomus argentipes. The protozoa is obliged intracellularly and causes a wide spectrum of clinical syndromes: VL ('kala azar'), cutaneous leishmaniasis and mucocutaneous leishmaniasis (espundia). Kala azar is the most aggressive form and if untreated causes high mortality. Here, we describe a case of VL that presented to us with high-grade fever and found to have Roth spots that were resolved after 15 days of therapy.", "label": 1, "is_selected": 0, "text": "Visceral leishmaniasis (VL) is caused by the protozoan parasite Leishmania donovani and transmitted by the bite of infected sandfly Phlebotomus argentipes. The protozoa is obliged intracellularly and causes a wide spectrum of clinical syndromes: VL ('kala azar'), cutaneous leishmaniasis and mucocutaneous leishmaniasis (espundia). Kala azar is the most aggressive form and if untreated causes high mortality. Here, we describe a case of VL that presented to us with high-grade fever and found to have Roth spots that were resolved after 15 days of therapy."}
{"qid": "56c71cb65795f9a73e00000b", "original_text": "Previous evidence suggests that epipodophyllotoxins, such as etoposide and teniposide, and the N-acyl anthracycline AD41 inhibit topoisomerase II resealing even though they apparently do not bind to DNA. Using experimental conditions designed to detect limited numbers of DNA binding sites, we now report that both epipodophyllotoxins and the N-acyl anthracyclines AD41 and AD32 bind to DNA. Binding was greater to kinetoplast DNA than to pUC18 plasmid DNA. There was also greater etoposide binding to single-stranded DNA than to double-stranded linear or supercoiled DNA. Based on binding competition experiments, etoposide and teniposide appear to have equal affinity for DNA, in spite of the fact that the latter is more potent as a topoisomerase inhibitor.", "label": 1, "is_selected": 0, "text": "Previous evidence suggests that epipodophyllotoxins, such as etoposide and teniposide, and the N-acyl anthracycline AD41 inhibit topoisomerase II resealing even though they apparently do not bind to DNA. Using experimental conditions designed to detect limited numbers of DNA binding sites, we now report that both epipodophyllotoxins and the N-acyl anthracyclines AD41 and AD32 bind to DNA. Binding was greater to kinetoplast DNA than to pUC18 plasmid DNA. There was also greater etoposide binding to single-stranded DNA than to double-stranded linear or supercoiled DNA. Based on binding competition experiments, etoposide and teniposide appear to have equal affinity for DNA, in spite of the fact that the latter is more potent as a topoisomerase inhibitor."}
{"qid": "625144c9e764a53204000016", "original_text": "Serum neurofilament light chain (sNfL) is a marker of neuroaxonal injury. There is a lack of studies investigating the dynamics of relationships between sNfL levels and radiological disease activity over long-term follow-up in multiple sclerosis (MS). To investigate the relationship among repeated measures of sNfL, lesion burden accumulation, brain volume loss and clinical measures. We investigated 172 patients in the early stages of MS (McDonald 2017 criteria). Clinical exams were performed every 3 months and brain magnetic resonance imaging (MRI) scans were collected annually over 48 months. sNfL levels were measured in serum by Simoa assay at the time of treatment initiation and then annually over 36 months. In repeated-measures analysis, considering all time points, we found a strong relationship between percentage changes of sNfL and lesion burden accumulation assessed by T1 lesion volume (p < 0.001) and T2 lesion number (p < 0.001). There was no relationship between percentage changes of sNfL and brain volume loss over 36 months (p > 0.1). Early sNfL levels were associated with delayed brain volume loss after 48 months (p < 0.001). Patients with No Evidence of Disease Activity (NEDA-3) status showed lower sNfL levels compared with active MS patients.", "label": 1, "is_selected": 0, "text": "Serum neurofilament light chain (sNfL) is a marker of neuroaxonal injury. There is a lack of studies investigating the dynamics of relationships between sNfL levels and radiological disease activity over long-term follow-up in multiple sclerosis (MS). To investigate the relationship among repeated measures of sNfL, lesion burden accumulation, brain volume loss and clinical measures. We investigated 172 patients in the early stages of MS (McDonald 2017 criteria). Clinical exams were performed every 3 months and brain magnetic resonance imaging (MRI) scans were collected annually over 48 months. sNfL levels were measured in serum by Simoa assay at the time of treatment initiation and then annually over 36 months. In repeated-measures analysis, considering all time points, we found a strong relationship between percentage changes of sNfL and lesion burden accumulation assessed by T1 lesion volume (p < 0.001) and T2 lesion number (p < 0.001). There was no relationship between percentage changes of sNfL and brain volume loss over 36 months (p > 0.1). Early sNfL levels were associated with delayed brain volume loss after 48 months (p < 0.001). Patients with No Evidence of Disease Activity (NEDA-3) status showed lower sNfL levels compared with active MS patients."}
{"qid": "54ede5df94afd61504000007", "original_text": "Yes, individuals with Dyskeratosis Congenita (DC) have an increased risk of developing cancer, particularly leukemia and lymphoma. Studies have shown that individuals with DC have a higher risk of developing leukemia, particularly acute myeloid leukemia (AML), than the general population. The risk of developing lymphoma, particularly non-Hodgkin's lymphoma, is also higher in DC patients. The exact mechanism by which DC increases cancer risk is not fully understood, but it is thought to be related to the bone marrow failure and impaired stem cell function that characterizes the condition.", "label": 0, "is_selected": 0, "text": "Yes, individuals with Dyskeratosis Congenita (DC) have an increased risk of developing cancer, particularly leukemia and lymphoma. Studies have shown that individuals with DC have a higher risk of developing leukemia, particularly acute myeloid leukemia (AML), than the general population. The risk of developing lymphoma, particularly non-Hodgkin's lymphoma, is also higher in DC patients. The exact mechanism by which DC increases cancer risk is not fully understood, but it is thought to be related to the bone marrow failure and impaired stem cell function that characterizes the condition."}
{"qid": "5a003e0a966455904c000001", "original_text": "TFIIS (Transcription Factor IIIS) is a transcriptional factor in yeast that plays a crucial role in the initiation of transcription. Dst1 is the yeast ortholog of the human TFIIS protein. It functions as a helicase and unwinds the DNA double helix near the transcription start site, allowing RNA polymerase to bind and initiate transcription. Dst1 also interacts with other transcription factors and regulates the recruitment of RNA polymerase to the promoter region. Overall, Dst1 is essential for proper transcriptional elongation and gene expression in yeast.", "label": 0, "is_selected": 0, "text": "TFIIS (Transcription Factor IIIS) is a transcriptional factor in yeast that plays a crucial role in the initiation of transcription. Dst1 is the yeast ortholog of the human TFIIS protein. It functions as a helicase and unwinds the DNA double helix near the transcription start site, allowing RNA polymerase to bind and initiate transcription. Dst1 also interacts with other transcription factors and regulates the recruitment of RNA polymerase to the promoter region. Overall, Dst1 is essential for proper transcriptional elongation and gene expression in yeast."}
{"qid": "514a4679d24251bc0500005b", "original_text": "Psammoma bodies are not characteristic of meningiomas. Meningiomas are benign tumors that arise from the meninges, the protective membranes covering the brain and spinal cord. Psammoma bodies, on the other hand, are small, calcified deposits that can occur in various tumor types, including meningiomas, but are not specific to them. They are usually seen in the context of degenerative or inflammatory conditions, such as osteoarthritis or rheumatoid arthritis, and are not a diagnostic feature of meningiomas.", "label": 0, "is_selected": 1, "text": "Psammoma bodies are a type of meningioma that is rarely seen in patients with brain cancer, according to a study in the Journal of the American College of Surgeons (JACS) by researchers at the University of Texas MD Anderson Cancer Center."}
{"qid": "5a6f829eb750ff4455000054", "original_text": "Yes, multiple myeloma patients can develop hyperviscosity syndrome, which is a condition characterized by an abnormal increase in the viscosity of blood. This can occur as a result of the accumulation of M protein in the blood, which can cause blood clots and alter blood flow. Hyperviscosity syndrome can lead to a range of symptoms, including fatigue, weakness, infections, and stroke. According to the International Myeloma Foundation, approximately 20-30% of multiple myeloma patients will develop hyperviscosity syndrome. Treatment options for hyperviscosity syndrome in myeloma patients include plasmapheresis, chemotherapy, and the use of drugs that target M protein production.", "label": 0, "is_selected": 0, "text": "Yes, multiple myeloma patients can develop hyperviscosity syndrome, which is a condition characterized by an abnormal increase in the viscosity of blood. This can occur as a result of the accumulation of M protein in the blood, which can cause blood clots and alter blood flow. Hyperviscosity syndrome can lead to a range of symptoms, including fatigue, weakness, infections, and stroke. According to the International Myeloma Foundation, approximately 20-30% of multiple myeloma patients will develop hyperviscosity syndrome. Treatment options for hyperviscosity syndrome in myeloma patients include plasmapheresis, chemotherapy, and the use of drugs that target M protein production."}
{"qid": "5149e23dd24251bc0500004b", "original_text": "Stroke is the third commonest cause of death and single largest cause of adult disability worldwide. Whilst the majority of strokes in older individuals are due to large or small vessel arterial disease or cardiac disease in association with classical vascular risk factors, strokes occurring in younger individuals may have atypical etiologies. Recreational substance misuse is on the increase worldwide, particularly in young adults in developed countries with commonly used substances including cocaine, amphetamines, heroin and other opiates, marijuana and gammahydroxybutyrate (GHB).", "label": 1, "is_selected": 0, "text": "Stroke is the third commonest cause of death and single largest cause of adult disability worldwide. Whilst the majority of strokes in older individuals are due to large or small vessel arterial disease or cardiac disease in association with classical vascular risk factors, strokes occurring in younger individuals may have atypical etiologies. Recreational substance misuse is on the increase worldwide, particularly in young adults in developed countries with commonly used substances including cocaine, amphetamines, heroin and other opiates, marijuana and gammahydroxybutyrate (GHB)."}
{"qid": "55031181e9bde69634000014", "original_text": "Hirschsprung disease is considered a multifactorial disorder, meaning that it is caused by a combination of genetic and environmental factors. While there is a known genetic component to the disease, the exact mutations that contribute to its development are not yet fully understood. Research suggests that several genetic mutations can lead to Hirschsprung disease, including those in genes involved in the formation and maintenance of the enteric nervous system, such as the RET gene. However, the disease can also occur spontaneously due to environmental factors, such as exposure to certain toxins or infections during fetal development. Therefore, Hirschsprung disease cannot be considered a solely Mendelian disorder, as it involves a complex interplay of genetic and environmental factors.", "label": 0, "is_selected": 0, "text": "Hirschsprung disease is considered a multifactorial disorder, meaning that it is caused by a combination of genetic and environmental factors. While there is a known genetic component to the disease, the exact mutations that contribute to its development are not yet fully understood. Research suggests that several genetic mutations can lead to Hirschsprung disease, including those in genes involved in the formation and maintenance of the enteric nervous system, such as the RET gene. However, the disease can also occur spontaneously due to environmental factors, such as exposure to certain toxins or infections during fetal development. Therefore, Hirschsprung disease cannot be considered a solely Mendelian disorder, as it involves a complex interplay of genetic and environmental factors."}
{"qid": "532aad53d6d3ac6a34000010", "original_text": "Dengue virus (DENV) nonstructural protein 5 (NS5) is composed of two globular domains separated by a 10-residue linker. The N-terminal domain participates in the synthesis of a mRNA cap 1 structure ((7Me)GpppA(2'OMe)) at the 5' end of the viral genome and possesses guanylyltransferase, guanine-N7-methyltransferase, and nucleoside-2'O-methyltransferase activities. The C-terminal domain is an RNA-dependent RNA polymerase responsible for viral RNA synthesis. Although crystal structures of the two isolated domains have been obtained, there are no structural data for full-length NS5. It is also unclear whether the two NS5 domains interact with each other to form a stable structure in which the relative orientation of the two domains is fixed.", "label": 1, "is_selected": 0, "text": "Dengue virus (DENV) nonstructural protein 5 (NS5) is composed of two globular domains separated by a 10-residue linker. The N-terminal domain participates in the synthesis of a mRNA cap 1 structure ((7Me)GpppA(2'OMe)) at the 5' end of the viral genome and possesses guanylyltransferase, guanine-N7-methyltransferase, and nucleoside-2'O-methyltransferase activities. The C-terminal domain is an RNA-dependent RNA polymerase responsible for viral RNA synthesis. Although crystal structures of the two isolated domains have been obtained, there are no structural data for full-length NS5. It is also unclear whether the two NS5 domains interact with each other to form a stable structure in which the relative orientation of the two domains is fixed."}
{"qid": "601d73c71cb411341a00003e", "original_text": "Calcaneodynia customarily induces inferior heel pain, specialists believe that the pain is principally caused by acute or chronic injury due to the plantar fascia from accumulative overload pressure. Acupotomy has been widely used to treat calcaneodynia. But its efficiency has not been scientifically and methodically evaluated. The aim of this study is to evaluate the efficacy and safety of the acupotomy treatment in patients with calcaneodynia. Relevant randomized controlled trials in 6 databases (PubMed, Embase, and Cochrane Library, Chinese literature databases, Chinese Biomedical Literature Database [CBM], China National Knowledge Infrastructure [CNKI], and Wanfang Database). The randomized controlled trials (RCTs) of the acupotomy for calcaneodynia patients will be searched in the databases from inception to December 2017 by 2 researchers. Visual analog scale (VAS) will be assessed as the primary outcomes. Roles and Maudsley Score (RM) will be assessed as the secondary outcome. The RevMan V.5.3 will be used for meta-analysis. Continuous outcomes will be presented as the mean difference or standard mean difference, while dichotomous data will be expressed as relative risk.", "label": 1, "is_selected": 0, "text": "Calcaneodynia customarily induces inferior heel pain, specialists believe that the pain is principally caused by acute or chronic injury due to the plantar fascia from accumulative overload pressure. Acupotomy has been widely used to treat calcaneodynia. But its efficiency has not been scientifically and methodically evaluated. The aim of this study is to evaluate the efficacy and safety of the acupotomy treatment in patients with calcaneodynia. Relevant randomized controlled trials in 6 databases (PubMed, Embase, and Cochrane Library, Chinese literature databases, Chinese Biomedical Literature Database [CBM], China National Knowledge Infrastructure [CNKI], and Wanfang Database). The randomized controlled trials (RCTs) of the acupotomy for calcaneodynia patients will be searched in the databases from inception to December 2017 by 2 researchers. Visual analog scale (VAS) will be assessed as the primary outcomes. Roles and Maudsley Score (RM) will be assessed as the secondary outcome. The RevMan V.5.3 will be used for meta-analysis. Continuous outcomes will be presented as the mean difference or standard mean difference, while dichotomous data will be expressed as relative risk."}
{"qid": "531464a6e3eabad021000014", "original_text": "McLeod neuroacanthocytosis syndrome is a late-onset X-linked multisystem disorder affecting the peripheral and central nervous systems, red blood cells (RBCs), and internal organs. A variety of mutations have been found in the responsible gene (XK) including single nonsense and missense mutations, nucleotide mutations at or near the splice junctions of introns of XK, and different deletion mutations. To date no clear phenotype-genotype correlation is apparent. The clinical details of one case of McLeod phenotype without apparent neuromuscular abnormalities have been reported.", "label": 1, "is_selected": 0, "text": "McLeod neuroacanthocytosis syndrome is a late-onset X-linked multisystem disorder affecting the peripheral and central nervous systems, red blood cells (RBCs), and internal organs. A variety of mutations have been found in the responsible gene (XK) including single nonsense and missense mutations, nucleotide mutations at or near the splice junctions of introns of XK, and different deletion mutations. To date no clear phenotype-genotype correlation is apparent. The clinical details of one case of McLeod phenotype without apparent neuromuscular abnormalities have been reported."}
{"qid": "5884755ce56acf5176000007", "original_text": "Valproic acid, also known as valproate, is an anticonvulsant medication that has been investigated for its potential to prolong survival in glioblastoma patients. Glioblastoma is a aggressive form of brain cancer with poor prognosis, and there is a need for effective treatments to improve patient outcomes. Several studies have suggested that valproic acid may have a beneficial effect on glioblastoma, including delayed tumor growth and increased survival. One study published in the Journal of Clinical Oncology in 2018 found that valproic acid improved overall survival in patients with newly diagnosed glioblastoma, with a median survival time of 19.6 months in the treatment group compared to 14.1 months in the control group. Another study published in the journal Neuro-Oncology in 2020 found that valproic acid significantly improved progression-free survival in patients with glioblastoma, with a median time to progression of 10.6 months in the treatment group compared to 6.3 months in the control group. While these findings are promising, it is important to note that these studies had small sample sizes and were open-label, which can potentially bias the results. Additionally, the mechanism underlying the anti-tumor effect of valproic acid in glioblastoma is not fully understood and requires further investigation. In summary, while there is some evidence to suggest that valproic acid may prolong survival in glioblastoma patients, further research is needed to confirm these findings and to better understand the mechanisms underlying its anti-tumor effect.", "label": 0, "is_selected": 1, "text": "In our series of letters from African journalists, film-maker and columnist Ahmed Rashid looks at some of the latest research into the use of valproic acid in the treatment of brain cancer, including two studies that suggest the drug may have a beneficial effect on glioblastoma patients, and one study that suggests the drug significantly improved progression-free survival in patients with glioblastoma, but further research is needed to confirm these findings and to better understand the mechanisms underlying its anti-inflammatory effect, as well as a third study that found the drug was not as effective as previously thought in treating lung cancer."}
{"qid": "553d02c1f321868558000012", "original_text": "Yes, conserved noncoding elements are often associated with developmental genes. These elements are sequences in the genome that are highly conserved across different species and are known to play important roles in regulating gene expression, particularly during development. Many developmental genes have been shown to be associated with conserved noncoding elements, and these elements have been implicated in a variety of developmental processes, including embryonic patterning, cell fate determination, and tissue differentiation.", "label": 0, "is_selected": 1, "text": "Can you tell me what is a conserved noncoding element and how is it associated with developmental genes in animals and human development?<n> Many developmental genes have been shown to be associated with conserved non coding elements, and these elements have been implicated in a variety of developmental processes, including embryonic patterning, cell fate determination, and tissue differentiation."}
{"qid": "57279ef20fd6f91b68000018", "original_text": "IFT57 is the IFT motor protein that has been linked to human skeletal ciliopathies. Skeletal ciliopathies are a group of rare genetic disorders characterized by abnormalities in the structure and function of cilia, which are microtubule-based organelles found on the surface of certain cells. IFT57 is a key component of the IFT complex, which is responsible for the transport of proteins and other cargo along the axoneme, the microtubule-based structure that makes up the cilium. Mutations in the IFT57 gene have been identified as the cause of several forms of skeletal ciliopathies, including primary ciliary dyskinesia (PCD) and other related disorders.", "label": 0, "is_selected": 1, "text": "Researchers at the University of Bristol have identified a gene involved in a group of rare genetic disorders that affect the ciliary body, the part of the body that moves blood and nutrients around the body.<n> Mutations in IFT57 gene have been identified as the cause of several forms of skeletal cilisia, including primary ciliary dyskinesia (PCD) and other related disorders."}
{"qid": "58df5efbc784871774000001", "original_text": "Yes, dupilumab is an antibody that targets the interleukin-4 (IL-4) receptor. Specifically, it is a monoclonal antibody that binds to the alpha subunit of the IL-4 receptor, which is responsible for the signaling of IL-4 and IL-13. By blocking the interaction between IL-4 and the IL-4 receptor, dupilumab can reduce the production of pro-inflammatory cytokines and eosinophils in the airways, which can help to alleviate symptoms of asthma and atopic dermatitis.", "label": 0, "is_selected": 1, "text": "dupilumab has been approved by the European Commission for the treatment of asthma and atopic dermatitis, two conditions in which inflammation can be a major cause of illness, as well as a condition in which the body's immune system attacks healthy tissue."}
{"qid": "54da0c524b1fd0d33c00000b", "original_text": "The sarcoplasmic reticulum (SR) plays a critical role in mediating cardiac contractility and its function is abnormal in the diabetic heart. However, the mechanisms underlying SR dysfunction in the diabetic heart are not clear. Because protein phosphorylation regulates SR function, this study examined the phosphorylation state of phospholamban, a key SR protein that regulates SR calcium (Ca2+) uptake in the heart. Diabetes was induced in male Sprague-Dawley rats by an injection of streptozotocin (STZ; 65 mg kg(-1) i.v.), and the animals were humanely killed after 6 weeks and cardiac SR function was examined.", "label": 1, "is_selected": 0, "text": "The sarcoplasmic reticulum (SR) plays a critical role in mediating cardiac contractility and its function is abnormal in the diabetic heart. However, the mechanisms underlying SR dysfunction in the diabetic heart are not clear. Because protein phosphorylation regulates SR function, this study examined the phosphorylation state of phospholamban, a key SR protein that regulates SR calcium (Ca2+) uptake in the heart. Diabetes was induced in male Sprague-Dawley rats by an injection of streptozotocin (STZ; 65 mg kg(-1) i.v.), and the animals were humanely killed after 6 weeks and cardiac SR function was examined."}
{"qid": "5c6d8b237c78d6947100003e", "original_text": "The exponential reduction in cost of genome sequencing has resulted in a rapid growth of genomic data. Most of the entropy of short read data lies not in the sequence of read bases themselves but in their Quality Scores-the confidence measurement that each base has been sequenced correctly. Lossless compression methods are now close to their theoretical limits and hence there is a need for lossy methods that further reduce the complexity of these data without impacting downstream analyses. We here propose GeneCodeq, a Bayesian method inspired by coding theory for adjusting quality scores to improve the compressibility of quality scores without adversely impacting genotyping accuracy. Our model leverages a corpus of k-mers to reduce the entropy of the quality scores and thereby the compressibility of these data (in FASTQ or SAM/BAM/CRAM files), resulting in compression ratios that significantly exceeds those of other methods. Our approach can also be combined with existing lossy compression schemes to further reduce entropy and allows the user to specify a reference panel of expected sequence variations to improve the model accuracy. In addition to extensive empirical evaluation, we also derive novel theoretical insights that explain the empirical performance and pitfalls of corpus-based quality score compression schemes in general. Finally, we show that as a positive side effect of compression, the model can lead to improved genotyping accuracy.", "label": 1, "is_selected": 0, "text": "The exponential reduction in cost of genome sequencing has resulted in a rapid growth of genomic data. Most of the entropy of short read data lies not in the sequence of read bases themselves but in their Quality Scores-the confidence measurement that each base has been sequenced correctly. Lossless compression methods are now close to their theoretical limits and hence there is a need for lossy methods that further reduce the complexity of these data without impacting downstream analyses. We here propose GeneCodeq, a Bayesian method inspired by coding theory for adjusting quality scores to improve the compressibility of quality scores without adversely impacting genotyping accuracy. Our model leverages a corpus of k-mers to reduce the entropy of the quality scores and thereby the compressibility of these data (in FASTQ or SAM/BAM/CRAM files), resulting in compression ratios that significantly exceeds those of other methods. Our approach can also be combined with existing lossy compression schemes to further reduce entropy and allows the user to specify a reference panel of expected sequence variations to improve the model accuracy. In addition to extensive empirical evaluation, we also derive novel theoretical insights that explain the empirical performance and pitfalls of corpus-based quality score compression schemes in general. Finally, we show that as a positive side effect of compression, the model can lead to improved genotyping accuracy."}
{"qid": "5c73ad0c7c78d69471000094", "original_text": "Cariprazine (RGH-188) is a D\u2083-preferring dopamine D\u2083/D\u2082 receptor partial agonist antipsychotic candidate for the treatment of schizophrenia and bipolar mania. Substance abuse is a frequent comorbidity of both disorders and is associated with serious health issues. Based on preclinical efficacy, dopamine D\u2082 and D\u2083 receptor partial agonists and antagonists are assumed to have relapse-preventing potential in human cocaine addiction. We investigated the anti-abuse potential of cariprazine in cocaine self-administration paradigms. Aripiprazole and bifeprunox were used as comparators because of their pharmacological similarity to cariprazine. The effects of compounds on cocaine's rewarding effect were investigated in a continuous self-administration regimen.", "label": 1, "is_selected": 0, "text": "Cariprazine (RGH-188) is a D\u2083-preferring dopamine D\u2083/D\u2082 receptor partial agonist antipsychotic candidate for the treatment of schizophrenia and bipolar mania. Substance abuse is a frequent comorbidity of both disorders and is associated with serious health issues. Based on preclinical efficacy, dopamine D\u2082 and D\u2083 receptor partial agonists and antagonists are assumed to have relapse-preventing potential in human cocaine addiction. We investigated the anti-abuse potential of cariprazine in cocaine self-administration paradigms. Aripiprazole and bifeprunox were used as comparators because of their pharmacological similarity to cariprazine. The effects of compounds on cocaine's rewarding effect were investigated in a continuous self-administration regimen."}
{"qid": "5a6d08d5b750ff445500002c", "original_text": "Ctf4 (cellular retinoic acid-binding protein 4) is a gene that plays a crucial role in the regulation of gene expression, particularly during embryonic development and stem cell maintenance. Researchers have designed a stapled peptide called Ctf4-binding peptide (CBP) that selectively binds to the C tf4 protein, which could be useful for targeting C tf4 in therapeutic applications.", "label": 0, "is_selected": 1, "text": "Researchers at the University of California, Los Angeles (UCLA) have developed a peptide that selectively binds to the C tf4 gene, which could be useful in the treatment of diseases such as Alzheimer's and Parkinson's, as well as in the development of stem cell therapies."}
{"qid": "589a247078275d0c4a000035", "original_text": "Dinutuximab (ch14.18; Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma cells. This intravenous drug is approved in the EU and USA as combination therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-2 and isotretinoin for the postconsolidation treatment of patients with high-risk neuroblastoma.", "label": 1, "is_selected": 0, "text": "Dinutuximab (ch14.18; Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma cells. This intravenous drug is approved in the EU and USA as combination therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-2 and isotretinoin for the postconsolidation treatment of patients with high-risk neuroblastoma."}
{"qid": "58adbe999ef3c34033000005", "original_text": "Faithful propagation of DNA methylation patterns during DNA replication is critical for maintaining cellular phenotypes of individual differentiated cells. Although it is well established that Uhrf1 (ubiquitin-like with PHD and ring finger domains 1; also known as Np95 and ICBP90) specifically binds to hemi-methylated DNA through its SRA (SET and RING finger associated) domain and has an essential role in maintenance of DNA methylation by recruiting Dnmt1 to hemi-methylated DNA sites, the mechanism by which Uhrf1 coordinates the maintenance of DNA methylation and DNA replication is largely unknown.", "label": 1, "is_selected": 0, "text": "Faithful propagation of DNA methylation patterns during DNA replication is critical for maintaining cellular phenotypes of individual differentiated cells. Although it is well established that Uhrf1 (ubiquitin-like with PHD and ring finger domains 1; also known as Np95 and ICBP90) specifically binds to hemi-methylated DNA through its SRA (SET and RING finger associated) domain and has an essential role in maintenance of DNA methylation by recruiting Dnmt1 to hemi-methylated DNA sites, the mechanism by which Uhrf1 coordinates the maintenance of DNA methylation and DNA replication is largely unknown."}
{"qid": "5157fce5d24251bc0500008c", "original_text": "Mass spectrometry has become a powerful tool for the analysis of large numbers of proteins in complex samples, enabling much of proteomics. Due to various analytical challenges, so far no proteome has been sequenced completely. O'Shea, Weissman and co-workers have recently determined the copy number of yeast proteins, making this proteome an excellent model system to study factors affecting coverage. To probe the yeast proteome in depth and determine factors currently preventing complete analysis, we grew yeast cells, extracted proteins and separated them by one-dimensional gel electrophoresis. Peptides resulting from trypsin digestion were analyzed by liquid chromatography mass spectrometry on a linear ion trap-Fourier transform mass spectrometer with very high mass accuracy and sequencing speed.", "label": 1, "is_selected": 0, "text": "Mass spectrometry has become a powerful tool for the analysis of large numbers of proteins in complex samples, enabling much of proteomics. Due to various analytical challenges, so far no proteome has been sequenced completely. O'Shea, Weissman and co-workers have recently determined the copy number of yeast proteins, making this proteome an excellent model system to study factors affecting coverage. To probe the yeast proteome in depth and determine factors currently preventing complete analysis, we grew yeast cells, extracted proteins and separated them by one-dimensional gel electrophoresis. Peptides resulting from trypsin digestion were analyzed by liquid chromatography mass spectrometry on a linear ion trap-Fourier transform mass spectrometer with very high mass accuracy and sequencing speed."}
{"qid": "56cf413f3975bb303a000009", "original_text": "Yes, there is evidence to suggest that happiness has a strong genetic component. Studies have shown that between 30% to 50% of individual differences in happiness are attributable to genetic variations. These genetic variations are thought to influence the production and regulation of neurotransmitters, such as serotonin and dopamine, which play a crucial role in mood and emotional well-being. However, it's important to note that genetics is not the sole determinant of happiness, and environmental factors such as life circumstances, relationships, and coping mechanisms also play a significant role in overall happiness.", "label": 0, "is_selected": 0, "text": "Yes, there is evidence to suggest that happiness has a strong genetic component. Studies have shown that between 30% to 50% of individual differences in happiness are attributable to genetic variations. These genetic variations are thought to influence the production and regulation of neurotransmitters, such as serotonin and dopamine, which play a crucial role in mood and emotional well-being. However, it's important to note that genetics is not the sole determinant of happiness, and environmental factors such as life circumstances, relationships, and coping mechanisms also play a significant role in overall happiness."}
{"qid": "5a7373f63b9d13c708000008", "original_text": "Introduction: The armamentarium of antileishmanial drugs is small. It is further being threatened by the development of resistance and decreasing sensitivity to the available drugs. The development of newer drugs is sorely needed. Areas covered: The authors have based their review on a literature search performed using PubMed. The article specifically looks at investigational drugs, which have demonstrated, at the very least, in vitro and in vivo activities against the leishmania species that cause visceral leishmaniasis. Specifically, the authors review the nitroimidazole compound fexinidazole, which is one of the few drugs which have reached Phase II trials.", "label": 1, "is_selected": 0, "text": "Introduction: The armamentarium of antileishmanial drugs is small. It is further being threatened by the development of resistance and decreasing sensitivity to the available drugs. The development of newer drugs is sorely needed. Areas covered: The authors have based their review on a literature search performed using PubMed. The article specifically looks at investigational drugs, which have demonstrated, at the very least, in vitro and in vivo activities against the leishmania species that cause visceral leishmaniasis. Specifically, the authors review the nitroimidazole compound fexinidazole, which is one of the few drugs which have reached Phase II trials."}
{"qid": "5c5f1f371a4c55d80b00001a", "original_text": "The tumor suppressor p53 is a key regulator of apoptosis induced by various cellular stresses. p53 can induce apoptosis by two mechanisms. First, p53 acts as a transcription factor inducing and repressing pro-apoptotic and anti-apoptotic targets genes, respectively. Second, p53 is able to translocate to the mitochondria, where it interacts with BCL-2 family members to induce membrane permeabilization and cytochrome c release. p53 transcriptional activity is regulated by a set of post-translational modifications that have been well documented. However, how these modifications impact the direct mitochondrial pathway of death remain poorly understood. In this study, we focused on the role of serine 392 phosphorylation in the control of p53-dependent apoptosis.", "label": 1, "is_selected": 0, "text": "The tumor suppressor p53 is a key regulator of apoptosis induced by various cellular stresses. p53 can induce apoptosis by two mechanisms. First, p53 acts as a transcription factor inducing and repressing pro-apoptotic and anti-apoptotic targets genes, respectively. Second, p53 is able to translocate to the mitochondria, where it interacts with BCL-2 family members to induce membrane permeabilization and cytochrome c release. p53 transcriptional activity is regulated by a set of post-translational modifications that have been well documented. However, how these modifications impact the direct mitochondrial pathway of death remain poorly understood. In this study, we focused on the role of serine 392 phosphorylation in the control of p53-dependent apoptosis."}
{"qid": "56b739d976d8bf8d13000005", "original_text": "There are several genetic multicolor cell labeling techniques available in Drosophila, including: 1. Armored sequence tagging (AST): Uses the armored sequence to tag genes of interest, which can then be detected using a multicolor FISH protocol. 2. Multicolor BAC (bacterial artificial chromosome) labeling: Utilizes BAC clones with multiple fluorescent probes to label different genomic regions. 3. Fluorescence in situ hybridization (FISH): A technique that uses labeled oligonucleotides to detect specific genomic sequences in interphase cells. 4. Chromosome painting: A technique that uses labeled DNA fragments to label specific chromosomes, allowing for visualization of chromosome structure and gene location. 5. Combinatorial labeling: A technique that combines multiple labeling methods to simultaneously detect multiple genes or genomic regions. I hope this information is helpful. If you have any further questions, please don't hesitate to ask!", "label": 0, "is_selected": 1, "text": "What is the most common method of genetic sequence to cell labeling in Drosophila melanogaster and what is the best method for your particular needs?, please follow the instructions in the box on the top right of this page., if you have any further questions, please don't hesitate to ask me!, I hope you find this helpful!,"}
{"qid": "58bc8e7a02b8c60953000007", "original_text": "Plantar fasciitis is a common condition characterized by inflammation of the plantar fascia, a band of tissue that runs along the bottom of the foot, connecting the heel bone to the toes. The plantar fascia supports the arch of the foot and helps to absorb shock during weight-bearing activities. However, when the plantar fascia becomes inflamed, it can cause pain and discomfort in the heel and bottom of the foot. The exact cause of plantar fasciitis is not known, but it is believed to be related to overuse or repetitive strain on the plantar fascia. It can occur in people of all ages and is more common in individuals who are overweight, stand for long periods, or engage in activities that involve running or jumping. Symptoms of plantar fasciitis may include heel pain, stiffness, and swelling in the morning or after resting. Treatment options include rest, ice, and physical therapy to stretch and strengthen the muscles and tendons in the foot. Nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroid injections may also be used to relieve pain and reduce inflammation. In severe cases, surgery may be necessary to release the plantar fascia or remove a bone spur.", "label": 0, "is_selected": 0, "text": "Plantar fasciitis is a common condition characterized by inflammation of the plantar fascia, a band of tissue that runs along the bottom of the foot, connecting the heel bone to the toes. The plantar fascia supports the arch of the foot and helps to absorb shock during weight-bearing activities. However, when the plantar fascia becomes inflamed, it can cause pain and discomfort in the heel and bottom of the foot. The exact cause of plantar fasciitis is not known, but it is believed to be related to overuse or repetitive strain on the plantar fascia. It can occur in people of all ages and is more common in individuals who are overweight, stand for long periods, or engage in activities that involve running or jumping. Symptoms of plantar fasciitis may include heel pain, stiffness, and swelling in the morning or after resting. Treatment options include rest, ice, and physical therapy to stretch and strengthen the muscles and tendons in the foot. Nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroid injections may also be used to relieve pain and reduce inflammation. In severe cases, surgery may be necessary to release the plantar fascia or remove a bone spur."}
{"qid": "622d0aa63a8413c6530000a0", "original_text": "Yes, ASF1 (Aspergillus transcription factor 1) is phosphorylated by Tousled-like kinases. Tousled-like kinases, also known as TLKs, are a family of protein kinases that are involved in various cellular processes, including transcriptional regulation and DNA repair. Studies have shown that TLKs phosphorylate and activate ASF1, leading to the regulation of transcriptional elongation and RNA polymerase II (RNAPII) activity. The phosphorylation of ASF1 by TLKs plays an important role in the regulation of gene expression, particularly during cellular stress response and development.", "label": 0, "is_selected": 0, "text": "Yes, ASF1 (Aspergillus transcription factor 1) is phosphorylated by Tousled-like kinases. Tousled-like kinases, also known as TLKs, are a family of protein kinases that are involved in various cellular processes, including transcriptional regulation and DNA repair. Studies have shown that TLKs phosphorylate and activate ASF1, leading to the regulation of transcriptional elongation and RNA polymerase II (RNAPII) activity. The phosphorylation of ASF1 by TLKs plays an important role in the regulation of gene expression, particularly during cellular stress response and development."}
{"qid": "513ce494bee46bd34c000009", "original_text": "Autosomal dominant polycystic kidney disease (ADPKD), an inherited disease, leads to cyst formation in the kidneys. In this condition, the kidneys are grossly enlarged with multiple cysts that result in kidney failure in a majority of individuals. This condition is also associated with cysts in other organs. Recent research has focused on defects in signaling mediated by the primary cilia as the causative factor in ADPKD. Primary cilia are also present in odontogenic epithelium.", "label": 1, "is_selected": 0, "text": "Autosomal dominant polycystic kidney disease (ADPKD), an inherited disease, leads to cyst formation in the kidneys. In this condition, the kidneys are grossly enlarged with multiple cysts that result in kidney failure in a majority of individuals. This condition is also associated with cysts in other organs. Recent research has focused on defects in signaling mediated by the primary cilia as the causative factor in ADPKD. Primary cilia are also present in odontogenic epithelium."}
{"qid": "5e80675d835f4e4777000026", "original_text": "Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in 2002 as a highly transmissible pathogenic human betacoronavirus. The viral spike glycoprotein (S) utilizes angiotensin-converting enzyme 2 (ACE2) as a host protein receptor and mediates fusion of the viral and host membranes, making S essential to viral entry into host cells and host species tropism. As SARS-CoV enters host cells, the viral S is believed to undergo a number of conformational transitions as it is cleaved by host proteases and binds to host receptors. We recently developed stabilizing mutations for coronavirus spikes that prevent the transition from the pre-fusion to post-fusion states. Here, we present cryo-EM analyses of a stabilized trimeric SARS-CoV S, as well as the trypsin-cleaved, stabilized S, and its interactions with ACE2. Neither binding to ACE2 nor cleavage by trypsin at the S1/S2 cleavage site impart large conformational changes within stabilized SARS-CoV S or expose the secondary cleavage site, S2'.", "label": 1, "is_selected": 0, "text": "Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in 2002 as a highly transmissible pathogenic human betacoronavirus. The viral spike glycoprotein (S) utilizes angiotensin-converting enzyme 2 (ACE2) as a host protein receptor and mediates fusion of the viral and host membranes, making S essential to viral entry into host cells and host species tropism. As SARS-CoV enters host cells, the viral S is believed to undergo a number of conformational transitions as it is cleaved by host proteases and binds to host receptors. We recently developed stabilizing mutations for coronavirus spikes that prevent the transition from the pre-fusion to post-fusion states. Here, we present cryo-EM analyses of a stabilized trimeric SARS-CoV S, as well as the trypsin-cleaved, stabilized S, and its interactions with ACE2. Neither binding to ACE2 nor cleavage by trypsin at the S1/S2 cleavage site impart large conformational changes within stabilized SARS-CoV S or expose the secondary cleavage site, S2'."}
{"qid": "5e3238bcfbd6abf43b000056", "original_text": "The incidence of all thyroid surgery was studied among 10,842 persons whose thyroid glands had been exposed in childhood to an average dose of 9 rads of X-radiation during treatment for tinea capitis and among 2 matched control groups. A statistically significant increased risk for both benign and malignant neoplasms was found in the exposed group. The excess risk was 8.3 cases/year/rad/million population. There were no differences in other surgical conditions between the irradiated and nonirradiated groups. Persons irradiated under age 6 years had the highest excess risk for developing carcinomas.", "label": 1, "is_selected": 0, "text": "The incidence of all thyroid surgery was studied among 10,842 persons whose thyroid glands had been exposed in childhood to an average dose of 9 rads of X-radiation during treatment for tinea capitis and among 2 matched control groups. A statistically significant increased risk for both benign and malignant neoplasms was found in the exposed group. The excess risk was 8.3 cases/year/rad/million population. There were no differences in other surgical conditions between the irradiated and nonirradiated groups. Persons irradiated under age 6 years had the highest excess risk for developing carcinomas."}
{"qid": "58da270d8acda34529000013", "original_text": "AA amyloidosis may be a complication of Familial Mediterranean Fever (FMF). This is a case history of a female patient who did not have the classic symptoms of FMF, which usually precede the renal manifestation. The patient was admitted with edema of both legs, and the nephrotic syndrome was discovered, leading to the diagnosis of AA amyloidosis on kidney biopsy. Genetic testing uncovered the homozygous M694V type mutation, the most common mutation of FMF, which renders the patients prone to amyloidosis. This case represents the phenotype II of FMF, which presents with amyloidosis without prior classic attacks of FMF.", "label": 1, "is_selected": 0, "text": "AA amyloidosis may be a complication of Familial Mediterranean Fever (FMF). This is a case history of a female patient who did not have the classic symptoms of FMF, which usually precede the renal manifestation. The patient was admitted with edema of both legs, and the nephrotic syndrome was discovered, leading to the diagnosis of AA amyloidosis on kidney biopsy. Genetic testing uncovered the homozygous M694V type mutation, the most common mutation of FMF, which renders the patients prone to amyloidosis. This case represents the phenotype II of FMF, which presents with amyloidosis without prior classic attacks of FMF."}
{"qid": "5c9906dcecadf2e73f00002f", "original_text": "Pachypodium (Apocynaceae) is a genus of iconic stem-succulent and poisonous plants endemic to Madagascar and southern Africa. We tested hypotheses about the mode of action and macroevolution of toxicity in this group. We further hypothesized that while monarch butterflies are highly resistant to cardenolide toxins (a type of cardiac glycoside) from American Asclepias, they may be negatively affected by Pachypodium defenses, which evolved independently. We grew 16 of 21 known Pachypodium spp. and quantified putative cardenolides by HPLC and also by inhibition of animal Na+ /K+ -ATPase (the physiological target of cardiac glycosides) using an in vitro assay. Pachypodium extracts were tested against monarch caterpillars in a feeding bioassay. We also tested four Asclepias spp. and five Pachypodium spp. extracts, contrasting inhibition of the cardenolide-sensitive porcine Na+ /K+ -ATPase to the monarch's resistant form. We found evidence for low cardenolides by HPLC, but substantial toxicity when extracts were assayed on Na+ /K+ -ATPases. Toxicity showed phylogenetic signal, and taller species showed greater toxicity (this was marginal after phylogenetic correction). Application of Pachypodium extracts to milkweed leaves reduced monarch growth, and this was predicted by inhibition of the sensitive Na+ /K+ -ATPase in phylogenetic analyses.", "label": 1, "is_selected": 0, "text": "Pachypodium (Apocynaceae) is a genus of iconic stem-succulent and poisonous plants endemic to Madagascar and southern Africa. We tested hypotheses about the mode of action and macroevolution of toxicity in this group. We further hypothesized that while monarch butterflies are highly resistant to cardenolide toxins (a type of cardiac glycoside) from American Asclepias, they may be negatively affected by Pachypodium defenses, which evolved independently. We grew 16 of 21 known Pachypodium spp. and quantified putative cardenolides by HPLC and also by inhibition of animal Na+ /K+ -ATPase (the physiological target of cardiac glycosides) using an in vitro assay. Pachypodium extracts were tested against monarch caterpillars in a feeding bioassay. We also tested four Asclepias spp. and five Pachypodium spp. extracts, contrasting inhibition of the cardenolide-sensitive porcine Na+ /K+ -ATPase to the monarch's resistant form. We found evidence for low cardenolides by HPLC, but substantial toxicity when extracts were assayed on Na+ /K+ -ATPases. Toxicity showed phylogenetic signal, and taller species showed greater toxicity (this was marginal after phylogenetic correction). Application of Pachypodium extracts to milkweed leaves reduced monarch growth, and this was predicted by inhibition of the sensitive Na+ /K+ -ATPase in phylogenetic analyses."}
{"qid": "54d62faf3706e89528000003", "original_text": "NXY-059 is a novel drug that has shown promise in preclinical studies for the treatment of acute ischemic stroke. However, there is limited clinical evidence to support its use in humans. Currently, NXY-059 is being studied in a phase II clinical trial for the treatment of acute ischemic stroke, known as the \"NXY-059 Stroke Study.\" The study is evaluating the safety and efficacy of NXY-059 in acute ischemic stroke patients who are receiving standard of care thrombolysis. The primary outcome measure is the amount of brain tissue salvaged after the stroke, as assessed by magnetic resonance imaging (MRI). Secondary outcomes include measures of functional recovery, such as the National Institutes of Health Stroke Scale (NIHSS) score, and the modified Rankin Scale (mRS) score. While the results of this study are pending, it is too early to determine whether NXY-059 is an effective treatment for acute ischemic stroke patients. More research is needed to confirm these findings and establish the safety and efficacy of NXY-059 in larger, more diverse patient populations. In summary, while NXY-059 shows promise as a potential treatment for acute ischemic stroke, additional clinical trials are necessary to confirm its effectiveness and establish its place in the management of this devastating condition.", "label": 0, "is_selected": 1, "text": "The American Heart Association (AHA) and the American Stroke Association (ASA) are funding a clinical trial of NXY-059 for the treatment of acute ischemic stroke, a devastating condition that affects more than half a million people in the United States each year, according to the US National Institutes of Health (NIH) and American Stroke Foundation (ASF) (see also \"Stroke: A Health Crisis\" and \"Stroke in the 21st Century\" for more information on acute ischemic strokes and their impact on human health)."}
{"qid": "5c9fb2aaecadf2e73f00003f", "original_text": "Aphasia is a communication disorder that results from damage to portions of the brain involved in language processing. It is characterized by difficulty speaking, understanding, reading, and writing. Aphasia can result from various causes such as stroke, brain injury, and neurodegenerative diseases like Alzheimer's. The severity and nature of the symptoms vary depending on the location and extent of the brain damage. Aphasia can affect an individual's ability to express their thoughts, feelings, and needs, leading to difficulty in communication and social interaction. Treatment options, including speech therapy, can help improve language skills and enhance the individual's quality of life. It is essential to seek medical attention if symptoms persist or worsen over time.", "label": 0, "is_selected": 0, "text": "Aphasia is a communication disorder that results from damage to portions of the brain involved in language processing. It is characterized by difficulty speaking, understanding, reading, and writing. Aphasia can result from various causes such as stroke, brain injury, and neurodegenerative diseases like Alzheimer's. The severity and nature of the symptoms vary depending on the location and extent of the brain damage. Aphasia can affect an individual's ability to express their thoughts, feelings, and needs, leading to difficulty in communication and social interaction. Treatment options, including speech therapy, can help improve language skills and enhance the individual's quality of life. It is essential to seek medical attention if symptoms persist or worsen over time."}
{"qid": "6056fd8a94d57fd87900001e", "original_text": "Carbendazim is a fungicide that is commonly used to control various fungal diseases in crops such as grapes, citrus, and tropical fruit. However, there is growing concern about the potential impact of carbendazim on bees and other pollinators. Several studies have shown that exposure to carbendazim can have adverse effects on bees. For example, a study published in the journal \"Environmental Sciences Europe\" found that exposure to carbendazim can cause reduced foraging activity, decreased queen production, and altered behavior in honey bees (Apis mellifera). Another study published in the \"Journal of Economic Entomology\" found that exposure to carbendazim can reduce the longevity and reproductive success of bumble bees (Bombus terrestris). The mechanism by which carbendazim affects bees is not fully understood, but it is thought to involve disruption of the bees' hormone system. Carbendazim is known to mimic the effects of the hormone estrogen in bees, which can lead to changes in behavior and physiology. For example, exposure to carbendazim has been shown to reduce the levels of the bee hormone octopamine, which plays a key role in regulating bee behavior and physiology. The impact of carbendazim on bees is of particular concern because bees are essential for pollinating many crops, and their decline can have significant economic and environmental consequences. For example, the loss of honey bees alone can result in a reduction in crop yields of up to 20%. There are several ways to minimize the impact of carbendazim on bees. One approach is to use alternative fungicides that are less toxic to bees. Another approach is to reduce the use of fungicides in general, by implementing integrated pest management (IPM) strategies that include measures such as crop rotation, biological control, and cultural practices. In conclusion, carbendazim can have adverse effects on bees, including reduced foraging activity, decreased queen production, and altered behavior. The mechanism by which carbendazim affects bees involves disruption of the bees' hormone system, and the impact of carbendazim on bees is of particular concern because bees are essential for pollinating many crops. Several ways to minimize the impact of carbendazim on bees include using alternative fungicides and implementing IPM strategies.", "label": 0, "is_selected": 1, "text": "A study published in the journal \"Environmental Sciences Europe\" found that exposure to carbendazim can cause reduced foraging activity, decreased queen production, and altered behavior in honey bees (Apis mellifera) and bumble bees (Bombus terrestris), and that it can reduce the longevity and reproductive success of bumble bees, which is of particular concern because bees are essential for pollinating many crops and their decline can have significant economic and environmental consequences. The impact of carbsendazim on bees involves disruption of the bees' hormone system, which can lead to changes in behavior and physiology, and the impact of carbohydrates on bees has been shown to mimic the effects of the hormone octopamine, which plays a key role in regulating bees' behaviour and physiology. The mechanism by which carbenda Zim affects bees involves disruptions of the bee's hormones system, and exposure to carbsenda Zim can have adverse effects on bees and other pollinators, such as bumble bees and honey bees."}
{"qid": "56f3faed09dd18d46b000002", "original_text": "Viroid replication mechanism involves the RNA-dependent RNA polymerase enzyme, which transcribes the viroid genome into complementary RNA (cRNA) through a process called \"negative sense\" transcription. This cRNA then acts as a template for the synthesis of new viroid genomes through a process called \"self-templated\" replication. This results in a rapid increase in the number of viroid genomes within a cell, leading to the formation of viroid aggregates and the spread of the virus.", "label": 0, "is_selected": 0, "text": "Viroid replication mechanism involves the RNA-dependent RNA polymerase enzyme, which transcribes the viroid genome into complementary RNA (cRNA) through a process called \"negative sense\" transcription. This cRNA then acts as a template for the synthesis of new viroid genomes through a process called \"self-templated\" replication. This results in a rapid increase in the number of viroid genomes within a cell, leading to the formation of viroid aggregates and the spread of the virus."}
{"qid": "5fdb2e74a43ad3127800000d", "original_text": "Cell fate acquisition is heavily influenced by direct interactions between master regulators and tissue-specific enhancers. However, it remains unclear how lineage-specifying transcription factors, which are often expressed in both progenitor and mature cell populations, influence cell differentiation. Using in vivo mouse liver development as a model, we identified thousands of enhancers that are bound by the master regulators HNF4A and FOXA2 in a differentiation-dependent manner, subject to chromatin remodeling, and associated with differentially expressed target genes. Enhancers exclusively occupied in the embryo were found to be responsive to developmentally regulated TEAD2 and coactivator YAP1. Our data suggest that Hippo signaling may affect hepatocyte differentiation by influencing HNF4A and FOXA2 interactions with temporal enhancers.", "label": 1, "is_selected": 0, "text": "Cell fate acquisition is heavily influenced by direct interactions between master regulators and tissue-specific enhancers. However, it remains unclear how lineage-specifying transcription factors, which are often expressed in both progenitor and mature cell populations, influence cell differentiation. Using in vivo mouse liver development as a model, we identified thousands of enhancers that are bound by the master regulators HNF4A and FOXA2 in a differentiation-dependent manner, subject to chromatin remodeling, and associated with differentially expressed target genes. Enhancers exclusively occupied in the embryo were found to be responsive to developmentally regulated TEAD2 and coactivator YAP1. Our data suggest that Hippo signaling may affect hepatocyte differentiation by influencing HNF4A and FOXA2 interactions with temporal enhancers."}
{"qid": "5ac138aa95d0062724000001", "original_text": "Type 2 diabetes (T2D) is associated with pancreatic \u03b2-cell dysfunction, manifested by reduced glucose-stimulated insulin secretion (GSIS). Several transcription factors enriched in \u03b2-cells, such as MafA, control \u03b2-cell function by organizing genes involved in GSIS. Here we demonstrate that nardilysin (N-arginine dibasic convertase; Nrd1 and NRDc) critically regulates \u03b2-cell function through MafA. Nrd1(-/-)", "label": 1, "is_selected": 0, "text": "Type 2 diabetes (T2D) is associated with pancreatic \u03b2-cell dysfunction, manifested by reduced glucose-stimulated insulin secretion (GSIS). Several transcription factors enriched in \u03b2-cells, such as MafA, control \u03b2-cell function by organizing genes involved in GSIS. Here we demonstrate that nardilysin (N-arginine dibasic convertase; Nrd1 and NRDc) critically regulates \u03b2-cell function through MafA. Nrd1(-/-)"}
{"qid": "553ccbaef32186855800000f", "original_text": "Conserved noncoding sequences, also known as cis-acting elements, play a crucial role in the regulation of Hox genes. These sequences, located upstream of the Hox genes, are responsible for recruiting proteins that regulate the expression of Hox genes during embryonic development. One of the best-studied cis-acting elements involved in Hox gene regulation is the homeodomain binding site (HBS). HBS are short sequences that are recognized by homeodomain proteins, which then recruit other transcription factors to regulate Hox gene expression. Another important cis-acting element is the insulator element, which acts as a barrier to the spread of gene activity and prevents the misexpression of Hox genes. Other conserved noncoding sequences that have been implicated in Hox gene regulation include the proximal upstream promoter-proximal (pup) element, the distal upstream promoter (dup), and the T-box binding site. These elements have been shown to work in conjunction with cis-acting proteins, such as the T-box protein, to regulate Hox gene expression. In addition to their role in regulating Hox gene expression, conserved noncoding sequences have also been implicated in the evolution of Hox genes. Studies have shown that changes in these sequences have played a significant role in the diversification of Hox genes across different species, highlighting their importance in shaping the evolution of developmental gene regulatory networks. In summary, conserved noncoding sequences play a critical role in regulating Hox gene expression during embryonic development. These sequences, along with cis-acting proteins, work together to control the expression of Hox genes, and their evolution has played a significant role in shaping the diversification of Hox genes across different species.", "label": 0, "is_selected": 0, "text": "Conserved noncoding sequences, also known as cis-acting elements, play a crucial role in the regulation of Hox genes. These sequences, located upstream of the Hox genes, are responsible for recruiting proteins that regulate the expression of Hox genes during embryonic development. One of the best-studied cis-acting elements involved in Hox gene regulation is the homeodomain binding site (HBS). HBS are short sequences that are recognized by homeodomain proteins, which then recruit other transcription factors to regulate Hox gene expression. Another important cis-acting element is the insulator element, which acts as a barrier to the spread of gene activity and prevents the misexpression of Hox genes. Other conserved noncoding sequences that have been implicated in Hox gene regulation include the proximal upstream promoter-proximal (pup) element, the distal upstream promoter (dup), and the T-box binding site. These elements have been shown to work in conjunction with cis-acting proteins, such as the T-box protein, to regulate Hox gene expression. In addition to their role in regulating Hox gene expression, conserved noncoding sequences have also been implicated in the evolution of Hox genes. Studies have shown that changes in these sequences have played a significant role in the diversification of Hox genes across different species, highlighting their importance in shaping the evolution of developmental gene regulatory networks. In summary, conserved noncoding sequences play a critical role in regulating Hox gene expression during embryonic development. These sequences, along with cis-acting proteins, work together to control the expression of Hox genes, and their evolution has played a significant role in shaping the diversification of Hox genes across different species."}
{"qid": "57092332cf1c325851000018", "original_text": "The ATP-dependent chromatin-remodelling enzyme Chd1 is a 168-kDa protein consisting of a double chromodomain, Snf2-related ATPase domain, and a C-terminal DNA-binding domain. Here, we show the DNA-binding domain is required for Saccharomyces cerevisiae Chd1 to bind and remodel nucleosomes. The crystal structure of this domain reveals the presence of structural homology to SANT and SLIDE domains previously identified in ISWI remodelling enzymes. The presence of these domains in ISWI and Chd1 chromatin-remodelling enzymes may provide a means of efficiently harnessing the action of the Snf2-related ATPase domain for the purpose of nucleosome spacing and provide an explanation for partial redundancy between these proteins.", "label": 1, "is_selected": 0, "text": "The ATP-dependent chromatin-remodelling enzyme Chd1 is a 168-kDa protein consisting of a double chromodomain, Snf2-related ATPase domain, and a C-terminal DNA-binding domain. Here, we show the DNA-binding domain is required for Saccharomyces cerevisiae Chd1 to bind and remodel nucleosomes. The crystal structure of this domain reveals the presence of structural homology to SANT and SLIDE domains previously identified in ISWI remodelling enzymes. The presence of these domains in ISWI and Chd1 chromatin-remodelling enzymes may provide a means of efficiently harnessing the action of the Snf2-related ATPase domain for the purpose of nucleosome spacing and provide an explanation for partial redundancy between these proteins."}
{"qid": "55414c65472cfd8617000001", "original_text": "The exponential growth in the volume of publications in the biomedical domain has made it impossible for an individual to keep pace with the advances. Even though evidence-based medicine has gained wide acceptance, the physicians are unable to access the relevant information in the required time, leaving most of the questions unanswered. This accentuates the need for fast and accurate biomedical question answering systems. In this paper we introduce INDOC--a biomedical question answering system based on novel ideas of indexing and extracting the answer to the questions posed. INDOC displays the results in clusters to help the user arrive the most relevant set of documents quickly. Evaluation was done against the standard OHSUMED test collection. Our system achieves high accuracy and minimizes user effort.", "label": 1, "is_selected": 0, "text": "The exponential growth in the volume of publications in the biomedical domain has made it impossible for an individual to keep pace with the advances. Even though evidence-based medicine has gained wide acceptance, the physicians are unable to access the relevant information in the required time, leaving most of the questions unanswered. This accentuates the need for fast and accurate biomedical question answering systems. In this paper we introduce INDOC--a biomedical question answering system based on novel ideas of indexing and extracting the answer to the questions posed. INDOC displays the results in clusters to help the user arrive the most relevant set of documents quickly. Evaluation was done against the standard OHSUMED test collection. Our system achieves high accuracy and minimizes user effort."}
{"qid": "571e3d42bb137a4b0c000007", "original_text": "Mood disorders cause much suffering and are the single greatest cause of lost productivity worldwide. Although multiple medications, along with behavioral therapies, have proven effective for some individuals, millions of people lack an effective therapeutic option. A common serotonin (5-HT) transporter (5-HTT/SERT, SLC6A4) polymorphism is believed to confer lower 5-HTT expression in vivo and elevates risk for multiple mood disorders including anxiety, alcoholism, and major depression. Importantly, this variant is also associated with reduced responsiveness to selective 5-HT reuptake inhibitor antidepressants. We hypothesized that a reduced antidepressant response in individuals with a constitutive reduction in 5-HTT expression could arise because of the compensatory expression of other genes that inactivate 5-HT in the brain. A functionally upregulated alternate transporter for 5-HT may prevent extracellular 5-HT from rising to levels sufficiently high enough to trigger the adaptive neurochemical events necessary for therapeutic benefit.", "label": 1, "is_selected": 0, "text": "Mood disorders cause much suffering and are the single greatest cause of lost productivity worldwide. Although multiple medications, along with behavioral therapies, have proven effective for some individuals, millions of people lack an effective therapeutic option. A common serotonin (5-HT) transporter (5-HTT/SERT, SLC6A4) polymorphism is believed to confer lower 5-HTT expression in vivo and elevates risk for multiple mood disorders including anxiety, alcoholism, and major depression. Importantly, this variant is also associated with reduced responsiveness to selective 5-HT reuptake inhibitor antidepressants. We hypothesized that a reduced antidepressant response in individuals with a constitutive reduction in 5-HTT expression could arise because of the compensatory expression of other genes that inactivate 5-HT in the brain. A functionally upregulated alternate transporter for 5-HT may prevent extracellular 5-HT from rising to levels sufficiently high enough to trigger the adaptive neurochemical events necessary for therapeutic benefit."}
{"qid": "52b06a68f828ad283c000005", "original_text": "Yes, tuberous sclerosis is a genetic disease that affects the growth and development of various organs in the body, including the brain, kidneys, heart, and lungs. It is caused by mutations in genes that code for proteins involved in the regulation of cell growth and division. These mutations lead to the formation of non-cancerous tumors, which can cause a range of symptoms and health problems. There are several different types of tuberous sclerosis, including TSC1 and TSC2, each with its own set of symptoms and genetic causes.", "label": 0, "is_selected": 0, "text": "Yes, tuberous sclerosis is a genetic disease that affects the growth and development of various organs in the body, including the brain, kidneys, heart, and lungs. It is caused by mutations in genes that code for proteins involved in the regulation of cell growth and division. These mutations lead to the formation of non-cancerous tumors, which can cause a range of symptoms and health problems. There are several different types of tuberous sclerosis, including TSC1 and TSC2, each with its own set of symptoms and genetic causes."}
{"qid": "5c5f03371a4c55d80b000009", "original_text": "The yeast protein cytochrome c peroxidase (Ccp1) is nuclearly encoded and imported into the mitochondrial intermembrane space, where it is involved in degradation of reactive oxygen species. It is known, that Ccp1 is synthesised as a precursor with a N-terminal pre-sequence, that is proteolytically removed during transport of the protein. Here we present evidence for a new processing pathway, involving novel signal peptidase activities. The mAAA protease subunits Yta10 (Afg3) and Yta12 (Rca1) were identified both to be essential for the first processing step. In addition, the Pcp1 (Ygr101w) gene product was found to be required for the second processing step, yielding the mature Ccp1 protein.", "label": 1, "is_selected": 0, "text": "The yeast protein cytochrome c peroxidase (Ccp1) is nuclearly encoded and imported into the mitochondrial intermembrane space, where it is involved in degradation of reactive oxygen species. It is known, that Ccp1 is synthesised as a precursor with a N-terminal pre-sequence, that is proteolytically removed during transport of the protein. Here we present evidence for a new processing pathway, involving novel signal peptidase activities. The mAAA protease subunits Yta10 (Afg3) and Yta12 (Rca1) were identified both to be essential for the first processing step. In addition, the Pcp1 (Ygr101w) gene product was found to be required for the second processing step, yielding the mature Ccp1 protein."}
{"qid": "515da6e2298dcd4e51000010", "original_text": "Although vulvodynia occurs in approximately 7% of adult American women, we hypothesize that vulvodynia also occurs in young girls and that they respond to treatments that are similar to those used in women with this disorder. This is a retrospective case study of vulvodynia in preadolescent girls seen in our referral practice. Records of all office visits and any telephone or e-mailed follow-up were reviewed. Between October 1996 and April 2006, 6 girls ages 4 to 11 years were evaluated and diagnosed with vulvodynia. Pain had been present for several months to 7 years, and most patients had been seen by several physicians before having this diagnosis made. Treatment was typically initiated with a tricyclic antidepressant, and 5 of the 6 girls noted improvement in their symptoms, including 2 who had marked improvement, and another 3 with substantial improvement who were able to discontinue therapy without a recurrence. Vulvodynia does occur among young girls and, when treated as a neuropathic pain disorder, was found to dramatically improve or remit in the majority of those treated in this small case series. This underrecognized disorder should be considered in cases of ongoing vulvar discomfort, regardless of age.", "label": 1, "is_selected": 0, "text": "Although vulvodynia occurs in approximately 7% of adult American women, we hypothesize that vulvodynia also occurs in young girls and that they respond to treatments that are similar to those used in women with this disorder. This is a retrospective case study of vulvodynia in preadolescent girls seen in our referral practice. Records of all office visits and any telephone or e-mailed follow-up were reviewed. Between October 1996 and April 2006, 6 girls ages 4 to 11 years were evaluated and diagnosed with vulvodynia. Pain had been present for several months to 7 years, and most patients had been seen by several physicians before having this diagnosis made. Treatment was typically initiated with a tricyclic antidepressant, and 5 of the 6 girls noted improvement in their symptoms, including 2 who had marked improvement, and another 3 with substantial improvement who were able to discontinue therapy without a recurrence. Vulvodynia does occur among young girls and, when treated as a neuropathic pain disorder, was found to dramatically improve or remit in the majority of those treated in this small case series. This underrecognized disorder should be considered in cases of ongoing vulvar discomfort, regardless of age."}
{"qid": "601c18921cb411341a00000f", "original_text": "Methotrexate, a folate antagonist, is a potent antiinflammatory agent when used weekly in low concentrations. We examined the hypothesis that the antiphlogistic effects of methotrexate result from its capacity to promote intracellular accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) that, under conditions of cell injury, increases local adenosine release.", "label": 1, "is_selected": 0, "text": "Methotrexate, a folate antagonist, is a potent antiinflammatory agent when used weekly in low concentrations. We examined the hypothesis that the antiphlogistic effects of methotrexate result from its capacity to promote intracellular accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) that, under conditions of cell injury, increases local adenosine release."}
{"qid": "53036faab24d855b11000001", "original_text": "According to the American Academy of Pediatrics, the incidence of sudden cardiac death (SCD) among young athletes is rare, occurring in approximately 1 to 2 per 100,000 young athletes per year. However, it is important to note that some underlying heart conditions can increase the risk of SCD, such as hypertrophic cardiomyopathy, long QT syndrome, and arrhythmic cardiomyopathy. It is recommended that young athletes undergo a preparticipation physical examination to identify any underlying cardiovascular conditions that may increase their risk of SCD.", "label": 0, "is_selected": 1, "text": "The sudden death of a young athlete in the United States has prompted a warning about the dangers of sudden cardiac death in young athletes.<n> it is recommended that young athletes undergo a preparticipation physical examination to identify any underlying cardiovascular conditions that may increase their risk of SCD."}
{"qid": "51635202298dcd4e5100004f", "original_text": "Myotonic dystrophy type 1 (DM1) is an autosomal dominant disorder, caused by an expansion of a CTG triplet repeat in the DMPK gene. The aims of the present study were to classify a cohort of children with DM1, to describe their neuropsychiatric problems and cognitive level, to estimate the size of the CTG expansion, and to correlate the molecular findings with the neuropsychiatric problems. Fifty-seven children and adolescents (26 females; 31 males) with DM1 (CTG repeats > 40) were included in the study. The following instruments were used: Autism Diagnostic Interview-Revised (ADI-R), 5-15, Griffiths Mental Development Scales, and the Wechsler Scales.", "label": 1, "is_selected": 0, "text": "Myotonic dystrophy type 1 (DM1) is an autosomal dominant disorder, caused by an expansion of a CTG triplet repeat in the DMPK gene. The aims of the present study were to classify a cohort of children with DM1, to describe their neuropsychiatric problems and cognitive level, to estimate the size of the CTG expansion, and to correlate the molecular findings with the neuropsychiatric problems. Fifty-seven children and adolescents (26 females; 31 males) with DM1 (CTG repeats > 40) were included in the study. The following instruments were used: Autism Diagnostic Interview-Revised (ADI-R), 5-15, Griffiths Mental Development Scales, and the Wechsler Scales."}
{"qid": "56f3f94109dd18d46b000001", "original_text": "ChIA-PET (Chromatin Immunoprecipitation-sequencing) is a genomic technique used to map the genome-wide locations of specific proteins or DNA sequences. The methodological principle of ChIA-PET involves the use of antibodies to immunoprecipitate specific DNA sequences or protein-DNA complexes from cells, followed by sequencing of the isolated DNA fragments to identify the corresponding protein-DNA interactions. This approach provides detailed information on the genomic locations of protein-DNA interactions and their dynamics in various cellular processes.", "label": 0, "is_selected": 0, "text": "ChIA-PET (Chromatin Immunoprecipitation-sequencing) is a genomic technique used to map the genome-wide locations of specific proteins or DNA sequences. The methodological principle of ChIA-PET involves the use of antibodies to immunoprecipitate specific DNA sequences or protein-DNA complexes from cells, followed by sequencing of the isolated DNA fragments to identify the corresponding protein-DNA interactions. This approach provides detailed information on the genomic locations of protein-DNA interactions and their dynamics in various cellular processes."}
{"qid": "5c7a4c35d774d04240000007", "original_text": "TIM-3 (T-cell immunoglobulin and mucin domain containing protein 3) is an emerging target for cancer immunotherapy in non-small cell lung cancer (NSCLC). TIM-3 is a cell surface protein that is expressed on regulatory T cells (Tregs) and a subset of immune cells, including natural killer cells and T cells. In cancer, TIM-3 is overexpressed on Tregs, which can suppress anti-tumor immune responses. Several studies have shown that TIM-3 is a potential target for cancer immunotherapy in NSCLC. For example, a phase 1b clinical trial published in the New England Journal of Medicine in 2018 found that the TIM-3 inhibitor, relatlimab, in combination with the PD-1 inhibitor, pembrolizumab, was well-tolerated and showed evidence of clinical activity in patients with NSCLC. Another study published in the Journal of Clinical Oncology in 2020 found that TIM-3 expression was associated with improved response to immune checkpoint blockade in NSCLC patients. Targeting TIM-3 with immunotherapy has several advantages over targeting PD-1, including the potential to overcome PD-1 resistance and improve efficacy in patients with high levels of TIM-3 expression. However, TIM-3 expression can also be a negative prognostic factor in some patient populations, and further research is needed to determine its clinical utility as a cancer immunotherapy target. In summary, TIM-3 is an attractive target for cancer immunotherapy in NSCLC, with several studies showing promising results in preclinical and clinical settings. However, further research is needed to fully understand its potential and to optimize its use in clinical practice.", "label": 0, "is_selected": 0, "text": "TIM-3 (T-cell immunoglobulin and mucin domain containing protein 3) is an emerging target for cancer immunotherapy in non-small cell lung cancer (NSCLC). TIM-3 is a cell surface protein that is expressed on regulatory T cells (Tregs) and a subset of immune cells, including natural killer cells and T cells. In cancer, TIM-3 is overexpressed on Tregs, which can suppress anti-tumor immune responses. Several studies have shown that TIM-3 is a potential target for cancer immunotherapy in NSCLC. For example, a phase 1b clinical trial published in the New England Journal of Medicine in 2018 found that the TIM-3 inhibitor, relatlimab, in combination with the PD-1 inhibitor, pembrolizumab, was well-tolerated and showed evidence of clinical activity in patients with NSCLC. Another study published in the Journal of Clinical Oncology in 2020 found that TIM-3 expression was associated with improved response to immune checkpoint blockade in NSCLC patients. Targeting TIM-3 with immunotherapy has several advantages over targeting PD-1, including the potential to overcome PD-1 resistance and improve efficacy in patients with high levels of TIM-3 expression. However, TIM-3 expression can also be a negative prognostic factor in some patient populations, and further research is needed to determine its clinical utility as a cancer immunotherapy target. In summary, TIM-3 is an attractive target for cancer immunotherapy in NSCLC, with several studies showing promising results in preclinical and clinical settings. However, further research is needed to fully understand its potential and to optimize its use in clinical practice."}
{"qid": "58962dac78275d0c4a000005", "original_text": "Peginesatide is a synthetic hormone that works by mimicking the action of endogenous hormones in the body, specifically parathyroid hormone (PTH). It is administered as an injection and binds to the PTH receptor, leading to a decrease in the levels of calcium in the blood and an increase in the levels of phosphorus in the blood. This helps to regulate the levels of calcium and phosphorus in the body, which are essential for bone health. The mechanism of action of peginesatide involves the binding of the drug to the PTH receptor, which is found on the surface of osteoclasts (cells that break down bone) and on the surface of osteoblasts (cells that form bone). When bound to the receptor, peginesatide inhibits the activity of osteoclasts and stimulates the activity of osteoblasts, leading to an increase in bone mineral density (BMD) and a decrease in the risk of fractures. Overall, the mechanism of action of peginesatide is to regulate the levels of calcium and phosphorus in the body and to stimulate bone growth and density, which helps to treat and prevent osteoporosis.", "label": 0, "is_selected": 0, "text": "Peginesatide is a synthetic hormone that works by mimicking the action of endogenous hormones in the body, specifically parathyroid hormone (PTH). It is administered as an injection and binds to the PTH receptor, leading to a decrease in the levels of calcium in the blood and an increase in the levels of phosphorus in the blood. This helps to regulate the levels of calcium and phosphorus in the body, which are essential for bone health. The mechanism of action of peginesatide involves the binding of the drug to the PTH receptor, which is found on the surface of osteoclasts (cells that break down bone) and on the surface of osteoblasts (cells that form bone). When bound to the receptor, peginesatide inhibits the activity of osteoclasts and stimulates the activity of osteoblasts, leading to an increase in bone mineral density (BMD) and a decrease in the risk of fractures. Overall, the mechanism of action of peginesatide is to regulate the levels of calcium and phosphorus in the body and to stimulate bone growth and density, which helps to treat and prevent osteoporosis."}
{"qid": "5e91ffc22d3121100d000002", "original_text": "Genome editing technology based on engineered nucleases has been increasingly applied for targeted modification of genes in a variety of cell types and organisms. However, the methods currently used for evaluating the editing efficiency still suffer from many limitations, including preferential detection of some mutation types, sensitivity to polymorphisms that hamper mismatch detection, lack of multiplex capability, or sensitivity to assay conditions. Here, we describe qEva-CRISPR, a new quantitative method that overcomes these limitations and allows simultaneous (multiplex) analysis of CRISPR/Cas9-induced modifications in a target and the corresponding off-targets or in several different targets. We demonstrate all of the advantages of the qEva-CRISPR method using a number of sgRNAs targeting the TP53, VEGFA, CCR5, EMX1 and HTT genes in different cell lines and under different experimental conditions. Unlike other methods, qEva-CRISPR detects all types of mutations, including point mutations and large deletions, and its sensitivity does not depend on the mutation type. Moreover, this approach allows for successful analysis of targets located in 'difficult' genomic regions.", "label": 1, "is_selected": 0, "text": "Genome editing technology based on engineered nucleases has been increasingly applied for targeted modification of genes in a variety of cell types and organisms. However, the methods currently used for evaluating the editing efficiency still suffer from many limitations, including preferential detection of some mutation types, sensitivity to polymorphisms that hamper mismatch detection, lack of multiplex capability, or sensitivity to assay conditions. Here, we describe qEva-CRISPR, a new quantitative method that overcomes these limitations and allows simultaneous (multiplex) analysis of CRISPR/Cas9-induced modifications in a target and the corresponding off-targets or in several different targets. We demonstrate all of the advantages of the qEva-CRISPR method using a number of sgRNAs targeting the TP53, VEGFA, CCR5, EMX1 and HTT genes in different cell lines and under different experimental conditions. Unlike other methods, qEva-CRISPR detects all types of mutations, including point mutations and large deletions, and its sensitivity does not depend on the mutation type. Moreover, this approach allows for successful analysis of targets located in 'difficult' genomic regions."}
{"qid": "531a34d5b166e2b806000036", "original_text": "Chinese people are more frequent carriers of cytochrome P450 2C19 (CYP2C19) loss-of-function alleles than Caucasians. The effect of the ATP-binding cassette, sub-family B, member 1 (ABCB1), and paraoxonase 1 (PON1) variants on platelet reactivity and clinical outcomes of clopidogrel treatment has not yet been reported in Chinese patients after percutaneous coronary intervention. The aim of this study was to investigate the effect of the CYP2C19, ABCB1, and PON1 variants on clopidogrel pharmacodynamics and clinical outcomes in these patients. Six hundred and seventy patients after percutaneous coronary intervention were enrolled in a single-center registry. The antiplatelet effect of clopidogrel was assessed by thromboelastography, and the CYP2C19, ABCB1, and PON1 genotypes were detected by the ligase detection reaction. Primary clinical endpoints included cardiovascular death, nonfatal myocardial infarction, target vessel revascularization, and stent thrombosis. The secondary clinical endpoints were thrombolysis in myocardial infarction bleeding. The follow-up period was 12 months. The frequency of the CYP2C19 loss-of-function alleles was relatively high (57.3 %).", "label": 1, "is_selected": 0, "text": "Chinese people are more frequent carriers of cytochrome P450 2C19 (CYP2C19) loss-of-function alleles than Caucasians. The effect of the ATP-binding cassette, sub-family B, member 1 (ABCB1), and paraoxonase 1 (PON1) variants on platelet reactivity and clinical outcomes of clopidogrel treatment has not yet been reported in Chinese patients after percutaneous coronary intervention. The aim of this study was to investigate the effect of the CYP2C19, ABCB1, and PON1 variants on clopidogrel pharmacodynamics and clinical outcomes in these patients. Six hundred and seventy patients after percutaneous coronary intervention were enrolled in a single-center registry. The antiplatelet effect of clopidogrel was assessed by thromboelastography, and the CYP2C19, ABCB1, and PON1 genotypes were detected by the ligase detection reaction. Primary clinical endpoints included cardiovascular death, nonfatal myocardial infarction, target vessel revascularization, and stent thrombosis. The secondary clinical endpoints were thrombolysis in myocardial infarction bleeding. The follow-up period was 12 months. The frequency of the CYP2C19 loss-of-function alleles was relatively high (57.3 %)."}
{"qid": "5319a73cb166e2b806000026", "original_text": "In this work we tried to identify mechanisms that could explain how chemical inhibition of heat-shock protein 90 reduces nerve growth factor signaling in rat pheochromocytoma PC12 cells. Geldanamycin is an antibiotic originally discovered based on its ability to bind heat-shock protein 90. This interaction can lead to the disruption of heat-shock protein 90-containing multimolecular complexes. It can also induce the inhibition or even degradation of partner proteins dissociated from the 90 kDa chaperone and, eventually, can cause apoptosis, for instance, in PC12 cells. Before the onset of initial apoptotic events, however, a marked decrease in the activity of extracellular signal-regulated kinases ERK 1/2 and protein kinase B/Akt can be observed together with reduced expression of the high affinity nerve growth factor receptor, tropomyosine-related kinase, TrkA, in this cell type. The proteasome inhibitor MG-132 can effectively counteract the geldanamycin-induced reduction of TrkA expression and it can render TrkA and ERK1/2 phosphorylation but not that of protein kinase B/Akt by nerve growth factor again inducible.", "label": 1, "is_selected": 0, "text": "In this work we tried to identify mechanisms that could explain how chemical inhibition of heat-shock protein 90 reduces nerve growth factor signaling in rat pheochromocytoma PC12 cells. Geldanamycin is an antibiotic originally discovered based on its ability to bind heat-shock protein 90. This interaction can lead to the disruption of heat-shock protein 90-containing multimolecular complexes. It can also induce the inhibition or even degradation of partner proteins dissociated from the 90 kDa chaperone and, eventually, can cause apoptosis, for instance, in PC12 cells. Before the onset of initial apoptotic events, however, a marked decrease in the activity of extracellular signal-regulated kinases ERK 1/2 and protein kinase B/Akt can be observed together with reduced expression of the high affinity nerve growth factor receptor, tropomyosine-related kinase, TrkA, in this cell type. The proteasome inhibitor MG-132 can effectively counteract the geldanamycin-induced reduction of TrkA expression and it can render TrkA and ERK1/2 phosphorylation but not that of protein kinase B/Akt by nerve growth factor again inducible."}
{"qid": "5880acbb0a76a87357000003", "original_text": "In humans, much of the information specifying splice sites is not at the splice site. Exonic splice enhancers are one of the principle non-splice site motifs. Four high-throughput studies have provided a compendium of motifs that function as exonic splice enhancers, but only one, RESCUE-ESE, has been generally employed to examine the properties of enhancers. Here we consider these four datasets to ask whether there is any consensus on the properties and impacts of exonic splice enhancers. While only about 1% of all the identified hexamer motifs are common to all analyses we can define reasonably sized sets that are found in most datasets. These consensus intersection datasets we presume reflect the true properties of exonic splice enhancers.", "label": 1, "is_selected": 0, "text": "In humans, much of the information specifying splice sites is not at the splice site. Exonic splice enhancers are one of the principle non-splice site motifs. Four high-throughput studies have provided a compendium of motifs that function as exonic splice enhancers, but only one, RESCUE-ESE, has been generally employed to examine the properties of enhancers. Here we consider these four datasets to ask whether there is any consensus on the properties and impacts of exonic splice enhancers. While only about 1% of all the identified hexamer motifs are common to all analyses we can define reasonably sized sets that are found in most datasets. These consensus intersection datasets we presume reflect the true properties of exonic splice enhancers."}
{"qid": "5318813ab166e2b806000016", "original_text": "Propionic acidemia is a rare genetic disorder caused by deficiency of the enzyme propionyl-CoA carboxyltransferase (PACT), which is essential for the breakdown of propionyl-CoA, a byproduct of protein and fat metabolism. The genetic basis of propionic acidemia is an autosomal recessive mutation in the PACT gene, which leads to a deficiency of functional enzyme. The mutation can occur in both copies of the PACT gene, resulting in reduced enzyme activity and the accumulation of propionyl-CoA in the body. Without proper treatment, propionic acidemia can lead to seizures, developmental delays, and other serious health problems.", "label": 0, "is_selected": 0, "text": "Propionic acidemia is a rare genetic disorder caused by deficiency of the enzyme propionyl-CoA carboxyltransferase (PACT), which is essential for the breakdown of propionyl-CoA, a byproduct of protein and fat metabolism. The genetic basis of propionic acidemia is an autosomal recessive mutation in the PACT gene, which leads to a deficiency of functional enzyme. The mutation can occur in both copies of the PACT gene, resulting in reduced enzyme activity and the accumulation of propionyl-CoA in the body. Without proper treatment, propionic acidemia can lead to seizures, developmental delays, and other serious health problems."}
{"qid": "5140569623fec90375000003", "original_text": "Diagnosis of lysosomal storage diseases (LSDs) can be problematic in atypical cases where clinical phenotype may overlap with other genetically distinct disorders. In addition, LSDs may result from mutations in genes not yet implicated in disease. Thus, there are individuals that are diagnosed with apparent LSD based upon clinical criteria where the gene defect remains elusive. The objective of this study was to determine whether comparative proteomics approaches could provide useful insights into such cases. Most LSDs arise from mutations in genes encoding lysosomal proteins that contain mannose 6-phosphate, a carbohydrate modification that acts as a signal for intracellular targeting to the lysosome. We purified mannose 6-phosphorylated proteins by affinity chromatography and estimated relative abundance of individual proteins in the mixture by spectral counting of peptides detected by tandem mass spectrometry. Our rationale was that proteins that are decreased or absent in patients compared with controls could represent candidates for the primary defect, directing biochemical or genetics studies. On a survey of brain autopsy specimens from 23 patients with either confirmed or possible lysosomal disease, this approach identified or validated the genetic basis for disease in eight cases. These results indicate that this protein expression approach is useful for identifying defects in cases of undiagnosed lysosomal disease, and we demonstrated that it can be used with more accessible patient samples, e.g. cultured cells.", "label": 1, "is_selected": 0, "text": "Diagnosis of lysosomal storage diseases (LSDs) can be problematic in atypical cases where clinical phenotype may overlap with other genetically distinct disorders. In addition, LSDs may result from mutations in genes not yet implicated in disease. Thus, there are individuals that are diagnosed with apparent LSD based upon clinical criteria where the gene defect remains elusive. The objective of this study was to determine whether comparative proteomics approaches could provide useful insights into such cases. Most LSDs arise from mutations in genes encoding lysosomal proteins that contain mannose 6-phosphate, a carbohydrate modification that acts as a signal for intracellular targeting to the lysosome. We purified mannose 6-phosphorylated proteins by affinity chromatography and estimated relative abundance of individual proteins in the mixture by spectral counting of peptides detected by tandem mass spectrometry. Our rationale was that proteins that are decreased or absent in patients compared with controls could represent candidates for the primary defect, directing biochemical or genetics studies. On a survey of brain autopsy specimens from 23 patients with either confirmed or possible lysosomal disease, this approach identified or validated the genetic basis for disease in eight cases. These results indicate that this protein expression approach is useful for identifying defects in cases of undiagnosed lysosomal disease, and we demonstrated that it can be used with more accessible patient samples, e.g. cultured cells."}
{"qid": "5e52c9266d0a27794100004e", "original_text": "Yes, AhR ligands are known to induce CYP1A1, a key enzyme involved in drug metabolism. Activation of the aryl hydrocarbon receptor (AhR) by ligands leads to the expression of CYP1A1, which can impact the metabolism of xenobiotics, including drugs, and affect their efficacy and toxicity. This property makes AhR ligands attractive drug targets for pharmaceutical development, as they may enable the development of drugs with improved pharmacokinetics and efficacy, as well as reduced toxicity.", "label": 0, "is_selected": 0, "text": "Yes, AhR ligands are known to induce CYP1A1, a key enzyme involved in drug metabolism. Activation of the aryl hydrocarbon receptor (AhR) by ligands leads to the expression of CYP1A1, which can impact the metabolism of xenobiotics, including drugs, and affect their efficacy and toxicity. This property makes AhR ligands attractive drug targets for pharmaceutical development, as they may enable the development of drugs with improved pharmacokinetics and efficacy, as well as reduced toxicity."}
{"qid": "5c6da11e7c78d69471000042", "original_text": "Yes, there are several tools available for reviewing variant calls. Bioinformatic tools such as Ensembl Variant Effect Predictor (VEP), SIFT, and PolyPhen-2 can be used to predict the functional impact of variants on gene function and protein structure. Additionally, tools like DEcIPHER and MutationTaster can be used for visualizing and interpreting variant calls.", "label": 0, "is_selected": 1, "text": "What tools are available for reviewing variant calls and predicting the functional impact of these variants on gene function and protein structure?, What are the tools available to review variant calls?, How do I use them?, and What are their uses?, can they be used to predict the Functional impact of variants on genes and proteins?,"}
{"qid": "6202f600c9dfcb9c0900002b", "original_text": "JASPAR 2022 is a part of JASPAR release 14.0, which was published in 2022. This release includes updated and expanded versions of the JASPAR protein-ligand binding site databases, as well as software tools for analyzing and visualizing the data. The JASPAR 2022 database contains over 137,000 protein-ligand complexes, including more than 10,000 new entries, and covers a wide range of protein-ligand interactions, such as enzyme-inhibitor, receptor-ligand, and protein-protein interactions.", "label": 0, "is_selected": 0, "text": "JASPAR 2022 is a part of JASPAR release 14.0, which was published in 2022. This release includes updated and expanded versions of the JASPAR protein-ligand binding site databases, as well as software tools for analyzing and visualizing the data. The JASPAR 2022 database contains over 137,000 protein-ligand complexes, including more than 10,000 new entries, and covers a wide range of protein-ligand interactions, such as enzyme-inhibitor, receptor-ligand, and protein-protein interactions."}
{"qid": "54e25eaaae9738404b000017", "original_text": "Papilin is an extracellular matrix glycoprotein that we have found to be involved in, (1) thin matrix layers during gastrulation, (2) matrix associated with wandering, phagocytic hemocytes, (3) basement membranes and (4) space-filling matrix during Drosophila development. Determination of its cDNA sequence led to the identification of Caenorhabditis and mammalian papilins.", "label": 1, "is_selected": 0, "text": "Papilin is an extracellular matrix glycoprotein that we have found to be involved in, (1) thin matrix layers during gastrulation, (2) matrix associated with wandering, phagocytic hemocytes, (3) basement membranes and (4) space-filling matrix during Drosophila development. Determination of its cDNA sequence led to the identification of Caenorhabditis and mammalian papilins."}
{"qid": "5c9fb428ecadf2e73f000041", "original_text": "Salivary cortisol is a biomarker for Cushing's syndrome, a rare endocrine disorder caused by excessive cortisol production due to a variety of reasons, including pituitary or adrenal gland tumors, inflammation, or autoimmune disorders. Salivary cortisol levels can be used to diagnose and monitor Cushing's syndrome, as well as to differentiate it from other conditions with similar symptoms, such as depression or anxiety disorders.", "label": 0, "is_selected": 0, "text": "Salivary cortisol is a biomarker for Cushing's syndrome, a rare endocrine disorder caused by excessive cortisol production due to a variety of reasons, including pituitary or adrenal gland tumors, inflammation, or autoimmune disorders. Salivary cortisol levels can be used to diagnose and monitor Cushing's syndrome, as well as to differentiate it from other conditions with similar symptoms, such as depression or anxiety disorders."}
{"qid": "5abcf010fcf4565872000023", "original_text": "In this study, it was aimed to determine whether median nerve epineurectomy is beneficial in the surgical management of carpal tunnel syndrome (CTS). The study enrolled 72 patients including 34 patients without epineurectomy (Group A) and 38 patients with epineurectomy (Group B). Surgery was performed in patients with severe electrodiagnostic CTS findings, CTS duration >1 year and flattening along with hypervascularization in median nerve.", "label": 1, "is_selected": 0, "text": "In this study, it was aimed to determine whether median nerve epineurectomy is beneficial in the surgical management of carpal tunnel syndrome (CTS). The study enrolled 72 patients including 34 patients without epineurectomy (Group A) and 38 patients with epineurectomy (Group B). Surgery was performed in patients with severe electrodiagnostic CTS findings, CTS duration >1 year and flattening along with hypervascularization in median nerve."}
{"qid": "533c3871c45e133714000007", "original_text": "Pseudoknots play critical roles in packing the active structure of various functional RNAs. The importance of the P3-P7 pseudoknot in refolding of group I intron ribozymes has been recently appreciated, while little is known about the pseudoknot function in co-transcriptional folding. Here we used the Candida group", "label": 1, "is_selected": 0, "text": "Pseudoknots play critical roles in packing the active structure of various functional RNAs. The importance of the P3-P7 pseudoknot in refolding of group I intron ribozymes has been recently appreciated, while little is known about the pseudoknot function in co-transcriptional folding. Here we used the Candida group"}
{"qid": "58e3d1743e8b6dc87c000001", "original_text": "Amajor reason for treatment failure during antiviral therapy of chronic hepatitis B infection is thought to be the persistence of the key replicative intermediate, the viral covalently closed circular (CCC) or supercoiled DNA (1,2). Investigators studying the structure and function of hepadnaviral CCC DNA (3) have provided evidence that suggests that this structure exists in the nucleus of infected hepatocytes as a heterogeneous population of viral minichromosomes, which range from half to fully chromatinized, thought to be owing to their association with variable numbers of nucleosomes.", "label": 1, "is_selected": 0, "text": "Amajor reason for treatment failure during antiviral therapy of chronic hepatitis B infection is thought to be the persistence of the key replicative intermediate, the viral covalently closed circular (CCC) or supercoiled DNA (1,2). Investigators studying the structure and function of hepadnaviral CCC DNA (3) have provided evidence that suggests that this structure exists in the nucleus of infected hepatocytes as a heterogeneous population of viral minichromosomes, which range from half to fully chromatinized, thought to be owing to their association with variable numbers of nucleosomes."}
{"qid": "52bf202003868f1b06000018", "original_text": "Neuropathic pain is a kind of pain related with functional abnormality of neurons. Despite large progress in pharmacotherapy, neuropathic pain is still considered an unmet need. Nowadays, there are few drugs registered for this condition, such as pregabalin, gabapentin, duloxetine, carbamazepine, and lidocaine. Among them, pregabalin, gabapentin and carbamazepine are well known antiepileptic drugs. Among the group of new antiepileptic drugs, which are addressed to 1% of human world population suffering from seizures, it turned out that 30% of the seizures resistant to pharmacotherapy has not enough market to justify the costs of drug development. Therefore, it is already a phenomenon that researchers turn their projects toward a larger market, related with possible similar mechanism.", "label": 1, "is_selected": 0, "text": "Neuropathic pain is a kind of pain related with functional abnormality of neurons. Despite large progress in pharmacotherapy, neuropathic pain is still considered an unmet need. Nowadays, there are few drugs registered for this condition, such as pregabalin, gabapentin, duloxetine, carbamazepine, and lidocaine. Among them, pregabalin, gabapentin and carbamazepine are well known antiepileptic drugs. Among the group of new antiepileptic drugs, which are addressed to 1% of human world population suffering from seizures, it turned out that 30% of the seizures resistant to pharmacotherapy has not enough market to justify the costs of drug development. Therefore, it is already a phenomenon that researchers turn their projects toward a larger market, related with possible similar mechanism."}
{"qid": "61f81785882a024a1000003f", "original_text": "Human 4-hydroxyphenylpyruvate dioxygenase-like (HPDL) is a putative iron-containing non-heme oxygenase of unknown specificity and biological significance. We report 25 families containing 34 individuals with neurological disease associated with biallelic HPDL variants. Phenotypes ranged from juvenile-onset pure hereditary spastic paraplegia to infantile-onset spasticity and global developmental delays, sometimes complicated by episodes of neurological and respiratory decompensation. Variants included bona fide pathogenic truncating changes, although most were missense substitutions. Functionality of variants could not be determined directly as the enzymatic specificity of HPDL is unknown; however, when HPDL missense substitutions were introduced into 4-hydroxyphenylpyruvate dioxygenase (HPPD, an HPDL orthologue), they impaired the ability of HPPD to convert 4-hydroxyphenylpyruvate into homogentisate. Moreover, three additional sets of experiments provided evidence for a role of HPDL in the nervous system and further supported its link to neurological disease: (i) HPDL was expressed in the nervous system and expression increased during neural differentiation; (ii) knockdown of zebrafish hpdl led to abnormal motor behaviour, replicating aspects of the human disease; and (iii) HPDL localized to mitochondria, consistent with mitochondrial disease that is often associated with neurological manifestations. Our findings suggest that biallelic HPDL variants cause a syndrome varying from juvenile-onset pure hereditary spastic paraplegia to infantile-onset spastic tetraplegia associated with global developmental delays.", "label": 1, "is_selected": 0, "text": "Human 4-hydroxyphenylpyruvate dioxygenase-like (HPDL) is a putative iron-containing non-heme oxygenase of unknown specificity and biological significance. We report 25 families containing 34 individuals with neurological disease associated with biallelic HPDL variants. Phenotypes ranged from juvenile-onset pure hereditary spastic paraplegia to infantile-onset spasticity and global developmental delays, sometimes complicated by episodes of neurological and respiratory decompensation. Variants included bona fide pathogenic truncating changes, although most were missense substitutions. Functionality of variants could not be determined directly as the enzymatic specificity of HPDL is unknown; however, when HPDL missense substitutions were introduced into 4-hydroxyphenylpyruvate dioxygenase (HPPD, an HPDL orthologue), they impaired the ability of HPPD to convert 4-hydroxyphenylpyruvate into homogentisate. Moreover, three additional sets of experiments provided evidence for a role of HPDL in the nervous system and further supported its link to neurological disease: (i) HPDL was expressed in the nervous system and expression increased during neural differentiation; (ii) knockdown of zebrafish hpdl led to abnormal motor behaviour, replicating aspects of the human disease; and (iii) HPDL localized to mitochondria, consistent with mitochondrial disease that is often associated with neurological manifestations. Our findings suggest that biallelic HPDL variants cause a syndrome varying from juvenile-onset pure hereditary spastic paraplegia to infantile-onset spastic tetraplegia associated with global developmental delays."}
{"qid": "5e48b397d14c9f295d000013", "original_text": "The MAGNIMS criteria are a set of guidelines used to diagnose multiple sclerosis (MS) based on clinical presentation. The acronym MAGNIMS stands for: M - Multiplicity: The patient experiences more than one symptom or episode of MS, such as relapses or progression. A - Accurate history: A detailed history of the patient's symptoms and experiences should be taken to help identify the likelihood of MS. G - Gradual onset: MS typically progresses gradually, with symptoms developing gradually over time. N - New symptoms: The patient experiences new symptoms that are consistent with MS, such as visual disturbances, numbness or weakness, or coordination problems. I - Inconsistent symptoms: The patient's symptoms are inconsistent and unpredictable, which is a characteristic of MS. M - MuSK-antibody positive: The patient tests positive for antibodies against myelin proteolipid protein (MPL), which is a marker of MS. S - Spinal cord involvement: The patient experiences spinal cord inflammation or demyelination, which is a common feature of MS. The MAGNIMS criteria are used to diagnose MS in patients who have experienced clinically isolated syndromes (CIS), which is a single episode of neurological symptoms that lasts for less than 24 hours. The criteria are designed to help healthcare providers diagnose MS early and accurately, and to rule out other conditions that may cause similar symptoms.", "label": 0, "is_selected": 1, "text": "The American Academy of Neurology (AAN) has released a set of criteria to help healthcare providers diagnose multiple sclerosis (MS) in patients who have experienced clinically isolated syndromes (CIS), which is a single episode of neurological symptoms that lasts for less than 24 hours. The MAGNIMS criteria are used to diagnose MS in patients whose symptoms are consistent with multiple sclerosis, such as visual disturbances, numbness or weakness, coordination problems, or spinal cord involvement, but who do not have any other conditions that may cause the symptoms to last for longer."}
{"qid": "5c5f30c91a4c55d80b000025", "original_text": "During inflammation lymphatic vessels (LVs) are enlarged and their density is increased to facilitate the migration of activated immune cells and antigens. However, after antigen clearance, the expanded LVs shrink to maintain homeostasis. Here we show that interleukin (IL)-17A, secreted from T helper type 17 (TH17) cells, is a negative regulator of lymphangiogenesis during the resolution phase of TH17-mediated immune responses. Moreover, IL-17A suppresses the expression of major lymphatic markers in lymphatic endothelial cells and decreases in vitro LV formation. To investigate the role of IL-17A in vivo, we utilized a cholera toxin-mediated inflammation model and identified inflammation and resolution phases based on the numbers of recruited immune cells. IL-17A, markedly produced by TH17 cells even after the peak of inflammation, was found to participate in the negative regulation of LV formation. Moreover, blockade of IL-17A resulted in not only increased density of LVs in tissues but also their enhanced function. Taken together, these findings improve the current understanding of the relationship between LVs and inflammatory cytokines in pathologic conditions.", "label": 1, "is_selected": 0, "text": "During inflammation lymphatic vessels (LVs) are enlarged and their density is increased to facilitate the migration of activated immune cells and antigens. However, after antigen clearance, the expanded LVs shrink to maintain homeostasis. Here we show that interleukin (IL)-17A, secreted from T helper type 17 (TH17) cells, is a negative regulator of lymphangiogenesis during the resolution phase of TH17-mediated immune responses. Moreover, IL-17A suppresses the expression of major lymphatic markers in lymphatic endothelial cells and decreases in vitro LV formation. To investigate the role of IL-17A in vivo, we utilized a cholera toxin-mediated inflammation model and identified inflammation and resolution phases based on the numbers of recruited immune cells. IL-17A, markedly produced by TH17 cells even after the peak of inflammation, was found to participate in the negative regulation of LV formation. Moreover, blockade of IL-17A resulted in not only increased density of LVs in tissues but also their enhanced function. Taken together, these findings improve the current understanding of the relationship between LVs and inflammatory cytokines in pathologic conditions."}
{"qid": "54dfcdf81388e8454a00000a", "original_text": "APOBEC3G (A3G) is a cytidine deaminase that acts as a restriction factor against HIV-1 replication. It works by converting cytidine residues in the viral DNA to uracil, leading to DNA repair and apoptosis of infected cells. Specifically, A3G selectively deaminates the viral DNA during the early stages of infection, causing mutations that inhibit viral transcription and integration. Additionally, A3G can also interact with the viral reverse transcriptase and inhibit its activity, further reducing viral replication. Overall, the mechanism of action of A3G is thought to involve a combination of DNA damage and inhibition of viral enzymes, which ultimately leads to a reduction in HIV-1 replication.", "label": 0, "is_selected": 0, "text": "APOBEC3G (A3G) is a cytidine deaminase that acts as a restriction factor against HIV-1 replication. It works by converting cytidine residues in the viral DNA to uracil, leading to DNA repair and apoptosis of infected cells. Specifically, A3G selectively deaminates the viral DNA during the early stages of infection, causing mutations that inhibit viral transcription and integration. Additionally, A3G can also interact with the viral reverse transcriptase and inhibit its activity, further reducing viral replication. Overall, the mechanism of action of A3G is thought to involve a combination of DNA damage and inhibition of viral enzymes, which ultimately leads to a reduction in HIV-1 replication."}
{"qid": "62265b4a3a8413c653000083", "original_text": "RUNX1T1 stands for Runt-related Transcription Factor 1, also known as Core-binding Factor Alpha Subunit (CBF\u03b1). It is a transcription factor that plays a crucial role in the regulation of gene expression and is involved in the development and maintenance of various cell types, including hematopoietic cells. The RUNX1T1 gene is located on chromosome 1 in humans and is a member of the Runt domain-containing transcription factors, which are characterized by the presence of a conserved Runt domain in their amino acid sequence. Deregulation of the RUNX1T1 gene has been implicated in various diseases, including leukemia and lymphoma.", "label": 0, "is_selected": 0, "text": "RUNX1T1 stands for Runt-related Transcription Factor 1, also known as Core-binding Factor Alpha Subunit (CBF\u03b1). It is a transcription factor that plays a crucial role in the regulation of gene expression and is involved in the development and maintenance of various cell types, including hematopoietic cells. The RUNX1T1 gene is located on chromosome 1 in humans and is a member of the Runt domain-containing transcription factors, which are characterized by the presence of a conserved Runt domain in their amino acid sequence. Deregulation of the RUNX1T1 gene has been implicated in various diseases, including leukemia and lymphoma."}
{"qid": "551c2cd26b348bb82c00000d", "original_text": "Helicobacter pylori (H. pylori) infection has been associated with several vascular obstructive disorders. The infection induces the production of proinflammatory cytokines that could increase platelet aggregates in circulation. The aim of this case-controlled study was to evaluate the prevalence of H. pylori infection in patients with acute ischemic stroke not related to cardiac causes. A group of 80 consecutive patients (58 males, age range: 49-65 years) with acute ischemic stroke was studied. All patients received a cranial CT and/or brain magnetic resonance imaging scan, extracranial vessel duplex ultrasonography, and transthoracic echocardiography. H. pylori infection was diagnosed by means of both 13C urea breath test and IgG antibodies to H. pylori. A group of 320 blood donors (232 males and 88 females, age range: 49-65 years) matched for sex and age served as controls. Among the patients, we investigated the presence of hypertension, cholesterol and glucose levels in serum, fibrinogen in plasma and the smoking habit. The presence of H. pylori infection was higher in patients than in controls: 64/80 (80%) versus 190/320 (59.4%) (P < 0.001); when analyzed for sex in 45/58 (77.5%) among male patients and in 139/232 (59.9%) among controls (P < 0.05); of the females 19 out of 22 (86.3%) patients were infected at variance with only 51/88 (57.9%) of the controls (P < 0.05). Classical risk factors for stroke did not differ among patients with and without H. pylori infection.", "label": 1, "is_selected": 0, "text": "Helicobacter pylori (H. pylori) infection has been associated with several vascular obstructive disorders. The infection induces the production of proinflammatory cytokines that could increase platelet aggregates in circulation. The aim of this case-controlled study was to evaluate the prevalence of H. pylori infection in patients with acute ischemic stroke not related to cardiac causes. A group of 80 consecutive patients (58 males, age range: 49-65 years) with acute ischemic stroke was studied. All patients received a cranial CT and/or brain magnetic resonance imaging scan, extracranial vessel duplex ultrasonography, and transthoracic echocardiography. H. pylori infection was diagnosed by means of both 13C urea breath test and IgG antibodies to H. pylori. A group of 320 blood donors (232 males and 88 females, age range: 49-65 years) matched for sex and age served as controls. Among the patients, we investigated the presence of hypertension, cholesterol and glucose levels in serum, fibrinogen in plasma and the smoking habit. The presence of H. pylori infection was higher in patients than in controls: 64/80 (80%) versus 190/320 (59.4%) (P < 0.001); when analyzed for sex in 45/58 (77.5%) among male patients and in 139/232 (59.9%) among controls (P < 0.05); of the females 19 out of 22 (86.3%) patients were infected at variance with only 51/88 (57.9%) of the controls (P < 0.05). Classical risk factors for stroke did not differ among patients with and without H. pylori infection."}
{"qid": "5c990241ecadf2e73f00002d", "original_text": "p300 is a transcriptional co-activator that plays a crucial role in regulating gene expression by modulating the activity of transcription factors. It does this by binding to specific DNA sequences near the transcription start site of target genes and recruiting RNA polymerase II, the enzyme responsible for transcribing DNA into RNA, to the promoter region of the gene. p300 also interacts with other transcription factors and co-activators to enhance the recruitment of RNA polymerase II and facilitate the initiation of transcription. Additionally, p300 can regulate the stability of mRNA transcripts and influence the splicing of RNA molecules. Overall, p300 plays a key role in the regulation of gene expression and the control of cellular processes such as cell proliferation, differentiation, and survival.", "label": 0, "is_selected": 0, "text": "p300 is a transcriptional co-activator that plays a crucial role in regulating gene expression by modulating the activity of transcription factors. It does this by binding to specific DNA sequences near the transcription start site of target genes and recruiting RNA polymerase II, the enzyme responsible for transcribing DNA into RNA, to the promoter region of the gene. p300 also interacts with other transcription factors and co-activators to enhance the recruitment of RNA polymerase II and facilitate the initiation of transcription. Additionally, p300 can regulate the stability of mRNA transcripts and influence the splicing of RNA molecules. Overall, p300 plays a key role in the regulation of gene expression and the control of cellular processes such as cell proliferation, differentiation, and survival."}
{"qid": "530cf4fe960c95ad0c000009", "original_text": "Complaints of enamel defects in American Indian children residing on the St. Regis reservation in New York State prompted an epidemiological study. The results of that study, reported earlier (Rebich et al., 1983), indicated that over one-fifth of the American Indian children had discoloration of the dentition due to ingestion of tetracycline during the years of tooth formation. These data also provided an ideal opportunity to examine the link between tetracycline staining and caries which has been postulated by previous authors.", "label": 1, "is_selected": 0, "text": "Complaints of enamel defects in American Indian children residing on the St. Regis reservation in New York State prompted an epidemiological study. The results of that study, reported earlier (Rebich et al., 1983), indicated that over one-fifth of the American Indian children had discoloration of the dentition due to ingestion of tetracycline during the years of tooth formation. These data also provided an ideal opportunity to examine the link between tetracycline staining and caries which has been postulated by previous authors."}
{"qid": "52fa74252059c6d71c00005b", "original_text": "We have previously described the development of oncoretrovirus vectors for human gamma-globin using a truncated beta-globin promoter, modified gamma-globin cassette, and alpha-globin enhancer. However, one of these vectors is genetically unstable, and both vectors exhibit variable expression patterns in cultured cells, common characteristics of oncoretrovirus vectors for globin genes. To address these problems, we identified and removed the vector sequences responsible for genetic instability and flanked the resultant vector with the chicken beta-globin HS4 chromatin insulator to protect expression from chromosomal position effects. After determining that flanking with the cHS4 element allowed higher, more uniform levels of gamma-globin expression in MEL cell lines, we tested these vectors using a mouse bone marrow transduction and transplantation model.", "label": 1, "is_selected": 0, "text": "We have previously described the development of oncoretrovirus vectors for human gamma-globin using a truncated beta-globin promoter, modified gamma-globin cassette, and alpha-globin enhancer. However, one of these vectors is genetically unstable, and both vectors exhibit variable expression patterns in cultured cells, common characteristics of oncoretrovirus vectors for globin genes. To address these problems, we identified and removed the vector sequences responsible for genetic instability and flanked the resultant vector with the chicken beta-globin HS4 chromatin insulator to protect expression from chromosomal position effects. After determining that flanking with the cHS4 element allowed higher, more uniform levels of gamma-globin expression in MEL cell lines, we tested these vectors using a mouse bone marrow transduction and transplantation model."}
{"qid": "54d8ea2c4b1fd0d33c000002", "original_text": "Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting up to 1-1.5% of the population. Regular physical activity reduces the risk of cardiovascular diseases, however several studies have shown paradoxically increased incidence of AF in people practicing sport, especially in elite athletes. The results of studies suggest a U-shape relationship between sport and risk of arrhythmia.", "label": 1, "is_selected": 0, "text": "Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting up to 1-1.5% of the population. Regular physical activity reduces the risk of cardiovascular diseases, however several studies have shown paradoxically increased incidence of AF in people practicing sport, especially in elite athletes. The results of studies suggest a U-shape relationship between sport and risk of arrhythmia."}
{"qid": "6026b0e01cb411341a0000ca", "original_text": "Epidermal CYLD inactivation has been implicated in the development and progression of sebaceous and basaloid skin tumors. CYLD is a negative regulator of \u03b2-catenin signaling, which is critical for maintenance of epidermal homeostasis. Inactivation of CYLD leads to uncontrolled \u03b2-catenin activation, promoting proliferation and survival of tumor cells. This is accompanied by changes in gene expression, including increased expression of genes involved in cell cycle progression and decreased expression of genes involved in cell adhesion and differentiation. Moreover, CYLD inactivation can also contribute to the development of chemotherapy resistance in skin cancer cells. Overall, CYLD inactivation plays a critical role in the development and progression of sebaceous and basaloid skin tumors, and targeting this pathway may provide a new therapeutic strategy for treating these aggressive skin cancers.", "label": 0, "is_selected": 1, "text": "Epidermal CYLD inactivation has been implicated in the development and progression of sebaceous and basaloid skin, which may provide a new therapeutic strategy for treating these aggressive skin cancers, according to researchers at the University of California, Los Angeles (UCLA) and the Keck School of Medicine of the USC Los Angeles."}
{"qid": "5aa0495bd6d6b54f79000002", "original_text": "The blood-brain barrier (BBB) plays a key role in maintaining the specialized microenvironment of the central nervous system (CNS), and enabling communication with the systemic compartment. BBB changes occur in several CNS pathologies. Here, we review disruptive and non-disruptive BBB changes in systemic infections and other forms of systemic inflammation, and how these changes may affect CNS function in health and disease. We first describe the structure and function of the BBB, and outline the techniques used to study the BBB in vitro, and in animal and human settings. We then summarise the evidence from a range of models linking BBB changes with systemic inflammation, and the underlying mechanisms. The clinical relevance of these BBB changes during systemic inflammation are discussed in the context of clinically-apparent syndromes such as sickness behaviour, delirium, and septic encephalopathy, as well as neurological conditions such as Alzheimer's disease and multiple sclerosis. We review emerging evidence for two novel concepts: (1) a heightened sensitivity of the diseased, versus healthy, BBB to systemic inflammation, and (2) the contribution of BBB changes induced by systemic inflammation to progression of the primary disease process.", "label": 1, "is_selected": 0, "text": "The blood-brain barrier (BBB) plays a key role in maintaining the specialized microenvironment of the central nervous system (CNS), and enabling communication with the systemic compartment. BBB changes occur in several CNS pathologies. Here, we review disruptive and non-disruptive BBB changes in systemic infections and other forms of systemic inflammation, and how these changes may affect CNS function in health and disease. We first describe the structure and function of the BBB, and outline the techniques used to study the BBB in vitro, and in animal and human settings. We then summarise the evidence from a range of models linking BBB changes with systemic inflammation, and the underlying mechanisms. The clinical relevance of these BBB changes during systemic inflammation are discussed in the context of clinically-apparent syndromes such as sickness behaviour, delirium, and septic encephalopathy, as well as neurological conditions such as Alzheimer's disease and multiple sclerosis. We review emerging evidence for two novel concepts: (1) a heightened sensitivity of the diseased, versus healthy, BBB to systemic inflammation, and (2) the contribution of BBB changes induced by systemic inflammation to progression of the primary disease process."}
{"qid": "58bd645702b8c60953000010", "original_text": "Mechanotransduction, the pathway by which mechanical forces are translated to biological signals, plays important but poorly characterized roles in physiology. PIEZOs are recently identified, widely expressed, mechanically activated ion channels that are hypothesized to play a role in mechanotransduction in mammals. Here, we describe two distinct PIEZO2 mutations in patients with a subtype of Distal Arthrogryposis Type 5 characterized by generalized autosomal dominant contractures with limited eye movements, restrictive lung disease, and variable absence of cruciate knee ligaments. Electrophysiological studies reveal that the two PIEZO2 mutations affect biophysical properties related to channel inactivation: both E2727del and I802F mutations cause the PIEZO2-dependent, mechanically activated currents to recover faster from inactivation, while E2727del also causes a slowing of inactivation.", "label": 1, "is_selected": 0, "text": "Mechanotransduction, the pathway by which mechanical forces are translated to biological signals, plays important but poorly characterized roles in physiology. PIEZOs are recently identified, widely expressed, mechanically activated ion channels that are hypothesized to play a role in mechanotransduction in mammals. Here, we describe two distinct PIEZO2 mutations in patients with a subtype of Distal Arthrogryposis Type 5 characterized by generalized autosomal dominant contractures with limited eye movements, restrictive lung disease, and variable absence of cruciate knee ligaments. Electrophysiological studies reveal that the two PIEZO2 mutations affect biophysical properties related to channel inactivation: both E2727del and I802F mutations cause the PIEZO2-dependent, mechanically activated currents to recover faster from inactivation, while E2727del also causes a slowing of inactivation."}
{"qid": "5e44bc4c48dab47f2600001b", "original_text": "The clinical activity of fibroblast growth factor receptor (FGFR) inhibitors seems restricted to cancers harbouring rare FGFR genetic aberrations. In preclinical studies, high tumour FGFR mRNA expression predicted response to rogaratinib, an oral pan-FGFR inhibitor. We aimed to assess the safety, maximum tolerated dose, recommended phase 2 dose, pharmacokinetics, and preliminary clinical activity of rogaratinib. We did a phase 1 dose-escalation and dose-expansion study of rogaratinib in adults with advanced cancers at 22 sites in Germany, Switzerland, South Korea, Singapore, Spain, and France. Eligible patients were aged 18 years or older, and were ineligible for standard therapy, with an Eastern Cooperative Oncology Group performance status of 0-2, a life expectancy of at least 3 months, and at least one measurable or evaluable lesion according to Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1.", "label": 1, "is_selected": 0, "text": "The clinical activity of fibroblast growth factor receptor (FGFR) inhibitors seems restricted to cancers harbouring rare FGFR genetic aberrations. In preclinical studies, high tumour FGFR mRNA expression predicted response to rogaratinib, an oral pan-FGFR inhibitor. We aimed to assess the safety, maximum tolerated dose, recommended phase 2 dose, pharmacokinetics, and preliminary clinical activity of rogaratinib. We did a phase 1 dose-escalation and dose-expansion study of rogaratinib in adults with advanced cancers at 22 sites in Germany, Switzerland, South Korea, Singapore, Spain, and France. Eligible patients were aged 18 years or older, and were ineligible for standard therapy, with an Eastern Cooperative Oncology Group performance status of 0-2, a life expectancy of at least 3 months, and at least one measurable or evaluable lesion according to Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1."}
{"qid": "57136cbf1174fb1755000007", "original_text": "Yes, fetal aneuploidy can be detected with non-invasive prenatal testing (NIPT). NIPT is a screening test that analyzes the DNA present in the mother's blood to identify genetic abnormalities in the fetus, including trisomy 21 (Down syndrome), trisomy 13 (Patau syndrome), and trisomy 18 (Edwards syndrome). The test can detect these conditions with a high degree of accuracy, typically ranging from 85% to 98%. However, it is important to note that NIPT cannot detect all types of genetic abnormalities, particularly those that are not accompanied by an extra copy of a chromosome. Additionally, the test results must be interpreted in conjunction with other medical information, such as the mother's age and medical history, to provide a complete picture of the baby's health.", "label": 0, "is_selected": 0, "text": "Yes, fetal aneuploidy can be detected with non-invasive prenatal testing (NIPT). NIPT is a screening test that analyzes the DNA present in the mother's blood to identify genetic abnormalities in the fetus, including trisomy 21 (Down syndrome), trisomy 13 (Patau syndrome), and trisomy 18 (Edwards syndrome). The test can detect these conditions with a high degree of accuracy, typically ranging from 85% to 98%. However, it is important to note that NIPT cannot detect all types of genetic abnormalities, particularly those that are not accompanied by an extra copy of a chromosome. Additionally, the test results must be interpreted in conjunction with other medical information, such as the mother's age and medical history, to provide a complete picture of the baby's health."}
{"qid": "51542dabd24251bc0500007d", "original_text": "X-linked centronuclear myopathy (XLMTM), also called myotubular myopathy, is a severe congenital myopathy characterized by generalized hypotonia and weakness at birth and the typical histological finding of centralization of myo-nuclei. It is caused by mutations in the MTM1 gene encoding the 3-phosphoinositides phosphatase myotubularin. Mutations in dynamin 2 and amphiphysin 2 genes lead to autosomal forms of centronuclear myopathy (CNM). While XLMTM is the most frequent and severe form of CNM, no mutations are found in about 30% of patients by sequencing all MTM1 exons.", "label": 1, "is_selected": 0, "text": "X-linked centronuclear myopathy (XLMTM), also called myotubular myopathy, is a severe congenital myopathy characterized by generalized hypotonia and weakness at birth and the typical histological finding of centralization of myo-nuclei. It is caused by mutations in the MTM1 gene encoding the 3-phosphoinositides phosphatase myotubularin. Mutations in dynamin 2 and amphiphysin 2 genes lead to autosomal forms of centronuclear myopathy (CNM). While XLMTM is the most frequent and severe form of CNM, no mutations are found in about 30% of patients by sequencing all MTM1 exons."}
{"qid": "5e94aadf0d431b5f73000002", "original_text": "Circumvention of apoptotic machinery is one of the distinctive properties of carcinogenesis. Extensively established key effectors of such apoptotic bypass mechanisms, the antiapoptotic BCL-2 (apoptosis regulator BCL-2) proteins, determine the response of cancer cells to chemotherapeutics. Within this background, research and development of antiapoptotic BCL-2 inhibitors were considered to have a tremendous amount of potential toward the discovery of novel pharmacological modulators in cancer. In this review, milestone achievements in the development of selective antiapoptotic BCL-2 proteins inhibitors for BCL-2, BCL-XL (BCL-2-like protein 1), and MCL-1 (induced myeloid leukemia cell differentiation protein MCL-1) were summarized and their future implications were discussed. In the first section, the design and development of BCL-2/BCL-XL dual inhibitor navitoclax, as well as the recent advances and clinical experience with selective BCL-2 inhibitor venetoclax, were synopsized. Preclinical data from selective BCL-XL inhibitors, which are currently undergoing extensive testing as a single agent or in combination with other therapeutic agents, were further summarized.", "label": 1, "is_selected": 0, "text": "Circumvention of apoptotic machinery is one of the distinctive properties of carcinogenesis. Extensively established key effectors of such apoptotic bypass mechanisms, the antiapoptotic BCL-2 (apoptosis regulator BCL-2) proteins, determine the response of cancer cells to chemotherapeutics. Within this background, research and development of antiapoptotic BCL-2 inhibitors were considered to have a tremendous amount of potential toward the discovery of novel pharmacological modulators in cancer. In this review, milestone achievements in the development of selective antiapoptotic BCL-2 proteins inhibitors for BCL-2, BCL-XL (BCL-2-like protein 1), and MCL-1 (induced myeloid leukemia cell differentiation protein MCL-1) were summarized and their future implications were discussed. In the first section, the design and development of BCL-2/BCL-XL dual inhibitor navitoclax, as well as the recent advances and clinical experience with selective BCL-2 inhibitor venetoclax, were synopsized. Preclinical data from selective BCL-XL inhibitors, which are currently undergoing extensive testing as a single agent or in combination with other therapeutic agents, were further summarized."}
{"qid": "534bf050aeec6fbd07000015", "original_text": "Thyronamines (TAMs) are a newly identified class of endogenous signaling compounds. Their structure is identical to that of thyroid hormone and deiodinated thyroid hormone derivatives, except that TAMs do not possess a carboxylate group. Despite some initial publications dating back to the 1950s, TAMs did not develop into an independent area of research until 2004, when they were rediscovered as potential ligands to a class of G protein-coupled receptors called trace-amine associated receptors. Since this discovery, two representatives of TAMs, namely 3-iodothyronamine (3-T(1)AM) and thyronamine (T(0)AM), have been detected in vivo.", "label": 1, "is_selected": 0, "text": "Thyronamines (TAMs) are a newly identified class of endogenous signaling compounds. Their structure is identical to that of thyroid hormone and deiodinated thyroid hormone derivatives, except that TAMs do not possess a carboxylate group. Despite some initial publications dating back to the 1950s, TAMs did not develop into an independent area of research until 2004, when they were rediscovered as potential ligands to a class of G protein-coupled receptors called trace-amine associated receptors. Since this discovery, two representatives of TAMs, namely 3-iodothyronamine (3-T(1)AM) and thyronamine (T(0)AM), have been detected in vivo."}
{"qid": "5a96c74cfcd1d6a10c000029", "original_text": "The Lone Star Tick, Amblyomma americanum, can transmit several illnesses, including: * Rocky Mountain Spotted Fever (RMSF): Caused by the bacterium Rickettsia rickettsii, which is transmitted through the tick's saliva. RMSF can cause fever, headache, and rash. * Southern Tick-Associated Rash Illness (STARI): Caused by the bacterium Spirochaeta isolationis, which is also transmitted through the tick's saliva. STARI causes a distinctive rash and flu-like symptoms. * Typhoid Fever: Transmitted through the tick's feces, which can enter the skin through a bite. Typhoid fever is caused by the bacterium Salmonella Typhi and can cause fever, headache, and abdominal pain. It's important to note that not all ticks carry these illnesses, and not all bites will result in illness. However, it's crucial to be aware of the potential risks when encountering ticks, especially in areas where these illnesses are common.", "label": 0, "is_selected": 0, "text": "The Lone Star Tick, Amblyomma americanum, can transmit several illnesses, including: * Rocky Mountain Spotted Fever (RMSF): Caused by the bacterium Rickettsia rickettsii, which is transmitted through the tick's saliva. RMSF can cause fever, headache, and rash. * Southern Tick-Associated Rash Illness (STARI): Caused by the bacterium Spirochaeta isolationis, which is also transmitted through the tick's saliva. STARI causes a distinctive rash and flu-like symptoms. * Typhoid Fever: Transmitted through the tick's feces, which can enter the skin through a bite. Typhoid fever is caused by the bacterium Salmonella Typhi and can cause fever, headache, and abdominal pain. It's important to note that not all ticks carry these illnesses, and not all bites will result in illness. However, it's crucial to be aware of the potential risks when encountering ticks, especially in areas where these illnesses are common."}
{"qid": "601c42ad1cb411341a00001b", "original_text": "Brensocatib is a drug that has been tested for the treatment of non-small cell lung cancer (NSCLC). Specifically, it has been investigated as a potential treatment for patients with metastatic NSCLC who have progressed after previous treatment with checkpoint inhibitors. Brensocatib is a potent and selective inhibitor of the enzyme Bruton's tyrosine kinase (BTK), which is involved in the B-cell receptor signaling pathway. By inhibiting BTK, brensocatib can help to slow the growth and progression of cancer cells, particularly in B-cell malignancies. However, the drug has not yet been approved by regulatory authorities for the treatment of NSCLC, and its efficacy and safety in this indication are still being studied in clinical trials.", "label": 0, "is_selected": 0, "text": "Brensocatib is a drug that has been tested for the treatment of non-small cell lung cancer (NSCLC). Specifically, it has been investigated as a potential treatment for patients with metastatic NSCLC who have progressed after previous treatment with checkpoint inhibitors. Brensocatib is a potent and selective inhibitor of the enzyme Bruton's tyrosine kinase (BTK), which is involved in the B-cell receptor signaling pathway. By inhibiting BTK, brensocatib can help to slow the growth and progression of cancer cells, particularly in B-cell malignancies. However, the drug has not yet been approved by regulatory authorities for the treatment of NSCLC, and its efficacy and safety in this indication are still being studied in clinical trials."}
{"qid": "621ec0313a8413c65300005e", "original_text": "Drug-induced interstitial lung disease (DIILD) is a rare but potentially life-threatening side effect of certain medications. The class of drugs most commonly associated with DIILD includes: 1. Macrolide antibiotics: These include drugs such as erythromycin, azithromycin, and clarithromycin. 2. Fluoroquinolones: These are a class of antibiotics that include drugs such as ciprofloxacin, levofloxacin, and moxifloxacin. 3. Corticosteroids: Long-term use of corticosteroids, such as prednisone, can lead to DIILD. 4. Chemotherapy drugs: Some chemotherapy drugs, such as paclitaxel and docetaxel, can cause DIILD as a side effect. 5. Rarely, other medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin, and ibuprofen can also cause DIILD in some cases. It is important to note that not all drugs in these classes will cause DIILD, and the risk of developing this condition can vary depending on several factors, including the specific drug, dosage, and individual patient factors. If you have any concerns about DIILD or any other medication side effects, it is important to discuss them with your healthcare provider.", "label": 0, "is_selected": 0, "text": "Drug-induced interstitial lung disease (DIILD) is a rare but potentially life-threatening side effect of certain medications. The class of drugs most commonly associated with DIILD includes: 1. Macrolide antibiotics: These include drugs such as erythromycin, azithromycin, and clarithromycin. 2. Fluoroquinolones: These are a class of antibiotics that include drugs such as ciprofloxacin, levofloxacin, and moxifloxacin. 3. Corticosteroids: Long-term use of corticosteroids, such as prednisone, can lead to DIILD. 4. Chemotherapy drugs: Some chemotherapy drugs, such as paclitaxel and docetaxel, can cause DIILD as a side effect. 5. Rarely, other medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin, and ibuprofen can also cause DIILD in some cases. It is important to note that not all drugs in these classes will cause DIILD, and the risk of developing this condition can vary depending on several factors, including the specific drug, dosage, and individual patient factors. If you have any concerns about DIILD or any other medication side effects, it is important to discuss them with your healthcare provider."}
{"qid": "61f52fca882a024a10000003", "original_text": "High myopia with alopecia areata in the occipital region has been observed in patients with Knobloch syndrome caused by COL18A1 mutations. This study investigated other possible genetic causes of high myopia in patients with alopecia areata in the cranial midline. Six patients with early onset high myopia and alopecia areata in the cranial midline were recruited. Targeted high-throughput sequencing was performed on the proband's DNA to detect potential pathogenic variants. Cosegregation analysis was performed for available family members. Minigene assay and RNA Sequencing were used to validate the abnormality of possible splicing change and gross deletion. Ophthalmological and neuroimaging examinations were performed. Eight novel and one known loss-of-function mutants were detected in all six patients, including a gross deletion detected by RNA sequencing.", "label": 1, "is_selected": 0, "text": "High myopia with alopecia areata in the occipital region has been observed in patients with Knobloch syndrome caused by COL18A1 mutations. This study investigated other possible genetic causes of high myopia in patients with alopecia areata in the cranial midline. Six patients with early onset high myopia and alopecia areata in the cranial midline were recruited. Targeted high-throughput sequencing was performed on the proband's DNA to detect potential pathogenic variants. Cosegregation analysis was performed for available family members. Minigene assay and RNA Sequencing were used to validate the abnormality of possible splicing change and gross deletion. Ophthalmological and neuroimaging examinations were performed. Eight novel and one known loss-of-function mutants were detected in all six patients, including a gross deletion detected by RNA sequencing."}
{"qid": "52ef7754c8da898910000014", "original_text": "In prokaryotes, there are several proteins that act as histone-like molecules. These include: 1. H-Antigens: These are the most well-known histone-like proteins in prokaryotes. They are found in the cytoplasm of certain bacteria and are involved in regulating gene expression. 2. HU (Hup) proteins: These proteins are involved in the regulation of DNA replication and repair in prokaryotes. 3. HM (Hmo) proteins: These proteins are involved in the regulation of DNA methylation in prokaryotes. It is important to note that these proteins have different functions and structures compared to histones in eukaryotes, and they are not directly involved in the packaging of DNA into nucleosomes.", "label": 0, "is_selected": 0, "text": "In prokaryotes, there are several proteins that act as histone-like molecules. These include: 1. H-Antigens: These are the most well-known histone-like proteins in prokaryotes. They are found in the cytoplasm of certain bacteria and are involved in regulating gene expression. 2. HU (Hup) proteins: These proteins are involved in the regulation of DNA replication and repair in prokaryotes. 3. HM (Hmo) proteins: These proteins are involved in the regulation of DNA methylation in prokaryotes. It is important to note that these proteins have different functions and structures compared to histones in eukaryotes, and they are not directly involved in the packaging of DNA into nucleosomes."}
{"qid": "530cefaaad0bf1360c00000b", "original_text": "Various bibliometric indices are now commonly used to assess academic productivity in medicine. Some evidence suggests that these measures are specific to subspecialty areas. The authors' goal was to measure the h index of academic pediatric neurosurgeons and compare it with previously reported results for academic neurosurgeons in general. Programs with an Accreditation Council for Pediatric Neurosurgery Fellowships-approved fellowship were identified, and the h and g indices of each of their surgeons were calculated. These were correlated with academic rank and compared with published literature on academic neurosurgical departments. Seventy-two pediatric neurosurgeons had a mean h index of 16.6 and a mean g index of 29.5. Both indices increased with progressive academic rank. The rank-specific mean index for academic pediatric neurosurgeons was similar to that of neurosurgeons from academic departments in general. Overall, the authors conclude that the h index metric is a reasonable measure of academic productivity in the pediatric neurosurgery arena that provides a robust measure of an individual's contribution to the pediatric neurosurgery literature. Like its counterpart in neurosurgery in general, the h index for pediatric neurosurgeons correlates with institutional rank. The h index calculation also reveals the productivity of the pediatric neurosurgeons to be on par with the productivity of neurosurgeons in general.", "label": 1, "is_selected": 0, "text": "Various bibliometric indices are now commonly used to assess academic productivity in medicine. Some evidence suggests that these measures are specific to subspecialty areas. The authors' goal was to measure the h index of academic pediatric neurosurgeons and compare it with previously reported results for academic neurosurgeons in general. Programs with an Accreditation Council for Pediatric Neurosurgery Fellowships-approved fellowship were identified, and the h and g indices of each of their surgeons were calculated. These were correlated with academic rank and compared with published literature on academic neurosurgical departments. Seventy-two pediatric neurosurgeons had a mean h index of 16.6 and a mean g index of 29.5. Both indices increased with progressive academic rank. The rank-specific mean index for academic pediatric neurosurgeons was similar to that of neurosurgeons from academic departments in general. Overall, the authors conclude that the h index metric is a reasonable measure of academic productivity in the pediatric neurosurgery arena that provides a robust measure of an individual's contribution to the pediatric neurosurgery literature. Like its counterpart in neurosurgery in general, the h index for pediatric neurosurgeons correlates with institutional rank. The h index calculation also reveals the productivity of the pediatric neurosurgeons to be on par with the productivity of neurosurgeons in general."}
{"qid": "5c58d9db86df2b9174000013", "original_text": "TissueEnrich is a biomaterial that is used to enhance the viability and function of tissue-engineered constructs. It is a porous, biocompatible, and biodegradable scaffold made of polylactic acid (PLA) or polycaprolactone (PCL) copolymer. TissueEnrich provides a conducive environment for cell growth and differentiation, promoting the formation of new tissue and improving tissue function. It is commonly used in the regeneration of tissues such as skin, bone, and cartilage.", "label": 0, "is_selected": 1, "text": "The global TissueEnrich market is valued at million US$ in 2017 and will reach million US dollar by the end of 2025, growing at a Steady pace during the forecast period 2017 to 2025, according to a new report published by MarketsandMarkets.com."}
{"qid": "62128a913a8413c653000017", "original_text": "Advances in cancer genomics have revealed genomic classes of acute myeloid leukemia (AML) characterized by class-defining mutations, such as chimeric fusion genes or in genes such as NPM1, MLL, and CEBPA. These class-defining mutations frequently synergize with internal tandem duplications in FLT3 (FLT3-ITDs) to drive leukemogenesis. However, \u223c20% of FLT3-ITD-positive AMLs bare no class-defining mutations, and mechanisms of leukemic transformation in these cases are unknown. To identify pathways that drive FLT3-ITD mutant AML in the absence of class-defining mutations, we performed an insertional mutagenesis (IM) screening in Flt3-ITD mice, using Sleeping Beauty transposons.", "label": 1, "is_selected": 0, "text": "Advances in cancer genomics have revealed genomic classes of acute myeloid leukemia (AML) characterized by class-defining mutations, such as chimeric fusion genes or in genes such as NPM1, MLL, and CEBPA. These class-defining mutations frequently synergize with internal tandem duplications in FLT3 (FLT3-ITDs) to drive leukemogenesis. However, \u223c20% of FLT3-ITD-positive AMLs bare no class-defining mutations, and mechanisms of leukemic transformation in these cases are unknown. To identify pathways that drive FLT3-ITD mutant AML in the absence of class-defining mutations, we performed an insertional mutagenesis (IM) screening in Flt3-ITD mice, using Sleeping Beauty transposons."}
{"qid": "5e36a4b7b5b409ea53000003", "original_text": "Uc.63+ is a biomarker that has been shown to be associated with sensitivity to treatment in prostate cancer. Studies have found that patients with Uc.63+ tumors are more likely to respond to hormone therapy and radiotherapy compared to those without this biomarker. Additionally, Uc.63+ has been found to be a predictor of better overall survival in patients with metastatic prostate cancer. The mechanism by which Uc.63+ promotes sensitivity to treatment is not fully understood, but it is thought to be related to the regulation of androgen receptor (AR) expression and activity. Androgen receptor is a key mediator of the effects of androgens on prostate cancer growth and development. In Uc.63+ tumors, the AR is more highly expressed and activated, leading to increased sensitivity to androgen-targeted therapies. In summary, Uc.63+ is a biomarker that is associated with sensitivity to treatment in prostate cancer, particularly hormone therapy and radiotherapy. Further research is needed to fully understand the mechanism by which Uc.63+ promotes sensitivity to treatment and to identify other potential biomarkers for personalized medicine in prostate cancer.", "label": 0, "is_selected": 0, "text": "Uc.63+ is a biomarker that has been shown to be associated with sensitivity to treatment in prostate cancer. Studies have found that patients with Uc.63+ tumors are more likely to respond to hormone therapy and radiotherapy compared to those without this biomarker. Additionally, Uc.63+ has been found to be a predictor of better overall survival in patients with metastatic prostate cancer. The mechanism by which Uc.63+ promotes sensitivity to treatment is not fully understood, but it is thought to be related to the regulation of androgen receptor (AR) expression and activity. Androgen receptor is a key mediator of the effects of androgens on prostate cancer growth and development. In Uc.63+ tumors, the AR is more highly expressed and activated, leading to increased sensitivity to androgen-targeted therapies. In summary, Uc.63+ is a biomarker that is associated with sensitivity to treatment in prostate cancer, particularly hormone therapy and radiotherapy. Further research is needed to fully understand the mechanism by which Uc.63+ promotes sensitivity to treatment and to identify other potential biomarkers for personalized medicine in prostate cancer."}
{"qid": "5be47bff133db5eb78000018", "original_text": "Early-life exposure to household pets has the capacity to reduce risk for overweight and allergic disease, especially following caesarean delivery. Since there is some evidence that pets also alter the gut microbial composition of infants, changes to the gut microbiome are putative pathways by which pet exposure can reduce these risks to health. To investigate the impact of pre- and postnatal pet exposure on infant gut microbiota following various birth scenarios, this study employed a large subsample of 746 infants from the Canadian Healthy Infant Longitudinal Development Study (CHILD) cohort, whose mothers were enrolled during pregnancy between 2009 and 2012. Participating mothers were asked to report on household pet ownership at recruitment during the second or third trimester and 3 months postpartum. Infant gut microbiota were profiled with 16S rRNA sequencing from faecal samples collected at the mean age of 3.3 months. Two categories of pet exposure (i) only during pregnancy and (ii) pre- and postnatally were compared to no pet exposure under different birth scenarios. Over half of studied infants were exposed to at least one furry pet in the prenatal and/or postnatal periods, of which 8% were exposed in pregnancy alone and 46.8% had exposure during both time periods. As a common effect in all birth scenarios, pre- and postnatal pet exposure enriched the abundance of Oscillospira and/or Ruminococcus (P < 0.05) with more than a twofold greater likelihood of high abundance.", "label": 1, "is_selected": 0, "text": "Early-life exposure to household pets has the capacity to reduce risk for overweight and allergic disease, especially following caesarean delivery. Since there is some evidence that pets also alter the gut microbial composition of infants, changes to the gut microbiome are putative pathways by which pet exposure can reduce these risks to health. To investigate the impact of pre- and postnatal pet exposure on infant gut microbiota following various birth scenarios, this study employed a large subsample of 746 infants from the Canadian Healthy Infant Longitudinal Development Study (CHILD) cohort, whose mothers were enrolled during pregnancy between 2009 and 2012. Participating mothers were asked to report on household pet ownership at recruitment during the second or third trimester and 3 months postpartum. Infant gut microbiota were profiled with 16S rRNA sequencing from faecal samples collected at the mean age of 3.3 months. Two categories of pet exposure (i) only during pregnancy and (ii) pre- and postnatally were compared to no pet exposure under different birth scenarios. Over half of studied infants were exposed to at least one furry pet in the prenatal and/or postnatal periods, of which 8% were exposed in pregnancy alone and 46.8% had exposure during both time periods. As a common effect in all birth scenarios, pre- and postnatal pet exposure enriched the abundance of Oscillospira and/or Ruminococcus (P < 0.05) with more than a twofold greater likelihood of high abundance."}
{"qid": "5c010e09133db5eb78000024", "original_text": "Statins have been shown to decrease depressive symptoms in certain groups of patients, an effect that is mostly attributed to their anti-inflammatory and neurotransmitter modulatory potentials. We aimed to investigate the antidepressant effects of simvastatin as an adjuvant therapy in patients with moderate to severe depression. In this double-blind placebo-controlled clinical trial, 48 patients were randomly allocated to receive simvastatin or placebo as an adjunct to fluoxetine for six weeks. Patients were evaluated with the Hamilton Depression Rating Scale (HDRS) at baseline and weeks 2, 4 and 6.", "label": 1, "is_selected": 0, "text": "Statins have been shown to decrease depressive symptoms in certain groups of patients, an effect that is mostly attributed to their anti-inflammatory and neurotransmitter modulatory potentials. We aimed to investigate the antidepressant effects of simvastatin as an adjuvant therapy in patients with moderate to severe depression. In this double-blind placebo-controlled clinical trial, 48 patients were randomly allocated to receive simvastatin or placebo as an adjunct to fluoxetine for six weeks. Patients were evaluated with the Hamilton Depression Rating Scale (HDRS) at baseline and weeks 2, 4 and 6."}
{"qid": "5c6ffee17c78d6947100005a", "original_text": "IHC4 and PAM50 assays have been shown to provide additional prognostic information for patients with early breast cancer. We evaluated whether incorporating TP53 mutation analysis can further enhance their prognostic accuracy. We examined TP53 mutation and the IHC4 score in tumors of 605 patients diagnosed with stage I-III breast cancer at National Taiwan University Hospital (the NTUH cohort). We obtained information regarding TP53 mutation and PAM50 subtypes in 699 tumors from the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) cohort. We found that TP53 mutation was significantly associated with high-risk IHC4 group and with luminal B, HER2-enriched, and basal-like subtypes.", "label": 1, "is_selected": 0, "text": "IHC4 and PAM50 assays have been shown to provide additional prognostic information for patients with early breast cancer. We evaluated whether incorporating TP53 mutation analysis can further enhance their prognostic accuracy. We examined TP53 mutation and the IHC4 score in tumors of 605 patients diagnosed with stage I-III breast cancer at National Taiwan University Hospital (the NTUH cohort). We obtained information regarding TP53 mutation and PAM50 subtypes in 699 tumors from the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) cohort. We found that TP53 mutation was significantly associated with high-risk IHC4 group and with luminal B, HER2-enriched, and basal-like subtypes."}
{"qid": "5344310baeec6fbd0700000c", "original_text": "Paternal duplications of chromosome 6q24, a region that contains the imprinted PLAGL1 and HYMAI transcripts, are associated with transient neonatal diabetes mellitus. A common feature of imprinted genes is that they tend to cluster together, presumably as a result of sharing common cis-acting regulatory elements. To determine the extent of this imprinted cluster in human and mouse, we have undertaken a systematic analysis of allelic expression and DNA methylation of the genes mapping within an \u223c1.4-Mb region flanking PLAGL1/Plagl1. We confirm that all nine neighbouring genes are biallelically expressed in both species. In human we identify two novel paternally expressed PLAGL1 coding transcripts that originate from unique promoter regions.", "label": 1, "is_selected": 0, "text": "Paternal duplications of chromosome 6q24, a region that contains the imprinted PLAGL1 and HYMAI transcripts, are associated with transient neonatal diabetes mellitus. A common feature of imprinted genes is that they tend to cluster together, presumably as a result of sharing common cis-acting regulatory elements. To determine the extent of this imprinted cluster in human and mouse, we have undertaken a systematic analysis of allelic expression and DNA methylation of the genes mapping within an \u223c1.4-Mb region flanking PLAGL1/Plagl1. We confirm that all nine neighbouring genes are biallelically expressed in both species. In human we identify two novel paternally expressed PLAGL1 coding transcripts that originate from unique promoter regions."}
{"qid": "534df8c9aeec6fbd07000016", "original_text": "Protein citrullination is an important post-translational modification that plays a critical role in various diseases. Here are some diseases where protein citrullination has been implicated: 1. Rheumatoid Arthritis (RA): Citrullinated proteins are hallmarks of RA. The immune system mistakenly attacks citrullinated autoantigens, leading to joint destruction and inflammation. 2. Alzheimer's Disease (AD): Citrullination of microtubule-associated proteins (MAPs) leads to the formation of toxic oligomers and contributes to AD pathology. 3. Cancer: Protein citrullination can act as a tumor-suppressor or promoter, depending on the context. Citrullination of p53 modulates its pro-apoptotic activity, while citrullination of histone H3 modifies chromatin structure and enhances transcriptional activity. 4. Neurodegenerative diseases: Citrullination of \u03b1-synuclein, a protein implicated in Parkinson's disease and dementia with Lewy bodies, promotes fibrillization and aggregation. 5. Cardiovascular diseases: Cardiac myosin heavy chain citrullination is associated with cardiac hypertrophy and heart failure. 6. Autoimmune diseases: Citrullination of self-antigens can trigger an immune response and contribute to the pathogenesis of autoimmune diseases such as lupus. In summary, protein citrullination plays a central role in various diseases, including RA, AD, cancer, neurodegenerative diseases, cardiovascular diseases, and autoimmune diseases. Understanding the mechanisms of protein citrullination can provide insights into disease pathogenesis and potential therapeutic targets.", "label": 0, "is_selected": 0, "text": "Protein citrullination is an important post-translational modification that plays a critical role in various diseases. Here are some diseases where protein citrullination has been implicated: 1. Rheumatoid Arthritis (RA): Citrullinated proteins are hallmarks of RA. The immune system mistakenly attacks citrullinated autoantigens, leading to joint destruction and inflammation. 2. Alzheimer's Disease (AD): Citrullination of microtubule-associated proteins (MAPs) leads to the formation of toxic oligomers and contributes to AD pathology. 3. Cancer: Protein citrullination can act as a tumor-suppressor or promoter, depending on the context. Citrullination of p53 modulates its pro-apoptotic activity, while citrullination of histone H3 modifies chromatin structure and enhances transcriptional activity. 4. Neurodegenerative diseases: Citrullination of \u03b1-synuclein, a protein implicated in Parkinson's disease and dementia with Lewy bodies, promotes fibrillization and aggregation. 5. Cardiovascular diseases: Cardiac myosin heavy chain citrullination is associated with cardiac hypertrophy and heart failure. 6. Autoimmune diseases: Citrullination of self-antigens can trigger an immune response and contribute to the pathogenesis of autoimmune diseases such as lupus. In summary, protein citrullination plays a central role in various diseases, including RA, AD, cancer, neurodegenerative diseases, cardiovascular diseases, and autoimmune diseases. Understanding the mechanisms of protein citrullination can provide insights into disease pathogenesis and potential therapeutic targets."}
{"qid": "601c18921cb411341a00000f", "original_text": "It has been shown in experiments on mice that sodium diclofenac and indomethacin inhibited antibody titers and the number of rosette-forming cells (RFC) in mice immunized with sheep red blood cells. Sodium salicylate in all test doses did not produce any shifts in rosette-formation but lowered the number of RFC.", "label": 1, "is_selected": 0, "text": "It has been shown in experiments on mice that sodium diclofenac and indomethacin inhibited antibody titers and the number of rosette-forming cells (RFC) in mice immunized with sheep red blood cells. Sodium salicylate in all test doses did not produce any shifts in rosette-formation but lowered the number of RFC."}
{"qid": "5e3c6e15b5b409ea53000023", "original_text": "Induction of DNA double strand breaks and alterations in the repair of these breaks is implicated in breast carcinogenesis. Prior studies have demonstrated that peripheral blood mononuclear cells (PBMC) from breast cancer patients exhibit increased numbers of DNA strand breaks after exposure to ionizing radiation, but these studies did not specifically measure DNA double strand breaks and it is not known whether chemical carcinogens produce similar effects.", "label": 1, "is_selected": 0, "text": "Induction of DNA double strand breaks and alterations in the repair of these breaks is implicated in breast carcinogenesis. Prior studies have demonstrated that peripheral blood mononuclear cells (PBMC) from breast cancer patients exhibit increased numbers of DNA strand breaks after exposure to ionizing radiation, but these studies did not specifically measure DNA double strand breaks and it is not known whether chemical carcinogens produce similar effects."}
{"qid": "601d742e1cb411341a000040", "original_text": "The tortoiseshell coat colour is characteristic to female cats, and its occurrence in tomcats is very rare and associated with chromosome abnormalities (additional copy of X chromosome). The aim of this study was identification of the genetic basis of a case of tortoiseshell colour in a fertile Maine coon tomcat. Cytogenetic and molecular genetic studies were carried out with painting molecular probes (WCPP) specific to the X and Y sex chromosomes as well as a DNA microsatellite panel for the parentage verification of cats.", "label": 1, "is_selected": 0, "text": "The tortoiseshell coat colour is characteristic to female cats, and its occurrence in tomcats is very rare and associated with chromosome abnormalities (additional copy of X chromosome). The aim of this study was identification of the genetic basis of a case of tortoiseshell colour in a fertile Maine coon tomcat. Cytogenetic and molecular genetic studies were carried out with painting molecular probes (WCPP) specific to the X and Y sex chromosomes as well as a DNA microsatellite panel for the parentage verification of cats."}
{"qid": "5c909b6cecadf2e73f000005", "original_text": "According to the most recent estimates, there are approximately 500-600 pseudokinases in the human kinome. These pseudokinases are proteins that have some features of kinases but do not have the full catalytic activity of kinases. They play a variety of roles in cells, including regulation of signaling pathways and cellular processes. The exact number of pseudokinases in the human kinome can vary depending on the source and method used to identify them, but the range of 500-600 is generally accepted.", "label": 0, "is_selected": 1, "text": "The human kinome contains a large number of pseudokinases, which are proteins that have some features of kinases but do not have the full catalytic activity of these kinases, but are nonetheless important molecules in the functioning of the human body."}
{"qid": "5a86fd5bfaa1ab7d2e00003b", "original_text": "Ependymomas are common childhood brain tumours that occur throughout the nervous system, but are most common in the paediatric hindbrain. Current standard therapy comprises surgery and radiation, but not cytotoxic chemotherapy as it does not further increase survival. Whole-genome and whole-exome sequencing of 47 hindbrain ependymomas reveals an extremely low mutation rate, and zero significant recurrent somatic single nucleotide variants. Although devoid of recurrent single nucleotide variants and focal copy number aberrations, poor-prognosis hindbrain ependymomas exhibit a CpG island methylator phenotype. Transcriptional silencing driven by CpG methylation converges exclusively on targets of the Polycomb repressive complex 2 which represses expression of differentiation genes through trimethylation of H3K27.", "label": 1, "is_selected": 0, "text": "Ependymomas are common childhood brain tumours that occur throughout the nervous system, but are most common in the paediatric hindbrain. Current standard therapy comprises surgery and radiation, but not cytotoxic chemotherapy as it does not further increase survival. Whole-genome and whole-exome sequencing of 47 hindbrain ependymomas reveals an extremely low mutation rate, and zero significant recurrent somatic single nucleotide variants. Although devoid of recurrent single nucleotide variants and focal copy number aberrations, poor-prognosis hindbrain ependymomas exhibit a CpG island methylator phenotype. Transcriptional silencing driven by CpG methylation converges exclusively on targets of the Polycomb repressive complex 2 which represses expression of differentiation genes through trimethylation of H3K27."}
{"qid": "515b30d8d24251bc050000b0", "original_text": "Lacrimal glands produce the protein lacritin, which is essential for tears' health. Tears' composition and the lacrimal gland's functional maintenance are both influenced by lacritin. This protein can be obtained by the following methods: 1. Blood Test: Measuring lacritin levels in the blood is one way to determine if a person has a lacrational gland issue. A lacrimal gland disorder can be detected by measuring the levels of lacritin in the blood. 2. Tear Collection: Tears can be collected for lab analysis using a special device called a Schirmer tear test. This test measures the quantity of tears produced and lacritin levels in the tears. 3. Biopsy: A lacrimal gland biopsy can determine if the gland is malfunctioning by examining a tiny sample of the gland under a microscope. This test can assist determine whether the gland is producing too many or too few tears and the amount of lacritin in the tears. By analyzing the levels of lacritin in tears or tissues, these tests can assist in diagnosing and treating lacrational gland issues.", "label": 0, "is_selected": 0, "text": "Lacrimal glands produce the protein lacritin, which is essential for tears' health. Tears' composition and the lacrimal gland's functional maintenance are both influenced by lacritin. This protein can be obtained by the following methods: 1. Blood Test: Measuring lacritin levels in the blood is one way to determine if a person has a lacrational gland issue. A lacrimal gland disorder can be detected by measuring the levels of lacritin in the blood. 2. Tear Collection: Tears can be collected for lab analysis using a special device called a Schirmer tear test. This test measures the quantity of tears produced and lacritin levels in the tears. 3. Biopsy: A lacrimal gland biopsy can determine if the gland is malfunctioning by examining a tiny sample of the gland under a microscope. This test can assist determine whether the gland is producing too many or too few tears and the amount of lacritin in the tears. By analyzing the levels of lacritin in tears or tissues, these tests can assist in diagnosing and treating lacrational gland issues."}
{"qid": "516d5bc5298dcd4e51000079", "original_text": "Tumor necrosis factor (TNF) is a pro-inflammatory cytokine that can have a profound impact on thyroid hormone receptors. TNF can induce the degradation of thyroid hormone receptors (TRs), leading to a decrease in the number of functional receptors available to bind thyroid hormones. This can result in decreased thyroid hormone sensitivity and a reduction in the expression of genes regulated by thyroid hormones. Additionally, TNF can also inhibit the conversion of thyroid hormones from their inactive form (thyroxine) to their active form (triiodothyronine), further contributing to decreased thyroid hormone levels. Overall, the effects of TNF on thyroid hormone receptors can lead to a range of thyroid-related disorders, including hypothyroidism and hyperthyroidism.", "label": 0, "is_selected": 1, "text": "The effects of rheumatoid arthritis (RA) on thyroid hormone receptors have been well established for a number of years, but the mechanism by which it affects thyroid hormone levels has not been well understood. Overall, the effects onthyroid hormone receptors can lead to a range of thyroid-related disorders, including hypothyroidism and hyperthyroidism."}
{"qid": "54fefff26ad7dcbc1200000b", "original_text": "Internet-based interventions are increasingly used to support self-management of individuals with chronic illnesses. Web-based interventions may also be effective in enhancing self-management for individuals with chronic pain, but little is known about long-term effects. Research on Web-based interventions to support self-management following participation in pain management programs is limited. The aim is to examine the long-term effects of a 4-week smartphone-intervention with diaries and therapist-written feedback following an inpatient chronic pain rehabilitation program, previously found to be effective at short-term and 5-month follow-ups. 140 women with chronic widespread pain, participating in a 4-week inpatient rehabilitation program, were randomized into two groups: with or without a smartphone intervention after the rehabilitation. The smartphone intervention consisted of one face-to-face individual session and 4 weeks of written communication via a smartphone, consisting of three diaries daily to elicit pain-related thoughts, feelings, and activities, as well as daily personalized written feedback based on cognitive behavioral principles from a therapist. Both groups were given access to an informational website to promote constructive self-management. Outcomes were measured with self-reported paper-and-pencil format questionnaires with catastrophizing as the primary outcome measure. Secondary outcomes included daily functioning and symptom levels, acceptance of pain, and emotional distress. By the 11-month follow-up, the favorable between-group differences previously reported post-intervention and at 5-month follow-up on catastrophizing, acceptance, functioning, and symptom level were no longer evident (P>.10). However, there was more improvement in catastrophizing scores during the follow-up period in the intervention group (M=-2.36, SD 8.41) compared to the control group (M=.40, SD 7.20), P=.045. Also, per protocol within-group analysis showed a small positive effect (Cohen's d=.33) on catastrophizing in the intervention group (P=.04) and no change in the control group from the smartphone intervention baseline to 11-month follow-up. A positive effect (Cohen's d=.73) on acceptance was found within the intervention group (P<.001) but not in the control group.", "label": 1, "is_selected": 0, "text": "Internet-based interventions are increasingly used to support self-management of individuals with chronic illnesses. Web-based interventions may also be effective in enhancing self-management for individuals with chronic pain, but little is known about long-term effects. Research on Web-based interventions to support self-management following participation in pain management programs is limited. The aim is to examine the long-term effects of a 4-week smartphone-intervention with diaries and therapist-written feedback following an inpatient chronic pain rehabilitation program, previously found to be effective at short-term and 5-month follow-ups. 140 women with chronic widespread pain, participating in a 4-week inpatient rehabilitation program, were randomized into two groups: with or without a smartphone intervention after the rehabilitation. The smartphone intervention consisted of one face-to-face individual session and 4 weeks of written communication via a smartphone, consisting of three diaries daily to elicit pain-related thoughts, feelings, and activities, as well as daily personalized written feedback based on cognitive behavioral principles from a therapist. Both groups were given access to an informational website to promote constructive self-management. Outcomes were measured with self-reported paper-and-pencil format questionnaires with catastrophizing as the primary outcome measure. Secondary outcomes included daily functioning and symptom levels, acceptance of pain, and emotional distress. By the 11-month follow-up, the favorable between-group differences previously reported post-intervention and at 5-month follow-up on catastrophizing, acceptance, functioning, and symptom level were no longer evident (P>.10). However, there was more improvement in catastrophizing scores during the follow-up period in the intervention group (M=-2.36, SD 8.41) compared to the control group (M=.40, SD 7.20), P=.045. Also, per protocol within-group analysis showed a small positive effect (Cohen's d=.33) on catastrophizing in the intervention group (P=.04) and no change in the control group from the smartphone intervention baseline to 11-month follow-up. A positive effect (Cohen's d=.73) on acceptance was found within the intervention group (P<.001) but not in the control group."}
{"qid": "517818508ed59a060a000035", "original_text": "Rett syndrome (RS) is a severe neurodevelopmental disorder characterised by normal neurological development followed by progressive developmental regression. The X-linked dominant inheritance of RS has been mapped to the gene that encodes the methyl-CpG-binding protein-2 (MECP2) at Xq28. In the present study, denaturing high-performance liquid chromatography (DHPLC) was used to detect mutations in the MECP2 gene in 20 Malaysian RS patients. Polymerase chain reaction (PCR) was carried out to amplify the MECP2 coding exons 2, 3, and 4 in a total of eight reactions (exons 2, 3a, 3b, 4a, 4b, 4c, 4d and 4e). Subsequently, PCR products were analysed by DHPLC.", "label": 1, "is_selected": 0, "text": "Rett syndrome (RS) is a severe neurodevelopmental disorder characterised by normal neurological development followed by progressive developmental regression. The X-linked dominant inheritance of RS has been mapped to the gene that encodes the methyl-CpG-binding protein-2 (MECP2) at Xq28. In the present study, denaturing high-performance liquid chromatography (DHPLC) was used to detect mutations in the MECP2 gene in 20 Malaysian RS patients. Polymerase chain reaction (PCR) was carried out to amplify the MECP2 coding exons 2, 3, and 4 in a total of eight reactions (exons 2, 3a, 3b, 4a, 4b, 4c, 4d and 4e). Subsequently, PCR products were analysed by DHPLC."}
{"qid": "5a805974faa1ab7d2e000020", "original_text": "Four popular somatic single nucleotide variant (SNV) calling methods (Varscan, SomaticSniper, Strelka and MuTect2) were carefully evaluated on the real whole exome sequencing (WES, depth of ~50X) and ultra-deep targeted sequencing (UDT-Seq, depth of ~370X) data. The four tools returned poor consensus on candidates (only 20% of calls were with multiple hits by the callers). For both WES and UDT-Seq, MuTect2 and Strelka obtained the largest proportion of COSMIC entries as well as the lowest rate of dbSNP presence and high-alternative-alleles-in-control calls, demonstrating their superior sensitivity and accuracy. Combining different callers does increase reliability of candidates, but narrows the list down to very limited range of tumor read depth and variant allele frequency. Calling SNV on UDT-Seq data, which were of much higher read-depth, discovered additional true-positive variations, despite an even more tremendous growth in false positive predictions. Our findings not only provide valuable benchmark for state-of-the-art SNV calling methods, but also shed light on the access to more accurate SNV identification in the future.", "label": 1, "is_selected": 0, "text": "Four popular somatic single nucleotide variant (SNV) calling methods (Varscan, SomaticSniper, Strelka and MuTect2) were carefully evaluated on the real whole exome sequencing (WES, depth of ~50X) and ultra-deep targeted sequencing (UDT-Seq, depth of ~370X) data. The four tools returned poor consensus on candidates (only 20% of calls were with multiple hits by the callers). For both WES and UDT-Seq, MuTect2 and Strelka obtained the largest proportion of COSMIC entries as well as the lowest rate of dbSNP presence and high-alternative-alleles-in-control calls, demonstrating their superior sensitivity and accuracy. Combining different callers does increase reliability of candidates, but narrows the list down to very limited range of tumor read depth and variant allele frequency. Calling SNV on UDT-Seq data, which were of much higher read-depth, discovered additional true-positive variations, despite an even more tremendous growth in false positive predictions. Our findings not only provide valuable benchmark for state-of-the-art SNV calling methods, but also shed light on the access to more accurate SNV identification in the future."}
{"qid": "52e7b4a198d023950500001b", "original_text": "Increased or reduced action of thyroid hormone on certain molecular pathways in the heart and vasculature causes relevant cardiovascular derangements. It is well established that hyperthyroidism induces a hyperdynamic cardiovascular state, which is associated with a faster heart rate, enhanced left ventricular systolic and diastolic function whereas hypothyroidism is characterized by the opposite changes. Hyperthyroidism and hypothyroidism represent opposite clinical conditions, albeit not mirror images. Recent experimental and clinical studies have suggested the involvement of ROS tissue damage under altered thyroid status. Altered-thyroid state-linked changes in heart modify their susceptibility to oxidants and the extent of the oxidative damage they suffer following oxidative challenge. Chronic increase in the cellular levels of ROS can lead to a catastrophic cycle of DNA damage, mitochondrial dysfunction, further ROS generation and cellular injury. Thus, these cellular events might play an important role in the development and progression of myocardial remodeling and heart failure in altered thyroid states (hypo- and hyper-thyroidism). The present review aims at elucidating the various signaling pathways mediated via ROS and their modulation under altered thyroid state and the possibility of antioxidant therapy.", "label": 1, "is_selected": 0, "text": "Increased or reduced action of thyroid hormone on certain molecular pathways in the heart and vasculature causes relevant cardiovascular derangements. It is well established that hyperthyroidism induces a hyperdynamic cardiovascular state, which is associated with a faster heart rate, enhanced left ventricular systolic and diastolic function whereas hypothyroidism is characterized by the opposite changes. Hyperthyroidism and hypothyroidism represent opposite clinical conditions, albeit not mirror images. Recent experimental and clinical studies have suggested the involvement of ROS tissue damage under altered thyroid status. Altered-thyroid state-linked changes in heart modify their susceptibility to oxidants and the extent of the oxidative damage they suffer following oxidative challenge. Chronic increase in the cellular levels of ROS can lead to a catastrophic cycle of DNA damage, mitochondrial dysfunction, further ROS generation and cellular injury. Thus, these cellular events might play an important role in the development and progression of myocardial remodeling and heart failure in altered thyroid states (hypo- and hyper-thyroidism). The present review aims at elucidating the various signaling pathways mediated via ROS and their modulation under altered thyroid state and the possibility of antioxidant therapy."}
{"qid": "515de127298dcd4e51000020", "original_text": "Treatment of childhood uveitis associated with juvenile idiopathic arthritis (JIA) is a challenge for both, ophthalmologists and pediatricians. In this study, we use the tools of evidence based medicine (EBM) to analyse studies concerning disease-modifying antirheumatic drugs (DMARD)/ immunosuppressive drugs and tumor necrosis factor alpha (TNFalpha) blocking agents. Most experience among DMARD's/ immunosuppressive drugs has been obtained with methotrexate (MTX) in juvenile idiopathic arthritis. However, controlled studies in uveitis are still missing, so that treatment with MTX and all other immunosuppressive drugs (ciclosporine A, azathioprine, mycophenolate mofetil) only reaches an evidence level III (expert opinion, clinical experience or descriptive study). Studies on TNFalpha-blocking agents reach an evidence level II-III, depending on the substance. In future, MTX will have to be examined in comparison to the new biological substance classes (e.g., tumor necrosis factor-alpha-blockers) for the treatment of uveitis in juvenile idiopathic arthritis. Controlled studies which have led to the approval of drugs for JIA are needed for uveitis in order to have the most effective and safe therapy for children with uveitis, who do not respond to conventional therapy with local and systemic steroids.", "label": 1, "is_selected": 0, "text": "Treatment of childhood uveitis associated with juvenile idiopathic arthritis (JIA) is a challenge for both, ophthalmologists and pediatricians. In this study, we use the tools of evidence based medicine (EBM) to analyse studies concerning disease-modifying antirheumatic drugs (DMARD)/ immunosuppressive drugs and tumor necrosis factor alpha (TNFalpha) blocking agents. Most experience among DMARD's/ immunosuppressive drugs has been obtained with methotrexate (MTX) in juvenile idiopathic arthritis. However, controlled studies in uveitis are still missing, so that treatment with MTX and all other immunosuppressive drugs (ciclosporine A, azathioprine, mycophenolate mofetil) only reaches an evidence level III (expert opinion, clinical experience or descriptive study). Studies on TNFalpha-blocking agents reach an evidence level II-III, depending on the substance. In future, MTX will have to be examined in comparison to the new biological substance classes (e.g., tumor necrosis factor-alpha-blockers) for the treatment of uveitis in juvenile idiopathic arthritis. Controlled studies which have led to the approval of drugs for JIA are needed for uveitis in order to have the most effective and safe therapy for children with uveitis, who do not respond to conventional therapy with local and systemic steroids."}
{"qid": "530cf22aa177c6630c000005", "original_text": "Eukaryotic cells contain multiple versions of the E3 ubiquitin ligase known as the SCF (Skp1/cullin/F box), each of which is distinguished by a different F box protein that uses a domain at the carboxyl terminus to recognize substrates [1, 2]. The F box protein Dia2 is an important determinant of genome stability in budding yeast [3-5], but its mode of action is poorly understood. Here we show that SCF(Dia2) associates with the replisome progression complex (RPC) that assembles around the MCM2-7 helicase at DNA replication forks [6]. This interaction requires the RPC components Mrc1 and Ctf4, both of which associate with a tetratricopeptide repeat (TPR) domain located at the amino terminus of Dia2.", "label": 1, "is_selected": 0, "text": "Eukaryotic cells contain multiple versions of the E3 ubiquitin ligase known as the SCF (Skp1/cullin/F box), each of which is distinguished by a different F box protein that uses a domain at the carboxyl terminus to recognize substrates [1, 2]. The F box protein Dia2 is an important determinant of genome stability in budding yeast [3-5], but its mode of action is poorly understood. Here we show that SCF(Dia2) associates with the replisome progression complex (RPC) that assembles around the MCM2-7 helicase at DNA replication forks [6]. This interaction requires the RPC components Mrc1 and Ctf4, both of which associate with a tetratricopeptide repeat (TPR) domain located at the amino terminus of Dia2."}
{"qid": "6033f5541cb411341a00014c", "original_text": "Phosphoenolpyruvate carboxykinase (PEPCK) is a metabolic enzyme in the gluconeogenesis pathway, where it catalyzes the reversible conversion of oxaloacetate (OAA) to phosphoenolpyruvate (PEP) and CO2. The substrates for Escherichia coli PEPCK are OAA and MgATP, with Mn2+ acting as a cofactor. Analysis of PEPCK structures have revealed amino acid residues involved in substrate/cofactor coordination during catalysis. Key residues involved in coordinating the different substrates and cofactor bound to E. coli PEPCK were mutated. Purified mutant enzymes were used for kinetic assays. The structure of some mutant enzymes were determined using X-ray crystallography. Mutation of residues D269 and H232, which comprise part of the coordination sphere of Mn2+, reduced kcat by 14-fold, and significantly increased the Km values for Mn2+ and OAA. Mutation of K254 a key residue in the P-loop motif that interacts with MgATP, significantly elevated the Km value for MgATP and reduced kcat. R65 and R333 are key residues that interacts with OAA. The R65Q and R333Q mutations significantly increased the Km value for OAA and reduced kcat respectively. Our results show that mutation of residues involved in coordinating OAA, MgATP and Mn2+ significantly reduce PEPCK activity.", "label": 1, "is_selected": 0, "text": "Phosphoenolpyruvate carboxykinase (PEPCK) is a metabolic enzyme in the gluconeogenesis pathway, where it catalyzes the reversible conversion of oxaloacetate (OAA) to phosphoenolpyruvate (PEP) and CO2. The substrates for Escherichia coli PEPCK are OAA and MgATP, with Mn2+ acting as a cofactor. Analysis of PEPCK structures have revealed amino acid residues involved in substrate/cofactor coordination during catalysis. Key residues involved in coordinating the different substrates and cofactor bound to E. coli PEPCK were mutated. Purified mutant enzymes were used for kinetic assays. The structure of some mutant enzymes were determined using X-ray crystallography. Mutation of residues D269 and H232, which comprise part of the coordination sphere of Mn2+, reduced kcat by 14-fold, and significantly increased the Km values for Mn2+ and OAA. Mutation of K254 a key residue in the P-loop motif that interacts with MgATP, significantly elevated the Km value for MgATP and reduced kcat. R65 and R333 are key residues that interacts with OAA. The R65Q and R333Q mutations significantly increased the Km value for OAA and reduced kcat respectively. Our results show that mutation of residues involved in coordinating OAA, MgATP and Mn2+ significantly reduce PEPCK activity."}
{"qid": "5a893da7bc7bade53a000001", "original_text": "CREB is an ubiquitous transcription factor regulating diverse cellular responses. Its phosphorylation at S133 is an essential event for its activation in both nervous and visual systems. The activated CREB is implicated in the regulation of development, protection, learning, memory and plasticity in the nerve system. Moreover, sumoylation, an important post-translational modification of protein, plays a key role in sustaining CREB activation in the rat hippocampus in order to enhance the long-term memory and other aspects. In the visual system, although the CREB activation by phosphorylation at S133 is similar to that as observed in the nervous system, the role of CREB sumoylation remains to be explored. This review will discuss the aspects of CREB functions and their regulation by phosphorylation and sumoylation in both systems.", "label": 1, "is_selected": 0, "text": "CREB is an ubiquitous transcription factor regulating diverse cellular responses. Its phosphorylation at S133 is an essential event for its activation in both nervous and visual systems. The activated CREB is implicated in the regulation of development, protection, learning, memory and plasticity in the nerve system. Moreover, sumoylation, an important post-translational modification of protein, plays a key role in sustaining CREB activation in the rat hippocampus in order to enhance the long-term memory and other aspects. In the visual system, although the CREB activation by phosphorylation at S133 is similar to that as observed in the nervous system, the role of CREB sumoylation remains to be explored. This review will discuss the aspects of CREB functions and their regulation by phosphorylation and sumoylation in both systems."}
{"qid": "5c783236d774d04240000001", "original_text": "Glycine, proline, and hydroxyproline (Hyp) contribute to 57% of total amino acids (AAs) in collagen, which accounts for one-third of proteins in animals. As the most abundant protein in the body, collagen is essential to maintain the normal structure and strength of connective tissue, such as bones, skin, cartilage, and blood vessels. Mammals, birds, and fish can synthesize: (1) glycine from threonine, serine, choline, and Hyp; (2) proline from arginine; and (3) Hyp from proline residues in collagen, in a cell- and tissue-specific manner.", "label": 1, "is_selected": 0, "text": "Glycine, proline, and hydroxyproline (Hyp) contribute to 57% of total amino acids (AAs) in collagen, which accounts for one-third of proteins in animals. As the most abundant protein in the body, collagen is essential to maintain the normal structure and strength of connective tissue, such as bones, skin, cartilage, and blood vessels. Mammals, birds, and fish can synthesize: (1) glycine from threonine, serine, choline, and Hyp; (2) proline from arginine; and (3) Hyp from proline residues in collagen, in a cell- and tissue-specific manner."}
{"qid": "5c54600207647bbc4b000004", "original_text": "DiseaseEnhancer is a relatively new term in the medical field that refers to a genetic variant that increases the risk of developing a specific disease. It can be thought of as a \"risk factor\" that enhances the likelihood of an individual developing a particular disease, such as a genetic mutation or variation that increases the risk of developing cancer. The term DiseaseEnhancer was coined to distinguish these genetic variants from traditional risk factors, such as smoking or obesity, which can also increase the risk of developing certain diseases.", "label": 0, "is_selected": 1, "text": "A new study has found that people who have a genetic variant that increases their risk of developing certain diseases, such as breast cancer, are more likely to live longer than those who have no such risk factor at all, despite having the same family history of the disease."}
{"qid": "58ca5cba02b8c6095300002b", "original_text": "Primary intestinal lymphangiectasia (PIL) is a rare disorder characterized by dilated intestinal lacteals resulting in lymph leakage into the small bowel lumen and responsible for protein-losing enteropathy leading to lymphopenia, hypoalbuminemia and hypogammaglobulinemia. PIL is generally diagnosed before 3 years of age but may be diagnosed in older patients. Prevalence is unknown. The main symptom is predominantly bilateral lower limb edema. Edema may be moderate to severe with anasarca and includes pleural effusion, pericarditis or chylous ascites.", "label": 1, "is_selected": 0, "text": "Primary intestinal lymphangiectasia (PIL) is a rare disorder characterized by dilated intestinal lacteals resulting in lymph leakage into the small bowel lumen and responsible for protein-losing enteropathy leading to lymphopenia, hypoalbuminemia and hypogammaglobulinemia. PIL is generally diagnosed before 3 years of age but may be diagnosed in older patients. Prevalence is unknown. The main symptom is predominantly bilateral lower limb edema. Edema may be moderate to severe with anasarca and includes pleural effusion, pericarditis or chylous ascites."}
{"qid": "6026ef9d1cb411341a0000d5", "original_text": "Eptinezumab received its first FDA approval in March 2019 for the treatment of chronic migraines.", "label": 0, "is_selected": 0, "text": "Eptinezumab received its first FDA approval in March 2019 for the treatment of chronic migraines."}
{"qid": "5a86bf2efaa1ab7d2e000033", "original_text": "The auxin-inducible degron (AID) system is a plant-specific degradation platform that allows for the regulated degradation of target proteins in response to auxin signaling. Auxin binds to the degron protein, which is flanked by two auxin-responsive elements (AREs), leading to the recruitment of the E3 ubiquitin ligase complex, which ubiquitinates and degrades the target protein. This mechanism provides a precise and reversible way to regulate protein levels in response to hormonal cues, allowing plants to adapt to changing environmental conditions.", "label": 0, "is_selected": 1, "text": "We have developed an auxin-inducible degron system that can be used to regulate plant protein levels in response to environmental cues such as auxin signaling, or to control the expression of genes involved in the regulation of plant growth and development, such as glucagon-like peptide-1 (GLP-1) receptors."}
{"qid": "6278df3c56bf9aee6f000015", "original_text": "There are several models used for predicting disease progression in Duchenne Muscular Dystrophy (DMD), a severe genetic disorder that affects muscle strength and function. These models take into account various factors, including genetic mutations, clinical measurements, and imaging techniques. 1. The Myotonic Dystrophy Progression Score (MDPS) is a widely used model that predicts disease progression based on clinical and imaging markers, such as the level of muscle weakness and the size of the muscles. 2. The Muscle Score (MS) is a model that evaluates muscle strength and function, using a combination of manual muscle testing and magnetic resonance imaging (MRI). 3. The DMD-MRI Score (DMD-MRI) is a model that uses MRI to assess muscle volume and fat infiltration, which can predict disease progression. 4. The Functional Muscle Clinical Scale (FMC-S) is a model that evaluates muscle function based on clinical assessments, such as gait speed and muscle strength. 5. The DMD-Clinical Score (DMD-CS) is a model that combines clinical and imaging measures to predict disease progression. It is important to note that no single model can accurately predict disease progression in all individuals with DMD, and the choice of model may depend on the specific needs and characteristics of each patient.", "label": 0, "is_selected": 0, "text": "There are several models used for predicting disease progression in Duchenne Muscular Dystrophy (DMD), a severe genetic disorder that affects muscle strength and function. These models take into account various factors, including genetic mutations, clinical measurements, and imaging techniques. 1. The Myotonic Dystrophy Progression Score (MDPS) is a widely used model that predicts disease progression based on clinical and imaging markers, such as the level of muscle weakness and the size of the muscles. 2. The Muscle Score (MS) is a model that evaluates muscle strength and function, using a combination of manual muscle testing and magnetic resonance imaging (MRI). 3. The DMD-MRI Score (DMD-MRI) is a model that uses MRI to assess muscle volume and fat infiltration, which can predict disease progression. 4. The Functional Muscle Clinical Scale (FMC-S) is a model that evaluates muscle function based on clinical assessments, such as gait speed and muscle strength. 5. The DMD-Clinical Score (DMD-CS) is a model that combines clinical and imaging measures to predict disease progression. It is important to note that no single model can accurately predict disease progression in all individuals with DMD, and the choice of model may depend on the specific needs and characteristics of each patient."}
{"qid": "5c5f08ad1a4c55d80b00000b", "original_text": "An Aquaporin channel is a type of transmembrane protein found in the plasma membrane of various cells, including water-permeable cells such as kidney collecting duct epithelial cells. Aquaporins are responsible for the efficient and selective diffusion of water across the plasma membrane, allowing for the reabsorption of water from the filtrate in the kidney. These channels are also involved in the regulation of ion and solute transport across the membrane. There are three subtypes of Aquaporin channels (AQP1-3) found in different tissues, each with distinct functional properties.", "label": 0, "is_selected": 0, "text": "An Aquaporin channel is a type of transmembrane protein found in the plasma membrane of various cells, including water-permeable cells such as kidney collecting duct epithelial cells. Aquaporins are responsible for the efficient and selective diffusion of water across the plasma membrane, allowing for the reabsorption of water from the filtrate in the kidney. These channels are also involved in the regulation of ion and solute transport across the membrane. There are three subtypes of Aquaporin channels (AQP1-3) found in different tissues, each with distinct functional properties."}
{"qid": "5505ad7ff73303d458000007", "original_text": "Under conditions of nutrient shortage autophagy is the primary cellular mechanism ensuring availability of substrates for continuous biosynthesis. Subjecting cells to starvation or rapamycin efficiently induces autophagy by inhibiting the MTOR signaling pathway triggering increased autophagic flux. To elucidate the regulation of early signaling events upon autophagy induction, we applied quantitative phosphoproteomics characterizing the temporal phosphorylation dynamics after starvation and rapamycin treatment. We obtained a comprehensive atlas of phosphorylation kinetics within the first 30 min upon induction of autophagy with both treatments affecting widely different cellular processes. The identification of dynamic phosphorylation already after 2 min demonstrates that the earliest events in autophagy signaling occur rapidly after induction.", "label": 1, "is_selected": 0, "text": "Under conditions of nutrient shortage autophagy is the primary cellular mechanism ensuring availability of substrates for continuous biosynthesis. Subjecting cells to starvation or rapamycin efficiently induces autophagy by inhibiting the MTOR signaling pathway triggering increased autophagic flux. To elucidate the regulation of early signaling events upon autophagy induction, we applied quantitative phosphoproteomics characterizing the temporal phosphorylation dynamics after starvation and rapamycin treatment. We obtained a comprehensive atlas of phosphorylation kinetics within the first 30 min upon induction of autophagy with both treatments affecting widely different cellular processes. The identification of dynamic phosphorylation already after 2 min demonstrates that the earliest events in autophagy signaling occur rapidly after induction."}
{"qid": "6217d8f03a8413c653000021", "original_text": "O-glycosylation is a highly diverse and complex form of protein post-translational modification. Mucin-type O-glycosylation is initiated by the transfer of N-acetyl-galactosamine (GalNAc) to the hydroxyl group of serine, threonine and tyrosine residues through catalysis by a family of glycosyltransferases, the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases (E.C. 2.4.1.41) that are conserved across metazoans. In the last decade, structural characterization of glycosylation has substantially advanced due to the development of analytical methods and advances in mass spectrometry. However, O-glycosite mapping remains challenging since mucin-type O-glycans are densely packed, often protecting proteins from cleavage by proteases. Adding to the complexity is the fact that a given glycosite can be modified by different glycans, resulting in an array of glycoforms rising from one glycosite.", "label": 1, "is_selected": 0, "text": "O-glycosylation is a highly diverse and complex form of protein post-translational modification. Mucin-type O-glycosylation is initiated by the transfer of N-acetyl-galactosamine (GalNAc) to the hydroxyl group of serine, threonine and tyrosine residues through catalysis by a family of glycosyltransferases, the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases (E.C. 2.4.1.41) that are conserved across metazoans. In the last decade, structural characterization of glycosylation has substantially advanced due to the development of analytical methods and advances in mass spectrometry. However, O-glycosite mapping remains challenging since mucin-type O-glycans are densely packed, often protecting proteins from cleavage by proteases. Adding to the complexity is the fact that a given glycosite can be modified by different glycans, resulting in an array of glycoforms rising from one glycosite."}
{"qid": "603e43d51cb411341a00015e", "original_text": "Yes, Ixodes is a genus of ticks that includes several species, such as Ixodes scapularis (blacklegged tick), Ixodes pacificus (west coast tick), and Ixodes ricinus (brown dog tick). These ticks are commonly found in North America, Europe, and Asia, and are known to transmit various diseases to humans and animals, including Lyme disease, anaplasmosis, babesiosis, and ehrlichiosis. Ixodes ticks are typically found in wooded areas with long grass and leaf litter, and can attach to a variety of hosts, including humans, dogs, and wildlife.", "label": 0, "is_selected": 0, "text": "Yes, Ixodes is a genus of ticks that includes several species, such as Ixodes scapularis (blacklegged tick), Ixodes pacificus (west coast tick), and Ixodes ricinus (brown dog tick). These ticks are commonly found in North America, Europe, and Asia, and are known to transmit various diseases to humans and animals, including Lyme disease, anaplasmosis, babesiosis, and ehrlichiosis. Ixodes ticks are typically found in wooded areas with long grass and leaf litter, and can attach to a variety of hosts, including humans, dogs, and wildlife."}
{"qid": "5c5f29a81a4c55d80b00001f", "original_text": "Truvada is getting a new lease on life as a preventive agent. It is the only drug approved to prevent HIV infections, and Truvada is the key pharmaceutical component of pre-exposure prophylaxis, which is aimed at preventing, rather than treating, HIV infection and transmission.", "label": 1, "is_selected": 0, "text": "Truvada is getting a new lease on life as a preventive agent. It is the only drug approved to prevent HIV infections, and Truvada is the key pharmaceutical component of pre-exposure prophylaxis, which is aimed at preventing, rather than treating, HIV infection and transmission."}
{"qid": "51bdb644047fa84d1d000001", "original_text": "Resident integral proteins of the inner nuclear membrane (INM) are synthesized as membrane-integrated proteins on the peripheral endoplasmic reticulum (ER) and are transported to the INM throughout interphase using an unknown trafficking mechanism. To study this transport, we developed a live cell assay that measures the movement of transmembrane reporters from the ER to the INM by rapamycin-mediated trapping at the nuclear lamina.", "label": 1, "is_selected": 0, "text": "Resident integral proteins of the inner nuclear membrane (INM) are synthesized as membrane-integrated proteins on the peripheral endoplasmic reticulum (ER) and are transported to the INM throughout interphase using an unknown trafficking mechanism. To study this transport, we developed a live cell assay that measures the movement of transmembrane reporters from the ER to the INM by rapamycin-mediated trapping at the nuclear lamina."}
{"qid": "56c1f031ef6e39474100004e", "original_text": "In this review we assess our currently available knowledge about reflex seizures with special emphasis on the difference between \"generalized\" reflex seizures induced by visual stimuli, thinking, praxis and language tasks, and \"focal\" seizures induced by startle, eating, music, hot water, somatosensory stimuli and orgasm. We discuss in particular evidence from animal, clinical, neurophysiological and neuroimaging studies supporting the concept that \"generalized\" reflex seizures, usually occurring in the setting of IGE, should be considered as focal seizures with quick secondary generalization.", "label": 1, "is_selected": 0, "text": "In this review we assess our currently available knowledge about reflex seizures with special emphasis on the difference between \"generalized\" reflex seizures induced by visual stimuli, thinking, praxis and language tasks, and \"focal\" seizures induced by startle, eating, music, hot water, somatosensory stimuli and orgasm. We discuss in particular evidence from animal, clinical, neurophysiological and neuroimaging studies supporting the concept that \"generalized\" reflex seizures, usually occurring in the setting of IGE, should be considered as focal seizures with quick secondary generalization."}
{"qid": "52bf1d3c03868f1b0600000d", "original_text": "Muenke syndrome, also known as distal osteochondrodysplasia type 2, is a rare genetic disorder that affects the development of the long bones of the extremities, especially the legs. The symptoms of Muenke syndrome can vary in severity and may include: * Short stature * Delayed growth and development * Bowed legs (knees that are more inward than usual) * Wide, shallow clavicles * Limited mobility in the joints, particularly in the elbows and hips * Curvature of the spine (scoliosis) * Wrist and neck flexion * Limited range of motion in the hands and feet * Distinctive face features, such as a flat nose, widely spaced eyes, and a small lower jaw It is important to note that not all individuals with Muenke syndrome will exhibit all of these symptoms, and the severity of the condition can vary widely. If you suspect that you or someone you know may have Muenke syndrome, it is essential to consult with a medical professional for proper diagnosis and treatment.", "label": 0, "is_selected": 0, "text": "Muenke syndrome, also known as distal osteochondrodysplasia type 2, is a rare genetic disorder that affects the development of the long bones of the extremities, especially the legs. The symptoms of Muenke syndrome can vary in severity and may include: * Short stature * Delayed growth and development * Bowed legs (knees that are more inward than usual) * Wide, shallow clavicles * Limited mobility in the joints, particularly in the elbows and hips * Curvature of the spine (scoliosis) * Wrist and neck flexion * Limited range of motion in the hands and feet * Distinctive face features, such as a flat nose, widely spaced eyes, and a small lower jaw It is important to note that not all individuals with Muenke syndrome will exhibit all of these symptoms, and the severity of the condition can vary widely. If you suspect that you or someone you know may have Muenke syndrome, it is essential to consult with a medical professional for proper diagnosis and treatment."}
{"qid": "58965a4178275d0c4a00000e", "original_text": "Yes, there is evidence to suggest that L1 retrotransposition may play a role in the development of Rett syndrome, a rare genetic disorder affecting primarily females. L1 is a retrotransposon, a type of mobile genetic element that can insert itself into new locations within the genome, and mutations in the L1 gene have been identified in individuals with Rett syndrome. These mutations can lead to the overexpression of the L1 protein, which may disrupt normal cellular processes and contribute to the development of the syndrome's characteristic symptoms, such as intellectual disability, seizures, and motor difficulties. However, the exact mechanisms by which L1 retrotransposition contributes to Rett syndrome are not yet fully understood and are the subject of ongoing research.", "label": 0, "is_selected": 0, "text": "Yes, there is evidence to suggest that L1 retrotransposition may play a role in the development of Rett syndrome, a rare genetic disorder affecting primarily females. L1 is a retrotransposon, a type of mobile genetic element that can insert itself into new locations within the genome, and mutations in the L1 gene have been identified in individuals with Rett syndrome. These mutations can lead to the overexpression of the L1 protein, which may disrupt normal cellular processes and contribute to the development of the syndrome's characteristic symptoms, such as intellectual disability, seizures, and motor difficulties. However, the exact mechanisms by which L1 retrotransposition contributes to Rett syndrome are not yet fully understood and are the subject of ongoing research."}
{"qid": "53372b66d6d3ac6a34000057", "original_text": "During the late stage of adenovirus 2 infection, RNA chains are initiated at a site near coordinate 16 (Evans et al., 1977) and transcribed approximately 30,000 nucleotides to the far end of the genome at coordinate 100. Late mRNAs processed from these transcripts contain a common spliced tripartite leader (Berget, Moore and Sharp, 1977; Chow et al., 1977a) encoded at approximately 16, 20 and 27, and protein coding sequences which map downstream. This report maps the late promoter and the capped 5' end of nuclear and cytoplasmic RNAs from this transciption unit, and analyzes their structures. We show that nascent RNA chains pulse-labeled in vivo are initiated at coordinate 16.5 +/- 0.5 and contain the sequences intervening between the leader segments. We map the capped 5' terminus of late nuclear transcripts at a site between 16.4 and 16.6 by aligning T1 RNAase oligonucleotides from nuclear RNA with the DNA sequence of the promoter region.", "label": 1, "is_selected": 0, "text": "During the late stage of adenovirus 2 infection, RNA chains are initiated at a site near coordinate 16 (Evans et al., 1977) and transcribed approximately 30,000 nucleotides to the far end of the genome at coordinate 100. Late mRNAs processed from these transcripts contain a common spliced tripartite leader (Berget, Moore and Sharp, 1977; Chow et al., 1977a) encoded at approximately 16, 20 and 27, and protein coding sequences which map downstream. This report maps the late promoter and the capped 5' end of nuclear and cytoplasmic RNAs from this transciption unit, and analyzes their structures. We show that nascent RNA chains pulse-labeled in vivo are initiated at coordinate 16.5 +/- 0.5 and contain the sequences intervening between the leader segments. We map the capped 5' terminus of late nuclear transcripts at a site between 16.4 and 16.6 by aligning T1 RNAase oligonucleotides from nuclear RNA with the DNA sequence of the promoter region."}
{"qid": "57090c33cf1c325851000013", "original_text": "Genomic imprinting is a mechanism by which only one copy of a gene pair is expressed, and this expression is determined by the parental origin of the copy. The deregulation of imprinted genes has been implicated in a number of human diseases. The Imprinted Gene Catalogue now has more than 200 genes listed, and estimates based on mouse models suggest many more may exist in humans. Therefore, the development of methods to identify such genes is important. In this communication, we present a parametric model-based approach to analyzing arbitrary-sized pedigree data for genomic imprinting.", "label": 1, "is_selected": 0, "text": "Genomic imprinting is a mechanism by which only one copy of a gene pair is expressed, and this expression is determined by the parental origin of the copy. The deregulation of imprinted genes has been implicated in a number of human diseases. The Imprinted Gene Catalogue now has more than 200 genes listed, and estimates based on mouse models suggest many more may exist in humans. Therefore, the development of methods to identify such genes is important. In this communication, we present a parametric model-based approach to analyzing arbitrary-sized pedigree data for genomic imprinting."}
{"qid": "620be7613a8413c653000003", "original_text": "SDE2 (Steroidogenic Factor 1 Enhancer 2) is a transcription factor that plays a crucial role in the regulation of steroid hormone biosynthesis, particularly in the adrenal cortex. SDE2 regulates the expression of the CYP11A1 gene, which is responsible for the conversion of cholesterol to cortisol, a major steroid hormone in the body. Additionally, SDE2 also regulates the expression of other genes involved in steroid hormone biosynthesis, such as CYP21A2 and CYP17A1. By modulating the expression of these genes, SDE2 plays a critical role in maintaining the balance of steroid hormones in the body.", "label": 0, "is_selected": 0, "text": "SDE2 (Steroidogenic Factor 1 Enhancer 2) is a transcription factor that plays a crucial role in the regulation of steroid hormone biosynthesis, particularly in the adrenal cortex. SDE2 regulates the expression of the CYP11A1 gene, which is responsible for the conversion of cholesterol to cortisol, a major steroid hormone in the body. Additionally, SDE2 also regulates the expression of other genes involved in steroid hormone biosynthesis, such as CYP21A2 and CYP17A1. By modulating the expression of these genes, SDE2 plays a critical role in maintaining the balance of steroid hormones in the body."}
{"qid": "516c0ed3298dcd4e5100006f", "original_text": "Mice expressing the mutant thyroid hormone receptor TRalpha1R384C, which has a 10-fold reduced affinity to the ligand T(3), exhibit hypermetabolism due to an overactivation of the sympathetic nervous system. To define the consequences in the liver, we analyzed hepatic metabolism and the regulation of liver genes in the mutant mice. Our results showed that hepatic phosphoenolpyruvate-carboxykinase was up-regulated and pyruvate kinase mRNA down-regulated, contrary to what observed after T(3) treatment. In contrast, mice expressing a mutant TRalpha1L400R specifically in the liver did not show a dysregulation of these genes; however, when the TRalpha1L400R was expressed ubiquitously, the hepatic phenotype differed from TRalpha1R384C animals, suggesting that the localization of the mutation plays an important role for its consequences on glucose metabolism. Furthermore, we observed that glycogen stores were completely depleted in TRalpha1R384C animals, despite increased gluconeogenesis and decreased glycolysis. Exposure of the mutant mice to high maternal levels of thyroid hormone during fetal development leads to a normal liver phenotype in the adult. Our results show how genetic and maternal factors interact to determine the metabolic setpoint of the offspring and indicate an important role for maternal thyroid hormone in the susceptibility to metabolic disorders in adulthood.", "label": 1, "is_selected": 0, "text": "Mice expressing the mutant thyroid hormone receptor TRalpha1R384C, which has a 10-fold reduced affinity to the ligand T(3), exhibit hypermetabolism due to an overactivation of the sympathetic nervous system. To define the consequences in the liver, we analyzed hepatic metabolism and the regulation of liver genes in the mutant mice. Our results showed that hepatic phosphoenolpyruvate-carboxykinase was up-regulated and pyruvate kinase mRNA down-regulated, contrary to what observed after T(3) treatment. In contrast, mice expressing a mutant TRalpha1L400R specifically in the liver did not show a dysregulation of these genes; however, when the TRalpha1L400R was expressed ubiquitously, the hepatic phenotype differed from TRalpha1R384C animals, suggesting that the localization of the mutation plays an important role for its consequences on glucose metabolism. Furthermore, we observed that glycogen stores were completely depleted in TRalpha1R384C animals, despite increased gluconeogenesis and decreased glycolysis. Exposure of the mutant mice to high maternal levels of thyroid hormone during fetal development leads to a normal liver phenotype in the adult. Our results show how genetic and maternal factors interact to determine the metabolic setpoint of the offspring and indicate an important role for maternal thyroid hormone in the susceptibility to metabolic disorders in adulthood."}
{"qid": "5314ad66dae131f847000004", "original_text": "Basic studies have proven that cranberries may prevent urinary tract infections through changing the adhesiveness of Escherichia coli (E. coli) to urothelial cells. Various cranberry preparations, including extract powder, capsules, and juice, have been shown to be effective in clinical and epidemiological research. Because cranberries are most commonly consumed as juice in a diluted concentration, the aim of this study was to investigate whether the equivalent daily dose of cranberry juice is sufficient to modify host urine to change the uropathogenicity of E. coli.", "label": 1, "is_selected": 0, "text": "Basic studies have proven that cranberries may prevent urinary tract infections through changing the adhesiveness of Escherichia coli (E. coli) to urothelial cells. Various cranberry preparations, including extract powder, capsules, and juice, have been shown to be effective in clinical and epidemiological research. Because cranberries are most commonly consumed as juice in a diluted concentration, the aim of this study was to investigate whether the equivalent daily dose of cranberry juice is sufficient to modify host urine to change the uropathogenicity of E. coli."}
{"qid": "5a7247182dc08e987e000010", "original_text": "Sphingosine 1-phosphate receptor (S1PR) modulators possess a unique mechanism of action in the treatment of multiple sclerosis (MS). Subtype 1 of the S1PR is expressed on the surface of lymphocytes and is important in regulating egression from lymph nodes. The S1PR modulators indirectly antagonize the receptor's function leading to sequestration of lymphocytes in the lymph nodes. Fingolimod was the first S1PR modulator to receive regulatory approval for relapsing-remitting MS after 2 phase III trials demonstrated potent efficacy, safety, and tolerability. Fingolimod can cause undesirable effects as a result of its interaction with other S1PR subtypes, which are expressed in diverse tissues, including cardiac myocytes.", "label": 1, "is_selected": 0, "text": "Sphingosine 1-phosphate receptor (S1PR) modulators possess a unique mechanism of action in the treatment of multiple sclerosis (MS). Subtype 1 of the S1PR is expressed on the surface of lymphocytes and is important in regulating egression from lymph nodes. The S1PR modulators indirectly antagonize the receptor's function leading to sequestration of lymphocytes in the lymph nodes. Fingolimod was the first S1PR modulator to receive regulatory approval for relapsing-remitting MS after 2 phase III trials demonstrated potent efficacy, safety, and tolerability. Fingolimod can cause undesirable effects as a result of its interaction with other S1PR subtypes, which are expressed in diverse tissues, including cardiac myocytes."}
{"qid": "601eaac81cb411341a000051", "original_text": "In carpal tunnel syndrome, the median nerve is affected. The median nerve is located in the wrist and runs from the forearm into the hand through a narrow passageway called the carpal tunnel. When the tunnel becomes compressed or pinched, the median nerve can become damaged, leading to symptoms such as numbness, tingling, and pain in the hand and fingers. The median nerve provides sensation to the palmar surface of the thumb, index finger, and long fingers, as well as motor function to the muscles at the base of the thumb. Compression of the median nerve can cause weakness or paralysis of these muscles, leading to difficulty gripping or holding objects. Treatment for carpal tunnel syndrome typically involves physical therapy, medication, or surgery to relieve pressure on the median nerve and restore function to the affected hand.", "label": 0, "is_selected": 1, "text": "Tunnel syndrome is a medical condition that causes numbness or tingling in the hand or fingers due to damage to a nerve in the wrist or forearm. Treatment for tunnel syndrome typically involves physical therapy, medication, or surgery to relieve pressure on the median nerve restore function to the affected hand and fingers.. and tunnel syndrome may be treated with a combination of physical therapy and medication."}
{"qid": "515870cdd24251bc0500008f", "original_text": "A total of 104 carbapenemase (serine- and metallo-beta-lactamase [MbetaL])-producing strains of the Enterobacteriaceae family collected from 2000 to 2005 in medical centers distributed worldwide were tested against tigecycline and 25 comparators by reference broth microdilution methods. The most frequent carbapenemase was KPC-2 or -3 (73 strains), followed by VIM-1 (14), IMP-1 (11), SME-2 (5), and NMC-A (1).", "label": 1, "is_selected": 0, "text": "A total of 104 carbapenemase (serine- and metallo-beta-lactamase [MbetaL])-producing strains of the Enterobacteriaceae family collected from 2000 to 2005 in medical centers distributed worldwide were tested against tigecycline and 25 comparators by reference broth microdilution methods. The most frequent carbapenemase was KPC-2 or -3 (73 strains), followed by VIM-1 (14), IMP-1 (11), SME-2 (5), and NMC-A (1)."}
{"qid": "58c0825502b8c6095300001b", "original_text": "Yes, T-cells have been shown to play a role in regulating neuropathic pain. Neuropathic pain is a chronic type of pain that results from damage or injury to the nervous system, and it is often difficult to treat. Studies have found that T-cells, specifically T-cells that produce cytokines such as interleukin-1\u03b2 (IL-1\u03b2) and tumor necrosis factor-alpha (TNF-\u03b1), are involved in the transmission and maintenance of neuropathic pain. These cytokines can activate nociceptive neurons, leading to the sensation of pain, and can also promote the growth and survival of nociceptive neurons. Additionally, T-cells can also modulate the activity of other immune cells, such as microglia and astrocytes, which are also involved in the regulation of neuropathic pain. Therefore, targeting T-cells or their cytokines may be a promising approach for the treatment of neuropathic pain.", "label": 0, "is_selected": 1, "text": "Can T-cells play a role in the treatment of neuropathic pain, such as post-traumatic stress disorder (PTSD) and spinal cord injury (SCI) and pain in the hands and feet?... and could they be used to treat other conditions as well, like rheumatoid arthritis (RA) and multiple sclerosis (MS)?"}
{"qid": "56e45bc651531f7e33000018", "original_text": "The circadian clock, an internal time-keeping system, has been linked with control of aging, but molecular mechanisms of regulation are not known. BMAL1 is a transcriptional factor and core component of the circadian clock; BMAL1 deficiency is associated with premature aging and reduced lifespan. Here we report that activity of mammalian Target of Rapamycin Complex 1 (mTORC1) is increased upon BMAL1 deficiency both in vivo and in cell culture. Increased mTOR signaling is associated with accelerated aging; in accordance with that, treatment with the mTORC1 inhibitor rapamycin increased lifespan of Bmal1-/- mice by 50%. Our data suggest that BMAL1 is a negative regulator of mTORC1 signaling. We propose that the circadian clock controls the activity of the mTOR pathway through BMAL1-dependent mechanisms and this regulation is important for control of aging and metabolism.", "label": 1, "is_selected": 0, "text": "The circadian clock, an internal time-keeping system, has been linked with control of aging, but molecular mechanisms of regulation are not known. BMAL1 is a transcriptional factor and core component of the circadian clock; BMAL1 deficiency is associated with premature aging and reduced lifespan. Here we report that activity of mammalian Target of Rapamycin Complex 1 (mTORC1) is increased upon BMAL1 deficiency both in vivo and in cell culture. Increased mTOR signaling is associated with accelerated aging; in accordance with that, treatment with the mTORC1 inhibitor rapamycin increased lifespan of Bmal1-/- mice by 50%. Our data suggest that BMAL1 is a negative regulator of mTORC1 signaling. We propose that the circadian clock controls the activity of the mTOR pathway through BMAL1-dependent mechanisms and this regulation is important for control of aging and metabolism."}
{"qid": "58caf0be02b8c6095300002f", "original_text": "Focusing on three Anglo-American outbreaks of industrial anthrax, this essay engages the question of how local circumstances influenced the transmission of scientific knowledge in the late nineteenth century. Walpole (Massachusetts), Glasgow, and Bradford (Yorkshire) served as important nodes of transnational investigation into anthrax. Knowledge about the morphology and behavior of Bacillus anthracis changed little while in transit between these nodes, even during complex debates about the nature of bacterial morphology, disease causation, and spontaneous generation.", "label": 1, "is_selected": 0, "text": "Focusing on three Anglo-American outbreaks of industrial anthrax, this essay engages the question of how local circumstances influenced the transmission of scientific knowledge in the late nineteenth century. Walpole (Massachusetts), Glasgow, and Bradford (Yorkshire) served as important nodes of transnational investigation into anthrax. Knowledge about the morphology and behavior of Bacillus anthracis changed little while in transit between these nodes, even during complex debates about the nature of bacterial morphology, disease causation, and spontaneous generation."}
{"qid": "5ac08fe7d0c506ce46000003", "original_text": "Breast cancer is the leading cause of cancer-related deaths among females in economically developing countries. Greater than 95% of breast malignancies are of epithelial origin; the induction of epithelial-to-mesenchymal transition (EMT) has been shown to initiate the metastatic process in breast carcinoma and remains the key target for drug development. Here, we examine the anti-metastatic potential of pterostilbene in modulating EMT process in breast cancer cells both in vitro and in vivo. The differential invasive ability among MCF7, Hs578t and MDA-MB-231 breast cancer cell lines were closely correlated with the expression of EMT markers, determined by Western blots and Matrigel-coated transwells assay.", "label": 1, "is_selected": 0, "text": "Breast cancer is the leading cause of cancer-related deaths among females in economically developing countries. Greater than 95% of breast malignancies are of epithelial origin; the induction of epithelial-to-mesenchymal transition (EMT) has been shown to initiate the metastatic process in breast carcinoma and remains the key target for drug development. Here, we examine the anti-metastatic potential of pterostilbene in modulating EMT process in breast cancer cells both in vitro and in vivo. The differential invasive ability among MCF7, Hs578t and MDA-MB-231 breast cancer cell lines were closely correlated with the expression of EMT markers, determined by Western blots and Matrigel-coated transwells assay."}
{"qid": "5c580aff07647bbc4b00001a", "original_text": "The ultraconserved element associated with Embryonic Stem Cells (ESC) self-renewal is the Nanog gene. Nanog is a transcription factor that plays a critical role in maintaining ESC self-renewal by regulating key cellular processes, including cell proliferation, survival, and pluripotency. Mutations in the Nanog gene have been shown to disrupt ESC self-renewal, leading to the loss of stem cell properties.", "label": 0, "is_selected": 1, "text": "The aim of this project is to understand how mutations in the Nanog gene can lead to the loss of stem cell properties, and to develop new ways to treat and prevent neurodegenerative diseases such as Parkinson's disease and Alzheimer's syndrome."}
{"qid": "54dc8ed6c0bb8dce23000002", "original_text": "Cardiomyocyte contraction depends on rapid changes in intracellular Ca(2+). In mammals, Ca(2+) influx as L-type Ca(2+) current (ICa) triggers the release of Ca(2+) from sarcoplasmic reticulum (SR) and Ca(2+)-induced Ca(2+) release (CICR) is critical for excitation-contraction coupling. In fish, the relative contribution of external and internal Ca(2+) is unclear. Here, we characterized the role of ICa to trigger SR Ca(2+) release in rainbow trout ventricular myocytes using ICa regulation by Ca(2+) as an index of CICR. ICa was recorded with a slow (EGTA) or fast (BAPTA) Ca(2+) chelator in control and isoproterenol conditions. In the absence of \u03b2-adrenergic stimulation, the rate of ICa inactivation was not significantly different in EGTA and BAPTA (27.1 \u00b1 1.8 vs. 30.3 \u00b1 2.4 ms), whereas with isoproterenol (1 \u03bcM), inactivation was significantly faster with EGTA (11.6 \u00b1 1.7 vs. 27.3 \u00b1 1.6 ms).", "label": 1, "is_selected": 0, "text": "Cardiomyocyte contraction depends on rapid changes in intracellular Ca(2+). In mammals, Ca(2+) influx as L-type Ca(2+) current (ICa) triggers the release of Ca(2+) from sarcoplasmic reticulum (SR) and Ca(2+)-induced Ca(2+) release (CICR) is critical for excitation-contraction coupling. In fish, the relative contribution of external and internal Ca(2+) is unclear. Here, we characterized the role of ICa to trigger SR Ca(2+) release in rainbow trout ventricular myocytes using ICa regulation by Ca(2+) as an index of CICR. ICa was recorded with a slow (EGTA) or fast (BAPTA) Ca(2+) chelator in control and isoproterenol conditions. In the absence of \u03b2-adrenergic stimulation, the rate of ICa inactivation was not significantly different in EGTA and BAPTA (27.1 \u00b1 1.8 vs. 30.3 \u00b1 2.4 ms), whereas with isoproterenol (1 \u03bcM), inactivation was significantly faster with EGTA (11.6 \u00b1 1.7 vs. 27.3 \u00b1 1.6 ms)."}
{"qid": "5a80d6cbfaa1ab7d2e000024", "original_text": "Kmt5a, also known as liver kinome target 5A, is a gene that plays a crucial role in the regulation of liver function. It is expressed exclusively in the liver and plays a key role in the development and maintenance of hepatocytes, the main cell type of the liver. Kmt5a regulates the expression of genes involved in lipid metabolism, glucose metabolism, and detoxification, among other functions. It also plays a role in the response to liver injury and the regeneration of hepatocytes. Mutations in Kmt5a have been associated with liver diseases such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).", "label": 0, "is_selected": 1, "text": "Researchers at the University of Bristol have identified a new class of drugs that target a gene that has been implicated in a number of liver diseases, including nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)."}
{"qid": "5aacd487fcf4565872000007", "original_text": "DNA polymerase theta (pol \u03b8) is an evolutionarily conserved protein encoded by the POLQ gene in mammalian genomes. Pol \u03b8 is the defining enzyme for a pathway of DSB repair termed \"alternative end-joining\" (altEJ) or \"theta-mediated end-joining.\" This pathway contributes significantly to the radiation resistance of mammalian cells. It also modulates accuracy in repair of breaks that occur at stalled DNA replication forks, during diversification steps of the mammalian immune system, during repair of CRISPR-Cas9, and in many DNA integration events. Pol \u03b8 is a potentially important clinical target, particularly for cancers deficient in other break repair strategies.", "label": 1, "is_selected": 0, "text": "DNA polymerase theta (pol \u03b8) is an evolutionarily conserved protein encoded by the POLQ gene in mammalian genomes. Pol \u03b8 is the defining enzyme for a pathway of DSB repair termed \"alternative end-joining\" (altEJ) or \"theta-mediated end-joining.\" This pathway contributes significantly to the radiation resistance of mammalian cells. It also modulates accuracy in repair of breaks that occur at stalled DNA replication forks, during diversification steps of the mammalian immune system, during repair of CRISPR-Cas9, and in many DNA integration events. Pol \u03b8 is a potentially important clinical target, particularly for cancers deficient in other break repair strategies."}
{"qid": "5e822615835f4e4777000034", "original_text": "Erythropoietic protoporphyria (EPP) is a rare inherited disorder of the heme biosynthesis pathway resulting in the accumulation of protoporphyrins in the blood, erythrocytes, and other tissues. Because of a gene mutation in the FECH gene, ferrochelatase, the enzyme involved in the final step of heme synthesis, is deficient in these patients.", "label": 1, "is_selected": 0, "text": "Erythropoietic protoporphyria (EPP) is a rare inherited disorder of the heme biosynthesis pathway resulting in the accumulation of protoporphyrins in the blood, erythrocytes, and other tissues. Because of a gene mutation in the FECH gene, ferrochelatase, the enzyme involved in the final step of heme synthesis, is deficient in these patients."}
{"qid": "551ae6c564b14b4618000001", "original_text": "People with blood group O have a slightly higher resistance to severe malaria compared to those with other blood groups. This is because individuals with blood group O have a unique genetic variation that makes it more difficult for the malaria parasite to infect their red blood cells. Specifically, people with blood group O have a higher levels of a protein called Band 3, which is found on the surface of red blood cells and helps to prevent the parasite from attaching and entering the cells. However, it's important to note that while individuals with blood group O may have some protection against severe malaria, they are not completely immune to infection.", "label": 0, "is_selected": 1, "text": "People with blood group O have a slightly higher resistance to severe malaria compared to those with other blood groups, according to a new study from researchers at the University of California, Los Angeles (UCLA) and the US Centers for Disease Control and Prevention (CDC), which was published in the journal Plos One."}
{"qid": "6024a6871cb411341a0000a4", "original_text": "Synthetic marijuana is a dangerous substance due to its potency, ever-changing composition, and unpredictable side effects. Recently, brodifacoum-contaminated synthetic marijuana has led to multiple deaths and morbidity throughout the USA from severe coagulopathy associated with use of this strain of the drug (brodifacoum is a rodenticide and potent Vitamin K antagonist/anticoagulant). We describe the clinical and radiologic findings in two patients who were diagnosed with, and treated for, ingestion of this new strain of synthetic marijuana. The radiologic manifestations were most notable for hemorrhagic pyelitis/ureteritis.", "label": 1, "is_selected": 0, "text": "Synthetic marijuana is a dangerous substance due to its potency, ever-changing composition, and unpredictable side effects. Recently, brodifacoum-contaminated synthetic marijuana has led to multiple deaths and morbidity throughout the USA from severe coagulopathy associated with use of this strain of the drug (brodifacoum is a rodenticide and potent Vitamin K antagonist/anticoagulant). We describe the clinical and radiologic findings in two patients who were diagnosed with, and treated for, ingestion of this new strain of synthetic marijuana. The radiologic manifestations were most notable for hemorrhagic pyelitis/ureteritis."}
{"qid": "61f9605f882a024a1000004f", "original_text": "Fibroblast growth factor homologous factors (FHFs) are intracellular proteins which regulate voltage-gated sodium (Nav) channels in the brain and other tissues. FHF dysfunction has been linked to neurological disorders including epilepsy. Here, we describe two sibling pairs and three unrelated males who presented in infancy with intractable focal seizures and severe developmental delay. Whole-exome sequencing identified hemi- and heterozygous variants in the N-terminal domain of the A isoform of FHF2 (FHF2A). The X-linked FHF2 gene (also known as FGF13) has alternative first exons which produce multiple protein isoforms that differ in their N-terminal sequence. The variants were located at highly conserved residues in the FHF2A inactivation particle that competes with the intrinsic fast inactivation mechanism of Nav channels.", "label": 1, "is_selected": 0, "text": "Fibroblast growth factor homologous factors (FHFs) are intracellular proteins which regulate voltage-gated sodium (Nav) channels in the brain and other tissues. FHF dysfunction has been linked to neurological disorders including epilepsy. Here, we describe two sibling pairs and three unrelated males who presented in infancy with intractable focal seizures and severe developmental delay. Whole-exome sequencing identified hemi- and heterozygous variants in the N-terminal domain of the A isoform of FHF2 (FHF2A). The X-linked FHF2 gene (also known as FGF13) has alternative first exons which produce multiple protein isoforms that differ in their N-terminal sequence. The variants were located at highly conserved residues in the FHF2A inactivation particle that competes with the intrinsic fast inactivation mechanism of Nav channels."}
{"qid": "5a67ab79b750ff445500000b", "original_text": "The performance of CURB65 in predicting mortality in community-acquired pneumonia (CAP) has been tested in two large observational studies. However, it has not been tested against generic sepsis and early warning scores, which are increasingly being advocated for identification of high-risk patients in acute medical wards. A retrospective analysis was performed of data prospectively collected for a CAP quality improvement study. The ability to stratify mortality and performance characteristics (sensitivity, specificity, positive predictive value, negative predictive value and area under the receiver operating curve) were calculated for stratifications of CURB65, CRB65, the systemic inflammatory response syndrome (SIRS) criteria and the standardised early warning score (SEWS). 419 patients were included in the main analysis with a median age of 74 years (men = 47%).", "label": 1, "is_selected": 0, "text": "The performance of CURB65 in predicting mortality in community-acquired pneumonia (CAP) has been tested in two large observational studies. However, it has not been tested against generic sepsis and early warning scores, which are increasingly being advocated for identification of high-risk patients in acute medical wards. A retrospective analysis was performed of data prospectively collected for a CAP quality improvement study. The ability to stratify mortality and performance characteristics (sensitivity, specificity, positive predictive value, negative predictive value and area under the receiver operating curve) were calculated for stratifications of CURB65, CRB65, the systemic inflammatory response syndrome (SIRS) criteria and the standardised early warning score (SEWS). 419 patients were included in the main analysis with a median age of 74 years (men = 47%)."}
{"qid": "5150b5c4d24251bc05000070", "original_text": "Patent expiry can significantly influence the prescribing of ACE inhibitors, as it affects the availability and cost of these medications. After a patent expires, generic versions of the drug become available, which can lead to increased competition and decreased prices. This can make ACE inhibitors more affordable and accessible to patients, potentially leading to increased prescribing rates. Additionally, the availability of generic ACE inhibitors can increase the options for clinicians when choosing a medication for their patients, as they may have more affordable and effective treatment options. On the other hand, the expiration of patents can also lead to a decrease in the marketing and promotion of ACE inhibitors, as the manufacturer may no longer have exclusive rights to the drug. This can result in a decrease in prescribing rates, as clinicians may be less likely to prescribe a drug that is no longer heavily marketed and promoted. However, it is important to note that the influence of patent expiry on ACE inhibitor prescribing can vary depending on the specific medication, the competitive market, and the patient population being treated.", "label": 0, "is_selected": 0, "text": "Patent expiry can significantly influence the prescribing of ACE inhibitors, as it affects the availability and cost of these medications. After a patent expires, generic versions of the drug become available, which can lead to increased competition and decreased prices. This can make ACE inhibitors more affordable and accessible to patients, potentially leading to increased prescribing rates. Additionally, the availability of generic ACE inhibitors can increase the options for clinicians when choosing a medication for their patients, as they may have more affordable and effective treatment options. On the other hand, the expiration of patents can also lead to a decrease in the marketing and promotion of ACE inhibitors, as the manufacturer may no longer have exclusive rights to the drug. This can result in a decrease in prescribing rates, as clinicians may be less likely to prescribe a drug that is no longer heavily marketed and promoted. However, it is important to note that the influence of patent expiry on ACE inhibitor prescribing can vary depending on the specific medication, the competitive market, and the patient population being treated."}
{"qid": "60274ec61cb411341a0000e5", "original_text": "A randomized study of 264 children and adults with previously untreated localized Ewing's sarcoma of bone was undertaken between 1973 and 1978 by 83 institutions of three national study groups: Children's Cancer Study Group, Southwest Oncology Group, and Cancer and Leukemia Group B. The Intergroup Study was designed to determine if the addition of adriamycin (ADR) or bilateral pulmonary radiotherapy (RT) to vincristine, dactinomycin, and cyclophosphamide (VAC therapy) would improve survival and reduce local recurrences and metastases. All patients received RT to the primary lesion, and the survival rate after 3 years was 65%. The most effective treatment regimen was VAC plus ADR; 74% of the patients were free of disease at 2 years. The lengths of disease-free status and survival of patients treated with VAC plus ADR or VAC plus RT did not differ. However, both regimens were significantly superior to treatment with VAC alone. The addition of ADR or bilateral pulmonary RT to VAC was highly advantageous to patients with nonpelvic primaries. Bone and lung were the major sites of distant relapse, but the addition of bilateral pulmonary RT showed no advantage over that of ADR in reducing the occurrence of lung metastases.", "label": 1, "is_selected": 0, "text": "A randomized study of 264 children and adults with previously untreated localized Ewing's sarcoma of bone was undertaken between 1973 and 1978 by 83 institutions of three national study groups: Children's Cancer Study Group, Southwest Oncology Group, and Cancer and Leukemia Group B. The Intergroup Study was designed to determine if the addition of adriamycin (ADR) or bilateral pulmonary radiotherapy (RT) to vincristine, dactinomycin, and cyclophosphamide (VAC therapy) would improve survival and reduce local recurrences and metastases. All patients received RT to the primary lesion, and the survival rate after 3 years was 65%. The most effective treatment regimen was VAC plus ADR; 74% of the patients were free of disease at 2 years. The lengths of disease-free status and survival of patients treated with VAC plus ADR or VAC plus RT did not differ. However, both regimens were significantly superior to treatment with VAC alone. The addition of ADR or bilateral pulmonary RT to VAC was highly advantageous to patients with nonpelvic primaries. Bone and lung were the major sites of distant relapse, but the addition of bilateral pulmonary RT showed no advantage over that of ADR in reducing the occurrence of lung metastases."}
{"qid": "60805c344e6a4cf630000001", "original_text": "The organ of Corti is located in the cochlea of the inner ear. It is a complex structure consisting of hair cells, their supporting cells, and neurons. The organ of Corti is responsible for detecting sound waves and transmitting them to the brain as electrical signals. Specifically, it is located in the basal turn of the cochlea, near the apex of the cochlea, and is composed of two turns of spiral ganglion cells, with the outer turn being the most sensitive to high-frequency sounds. The organ of Corti is the site of auditory transduction, where sound waves are converted into electrical signals that can be interpreted by the brain.", "label": 0, "is_selected": 1, "text": "The organ of Corti is one of the most important parts of the inner ear, and is the most sensitive part of the ear to high-frequency sounds such as whistles and bells.<n> This page was last updated on 7 February 2016, at 18:55 (GMT)."}
{"qid": "52ee065d98d0239505000033", "original_text": "Machine learning is used in a large number of bioinformatics applications and studies. The application of machine learning techniques in other areas such as pattern recognition has resulted in accumulated experience as to correct and principled approaches for their use. The aim of this paper is to give an account of issues affecting the application of machine learning tools, focusing primarily on general aspects of feature and model parameter selection, rather than any single specific algorithm. These aspects are discussed in the context of published bioinformatics studies in leading journals over the last 5 years. We assess to what degree the experience gained by the pattern recognition research community pervades these bioinformatics studies. We finally discuss various critical issues relating to bioinformatic data sets and make a number of recommendations on the proper use of machine learning techniques for bioinformatics research based upon previously published research on machine learning.", "label": 1, "is_selected": 0, "text": "Machine learning is used in a large number of bioinformatics applications and studies. The application of machine learning techniques in other areas such as pattern recognition has resulted in accumulated experience as to correct and principled approaches for their use. The aim of this paper is to give an account of issues affecting the application of machine learning tools, focusing primarily on general aspects of feature and model parameter selection, rather than any single specific algorithm. These aspects are discussed in the context of published bioinformatics studies in leading journals over the last 5 years. We assess to what degree the experience gained by the pattern recognition research community pervades these bioinformatics studies. We finally discuss various critical issues relating to bioinformatic data sets and make a number of recommendations on the proper use of machine learning techniques for bioinformatics research based upon previously published research on machine learning."}
{"qid": "570921e4cf1c325851000017", "original_text": "Alu elements belonging to the previously identified \"young\" subfamilies are thought to have inserted in the human genome after the divergence of humans from non-human primates and therefore should not be present in non-human primate genomes. Polymerase chain reaction (PCR) based screening of over 500 Alu insertion loci resulted in the recovery of a few \"young\" Alu elements that also resided at orthologous positions in non-human primate genomes.", "label": 1, "is_selected": 0, "text": "Alu elements belonging to the previously identified \"young\" subfamilies are thought to have inserted in the human genome after the divergence of humans from non-human primates and therefore should not be present in non-human primate genomes. Polymerase chain reaction (PCR) based screening of over 500 Alu insertion loci resulted in the recovery of a few \"young\" Alu elements that also resided at orthologous positions in non-human primate genomes."}
{"qid": "5a68f448b750ff4455000018", "original_text": "Erythrasma is caused by the bacterium Corynebacterium minutissimum. It is a gram-positive, rod-shaped bacterium that is commonly found on the skin and is responsible for a variety of skin infections, including erythrasma. C. minutissimum can also cause other infections, such as superficial cellulitis and folliculitis. It is important to note that erythrasma can be difficult to diagnose, as it can resemble other skin conditions, and a proper diagnosis may require a skin scraping or culture.", "label": 0, "is_selected": 0, "text": "Erythrasma is caused by the bacterium Corynebacterium minutissimum. It is a gram-positive, rod-shaped bacterium that is commonly found on the skin and is responsible for a variety of skin infections, including erythrasma. C. minutissimum can also cause other infections, such as superficial cellulitis and folliculitis. It is important to note that erythrasma can be difficult to diagnose, as it can resemble other skin conditions, and a proper diagnosis may require a skin scraping or culture."}
{"qid": "5715c16dcb4ef8864c000004", "original_text": "Fibronectin is a protein that has been explored as a potential serum biomarker for Duchenne muscular dystrophy (DMD), a severe genetic disorder characterized by progressive muscle degeneration. Studies have shown that levels of fibronectin in the bloodstream are significantly reduced in patients with DMD, particularly during the early stages of the disease. These findings suggest that fibronectin may serve as a useful biomarker for DMD, allowing for early detection and monitoring of the disease. However, further research is necessary to confirm these findings and establish the diagnostic accuracy of fibronectin as a biomarker for DMD.", "label": 0, "is_selected": 0, "text": "Fibronectin is a protein that has been explored as a potential serum biomarker for Duchenne muscular dystrophy (DMD), a severe genetic disorder characterized by progressive muscle degeneration. Studies have shown that levels of fibronectin in the bloodstream are significantly reduced in patients with DMD, particularly during the early stages of the disease. These findings suggest that fibronectin may serve as a useful biomarker for DMD, allowing for early detection and monitoring of the disease. However, further research is necessary to confirm these findings and establish the diagnostic accuracy of fibronectin as a biomarker for DMD."}
{"qid": "6275199fe764a5320400004d", "original_text": "Inhibition of MYC/MAX dimerization by a small-molecule antagonist (IIA6B17) has been shown to interfere with MYC-induced transformation of chick embryo fibroblasts, suggesting that the functional inhibitors of the MYC family of oncoproteins have potential as therapeutic agents. In the present study, a functional MYC reporter gene assay has been developed, using a luciferase gene construct under the control of the ornithine decarboxylase (ODC) gene promoter. This luciferase gene construct has been stably transfected into the MYCN amplified neuroblastoma cell line (NGP) and MYCC-overexpressed neuroepithelioma cell line (NB100). After exposure of the cell lines to IIA6B17 for 24 h, a significant reduction of luciferase activity was only observed in the NB100 cells, with IC50 values of approximately 28+/-9 microM, indicating that IIA6B17 has cell line-specific activity which may be selective for individual members of the MYC family.", "label": 1, "is_selected": 0, "text": "Inhibition of MYC/MAX dimerization by a small-molecule antagonist (IIA6B17) has been shown to interfere with MYC-induced transformation of chick embryo fibroblasts, suggesting that the functional inhibitors of the MYC family of oncoproteins have potential as therapeutic agents. In the present study, a functional MYC reporter gene assay has been developed, using a luciferase gene construct under the control of the ornithine decarboxylase (ODC) gene promoter. This luciferase gene construct has been stably transfected into the MYCN amplified neuroblastoma cell line (NGP) and MYCC-overexpressed neuroepithelioma cell line (NB100). After exposure of the cell lines to IIA6B17 for 24 h, a significant reduction of luciferase activity was only observed in the NB100 cells, with IC50 values of approximately 28+/-9 microM, indicating that IIA6B17 has cell line-specific activity which may be selective for individual members of the MYC family."}
{"qid": "6217dc9d3a8413c65300002d", "original_text": "Frontotemporal dementia (FTD) is the second most frequent dementia, after Alzheimer's, in patients under the age of 65. It encompasses clinical entities characterized by behavioral, language, and executive control dysfunction. Neurofilament light chain (NfL) is a new, non-disease specific, widely studied biomarker indicative of axonal injury and degeneration. Various studies have previously explored the role of NfL in the diagnostic process, monitoring, and prognosis of dementia. The current systematic review and meta-analysis include all the available data concerning the role of NfL in frontotemporal dementia and its use as a potential biomarker in differentiating patients with FTD from (a) healthy individuals, (b) Alzheimer's dementia, (c) Dementia with Lewy bodies, (d) Motor Neuron disease, (e) Parkinsonian syndromes, and (f) psychiatric disorders.", "label": 1, "is_selected": 0, "text": "Frontotemporal dementia (FTD) is the second most frequent dementia, after Alzheimer's, in patients under the age of 65. It encompasses clinical entities characterized by behavioral, language, and executive control dysfunction. Neurofilament light chain (NfL) is a new, non-disease specific, widely studied biomarker indicative of axonal injury and degeneration. Various studies have previously explored the role of NfL in the diagnostic process, monitoring, and prognosis of dementia. The current systematic review and meta-analysis include all the available data concerning the role of NfL in frontotemporal dementia and its use as a potential biomarker in differentiating patients with FTD from (a) healthy individuals, (b) Alzheimer's dementia, (c) Dementia with Lewy bodies, (d) Motor Neuron disease, (e) Parkinsonian syndromes, and (f) psychiatric disorders."}
{"qid": "5a6e4592b750ff4455000047", "original_text": "The sequencing of the complete genome of the nematode Caenorhabditis elegans was a landmark achievement and ushered in a new era of whole-organism, systems analyses of the biology of this powerful model organism. The success of the C. elegans genome sequencing project also inspired communities working on other organisms to approach genome sequencing of their species. The phylum Nematoda is rich and diverse and of interest to a wide range of research fields from basic biology through ecology and parasitic disease. For all these communities, it is now clear that access to genome scale data will be key to advancing understanding, and in the case of parasites, developing new ways to control or cure diseases. The advent of second-generation sequencing technologies, improvements in computing algorithms and infrastructure and growth in bioinformatics and genomics literacy is making the addition of genome sequencing to the research goals of any nematode research program a less daunting prospect. To inspire, promote and coordinate genomic sequencing across the diversity of the phylum, we have launched a community wiki and the 959 Nematode Genomes initiative (www.nematodegenomes.org/).", "label": 1, "is_selected": 0, "text": "The sequencing of the complete genome of the nematode Caenorhabditis elegans was a landmark achievement and ushered in a new era of whole-organism, systems analyses of the biology of this powerful model organism. The success of the C. elegans genome sequencing project also inspired communities working on other organisms to approach genome sequencing of their species. The phylum Nematoda is rich and diverse and of interest to a wide range of research fields from basic biology through ecology and parasitic disease. For all these communities, it is now clear that access to genome scale data will be key to advancing understanding, and in the case of parasites, developing new ways to control or cure diseases. The advent of second-generation sequencing technologies, improvements in computing algorithms and infrastructure and growth in bioinformatics and genomics literacy is making the addition of genome sequencing to the research goals of any nematode research program a less daunting prospect. To inspire, promote and coordinate genomic sequencing across the diversity of the phylum, we have launched a community wiki and the 959 Nematode Genomes initiative (www.nematodegenomes.org/)."}
{"qid": "5e92005c2d3121100d000003", "original_text": "There are several deadly viruses found in the world, and the severity of their impact can vary depending on factors such as geographical location, population density, and existing medical infrastructure. Here are some of the deadliest viruses known to man: 1. Ebola virus - With a fatality rate of up to 90%, Ebola is one of the deadliest viruses in the world. It is transmitted through contact with bodily fluids and can cause severe bleeding, organ failure, and death. 2. Marburg virus - This virus has a fatality rate of up to 88% and is transmitted through contact with infected bodily fluids. It can cause severe bleeding, fever, and vomiting, leading to death within days of symptom onset. 3. SARS-CoV-2 - The virus behind COVID-19, SARS-CoV-2 has a fatality rate of around 3-4% globally. It is transmitted through respiratory droplets and can cause severe pneumonia, acute respiratory distress syndrome, and death. 4. Lassa fever virus - This virus is found in West Africa and has a fatality rate of up to 80%. It is transmitted through contact with infected rodents and can cause fever, vomiting, and kidney failure leading to death. 5. HIV - While HIV is not a virus, it is a significant cause of death worldwide due to its ability to progress to AIDS. The fatality rate of HIV without treatment is around 90%, while the rate with antiretroviral therapy (ART) is around 10-20%. These are some of the deadliest viruses known to man, and understanding their transmission, symptoms, and fatality rates is crucial for developing effective prevention and treatment strategies.", "label": 0, "is_selected": 0, "text": "There are several deadly viruses found in the world, and the severity of their impact can vary depending on factors such as geographical location, population density, and existing medical infrastructure. Here are some of the deadliest viruses known to man: 1. Ebola virus - With a fatality rate of up to 90%, Ebola is one of the deadliest viruses in the world. It is transmitted through contact with bodily fluids and can cause severe bleeding, organ failure, and death. 2. Marburg virus - This virus has a fatality rate of up to 88% and is transmitted through contact with infected bodily fluids. It can cause severe bleeding, fever, and vomiting, leading to death within days of symptom onset. 3. SARS-CoV-2 - The virus behind COVID-19, SARS-CoV-2 has a fatality rate of around 3-4% globally. It is transmitted through respiratory droplets and can cause severe pneumonia, acute respiratory distress syndrome, and death. 4. Lassa fever virus - This virus is found in West Africa and has a fatality rate of up to 80%. It is transmitted through contact with infected rodents and can cause fever, vomiting, and kidney failure leading to death. 5. HIV - While HIV is not a virus, it is a significant cause of death worldwide due to its ability to progress to AIDS. The fatality rate of HIV without treatment is around 90%, while the rate with antiretroviral therapy (ART) is around 10-20%. These are some of the deadliest viruses known to man, and understanding their transmission, symptoms, and fatality rates is crucial for developing effective prevention and treatment strategies."}
{"qid": "56c868a95795f9a73e000017", "original_text": "Protein-protein interactions play a pivotal role in coordinating many cellular processes. Determination of subcellular localization of interacting proteins and visualization of dynamic interactions in living cells are crucial to elucidate cellular functions of proteins. Using fluorescent proteins, we previously developed a bimolecular fluorescence complementation (BiFC) assay and a multicolor BiFC assay to visualize protein-protein interactions in living cells. However, the sensitivity of chromophore maturation of enhanced yellow fluorescent protein (YFP) to higher temperatures requires preincubation at lower temperatures prior to visualizing the BiFC signal. This could potentially limit their applications for the study of many signaling molecules.", "label": 1, "is_selected": 0, "text": "Protein-protein interactions play a pivotal role in coordinating many cellular processes. Determination of subcellular localization of interacting proteins and visualization of dynamic interactions in living cells are crucial to elucidate cellular functions of proteins. Using fluorescent proteins, we previously developed a bimolecular fluorescence complementation (BiFC) assay and a multicolor BiFC assay to visualize protein-protein interactions in living cells. However, the sensitivity of chromophore maturation of enhanced yellow fluorescent protein (YFP) to higher temperatures requires preincubation at lower temperatures prior to visualizing the BiFC signal. This could potentially limit their applications for the study of many signaling molecules."}
{"qid": "5a9922981d1251d03b000007", "original_text": "Circular RNAs (circRNAs) are RNA transcripts that are widespread in the eukaryotic genome. Recent evidence indicates that circRNAs play important roles in tissue development, gene regulation, and carcinogenesis. However, whether circRNAs encode functional proteins remains elusive, although translation of several circRNAs was recently reported. CircRNA deep sequencing was performed by using 10 pathologically diagnosed glioblastoma samples and their paired adjacent normal brain tissues. Northern blotting, Sanger sequencing, antibody, and liquid chromatograph Tandem Mass Spectrometer were used to confirm the existence of circ-FBXW7 and its encoded protein in in two cell lines. Lentivirus-transfected stable U251 and U373 cells were used to assess the biological functions of the novel protein invitro and invivo (five mice per group). Clinical implications of circ-FBXW7 were assessed in 38 pathologically diagnosed glioblastoma samples and their paired periphery normal brain tissues by using quantitative polymerase chain reaction (two-sided log-rank test). Circ-FBXW7 is abundantly expressed in the normal human brain (reads per kilobase per million mapped reads [RPKM] = 9.31).", "label": 1, "is_selected": 0, "text": "Circular RNAs (circRNAs) are RNA transcripts that are widespread in the eukaryotic genome. Recent evidence indicates that circRNAs play important roles in tissue development, gene regulation, and carcinogenesis. However, whether circRNAs encode functional proteins remains elusive, although translation of several circRNAs was recently reported. CircRNA deep sequencing was performed by using 10 pathologically diagnosed glioblastoma samples and their paired adjacent normal brain tissues. Northern blotting, Sanger sequencing, antibody, and liquid chromatograph Tandem Mass Spectrometer were used to confirm the existence of circ-FBXW7 and its encoded protein in in two cell lines. Lentivirus-transfected stable U251 and U373 cells were used to assess the biological functions of the novel protein invitro and invivo (five mice per group). Clinical implications of circ-FBXW7 were assessed in 38 pathologically diagnosed glioblastoma samples and their paired periphery normal brain tissues by using quantitative polymerase chain reaction (two-sided log-rank test). Circ-FBXW7 is abundantly expressed in the normal human brain (reads per kilobase per million mapped reads [RPKM] = 9.31)."}
{"qid": "5c62a529e842deac6700000b", "original_text": "Yes, the yeast genome (Saccharomyces cerevisiae) is organized into topologically associated domains (TADs). TADs are regions of the genome that are physically associated with each other in three-dimensional space, and are often found to be organized into specific chromosomal domains. In the case of S. cerevisiae, the genome is organized into 14 TADs, each of which is defined by a specific set of genomic coordinates. These TADs are thought to play a role in regulating gene expression and other cellular processes, and may be involved in the development of diseases such as cancer. It is worth noting that the organization of the genome into TADs is not unique to S. cerevisiae, and is a common feature of many organisms, including humans.", "label": 0, "is_selected": 0, "text": "Yes, the yeast genome (Saccharomyces cerevisiae) is organized into topologically associated domains (TADs). TADs are regions of the genome that are physically associated with each other in three-dimensional space, and are often found to be organized into specific chromosomal domains. In the case of S. cerevisiae, the genome is organized into 14 TADs, each of which is defined by a specific set of genomic coordinates. These TADs are thought to play a role in regulating gene expression and other cellular processes, and may be involved in the development of diseases such as cancer. It is worth noting that the organization of the genome into TADs is not unique to S. cerevisiae, and is a common feature of many organisms, including humans."}
{"qid": "602c21501cb411341a000121", "original_text": "SAR425899, also known as Ruxolitinib, is a drug used to treat myelofibrosis, a type of blood cancer. It has been tested in several clinical trials for its safety and efficacy in treating various types of cancer, including: * Study 1 (NCT01435670): This phase 2 trial evaluated the safety and efficacy of Ruxolitinib in patients with myelofibrosis, including those with intermediate-2 or high-risk disease. * Study 2 (NCT01824384): This phase 2/3 trial compared Ruxolitinib to best available therapy in patients with myelofibrosis, including those with intermediate-2 or high-risk disease. * Study 3 (NCT02006444): This phase 3 trial evaluated the safety and efficacy of Ruxolitinib in combination with jakavi (rux) in patients with primary myelofibrosis (PMF) or post-polycythemia vera (PV) myelofibrosis (MF) who have not responded to previous treatments. * Study 4 (NCT02446914): This phase 2 trial evaluated the safety and efficacy of Ruxolitinib in patients with chronic graft-versus-host disease (cGVHD) after allogenic hematopoietic stem cell transplantation. * Study 5 (NCT02666457): This phase 2 trial evaluated the safety and efficacy of Ruxolitinib in patients with myelofibrosis who have not responded to previous treatments. * Study 6 (NCT03357578): This ongoing phase 3 trial is evaluating the safety and efficacy of Ruxolitinib plus navitoclax (ABT-263) in patients with myelofibrosis, including those with intermediate-2 or high-risk disease. It is important to note that clinical trials are ongoing and the results may change over time. It is recommended to consult with a healthcare professional for the most up-to-date information on SAR425899 clinical trials.", "label": 0, "is_selected": 0, "text": "SAR425899, also known as Ruxolitinib, is a drug used to treat myelofibrosis, a type of blood cancer. It has been tested in several clinical trials for its safety and efficacy in treating various types of cancer, including: * Study 1 (NCT01435670): This phase 2 trial evaluated the safety and efficacy of Ruxolitinib in patients with myelofibrosis, including those with intermediate-2 or high-risk disease. * Study 2 (NCT01824384): This phase 2/3 trial compared Ruxolitinib to best available therapy in patients with myelofibrosis, including those with intermediate-2 or high-risk disease. * Study 3 (NCT02006444): This phase 3 trial evaluated the safety and efficacy of Ruxolitinib in combination with jakavi (rux) in patients with primary myelofibrosis (PMF) or post-polycythemia vera (PV) myelofibrosis (MF) who have not responded to previous treatments. * Study 4 (NCT02446914): This phase 2 trial evaluated the safety and efficacy of Ruxolitinib in patients with chronic graft-versus-host disease (cGVHD) after allogenic hematopoietic stem cell transplantation. * Study 5 (NCT02666457): This phase 2 trial evaluated the safety and efficacy of Ruxolitinib in patients with myelofibrosis who have not responded to previous treatments. * Study 6 (NCT03357578): This ongoing phase 3 trial is evaluating the safety and efficacy of Ruxolitinib plus navitoclax (ABT-263) in patients with myelofibrosis, including those with intermediate-2 or high-risk disease. It is important to note that clinical trials are ongoing and the results may change over time. It is recommended to consult with a healthcare professional for the most up-to-date information on SAR425899 clinical trials."}
{"qid": "58dbbdac8acda3452900001e", "original_text": "Clinical experience with hydroxyurea for patients with sickle cell disease (SCD) has been accumulating for the past 25 years. The bulk of the current evidence suggests that hydroxyurea is well-tolerated, safe, and efficacious for most patients with SCD. Hydroxyurea has proven clinical efficacy for reducing acute vaso-occlusive events including pain episodes and acute chest syndrome. Salutary effects on hematological parameters include increases in fetal hemoglobin (HbF), hemoglobin, and MCV; also significant decreases occur in WBC, ANC, reticulocytes, LDH, and bilirubin.", "label": 1, "is_selected": 0, "text": "Clinical experience with hydroxyurea for patients with sickle cell disease (SCD) has been accumulating for the past 25 years. The bulk of the current evidence suggests that hydroxyurea is well-tolerated, safe, and efficacious for most patients with SCD. Hydroxyurea has proven clinical efficacy for reducing acute vaso-occlusive events including pain episodes and acute chest syndrome. Salutary effects on hematological parameters include increases in fetal hemoglobin (HbF), hemoglobin, and MCV; also significant decreases occur in WBC, ANC, reticulocytes, LDH, and bilirubin."}
{"qid": "5e30f76afbd6abf43b000046", "original_text": "Interstitial lung disease (ILD) is a common manifestation of systemic autoimmune diseases and a leading cause of death in these patients. A proportion of patients with autoimmune ILDs develop a progressive fibrosing form of ILD, characterized by increasing fibrosis on high-resolution computed tomography, worsening of lung function, and early mortality. Autoimmune disease-related ILDs have a variable clinical course and not all patients will require treatment, but all patients should be monitored for signs of progression. Apart from systemic sclerosis-associated ILD, the limited evidence to support the efficacy of immunosuppression as a treatment for ILDs is based mainly on small retrospective series and expert opinion. Non-clinical data suggest that there are commonalities in the mechanisms that drive progressive fibrosis in ILDs with an immunological trigger as in other forms of progressive fibrosing ILD.", "label": 1, "is_selected": 0, "text": "Interstitial lung disease (ILD) is a common manifestation of systemic autoimmune diseases and a leading cause of death in these patients. A proportion of patients with autoimmune ILDs develop a progressive fibrosing form of ILD, characterized by increasing fibrosis on high-resolution computed tomography, worsening of lung function, and early mortality. Autoimmune disease-related ILDs have a variable clinical course and not all patients will require treatment, but all patients should be monitored for signs of progression. Apart from systemic sclerosis-associated ILD, the limited evidence to support the efficacy of immunosuppression as a treatment for ILDs is based mainly on small retrospective series and expert opinion. Non-clinical data suggest that there are commonalities in the mechanisms that drive progressive fibrosis in ILDs with an immunological trigger as in other forms of progressive fibrosing ILD."}
{"qid": "5abcf755fcf4565872000028", "original_text": "Famciclovir is a guanine analog antiviral drug used commonly for herpes zoster. Efficacy of famciclovir treatment has been reported to be comparable to valacyclovir treatment. Both of these medications reduce the time to complete cessation of zoster-associated pain including post-herpetic neuralgia, as compared to acyclovir. We conducted a multicenter, randomized, open clinical trial in order to evaluate the extent of pain relief afforded by these two antiviral drugs during the acute disease phase of herpes zoster.", "label": 1, "is_selected": 0, "text": "Famciclovir is a guanine analog antiviral drug used commonly for herpes zoster. Efficacy of famciclovir treatment has been reported to be comparable to valacyclovir treatment. Both of these medications reduce the time to complete cessation of zoster-associated pain including post-herpetic neuralgia, as compared to acyclovir. We conducted a multicenter, randomized, open clinical trial in order to evaluate the extent of pain relief afforded by these two antiviral drugs during the acute disease phase of herpes zoster."}
{"qid": "53318685d6d3ac6a3400003d", "original_text": "Acromicric dysplasia is a rare bone dysplasia characterised by short stature, short hands and feet, normal intelligence, mild facial dysmorphism, and characteristic x ray abnormalities of the hands. Only a very small number of children with this condition have been reported so far. Here we report on a series of 22 patients including 10 boys and 12 girls with acromicric dysplasia. Length was normal at birth and height fell progressively off the centiles postnatally. The mean adult height was 130 cm (133 cm in males, 129 cm in females). The hands, feet, and limbs were short and OFC was normal. Intelligence was normal and mild dysmorphic features were noted. Other occasional features included well developed muscles, a hoarse voice, generalised joint limitation in some patients, frequent ear, tracheal, and respiratory complication, and spine abnormalities. Long term follow up showed that facial dysmorphism was less obvious in adults and that carpal tunnel syndrome was frequent in older patients. Apart from short metacarpals and phalanges, internal notch of the second metacarpal, external notch of the fifth metacarpal, and internal notch of the femoral heads, there were no major x ray abnormalities. No major complications, such as cardiac disease or major orthopaedic problems, occurred in the course of the disease. The condition appeared to be sporadic in 16 cases but the observation of vertical transmission in three families was consistent with an autosomal dominant mode of inheritance.", "label": 1, "is_selected": 0, "text": "Acromicric dysplasia is a rare bone dysplasia characterised by short stature, short hands and feet, normal intelligence, mild facial dysmorphism, and characteristic x ray abnormalities of the hands. Only a very small number of children with this condition have been reported so far. Here we report on a series of 22 patients including 10 boys and 12 girls with acromicric dysplasia. Length was normal at birth and height fell progressively off the centiles postnatally. The mean adult height was 130 cm (133 cm in males, 129 cm in females). The hands, feet, and limbs were short and OFC was normal. Intelligence was normal and mild dysmorphic features were noted. Other occasional features included well developed muscles, a hoarse voice, generalised joint limitation in some patients, frequent ear, tracheal, and respiratory complication, and spine abnormalities. Long term follow up showed that facial dysmorphism was less obvious in adults and that carpal tunnel syndrome was frequent in older patients. Apart from short metacarpals and phalanges, internal notch of the second metacarpal, external notch of the fifth metacarpal, and internal notch of the femoral heads, there were no major x ray abnormalities. No major complications, such as cardiac disease or major orthopaedic problems, occurred in the course of the disease. The condition appeared to be sporadic in 16 cases but the observation of vertical transmission in three families was consistent with an autosomal dominant mode of inheritance."}
{"qid": "5e92021a2d3121100d000005", "original_text": "Alpha-Lactalbumin is the main whey protein in human milk rising 2,44 g/L in mature milk. It has a key function in the synthesis of lactose from glucose and galactose in the mammary gland although this compound has also other beneficial effects on the infant health due to the high proportion of essential aminoacids (tryptophan and cysteine). It seems also to increase iron absorption in the digestive track, and in in vitro experiments, linked to oleic acid (HAMLET complex), has shown anticarcinogenic effects against cellular tumor such as human papilloma.", "label": 1, "is_selected": 0, "text": "Alpha-Lactalbumin is the main whey protein in human milk rising 2,44 g/L in mature milk. It has a key function in the synthesis of lactose from glucose and galactose in the mammary gland although this compound has also other beneficial effects on the infant health due to the high proportion of essential aminoacids (tryptophan and cysteine). It seems also to increase iron absorption in the digestive track, and in in vitro experiments, linked to oleic acid (HAMLET complex), has shown anticarcinogenic effects against cellular tumor such as human papilloma."}
{"qid": "52ee9f55c8da898910000009", "original_text": "Recurrent syncope, malignant ventricular arrhythmias, and sudden death are complications of the long QT syndrome (LQTS). Two well-known syndromes with long QT intervals are known. The Jervell and Lange-Nielsen syndrome (JLNS) is characterized by prolongation of the QT interval, deafness, and autosomal-recessive inheritance, and the Romano-Ward syndrome is characterized by a prolonged QT interval, autosomal-dominant inheritance, and no deafness. In the present study assessment was performed of the diagnostic importance of the ventricular derepolarization parameters, clinical features, and prevalence of JLNS among 132 children with congenital hearing loss (CHL).", "label": 1, "is_selected": 0, "text": "Recurrent syncope, malignant ventricular arrhythmias, and sudden death are complications of the long QT syndrome (LQTS). Two well-known syndromes with long QT intervals are known. The Jervell and Lange-Nielsen syndrome (JLNS) is characterized by prolongation of the QT interval, deafness, and autosomal-recessive inheritance, and the Romano-Ward syndrome is characterized by a prolonged QT interval, autosomal-dominant inheritance, and no deafness. In the present study assessment was performed of the diagnostic importance of the ventricular derepolarization parameters, clinical features, and prevalence of JLNS among 132 children with congenital hearing loss (CHL)."}
{"qid": "5883781b2305cd7e21000001", "original_text": "JARID2 is an accessory component of Polycomb repressive complex-2 (PRC2) required for the differentiation of embryonic stem cells (ESCs). A role for JARID2 in the recruitment of PRC2 to target genes silenced during differentiation has been put forward, but the molecular details remain unclear. We identified a 30-amino-acid region of JARID2 that mediates interactions with long noncoding RNAs (lncRNAs) and found that the presence of lncRNAs stimulated JARID2-EZH2 interactions in vitro and JARID2-mediated recruitment of PRC2 to chromatin in vivo.", "label": 1, "is_selected": 0, "text": "JARID2 is an accessory component of Polycomb repressive complex-2 (PRC2) required for the differentiation of embryonic stem cells (ESCs). A role for JARID2 in the recruitment of PRC2 to target genes silenced during differentiation has been put forward, but the molecular details remain unclear. We identified a 30-amino-acid region of JARID2 that mediates interactions with long noncoding RNAs (lncRNAs) and found that the presence of lncRNAs stimulated JARID2-EZH2 interactions in vitro and JARID2-mediated recruitment of PRC2 to chromatin in vivo."}
{"qid": "54f60ae05f206a0c06000008", "original_text": "Approximately 1 million tons of Agave tequilana plants are processed annually by the Mexican Tequila industry generating vast amounts of agricultural waste. The aim of this study was to investigate the potential use of Agave tequilana waste as substrate for the production of commercially important enzymes. Two strains of Aspergillus niger (CH-A-2010 and CH-A-2016), isolated from agave fields, were found to grow and propagate in submerged cultures using Agave tequilana waste as substrate. Isolates showed simultaneous extracellular inulinase, xylanase, pectinase, and cellulase activities.", "label": 1, "is_selected": 0, "text": "Approximately 1 million tons of Agave tequilana plants are processed annually by the Mexican Tequila industry generating vast amounts of agricultural waste. The aim of this study was to investigate the potential use of Agave tequilana waste as substrate for the production of commercially important enzymes. Two strains of Aspergillus niger (CH-A-2010 and CH-A-2016), isolated from agave fields, were found to grow and propagate in submerged cultures using Agave tequilana waste as substrate. Isolates showed simultaneous extracellular inulinase, xylanase, pectinase, and cellulase activities."}
{"qid": "5c8cfca70101eac870000005", "original_text": "RhoGDI\u03b1 is a key regulator of Rho proteins, coordinating their GTP/GDP and membrane/cytosol cycle. Recently, it was demonstrated by quantitative mass spectrometry that RhoGDI\u03b1 is heavily targeted by post-translational lysine acetylation. For one site in its N-terminal domain, namely K52, we reported earlier that acetylation completely switches off RhoGDI\u03b1 function. Herein we show that K52-acetylated RhoGDI\u03b1 is specifically deacetylated by the sirtuin deacetylase Sirt2. We show that acetylation at K52 decelerates cervical cancer cell proliferation, suggesting RhoGDI\u03b1 acetylation to be a promising therapeutic target. We demonstrate that treatment of cervical cancer cells with a RhoGDI\u03b1-derived K52-trifluoroacetylated, substrate-derived peptidic sirtuin inhibitor severely impairs cell proliferation. Finally, we conclude that the potency of substrate-derived sirtuin inhibitors depends on structural features, the substrate-derived amino acid sequence as a determinant for selectivity, as well as the presence of an acetyl-lysine analogue to increase its potency. These data reveal a prospective therapeutic potential for novel substrate-derived sirtuin inhibitors.", "label": 1, "is_selected": 0, "text": "RhoGDI\u03b1 is a key regulator of Rho proteins, coordinating their GTP/GDP and membrane/cytosol cycle. Recently, it was demonstrated by quantitative mass spectrometry that RhoGDI\u03b1 is heavily targeted by post-translational lysine acetylation. For one site in its N-terminal domain, namely K52, we reported earlier that acetylation completely switches off RhoGDI\u03b1 function. Herein we show that K52-acetylated RhoGDI\u03b1 is specifically deacetylated by the sirtuin deacetylase Sirt2. We show that acetylation at K52 decelerates cervical cancer cell proliferation, suggesting RhoGDI\u03b1 acetylation to be a promising therapeutic target. We demonstrate that treatment of cervical cancer cells with a RhoGDI\u03b1-derived K52-trifluoroacetylated, substrate-derived peptidic sirtuin inhibitor severely impairs cell proliferation. Finally, we conclude that the potency of substrate-derived sirtuin inhibitors depends on structural features, the substrate-derived amino acid sequence as a determinant for selectivity, as well as the presence of an acetyl-lysine analogue to increase its potency. These data reveal a prospective therapeutic potential for novel substrate-derived sirtuin inhibitors."}
{"qid": "52f20d802059c6d71c00000a", "original_text": "Yes, the length of the poly(A) tail has been implicated in various human diseases. For instance, aberrant poly(A) tail length has been observed in cancer cells, where it can promote tumor progression and cancer stem cell maintenance. Additionally, mutations in genes responsible for poly(A) tail length regulation, such as TARDBP, have been linked to neurodegenerative disorders like ALS and FTD.", "label": 0, "is_selected": 0, "text": "Yes, the length of the poly(A) tail has been implicated in various human diseases. For instance, aberrant poly(A) tail length has been observed in cancer cells, where it can promote tumor progression and cancer stem cell maintenance. Additionally, mutations in genes responsible for poly(A) tail length regulation, such as TARDBP, have been linked to neurodegenerative disorders like ALS and FTD."}
{"qid": "5c8908a475a4a5d21900000c", "original_text": "Pancreatic cancer is an aggressive malignancy that is unresponsive to conventional radiation and chemotherapy. Therefore, development of novel immune therapeutic strategies is urgently needed. L-4F, an Apolipoprotein A-I (ApoA-I) mimetic peptide, is engineered to mimic the anti-inflammatory and anti-oxidative functionalities of ApoA-I. In this work, H7 cells were orthotopically implanted in C57BL/6 mice and treated with L-4F. Then, pancreatic cancer progression and the inflammatory microenvironment were investigated in vivo.", "label": 1, "is_selected": 0, "text": "Pancreatic cancer is an aggressive malignancy that is unresponsive to conventional radiation and chemotherapy. Therefore, development of novel immune therapeutic strategies is urgently needed. L-4F, an Apolipoprotein A-I (ApoA-I) mimetic peptide, is engineered to mimic the anti-inflammatory and anti-oxidative functionalities of ApoA-I. In this work, H7 cells were orthotopically implanted in C57BL/6 mice and treated with L-4F. Then, pancreatic cancer progression and the inflammatory microenvironment were investigated in vivo."}
{"qid": "5a897a06fcd1d6a10c00000b", "original_text": "A 4-year-old cocker spaniel, male, of 12kg body weight was presented because of the onset of polyuria or polydipsia. From the first months of its life, the dog had exhibited constant serous to mucopurulent nasal discharge, productive cough, sneezing, reverse sneezing, otitis, and recurrent episodes of fever. The respiratory signs had been treated several times with antibiotics, without ever achieving a complete resolution. Clinical examination revealed normal rectal temperature (38.3\u00b0C), increased respiratory rate (40breaths/min), a copious mucous nasal discharge and right deviation of the heart apex beat (ictus cordis).", "label": 1, "is_selected": 0, "text": "A 4-year-old cocker spaniel, male, of 12kg body weight was presented because of the onset of polyuria or polydipsia. From the first months of its life, the dog had exhibited constant serous to mucopurulent nasal discharge, productive cough, sneezing, reverse sneezing, otitis, and recurrent episodes of fever. The respiratory signs had been treated several times with antibiotics, without ever achieving a complete resolution. Clinical examination revealed normal rectal temperature (38.3\u00b0C), increased respiratory rate (40breaths/min), a copious mucous nasal discharge and right deviation of the heart apex beat (ictus cordis)."}
{"qid": "622df6663a8413c6530000a7", "original_text": "Cell competition involves a conserved fitness-sensing process during which fitter cells eliminate neighbouring less-fit but viable cells1. Cell competition has been proposed as a surveillance mechanism to ensure normal development and tissue homeostasis, and has also been suggested to act as a barrier to interspecies chimerism2. However, cell competition has not been studied in an interspecies context during early development owing to the lack of an in vitro model. Here we developed an interspecies pluripotent stem cell (PSC) co-culture strategy and uncovered a previously unknown mode of cell competition between species.", "label": 1, "is_selected": 0, "text": "Cell competition involves a conserved fitness-sensing process during which fitter cells eliminate neighbouring less-fit but viable cells1. Cell competition has been proposed as a surveillance mechanism to ensure normal development and tissue homeostasis, and has also been suggested to act as a barrier to interspecies chimerism2. However, cell competition has not been studied in an interspecies context during early development owing to the lack of an in vitro model. Here we developed an interspecies pluripotent stem cell (PSC) co-culture strategy and uncovered a previously unknown mode of cell competition between species."}
{"qid": "60266cf31cb411341a0000c4", "original_text": "Neuromyelitis Optica Spectrum Disorder (NMOSD) is a chronic autoimmune disease of the central nervous system that causes recurrent attacks of optic neuritis, myelitis, and brainstem symptoms, resulting in severe neurological disability. Preventive treatment with immunosuppressive agents reduces relapse rate and improves long-term prognosis. In recent years, the potential therapeutical effect of new agents has been investigated. Two of these, the anti-interleukin 6 (IL-6) agents tocilizumab and satralizumab, have been studied in active NMOSD. To systematically review the current data regarding the efficacy and safety of anti-IL-6 agents in NMOSD.", "label": 1, "is_selected": 0, "text": "Neuromyelitis Optica Spectrum Disorder (NMOSD) is a chronic autoimmune disease of the central nervous system that causes recurrent attacks of optic neuritis, myelitis, and brainstem symptoms, resulting in severe neurological disability. Preventive treatment with immunosuppressive agents reduces relapse rate and improves long-term prognosis. In recent years, the potential therapeutical effect of new agents has been investigated. Two of these, the anti-interleukin 6 (IL-6) agents tocilizumab and satralizumab, have been studied in active NMOSD. To systematically review the current data regarding the efficacy and safety of anti-IL-6 agents in NMOSD."}
{"qid": "56c8f7445795f9a73e00001b", "original_text": "DNAshape is a protein structure prediction software tool that uses machine learning algorithms to predict the three-dimensional structure of a protein based on its amino acid sequence. It is a widely used tool in the field of protein structure prediction and has been shown to provide accurate predictions for a wide range of protein structures.", "label": 0, "is_selected": 1, "text": "We have developed a new version of DNAshape, a protein structure prediction software tool, which can be used to predict the three-dimensional structure of a protein based on its amino acid sequence, and has been shown to provide accurate predictions for a wide range of protein structures."}
{"qid": "533aaab6d6d3ac6a34000062", "original_text": "Yellow fever virus is primarily transmitted through the bite of an infected mosquito, specifically the Aedes aegypti and Aedes albopictus species. These mosquitoes become infected with the virus when they feed on the blood of an infected human or animal, and then go on to transmit the virus to other hosts through their saliva. The virus can also be transmitted through direct contact with infected blood or body fluids, such as during medical procedures or through organ transplantation. However, these modes of transmission are much less common than mosquito-borne transmission.", "label": 0, "is_selected": 0, "text": "Yellow fever virus is primarily transmitted through the bite of an infected mosquito, specifically the Aedes aegypti and Aedes albopictus species. These mosquitoes become infected with the virus when they feed on the blood of an infected human or animal, and then go on to transmit the virus to other hosts through their saliva. The virus can also be transmitted through direct contact with infected blood or body fluids, such as during medical procedures or through organ transplantation. However, these modes of transmission are much less common than mosquito-borne transmission."}
{"qid": "5e4d6e446d0a27794100002f", "original_text": "MAGE-A3 is a tumor-associated antigen that has been investigated as a potential target for immunotherapy in non-small-cell lung cancer (NSCLC). While the results of clinical trials have been promising, the overall effectiveness of MAGE-A3 immunotherapy for NSCLC remains uncertain. Several studies have shown that MAGE-A3 is overexpressed in a significant proportion of NSCLC cases, including adenocarcinoma and squamous cell carcinoma. High MAGE-A3 expression has been associated with poor prognosis and treatment resistance in NSCLC patients. Therefore, targeting MAGE-A3 with immunotherapy has been proposed as a potential strategy to enhance the antitumor immune response and improve clinical outcomes. Several MAGE-A3-targeting immunotherapeutic approaches have been evaluated in clinical trials, including cancer vaccines, monoclonal antibodies, and T-cell therapies. These studies have demonstrated encouraging responses, including complete and partial responses, in a subset of NSCLC patients. For example, a phase II clinical trial published in the Journal of Clinical Oncology in 2018 evaluated the safety and efficacy of the MAGE-A3 cancer vaccine, CT-011, in patients with advanced NSCLC. The study found that CT-011 was well-tolerated and induced immune responses against MAGE-A3 in most patients. The overall response rate (ORR) was 18%, and the duration of response was median 6.4 months. Another study published in the New England Journal of Medicine in 2019 evaluated the efficacy and safety of the monoclonal antibody, blinatumomab, in patients with relapsed or refractory NSCLC. The study found that blinatumomab improved overall survival compared to chemotherapy in this patient population, with an ORR of 33%. Despite these encouraging results, the broader adoption of MAGE-A3 immunotherapy for NSCLC has been limited by several factors, including the relatively small size of the treatment-naive patient population, the lack of robust biomarkers to identify responders, and the potential for off-target effects. In conclusion, while the results of clinical trials suggest that MAGE-A3 immunotherapy may be effective for some patients with NSCLC, further research is needed to confirm these findings and to identify the optimal population and treatment approach. until more data are available, MAGE-A3 immunotherapy remains an investigational strategy for NSCLC.", "label": 0, "is_selected": 0, "text": "MAGE-A3 is a tumor-associated antigen that has been investigated as a potential target for immunotherapy in non-small-cell lung cancer (NSCLC). While the results of clinical trials have been promising, the overall effectiveness of MAGE-A3 immunotherapy for NSCLC remains uncertain. Several studies have shown that MAGE-A3 is overexpressed in a significant proportion of NSCLC cases, including adenocarcinoma and squamous cell carcinoma. High MAGE-A3 expression has been associated with poor prognosis and treatment resistance in NSCLC patients. Therefore, targeting MAGE-A3 with immunotherapy has been proposed as a potential strategy to enhance the antitumor immune response and improve clinical outcomes. Several MAGE-A3-targeting immunotherapeutic approaches have been evaluated in clinical trials, including cancer vaccines, monoclonal antibodies, and T-cell therapies. These studies have demonstrated encouraging responses, including complete and partial responses, in a subset of NSCLC patients. For example, a phase II clinical trial published in the Journal of Clinical Oncology in 2018 evaluated the safety and efficacy of the MAGE-A3 cancer vaccine, CT-011, in patients with advanced NSCLC. The study found that CT-011 was well-tolerated and induced immune responses against MAGE-A3 in most patients. The overall response rate (ORR) was 18%, and the duration of response was median 6.4 months. Another study published in the New England Journal of Medicine in 2019 evaluated the efficacy and safety of the monoclonal antibody, blinatumomab, in patients with relapsed or refractory NSCLC. The study found that blinatumomab improved overall survival compared to chemotherapy in this patient population, with an ORR of 33%. Despite these encouraging results, the broader adoption of MAGE-A3 immunotherapy for NSCLC has been limited by several factors, including the relatively small size of the treatment-naive patient population, the lack of robust biomarkers to identify responders, and the potential for off-target effects. In conclusion, while the results of clinical trials suggest that MAGE-A3 immunotherapy may be effective for some patients with NSCLC, further research is needed to confirm these findings and to identify the optimal population and treatment approach. until more data are available, MAGE-A3 immunotherapy remains an investigational strategy for NSCLC."}
{"qid": "601db7fb1cb411341a00004a", "original_text": "Ionizing radiation is known to induce genetic damage in diverse groups of organisms. Under accidental situations, large quantities of radioactive elements get released into the environment and radiation emitted from these radionuclides may adversely affect both the man and the non-human biota. The present study is aimed (a) to know the genotoxic effect of gamma radiation on aquatic fauna employing two species of selected bivalves, (b) to evaluate the possible use of 'Comet assay' for detecting genetic damage in haemocytes of bivalves as a biomarker for environmental biomonitoring and also (c) to compare the relative sensitivity of two species of bivalves viz. Paphia malabarica and Meretrix casta to gamma radiation.", "label": 1, "is_selected": 0, "text": "Ionizing radiation is known to induce genetic damage in diverse groups of organisms. Under accidental situations, large quantities of radioactive elements get released into the environment and radiation emitted from these radionuclides may adversely affect both the man and the non-human biota. The present study is aimed (a) to know the genotoxic effect of gamma radiation on aquatic fauna employing two species of selected bivalves, (b) to evaluate the possible use of 'Comet assay' for detecting genetic damage in haemocytes of bivalves as a biomarker for environmental biomonitoring and also (c) to compare the relative sensitivity of two species of bivalves viz. Paphia malabarica and Meretrix casta to gamma radiation."}
{"qid": "5c7036127c78d69471000064", "original_text": "The RAZOR trial compared two surgical methods for the treatment of groin hernias: open hernia repair and laparoscopic hernia repair. In the open hernia repair group, the surgeon makes an incision in the abdomen to directly visualize and repair the hernia. In contrast, the laparoscopic hernia repair group underwent a minimally invasive procedure, where a few small incisions were made in the abdomen, and a laparoscope (a thin tube with a camera and light) was used to visualize the hernia. The surgeon then repaired the hernia through these small incisions using specialized instruments.", "label": 0, "is_selected": 1, "text": "The results of a clinical trial have shown that a minimally invasive method of hernia repair is more effective than an open method in the treatment of groin hernias, according to researchers at the University of California, Los Angeles (UCLA) and the Keck School of Medicine of USC."}
{"qid": "58a9d3cd396a458e50000004", "original_text": "Restoration of the open reading frame of the DMD gene and dystrophin protein production in Duchenne muscular dystrophy (DMD) can be achieved by exon skipping using antisense oligomers (AOs) targeted to splicing elements. Several such RNA-based gene therapy approaches are in clinical development in which all studies to date have assessed AO efficacy by semiquantitative nested reverse-transcription polymerase chain reaction (RT-PCR). Precise evaluation of dystrophin protein levels is complex and hindered by the large size and low abundance of dystrophin; thus an accurate and standardized measurement of DMD exon skipping at the RNA level remains important to assess and compare patient responses in DMD exon skipping clinical trials.", "label": 1, "is_selected": 0, "text": "Restoration of the open reading frame of the DMD gene and dystrophin protein production in Duchenne muscular dystrophy (DMD) can be achieved by exon skipping using antisense oligomers (AOs) targeted to splicing elements. Several such RNA-based gene therapy approaches are in clinical development in which all studies to date have assessed AO efficacy by semiquantitative nested reverse-transcription polymerase chain reaction (RT-PCR). Precise evaluation of dystrophin protein levels is complex and hindered by the large size and low abundance of dystrophin; thus an accurate and standardized measurement of DMD exon skipping at the RNA level remains important to assess and compare patient responses in DMD exon skipping clinical trials."}
{"qid": "5a6cfe27b750ff4455000029", "original_text": "SMiLE-seq is a single-cell sequencing technique that allows for the simultaneous analysis of multiple genomic features, including DNA methylation, histone modification, and transcriptome profiling, from the same cell. This approach enables the study of cellular heterogeneity at an unprecedented level, providing valuable insights into cellular differentiation, lineage commitment, and cellular states. By combining multiple omics data types, SMiLE-seq enables researchers to gain a comprehensive understanding of cellular regulation and function.", "label": 0, "is_selected": 1, "text": "SMiLE-seq is a single-cell sequencing technique that allows for the simultaneous analysis of multiple genomic features, including DNA histone modification, and transcript profiling, from the same cell, enabling researchers to gain a comprehensive understanding of cellular regulation and function."}
{"qid": "5541ffc3472cfd8617000004", "original_text": "V79 Chinese hamster cells expressing either the O6-alkylguanine-DNA-alkyltransferase (ATase) encoded by the E. coli ogt gene or a truncated version of the E. coli ada gene have been exposed to various alkylnitrosoureas to investigate the contribution of ATase repairable lesions to the toxicity of these compounds. Both ATases are able to repair O6-alkylguanine (O6-AlkG) and O4-alkylthymine (O4-AlkT) but the ogt ATase is more efficient in the repair of O4-methylthymine (O4-MeT) and higher alkyl derivatives of O6-AlkG than is the ada ATase. Expression of the ogt ATase provided greater protection against the toxic effects of the alkylating agents then the ada ATase particularly with N-ethyl-N-nitrosourea (ENU) and N-butyl-N-nitrosourea (BNU) to which the ada ATase expressing cells were as sensitive as parent vector transfected cells.", "label": 1, "is_selected": 0, "text": "V79 Chinese hamster cells expressing either the O6-alkylguanine-DNA-alkyltransferase (ATase) encoded by the E. coli ogt gene or a truncated version of the E. coli ada gene have been exposed to various alkylnitrosoureas to investigate the contribution of ATase repairable lesions to the toxicity of these compounds. Both ATases are able to repair O6-alkylguanine (O6-AlkG) and O4-alkylthymine (O4-AlkT) but the ogt ATase is more efficient in the repair of O4-methylthymine (O4-MeT) and higher alkyl derivatives of O6-AlkG than is the ada ATase. Expression of the ogt ATase provided greater protection against the toxic effects of the alkylating agents then the ada ATase particularly with N-ethyl-N-nitrosourea (ENU) and N-butyl-N-nitrosourea (BNU) to which the ada ATase expressing cells were as sensitive as parent vector transfected cells."}
{"qid": "571696d9cb4ef8864c000009", "original_text": "RNA polymerase (Pol) II catalyses DNA-dependent RNA synthesis during gene transcription. There is, however, evidence that Pol II also possesses RNA-dependent RNA polymerase (RdRP) activity. Pol II can use a homopolymeric RNA template, can extend RNA by several nucleotides in the absence of DNA, and has been implicated in the replication of the RNA genomes of hepatitis delta virus (HDV) and plant viroids. Here we show the intrinsic RdRP activity of Pol II with only pure polymerase, an RNA template-product scaffold and nucleoside triphosphates (NTPs).", "label": 1, "is_selected": 0, "text": "RNA polymerase (Pol) II catalyses DNA-dependent RNA synthesis during gene transcription. There is, however, evidence that Pol II also possesses RNA-dependent RNA polymerase (RdRP) activity. Pol II can use a homopolymeric RNA template, can extend RNA by several nucleotides in the absence of DNA, and has been implicated in the replication of the RNA genomes of hepatitis delta virus (HDV) and plant viroids. Here we show the intrinsic RdRP activity of Pol II with only pure polymerase, an RNA template-product scaffold and nucleoside triphosphates (NTPs)."}
{"qid": "5e550b5db761aafe09000007", "original_text": "Osanetant and talnetant are both anticholinergic drugs used to treat various respiratory and gastrointestinal conditions. They have several common properties and mechanisms of action: Both osanetant and talnetant are antagonists of acetylcholine, a neurotransmitter that plays a crucial role in the regulation of smooth muscle relaxation and contraction. By blocking acetylcholine receptors, these drugs can help to relax airway muscles and improve lung function in conditions such as asthma and chronic obstructive pulmonary disease (COPD). In addition, both osanetant and talnetant have antispasmodic effects, reducing abnormal muscle contractions in the digestive tract that can cause symptoms such as cramping, abdominal pain, and diarrhea. It is worth noting that while these drugs have similar mechanisms of action, they have different chemical structures and may have different pharmacokinetic and pharmacodynamic properties, which may affect their efficacy and safety profiles.", "label": 0, "is_selected": 1, "text": "Both osanetant and talnetant have similar mechanisms of action and have different chemical structures and pharmacodynamic properties, which may affect their efficacy and safety profiles. It is worth noting that while these drugs have similar properties and mechanisms of Action, they have different Chemical Structures and Pharmacodynamic Properties, Which May Affect Their efficacy and Safety Profiles."}
{"qid": "5e550b5db761aafe09000007", "original_text": "The NK3 receptor is a GPCR that is prominently expressed in limbic areas of the brain, many of which have been implicated in schizophrenia. Phase II clinical trials in schizophrenia with two selective NK3 antagonists (osanetant and talnetant) have demonstrated significant improvement in positive symptoms. The objective of this study was to characterize the properties of a novel dual NK2/NK3 antagonist, RO5328673. [(3)H]RO5328673 bound to a single saturable site on hNK2, hNK3 and gpNK3 with high-affinity. RO5328673 acted as an insurmountable antagonist at both human and guinea-pig NK3 receptors in the [(3)H]IP accumulation assay. In binding kinetic analyses, [(3)H]RO5328673 had fast association and dissociation rates at hNK2 while it had a fast association rate and a remarkably slow dissociation rate at gp and hNK3. In electrophysiological recordings of gp SNpc, RO5328673 inhibited the senktide-induced potentiation of spontaneous activity of dopaminergic neurons with an insurmountable mechanism of action.", "label": 1, "is_selected": 0, "text": "The NK3 receptor is a GPCR that is prominently expressed in limbic areas of the brain, many of which have been implicated in schizophrenia. Phase II clinical trials in schizophrenia with two selective NK3 antagonists (osanetant and talnetant) have demonstrated significant improvement in positive symptoms. The objective of this study was to characterize the properties of a novel dual NK2/NK3 antagonist, RO5328673. [(3)H]RO5328673 bound to a single saturable site on hNK2, hNK3 and gpNK3 with high-affinity. RO5328673 acted as an insurmountable antagonist at both human and guinea-pig NK3 receptors in the [(3)H]IP accumulation assay. In binding kinetic analyses, [(3)H]RO5328673 had fast association and dissociation rates at hNK2 while it had a fast association rate and a remarkably slow dissociation rate at gp and hNK3. In electrophysiological recordings of gp SNpc, RO5328673 inhibited the senktide-induced potentiation of spontaneous activity of dopaminergic neurons with an insurmountable mechanism of action."}
{"qid": "5548da00f35db7552600000b", "original_text": "To understand how cells differentially use the dozens of myosin isozymes present in each genome, we examined the distribution of four unconventional myosin isozymes in the inner ear, a tissue that is particularly reliant on actin-rich structures and unconventional myosin isozymes. Of the four isozymes, each from a different class, three are expressed in the hair cells of amphibia and mammals. In stereocilia, constructed of cross-linked F-actin filaments, myosin-Ibeta is found mostly near stereociliary tips, myosin-VI is largely absent, and myosin-VIIa colocalizes with crosslinks that connect adjacent stereocilia.", "label": 1, "is_selected": 0, "text": "To understand how cells differentially use the dozens of myosin isozymes present in each genome, we examined the distribution of four unconventional myosin isozymes in the inner ear, a tissue that is particularly reliant on actin-rich structures and unconventional myosin isozymes. Of the four isozymes, each from a different class, three are expressed in the hair cells of amphibia and mammals. In stereocilia, constructed of cross-linked F-actin filaments, myosin-Ibeta is found mostly near stereociliary tips, myosin-VI is largely absent, and myosin-VIIa colocalizes with crosslinks that connect adjacent stereocilia."}
{"qid": "55031406e9bde69634000021", "original_text": "Patients with severe chronic neutropenia have blood neutrophil level <0.5 \u00d7 10(9)/L, predisposing them to increased susceptibility to life-threatening bacterial infections. This chapter focuses on cyclic and congenital neutropenia, two very interesting and rare hematological conditions causing severe chronic neutropenia. Both disorders respond well to treatment with the myeloid growth factor, granulocyte colony-stimulating factor (G-CSF). This chapter describes the basic features of these diseases and addresses several current clinical issues regarding their diagnosis and management. Cyclic neutropenia is a rare, inherited autosomal dominant disorder due to mutations in the gene for neutrophil elastase (ELA-2 or ELANE). Usually these patients have regular oscillation of blood neutrophil counts with periods of severe neutropenia occurring every 21 days. During these periods, they have painful mouth ulcers, fevers, and bacterial infections. The most severe consequences are gangrene, bacteremia, and septic shock. Cyclic neutropenia patients respond well to treatment with granulocyte colony-stimulating factor (G-CSF) given by subcutaneous injections on a daily or alternate-day basis.", "label": 1, "is_selected": 0, "text": "Patients with severe chronic neutropenia have blood neutrophil level <0.5 \u00d7 10(9)/L, predisposing them to increased susceptibility to life-threatening bacterial infections. This chapter focuses on cyclic and congenital neutropenia, two very interesting and rare hematological conditions causing severe chronic neutropenia. Both disorders respond well to treatment with the myeloid growth factor, granulocyte colony-stimulating factor (G-CSF). This chapter describes the basic features of these diseases and addresses several current clinical issues regarding their diagnosis and management. Cyclic neutropenia is a rare, inherited autosomal dominant disorder due to mutations in the gene for neutrophil elastase (ELA-2 or ELANE). Usually these patients have regular oscillation of blood neutrophil counts with periods of severe neutropenia occurring every 21 days. During these periods, they have painful mouth ulcers, fevers, and bacterial infections. The most severe consequences are gangrene, bacteremia, and septic shock. Cyclic neutropenia patients respond well to treatment with granulocyte colony-stimulating factor (G-CSF) given by subcutaneous injections on a daily or alternate-day basis."}
{"qid": "621911323a8413c653000038", "original_text": "The tool developed to discover VNTR-associated deletions is PCR-based methods, such as PCR-SSCP (Polymerase Chain Reaction-Single Strand Conformation Polymorphism) or PCR-DGGE (Polymerase Chain Reaction-Denaturing Gradient Gel Electrophoresis). These methods use PCR to amplify the VNTR region and then analyze the resulting fragments using SSCP or DGGE to identify deletions.", "label": 0, "is_selected": 0, "text": "The tool developed to discover VNTR-associated deletions is PCR-based methods, such as PCR-SSCP (Polymerase Chain Reaction-Single Strand Conformation Polymorphism) or PCR-DGGE (Polymerase Chain Reaction-Denaturing Gradient Gel Electrophoresis). These methods use PCR to amplify the VNTR region and then analyze the resulting fragments using SSCP or DGGE to identify deletions."}
{"qid": "533c384dc45e133714000006", "original_text": "Adaptation to cold and warm conditions requires dramatic change in gene expression. The acclimatization process of the common carp Cyprinus carpio L. in its natural habitat has been used to study how organisms respond to natural environmental changes. At the cellular level, adaptation to cold condition is accompanied by a dramatic alteration in nucleolar structure and a down regulation of the expression of ribosomal genes. We show that the enrichment of condensed chromatin in winter adapted cells is not correlated with an increase of the heterochromatin marker trimethyl and monomethyl K20H4.", "label": 1, "is_selected": 0, "text": "Adaptation to cold and warm conditions requires dramatic change in gene expression. The acclimatization process of the common carp Cyprinus carpio L. in its natural habitat has been used to study how organisms respond to natural environmental changes. At the cellular level, adaptation to cold condition is accompanied by a dramatic alteration in nucleolar structure and a down regulation of the expression of ribosomal genes. We show that the enrichment of condensed chromatin in winter adapted cells is not correlated with an increase of the heterochromatin marker trimethyl and monomethyl K20H4."}
{"qid": "51716e808ed59a060a00000b", "original_text": "The vector of Louping ill virus is the Culicoides midges. These midge species are found throughout the United Kingdom and are responsible for transmitting the virus to sheep and other livestock. The virus is primarily transmitted through the bite of an infected midge, which can lead to the development of louping ill disease in sheep.", "label": 0, "is_selected": 0, "text": "The vector of Louping ill virus is the Culicoides midges. These midge species are found throughout the United Kingdom and are responsible for transmitting the virus to sheep and other livestock. The virus is primarily transmitted through the bite of an infected midge, which can lead to the development of louping ill disease in sheep."}
{"qid": "606b7e5694d57fd879000070", "original_text": "The FoundationOne companion diagnostic screens for a total of 324 genes, including both rare and common mutations, across various cancer types. These genes are selected based on their known importance in cancer development and progression, and their potential as targets for cancer therapy. The test provides genomic information on a patient's tumor DNA, which can help identify actionable mutations and guide personalized treatment decisions. The 324 genes screened by FoundationOne include genes involved in cell growth and division, DNA repair, and other cellular processes, as well as genes that are commonly mutated in various cancers, such as HER2 in breast cancer and EGFR in non-small cell lung cancer.", "label": 0, "is_selected": 0, "text": "The FoundationOne companion diagnostic screens for a total of 324 genes, including both rare and common mutations, across various cancer types. These genes are selected based on their known importance in cancer development and progression, and their potential as targets for cancer therapy. The test provides genomic information on a patient's tumor DNA, which can help identify actionable mutations and guide personalized treatment decisions. The 324 genes screened by FoundationOne include genes involved in cell growth and division, DNA repair, and other cellular processes, as well as genes that are commonly mutated in various cancers, such as HER2 in breast cancer and EGFR in non-small cell lung cancer."}
{"qid": "5173a8b48ed59a060a00001d", "original_text": "The characteristic AA(TT) sequence pattern of the nucleosome DNA derived earlier is used for prediction of nucleosome positions around splice junctions of eukaryotic genes. Two large datasets (2000 sequences each) were collected consisting of DNA segments with the exon/intron and intron/exon splice junctions, from various eukaryotic species. Positions of predicted nucleosomes near the junction sites were calculated. Those junctions which are found to belong to the nucleosomes, are located preferentially within a few base pairs from the midpoint of the nucleosome DNA. That is, obligatory GT- and AG-ends of the introns are more frequently located near the nucleosome dyad axis, within the best protected middle 10-15 base pairs of the nucleosome DNA.", "label": 1, "is_selected": 0, "text": "The characteristic AA(TT) sequence pattern of the nucleosome DNA derived earlier is used for prediction of nucleosome positions around splice junctions of eukaryotic genes. Two large datasets (2000 sequences each) were collected consisting of DNA segments with the exon/intron and intron/exon splice junctions, from various eukaryotic species. Positions of predicted nucleosomes near the junction sites were calculated. Those junctions which are found to belong to the nucleosomes, are located preferentially within a few base pairs from the midpoint of the nucleosome DNA. That is, obligatory GT- and AG-ends of the introns are more frequently located near the nucleosome dyad axis, within the best protected middle 10-15 base pairs of the nucleosome DNA."}
{"qid": "56d2adc5f22319765a000005", "original_text": "CCDC39 and CCDC40 genes have recently been implicated in primary ciliary dyskinesia (PCD) with inner dynein arm (IDA) defects and axonemal disorganisation; their contribution to the disease is, however, unknown. Aiming to delineate the CCDC39/CCDC40 mutation spectrum and associated phenotypes, this study screened a large cohort of patients with IDA defects, in whom clinical and ciliary phenotypes were accurately described. All CCDC39 and CCDC40 exons and intronic boundaries were sequenced in 43 patients from 40 unrelated families.", "label": 1, "is_selected": 0, "text": "CCDC39 and CCDC40 genes have recently been implicated in primary ciliary dyskinesia (PCD) with inner dynein arm (IDA) defects and axonemal disorganisation; their contribution to the disease is, however, unknown. Aiming to delineate the CCDC39/CCDC40 mutation spectrum and associated phenotypes, this study screened a large cohort of patients with IDA defects, in whom clinical and ciliary phenotypes were accurately described. All CCDC39 and CCDC40 exons and intronic boundaries were sequenced in 43 patients from 40 unrelated families."}
{"qid": "551af9106b348bb82c000002", "original_text": "The MTH1 enzyme is a DNA glycosylase that plays a crucial role in maintaining genome stability by repairing DNA damage caused by oxidative stress. In cancer cells, MTH1 is overexpressed and promotes cancer progression by suppressing the repair of DNA single-strand breaks. This allows cancer cells to accumulate DNA damage and develop resistance to chemotherapy and radiation therapy. Additionally, MTH1 has been shown to interact with oncogenic proteins and promote their activity, thereby contributing to tumorigenesis. Overall, the dysregulation of MTH1 has been implicated in various types of cancer, highlighting its potential as a therapeutic target for cancer treatment.", "label": 0, "is_selected": 1, "text": "The MTH1 enzyme has been implicated in a number of cancers, including breast cancer, lung cancer, pancreatic cancer, and prostate cancer, as well as in other neurodegenerative diseases, such as Alzheimer's disease and Parkinson's syndrome."}
{"qid": "61faa1fcc9dfcb9c0900000a", "original_text": "Findings from a phase I study suggest that delivering high concentrations of the chemotherapy 5-FU directly to brain tumors via the retroviral vector vocimagene amiretrorepvec, or Toca 511, may benefit patients with recurrent high-grade glioma. This investigational treatment was well tolerated and induced robust, durable responses lasting a median of 3 years.", "label": 1, "is_selected": 0, "text": "Findings from a phase I study suggest that delivering high concentrations of the chemotherapy 5-FU directly to brain tumors via the retroviral vector vocimagene amiretrorepvec, or Toca 511, may benefit patients with recurrent high-grade glioma. This investigational treatment was well tolerated and induced robust, durable responses lasting a median of 3 years."}
{"qid": "6026754f1cb411341a0000c8", "original_text": "There are no disease-modifying treatments for Alzheimer disease (AD), the most common cause of dementia. Minocycline is anti-inflammatory, protects against the toxic effects of \u03b2-amyloid in vitro and in animal models of AD, and is a credible repurposed treatment candidate. To determine whether 24 months of minocycline treatment can modify cognitive and functional decline in patients with mild AD. Participants were recruited into a double-blind randomized clinical trial from May 23, 2014, to April 14, 2016, with 24 months of treatment and follow-up. This multicenter study in England and Scotland involved 32 National Health Service memory clinics within secondary specialist services for people with dementia. From 886 screened patients, 554 patients with a diagnosis of mild AD (Standardised Mini-Mental State Examination [sMMSE] score \u226524) were randomized. Participants were randomly allocated 1:1:1 in a semifactorial design to receive minocycline (400 mg/d or 200 mg/d) or placebo for 24 months. Primary outcome measures were decrease in sMMSE score and Bristol Activities of Daily Living Scale (BADLS), analyzed by intention-to-treat repeated-measures regression. Of 544 eligible participants (241 women and 303 men), the mean (SD) age was 74.3 (8.2) years, and the mean (SD) sMMSE score was 26.4 (1.9). Fewer participants completed 400-mg minocycline hydrochloride treatment (28.8% [53 of 184]) than 200-mg minocycline treatment (61.9% [112 of 181]) or placebo (63.7% [114 of 179]; P < .001), mainly because of gastrointestinal symptoms (42 in the 400-mg group, 15 in the 200-mg group, and 10 in the placebo group; P < .001), dermatologic adverse effects (10 in the 400-mg group, 5 in the 200-mg group, and 1 in the placebo group; P = .02), and dizziness (14 in the 400-mg group, 3 in the 200-mg group, and 1 in the placebo group; P = .01). Assessment rates were lower in the 400-mg group: 68.4% (119 of 174 expected) for sMMSE at 24 months compared with 81.8% (144 of 176) for the 200-mg group and 83.8% (140 of 167) for the placebo group. Decrease in sMMSE scores over 24 months in the combined minocycline group was similar to that in the placebo group (4.1 vs 4.3 points). The combined minocycline group had mean sMMSE scores 0.1 points higher than the placebo group (95% CI, -1.1 to 1.2; P = .90). The decrease in mean sMMSE scores was less in the 400-mg group than in the 200-mg group (3.3 vs 4.7 points; treatment effect = 1.2; 95% CI, -0.1 to 2.5; P = .08). Worsening of BADLS scores over 24 months was similar in all groups: 5.7 in the 400-mg group, 6.6 in the 200-mg group, and 6.2 in the placebo groups (treatment effect for minocycline vs placebo = -0.53; 95% CI, -2.4 to 1.3; P = .57; treatment effect for 400 mg vs 200 mg of minocycline = -0.31; 95% CI, -0.2 to 1.8; P = .77).", "label": 1, "is_selected": 0, "text": "There are no disease-modifying treatments for Alzheimer disease (AD), the most common cause of dementia. Minocycline is anti-inflammatory, protects against the toxic effects of \u03b2-amyloid in vitro and in animal models of AD, and is a credible repurposed treatment candidate. To determine whether 24 months of minocycline treatment can modify cognitive and functional decline in patients with mild AD. Participants were recruited into a double-blind randomized clinical trial from May 23, 2014, to April 14, 2016, with 24 months of treatment and follow-up. This multicenter study in England and Scotland involved 32 National Health Service memory clinics within secondary specialist services for people with dementia. From 886 screened patients, 554 patients with a diagnosis of mild AD (Standardised Mini-Mental State Examination [sMMSE] score \u226524) were randomized. Participants were randomly allocated 1:1:1 in a semifactorial design to receive minocycline (400 mg/d or 200 mg/d) or placebo for 24 months. Primary outcome measures were decrease in sMMSE score and Bristol Activities of Daily Living Scale (BADLS), analyzed by intention-to-treat repeated-measures regression. Of 544 eligible participants (241 women and 303 men), the mean (SD) age was 74.3 (8.2) years, and the mean (SD) sMMSE score was 26.4 (1.9). Fewer participants completed 400-mg minocycline hydrochloride treatment (28.8% [53 of 184]) than 200-mg minocycline treatment (61.9% [112 of 181]) or placebo (63.7% [114 of 179]; P < .001), mainly because of gastrointestinal symptoms (42 in the 400-mg group, 15 in the 200-mg group, and 10 in the placebo group; P < .001), dermatologic adverse effects (10 in the 400-mg group, 5 in the 200-mg group, and 1 in the placebo group; P = .02), and dizziness (14 in the 400-mg group, 3 in the 200-mg group, and 1 in the placebo group; P = .01). Assessment rates were lower in the 400-mg group: 68.4% (119 of 174 expected) for sMMSE at 24 months compared with 81.8% (144 of 176) for the 200-mg group and 83.8% (140 of 167) for the placebo group. Decrease in sMMSE scores over 24 months in the combined minocycline group was similar to that in the placebo group (4.1 vs 4.3 points). The combined minocycline group had mean sMMSE scores 0.1 points higher than the placebo group (95% CI, -1.1 to 1.2; P = .90). The decrease in mean sMMSE scores was less in the 400-mg group than in the 200-mg group (3.3 vs 4.7 points; treatment effect = 1.2; 95% CI, -0.1 to 2.5; P = .08). Worsening of BADLS scores over 24 months was similar in all groups: 5.7 in the 400-mg group, 6.6 in the 200-mg group, and 6.2 in the placebo groups (treatment effect for minocycline vs placebo = -0.53; 95% CI, -2.4 to 1.3; P = .57; treatment effect for 400 mg vs 200 mg of minocycline = -0.31; 95% CI, -0.2 to 1.8; P = .77)."}
{"qid": "58963b0278275d0c4a00000c", "original_text": "Yes, alternative polyadenylation (APA) occurs during zebrafish development. APA is a mechanism of gene regulation where different polyadenylation sites are used for the same mRNA transcript, leading to different 3' UTR sequences and potentially altered gene expression. Studies have shown that APA plays a crucial role in zebrafish development, particularly during embryogenesis and tissue differentiation. For example, APA has been observed to influence the expression of genes involved in neural development andpatterning. Moreover, APA has been implicated in the regulation of key developmental genes, such as bcd and cdx1, which are crucial for proper embryonic development. Overall, APA is an important regulatory mechanism during zebrafish development, contributing to the precise control of gene expression needed for proper development and patterning.", "label": 0, "is_selected": 1, "text": "What is alternative polyadenylation and what is its role in zebrafish development and how is it important for the proper development and patterning of the embryos in terms of the expression of genes and the formation of new tissue and tissue differentiating cells?, by Simona De Simone, University of Bristol, Bristol, United Kingdom."}
{"qid": "56a37e33496b62f23f000003", "original_text": "Short palindromic sequences (4, 5 and 6 bp palindromes) are avoided at a statistically significant level in the genomes of several bacteria, including the completely sequenced Haemophilus influenzae and Synechocystis sp. genomes and in the complete genome of the archaeon Methanococcus jannaschii. In contrast, there is only moderate avoidance of palindromes in the small genome of the bacterium Mycoplasma genitalium and no detectable avoidance in the genomes of chloroplasts and mitochondria. The sites for type II restriction-modification enzymes detected in the given species tend to be among the most avoided palindromes in a particular genome, indicating a direct connection between the avoidance of short oligonucleotide words and restriction-modification systems with the respective specificity. Palindromes corresponding to sites for restriction enzymes from other species are also avoided, albeit less significantly, suggesting that in the course of evolution bacterial DNA has been exposed to a wide spectrum of restriction enzymes, probably as the result of lateral transfer mediated by mobile genetic elements, such as plasmids and prophages. Palindromic words appear to accumulate in DNA once it becomes isolated from restriction-modification systems, as demonstrated by the case of organellar genomes. By combining these observations with protein sequence analysis, we show that the most avoided 4-palindrome and the most avoided 6-palindrome in the archaeon M.jannaschii are likely to be recognition sites for two novel restriction-modification systems.", "label": 1, "is_selected": 0, "text": "Short palindromic sequences (4, 5 and 6 bp palindromes) are avoided at a statistically significant level in the genomes of several bacteria, including the completely sequenced Haemophilus influenzae and Synechocystis sp. genomes and in the complete genome of the archaeon Methanococcus jannaschii. In contrast, there is only moderate avoidance of palindromes in the small genome of the bacterium Mycoplasma genitalium and no detectable avoidance in the genomes of chloroplasts and mitochondria. The sites for type II restriction-modification enzymes detected in the given species tend to be among the most avoided palindromes in a particular genome, indicating a direct connection between the avoidance of short oligonucleotide words and restriction-modification systems with the respective specificity. Palindromes corresponding to sites for restriction enzymes from other species are also avoided, albeit less significantly, suggesting that in the course of evolution bacterial DNA has been exposed to a wide spectrum of restriction enzymes, probably as the result of lateral transfer mediated by mobile genetic elements, such as plasmids and prophages. Palindromic words appear to accumulate in DNA once it becomes isolated from restriction-modification systems, as demonstrated by the case of organellar genomes. By combining these observations with protein sequence analysis, we show that the most avoided 4-palindrome and the most avoided 6-palindrome in the archaeon M.jannaschii are likely to be recognition sites for two novel restriction-modification systems."}
{"qid": "52f77f042059c6d71c000029", "original_text": "In recent years, a group of tumors that have been designated \"perivascular epithelioid cell tumors\" (PEComa) have been reported with increasing frequency from a wide variety of anatomic locations. The uterus and retroperitoneum appear to be the most frequent sites of origin for these lesions. PEComas belong to an identically named family of tumors comprised of conventional angiomyolipomas, clear cell sugar tumors, lymphangiomyomatosis and clear cell myomelanocytic tumor of the falciform ligament/ligament teres, and are also known as PEComa-NOS. This article is a primer for clinicians on the most salient clinicopathologic features of uterine PEComas, as most of the debate and discussion have taken place in the pathologic literature. The author appraises in detail the current state of knowledge on PEComas of the uterus based on a review of published data on the 44 previously reported cases, and comments on areas of controversy. The latter are centered predominantly on the significant morphologic and immunophenotypic overlap that exists between uterine PEComa and some smooth muscle tumors of the uterus.", "label": 1, "is_selected": 0, "text": "In recent years, a group of tumors that have been designated \"perivascular epithelioid cell tumors\" (PEComa) have been reported with increasing frequency from a wide variety of anatomic locations. The uterus and retroperitoneum appear to be the most frequent sites of origin for these lesions. PEComas belong to an identically named family of tumors comprised of conventional angiomyolipomas, clear cell sugar tumors, lymphangiomyomatosis and clear cell myomelanocytic tumor of the falciform ligament/ligament teres, and are also known as PEComa-NOS. This article is a primer for clinicians on the most salient clinicopathologic features of uterine PEComas, as most of the debate and discussion have taken place in the pathologic literature. The author appraises in detail the current state of knowledge on PEComas of the uterus based on a review of published data on the 44 previously reported cases, and comments on areas of controversy. The latter are centered predominantly on the significant morphologic and immunophenotypic overlap that exists between uterine PEComa and some smooth muscle tumors of the uterus."}
{"qid": "5c3479dcda8336e21a000002", "original_text": "Identifying the molecular changes that lead to ecological specialization during speciation is one of the major goals of molecular evolution. One question that remains to be thoroughly investigated is whether ecological specialization derives strictly from adaptive changes and their associated trade-offs, or from conditionally neutral mutations that accumulate under relaxed selection. We used whole-genome sequencing, genome annotation and computational analyses to identify genes that have rapidly diverged between two incipient species of Saccharomyces paradoxus that occupy different climatic regions along a south-west to north-east gradient.", "label": 1, "is_selected": 0, "text": "Identifying the molecular changes that lead to ecological specialization during speciation is one of the major goals of molecular evolution. One question that remains to be thoroughly investigated is whether ecological specialization derives strictly from adaptive changes and their associated trade-offs, or from conditionally neutral mutations that accumulate under relaxed selection. We used whole-genome sequencing, genome annotation and computational analyses to identify genes that have rapidly diverged between two incipient species of Saccharomyces paradoxus that occupy different climatic regions along a south-west to north-east gradient."}
{"qid": "58da14178acda34529000011", "original_text": "Of the 23 human chromosomes, Robertsonian translocations typically involve chromosomes 14, 15, and/or 21. These acrocentric chromosomes are characterized by their short arm (p) being much shorter than their long arm (q), with a total length ratio of approximately 1:3 to 1:4. The most common Robertsonian translocation is t(14;21)(q32;q31), which results in the fusion of the maternal chromosome 14 with the paternal chromosome 21, leading to Down syndrome. Other acrocentric chromosomes that may be involved in Robertsonian translocations include chromosomes 15 and 16.", "label": 0, "is_selected": 0, "text": "Of the 23 human chromosomes, Robertsonian translocations typically involve chromosomes 14, 15, and/or 21. These acrocentric chromosomes are characterized by their short arm (p) being much shorter than their long arm (q), with a total length ratio of approximately 1:3 to 1:4. The most common Robertsonian translocation is t(14;21)(q32;q31), which results in the fusion of the maternal chromosome 14 with the paternal chromosome 21, leading to Down syndrome. Other acrocentric chromosomes that may be involved in Robertsonian translocations include chromosomes 15 and 16."}
{"qid": "587d2700fe8a08052f000001", "original_text": "As an helpful assistant, I can provide you with a list of known databases of super enhancers in the medical domain. These databases are constantly evolving, as new research is published and new super enhancers are identified. Here are some of the most notable databases: 1. SuperEnhancerDB: This database is the most comprehensive resource for super enhancers, containing information on over 12,000 enhancers from various species, including humans. It also provides functional and protein binding data for each enhancer. 2. ENCODE: The Encyclopedia of DNA Elements (ENCODE) project is a large-scale effort to map all the functional elements in the human genome. It includes super enhancer data, as well as other types of regulatory elements. 3. Roadmap Epigenomics Consortium: This consortium is a collaborative effort to map the epigenetic landscape of various organisms, including humans. It includes data on super enhancers and other regulatory elements. 4. The Cancer Genome Atlas (TCGA): This database contains genomic and transcriptomic data for various types of cancer, including information on super enhancers. 5. The Genomic Atlas of Disease (GAD): This database is focused on the genetic and epigenetic changes associated with various diseases, including information on super enhancers. 6. The Epigenomics Roadmap (TERRA): This database is a comprehensive resource for epigenetic data, including super enhancer data. 7. The Epigenetic Code (TEC): This database is focused on the regulatory code that governs the expression of genes, including super enhancers. 8. The Human Epigenome Atlas (HEA): This database is a comprehensive resource for epigenetic data in humans, including super enhancer data. 9. The Epigenetic Landscape of Disease (ELD): This database is focused on the epigenetic changes associated with various diseases, including information on super enhancers. 10. The Epigenetic Regulation of Gene Expression (ERGE): This database is focused on the regulation of gene expression, including super enhancer data. Please note that these databases are constantly updated, and new databases may be developed as research in the field evolves. I hope this information helps you in your research. If you have any further questions, please don't hesitate to ask.", "label": 0, "is_selected": 0, "text": "As an helpful assistant, I can provide you with a list of known databases of super enhancers in the medical domain. These databases are constantly evolving, as new research is published and new super enhancers are identified. Here are some of the most notable databases: 1. SuperEnhancerDB: This database is the most comprehensive resource for super enhancers, containing information on over 12,000 enhancers from various species, including humans. It also provides functional and protein binding data for each enhancer. 2. ENCODE: The Encyclopedia of DNA Elements (ENCODE) project is a large-scale effort to map all the functional elements in the human genome. It includes super enhancer data, as well as other types of regulatory elements. 3. Roadmap Epigenomics Consortium: This consortium is a collaborative effort to map the epigenetic landscape of various organisms, including humans. It includes data on super enhancers and other regulatory elements. 4. The Cancer Genome Atlas (TCGA): This database contains genomic and transcriptomic data for various types of cancer, including information on super enhancers. 5. The Genomic Atlas of Disease (GAD): This database is focused on the genetic and epigenetic changes associated with various diseases, including information on super enhancers. 6. The Epigenomics Roadmap (TERRA): This database is a comprehensive resource for epigenetic data, including super enhancer data. 7. The Epigenetic Code (TEC): This database is focused on the regulatory code that governs the expression of genes, including super enhancers. 8. The Human Epigenome Atlas (HEA): This database is a comprehensive resource for epigenetic data in humans, including super enhancer data. 9. The Epigenetic Landscape of Disease (ELD): This database is focused on the epigenetic changes associated with various diseases, including information on super enhancers. 10. The Epigenetic Regulation of Gene Expression (ERGE): This database is focused on the regulation of gene expression, including super enhancer data. Please note that these databases are constantly updated, and new databases may be developed as research in the field evolves. I hope this information helps you in your research. If you have any further questions, please don't hesitate to ask."}
{"qid": "5c6f107c7c78d69471000051", "original_text": "Defectinib is a drug that targets several key molecules involved in the growth and survival of cancer cells. These molecules include: 1. Fibroblast Growth Factor Receptors (FGFR): Defectinib selectively binds to and inhibits the activity of FGFR1, 2, and 3, which are overexpressed in many types of cancer, including lung, breast, and gastric cancer. 2. Vascular Endothelial Growth Factor Receptors (VEGFR): Defectinib also targets VEGFR1 and VEGFR2, which are involved in angiogenesis, the formation of new blood vessels that supply tumors with oxygen and nutrients. 3. Epidermal Growth Factor Receptor (EGFR): Defectinib has been shown to inhibit the activity of EGFR, which is overexpressed in many cancer types and plays a role in cell growth and survival. 4. B-Raf: Defectinib has been shown to inhibit the activity of B-Raf, a protein that is mutated in many types of cancer, including melanoma and colorectal cancer. By targeting these molecules, defectinib can inhibit the growth and spread of cancer cells, leading to a decrease in tumor size and improved cancer outcomes.", "label": 0, "is_selected": 1, "text": "Defectinib is a drug that targets several key molecules involved in the growth and survival of cancer cells and has been shown to inhibit the activity of B-Raf, a protein that is mutated in many types of cancer, including lung, breast, and gastric cancer and melanoma and colorectal cancer.B-Raf is a member of the epidermal growth factor receptor family, which is a family of proteins involved in many important biological processes."}
{"qid": "5d371ec97bc3fee31f00000c", "original_text": "Yes, CTCF (CCCTC-binding factor) is known to bind at nucleosome-free regions (NFRs) of DNA. NFRs are regions of chromatin that lack nucleosomes, which are the histone-DNA complexes that make up the chromatin fiber. CTCF binding is enriched at these regions, which are often associated with regulatory elements such as promoters, enhancers, and insulators. CTCF acts as a loop-forming factor, binding to specific DNA sequences and creating higher-order chromatin structures that regulate gene expression. The binding of CTCF at NFRs plays a crucial role in the regulation of gene expression, particularly in the context of stem cell maintenance and differentiation.", "label": 0, "is_selected": 0, "text": "Yes, CTCF (CCCTC-binding factor) is known to bind at nucleosome-free regions (NFRs) of DNA. NFRs are regions of chromatin that lack nucleosomes, which are the histone-DNA complexes that make up the chromatin fiber. CTCF binding is enriched at these regions, which are often associated with regulatory elements such as promoters, enhancers, and insulators. CTCF acts as a loop-forming factor, binding to specific DNA sequences and creating higher-order chromatin structures that regulate gene expression. The binding of CTCF at NFRs plays a crucial role in the regulation of gene expression, particularly in the context of stem cell maintenance and differentiation."}
{"qid": "5be48c39133db5eb7800001d", "original_text": "The pembrolizumab companion diagnostic test, also known as CDx, assesses the presence of tumor-infiltrating lymphocytes (TILs) in a patient's tumor. TILs are a type of immune cell that can recognize and attack cancer cells. Pembrolizumab is a drug that works by stimulating the immune system to attack cancer cells, and the CDx test helps to identify which patients are most likely to benefit from this treatment. The test analyzes tumor tissue samples for the presence of TILs and calculates a score based on the percentage of TILs present. This score, along with other clinical and biological factors, helps healthcare providers determine whether a patient is eligible for pembrolizumab therapy.", "label": 0, "is_selected": 0, "text": "The pembrolizumab companion diagnostic test, also known as CDx, assesses the presence of tumor-infiltrating lymphocytes (TILs) in a patient's tumor. TILs are a type of immune cell that can recognize and attack cancer cells. Pembrolizumab is a drug that works by stimulating the immune system to attack cancer cells, and the CDx test helps to identify which patients are most likely to benefit from this treatment. The test analyzes tumor tissue samples for the presence of TILs and calculates a score based on the percentage of TILs present. This score, along with other clinical and biological factors, helps healthcare providers determine whether a patient is eligible for pembrolizumab therapy."}
{"qid": "56bc77a3ac7ad10019000015", "original_text": "A malaria vaccine could be an important addition to current control strategies. We report the safety and vaccine efficacy (VE) of the RTS,S/AS01 vaccine during 18 mo following vaccination at 11 African sites with varying malaria transmission. 6,537 infants aged 6-12 wk and 8,923 children aged 5-17 mo were randomized to receive three doses of RTS,S/AS01 or comparator vaccine. VE against clinical malaria in children during the 18 mo after vaccine dose 3 (per protocol) was 46% (95% CI 42% to 50%) (range 40% to 77%; VE, p<0.01 across all sites).", "label": 1, "is_selected": 0, "text": "A malaria vaccine could be an important addition to current control strategies. We report the safety and vaccine efficacy (VE) of the RTS,S/AS01 vaccine during 18 mo following vaccination at 11 African sites with varying malaria transmission. 6,537 infants aged 6-12 wk and 8,923 children aged 5-17 mo were randomized to receive three doses of RTS,S/AS01 or comparator vaccine. VE against clinical malaria in children during the 18 mo after vaccine dose 3 (per protocol) was 46% (95% CI 42% to 50%) (range 40% to 77%; VE, p<0.01 across all sites)."}
{"qid": "54cf45e7f693c3b16b00000a", "original_text": "The main calcium-binding protein of the sarcoplasmic reticulum is troponin. Troponin is a regulatory protein that plays a crucial role in muscle contraction by modulating the interactions between calcium ions and actin and tropomyosin in the sarcoplasmic reticulum. It is composed of three subunits: troponin C, troponin I, and troponin T, which work together to control muscle contraction by altering the calcium-actin interaction.", "label": 0, "is_selected": 0, "text": "The main calcium-binding protein of the sarcoplasmic reticulum is troponin. Troponin is a regulatory protein that plays a crucial role in muscle contraction by modulating the interactions between calcium ions and actin and tropomyosin in the sarcoplasmic reticulum. It is composed of three subunits: troponin C, troponin I, and troponin T, which work together to control muscle contraction by altering the calcium-actin interaction."}
{"qid": "5e49c5336d0a277941000011", "original_text": "LY6K is a protein that has been shown to have a role in the development and progression of non-small cell lung cancer (NSCLC). Recent studies have suggested that overexpression of LY6K may be associated with better prognosis for NSCLC patients. One study published in the journal Cancer Research found that high levels of LY6K were associated with longer overall survival and lower rates of disease recurrence in NSCLC patients. Another study published in the European Respiratory Journal found that LY6K expression was higher in tumors from patients who had a better prognosis, as determined by clinical outcomes. The mechanism by which LY6K may improve prognosis in NSCLC is thought to involve its ability to inhibit the growth of cancer cells and promote apoptosis, or programmed cell death. LY6K has also been shown to have antitumor effects by inhibiting the activity of inflammatory cytokines and chemokines. It is important to note that while these findings are promising, further research is needed to confirm the prognostic value of LY6K expression in NSCLC. Additionally, more work is needed to understand the underlying mechanisms and to determine the potential role of LY6K as a therapeutic target for NSCLC treatment.", "label": 0, "is_selected": 1, "text": "Researchers at the University of California, San Francisco (UCSD) have discovered that overexpression of LY6K may be associated with a better prognosis for lung cancer patients, according to a study published in the journal Cancer Research, and has been reported in the European Respiratory Journal, as well as in the Journal of the National Cancer Institute (JNI) and the American Journal of Respiratory and Critical Care Medicine (ARJ).<n> One study published on the journal cancer Research found that high levels of ly6K were associated with longer overall survival and lower rates of disease recurrence in NSCLC patients."}
{"qid": "5c6ffa257c78d69471000056", "original_text": "Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III), is a group of inherited disorders caused by deficiencies of enzymes that break down mucopolysaccharides, complex carbohydrates found in various tissues and organs throughout the body. The four genes involved in Sanfilippo syndrome are: 1. NAGLU (N-acetylgalactosamine-6-sulfatase) gene: codes for the enzyme sulfatase, which breaks down galactosamine-6-sulfate. 2. NAGLU (N-acetylgalactosamine-6-sulfatase) gene: codes for the enzyme sulfatase, which breaks down galactosamine-6-sulfate. 3. GNS (Glucocerebrosidase) gene: codes for the enzyme glucocerebrosidase, which breaks down glucocerebroside. 4. HGS (Hexosaminidase A) gene: codes for the enzyme hexosaminidase A, which breaks down hexosaminide. Note: Each of these genes is associated with a specific type of Sanfilippo syndrome, and each type has distinct clinical symptoms and characteristics.", "label": 0, "is_selected": 0, "text": "Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III), is a group of inherited disorders caused by deficiencies of enzymes that break down mucopolysaccharides, complex carbohydrates found in various tissues and organs throughout the body. The four genes involved in Sanfilippo syndrome are: 1. NAGLU (N-acetylgalactosamine-6-sulfatase) gene: codes for the enzyme sulfatase, which breaks down galactosamine-6-sulfate. 2. NAGLU (N-acetylgalactosamine-6-sulfatase) gene: codes for the enzyme sulfatase, which breaks down galactosamine-6-sulfate. 3. GNS (Glucocerebrosidase) gene: codes for the enzyme glucocerebrosidase, which breaks down glucocerebroside. 4. HGS (Hexosaminidase A) gene: codes for the enzyme hexosaminidase A, which breaks down hexosaminide. Note: Each of these genes is associated with a specific type of Sanfilippo syndrome, and each type has distinct clinical symptoms and characteristics."}
{"qid": "56cae51f5795f9a73e000025", "original_text": "Amyotrophic lateral sclerosis (ALS) is a devastating fatal motor neuron disease, for which there is currently no cure or effective treatment. In this disease, local neuroinflammation develops along the disease course and contributes to its rapid progression. In several models of CNS pathologies, circulating immune cells were shown to display an indispensable role in the resolution of the neuroinflammatory response. The recruitment of such cells to the CNS involves activation of the choroid plexus (CP) of the brain for leukocyte trafficking, through a mechanism that requires IFN-\u03b3 signaling.", "label": 1, "is_selected": 0, "text": "Amyotrophic lateral sclerosis (ALS) is a devastating fatal motor neuron disease, for which there is currently no cure or effective treatment. In this disease, local neuroinflammation develops along the disease course and contributes to its rapid progression. In several models of CNS pathologies, circulating immune cells were shown to display an indispensable role in the resolution of the neuroinflammatory response. The recruitment of such cells to the CNS involves activation of the choroid plexus (CP) of the brain for leukocyte trafficking, through a mechanism that requires IFN-\u03b3 signaling."}
{"qid": "53617eeb7d100faa0900000a", "original_text": "The name for anorexia in gymnasts is \"gymnastics-related eating disorder\" (GRED). This term was introduced in 2009 to emphasize the unique factors that contribute to the development of eating disorders in gymnasts, such as the high physical demands of the sport, the pressure to maintain a low body weight, and the cultural and social factors that promote thinness. GRED is characterized by a disturbed body image, food restriction, and excessive exercise, all of which can lead to serious health complications if left untreated. Early detection and intervention are critical to preventing the progression of GRED and promoting a healthy and safe environment for gymnasts.", "label": 0, "is_selected": 0, "text": "The name for anorexia in gymnasts is \"gymnastics-related eating disorder\" (GRED). This term was introduced in 2009 to emphasize the unique factors that contribute to the development of eating disorders in gymnasts, such as the high physical demands of the sport, the pressure to maintain a low body weight, and the cultural and social factors that promote thinness. GRED is characterized by a disturbed body image, food restriction, and excessive exercise, all of which can lead to serious health complications if left untreated. Early detection and intervention are critical to preventing the progression of GRED and promoting a healthy and safe environment for gymnasts."}
{"qid": "5e2e11a1fbd6abf43b000021", "original_text": "Achondroplasia is a genetic disorder caused by mutations in the FGFR3 gene. Specifically, de novo mutations in the FGFR3 gene's fibroblast growth factor receptor 3 (FGFR3) gene can cause achondroplasia. These mutations result in the production of a faulty protein that disrupts the normal development of cartilage and bone, leading to the characteristic short stature and other physical features of achondroplasia. The most common mutation associated with achondroplasia is a point mutation in the FGFR3 gene's codon 3078, which results in the production of a protein that is unable to function properly. Other mutations in the FGFR3 gene can also cause achondroplasia, but the 3078 point mutation is the most well-known and well-studied.", "label": 0, "is_selected": 0, "text": "Achondroplasia is a genetic disorder caused by mutations in the FGFR3 gene. Specifically, de novo mutations in the FGFR3 gene's fibroblast growth factor receptor 3 (FGFR3) gene can cause achondroplasia. These mutations result in the production of a faulty protein that disrupts the normal development of cartilage and bone, leading to the characteristic short stature and other physical features of achondroplasia. The most common mutation associated with achondroplasia is a point mutation in the FGFR3 gene's codon 3078, which results in the production of a protein that is unable to function properly. Other mutations in the FGFR3 gene can also cause achondroplasia, but the 3078 point mutation is the most well-known and well-studied."}
{"qid": "5a6e1db0b750ff4455000039", "original_text": "Q-nexus is a term used in the medical field to refer to a specific type of clinical decision support tool. It is a computational framework that uses machine learning and natural language processing algorithms to analyze electronic health records (EHRs) and other medical data to identify patterns and relationships that can inform clinical decision-making. Q-nexus platforms aim to provide healthcare providers with accurate and relevant clinical information at the point of care, helping them make more informed decisions and improve patient outcomes. These platforms can also be used to identify potential safety issues and reduce the risk of adverse events. Overall, Q-nexus represents an innovative approach to clinical decision support, leveraging the power of machine learning and natural language processing to improve the quality and safety of healthcare.", "label": 0, "is_selected": 1, "text": "Q-nexus is a computational framework that uses machine learning and natural language processing algorithms to analyze electronic health records (EHRs) and other medical data to identify patterns and relationships that can inform clinical decision-making.It is a Computational Framework that uses Machine Learning and Natural Language Processing algorithms to analyse Electronic Health Records (EHS) and Other Medical Data to identify Patterns and Relationships that can Inform Clinical Decision-Making."}
{"qid": "52fa73c62059c6d71c000058", "original_text": "In patients with resistant hypertension (RH) we investigated the importance of urinary neutrophil gelatinase-associated lipocalin (uNGAL- a chemiluminescent microparticle immunoassay (CMIA) method became using (Abbott Diagnostics) for the measurement of NGAL in urine samples) and incidence of chronic kidney disease using the Modification of Diet in Renal Disease Study (MDRD) and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations in estimating glomerular filtration rate (eGFR) based on standardised serum creatinine method traceable to isotope dilution mass spectrometry (IDMS) method. It would have been difficult to predict that levels of these biomarker would perform better organ damage than traditional measurements of kidney function such as standardised serum creatinine, MDRD, or CKD-EPI equations in special population such as RH. Serum creatinine concentrations were measured in 50 patients (24M:26F from RH Registar in Clinical Hospital Merkur) by the kinetic Jaffe method. There were no significant differences between the GFR values derived by MDRD and CKD-EPI equations in the group of patients with RH. 62% of patients have eGFR > 60 mL/minl/1.73 m2, while a 38% of patients have eGFR < 60 mL/min/1.73 m2. The measurement of NGAL in urine samples of 40 patients with RH showed no difference and seems to be of no use in further determination of renal impairement. Higher value of uNGAL in some resistant hypertension patients could have link in the repair stage after AKI and would reveal pathways that could link AKI and CKD.", "label": 1, "is_selected": 0, "text": "In patients with resistant hypertension (RH) we investigated the importance of urinary neutrophil gelatinase-associated lipocalin (uNGAL- a chemiluminescent microparticle immunoassay (CMIA) method became using (Abbott Diagnostics) for the measurement of NGAL in urine samples) and incidence of chronic kidney disease using the Modification of Diet in Renal Disease Study (MDRD) and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations in estimating glomerular filtration rate (eGFR) based on standardised serum creatinine method traceable to isotope dilution mass spectrometry (IDMS) method. It would have been difficult to predict that levels of these biomarker would perform better organ damage than traditional measurements of kidney function such as standardised serum creatinine, MDRD, or CKD-EPI equations in special population such as RH. Serum creatinine concentrations were measured in 50 patients (24M:26F from RH Registar in Clinical Hospital Merkur) by the kinetic Jaffe method. There were no significant differences between the GFR values derived by MDRD and CKD-EPI equations in the group of patients with RH. 62% of patients have eGFR > 60 mL/minl/1.73 m2, while a 38% of patients have eGFR < 60 mL/min/1.73 m2. The measurement of NGAL in urine samples of 40 patients with RH showed no difference and seems to be of no use in further determination of renal impairement. Higher value of uNGAL in some resistant hypertension patients could have link in the repair stage after AKI and would reveal pathways that could link AKI and CKD."}
{"qid": "56a24dfffe92d6fd19000002", "original_text": "Restoration of the open reading frame of the DMD gene and dystrophin protein production in Duchenne muscular dystrophy (DMD) can be achieved by exon skipping using antisense oligomers (AOs) targeted to splicing elements. Several such RNA-based gene therapy approaches are in clinical development in which all studies to date have assessed AO efficacy by semiquantitative nested reverse-transcription polymerase chain reaction (RT-PCR). Precise evaluation of dystrophin protein levels is complex and hindered by the large size and low abundance of dystrophin; thus an accurate and standardized measurement of DMD exon skipping at the RNA level remains important to assess and compare patient responses in DMD exon skipping clinical trials. Here we describe the development of a Taqman quantitative (q)RT-PCR assay to quantify exon skipping and highlight its use to determine the levels of exon skipping in DMD patients treated intramuscularly with a morpholino AO to skip exon 51, eteplirsen (AVI-4658).", "label": 1, "is_selected": 0, "text": "Restoration of the open reading frame of the DMD gene and dystrophin protein production in Duchenne muscular dystrophy (DMD) can be achieved by exon skipping using antisense oligomers (AOs) targeted to splicing elements. Several such RNA-based gene therapy approaches are in clinical development in which all studies to date have assessed AO efficacy by semiquantitative nested reverse-transcription polymerase chain reaction (RT-PCR). Precise evaluation of dystrophin protein levels is complex and hindered by the large size and low abundance of dystrophin; thus an accurate and standardized measurement of DMD exon skipping at the RNA level remains important to assess and compare patient responses in DMD exon skipping clinical trials. Here we describe the development of a Taqman quantitative (q)RT-PCR assay to quantify exon skipping and highlight its use to determine the levels of exon skipping in DMD patients treated intramuscularly with a morpholino AO to skip exon 51, eteplirsen (AVI-4658)."}
{"qid": "5e5b626fb761aafe0900000c", "original_text": "The ATP-binding cassette transporter ABCB4/MDR3 is critical for biliary phosphatidylcholine (PC) excretion at the canalicular membrane of hepatocytes. Defective ABCB4 gene expression and protein function result in various cholestatic liver and bile duct injuries. Thyroid hormone receptor (THR) is a major regulator of hepatic lipid metabolism; we explored its potential role in ABCB4 regulation.", "label": 1, "is_selected": 0, "text": "The ATP-binding cassette transporter ABCB4/MDR3 is critical for biliary phosphatidylcholine (PC) excretion at the canalicular membrane of hepatocytes. Defective ABCB4 gene expression and protein function result in various cholestatic liver and bile duct injuries. Thyroid hormone receptor (THR) is a major regulator of hepatic lipid metabolism; we explored its potential role in ABCB4 regulation."}
{"qid": "5505eed08e1671127b000006", "original_text": "The receptor tyrosine kinase ErbB2 is a breast cancer biomarker whose posttranslational modifications (PTMs) are a key indicator of its activation. Quantifying the expression and PTMs of biomarkers such as ErbB2 by selected reaction monitoring (SRM) mass spectrometry has several limitations, including minimal coverage and extensive assay development time. Therefore, we assessed the utility of two high resolution, full scan mass spectrometry approaches, MS1 Filtering and SWATH MS2, for targeted ErbB2 proteomics. Endogenous ErbB2 immunoprecipitated from SK-BR-3 cells was in-gel digested with trypsin, chymotrypsin, Asp-N, or trypsin plus Asp-N in triplicate. Data-dependent acquisition with an AB SCIEX TripleTOF 5600 and MS1 Filtering data processing was used to assess peptide and PTM coverage as well as the reproducibility of enzyme digestion. Data-independent acquisition (SWATH) was also performed for MS2 quantitation. MS1 Filtering and SWATH MS2 allow quantitation of all detected analytes after acquisition, enabling the use of multiple proteases for quantitative assessment of target proteins. Combining high resolution proteomics with multiprotease digestion enabled quantitative mapping of ErbB2 with excellent reproducibility, improved amino acid sequence and PTM coverage, and decreased assay development time compared to typical SRM assays.", "label": 1, "is_selected": 0, "text": "The receptor tyrosine kinase ErbB2 is a breast cancer biomarker whose posttranslational modifications (PTMs) are a key indicator of its activation. Quantifying the expression and PTMs of biomarkers such as ErbB2 by selected reaction monitoring (SRM) mass spectrometry has several limitations, including minimal coverage and extensive assay development time. Therefore, we assessed the utility of two high resolution, full scan mass spectrometry approaches, MS1 Filtering and SWATH MS2, for targeted ErbB2 proteomics. Endogenous ErbB2 immunoprecipitated from SK-BR-3 cells was in-gel digested with trypsin, chymotrypsin, Asp-N, or trypsin plus Asp-N in triplicate. Data-dependent acquisition with an AB SCIEX TripleTOF 5600 and MS1 Filtering data processing was used to assess peptide and PTM coverage as well as the reproducibility of enzyme digestion. Data-independent acquisition (SWATH) was also performed for MS2 quantitation. MS1 Filtering and SWATH MS2 allow quantitation of all detected analytes after acquisition, enabling the use of multiple proteases for quantitative assessment of target proteins. Combining high resolution proteomics with multiprotease digestion enabled quantitative mapping of ErbB2 with excellent reproducibility, improved amino acid sequence and PTM coverage, and decreased assay development time compared to typical SRM assays."}
{"qid": "550e9d2cb305b40c5c000001", "original_text": "The Stroke Prognostication using Age and the NIH Stroke Scale index, created by combining age in years plus a National Institutes of Health (NIH) Stroke Scale score of 100 or higher (and hereafter referred to as the SPAN-100 index), is a simple risk score for estimating clinical outcomes for patients with acute ischemic stroke (AIS). The association between this index and response to intravenous thrombolysis for AIS has not been properly evaluated. To assess the relationship between SPAN-100 index status and outcome following treatment with intravenous thrombolysis for AIS. Using the Virtual International Stroke Trials Archive (VISTA) database, an international repository of clinical trials data, we assessed the SPAN-100 index among 7093 patients with AIS who participated in 4 clinical trials from 2000 to 2006. The SPAN-100 index is considered positive if the sum of the age and the NIH Stroke Scale (a 15-item neurological examination scale with scores ranging from 0 to 42, with higher scores indicating more severe strokes) score is greater than or equal to 100. Multivariable logistic regression analyses were used to determine the independent association between SPAN-100 index status and 90-day outcomes. The primary outcome was a composite of severe disability or death measured 90 days after stroke, and the secondary outcomes were death alone and a composite of no disability/modest disability.", "label": 1, "is_selected": 0, "text": "The Stroke Prognostication using Age and the NIH Stroke Scale index, created by combining age in years plus a National Institutes of Health (NIH) Stroke Scale score of 100 or higher (and hereafter referred to as the SPAN-100 index), is a simple risk score for estimating clinical outcomes for patients with acute ischemic stroke (AIS). The association between this index and response to intravenous thrombolysis for AIS has not been properly evaluated. To assess the relationship between SPAN-100 index status and outcome following treatment with intravenous thrombolysis for AIS. Using the Virtual International Stroke Trials Archive (VISTA) database, an international repository of clinical trials data, we assessed the SPAN-100 index among 7093 patients with AIS who participated in 4 clinical trials from 2000 to 2006. The SPAN-100 index is considered positive if the sum of the age and the NIH Stroke Scale (a 15-item neurological examination scale with scores ranging from 0 to 42, with higher scores indicating more severe strokes) score is greater than or equal to 100. Multivariable logistic regression analyses were used to determine the independent association between SPAN-100 index status and 90-day outcomes. The primary outcome was a composite of severe disability or death measured 90 days after stroke, and the secondary outcomes were death alone and a composite of no disability/modest disability."}
{"qid": "56c08702ef6e394741000024", "original_text": "Afamelanotide is a melanocortin 1 receptor (MC1R) agonist that has shown potential in treating various diseases associated with melanogenesis. Some of the diseases that can be treated with afamelanotide include: 1. Erytholipidosis: A rare genetic disorder characterized by the accumulation of chyle (lipid-rich fluid) in the body, which can lead to recurrent infections, liver disease, and other complications. Afamelanotide has been shown to reduce the accumulation of chyle in erythrolipidosis patients. 2. X-linked ocular albinism: A genetic disorder causing vision loss and other ocular manifestations due to the absence or defect of melanin in the eyes. Afamelanotide has been used to treat x-linked ocular albinism by promoting melanin synthesis in the eyes. 3. Hermansky-Pudlak syndrome: A rare genetic disorder characterized by oculocutaneous albinism, bleeding disorders, and lung disease. Afamelanotide has been used in some cases to treat Hermansky-Pudlak syndrome by promoting melanin synthesis and reducing bleeding episodes. 4. Vitiligo: An autoimmune disorder causing depigmentation of skin patches due to the loss of melanin-producing cells. While afamelanotide has not been specifically approved for the treatment of vitiligo, it has been used off-label in some cases to promote melanin synthesis and restore skin pigmentation. It's important to note that afamelanotide is still a relatively new drug, and its long-term safety and efficacy in treating these diseases are still being studied. Additionally, afamelanotide may not be effective in all patients, and other treatments may be necessary in some cases.", "label": 0, "is_selected": 1, "text": "The US Food and Drug Administration (FDA) has approved afamelanotide for the treatment of a number of rare genetic diseases associated with melanogenesis, or the loss of melanin-producing cells in the skin, hair, and eyes. Afamela notide has been used in some cases to treat Hermansky-Pudlak syndrome by promoting melanin synthesis and reducing bleeding episodes. (Please note that this article is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment of any medical condition or disease.) and is not recommended for use in children under the age of 12."}
{"qid": "5e5b8b4e752ebcdc7a000001", "original_text": "Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder that is characterized by the abnormal transformation of soft tissue into bone, leading to progressive skeletal deformities and disability. The phenotype of FOP is highly variable and can range from mild to severe forms of the disease. Common clinical features of FOP include: * Protrusion of the nasal septum and turbinate bones * Enlargement of the tongue and floor of the mouth * Distension of the eyes and eyelids * Shortened limbs * Kyphosis and scoliosis * Difficulty swallowing and breathing * Respiratory infections * Difficulty speaking and eating I don't have answer to the question, \"What is the life expectancy of a person with FOP?\".", "label": 0, "is_selected": 0, "text": "Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder that is characterized by the abnormal transformation of soft tissue into bone, leading to progressive skeletal deformities and disability. The phenotype of FOP is highly variable and can range from mild to severe forms of the disease. Common clinical features of FOP include: * Protrusion of the nasal septum and turbinate bones * Enlargement of the tongue and floor of the mouth * Distension of the eyes and eyelids * Shortened limbs * Kyphosis and scoliosis * Difficulty swallowing and breathing * Respiratory infections * Difficulty speaking and eating I don't have answer to the question, \"What is the life expectancy of a person with FOP?\"."}
{"qid": "5d31daacb3a6380763000003", "original_text": "Yes, members of the KRAB-ZNF (Kr\u00fcppel-associated box-Zinc finger) gene family are known to be involved in gene repression. The KRAB-ZNF proteins are transcriptional repressors that bind to specific DNA sequences and prevent the activation of target genes. They are characterized by the presence of Kr\u00fcppel-associated boxes (KRABs) and zinc fingers, which are responsible for recognizing and binding to specific DNA elements involved in gene regulation. KRAB-ZNF proteins are known to repress a wide range of genes involved in various cellular processes, including cell growth, differentiation, and survival. The dysregulation of KRAB-ZNF proteins has been implicated in various diseases, including cancer and neurological disorders.", "label": 0, "is_selected": 1, "text": "The B-ZNF gene family has been implicated in a wide range of diseases, including cancer, neurological disorders and epilepsy.<n> The dysregulation ofB-Z NF proteins has been associated with various diseases, such as cancer and Parkinson's disease."}
{"qid": "530a5117970c65fa6b000007", "original_text": "Proteolysis is a major protein posttranslational modification that, by altering protein structure, affects protein function and, by truncating the protein sequence, alters peptide signatures of proteins analyzed by proteomics. To identify such modified and shortened protease-generated neo-N-termini on a proteome-wide basis, we developed a whole protein isobaric tag for relative and absolute quantitation (iTRAQ) labeling method that simultaneously labels and blocks all primary amines including protein N- termini and lysine side chains. Blocking lysines limits trypsin cleavage to arginine, which effectively elongates the proteolytically truncated peptides for improved MS/MS analysis and peptide identification.", "label": 1, "is_selected": 0, "text": "Proteolysis is a major protein posttranslational modification that, by altering protein structure, affects protein function and, by truncating the protein sequence, alters peptide signatures of proteins analyzed by proteomics. To identify such modified and shortened protease-generated neo-N-termini on a proteome-wide basis, we developed a whole protein isobaric tag for relative and absolute quantitation (iTRAQ) labeling method that simultaneously labels and blocks all primary amines including protein N- termini and lysine side chains. Blocking lysines limits trypsin cleavage to arginine, which effectively elongates the proteolytically truncated peptides for improved MS/MS analysis and peptide identification."}
{"qid": "550342a8f8aee20f27000002", "original_text": "One of the most important achievement of contemporary epileptology has been a concept of epileptic syndromes. According to the Commission on Classification and Terminology of the International League Against Epilepsy there are many epileptic syndromes which differ from each other not only by prognosis but also by reaction to pharmacotherapy. Nevertheless the differentation between the some of epileptic syndromes may be difficult in spite of quite precise clinical and electrophysiological criteria. Good example of this problem may be the course of disease of the boy who is now eleven years old.", "label": 1, "is_selected": 0, "text": "One of the most important achievement of contemporary epileptology has been a concept of epileptic syndromes. According to the Commission on Classification and Terminology of the International League Against Epilepsy there are many epileptic syndromes which differ from each other not only by prognosis but also by reaction to pharmacotherapy. Nevertheless the differentation between the some of epileptic syndromes may be difficult in spite of quite precise clinical and electrophysiological criteria. Good example of this problem may be the course of disease of the boy who is now eleven years old."}
{"qid": "5ac37afc0340b9f058000002", "original_text": "The sequences of some gene regulatory elements diverge considerably, even between closely related species. A detailed analysis of the fast-evolving sparkling enhancer in Drosophila now identifies key compensatory mechanisms and 'grammar' elements that are critical for maintaining functional integrity.", "label": 1, "is_selected": 0, "text": "The sequences of some gene regulatory elements diverge considerably, even between closely related species. A detailed analysis of the fast-evolving sparkling enhancer in Drosophila now identifies key compensatory mechanisms and 'grammar' elements that are critical for maintaining functional integrity."}
{"qid": "56e30dd551531f7e33000016", "original_text": "The core circadian clock genes are a set of genes that play a critical role in regulating the internal biological clock that controls various physiological processes, including sleep-wake cycles, hormone secretion, and metabolism. These genes are found in almost all living organisms, including humans, and are involved in the regulation of circadian rhythms. Here are some of the core circadian clock genes: 1. Per1 (Period 1) The Per1 gene encodes a protein that regulates the expression of other circadian clock genes and is involved in the regulation of the circadian oscillator. Mutations in the Per1 gene have been linked to circadian rhythm sleep disorders. 2. Per2 (Period 2) The Per2 gene plays a similar role to Per1 and is involved in the regulation of the circadian oscillator. Mutations in the Per2 gene have been linked to sleep disorders, obesity, and other metabolic disorders. 3. Bmal1 (Brain and Muscle Arnt-Like 1) The Bmal1 gene encodes a transcription factor that regulates the expression of other circadian clock genes. It is primarily expressed in the brain and plays a key role in regulating the circadian oscillator. 4. Clock (Circadian Locomotor Clock) The Clock gene encodes a transcription factor that regulates the expression of other circadian clock genes. It is primarily expressed in the brain and plays a key role in regulating the circadian oscillator. 5. Bmal2 (Brain and Muscle Arnt-Like 2) The Bmal2 gene encodes a transcription factor that regulates the expression of other circadian clock genes. It is primarily expressed in the brain and plays a key role in regulating the circadian oscillator. 6. Cry (Circadian Rhythm Gene) The Cry gene encodes a transcription factor that regulates the expression of other circadian clock genes. It is primarily expressed in the brain and plays a key role in regulating the circadian oscillator. These core circadian clock genes are essential for maintaining the internal biological clock and regulating various physiological processes that follow a circadian rhythm. Mutations or dysregulation of these genes have been linked to various sleep disorders and other diseases.", "label": 0, "is_selected": 1, "text": "The circadian clock is a set of genes that play a critical role in regulating the internal biological clock that controls various physiological processes, including sleep-wake cycles, hormone secretion, and metabolism. The core circadian clock genes are a set Of genes that Play a Critical Role in Maintaining the Internal Biological Clock and regulating Various physiological Processes that Follow a circadian rhythm. These core circadian Clock genes are essential for maintaining the internal Biological clock and regulatingvarious physiological processes that follow a circadian rhythms. They have been linked to various sleep disorders, obesity, and other diseases, and they have been implicated in the regulation of the body's internal clock and its circadian oscillator, which regulates the timing of sleepwake cycles and the amount of time it takes for the body to wake up and fall asleep, as well as in the development and maintenance of healthy bones, muscles, and nervous systems."}
{"qid": "56b7210b76d8bf8d13000004", "original_text": "Baicalein (5,6,7-trihydroxyflavone) (1) has been found to be active against a wide variety of cancer cells. However, the molecular mechanism underlying the effects of 1 on the induction of Ca(2+) movement and cytotoxicity in human breast cancer cells is unknown. This study examined the relationship between 1-induced Ca(2+) signaling and cytotoxicity in ZR-75-1 human breast cancer cells. The in vitro investigations reported herein produced the following results: (i) Compound 1 increased intracellular Ca(2+) concentration ([Ca(2+)]i) in a concentration-dependent manner. The signal was decreased by approximately 50% by removal of extracellular Ca(2+). (ii) Compound 1-triggered [Ca(2+)]i increases were significantly suppressed by store-operated Ca(2+) channel blockers 2-aminoethoxydiphenyl borate (2-APB) and the PKC inhibitor GF109203X. (iii) In Ca(2+)-free medium, compound", "label": 1, "is_selected": 0, "text": "Baicalein (5,6,7-trihydroxyflavone) (1) has been found to be active against a wide variety of cancer cells. However, the molecular mechanism underlying the effects of 1 on the induction of Ca(2+) movement and cytotoxicity in human breast cancer cells is unknown. This study examined the relationship between 1-induced Ca(2+) signaling and cytotoxicity in ZR-75-1 human breast cancer cells. The in vitro investigations reported herein produced the following results: (i) Compound 1 increased intracellular Ca(2+) concentration ([Ca(2+)]i) in a concentration-dependent manner. The signal was decreased by approximately 50% by removal of extracellular Ca(2+). (ii) Compound 1-triggered [Ca(2+)]i increases were significantly suppressed by store-operated Ca(2+) channel blockers 2-aminoethoxydiphenyl borate (2-APB) and the PKC inhibitor GF109203X. (iii) In Ca(2+)-free medium, compound"}
{"qid": "531af8cbb166e2b80600003a", "original_text": "Recent human genetic discoveries have increased our understanding of rheumatoid arthritis (RA) susceptibility. Genome-wide association studies have expanded the number of validated RA risk loci beyond HLA-DRB1 \"shared epitope\" alleles to include additional major histocompatibility complex (MHC) risk alleles and more than 10 regions outside the MHC. The newly discovered risk alleles are common in the general population, have a modest effect on RA risk, and together explain less than 5% of the variance in disease risk. Whereas the actual causal mutation and causal gene for most loci remain to be determined, these studies are beginning to reveal general themes: many risk loci are associated with other autoimmune diseases; many genes fall within discrete biological pathways (eg, the nuclear factor kappa-light-chain-enhancer of activated B cells signaling pathway); and human genetics can group diseases into clinically meaningful subset categories (eg, presence or absence of autoantibodies).", "label": 1, "is_selected": 0, "text": "Recent human genetic discoveries have increased our understanding of rheumatoid arthritis (RA) susceptibility. Genome-wide association studies have expanded the number of validated RA risk loci beyond HLA-DRB1 \"shared epitope\" alleles to include additional major histocompatibility complex (MHC) risk alleles and more than 10 regions outside the MHC. The newly discovered risk alleles are common in the general population, have a modest effect on RA risk, and together explain less than 5% of the variance in disease risk. Whereas the actual causal mutation and causal gene for most loci remain to be determined, these studies are beginning to reveal general themes: many risk loci are associated with other autoimmune diseases; many genes fall within discrete biological pathways (eg, the nuclear factor kappa-light-chain-enhancer of activated B cells signaling pathway); and human genetics can group diseases into clinically meaningful subset categories (eg, presence or absence of autoantibodies)."}
{"qid": "589a246778275d0c4a00002f", "original_text": "Mondor reported the first superficial venous thrombosis on the chest wall in 1939. This condition is usually a benign and self-limited process, requiring only symptomatic treatment. Mondor's disease of the penis is an uncommon condition, which usually involves the superficial dorsal veins, it was first described by Braun-Falco in 1955. Isolated superficial dorsal vein-thrombosis was reported in 1958 by Helm et al. Since then around fifty cases have been reported. Patients experience a cord or string-like induration along the penile superficial dorsal vein, which is often painful and accompanied by localized inflammatory changes.", "label": 1, "is_selected": 0, "text": "Mondor reported the first superficial venous thrombosis on the chest wall in 1939. This condition is usually a benign and self-limited process, requiring only symptomatic treatment. Mondor's disease of the penis is an uncommon condition, which usually involves the superficial dorsal veins, it was first described by Braun-Falco in 1955. Isolated superficial dorsal vein-thrombosis was reported in 1958 by Helm et al. Since then around fifty cases have been reported. Patients experience a cord or string-like induration along the penile superficial dorsal vein, which is often painful and accompanied by localized inflammatory changes."}
{"qid": "5c8feae70101eac87000000e", "original_text": "CRISPR-Cas12a (Cpf1) proteins are RNA-guided enzymes that bind and cut DNA as components of bacterial adaptive immune systems. Like CRISPR-Cas9, Cas12a has been harnessed for genome editing on the basis of its ability to generate targeted, double-stranded DNA breaks. Here we show that RNA-guided DNA binding unleashes indiscriminate single-stranded DNA (ssDNA) cleavage activity by Cas12a that completely degrades ssDNA molecules. We find that target-activated, nonspecific single-stranded deoxyribonuclease (ssDNase) cleavage is also a property of other type V CRISPR-Cas12 enzymes. By combining Cas12a ssDNase activation with isothermal amplification, we create a method termed DNA endonuclease-targeted CRISPR trans reporter (DETECTR), which achieves attomolar sensitivity for DNA detection.", "label": 1, "is_selected": 0, "text": "CRISPR-Cas12a (Cpf1) proteins are RNA-guided enzymes that bind and cut DNA as components of bacterial adaptive immune systems. Like CRISPR-Cas9, Cas12a has been harnessed for genome editing on the basis of its ability to generate targeted, double-stranded DNA breaks. Here we show that RNA-guided DNA binding unleashes indiscriminate single-stranded DNA (ssDNA) cleavage activity by Cas12a that completely degrades ssDNA molecules. We find that target-activated, nonspecific single-stranded deoxyribonuclease (ssDNase) cleavage is also a property of other type V CRISPR-Cas12 enzymes. By combining Cas12a ssDNase activation with isothermal amplification, we create a method termed DNA endonuclease-targeted CRISPR trans reporter (DETECTR), which achieves attomolar sensitivity for DNA detection."}
{"qid": "56ae70050a360a5e4500000f", "original_text": "The RUNX1-MYEF2 complex is a critical regulator of hematopoiesis, playing a crucial role in the development and maintenance of the hematopoietic lineage. RUNX1 is a transcription factor that interacts with MYEF2, a myeloid-specific exchange factor, to modulate the expression of genes involved in myeloid cell development and function. The RUNX1-MYEF2 complex regulates the expression of genes involved in the myeloid lineage, including genes involved in the development of granulocytes, monocytes, and macrophages. Dysregulation of the RUNX1-MYEF2 complex has been implicated in the development of hematological malignancies, such as acute myeloid leukemia (AML).", "label": 0, "is_selected": 1, "text": "The RUNX1-MYEF2 complex has been implicated in the development and maintenance of hematological cancers, such as acute myeloid leukemia (AML) and acute lymphoblastic leukaemia (A leukaemia). Dysregulation of the RUNX1/MYEF2] complex has be implicated inthe development of hematopoiesis, playing a crucial regulator of the hematopoietic lineage."}
{"qid": "5c5f39011a4c55d80b000027", "original_text": "We present a 63-year-old male patient with major depression, characterised by prominent somatic symptoms localised especially around the mouth, whose complaints started just after a prostate operation. The symptoms consisting of burning in the mouth, pain, dry mouth (xerostomia), an unpleasant and strange feeling of taste and itching, are all consistent with burning mouth syndrome. Burning mouth syndrome is a common disorder, usually affecting elderly females, characterised by intractable pain and burning in the oral cavity, evident especially in the tongue, together with a normal mouth mucosa. In the scientific literature a variety of terms are used to describe similar symptoms, such as glossodynia, glossopyrosis, stomatodynia and oral dysestesia. Most patients suffer from the syndrome for a long time, ranging from months up to years.", "label": 1, "is_selected": 0, "text": "We present a 63-year-old male patient with major depression, characterised by prominent somatic symptoms localised especially around the mouth, whose complaints started just after a prostate operation. The symptoms consisting of burning in the mouth, pain, dry mouth (xerostomia), an unpleasant and strange feeling of taste and itching, are all consistent with burning mouth syndrome. Burning mouth syndrome is a common disorder, usually affecting elderly females, characterised by intractable pain and burning in the oral cavity, evident especially in the tongue, together with a normal mouth mucosa. In the scientific literature a variety of terms are used to describe similar symptoms, such as glossodynia, glossopyrosis, stomatodynia and oral dysestesia. Most patients suffer from the syndrome for a long time, ranging from months up to years."}
{"qid": "55376b37bc4f83e82800000b", "original_text": "CD99, also known as killer cell lectin-like receptor subfamily K (KLRK1), is encoded by the MIC2 gene (also known as major histocompatibility complex (MHC) class II-related genes). The MIC2 gene is located on chromosome 6p21 and consists of 18 exons that encode a protein of approximately 30 kDa. The MIC2 gene is involved in the expression of CD99, a transmembrane glycoprotein that is expressed on the surface of natural killer cells, T cells, and a subset of B cells. CD99 plays a role in the regulation of immune responses, including the recognition and elimination of infected cells and tumor cells.", "label": 0, "is_selected": 1, "text": "The CD992 gene is involved in the regulation of the innate immune system and the recognition and elimination of infected cells and cancer cells, including a subset of immune cells that are known as T cells.<n> CD99 plays a role in the immune responses, including recognition and Elimination of infected Cells and Cells."}
{"qid": "5e323d79fbd6abf43b000058", "original_text": "We describe our institution's experience with seven patients who developed second brain tumors following cranial irradiation. The median age at first irradiation was 8 years (range, 3-20 years). Initial diagnoses were two cases of germinoma, one non-germinomatous germ cell tumor (NGGCT), three cases of medulloblastoma, and one pineal gland tumor (pathology undetermined). All patients received craniospinal irradiation followed by local boost and the median dose to the initial tumor area was 54.0 Gy (range, 49.8-60.6 Gy). Four patients (two medulloblastomas, one germinoma, and one NGGCT) received chemotherapy. Second brain tumors were diagnosed a median of 114 months (range, 64-203) after initial radiation. Pathologic diagnoses were one glioblastoma, two cases of anaplastic astrocytoma, one medulloblastoma, one low-grade glioma, one high-grade glial tumor, and one atypical meningioma. Five patients underwent surgical resection with subsequent radiotherapy. One anaplastic astrocytoma patient received chemotherapy only following stereotactic biopsy. The meningioma patient was alive 32 months after total resection and radiosurgery for subsequent recurrences. Six patients died within 18 months and most deaths were due to disease progression. Most patients diagnosed with second brain tumors had received high-dose, large-volume radiotherapy with chemotherapy at a young age.", "label": 1, "is_selected": 0, "text": "We describe our institution's experience with seven patients who developed second brain tumors following cranial irradiation. The median age at first irradiation was 8 years (range, 3-20 years). Initial diagnoses were two cases of germinoma, one non-germinomatous germ cell tumor (NGGCT), three cases of medulloblastoma, and one pineal gland tumor (pathology undetermined). All patients received craniospinal irradiation followed by local boost and the median dose to the initial tumor area was 54.0 Gy (range, 49.8-60.6 Gy). Four patients (two medulloblastomas, one germinoma, and one NGGCT) received chemotherapy. Second brain tumors were diagnosed a median of 114 months (range, 64-203) after initial radiation. Pathologic diagnoses were one glioblastoma, two cases of anaplastic astrocytoma, one medulloblastoma, one low-grade glioma, one high-grade glial tumor, and one atypical meningioma. Five patients underwent surgical resection with subsequent radiotherapy. One anaplastic astrocytoma patient received chemotherapy only following stereotactic biopsy. The meningioma patient was alive 32 months after total resection and radiosurgery for subsequent recurrences. Six patients died within 18 months and most deaths were due to disease progression. Most patients diagnosed with second brain tumors had received high-dose, large-volume radiotherapy with chemotherapy at a young age."}
{"qid": "5a7373f63b9d13c708000008", "original_text": "The insect-transmitted protozoan parasite Trypanosoma cruzi is the causative agent of Chagas disease, and infects 5-8 million people in Latin America. Chagas disease is characterised by an acute phase, which is partially resolved by the immune system, but then develops as a chronic life-long infection. There is a consensus that the front-line drugs benznidazole and nifurtimox are more effective against the acute stage in both clinical and experimental settings. However, confirmative studies have been restricted by difficulties in demonstrating sterile parasitological cure. Here, we describe a systematic study of nitroheterocyclic drug efficacy using highly sensitive bioluminescence imaging of murine infections.", "label": 1, "is_selected": 0, "text": "The insect-transmitted protozoan parasite Trypanosoma cruzi is the causative agent of Chagas disease, and infects 5-8 million people in Latin America. Chagas disease is characterised by an acute phase, which is partially resolved by the immune system, but then develops as a chronic life-long infection. There is a consensus that the front-line drugs benznidazole and nifurtimox are more effective against the acute stage in both clinical and experimental settings. However, confirmative studies have been restricted by difficulties in demonstrating sterile parasitological cure. Here, we describe a systematic study of nitroheterocyclic drug efficacy using highly sensitive bioluminescence imaging of murine infections."}
{"qid": "5171a1498ed59a060a000012", "original_text": "BCL6 somatic mutations affect normal and tumoral post germinal center B-lymphocytes. Our objective was to analyse expression, mutations and polymorphisms in the BCL6 gene and to correlate those variables with the clinical outcome in early-stage chronic lymphocytic leukemia (CLL). CLL samples were used for characterisation of the mutational status of BCL6/ immunoglobulin variable heavy chain (IGHV) genes, and expression of BCL6 was determined by real time PCR and immunoblot. Out of 68 cases, 29% show somatic mutations on BCL6 which occur exclusively in IGHV mutated cases. They are single nucleotide substitutions located mainly in two short mutational hot spots. CLL cells express different levels of BCL6 regardless of the mutational status, the number of mutations and polymorphisms. CLL cases expressing high levels of BCL6 have significantly shorter treatment-free interval. In conclusion, in early-stage patients with CLL, we found no correlation between expression and the mutations or polymorphism in BCL6, but high levels of BCL6 can discriminate patients with a worse prognosis.", "label": 1, "is_selected": 0, "text": "BCL6 somatic mutations affect normal and tumoral post germinal center B-lymphocytes. Our objective was to analyse expression, mutations and polymorphisms in the BCL6 gene and to correlate those variables with the clinical outcome in early-stage chronic lymphocytic leukemia (CLL). CLL samples were used for characterisation of the mutational status of BCL6/ immunoglobulin variable heavy chain (IGHV) genes, and expression of BCL6 was determined by real time PCR and immunoblot. Out of 68 cases, 29% show somatic mutations on BCL6 which occur exclusively in IGHV mutated cases. They are single nucleotide substitutions located mainly in two short mutational hot spots. CLL cells express different levels of BCL6 regardless of the mutational status, the number of mutations and polymorphisms. CLL cases expressing high levels of BCL6 have significantly shorter treatment-free interval. In conclusion, in early-stage patients with CLL, we found no correlation between expression and the mutations or polymorphism in BCL6, but high levels of BCL6 can discriminate patients with a worse prognosis."}
{"qid": "56c9e9d15795f9a73e00001d", "original_text": "The packaging of cytoplasmic mRNA into discrete RNA granules regulates gene expression by delaying the translation of specific transcripts. Specialized RNA granules found in germ cells direct the timing of maternal mRNA translation to promote germ cell development in the early embryo and establish the germ line for the next generation. Similarly, select neuronal mRNA transcripts are packaged into translationally inert RNA granules, transported to sites where their protein products are required, and only then activated and translated.", "label": 1, "is_selected": 0, "text": "The packaging of cytoplasmic mRNA into discrete RNA granules regulates gene expression by delaying the translation of specific transcripts. Specialized RNA granules found in germ cells direct the timing of maternal mRNA translation to promote germ cell development in the early embryo and establish the germ line for the next generation. Similarly, select neuronal mRNA transcripts are packaged into translationally inert RNA granules, transported to sites where their protein products are required, and only then activated and translated."}
{"qid": "52c7311903868f1b0600001d", "original_text": "Muenke syndrome, also known as autosomal dominant craniofacial microsomia (ADCM), is a rare genetic disorder caused by mutations in the TFAP2A gene. To date, more than 30 different mutations have been identified as causative for Muenke syndrome. These mutations can occur in different parts of the TFAP2A gene, including the promoter region, exons, and introns. The most common mutation is a point mutation in exon 3, which accounts for approximately 70% of cases. Other mutations include deletions, duplications, and mutations in splice sites, leading to a range of clinical manifestations such as craniofacial anomalies, neural tube defects, and growth restriction. It's worth noting that some individuals with Muenke syndrome may have de novo mutations, meaning they are not inherited from their parents, while others may have inherited the mutation from one or both parents.", "label": 0, "is_selected": 0, "text": "Muenke syndrome, also known as autosomal dominant craniofacial microsomia (ADCM), is a rare genetic disorder caused by mutations in the TFAP2A gene. To date, more than 30 different mutations have been identified as causative for Muenke syndrome. These mutations can occur in different parts of the TFAP2A gene, including the promoter region, exons, and introns. The most common mutation is a point mutation in exon 3, which accounts for approximately 70% of cases. Other mutations include deletions, duplications, and mutations in splice sites, leading to a range of clinical manifestations such as craniofacial anomalies, neural tube defects, and growth restriction. It's worth noting that some individuals with Muenke syndrome may have de novo mutations, meaning they are not inherited from their parents, while others may have inherited the mutation from one or both parents."}
{"qid": "5335b373d6d3ac6a34000050", "original_text": "The aim of this study was to study the efficacy and safety of ospemifene, a new selective estrogen receptor modulator, in the treatment of vulvovaginal atrophy in postmenopausal women. A randomized, double-blind phase 3 study in which 826 postmenopausal women were randomized 1:1:1 to receive treatment with ospemifene 30 or 60 mg/day or placebo orally for 12 weeks was conducted. The primary inclusion criteria were having 5% or less superficial cells on the vaginal smear (maturation index), vaginal pH greater than 5.0, and at least one moderate or severe symptom of vulvovaginal atrophy. The four coprimary endpoints were the change from baseline to 12 weeks in the percentage of superficial and parabasal cells on the vaginal smear, change in vaginal pH, and change in severity of most bothersome symptom (vaginal dryness or dyspareunia) compared with placebo.", "label": 1, "is_selected": 0, "text": "The aim of this study was to study the efficacy and safety of ospemifene, a new selective estrogen receptor modulator, in the treatment of vulvovaginal atrophy in postmenopausal women. A randomized, double-blind phase 3 study in which 826 postmenopausal women were randomized 1:1:1 to receive treatment with ospemifene 30 or 60 mg/day or placebo orally for 12 weeks was conducted. The primary inclusion criteria were having 5% or less superficial cells on the vaginal smear (maturation index), vaginal pH greater than 5.0, and at least one moderate or severe symptom of vulvovaginal atrophy. The four coprimary endpoints were the change from baseline to 12 weeks in the percentage of superficial and parabasal cells on the vaginal smear, change in vaginal pH, and change in severity of most bothersome symptom (vaginal dryness or dyspareunia) compared with placebo."}
{"qid": "57136cbf1174fb1755000007", "original_text": "To explore the value of next-generation sequencing for the non-invasive prenatal testing of fetal chromosomal aneuploidies. Plasma from 4004 women with singleton pregnancy at a gestational age between 12-35(+5) weeks was collected prior to amniocentesis between April 19th 2011 and December 31st 2013. The samples were divided into three groups: (1) High risk for Down syndrome by biochemical screening; (2) Advanced maternal age; (3) Abnormalities by ultrasound or other methods. Plasma DNA extracted from above samples was sequenced at low coverage. Positive results were verified against the karyotypes of the fetuses. For those with negative results, the fetuses were followed up by telephone call for at least six months after birth. Among 4003 samples subjected to non-invasive prenatal diagnosis, 66 (1.65%) had a positive result.", "label": 1, "is_selected": 0, "text": "To explore the value of next-generation sequencing for the non-invasive prenatal testing of fetal chromosomal aneuploidies. Plasma from 4004 women with singleton pregnancy at a gestational age between 12-35(+5) weeks was collected prior to amniocentesis between April 19th 2011 and December 31st 2013. The samples were divided into three groups: (1) High risk for Down syndrome by biochemical screening; (2) Advanced maternal age; (3) Abnormalities by ultrasound or other methods. Plasma DNA extracted from above samples was sequenced at low coverage. Positive results were verified against the karyotypes of the fetuses. For those with negative results, the fetuses were followed up by telephone call for at least six months after birth. Among 4003 samples subjected to non-invasive prenatal diagnosis, 66 (1.65%) had a positive result."}
{"qid": "58d900428acda3452900000c", "original_text": "Barth syndrome (BTHS) is a genetic, X-linked, rare but often fatal, pediatric skeletal- and cardiomyopathy occurring due to mutations in the tafazzin gene (TAZ). TAZ encodes a transacylase involved in phospholipid biosynthesis, also called tafazzin, which is responsible for remodeling the inner mitochondrial membrane phospholipid, cardiolipin (CL). Tafazzin mutations lead to compositional alterations in CL molecular species, causing extensive mitochondrial aberrations and ultrastructural muscle damage. There are no specific treatments or cure for BTHS. Current therapy is largely palliative and aimed at treatment of organ-specific complications during disease progression. Polypharmacy frequently occurs during treatment and may lead to severe adverse events. Adverse reactions may originate from exogenous factors such as the inadvertent co-administration of contraindicated drugs. Theoretically, endogenous factors such as polymorphic variations in genes encoding drug metabolizing enzymes may also precipitate fatal toxicity.", "label": 1, "is_selected": 0, "text": "Barth syndrome (BTHS) is a genetic, X-linked, rare but often fatal, pediatric skeletal- and cardiomyopathy occurring due to mutations in the tafazzin gene (TAZ). TAZ encodes a transacylase involved in phospholipid biosynthesis, also called tafazzin, which is responsible for remodeling the inner mitochondrial membrane phospholipid, cardiolipin (CL). Tafazzin mutations lead to compositional alterations in CL molecular species, causing extensive mitochondrial aberrations and ultrastructural muscle damage. There are no specific treatments or cure for BTHS. Current therapy is largely palliative and aimed at treatment of organ-specific complications during disease progression. Polypharmacy frequently occurs during treatment and may lead to severe adverse events. Adverse reactions may originate from exogenous factors such as the inadvertent co-administration of contraindicated drugs. Theoretically, endogenous factors such as polymorphic variations in genes encoding drug metabolizing enzymes may also precipitate fatal toxicity."}
{"qid": "550748a3bde8548216000001", "original_text": "Heterozygous mutations in STXBP1, encoding the syntaxin binding protein 1, have recently been identified in Ohtahara syndrome, an epileptic encephalopathy with very early onset. In order to explore the phenotypic spectrum associated with STXBP1 mutations, we analyzed a cohort of patients with unexplained early-onset epileptic encephalopathies. We collected and clinically characterized 106 patients with early-onset epileptic encephalopathies. Mutation analysis of the STXBP1 gene was done using sequence analysis of the exon and intron-exon boundaries and multiplex amplification quantification to detect copy number variations. We identified 4 truncating mutations and 2 microdeletions partially affecting STXBP1 in 6 of the 106 patients. All mutations are predicted to abolish STXBP1 function and 5 mutations were proven to occur de novo. None of the mutation-carrying patients had Ohtahara syndrome. One patient was diagnosed with West syndrome at disease onset, while the initial phenotype of 5 further patients did not fit into a specific recognized epilepsy syndrome.", "label": 1, "is_selected": 0, "text": "Heterozygous mutations in STXBP1, encoding the syntaxin binding protein 1, have recently been identified in Ohtahara syndrome, an epileptic encephalopathy with very early onset. In order to explore the phenotypic spectrum associated with STXBP1 mutations, we analyzed a cohort of patients with unexplained early-onset epileptic encephalopathies. We collected and clinically characterized 106 patients with early-onset epileptic encephalopathies. Mutation analysis of the STXBP1 gene was done using sequence analysis of the exon and intron-exon boundaries and multiplex amplification quantification to detect copy number variations. We identified 4 truncating mutations and 2 microdeletions partially affecting STXBP1 in 6 of the 106 patients. All mutations are predicted to abolish STXBP1 function and 5 mutations were proven to occur de novo. None of the mutation-carrying patients had Ohtahara syndrome. One patient was diagnosed with West syndrome at disease onset, while the initial phenotype of 5 further patients did not fit into a specific recognized epilepsy syndrome."}
{"qid": "511a1e12df1ebcce7d000009", "original_text": "FFPE tissue is a standard method of specimen preservation for hospital pathology departments. Formalin-fixed paraffin-embedded tissue banks are a resource of histologically characterized specimens for retrospective biomarker investigation. We aim to establish liquid chromatography coupled with tandem mass spectrometry analysis of FFPE pancreatic tissue as a suitable strategy for the study of the pancreas proteome. We investigated the proteomic profile of FFPE pancreatic tissue specimens, using liquid chromatography coupled with tandem mass spectrometry, from 9 archived specimens that were histologically classified as normal (n = 3), chronic pancreatitis (n = 3), and pancreatic cancer (n = 3). We identified 525 nonredundant proteins from 9 specimens. Implementing our filtering criteria, 78, 15, and 21 proteins were identified exclusively in normal, chronic pancreatitis, and pancreatic cancer specimens, respectively. Several proteins were identified exclusively in specimens with no pancreatic disease: spink 1, retinol dehydrogenase, and common pancreatic enzymes. Similarly, proteins were identified exclusively in chronic pancreatitis specimens: collagen \u03b11 (XIV), filamin A, collagen \u03b13 (VI), and SNC73.", "label": 1, "is_selected": 0, "text": "FFPE tissue is a standard method of specimen preservation for hospital pathology departments. Formalin-fixed paraffin-embedded tissue banks are a resource of histologically characterized specimens for retrospective biomarker investigation. We aim to establish liquid chromatography coupled with tandem mass spectrometry analysis of FFPE pancreatic tissue as a suitable strategy for the study of the pancreas proteome. We investigated the proteomic profile of FFPE pancreatic tissue specimens, using liquid chromatography coupled with tandem mass spectrometry, from 9 archived specimens that were histologically classified as normal (n = 3), chronic pancreatitis (n = 3), and pancreatic cancer (n = 3). We identified 525 nonredundant proteins from 9 specimens. Implementing our filtering criteria, 78, 15, and 21 proteins were identified exclusively in normal, chronic pancreatitis, and pancreatic cancer specimens, respectively. Several proteins were identified exclusively in specimens with no pancreatic disease: spink 1, retinol dehydrogenase, and common pancreatic enzymes. Similarly, proteins were identified exclusively in chronic pancreatitis specimens: collagen \u03b11 (XIV), filamin A, collagen \u03b13 (VI), and SNC73."}
{"qid": "58df73bd38f7f3e93a000001", "original_text": "Osteocrin is a protein that is expressed in the bone tissue and plays a role in the regulation of bone metabolism. While it is true that osteocrin is primarily expressed in the bone, it is not exclusively expressed in the bone. Studies have shown that osteocrin is also expressed in a number of other tissues, including the kidney, lung, and brain. In the kidney, osteocrin is expressed in the proximal tubule cells, where it regulates the expression of genes involved in the transport of ions and waste products. In the lung, osteocrin is expressed in the alveolar epithelial cells, where it may play a role in the regulation of inflammation. In the brain, osteocrin is expressed in the astrocytes, where it may be involved in the regulation of neurotransmission. Therefore, while osteocrin is primarily expressed in the bone, it is also expressed in other tissues, highlighting its broader tissue distribution and the complexity of its biological functions.", "label": 0, "is_selected": 0, "text": "Osteocrin is a protein that is expressed in the bone tissue and plays a role in the regulation of bone metabolism. While it is true that osteocrin is primarily expressed in the bone, it is not exclusively expressed in the bone. Studies have shown that osteocrin is also expressed in a number of other tissues, including the kidney, lung, and brain. In the kidney, osteocrin is expressed in the proximal tubule cells, where it regulates the expression of genes involved in the transport of ions and waste products. In the lung, osteocrin is expressed in the alveolar epithelial cells, where it may play a role in the regulation of inflammation. In the brain, osteocrin is expressed in the astrocytes, where it may be involved in the regulation of neurotransmission. Therefore, while osteocrin is primarily expressed in the bone, it is also expressed in other tissues, highlighting its broader tissue distribution and the complexity of its biological functions."}
{"qid": "54fb5720d176fff445000002", "original_text": "The four \"Yamanaka factors\" used to create induced pluripotent stem cells (iPSCs) are: 1. Oct4 (also known as Pou5f1): a transcription factor that regulates cell fate and differentiation. 2. Sox2: a transcription factor involved in the maintenance of stem cell self-renewal and pluripotency. 3. Klf4: a transcription factor that regulates cell proliferation and differentiation. 4. c-Myc: a transcription factor that regulates cell growth and differentiation. These four factors are typically introduced into adult cells using viral vectors to reprogram them into iPSCs, which have the same properties as embryonic stem cells.", "label": 0, "is_selected": 0, "text": "The four \"Yamanaka factors\" used to create induced pluripotent stem cells (iPSCs) are: 1. Oct4 (also known as Pou5f1): a transcription factor that regulates cell fate and differentiation. 2. Sox2: a transcription factor involved in the maintenance of stem cell self-renewal and pluripotency. 3. Klf4: a transcription factor that regulates cell proliferation and differentiation. 4. c-Myc: a transcription factor that regulates cell growth and differentiation. These four factors are typically introduced into adult cells using viral vectors to reprogram them into iPSCs, which have the same properties as embryonic stem cells."}
{"qid": "58bca3eb02b8c6095300000d", "original_text": "Adhesive capsulitis, also known as frozen shoulder, is a condition characterized by inflammation and scar tissue formation in the connective tissue of the shoulder joint. It leads to stiffness, pain, and limited range of motion in the shoulder. The exact cause of adhesive capsulitis is not fully understood, but it can occur after an injury or surgery, or as a result of chronic conditions such as diabetes, thyroid disorders, or cardiovascular disease. The symptoms of adhesive capsulitis typically begin gradually and worsen over time. The early stages of the condition may present with pain and stiffness in the shoulder, particularly at night, and a slow decrease in range of motion. As the condition progresses, the affected shoulder can become increasingly stiff and rigid, making it difficult to move the arm. Treatment for adhesive capsulitis involves a combination of physical therapy, medication, and in some cases, surgery. Physical therapy can help to improve range of motion and reduce stiffness, while medication can help to manage pain. Surgery may be necessary in severe cases where there is significant scarring and adhesions in the shoulder joint. It is important to seek medical attention if you experience persistent pain or stiffness in the shoulder, especially if it interferes with your daily activities. A healthcare professional can diagnose adhesive capsulitis and recommend an appropriate treatment plan.", "label": 0, "is_selected": 0, "text": "Adhesive capsulitis, also known as frozen shoulder, is a condition characterized by inflammation and scar tissue formation in the connective tissue of the shoulder joint. It leads to stiffness, pain, and limited range of motion in the shoulder. The exact cause of adhesive capsulitis is not fully understood, but it can occur after an injury or surgery, or as a result of chronic conditions such as diabetes, thyroid disorders, or cardiovascular disease. The symptoms of adhesive capsulitis typically begin gradually and worsen over time. The early stages of the condition may present with pain and stiffness in the shoulder, particularly at night, and a slow decrease in range of motion. As the condition progresses, the affected shoulder can become increasingly stiff and rigid, making it difficult to move the arm. Treatment for adhesive capsulitis involves a combination of physical therapy, medication, and in some cases, surgery. Physical therapy can help to improve range of motion and reduce stiffness, while medication can help to manage pain. Surgery may be necessary in severe cases where there is significant scarring and adhesions in the shoulder joint. It is important to seek medical attention if you experience persistent pain or stiffness in the shoulder, especially if it interferes with your daily activities. A healthcare professional can diagnose adhesive capsulitis and recommend an appropriate treatment plan."}
{"qid": "5e2f9596fbd6abf43b00002f", "original_text": "Allgrove syndrome (AS) is a rare autosomal recessive disorder characterized by achalasia cardia, alacrimia, and adrenocorticotropic hormone-resistant adrenal insufficiency which is sometimes associated with autonomic dysfunction. It has also been referred to as the triple A syndrome in view of the cardinal symptoms described above. First described by Allgrove et al in 1978, the disorder usually presents mostly during the first decade of life. These patients have the threat of adrenal crisis, shock, and hypoglycemia and are usually on steroid supplementation. The anesthesiologist's encounter with such patients, although rare, is mostly for repair of the achalasia cardia. We thus report a similar case of AS in a 2-year-old girl who was scheduled to undergo Heller myotomy along with the preoperative evaluation and intraoperative management of the same. Being aware of the pathophysiology of AS gives useful insight about the disease and successful perioperative management in the form of the triple S strategy, that is, stress dose of steroids, slow induction and positioning, and finally maintenance of stable hemodynamics and euglycemia.", "label": 1, "is_selected": 0, "text": "Allgrove syndrome (AS) is a rare autosomal recessive disorder characterized by achalasia cardia, alacrimia, and adrenocorticotropic hormone-resistant adrenal insufficiency which is sometimes associated with autonomic dysfunction. It has also been referred to as the triple A syndrome in view of the cardinal symptoms described above. First described by Allgrove et al in 1978, the disorder usually presents mostly during the first decade of life. These patients have the threat of adrenal crisis, shock, and hypoglycemia and are usually on steroid supplementation. The anesthesiologist's encounter with such patients, although rare, is mostly for repair of the achalasia cardia. We thus report a similar case of AS in a 2-year-old girl who was scheduled to undergo Heller myotomy along with the preoperative evaluation and intraoperative management of the same. Being aware of the pathophysiology of AS gives useful insight about the disease and successful perioperative management in the form of the triple S strategy, that is, stress dose of steroids, slow induction and positioning, and finally maintenance of stable hemodynamics and euglycemia."}
{"qid": "56ed0ba22ac5ed1459000007", "original_text": "Yes, Revlimid (lenalidomide) has been approved by the US Food and Drug Administration (FDA) for the treatment of several types of cancer, including multiple myeloma, mantle cell lymphoma, and cutaneous T-cell lymphoma. It was first approved in 2006 for the treatment of multiple myeloma and has since been approved for other indications. The FDA has approved Revlimid for adults with these types of cancer who have already received at least one prior therapy.", "label": 0, "is_selected": 0, "text": "Yes, Revlimid (lenalidomide) has been approved by the US Food and Drug Administration (FDA) for the treatment of several types of cancer, including multiple myeloma, mantle cell lymphoma, and cutaneous T-cell lymphoma. It was first approved in 2006 for the treatment of multiple myeloma and has since been approved for other indications. The FDA has approved Revlimid for adults with these types of cancer who have already received at least one prior therapy."}
{"qid": "623e04e4f0baec9a1b000006", "original_text": "JAK2, CALR, and MPL are myeloproliferative neoplasm (MPN)-driver mutations, whereas SF3B1 is strongly associated with ring sideroblasts (RS) in myelodysplastic syndrome (MDS). Concomitant mutations of SF3B1 and MPN-driver mutations out of the context of MDS/MPN with RS and thrombocytosis (MDS/MPN-RS-T) are not well-studied. From the cases (<5% blasts) tested by NGS panels interrogating at least 42 myeloid neoplasm-related genes, we identified 18 MDS/MPN-RS-T, 42 MPN, 10 MDS, and 6 MDS/MPN-U cases with an SF3B1 and an MPN-driver mutation. Using a 10% VAF difference to define \"SF3B1-dominant,\" \"MPN-mutation dominant,\" and \"no dominance,\" the majority of MDS/MPN-RS-T clustered in \"SF3B1-dominant\" and \"no dominance\" regions. Aside from parameters as thrombocytosis and \u226515% RS required for RS-T, MDS also differed in frequent neutropenia, multilineage dysplasia, and notably more cases with <10% VAF of MPN-driver mutations (60%, p = 0.0346); MPN differed in more frequent splenomegaly, myelofibrosis, and higher VAF of \"MPN-driver mutations.\"", "label": 1, "is_selected": 0, "text": "JAK2, CALR, and MPL are myeloproliferative neoplasm (MPN)-driver mutations, whereas SF3B1 is strongly associated with ring sideroblasts (RS) in myelodysplastic syndrome (MDS). Concomitant mutations of SF3B1 and MPN-driver mutations out of the context of MDS/MPN with RS and thrombocytosis (MDS/MPN-RS-T) are not well-studied. From the cases (<5% blasts) tested by NGS panels interrogating at least 42 myeloid neoplasm-related genes, we identified 18 MDS/MPN-RS-T, 42 MPN, 10 MDS, and 6 MDS/MPN-U cases with an SF3B1 and an MPN-driver mutation. Using a 10% VAF difference to define \"SF3B1-dominant,\" \"MPN-mutation dominant,\" and \"no dominance,\" the majority of MDS/MPN-RS-T clustered in \"SF3B1-dominant\" and \"no dominance\" regions. Aside from parameters as thrombocytosis and \u226515% RS required for RS-T, MDS also differed in frequent neutropenia, multilineage dysplasia, and notably more cases with <10% VAF of MPN-driver mutations (60%, p = 0.0346); MPN differed in more frequent splenomegaly, myelofibrosis, and higher VAF of \"MPN-driver mutations.\""}
{"qid": "571f5c150fd6f91b68000009", "original_text": "It is generally accepted that Friedreich's ataxia (FRDA) is caused by a deficiency in frataxin expression, a mitochondrial protein involved in iron homeostasis, which mainly affects the brain, dorsal root ganglia of the spinal cord, heart and in certain cases the pancreas. However, there is little knowledge as to other possible genes that may be affected in this disorder, and which can contribute to its complexity.", "label": 1, "is_selected": 0, "text": "It is generally accepted that Friedreich's ataxia (FRDA) is caused by a deficiency in frataxin expression, a mitochondrial protein involved in iron homeostasis, which mainly affects the brain, dorsal root ganglia of the spinal cord, heart and in certain cases the pancreas. However, there is little knowledge as to other possible genes that may be affected in this disorder, and which can contribute to its complexity."}
{"qid": "516c3960298dcd4e51000073", "original_text": "The Dnmt2 enzymes show strong amino acid sequence similarity with eukaryotic and prokaryotic DNA-(cytosine C5)-methyltransferases. Yet, Dnmt2 enzymes from several species were shown to methylate tRNA-Asp and had been proposed that eukaryotic DNA methyltransferases evolved from a Dnmt2-like tRNA methyltransferase ancestor [Goll et al., 2006, Science, 311, 395-8]. It was the aim of this study to investigate if this hypothesis could be supported by evidence from sequence alignments. We present phylogenetic analyses based on sequence alignments of the methyltransferase catalytic domains of more than 2300 eukaryotic and prokaryotic DNA-(cytosine C5)-methyltransferases and analyzed the distribution of DNA methyltransferases in eukaryotic species. The Dnmt2 homologues were reliably identified by an additional conserved CFT motif next to motif IX. All DNA methyltransferases and Dnmt2 enzymes were clearly separated from other RNA-(cytosine-C5)-methyltransferases. Our sequence alignments and phylogenetic analyses indicate that the last universal eukaryotic ancestor contained at least one member of the Dnmt1, Dnmt2 and Dnmt3 families of enzymes and additional RNA methyltransferases.", "label": 1, "is_selected": 0, "text": "The Dnmt2 enzymes show strong amino acid sequence similarity with eukaryotic and prokaryotic DNA-(cytosine C5)-methyltransferases. Yet, Dnmt2 enzymes from several species were shown to methylate tRNA-Asp and had been proposed that eukaryotic DNA methyltransferases evolved from a Dnmt2-like tRNA methyltransferase ancestor [Goll et al., 2006, Science, 311, 395-8]. It was the aim of this study to investigate if this hypothesis could be supported by evidence from sequence alignments. We present phylogenetic analyses based on sequence alignments of the methyltransferase catalytic domains of more than 2300 eukaryotic and prokaryotic DNA-(cytosine C5)-methyltransferases and analyzed the distribution of DNA methyltransferases in eukaryotic species. The Dnmt2 homologues were reliably identified by an additional conserved CFT motif next to motif IX. All DNA methyltransferases and Dnmt2 enzymes were clearly separated from other RNA-(cytosine-C5)-methyltransferases. Our sequence alignments and phylogenetic analyses indicate that the last universal eukaryotic ancestor contained at least one member of the Dnmt1, Dnmt2 and Dnmt3 families of enzymes and additional RNA methyltransferases."}
{"qid": "5c644c3de842deac67000018", "original_text": "Cohesin is important for 3D genome organization. Nevertheless, even the complete removal of cohesin has surprisingly little impact on steady-state gene transcription and enhancer activity. Here we show that cohesin is required for the core transcriptional response of primary macrophages to microbial signals, and for inducible enhancer activity that underpins inflammatory gene expression.", "label": 1, "is_selected": 0, "text": "Cohesin is important for 3D genome organization. Nevertheless, even the complete removal of cohesin has surprisingly little impact on steady-state gene transcription and enhancer activity. Here we show that cohesin is required for the core transcriptional response of primary macrophages to microbial signals, and for inducible enhancer activity that underpins inflammatory gene expression."}
{"qid": "54edeb4394afd6150400000b", "original_text": "Both Fanconi anemia (FA) and telomere dysfunction are associated with chromosome instability and an increased risk of cancer. Because of these similarities, we have investigated whether there is a relationship between the FA protein, FANCD2 and telomeres. We find that FANCD2 nuclear foci colocalize with telomeres and PML bodies in immortalized telomerase-negative cells. These cells maintain telomeres by alternative lengthening of telomeres (ALT). In contrast, FANCD2 does not colocalize with telomeres or PML bodies in cells which express telomerase. Using a siRNA approach we find that FANCA and FANCL, which are components of the FA nuclear core complex, regulate FANCD2 monoubiquitination and the telomeric localization of FANCD2 in ALT cells. Transient depletion of FANCD2, or FANCA, results in a dramatic loss of detectable telomeres in ALT cells but not in telomerase-expressing cells.", "label": 1, "is_selected": 0, "text": "Both Fanconi anemia (FA) and telomere dysfunction are associated with chromosome instability and an increased risk of cancer. Because of these similarities, we have investigated whether there is a relationship between the FA protein, FANCD2 and telomeres. We find that FANCD2 nuclear foci colocalize with telomeres and PML bodies in immortalized telomerase-negative cells. These cells maintain telomeres by alternative lengthening of telomeres (ALT). In contrast, FANCD2 does not colocalize with telomeres or PML bodies in cells which express telomerase. Using a siRNA approach we find that FANCA and FANCL, which are components of the FA nuclear core complex, regulate FANCD2 monoubiquitination and the telomeric localization of FANCD2 in ALT cells. Transient depletion of FANCD2, or FANCA, results in a dramatic loss of detectable telomeres in ALT cells but not in telomerase-expressing cells."}
{"qid": "588482f5e56acf517600000a", "original_text": "Glyburide is an antidiabetic medication that belongs to the class of sulfonylureas. While it has been shown to have neuroprotective effects in some studies, there is limited evidence to suggest that it can directly reduce cerebral edema. Cerebral edema is a complex condition that can have various causes, including traumatic brain injury, stroke, and cerebral vasospasm. Treatment of cerebral edema usually involves supportive care and management of the underlying cause. In some cases, medications such as corticosteroids, diuretics, and calcium channel blockers may be used to help manage edema. However, glyburide is not typically used for this purpose. Therefore, I do not have an answer to whether glyburide can reduce cerebral edema.", "label": 0, "is_selected": 0, "text": "Glyburide is an antidiabetic medication that belongs to the class of sulfonylureas. While it has been shown to have neuroprotective effects in some studies, there is limited evidence to suggest that it can directly reduce cerebral edema. Cerebral edema is a complex condition that can have various causes, including traumatic brain injury, stroke, and cerebral vasospasm. Treatment of cerebral edema usually involves supportive care and management of the underlying cause. In some cases, medications such as corticosteroids, diuretics, and calcium channel blockers may be used to help manage edema. However, glyburide is not typically used for this purpose. Therefore, I do not have an answer to whether glyburide can reduce cerebral edema."}
{"qid": "601f0c161cb411341a00006e", "original_text": "Mitochondria are known to be a major target during ischemic cardiac injury. Previous studies have shown that in rodent myogenic cells and in the hearts of transgenic mice in which the heat shock or stress protein 70 is increased, there is a marked tolerance to ischemia/reperfusion injury. Two other heat shock proteins (HSP60 and HSP10) are known to form, within the mitochondria, a chaperonin complex that is important for mitochondrial protein folding and function. We were then interested in investigating whether increased expression of these two stress proteins is able to protect myogenic cells against ischemia/reperfusion injury.", "label": 1, "is_selected": 0, "text": "Mitochondria are known to be a major target during ischemic cardiac injury. Previous studies have shown that in rodent myogenic cells and in the hearts of transgenic mice in which the heat shock or stress protein 70 is increased, there is a marked tolerance to ischemia/reperfusion injury. Two other heat shock proteins (HSP60 and HSP10) are known to form, within the mitochondria, a chaperonin complex that is important for mitochondrial protein folding and function. We were then interested in investigating whether increased expression of these two stress proteins is able to protect myogenic cells against ischemia/reperfusion injury."}
{"qid": "56b397a98525abca1e000003", "original_text": "Eukaryotic cells store excess fatty acids as neutral lipids, predominantly triacylglycerols and sterol esters, in organelles termed lipid droplets (LDs) that bulge out from the endoplasmic reticulum. LDs are highly dynamic and contribute to diverse cellular functions. The catabolism of the storage lipids within LDs is channeled to multiple metabolic pathways, providing molecules for energy production, membrane building blocks, and lipid signaling. LDs have been implicated in a number of protein degradation and pathogen infection processes. LDs may be linked to prevalent human metabolic diseases and have marked potential for biofuel production. The knowledge accumulated on LDs in recent years provides a foundation for diverse, and even unexpected, future research.", "label": 1, "is_selected": 0, "text": "Eukaryotic cells store excess fatty acids as neutral lipids, predominantly triacylglycerols and sterol esters, in organelles termed lipid droplets (LDs) that bulge out from the endoplasmic reticulum. LDs are highly dynamic and contribute to diverse cellular functions. The catabolism of the storage lipids within LDs is channeled to multiple metabolic pathways, providing molecules for energy production, membrane building blocks, and lipid signaling. LDs have been implicated in a number of protein degradation and pathogen infection processes. LDs may be linked to prevalent human metabolic diseases and have marked potential for biofuel production. The knowledge accumulated on LDs in recent years provides a foundation for diverse, and even unexpected, future research."}
{"qid": "5506eca18e1671127b00000f", "original_text": "The transcription factor NF-\u03baB plays a critical role in the regulation of genes involved in inflammation and immune responses. The canonical pathway of NF-\u03baB activation involves the following subunits: 1. RelA (p65): also known as NF-\u03baB1, this subunit is constitutively expressed in most cell types and plays a key role in the regulation of genes involved in inflammation and immune responses. 2. RelB: also known as NF-\u03baB2, this subunit is expressed in a cell-type-specific manner and plays a role in the regulation of genes involved in immune responses and cell survival. 3. c-Rel: a subunit that is specifically expressed in hematopoietic cells and plays a role in the regulation of genes involved in inflammation and immune responses. 4. p50/p105: a subunit that is composed of two distinct subunits, p50 and p105, which are synthesized as separate proteins and then processed to form the active heterodimer. 5. p52/c-Fos: a subunit that is expressed primarily in immune cells and plays a role in the regulation of genes involved in inflammation and immune responses. By bringing together these subunits, the NF-\u03baB complex can activate the transcription of target genes involved in inflammation, immune responses, and cell survival.", "label": 0, "is_selected": 0, "text": "The transcription factor NF-\u03baB plays a critical role in the regulation of genes involved in inflammation and immune responses. The canonical pathway of NF-\u03baB activation involves the following subunits: 1. RelA (p65): also known as NF-\u03baB1, this subunit is constitutively expressed in most cell types and plays a key role in the regulation of genes involved in inflammation and immune responses. 2. RelB: also known as NF-\u03baB2, this subunit is expressed in a cell-type-specific manner and plays a role in the regulation of genes involved in immune responses and cell survival. 3. c-Rel: a subunit that is specifically expressed in hematopoietic cells and plays a role in the regulation of genes involved in inflammation and immune responses. 4. p50/p105: a subunit that is composed of two distinct subunits, p50 and p105, which are synthesized as separate proteins and then processed to form the active heterodimer. 5. p52/c-Fos: a subunit that is expressed primarily in immune cells and plays a role in the regulation of genes involved in inflammation and immune responses. By bringing together these subunits, the NF-\u03baB complex can activate the transcription of target genes involved in inflammation, immune responses, and cell survival."}
{"qid": "5a8718a261bb38fb24000007", "original_text": "Telomere-repeat-encoding RNA (referred to as TERRA) has been identified as a potential component of yeast and mammalian telomeres. We show here that TERRA RNA interacts with several telomere-associated proteins, including telomere repeat factors 1 (TRF1) and 2 (TRF2), subunits of the origin recognition complex (ORC), heterochromatin protein 1 (HP1), histone H3 trimethyl K9 (H3 K9me3), and members of the DNA-damage-sensing pathway. siRNA depletion of TERRA caused an increase in telomere dysfunction-induced foci, aberrations in metaphase telomeres, and a loss of histone H3 K9me3 and ORC at telomere repeat DNA. Previous studies found that TRF2 amino-terminal GAR domain recruited ORC to telomeres.", "label": 1, "is_selected": 0, "text": "Telomere-repeat-encoding RNA (referred to as TERRA) has been identified as a potential component of yeast and mammalian telomeres. We show here that TERRA RNA interacts with several telomere-associated proteins, including telomere repeat factors 1 (TRF1) and 2 (TRF2), subunits of the origin recognition complex (ORC), heterochromatin protein 1 (HP1), histone H3 trimethyl K9 (H3 K9me3), and members of the DNA-damage-sensing pathway. siRNA depletion of TERRA caused an increase in telomere dysfunction-induced foci, aberrations in metaphase telomeres, and a loss of histone H3 K9me3 and ORC at telomere repeat DNA. Previous studies found that TRF2 amino-terminal GAR domain recruited ORC to telomeres."}
{"qid": "553f78c7ab98a37113000008", "original_text": "The development of colorectal cancer (CRC) is characterized by multiple genetic alterations. Transcribed ultraconserved regions (T-UCRs) are a subset of 481 sequences longer than 200 bp, which are absolutely conserved between orthologous regions of human, rat and mouse genomes, and are actively transcribed. It has recently been proven in cancer systems that differentially expressed T-UCRs could alter the functional characteristics of malignant cells. Genome-wide profiling revealed that T-UCRs have distinct signatures in human leukemia and carcinoma. In our study, we examined the expression levels of uc.43, uc.73, uc.134, uc.230, uc.339, uc.388 and uc.399 in 54 samples of primary colorectal carcinomas and 15 samples of non-tumoral adjacent tissues by real-time PCR.", "label": 1, "is_selected": 0, "text": "The development of colorectal cancer (CRC) is characterized by multiple genetic alterations. Transcribed ultraconserved regions (T-UCRs) are a subset of 481 sequences longer than 200 bp, which are absolutely conserved between orthologous regions of human, rat and mouse genomes, and are actively transcribed. It has recently been proven in cancer systems that differentially expressed T-UCRs could alter the functional characteristics of malignant cells. Genome-wide profiling revealed that T-UCRs have distinct signatures in human leukemia and carcinoma. In our study, we examined the expression levels of uc.43, uc.73, uc.134, uc.230, uc.339, uc.388 and uc.399 in 54 samples of primary colorectal carcinomas and 15 samples of non-tumoral adjacent tissues by real-time PCR."}
{"qid": "60292e1b1cb411341a000111", "original_text": "Curare is a plant-based toxin that has been used for centuries by indigenous cultures in South America as a means of hunting and warfare. While it has been known to cause paralysis and death in humans, its mechanism of action is not fully understood. However, research suggests that curare functions by blocking the acetylcholine receptor at the neuromuscular junction. Acetylcholine is a neurotransmitter that plays a crucial role in the transmission of nerve impulses. When it binds to the acetylcholine receptor, it triggers a cascade of events that ultimately lead to muscle contraction. Curare, on the other hand, binds to the same receptor, but in a way that prevents acetylcholine from binding. By doing so, curare blocks the transmission of nerve impulses and causes paralysis. In summary, Curare functions by blocking the acetylcholine receptor at the neuromuscular junction, leading to paralysis and eventual death. While more research is needed to fully understand its mechanism of action, it is clear that curare is a highly toxic substance with significant effects on the nervous system.", "label": 0, "is_selected": 0, "text": "Curare is a plant-based toxin that has been used for centuries by indigenous cultures in South America as a means of hunting and warfare. While it has been known to cause paralysis and death in humans, its mechanism of action is not fully understood. However, research suggests that curare functions by blocking the acetylcholine receptor at the neuromuscular junction. Acetylcholine is a neurotransmitter that plays a crucial role in the transmission of nerve impulses. When it binds to the acetylcholine receptor, it triggers a cascade of events that ultimately lead to muscle contraction. Curare, on the other hand, binds to the same receptor, but in a way that prevents acetylcholine from binding. By doing so, curare blocks the transmission of nerve impulses and causes paralysis. In summary, Curare functions by blocking the acetylcholine receptor at the neuromuscular junction, leading to paralysis and eventual death. While more research is needed to fully understand its mechanism of action, it is clear that curare is a highly toxic substance with significant effects on the nervous system."}
{"qid": "5c8aa082d558e5f23200000c", "original_text": "The cationic polysaccharide chitosan is an attractive candidate adjuvant capable of driving potent cell-mediated immunity, but the mechanism by which it acts is not clear. We show that chitosan promotes dendritic cell maturation by inducing type I interferons (IFNs) and enhances antigen-specific T helper 1 (Th1) responses in a type I IFN receptor-dependent manner. The induction of type I IFNs, IFN-stimulated genes and dendritic cell maturation by chitosan required the cytoplasmic DNA sensor cGAS and STING, implicating this pathway in dendritic cell activation. Additionally, this process was dependent on mitochondrial reactive oxygen species and the presence of cytoplasmic DNA.", "label": 1, "is_selected": 0, "text": "The cationic polysaccharide chitosan is an attractive candidate adjuvant capable of driving potent cell-mediated immunity, but the mechanism by which it acts is not clear. We show that chitosan promotes dendritic cell maturation by inducing type I interferons (IFNs) and enhances antigen-specific T helper 1 (Th1) responses in a type I IFN receptor-dependent manner. The induction of type I IFNs, IFN-stimulated genes and dendritic cell maturation by chitosan required the cytoplasmic DNA sensor cGAS and STING, implicating this pathway in dendritic cell activation. Additionally, this process was dependent on mitochondrial reactive oxygen species and the presence of cytoplasmic DNA."}
{"qid": "5e2f43bafbd6abf43b000029", "original_text": "Of course! Here are two human diseases caused by coronaviruses: 1. Middle East Respiratory Syndrome (MERS-CoV): This is a viral respiratory disease that was first identified in 2012 in Saudi Arabia. MERS-CoV is transmitted through close contact with an infected person, and can cause severe respiratory symptoms, including pneumonia and respiratory failure. The disease has a high mortality rate, with approximately 35% of infected individuals dying from the disease. 2. Severe Acute Respiratory Syndrome (SARS-CoV): This is a highly contagious respiratory disease that was first identified in 2002 in China. SARS-CoV is transmitted through close contact with an infected person, and can cause severe respiratory symptoms, including pneumonia and respiratory failure. The disease has a high mortality rate, with approximately 9% of infected individuals dying from the disease.", "label": 0, "is_selected": 1, "text": "Do you know what a coronavirus is? SARS-CoV is transmitted through close contact with an infected person, and can cause severe respiratory symptoms, including pneumonia and respiratory failure. SARS- CoV is transmits through close proximity with an Infected Person, and has a high mortality rate, with approximately 9% of infected individuals dying from the disease."}
{"qid": "5ac7185f0340b9f058000004", "original_text": "In the previous study, we generated a rat model of dilated cardiomyopathy (DCM) induced by adriamycin and found that the expression of lncRNA H19 was significantly upregulated in myocardial tissue. The present study was aimed to investigate the potential role of H19 in the pathogenesis of adriamycin-induced DCM. H19 knockdown in the myocardium of DCM rats attenuated cardiomyocyte apoptosis and improved left ventricular structure and function. Adriamycin treatment was associated with elevated H19 and miR-675 expression and increased apoptosis in neonatal cardiomyocytes. Enforced expression of miR-675 was found to induce apoptosis in cardiomyocytes with adriamycin treatment and H19-siRNA transfection. The 3'-untranslated region of PA2G4 was cloned downstream of a luciferase reporter construct and cotransfected into HEK293 cells with miR-675 mimic. The results of luciferase assay showed that PA2G4 was a direct target of miR-675. The expression of PA2G4 was reduced in cardiomyocytes transfected with miR-675 mimic. Moreover, H19 knockdown was found to increase PA2G4 expression and suppress apoptosis in cardiomyocytes exposed to adriamycin.", "label": 1, "is_selected": 0, "text": "In the previous study, we generated a rat model of dilated cardiomyopathy (DCM) induced by adriamycin and found that the expression of lncRNA H19 was significantly upregulated in myocardial tissue. The present study was aimed to investigate the potential role of H19 in the pathogenesis of adriamycin-induced DCM. H19 knockdown in the myocardium of DCM rats attenuated cardiomyocyte apoptosis and improved left ventricular structure and function. Adriamycin treatment was associated with elevated H19 and miR-675 expression and increased apoptosis in neonatal cardiomyocytes. Enforced expression of miR-675 was found to induce apoptosis in cardiomyocytes with adriamycin treatment and H19-siRNA transfection. The 3'-untranslated region of PA2G4 was cloned downstream of a luciferase reporter construct and cotransfected into HEK293 cells with miR-675 mimic. The results of luciferase assay showed that PA2G4 was a direct target of miR-675. The expression of PA2G4 was reduced in cardiomyocytes transfected with miR-675 mimic. Moreover, H19 knockdown was found to increase PA2G4 expression and suppress apoptosis in cardiomyocytes exposed to adriamycin."}
{"qid": "56accec70a360a5e45000003", "original_text": "Accurate reconstruction of the regulatory networks that control gene expression is one of the key current challenges in molecular biology. Although gene expression and chromatin state dynamics are ultimately encoded by constellations of binding sites recognized by regulators such as transcriptions factors (TFs) and microRNAs (miRNAs), our understanding of this regulatory code and its context-dependent read-out remains very limited. Given that there are thousands of potential regulators in mammals, it is not practical to use direct experimentation to identify which of these play a key role for a particular system of interest. We developed a methodology that models gene expression or chromatin modifications in terms of genome-wide predictions of regulatory sites and completely automated it into a web-based tool called ISMARA (Integrated System for Motif Activity Response Analysis). Given only gene expression or chromatin state data across a set of samples as input, ISMARA identifies the key TFs and miRNAs driving expression/chromatin changes and makes detailed predictions regarding their regulatory roles. These include predicted activities of the regulators across the samples, their genome-wide targets, enriched gene categories among the targets, and direct interactions between the regulators.", "label": 1, "is_selected": 0, "text": "Accurate reconstruction of the regulatory networks that control gene expression is one of the key current challenges in molecular biology. Although gene expression and chromatin state dynamics are ultimately encoded by constellations of binding sites recognized by regulators such as transcriptions factors (TFs) and microRNAs (miRNAs), our understanding of this regulatory code and its context-dependent read-out remains very limited. Given that there are thousands of potential regulators in mammals, it is not practical to use direct experimentation to identify which of these play a key role for a particular system of interest. We developed a methodology that models gene expression or chromatin modifications in terms of genome-wide predictions of regulatory sites and completely automated it into a web-based tool called ISMARA (Integrated System for Motif Activity Response Analysis). Given only gene expression or chromatin state data across a set of samples as input, ISMARA identifies the key TFs and miRNAs driving expression/chromatin changes and makes detailed predictions regarding their regulatory roles. These include predicted activities of the regulators across the samples, their genome-wide targets, enriched gene categories among the targets, and direct interactions between the regulators."}
{"qid": "515ac941d24251bc050000ab", "original_text": "Exogenous thyroid hormones are regulators of cellular metabolism that involves, along with other cell structures, mitochondria. Mechanisms of the influence of thyroid hormones on the biogenesis of mtDNA are not fully understood due to their pleiotropic nature. Different ways of regulation of mitochondrial biogenesis by thyroid hormones are discussed in literature, but thyroid receptors, localized in both the nucleus and mitochondria, are the main elements of most pathways. Data on events occurring after receptor activation are rather contradictory. We investigated the degree of involvement of mitochondrial transcription factors in the biogenesis of mtDNA induced by triiodothyronine. The contribution of TFAM, TFB2M, and helicase Twinkle in thyroid-induced mtDNA biogenesis was assessed. The activation of TFAM and TFB2M expression is shown to be required for the induction of mtDNA biogenesis.", "label": 1, "is_selected": 0, "text": "Exogenous thyroid hormones are regulators of cellular metabolism that involves, along with other cell structures, mitochondria. Mechanisms of the influence of thyroid hormones on the biogenesis of mtDNA are not fully understood due to their pleiotropic nature. Different ways of regulation of mitochondrial biogenesis by thyroid hormones are discussed in literature, but thyroid receptors, localized in both the nucleus and mitochondria, are the main elements of most pathways. Data on events occurring after receptor activation are rather contradictory. We investigated the degree of involvement of mitochondrial transcription factors in the biogenesis of mtDNA induced by triiodothyronine. The contribution of TFAM, TFB2M, and helicase Twinkle in thyroid-induced mtDNA biogenesis was assessed. The activation of TFAM and TFB2M expression is shown to be required for the induction of mtDNA biogenesis."}
{"qid": "5e480909d14c9f295d000003", "original_text": "Understanding space radiation health effects is critical due to potential increased morbidity and mortality following spaceflight. We evaluated whether there is evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts and if a correlation exists between space radiation exposure and mortality. Astronauts selected from 1959-1969 were included and followed until death or February 2017, with 39 of 73 individuals still alive at that time. Calculated standardized mortality rates for tested outcomes were significantly below U.S. white male population rates, including all-cardiovascular disease (n = 7, SMR = 33; 95% CI, 14-65) and all-cancer (n = 7, SMR = 43; 95% CI, 18-83), as anticipated in a healthy worker population. Space radiation doses for cohort members ranged from 0-78 mGy.", "label": 1, "is_selected": 0, "text": "Understanding space radiation health effects is critical due to potential increased morbidity and mortality following spaceflight. We evaluated whether there is evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts and if a correlation exists between space radiation exposure and mortality. Astronauts selected from 1959-1969 were included and followed until death or February 2017, with 39 of 73 individuals still alive at that time. Calculated standardized mortality rates for tested outcomes were significantly below U.S. white male population rates, including all-cardiovascular disease (n = 7, SMR = 33; 95% CI, 14-65) and all-cancer (n = 7, SMR = 43; 95% CI, 18-83), as anticipated in a healthy worker population. Space radiation doses for cohort members ranged from 0-78 mGy."}
{"qid": "5162e011298dcd4e51000049", "original_text": "Desmin is a muscle-specific protein and a constitutive subunit of the intermediate filaments (IF) in skeletal, cardiac and smooth muscles. It is an early marker of skeletal muscle myogenesis. We have characterized a clone of desmin cDNA from an embryonic zebrafish (Danio rerio) cDNA library. The full-length cDNA comprised 1798 nucleotides, encoding a protein of 473 amino acids. The predicted amino acid sequence of the zebrafish desmin shares a high degree of similarity to other vertebrate desmins, but also contains a sequence at the carboxyl terminal of the tail domain that is unique to the zebrafish. It carries many features which are distinctive of IF subunit proteins. These include the T/SSYRRXF/Y motif in the head domain, and the intermediate filament signature consensus, [I/V]-X-[T/A/C/I]-Y-[R/K/H]-X-[L/M]-L-[D/E], located in the carboxyl terminus of the central helical rod. Unlike other 3' UTR sequences, the 3' UTR of the zebrafish cDNA sequence has two CAYUG elements flanking a single polyadenylation site. The temporal and spatial expression patterns of desmin mRNA during early zebrafish development were studied. The onset of desmin expression occurred at the 1-3 somite stage (11 hpf). It increased throughout somitogenesis, with maximum expression at the Prim-6 stage (25 hpf), and decreasing expression towards the protruding-mouth stage (72 hpf).", "label": 1, "is_selected": 0, "text": "Desmin is a muscle-specific protein and a constitutive subunit of the intermediate filaments (IF) in skeletal, cardiac and smooth muscles. It is an early marker of skeletal muscle myogenesis. We have characterized a clone of desmin cDNA from an embryonic zebrafish (Danio rerio) cDNA library. The full-length cDNA comprised 1798 nucleotides, encoding a protein of 473 amino acids. The predicted amino acid sequence of the zebrafish desmin shares a high degree of similarity to other vertebrate desmins, but also contains a sequence at the carboxyl terminal of the tail domain that is unique to the zebrafish. It carries many features which are distinctive of IF subunit proteins. These include the T/SSYRRXF/Y motif in the head domain, and the intermediate filament signature consensus, [I/V]-X-[T/A/C/I]-Y-[R/K/H]-X-[L/M]-L-[D/E], located in the carboxyl terminus of the central helical rod. Unlike other 3' UTR sequences, the 3' UTR of the zebrafish cDNA sequence has two CAYUG elements flanking a single polyadenylation site. The temporal and spatial expression patterns of desmin mRNA during early zebrafish development were studied. The onset of desmin expression occurred at the 1-3 somite stage (11 hpf). It increased throughout somitogenesis, with maximum expression at the Prim-6 stage (25 hpf), and decreasing expression towards the protruding-mouth stage (72 hpf)."}
{"qid": "58e75d483e8b6dc87c000005", "original_text": "Coexpression of PU.1 and GATA-1 is required for proper specification of the mast cell lineage; however, in the myeloid and erythroid lineages, PU.1 and GATA-1 are functionally antagonistic. In this study, we report a transcriptional network in which PU.1 positively regulates GATA-1 expression in mast cell development. We isolated a variant mRNA isoform of GATA-1 in murine mast cells that is significantly upregulated during mast cell differentiation.", "label": 1, "is_selected": 0, "text": "Coexpression of PU.1 and GATA-1 is required for proper specification of the mast cell lineage; however, in the myeloid and erythroid lineages, PU.1 and GATA-1 are functionally antagonistic. In this study, we report a transcriptional network in which PU.1 positively regulates GATA-1 expression in mast cell development. We isolated a variant mRNA isoform of GATA-1 in murine mast cells that is significantly upregulated during mast cell differentiation."}
{"qid": "5a68f005b750ff4455000016", "original_text": "Objective Investigate influence and change of self-directedness (SD) in Dialectical-Behavior Therapy (DBT) for 26 female outpatients with borderline personality disorder (BPS). Method Variance analyses are used to evaluate psychopathology and interpersonal problems in 2 subgroups (low vs. high SD) with questionnaires at 3 measuring times over the period of 1 year. Results Low SD was associated with higher psychopathology, more interpersonal problems and lower symptomreduction. Over time of intervention the SD of all patients improved significantly.", "label": 1, "is_selected": 0, "text": "Objective Investigate influence and change of self-directedness (SD) in Dialectical-Behavior Therapy (DBT) for 26 female outpatients with borderline personality disorder (BPS). Method Variance analyses are used to evaluate psychopathology and interpersonal problems in 2 subgroups (low vs. high SD) with questionnaires at 3 measuring times over the period of 1 year. Results Low SD was associated with higher psychopathology, more interpersonal problems and lower symptomreduction. Over time of intervention the SD of all patients improved significantly."}
{"qid": "5abc9c1efcf4565872000020", "original_text": "Thailand deletion of alpha-Thalassemia (thal) 1 involves the zeta2-, phi zeta1-, alpha2-, alpha1-, and theta1-globin genes. In Southeast Asians and Taiwanese, this mutation is the second most common long-segment deletion of two alpha-globin genes, after the Southeast Asian deletion. To define the Thailand deletion breakpoints, we used polymerase chain reaction (PCR) to amplify the normal-sequence DNA fragments across the breakpoints. The amplified products were sequenced directly or after cloning into pGem-3Z or pCR2.1 vectors. Comparison of the normal and mutant sequences revealed that the 5' breakpoint lies between nucleotides 1,269 and 1,290 upstream of the initiator codon adenine of the zeta2-globin gene, and the 3' breakpoint lies between nucleotides 29,387 and 29,408 downstream of it.", "label": 1, "is_selected": 0, "text": "Thailand deletion of alpha-Thalassemia (thal) 1 involves the zeta2-, phi zeta1-, alpha2-, alpha1-, and theta1-globin genes. In Southeast Asians and Taiwanese, this mutation is the second most common long-segment deletion of two alpha-globin genes, after the Southeast Asian deletion. To define the Thailand deletion breakpoints, we used polymerase chain reaction (PCR) to amplify the normal-sequence DNA fragments across the breakpoints. The amplified products were sequenced directly or after cloning into pGem-3Z or pCR2.1 vectors. Comparison of the normal and mutant sequences revealed that the 5' breakpoint lies between nucleotides 1,269 and 1,290 upstream of the initiator codon adenine of the zeta2-globin gene, and the 3' breakpoint lies between nucleotides 29,387 and 29,408 downstream of it."}
{"qid": "533675ced6d3ac6a34000056", "original_text": "Histone variants play a crucial role in the DNA damage response. They are involved in the repair of DNA damage through various mechanisms, including nucleosome remodeling and histone modifications. Some histone variants, such as H2A.Z and H3.3, are specifically implicated in the repair of DNA double-strand breaks, which are one of the most severe forms of DNA damage. These variants can help to facilitate the assembly of repair proteins at the site of damage and promote the repair process. Additionally, histone variants can also affect the expression of genes involved in the DNA damage response, such as ATM and ATR, which are crucial for initiating the repair process. Overall, histone variants play a vital role in the DNA damage response by coordinating the repair of DNA damage and maintaining genome stability.", "label": 0, "is_selected": 1, "text": "The purpose of this paper is to describe the role of histone variants in the repair of DNA damage and their contribution to genome stability. Overall, histone variant expression plays a vital role in the DNA damage response by coordinating the Repair of DNA Damage and Maintaining Genome Stability. (Please note: This paper is not intended to diagnose, treat, or prevent any disease.)"}
{"qid": "58da14178acda34529000011", "original_text": "Satellite III DNA has been located by in situ hybridization in chromosomes 1, 3--5, 7, 9, 10, 13--18, 20--22, and Y and ribosomal DNA (rDNA) in the acrocentric chromosomes 13--15, 21, and 22. In the acrocentric chromosomes, the satellite DNA is located in the short arm. Here we report comparisons by in situ hybridization of the amount of satellite DNA in Robertsonian translocation and \"normal variant\" chromosomes with that in their homologs.", "label": 1, "is_selected": 0, "text": "Satellite III DNA has been located by in situ hybridization in chromosomes 1, 3--5, 7, 9, 10, 13--18, 20--22, and Y and ribosomal DNA (rDNA) in the acrocentric chromosomes 13--15, 21, and 22. In the acrocentric chromosomes, the satellite DNA is located in the short arm. Here we report comparisons by in situ hybridization of the amount of satellite DNA in Robertsonian translocation and \"normal variant\" chromosomes with that in their homologs."}
{"qid": "62793bad56bf9aee6f00001f", "original_text": "A basilar skull fracture is a type of skull fracture that occurs in the bottom third of the skull, near the base of the skull. The classic signs of a basilar skull fracture include: 1. Headache: A headache is the most common symptom of a basilar skull fracture, and it can be severe and persistent. 2. Dizziness or loss of balance: Patients with a basilar skull fracture may experience dizziness or loss of balance due to damage to the vestibular system in the inner ear. 3. Nausea and vomiting: Nausea and vomiting are common in patients with a basilar skull fracture, especially in the acute phase. 4. Ocular symptoms: A basilar skull fracture can cause eye movements to be restricted, leading to double vision, blurred vision, or loss of vision in one eye. 5. Cranial nerve deficits: Damage to the cranial nerves, such as the olfactory nerve, facial nerve, or vestibular nerve, can cause a range of symptoms including smell loss, facial weakness or paralysis, and hearing or balance problems. 6. Hearing loss: A basilar skull fracture can cause hearing loss or tinnitus (ringing in the ears). 7. Fatigue and lethargy: Patients with a basilar skull fracture may feel tired and lethargic due to the injury. 8. Personality changes: In some cases, a basilar skull fracture can cause personality changes, such as irritability, apathy, or confusion. It's important to note that not all patients with a basilar skull fracture will exhibit all of these symptoms, and some may have only subtle symptoms that are difficult to detect. If you suspect that you or someone else may have a basilar skull fracture, it's crucial to seek medical attention immediately.", "label": 0, "is_selected": 0, "text": "A basilar skull fracture is a type of skull fracture that occurs in the bottom third of the skull, near the base of the skull. The classic signs of a basilar skull fracture include: 1. Headache: A headache is the most common symptom of a basilar skull fracture, and it can be severe and persistent. 2. Dizziness or loss of balance: Patients with a basilar skull fracture may experience dizziness or loss of balance due to damage to the vestibular system in the inner ear. 3. Nausea and vomiting: Nausea and vomiting are common in patients with a basilar skull fracture, especially in the acute phase. 4. Ocular symptoms: A basilar skull fracture can cause eye movements to be restricted, leading to double vision, blurred vision, or loss of vision in one eye. 5. Cranial nerve deficits: Damage to the cranial nerves, such as the olfactory nerve, facial nerve, or vestibular nerve, can cause a range of symptoms including smell loss, facial weakness or paralysis, and hearing or balance problems. 6. Hearing loss: A basilar skull fracture can cause hearing loss or tinnitus (ringing in the ears). 7. Fatigue and lethargy: Patients with a basilar skull fracture may feel tired and lethargic due to the injury. 8. Personality changes: In some cases, a basilar skull fracture can cause personality changes, such as irritability, apathy, or confusion. It's important to note that not all patients with a basilar skull fracture will exhibit all of these symptoms, and some may have only subtle symptoms that are difficult to detect. If you suspect that you or someone else may have a basilar skull fracture, it's crucial to seek medical attention immediately."}
{"qid": "5e6d1c6f1af46fc130000021", "original_text": "The aim of this study was to determine the range and incidences of spontaneous microscopic lesions of the pituitary gland in control Han-Wistar and Sprague-Dawley rats and CD-1 mice from 104-week carcinogenicity studies carried out between 1998 and 2010 at Charles River Edinburgh. In both strains of rats and in CD-1 mice, non-proliferative lesions of the pituitary gland were generally uncommon, excluding cysts/pseudocysts (6.42% in Han-Wistar rats, 5.85% in Sprague-Dawley rats, and 2.08% in CD-1 mice).", "label": 1, "is_selected": 0, "text": "The aim of this study was to determine the range and incidences of spontaneous microscopic lesions of the pituitary gland in control Han-Wistar and Sprague-Dawley rats and CD-1 mice from 104-week carcinogenicity studies carried out between 1998 and 2010 at Charles River Edinburgh. In both strains of rats and in CD-1 mice, non-proliferative lesions of the pituitary gland were generally uncommon, excluding cysts/pseudocysts (6.42% in Han-Wistar rats, 5.85% in Sprague-Dawley rats, and 2.08% in CD-1 mice)."}
{"qid": "5e4fd44a6d0a277941000033", "original_text": "Endocytosis is an essential cellular process in eukaryotic cells that involves concordant functions of clathrin and adaptor proteins, various protein and lipid kinases, phosphatases and the actin cytoskeleton. In Saccharomyces cerevisiae, Ark1p is a member of the serine/threonine protein kinase (SPK) family that affects profoundly the organization of the cortical actin cytoskeleton. To study the function of MoArk1, an Ark1p homologue identified in Magnaporthe oryzae, we disrupted the MoARK1 gene and characterized the \u0394Moark1 mutant strain. The \u0394Moark1 mutant exhibited various defects ranging from mycelial growth and conidial formation to appressorium-mediated host infection.", "label": 1, "is_selected": 0, "text": "Endocytosis is an essential cellular process in eukaryotic cells that involves concordant functions of clathrin and adaptor proteins, various protein and lipid kinases, phosphatases and the actin cytoskeleton. In Saccharomyces cerevisiae, Ark1p is a member of the serine/threonine protein kinase (SPK) family that affects profoundly the organization of the cortical actin cytoskeleton. To study the function of MoArk1, an Ark1p homologue identified in Magnaporthe oryzae, we disrupted the MoARK1 gene and characterized the \u0394Moark1 mutant strain. The \u0394Moark1 mutant exhibited various defects ranging from mycelial growth and conidial formation to appressorium-mediated host infection."}
{"qid": "57135fae1174fb1755000004", "original_text": "Non-invasive prenatal testing of cell-free fetal DNA (cffDNA) in maternal plasma can predict the fetal RhD type in D negative pregnant women. In Denmark, routine antenatal screening for the fetal RhD gene (RHD) directs the administration of antenatal anti-D prophylaxis only to women who carry an RhD positive fetus. Prophylaxis reduces the risk of immunization that may lead to hemolytic disease of the fetus and the newborn. The reliability of predicting the fetal RhD type depends on pre-analytical factors and assay sensitivity. We evaluated the testing setup in the Capital Region of Denmark, based on data from routine antenatal RHD screening. Blood samples were drawn at gestational age 25 weeks. DNA extracted from 1 mL of plasma was analyzed for fetal RHD using a duplex method for exon 7/10. We investigated the effect of blood sample transportation time (n = 110) and ambient outdoor temperatures (n = 1539) on the levels of cffDNA and total DNA. We compared two different quantification methods, the delta Ct method and a universal standard curve. PCR pipetting was compared on two systems (n = 104). The cffDNA level was unaffected by blood sample transportation for up to 9 days and by ambient outdoor temperatures ranging from -10 \u00b0C to 28 \u00b0C during transport.", "label": 1, "is_selected": 0, "text": "Non-invasive prenatal testing of cell-free fetal DNA (cffDNA) in maternal plasma can predict the fetal RhD type in D negative pregnant women. In Denmark, routine antenatal screening for the fetal RhD gene (RHD) directs the administration of antenatal anti-D prophylaxis only to women who carry an RhD positive fetus. Prophylaxis reduces the risk of immunization that may lead to hemolytic disease of the fetus and the newborn. The reliability of predicting the fetal RhD type depends on pre-analytical factors and assay sensitivity. We evaluated the testing setup in the Capital Region of Denmark, based on data from routine antenatal RHD screening. Blood samples were drawn at gestational age 25 weeks. DNA extracted from 1 mL of plasma was analyzed for fetal RHD using a duplex method for exon 7/10. We investigated the effect of blood sample transportation time (n = 110) and ambient outdoor temperatures (n = 1539) on the levels of cffDNA and total DNA. We compared two different quantification methods, the delta Ct method and a universal standard curve. PCR pipetting was compared on two systems (n = 104). The cffDNA level was unaffected by blood sample transportation for up to 9 days and by ambient outdoor temperatures ranging from -10 \u00b0C to 28 \u00b0C during transport."}
{"qid": "606b2b1994d57fd87900005c", "original_text": "Lactose is a reducing sugar consisting of galactose and glucose, linked by a \u03b2 (1\u21924) glycosidic bond, considered as an antioxidant due to its \u03b1-hydroxycarbonyl group. Lactose is widely ingested through the milk and other unfermented dairy products and is considered to be one of the primary foods. On the other hand, lactose is also considered as one of the most widely used excipients for the development of pharmaceutical formulations. In this sense, lactose has been related to numerous drug-excipient or drug-food pharmacokinetic interactions. Intolerance, maldigestion and malabsorption of carbohydrates are common disorders in clinical practice, with lactose-intolerance being the most frequently diagnosed, afflicting 10% of the world's population. Four clinical subtypes of lactose intolerance may be distinguished, namely lactase deficiency in premature infants, congenital lactase deficiency, adult-type hypolactasia and secondary lactase intolerance.", "label": 1, "is_selected": 0, "text": "Lactose is a reducing sugar consisting of galactose and glucose, linked by a \u03b2 (1\u21924) glycosidic bond, considered as an antioxidant due to its \u03b1-hydroxycarbonyl group. Lactose is widely ingested through the milk and other unfermented dairy products and is considered to be one of the primary foods. On the other hand, lactose is also considered as one of the most widely used excipients for the development of pharmaceutical formulations. In this sense, lactose has been related to numerous drug-excipient or drug-food pharmacokinetic interactions. Intolerance, maldigestion and malabsorption of carbohydrates are common disorders in clinical practice, with lactose-intolerance being the most frequently diagnosed, afflicting 10% of the world's population. Four clinical subtypes of lactose intolerance may be distinguished, namely lactase deficiency in premature infants, congenital lactase deficiency, adult-type hypolactasia and secondary lactase intolerance."}
{"qid": "5c73ad047c78d6947100008e", "original_text": "Inclisiran is a novel drug that inhibits PCSK9 synthesis specifically in the liver, harnessing the natural mechanism of RNAi. Phase I and II data show that inclisiran lowers low-density lipoprotein cholesterol levels on average by >50% with a duration of effect that enables twice-yearly dosing. Phases I, II and emerging Phase III data support inclisiran's safety, tolerability and risk-benefit profile. The ongoing ORION program includes Phase III trials that will provide robust evidence of inclisiran's safety and efficacy in individuals at high risk of atherosclerotic cardiovascular disease (ASCVD), including established ASCVD and familial hypercholesterolemia.", "label": 1, "is_selected": 0, "text": "Inclisiran is a novel drug that inhibits PCSK9 synthesis specifically in the liver, harnessing the natural mechanism of RNAi. Phase I and II data show that inclisiran lowers low-density lipoprotein cholesterol levels on average by >50% with a duration of effect that enables twice-yearly dosing. Phases I, II and emerging Phase III data support inclisiran's safety, tolerability and risk-benefit profile. The ongoing ORION program includes Phase III trials that will provide robust evidence of inclisiran's safety and efficacy in individuals at high risk of atherosclerotic cardiovascular disease (ASCVD), including established ASCVD and familial hypercholesterolemia."}
{"qid": "5d3802a27bc3fee31f00000e", "original_text": "Silencing of the paternal allele of three imprinted genes (Igf2r, Slc22a2 and Slc22a3) requires cis expression of the Air RNA that overlaps the promoter of one of them (Igf2r). Air is a non-coding RNA whose mode of action is unknown. We tested the role of the Igf2r promoter and the role of transcriptional overlap between Igf2r and Air in silencing in this cluster. We analyzed imprinted expression in mice in which the Igf2r promoter is replaced by a thymidine kinase promoter that preserves a transcription overlap with Air, and in mice with a deleted Igf2r promoter that lack any transcriptional overlap with Air. Imprinted silencing of Air, Slc22a2 and Slc22a3 is maintained by the replacement promoter and also in the absence of transcriptional overlap with Air. These results exclude a role for the Igf2r promoter and for transcriptional overlap between Igf2r and Air in silencing Air, Slc22a2 and Slc22a3. Although these results do not completely exclude a role for a double-stranded RNA silencing mechanism, they do allow the possibility that the Air RNA has intrinsic cis silencing properties.", "label": 1, "is_selected": 0, "text": "Silencing of the paternal allele of three imprinted genes (Igf2r, Slc22a2 and Slc22a3) requires cis expression of the Air RNA that overlaps the promoter of one of them (Igf2r). Air is a non-coding RNA whose mode of action is unknown. We tested the role of the Igf2r promoter and the role of transcriptional overlap between Igf2r and Air in silencing in this cluster. We analyzed imprinted expression in mice in which the Igf2r promoter is replaced by a thymidine kinase promoter that preserves a transcription overlap with Air, and in mice with a deleted Igf2r promoter that lack any transcriptional overlap with Air. Imprinted silencing of Air, Slc22a2 and Slc22a3 is maintained by the replacement promoter and also in the absence of transcriptional overlap with Air. These results exclude a role for the Igf2r promoter and for transcriptional overlap between Igf2r and Air in silencing Air, Slc22a2 and Slc22a3. Although these results do not completely exclude a role for a double-stranded RNA silencing mechanism, they do allow the possibility that the Air RNA has intrinsic cis silencing properties."}
{"qid": "5c61d278e842deac67000005", "original_text": "To assess whether Awaji criteria improve the sensitivity of diagnosis for amyotrophic lateral sclerosis (ALS). In Awaji ALS criteria, fasciculation potentials are regarded as evidence of acute denervation in the presence of chronic neurogenic changes on needle electromyography. We reviewed clinical and neurophysiological data of 113 consecutive patients who were suspected as suffering ALS. The six muscles (trapezius, biceps, first dorsal interosseous, T10-paraspinalis, vastus lateralis, and tibialis anterior muscles) were examined by EMG, focusing on the presence of fasciculation potentials. The sensitivity of revised El Escorial (R-EEC) and Awaji criteria was compared. Probable or definite ALS was diagnosed in 61% of the patients by R-EEC and 71% by Awaji criteria.", "label": 1, "is_selected": 0, "text": "To assess whether Awaji criteria improve the sensitivity of diagnosis for amyotrophic lateral sclerosis (ALS). In Awaji ALS criteria, fasciculation potentials are regarded as evidence of acute denervation in the presence of chronic neurogenic changes on needle electromyography. We reviewed clinical and neurophysiological data of 113 consecutive patients who were suspected as suffering ALS. The six muscles (trapezius, biceps, first dorsal interosseous, T10-paraspinalis, vastus lateralis, and tibialis anterior muscles) were examined by EMG, focusing on the presence of fasciculation potentials. The sensitivity of revised El Escorial (R-EEC) and Awaji criteria was compared. Probable or definite ALS was diagnosed in 61% of the patients by R-EEC and 71% by Awaji criteria."}
{"qid": "6053c11094d57fd87900001a", "original_text": "Fingolimod, a drug used to treat multiple sclerosis, binds to both S1P1 and S1P5 receptors. Specifically, fingolimod binds to the sphingosine 1-phosphate (S1P) receptor subtype 1 (S1P1) with high affinity and to a lesser extent to S1P receptor subtype 5 (S1P5). The binding of fingolimod to S1P1 receptors inhibits the migration of immune cells, including T cells and macrophages, out of the central nervous system (CNS), which is thought to contribute to its therapeutic effects in multiple sclerosis.", "label": 0, "is_selected": 1, "text": "The mechanism by which the drug fingolimod binds to two different receptors has been discovered by scientists at the University of California, Los Angeles (UCLA) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAM-SMD)."}
{"qid": "5e2f43bafbd6abf43b000029", "original_text": "Coronaviruses are pathogens with a serious impact on human and animal health. They mostly cause enteric or respiratory disease, which can be severe and life threatening, e.g., in the case of the zoonotic coronaviruses causing severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) in humans. Despite the economic and societal impact of such coronavirus infections, and the likelihood of future outbreaks of additional pathogenic coronaviruses, our options to prevent or treat coronavirus infections remain very limited. This highlights the importance of advancing our knowledge on the replication of these viruses and their interactions with the host. Compared to other +RNA viruses, coronaviruses have an exceptionally large genome and employ a complex genome expression strategy.", "label": 1, "is_selected": 0, "text": "Coronaviruses are pathogens with a serious impact on human and animal health. They mostly cause enteric or respiratory disease, which can be severe and life threatening, e.g., in the case of the zoonotic coronaviruses causing severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) in humans. Despite the economic and societal impact of such coronavirus infections, and the likelihood of future outbreaks of additional pathogenic coronaviruses, our options to prevent or treat coronavirus infections remain very limited. This highlights the importance of advancing our knowledge on the replication of these viruses and their interactions with the host. Compared to other +RNA viruses, coronaviruses have an exceptionally large genome and employ a complex genome expression strategy."}
{"qid": "551177626a8cde6b72000005", "original_text": "Resveratrol is a plant-derived polyphenol that extends lifespan and healthspan in model organism. Despite extensive investigation, the biological processes mediating resveratrol's effects have yet to be elucidated. Because repression of translation shares many of resveratrol's beneficial effects, we hypothesized that resveratrol was a modulator of protein synthesis. We studied the effect of the drug on the H4-II-E rat hepatoma cell line. Initial studies showed that resveratrol inhibited global protein synthesis. Given the role of the mammalian Target of Rapamycin (mTOR) in regulating protein synthesis, we examined the effect of resveratrol on mTOR signaling. Resveratrol inhibited mTOR self-phosphorylation and the phosphorylation of mTOR targets S6K1 and eIF4E-BP1. It attenuated the formation of the translation initiation complex eIF4F and increased the phosphorylation of eIF2\u03b1. The latter event, also a mechanism for translation inhibition, was not recapitulated by mTOR inhibitors. The effects on mTOR signaling were independent of effects on AMP-activated kinase or AKT. We conclude that resveratrol is an inhibitor of global protein synthesis, and that this effect is mediated through modulation of mTOR-dependent and independent signaling.", "label": 1, "is_selected": 0, "text": "Resveratrol is a plant-derived polyphenol that extends lifespan and healthspan in model organism. Despite extensive investigation, the biological processes mediating resveratrol's effects have yet to be elucidated. Because repression of translation shares many of resveratrol's beneficial effects, we hypothesized that resveratrol was a modulator of protein synthesis. We studied the effect of the drug on the H4-II-E rat hepatoma cell line. Initial studies showed that resveratrol inhibited global protein synthesis. Given the role of the mammalian Target of Rapamycin (mTOR) in regulating protein synthesis, we examined the effect of resveratrol on mTOR signaling. Resveratrol inhibited mTOR self-phosphorylation and the phosphorylation of mTOR targets S6K1 and eIF4E-BP1. It attenuated the formation of the translation initiation complex eIF4F and increased the phosphorylation of eIF2\u03b1. The latter event, also a mechanism for translation inhibition, was not recapitulated by mTOR inhibitors. The effects on mTOR signaling were independent of effects on AMP-activated kinase or AKT. We conclude that resveratrol is an inhibitor of global protein synthesis, and that this effect is mediated through modulation of mTOR-dependent and independent signaling."}
{"qid": "56c1f03cef6e394741000054", "original_text": "Mulibrey nanism (MUL) is a monogenic disorder with prenatal-onset growth failure, typical clinical characteristics, cardiopathy and tendency for a metabolic syndrome. It is caused by recessive mutations in the TRIM37 gene encoding for the peroxisomal TRIM37 protein with ubiquitin-ligase activity. In this work, the frequency and pathology of malignant and benign tumours were analysed in a national cohort of 89 Finnish MUL patients aged 0.7-76 years. The subjects had a clinical and radiological evaluation, and histological and immunohistocemical analyses on specimens obtained from biopsy, surgery or autopsy, were performed. The results show that the MUL patients have disturbed architecture with ectopic tissues and a high frequency of both benign and malignant tumours detectable in several internal organs. A total of 210 tumorous lesions were detected in 66/89 patients (74%).", "label": 1, "is_selected": 0, "text": "Mulibrey nanism (MUL) is a monogenic disorder with prenatal-onset growth failure, typical clinical characteristics, cardiopathy and tendency for a metabolic syndrome. It is caused by recessive mutations in the TRIM37 gene encoding for the peroxisomal TRIM37 protein with ubiquitin-ligase activity. In this work, the frequency and pathology of malignant and benign tumours were analysed in a national cohort of 89 Finnish MUL patients aged 0.7-76 years. The subjects had a clinical and radiological evaluation, and histological and immunohistocemical analyses on specimens obtained from biopsy, surgery or autopsy, were performed. The results show that the MUL patients have disturbed architecture with ectopic tissues and a high frequency of both benign and malignant tumours detectable in several internal organs. A total of 210 tumorous lesions were detected in 66/89 patients (74%)."}
{"qid": "5c72f9847c78d69471000081", "original_text": "Background The symptom \"visual snow\" describes the continuous perception of tiny flickering dots within the whole visual field of both eyes. The diagnosis of a visual snow syndrome requires the appearance of typical additional visual symptoms and the exclusion of ophthalmological or neurological causes, or pharmacological influences. Patients and Methods Three male and four female subjects between 13 and 36 years of age referred with visual snow were investigated and asked about their symptoms. A complete ophthalmological investigation, including binocular fundoscopy, was performed in all patients. Furthermore, best corrected visual acuity, perimetry, binocular functions, colour vision (D15-test), full-field ERG, pattern-reversal VEP and SD-OCT images of macula and optic nerve (RNFL) were analysed. Results Visual acuity of at least 1.0 and normal findings for all further investigations were observed in all patients. The following additional visual symptoms were identified: illusionary palinopsia (n = 6), disturbance of night vision (n = 5), positive light phenomena (n = 7). A history of migraine with aura was reported in five patients. The intake of hallucinogenic drugs or centrally active pharmaceuticals was denied by all patients.", "label": 1, "is_selected": 0, "text": "Background The symptom \"visual snow\" describes the continuous perception of tiny flickering dots within the whole visual field of both eyes. The diagnosis of a visual snow syndrome requires the appearance of typical additional visual symptoms and the exclusion of ophthalmological or neurological causes, or pharmacological influences. Patients and Methods Three male and four female subjects between 13 and 36 years of age referred with visual snow were investigated and asked about their symptoms. A complete ophthalmological investigation, including binocular fundoscopy, was performed in all patients. Furthermore, best corrected visual acuity, perimetry, binocular functions, colour vision (D15-test), full-field ERG, pattern-reversal VEP and SD-OCT images of macula and optic nerve (RNFL) were analysed. Results Visual acuity of at least 1.0 and normal findings for all further investigations were observed in all patients. The following additional visual symptoms were identified: illusionary palinopsia (n = 6), disturbance of night vision (n = 5), positive light phenomena (n = 7). A history of migraine with aura was reported in five patients. The intake of hallucinogenic drugs or centrally active pharmaceuticals was denied by all patients."}
{"qid": "5e4025f148dab47f2600000b", "original_text": "A PET (Positron Emission Tomography) measure is a non-invasive imaging technique that uses small amounts of radioactive tracers to visualize the activity of cells and tissues in the body. PET measures the distribution and metabolism of these tracers in the body, providing information on various physiological processes such as glucose metabolism, neural activity, and blood flow. The images generated by PET provide detailed information on the location and intensity of the tracer uptake in the body, allowing for the diagnosis and monitoring of various diseases, including cancer, heart disease, and neurological disorders.", "label": 0, "is_selected": 1, "text": "The Department of Radiology at the University of California, Los Angeles (UCLA) is one of the leading teaching hospitals in the United States for the use of positron emission tomography (PET) imaging. The images generated by PET provide detailed information on the location and intensity of the tracer uptake in the body, allowing for the diagnosis and monitoring of various diseases, including cancer, heart disease, and neurological disorders."}
{"qid": "5cb0e4a6ecadf2e73f00005b", "original_text": "Cell-surface proteins are of great biomedical importance, as demonstrated by the fact that 66% of approved human drugs listed in the DrugBank database target a cell-surface protein. Despite this biomedical relevance, there has been no comprehensive assessment of the human surfaceome, and only a fraction of the predicted 5,000 human transmembrane proteins have been shown to be located at the plasma membrane. To enable analysis of the human surfaceome, we developed the surfaceome predictor SURFY, based on machine learning.", "label": 1, "is_selected": 0, "text": "Cell-surface proteins are of great biomedical importance, as demonstrated by the fact that 66% of approved human drugs listed in the DrugBank database target a cell-surface protein. Despite this biomedical relevance, there has been no comprehensive assessment of the human surfaceome, and only a fraction of the predicted 5,000 human transmembrane proteins have been shown to be located at the plasma membrane. To enable analysis of the human surfaceome, we developed the surfaceome predictor SURFY, based on machine learning."}
{"qid": "56d094f33975bb303a000012", "original_text": "Group A streptococcus (GAS) is a human pathogen causing a wide repertoire of mild and severe diseases for which no vaccine is yet available. We recently reported the identification of three protein antigens that in combination conferred wide protection against GAS infection in mice. Here we focused our attention on the characterization of one of these three antigens, Spy0269, a highly conserved, surface-exposed, and immunogenic protein of unknown function. Deletion of the spy0269 gene in a GAS M1 isolate resulted in very long bacterial chains, which is indicative of an impaired capacity of the knockout mutant to properly divide. Confocal microscopy and immunoprecipitation experiments demonstrated that the protein was mainly localized at the cell septum and could interact in vitro with the cell division protein FtsZ, leading us to hypothesize that Spy0269 is a member of the GAS divisome machinery. Predicted structural domains and sequence homologies with known streptococcal adhesins suggested that this antigen could also play a role in mediating GAS interaction with host cells.", "label": 1, "is_selected": 0, "text": "Group A streptococcus (GAS) is a human pathogen causing a wide repertoire of mild and severe diseases for which no vaccine is yet available. We recently reported the identification of three protein antigens that in combination conferred wide protection against GAS infection in mice. Here we focused our attention on the characterization of one of these three antigens, Spy0269, a highly conserved, surface-exposed, and immunogenic protein of unknown function. Deletion of the spy0269 gene in a GAS M1 isolate resulted in very long bacterial chains, which is indicative of an impaired capacity of the knockout mutant to properly divide. Confocal microscopy and immunoprecipitation experiments demonstrated that the protein was mainly localized at the cell septum and could interact in vitro with the cell division protein FtsZ, leading us to hypothesize that Spy0269 is a member of the GAS divisome machinery. Predicted structural domains and sequence homologies with known streptococcal adhesins suggested that this antigen could also play a role in mediating GAS interaction with host cells."}
{"qid": "5523dc8c7b523f2123000002", "original_text": "Affinity chromatography with protein A from Staphylococcus aureus (SpA) is the most widespread and accepted methodology for antibody capture during the downstream process of antibody manufacturing. A triazine based ligand (ligand 22/8) was previously developed as an inexpensive and robust alternative to SpA chromatography (Li et al. and Teng et al.). Despite the experimental success, there is no structural information on the binding modes of ligand 22/8 to antibodies, namely to Immunoglobulin G (IgG) molecules and fragments. In this work, we addressed this issue by a molecular docking approach allied to molecular dynamics simulations. Theoretical results confirmed the preference of the synthetic ligand to bind IgG through the binding site found in the crystallographic structure of the natural complex between SpA and the Fc fragment of IgG.", "label": 1, "is_selected": 0, "text": "Affinity chromatography with protein A from Staphylococcus aureus (SpA) is the most widespread and accepted methodology for antibody capture during the downstream process of antibody manufacturing. A triazine based ligand (ligand 22/8) was previously developed as an inexpensive and robust alternative to SpA chromatography (Li et al. and Teng et al.). Despite the experimental success, there is no structural information on the binding modes of ligand 22/8 to antibodies, namely to Immunoglobulin G (IgG) molecules and fragments. In this work, we addressed this issue by a molecular docking approach allied to molecular dynamics simulations. Theoretical results confirmed the preference of the synthetic ligand to bind IgG through the binding site found in the crystallographic structure of the natural complex between SpA and the Fc fragment of IgG."}
{"qid": "5c62a529e842deac6700000b", "original_text": "Recent advances in our understanding of the three-dimensional organization of the eukaryotic nucleus have rendered the spatial distribution of genes increasingly relevant. In a recent work (Tsochatzidou et al., Nucleic Acids Res 45:5818-5828, 2017), we proposed the existence of a functional compartmentalization of the yeast genome according to which, genes occupying the chromosomal regions at the nuclear periphery have distinct structural, functional and evolutionary characteristics compared to their centromeric-proximal counterparts. Around the same time, it was also shown that the genome of Saccharomyces cerevisiae is organized in topologically associated domains (TADs), which are largely associated with the replication timing. In this work, we proceed to investigate whether such units of three-dimensional genomic organization can be linked to transcriptional activity as a driving force for the shaping of genomic architecture.", "label": 1, "is_selected": 0, "text": "Recent advances in our understanding of the three-dimensional organization of the eukaryotic nucleus have rendered the spatial distribution of genes increasingly relevant. In a recent work (Tsochatzidou et al., Nucleic Acids Res 45:5818-5828, 2017), we proposed the existence of a functional compartmentalization of the yeast genome according to which, genes occupying the chromosomal regions at the nuclear periphery have distinct structural, functional and evolutionary characteristics compared to their centromeric-proximal counterparts. Around the same time, it was also shown that the genome of Saccharomyces cerevisiae is organized in topologically associated domains (TADs), which are largely associated with the replication timing. In this work, we proceed to investigate whether such units of three-dimensional genomic organization can be linked to transcriptional activity as a driving force for the shaping of genomic architecture."}
{"qid": "588fa4b9ed9bbee70d000006", "original_text": "The purpose of this study is to highlight the pathological features and clinical aspects of progressive multiple sclerosis (PMS) and also the results of clinical trial experience to date and review ongoing clinical trials and prospective new treatment options. This study will explain the challenges of clinical trial design in PMS. Multiple sclerosis (MS) has been identified as a chronic immune mediated disease, and the progressive phase of the disease appears to have significant neurodegenerative mechanisms. The classification of the course of PMS has been reorganized into categories of active vs. inactive inflammatory disease and the presence vs. absence of gradual disease progression. This differentiation allows clearer conceptualization of PMS and possibly even more efficient recruitment of PMS patients into clinical trials. Clinical trial experience to date in PMS has been negative with anti-inflammatory medications used in relapsing MS. Simvastatin was recently tested in a phase II trial and showed a 43% reduction of annualized atrophy progression in secondary progressive MS. Ongoing PMS trials are currently being conducted with the phosphodiesterase inhibitor ibudilast, S1P modulator siponimod and anti-B-cell therapy ocrelizumab. Several efforts for development of outcome measures in PMS are ongoing. PMS represents a significant challenge, as the pathogenesis of the disease is not well understood, no validated outcome metrics have been established and clinical trial experience to date has been disappointing. Advances in the understanding of the disease and lessons learned in previous clinical trials are paving the way for successful development of disease-modifying agents for this disease.", "label": 1, "is_selected": 0, "text": "The purpose of this study is to highlight the pathological features and clinical aspects of progressive multiple sclerosis (PMS) and also the results of clinical trial experience to date and review ongoing clinical trials and prospective new treatment options. This study will explain the challenges of clinical trial design in PMS. Multiple sclerosis (MS) has been identified as a chronic immune mediated disease, and the progressive phase of the disease appears to have significant neurodegenerative mechanisms. The classification of the course of PMS has been reorganized into categories of active vs. inactive inflammatory disease and the presence vs. absence of gradual disease progression. This differentiation allows clearer conceptualization of PMS and possibly even more efficient recruitment of PMS patients into clinical trials. Clinical trial experience to date in PMS has been negative with anti-inflammatory medications used in relapsing MS. Simvastatin was recently tested in a phase II trial and showed a 43% reduction of annualized atrophy progression in secondary progressive MS. Ongoing PMS trials are currently being conducted with the phosphodiesterase inhibitor ibudilast, S1P modulator siponimod and anti-B-cell therapy ocrelizumab. Several efforts for development of outcome measures in PMS are ongoing. PMS represents a significant challenge, as the pathogenesis of the disease is not well understood, no validated outcome metrics have been established and clinical trial experience to date has been disappointing. Advances in the understanding of the disease and lessons learned in previous clinical trials are paving the way for successful development of disease-modifying agents for this disease."}
{"qid": "5516757c46478f2f2c000008", "original_text": "Saccharomyces cerevisiae, a species of yeast, has several non-metabolizable drug (NMD) factors that affect its sensitivity to various drugs. The main NMD factors in S. cerevisiae include: 1. Multidrug resistance proteins: These proteins are responsible for pumping drugs out of the cell, making the yeast more resistant to multiple drugs. Examples include the ATP-binding cassette (ABC) transporters and the major facilitator superfamily (MFS) transporters. 2. Drug efflux pumps: These pumps are responsible for actively removing drugs from the cell. Examples include the ATP-dependent efflux pump, SacY, and the MFS efflux pump, Cyp7A1. 3. Modulation of drug targets: S. cerevisiae has multiple drug targets, including proteins involved in DNA repair, protein synthesis, and membrane transport. Modulation of these targets can affect the sensitivity of the yeast to drugs. 4. Up-regulation of drug metabolism: S. cerevisiae can up-regulate drug metabolism genes in response to drug exposure, leading to increased clearance of drugs and reduced efficacy. 5. Down-regulation of drug uptake: S. cerevisiae can down-regulate drug uptake genes in response to drug exposure, reducing the amount of drug that is taken up into the cell. I hope this helps! Let me know if you have any further questions.", "label": 0, "is_selected": 1, "text": "What are the factors that make Saccharomyces cerevisiae more or less resistant to drugs such as cocaine, methamphetamine, and ecstasy? ceresiae can down-regulate drug uptake genes in response to drug exposure, reducing the amount of drug that is taken up into the cell. I hope you have found this post useful and hope to see more of your questions about drug resistance in yeast in the near future, so please feel free to contact me if you have any further questions."}
{"qid": "56c344abfedd0b786b000003", "original_text": "The human body contains several hundred cell types, all of which share the same genome. In metazoans, much of the regulatory code that drives cell type-specific gene expression is located in distal elements called enhancers. Although mammalian genomes contain millions of potential enhancers, only a small subset of them is active in a given cell type. Cell type-specific enhancer selection involves the binding of lineage-determining transcription factors that prime enhancers. Signal-dependent transcription factors bind to primed enhancers, which enables these broadly expressed factors to regulate gene expression in a cell type-specific manner. The expression of genes that specify cell type identity and function is associated with densely spaced clusters of active enhancers known as super-enhancers.", "label": 1, "is_selected": 0, "text": "The human body contains several hundred cell types, all of which share the same genome. In metazoans, much of the regulatory code that drives cell type-specific gene expression is located in distal elements called enhancers. Although mammalian genomes contain millions of potential enhancers, only a small subset of them is active in a given cell type. Cell type-specific enhancer selection involves the binding of lineage-determining transcription factors that prime enhancers. Signal-dependent transcription factors bind to primed enhancers, which enables these broadly expressed factors to regulate gene expression in a cell type-specific manner. The expression of genes that specify cell type identity and function is associated with densely spaced clusters of active enhancers known as super-enhancers."}
{"qid": "53188480b166e2b806000018", "original_text": "Gefitinib is a tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR), specifically the wild-type EGFR (wtEGFR) mutation. It works by inhibiting the activation of downstream signaling pathways that promote cell proliferation and survival, including the RAS/RAF/MEK/ERK pathway. The EGFR is a cell surface receptor that is overexpressed in many types of cancer, including non-small cell lung cancer (NSCLC), and plays a key role in cancer cell growth, migration, and angiogenesis. Gefitinib selectively binds to the EGFR and prevents the activation of its downstream signaling pathways, leading to the inhibition of cell proliferation and induction of apoptosis in cancer cells. Therefore, the cellular target of gefitinib is the EGFR.", "label": 0, "is_selected": 0, "text": "Gefitinib is a tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR), specifically the wild-type EGFR (wtEGFR) mutation. It works by inhibiting the activation of downstream signaling pathways that promote cell proliferation and survival, including the RAS/RAF/MEK/ERK pathway. The EGFR is a cell surface receptor that is overexpressed in many types of cancer, including non-small cell lung cancer (NSCLC), and plays a key role in cancer cell growth, migration, and angiogenesis. Gefitinib selectively binds to the EGFR and prevents the activation of its downstream signaling pathways, leading to the inhibition of cell proliferation and induction of apoptosis in cancer cells. Therefore, the cellular target of gefitinib is the EGFR."}
{"qid": "5a67b2f7b750ff445500000f", "original_text": "To clarify the association between clinically defined simple stress urinary incontinence (SUI) symptoms and urodynamic SUI, we examined the relationship between Valsalva leak point pressure (VLPP) as measured by the Q-tip test and Stamey grade in simple female SUI. Two hundred grade I or II female SUI patients with SUI symptom were examined by reviewing medical history; physical examination; urethral mobility as assessed by Q-tip test; stress test; and cystometry, including VLPP measurement. On the basis of the VLPP, patients were classified into urethral hypermobility [UH, subdivided into anatomical incontinence (AI) and equivocal incontinence (EI)] or intrinsic sphincter deficiency groups for analysis of the relationship between VLPP and Stamey grade and Q-tip angle.", "label": 1, "is_selected": 0, "text": "To clarify the association between clinically defined simple stress urinary incontinence (SUI) symptoms and urodynamic SUI, we examined the relationship between Valsalva leak point pressure (VLPP) as measured by the Q-tip test and Stamey grade in simple female SUI. Two hundred grade I or II female SUI patients with SUI symptom were examined by reviewing medical history; physical examination; urethral mobility as assessed by Q-tip test; stress test; and cystometry, including VLPP measurement. On the basis of the VLPP, patients were classified into urethral hypermobility [UH, subdivided into anatomical incontinence (AI) and equivocal incontinence (EI)] or intrinsic sphincter deficiency groups for analysis of the relationship between VLPP and Stamey grade and Q-tip angle."}
{"qid": "5c597a5086df2b9174000016", "original_text": "I apologize, but I'm not familiar with the term \"VCFanno.\" It is possible that it is a misspelling or a term used in a specific medical context that I am not aware of. Can you please provide more context or information about where you encountered this term?", "label": 0, "is_selected": 0, "text": "I apologize, but I'm not familiar with the term \"VCFanno.\" It is possible that it is a misspelling or a term used in a specific medical context that I am not aware of. Can you please provide more context or information about where you encountered this term?"}
{"qid": "5e639c051af46fc130000013", "original_text": "Chemokinesis is a process by which chemokines, a type of protein, attract and direct the movement of immune cells, such as leukocytes (white blood cells), within the body. Chemokines are produced by cells in response to inflammation or infection, and they bind to specific receptors on the surface of immune cells, triggering a variety of responses, including movement towards the site of inflammation or infection. This process plays a crucial role in the immune system's defense against infection and disease, as it helps to direct immune cells to areas of the body where they are needed to fight off pathogens. There are several different subtypes of chemokines, each with its own specific functions and targets.", "label": 0, "is_selected": 1, "text": "A new study by researchers at the University of California, Los Angeles (UCLA) has found that a particular type of chemokine helps the body's immune system to fight off infection and disease. This process plays a crucial role in the immune system's defense against infection and Disease, as it helps to direct immune cells to areas of the body where they are needed to fightoff pathogens."}
{"qid": "5727b6410fd6f91b6800001b", "original_text": "Fifty-nine cases with infantile autism/autistic disorder were subclassified according to associated medical condition (fragile-X, tuberous sclerosis, neurofibromatosis, hypo-melanosis of Ito, Moebius syndrome, Rett syndrome, and a 'new' syndrome associated with a marker chromosome). It was concluded that, even within a group of cases fitting currently accepted criteria for autism, there is considerable variation in symptom profile depending on the exact type of associated medical condition.", "label": 1, "is_selected": 0, "text": "Fifty-nine cases with infantile autism/autistic disorder were subclassified according to associated medical condition (fragile-X, tuberous sclerosis, neurofibromatosis, hypo-melanosis of Ito, Moebius syndrome, Rett syndrome, and a 'new' syndrome associated with a marker chromosome). It was concluded that, even within a group of cases fitting currently accepted criteria for autism, there is considerable variation in symptom profile depending on the exact type of associated medical condition."}
{"qid": "621eb93b3a8413c65300005b", "original_text": "Faricimab, the first bispecific antibody designed for intraocular use, simultaneously and independently binds and neutralizes angiopoietin 2 (Ang-2) and vascular endothelial growth factor A (VEGF-A). To assess the efficacy and safety of different doses and regimens of faricimab vs ranibizumab in patients with neovascular age-related macular degeneration (nAMD). AVENUE was a 36-week, multiple-dose-regimen, active comparator-controlled, double-masked, phase 2 randomized clinical study performed at 58 sites in the United States. Eligible participants were anti-VEGF treatment naive with choroidal neovascularization secondary to nAMD and best-corrected visual acuity (BCVA) Early Treatment Diabetic Retinopathy Study (ETDRS) letter score of 73 (Snellen equivalent, 20/40) to 24 (Snellen equivalent, 20/320). Data were collected from August 11, 2015, to January 12, 2017, with the final patient visit completed September 26, 2017. Data were analyzed from August 11, 2015, to October 4, 2019. Patients were randomized 3:2:2:2:3 to receive ranibizumab, 0.5 mg every 4 weeks (arm A", "label": 1, "is_selected": 0, "text": "Faricimab, the first bispecific antibody designed for intraocular use, simultaneously and independently binds and neutralizes angiopoietin 2 (Ang-2) and vascular endothelial growth factor A (VEGF-A). To assess the efficacy and safety of different doses and regimens of faricimab vs ranibizumab in patients with neovascular age-related macular degeneration (nAMD). AVENUE was a 36-week, multiple-dose-regimen, active comparator-controlled, double-masked, phase 2 randomized clinical study performed at 58 sites in the United States. Eligible participants were anti-VEGF treatment naive with choroidal neovascularization secondary to nAMD and best-corrected visual acuity (BCVA) Early Treatment Diabetic Retinopathy Study (ETDRS) letter score of 73 (Snellen equivalent, 20/40) to 24 (Snellen equivalent, 20/320). Data were collected from August 11, 2015, to January 12, 2017, with the final patient visit completed September 26, 2017. Data were analyzed from August 11, 2015, to October 4, 2019. Patients were randomized 3:2:2:2:3 to receive ranibizumab, 0.5 mg every 4 weeks (arm A"}
{"qid": "56c1f01aef6e394741000043", "original_text": "Somatic mutations have the potential to encode \"non-self\" immunogenic antigens. We hypothesized that tumors with a large number of somatic mutations due to mismatch-repair defects may be susceptible to immune checkpoint blockade. We conducted a phase 2 study to evaluate the clinical activity of pembrolizumab, an anti-programmed death 1 immune checkpoint inhibitor, in 41 patients with progressive metastatic carcinoma with or without mismatch-repair deficiency. Pembrolizumab was administered intravenously at a dose of 10 mg per kilogram of body weight every 14 days in patients with mismatch repair-deficient colorectal cancers, patients with mismatch repair-proficient colorectal cancers, and patients with mismatch repair-deficient cancers that were not colorectal. The coprimary end points were the immune-related objective response rate and the 20-week immune-related progression-free survival rate.", "label": 1, "is_selected": 0, "text": "Somatic mutations have the potential to encode \"non-self\" immunogenic antigens. We hypothesized that tumors with a large number of somatic mutations due to mismatch-repair defects may be susceptible to immune checkpoint blockade. We conducted a phase 2 study to evaluate the clinical activity of pembrolizumab, an anti-programmed death 1 immune checkpoint inhibitor, in 41 patients with progressive metastatic carcinoma with or without mismatch-repair deficiency. Pembrolizumab was administered intravenously at a dose of 10 mg per kilogram of body weight every 14 days in patients with mismatch repair-deficient colorectal cancers, patients with mismatch repair-proficient colorectal cancers, and patients with mismatch repair-deficient cancers that were not colorectal. The coprimary end points were the immune-related objective response rate and the 20-week immune-related progression-free survival rate."}
{"qid": "56b76f496e3f8eaf4c000002", "original_text": "SAGA stands for Systems Access Group for Accessibility. It is a complex acronym that represents a set of accessibility features in the medical field. The acronym is used to describe a system that provides access to medical information and data for patients with disabilities. The features included in the SAGA complex acronym are: * S: System interoperability, which refers to the ability of different healthcare systems to communicate and exchange data. * A: Accessibility, which refers to the ease with which patients can access and use medical information. * G: Graphical user interface (GUI), which refers to the visual display and navigation of the medical system. * A: Assistive technology, which refers to devices or software that help patients with disabilities access medical information. * T: Training and education, which refers to the support and resources provided to patients and healthcare providers to help them use the medical system. * A: Access control, which refers to the security measures in place to protect patient data and prevent unauthorized access.", "label": 0, "is_selected": 1, "text": "The SAGA is an international network of medical technology companies, academic institutions, government agencies, and patient groups that work together to improve access to medical information for patients with disabilities and other special needs in the United States and around the world, according to a press release from the American Academy of Motion Picture Arts and Sciences (AAPS) and the National Academy of Sciences (NAS) in Washington, DC, on Monday."}
{"qid": "5c6d441d7c78d69471000037", "original_text": "This study examined the effect of a Du-zhong (Eucommia ulmoides Oliver) leaf extract (0.175 g/100 g diet) that was supplemented with a high-fat diet (10% coconut oil, 0.2% cholesterol, wt/wt) on hyperlipidemic hamsters. Hamsters fed with Du-zhong leaf extract for 10 weeks showed a smaller size of epididymal adipocytes compared to the control group. The supplementation of the Du-zhong leaf extract significantly lowered the plasma levels of triglyceride, total cholesterol, LDL-cholesterol, non HDL-cholesterol, and free fatty acid, whereas it elevated the HDL-cholesterol/total cholesterol ratio and apolipoprotein A-I levels. The hepatic cholesterol concentration was lower in the Du-zhong group than in the control group. The plasma total cholesterol concentration was positively correlated with hepatic HMG-CoA reductase activity (r = 0.547, p < 0.05) and hepatic cholesterol concentration (r = 0.769, p < 0.001). The hepatic fatty acid synthase and HMG-CoA reductase activities were significantly lowered by a Du-zhong leaf extract supplement in high fat-fed hamsters. Hepatic fatty acid synthase activity was positively correlated with plasma fatty acid concentration (r = 0.513, p < 0.05) that was lower in the Du-zhong group. These results demonstrate that the Du-zhong leaf extract exhibits antihyperlipidemic properties by suppressing hepatic fatty acid and cholesterol biosynthesis with the simultaneous reduction of plasma and hepatic lipids in high fat-fed hamsters.", "label": 1, "is_selected": 0, "text": "This study examined the effect of a Du-zhong (Eucommia ulmoides Oliver) leaf extract (0.175 g/100 g diet) that was supplemented with a high-fat diet (10% coconut oil, 0.2% cholesterol, wt/wt) on hyperlipidemic hamsters. Hamsters fed with Du-zhong leaf extract for 10 weeks showed a smaller size of epididymal adipocytes compared to the control group. The supplementation of the Du-zhong leaf extract significantly lowered the plasma levels of triglyceride, total cholesterol, LDL-cholesterol, non HDL-cholesterol, and free fatty acid, whereas it elevated the HDL-cholesterol/total cholesterol ratio and apolipoprotein A-I levels. The hepatic cholesterol concentration was lower in the Du-zhong group than in the control group. The plasma total cholesterol concentration was positively correlated with hepatic HMG-CoA reductase activity (r = 0.547, p < 0.05) and hepatic cholesterol concentration (r = 0.769, p < 0.001). The hepatic fatty acid synthase and HMG-CoA reductase activities were significantly lowered by a Du-zhong leaf extract supplement in high fat-fed hamsters. Hepatic fatty acid synthase activity was positively correlated with plasma fatty acid concentration (r = 0.513, p < 0.05) that was lower in the Du-zhong group. These results demonstrate that the Du-zhong leaf extract exhibits antihyperlipidemic properties by suppressing hepatic fatty acid and cholesterol biosynthesis with the simultaneous reduction of plasma and hepatic lipids in high fat-fed hamsters."}
{"qid": "56ed27202ac5ed145900000c", "original_text": "A-type lamins are expressed in various cell types throughout the body, including: 1. Nerve cells (neurons): A-type lamins are abundant in the nuclei of neurons, particularly in the cerebellum and brain stem. 2. Fibroblasts: A-type lamins are expressed in fibroblasts, which are cells that produce collagen and other extracellular matrix components. 3. Endothelial cells: A-type lamins are expressed in endothelial cells, which line blood vessels and play a role in maintaining their integrity. 4. Immune cells (macrophages and dendritic cells): A-type lamins are expressed in certain immune cells, including macrophages and dendritic cells. 5. Muscle cells (muscle fibers): A-type lamins are expressed in muscle fibers, where they play a role in maintaining muscle cell structure and function. It is important to note that the expression of A-type lamins can vary depending on the specific cell type and tissue, and their functions can also be cell-specific.", "label": 0, "is_selected": 1, "text": "A-type lamins are a type of amino acid that can be expressed in a wide range of cells in the body, including nerve cells, fibroblasts, endothelial cells, immune cells, muscle cells and connective tissue. Muscle cells (muscle lamins): A- type lamins were expressed in muscle where they play a role in maintaining muscle cell structure and function."}
{"qid": "621b45943a8413c653000039", "original_text": "Recently, crAssphage has been proposed as a human-specific marker for tracking fecal contamination. However, its performance has always been validated in a limited number of host samples, which may obscure our understanding of its utility. Furthermore, few studies have quantified confidence of fecal contamination when using crAssphage. Here, we evaluate the performance and confidence of crAssphage by analyzing a large panel of metagenomic data sets combined with Bayesian analyses.", "label": 1, "is_selected": 0, "text": "Recently, crAssphage has been proposed as a human-specific marker for tracking fecal contamination. However, its performance has always been validated in a limited number of host samples, which may obscure our understanding of its utility. Furthermore, few studies have quantified confidence of fecal contamination when using crAssphage. Here, we evaluate the performance and confidence of crAssphage by analyzing a large panel of metagenomic data sets combined with Bayesian analyses."}
{"qid": "56c1f020ef6e394741000047", "original_text": "The purpose of this study is to determine the sensibility of each imaging tool in identifying focal cortical dysplasia (FCD) in children and adolescents with epilepsy and to define the prognostic factors of pediatric and adolescent epilepsy surgery. We identified 48 children with FCD who underwent resective surgery and analyzed their preoperative data. The results of various anatomic and functional neuroimaging studies were compared for accuracy in locating the lesion. We also investigated clinical factors that affected the outcome of surgical treatment. Brain magnetic resonance imaging (MRI) was able to localize FCD in 30 patients and fluorodeoxyglucose positron emission tomography (FDG-PET) and/or subtraction ictal single photon emission computed tomography (SPECT) coregistered with MRI provided additional information that helped to define the lesion in 13 patients.", "label": 1, "is_selected": 0, "text": "The purpose of this study is to determine the sensibility of each imaging tool in identifying focal cortical dysplasia (FCD) in children and adolescents with epilepsy and to define the prognostic factors of pediatric and adolescent epilepsy surgery. We identified 48 children with FCD who underwent resective surgery and analyzed their preoperative data. The results of various anatomic and functional neuroimaging studies were compared for accuracy in locating the lesion. We also investigated clinical factors that affected the outcome of surgical treatment. Brain magnetic resonance imaging (MRI) was able to localize FCD in 30 patients and fluorodeoxyglucose positron emission tomography (FDG-PET) and/or subtraction ictal single photon emission computed tomography (SPECT) coregistered with MRI provided additional information that helped to define the lesion in 13 patients."}
{"qid": "5339ed7bd6d3ac6a34000060", "original_text": "Patients with non-ischemic cardiomyopathy often represent a diagnostic challenge, and correct etiologic diagnosis may influence outcomes. Lately, delayed myocardial enhancement MR imaging has been developed and is currently being used for a growing number of clinical applications. On delayed enhancement MR images, scarring or fibrosis appears as an area of high signal intensity, and the pattern by which this enhancement occurs in the myocardium allows distinction of many different pathologies. In nonischemic cardiomyopathy, the delayed enhancement usually does not occur in a coronary artery distribution and is often midwall rather than subendocardial or transmural. It could also guide myocardial biopsy to an affected area, increasing its yield. Cardiac magnetic resonance imaging has now a definitive role in clinical practice, and its capability to non-invasively provide high resolution images of the heart with good tissue characterization is redefining the understanding of the conditions that can adversely affect the myocardium.", "label": 1, "is_selected": 0, "text": "Patients with non-ischemic cardiomyopathy often represent a diagnostic challenge, and correct etiologic diagnosis may influence outcomes. Lately, delayed myocardial enhancement MR imaging has been developed and is currently being used for a growing number of clinical applications. On delayed enhancement MR images, scarring or fibrosis appears as an area of high signal intensity, and the pattern by which this enhancement occurs in the myocardium allows distinction of many different pathologies. In nonischemic cardiomyopathy, the delayed enhancement usually does not occur in a coronary artery distribution and is often midwall rather than subendocardial or transmural. It could also guide myocardial biopsy to an affected area, increasing its yield. Cardiac magnetic resonance imaging has now a definitive role in clinical practice, and its capability to non-invasively provide high resolution images of the heart with good tissue characterization is redefining the understanding of the conditions that can adversely affect the myocardium."}
{"qid": "5ac07b67dd95b2cd42000001", "original_text": "Lung cancer is the leading cause of cancer-related deaths, primarily due to distant metastatic disease. Metastatic lung cancer cells can undergo an epithelial-to-mesenchymal transition (EMT) regulated by various transcription factors, including a double-negative feedback loop between the microRNA-200 (miR-200) family and ZEB1, but the precise mechanisms by which ZEB1-dependent EMT promotes malignancy remain largely undefined. Although the cell-intrinsic effects of EMT are important for tumor progression, the reciprocal dynamic crosstalk between mesenchymal cancer cells and the extracellular matrix (ECM) is equally critical in regulating invasion and metastasis.", "label": 1, "is_selected": 0, "text": "Lung cancer is the leading cause of cancer-related deaths, primarily due to distant metastatic disease. Metastatic lung cancer cells can undergo an epithelial-to-mesenchymal transition (EMT) regulated by various transcription factors, including a double-negative feedback loop between the microRNA-200 (miR-200) family and ZEB1, but the precise mechanisms by which ZEB1-dependent EMT promotes malignancy remain largely undefined. Although the cell-intrinsic effects of EMT are important for tumor progression, the reciprocal dynamic crosstalk between mesenchymal cancer cells and the extracellular matrix (ECM) is equally critical in regulating invasion and metastasis."}
{"qid": "623e04e4f0baec9a1b000006", "original_text": "Somatic mutations of calreticulin (CALR) have been identified as a main disease driver of myeloproliferative neoplasms, suggesting that development of drugs targeting mutant CALR is of great significance. Site-directed mutagenesis in the N-glycan binding domain (GBD) abolishes the ability of mutant CALR to oncogenically activate the thrombopoietin receptor (MPL). We therefore hypothesized that a small molecule targeting the GBD might inhibit the oncogenicity of the mutant CALR. Using an in silico molecular docking study, we identified candidate binders to the GBD of CALR. Further experimental validation of the hits identified a group of catechols inducing a selective growth inhibitory effect on cells that depend on oncogenic CALR for survival and proliferation. Apoptosis-inducing effects by the compound were significantly higher in the CALR-mutated cells than in CALR wild-type cells.", "label": 1, "is_selected": 0, "text": "Somatic mutations of calreticulin (CALR) have been identified as a main disease driver of myeloproliferative neoplasms, suggesting that development of drugs targeting mutant CALR is of great significance. Site-directed mutagenesis in the N-glycan binding domain (GBD) abolishes the ability of mutant CALR to oncogenically activate the thrombopoietin receptor (MPL). We therefore hypothesized that a small molecule targeting the GBD might inhibit the oncogenicity of the mutant CALR. Using an in silico molecular docking study, we identified candidate binders to the GBD of CALR. Further experimental validation of the hits identified a group of catechols inducing a selective growth inhibitory effect on cells that depend on oncogenic CALR for survival and proliferation. Apoptosis-inducing effects by the compound were significantly higher in the CALR-mutated cells than in CALR wild-type cells."}
{"qid": "52df887498d023950500000c", "original_text": "Yes, oxalate renal excretion may be increased after bariatric surgery. Bariatric surgery has been shown to cause changes in gut hormone levels, including increased levels of glucagon-like peptide-1 (GLP-1) and peptide Y (PYY), which can stimulate the kidneys to excrete oxalate. Additionally, bariatric surgery can alter the gut microbiome, leading to a greater concentration of oxalate in the gut and increased absorption of oxalate into the bloodstream. Studies have shown that bariatric surgery can lead to an increase in 24-hour urinary oxalate excretion, with some reports suggesting an average increase of 25-50% after surgery. However, it is important to note that the extent of these changes may vary depending on the type of bariatric surgery performed and the individual's baseline health status.", "label": 0, "is_selected": 0, "text": "Yes, oxalate renal excretion may be increased after bariatric surgery. Bariatric surgery has been shown to cause changes in gut hormone levels, including increased levels of glucagon-like peptide-1 (GLP-1) and peptide Y (PYY), which can stimulate the kidneys to excrete oxalate. Additionally, bariatric surgery can alter the gut microbiome, leading to a greater concentration of oxalate in the gut and increased absorption of oxalate into the bloodstream. Studies have shown that bariatric surgery can lead to an increase in 24-hour urinary oxalate excretion, with some reports suggesting an average increase of 25-50% after surgery. However, it is important to note that the extent of these changes may vary depending on the type of bariatric surgery performed and the individual's baseline health status."}
{"qid": "5a6e1280b750ff4455000037", "original_text": "Ultraconserved elements (UCEs) encoding noncoding RNAs serve as important regulators in cancer biology. Until now, the role of the UCE uc.189 in human cancers remains undefined and the clinical significance of uc.189 in esophageal cancers remains unknown. This study was to identify the prognostic value of uc.189 expression in esophageal squamous cell carcinomas (ESCC). Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression level of uc.189 in matched cancerous tissues and adjacent noncancerous tissues from 152 patients with ESCC. The correlation of uc.189 with clinicopathological features and prognosis were also analyzed. The expression of uc.189 was significantly higher in human ESCC compared with the adjacent noncancerous tissues (122/152, 80.3%, p<0.01), and the high level of uc.189 expression was significantly correlated with invasion of the tumor (p=0.009), advanced clinical stage (p=0.000), lymph node metastasis (p=0.000), and poor prognosis.", "label": 1, "is_selected": 0, "text": "Ultraconserved elements (UCEs) encoding noncoding RNAs serve as important regulators in cancer biology. Until now, the role of the UCE uc.189 in human cancers remains undefined and the clinical significance of uc.189 in esophageal cancers remains unknown. This study was to identify the prognostic value of uc.189 expression in esophageal squamous cell carcinomas (ESCC). Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression level of uc.189 in matched cancerous tissues and adjacent noncancerous tissues from 152 patients with ESCC. The correlation of uc.189 with clinicopathological features and prognosis were also analyzed. The expression of uc.189 was significantly higher in human ESCC compared with the adjacent noncancerous tissues (122/152, 80.3%, p<0.01), and the high level of uc.189 expression was significantly correlated with invasion of the tumor (p=0.009), advanced clinical stage (p=0.000), lymph node metastasis (p=0.000), and poor prognosis."}
{"qid": "5fdb4392a43ad3127800002a", "original_text": "The purpose of this study was to test whether gene copy number variations (CNVs) of Toll-like receptors (TLRs) are associated with uveitis. Copy number variations of TLRs were detected by real-time PCR. The first stage of the study consisted of enrolling 400 Beh\u00e7et's disease (BD) patients, 400 Vogt-Koyanagi-Harada syndrome patients, 400 patients with acute anterior uveitis associated with or without ankylosing spondylitis, and 600 healthy subjects.", "label": 1, "is_selected": 0, "text": "The purpose of this study was to test whether gene copy number variations (CNVs) of Toll-like receptors (TLRs) are associated with uveitis. Copy number variations of TLRs were detected by real-time PCR. The first stage of the study consisted of enrolling 400 Beh\u00e7et's disease (BD) patients, 400 Vogt-Koyanagi-Harada syndrome patients, 400 patients with acute anterior uveitis associated with or without ankylosing spondylitis, and 600 healthy subjects."}
{"qid": "53482bfcaeec6fbd07000010", "original_text": "Liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based proteomics provides a wealth of information about proteins present in biological samples. In bottom-up LC-MS/MS-based proteomics, proteins are enzymatically digested into peptides prior to query by LC-MS/MS. Thus, the information directly available from the LC-MS/MS data is at the peptide level. If a protein-level analysis is desired, the peptide-level information must be rolled up into protein-level information. We propose a principal component analysis-based statistical method, ProPCA, for efficiently estimating relative protein abundance from bottom-up label-free LC-MS/MS data that incorporates both spectral count information and LC-MS peptide ion peak attributes, such as peak area, volume, or height. ProPCA may be used effectively with a variety of quantification platforms and is easily implemented. We show that ProPCA outperformed existing quantitative methods for peptide-protein roll-up, including spectral counting methods and other methods for combining LC-MS peptide peak attributes. The performance of ProPCA was validated using a data set derived from the LC-MS/MS analysis of a mixture of protein standards (the UPS2 proteomic dynamic range standard introduced by The Association of Biomolecular Resource Facilities Proteomics Standards Research Group in 2006). Finally, we applied ProPCA to a comparative LC-MS/MS analysis of digested total cell lysates prepared for LC-MS/MS analysis by alternative lysis methods and show that ProPCA identified more differentially abundant proteins than competing methods.", "label": 1, "is_selected": 0, "text": "Liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based proteomics provides a wealth of information about proteins present in biological samples. In bottom-up LC-MS/MS-based proteomics, proteins are enzymatically digested into peptides prior to query by LC-MS/MS. Thus, the information directly available from the LC-MS/MS data is at the peptide level. If a protein-level analysis is desired, the peptide-level information must be rolled up into protein-level information. We propose a principal component analysis-based statistical method, ProPCA, for efficiently estimating relative protein abundance from bottom-up label-free LC-MS/MS data that incorporates both spectral count information and LC-MS peptide ion peak attributes, such as peak area, volume, or height. ProPCA may be used effectively with a variety of quantification platforms and is easily implemented. We show that ProPCA outperformed existing quantitative methods for peptide-protein roll-up, including spectral counting methods and other methods for combining LC-MS peptide peak attributes. The performance of ProPCA was validated using a data set derived from the LC-MS/MS analysis of a mixture of protein standards (the UPS2 proteomic dynamic range standard introduced by The Association of Biomolecular Resource Facilities Proteomics Standards Research Group in 2006). Finally, we applied ProPCA to a comparative LC-MS/MS analysis of digested total cell lysates prepared for LC-MS/MS analysis by alternative lysis methods and show that ProPCA identified more differentially abundant proteins than competing methods."}
{"qid": "5e371a1db5b409ea53000015", "original_text": "Pancreatic ductal adenocarcinoma (PDAC) has the worst prognosis among solid malignancies and improved therapeutic strategies are needed to improve outcomes. Patient-derived xenografts (PDX) and patient-derived organoids (PDO) serve as promising tools to identify new drugs with therapeutic potential in PDAC. For these preclinical disease models to be effective, they should both recapitulate the molecular heterogeneity of PDAC and validate patient-specific therapeutic sensitivities. To date however, deep characterization of the molecular heterogeneity of PDAC PDX and PDO models and comparison with matched human tumour remains largely unaddressed at the whole genome level. We conducted a comprehensive assessment of the genetic landscape of 16 whole-genome pairs of tumours and matched PDX, from primary PDAC and liver metastasis, including a unique cohort of 5 'trios' of matched primary tumour, PDX, and PDO. We developed a pipeline to score concordance between PDAC models and their paired human tumours for genomic events, including mutations, structural variations, and copy number variations.", "label": 1, "is_selected": 0, "text": "Pancreatic ductal adenocarcinoma (PDAC) has the worst prognosis among solid malignancies and improved therapeutic strategies are needed to improve outcomes. Patient-derived xenografts (PDX) and patient-derived organoids (PDO) serve as promising tools to identify new drugs with therapeutic potential in PDAC. For these preclinical disease models to be effective, they should both recapitulate the molecular heterogeneity of PDAC and validate patient-specific therapeutic sensitivities. To date however, deep characterization of the molecular heterogeneity of PDAC PDX and PDO models and comparison with matched human tumour remains largely unaddressed at the whole genome level. We conducted a comprehensive assessment of the genetic landscape of 16 whole-genome pairs of tumours and matched PDX, from primary PDAC and liver metastasis, including a unique cohort of 5 'trios' of matched primary tumour, PDX, and PDO. We developed a pipeline to score concordance between PDAC models and their paired human tumours for genomic events, including mutations, structural variations, and copy number variations."}
{"qid": "5c8c095e0101eac870000002", "original_text": "Considerable effort has been expended to identify genes that account for myeloid lineage commitment and development. However, currently available non-invasive mouse models utilize myeloid-specific reporters that are significantly expressed in hematopoietic stem cells as well as lymphoid compartments. Here, we describe a myeloid-specific marker that is not shared by any other lineage. We show that lactotransferrin mRNA is expressed by Gr-1(+)/CD11b(+) cells in the bone marrow, as opposed to hematopoietic stem cells or any peripheral cell population. To follow the progeny of lactotransferrin-expressing bone marrow cells, we generated a mouse model in which a reporter gene is irreversibly activated from the lactotransferrin-promoter.", "label": 1, "is_selected": 0, "text": "Considerable effort has been expended to identify genes that account for myeloid lineage commitment and development. However, currently available non-invasive mouse models utilize myeloid-specific reporters that are significantly expressed in hematopoietic stem cells as well as lymphoid compartments. Here, we describe a myeloid-specific marker that is not shared by any other lineage. We show that lactotransferrin mRNA is expressed by Gr-1(+)/CD11b(+) cells in the bone marrow, as opposed to hematopoietic stem cells or any peripheral cell population. To follow the progeny of lactotransferrin-expressing bone marrow cells, we generated a mouse model in which a reporter gene is irreversibly activated from the lactotransferrin-promoter."}
{"qid": "60206bae1cb411341a00007d", "original_text": "Metastatic castration-resistant prostate cancer (mCRPC) with low androgen receptor (AR) and without neuroendocrine signaling, termed double-negative prostate cancer (DNPC), is increasingly prevalent in patients treated with AR signaling inhibitors and is in need of new biomarkers and therapeutic targets. Candidate genes enriched in DNPC were determined using differential gene expression analysis of discovery and validation cohorts of mCRPC biopsies. Laboratory studies were carried out in human mCRPC organoid cultures, prostate cancer (PCa) cell lines, and mouse xenograft models. Epigenetic studies were carried out in a rapid autopsy cohort. Dickkopf-1 (DKK1) expression is increased in DNPC relative to prostate-specific antigen (PSA)-expressing mCRPC in the Stand Up to Cancer/Prostate Cancer Foundation discovery cohort (11.2 v 0.28 reads per kilobase per million mapped reads; q < 0.05; n = 117) and in the University of Washington/Fred Hutchinson Cancer Research Center cohort (9.2 v 0.99 fragments per kilobase of transcript per million mapped reads; P < .0001).", "label": 1, "is_selected": 0, "text": "Metastatic castration-resistant prostate cancer (mCRPC) with low androgen receptor (AR) and without neuroendocrine signaling, termed double-negative prostate cancer (DNPC), is increasingly prevalent in patients treated with AR signaling inhibitors and is in need of new biomarkers and therapeutic targets. Candidate genes enriched in DNPC were determined using differential gene expression analysis of discovery and validation cohorts of mCRPC biopsies. Laboratory studies were carried out in human mCRPC organoid cultures, prostate cancer (PCa) cell lines, and mouse xenograft models. Epigenetic studies were carried out in a rapid autopsy cohort. Dickkopf-1 (DKK1) expression is increased in DNPC relative to prostate-specific antigen (PSA)-expressing mCRPC in the Stand Up to Cancer/Prostate Cancer Foundation discovery cohort (11.2 v 0.28 reads per kilobase per million mapped reads; q < 0.05; n = 117) and in the University of Washington/Fred Hutchinson Cancer Research Center cohort (9.2 v 0.99 fragments per kilobase of transcript per million mapped reads; P < .0001)."}
{"qid": "56d12d643975bb303a000014", "original_text": "Intrinsically disordered proteins (IDPs) frequently function in protein interaction networks that regulate crucial cellular signaling pathways. Many IDPs undergo transitions from disordered conformational ensembles to folded structures upon binding to their cellular targets. Several possible binding mechanisms for coupled folding and binding have been identified: folding of the IDP after association with the target (\"induced fit\"), or binding of a prefolded state in the conformational ensemble of the IDP to the target protein (\"conformational selection\"), or some combination of these two extremes. The interaction of the intrinsically disordered phosphorylated kinase-inducible domain (pKID) of the cAMP-response element binding (CREB) protein with the KIX domain of a general transcriptional coactivator CREB-binding protein (CBP) provides an example of the induced-fit mechanism. Here we show by NMR relaxation dispersion experiments that a different intrinsically disordered ligand, the transactivation domain of the transcription factor c-Myb, interacts with KIX at the same site as pKID but via a different binding mechanism that involves elements of conformational selection and induced fit. In contrast to pKID, the c-Myb activation domain has a strong propensity for spontaneous helix formation in its N-terminal region, which binds to KIX in a predominantly folded conformation.", "label": 1, "is_selected": 0, "text": "Intrinsically disordered proteins (IDPs) frequently function in protein interaction networks that regulate crucial cellular signaling pathways. Many IDPs undergo transitions from disordered conformational ensembles to folded structures upon binding to their cellular targets. Several possible binding mechanisms for coupled folding and binding have been identified: folding of the IDP after association with the target (\"induced fit\"), or binding of a prefolded state in the conformational ensemble of the IDP to the target protein (\"conformational selection\"), or some combination of these two extremes. The interaction of the intrinsically disordered phosphorylated kinase-inducible domain (pKID) of the cAMP-response element binding (CREB) protein with the KIX domain of a general transcriptional coactivator CREB-binding protein (CBP) provides an example of the induced-fit mechanism. Here we show by NMR relaxation dispersion experiments that a different intrinsically disordered ligand, the transactivation domain of the transcription factor c-Myb, interacts with KIX at the same site as pKID but via a different binding mechanism that involves elements of conformational selection and induced fit. In contrast to pKID, the c-Myb activation domain has a strong propensity for spontaneous helix formation in its N-terminal region, which binds to KIX in a predominantly folded conformation."}
{"qid": "5e764647c6a8763d23000016", "original_text": "The first genetically modified organism (GMO) to be used as a vaccine is the hepatitis B vaccine, which was developed in the early 1980s by scientists at the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). The vaccine was created using a recombinant DNA technology that allowed the insertion of the hepatitis B virus into a bacterium, such as the yeast Saccharomyces cerevisiae, which was then used to produce large quantities of the virus-like particles (VLPs) that could be used as a vaccine. The hepatitis B vaccine was approved for use in 1989 and has been widely used to prevent hepatitis B infections worldwide.", "label": 0, "is_selected": 1, "text": "The use of genetically modified organisms (GMOs) to produce vaccines has come a long way since the early 1980s, when scientists at the US National Institutes of Health (NIH) and the Food and Drug Administration (FDA) first developed a vaccine using a genetically modified organism."}
{"qid": "623c8330f0baec9a1b000003", "original_text": "Previous studies have demonstrated a requirement for RANTES (regulated on activated normal T-cell expressed, and secreted) at immune privileged sites; we have investigated the role of RANTES in the induction of maternal-fetal tolerance. Endometrial and peripheral T lymphocytes were obtained from women with recurrent pregnancy losses (RPLs) and fertile women. RANTES modulation by progesterone or paternal alloantigens was measured by enzyme-linked immunosorbent assay or flow cytometry analysis. Progesterone significantly increased intracellular RANTES expression in CD4+ and CD8+ endometrial T cells. Moreover, alloreactive lymphocytes from RPL patients produced lower RANTES levels when compared with those from fertile women. At the local level, treatment with recombinant RANTES induced a decrease in CCR5 and CXCR4 messenger RNA that correlated with an increase in T-bet expression. RPL patients and normally fertile women express RANTES similarly, but differ in their patterns of RANTES receptor expression. RANTES may be implicated in the local induction of a Th1-type response necessary for successful implantation. Altered response to RANTES stimulation among some RPL patients may be responsible for poor pregnancy outcomes.", "label": 1, "is_selected": 0, "text": "Previous studies have demonstrated a requirement for RANTES (regulated on activated normal T-cell expressed, and secreted) at immune privileged sites; we have investigated the role of RANTES in the induction of maternal-fetal tolerance. Endometrial and peripheral T lymphocytes were obtained from women with recurrent pregnancy losses (RPLs) and fertile women. RANTES modulation by progesterone or paternal alloantigens was measured by enzyme-linked immunosorbent assay or flow cytometry analysis. Progesterone significantly increased intracellular RANTES expression in CD4+ and CD8+ endometrial T cells. Moreover, alloreactive lymphocytes from RPL patients produced lower RANTES levels when compared with those from fertile women. At the local level, treatment with recombinant RANTES induced a decrease in CCR5 and CXCR4 messenger RNA that correlated with an increase in T-bet expression. RPL patients and normally fertile women express RANTES similarly, but differ in their patterns of RANTES receptor expression. RANTES may be implicated in the local induction of a Th1-type response necessary for successful implantation. Altered response to RANTES stimulation among some RPL patients may be responsible for poor pregnancy outcomes."}
{"qid": "601c46f61cb411341a00001d", "original_text": "Thank you for reaching out! I'm happy to help you with your question. After conducting extensive research, I found that golimumab, a tumor necrosis factor (TNF) inhibitor, has not been specifically tested for diabetes. Golimumab is primarily used to treat autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and crohn's disease. While there is some evidence to suggest that TNF inhibitors like golimumab may have a potential role in improving insulin sensitivity and glycemic control in patients with type 2 diabetes, there are limited studies specifically investigating golimumab's effectiveness in this context. A study published in the Journal of Clinical Rheumatology found that golimumab treatment improved insulin sensitivity and reduced inflammation in patients with type 2 diabetes and rheumatoid arthritis. However, this study was small and had limited statistical power, so further research is needed to confirm these findings. Another study published in the journal Diabetes Care explored the potential benefits of TNF inhibitors, including golimumab, in patients with type 2 diabetes and insulin resistance. The results suggested that TNF inhibitors may improve insulin sensitivity and reduce oxidative stress in these patients, but larger, more rigorous trials are needed to confirm these findings. In summary, while there is some evidence to suggest that golimumab may have a potential role in improving insulin sensitivity and glycemic control in patients with type 2 diabetes, further research is needed to fully understand its effects in this context. If you have any other questions or concerns, please feel free to ask!", "label": 0, "is_selected": 0, "text": "Thank you for reaching out! I'm happy to help you with your question. After conducting extensive research, I found that golimumab, a tumor necrosis factor (TNF) inhibitor, has not been specifically tested for diabetes. Golimumab is primarily used to treat autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and crohn's disease. While there is some evidence to suggest that TNF inhibitors like golimumab may have a potential role in improving insulin sensitivity and glycemic control in patients with type 2 diabetes, there are limited studies specifically investigating golimumab's effectiveness in this context. A study published in the Journal of Clinical Rheumatology found that golimumab treatment improved insulin sensitivity and reduced inflammation in patients with type 2 diabetes and rheumatoid arthritis. However, this study was small and had limited statistical power, so further research is needed to confirm these findings. Another study published in the journal Diabetes Care explored the potential benefits of TNF inhibitors, including golimumab, in patients with type 2 diabetes and insulin resistance. The results suggested that TNF inhibitors may improve insulin sensitivity and reduce oxidative stress in these patients, but larger, more rigorous trials are needed to confirm these findings. In summary, while there is some evidence to suggest that golimumab may have a potential role in improving insulin sensitivity and glycemic control in patients with type 2 diabetes, further research is needed to fully understand its effects in this context. If you have any other questions or concerns, please feel free to ask!"}
{"qid": "6053ba5b94d57fd879000017", "original_text": "The first oral drug approved by the US Food and Drug Administration (FDA) for the treatment of multiple sclerosis (MS) was Copolymer 1 (Copaxone) in 1997. Copaxone, also known as glatiramer acetate, is an immunosuppressive drug that reduces inflammation and slows down the progression of MS. It works by reducing the number of white blood cells that attack the protective coating of nerve fibers in the central nervous system, which is damaged in MS patients. Since then, several other oral drugs have been approved for the treatment of MS, including Tysabri (natalizumab), Avonex (interferon beta-1a), and Aubagio (teriflunomide).", "label": 0, "is_selected": 0, "text": "The first oral drug approved by the US Food and Drug Administration (FDA) for the treatment of multiple sclerosis (MS) was Copolymer 1 (Copaxone) in 1997. Copaxone, also known as glatiramer acetate, is an immunosuppressive drug that reduces inflammation and slows down the progression of MS. It works by reducing the number of white blood cells that attack the protective coating of nerve fibers in the central nervous system, which is damaged in MS patients. Since then, several other oral drugs have been approved for the treatment of MS, including Tysabri (natalizumab), Avonex (interferon beta-1a), and Aubagio (teriflunomide)."}
{"qid": "5c6d7ff87c78d6947100003c", "original_text": "ZCCHC17 is a protein that plays a critical role in the regulation of gene expression, particularly in the context of cancer. It is a chromatin remodeler, which means it helps to alter the structure of chromatin, the complex of DNA and proteins that makes up the chromosomes, to create a more accessible chromatin environment for transcriptional activators to bind and recruit RNA polymerase II (RNAPII) to initiate transcription. In cancer, ZCCHC17 has been shown to be overexpressed in many different tumor types, including breast, lung, and colon cancer. Overexpression of ZCCHC17 has been associated with increased cancer cell proliferation, migration, and invasivity, as well as poor prognosis and treatment response.", "label": 0, "is_selected": 1, "text": "The research team at the University of California, Los Angeles (UCLA) has developed a new approach to understanding the role of ZCCHC17 in cancer, by analysing the expression of the gene in samples from breast, lung and colon cancer, as well as in healthy tissue."}
{"qid": "5ca0c81eecadf2e73f000047", "original_text": "Subdural empyema is a rare complication of sinusitis, occurring in approximately 1-2% of cases. It is caused by spread of bacterial infection from the nasal sinuses to the subdural space, leading to inflammation and collection of pus. Symptoms may include headache, fever, meningism, and confusion. prompt diagnosis and treatment are essential to prevent serious complications. Treatment typically involves antibiotics, draining the abscess, and sometimes surgical intervention. I don't have answer.", "label": 0, "is_selected": 0, "text": "Subdural empyema is a rare complication of sinusitis, occurring in approximately 1-2% of cases. It is caused by spread of bacterial infection from the nasal sinuses to the subdural space, leading to inflammation and collection of pus. Symptoms may include headache, fever, meningism, and confusion. prompt diagnosis and treatment are essential to prevent serious complications. Treatment typically involves antibiotics, draining the abscess, and sometimes surgical intervention. I don't have answer."}
{"qid": "56c036afef6e394741000019", "original_text": "We present a case of erucism (caterpillar dermatitis) in a British serviceman deployed in Croatia on Operation Resolute. The aetiology, clinical features and diagnosis of erucism are discussed. Erucism should be highlighted as an environmental hazard in future troop deployments to the Mediterranean area.", "label": 1, "is_selected": 0, "text": "We present a case of erucism (caterpillar dermatitis) in a British serviceman deployed in Croatia on Operation Resolute. The aetiology, clinical features and diagnosis of erucism are discussed. Erucism should be highlighted as an environmental hazard in future troop deployments to the Mediterranean area."}
{"qid": "5710a650cf1c32585100002b", "original_text": "Mycobacterium avium causes disseminated infection in patients with acquired immune deficiency syndrome. Mycobacterium tuberculosis is a pathogen associated with the deaths of millions of people worldwide annually. Effective therapeutic regimens exist that are limited by the emergence of drug resistance and the inability of antibiotics to kill dormant organisms. The present study describes a system using Mycobacterium smegmatis, an avirulent mycobacterium, to deliver the lytic phage TM4 where both M. avium and M. tuberculosis reside within macrophages. These results showed that treatment of M. avium-infected, as well as M. tuberculosis-infected, RAW 264.7 macrophages, with M. smegmatis transiently infected with TM4, resulted in a significant time- and titer-dependent reduction in the number of viable intracellular bacilli. In addition, the M. smegmatis vacuole harboring TM4 fuses with the M. avium vacuole in macrophages.", "label": 1, "is_selected": 0, "text": "Mycobacterium avium causes disseminated infection in patients with acquired immune deficiency syndrome. Mycobacterium tuberculosis is a pathogen associated with the deaths of millions of people worldwide annually. Effective therapeutic regimens exist that are limited by the emergence of drug resistance and the inability of antibiotics to kill dormant organisms. The present study describes a system using Mycobacterium smegmatis, an avirulent mycobacterium, to deliver the lytic phage TM4 where both M. avium and M. tuberculosis reside within macrophages. These results showed that treatment of M. avium-infected, as well as M. tuberculosis-infected, RAW 264.7 macrophages, with M. smegmatis transiently infected with TM4, resulted in a significant time- and titer-dependent reduction in the number of viable intracellular bacilli. In addition, the M. smegmatis vacuole harboring TM4 fuses with the M. avium vacuole in macrophages."}
{"qid": "625bb257e764a5320400002e", "original_text": "Lorlatinib is a third-generation ALK inhibitor that can overcome the largest number of acquired ALK resistance mutations, including the solvent-front mutation G1202R. Here, we report, for the first time, a novel, sequentially-evolved EML4-ALK variant 3 G1202R/S1206Y double mutation in cis detected in a patient with ALK-positive NSCLC after disease progression on sequential crizotinib, alectinib, and then lorlatinib. Three-dimensional computer modeling of this double mutation and other G1202R-based double mutations with lorlatinib (ALK G1202R/L1196M, ALK G1202R/F1174C, ALK G1202R/l1198F, ALK G1202R/G1269A) were provided to reveal how these double mutations may confer resistance to lorlatinib through diverse steric hindrances in the ALK kinase domain. In addition, we performed a comprehensive literature review on published acquired double or triple ALK mutations that are resistant to lorlatinib from both patient samples and in vitro mutagenesis experiments.", "label": 1, "is_selected": 0, "text": "Lorlatinib is a third-generation ALK inhibitor that can overcome the largest number of acquired ALK resistance mutations, including the solvent-front mutation G1202R. Here, we report, for the first time, a novel, sequentially-evolved EML4-ALK variant 3 G1202R/S1206Y double mutation in cis detected in a patient with ALK-positive NSCLC after disease progression on sequential crizotinib, alectinib, and then lorlatinib. Three-dimensional computer modeling of this double mutation and other G1202R-based double mutations with lorlatinib (ALK G1202R/L1196M, ALK G1202R/F1174C, ALK G1202R/l1198F, ALK G1202R/G1269A) were provided to reveal how these double mutations may confer resistance to lorlatinib through diverse steric hindrances in the ALK kinase domain. In addition, we performed a comprehensive literature review on published acquired double or triple ALK mutations that are resistant to lorlatinib from both patient samples and in vitro mutagenesis experiments."}
{"qid": "58dbba438acda3452900001c", "original_text": "Cri du chat syndrome is characterized by cat-like cry, facial dysmorphisms, microcephaly, speech delay, intellectual disability and slow growth rate, which are present with variable frequency. The typical cri du chat syndrome, due to 5p15.2 deletion, includes severe intellectual disability, facial dysmorphisms, neonatal hypotonia and pre- and post-natal growth retardation, whereas more distal deletions in 5p15.3 lead to cat-like cry and speech delay and produce the clinical picture of the atypical cri du chat syndrome, with minimal or absent intellectual impairment.", "label": 1, "is_selected": 0, "text": "Cri du chat syndrome is characterized by cat-like cry, facial dysmorphisms, microcephaly, speech delay, intellectual disability and slow growth rate, which are present with variable frequency. The typical cri du chat syndrome, due to 5p15.2 deletion, includes severe intellectual disability, facial dysmorphisms, neonatal hypotonia and pre- and post-natal growth retardation, whereas more distal deletions in 5p15.3 lead to cat-like cry and speech delay and produce the clinical picture of the atypical cri du chat syndrome, with minimal or absent intellectual impairment."}
{"qid": "620c2f4f3a8413c653000009", "original_text": "meCLICK-Seq is a single-cell transcriptomic technique that combines the benefits of both click-seq and Drop-Seq. Click-seq is a method that encodes RNA molecules into cRNA (complementary RNA) using a modified enzyme called KRAS-C34. Drop-Seq, on the other hand, uses an enzyme called Drop, which produces a mixture of RNA oligonucleotides that are then used to amplify specific RNA molecules. In meCLICK-Seq, the cRNA generated from the KRAS-C34 enzyme is first captured using an antibody, and then the captured cRNA is used as input for the Drop-Seq reaction. This allows for the simultaneous capture of both mRNA and lncRNA, which is not possible with traditional click-seq methods. Additionally, meCLICK-Seq can capture RNA molecules from a wide range of cell types, including those that are difficult to isolate using other methods. The advantages of meCLICK-Seq over traditional single-cell transcriptomics methods include its ability to capture both mRNA and lncRNA, its high sensitivity and specificity, and its ability to be used with a wide range of cell types. These features make meCLICK-Seq a valuable tool for understanding the complex regulatory networks that govern cellular behavior and development.", "label": 0, "is_selected": 0, "text": "meCLICK-Seq is a single-cell transcriptomic technique that combines the benefits of both click-seq and Drop-Seq. Click-seq is a method that encodes RNA molecules into cRNA (complementary RNA) using a modified enzyme called KRAS-C34. Drop-Seq, on the other hand, uses an enzyme called Drop, which produces a mixture of RNA oligonucleotides that are then used to amplify specific RNA molecules. In meCLICK-Seq, the cRNA generated from the KRAS-C34 enzyme is first captured using an antibody, and then the captured cRNA is used as input for the Drop-Seq reaction. This allows for the simultaneous capture of both mRNA and lncRNA, which is not possible with traditional click-seq methods. Additionally, meCLICK-Seq can capture RNA molecules from a wide range of cell types, including those that are difficult to isolate using other methods. The advantages of meCLICK-Seq over traditional single-cell transcriptomics methods include its ability to capture both mRNA and lncRNA, its high sensitivity and specificity, and its ability to be used with a wide range of cell types. These features make meCLICK-Seq a valuable tool for understanding the complex regulatory networks that govern cellular behavior and development."}
{"qid": "61f563f7882a024a10000006", "original_text": "Biallelic variants in PCDHGC4 have been identified as a cause of a rare genetic disorder called Cornelia de Lange syndrome (CdLS). Cornelia de Lange syndrome is a spectrum of genetic disorders characterized by developmental delays, intellectual disability, and physical abnormalities. Biallelic variants in PCDHGC4 are the most common cause of CdLS, accounting for approximately 70% of cases. The variants affect the expression of proteins involved in cell signaling and communication, leading to the developmental delays and physical abnormalities seen in CdLS patients. These variants can also affect the function of other genes, leading to the diverse range of clinical features seen in CdLS.", "label": 0, "is_selected": 1, "text": "A team of researchers at the University of California, San Francisco (UCSD) has identified a new genetic disorder in which a single copy of the PCDHGC4 gene is responsible for most of the clinical features seen in patients with Cornelia de Lange syndrome."}
{"qid": "61fa904fc9dfcb9c09000004", "original_text": "Erythropoietin (EPO) is a hormone that stimulates the production of red blood cells in the body. In recent years, EPO has been investigated for its potential neuroprotective effects in preterm infants, who are at risk of developing brain damage due to the lack of oxygen and nutrients during the birthing process. Several studies have suggested that EPO may be effective in reducing the risk of neurological damage in preterm infants. For example, a 2019 meta-analysis published in the journal Pediatrics found that EPO therapy was associated with a reduced risk of bronchopulmonary dysplasia (BPD), a common complication in preterm infants that can lead to long-term lung problems. Another study published in 2020 in the Journal of Perinatology found that EPO therapy was associated with improved cognitive outcomes in preterm infants at 18 months of age. However, it is important to note that the evidence for EPO's neuroprotective effects in preterm infants is still limited and inconclusive. Many of the existing studies have small sample sizes, and the results may be influenced by various factors, such as gestational age and birth weight. Moreover, the long-term effects of EPO therapy on cognitive and neurological development in preterm infants are not well understood. In conclusion, while there is some evidence to suggest that EPO may be effective in reducing the risk of neurological damage in preterm infants, further research is needed to establish its efficacy and safety in this population. As an assistant, I cannot provide false information or make unsubstantiated claims, so the answer to the question is not definitively yes or no, but rather it is still under investigation and requires more research to fully understand its effects.", "label": 0, "is_selected": 0, "text": "Erythropoietin (EPO) is a hormone that stimulates the production of red blood cells in the body. In recent years, EPO has been investigated for its potential neuroprotective effects in preterm infants, who are at risk of developing brain damage due to the lack of oxygen and nutrients during the birthing process. Several studies have suggested that EPO may be effective in reducing the risk of neurological damage in preterm infants. For example, a 2019 meta-analysis published in the journal Pediatrics found that EPO therapy was associated with a reduced risk of bronchopulmonary dysplasia (BPD), a common complication in preterm infants that can lead to long-term lung problems. Another study published in 2020 in the Journal of Perinatology found that EPO therapy was associated with improved cognitive outcomes in preterm infants at 18 months of age. However, it is important to note that the evidence for EPO's neuroprotective effects in preterm infants is still limited and inconclusive. Many of the existing studies have small sample sizes, and the results may be influenced by various factors, such as gestational age and birth weight. Moreover, the long-term effects of EPO therapy on cognitive and neurological development in preterm infants are not well understood. In conclusion, while there is some evidence to suggest that EPO may be effective in reducing the risk of neurological damage in preterm infants, further research is needed to establish its efficacy and safety in this population. As an assistant, I cannot provide false information or make unsubstantiated claims, so the answer to the question is not definitively yes or no, but rather it is still under investigation and requires more research to fully understand its effects."}
{"qid": "58ab1e19396a458e5000000f", "original_text": "Yeast Clr4 is a chromatin-remodeling complex that plays a crucial role in regulating various cellular processes, including transcriptional elongation, chromatin remodeling, and DNA repair. Clr4 is composed of several subunits, including Clr4a, Clr4b, and Clr4c, which work together to recognize and bind to specific DNA sequences, known as histone modification marks. Once bound, Clr4 mediates the exchange of histones H2A and H2B with modified histones, leading to changes in chromatin structure and dynamics. Clr4 has been shown to be involved in various cellular processes, including transcriptional pausing, RNA polymerase II (RNAPII) recruitment, and the regulation of gene expression. Specifically, Clr4 has been shown to be required for the efficient elongation of actively transcribed genes, as it helps to maintain the stability of RNAPII- DNA interactions during transcriptional elongation. Clr4 also interacts with other chromatin-remodeling complexes, such as SWI/SNF, to coordinate chromatin remodeling and transcriptional activation. In addition, Clr4 has been implicated in the regulation of various developmental and cellular processes, including cell fate determination, differentiation, and survival. For example, Clr4 has been shown to be required for the proper differentiation of stem cells into specific cell lineages, and it has been implicated in the regulation of cell fate decisions in response to environmental cues. Overall, the function of yeast Clr4 on chromatin is to regulate chromatin structure and dynamics, which in turn affects gene expression and various cellular processes.", "label": 0, "is_selected": 0, "text": "Yeast Clr4 is a chromatin-remodeling complex that plays a crucial role in regulating various cellular processes, including transcriptional elongation, chromatin remodeling, and DNA repair. Clr4 is composed of several subunits, including Clr4a, Clr4b, and Clr4c, which work together to recognize and bind to specific DNA sequences, known as histone modification marks. Once bound, Clr4 mediates the exchange of histones H2A and H2B with modified histones, leading to changes in chromatin structure and dynamics. Clr4 has been shown to be involved in various cellular processes, including transcriptional pausing, RNA polymerase II (RNAPII) recruitment, and the regulation of gene expression. Specifically, Clr4 has been shown to be required for the efficient elongation of actively transcribed genes, as it helps to maintain the stability of RNAPII- DNA interactions during transcriptional elongation. Clr4 also interacts with other chromatin-remodeling complexes, such as SWI/SNF, to coordinate chromatin remodeling and transcriptional activation. In addition, Clr4 has been implicated in the regulation of various developmental and cellular processes, including cell fate determination, differentiation, and survival. For example, Clr4 has been shown to be required for the proper differentiation of stem cells into specific cell lineages, and it has been implicated in the regulation of cell fate decisions in response to environmental cues. Overall, the function of yeast Clr4 on chromatin is to regulate chromatin structure and dynamics, which in turn affects gene expression and various cellular processes."}
{"qid": "621b8dee3a8413c653000042", "original_text": "Lysozyme is a naturally occurring enzyme present in various bodily fluids, including tears. Yes, lysozyme is abundant in human tears, where it serves as a component of the tear film. The tear film is a complex fluid that lubricates and protects the surface of the eye, and lysozyme plays a significant role in maintaining its homeostasis. Research studies have shown that the concentration of lysozyme in human tears can range from 0.1 to 1.3 \u03bcg/ml, with an average value of around 0.5 \u03bcg/ml. This concentration is similar to or even higher than that found in other bodily fluids, such as saliva and respiratory secretions. The presence of lysozyme in tears suggests that it may have a role in ocular health and may be useful as a diagnostic marker for certain eye diseases.", "label": 0, "is_selected": 1, "text": "What is lysozyme and what is its importance in the human eye and the human tear film, and why is it found in human tears and not in other bodily fluids such as saliva or respiratory secretions? This concentration is similar to or even higher than that found in other biological fluids, such as blood, saliva and respiratory secretions."}
{"qid": "5c7a4ed5d774d04240000008", "original_text": "Assessment of EGFR mutation in non-small cell lung cancer (NSCLC) patients is mandatory for optimization of pharmacologic treatment. In this respect, mutation analysis of circulating tumor cells (CTCs) may be desirable since they may provide real-time information on patient's disease status. Blood samples were collected from 37 patients enrolled in the TRIGGER study, a prospective phase II multi-center trial of erlotinib treatment in advanced NSCLC patients with activating EGFR mutations in tumor tissue. 10 CTC preparations from breast cancer patients without EGFR mutations in their primary tumors and 12 blood samples from healthy subjects were analyzed as negative controls. CTC preparations, obtained by the Veridex CellSearch System, were subjected to ultra-deep next generation sequencing (NGS) on the Roche 454 GS junior platform.", "label": 1, "is_selected": 0, "text": "Assessment of EGFR mutation in non-small cell lung cancer (NSCLC) patients is mandatory for optimization of pharmacologic treatment. In this respect, mutation analysis of circulating tumor cells (CTCs) may be desirable since they may provide real-time information on patient's disease status. Blood samples were collected from 37 patients enrolled in the TRIGGER study, a prospective phase II multi-center trial of erlotinib treatment in advanced NSCLC patients with activating EGFR mutations in tumor tissue. 10 CTC preparations from breast cancer patients without EGFR mutations in their primary tumors and 12 blood samples from healthy subjects were analyzed as negative controls. CTC preparations, obtained by the Veridex CellSearch System, were subjected to ultra-deep next generation sequencing (NGS) on the Roche 454 GS junior platform."}
{"qid": "60490c421cb411341a000166", "original_text": "Detection of intracellular DNA by the cGAS-STING pathway activates a type I interferon-mediated innate immune response that protects from virus infection. Whether there are additional DNA sensing pathways, and how such pathways might function, remains controversial. We show here that humans-but not laboratory mice-have a second, potent, STING-independent DNA sensing pathway (SIDSP). We identify human DNA-dependent protein kinase (DNA-PK) as the sensor of this pathway and demonstrate that DNA-PK activity drives a robust and broad antiviral response. We show that the E1A oncoprotein of human adenovirus 5 and the ICP0 protein of herpes simplex virus 1 block this response. We found heat shock protein HSPA8/HSC70 as a target for inducible phosphorylation in the DNA-PK antiviral pathway.", "label": 1, "is_selected": 0, "text": "Detection of intracellular DNA by the cGAS-STING pathway activates a type I interferon-mediated innate immune response that protects from virus infection. Whether there are additional DNA sensing pathways, and how such pathways might function, remains controversial. We show here that humans-but not laboratory mice-have a second, potent, STING-independent DNA sensing pathway (SIDSP). We identify human DNA-dependent protein kinase (DNA-PK) as the sensor of this pathway and demonstrate that DNA-PK activity drives a robust and broad antiviral response. We show that the E1A oncoprotein of human adenovirus 5 and the ICP0 protein of herpes simplex virus 1 block this response. We found heat shock protein HSPA8/HSC70 as a target for inducible phosphorylation in the DNA-PK antiviral pathway."}
{"qid": "601ef0571cb411341a000067", "original_text": "LASIK (Laser in situ keratomileusis) is used in refractive surgery especially for correction of higher degrees of myopia. Preservation of Bowman's layer as well as less postoperative pain and the slight to absent subepithelial haze are regarded as advantages compared to photorefractive keratectomy (PRK). However, numerous serious complications have been described in the literature. LASIK treatment was performed elsewhere in two patients to treat myopia or myopic astigmatism between -6 and -9 diopters (D).", "label": 1, "is_selected": 0, "text": "LASIK (Laser in situ keratomileusis) is used in refractive surgery especially for correction of higher degrees of myopia. Preservation of Bowman's layer as well as less postoperative pain and the slight to absent subepithelial haze are regarded as advantages compared to photorefractive keratectomy (PRK). However, numerous serious complications have been described in the literature. LASIK treatment was performed elsewhere in two patients to treat myopia or myopic astigmatism between -6 and -9 diopters (D)."}
{"qid": "5c5205137e3cb0e231000001", "original_text": "The UK Biobank is a unique resource for biomedical research, with extensive phenotypic and genetic data on half a million adults from the general population. We aimed to examine the effect of neurodevelopmental copy number variants (CNVs) on the cognitive performance of participants. We used Affymetrix Power Tools and PennCNV-Affy software to analyze Affymetrix microarrays of the first 152,728 genotyped individuals. We annotated a list of 93 CNVs and compared their frequencies with control datasets. We analyzed the performance on seven cognitive tests of carriers of 12 CNVs associated with schizophrenia (n = 1087) and of carriers of another 41 neurodevelopmental CNVs (n = 484). The frequencies of the 93 CNVs in the Biobank subjects were remarkably similar to those among 26,628 control subjects from other datasets.", "label": 1, "is_selected": 0, "text": "The UK Biobank is a unique resource for biomedical research, with extensive phenotypic and genetic data on half a million adults from the general population. We aimed to examine the effect of neurodevelopmental copy number variants (CNVs) on the cognitive performance of participants. We used Affymetrix Power Tools and PennCNV-Affy software to analyze Affymetrix microarrays of the first 152,728 genotyped individuals. We annotated a list of 93 CNVs and compared their frequencies with control datasets. We analyzed the performance on seven cognitive tests of carriers of 12 CNVs associated with schizophrenia (n = 1087) and of carriers of another 41 neurodevelopmental CNVs (n = 484). The frequencies of the 93 CNVs in the Biobank subjects were remarkably similar to those among 26,628 control subjects from other datasets."}
{"qid": "56d1e23c67f0cb3d66000009", "original_text": "TEAD proteins are transcription factors that are crucial for development, but also play a role in cancers. Several developmentally and pathologically important genes are upregulated by TEADs. TEADs have a TEA domain that enables them to bind specific DNA elements and a transactivation domain that enables them to interact with coactivators. TEADs on their own are unable to activate transcription and they require the help of coactivators. Several TEAD-interacting coactivators are known and they can be classified into three groups: (1) YAP and its paralog TAZ; (2) Vgll proteins; and (3) p160s.", "label": 1, "is_selected": 0, "text": "TEAD proteins are transcription factors that are crucial for development, but also play a role in cancers. Several developmentally and pathologically important genes are upregulated by TEADs. TEADs have a TEA domain that enables them to bind specific DNA elements and a transactivation domain that enables them to interact with coactivators. TEADs on their own are unable to activate transcription and they require the help of coactivators. Several TEAD-interacting coactivators are known and they can be classified into three groups: (1) YAP and its paralog TAZ; (2) Vgll proteins; and (3) p160s."}
{"qid": "58cf5c5a8acda34529000003", "original_text": "Base J is a hypermodified DNA base localized primarily to telomeric regions of the genome of Trypanosoma brucei. We have previously characterized two thymidine-hydroxylases (TH), JBP1 and JBP2, which regulate J-biosynthesis. JBP2 is a chromatin re-modeling protein that induces de novo J-synthesis, allowing JBP1, a J-DNA binding protein, to stimulate additional J-synthesis. Here, we show that both JBP2 and JBP1 are capable of stimulating de novo J-synthesis. We localized the JBP1- and JBP2-stimulated J by anti-J immunoprecipitation and high-throughput sequencing. This genome-wide analysis revealed an enrichment of base J at regions flanking polymerase II polycistronic transcription units (Pol II PTUs) throughout the T. brucei genome.", "label": 1, "is_selected": 0, "text": "Base J is a hypermodified DNA base localized primarily to telomeric regions of the genome of Trypanosoma brucei. We have previously characterized two thymidine-hydroxylases (TH), JBP1 and JBP2, which regulate J-biosynthesis. JBP2 is a chromatin re-modeling protein that induces de novo J-synthesis, allowing JBP1, a J-DNA binding protein, to stimulate additional J-synthesis. Here, we show that both JBP2 and JBP1 are capable of stimulating de novo J-synthesis. We localized the JBP1- and JBP2-stimulated J by anti-J immunoprecipitation and high-throughput sequencing. This genome-wide analysis revealed an enrichment of base J at regions flanking polymerase II polycistronic transcription units (Pol II PTUs) throughout the T. brucei genome."}
{"qid": "58c99acf02b8c60953000028", "original_text": "Certainly! A torn rotator cuff is a common injury that can cause shoulder pain and weakness. Here are two common treatments for a torn rotator cuff: 1. Surgery: Surgery is often the most effective treatment for a torn rotator cuff. The goal of surgery is to repair the torn tendon and restore shoulder function. There are several types of surgical procedures, including open repair, arthroscopy, and tendon transfer. The choice of surgery depends on the severity and location of the tear, as well as the patient's overall health. 2. Physical Therapy: Physical therapy can also be effective in treating a torn rotator cuff. The goal of physical therapy is to help the patient regain shoulder strength and range of motion. A physical therapist will develop a customized exercise program that includes stretching and strengthening exercises, as well as other interventions such as heat or cold therapy, electrical stimulation, and ultrasound. Physical therapy can help improve shoulder function and reduce pain, but it may take several months to see significant improvements. I hope this information is helpful! Let me know if you have any further questions.", "label": 0, "is_selected": 1, "text": "Is there a treatment for a torn rotator cuff? Physical therapy can help improve shoulder function and reduce pain, but it may take several months to see significant improvements. The goal of physical therapy is to help the patient regain shoulder strength and range of motion, as well as the patient's overall health and well-being, and to prevent future shoulder injuries. Physical therapy is an excellent option for patients who have suffered a torn shoulder cuff, as it can help them regain their ability to walk, stand, and use their arms and legs."}
{"qid": "61f5f580882a024a10000017", "original_text": "Background Non-alcoholic steatohepatitis (NASH), a multifactorial disease, can progress to hepatic fibrosis and cirrhosis. The Peroxysomal Proliferator-Activated Receptors, PPAR\u03b1, \u03b2/\u03b4 and \u03b3, play a central role in the regulation of glucose and lipid metabolism and of the inflammatory and fibrogenic pathways in liver and in other organs that all contribute to NASH pathogenesis. Lanifibranor (IVA337), a panPPAR agonist, by acting on these three different PPAR isotypes, combines pharmacological effects that could address the different components of the disease as demonstrated in preclinical models. Objectives NATIVE study (EudraCT: 2016-001979-70, NCT: NCT03008070) aims to assess the safety and the efficacy of a 24-week treatment with lanifibranor (800 and 1200 mg/day) in adult non-cirrhotic NASH patients. The primary efficacy endpoint is a 2-point reduction in the activity part of the Steatosis Activity Fibrosis (SAF) histological score (combining inflammation and ballooning) without worsening of fibrosis. Design NATIVE is a Phase 2b randomised, placebo-controlled, double-blind, parallel-assignment, dose-range study. Eligible adult patients with a confirmed histological diagnosis of NASH should have a SAF Activity score of 3 or 4 (>2) and a SAF Steatosis score \u2265 1.", "label": 1, "is_selected": 0, "text": "Background Non-alcoholic steatohepatitis (NASH), a multifactorial disease, can progress to hepatic fibrosis and cirrhosis. The Peroxysomal Proliferator-Activated Receptors, PPAR\u03b1, \u03b2/\u03b4 and \u03b3, play a central role in the regulation of glucose and lipid metabolism and of the inflammatory and fibrogenic pathways in liver and in other organs that all contribute to NASH pathogenesis. Lanifibranor (IVA337), a panPPAR agonist, by acting on these three different PPAR isotypes, combines pharmacological effects that could address the different components of the disease as demonstrated in preclinical models. Objectives NATIVE study (EudraCT: 2016-001979-70, NCT: NCT03008070) aims to assess the safety and the efficacy of a 24-week treatment with lanifibranor (800 and 1200 mg/day) in adult non-cirrhotic NASH patients. The primary efficacy endpoint is a 2-point reduction in the activity part of the Steatosis Activity Fibrosis (SAF) histological score (combining inflammation and ballooning) without worsening of fibrosis. Design NATIVE is a Phase 2b randomised, placebo-controlled, double-blind, parallel-assignment, dose-range study. Eligible adult patients with a confirmed histological diagnosis of NASH should have a SAF Activity score of 3 or 4 (>2) and a SAF Steatosis score \u2265 1."}
{"qid": "58cdbbd102b8c60953000045", "original_text": "In this study, we investigated the influence of children's level of executive functioning on two types of metamemory knowledge following a traumatic brain injury (TBI). For this purpose, 22 children (aged 7 to 14 years) who had sustained a moderate to severe TBI and 44 typically developing children were recruited. The children with TBI were divided into two groups according to the severity of their executive impairment. Injury severity was determined by the Glasgow Coma Scale (GCS) score on admission or by the duration of unconsciousness. All children were then tested on both their knowledge of general memory functioning and their level of memory self-awareness, respectively assessed using the total number of correct responses on an adapted version of a metamemory interview and a self-other discrepancy score on a questionnaire evaluating everyday memory abilities.", "label": 1, "is_selected": 0, "text": "In this study, we investigated the influence of children's level of executive functioning on two types of metamemory knowledge following a traumatic brain injury (TBI). For this purpose, 22 children (aged 7 to 14 years) who had sustained a moderate to severe TBI and 44 typically developing children were recruited. The children with TBI were divided into two groups according to the severity of their executive impairment. Injury severity was determined by the Glasgow Coma Scale (GCS) score on admission or by the duration of unconsciousness. All children were then tested on both their knowledge of general memory functioning and their level of memory self-awareness, respectively assessed using the total number of correct responses on an adapted version of a metamemory interview and a self-other discrepancy score on a questionnaire evaluating everyday memory abilities."}
{"qid": "5c83f858617e120c34000003", "original_text": "Yes, treatment with Bacillus Calmette-Guerin (BCG) is used for bladder cancer in some cases. BCG is a type of immunotherapy, which is a treatment that uses the body's immune system to fight cancer. It is typically used to treat non-muscle invasive bladder cancer, which is the most common type of bladder cancer. BCG works by stimulating the immune system to recognize and attack cancer cells in the bladder. It is usually given through a catheter inserted into the bladder, and a course of treatment typically lasts several weeks. While BCG therapy can be effective in preventing the cancer from coming back, it is not a cure for bladder cancer and may have side effects such as fatigue, nausea, and skin rash.", "label": 0, "is_selected": 1, "text": "Bladder cancer is one of the most common types of cancer in the United States, and it is the second leading cause of cancer-related deaths in men and women, according to the American Cancer Society (ACS) and the National Comprehensive Cancer Network (NCCN) both of which are part of the National Institutes of Health (NIH)."}
{"qid": "5e48b9abd14c9f295d000015", "original_text": "Multipotent adult progenitor cells (MAPCs) are a type of adult stem cell that has generated significant interest in the medical community due to their potential therapeutic applications, including the treatment of stroke. However, the effectiveness of MAPCs in treating stroke is a topic of ongoing research and debate. Stroke is a leading cause of disability worldwide, affecting millions of people every year. Current treatments for stroke, such as tissue plasminogen activator (tPA), are effective for only a small percentage of patients, and there is a pressing need for new and innovative therapies. MAPCs have been proposed as a promising new treatment option for stroke due to their ability to differentiate into various cell types, including neurons, astrocytes, and oligodendrocytes. Several studies have investigated the use of MAPCs in the treatment of stroke in animal models. For example, a study published in the journal Stem Cells in 2010 found that intravenous injection of MAPCs into rats after a stroke resulted in improved motor function and reduced infarct volume compared to the control group. Similarly, a study published in the Journal of Cerebral Blood Flow & Metabolism in 2013 found that MAPCs injection into rabbits after a stroke resulted in improved functional recovery and reduced inflammation compared to the control group. While these results are promising, it is important to note that the studies were conducted in animal models, and the effectiveness of MAPCs in humans is still unknown. There are several challenges to overcome before MAPCs can be used safely and effectively in humans, including the risk of tumor formation, immune reaction, and the lack of standardization in the isolation and expansion of MAPCs. Currently, there are several ongoing clinical trials investigating the safety and efficacy of MAPCs in humans, including the Stem cells for Acute Stroke Trial (SAST) and the Multipotent Adult Progenitor Cells (MAPCs) for Stroke Treatment Trial (MAST). These trials are evaluating the safety and efficacy of MAPCs in patients with acute ischemic stroke and are expected to provide more definitive answers regarding the effectiveness of MAPCs in treating stroke. In conclusion, while there is some promising evidence from animal studies suggesting that MAPCs may be effective in treating stroke, more research is needed to overcome the challenges associated with their use in humans. Ongoing clinical trials will provide more definitive answers regarding the safety and efficacy of MAPCs in the treatment of stroke. As of now, I don't have answer to the question of whether MAPCs are effective for treatment of stroke.", "label": 0, "is_selected": 1, "text": "In our series of letters from African-American journalists, film-maker, and columnist Ahmed Rashid looks at the potential use of stem cells in the treatment of stroke. Currently, there are several ongoing clinical trials investigating the safety and efficacy of MAPCs in humans, including the Stem cells for Acute Stroke Trial (SAST) and the Multipotent Adult Progenitor Cells (MAPCs) for Stroke Treatment Trial (MAST). These trials are evaluating the safety, efficacy, and potential safety of MAPcs in patients with acute ischemic stroke and are expected to provide more definitive answers regarding the effectiveness of these cells in treating stroke. I don't have answer to the question of whether MAPC's are effective for treatment of Stroke. As of now, I do not have Answer to the Question of Whether MAPCS are Effective for Treatment of Stroke... as of now... I haven't answered to thequestion of whether they're effective for treating stroke, as of right now, but Ongoing clinical trials will provide more conclusive answers regarding their use in humans."}
{"qid": "58bfeb2b02b8c6095300001a", "original_text": "We report a 12 years old female patient with an overlap syndrome involving autoimmune hepatitis (AIH) and systemic lupus erythematosus (SLE). The patient presented with jaundice, hepatosplenomegaly, malaise, polyarthralgia, arthritis and butterfly rash on the face. Laboratory tests revealed severe liver dysfunction, Coombs positive hemolytic anemia and a positive ANA/anti-dsDNA test. Renal biopsy showed class IIA kidney disease, while liver biopsy showed chronic hepatitis with severe inflammatory activity. The patient satisfied the international criteria for both SLE and AIH. Clinical symptoms and laboratory findings of SLE improved with high dose treatment with corticosteroids and azathioprine, however, remission of the liver disease could not be achieved. Repeat biopsy of the liver after three years of therapy revealed ongoing chronic hepatitis with high level of inflammatory activity. The present case indicates that children with liver dysfunction and SLE should be investigated for AIH.", "label": 1, "is_selected": 0, "text": "We report a 12 years old female patient with an overlap syndrome involving autoimmune hepatitis (AIH) and systemic lupus erythematosus (SLE). The patient presented with jaundice, hepatosplenomegaly, malaise, polyarthralgia, arthritis and butterfly rash on the face. Laboratory tests revealed severe liver dysfunction, Coombs positive hemolytic anemia and a positive ANA/anti-dsDNA test. Renal biopsy showed class IIA kidney disease, while liver biopsy showed chronic hepatitis with severe inflammatory activity. The patient satisfied the international criteria for both SLE and AIH. Clinical symptoms and laboratory findings of SLE improved with high dose treatment with corticosteroids and azathioprine, however, remission of the liver disease could not be achieved. Repeat biopsy of the liver after three years of therapy revealed ongoing chronic hepatitis with high level of inflammatory activity. The present case indicates that children with liver dysfunction and SLE should be investigated for AIH."}
{"qid": "552fac4fbc4f83e828000006", "original_text": "Ewing sarcoma family tumors (ESFT) are highly aggressive and highly metastatic tumors caused by a chromosomal fusion between the Ewing sarcoma protein (EWS) with the transcription factor FLI-1. However, expression of the EWS/FLI-1 chimeric oncogene by itself is insufficient for carcinogenesis, suggesting that additional events are required. Here, we report the identification of the Akt substrate PRAS40 as an EWS target gene. EWS negatively regulates PRAS40 expression by binding the 3' untranslated region in PRAS40 mRNA. ESFT cell proliferation was suppressed by treatment with an Akt inhibitor, and ESFT cell proliferation and metastatic growth were suppressed by siRNA-mediated PRAS40 knockdown.", "label": 1, "is_selected": 0, "text": "Ewing sarcoma family tumors (ESFT) are highly aggressive and highly metastatic tumors caused by a chromosomal fusion between the Ewing sarcoma protein (EWS) with the transcription factor FLI-1. However, expression of the EWS/FLI-1 chimeric oncogene by itself is insufficient for carcinogenesis, suggesting that additional events are required. Here, we report the identification of the Akt substrate PRAS40 as an EWS target gene. EWS negatively regulates PRAS40 expression by binding the 3' untranslated region in PRAS40 mRNA. ESFT cell proliferation was suppressed by treatment with an Akt inhibitor, and ESFT cell proliferation and metastatic growth were suppressed by siRNA-mediated PRAS40 knockdown."}
{"qid": "622901d23a8413c65300008c", "original_text": "Ameloblastoma (AB) is a rare benign odontogenic tumor that arises from the odontogenic epithelium of the dental lamina. While it is generally considered to be a benign tumor, there have been rare cases of metastasis observed in the literature. The risk of metastasis varies depending on the location and size of the tumor, with a higher risk observed in larger tumors. Therefore, while AB is generally considered to be a benign tumor, it is important to monitor for any signs of metastasis during treatment and follow-up.", "label": 0, "is_selected": 1, "text": "The purpose of this study is to assess the risk of metastasis in patients with ameloblastoma who are receiving treatment for the disease.<n> Therefore, while AB is generally considered to be a benign tumor, it is important to monitor for any signs of metastasis during treatment and follow-up."}
{"qid": "51490275d24251bc0500003d", "original_text": "Aneurysmal subarachnoid hemorrhage (SAH) is a neurologic emergency and often a neurologic catastrophe. Nontraumatic subarachnoid hemorrhage is characterized by the extravasation of blood into the spaces covering the central nervous system. The leading cause of SAH is rupture of an intracranial aneurysm, which accounts for about 80-85% of cases. Mortality and morbidity can be reduced if SAH is treated urgently. Sudden, explosive headache is a cardinal but nonspecific feature in the diagnosis of SAH; computered tomography (CT) scanning is mandatory in all the patients with symp toms that are suggestive of SAH.", "label": 1, "is_selected": 0, "text": "Aneurysmal subarachnoid hemorrhage (SAH) is a neurologic emergency and often a neurologic catastrophe. Nontraumatic subarachnoid hemorrhage is characterized by the extravasation of blood into the spaces covering the central nervous system. The leading cause of SAH is rupture of an intracranial aneurysm, which accounts for about 80-85% of cases. Mortality and morbidity can be reduced if SAH is treated urgently. Sudden, explosive headache is a cardinal but nonspecific feature in the diagnosis of SAH; computered tomography (CT) scanning is mandatory in all the patients with symp toms that are suggestive of SAH."}
{"qid": "58a2df9c60087bc10a000006", "original_text": "A program for the detection of thalassemias and other hemoglobinopathies in high-risk populations is described. This program, based on two screening tests, was applied to the Hellenic Army recruits and was found to work well. Red cell one-point osmotic fragility was used for the detection of thalassemic samples and hemoglobin electrophoresis for screening of other hemoglobinopathies.", "label": 1, "is_selected": 0, "text": "A program for the detection of thalassemias and other hemoglobinopathies in high-risk populations is described. This program, based on two screening tests, was applied to the Hellenic Army recruits and was found to work well. Red cell one-point osmotic fragility was used for the detection of thalassemic samples and hemoglobin electrophoresis for screening of other hemoglobinopathies."}
{"qid": "6206bf3cc9dfcb9c0900003d", "original_text": "PD98059 is a specific inhibitor of the protein kinase MEK (Mitogen-activated protein kinase/Extracellular signal-regulated kinase kinase 1/2), specifically targeting the MEK1/2 isoforms. MEK1/2 is a key component of the MAPK/ERK signaling pathway, which plays a crucial role in various cellular processes, including proliferation, differentiation, and survival. Inhibition of MEK1/2 by PD98059 can suppress the activation of downstream effectors in this pathway, leading to anti-proliferative and anti-inflammatory effects in various diseases, including cancer and neurodegenerative disorders.", "label": 0, "is_selected": 1, "text": "The report provides comprehensive information on the therapeutics under development for MEK1/2, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), molecule type, and molecule type (as well as dormant and discontinued projects)."}
{"qid": "5c5f21a81a4c55d80b00001c", "original_text": "Selenocysteine is not an amino acid. It is a type of amino sugar, specifically a selenol, which is a class of compounds that contain selenium. Amino acids are the building blocks of proteins and are characterized by their chemical structure, which includes a carboxyl group, an amino group, and a side chain. Selenocysteine, on the other hand, is a modified amino acid that contains selenium instead of carbon. It is found in small amounts in some proteins and is involved in various cellular processes, including the synthesis of glutathione, a powerful antioxidant.", "label": 0, "is_selected": 0, "text": "Selenocysteine is not an amino acid. It is a type of amino sugar, specifically a selenol, which is a class of compounds that contain selenium. Amino acids are the building blocks of proteins and are characterized by their chemical structure, which includes a carboxyl group, an amino group, and a side chain. Selenocysteine, on the other hand, is a modified amino acid that contains selenium instead of carbon. It is found in small amounts in some proteins and is involved in various cellular processes, including the synthesis of glutathione, a powerful antioxidant."}
{"qid": "58965a4178275d0c4a00000e", "original_text": "Long interspersed nuclear elements-1 (LINE-1 or L1s) are abundant retrotransposons that comprise approximately 20% of mammalian genomes. Active L1 retrotransposons can impact the genome in a variety of ways, creating insertions, deletions, new splice sites or gene expression fine-tuning. We have shown previously that L1 retrotransposons are capable of mobilization in neuronal progenitor cells from rodents and humans and evidence of massive L1 insertions was observed in adult brain tissues but not in other somatic tissues. In addition, L1 mobility in the adult hippocampus can be influenced by the environment. The neuronal specificity of somatic L1 retrotransposition in neural progenitors is partially due to the transition of a Sox2/HDAC1 repressor complex to a Wnt-mediated T-cell factor/lymphoid enhancer factor (TCF/LEF) transcriptional activator.", "label": 1, "is_selected": 0, "text": "Long interspersed nuclear elements-1 (LINE-1 or L1s) are abundant retrotransposons that comprise approximately 20% of mammalian genomes. Active L1 retrotransposons can impact the genome in a variety of ways, creating insertions, deletions, new splice sites or gene expression fine-tuning. We have shown previously that L1 retrotransposons are capable of mobilization in neuronal progenitor cells from rodents and humans and evidence of massive L1 insertions was observed in adult brain tissues but not in other somatic tissues. In addition, L1 mobility in the adult hippocampus can be influenced by the environment. The neuronal specificity of somatic L1 retrotransposition in neural progenitors is partially due to the transition of a Sox2/HDAC1 repressor complex to a Wnt-mediated T-cell factor/lymphoid enhancer factor (TCF/LEF) transcriptional activator."}
{"qid": "5fe1fc84a43ad31278000036", "original_text": "According to current scientific understanding, approximately 80% of human genes have no introns. Introns are non-coding regions within a gene that are removed during the process of gene transcription, resulting in a mature mRNA molecule. The remaining 20% of human genes have one or more introns. This percentage can vary across species, with some organisms having a higher percentage of intron-containing genes.", "label": 0, "is_selected": 1, "text": "Introns are tiny, non-coding regions within genes that can affect the functioning of the gene and its translation into RNA or DNA.s The introns of human genes are thought to be involved in the translation of RNA and DNA into proteins and nucleic acids."}
{"qid": "571e172bbb137a4b0c000002", "original_text": "Empagliflozin was FDA approved in 2014. Specifically, it was approved on August 27, 2014, for the treatment of type 2 diabetes.", "label": 0, "is_selected": 0, "text": "Empagliflozin was FDA approved in 2014. Specifically, it was approved on August 27, 2014, for the treatment of type 2 diabetes."}
{"qid": "54f2210164850a5854000001", "original_text": "We report the isolation of a novel antimicrobial peptide, bass hepcidin, from the gill of hybrid striped bass, white bass (Morone chrysops) x striped bass (M. saxatilis). After the intraperitoneal injection of Micrococcus luteus and Escherichia coli, the peptide was purified from HPLC fractions with antimicrobial activity against Escherichia coli.", "label": 1, "is_selected": 0, "text": "We report the isolation of a novel antimicrobial peptide, bass hepcidin, from the gill of hybrid striped bass, white bass (Morone chrysops) x striped bass (M. saxatilis). After the intraperitoneal injection of Micrococcus luteus and Escherichia coli, the peptide was purified from HPLC fractions with antimicrobial activity against Escherichia coli."}
{"qid": "5e48b7e2d14c9f295d000014", "original_text": "Objectives To assess the cost-effectiveness of erenumab 140 mg (\"erenumab\") for the prophylactic treatment of episodic migraine and chronic migraine. Study design A hybrid Monte Carlo patient simulation and Markov cohort model was constructed to compare erenumab to no preventive treatment or onabotulinumtoxinA among adult ( \u2265 18 years) patients with episodic migraine and chronic migraine who failed prior preventive therapy from the US societal and payer perspectives. Methods Patients entered the model one at a time and were assigned to a post-treatment monthly migraine day category based on baseline monthly migraine days and treatment effect. Using monthly cycles, patients were followed for 2 years and accumulated costs and utilities associated with their post-treatment monthly migraine days. The primary outcome included the incremental cost-effectiveness ratio presented as cost per quality-adjusted life year gained. Results With an annual drug price of erenumab of $6900, treatment with erenumab in the societal perspective ranges from a dominant strategy versus no preventive treatment among chronic migraine patients to an incremental cost-effectiveness ratio of $122,167 versus no preventive treatment among episodic migraine patients. When excluding indirect costs (i.e. payer perspective), the incremental cost-effectiveness ratios are cost-effective among chronic migraine patients ($23,079 and $65,720 versus no preventive treatment and onabotulinumtoxinA, respectively), but not among episodic migraine patients ($180,012 versus no preventive treatment).", "label": 1, "is_selected": 0, "text": "Objectives To assess the cost-effectiveness of erenumab 140 mg (\"erenumab\") for the prophylactic treatment of episodic migraine and chronic migraine. Study design A hybrid Monte Carlo patient simulation and Markov cohort model was constructed to compare erenumab to no preventive treatment or onabotulinumtoxinA among adult ( \u2265 18 years) patients with episodic migraine and chronic migraine who failed prior preventive therapy from the US societal and payer perspectives. Methods Patients entered the model one at a time and were assigned to a post-treatment monthly migraine day category based on baseline monthly migraine days and treatment effect. Using monthly cycles, patients were followed for 2 years and accumulated costs and utilities associated with their post-treatment monthly migraine days. The primary outcome included the incremental cost-effectiveness ratio presented as cost per quality-adjusted life year gained. Results With an annual drug price of erenumab of $6900, treatment with erenumab in the societal perspective ranges from a dominant strategy versus no preventive treatment among chronic migraine patients to an incremental cost-effectiveness ratio of $122,167 versus no preventive treatment among episodic migraine patients. When excluding indirect costs (i.e. payer perspective), the incremental cost-effectiveness ratios are cost-effective among chronic migraine patients ($23,079 and $65,720 versus no preventive treatment and onabotulinumtoxinA, respectively), but not among episodic migraine patients ($180,012 versus no preventive treatment)."}
{"qid": "553e1aa5a3cf796f71000003", "original_text": "According to recent studies, 2-hydroxy-dATP (2-OH-dATP) has been shown to induce various types of DNA mutations, including point mutations, insertions, deletions, and chromosomal alterations. These mutations can occur in both prokaryotic and eukaryotic cells and can lead to changes in gene expression, protein function, and overall cellular behavior. The specific types and frequencies of DNA mutations induced by 2-OH-dATP may vary depending on factors such as the dose, duration of exposure, and cellular context.", "label": 0, "is_selected": 1, "text": "Two-hydroxy-dATP is a synthetic molecule that can be used to induce DNA mutations in a variety of eukaryotic and prokaryotic cell types, including human embryonic fibroblasts, Caenorhabditis elegans, and human prostate cancer cells."}
{"qid": "5e360b81158f994d3a000008", "original_text": "The Smith-Waterman algorithm is a widely used algorithm in bioinformatics for comparing biological sequences, such as DNA or protein sequences, to identify similarities and differences. It is a local alignment algorithm that measures the similarity between two sequences by counting the number of matching positions (homologies) between them. The algorithm works by assigning scores to each position in one of the sequences based on the number of matching positions in the other sequence, and then finding the maximum score by comparing the two sequences. The resulting alignment of the sequences shows the areas with high similarity and can be used for various applications, such as gene identification, mutation detection, and phylogenetic analysis. The Smith-Waterman algorithm is highly sensitive and can detect small differences between sequences, but it can be computationally intensive for long sequences.", "label": 0, "is_selected": 0, "text": "The Smith-Waterman algorithm is a widely used algorithm in bioinformatics for comparing biological sequences, such as DNA or protein sequences, to identify similarities and differences. It is a local alignment algorithm that measures the similarity between two sequences by counting the number of matching positions (homologies) between them. The algorithm works by assigning scores to each position in one of the sequences based on the number of matching positions in the other sequence, and then finding the maximum score by comparing the two sequences. The resulting alignment of the sequences shows the areas with high similarity and can be used for various applications, such as gene identification, mutation detection, and phylogenetic analysis. The Smith-Waterman algorithm is highly sensitive and can detect small differences between sequences, but it can be computationally intensive for long sequences."}
{"qid": "58eb6061eda5a57672000005", "original_text": "The deluge of current sequenced data has exceeded Moore's Law, more than doubling every 2 years since the next-generation sequencing (NGS) technologies were invented. Accordingly, we will able to generate more and more data with high speed at fixed cost, but lack the computational resources to store, process and analyze it. With error prone high throughput NGS reads and genomic repeats, the assembly graph contains massive amount of redundant nodes and branching edges. Most assembly pipelines require this large graph to reside in memory to start their workflows, which is intractable for mammalian genomes. Resource-efficient genome assemblers combine both the power of advanced computing techniques and innovative data structures to encode the assembly graph efficiently in a computer memory. LightAssembler is a lightweight assembly algorithm designed to be executed on a desktop machine. It uses a pair of cache oblivious Bloom filters, one holding a uniform sample of [Formula: see text]-spaced sequenced", "label": 1, "is_selected": 0, "text": "The deluge of current sequenced data has exceeded Moore's Law, more than doubling every 2 years since the next-generation sequencing (NGS) technologies were invented. Accordingly, we will able to generate more and more data with high speed at fixed cost, but lack the computational resources to store, process and analyze it. With error prone high throughput NGS reads and genomic repeats, the assembly graph contains massive amount of redundant nodes and branching edges. Most assembly pipelines require this large graph to reside in memory to start their workflows, which is intractable for mammalian genomes. Resource-efficient genome assemblers combine both the power of advanced computing techniques and innovative data structures to encode the assembly graph efficiently in a computer memory. LightAssembler is a lightweight assembly algorithm designed to be executed on a desktop machine. It uses a pair of cache oblivious Bloom filters, one holding a uniform sample of [Formula: see text]-spaced sequenced"}
{"qid": "602c2ade1cb411341a000124", "original_text": "Tumor-associated macrophages (TAMs) have been recognized as promising anticancer therapeutic targets. TAMs are a subset of immune cells that reside within tumors and play a complex role in tumor progression. Research has shown that TAMs can promote tumor angiogenesis, immune suppression, and tumor growth, making them an attractive target for cancer therapy. Strategies to target TAMs include using macrophage-targeted drugs, such as sulindac, or blocking TAM-derived cytokines, such as IL-10. These approaches have shown promise in preclinical studies, and early clinical trials are underway to evaluate their safety and efficacy in humans. However, it is important to note that TAMs also play a role in protecting against infection and maintaining tissue homeostasis, so targeting them without careful consideration of their normal functions may have unintended consequences.", "label": 0, "is_selected": 1, "text": "This report presents an overview of the current state of research into the role of macrophages in cancer therapy, and highlights some of the key areas of interest in this field.s Research has shown that macrophage-associated macrophages (TAMs) can promote tumor immune suppression, and tumor growth, making them an attractive target for cancer therapy."}
{"qid": "5aacd83ffcf4565872000008", "original_text": "Olaparib is an FDA-approved PARP inhibitor (PARPi) that has shown promise as a synthetic lethal treatment approach for BRCA-mutant castration-resistant prostate cancer (CRPC) in clinical use. However, emerging data have also shown that even BRCA-mutant cells may be resistant to PARPi. The mechanistic basis for these drug resistances is poorly understood. Polo-like kinase 1 (Plk1), a critical regulator of many cell-cycle events, is significantly elevated upon castration of mice carrying xenograft prostate tumors. Herein, by combination with Plk1 inhibitor BI2536, we show a robust sensitization of olaparib in 22RV1, a BRCA1-deficient CRPC cell line, as well as in CRPC xenograft tumors. Mechanistically, monotherapy with olaparib results in an override of the G1-S checkpoint, leading to high expression of Plk1, which attenuates olaparib's overall efficacy.", "label": 1, "is_selected": 0, "text": "Olaparib is an FDA-approved PARP inhibitor (PARPi) that has shown promise as a synthetic lethal treatment approach for BRCA-mutant castration-resistant prostate cancer (CRPC) in clinical use. However, emerging data have also shown that even BRCA-mutant cells may be resistant to PARPi. The mechanistic basis for these drug resistances is poorly understood. Polo-like kinase 1 (Plk1), a critical regulator of many cell-cycle events, is significantly elevated upon castration of mice carrying xenograft prostate tumors. Herein, by combination with Plk1 inhibitor BI2536, we show a robust sensitization of olaparib in 22RV1, a BRCA1-deficient CRPC cell line, as well as in CRPC xenograft tumors. Mechanistically, monotherapy with olaparib results in an override of the G1-S checkpoint, leading to high expression of Plk1, which attenuates olaparib's overall efficacy."}
{"qid": "532f55fed6d3ac6a34000036", "original_text": "Gaucher disease results, in most patients, from mutations in the gene encoding glucocerebrosidase. Mutation D409H is the third most frequent in Spanish patients, accounting for 5.7% of all mutated alleles. This allele is associated mainly with the neurological forms of the disease. Recently, homozygosity for the D409H mutation has been associated with a particular phenotype, including specific cardiovascular symptoms. Here we report a second Spanish patient bearing the D409H/D409H genotype with a very early manifestation of the disease. The patient started enzyme replacement therapy at 3 months of age. A common origin for the Spanish D409H alleles was ruled out by haplotype analysis using an internal polymorphism of the glucocerebrosidase gene and two external microsatellite markers.", "label": 1, "is_selected": 0, "text": "Gaucher disease results, in most patients, from mutations in the gene encoding glucocerebrosidase. Mutation D409H is the third most frequent in Spanish patients, accounting for 5.7% of all mutated alleles. This allele is associated mainly with the neurological forms of the disease. Recently, homozygosity for the D409H mutation has been associated with a particular phenotype, including specific cardiovascular symptoms. Here we report a second Spanish patient bearing the D409H/D409H genotype with a very early manifestation of the disease. The patient started enzyme replacement therapy at 3 months of age. A common origin for the Spanish D409H alleles was ruled out by haplotype analysis using an internal polymorphism of the glucocerebrosidase gene and two external microsatellite markers."}
{"qid": "5e46eb7a3f5415952900000d", "original_text": "The Fahn-Tolosa-Marin (FTM) scale is used to rate the severity of Parkinson's disease (PD). The scale assesses the severity of motor symptoms, including tremor, rigidity, bradykinesia (slowness of movement), and postural instability. The FTM scale ranges from 0 to 40, with higher scores indicating greater severity of symptoms. The scale has been widely used in clinical practice and research to measure the effectiveness of treatments for PD and to monitor disease progression.", "label": 0, "is_selected": 1, "text": "A scale used to assess the severity of Parkinson's disease symptoms has been developed by researchers at the University of Oxford and King's College Hospital, London, in partnership with the French National Institute for Health and Care Excellence (IHCE)."}
{"qid": "571e2beabb137a4b0c000006", "original_text": "The dorsomedial hypothalamus (DMH) plays an important role in coordinating physiological and behavioral responses to stress-related stimuli. In vertebrates, DMH serotonin (5-HT) concentrations increase rapidly in response to acute stressors or corticosterone (CORT). Recent studies suggest that CORT inhibits postsynaptic clearance of 5-HT from the extracellular fluid in the DMH by blocking organic cation transporter 3 (OCT3), a polyspecific CORT-sensitive transport protein. Because OCTs are low-affinity, high-capacity transporters, we hypothesized that CORT effects on extracellular 5-HT are most pronounced in the presence of elevated 5-HT release. We predicted that local application of CORT into the DMH would potentiate the effects of d-fenfluramine, a 5-HT-releasing agent, on extracellular 5-HT. These experiments were conducted using in vivo microdialysis in freely-moving male Sprague-Dawley rats implanted with a microdialysis probe into the medial hypothalamus (MH), which includes the DMH. In Experiment 1, rats simultaneously received intraperitoneal (i.p.) injections of 1 mg/kg D-fenfluramine or saline and either 200 ng/mL CORT or dilute ethanol (EtOH) vehicle delivered to the MH by reverse-dialysis for 40 min.", "label": 1, "is_selected": 0, "text": "The dorsomedial hypothalamus (DMH) plays an important role in coordinating physiological and behavioral responses to stress-related stimuli. In vertebrates, DMH serotonin (5-HT) concentrations increase rapidly in response to acute stressors or corticosterone (CORT). Recent studies suggest that CORT inhibits postsynaptic clearance of 5-HT from the extracellular fluid in the DMH by blocking organic cation transporter 3 (OCT3), a polyspecific CORT-sensitive transport protein. Because OCTs are low-affinity, high-capacity transporters, we hypothesized that CORT effects on extracellular 5-HT are most pronounced in the presence of elevated 5-HT release. We predicted that local application of CORT into the DMH would potentiate the effects of d-fenfluramine, a 5-HT-releasing agent, on extracellular 5-HT. These experiments were conducted using in vivo microdialysis in freely-moving male Sprague-Dawley rats implanted with a microdialysis probe into the medial hypothalamus (MH), which includes the DMH. In Experiment 1, rats simultaneously received intraperitoneal (i.p.) injections of 1 mg/kg D-fenfluramine or saline and either 200 ng/mL CORT or dilute ethanol (EtOH) vehicle delivered to the MH by reverse-dialysis for 40 min."}
{"qid": "53358cd2d6d3ac6a3400004e", "original_text": "We report a 5-year-old boy affected with the Tay syndrome, and give a review of 12 pertinent cases previously reported under various designations. The Tay syndrome is a distinct type of congenital ichthyosis characterized by a peculiar anomaly of hair growth which has been termed trichothiodystrophy.", "label": 1, "is_selected": 0, "text": "We report a 5-year-old boy affected with the Tay syndrome, and give a review of 12 pertinent cases previously reported under various designations. The Tay syndrome is a distinct type of congenital ichthyosis characterized by a peculiar anomaly of hair growth which has been termed trichothiodystrophy."}
{"qid": "5165932e298dcd4e51000059", "original_text": "The incorporation of 5-azacytosine residues into DNA causes potent inhibition of DNA (Cytosine-C5) methyltransferases. The synthesis of oligodeoxyribonucleotides incorporating single or multiple 5-aza-2'-deoxycytidine residues at precise sites was undertaken to generate an array of sequences containing the reactive 5-azacytosine base as specific target sites for enzymatic methylation. Preparation of these modified oligonucleotides requires the use of 2-(p-nitrophenyl)ethyloxycarbonyl (NPEOC) groups for the protection of exocyclic amino functions. These groups are removed under mild conditions, thus avoiding conventional protocols that are detrimental to the integrity of the 5-azacytosine ring.", "label": 1, "is_selected": 0, "text": "The incorporation of 5-azacytosine residues into DNA causes potent inhibition of DNA (Cytosine-C5) methyltransferases. The synthesis of oligodeoxyribonucleotides incorporating single or multiple 5-aza-2'-deoxycytidine residues at precise sites was undertaken to generate an array of sequences containing the reactive 5-azacytosine base as specific target sites for enzymatic methylation. Preparation of these modified oligonucleotides requires the use of 2-(p-nitrophenyl)ethyloxycarbonyl (NPEOC) groups for the protection of exocyclic amino functions. These groups are removed under mild conditions, thus avoiding conventional protocols that are detrimental to the integrity of the 5-azacytosine ring."}
{"qid": "5a9d29571d1251d03b000018", "original_text": "Currently available drugs against Alzheimer's disease (AD) target cholinergic and glutamatergic neurotransmissions without affecting the underlying disease process. Putative disease-modifying drugs are in development and target \u03b2-amyloid (A\u03b2) peptide and tau protein, the principal neurophatological hallmarks of the disease. Areas covered: Phase III clinical studies of emerging anti-A\u03b2 drugs for the treatment of AD were searched in US and EU clinical trial registries and in the medical literature until May 2016. Expert opinion: Drugs in Phase III clinical development for AD include one inhibitor of the \u03b2-secretase cleaving enzyme (BACE) (verubecestat), three anti-A\u03b2 monoclonal antibodies (solanezumab, gantenerumab, and aducanumab), an inhibitor of receptor for advanced glycation end products (RAGE) (azeliragon) and the combination of cromolyn sodium and ibuprofen (ALZT-OP1). These drugs are mainly being tested in subjects during early phases of AD or in subjects at preclinical stage of familial AD or even in asymptomatic subjects at high risk of developing AD.", "label": 1, "is_selected": 0, "text": "Currently available drugs against Alzheimer's disease (AD) target cholinergic and glutamatergic neurotransmissions without affecting the underlying disease process. Putative disease-modifying drugs are in development and target \u03b2-amyloid (A\u03b2) peptide and tau protein, the principal neurophatological hallmarks of the disease. Areas covered: Phase III clinical studies of emerging anti-A\u03b2 drugs for the treatment of AD were searched in US and EU clinical trial registries and in the medical literature until May 2016. Expert opinion: Drugs in Phase III clinical development for AD include one inhibitor of the \u03b2-secretase cleaving enzyme (BACE) (verubecestat), three anti-A\u03b2 monoclonal antibodies (solanezumab, gantenerumab, and aducanumab), an inhibitor of receptor for advanced glycation end products (RAGE) (azeliragon) and the combination of cromolyn sodium and ibuprofen (ALZT-OP1). These drugs are mainly being tested in subjects during early phases of AD or in subjects at preclinical stage of familial AD or even in asymptomatic subjects at high risk of developing AD."}
{"qid": "56c1f000ef6e394741000037", "original_text": "Trifluridine (TFT) is an antitumor component of a novel nucleoside antitumor agent, TAS-102, which consists of TFT and tipiracil hydrochloride (thymidine phosphorylase inhibitor). Incorporation of TFT into DNA is a probable mechanism of antitumor activity and hematological toxicity. The objective of this study was to examine the TFT incorporation into tumor- and white blood cell-DNA, and to elucidate the mechanism of TFT-related effect and toxicity. TFT effect on the colony formation of mouse bone marrow cells was also investigated.", "label": 1, "is_selected": 0, "text": "Trifluridine (TFT) is an antitumor component of a novel nucleoside antitumor agent, TAS-102, which consists of TFT and tipiracil hydrochloride (thymidine phosphorylase inhibitor). Incorporation of TFT into DNA is a probable mechanism of antitumor activity and hematological toxicity. The objective of this study was to examine the TFT incorporation into tumor- and white blood cell-DNA, and to elucidate the mechanism of TFT-related effect and toxicity. TFT effect on the colony formation of mouse bone marrow cells was also investigated."}
{"qid": "5c8c095e0101eac870000002", "original_text": "Lactotransferrin is a glycoprotein protein produced by cells in the body, particularly by cells in the liver and bone marrow. These cells secrete lactotransferrin into the bloodstream, where it can be transported to other tissues and organs. Specifically, the liver is the primary site of lactotransferrin synthesis and secretion, with the liver producing approximately 75% of the body's total lactotransferrin. The bone marrow is also a significant site of lactotransferrin production, producing around 20% of the body's total lactotransferrin. Other cells, such as the kidneys, also produce smaller amounts of lactotransferrin.", "label": 0, "is_selected": 0, "text": "Lactotransferrin is a glycoprotein protein produced by cells in the body, particularly by cells in the liver and bone marrow. These cells secrete lactotransferrin into the bloodstream, where it can be transported to other tissues and organs. Specifically, the liver is the primary site of lactotransferrin synthesis and secretion, with the liver producing approximately 75% of the body's total lactotransferrin. The bone marrow is also a significant site of lactotransferrin production, producing around 20% of the body's total lactotransferrin. Other cells, such as the kidneys, also produce smaller amounts of lactotransferrin."}
{"qid": "5c5410647e3cb0e23100001e", "original_text": "Although essential for epigenetic inheritance, the transfer of parental histone (H3-H4)2 tetramers that contain epigenetic modifications to replicating DNA strands is poorly understood. Here, we show that the Mcm2-Ctf4-Pol\u03b1 axis facilitates the transfer of parental (H3-H4)2 tetramers to lagging-strand DNA at replication forks. Mutating the conserved histone-binding domain of the Mcm2 subunit of the CMG (Cdc45-MCM-GINS) DNA helicase, which translocates along the leading-strand template, results in a marked enrichment of parental (H3-H4)2 on leading strand, due to the impairment of the transfer of parental (H3-H4)2 to lagging strands.", "label": 1, "is_selected": 0, "text": "Although essential for epigenetic inheritance, the transfer of parental histone (H3-H4)2 tetramers that contain epigenetic modifications to replicating DNA strands is poorly understood. Here, we show that the Mcm2-Ctf4-Pol\u03b1 axis facilitates the transfer of parental (H3-H4)2 tetramers to lagging-strand DNA at replication forks. Mutating the conserved histone-binding domain of the Mcm2 subunit of the CMG (Cdc45-MCM-GINS) DNA helicase, which translocates along the leading-strand template, results in a marked enrichment of parental (H3-H4)2 on leading strand, due to the impairment of the transfer of parental (H3-H4)2 to lagging strands."}
{"qid": "5e47612035b8f0833c000003", "original_text": "Idiopathic toe walking, also known as idiopathic gait disturbances, is a condition characterized by an abnormal gait pattern, where the individual walks on their toes without any apparent reason or underlying cause. It is estimated to affect approximately 1 in 500 children and is more common in males than females. The exact cause of idiopathic toe walking is not known, but it is believed to be related to a combination of genetic and neurological factors. Some studies suggest that it may be associated with certain gene mutations, while others have found evidence of abnormalities in the brain regions responsible for controlling movement and balance. The symptoms of idiopathic toe walking typically become apparent during early childhood, around 2-3 years of age, and may persist into adulthood in some cases. The individual may walk on their toes exclusively, or they may alternate between walking on their toes and heels. The condition can also cause difficulty with balance and coordination, leading to an increased risk of falls. While there is no cure for idiopathic toe walking, treatment options are available to help manage the symptoms. These may include physical therapy to improve balance and coordination, orthotics or braces to support the feet, and in some cases, medication to help relax the muscles and improves balance. In severe cases, surgery may be considered to realign the bones in the feet and ankles. It's important to consult a healthcare professional if you suspect your child may have idiopathic toe walking, as early diagnosis and treatment can help improve the chances of successful management and reduce the risk of complications.", "label": 0, "is_selected": 0, "text": "Idiopathic toe walking, also known as idiopathic gait disturbances, is a condition characterized by an abnormal gait pattern, where the individual walks on their toes without any apparent reason or underlying cause. It is estimated to affect approximately 1 in 500 children and is more common in males than females. The exact cause of idiopathic toe walking is not known, but it is believed to be related to a combination of genetic and neurological factors. Some studies suggest that it may be associated with certain gene mutations, while others have found evidence of abnormalities in the brain regions responsible for controlling movement and balance. The symptoms of idiopathic toe walking typically become apparent during early childhood, around 2-3 years of age, and may persist into adulthood in some cases. The individual may walk on their toes exclusively, or they may alternate between walking on their toes and heels. The condition can also cause difficulty with balance and coordination, leading to an increased risk of falls. While there is no cure for idiopathic toe walking, treatment options are available to help manage the symptoms. These may include physical therapy to improve balance and coordination, orthotics or braces to support the feet, and in some cases, medication to help relax the muscles and improves balance. In severe cases, surgery may be considered to realign the bones in the feet and ankles. It's important to consult a healthcare professional if you suspect your child may have idiopathic toe walking, as early diagnosis and treatment can help improve the chances of successful management and reduce the risk of complications."}
{"qid": "5ca0fdb0ecadf2e73f000049", "original_text": "While actin was discovered in the nucleus over 50 years ago, research lagged for decades due to strong skepticism. The revitalization of research into nuclear actin occurred after it was found that cellular stresses induce the nuclear localization and alter the structure of actin. These studies provided the first hints that actin has a nuclear function.", "label": 1, "is_selected": 0, "text": "While actin was discovered in the nucleus over 50 years ago, research lagged for decades due to strong skepticism. The revitalization of research into nuclear actin occurred after it was found that cellular stresses induce the nuclear localization and alter the structure of actin. These studies provided the first hints that actin has a nuclear function."}
{"qid": "5e48b9abd14c9f295d000015", "original_text": "Multipotent adult progenitor cells are a bone marrow-derived, allogeneic, cell therapy product that modulates the immune system, and represents a promising therapy for acute stroke. We aimed to identify the highest, well-tolerated, and safest single dose of multipotent adult progenitor cells, and if they were efficacious as a treatment for stroke recovery. We did a phase 2, randomised, double-blind, placebo-controlled, dose-escalation trial of intravenous multipotent adult progenitor cells in 33 centres in the UK and the USA. We used a computer-generated randomisation sequence and interactive voice and web response system to assign patients aged 18-83 years with moderately severe acute ischaemic stroke and a National Institutes of Health Stroke Scale (NIHSS) score of 8-20 to treatment with intravenous multipotent adult progenitor cells (400 million or 1200 million cells) or placebo between 24 h and 48 h after symptom onset. Patients were ineligible if there was a change in NIHSS of four or more points during at least a 6 h period between screening and randomisation, had brainstem or lacunar infarct, a substantial comorbid disease, an inability to undergo an MRI scan, or had a history of splenectomy. In group 1, patients were enrolled and randomly assigned in a 3:1 ratio to receive 400 million cells or placebo and assessed for safety through 7 days. In group 2, patients were randomly assigned in a 3:1 ratio to receive 1200 million cells or placebo and assessed for safety through the first 7 days. In group 3, patients were enrolled, randomly assigned, and stratified by baseline NIHSS score to receive 1200 million cells or placebo in a 1:1 ratio within 24-48 h. Patients, investigators, and clinicians were masked to treatment assignment. The primary safety outcome was dose-limiting toxicity effects. The primary efficacy endpoint was global stroke recovery, which combines dichotomised results from the modified Rankin scale, change in NIHSS score from baseline, and Barthel index at day 90. Analysis was by intention to treat (ITT) including all patients in groups 2 and 3 who received the investigational agent or placebo. This study is registered with ClinicalTrials.gov, number NCT01436487. The study was done between Oct 24, 2011, and Dec 7, 2015. After safety assessments in eight patients in group 1, 129 patients were randomly assigned (67 to receive multipotent adult progenitor cells and 62 to receive placebo) in groups 2 and 3 (1200 million cells). The ITT populations consisted of 65 patients who received multipotent adult progenitor cells and 61 patients who received placebo. There were no dose-limiting toxicity events in either group.", "label": 1, "is_selected": 0, "text": "Multipotent adult progenitor cells are a bone marrow-derived, allogeneic, cell therapy product that modulates the immune system, and represents a promising therapy for acute stroke. We aimed to identify the highest, well-tolerated, and safest single dose of multipotent adult progenitor cells, and if they were efficacious as a treatment for stroke recovery. We did a phase 2, randomised, double-blind, placebo-controlled, dose-escalation trial of intravenous multipotent adult progenitor cells in 33 centres in the UK and the USA. We used a computer-generated randomisation sequence and interactive voice and web response system to assign patients aged 18-83 years with moderately severe acute ischaemic stroke and a National Institutes of Health Stroke Scale (NIHSS) score of 8-20 to treatment with intravenous multipotent adult progenitor cells (400 million or 1200 million cells) or placebo between 24 h and 48 h after symptom onset. Patients were ineligible if there was a change in NIHSS of four or more points during at least a 6 h period between screening and randomisation, had brainstem or lacunar infarct, a substantial comorbid disease, an inability to undergo an MRI scan, or had a history of splenectomy. In group 1, patients were enrolled and randomly assigned in a 3:1 ratio to receive 400 million cells or placebo and assessed for safety through 7 days. In group 2, patients were randomly assigned in a 3:1 ratio to receive 1200 million cells or placebo and assessed for safety through the first 7 days. In group 3, patients were enrolled, randomly assigned, and stratified by baseline NIHSS score to receive 1200 million cells or placebo in a 1:1 ratio within 24-48 h. Patients, investigators, and clinicians were masked to treatment assignment. The primary safety outcome was dose-limiting toxicity effects. The primary efficacy endpoint was global stroke recovery, which combines dichotomised results from the modified Rankin scale, change in NIHSS score from baseline, and Barthel index at day 90. Analysis was by intention to treat (ITT) including all patients in groups 2 and 3 who received the investigational agent or placebo. This study is registered with ClinicalTrials.gov, number NCT01436487. The study was done between Oct 24, 2011, and Dec 7, 2015. After safety assessments in eight patients in group 1, 129 patients were randomly assigned (67 to receive multipotent adult progenitor cells and 62 to receive placebo) in groups 2 and 3 (1200 million cells). The ITT populations consisted of 65 patients who received multipotent adult progenitor cells and 61 patients who received placebo. There were no dose-limiting toxicity events in either group."}
{"qid": "56d1d14567f0cb3d66000003", "original_text": "The chemical modification of histones at specific DNA regulatory elements is linked to the activation, inactivation and poising of genes. A number of tools exist to predict enhancers from chromatin modification maps, but their practical application is limited because they either (i) consider a smaller number of marks than those necessary to define the various enhancer classes or (ii) work with an excessive number of marks, which is experimentally unviable. We have developed a method for chromatin state detection using support vector machines in combination with genetic algorithm optimization, called ChromaGenSVM. ChromaGenSVM selects optimum combinations of specific histone epigenetic marks to predict enhancers. In an independent test, ChromaGenSVM recovered 88% of the experimentally supported enhancers in the pilot ENCODE region of interferon gamma-treated HeLa cells. Furthermore, ChromaGenSVM successfully combined the profiles of only five distinct methylation and acetylation marks from ChIP-seq libraries done in human CD4(+)", "label": 1, "is_selected": 0, "text": "The chemical modification of histones at specific DNA regulatory elements is linked to the activation, inactivation and poising of genes. A number of tools exist to predict enhancers from chromatin modification maps, but their practical application is limited because they either (i) consider a smaller number of marks than those necessary to define the various enhancer classes or (ii) work with an excessive number of marks, which is experimentally unviable. We have developed a method for chromatin state detection using support vector machines in combination with genetic algorithm optimization, called ChromaGenSVM. ChromaGenSVM selects optimum combinations of specific histone epigenetic marks to predict enhancers. In an independent test, ChromaGenSVM recovered 88% of the experimentally supported enhancers in the pilot ENCODE region of interferon gamma-treated HeLa cells. Furthermore, ChromaGenSVM successfully combined the profiles of only five distinct methylation and acetylation marks from ChIP-seq libraries done in human CD4(+)"}
{"qid": "5ac37afc0340b9f058000002", "original_text": "A central goal of evolutionary biology is to understand the genetic origin of morphological novelties-i.e. anatomical structures unique to a taxonomic group. Elaboration of morphology during development depends on networks of regulatory genes that activate patterned gene expression through transcriptional enhancer regions. We summarize recent case studies and genome-wide investigations that have uncovered diverse mechanisms though which new enhancers arise. We also discuss how these enhancer-originating mechanisms have clarified the history of genetic networks underlying diversification of genital structures in flies, limbs and neural crest in chordates, and plant leaves.", "label": 1, "is_selected": 0, "text": "A central goal of evolutionary biology is to understand the genetic origin of morphological novelties-i.e. anatomical structures unique to a taxonomic group. Elaboration of morphology during development depends on networks of regulatory genes that activate patterned gene expression through transcriptional enhancer regions. We summarize recent case studies and genome-wide investigations that have uncovered diverse mechanisms though which new enhancers arise. We also discuss how these enhancer-originating mechanisms have clarified the history of genetic networks underlying diversification of genital structures in flies, limbs and neural crest in chordates, and plant leaves."}
{"qid": "5148e1d6d24251bc0500003a", "original_text": "A Chinese family affected with autosomal dominant disorder-neurofibromatosis type I was identified in this study. Linkage analysis was performed, and DNA sequencing for whole coding region of NF1 was carried out to identify the disease-causing mutation. The disease gene of the Chinese NF1 family was linked to NF1 locus, and a nonsense mutation, G1336X in the NF1 gene was identified.", "label": 1, "is_selected": 0, "text": "A Chinese family affected with autosomal dominant disorder-neurofibromatosis type I was identified in this study. Linkage analysis was performed, and DNA sequencing for whole coding region of NF1 was carried out to identify the disease-causing mutation. The disease gene of the Chinese NF1 family was linked to NF1 locus, and a nonsense mutation, G1336X in the NF1 gene was identified."}
{"qid": "517151f28ed59a060a000008", "original_text": "The correlation between SPARC expression and growth inhibition in human cancer is complex and context-dependent. SPARC (secreted protein, acidic, rich in cysteine) is a secreted protein that has been shown to inhibit cell growth and induce apoptosis (programmed cell death) in various types of cancer, including breast, lung, and colon cancer. High levels of SPARC expression have been associated with decreased cancer cell proliferation, migration, and invasion, as well as improved overall survival. However, the mechanism by which SPARC inhibits cancer growth is still not fully understood and may involve multiple signaling pathways. In summary, SPARC expression appears to be inversely correlated with cancer cell growth, suggesting a potential role for SPARC as a tumor suppressor in human cancer.", "label": 0, "is_selected": 0, "text": "The correlation between SPARC expression and growth inhibition in human cancer is complex and context-dependent. SPARC (secreted protein, acidic, rich in cysteine) is a secreted protein that has been shown to inhibit cell growth and induce apoptosis (programmed cell death) in various types of cancer, including breast, lung, and colon cancer. High levels of SPARC expression have been associated with decreased cancer cell proliferation, migration, and invasion, as well as improved overall survival. However, the mechanism by which SPARC inhibits cancer growth is still not fully understood and may involve multiple signaling pathways. In summary, SPARC expression appears to be inversely correlated with cancer cell growth, suggesting a potential role for SPARC as a tumor suppressor in human cancer."}
{"qid": "5e3daf7648dab47f26000005", "original_text": "There is no consensus as to which ileoanal pouch design provides better outcomes after restorative proctocolectomy. This study compares different pouch designs. A systematic review of the literature was performed. A random effects meta-analytical model was used to compare adverse events and functional outcome. Thirty comparative studies comparing J, W, S and K pouch designs were included. No significant differences were identified between the different pouch designs with regard to anastomotic dehiscence, anastomotic stricture, pelvic sepsis, wound infection, pouch fistula, pouch ischaemia, perioperative haemorrhage, small bowel obstruction, pouchitis and sexual dysfunction. The W and K designs resulted in fewer cases of pouch failure compared with the J and S designs. J pouch construction resulted in a smaller maximum pouch volume compared with W and K pouches. Stool frequency per 24 h and during daytime was higher following a J pouch than W, S or K constructions. The J design resulted in increased faecal urgency and seepage during daytime compared with the K design. The use of protective pads during daytime and night-time was greater with a J pouch compared to S or K. The use of antidiarrhoeal medication was greater after a J reservoir than a W reservoir. Difficulty in pouch evacuation requiring intubation was higher with an S pouch than with W or J pouches. Despite its ease of construction and comparable complication rates, the J pouch is associated with higher pouch failure rates and worse function.", "label": 1, "is_selected": 0, "text": "There is no consensus as to which ileoanal pouch design provides better outcomes after restorative proctocolectomy. This study compares different pouch designs. A systematic review of the literature was performed. A random effects meta-analytical model was used to compare adverse events and functional outcome. Thirty comparative studies comparing J, W, S and K pouch designs were included. No significant differences were identified between the different pouch designs with regard to anastomotic dehiscence, anastomotic stricture, pelvic sepsis, wound infection, pouch fistula, pouch ischaemia, perioperative haemorrhage, small bowel obstruction, pouchitis and sexual dysfunction. The W and K designs resulted in fewer cases of pouch failure compared with the J and S designs. J pouch construction resulted in a smaller maximum pouch volume compared with W and K pouches. Stool frequency per 24 h and during daytime was higher following a J pouch than W, S or K constructions. The J design resulted in increased faecal urgency and seepage during daytime compared with the K design. The use of protective pads during daytime and night-time was greater with a J pouch compared to S or K. The use of antidiarrhoeal medication was greater after a J reservoir than a W reservoir. Difficulty in pouch evacuation requiring intubation was higher with an S pouch than with W or J pouches. Despite its ease of construction and comparable complication rates, the J pouch is associated with higher pouch failure rates and worse function."}
{"qid": "5a6d0b2db750ff445500002d", "original_text": "During DNA replication termination and mitosis, the replisome, a complex of proteins and nucleic acids that carries out DNA replication, undergoes disassembly. This process is driven by several factors, including the binding of the leading strand fork migration factor, SCFD, to the replisome, the release of the replisome from the template, and the degradation of the replisome component, RPA. Additionally, the binding of proteins such as the minichromosome maintenance (MCM) complex and the origin recognition complex (ORC) can also contribute to replisome disassembly.", "label": 0, "is_selected": 0, "text": "During DNA replication termination and mitosis, the replisome, a complex of proteins and nucleic acids that carries out DNA replication, undergoes disassembly. This process is driven by several factors, including the binding of the leading strand fork migration factor, SCFD, to the replisome, the release of the replisome from the template, and the degradation of the replisome component, RPA. Additionally, the binding of proteins such as the minichromosome maintenance (MCM) complex and the origin recognition complex (ORC) can also contribute to replisome disassembly."}
{"qid": "5abcf0b0fcf4565872000024", "original_text": "Leishmaniasis is caused by a parasitic infection with the Leishmania protozoa, which is transmitted through the bite of an infected sandfly. There are several different forms of leishmaniasis, including cutaneous, visceral, and mucocutaneous, each with different causes and risk factors. Cutaneous leishmaniasis is typically caused by Leishmania tropica or Leishmania aethiopica, while visceral leishmaniasis is caused by Leishmania donovani. The parasite enters the body through the bite of an infected sandfly and causes inflammation and damage to the affected tissues.", "label": 0, "is_selected": 0, "text": "Leishmaniasis is caused by a parasitic infection with the Leishmania protozoa, which is transmitted through the bite of an infected sandfly. There are several different forms of leishmaniasis, including cutaneous, visceral, and mucocutaneous, each with different causes and risk factors. Cutaneous leishmaniasis is typically caused by Leishmania tropica or Leishmania aethiopica, while visceral leishmaniasis is caused by Leishmania donovani. The parasite enters the body through the bite of an infected sandfly and causes inflammation and damage to the affected tissues."}
{"qid": "56f802ea09dd18d46b000017", "original_text": "Adaptive metabolic reprogramming gives cancer cells a proliferative advantage. Tumour cells extensively use glycolysis to sustain anabolism and produce serine, which not only refuels the one-carbon units necessary for the synthesis of nucleotide precursors and for DNA methylation, but also affects the cellular redox homeostasis. Given its central role in serine metabolism, serine hydroxymethyltransferase (SHMT), a pyridoxal 5'-phosphate (PLP)-dependent enzyme, is an attractive target for tumour chemotherapy. In humans, the cytosolic isoform (SHMT1) and the mitochondrial isoform (SHMT2) have distinct cellular roles, but high sequence identity and comparable catalytic properties, which may complicate development of successful therapeutic strategies. Here, we investigated how binding of the cofactor PLP controls the oligomeric state of the human isoforms. The fact that eukaryotic SHMTs are tetrameric proteins while bacterial SHMTs function as dimers may suggest that the quaternary assembly in eukaryotes provides an advantage to fine-tune SHMT function and differentially regulate intertwined metabolic fluxes, and may provide a tool to address the specificity problem. We determined the crystal structure of SHMT2, and compared it to the apo-enzyme structure, showing that PLP binding triggers a disorder-to-order transition accompanied by a large rigid-body movement of the two cofactor-binding domains. Moreover, we demonstrated that SHMT1 exists in solution as a tetramer, both in the absence and presence of PLP, while SHMT2 undergoes a dimer-to-tetramer transition upon PLP binding. These findings indicate an unexpected structural difference between the two human SHMT isoforms, which opens new perspectives for understanding their differing behaviours, roles or regulation mechanisms in response to PLP availability in vivo.", "label": 1, "is_selected": 0, "text": "Adaptive metabolic reprogramming gives cancer cells a proliferative advantage. Tumour cells extensively use glycolysis to sustain anabolism and produce serine, which not only refuels the one-carbon units necessary for the synthesis of nucleotide precursors and for DNA methylation, but also affects the cellular redox homeostasis. Given its central role in serine metabolism, serine hydroxymethyltransferase (SHMT), a pyridoxal 5'-phosphate (PLP)-dependent enzyme, is an attractive target for tumour chemotherapy. In humans, the cytosolic isoform (SHMT1) and the mitochondrial isoform (SHMT2) have distinct cellular roles, but high sequence identity and comparable catalytic properties, which may complicate development of successful therapeutic strategies. Here, we investigated how binding of the cofactor PLP controls the oligomeric state of the human isoforms. The fact that eukaryotic SHMTs are tetrameric proteins while bacterial SHMTs function as dimers may suggest that the quaternary assembly in eukaryotes provides an advantage to fine-tune SHMT function and differentially regulate intertwined metabolic fluxes, and may provide a tool to address the specificity problem. We determined the crystal structure of SHMT2, and compared it to the apo-enzyme structure, showing that PLP binding triggers a disorder-to-order transition accompanied by a large rigid-body movement of the two cofactor-binding domains. Moreover, we demonstrated that SHMT1 exists in solution as a tetramer, both in the absence and presence of PLP, while SHMT2 undergoes a dimer-to-tetramer transition upon PLP binding. These findings indicate an unexpected structural difference between the two human SHMT isoforms, which opens new perspectives for understanding their differing behaviours, roles or regulation mechanisms in response to PLP availability in vivo."}
{"qid": "533eba45c45e133714000014", "original_text": "Placental extracts have been reported to have anti-oxidative and anti-inflammatory activities. Because there is increasing evidence that ionizing radiation induces the release of reactive oxygen species (ROS) and inflammatory cytokines, we examined the protective effects of a placental extract against radiation injury. C57BL/6 mice were exposed to 1 Gy of \u03b3-ray radiation every day for 5 days, and placental extract (1 mg/day) was administrated orally soon after each exposure. At 2 days after the last irradiation, mice were euthanized to examine the numbers, colony-forming capacity, and DNA damage of stem/progenitor cells in the peripheral blood and bone marrow. To understand the related mechanisms, we also measured the levels of intracellular and mitochondrial ROS, and 8-OHdG in the plasma and urine, and IL-6 and TNF-\u03b1 in the plasma.", "label": 1, "is_selected": 0, "text": "Placental extracts have been reported to have anti-oxidative and anti-inflammatory activities. Because there is increasing evidence that ionizing radiation induces the release of reactive oxygen species (ROS) and inflammatory cytokines, we examined the protective effects of a placental extract against radiation injury. C57BL/6 mice were exposed to 1 Gy of \u03b3-ray radiation every day for 5 days, and placental extract (1 mg/day) was administrated orally soon after each exposure. At 2 days after the last irradiation, mice were euthanized to examine the numbers, colony-forming capacity, and DNA damage of stem/progenitor cells in the peripheral blood and bone marrow. To understand the related mechanisms, we also measured the levels of intracellular and mitochondrial ROS, and 8-OHdG in the plasma and urine, and IL-6 and TNF-\u03b1 in the plasma."}
{"qid": "6025a1e91cb411341a0000b4", "original_text": "In light of the recent emergence of new therapeutics for rheumatoid arthritis, such as kinase inhibitors and biosimilars, a new nomenclature for disease-modifying antirheumatic drugs (DMARDs), which are currently often classified as synthetic (or chemical) DMARDs (sDMARDS) and biological DMARDs (bDMARDs), may be needed. We propose to divide the latter into biological original and biosimilar DMARDs (boDMARDs and bsDMARDs, respectively, such as abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, rituximab or tocilizumab, but also emerging ones like clazakizumab, ixekizumab, sarilumab, secukinumab or sirukumab) and the former into conventional synthetic and targeted synthetic DMARDs (csDMARDs and tsDMARDs, respectively). tsDMARDs would then constitute only those that were specifically developed to target a particular molecular structure (such as tofacitinib, fostamatinib, baricitinib or apremilast, or agents not focused primarily on rheumatic diseases, such as imatinib or ibrutinib), while csDMARDs would comprise the traditional drugs (such as methotrexate, sulfasalazine, leflunomide, hydroxychloroquine, gold salts and others).", "label": 1, "is_selected": 0, "text": "In light of the recent emergence of new therapeutics for rheumatoid arthritis, such as kinase inhibitors and biosimilars, a new nomenclature for disease-modifying antirheumatic drugs (DMARDs), which are currently often classified as synthetic (or chemical) DMARDs (sDMARDS) and biological DMARDs (bDMARDs), may be needed. We propose to divide the latter into biological original and biosimilar DMARDs (boDMARDs and bsDMARDs, respectively, such as abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, rituximab or tocilizumab, but also emerging ones like clazakizumab, ixekizumab, sarilumab, secukinumab or sirukumab) and the former into conventional synthetic and targeted synthetic DMARDs (csDMARDs and tsDMARDs, respectively). tsDMARDs would then constitute only those that were specifically developed to target a particular molecular structure (such as tofacitinib, fostamatinib, baricitinib or apremilast, or agents not focused primarily on rheumatic diseases, such as imatinib or ibrutinib), while csDMARDs would comprise the traditional drugs (such as methotrexate, sulfasalazine, leflunomide, hydroxychloroquine, gold salts and others)."}
{"qid": "517a8bef8ed59a060a000041", "original_text": "Skeletal muscle contains several types of deiodinases, which play a crucial role in regulating thyroid hormone metabolism. The main deiodinases present in skeletal muscle are: 1. Type 1 iodothyronine deiodinase (D1): This enzyme is responsible for converting T4 to T3 within skeletal muscle. 2. Type 2 iodothyronine deiodinase (D2): D2 is involved in the conversion of both T4 and T3 to reverse T3 (rT3) in skeletal muscle. 3. Triiodothyronine-induced deiodinase (TID): TID is a recently identified deiodinase that is primarily activated by T3 and involved in the regulation of T3 levels in skeletal muscle. It is worth noting that the relative abundance of these deiodinases in skeletal muscle can vary depending on factors such as age, gender, and disease status. Therefore, understanding the specific distribution and function of each deiodinase in skeletal muscle is crucial for understanding the regulation of thyroid hormone metabolism in this tissue.", "label": 0, "is_selected": 0, "text": "Skeletal muscle contains several types of deiodinases, which play a crucial role in regulating thyroid hormone metabolism. The main deiodinases present in skeletal muscle are: 1. Type 1 iodothyronine deiodinase (D1): This enzyme is responsible for converting T4 to T3 within skeletal muscle. 2. Type 2 iodothyronine deiodinase (D2): D2 is involved in the conversion of both T4 and T3 to reverse T3 (rT3) in skeletal muscle. 3. Triiodothyronine-induced deiodinase (TID): TID is a recently identified deiodinase that is primarily activated by T3 and involved in the regulation of T3 levels in skeletal muscle. It is worth noting that the relative abundance of these deiodinases in skeletal muscle can vary depending on factors such as age, gender, and disease status. Therefore, understanding the specific distribution and function of each deiodinase in skeletal muscle is crucial for understanding the regulation of thyroid hormone metabolism in this tissue."}
{"qid": "58add7699ef3c34033000009", "original_text": "Eukaryotic RNA polymerase II transcribes precursors of mRNAs and of non-protein-coding RNAs such as snRNAs and snoRNAs. These RNAs have to be processed at their 3' ends to be functional. mRNAs are matured by cleavage and polyadenylation that require a well-characterized protein complex. Small RNAs are also subject to 3' end cleavage but are not polyadenylated. Here we show that two newly identified proteins, Pti1p and Ref2p, although they were found associated with the pre-mRNA 3' end processing complex, are essential for yeast", "label": 1, "is_selected": 0, "text": "Eukaryotic RNA polymerase II transcribes precursors of mRNAs and of non-protein-coding RNAs such as snRNAs and snoRNAs. These RNAs have to be processed at their 3' ends to be functional. mRNAs are matured by cleavage and polyadenylation that require a well-characterized protein complex. Small RNAs are also subject to 3' end cleavage but are not polyadenylated. Here we show that two newly identified proteins, Pti1p and Ref2p, although they were found associated with the pre-mRNA 3' end processing complex, are essential for yeast"}
{"qid": "533c2230c45e133714000002", "original_text": "Tripartite motif (TRIM)-containing proteins, which are defined by the presence of a common domain structure composed of a RING finger, one or two B-box motifs and a coiled-coil motif, are involved in many biological processes including innate immunity, viral infection, carcinogenesis, and development. Here we show that TRIM67, which has a TRIM motif, an FN3 domain and a SPRY domain, is highly expressed in the cerebellum and that TRIM67 interacts with PRG-1 and 80K-H, which is involved in the Ras-mediated signaling pathway.", "label": 1, "is_selected": 0, "text": "Tripartite motif (TRIM)-containing proteins, which are defined by the presence of a common domain structure composed of a RING finger, one or two B-box motifs and a coiled-coil motif, are involved in many biological processes including innate immunity, viral infection, carcinogenesis, and development. Here we show that TRIM67, which has a TRIM motif, an FN3 domain and a SPRY domain, is highly expressed in the cerebellum and that TRIM67 interacts with PRG-1 and 80K-H, which is involved in the Ras-mediated signaling pathway."}
{"qid": "6251465ae764a53204000017", "original_text": "Phospholemman (Phospholipid Protein Lemur) is a transmembrane protein that spans the cell membrane and plays a crucial role in regulating the structure and function of cell membranes. It is a 32-34 kDa protein that is composed of an N-terminal transmembrane domain, a coiled-coil domain, and a C-terminal cytoplasmic tail. Phospholemman is primarily involved in regulating the organization of lipids in the cell membrane and maintaining the structural integrity of the membrane. Therefore, it can be classified as a membrane protein.", "label": 0, "is_selected": 0, "text": "Phospholemman (Phospholipid Protein Lemur) is a transmembrane protein that spans the cell membrane and plays a crucial role in regulating the structure and function of cell membranes. It is a 32-34 kDa protein that is composed of an N-terminal transmembrane domain, a coiled-coil domain, and a C-terminal cytoplasmic tail. Phospholemman is primarily involved in regulating the organization of lipids in the cell membrane and maintaining the structural integrity of the membrane. Therefore, it can be classified as a membrane protein."}
{"qid": "58d8e9bd8acda3452900000b", "original_text": "Barth syndrome is an X-linked disorder usually diagnosed in infancy. It is characterized by hypotonia, dilated cardiomyopathy, neutropenia, growth retardation, and 3-methylglutaconic aciduria. The syndrome is typically caused by mutations in the TAZ (G4.5) gene, which encodes a novel protein family called the tafazzins. We report the case of two brothers with Barth syndrome and left ventricular noncompaction (LVNC) caused by a splice donor mutation in TAZ. Both had impaired sucking ability at the age of 2 months. The elder brother was diagnosed with LVNC at the age of 4 months; by that time he had developed severe heart failure with metabolic decompensation.", "label": 1, "is_selected": 0, "text": "Barth syndrome is an X-linked disorder usually diagnosed in infancy. It is characterized by hypotonia, dilated cardiomyopathy, neutropenia, growth retardation, and 3-methylglutaconic aciduria. The syndrome is typically caused by mutations in the TAZ (G4.5) gene, which encodes a novel protein family called the tafazzins. We report the case of two brothers with Barth syndrome and left ventricular noncompaction (LVNC) caused by a splice donor mutation in TAZ. Both had impaired sucking ability at the age of 2 months. The elder brother was diagnosed with LVNC at the age of 4 months; by that time he had developed severe heart failure with metabolic decompensation."}
{"qid": "5e52a7b66d0a277941000045", "original_text": "A tool developed for prediction of single-cell DNA methylation states using deep learning is the'scmCpG' model. This tool utilizes a deep neural network to predict the methylation status of CpG dinucleotides in single cells based on the sequence context of the CpG sites. The model was trained on a large dataset of methylation profiles from various cell types and has been shown to accurately predict methylation states in new samples.", "label": 0, "is_selected": 1, "text": "Researchers at the University of Bristol have developed a new tool to predict single-cell DNA states using deep learning, which is a branch of computer science that uses machine learning to learn from large amounts of unstructured data, such as DNA sequences and RNA sequences."}
{"qid": "60274a2a1cb411341a0000e2", "original_text": "Narcolepsy is a disabling sleep-wake disorder characterized by the pentad symptoms of excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and cataplexy. There is no curative therapy for narcolepsy. Treatment is therefore symptom directed. Symptom management is generally directed at improving excessive daytime sleepiness, sleep fragmentation, and cataplexy. First-line treatment for excessive daytime sleepiness is typically daily use of wake-promoting agents, such as modafinil or armodafinil, or stimulant therapy, such as methylphenidate or amphetamines. Alternatively, sodium oxybate can be used nightly for improved cataplexy, sleep consolidation, and following day wakefulness. These therapies can be limited in some patients because of inadequate efficacy, poor tolerability, or side effects. We describe five narcolepsy patients with severe excessive daytime sleepiness who had an inadequate response or experienced side effects with the initial therapies but had a positive response to treatment with baclofen. These patients reported subjective improvement in sleep maintenance without fragmentation and daytime sleepiness. Average Epworth Sleepiness Scale assessment before treatment was 15.8 with post-treatment assessment being 10.4 (P < 0.05). Baclofen may be an effective treatment for excessive daytime sleepiness and sleep fragmentation in narcolepsy and warrants further study.", "label": 1, "is_selected": 0, "text": "Narcolepsy is a disabling sleep-wake disorder characterized by the pentad symptoms of excessive daytime sleepiness, sleep paralysis, sleep fragmentation, sleep-related hallucinations, and cataplexy. There is no curative therapy for narcolepsy. Treatment is therefore symptom directed. Symptom management is generally directed at improving excessive daytime sleepiness, sleep fragmentation, and cataplexy. First-line treatment for excessive daytime sleepiness is typically daily use of wake-promoting agents, such as modafinil or armodafinil, or stimulant therapy, such as methylphenidate or amphetamines. Alternatively, sodium oxybate can be used nightly for improved cataplexy, sleep consolidation, and following day wakefulness. These therapies can be limited in some patients because of inadequate efficacy, poor tolerability, or side effects. We describe five narcolepsy patients with severe excessive daytime sleepiness who had an inadequate response or experienced side effects with the initial therapies but had a positive response to treatment with baclofen. These patients reported subjective improvement in sleep maintenance without fragmentation and daytime sleepiness. Average Epworth Sleepiness Scale assessment before treatment was 15.8 with post-treatment assessment being 10.4 (P < 0.05). Baclofen may be an effective treatment for excessive daytime sleepiness and sleep fragmentation in narcolepsy and warrants further study."}
{"qid": "56c036afef6e394741000019", "original_text": "Larvae of the caterpillar Thaumetopoea wilkinsoni are widely distributed in pine groves throughout Israel. Erucism is defined as urtication by Lepidoptera larvae. Both irritating effects on contact with skin and eyes and toxic effects on ingestion have been described after exposure to several species of Lepidoptera. We report the case of a 4-year-old child who vomited repeatedly and developed symmetrical swelling of both hands after touching a larva of Thaumetopoea wilkinsoni.", "label": 1, "is_selected": 0, "text": "Larvae of the caterpillar Thaumetopoea wilkinsoni are widely distributed in pine groves throughout Israel. Erucism is defined as urtication by Lepidoptera larvae. Both irritating effects on contact with skin and eyes and toxic effects on ingestion have been described after exposure to several species of Lepidoptera. We report the case of a 4-year-old child who vomited repeatedly and developed symmetrical swelling of both hands after touching a larva of Thaumetopoea wilkinsoni."}
{"qid": "5d36a9507bc3fee31f000005", "original_text": "The human thymus is a gland located in the chest, responsible for the maturation and development of T-lymphocytes (T-cells) also known as CD4+ and CD8+ T-cells. The thymus matures these cells from hematopoietic stem cells through a process known as thymocyte development. During this process, these immature T-cells undergo a series of intrathymic selection and elimination, resulting in the maturation of approximately 75% of T-cells. The remaining 25% of T-cells will enter the circulation as mature cells. The mature T-cells then travel to the secondary lymphoid organs, such as the lymph nodes and spleen, where they can recognize and respond to antigens. The thymus continues to produce and mature T-cells throughout a person's lifetime, with the highest activity occurring during infancy and childhood.", "label": 0, "is_selected": 1, "text": "The human thymus is an important part of the immune system and plays a key role in the regulation of the body's innate and adaptive immune responses to antigens, such as those antigens found in cancer and autoimmune diseases. The thymus continues to produce and mature T-cells throughout a person's lifetime, with the highest activity occurring during infancy and childhood."}
{"qid": "5e30fa32fbd6abf43b000048", "original_text": "We report acute tetraplegia caused by rat bite fever in a 59-year old man (snake keeper) and transmission of Streptobacillus moniliformis. We found an identical characteristic bacterial pattern in rat and human samples, which validated genotyping-based evidence for infection with the same strain, and identified diagnostic difficulties concerning infection with this microorganism.", "label": 1, "is_selected": 0, "text": "We report acute tetraplegia caused by rat bite fever in a 59-year old man (snake keeper) and transmission of Streptobacillus moniliformis. We found an identical characteristic bacterial pattern in rat and human samples, which validated genotyping-based evidence for infection with the same strain, and identified diagnostic difficulties concerning infection with this microorganism."}
{"qid": "5e52bc986d0a277941000049", "original_text": "Yes, the CADM2 gene has been associated with differences in information processing speed. CADM2 is a gene that codes for a protein called cadherin-2, which is involved in the formation and maintenance of synapses, the connections between neurons that facilitate communication and information processing. Variants of the CADM2 gene have been found to be associated with differences in information processing speed, particularly in the context of certain neurological and psychiatric disorders, such as autism spectrum disorder and attention deficit hyperactivity disorder (ADHD). These findings suggest that the CADM2 gene may play a role in the development and function of neural circuits involved in information processing, and that variations in the gene may contribute to differences in information processing speed. However, it is important to note that the relationship between the CADM2 gene and information processing speed is complex and multi-factorial, and additional research is needed to fully understand the mechanisms involved.", "label": 0, "is_selected": 0, "text": "Yes, the CADM2 gene has been associated with differences in information processing speed. CADM2 is a gene that codes for a protein called cadherin-2, which is involved in the formation and maintenance of synapses, the connections between neurons that facilitate communication and information processing. Variants of the CADM2 gene have been found to be associated with differences in information processing speed, particularly in the context of certain neurological and psychiatric disorders, such as autism spectrum disorder and attention deficit hyperactivity disorder (ADHD). These findings suggest that the CADM2 gene may play a role in the development and function of neural circuits involved in information processing, and that variations in the gene may contribute to differences in information processing speed. However, it is important to note that the relationship between the CADM2 gene and information processing speed is complex and multi-factorial, and additional research is needed to fully understand the mechanisms involved."}
{"qid": "5148e42cd24251bc0500003b", "original_text": "Molecular etiologies of heart failure, an emerging cardiovascular epidemic affecting 4.7 million Americans and costing 17.8 billion health-care dollars annually, remain poorly understood. Here we report that an inherited human dilated cardiomyopathy with refractory congestive heart failure is caused by a dominant Arg --> Cys missense mutation at residue 9 (R9C) in phospholamban (PLN), a transmembrane phosphoprotein that inhibits the cardiac sarcoplasmic reticular Ca2+-adenosine triphosphatase (SERCA2a) pump. Transgenic PLN(R9C) mice recapitulated human heart failure with premature death. Cellular and biochemical studies revealed that, unlike wild-type PLN, PLN(R9C) did not directly inhibit SERCA2a. Rather, PLN(R9C) trapped protein kinase A (PKA), which blocked PKA-mediated phosphorylation of wild-type PLN and in turn delayed decay of calcium transients in myocytes. These results indicate that myocellular calcium dysregulation can initiate human heart failure-a finding that may lead to therapeutic opportunities.", "label": 1, "is_selected": 0, "text": "Molecular etiologies of heart failure, an emerging cardiovascular epidemic affecting 4.7 million Americans and costing 17.8 billion health-care dollars annually, remain poorly understood. Here we report that an inherited human dilated cardiomyopathy with refractory congestive heart failure is caused by a dominant Arg --> Cys missense mutation at residue 9 (R9C) in phospholamban (PLN), a transmembrane phosphoprotein that inhibits the cardiac sarcoplasmic reticular Ca2+-adenosine triphosphatase (SERCA2a) pump. Transgenic PLN(R9C) mice recapitulated human heart failure with premature death. Cellular and biochemical studies revealed that, unlike wild-type PLN, PLN(R9C) did not directly inhibit SERCA2a. Rather, PLN(R9C) trapped protein kinase A (PKA), which blocked PKA-mediated phosphorylation of wild-type PLN and in turn delayed decay of calcium transients in myocytes. These results indicate that myocellular calcium dysregulation can initiate human heart failure-a finding that may lead to therapeutic opportunities."}
{"qid": "5a9ac4e81d1251d03b000011", "original_text": "High-grade gliomas (HGG) are a devastating group of cancers, and represent the leading cause of brain tumour-related death in both children and adults. Therapies aimed at mechanisms intrinsic to glioma cells have translated to only limited success; effective therapeutic strategies will need also to target elements of the tumour microenvironment that promote glioma progression. Neuronal activity promotes the growth of a range of molecularly and clinically distinct HGG types, including adult and paediatric glioblastoma (GBM), anaplastic oligodendroglioma, and diffuse intrinsic pontine glioma (DIPG). An important mechanism that mediates this neural regulation of brain cancer is activity-dependent cleavage and secretion of the synaptic adhesion molecule neuroligin-3 (NLGN3), which promotes glioma proliferation through the PI3K-mTOR pathway. However, the necessity of NLGN3 for glioma growth, the proteolytic mechanism of NLGN3 secretion, and the further molecular consequences of NLGN3 secretion in glioma cells remain unknown.", "label": 1, "is_selected": 0, "text": "High-grade gliomas (HGG) are a devastating group of cancers, and represent the leading cause of brain tumour-related death in both children and adults. Therapies aimed at mechanisms intrinsic to glioma cells have translated to only limited success; effective therapeutic strategies will need also to target elements of the tumour microenvironment that promote glioma progression. Neuronal activity promotes the growth of a range of molecularly and clinically distinct HGG types, including adult and paediatric glioblastoma (GBM), anaplastic oligodendroglioma, and diffuse intrinsic pontine glioma (DIPG). An important mechanism that mediates this neural regulation of brain cancer is activity-dependent cleavage and secretion of the synaptic adhesion molecule neuroligin-3 (NLGN3), which promotes glioma proliferation through the PI3K-mTOR pathway. However, the necessity of NLGN3 for glioma growth, the proteolytic mechanism of NLGN3 secretion, and the further molecular consequences of NLGN3 secretion in glioma cells remain unknown."}
{"qid": "56e460d051531f7e33000019", "original_text": "Efforts to identify the genetic basis of mammalian sleep have included quantitative trait locus (QTL) mapping and gene targeting of known core circadian clock genes. We combined three different genetic approaches to identify and test a positional candidate sleep gene - the circadian gene casein kinase 1 epsilon (Csnk1e), which is located in a QTL we identified for rapid eye movement (REM) sleep on chromosome 15. Using electroencephalographic (EEG) and electromyographic (EMG) recordings, baseline sleep was examined in a 12-h light:12-h dark (LD 12:12) cycle in mice of seven genotypes, including Csnk1e(tau/tau) and Csnk1e(-/-) mutant mice, Csnk1e (B6.D2) and Csnk1e (D2.B6) congenic mice, and their respective wild-type littermate control mice. Additionally, Csnk1e(tau/tau) and wild-type mice were examined in constant darkness (DD). Csnk1e(tau/tau) mutant mice and both Csnk1e (B6.D2) and Csnk1e (D2.B6) congenic mice showed significantly higher proportion of sleep time spent in REM sleep during the dark period than wild-type controls - the original phenotype for which the QTL on chromosome 15 was identified.", "label": 1, "is_selected": 0, "text": "Efforts to identify the genetic basis of mammalian sleep have included quantitative trait locus (QTL) mapping and gene targeting of known core circadian clock genes. We combined three different genetic approaches to identify and test a positional candidate sleep gene - the circadian gene casein kinase 1 epsilon (Csnk1e), which is located in a QTL we identified for rapid eye movement (REM) sleep on chromosome 15. Using electroencephalographic (EEG) and electromyographic (EMG) recordings, baseline sleep was examined in a 12-h light:12-h dark (LD 12:12) cycle in mice of seven genotypes, including Csnk1e(tau/tau) and Csnk1e(-/-) mutant mice, Csnk1e (B6.D2) and Csnk1e (D2.B6) congenic mice, and their respective wild-type littermate control mice. Additionally, Csnk1e(tau/tau) and wild-type mice were examined in constant darkness (DD). Csnk1e(tau/tau) mutant mice and both Csnk1e (B6.D2) and Csnk1e (D2.B6) congenic mice showed significantly higher proportion of sleep time spent in REM sleep during the dark period than wild-type controls - the original phenotype for which the QTL on chromosome 15 was identified."}
{"qid": "5c5b52731a4c55d80b000003", "original_text": "We aimed to evaluate the prognostic and predictive value of the nucleotide excision repair-related gene GTF2H5, which is localized at the 6q24.2-26 deletion previously reported by our group to predict longer survival of high-grade serous ovarian cancer patients. In order to test if protein levels of GTF2H5 are associated with patients' outcome, we performed GTF2H5 immunohistochemical staining in 139 high-grade serous ovarian carcinomas included in tissue microarrays. Upon stratification of cases into high- and low-GTF2H5 staining categories (> and \u2264 median staining, respectively) Kaplan-Meier and log-rank test were used to estimate patients' survival and assess statistical differences. We also evaluated the association of GTF2H5 with survival at the transcriptional level by using the on-line Kaplan-Meier plotter tool, which includes gene expression and survival data of 855 high-grade serous ovarian cancer patients from 13 different datasets.", "label": 1, "is_selected": 0, "text": "We aimed to evaluate the prognostic and predictive value of the nucleotide excision repair-related gene GTF2H5, which is localized at the 6q24.2-26 deletion previously reported by our group to predict longer survival of high-grade serous ovarian cancer patients. In order to test if protein levels of GTF2H5 are associated with patients' outcome, we performed GTF2H5 immunohistochemical staining in 139 high-grade serous ovarian carcinomas included in tissue microarrays. Upon stratification of cases into high- and low-GTF2H5 staining categories (> and \u2264 median staining, respectively) Kaplan-Meier and log-rank test were used to estimate patients' survival and assess statistical differences. We also evaluated the association of GTF2H5 with survival at the transcriptional level by using the on-line Kaplan-Meier plotter tool, which includes gene expression and survival data of 855 high-grade serous ovarian cancer patients from 13 different datasets."}
{"qid": "51766e438ed59a060a000031", "original_text": "The specialized translation factor SelB forms a quaternary complex in vitro with selenocysteyl-tRNA(Sec), the selenoprotein mRNA and guanine nucleotides. To gain information on whether this complex is required for selenocysteine insertion in vivo we have studied the effect of unbalanced ratios of the individual components of the complex on UGA readthrough. It was found that overproduction of SelB in an otherwise wild-type genetic background reduced UGA readthrough to less than 1%. Concomitant overexpression of selC (the gene for selenocysteine-specific tRNA(Sec)) completely reversed the inhibition. Truncation of SelB from the C-terminal end abolished function as a translation factor but the truncated molecules, when overproduced, were still able to suppress UGA read-through. The inhibition was also reversed by overproduction of tRNA(Sec). The most plausible explanation is that overproduction of SelB impairs the statistics of formation of the quaternary complex and that the C-terminally truncated molecules are still able to bind selenocysteyl-tRNA(Sec) and remove it from the pool.", "label": 1, "is_selected": 0, "text": "The specialized translation factor SelB forms a quaternary complex in vitro with selenocysteyl-tRNA(Sec), the selenoprotein mRNA and guanine nucleotides. To gain information on whether this complex is required for selenocysteine insertion in vivo we have studied the effect of unbalanced ratios of the individual components of the complex on UGA readthrough. It was found that overproduction of SelB in an otherwise wild-type genetic background reduced UGA readthrough to less than 1%. Concomitant overexpression of selC (the gene for selenocysteine-specific tRNA(Sec)) completely reversed the inhibition. Truncation of SelB from the C-terminal end abolished function as a translation factor but the truncated molecules, when overproduced, were still able to suppress UGA read-through. The inhibition was also reversed by overproduction of tRNA(Sec). The most plausible explanation is that overproduction of SelB impairs the statistics of formation of the quaternary complex and that the C-terminally truncated molecules are still able to bind selenocysteyl-tRNA(Sec) and remove it from the pool."}
{"qid": "5133b9455274a5fb0700000c", "original_text": "A single U leads to G transversion in the 3' consensus sequence AAUAAA of the adenovirus early region 1A gene was constructed and the effect of this mutation on processing of the 3' end of the nuclear early region 1A RNAs was analysed. The results demonstrate that the intact AAUAAA is not required for RNA polyadenylation but is required for the cleavage step preceding polyadenylation to occur efficiently.", "label": 1, "is_selected": 0, "text": "A single U leads to G transversion in the 3' consensus sequence AAUAAA of the adenovirus early region 1A gene was constructed and the effect of this mutation on processing of the 3' end of the nuclear early region 1A RNAs was analysed. The results demonstrate that the intact AAUAAA is not required for RNA polyadenylation but is required for the cleavage step preceding polyadenylation to occur efficiently."}
{"qid": "587d2700fe8a08052f000001", "original_text": "Super-enhancers are large clusters of transcriptional enhancers regarded as having essential roles in driving the expression of genes that control cell identity during development and tumorigenesis. The construction of a genome-wide super-enhancer database is urgently needed to better understand super-enhancer-directed gene expression regulation for a given biology process. Here, we present a specifically designed web-accessible database, Super-Enhancer Archive (SEA, http://sea.edbc.org). SEA focuses on integrating super-enhancers in multiple species and annotating their potential roles in the regulation of cell identity gene expression. The current release of SEA incorporates 83 996 super-enhancers computationally or experimentally identified in 134 cell types/tissues/diseases, including human (75 439, three of which were experimentally identified), mouse (5879, five of which were experimentally identified), Drosophila melanogaster (1774) and Caenorhabditis elegans (904). To facilitate data extraction, SEA supports multiple search options, including species, genome location, gene name, cell type/tissue and super-enhancer name. The response provides detailed (epi)genetic information, incorporating cell type specificity, nearby genes, transcriptional factor binding sites, CRISPR/Cas9 target sites, evolutionary conservation, SNPs, H3K27ac, DNA methylation, gene expression and TF ChIP-seq data. Moreover, analytical tools and a genome browser were developed for users to explore super-enhancers and their roles in defining cell identity and disease processes in depth.", "label": 1, "is_selected": 0, "text": "Super-enhancers are large clusters of transcriptional enhancers regarded as having essential roles in driving the expression of genes that control cell identity during development and tumorigenesis. The construction of a genome-wide super-enhancer database is urgently needed to better understand super-enhancer-directed gene expression regulation for a given biology process. Here, we present a specifically designed web-accessible database, Super-Enhancer Archive (SEA, http://sea.edbc.org). SEA focuses on integrating super-enhancers in multiple species and annotating their potential roles in the regulation of cell identity gene expression. The current release of SEA incorporates 83 996 super-enhancers computationally or experimentally identified in 134 cell types/tissues/diseases, including human (75 439, three of which were experimentally identified), mouse (5879, five of which were experimentally identified), Drosophila melanogaster (1774) and Caenorhabditis elegans (904). To facilitate data extraction, SEA supports multiple search options, including species, genome location, gene name, cell type/tissue and super-enhancer name. The response provides detailed (epi)genetic information, incorporating cell type specificity, nearby genes, transcriptional factor binding sites, CRISPR/Cas9 target sites, evolutionary conservation, SNPs, H3K27ac, DNA methylation, gene expression and TF ChIP-seq data. Moreover, analytical tools and a genome browser were developed for users to explore super-enhancers and their roles in defining cell identity and disease processes in depth."}
{"qid": "5509df4ac2af5d5b70000003", "original_text": "Amiodarone has been used as an anti-arrhythmic drug since the 1970s and has an established role in the treatment of ventricular tachyarrhythmias. Although considered to be a class III anti-arrhythmic, amiodarone also has class I, II and IV actions, which gives it a unique pharmacological and anti-arrhythmic profile. Amiodarone is a structural analogue of thyroid hormone and some of its anti-arrhythmic properties and toxicity may be attributable to interactions with nuclear thyroid hormone receptors.", "label": 1, "is_selected": 0, "text": "Amiodarone has been used as an anti-arrhythmic drug since the 1970s and has an established role in the treatment of ventricular tachyarrhythmias. Although considered to be a class III anti-arrhythmic, amiodarone also has class I, II and IV actions, which gives it a unique pharmacological and anti-arrhythmic profile. Amiodarone is a structural analogue of thyroid hormone and some of its anti-arrhythmic properties and toxicity may be attributable to interactions with nuclear thyroid hormone receptors."}
{"qid": "5a6e47b1b750ff4455000049", "original_text": "Abnormal deposition of aggregated wild-type (WT) human transthyretin (TTR) and its pathogenic variants is responsible for cardiomyopathy and neuropathy related to TTR amyloidosis. The tryptophan (Trp) fluorescence measurements typically used to study structural changes of TTR do not yield site-specific information on the two Trp residues per TTR protomer. To obtain such information, tryptophan labeled with fluorine at the 5 and 6 positions (5FW and 6FW) was incorporated into TTR.", "label": 1, "is_selected": 0, "text": "Abnormal deposition of aggregated wild-type (WT) human transthyretin (TTR) and its pathogenic variants is responsible for cardiomyopathy and neuropathy related to TTR amyloidosis. The tryptophan (Trp) fluorescence measurements typically used to study structural changes of TTR do not yield site-specific information on the two Trp residues per TTR protomer. To obtain such information, tryptophan labeled with fluorine at the 5 and 6 positions (5FW and 6FW) was incorporated into TTR."}
{"qid": "53175e4fb166e2b806000008", "original_text": "Period (Per) genes are key circadian rhythm regulators in mammals. Expression of mouse Per (mPer) genes has a diurnal pattern in the suprachiasmatic nucleus and in peripheral tissues. Genetic ablation mPER1 and mPER2 function results in a complete loss of circadian rhythm control based on wheel-running activity in mice. In addition, these animals also display apparent premature aging and a significant increase in neoplastic and hyperplastic phenotypes. When challenged by gamma radiation, mPer2-deficient mice respond by rapid hair graying, are deficient in p53-mediated apoptosis in thymocytes, and have robust tumor occurrences. Studies have demonstrated that the circadian clock function is very important for cell cycle, DNA damage response, and tumor suppression in vivo.", "label": 1, "is_selected": 0, "text": "Period (Per) genes are key circadian rhythm regulators in mammals. Expression of mouse Per (mPer) genes has a diurnal pattern in the suprachiasmatic nucleus and in peripheral tissues. Genetic ablation mPER1 and mPER2 function results in a complete loss of circadian rhythm control based on wheel-running activity in mice. In addition, these animals also display apparent premature aging and a significant increase in neoplastic and hyperplastic phenotypes. When challenged by gamma radiation, mPer2-deficient mice respond by rapid hair graying, are deficient in p53-mediated apoptosis in thymocytes, and have robust tumor occurrences. Studies have demonstrated that the circadian clock function is very important for cell cycle, DNA damage response, and tumor suppression in vivo."}
{"qid": "626aa68ce764a53204000037", "original_text": "Piwi-interacting RNAs (piRNAs) are a type of non-coding RNA that play a crucial role in regulating gene expression by binding to the Piwi protein. piRNAs are typically 24-30 nucleotides in length and are derived from long single-stranded RNA precursors. They are primarily found in the germline cells and play a key role in the epigenetic silencing of genes that are important for meiosis and germline development. piRNAs have been implicated in the regulation of aging, cancer, and neurodegenerative diseases, among others.", "label": 0, "is_selected": 1, "text": "The research team at the University of California, Los Angeles (UCLA) is studying the role of Piwi-interacting RNAs (piRNAs) in the regulation of gene expression and epigenetic silencing in a wide range of diseases, including cancer, neurodegenerative diseases, and Parkinson's disease."}
{"qid": "5a9da37e4e03427e73000004", "original_text": "Mendelian randomization is a statistical technique used in epidemiology and genetics to establish causal relationships between a modifiable exposure (or risk factor) and an outcome of interest, while controlling for confounding variables. It is named after Gregor Mendel, who described the principles of inheritance. In Mendelian randomization, a genetic variant associated with the exposure of interest is used as a proxy for the exposure itself. The rationale is that if the genetic variant affects the exposure, it should also affect the outcome, provided there are no confounding variables. By comparing the distribution of the genetic variant between the exposure and non-exposure groups, the study can infer the causal relationship between the exposure and the outcome. Mendelian randomization can identify both directional and inverse causal relationships and can be used to evaluate the effectiveness of interventions or treatments with which there is no established causal relationship. This approach has been applied to various diseases and conditions, including cardiovascular disease, diabetes, and mental health. However, it is important to ensure that the genetic variant being used as a proxy is truly independent of the exposure of interest and that there are no confounding variables that could affect the results.", "label": 0, "is_selected": 1, "text": "The aim of this study is to use Mendelian randomization to investigate the effect of a genetic variant on the risk of coronary heart disease (CHD) in a population-based cohort study of more than 100,000 people in the United States, Canada, and the United Kingdom, using data from the Nurses' Health Study (NHS) database.<n> However, it is important to ensure that the genetic variant being used as a proxy is truly independent of the exposure of interest and that there are no confounding variables that could affect the results."}
{"qid": "58a2efec60087bc10a000008", "original_text": "Microtubule-associated protein tau is abnormally hyperphosphorylated and aggregated in affected neurons of Alzheimer disease brain. This hyperphosphorylated tau can be dephosphorylated at some of the abnormal phosphorylated sites by purified protein phosphatase-1, 2A, and 2B in vitro. In the present study, we have developed an assay to measure protein phosphatase activity toward tau-1 sites (Ser199/Ser202) using the hyperphosphorylated tau isolated from Alzheimer disease brain as substrate. Using this assay, we have identified that in normal brain, protein phosphatase-2A and 2B and, to a lesser extent, 1 are involved in the dephosphorylation of tau. The Km values of dephosphorylation of the hyperphosphorylated tau by protein phosphatase-2A and 2B are similar. The tau phosphatase activity is decreased by approximately 30% in brain of Alzheimer disease patients compared with those of age-matched controls. These findings suggest that a defect of protein phosphatase could be the cause of the abnormal hyperphosphorylation of tau in Alzheimer disease.", "label": 1, "is_selected": 0, "text": "Microtubule-associated protein tau is abnormally hyperphosphorylated and aggregated in affected neurons of Alzheimer disease brain. This hyperphosphorylated tau can be dephosphorylated at some of the abnormal phosphorylated sites by purified protein phosphatase-1, 2A, and 2B in vitro. In the present study, we have developed an assay to measure protein phosphatase activity toward tau-1 sites (Ser199/Ser202) using the hyperphosphorylated tau isolated from Alzheimer disease brain as substrate. Using this assay, we have identified that in normal brain, protein phosphatase-2A and 2B and, to a lesser extent, 1 are involved in the dephosphorylation of tau. The Km values of dephosphorylation of the hyperphosphorylated tau by protein phosphatase-2A and 2B are similar. The tau phosphatase activity is decreased by approximately 30% in brain of Alzheimer disease patients compared with those of age-matched controls. These findings suggest that a defect of protein phosphatase could be the cause of the abnormal hyperphosphorylation of tau in Alzheimer disease."}
{"qid": "517138d98ed59a060a000003", "original_text": "Ranolazine is a medication that is primarily used to treat angina, a condition characterized by chest pain due to reduced blood flow to the heart muscle. However, it has also been found to affect calcium handling in the heart. Calcium is an essential ion that plays a crucial role in the proper functioning of the heart muscle. It is involved in the regulation of cardiac contractility, excitability, and relaxation. Ranolazine has been shown to increase the intracellular concentration of calcium in cardiac muscle cells, which can lead to a number of effects, including: 1. Enhanced cardiac contractility: Increased intracellular calcium concentrations can enhance the contractility of the heart muscle, leading to improved cardiac output and reduced angina symptoms. 2. Reduced cardiac inflammation: Ranolazine has anti-inflammatory properties, which may contribute to its protective effects on the heart muscle. Reduced inflammation can help to reduce the risk of cardiac events, such as heart failure and arrhythmias. 3. Increased mitochondrial function: Mitochondria are the energy-producing structures within cells. Ranolazine has been shown to increase the function of mitochondria in cardiac muscle cells, which can help to improve cardiac energy metabolism and reduce the risk of cardiac events. Overall, the effects of ranolazine on calcium handling in the heart are complex and can vary depending on the specific conditions being studied. While it can have positive effects on cardiac function, it is important to note that ranolazine is not a calcium channel blocker, and its effects on calcium handling are different from those of other medications in this class.", "label": 0, "is_selected": 1, "text": "The effects of ranolazine on calcium handling in the heart are complex and can vary depending on the specific conditions being studied, but it has been shown to increase the intracellular concentration of calcium in cardiac muscle cells, which can lead to a number of effects, including: Ranolazine is a medication that is primarily used to treat angina, a condition characterized by chest pain due to reduced blood flow to the heart muscle, however, it has also been found to affect calcium handling, and its effects on calcium Handling in the Heart are different from those of other medications in this class, and it can have positive effects on cardiac function, such as reduced cardiac inflammation and reduced cardiac events."}
{"qid": "58e120036fddd3e83e00000d", "original_text": "Cryptococcus is a ubiquitous fungus and is known for causing meningitis and cutaneous infections in immunocompromised individuals. Disseminated cryptococcal infection is very rare and almost always found to occur in immunocompromised individuals especially in persons infected with HIV. This is particularly attributed to its capsulated spores. But there are few reported cases in which it has been found to cause disseminated infections even in immunocompetent individuals.", "label": 1, "is_selected": 0, "text": "Cryptococcus is a ubiquitous fungus and is known for causing meningitis and cutaneous infections in immunocompromised individuals. Disseminated cryptococcal infection is very rare and almost always found to occur in immunocompromised individuals especially in persons infected with HIV. This is particularly attributed to its capsulated spores. But there are few reported cases in which it has been found to cause disseminated infections even in immunocompetent individuals."}
{"qid": "530cf4e0c8a0b4a00c000007", "original_text": "Commotio cordis is arrhythmia or sudden death from low-impact, blunt trauma to the chest without apparent heart injury. Ventricular fibrillation is the most common associated arrhythmia, and heart block, bundle branch block, and ST-segment elevation are also seen. Commotio cordis occurs most commonly in baseball but has also been reported in hockey, softball, and several other sports. Approximately two to four cases are reported each year, but the true incidence is uncertain. Survival is low, even when resuscitation is performed. Preventive measures include education of participants and coaches, chest protection, and softer baseballs. Other considerations include having external automatic defibrillators and trained personnel at youth sporting events.", "label": 1, "is_selected": 0, "text": "Commotio cordis is arrhythmia or sudden death from low-impact, blunt trauma to the chest without apparent heart injury. Ventricular fibrillation is the most common associated arrhythmia, and heart block, bundle branch block, and ST-segment elevation are also seen. Commotio cordis occurs most commonly in baseball but has also been reported in hockey, softball, and several other sports. Approximately two to four cases are reported each year, but the true incidence is uncertain. Survival is low, even when resuscitation is performed. Preventive measures include education of participants and coaches, chest protection, and softer baseballs. Other considerations include having external automatic defibrillators and trained personnel at youth sporting events."}
{"qid": "602c1b141cb411341a00011c", "original_text": "To assess the long-term safety and tolerability and to monitor benefits of extended use of bimagrumab in individuals with sporadic inclusion body myositis (sIBM) who completed a single-dose core study.", "label": 1, "is_selected": 0, "text": "To assess the long-term safety and tolerability and to monitor benefits of extended use of bimagrumab in individuals with sporadic inclusion body myositis (sIBM) who completed a single-dose core study."}
{"qid": "5c83ff91617e120c34000005", "original_text": "CRT0066101 is a drug that works by targeting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys. SGLT2 is a protein that plays a critical role in the reabsorption of glucose in the kidneys, allowing it to reach the bloodstream. By inhibiting the activity of SGLT2, CRT0066101 reduces the amount of glucose that is reabsorbed in the kidneys, leading to increased glomerular filtration and increased excretion of glucose in the urine. This results in a reduction in blood glucose levels. The mechanism of action of CRT0066101 is similar to that of other SGLT2 inhibitors, such as canagliflozin and dapagliflozin, which are also used to treat type 2 diabetes. However, CRT0066101 has a unique chemical structure and pharmacokinetic properties that allow it to be more effective and have a more favorable safety profile compared to other SGLT2 inhibitors. It is important to note that CRT0066101 is still a relatively new drug, and more research is needed to fully understand its mechanism of action and its potential effects on the body. Additionally, while SGLT2 inhibitors have been shown to be effective in reducing blood glucose levels, they may also increase the risk of certain adverse events, such as urinary tract infections and genital infections, due to the increased glucose excretion in the urine. Therefore, it is important to use these drugs under the close supervision of a healthcare provider and to follow their instructions carefully.", "label": 0, "is_selected": 0, "text": "CRT0066101 is a drug that works by targeting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys. SGLT2 is a protein that plays a critical role in the reabsorption of glucose in the kidneys, allowing it to reach the bloodstream. By inhibiting the activity of SGLT2, CRT0066101 reduces the amount of glucose that is reabsorbed in the kidneys, leading to increased glomerular filtration and increased excretion of glucose in the urine. This results in a reduction in blood glucose levels. The mechanism of action of CRT0066101 is similar to that of other SGLT2 inhibitors, such as canagliflozin and dapagliflozin, which are also used to treat type 2 diabetes. However, CRT0066101 has a unique chemical structure and pharmacokinetic properties that allow it to be more effective and have a more favorable safety profile compared to other SGLT2 inhibitors. It is important to note that CRT0066101 is still a relatively new drug, and more research is needed to fully understand its mechanism of action and its potential effects on the body. Additionally, while SGLT2 inhibitors have been shown to be effective in reducing blood glucose levels, they may also increase the risk of certain adverse events, such as urinary tract infections and genital infections, due to the increased glucose excretion in the urine. Therefore, it is important to use these drugs under the close supervision of a healthcare provider and to follow their instructions carefully."}
{"qid": "5c915ca7ecadf2e73f00000b", "original_text": "Prevnar 13 is a 13-valent pneumococcal conjugate vaccine that contains 13 serotypes of Streptococcus pneumoniae: 4\u03b2-Lactamase-producing isolates of serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, and 19A. It is designed to provide protection against the most common causes of pneumococcal disease, including invasive disease, pneumonia, and meningitis.", "label": 0, "is_selected": 1, "text": "Prevnar 13 is a vaccine that protects against Streptococcus pneumoniae, a leading cause of morbidity and mortality in adults and children in the United States, Canada, and the United Arab Emirates (UAE) and other parts of the world."}
{"qid": "51485008d24251bc05000028", "original_text": "Yes, miR-126 has been shown to be involved in heart failure. MicroRNA-126 (miR-126) is a small non-coding RNA molecule that plays a critical role in regulating cardiovascular function and has been implicated in the development and progression of heart failure. Studies have shown that miR-126 is downregulated in the hearts of patients with heart failure, and this downregulation has been associated with increased fibrosis, inflammation, and decreased cardiac function. In addition, miR-126 has been shown to regulate genes involved in cardiac hypertrophy and fibrosis, suggesting a potential role for this microRNA in the development of heart failure. Overall, the available evidence suggests that miR-126 is involved in the development and progression of heart failure, and further research is needed to fully understand its role in this disease.", "label": 0, "is_selected": 1, "text": "Is MicroRNA-126 involved in the development and progression of heart failure, or is it just a matter of time before this molecule is implicated in other diseases, such as diabetes and Alzheimer's disease, as well as heart attacks and strokes, as a result of this molecule being downregulated in the hearts of patients with heart failure?"}
{"qid": "5c674eac7c78d6947100001b", "original_text": "Hesperidin, a bioflavonoid found in citrus fruits, has been studied for its potential neuroprotective effects. Research has shown that hesperidin can cross the blood-brain barrier and protect against oxidative stress and inflammation in the brain, which are known to contribute to neurodegenerative diseases such as Alzheimer's and Parkinson's. Studies have shown that hesperidin can inhibit the activation of inflammatory pathways and reduce the production of pro-inflammatory cytokines in the brain. This may help to slow the progression of neurodegeneration in diseases such as Alzheimer's, where inflammation is a key component. Additionally, hesperidin has been shown to increase the expression of neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), which are important for maintaining healthy neurons. Decreased levels of BDNF have been linked to neurodegenerative diseases, and hesperidin may help to restore these levels. While the current evidence suggests that hesperidin has neuroprotective effects, further research is needed to fully understand its mechanisms of action and to determine its potential as a therapeutic agent for neurodegenerative diseases.", "label": 0, "is_selected": 1, "text": "Researchers at the University of California, Los Angeles (UCLA), have discovered that a chemical found in citrus fruits may help to slow the progression of neurodegenerative diseases, such as Alzheimer's and Parkinson's, by protecting the brain against oxidative stress and inflammation, and restoring neurotrophic factors, which are important for maintaining healthy neurons, in experiments on mice and in human models of Alzheimer' s disease and Parkinson s disease."}
{"qid": "53147b52e3eabad021000015", "original_text": "To discuss regulatory guidelines excluding subjects with erythrocyte glucose-6-phosphate dehydrogenase (G6PD) deficiency from lead-exposed jobs in the light of epidemiology findings on the mortality of these subjects. Two mortality follow-up studies were conducted. The first comprised 1979 male subjects newly identified as G6PD-deficient during a 1981 screening of the G6PD polymorphism among the general population in Sardinia, Italy. The second comprised 1080 male workers employed in maintenance and production departments of a lead smelting plant, who were divided into two subcohorts by erythrocyte G6PD phenotype. As compared with the general male population, G6PD-deficient subjects had significantly fewer deaths than expected from ischemic heart disease (standardized mortality ratio (SMR) = 28; 95% CI 10-62), cerebrovascular diseases (SMR = 22; 95% CI 6-55), and liver cirrhosis (SMR = 12; 95% CI 0-66). Among lead smelters the standardized mortality rates from cardiovascular diseases and all cancers observed among the G6PD-deficient subcohort were lower than those seen among subjects with the wild-type G6PD.", "label": 1, "is_selected": 0, "text": "To discuss regulatory guidelines excluding subjects with erythrocyte glucose-6-phosphate dehydrogenase (G6PD) deficiency from lead-exposed jobs in the light of epidemiology findings on the mortality of these subjects. Two mortality follow-up studies were conducted. The first comprised 1979 male subjects newly identified as G6PD-deficient during a 1981 screening of the G6PD polymorphism among the general population in Sardinia, Italy. The second comprised 1080 male workers employed in maintenance and production departments of a lead smelting plant, who were divided into two subcohorts by erythrocyte G6PD phenotype. As compared with the general male population, G6PD-deficient subjects had significantly fewer deaths than expected from ischemic heart disease (standardized mortality ratio (SMR) = 28; 95% CI 10-62), cerebrovascular diseases (SMR = 22; 95% CI 6-55), and liver cirrhosis (SMR = 12; 95% CI 0-66). Among lead smelters the standardized mortality rates from cardiovascular diseases and all cancers observed among the G6PD-deficient subcohort were lower than those seen among subjects with the wild-type G6PD."}
{"qid": "5318b452b166e2b806000021", "original_text": "Exome sequencing is a highly efficient method for detecting germline mutations, which are inherited mutations that occur in the DNA of reproductive cells. The exome consists of the protein-coding regions of the genome, and exome sequencing involves sequencing the DNA of these regions. This approach is efficient because the exome is a relatively small portion of the genome, accounting for only about 1-2% of the total DNA. As a result, exome sequencing can provide comprehensive coverage of the most common germline mutations, including those associated with inherited genetic disorders. Additionally, the technology and computational methods used in exome sequencing have improved significantly in recent years, allowing for faster and more accurate analysis of the exome. Overall, exome sequencing is a highly efficient and effective method for detecting germline mutations.", "label": 0, "is_selected": 1, "text": "The germline exome is a small part of the human genome that can be used to detect mutations in the DNA of human eggs and other cells, as well as to diagnose genetic disorders such as cystic fibrosis and inherited disorders of the central nervous system (IDRs) and brain, among other conditions and diseases."}
{"qid": "5d38663da1e1595105000001", "original_text": "We report that embryos deficient in the histone acetyltransferase Moz (Myst3/Kat6a) show histone H3 lysine 9 (H3K9) hypoacetylation, corresponding H3K9 hypermethylation, and reduced transcription at Hox gene loci. Consistent with an observed caudal shift in Hox gene expression, segment identity is shifted anteriorly, such that Moz-deficient mice show a profound homeotic transformation of the axial skeleton and the nervous system.", "label": 1, "is_selected": 0, "text": "We report that embryos deficient in the histone acetyltransferase Moz (Myst3/Kat6a) show histone H3 lysine 9 (H3K9) hypoacetylation, corresponding H3K9 hypermethylation, and reduced transcription at Hox gene loci. Consistent with an observed caudal shift in Hox gene expression, segment identity is shifted anteriorly, such that Moz-deficient mice show a profound homeotic transformation of the axial skeleton and the nervous system."}
{"qid": "5e46bdcd3f54159529000007", "original_text": "This article presents an overview of potential treatments of food allergy, with an emphasis on various forms of immunotherapy (including oral immunotherapy, sublingual immunotherapy, epicutaneous immunotherapy, immunotherapy with modified food antigens, and immunotherapy with a recombinant peanut vaccine). Allergen nonspecific treatments, such as Chinese herbal formulas, probiotics/prebiotics, helminths, monoclonal antibodies, and toll-like receptor agonists, are also summarized.", "label": 1, "is_selected": 0, "text": "This article presents an overview of potential treatments of food allergy, with an emphasis on various forms of immunotherapy (including oral immunotherapy, sublingual immunotherapy, epicutaneous immunotherapy, immunotherapy with modified food antigens, and immunotherapy with a recombinant peanut vaccine). Allergen nonspecific treatments, such as Chinese herbal formulas, probiotics/prebiotics, helminths, monoclonal antibodies, and toll-like receptor agonists, are also summarized."}
{"qid": "530cf4e0c8a0b4a00c000006", "original_text": "Sudden cardiac death in athletes is a growing problem, despite the huge existing knowledge in medicine and sports. In response to vigorous physical activity, the body undergoes profound morphologic and functional changes. These changes are usually healthy, but sometimes may gravitate to some cardiac diseases. But still, most saudden cardiac deaths are due to previous unknown diseases. The most common cause of sudden cardiac death in athletes is hypertrophic cardiomyopathy.", "label": 1, "is_selected": 0, "text": "Sudden cardiac death in athletes is a growing problem, despite the huge existing knowledge in medicine and sports. In response to vigorous physical activity, the body undergoes profound morphologic and functional changes. These changes are usually healthy, but sometimes may gravitate to some cardiac diseases. But still, most saudden cardiac deaths are due to previous unknown diseases. The most common cause of sudden cardiac death in athletes is hypertrophic cardiomyopathy."}
{"qid": "5519113b622b19434500000f", "original_text": "Recently mutations in the gene ZFHX1B (SIP1) were shown in patients with \"syndromic Hirschsprung disease\" with mental retardation (MR) and multiple congenital anomalies (MCA), but it was unclear if Hirschsprung disease is an obligate symptom of these mutations and if the distinct facial phenotype delineated by Mowat et al. [1998: J Med Genet 35: 617-623] is specific for ZFHX1B mutations.", "label": 1, "is_selected": 0, "text": "Recently mutations in the gene ZFHX1B (SIP1) were shown in patients with \"syndromic Hirschsprung disease\" with mental retardation (MR) and multiple congenital anomalies (MCA), but it was unclear if Hirschsprung disease is an obligate symptom of these mutations and if the distinct facial phenotype delineated by Mowat et al. [1998: J Med Genet 35: 617-623] is specific for ZFHX1B mutations."}
{"qid": "531b1e3cb166e2b80600003b", "original_text": "Polycomb group (PcG) proteins are epigenetic regulators that play a crucial role in the maintenance of gene silencing by altering histone modifications. PcG proteins are known to associate with histones and modify them through the addition of various histone modifications. These modifications include histone 3 lysine 27 trimethylation (H3K27me3), histone 3 lysine 27 acetylation (H3K27ac), and histone 4 lysine 20 trimethylation (H4K20me3). These modifications are associated with the repressive chromatin structure and are crucial for the maintenance of gene silencing. PcG proteins also play a role in the regulation of stem cell self-renewal and pluripotency, and are implicated in various developmental processes and cancers.", "label": 0, "is_selected": 0, "text": "Polycomb group (PcG) proteins are epigenetic regulators that play a crucial role in the maintenance of gene silencing by altering histone modifications. PcG proteins are known to associate with histones and modify them through the addition of various histone modifications. These modifications include histone 3 lysine 27 trimethylation (H3K27me3), histone 3 lysine 27 acetylation (H3K27ac), and histone 4 lysine 20 trimethylation (H4K20me3). These modifications are associated with the repressive chromatin structure and are crucial for the maintenance of gene silencing. PcG proteins also play a role in the regulation of stem cell self-renewal and pluripotency, and are implicated in various developmental processes and cancers."}
{"qid": "6211566a3a8413c653000010", "original_text": "CPX-351 (United States: Vyxeos\u00ae; Europe: Vyxeos\u00ae Liposomal), a dual-drug liposomal encapsulation of daunorubicin and cytarabine in a synergistic 1:5 molar ratio, is approved by the US FDA and the EMA for the treatment of adults with newly diagnosed therapy-related acute myeloid leukemia or acute myeloid leukemia with myelodysplasia-related changes. In a pivotal phase 3 study that evaluated 309 patients aged 60 to 75 years with newly diagnosed high-risk/secondary acute myeloid leukemia, CPX-351 significantly improved median overall survival versus conventional 7 + 3 chemotherapy (cytarabine continuous infusion for 7 days plus daunorubicin for 3 days), with a comparable safety profile. A Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of the phase 3 study was performed to compare survival quality between patients receiving CPX-351 versus conventional 7 + 3 after 5 years of follow-up. Patients were randomized 1:1 between December 20, 2012 and November 11, 2014 to receive induction with CPX-351 or 7 + 3.", "label": 1, "is_selected": 0, "text": "CPX-351 (United States: Vyxeos\u00ae; Europe: Vyxeos\u00ae Liposomal), a dual-drug liposomal encapsulation of daunorubicin and cytarabine in a synergistic 1:5 molar ratio, is approved by the US FDA and the EMA for the treatment of adults with newly diagnosed therapy-related acute myeloid leukemia or acute myeloid leukemia with myelodysplasia-related changes. In a pivotal phase 3 study that evaluated 309 patients aged 60 to 75 years with newly diagnosed high-risk/secondary acute myeloid leukemia, CPX-351 significantly improved median overall survival versus conventional 7 + 3 chemotherapy (cytarabine continuous infusion for 7 days plus daunorubicin for 3 days), with a comparable safety profile. A Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of the phase 3 study was performed to compare survival quality between patients receiving CPX-351 versus conventional 7 + 3 after 5 years of follow-up. Patients were randomized 1:1 between December 20, 2012 and November 11, 2014 to receive induction with CPX-351 or 7 + 3."}
{"qid": "604cda0994d57fd879000002", "original_text": "Balovaptan is a selective serotonin 5-hydroxytryptamine receptor subtype 1A (5-HT1A) agonist that is used to treat anxiety disorders. It works by activating the 5-HT1A receptor in the brain, which helps to regulate the excessive or abnormal activity of certain neurons in the brain that may contribute to anxiety. By activating the 5-HT1A receptor, balovaptan can help to reduce the symptoms of anxiety, such as excessive worry, fear, and apprehension. It has been shown to be effective in reducing anxiety in patients with generalized anxiety disorder (GAD) and social anxiety disorder (SAD). However, it is important to note that balovaptan has not been approved by the US Food and Drug Administration (FDA) for the treatment of anxiety disorders and is only available for use in clinical trials.", "label": 0, "is_selected": 0, "text": "Balovaptan is a selective serotonin 5-hydroxytryptamine receptor subtype 1A (5-HT1A) agonist that is used to treat anxiety disorders. It works by activating the 5-HT1A receptor in the brain, which helps to regulate the excessive or abnormal activity of certain neurons in the brain that may contribute to anxiety. By activating the 5-HT1A receptor, balovaptan can help to reduce the symptoms of anxiety, such as excessive worry, fear, and apprehension. It has been shown to be effective in reducing anxiety in patients with generalized anxiety disorder (GAD) and social anxiety disorder (SAD). However, it is important to note that balovaptan has not been approved by the US Food and Drug Administration (FDA) for the treatment of anxiety disorders and is only available for use in clinical trials."}
{"qid": "5c73ad087c78d69471000091", "original_text": "Ivacaftor is currently used for the treatment of cystic fibrosis as both monotherapy (Kalydeco; Vertex Pharmaceuticals, Boston, MA) and combination therapy with lumacaftor (Orkambi; Vertex Pharmaceuticals). Each therapy targets specific patient populations: Kalydeco treats patients carrying one of nine gating mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein, whereas Orkambi treats patients homozygous for the F508del CFTR mutation. In this study, we explored the pharmacological and metabolic effects of precision deuteration chemistry on ivacaftor by synthesizing two novel deuterated ivacaftor analogs, CTP-656 (d9-ivacaftor) and d18-ivacaftor.", "label": 1, "is_selected": 0, "text": "Ivacaftor is currently used for the treatment of cystic fibrosis as both monotherapy (Kalydeco; Vertex Pharmaceuticals, Boston, MA) and combination therapy with lumacaftor (Orkambi; Vertex Pharmaceuticals). Each therapy targets specific patient populations: Kalydeco treats patients carrying one of nine gating mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein, whereas Orkambi treats patients homozygous for the F508del CFTR mutation. In this study, we explored the pharmacological and metabolic effects of precision deuteration chemistry on ivacaftor by synthesizing two novel deuterated ivacaftor analogs, CTP-656 (d9-ivacaftor) and d18-ivacaftor."}
{"qid": "56c58f1b5795f9a73e000001", "original_text": "Mitochondria originated by permanent enslavement of purple non-sulphur bacteria. These endosymbionts became organelles through the origin of complex protein-import machinery and insertion into their inner membranes of protein carriers for extracting energy for the host. A chicken-and-egg problem exists: selective advantages for evolving import machinery were absent until inner membrane carriers were present, but this very machinery is now required for carrier insertion.", "label": 1, "is_selected": 0, "text": "Mitochondria originated by permanent enslavement of purple non-sulphur bacteria. These endosymbionts became organelles through the origin of complex protein-import machinery and insertion into their inner membranes of protein carriers for extracting energy for the host. A chicken-and-egg problem exists: selective advantages for evolving import machinery were absent until inner membrane carriers were present, but this very machinery is now required for carrier insertion."}
{"qid": "623dfd2ef0baec9a1b000004", "original_text": "The lectin chaperones calnexin (CNX) and calreticulin (CRT) localized in the endoplasmic reticulum play important roles in glycoprotein quality control. Although the interaction between these lectin chaperones and ERp57 is well known, it has been recently reported that endoplasmic reticulum protein 29 (ERp29), a member of PDI family, interacts with CNX and CRT. The biochemical function of ERp29 is unclear because it exhibits no ERp57-like redox activity. In this study, we addressed the possibility that ER chaperones CNX and CRT are connected via ERp29, based on our observation that ERp29 exists as a dimer.", "label": 1, "is_selected": 0, "text": "The lectin chaperones calnexin (CNX) and calreticulin (CRT) localized in the endoplasmic reticulum play important roles in glycoprotein quality control. Although the interaction between these lectin chaperones and ERp57 is well known, it has been recently reported that endoplasmic reticulum protein 29 (ERp29), a member of PDI family, interacts with CNX and CRT. The biochemical function of ERp29 is unclear because it exhibits no ERp57-like redox activity. In this study, we addressed the possibility that ER chaperones CNX and CRT are connected via ERp29, based on our observation that ERp29 exists as a dimer."}
{"qid": "5e2f9ceefbd6abf43b000033", "original_text": "Cardiovascular disease (CVD) is among the most common causes of mortality in all populations. Nonalcoholic steatohepatitis is a common finding in patients with CVD. Prevention of CVD in individual patients typically requires periodic clinical evaluation, as well as diagnosis and management of risk factors such as hypertension and hyperlipidemia. However, this is resource consuming and hard to implement, especially in developing countries. We designed a study to investigate the effects of a simpler strategy: a fixed-dose combination pill consisting of aspirin, valsartan, atorvastatin and hydrochlorthiazide (PolyPill) in an unselected group of persons aged over 50 years. The PolyIran-Liver study was performed in Gonbad city as an open label pragmatic randomized controlled trial nested within the Golestan Cohort Study.", "label": 1, "is_selected": 0, "text": "Cardiovascular disease (CVD) is among the most common causes of mortality in all populations. Nonalcoholic steatohepatitis is a common finding in patients with CVD. Prevention of CVD in individual patients typically requires periodic clinical evaluation, as well as diagnosis and management of risk factors such as hypertension and hyperlipidemia. However, this is resource consuming and hard to implement, especially in developing countries. We designed a study to investigate the effects of a simpler strategy: a fixed-dose combination pill consisting of aspirin, valsartan, atorvastatin and hydrochlorthiazide (PolyPill) in an unselected group of persons aged over 50 years. The PolyIran-Liver study was performed in Gonbad city as an open label pragmatic randomized controlled trial nested within the Golestan Cohort Study."}
{"qid": "5890eb22621ea6ff7e000006", "original_text": "The long pentraxin PTX3 is a key component of the humoral arm of innate immunity related to sepsis severity and mortality. We evaluated the clinical and prognostic significance of circulating PTX3 in the largest cohort ever reported of patients with severe sepsis or septic shock. Plasma PTX3 was measured on days 1, 2 and 7 after randomization of 958 patients to albumin or crystalloids for fluid resuscitation in the multicentre Albumin Italian Outcome Sepsis (ALBIOS) trial. We tested the association of PTX3 and its changes over time with clinical severity, prevalent and incident organ dysfunctions, 90-day mortality and treatment. PTX3 was high at baseline (72 [33-186] ng/mL) and rose with the severity and number of organ dysfunctions (P < 0\u00b7001) and the incidence of subsequent new failures. The PTX3 concentration dropped from day 1 to 7, but this decrease was less pronounced in patients with septic shock (P = 0\u00b70004). Higher concentrations of PTX3 on day 1 predicted incident organ dysfunctions. Albumin supplementation was associated with lower levels of PTX3 in patients with septic shock (P = 0\u00b7005) but not in those without shock. In a fully adjusted multivariable model, PTX3 on day 7 predicted 90-day mortality. Smaller drops in PTX3 predicted higher 90-day mortality. In severe sepsis and septic shock, early high PTX3 predict subsequent new organ failures, while a smaller drop in circulating PTX3 over time predicts an increased risk of death. Patients with septic shock show lower levels of PTX3 when assigned to albumin than to crystalloids.", "label": 1, "is_selected": 0, "text": "The long pentraxin PTX3 is a key component of the humoral arm of innate immunity related to sepsis severity and mortality. We evaluated the clinical and prognostic significance of circulating PTX3 in the largest cohort ever reported of patients with severe sepsis or septic shock. Plasma PTX3 was measured on days 1, 2 and 7 after randomization of 958 patients to albumin or crystalloids for fluid resuscitation in the multicentre Albumin Italian Outcome Sepsis (ALBIOS) trial. We tested the association of PTX3 and its changes over time with clinical severity, prevalent and incident organ dysfunctions, 90-day mortality and treatment. PTX3 was high at baseline (72 [33-186] ng/mL) and rose with the severity and number of organ dysfunctions (P < 0\u00b7001) and the incidence of subsequent new failures. The PTX3 concentration dropped from day 1 to 7, but this decrease was less pronounced in patients with septic shock (P = 0\u00b70004). Higher concentrations of PTX3 on day 1 predicted incident organ dysfunctions. Albumin supplementation was associated with lower levels of PTX3 in patients with septic shock (P = 0\u00b7005) but not in those without shock. In a fully adjusted multivariable model, PTX3 on day 7 predicted 90-day mortality. Smaller drops in PTX3 predicted higher 90-day mortality. In severe sepsis and septic shock, early high PTX3 predict subsequent new organ failures, while a smaller drop in circulating PTX3 over time predicts an increased risk of death. Patients with septic shock show lower levels of PTX3 when assigned to albumin than to crystalloids."}
{"qid": "58b548d722d3005309000005", "original_text": "Corynebacterium pseudodiphtheriticum is a common commensal flora of the upper respiratory tract in humans. Though the pathogenicity of C. pseudodiphtheriticum is not rare, its role as an opportunistic pathogen is mainly limited to the lower respiratory tract, particularly in patients with underlying systemic conditions or immune-compromisation. We hereby present the first case of C. pseudodiphtheriticum causing diphtheria-like illness affecting the upper respiratory tract of a 6-year-old fully immunised otherwise healthy child.", "label": 1, "is_selected": 0, "text": "Corynebacterium pseudodiphtheriticum is a common commensal flora of the upper respiratory tract in humans. Though the pathogenicity of C. pseudodiphtheriticum is not rare, its role as an opportunistic pathogen is mainly limited to the lower respiratory tract, particularly in patients with underlying systemic conditions or immune-compromisation. We hereby present the first case of C. pseudodiphtheriticum causing diphtheria-like illness affecting the upper respiratory tract of a 6-year-old fully immunised otherwise healthy child."}
{"qid": "5a7600b983b0d9ea6600000c", "original_text": "Tofacitinib is an oral Janus kinase inhibitor. Efficacy and safety of tofacitinib in patients with moderate-to-severe plaque psoriasis have been demonstrated. We sought to assess the efficacy of tofacitinib for the treatment of nail psoriasis over a period of 52 weeks. In 2 identical phase 3 studies (OPT Pivotal 1 and 2), patients were randomized 2:2:1 to receive tofacitinib 5 mg, tofacitinib 10 mg, or placebo, twice daily. At week 16, placebo-treated patients were re-randomized to tofacitinib. This post hoc analysis of patients with existing nail psoriasis assessed the Nail Psoriasis Severity Index (NAPSI) score and proportions of patients achieving \u226550% reduction in NAPSI from baseline (NAPSI50), NAPSI75, or NAPSI100. Baseline mean NAPSI scores for patients treated with tofacitinib 5 mg (N = 487), tofacitinib 10 mg (N = 476), and placebo (N = 233) twice daily were 27.0, 27.3, and 26.9, respectively. At week 16, significantly (all P < .05) more patients receiving tofacitinib 5 mg and tofacitinib 10 mg versus placebo twice daily achieved NAPSI50 (32.8%, 44.2% vs 12.0%), NAPSI75 (16.9%, 28.1% vs 6.8%), and NAPSI100 (10.3%, 18.2% vs 5.1%), respectively. Improvements were sustained to week 52. Limitations include discontinuation of clinical nonresponders at week 28. Tofacitinib treatment resulted in improvements in nail psoriasis versus placebo at week 16; improvements were maintained over 52 weeks [NCT01276639; NCT01309737].", "label": 1, "is_selected": 0, "text": "Tofacitinib is an oral Janus kinase inhibitor. Efficacy and safety of tofacitinib in patients with moderate-to-severe plaque psoriasis have been demonstrated. We sought to assess the efficacy of tofacitinib for the treatment of nail psoriasis over a period of 52 weeks. In 2 identical phase 3 studies (OPT Pivotal 1 and 2), patients were randomized 2:2:1 to receive tofacitinib 5 mg, tofacitinib 10 mg, or placebo, twice daily. At week 16, placebo-treated patients were re-randomized to tofacitinib. This post hoc analysis of patients with existing nail psoriasis assessed the Nail Psoriasis Severity Index (NAPSI) score and proportions of patients achieving \u226550% reduction in NAPSI from baseline (NAPSI50), NAPSI75, or NAPSI100. Baseline mean NAPSI scores for patients treated with tofacitinib 5 mg (N = 487), tofacitinib 10 mg (N = 476), and placebo (N = 233) twice daily were 27.0, 27.3, and 26.9, respectively. At week 16, significantly (all P < .05) more patients receiving tofacitinib 5 mg and tofacitinib 10 mg versus placebo twice daily achieved NAPSI50 (32.8%, 44.2% vs 12.0%), NAPSI75 (16.9%, 28.1% vs 6.8%), and NAPSI100 (10.3%, 18.2% vs 5.1%), respectively. Improvements were sustained to week 52. Limitations include discontinuation of clinical nonresponders at week 28. Tofacitinib treatment resulted in improvements in nail psoriasis versus placebo at week 16; improvements were maintained over 52 weeks [NCT01276639; NCT01309737]."}
{"qid": "604919411cb411341a00016c", "original_text": "Palmitoylation (S-acylation) is the reversible conjugation of a fatty acid (usually C16 palmitate) to intracellular cysteine residues of proteins via a thioester linkage. Palmitoylation anchors intracellular regions of proteins to membranes because the palmitoylated cysteine is recruited to the lipid bilayer. NCX1 is palmitoylated at a single cysteine in its large regulatory intracellular loop. The presence of an amphipathic \u03b1-helix immediately adjacent to the NCX1 palmitoylation site is required for NCX1 palmitoylation. The NCX1 palmitoylation site is conserved through most metazoan phlya.", "label": 1, "is_selected": 0, "text": "Palmitoylation (S-acylation) is the reversible conjugation of a fatty acid (usually C16 palmitate) to intracellular cysteine residues of proteins via a thioester linkage. Palmitoylation anchors intracellular regions of proteins to membranes because the palmitoylated cysteine is recruited to the lipid bilayer. NCX1 is palmitoylated at a single cysteine in its large regulatory intracellular loop. The presence of an amphipathic \u03b1-helix immediately adjacent to the NCX1 palmitoylation site is required for NCX1 palmitoylation. The NCX1 palmitoylation site is conserved through most metazoan phlya."}
{"qid": "5710ed19a5ed216440000003", "original_text": "Initiation of eukaryotic DNA replication requires phosphorylation of the MCM complex by Dbf4-dependent kinase (DDK), composed of Cdc7 kinase and its activator, Dbf4. We report here that budding yeast Rif1 (Rap1-interacting factor 1) controls DNA replication genome-wide and describe how Rif1 opposes DDK function by directing Protein Phosphatase 1 (PP1)-mediated dephosphorylation of the MCM complex. Deleting RIF1 partially compensates for the limited DDK activity in a cdc7-1 mutant strain by allowing increased, premature phosphorylation of Mcm4.", "label": 1, "is_selected": 0, "text": "Initiation of eukaryotic DNA replication requires phosphorylation of the MCM complex by Dbf4-dependent kinase (DDK), composed of Cdc7 kinase and its activator, Dbf4. We report here that budding yeast Rif1 (Rap1-interacting factor 1) controls DNA replication genome-wide and describe how Rif1 opposes DDK function by directing Protein Phosphatase 1 (PP1)-mediated dephosphorylation of the MCM complex. Deleting RIF1 partially compensates for the limited DDK activity in a cdc7-1 mutant strain by allowing increased, premature phosphorylation of Mcm4."}
{"qid": "51753a948ed59a060a000029", "original_text": "AMP-activated protein kinase (AMPK) plays a crucial role in diabetic cardiomyopathy, a condition characterized by impaired cardiac function and fibrosis in diabetic patients. AMPK is an enzyme that acts as a master regulator of cellular energy homeostasis, and its activation has been shown to attenuate diabetic cardiomyopathy by improving insulin sensitivity, reducing oxidative stress, and promoting cardiac functional recovery. Activation of AMPK can be achieved through various means, including pharmacological activation, exercise training, and metformin treatment. In diabetic animals, AMPK activation has been shown to reduce cardiac fibrosis, improve cardiac function, and reduce inflammation. Similarly, AMPK activators have been shown to improve cardiac function and reduce fibrosis in diabetic patients. Overall, AMPK plays a key role in protecting the heart against diabetic injury and may be a potential therapeutic target for the treatment of diabetic cardiomyopathy.", "label": 0, "is_selected": 0, "text": "AMP-activated protein kinase (AMPK) plays a crucial role in diabetic cardiomyopathy, a condition characterized by impaired cardiac function and fibrosis in diabetic patients. AMPK is an enzyme that acts as a master regulator of cellular energy homeostasis, and its activation has been shown to attenuate diabetic cardiomyopathy by improving insulin sensitivity, reducing oxidative stress, and promoting cardiac functional recovery. Activation of AMPK can be achieved through various means, including pharmacological activation, exercise training, and metformin treatment. In diabetic animals, AMPK activation has been shown to reduce cardiac fibrosis, improve cardiac function, and reduce inflammation. Similarly, AMPK activators have been shown to improve cardiac function and reduce fibrosis in diabetic patients. Overall, AMPK plays a key role in protecting the heart against diabetic injury and may be a potential therapeutic target for the treatment of diabetic cardiomyopathy."}
{"qid": "61f5f377882a024a10000016", "original_text": "Pegcetacoplan is an investigational drug being developed for the treatment of geographic atrophy (GA), a form of age-related macular degeneration (AMD). It is an antisense oligonucleotide that targets the protein rhodopsin, which is involved in the formation of the retinal pigment epithelium (RPE) and the maintenance of the retina. By inhibiting the expression of rhodopsin, pegcetacoplan aims to promote the survival and function of the RPE, which can help slow down the progression of GA. Pegcetacoplan has shown promise in early clinical trials, with results suggesting that it can help preserve vision in patients with GA. In a phase 2 clinical trial, pegcetacoplan was shown to improve visual acuity and reduce the size of the GA lesion compared to placebo. Additionally, pegcetacoplan has been shown to be well-tolerated in clinical trials, with the most common adverse events being mild and transient. While pegcetacoplan is still an investigational drug and has not yet been approved by regulatory authorities, it holds promise as a potential treatment for GA, a sight-threatening condition that affects millions of people worldwide. Further research is needed to confirm its safety and efficacy, but the early results are encouraging.", "label": 0, "is_selected": 0, "text": "Pegcetacoplan is an investigational drug being developed for the treatment of geographic atrophy (GA), a form of age-related macular degeneration (AMD). It is an antisense oligonucleotide that targets the protein rhodopsin, which is involved in the formation of the retinal pigment epithelium (RPE) and the maintenance of the retina. By inhibiting the expression of rhodopsin, pegcetacoplan aims to promote the survival and function of the RPE, which can help slow down the progression of GA. Pegcetacoplan has shown promise in early clinical trials, with results suggesting that it can help preserve vision in patients with GA. In a phase 2 clinical trial, pegcetacoplan was shown to improve visual acuity and reduce the size of the GA lesion compared to placebo. Additionally, pegcetacoplan has been shown to be well-tolerated in clinical trials, with the most common adverse events being mild and transient. While pegcetacoplan is still an investigational drug and has not yet been approved by regulatory authorities, it holds promise as a potential treatment for GA, a sight-threatening condition that affects millions of people worldwide. Further research is needed to confirm its safety and efficacy, but the early results are encouraging."}
{"qid": "58ee2515eda5a57672000016", "original_text": "Prevotella bacteria are known to preferentially colonize the guts of certain individuals. These include: 1. Obese individuals: Studies have shown that obese individuals have higher levels of Prevotella in their gut microbiota compared to non-obese individuals. 2. Diabetic individuals: Prevotella bacteria have been found to be more abundant in the gut microbiota of individuals with type 2 diabetes compared to healthy individuals. 3. Elderly individuals: Aging has been associated with a shift in the gut microbiota towards more Prevotella and other Gram-negative bacteria. 4. Individuals with a Western diet: A diet high in processed foods, sugar, and saturated fats can lead to an imbalance in the gut microbiota, with an overgrowth of Prevotella. 5. Individuals with inflammatory bowel diseases: Prevotella infection has been linked to the development of inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. Please keep in mind that the information provided is based on the latest medical knowledge and practices, but medical knowledge is constantly evolving, and new information may become available in the future. If you have any further questions or concerns, please don't hesitate to ask.", "label": 0, "is_selected": 0, "text": "Prevotella bacteria are known to preferentially colonize the guts of certain individuals. These include: 1. Obese individuals: Studies have shown that obese individuals have higher levels of Prevotella in their gut microbiota compared to non-obese individuals. 2. Diabetic individuals: Prevotella bacteria have been found to be more abundant in the gut microbiota of individuals with type 2 diabetes compared to healthy individuals. 3. Elderly individuals: Aging has been associated with a shift in the gut microbiota towards more Prevotella and other Gram-negative bacteria. 4. Individuals with a Western diet: A diet high in processed foods, sugar, and saturated fats can lead to an imbalance in the gut microbiota, with an overgrowth of Prevotella. 5. Individuals with inflammatory bowel diseases: Prevotella infection has been linked to the development of inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. Please keep in mind that the information provided is based on the latest medical knowledge and practices, but medical knowledge is constantly evolving, and new information may become available in the future. If you have any further questions or concerns, please don't hesitate to ask."}
{"qid": "6026ee821cb411341a0000d3", "original_text": "Eptinezumab-jjmr (referred to as eptinezumab hereafter; Vyepti\u2122) is a humanised monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. CGRP is believed to play a major role in the pathophysiology of migraine. Eptinezumab, delivered by intravenous (IV) administration, is being developed by Lundbeck Seattle BioPharmaceuticals for the prevention of migraine.", "label": 1, "is_selected": 0, "text": "Eptinezumab-jjmr (referred to as eptinezumab hereafter; Vyepti\u2122) is a humanised monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. CGRP is believed to play a major role in the pathophysiology of migraine. Eptinezumab, delivered by intravenous (IV) administration, is being developed by Lundbeck Seattle BioPharmaceuticals for the prevention of migraine."}
{"qid": "5abd31e0fcf456587200002c", "original_text": "The study of epigenetic properties of the human genome, including structural modifications of DNA and chromatin, has increased tremendously as mounting evidence has demonstrated how much epigenetics affects human gene expression. Buenrostro et al. have developed a rapid method, requiring low numbers of living cells as input, for examining chromatin accessibility across the epigenome, known as the assay for transposase-accessible chromatin using sequencing (ATAC-seq).", "label": 1, "is_selected": 0, "text": "The study of epigenetic properties of the human genome, including structural modifications of DNA and chromatin, has increased tremendously as mounting evidence has demonstrated how much epigenetics affects human gene expression. Buenrostro et al. have developed a rapid method, requiring low numbers of living cells as input, for examining chromatin accessibility across the epigenome, known as the assay for transposase-accessible chromatin using sequencing (ATAC-seq)."}
{"qid": "5d38542b7bc3fee31f000015", "original_text": "Nucleosome positions are highly correlated with the distribution of 5-methyl-cytosine (5mC) and 5-hydroxy-methyl-cytosine (5hmC) in the DNA molecule. Studies have shown that 5mC and 5hmC are often found in regions of the genome that are more accessible to the histone-modifying enzymes that add these modifications. This includes regions near nucleosomes, where the histone-DNA interaction is weaker. Conversely, 5mC and 5hmC are less frequent in regions of the genome that are more highly compacted, such as heterochromatin. This suggests that the positioning of nucleosomes may play a role in regulating the accessibility of the chromatin to histone-modifying enzymes, and thus influence the distribution of 5mC and 5hmC.", "label": 0, "is_selected": 1, "text": "The position of nucleosomes may play a role in regulating the accessibility of histone-modifying enzymes, and thus influence the distribution of 5mC and 5hmC in the DNA molecule, according to a study in Plos One, published in the journal Science."}
{"qid": "62265c953a8413c653000084", "original_text": "Natural killer (NK) cells exert critical roles in anti-tumor immunity but how their functions are regulated by epitranscriptional modification (e.g., N6-methyladenosine (m6A) methylation) is unclear. Here we report decreased expression of the m6A \"writer\" METTL3 in tumor-infiltrating NK cells, and a positive correlation between protein expression levels of METTL3 and effector molecules in NK cells.", "label": 1, "is_selected": 0, "text": "Natural killer (NK) cells exert critical roles in anti-tumor immunity but how their functions are regulated by epitranscriptional modification (e.g., N6-methyladenosine (m6A) methylation) is unclear. Here we report decreased expression of the m6A \"writer\" METTL3 in tumor-infiltrating NK cells, and a positive correlation between protein expression levels of METTL3 and effector molecules in NK cells."}
{"qid": "5ca0fa96ecadf2e73f000048", "original_text": "We suggest a novel method that uses artificial blood cells (hemoglobin vesicles, Hb-Vs) as photosensitizers in dye laser treatment (at 595-nm wavelength) for port-wine stains (i.e., capillary malformations presenting as red birthmarks) based on the results of animal experiments. As compared with human red blood cells, Hb-Vs have the same absorbance of 595 nm wavelength light and produce the same level of heat following dye laser irradiation. Small sized Hb-Vs (250 nm) distribute in the plasma phase in blood and tend to flow in the marginal zone of microvessels. Intravenous injections of Hb-Vs caused the dilatation of microvessels, and dye laser treatment with Hb-Vs destroyed the vessel wall effectively.", "label": 1, "is_selected": 0, "text": "We suggest a novel method that uses artificial blood cells (hemoglobin vesicles, Hb-Vs) as photosensitizers in dye laser treatment (at 595-nm wavelength) for port-wine stains (i.e., capillary malformations presenting as red birthmarks) based on the results of animal experiments. As compared with human red blood cells, Hb-Vs have the same absorbance of 595 nm wavelength light and produce the same level of heat following dye laser irradiation. Small sized Hb-Vs (250 nm) distribute in the plasma phase in blood and tend to flow in the marginal zone of microvessels. Intravenous injections of Hb-Vs caused the dilatation of microvessels, and dye laser treatment with Hb-Vs destroyed the vessel wall effectively."}
{"qid": "56bb6b0eac7ad1001900000e", "original_text": "This study aimed to assess the efficacy and safety of flibanserin, a serotonin receptor 1A agonist/serotonin receptor 2A antagonist, in postmenopausal women with hypoactive sexual desire disorder (HSDD). Naturally postmenopausal women with HSDD received flibanserin 100 mg once daily at bedtime (n = 468) or placebo (n = 481) for 24 weeks. Co-primary endpoints were changes from baseline to week 24 in the number of satisfying sexual events (SSEs) across 28 days and in the Female Sexual Function Index (FSFI) desire domain score. Secondary endpoints included change from baseline in Female Sexual Distress Scale-Revised (FSDS-R) Item 13 score (which assesses distress due to low sexual desire), FSDS-R total score, and FSFI total score. The Patient Benefit Evaluation was asked on treatment discontinuation. There were significant improvements with flibanserin versus placebo in the mean (SE) changes in the number of SSEs (1.0 [0.1] vs 0.6 [0.1]), FSFI desire domain score (0.7 [0.1] vs 0.4 [0.1]), FSDS-R Item 13 score (-0.8 [0.1] vs -0.6 [0.1]), FSDS-R total score (-8.3 [0.6] vs -6.3 [0.6]), and FSFI total score (4.2 [0.4] vs 2.7 [0.4]; all P < 0.01). More women on flibanserin (37.6%) than women on placebo (28.0%) reported experiencing meaningful benefits from the study medication on treatment discontinuation.", "label": 1, "is_selected": 0, "text": "This study aimed to assess the efficacy and safety of flibanserin, a serotonin receptor 1A agonist/serotonin receptor 2A antagonist, in postmenopausal women with hypoactive sexual desire disorder (HSDD). Naturally postmenopausal women with HSDD received flibanserin 100 mg once daily at bedtime (n = 468) or placebo (n = 481) for 24 weeks. Co-primary endpoints were changes from baseline to week 24 in the number of satisfying sexual events (SSEs) across 28 days and in the Female Sexual Function Index (FSFI) desire domain score. Secondary endpoints included change from baseline in Female Sexual Distress Scale-Revised (FSDS-R) Item 13 score (which assesses distress due to low sexual desire), FSDS-R total score, and FSFI total score. The Patient Benefit Evaluation was asked on treatment discontinuation. There were significant improvements with flibanserin versus placebo in the mean (SE) changes in the number of SSEs (1.0 [0.1] vs 0.6 [0.1]), FSFI desire domain score (0.7 [0.1] vs 0.4 [0.1]), FSDS-R Item 13 score (-0.8 [0.1] vs -0.6 [0.1]), FSDS-R total score (-8.3 [0.6] vs -6.3 [0.6]), and FSFI total score (4.2 [0.4] vs 2.7 [0.4]; all P < 0.01). More women on flibanserin (37.6%) than women on placebo (28.0%) reported experiencing meaningful benefits from the study medication on treatment discontinuation."}
{"qid": "515def40298dcd4e51000028", "original_text": "Vitamin D deficiency has long been suspected as a risk factor for glucose intolerance. This study compared serum levels of 25-hydroxy vitamin D(3) in pregnant women with gestational diabetes mellitus (GDM), impaired glucose tolerance (IGT), and non-GDM control subjects. In this case-control study, 54 women with diagnosed GDM and 39 women with IGT (1 abnormal oral glucose tolerance test) were compared with 111 non-GDM control women in whom GDM were excluded by glucose challenge test. Controls were matched in gestational age, age, and body mass index with IGT and GDM groups. Maternal serum 25-hydroxy vitamin D(3) concentration in GDM and IGT groups at 24-28 weeks of gestation were significantly lower than non-GDM controls (P = .001). A total of 83.3% of GDM compared with 71.2% of the control group had plasma 25-hydroxy vitamin D(3) concentrations consistent with a diagnosis of vitamin D deficiency (<20 ng/mL; P = .03). Women with GDM had a 2.66-fold increased risk of deficient status (25-hydroxy vitamin D(3) <15 ng/mL) compared with control group. These results suggested that rates of vitamin D deficiency are higher among women with IGT/GDM, and the relationship between vitamin D status and glucose tolerance in pregnancy needs further study.", "label": 1, "is_selected": 0, "text": "Vitamin D deficiency has long been suspected as a risk factor for glucose intolerance. This study compared serum levels of 25-hydroxy vitamin D(3) in pregnant women with gestational diabetes mellitus (GDM), impaired glucose tolerance (IGT), and non-GDM control subjects. In this case-control study, 54 women with diagnosed GDM and 39 women with IGT (1 abnormal oral glucose tolerance test) were compared with 111 non-GDM control women in whom GDM were excluded by glucose challenge test. Controls were matched in gestational age, age, and body mass index with IGT and GDM groups. Maternal serum 25-hydroxy vitamin D(3) concentration in GDM and IGT groups at 24-28 weeks of gestation were significantly lower than non-GDM controls (P = .001). A total of 83.3% of GDM compared with 71.2% of the control group had plasma 25-hydroxy vitamin D(3) concentrations consistent with a diagnosis of vitamin D deficiency (<20 ng/mL; P = .03). Women with GDM had a 2.66-fold increased risk of deficient status (25-hydroxy vitamin D(3) <15 ng/mL) compared with control group. These results suggested that rates of vitamin D deficiency are higher among women with IGT/GDM, and the relationship between vitamin D status and glucose tolerance in pregnancy needs further study."}
{"qid": "5157fce5d24251bc0500008c", "original_text": "Although mass spectrometry has become a powerful tool for the functional analysis of biological systems, complete proteome characterization cannot yet be achieved. Instead, the sheer complexity of living organisms demands fractionation of cellular extracts to enable more targeted analyses. Here, we introduce the concept of \"fluorous proteomics,\" whereby specific peptide subsets from samples of biological origin are tagged with perfluorinated moieties and subsequently enriched by solid-phase extraction over a fluorous-functionalized stationary phase. This approach is extremely selective, yet can readily be tailored to enrich different subsets of peptides. Additionally, this methodology overcomes many of the limitations of traditional bioaffinity-based enrichment strategies, while enabling new affinity enrichment schemes impossible to implement with bioaffinity reagents.", "label": 1, "is_selected": 0, "text": "Although mass spectrometry has become a powerful tool for the functional analysis of biological systems, complete proteome characterization cannot yet be achieved. Instead, the sheer complexity of living organisms demands fractionation of cellular extracts to enable more targeted analyses. Here, we introduce the concept of \"fluorous proteomics,\" whereby specific peptide subsets from samples of biological origin are tagged with perfluorinated moieties and subsequently enriched by solid-phase extraction over a fluorous-functionalized stationary phase. This approach is extremely selective, yet can readily be tailored to enrich different subsets of peptides. Additionally, this methodology overcomes many of the limitations of traditional bioaffinity-based enrichment strategies, while enabling new affinity enrichment schemes impossible to implement with bioaffinity reagents."}
{"qid": "622d17b83a8413c6530000a2", "original_text": "Diamond-Blackfan anemia is an autosomal dominant syndrome, characterized by anemia and a predisposition for malignancies. Ribosomal proteins are responsible for this syndrome, and the incidence of colorectal cancer in patients with this syndrome is higher than the general population. This patient's Diamond-Blackfan anemia was caused by a novel ribosomal protein S19 gene mutation, and he received chemotherapy for colorectal cancer caused by it. In his cancer, ribosomal proteins S19 and TP53 were overexpressed. He received 5FU and cetuximab; however, his anemia made chemotherapy difficult, and he did not survive long.", "label": 1, "is_selected": 0, "text": "Diamond-Blackfan anemia is an autosomal dominant syndrome, characterized by anemia and a predisposition for malignancies. Ribosomal proteins are responsible for this syndrome, and the incidence of colorectal cancer in patients with this syndrome is higher than the general population. This patient's Diamond-Blackfan anemia was caused by a novel ribosomal protein S19 gene mutation, and he received chemotherapy for colorectal cancer caused by it. In his cancer, ribosomal proteins S19 and TP53 were overexpressed. He received 5FU and cetuximab; however, his anemia made chemotherapy difficult, and he did not survive long."}
{"qid": "60607fea94d57fd87900003f", "original_text": "Recent research using chromatin conformation capture technologies, such as Hi-C, has demonstrated the importance of topologically associated domains (TADs) and smaller chromatin loops, collectively referred hereafter as \"interacting domains.\" Many such domains change during development or disease, and exhibit cell- and condition-specific differences. Quantification of the dynamic behavior of interacting domains will help to better understand genome regulation. Methods for comparing interacting domains between cells and conditions are highly limited. We developed TADCompare, a method for differential analysis of boundaries of interacting domains between two or more Hi-C datasets. TADCompare is based on a spectral clustering-derived measure called the eigenvector gap, which enables a loci-by-loci comparison of boundary differences. Using this measure, we introduce methods for identifying differential and consensus boundaries of interacting domains and tracking boundary changes over time.", "label": 1, "is_selected": 0, "text": "Recent research using chromatin conformation capture technologies, such as Hi-C, has demonstrated the importance of topologically associated domains (TADs) and smaller chromatin loops, collectively referred hereafter as \"interacting domains.\" Many such domains change during development or disease, and exhibit cell- and condition-specific differences. Quantification of the dynamic behavior of interacting domains will help to better understand genome regulation. Methods for comparing interacting domains between cells and conditions are highly limited. We developed TADCompare, a method for differential analysis of boundaries of interacting domains between two or more Hi-C datasets. TADCompare is based on a spectral clustering-derived measure called the eigenvector gap, which enables a loci-by-loci comparison of boundary differences. Using this measure, we introduce methods for identifying differential and consensus boundaries of interacting domains and tracking boundary changes over time."}
{"qid": "58965ed478275d0c4a000010", "original_text": "The cortical area map is initially patterned by transcription factor (TF) gradients in the neocortical primordium, which define a \"protomap\" in the embryonic ventricular zone (VZ). However, mechanisms that propagate regional identity from VZ progenitors to cortical plate (CP) neurons are unknown. Here we show that the VZ, subventricular zone (SVZ), and CP contain distinct molecular maps of regional identity, reflecting different gene expression gradients in radial glia progenitors, intermediate progenitors, and projection neurons, respectively. The \"intermediate map\" in the SVZ is modulated by Eomes (also known as Tbr2), a T-box TF. Eomes inactivation caused rostrocaudal shifts in SVZ and CP gene expression, with loss of corticospinal axons and gain of corticotectal projections. These findings suggest that cortical areas and connections are shaped by sequential maps of regional identity, propagated by the Pax6 \u2192 Eomes \u2192 Tbr1 TF cascade. In humans, PAX6, EOMES, and TBR1 have been linked to intellectual disability and autism.", "label": 1, "is_selected": 0, "text": "The cortical area map is initially patterned by transcription factor (TF) gradients in the neocortical primordium, which define a \"protomap\" in the embryonic ventricular zone (VZ). However, mechanisms that propagate regional identity from VZ progenitors to cortical plate (CP) neurons are unknown. Here we show that the VZ, subventricular zone (SVZ), and CP contain distinct molecular maps of regional identity, reflecting different gene expression gradients in radial glia progenitors, intermediate progenitors, and projection neurons, respectively. The \"intermediate map\" in the SVZ is modulated by Eomes (also known as Tbr2), a T-box TF. Eomes inactivation caused rostrocaudal shifts in SVZ and CP gene expression, with loss of corticospinal axons and gain of corticotectal projections. These findings suggest that cortical areas and connections are shaped by sequential maps of regional identity, propagated by the Pax6 \u2192 Eomes \u2192 Tbr1 TF cascade. In humans, PAX6, EOMES, and TBR1 have been linked to intellectual disability and autism."}
{"qid": "5e4b5fd86d0a277941000022", "original_text": "Minocycline has anti-apoptotic and anti-inflammatory effects in vitro, and extends survival in mouse models of some neurological conditions. Several trials are planned or are in progress to assess whether minocycline slows human neurodegeneration. We aimed to test the efficacy of minocycline as a treatment for amyotrophic lateral sclerosis (ALS). We did a multicentre, randomised placebo-controlled phase III trial. After a 4-month lead-in phase, 412 patients were randomly assigned to receive placebo or minocycline in escalating doses of up to 400 mg/day for 9 months. The primary outcome measure was the difference in rate of change in the revised ALS functional rating scale (ALSFRS-R). Secondary outcome measures were forced vital capacity (FVC), manual muscle testing (MMT), quality of life, survival, and safety. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00047723. ALSFRS-R score deterioration was faster in the minocycline group than in the placebo group (-1.30 vs -1.04 units/month, 95% CI for difference -0.44 to -0.08; p=0.005). Patients on minocycline also had non-significant tendencies towards faster decline in FVC (-3.48 vs -3.01, -1.03 to 0.11; p=0.11) and MMT score (-0.30 vs -0.26, -0.08 to 0.01; p=0.11), and greater mortality during the 9-month treatment phase (hazard ratio=1.32, 95% CI 0.83 to 2.10; p=0.23) than did patients on placebo.", "label": 1, "is_selected": 0, "text": "Minocycline has anti-apoptotic and anti-inflammatory effects in vitro, and extends survival in mouse models of some neurological conditions. Several trials are planned or are in progress to assess whether minocycline slows human neurodegeneration. We aimed to test the efficacy of minocycline as a treatment for amyotrophic lateral sclerosis (ALS). We did a multicentre, randomised placebo-controlled phase III trial. After a 4-month lead-in phase, 412 patients were randomly assigned to receive placebo or minocycline in escalating doses of up to 400 mg/day for 9 months. The primary outcome measure was the difference in rate of change in the revised ALS functional rating scale (ALSFRS-R). Secondary outcome measures were forced vital capacity (FVC), manual muscle testing (MMT), quality of life, survival, and safety. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00047723. ALSFRS-R score deterioration was faster in the minocycline group than in the placebo group (-1.30 vs -1.04 units/month, 95% CI for difference -0.44 to -0.08; p=0.005). Patients on minocycline also had non-significant tendencies towards faster decline in FVC (-3.48 vs -3.01, -1.03 to 0.11; p=0.11) and MMT score (-0.30 vs -0.26, -0.08 to 0.01; p=0.11), and greater mortality during the 9-month treatment phase (hazard ratio=1.32, 95% CI 0.83 to 2.10; p=0.23) than did patients on placebo."}
{"qid": "5ace17c30340b9f058000009", "original_text": "Specific anosmia is a term that describes an inability to perceive a particular odorant in the context of an otherwise normal olfactory acuity. The most common example, for the odor of androstenone, has been ascribed a prevalence ranging from 2 to 45%.", "label": 1, "is_selected": 0, "text": "Specific anosmia is a term that describes an inability to perceive a particular odorant in the context of an otherwise normal olfactory acuity. The most common example, for the odor of androstenone, has been ascribed a prevalence ranging from 2 to 45%."}
{"qid": "55031d82e9bde6963400002c", "original_text": "Adiponectin is a protein hormone produced by adipocytes (fat cells) that plays a role in glucose and lipid metabolism, inflammation, and cardiovascular health. Recent studies have also implicated adiponectin in the pathophysiology of migraine. Research has shown that low adiponectin levels are associated with an increased risk of migraine in both human and animal studies. For example, a study published in the Journal of Headache and Pain found that migraine patients had significantly lower adiponectin levels compared to healthy controls. Additionally, another study published in the European Journal of Neurology found that adiponectin levels were inversely correlated with the frequency and severity of migraine attacks. The exact mechanisms by which adiponectin is involved in migraine are not fully understood, but several theories have been proposed. One possibility is that adiponectin may modulate the activation of pain-sensing neurons in the trigeminal nerve, which is involved in migraine. Another theory is that adiponectin may affect the regulation of blood flow and vessel diameter in the brain, which can contribute to the development of migraine. In summary, there is evidence to suggest that adiponectin is associated with migraine, with lower levels of adiponectin being linked to an increased risk of migraine. Further research is needed to fully understand the mechanisms by which adiponectin is involved in migraine and to identify potential therapeutic targets for the treatment of migraine.", "label": 0, "is_selected": 0, "text": "Adiponectin is a protein hormone produced by adipocytes (fat cells) that plays a role in glucose and lipid metabolism, inflammation, and cardiovascular health. Recent studies have also implicated adiponectin in the pathophysiology of migraine. Research has shown that low adiponectin levels are associated with an increased risk of migraine in both human and animal studies. For example, a study published in the Journal of Headache and Pain found that migraine patients had significantly lower adiponectin levels compared to healthy controls. Additionally, another study published in the European Journal of Neurology found that adiponectin levels were inversely correlated with the frequency and severity of migraine attacks. The exact mechanisms by which adiponectin is involved in migraine are not fully understood, but several theories have been proposed. One possibility is that adiponectin may modulate the activation of pain-sensing neurons in the trigeminal nerve, which is involved in migraine. Another theory is that adiponectin may affect the regulation of blood flow and vessel diameter in the brain, which can contribute to the development of migraine. In summary, there is evidence to suggest that adiponectin is associated with migraine, with lower levels of adiponectin being linked to an increased risk of migraine. Further research is needed to fully understand the mechanisms by which adiponectin is involved in migraine and to identify potential therapeutic targets for the treatment of migraine."}
{"qid": "5a6d1db1b750ff4455000033", "original_text": "The FaceBase Consortium, funded by the National Institute of Dental and Craniofacial Research, National Institutes of Health, is designed to accelerate understanding of craniofacial developmental biology by generating comprehensive data resources to empower the research community, exploring high-throughput technology, fostering new scientific collaborations among researchers and human/computer interactions, facilitating hypothesis-driven research and translating science into improved health care to benefit patients. The resources generated by the FaceBase projects include a number of dynamic imaging modalities, genome-wide association studies, software tools for analyzing human facial abnormalities, detailed phenotyping, anatomical and molecular atlases, global and specific gene expression patterns, and transcriptional profiling over the course of embryonic and postnatal development in animal models and humans.", "label": 1, "is_selected": 0, "text": "The FaceBase Consortium, funded by the National Institute of Dental and Craniofacial Research, National Institutes of Health, is designed to accelerate understanding of craniofacial developmental biology by generating comprehensive data resources to empower the research community, exploring high-throughput technology, fostering new scientific collaborations among researchers and human/computer interactions, facilitating hypothesis-driven research and translating science into improved health care to benefit patients. The resources generated by the FaceBase projects include a number of dynamic imaging modalities, genome-wide association studies, software tools for analyzing human facial abnormalities, detailed phenotyping, anatomical and molecular atlases, global and specific gene expression patterns, and transcriptional profiling over the course of embryonic and postnatal development in animal models and humans."}
{"qid": "5e2fa276fbd6abf43b000035", "original_text": "The morphologic changes are described found in the gallbladder of a female patient, aged 40; she had xanthogranulomatous cholecystitis secondary to cholelithiasis combined with a hiatal hernia and multiple duodenal diverticulae (Saint's triad).", "label": 1, "is_selected": 0, "text": "The morphologic changes are described found in the gallbladder of a female patient, aged 40; she had xanthogranulomatous cholecystitis secondary to cholelithiasis combined with a hiatal hernia and multiple duodenal diverticulae (Saint's triad)."}
{"qid": "56be143eef6e394741000009", "original_text": "Wernicke's encephalopathy may be fatal if untreated. Because Wernicke's encephalopathy is suspected to be underdiagnosed in children, the authors wished to assess the frequency of overlooked diagnosis and to establish pertinent findings that could lead to early identification of pediatric Wernicke's encephalopathy. The authors performed multiple literature searches seeking pediatric patients with Wernicke's encephalopathy (age = 20 years or younger). A total of 30 patients was found, and the authors added a new patient. Each case report had its clinical, radiologic, and laboratory data, diagnostic method, and outcome analyzed.", "label": 1, "is_selected": 0, "text": "Wernicke's encephalopathy may be fatal if untreated. Because Wernicke's encephalopathy is suspected to be underdiagnosed in children, the authors wished to assess the frequency of overlooked diagnosis and to establish pertinent findings that could lead to early identification of pediatric Wernicke's encephalopathy. The authors performed multiple literature searches seeking pediatric patients with Wernicke's encephalopathy (age = 20 years or younger). A total of 30 patients was found, and the authors added a new patient. Each case report had its clinical, radiologic, and laboratory data, diagnostic method, and outcome analyzed."}
{"qid": "5318a955b166e2b806000020", "original_text": "The mechanisms by which growth factors trigger signal transduction pathways leading to protection against apoptosis are of great interest. In this study, we investigated the effect of hepatocyte growth factor (HGF/SF) and epidermal growth factor (EGF) on adriamycin (ADR)-induced apoptosis. Treatment of human epithelial MKN74 cells with ADR, a DNA topoisomerase IIalpha inhibitor, caused apoptosis. However, cells pretreated with HGF/SF, but not those pretreated with EGF, were resistant to this apoptosis. The protective effect of HGF/SF against the ADR-induced apoptosis was abolished in the presence of either LY294002, an inhibitor of phosphatidylinositol-3'-OH kinase (PI3-K) or 1L-6-hydroxymethyl-chiro-inositol 2-(R)-2-O-methyl-3-O-octadecylcarbonate, an inhibitor of Akt, thus implicating the activation of PI3-K-Akt signaling in the antiapoptotic action of HGF/SF.", "label": 1, "is_selected": 0, "text": "The mechanisms by which growth factors trigger signal transduction pathways leading to protection against apoptosis are of great interest. In this study, we investigated the effect of hepatocyte growth factor (HGF/SF) and epidermal growth factor (EGF) on adriamycin (ADR)-induced apoptosis. Treatment of human epithelial MKN74 cells with ADR, a DNA topoisomerase IIalpha inhibitor, caused apoptosis. However, cells pretreated with HGF/SF, but not those pretreated with EGF, were resistant to this apoptosis. The protective effect of HGF/SF against the ADR-induced apoptosis was abolished in the presence of either LY294002, an inhibitor of phosphatidylinositol-3'-OH kinase (PI3-K) or 1L-6-hydroxymethyl-chiro-inositol 2-(R)-2-O-methyl-3-O-octadecylcarbonate, an inhibitor of Akt, thus implicating the activation of PI3-K-Akt signaling in the antiapoptotic action of HGF/SF."}
{"qid": "53148a07dae131f847000002", "original_text": "Pendred syndrome is a rare genetic disorder caused by mutations in the SF3B1 gene. This condition primarily affects the inner ear and can cause hearing loss, as well as other symptoms such as branchial arch abnormalities, cleft palate, and/or conductive hearing loss. One of the key hormone abnormalities associated with Pendred syndrome is a deficiency of the hormone glucocorticoid. This hormone plays a crucial role in the body's response to stress, and individuals with Pendred syndrome may experience reduced levels of glucocorticoids, leading to a variety of symptoms including hearing loss, growth retardation, and developmental delays. Other hormone abnormalities that have been reported in individuals with Pendred syndrome include elevated levels of thyroid-stimulating hormone (TSH) and decreased levels of thyroxine (T4).", "label": 0, "is_selected": 0, "text": "Pendred syndrome is a rare genetic disorder caused by mutations in the SF3B1 gene. This condition primarily affects the inner ear and can cause hearing loss, as well as other symptoms such as branchial arch abnormalities, cleft palate, and/or conductive hearing loss. One of the key hormone abnormalities associated with Pendred syndrome is a deficiency of the hormone glucocorticoid. This hormone plays a crucial role in the body's response to stress, and individuals with Pendred syndrome may experience reduced levels of glucocorticoids, leading to a variety of symptoms including hearing loss, growth retardation, and developmental delays. Other hormone abnormalities that have been reported in individuals with Pendred syndrome include elevated levels of thyroid-stimulating hormone (TSH) and decreased levels of thyroxine (T4)."}
{"qid": "514a2649d24251bc0500005a", "original_text": "In patients with disorders of consciousness, the functional connectivity of the default mode network (DMN) has been found to be altered. The DMN is a network of brain regions that are active when a person is not focused on the external environment, and is thought to be involved in tasks such as self-reflection, memory retrieval, and mind-wandering. Studies have shown that patients with disorders of consciousness, such as vegetative state, Minimally Conscious State (MCS), and Locked-In Syndrome (LIS), exhibit altered functional connectivity within the DMN compared to healthy controls. These alterations have been found to be associated with the severity of consciousness impairment and can potentially be used as biomarkers for assessing the level of consciousness. For example, one study found that patients in a vegetative state showed reduced functional connectivity within the DMN compared to MCS patients, and that this reduction was associated with greater impairment in awareness and cognition. Another study found that LIS patients showed increased functional connectivity within the DMN compared to healthy controls, which was found to be associated with greater cognitive ability. These findings suggest that the functional connectivity of the DMN may be a useful tool for assessing the level of consciousness in patients with disorders of consciousness.", "label": 0, "is_selected": 0, "text": "In patients with disorders of consciousness, the functional connectivity of the default mode network (DMN) has been found to be altered. The DMN is a network of brain regions that are active when a person is not focused on the external environment, and is thought to be involved in tasks such as self-reflection, memory retrieval, and mind-wandering. Studies have shown that patients with disorders of consciousness, such as vegetative state, Minimally Conscious State (MCS), and Locked-In Syndrome (LIS), exhibit altered functional connectivity within the DMN compared to healthy controls. These alterations have been found to be associated with the severity of consciousness impairment and can potentially be used as biomarkers for assessing the level of consciousness. For example, one study found that patients in a vegetative state showed reduced functional connectivity within the DMN compared to MCS patients, and that this reduction was associated with greater impairment in awareness and cognition. Another study found that LIS patients showed increased functional connectivity within the DMN compared to healthy controls, which was found to be associated with greater cognitive ability. These findings suggest that the functional connectivity of the DMN may be a useful tool for assessing the level of consciousness in patients with disorders of consciousness."}
{"qid": "602498cb1cb411341a00009e", "original_text": "A phase II study of the PARP inhibitor olaparib (AstraZeneca) for cancer patients with inherited BRCA1 and BRCA2 gene mutations confirmed earlier results showing clinical benefit for advanced breast and ovarian cancers, and demonstrated evidence of effectiveness against pancreatic and prostate cancers.", "label": 1, "is_selected": 0, "text": "A phase II study of the PARP inhibitor olaparib (AstraZeneca) for cancer patients with inherited BRCA1 and BRCA2 gene mutations confirmed earlier results showing clinical benefit for advanced breast and ovarian cancers, and demonstrated evidence of effectiveness against pancreatic and prostate cancers."}
{"qid": "5e36ad01b5b409ea53000006", "original_text": "Gastric cancer, also known as stomach cancer, is a complex disease that has been linked to various T-cell umbilical cord blood regulatory (T-UCBR) cells. T-UCBRs are a subset of T cells that play a crucial role in maintaining immune homeostasis and preventing autoimmune diseases. However, in some cases, these cells can also promote cancer development and progression. Several T-UCRs have been implicated in gastric cancer, including: 1. T-bet: A transcription factor that regulates the expression of genes involved in immune response and inflammation. Overexpression of T-bet has been linked to gastric cancer development and progression. 2. Eomesodermin (Eomes): A transcription factor that regulates the expression of genes involved in cell proliferation and differentiation. Eomes has been shown to promote gastric cancer development and progression. 3. ROR\u03b3t: A transcription factor that regulates the expression of genes involved in immune response and inflammation. Overexpression of ROR\u03b3t has been linked to gastric cancer development and progression. 4. Foxp1: A transcription factor that regulates the expression of genes involved in immune response and inflammation. Foxp1 has been shown to promote gastric cancer development and progression. It is important to note that these findings are based on experimental studies, and further research is needed to confirm these results in humans. Additionally, the role of T-UCRs in gastric cancer development and progression may vary depending on the individual and the specific molecular mechanisms involved.", "label": 0, "is_selected": 0, "text": "Gastric cancer, also known as stomach cancer, is a complex disease that has been linked to various T-cell umbilical cord blood regulatory (T-UCBR) cells. T-UCBRs are a subset of T cells that play a crucial role in maintaining immune homeostasis and preventing autoimmune diseases. However, in some cases, these cells can also promote cancer development and progression. Several T-UCRs have been implicated in gastric cancer, including: 1. T-bet: A transcription factor that regulates the expression of genes involved in immune response and inflammation. Overexpression of T-bet has been linked to gastric cancer development and progression. 2. Eomesodermin (Eomes): A transcription factor that regulates the expression of genes involved in cell proliferation and differentiation. Eomes has been shown to promote gastric cancer development and progression. 3. ROR\u03b3t: A transcription factor that regulates the expression of genes involved in immune response and inflammation. Overexpression of ROR\u03b3t has been linked to gastric cancer development and progression. 4. Foxp1: A transcription factor that regulates the expression of genes involved in immune response and inflammation. Foxp1 has been shown to promote gastric cancer development and progression. It is important to note that these findings are based on experimental studies, and further research is needed to confirm these results in humans. Additionally, the role of T-UCRs in gastric cancer development and progression may vary depending on the individual and the specific molecular mechanisms involved."}
{"qid": "6027505c1cb411341a0000e6", "original_text": "Transurethral resection of the prostate (TURP) is the standard operation for benign prostatic obstruction. Thulium laser transurethral vaporesection of the prostate (ThuVARP) is a technique with suggested advantages over TURP, including reduced complications and hospital stay. We aimed to investigate TURP versus ThuVARP in men with lower urinary tract symptoms or urinary retention secondary to benign prostatic obstruction. In this randomised, blinded, parallel-group, pragmatic equivalence trial, men in seven UK hospitals with bothersome lower urinary tract symptoms or urinary retention secondary to benign prostatic obstruction were randomly assigned (1:1) at the point of surgery to receive ThuVARP or TURP. Patients were masked until follow-up completion. Centres used their usual TURP procedure (monopolar or bipolar). All trial surgeons underwent training on the ThuVARP technique. Co-primary outcomes were maximum urinary flow rate (Qmax) and International Prostate Symptom Score (IPSS) at 12-months post-surgery. Equivalence was defined as a difference of 2\u00b75 points or less for IPSS and 4 mL per s or less for Qmax. Analysis was done according to the intention-to-treat principle. The trial is registered with the ISRCTN Registry, ISRCTN00788389. Between July 23, 2014, and Dec 30, 2016, 410 men were randomly assigned to ThuVARP or TURP, 205 per study group.", "label": 1, "is_selected": 0, "text": "Transurethral resection of the prostate (TURP) is the standard operation for benign prostatic obstruction. Thulium laser transurethral vaporesection of the prostate (ThuVARP) is a technique with suggested advantages over TURP, including reduced complications and hospital stay. We aimed to investigate TURP versus ThuVARP in men with lower urinary tract symptoms or urinary retention secondary to benign prostatic obstruction. In this randomised, blinded, parallel-group, pragmatic equivalence trial, men in seven UK hospitals with bothersome lower urinary tract symptoms or urinary retention secondary to benign prostatic obstruction were randomly assigned (1:1) at the point of surgery to receive ThuVARP or TURP. Patients were masked until follow-up completion. Centres used their usual TURP procedure (monopolar or bipolar). All trial surgeons underwent training on the ThuVARP technique. Co-primary outcomes were maximum urinary flow rate (Qmax) and International Prostate Symptom Score (IPSS) at 12-months post-surgery. Equivalence was defined as a difference of 2\u00b75 points or less for IPSS and 4 mL per s or less for Qmax. Analysis was done according to the intention-to-treat principle. The trial is registered with the ISRCTN Registry, ISRCTN00788389. Between July 23, 2014, and Dec 30, 2016, 410 men were randomly assigned to ThuVARP or TURP, 205 per study group."}
{"qid": "5e6e35b07fc1ee872b000004", "original_text": "The blood-brain barrier (BBB) consists of endothelial cells, astrocytes, and pericytes embedded in basal lamina (BL). Most in vitro models use nonhuman, monolayer cultures for therapeutic-delivery studies, relying on transendothelial electrical resistance (TEER) measurements without other tight-junction (TJ) formation parameters. We aimed to develop reliable, reproducible, in vitro 3-dimensional (3D) models incorporating relevant human, in vivo cell types and BL proteins. The 3D BBB models were constructed with human brain endothelial cells, human astrocytes, and human brain pericytes in mono-, co-, and tricultures. TEER was measured in 3D models using a volt/ohmmeter and cellZscope. Influence of BL proteins-laminin, fibronectin, collagen type IV, agrin, and perlecan-on adhesion and TEER was assessed using an electric cell-substrate impedance-sensing system.", "label": 1, "is_selected": 0, "text": "The blood-brain barrier (BBB) consists of endothelial cells, astrocytes, and pericytes embedded in basal lamina (BL). Most in vitro models use nonhuman, monolayer cultures for therapeutic-delivery studies, relying on transendothelial electrical resistance (TEER) measurements without other tight-junction (TJ) formation parameters. We aimed to develop reliable, reproducible, in vitro 3-dimensional (3D) models incorporating relevant human, in vivo cell types and BL proteins. The 3D BBB models were constructed with human brain endothelial cells, human astrocytes, and human brain pericytes in mono-, co-, and tricultures. TEER was measured in 3D models using a volt/ohmmeter and cellZscope. Influence of BL proteins-laminin, fibronectin, collagen type IV, agrin, and perlecan-on adhesion and TEER was assessed using an electric cell-substrate impedance-sensing system."}
{"qid": "5c74285c7c78d694710000a3", "original_text": "Stress granules are non-membranous structures that transiently form in the cytoplasm during cellular stress, where they promote translational repression of non-essential RNAs and modulate cell signaling by sequestering key signal transduction proteins. These and other functions of stress granules facilitate an adaptive cellular response to environmental adversity. A key component of stress granules is the prion-related RNA-binding protein, T cell intracellular antigen-1 (TIA-1).", "label": 1, "is_selected": 0, "text": "Stress granules are non-membranous structures that transiently form in the cytoplasm during cellular stress, where they promote translational repression of non-essential RNAs and modulate cell signaling by sequestering key signal transduction proteins. These and other functions of stress granules facilitate an adaptive cellular response to environmental adversity. A key component of stress granules is the prion-related RNA-binding protein, T cell intracellular antigen-1 (TIA-1)."}
{"qid": "5157539ed24251bc0500008a", "original_text": "In prokaryotic organisms, the analogous process to RNA interference (RNAi) for gene silencing is CRISPR-Cas systems (Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-associated proteins). CRISPR-Cas systems use a small RNA molecule, known as a guide RNA, to locate specific DNA sequences and cleave them, leading to the silencing of the corresponding gene. This process is a natural defense mechanism that prokaryotes use to protect themselves against foreign genetic material, and it has been adapted for use in basic research and gene therapy.", "label": 0, "is_selected": 1, "text": "A new method for silencing genes has been developed by scientists at the Massachusetts Institute of Technology (MIT) and the University of California, Los Angeles (UCLA). This work is part of a series of papers published in Plos One on the use of CRISPR-Cas systems for gene silencing."}
{"qid": "5a67c497b750ff4455000012", "original_text": "The interpretation of non-coding variants still constitutes a major challenge in the application of whole-genome sequencing in Mendelian disease, especially for single-nucleotide and other small non-coding variants. Here we present Genomiser, an analysis framework that is able not only to score the relevance of variation in the non-coding genome, but also to associate regulatory variants to specific Mendelian diseases. Genomiser scores variants through either existing methods such as CADD or a bespoke machine learning method and combines these with allele frequency, regulatory sequences, chromosomal topological domains, and phenotypic relevance to discover variants associated to specific Mendelian disorders.", "label": 1, "is_selected": 0, "text": "The interpretation of non-coding variants still constitutes a major challenge in the application of whole-genome sequencing in Mendelian disease, especially for single-nucleotide and other small non-coding variants. Here we present Genomiser, an analysis framework that is able not only to score the relevance of variation in the non-coding genome, but also to associate regulatory variants to specific Mendelian diseases. Genomiser scores variants through either existing methods such as CADD or a bespoke machine learning method and combines these with allele frequency, regulatory sequences, chromosomal topological domains, and phenotypic relevance to discover variants associated to specific Mendelian disorders."}
{"qid": "52f89ee42059c6d71c00004d", "original_text": "Valproic acid (VPA) is a widely prescribed anticonvulsant for the treatment of epilepsy. Here we demonstrate that VPA is a novel activator of AMP-activated protein kinase (AMPK), a key regulator of cellular metabolism, using primary mouse and human hepatocytes. Incubation of primary mouse hepatocytes with VPA resulted in increased levels of phosphorylated AMPK and acetyl-CoA carboxylase (ACC). This finding was recapitulated using primary human hepatocytes. Pretreatment of mouse hepatocytes with a small-molecule inhibitor of AMPK, Compound C (6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine), abrogated the phosphorylation of ACC following treatment with VPA.", "label": 1, "is_selected": 0, "text": "Valproic acid (VPA) is a widely prescribed anticonvulsant for the treatment of epilepsy. Here we demonstrate that VPA is a novel activator of AMP-activated protein kinase (AMPK), a key regulator of cellular metabolism, using primary mouse and human hepatocytes. Incubation of primary mouse hepatocytes with VPA resulted in increased levels of phosphorylated AMPK and acetyl-CoA carboxylase (ACC). This finding was recapitulated using primary human hepatocytes. Pretreatment of mouse hepatocytes with a small-molecule inhibitor of AMPK, Compound C (6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine), abrogated the phosphorylation of ACC following treatment with VPA."}
{"qid": "52f65f372059c6d71c000027", "original_text": "Thyroid hormones (THs) enhance MHC alpha gene- and repress MHC beta gene-transcription in the heart, by interacting with specific nuclear receptors (TRs), that bind to regulatory sequences localized upstream of basal promoter of myosin heavy chain (MHC) genes. The overall effects of THs include an increase in V1- and a decrease in V3-myosin isozyme concentration in the heart. Myosin V1 contains two MHC alpha chains and has a higher ATPase activity than V3 isoform, which contains two beta chains. Previous studies on papillary muscles of spontaneously hypertensive rats (SHRs) showed that heart hypertrophy is accompanied by a shift from alpha to beta MHC accumulation. The present study was aimed at evaluating whether this event relates to differential expression of alpha1, alpha2, and beta1 isoforms of TRs. At the ages of 8 and 15 weeks, SHRs and Harlan Sprague-Dawley control rats were sacrificed under anesthesia and their hearts were dissected into left and right ventricles, free of atria and great vessels. The results of Western blot analyses showed that the levels of the three TR isoforms do not differ significantly between SHRs and control rats of the same age, either in the left or in the right ventricle. Thus, the expression of MHC beta in SHR hypertrophic heart does not seem to depend on changes in TR isoform concentrations.", "label": 1, "is_selected": 0, "text": "Thyroid hormones (THs) enhance MHC alpha gene- and repress MHC beta gene-transcription in the heart, by interacting with specific nuclear receptors (TRs), that bind to regulatory sequences localized upstream of basal promoter of myosin heavy chain (MHC) genes. The overall effects of THs include an increase in V1- and a decrease in V3-myosin isozyme concentration in the heart. Myosin V1 contains two MHC alpha chains and has a higher ATPase activity than V3 isoform, which contains two beta chains. Previous studies on papillary muscles of spontaneously hypertensive rats (SHRs) showed that heart hypertrophy is accompanied by a shift from alpha to beta MHC accumulation. The present study was aimed at evaluating whether this event relates to differential expression of alpha1, alpha2, and beta1 isoforms of TRs. At the ages of 8 and 15 weeks, SHRs and Harlan Sprague-Dawley control rats were sacrificed under anesthesia and their hearts were dissected into left and right ventricles, free of atria and great vessels. The results of Western blot analyses showed that the levels of the three TR isoforms do not differ significantly between SHRs and control rats of the same age, either in the left or in the right ventricle. Thus, the expression of MHC beta in SHR hypertrophic heart does not seem to depend on changes in TR isoform concentrations."}
{"qid": "605b9c2a94d57fd879000035", "original_text": "Amblyopia is defined as the reduction of best-corrected visual acuity of one or both eyes caused by conditions that affect normal visual development. The basic strategy to treat amblyopia is to obtain a clear retinal image in each eye and correct ocular dominance through forced use of the amblyopic eye. Treatment modalities include correcting any underlying organic disease, prescribing appropriate optical correction, and providing occlusion/penalization therapy for the non-amblyopic eye. Given the success of amblyopia treatment declines with increasing age, the detection and management of amblyopia should begin as early as possible during the sensitive period for visual development. Proper management of amblyopia during childhood can reduce the overall prevalence and severity of visual loss.", "label": 1, "is_selected": 0, "text": "Amblyopia is defined as the reduction of best-corrected visual acuity of one or both eyes caused by conditions that affect normal visual development. The basic strategy to treat amblyopia is to obtain a clear retinal image in each eye and correct ocular dominance through forced use of the amblyopic eye. Treatment modalities include correcting any underlying organic disease, prescribing appropriate optical correction, and providing occlusion/penalization therapy for the non-amblyopic eye. Given the success of amblyopia treatment declines with increasing age, the detection and management of amblyopia should begin as early as possible during the sensitive period for visual development. Proper management of amblyopia during childhood can reduce the overall prevalence and severity of visual loss."}
{"qid": "621b78e63a8413c65300003f", "original_text": "Bioconjugate vaccines, consisting of polysaccharides attached to carrier proteins, are enzymatically generated using prokaryotic glycosylation systems in a process termed bioconjugation. Key to bioconjugation are a group of enzymes known as oligosaccharyltransferases (OTases) that transfer polysaccharides to engineered carrier proteins containing conserved amino acid sequences known as sequons. The most recently discovered OTase, PglS, has been shown to have the broadest substrate scope, transferring many different types of bacterial glycans including those with glucose at the reducing end. However, PglS is currently the least understood in terms of the sequon it recognizes. PglS is a pilin-specific O-linking OTase that naturally glycosylates a single protein, ComP. In addition to ComP, we previously demonstrated that an engineered carrier protein containing a large fragment of ComP is also glycosylated by PglS. Here we sought to identify the minimal ComP sequon sufficient for PglS glycosylation. We tested >100 different ComP fragments individually fused to Pseudomonas aeruginosa exotoxin", "label": 1, "is_selected": 0, "text": "Bioconjugate vaccines, consisting of polysaccharides attached to carrier proteins, are enzymatically generated using prokaryotic glycosylation systems in a process termed bioconjugation. Key to bioconjugation are a group of enzymes known as oligosaccharyltransferases (OTases) that transfer polysaccharides to engineered carrier proteins containing conserved amino acid sequences known as sequons. The most recently discovered OTase, PglS, has been shown to have the broadest substrate scope, transferring many different types of bacterial glycans including those with glucose at the reducing end. However, PglS is currently the least understood in terms of the sequon it recognizes. PglS is a pilin-specific O-linking OTase that naturally glycosylates a single protein, ComP. In addition to ComP, we previously demonstrated that an engineered carrier protein containing a large fragment of ComP is also glycosylated by PglS. Here we sought to identify the minimal ComP sequon sufficient for PglS glycosylation. We tested >100 different ComP fragments individually fused to Pseudomonas aeruginosa exotoxin"}
{"qid": "5c5f2c0c1a4c55d80b000021", "original_text": "The present study was aimed to determine whether trefoil factor family (TFF) peptides which were generally considered to be resistant to proteolysis could be digested by gingipains, a major proteinases produced by Porphyromonas gingivalis. Recombinant human TFF1, TFF2, and TFF3 peptides were used as substrates. Gingipains including arginine gingipain (RgpB) and lysine gingipain (Kgp) were used as enzymes. Trypsin was used as a control protease. Matrix-assisted laser desorption/ionization with time-of-flight / time-of-flight (MALDI-TOF/TOF) and liquid chromatography mass spectrometry (LC-MS) were used for analyzing peptide mass signals and amino acid sequences of digested TFF peptides. MALDI-TOF/TOF analyses demonstrated that Kgp, RgpB, and trypsin were able to cleave TFF1 and TFF2 peptides, resulting in different patterns of digested fragments.", "label": 1, "is_selected": 0, "text": "The present study was aimed to determine whether trefoil factor family (TFF) peptides which were generally considered to be resistant to proteolysis could be digested by gingipains, a major proteinases produced by Porphyromonas gingivalis. Recombinant human TFF1, TFF2, and TFF3 peptides were used as substrates. Gingipains including arginine gingipain (RgpB) and lysine gingipain (Kgp) were used as enzymes. Trypsin was used as a control protease. Matrix-assisted laser desorption/ionization with time-of-flight / time-of-flight (MALDI-TOF/TOF) and liquid chromatography mass spectrometry (LC-MS) were used for analyzing peptide mass signals and amino acid sequences of digested TFF peptides. MALDI-TOF/TOF analyses demonstrated that Kgp, RgpB, and trypsin were able to cleave TFF1 and TFF2 peptides, resulting in different patterns of digested fragments."}
{"qid": "5a760ed883b0d9ea66000019", "original_text": "Dasatinib, a tyrosine kinase inhibitor, has been investigated as a potential treatment for glioblastoma, an aggressive and malignant brain tumor. While early clinical trials showed promise, subsequent studies have yielded mixed results. Several phase II and III clinical trials have evaluated the efficacy of dasatinib in treating glioblastoma. However, these studies have generally failed to demonstrate a significant clinical benefit for dasatinib compared to standard of care chemotherapy or other treatments. For example, a phase III clinical trial published in the New England Journal of Medicine in 2012 found that dasatinib did not improve overall survival compared to standard chemotherapy in patients with newly diagnosed glioblastoma. More recent studies have suggested that dasatinib may be effective in specific patient subgroups, such as those with IDH1/2 mutations. IDH1/2 mutations are genetic alterations that are present in a subset of glioblastomas and are associated with a more favorable prognosis. However, these findings are based on smaller, more limited studies and have not been consistently demonstrated in larger, more definitive trials. In summary, while there is some evidence to suggest that dasatinib may be effective in the treatment of glioblastoma, particularly in certain patient subgroups, the current evidence base is mixed and more research is needed to determine its full potential as a treatment for this devastating disease.", "label": 0, "is_selected": 0, "text": "Dasatinib, a tyrosine kinase inhibitor, has been investigated as a potential treatment for glioblastoma, an aggressive and malignant brain tumor. While early clinical trials showed promise, subsequent studies have yielded mixed results. Several phase II and III clinical trials have evaluated the efficacy of dasatinib in treating glioblastoma. However, these studies have generally failed to demonstrate a significant clinical benefit for dasatinib compared to standard of care chemotherapy or other treatments. For example, a phase III clinical trial published in the New England Journal of Medicine in 2012 found that dasatinib did not improve overall survival compared to standard chemotherapy in patients with newly diagnosed glioblastoma. More recent studies have suggested that dasatinib may be effective in specific patient subgroups, such as those with IDH1/2 mutations. IDH1/2 mutations are genetic alterations that are present in a subset of glioblastomas and are associated with a more favorable prognosis. However, these findings are based on smaller, more limited studies and have not been consistently demonstrated in larger, more definitive trials. In summary, while there is some evidence to suggest that dasatinib may be effective in the treatment of glioblastoma, particularly in certain patient subgroups, the current evidence base is mixed and more research is needed to determine its full potential as a treatment for this devastating disease."}
{"qid": "550b0408c2af5d5b7000000c", "original_text": "The development of enzyme immobilization techniques that will not affect catalytic activity and conformation is an important research task. Affinity tags that are present or added at a specific position far from the active site in the structure of the native enzyme could be used to create strong affinity bonds between the protein structure and a surface functionalized with the complementary affinity ligand. These immobilization techniques are based on affinity interactions between biotin and (strept)avidin molecules, lectins and sugars, or metal chelate and histidine tag. Recent developments involve immobilization of tagged enzymes onto magnetic nanoparticles. These supports can improve the performance of immobilized biomolecules in analytical assay because magnetic beads provide a relative large numbers of binding sites for biochemical reactions resulting in faster assay kinetics. This chapter describes immobilization procedures of tagged enzymes onto various magnetic beads.", "label": 1, "is_selected": 0, "text": "The development of enzyme immobilization techniques that will not affect catalytic activity and conformation is an important research task. Affinity tags that are present or added at a specific position far from the active site in the structure of the native enzyme could be used to create strong affinity bonds between the protein structure and a surface functionalized with the complementary affinity ligand. These immobilization techniques are based on affinity interactions between biotin and (strept)avidin molecules, lectins and sugars, or metal chelate and histidine tag. Recent developments involve immobilization of tagged enzymes onto magnetic nanoparticles. These supports can improve the performance of immobilized biomolecules in analytical assay because magnetic beads provide a relative large numbers of binding sites for biochemical reactions resulting in faster assay kinetics. This chapter describes immobilization procedures of tagged enzymes onto various magnetic beads."}
{"qid": "5c8962e8d558e5f232000001", "original_text": "Super-enhancers are genomic elements that potently enhance the expression of nearby genes, and they have shown promise in disease diagnosis. These enhancers can be used to identify specific disease-associated genetic variants by analyzing the pattern of super-enhancer activity in patient cells. For instance, studies have shown that super-enhancers can be exploited to detect the presence of mutations in cancer cells, allowing for earlier and more accurate diagnosis. Additionally, super-enhancers can be used to identify specific biomarkers for neurological disorders, such as Alzheimer's disease, by analyzing the expression patterns of super-enhancer-controlled genes. Overall, super-enhancers offer a powerful tool for disease diagnosis, as they can provide a detailed and accurate picture of the molecular changes that occur in disease.", "label": 0, "is_selected": 0, "text": "Super-enhancers are genomic elements that potently enhance the expression of nearby genes, and they have shown promise in disease diagnosis. These enhancers can be used to identify specific disease-associated genetic variants by analyzing the pattern of super-enhancer activity in patient cells. For instance, studies have shown that super-enhancers can be exploited to detect the presence of mutations in cancer cells, allowing for earlier and more accurate diagnosis. Additionally, super-enhancers can be used to identify specific biomarkers for neurological disorders, such as Alzheimer's disease, by analyzing the expression patterns of super-enhancer-controlled genes. Overall, super-enhancers offer a powerful tool for disease diagnosis, as they can provide a detailed and accurate picture of the molecular changes that occur in disease."}
{"qid": "625ebf76e764a53204000033", "original_text": "When untreated, Aortic intramural hematoma (IMH) can evolve into more severe complications, including: 1. Aortic dissection: The hematoma can tear the tunica intima, leading to bleeding into the media and potentially causing aortic dissection, which is a life-threatening condition. 2. Aortic aneurysm: The hematoma can lead to a dilatation of the aortic root and subsequent development of an aortic aneurysm, which can result in acute rupture. 3. Cardiac tamponade: The hematoma can compress the heart and cause cardiac tamponade, which can lead to decreased cardiac output, hypotension, and circulatory collapse. 4. Heart failure: The hematoma can lead to myocardial injury and left ventricular dysfunction, ultimately resulting in heart failure. It is crucial to seek medical attention immediately if symptoms persist or worsen over time, as timely treatment can prevent these complications and reduce the risk of severe outcomes.", "label": 0, "is_selected": 1, "text": "Aortic hematoma is a potentially life-threatening condition that causes blood to build-up in the heart muscle, leading to bleeding into the media and potentially causing aortic dissection, according to the American College of Cardiology (ACL) and the American Heart Association (AHA) in a joint statement. aortic dissection: The hematoma can lead to teara tunica to tear the aorta, which is a life- threatening condition."}
{"qid": "56f157a52ac5ed1459000011", "original_text": "In microbial communities, bacterial populations are commonly controlled using indiscriminate, broad range antibiotics. There are few ways to target specific strains effectively without disrupting the entire microbiome and local environment. Here, we use conjugation, a natural DNA horizontal transfer process among bacterial species, to deliver an engineered CRISPR interference (CRISPRi) system for targeting specific genes in recipient Escherichia coli cells. We show that delivery of the CRISPRi system is successful and can specifically repress a reporter gene in recipient cells, thereby establishing a new tool for gene regulation across bacterial cells and potentially for bacterial population control.", "label": 1, "is_selected": 0, "text": "In microbial communities, bacterial populations are commonly controlled using indiscriminate, broad range antibiotics. There are few ways to target specific strains effectively without disrupting the entire microbiome and local environment. Here, we use conjugation, a natural DNA horizontal transfer process among bacterial species, to deliver an engineered CRISPR interference (CRISPRi) system for targeting specific genes in recipient Escherichia coli cells. We show that delivery of the CRISPRi system is successful and can specifically repress a reporter gene in recipient cells, thereby establishing a new tool for gene regulation across bacterial cells and potentially for bacterial population control."}
{"qid": "5a87f44061bb38fb2400000f", "original_text": "Alk (Alcohol dehydrogenase) inhibitors have been approved for the treatment of certain disorders, including: * Breast cancer: Alk inhibitors are used in the treatment of breast cancer that has spread to other parts of the body (metastatic breast cancer) and has a specific genetic mutation known as ALK fusion. In summary, Alk inhibitors are most commonly used in the treatment of metastatic breast cancer with an ALK fusion, as it can help slow the growth and progression of the cancer. However, it's important to note that not everyone with breast cancer has this genetic mutation, and other treatments may be more appropriate for some individuals. It is best to consult with a qualified healthcare professional for personalized medical advice.", "label": 0, "is_selected": 0, "text": "Alk (Alcohol dehydrogenase) inhibitors have been approved for the treatment of certain disorders, including: * Breast cancer: Alk inhibitors are used in the treatment of breast cancer that has spread to other parts of the body (metastatic breast cancer) and has a specific genetic mutation known as ALK fusion. In summary, Alk inhibitors are most commonly used in the treatment of metastatic breast cancer with an ALK fusion, as it can help slow the growth and progression of the cancer. However, it's important to note that not everyone with breast cancer has this genetic mutation, and other treatments may be more appropriate for some individuals. It is best to consult with a qualified healthcare professional for personalized medical advice."}
{"qid": "58850e50e56acf5176000013", "original_text": "The FUNC (Favorable Outcome After Non-traumatic Cerebral Hemorrhage) score is a clinical prediction rule used to predict the outcome of patients with intracerebral hemorrhage (ICH). The score assesses several clinical factors that are associated with better or worse outcomes in patients with ICH. These factors include: * Age (0 points for patients under 60 years old, 1 point for each year over 60) * GCS (Glasgow Coma Scale) at admission (0-12 points) * ALT (aspartate transaminase) level (higher levels indicate worse outcome) * AST (aspartate aminotransaminase) level (higher levels indicate worse outcome) * Hct (hemoglobin level) at admission (lower levels indicate worse outcome) * ICP (intracranial pressure) at admission (higher levels indicate worse outcome) * SBP (systolic blood pressure) at admission (lower levels indicate worse outcome) * BB (base excess) at admission (higher levels indicate worse outcome) The score ranges from 0 to 12, with higher scores indicating a better outcome. A score of 0-2 is associated with a favorable outcome, while a score of 3-6 is associated with an unfavorable outcome, and a score of 7-12 is associated with a poor outcome. It's important to note that the FUNC score is not a diagnostic tool, but rather a predictive tool that can help doctors estimate the likelihood of a good outcome in patients with ICH.", "label": 0, "is_selected": 1, "text": "The British Medical Journal (BMJ) has published the results of a study showing that the FUNC score can be used to predict the outcome of patients with intracerebral hemorrhage, as well as to assess the likelihood of a good outcome in those with a worse outcome., here's what you need to know about the score and how it can help you decide whether or not to treat a patient with ICH, and how you can use it to help your own treatment decisions, and your hospital's treatment decisions."}
{"qid": "56c1d848ef6e39474100002f", "original_text": "A Tarlov cyst is a type of fluid-filled cyst that forms within the sacrum, the triangular bone at the base of the spine. These cysts are caused by a abnormal communication between the sacrum and the surrounding soft tissues, allowing fluid to enter and accumulate within the sacrum. Tarlov cysts can cause back pain, sciatica, and other symptoms depending on their location and size. Treatment options include observation, pain management, and surgery to remove the cyst. The exact cause of Tarlov cysts is not fully understood, but they are more common in people with a family history of the condition.", "label": 0, "is_selected": 0, "text": "A Tarlov cyst is a type of fluid-filled cyst that forms within the sacrum, the triangular bone at the base of the spine. These cysts are caused by a abnormal communication between the sacrum and the surrounding soft tissues, allowing fluid to enter and accumulate within the sacrum. Tarlov cysts can cause back pain, sciatica, and other symptoms depending on their location and size. Treatment options include observation, pain management, and surgery to remove the cyst. The exact cause of Tarlov cysts is not fully understood, but they are more common in people with a family history of the condition."}
{"qid": "5e48b1ddd14c9f295d000012", "original_text": "Multiple sclerosis (MS) is a common and chronic central nervous system (CNS) demyelinating disease and a leading cause of permanent disability. Patients most often present with a relapsing-remitting disease course, typically progressing over time to a phase of relentless advancement in secondary progressive MS (SPMS), for which approved disease-modifying therapies are limited. In this review, we summarize the pathophysiological mechanisms involved in the development of SPMS and the rationale and clinical potential for natalizumab, which is currently approved for the treatment of relapsing forms of MS, to exert beneficial effects in reducing disease progression unrelated to relapses in SPMS. In both forms of MS, active brain-tissue injury is associated with inflammation; but in SPMS, the inflammatory response occurs at least partly behind the blood-brain barrier and is followed by a cascade of events, including persistent microglial activation that may lead to chronic demyelination and neurodegeneration associated with irreversible disability. In patients with relapsing forms of MS, natalizumab therapy is known to significantly reduce intrathecal inflammatory responses which results in reductions in brain lesions and brain atrophy as well as beneficial effects on clinical measures, such as reduced frequency and severity of relapse and reduced accumulation of disability. Natalizumab treatment also reduces levels of cerebrospinal fluid chemokines and other biomarkers of intrathecal inflammation, axonal damage and demyelination, and has demonstrated the ability to reduce innate immune activation and intrathecal immunoglobulin synthesis in patients with MS. The efficacy of natalizumab therapy in SPMS is currently being investigated in a randomized, double-blind, placebo-controlled trial.", "label": 1, "is_selected": 0, "text": "Multiple sclerosis (MS) is a common and chronic central nervous system (CNS) demyelinating disease and a leading cause of permanent disability. Patients most often present with a relapsing-remitting disease course, typically progressing over time to a phase of relentless advancement in secondary progressive MS (SPMS), for which approved disease-modifying therapies are limited. In this review, we summarize the pathophysiological mechanisms involved in the development of SPMS and the rationale and clinical potential for natalizumab, which is currently approved for the treatment of relapsing forms of MS, to exert beneficial effects in reducing disease progression unrelated to relapses in SPMS. In both forms of MS, active brain-tissue injury is associated with inflammation; but in SPMS, the inflammatory response occurs at least partly behind the blood-brain barrier and is followed by a cascade of events, including persistent microglial activation that may lead to chronic demyelination and neurodegeneration associated with irreversible disability. In patients with relapsing forms of MS, natalizumab therapy is known to significantly reduce intrathecal inflammatory responses which results in reductions in brain lesions and brain atrophy as well as beneficial effects on clinical measures, such as reduced frequency and severity of relapse and reduced accumulation of disability. Natalizumab treatment also reduces levels of cerebrospinal fluid chemokines and other biomarkers of intrathecal inflammation, axonal damage and demyelination, and has demonstrated the ability to reduce innate immune activation and intrathecal immunoglobulin synthesis in patients with MS. The efficacy of natalizumab therapy in SPMS is currently being investigated in a randomized, double-blind, placebo-controlled trial."}
{"qid": "55152c0a46478f2f2c000004", "original_text": "The Barr body has long been recognized as the cytological manifestation of the inactive X chromosome (Xi) in interphase nuclei. Despite being known for over 50 years, relatively few components of the Barr body have been identified. In this study, we have screened over 30 histone variants, modified histones and non-histone proteins for their association with or exclusion from the Barr body. We demonstrate that, similar to the histone variant macroH2A, heterochromatin protein-1 (HP1), histone H1 and the high mobility group protein HMG-I/Y are elevated at the territory of the Xi in interphase in human cell lines, but only when the Xi chromatin is heteropycnotic, implicating each as a component of the Barr body.", "label": 1, "is_selected": 0, "text": "The Barr body has long been recognized as the cytological manifestation of the inactive X chromosome (Xi) in interphase nuclei. Despite being known for over 50 years, relatively few components of the Barr body have been identified. In this study, we have screened over 30 histone variants, modified histones and non-histone proteins for their association with or exclusion from the Barr body. We demonstrate that, similar to the histone variant macroH2A, heterochromatin protein-1 (HP1), histone H1 and the high mobility group protein HMG-I/Y are elevated at the territory of the Xi in interphase in human cell lines, but only when the Xi chromatin is heteropycnotic, implicating each as a component of the Barr body."}
{"qid": "5ca60a77ecadf2e73f00004d", "original_text": "According to current models, once the cell has reached terminal differentiation, the enhancer repertoire is completely established and maintained by cooperatively acting lineage-specific transcription factors (TFs). TFs activated by extracellular stimuli operate within this predetermined repertoire, landing close to where master regulators are constitutively bound. Here, we describe latent enhancers, defined as regions of the genome that in terminally differentiated cells are unbound by TFs and lack the histone marks characteristic of enhancers but acquire these features in response to stimulation.", "label": 1, "is_selected": 0, "text": "According to current models, once the cell has reached terminal differentiation, the enhancer repertoire is completely established and maintained by cooperatively acting lineage-specific transcription factors (TFs). TFs activated by extracellular stimuli operate within this predetermined repertoire, landing close to where master regulators are constitutively bound. Here, we describe latent enhancers, defined as regions of the genome that in terminally differentiated cells are unbound by TFs and lack the histone marks characteristic of enhancers but acquire these features in response to stimulation."}
{"qid": "530c7cfd970c65fa6b00000c", "original_text": "Yes, there are proteins that undergo both mono-ubiquitination and poly-ubiquitination. An example of such a protein is the tumor protein 53 (TP53), which can be mono-ubiquitinated at specific lysine residues, leading to its activation, and poly-ubiquitinated, leading to its degradation. Other proteins that exhibit both mono- and poly-ubiquitination include p52 (CDC45L1) and RING1B.", "label": 0, "is_selected": 0, "text": "Yes, there are proteins that undergo both mono-ubiquitination and poly-ubiquitination. An example of such a protein is the tumor protein 53 (TP53), which can be mono-ubiquitinated at specific lysine residues, leading to its activation, and poly-ubiquitinated, leading to its degradation. Other proteins that exhibit both mono- and poly-ubiquitination include p52 (CDC45L1) and RING1B."}
{"qid": "518cb6ab310faafe08000009", "original_text": "Serum thyroid hormone concentrations were measured before and during 6 months treatment with propranolol (160 mg/day) in eight patients with T3 (triiodothyronine) toxicosis. Serum total T3 concentrations showed a significant (p less than 0.01) and sustained fall to approximately 80% of pre-treatment values. Six of the patients, however, remained clinically and biochemically hyperthyroid and our data do not support the use of propranolol as sole therapy in T3 toxicosis.", "label": 1, "is_selected": 0, "text": "Serum thyroid hormone concentrations were measured before and during 6 months treatment with propranolol (160 mg/day) in eight patients with T3 (triiodothyronine) toxicosis. Serum total T3 concentrations showed a significant (p less than 0.01) and sustained fall to approximately 80% of pre-treatment values. Six of the patients, however, remained clinically and biochemically hyperthyroid and our data do not support the use of propranolol as sole therapy in T3 toxicosis."}
{"qid": "5c7034ae7c78d69471000063", "original_text": "The TRIUMEQ pill is a fixed-dose combination medication that contains three drugs: trimethoprim, sulfamethoxazole, and trimethoprim-sulfamethoxazole. These drugs are used to treat a variety of bacterial infections, including urinary tract infections, bronchitis, and pneumonia. The specific dosages and combinations of these drugs in the TRIUMEQ pill may vary depending on the individual patient and the specific infection being treated.", "label": 0, "is_selected": 0, "text": "The TRIUMEQ pill is a fixed-dose combination medication that contains three drugs: trimethoprim, sulfamethoxazole, and trimethoprim-sulfamethoxazole. These drugs are used to treat a variety of bacterial infections, including urinary tract infections, bronchitis, and pneumonia. The specific dosages and combinations of these drugs in the TRIUMEQ pill may vary depending on the individual patient and the specific infection being treated."}
{"qid": "5e2dad57fbd6abf43b000010", "original_text": "No, amantadine ER is not the first approved treatment for akinesia. The first approved treatment for akinesia was donepezil, which was approved by the FDA in 1996. Amantadine ER was approved in 2000 for the treatment of Parkinson's disease, but it is not specifically approved for the treatment of akinesia.", "label": 0, "is_selected": 1, "text": "The US Food and Drug Administration (FDA) has approved amantadine ER for the treatment of akinesia, a condition that affects movement in people with Parkinson's disease, as well as in people who have already been treated with other treatments."}
{"qid": "5e6e5d1d51b80c9423000003", "original_text": "Autism spectrum disorder (ASD) is a common, complex neurological condition, affecting approximately 1% of people worldwide. Monogenic neurodevelopmental disorders which showed autistic behavior patterns have suggested synaptic dysfunction, as a key mechanism in the pathophysiology of ASD. Subsequently, genes involved in synaptic signaling have been investigated with a priority for candidate gene studies. A synaptosomal-associated protein 25 (SNAP25) gene plays a crucial role in the central nervous system, contributing to exocytosis by targeting and fusion of vesicles to the cell membrane. Studies have shown a correlation between aberrant expression of the SNAP25 and a variety of brain diseases. Single nucleotide polymorphisms (SNPs) in this gene are associated with several psychiatric diseases, such as bipolar, schizophrenia, and attention-deficit/hyperactivity disorder. The aim of the present study was to investigate whether polymorphisms (rs3746544 and rs1051312) in the regulatory 3'-untranslated region (3'UTR) of the SNAP25 gene have an association with ASD in unrelated Iranian case (N = 524)-control (N = 472) samples. We observed robust association of the rs3746544 SNP and ASD patients, in both allele and haplotype-based analyses. Our results supported the previous observations and indicated a possible role for SNAP25 polymorphisms as susceptibility genetic factors involved in developing ASD.", "label": 1, "is_selected": 0, "text": "Autism spectrum disorder (ASD) is a common, complex neurological condition, affecting approximately 1% of people worldwide. Monogenic neurodevelopmental disorders which showed autistic behavior patterns have suggested synaptic dysfunction, as a key mechanism in the pathophysiology of ASD. Subsequently, genes involved in synaptic signaling have been investigated with a priority for candidate gene studies. A synaptosomal-associated protein 25 (SNAP25) gene plays a crucial role in the central nervous system, contributing to exocytosis by targeting and fusion of vesicles to the cell membrane. Studies have shown a correlation between aberrant expression of the SNAP25 and a variety of brain diseases. Single nucleotide polymorphisms (SNPs) in this gene are associated with several psychiatric diseases, such as bipolar, schizophrenia, and attention-deficit/hyperactivity disorder. The aim of the present study was to investigate whether polymorphisms (rs3746544 and rs1051312) in the regulatory 3'-untranslated region (3'UTR) of the SNAP25 gene have an association with ASD in unrelated Iranian case (N = 524)-control (N = 472) samples. We observed robust association of the rs3746544 SNP and ASD patients, in both allele and haplotype-based analyses. Our results supported the previous observations and indicated a possible role for SNAP25 polymorphisms as susceptibility genetic factors involved in developing ASD."}
{"qid": "5e2b2c85fbd6abf43b000007", "original_text": "Grade IV vestibular schwannoma (Koos classification) is generally considered to be an indication for microsurgical resection or combined radiosurgery-microsurgery. However, the place of Gamma Knife stereotactic surgery (GK-SRS), either as first-line treatment or when progression of residual tumor compresses the brainstem, has not been clearly evaluated. This article reports the results of a large case series of patients with grade 4 vestibular schwannoma treated by GK-SRS. All consecutive patients with grade IV vestibular schwannoma treated by GK-SRS in our department between 1996 and 2011 with a minimum follow-up of 3 years were included in this study. 86 patients were treated by GK-SRS with a minimum follow-up of 3 years. Mean follow-up was 6.2 years (3-16 years). The mean age of the patients at the time of GK-SRS was 54.6 years (range: 23-84) and the sex ratio was 0.6. At the time of radiosurgery, no patient presented brainstem dysfunction prior to GK-SRS. 38 patients had functional hearing before treatment. One patient presented mild trigeminal neuralgia before GK-SRS. Tumor control with no clinical deterioration was obtained in 78 patients (90.7%). No radiation-induced brainstem or cranial nerve toxicity was observed in any of these patients. Functional hearing was maintained in 25 patients.", "label": 1, "is_selected": 0, "text": "Grade IV vestibular schwannoma (Koos classification) is generally considered to be an indication for microsurgical resection or combined radiosurgery-microsurgery. However, the place of Gamma Knife stereotactic surgery (GK-SRS), either as first-line treatment or when progression of residual tumor compresses the brainstem, has not been clearly evaluated. This article reports the results of a large case series of patients with grade 4 vestibular schwannoma treated by GK-SRS. All consecutive patients with grade IV vestibular schwannoma treated by GK-SRS in our department between 1996 and 2011 with a minimum follow-up of 3 years were included in this study. 86 patients were treated by GK-SRS with a minimum follow-up of 3 years. Mean follow-up was 6.2 years (3-16 years). The mean age of the patients at the time of GK-SRS was 54.6 years (range: 23-84) and the sex ratio was 0.6. At the time of radiosurgery, no patient presented brainstem dysfunction prior to GK-SRS. 38 patients had functional hearing before treatment. One patient presented mild trigeminal neuralgia before GK-SRS. Tumor control with no clinical deterioration was obtained in 78 patients (90.7%). No radiation-induced brainstem or cranial nerve toxicity was observed in any of these patients. Functional hearing was maintained in 25 patients."}
{"qid": "60571d4294d57fd879000028", "original_text": "Aberrant proteolytic activity has been implicated in various diseases, including cancer, neurodegenerative disorders, and metabolic conditions. Proteolytic enzymes play a crucial role in regulating key cellular processes, such as cell signaling, protein degradation, and gene expression. In disease states, altered proteolytic activity can lead to uncontrolled growth and proliferation, tissue damage, and dysregulation of cellular processes. For example, in cancer, proteolytic enzymes can promote tumor growth and progression by degrading tumor suppressor proteins and activating oncogenic proteins. In neurodegenerative disorders, proteolytic activity has been linked to the accumulation of toxic protein aggregates, such as amyloid-beta in Alzheimer's disease. Understanding the role of aberrant proteolytic activity in disease can lead to the development of novel therapeutic strategies for disease treatment and prevention.", "label": 0, "is_selected": 1, "text": "The global aberrant proteolytic activity market is forecast to grow at a Compound Annual Growth Rate (CGR) of more than 9% from 2016 to 2024, to reach a value of $30.3bn by 2024.Understanding the role of aberrant Proteolytic Activity in Disease can lead to the development of novel therapeutic strategies for disease treatment and prevention."}
{"qid": "55031270e9bde6963400001a", "original_text": "The inherited bone marrow failure syndromes (IBMFS) are a heterogeneous group of genetic disorders that share the inability of the bone marrow to produce an adequate number of blood cells. The 4 most frequent syndromes are Fanconi anemia (FA), dyskeratosis congenita (DC), Diamond-Blackfan anemia (DBA), and Shwachman-Diamond syndrome (SDS). All 4 syndromes have been associated with various physical abnormalities. As part of a genotype/phenotype/cancer susceptibility study, we determined the prevalence of ophthalmic manifestations in these 4 syndromes. Cross-sectional study of a patient cohort. Seventy-five patients with an IBMFS and 121 of their first-degree relatives were seen in the National Eye Institute, National Institutes of Health, from 2001 to 2007. The patient group included 22 with FA, 28 with DC, 19 with DBA, and 6 with SDS. Every participant underwent a complete ophthalmic evaluation and digital facial photography with an adhesive paper ruler on the patient's forehead for an internal measure of scale. Interpupillary distance (IPD), inner canthal distance (ICD), outer canthal distance (OCD), palpebral fissure length (PFL), and corneal diameter (CD) were measured. Thirteen of the 22 patients with FA underwent axial length (AL) measurements by A-scan ultrasonography. Type and prevalence of ophthalmic manifestations. Ninety-five percent of patients with FA had at least 1 abnormal parameter, and 25% of patients had at least 4 abnormal parameters. Eighty-two percent of patients had small palpebral fissures, 69% of patients had simple microphthalmia, 64% of patients had small OCD, 55% of patients had microcornea, 28% of patients had ptosis, and 6% of patients had epicanthal folds.", "label": 1, "is_selected": 0, "text": "The inherited bone marrow failure syndromes (IBMFS) are a heterogeneous group of genetic disorders that share the inability of the bone marrow to produce an adequate number of blood cells. The 4 most frequent syndromes are Fanconi anemia (FA), dyskeratosis congenita (DC), Diamond-Blackfan anemia (DBA), and Shwachman-Diamond syndrome (SDS). All 4 syndromes have been associated with various physical abnormalities. As part of a genotype/phenotype/cancer susceptibility study, we determined the prevalence of ophthalmic manifestations in these 4 syndromes. Cross-sectional study of a patient cohort. Seventy-five patients with an IBMFS and 121 of their first-degree relatives were seen in the National Eye Institute, National Institutes of Health, from 2001 to 2007. The patient group included 22 with FA, 28 with DC, 19 with DBA, and 6 with SDS. Every participant underwent a complete ophthalmic evaluation and digital facial photography with an adhesive paper ruler on the patient's forehead for an internal measure of scale. Interpupillary distance (IPD), inner canthal distance (ICD), outer canthal distance (OCD), palpebral fissure length (PFL), and corneal diameter (CD) were measured. Thirteen of the 22 patients with FA underwent axial length (AL) measurements by A-scan ultrasonography. Type and prevalence of ophthalmic manifestations. Ninety-five percent of patients with FA had at least 1 abnormal parameter, and 25% of patients had at least 4 abnormal parameters. Eighty-two percent of patients had small palpebral fissures, 69% of patients had simple microphthalmia, 64% of patients had small OCD, 55% of patients had microcornea, 28% of patients had ptosis, and 6% of patients had epicanthal folds."}
{"qid": "5880aef4c872c95565000001", "original_text": "Daratumumab is a human monoclonal antibody that targets CD38, a cell surface protein that is overexpressed on multiple myeloma (MM) cells. Preclinical studies have shown that daratumumab induces MM cell death through several mechanisms, including complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and apoptosis. Given the encouraging efficacy and acceptable safety profile of daratumumab demonstrated in clinical trials, daratumumab has emerged as a novel treatment option for myeloma and became the first monoclonal antibody approved by the FDA for the treatment of MM.", "label": 1, "is_selected": 0, "text": "Daratumumab is a human monoclonal antibody that targets CD38, a cell surface protein that is overexpressed on multiple myeloma (MM) cells. Preclinical studies have shown that daratumumab induces MM cell death through several mechanisms, including complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and apoptosis. Given the encouraging efficacy and acceptable safety profile of daratumumab demonstrated in clinical trials, daratumumab has emerged as a novel treatment option for myeloma and became the first monoclonal antibody approved by the FDA for the treatment of MM."}
{"qid": "5a74eaa50384be955100000b", "original_text": "Mesothelioma is a rare and malignant cancer that affects the lining of the lungs, abdomen, or heart. The most common type of mesothelioma is pleural mesothelioma, which affects the lining of the lungs. This type of cancer is caused by exposure to asbestos fibers, which can become airborne when asbestos is cut or disturbed. The cancer cells can grow and spread quickly, leading to severe symptoms and a poor prognosis if left untreated.", "label": 0, "is_selected": 0, "text": "Mesothelioma is a rare and malignant cancer that affects the lining of the lungs, abdomen, or heart. The most common type of mesothelioma is pleural mesothelioma, which affects the lining of the lungs. This type of cancer is caused by exposure to asbestos fibers, which can become airborne when asbestos is cut or disturbed. The cancer cells can grow and spread quickly, leading to severe symptoms and a poor prognosis if left untreated."}
{"qid": "56cafca85795f9a73e000030", "original_text": "Protein synthesis is a key regulated cellular process that links nutrient availability and organismal growth. It has long been known that some cellular proteins continue to be synthesized under conditions where global translation is severely compromised. One prominent example is the selective translation of heat shock proteins (Hsps) under stress conditions. Although the transcriptional regulation of Hsp genes has been well established, neither the specific translation-promoting features nor the regulatory mechanism of the translation machinery have been clearly defined. Here we show that the stress-induced preferential translation of Hsp70 mRNA is negatively regulated by PI3K-mTORC1 signaling. Despite the transcriptional up-regulation, the translation of Hsp70 mRNA is deficient in cells lacking tuberous sclerosis complex 2.", "label": 1, "is_selected": 0, "text": "Protein synthesis is a key regulated cellular process that links nutrient availability and organismal growth. It has long been known that some cellular proteins continue to be synthesized under conditions where global translation is severely compromised. One prominent example is the selective translation of heat shock proteins (Hsps) under stress conditions. Although the transcriptional regulation of Hsp genes has been well established, neither the specific translation-promoting features nor the regulatory mechanism of the translation machinery have been clearly defined. Here we show that the stress-induced preferential translation of Hsp70 mRNA is negatively regulated by PI3K-mTORC1 signaling. Despite the transcriptional up-regulation, the translation of Hsp70 mRNA is deficient in cells lacking tuberous sclerosis complex 2."}
{"qid": "5c6ffc5b7c78d69471000057", "original_text": "ADAM17 (a disintegrin and metalloproteinase domain-containing protein 17) is an enzyme that plays a crucial role in the regulation of NK cell function. specifically, ADAM17 mediates the shedding of the NK cell surface receptor, Killer cell lectin-like receptor subfamily K (KLRK1), also known as CD160. This shedding leads to the activation of the NK cell and enhances its cytotoxic activity. Additionally, ADAM17 has been shown to regulate the expression of other NK cell surface receptors, such as the NKG2D receptor, which is involved in the recognition and elimination of infected cells or tumor cells. Overall, the shedding of surface receptors by ADAM17 is an important mechanism for the regulation of NK cell function and immune response.", "label": 0, "is_selected": 0, "text": "ADAM17 (a disintegrin and metalloproteinase domain-containing protein 17) is an enzyme that plays a crucial role in the regulation of NK cell function. specifically, ADAM17 mediates the shedding of the NK cell surface receptor, Killer cell lectin-like receptor subfamily K (KLRK1), also known as CD160. This shedding leads to the activation of the NK cell and enhances its cytotoxic activity. Additionally, ADAM17 has been shown to regulate the expression of other NK cell surface receptors, such as the NKG2D receptor, which is involved in the recognition and elimination of infected cells or tumor cells. Overall, the shedding of surface receptors by ADAM17 is an important mechanism for the regulation of NK cell function and immune response."}
{"qid": "5c61cdd7e842deac67000004", "original_text": "Dolutegravir/rilpivirine (Juluca\u00ae) is the first two-drug single-tablet regimen (STR) to be approved for the treatment of HIV-1 infection in adults. The fixed-dose STR combines the integrase strand transfer inhibitor dolutegravir with the non-nucleoside reverse transcriptase inhibitor rilpivirine. In two phase III non-inferiority trials (SWORD-1 and SWORD-2) in treatment-experienced patients already virologically suppressed on their current antiretroviral (ART) regimen, switching to once-daily dolutegravir plus rilpivirine maintained virological suppression over 48 weeks.", "label": 1, "is_selected": 0, "text": "Dolutegravir/rilpivirine (Juluca\u00ae) is the first two-drug single-tablet regimen (STR) to be approved for the treatment of HIV-1 infection in adults. The fixed-dose STR combines the integrase strand transfer inhibitor dolutegravir with the non-nucleoside reverse transcriptase inhibitor rilpivirine. In two phase III non-inferiority trials (SWORD-1 and SWORD-2) in treatment-experienced patients already virologically suppressed on their current antiretroviral (ART) regimen, switching to once-daily dolutegravir plus rilpivirine maintained virological suppression over 48 weeks."}
{"qid": "60527fc794d57fd879000013", "original_text": "The mechanism of action of fingolimod within the central nervous system and its efficacy in reducing/preventing both focal and diffuse grey matter (GM) damage in active multiple sclerosis (MS) are not completely understood. In this longitudinal, 2-year prospective, phase IV, single-blind study, 40 MS patients treated with fingolimod and 39 untreated age, gender, and disability-matched MS patients were enrolled. Each patient underwent a neurological examination every 6 months and a 3T MRI at the beginning of the treatment and after 24 months. The accumulation of new cortical lesions (CLs) and the progression of regional GM atrophy were compared between the two groups. At the end of the study (T24), the percentage of patients with new CLs (13.5 vs. 89%, p < 0.001) and the percentage of GM volume change was lower in the treated group (p < 0.001).", "label": 1, "is_selected": 0, "text": "The mechanism of action of fingolimod within the central nervous system and its efficacy in reducing/preventing both focal and diffuse grey matter (GM) damage in active multiple sclerosis (MS) are not completely understood. In this longitudinal, 2-year prospective, phase IV, single-blind study, 40 MS patients treated with fingolimod and 39 untreated age, gender, and disability-matched MS patients were enrolled. Each patient underwent a neurological examination every 6 months and a 3T MRI at the beginning of the treatment and after 24 months. The accumulation of new cortical lesions (CLs) and the progression of regional GM atrophy were compared between the two groups. At the end of the study (T24), the percentage of patients with new CLs (13.5 vs. 89%, p < 0.001) and the percentage of GM volume change was lower in the treated group (p < 0.001)."}
{"qid": "60322b501cb411341a000137", "original_text": "Remodelling of the extracellular matrix is accomplished by altering the balance between matrix macromolecule production and degradation. However, it is not well understood how cells balance production of new matrix molecules and degradation of existing ones during tissue remodelling and regeneration. In this study, we used decellularized lung scaffolds repopulated with allogenic lung fibroblasts cultured with stable isotope labelled amino acids to quantify the balance between matrix production and degradation at a proteome-wide scale. Specific temporal dynamics of different matrisome proteins were found to correspond to the proliferative activity of the repopulating cells and the degree of extracellular deposition. The remodeling of the scaffold was characterized by an initial phase with cell proliferation and high production of cell adhesion proteins such as emilin-1 and fibronectin. Extended culture time resulted in increased levels of core matrisome proteins. In a comparison with monolayer cultures on plastic, culture in lung scaffolds lead to a pronounced accumulation of proteoglycans, such as versican and decorin, resulting in regeneration of an extracellular matrix with greater resemblance to native lung tissue compared to standard monolayer cultures. Collectively, the study presents a promising technique for increasing the understanding of cell- extracellular matrix interactions under healthy and diseased conditions.", "label": 1, "is_selected": 0, "text": "Remodelling of the extracellular matrix is accomplished by altering the balance between matrix macromolecule production and degradation. However, it is not well understood how cells balance production of new matrix molecules and degradation of existing ones during tissue remodelling and regeneration. In this study, we used decellularized lung scaffolds repopulated with allogenic lung fibroblasts cultured with stable isotope labelled amino acids to quantify the balance between matrix production and degradation at a proteome-wide scale. Specific temporal dynamics of different matrisome proteins were found to correspond to the proliferative activity of the repopulating cells and the degree of extracellular deposition. The remodeling of the scaffold was characterized by an initial phase with cell proliferation and high production of cell adhesion proteins such as emilin-1 and fibronectin. Extended culture time resulted in increased levels of core matrisome proteins. In a comparison with monolayer cultures on plastic, culture in lung scaffolds lead to a pronounced accumulation of proteoglycans, such as versican and decorin, resulting in regeneration of an extracellular matrix with greater resemblance to native lung tissue compared to standard monolayer cultures. Collectively, the study presents a promising technique for increasing the understanding of cell- extracellular matrix interactions under healthy and diseased conditions."}
{"qid": "530cf4e0c8a0b4a00c000004", "original_text": "Hypertrophic cardiomyopathy (HCM) is a genetic disorder caused by mutations in various genes, including the alpha-myosin heavy chain gene (MYH7).specifically, mutations in the MYH7 gene can lead to HCM by altering the function of the cardiac myosin heavy chain protein, resulting in abnormal cardiac muscle contraction and hypertrophy. Some of the most common mutations associated with HCM in the MYH7 gene include R145G, R164Q, R172W, R174W, and R192H. These mutations can be identified through genetic testing and can help diagnose and manage HCM.", "label": 0, "is_selected": 1, "text": "The aim of this study is to define the genetic basis of hypertrophic cardiomyopathy and to identify the most common genetic mutations associated with the condition in order to help diagnose and manage the disease in the future.These findings will be used to develop new treatments and therapies for the condition."}
{"qid": "532ad4b4d6d3ac6a34000012", "original_text": "The utility of immunohistochemistry (IHC) as a screening method for the identification of persons with mutations in the DNA mismatch repair (MMR) genes in hereditary nonpolyposis colorectal cancer (HNPCC) remains to be defined. In this study, we analyzed the value of IHC versus that of microsatellite instability (MSI) testing in predicting mutation status of the MLH1, MSH2, and MSH6 genes in colorectal carcinomas and adenomas, and explored the frequency and significance of immunohistochemical staining variability. The study samples included 83 carcinomas and 29 adenomas derived from 110 patients who had strong family histories of colorectal cancer. Our results showed that IHC correctly predicted MSI status in 76% of the cases with a specificity of 100%. The overall sensitivity of IHC in predicting a germline mutation was 79% (30 of 38) with a specificity of 89% (48 of 54), whereas that of MSI testing was 97% (30 of 31) with a specificity of 83% (35 of 42). Six of 31 analyzable cases that had a disease-causing mutation and exhibited MSI showed normal IHC. The lower sensitivity of IHC was caused mainly by its low sensitivity in detecting MLH1 gene mutation (4 of 9). Coexisting adenomas and carcinomas observed in the same slide (n=12) showed a similar or identical staining pattern for all three proteins. No significant difference was detected in the sensitivity of IHC or MSI in detecting a germline mutation between isolated adenomas and carcinomas.", "label": 1, "is_selected": 0, "text": "The utility of immunohistochemistry (IHC) as a screening method for the identification of persons with mutations in the DNA mismatch repair (MMR) genes in hereditary nonpolyposis colorectal cancer (HNPCC) remains to be defined. In this study, we analyzed the value of IHC versus that of microsatellite instability (MSI) testing in predicting mutation status of the MLH1, MSH2, and MSH6 genes in colorectal carcinomas and adenomas, and explored the frequency and significance of immunohistochemical staining variability. The study samples included 83 carcinomas and 29 adenomas derived from 110 patients who had strong family histories of colorectal cancer. Our results showed that IHC correctly predicted MSI status in 76% of the cases with a specificity of 100%. The overall sensitivity of IHC in predicting a germline mutation was 79% (30 of 38) with a specificity of 89% (48 of 54), whereas that of MSI testing was 97% (30 of 31) with a specificity of 83% (35 of 42). Six of 31 analyzable cases that had a disease-causing mutation and exhibited MSI showed normal IHC. The lower sensitivity of IHC was caused mainly by its low sensitivity in detecting MLH1 gene mutation (4 of 9). Coexisting adenomas and carcinomas observed in the same slide (n=12) showed a similar or identical staining pattern for all three proteins. No significant difference was detected in the sensitivity of IHC or MSI in detecting a germline mutation between isolated adenomas and carcinomas."}
{"qid": "5a75df9483b0d9ea66000001", "original_text": "Tisagenlecleucel, a CD19-targeted chimeric antigen receptor (CAR) T cell therapy, works by expanding and activating autologous T cells to recognize and target cancer cells. The CAR binds to the CD19 protein on B cells, activating the T cells through signaling pathways, leading to cell death and immune response. The CAR also induces T cells to produce cytokines, recruiting other immune cells to collaborate in the immune response.", "label": 0, "is_selected": 1, "text": "The US Food and Drug Administration (FDA) has granted orphan drug status to Tisagenlecleucel for the treatment of patients with relapsed or relapsed follicular lymphoma who have failed at least one prior treatment with platinum- or rituximab-containing regimens."}
{"qid": "5fe31304a43ad3127800003a", "original_text": "The folate antagonist methotrexate (MTX) has become established as the most commonly used disease-modifying anti-rheumatic drug (DMARD) in the treatment of rheumatoid arthritis (RA) but is commonly discontinued due to adverse effects. Adverse effects are thought to be mediated via folate antagonism. In this paper we summarize the current data on the use of folates as a supplement to MTX use in RA for the prevention of adverse effects and as a potential modulator of cardiovascular risk, and propose guidelines for standard practice.", "label": 1, "is_selected": 0, "text": "The folate antagonist methotrexate (MTX) has become established as the most commonly used disease-modifying anti-rheumatic drug (DMARD) in the treatment of rheumatoid arthritis (RA) but is commonly discontinued due to adverse effects. Adverse effects are thought to be mediated via folate antagonism. In this paper we summarize the current data on the use of folates as a supplement to MTX use in RA for the prevention of adverse effects and as a potential modulator of cardiovascular risk, and propose guidelines for standard practice."}
{"qid": "530cf57efe2466f70c000006", "original_text": "Vitamin D affects bone and muscle health and likely reduces the risk of falls in the elderly. The aim of this systematic review is to summarize the existing evidence on vitamin D use and the risk of falls. We searched electronic databases from inception through August 2010. Eligible studies were randomized controlled trials in which the intervention was vitamin D and the incidence of falls was reported. Reviewers working in duplicate and independently extracted study characteristics, quality, and outcomes data. Odds ratio and associated 95% confidence interval were estimated from each study and pooled using the random effects model. We found 26 eligible trials of moderate quality that enrolled 45,782 participants, the majority of which were elderly and female. Vitamin D use was associated with statistically significant reduction in the risk of falls (odds ratio for suffering at least one fall, 0.86; 95% confidence interval, 0.77-0.96). This effect was more prominent in patients who were vitamin D deficient at baseline and in studies in which calcium was coadministered with vitamin D. The quality of evidence was low to moderate because of heterogeneity and publication bias. Vitamin D combined with calcium reduces the risk of falls. The reduction in studies without calcium coadministration did not reach statistical significance. The majority of the evidence is derived from trials enrolling elderly women.", "label": 1, "is_selected": 0, "text": "Vitamin D affects bone and muscle health and likely reduces the risk of falls in the elderly. The aim of this systematic review is to summarize the existing evidence on vitamin D use and the risk of falls. We searched electronic databases from inception through August 2010. Eligible studies were randomized controlled trials in which the intervention was vitamin D and the incidence of falls was reported. Reviewers working in duplicate and independently extracted study characteristics, quality, and outcomes data. Odds ratio and associated 95% confidence interval were estimated from each study and pooled using the random effects model. We found 26 eligible trials of moderate quality that enrolled 45,782 participants, the majority of which were elderly and female. Vitamin D use was associated with statistically significant reduction in the risk of falls (odds ratio for suffering at least one fall, 0.86; 95% confidence interval, 0.77-0.96). This effect was more prominent in patients who were vitamin D deficient at baseline and in studies in which calcium was coadministered with vitamin D. The quality of evidence was low to moderate because of heterogeneity and publication bias. Vitamin D combined with calcium reduces the risk of falls. The reduction in studies without calcium coadministration did not reach statistical significance. The majority of the evidence is derived from trials enrolling elderly women."}
{"qid": "5358e067f1005d6b5800000b", "original_text": "Actin-crosslinking proteins organize actin into highly dynamic and architecturally diverse subcellular scaffolds that orchestrate a variety of mechanical processes, including lamellipodial and filopodial protrusions in motile cells. How signalling pathways control and coordinate the activity of these crosslinkers is poorly defined. IRSp53, a multi-domain protein that can associate with the Rho-GTPases Rac and Cdc42, participates in these processes mainly through its amino-terminal IMD (IRSp53 and MIM domain). The isolated IMD has actin-bundling activity in vitro and is sufficient to induce filopodia in vivo. However, the manner of regulation of this activity in the full-length protein remains largely unknown. Eps8 is involved in actin dynamics through its actin barbed-ends capping activity and its ability to modulate Rac activity. Moreover, Eps8 binds to IRSp53. Here, we describe a novel actin crosslinking activity of Eps8. Additionally, Eps8 activates and synergizes with IRSp53 in mediating actin bundling in vitro, enhancing IRSp53-dependent membrane extensions in vivo. Cdc42 binds to and controls the cellular distribution of the IRSp53-Eps8 complex, supporting the existence of a Cdc42-IRSp53-Eps8 signalling pathway. Consistently, Cdc42-induced filopodia are inhibited following individual removal of either IRSp53 or Eps8. Collectively, these results support a model whereby the synergic bundling activity of the IRSp53-Eps8 complex, regulated by Cdc42, contributes to the generation of actin bundles, thus promoting filopodial protrusions.", "label": 1, "is_selected": 0, "text": "Actin-crosslinking proteins organize actin into highly dynamic and architecturally diverse subcellular scaffolds that orchestrate a variety of mechanical processes, including lamellipodial and filopodial protrusions in motile cells. How signalling pathways control and coordinate the activity of these crosslinkers is poorly defined. IRSp53, a multi-domain protein that can associate with the Rho-GTPases Rac and Cdc42, participates in these processes mainly through its amino-terminal IMD (IRSp53 and MIM domain). The isolated IMD has actin-bundling activity in vitro and is sufficient to induce filopodia in vivo. However, the manner of regulation of this activity in the full-length protein remains largely unknown. Eps8 is involved in actin dynamics through its actin barbed-ends capping activity and its ability to modulate Rac activity. Moreover, Eps8 binds to IRSp53. Here, we describe a novel actin crosslinking activity of Eps8. Additionally, Eps8 activates and synergizes with IRSp53 in mediating actin bundling in vitro, enhancing IRSp53-dependent membrane extensions in vivo. Cdc42 binds to and controls the cellular distribution of the IRSp53-Eps8 complex, supporting the existence of a Cdc42-IRSp53-Eps8 signalling pathway. Consistently, Cdc42-induced filopodia are inhibited following individual removal of either IRSp53 or Eps8. Collectively, these results support a model whereby the synergic bundling activity of the IRSp53-Eps8 complex, regulated by Cdc42, contributes to the generation of actin bundles, thus promoting filopodial protrusions."}
{"qid": "51631154298dcd4e5100004e", "original_text": "Velcade (bortezomib) is mainly used for the treatment of multiple myeloma, a type of cancer that affects the plasma cells in the bone marrow. It is used in combination with other drugs to treat newly diagnosed and relapsed/refractory multiple myeloma. Velcade works by inhibiting the activity of the proteasome, a structure that is involved in the production of proteins in cancer cells, leading to cell death. It is typically administered via intravenous infusion and is a key component of the current standard of care for multiple myeloma.", "label": 0, "is_selected": 1, "text": "The US Food and Drug Administration (FDA) has approved Velcade (bortezomib) tablets for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior therapy.Velcade is a proteasome inhibitor."}
{"qid": "53442023aeec6fbd07000007", "original_text": "The fidelity of chromosome segregation during cell division is critical to maintain genomic stability and to prevent cancer and birth defects. A key set of kinases that regulates this process has been identified and characterized over the last few years, including the Aurora, Polo and Nek families. Recently we proposed that a little-studied kinase known as haspin is a new member of this important group.", "label": 1, "is_selected": 0, "text": "The fidelity of chromosome segregation during cell division is critical to maintain genomic stability and to prevent cancer and birth defects. A key set of kinases that regulates this process has been identified and characterized over the last few years, including the Aurora, Polo and Nek families. Recently we proposed that a little-studied kinase known as haspin is a new member of this important group."}
{"qid": "58bbb77e22d3005309000017", "original_text": "The number and position of the pseudouridines of Haloarcula marismortui and Deinococcus radiodurans large subunit RNA have been determined by a combination of total nucleoside analysis by HPLC-mass spectrometry and pseudouridine sequencing by the reverse transcriptase method and by LC/MS/MS. Three pseudouridines were found in H. marismortui, located at positions 1956, 1958, and 2621 corresponding to Escherichia coli positions 1915, 1917, and 2586, respectively. The three pseudouridines are all in locations found in other organisms. Previous reports of a larger number of pseudouridines in this organism were incorrect.", "label": 1, "is_selected": 0, "text": "The number and position of the pseudouridines of Haloarcula marismortui and Deinococcus radiodurans large subunit RNA have been determined by a combination of total nucleoside analysis by HPLC-mass spectrometry and pseudouridine sequencing by the reverse transcriptase method and by LC/MS/MS. Three pseudouridines were found in H. marismortui, located at positions 1956, 1958, and 2621 corresponding to Escherichia coli positions 1915, 1917, and 2586, respectively. The three pseudouridines are all in locations found in other organisms. Previous reports of a larger number of pseudouridines in this organism were incorrect."}
{"qid": "5c645313e842deac67000019", "original_text": "Tricluster deletion, also known as the deletion of all three Pcdh clusters (Pcaudetricluster), in mice results in severe developmental and physiological abnormalities. These mice often die in utero or shortly after birth due to cardiac and respiratory defects. Surviving mice exhibit various developmental delays, including delayed eye opening, coordination, and learning. Behavioral abnormalities include enhanced anxiety-like behavior, altered social interactions, and hyperactivity. The deleted genes play critical roles in neural crest cell development, synapse formation, and neural function, leading to the observed phenotypes.", "label": 0, "is_selected": 0, "text": "Tricluster deletion, also known as the deletion of all three Pcdh clusters (Pcaudetricluster), in mice results in severe developmental and physiological abnormalities. These mice often die in utero or shortly after birth due to cardiac and respiratory defects. Surviving mice exhibit various developmental delays, including delayed eye opening, coordination, and learning. Behavioral abnormalities include enhanced anxiety-like behavior, altered social interactions, and hyperactivity. The deleted genes play critical roles in neural crest cell development, synapse formation, and neural function, leading to the observed phenotypes."}
{"qid": "58d131218acda34529000005", "original_text": "The transcription factor signal transducer and activator of transcription (Stat) 3 is activated through the interleukin-6 family of cytokines and by binding of growth factors to the epidermal growth factor (EGF) receptor. It plays an essential role in embryonic development and assumes specialized tasks in many differentiated tissues. Constitutively activated Stat3 has been found in tumor cell lines and primary tumors and plays a crucial role in tumor cell survival and proliferation. To inhibit the oncogenic action of Stat3 in tumor cells, we have selected short peptides, so-called peptide aptamers, which specifically interact with defined functional domains of this transcription factor. The peptide aptamers were selected from a peptide library of high complexity by an adaptation of the yeast two-hybrid procedure. Peptide aptamers specifically interacting with the Stat3 dimerization domain caused inhibition of DNA binding activity and suppression of transactivation by Stat3 in EGF-responsive cells.", "label": 1, "is_selected": 0, "text": "The transcription factor signal transducer and activator of transcription (Stat) 3 is activated through the interleukin-6 family of cytokines and by binding of growth factors to the epidermal growth factor (EGF) receptor. It plays an essential role in embryonic development and assumes specialized tasks in many differentiated tissues. Constitutively activated Stat3 has been found in tumor cell lines and primary tumors and plays a crucial role in tumor cell survival and proliferation. To inhibit the oncogenic action of Stat3 in tumor cells, we have selected short peptides, so-called peptide aptamers, which specifically interact with defined functional domains of this transcription factor. The peptide aptamers were selected from a peptide library of high complexity by an adaptation of the yeast two-hybrid procedure. Peptide aptamers specifically interacting with the Stat3 dimerization domain caused inhibition of DNA binding activity and suppression of transactivation by Stat3 in EGF-responsive cells."}
{"qid": "5e2894109499698331000002", "original_text": "The algorithm developed for finding conserved non-coding elements (CNEs) is called the Conserved Non-Coding Element Finder (CNCF) algorithm. CNCF is a computational tool that identifies CNEs by analyzing multiple alignments of genomic sequences from multiple organisms. It was developed by the University of California, San Diego, and is freely available online. CNCF uses a probabilistic approach to identify CNEs that are conserved across different species, and can be used to identify functional non-coding regions in the genome.", "label": 0, "is_selected": 1, "text": "Researchers have developed an algorithm that can identify functional non-coding elements in the genome.<n> The algorithm developed for finding conserved non- coding elements (CNEs) is called the Conserved Non-Coding Element Finder (CNCF) algorithm."}
{"qid": "6278dfe956bf9aee6f000016", "original_text": "Duchenne muscular dystrophy (DMD) is the most common single-gene lethal disorder. Substantial patient-patient variability in disease onset and progression and response to glucocorticoids is seen, suggesting genetic or environmental modifiers. Two DMD cohorts were used as test and validation groups to define genetic modifiers: a Padova longitudinal cohort (n = 106) and the Cooperative International Neuromuscular Research Group (CINRG) cross-sectional natural history cohort (n = 156). Single nucleotide polymorphisms to be genotyped were selected from mRNA profiling in patients with severe vs mild DMD, and genome-wide association studies in metabolism and polymorphisms influencing muscle phenotypes in normal volunteers were studied. Effects on both disease progression and response to glucocorticoids were observed with polymorphism rs28357094 in the gene promoter of SPP1 (osteopontin).", "label": 1, "is_selected": 0, "text": "Duchenne muscular dystrophy (DMD) is the most common single-gene lethal disorder. Substantial patient-patient variability in disease onset and progression and response to glucocorticoids is seen, suggesting genetic or environmental modifiers. Two DMD cohorts were used as test and validation groups to define genetic modifiers: a Padova longitudinal cohort (n = 106) and the Cooperative International Neuromuscular Research Group (CINRG) cross-sectional natural history cohort (n = 156). Single nucleotide polymorphisms to be genotyped were selected from mRNA profiling in patients with severe vs mild DMD, and genome-wide association studies in metabolism and polymorphisms influencing muscle phenotypes in normal volunteers were studied. Effects on both disease progression and response to glucocorticoids were observed with polymorphism rs28357094 in the gene promoter of SPP1 (osteopontin)."}
{"qid": "553a7a59f321868558000002", "original_text": "Efficient tagging methodologies are an integral aspect of protein complex characterization by proteomic approaches. Owing to the very high affinity of biotin for avidin and streptavidin, biotinylation tagging offers an attractive approach for the efficient purification of protein complexes. The very high affinity of the biotin/(strept)avidin system also offers the potential for the single-step capture of lower abundance protein complexes, such as transcription factor complexes. The identification of short peptide tags that are efficiently biotinylated by the bacterial BirA biotin ligase led to an approach for the single-step purification of transcription factor complexes by specific in vivo biotinylation tagging. A short sequence tag fused N-terminally to the transcription factor of interest is very efficiently biotinylated by BirA coexpressed in the same cells, as was demonstrated by the tagging of the essential hematopoietic transcription factor GATA-1. The direct binding to streptavidin of biotinylated GATA-1 in nuclear extracts resulted in the single-step capture of the tagged factor and associated proteins, which were eluted and identified by mass spectrometry. This led to the characterization of several distinct GATA-1 complexes with other transcription factors and chromatin remodeling cofactors, which are involved in activation and repression of gene targets.", "label": 1, "is_selected": 0, "text": "Efficient tagging methodologies are an integral aspect of protein complex characterization by proteomic approaches. Owing to the very high affinity of biotin for avidin and streptavidin, biotinylation tagging offers an attractive approach for the efficient purification of protein complexes. The very high affinity of the biotin/(strept)avidin system also offers the potential for the single-step capture of lower abundance protein complexes, such as transcription factor complexes. The identification of short peptide tags that are efficiently biotinylated by the bacterial BirA biotin ligase led to an approach for the single-step purification of transcription factor complexes by specific in vivo biotinylation tagging. A short sequence tag fused N-terminally to the transcription factor of interest is very efficiently biotinylated by BirA coexpressed in the same cells, as was demonstrated by the tagging of the essential hematopoietic transcription factor GATA-1. The direct binding to streptavidin of biotinylated GATA-1 in nuclear extracts resulted in the single-step capture of the tagged factor and associated proteins, which were eluted and identified by mass spectrometry. This led to the characterization of several distinct GATA-1 complexes with other transcription factors and chromatin remodeling cofactors, which are involved in activation and repression of gene targets."}
{"qid": "514a59c2d24251bc0500005d", "original_text": "This is a substantive update of a previous review. Severe premenstrual syndrome (PMS) affects between 3% to 5% of women of reproductive age. Severe PMS is classified under the Diagnostic and Statistical Manual of Mental Disorders as premenstrual dysphoric disorder (PMDD). Selective serotonin reuptake inhibitors (SSRIs) are increasingly used as front-line therapy for PMS. A systematic review was undertaken on the efficacy of SSRIs in the management of severe PMS, or PMDD, to assess the evidence for this treatment option. The objective of this review was to evaluate the effectiveness of SSRIs in reducing premenstrual syndrome symptoms in women diagnosed with severe premenstrual syndrome.", "label": 1, "is_selected": 0, "text": "This is a substantive update of a previous review. Severe premenstrual syndrome (PMS) affects between 3% to 5% of women of reproductive age. Severe PMS is classified under the Diagnostic and Statistical Manual of Mental Disorders as premenstrual dysphoric disorder (PMDD). Selective serotonin reuptake inhibitors (SSRIs) are increasingly used as front-line therapy for PMS. A systematic review was undertaken on the efficacy of SSRIs in the management of severe PMS, or PMDD, to assess the evidence for this treatment option. The objective of this review was to evaluate the effectiveness of SSRIs in reducing premenstrual syndrome symptoms in women diagnosed with severe premenstrual syndrome."}
{"qid": "5a6f87c5b750ff4455000056", "original_text": "The diverse hematologic manifestations of primary Sj\u00f6gren syndrome (pSS) have not been systematically investigated, and their prognostic relevance remains unclear. We conducted a retrospective study of 536 consecutive patients followed in our institution to assess the prevalence of hematologic abnormalities and their associations with various disease manifestations in pSS. We also aimed to identify risk factors for the development of non-Hodgkin lymphoma (NHL) overall and by subtype. Anemia of chronic disease and hypergammaglobulinemia were the most prevalent hematologic manifestations encountered at diagnosis and during the course of pSS. Univariate analysis between cytopenias and glandular manifestations revealed a statistically significant correlation between lymphocytopenia and parotid gland enlargement (p = 0.002), as well as between neutropenia and xerostomia (p = 0.019).", "label": 1, "is_selected": 0, "text": "The diverse hematologic manifestations of primary Sj\u00f6gren syndrome (pSS) have not been systematically investigated, and their prognostic relevance remains unclear. We conducted a retrospective study of 536 consecutive patients followed in our institution to assess the prevalence of hematologic abnormalities and their associations with various disease manifestations in pSS. We also aimed to identify risk factors for the development of non-Hodgkin lymphoma (NHL) overall and by subtype. Anemia of chronic disease and hypergammaglobulinemia were the most prevalent hematologic manifestations encountered at diagnosis and during the course of pSS. Univariate analysis between cytopenias and glandular manifestations revealed a statistically significant correlation between lymphocytopenia and parotid gland enlargement (p = 0.002), as well as between neutropenia and xerostomia (p = 0.019)."}
{"qid": "52b2e97df828ad283c000012", "original_text": "Telomere dysfunction is linked with genome instability and premature aging. Roles for sirtuin proteins at telomeres are thought to promote lifespan in yeast and mammals. However, replicative lifespan of the budding yeast Saccharomyces cerevisiae shortens upon deletion of Rif1, a protein that limits the recruitment of the sirtuin histone deacetylase Sir2 to telomeres. Here we show that Rif1 maintains replicative lifespan by ultimately stabilizing another age-related chromosomal domain harboring the ribosomal DNA (rDNA) repeats.", "label": 1, "is_selected": 0, "text": "Telomere dysfunction is linked with genome instability and premature aging. Roles for sirtuin proteins at telomeres are thought to promote lifespan in yeast and mammals. However, replicative lifespan of the budding yeast Saccharomyces cerevisiae shortens upon deletion of Rif1, a protein that limits the recruitment of the sirtuin histone deacetylase Sir2 to telomeres. Here we show that Rif1 maintains replicative lifespan by ultimately stabilizing another age-related chromosomal domain harboring the ribosomal DNA (rDNA) repeats."}
{"qid": "56c1f039ef6e394741000052", "original_text": "In the 1950s, Bickerstaff and Fisher independently described cases with a unique presentation of ophthalmoplegia and ataxia. The neurological features were typically preceded by an antecedent infection and the majority of patients made a spontaneous recovery.", "label": 1, "is_selected": 0, "text": "In the 1950s, Bickerstaff and Fisher independently described cases with a unique presentation of ophthalmoplegia and ataxia. The neurological features were typically preceded by an antecedent infection and the majority of patients made a spontaneous recovery."}
{"qid": "5a67ade5b750ff445500000c", "original_text": "To evaluate the risk for infantile hypertrophic pyloric stenosis (IHPS) among infants prescribed systemic erythromycin, infants prescribed a course of erythromycin ophthalmic ointment, and infants whose mothers were prescribed a macrolide antibiotic during pregnancy. Retrospective cohort study of infants born at an urban hospital from June 1993 through December 1999. Of 14,876 eligible infants, 43 (0.29%) developed IHPS. Infants prescribed systemic erythromycin had increased risk of IHPS, with the highest risk in the first 2 weeks of age (relative risk = 10.51 for erythromycin in first 2 weeks, 95% CI 4.48, 24.66).", "label": 1, "is_selected": 0, "text": "To evaluate the risk for infantile hypertrophic pyloric stenosis (IHPS) among infants prescribed systemic erythromycin, infants prescribed a course of erythromycin ophthalmic ointment, and infants whose mothers were prescribed a macrolide antibiotic during pregnancy. Retrospective cohort study of infants born at an urban hospital from June 1993 through December 1999. Of 14,876 eligible infants, 43 (0.29%) developed IHPS. Infants prescribed systemic erythromycin had increased risk of IHPS, with the highest risk in the first 2 weeks of age (relative risk = 10.51 for erythromycin in first 2 weeks, 95% CI 4.48, 24.66)."}
{"qid": "601d74391cb411341a000041", "original_text": "ECMO, or Extracorporeal Membrane Oxygenation, is a type of lifesaving technology used to provide both cardiac and pulmonary support to patients with severe respiratory or cardiac failure. ECMO involves using a machine to take over the work of the heart and lungs, removing blood from the body, oxygenating it, and then returning it to the body. This allows the heart and lungs to rest and recover, giving the patient a chance to recover from their illness or injury. ECMO is typically used in emergency situations, such as during a cardiac arrest or in the early stages of severe pneumonia, and is usually only used for a short period of time until the patient's condition improves.", "label": 0, "is_selected": 0, "text": "ECMO, or Extracorporeal Membrane Oxygenation, is a type of lifesaving technology used to provide both cardiac and pulmonary support to patients with severe respiratory or cardiac failure. ECMO involves using a machine to take over the work of the heart and lungs, removing blood from the body, oxygenating it, and then returning it to the body. This allows the heart and lungs to rest and recover, giving the patient a chance to recover from their illness or injury. ECMO is typically used in emergency situations, such as during a cardiac arrest or in the early stages of severe pneumonia, and is usually only used for a short period of time until the patient's condition improves."}
{"qid": "58f3ca5c70f9fc6f0f00000d", "original_text": "Fusarium graminearum is an important plant pathogen that causes head blight of major cereal crops. The fungus produces mycotoxins that are harmful to animal and human. In this study, a systematic analysis of 17 phenotypes of the mutants in 657 Fusarium graminearum genes encoding putative transcription factors (TFs) resulted in a database of over 11,000 phenotypes (phenome).", "label": 1, "is_selected": 0, "text": "Fusarium graminearum is an important plant pathogen that causes head blight of major cereal crops. The fungus produces mycotoxins that are harmful to animal and human. In this study, a systematic analysis of 17 phenotypes of the mutants in 657 Fusarium graminearum genes encoding putative transcription factors (TFs) resulted in a database of over 11,000 phenotypes (phenome)."}
{"qid": "55031406e9bde69634000021", "original_text": "G-CSF (Grant-CSF) treatment for severe congenital neutropenia (SCN) carries several risks. One of the most significant risks is the development of a secondary immune response, which can lead to a severe allergic reaction known as a cytokine storm. This can cause fever, nausea, and fatigue, and in severe cases, it can lead to life-threatening complications such as respiratory distress syndrome, cardiovascular instability, and organ failure. Another risk is the potential for bone marrow suppression, which can impair the body's ability to produce healthy white blood cells. Additionally, G-CSF can cause an increase in the risk of infection, particularly during the period of bone marrow suppression. Other risks associated with G-CSF treatment for SCN include injection site reactions, nausea, vomiting, and headache. It is important to note that each patient may respond differently to G-CSF treatment, and the risks associated with this treatment should be carefully weighed against the potential benefits for each individual patient.", "label": 0, "is_selected": 1, "text": "The risks and benefits of G-CSF treatment for severe congenital neutropenia are discussed in detail in this article from the American College of Obstetricians and Gynaecologists (ACOG) and the British Medical Association (BMA) in an effort to help patients and their families make more informed decisions about this treatment option..Continued on this page at the end of this article."}
{"qid": "5162a089298dcd4e51000043", "original_text": "Yes, microRNAs (miRNAs) have been implicated in pharmacogenomics. miRNAs are small non-coding RNAs that play a crucial role in regulating gene expression and have been shown to be involved in the metabolism and response to drugs. Studies have identified miRNAs as potential biomarkers for drug response and toxicity, as well as for predicting drug efficacy and adverse events. For example, miR-148a has been shown to be associated with the response to the chemotherapeutic drug paclitaxel, while miR-34a has been linked to the response to the antipsychotic drug haloperidol. In addition, miRNAs have been identified as potential therapeutic targets for personalized medicine, as they can be modulated to improve drug response or reduce adverse events. Overall, the study of miRNAs has the potential to lead to the development of new pharmacogenomic biomarkers and personalized medication strategies.", "label": 0, "is_selected": 1, "text": "pharmacogenomics refers to the study of genes and their expression in relation to the development and use of new drugs and medical devices. Overall, study biomarkers has the potential to lead to new pharmacogenomic and drug development strategies, as they can be modulated to improve drug response or reduce adverse events, as well as for predicting drug efficacy and toxicity."}
{"qid": "5abcf108fcf4565872000025", "original_text": "Myelination is a recent evolutionary addition that significantly enhances the speed of transmission in the neural network. Even slight defects in myelin integrity impair performance and enhance the risk of neurological disorders. Indeed, myelin degeneration is an early and well-recognized neuropathology that is age associated, but appears before cognitive decline. Myelin is only formed by fully differentiated oligodendrocytes, but the entire oligodendrocyte lineage are clear targets of the altered chemistry of the aging brain.", "label": 1, "is_selected": 0, "text": "Myelination is a recent evolutionary addition that significantly enhances the speed of transmission in the neural network. Even slight defects in myelin integrity impair performance and enhance the risk of neurological disorders. Indeed, myelin degeneration is an early and well-recognized neuropathology that is age associated, but appears before cognitive decline. Myelin is only formed by fully differentiated oligodendrocytes, but the entire oligodendrocyte lineage are clear targets of the altered chemistry of the aging brain."}
{"qid": "5c5f2d5a1a4c55d80b000023", "original_text": "The human gut is a composite anaerobic environment with a large, diverse and dynamic enteric microbiota, represented by more than 100 trillion microorganisms, including at least 1000 distinct species. The discovery that a different microbial composition can influence behavior and cognition, and in turn the nervous system can indirectly influence enteric microbiota composition, has significantly contributed to establish the well-accepted concept of gut-brain axis. This hypothesis is supported by several evidence showing mutual mechanisms, which involve the vague nerve, the immune system, the hypothalamic-pituitaryadrenal (HPA) axis modulation and the bacteria-derived metabolites. Many studies have focused on delineating a role for this axis in health and disease, ranging from stress-related disorders such as depression, anxiety and irritable bowel syndrome (IBS) to neurodevelopmental disorders, such as autism, and to neurodegenerative diseases, such as Parkinson Disease, Alzheimer's Disease etc. Based on this background, and considering the relevance of alteration of the symbiotic state between host and microbiota, this review focuses on the role and the involvement of bioactive lipids, such as the N-acylethanolamine (NAE) family whose main members are N-arachidonoylethanolamine (AEA), palmitoylethanolamide (PEA) and oleoilethanolamide (OEA), and short chain fatty acids (SCFAs), such as butyrate, belonging to a large group of bioactive lipids able to modulate peripheral and central pathologic processes. Their effective role has been studied in inflammation, acute and chronic pain, obesity and central nervous system diseases. A possible correlation has been shown between these lipids and gut microbiota through different mechanisms.", "label": 1, "is_selected": 0, "text": "The human gut is a composite anaerobic environment with a large, diverse and dynamic enteric microbiota, represented by more than 100 trillion microorganisms, including at least 1000 distinct species. The discovery that a different microbial composition can influence behavior and cognition, and in turn the nervous system can indirectly influence enteric microbiota composition, has significantly contributed to establish the well-accepted concept of gut-brain axis. This hypothesis is supported by several evidence showing mutual mechanisms, which involve the vague nerve, the immune system, the hypothalamic-pituitaryadrenal (HPA) axis modulation and the bacteria-derived metabolites. Many studies have focused on delineating a role for this axis in health and disease, ranging from stress-related disorders such as depression, anxiety and irritable bowel syndrome (IBS) to neurodevelopmental disorders, such as autism, and to neurodegenerative diseases, such as Parkinson Disease, Alzheimer's Disease etc. Based on this background, and considering the relevance of alteration of the symbiotic state between host and microbiota, this review focuses on the role and the involvement of bioactive lipids, such as the N-acylethanolamine (NAE) family whose main members are N-arachidonoylethanolamine (AEA), palmitoylethanolamide (PEA) and oleoilethanolamide (OEA), and short chain fatty acids (SCFAs), such as butyrate, belonging to a large group of bioactive lipids able to modulate peripheral and central pathologic processes. Their effective role has been studied in inflammation, acute and chronic pain, obesity and central nervous system diseases. A possible correlation has been shown between these lipids and gut microbiota through different mechanisms."}
{"qid": "5508685b4b2a315d4100000a", "original_text": "Vedolizumab is a monoclonal antibody that is used to treat several inflammatory bowel diseases, including: 1. Ulcerative Colitis (UC): Vedolizumab is approved for the treatment of moderate-to-severe UC, and has been shown to reduce the rate of clinical remission, endoscopic improvement, and hospitalizations in patients with this condition. 2. Crohn's Disease (CD): Vedolizumab is also approved for the treatment of moderate-to-severe CD, and has been shown to reduce the rate of clinical remission and hospitalizations in patients with this condition. 3. Primary Sjogren's Syndrome (PSS): Vedolizumab has been studied in patients with PSS, and has been shown to reduce the severity of gastrointestinal symptoms and improve quality of life. 4. Indeterminate Colitis: Vedolizumab has been studied in patients with indeterminate colitis, a condition where the symptoms are not typical of UC or CD, and has been shown to improve symptoms and quality of life. It is important to note that Vedolizumab is not recommended for the treatment of irritable bowel syndrome (IBS), as it is not an inflammatory condition. Also, it is not approved for the treatment of other conditions, such as irritable bowel syndrome (IBS), as it is not an inflammatory condition.", "label": 0, "is_selected": 0, "text": "Vedolizumab is a monoclonal antibody that is used to treat several inflammatory bowel diseases, including: 1. Ulcerative Colitis (UC): Vedolizumab is approved for the treatment of moderate-to-severe UC, and has been shown to reduce the rate of clinical remission, endoscopic improvement, and hospitalizations in patients with this condition. 2. Crohn's Disease (CD): Vedolizumab is also approved for the treatment of moderate-to-severe CD, and has been shown to reduce the rate of clinical remission and hospitalizations in patients with this condition. 3. Primary Sjogren's Syndrome (PSS): Vedolizumab has been studied in patients with PSS, and has been shown to reduce the severity of gastrointestinal symptoms and improve quality of life. 4. Indeterminate Colitis: Vedolizumab has been studied in patients with indeterminate colitis, a condition where the symptoms are not typical of UC or CD, and has been shown to improve symptoms and quality of life. It is important to note that Vedolizumab is not recommended for the treatment of irritable bowel syndrome (IBS), as it is not an inflammatory condition. Also, it is not approved for the treatment of other conditions, such as irritable bowel syndrome (IBS), as it is not an inflammatory condition."}
{"qid": "5a43a139966455904c000008", "original_text": "The NOMe-Seq methodology measures the taxonomic composition of the human microbiome by sequencing the 16S ribosomal RNA (rRNA) gene. This gene is present in all bacteria and archaea, and its sequence can be used to identify and quantify different species within the microbiome. The NOMe-Seq methodology involves a combination of DNA extraction, PCR amplification, and sequencing, followed by data analysis using specialized software to assign taxonomy to the sequenced reads based on their 16S rRNA gene sequences.", "label": 0, "is_selected": 1, "text": "The NOMe-Seq methodology has been developed at the University of California, San Francisco (UCSD) to study the human microbiome, a community of bacteria and archaea that live in the digestive and respiratory tracts of humans and other animals, such as humans and animals with cystic fibrosis."}
{"qid": "62005e02c9dfcb9c09000018", "original_text": "The tool developed for proteome-wide detection of membrane lipid-binding proteins is called LiPID- bind. It is a computational method that uses a combination of machine learning algorithms and structural modeling to predict the binding of lipids to integral membrane proteins in a proteome-wide manner. LiPID-bind has been shown to be highly accurate in predicting lipid-binding sites in membrane proteins, making it a valuable tool for investigating lipid-protein interactions in various biological systems.", "label": 0, "is_selected": 0, "text": "The tool developed for proteome-wide detection of membrane lipid-binding proteins is called LiPID- bind. It is a computational method that uses a combination of machine learning algorithms and structural modeling to predict the binding of lipids to integral membrane proteins in a proteome-wide manner. LiPID-bind has been shown to be highly accurate in predicting lipid-binding sites in membrane proteins, making it a valuable tool for investigating lipid-protein interactions in various biological systems."}
{"qid": "58d8d8108acda34529000009", "original_text": "To examine the fibrillin-1 (FBN1) gene for mutations in members of a Chinese family with isolated ectopia lentis. Clinically relevant laboratory investigation. Family members underwent clinical examinations. Genomic DNA was extracted from leukocytes of peripheral blood from the available members and 100 controls for mutation analysis. The 65 exons of FBN1 were amplified by polymerase chain reaction and screened for mutations by a combination of denaturing high-performance liquid chromatography analysis and direct DNA sequencing. A mutation, c.184C-->T in exon 2 of FBN1, which results in substitution of arginine by cysteine at position 62 of the fibrillin-1 protein (p.R62C) in all affected family members but in none of the unaffected individuals.", "label": 1, "is_selected": 0, "text": "To examine the fibrillin-1 (FBN1) gene for mutations in members of a Chinese family with isolated ectopia lentis. Clinically relevant laboratory investigation. Family members underwent clinical examinations. Genomic DNA was extracted from leukocytes of peripheral blood from the available members and 100 controls for mutation analysis. The 65 exons of FBN1 were amplified by polymerase chain reaction and screened for mutations by a combination of denaturing high-performance liquid chromatography analysis and direct DNA sequencing. A mutation, c.184C-->T in exon 2 of FBN1, which results in substitution of arginine by cysteine at position 62 of the fibrillin-1 protein (p.R62C) in all affected family members but in none of the unaffected individuals."}
{"qid": "57135fae1174fb1755000004", "original_text": "To determine how adults in the United States view non-invasive prenatal testing using cell-free fetal DNA (cffDNA testing) in order to help estimate uptake. A national sample of 1861 US-based adults was surveyed using a validated online survey instrument. The survey was administered by a commercial survey research company. Respondents were randomized to receive a survey about prenatal testing for trisomy 13 and 18 or trisomy 21. Participants were asked to select among testing modalities, including cffDNA testing, and rank the features of testing that they considered most important to decision making. There was substantive interest in the use of cffDNA testing rather than traditional screening mechanisms, with a minority of respondents reporting that they would support the use of both methods in combination. The lower rates of false-negative and false-positive test results and the ability to use the test earlier in the pregnancy were the most highly rated benefits of cffDNA testing. Participants expressed strong support for diagnostic confirmation via invasive testing after a positive result from either screening or cffDNA testing. However, almost one-third of participants reported that they would not endorse the use of either invasive or non-invasive prenatal testing.", "label": 1, "is_selected": 0, "text": "To determine how adults in the United States view non-invasive prenatal testing using cell-free fetal DNA (cffDNA testing) in order to help estimate uptake. A national sample of 1861 US-based adults was surveyed using a validated online survey instrument. The survey was administered by a commercial survey research company. Respondents were randomized to receive a survey about prenatal testing for trisomy 13 and 18 or trisomy 21. Participants were asked to select among testing modalities, including cffDNA testing, and rank the features of testing that they considered most important to decision making. There was substantive interest in the use of cffDNA testing rather than traditional screening mechanisms, with a minority of respondents reporting that they would support the use of both methods in combination. The lower rates of false-negative and false-positive test results and the ability to use the test earlier in the pregnancy were the most highly rated benefits of cffDNA testing. Participants expressed strong support for diagnostic confirmation via invasive testing after a positive result from either screening or cffDNA testing. However, almost one-third of participants reported that they would not endorse the use of either invasive or non-invasive prenatal testing."}
{"qid": "5a895f51fcd1d6a10c000004", "original_text": "CTCF and the associated cohesin complex play a central role in insulator function and higher-order chromatin organization of mammalian genomes. Recent studies identified a correlation between the orientation of CTCF-binding sites (CBSs) and chromatin loops. To test the functional significance of this observation, we combined CRISPR/Cas9-based genomic-DNA-fragment editing with chromosome-conformation-capture experiments to show that the location and relative orientations of CBSs determine the specificity of long-range chromatin looping in mammalian genomes, using protocadherin (Pcdh) and \u03b2-globin as model genes.", "label": 1, "is_selected": 0, "text": "CTCF and the associated cohesin complex play a central role in insulator function and higher-order chromatin organization of mammalian genomes. Recent studies identified a correlation between the orientation of CTCF-binding sites (CBSs) and chromatin loops. To test the functional significance of this observation, we combined CRISPR/Cas9-based genomic-DNA-fragment editing with chromosome-conformation-capture experiments to show that the location and relative orientations of CBSs determine the specificity of long-range chromatin looping in mammalian genomes, using protocadherin (Pcdh) and \u03b2-globin as model genes."}
{"qid": "5a70e1d999e2c3af26000007", "original_text": "Alzheimer's disease is characterized by amyloid-beta plaques, neurofibrillary tangles, gliosis, and neuronal loss. Solanezumab, a humanized monoclonal antibody, preferentially binds soluble forms of amyloid and in preclinical studies promoted its clearance from the brain. In two phase 3, double-blind trials (EXPEDITION 1 and EXPEDITION 2), we randomly assigned 1012 and 1040 patients, respectively, with mild-to-moderate Alzheimer's disease to receive placebo or solanezumab (administered intravenously at a dose of 400 mg) every 4 weeks for 18 months. The primary outcomes were the changes from baseline to week 80 in scores on the 11-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog11; range, 0 to 70, with higher scores indicating greater cognitive impairment) and the Alzheimer's Disease Cooperative Study-Activities of Daily Living scale (ADCS-ADL; range, 0 to 78, with lower scores indicating worse functioning). After analysis of data from EXPEDITION 1, the primary outcome for EXPEDITION 2 was revised to the change in scores on the 14-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog14; range, 0 to 90, with higher scores indicating greater impairment), in patients with mild Alzheimer's disease.", "label": 1, "is_selected": 0, "text": "Alzheimer's disease is characterized by amyloid-beta plaques, neurofibrillary tangles, gliosis, and neuronal loss. Solanezumab, a humanized monoclonal antibody, preferentially binds soluble forms of amyloid and in preclinical studies promoted its clearance from the brain. In two phase 3, double-blind trials (EXPEDITION 1 and EXPEDITION 2), we randomly assigned 1012 and 1040 patients, respectively, with mild-to-moderate Alzheimer's disease to receive placebo or solanezumab (administered intravenously at a dose of 400 mg) every 4 weeks for 18 months. The primary outcomes were the changes from baseline to week 80 in scores on the 11-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog11; range, 0 to 70, with higher scores indicating greater cognitive impairment) and the Alzheimer's Disease Cooperative Study-Activities of Daily Living scale (ADCS-ADL; range, 0 to 78, with lower scores indicating worse functioning). After analysis of data from EXPEDITION 1, the primary outcome for EXPEDITION 2 was revised to the change in scores on the 14-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog14; range, 0 to 90, with higher scores indicating greater impairment), in patients with mild Alzheimer's disease."}
{"qid": "5c783236d774d04240000001", "original_text": "Collagen is a fibrillar protein that conforms the conjunctive and connective tissues in the human body, essentially skin, joints, and bones. This molecule is one of the most abundant in many of the living organisms due to its connective role in biological structures. Due to its abundance, strength and its directly proportional relation with skin aging, collagen has gained great interest in the cosmetic industry. It has been established that the collagen fibers are damaged with the pass of time, losing thickness and strength which has been strongly related with skin aging phenomena [Col\u00e1geno para todo.", "label": 1, "is_selected": 0, "text": "Collagen is a fibrillar protein that conforms the conjunctive and connective tissues in the human body, essentially skin, joints, and bones. This molecule is one of the most abundant in many of the living organisms due to its connective role in biological structures. Due to its abundance, strength and its directly proportional relation with skin aging, collagen has gained great interest in the cosmetic industry. It has been established that the collagen fibers are damaged with the pass of time, losing thickness and strength which has been strongly related with skin aging phenomena [Col\u00e1geno para todo."}
{"qid": "5e4adcbe6d0a277941000017", "original_text": "Radioiodine ablation (RIA) therapy is one of the most important treatments for papillary thyroid carcinoma (PTC), but some patients who received (131)I have radioiodine-refractory disease caused by the decreased expression of the Na(+)/I(-) symporter (NIS). BRAF(V600E) mutation is one possible risk factor that can disturb the NIS expression, but the roles are unclear in clinical practice. This research discussed the association of BRAF(V600E) mutation and NIS expression in PTC tissue and the clinical implications in RIA therapy. 134 PTC samples were collected between June 2013 and June 2014 from Tongji Hospital affiliated to Tongji Medical College, and their clinical characteristics were analyzed. RT-PCR was used to detect the BRAF(V600E) mutation from formalin-fixed paraffin-embedded samples, and immunohistochemistry was applied to detect the NIS expression. IPP software was used to calculate the relative expression quantity of NIS. We found that there was no significant correlation between the absorbance (A) values of NIS and clinicopathologic features in these cases, even thyroid stimulating hormone. BRAF(V600E) mutation showed inhibitory effect on the NIS expression without statistically significant difference in all PTC cases (\u03b2=-0.0195, P=0.085), but in the subgroup without hashimoto's thyroiditis (HT), BRAF(V600E) mutation could significantly inhibit the NIS expression (\u03b2=-0.0257, P=0.046). The results indicate that BRAF(V600E) mutation is correlated with a lower expression of NIS in PTCs without HT, suggesting the radioiodine-refractory effects during RIA therapy in these patients.", "label": 1, "is_selected": 0, "text": "Radioiodine ablation (RIA) therapy is one of the most important treatments for papillary thyroid carcinoma (PTC), but some patients who received (131)I have radioiodine-refractory disease caused by the decreased expression of the Na(+)/I(-) symporter (NIS). BRAF(V600E) mutation is one possible risk factor that can disturb the NIS expression, but the roles are unclear in clinical practice. This research discussed the association of BRAF(V600E) mutation and NIS expression in PTC tissue and the clinical implications in RIA therapy. 134 PTC samples were collected between June 2013 and June 2014 from Tongji Hospital affiliated to Tongji Medical College, and their clinical characteristics were analyzed. RT-PCR was used to detect the BRAF(V600E) mutation from formalin-fixed paraffin-embedded samples, and immunohistochemistry was applied to detect the NIS expression. IPP software was used to calculate the relative expression quantity of NIS. We found that there was no significant correlation between the absorbance (A) values of NIS and clinicopathologic features in these cases, even thyroid stimulating hormone. BRAF(V600E) mutation showed inhibitory effect on the NIS expression without statistically significant difference in all PTC cases (\u03b2=-0.0195, P=0.085), but in the subgroup without hashimoto's thyroiditis (HT), BRAF(V600E) mutation could significantly inhibit the NIS expression (\u03b2=-0.0257, P=0.046). The results indicate that BRAF(V600E) mutation is correlated with a lower expression of NIS in PTCs without HT, suggesting the radioiodine-refractory effects during RIA therapy in these patients."}
{"qid": "5713c8d71174fb1755000015", "original_text": "NDRG1 (NeuroDifferentiation Factor 1) mutations have been associated with several types of peripheral neuropathy, including: 1. Charcot-Marie-Tooth disease (CMT): CMT is the most common peripheral neuropathy associated with NDRG1 mutations. It is a genetic disorder characterized by progressive damage to the peripheral nerves, leading to muscle weakness, numbness, and loss of balance. 2. Familial axonal neuropathy (FAN): FAN is a rare genetic disorder that affects the peripheral nerves, leading to progressive muscle weakness, atrophy, and sensory loss. NDRG1 mutations have been identified in some cases of FAN. 3. Autonomic neuropathy: Autonomic neuropathy is a type of peripheral neuropathy that affects the autonomic nervous system, which controls involuntary functions such as heart rate, blood pressure, and digestion. NDRG1 mutations have been associated with certain forms of autonomic neuropathy. It is important to note that NDRG1 mutations are relatively rare causes of peripheral neuropathy, and other genetic and environmental factors may also contribute to the development of these conditions. A thorough clinical evaluation and genetic testing can help identify the underlying cause of peripheral neuropathy in an individual.", "label": 0, "is_selected": 0, "text": "NDRG1 (NeuroDifferentiation Factor 1) mutations have been associated with several types of peripheral neuropathy, including: 1. Charcot-Marie-Tooth disease (CMT): CMT is the most common peripheral neuropathy associated with NDRG1 mutations. It is a genetic disorder characterized by progressive damage to the peripheral nerves, leading to muscle weakness, numbness, and loss of balance. 2. Familial axonal neuropathy (FAN): FAN is a rare genetic disorder that affects the peripheral nerves, leading to progressive muscle weakness, atrophy, and sensory loss. NDRG1 mutations have been identified in some cases of FAN. 3. Autonomic neuropathy: Autonomic neuropathy is a type of peripheral neuropathy that affects the autonomic nervous system, which controls involuntary functions such as heart rate, blood pressure, and digestion. NDRG1 mutations have been associated with certain forms of autonomic neuropathy. It is important to note that NDRG1 mutations are relatively rare causes of peripheral neuropathy, and other genetic and environmental factors may also contribute to the development of these conditions. A thorough clinical evaluation and genetic testing can help identify the underlying cause of peripheral neuropathy in an individual."}
{"qid": "56c3327c50c68dd41600000c", "original_text": "The formation of R-loops is a natural consequence of the transcription process, caused by invasion of the DNA duplex by nascent transcripts. These structures have been considered rare transcriptional by-products with potentially harmful effects on genome integrity owing to the fragility of the displaced DNA coding strand. However, R-loops may also possess beneficial effects, as their widespread formation has been detected over CpG island promoters in human genes. Furthermore, we have previously shown that R-loops are particularly enriched over G-rich terminator elements.", "label": 1, "is_selected": 0, "text": "The formation of R-loops is a natural consequence of the transcription process, caused by invasion of the DNA duplex by nascent transcripts. These structures have been considered rare transcriptional by-products with potentially harmful effects on genome integrity owing to the fragility of the displaced DNA coding strand. However, R-loops may also possess beneficial effects, as their widespread formation has been detected over CpG island promoters in human genes. Furthermore, we have previously shown that R-loops are particularly enriched over G-rich terminator elements."}
{"qid": "6057014c94d57fd879000022", "original_text": "Phenotypic plasticity, the ability of an organism to alter its phenotype in response to an environmental cue, facilitates rapid adaptation to changing environments. Plastic changes in morphology and behavior are underpinned by widespread gene expression changes. However, it is unknown if, or how, genomes are structured to ensure these robust responses. Here, we use repression of honeybee worker ovaries as a model of plasticity. We show that the honeybee genome is structured with respect to plasticity; genes that respond to an environmental trigger are colocated in the honeybee genome in a series of gene clusters, many of which have been assembled in the last 80 My during the evolution of the Apidae.", "label": 1, "is_selected": 0, "text": "Phenotypic plasticity, the ability of an organism to alter its phenotype in response to an environmental cue, facilitates rapid adaptation to changing environments. Plastic changes in morphology and behavior are underpinned by widespread gene expression changes. However, it is unknown if, or how, genomes are structured to ensure these robust responses. Here, we use repression of honeybee worker ovaries as a model of plasticity. We show that the honeybee genome is structured with respect to plasticity; genes that respond to an environmental trigger are colocated in the honeybee genome in a series of gene clusters, many of which have been assembled in the last 80 My during the evolution of the Apidae."}
{"qid": "5883b8e6e56acf5176000002", "original_text": "Yes, POLD3 is essential for mouse development. POLD3 is a polo-like kinase domain containing protein 3 that plays a critical role in the regulation of embryonic stem cell self-renewal and differentiation. Mutations in the Pold3 gene have been shown to lead to defects in mouse embryonic development, including abnormalities in the formation of the neural tube, limbs, and other body structures. Without Pold3, mice fail to develop properly, highlighting its essentiality for embryonic development.", "label": 0, "is_selected": 1, "text": "What is the POLD3 gene and is it essential for mouse embryonic development?<n> The Pold3 gene has been shown to lead to defects in mice embryonic development, including abnormalities in the formation of the neural tube, limbs, and the body structures."}
{"qid": "51640b4a298dcd4e51000050", "original_text": "Recent clinical observations strongly suggest that isotretinoin [13-cis-retinoic acid (cis RA)] is a human teratogen causing primarily heart and craniofacial malformations including ear and palatal defects. The purpose of the present study was to determine if cis RA could induce similar craniofacial malformations in mouse embryo culture. Day 8 CD-1 mouse embryos were cultured for 48 hours in rat serum in the presence or absence of various concentrations of cis RA dissolved in DMSO. DMSO by itself had no effect on embryonic development; however, cis RA at 2 X 10(-5) M (6 micrograms/ml) was clearly toxic. At 2 X 10(-6)", "label": 1, "is_selected": 0, "text": "Recent clinical observations strongly suggest that isotretinoin [13-cis-retinoic acid (cis RA)] is a human teratogen causing primarily heart and craniofacial malformations including ear and palatal defects. The purpose of the present study was to determine if cis RA could induce similar craniofacial malformations in mouse embryo culture. Day 8 CD-1 mouse embryos were cultured for 48 hours in rat serum in the presence or absence of various concentrations of cis RA dissolved in DMSO. DMSO by itself had no effect on embryonic development; however, cis RA at 2 X 10(-5) M (6 micrograms/ml) was clearly toxic. At 2 X 10(-6)"}
{"qid": "514a11add24251bc05000054", "original_text": "Oncotype DX is a genomic assay that can be used to guide treatment decisions for several types of cancer, including: Breast cancer: Oncotype DX can help determine the likelihood of breast cancer recurrence in patients with early-stage, hormone receptor-positive (HR+) breast cancer. It can also help identify patients who may benefit from chemotherapy. Lung cancer: Oncotype DX can help predict the likelihood of disease progression in patients with non-small cell lung cancer (NSCLC) and determine the likelihood of benefit from chemotherapy. Prostate cancer: Oncotype DX can help determine the likelihood of metastasis and death from prostate cancer in patients with localized disease. It can also help identify patients who may benefit from more aggressive treatment. Colorectal cancer: Oncotype DX can help predict the likelihood of disease progression in patients with stage II colon cancer. It is important to note that Oncotype DX is not a diagnostic test, but rather a predictive test that helps doctors determine the likelihood of disease progression and the potential benefit of specific treatments. The results of the test can help guide personalized treatment decisions and improve patient outcomes.", "label": 0, "is_selected": 0, "text": "Oncotype DX is a genomic assay that can be used to guide treatment decisions for several types of cancer, including: Breast cancer: Oncotype DX can help determine the likelihood of breast cancer recurrence in patients with early-stage, hormone receptor-positive (HR+) breast cancer. It can also help identify patients who may benefit from chemotherapy. Lung cancer: Oncotype DX can help predict the likelihood of disease progression in patients with non-small cell lung cancer (NSCLC) and determine the likelihood of benefit from chemotherapy. Prostate cancer: Oncotype DX can help determine the likelihood of metastasis and death from prostate cancer in patients with localized disease. It can also help identify patients who may benefit from more aggressive treatment. Colorectal cancer: Oncotype DX can help predict the likelihood of disease progression in patients with stage II colon cancer. It is important to note that Oncotype DX is not a diagnostic test, but rather a predictive test that helps doctors determine the likelihood of disease progression and the potential benefit of specific treatments. The results of the test can help guide personalized treatment decisions and improve patient outcomes."}
{"qid": "54d8e319014675820d000009", "original_text": "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a severe inherited cardiac disorder caused by mutations predominantly in the ryanodine receptor (RyR2) gene. We sought to identify mutations in genes affecting cardiac calcium cycling in patients with CPVT and in less typical familial exercise-related ventricular arrhythmias. We recruited 33 consecutive patients with frequent ventricular premature complexes (VPCs) without structural heart disease and often history of syncope or sudden death in family. Sixteen of the patients featured a phenotype typical of CPVT. In 17 patients, VPCs emerged also at rest. Exercise stress test and echocardiography were performed to each patient and 232 family members. Familial background was evident in 42% of cases (n = 14). We sequenced all the coding exons of the RyR2, FKBP1B, ATP2A2 and SLC8A1 genes from the index patients. Single channel recordings of a mutant RyR2 were performed in planar lipid bilayers.", "label": 1, "is_selected": 0, "text": "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a severe inherited cardiac disorder caused by mutations predominantly in the ryanodine receptor (RyR2) gene. We sought to identify mutations in genes affecting cardiac calcium cycling in patients with CPVT and in less typical familial exercise-related ventricular arrhythmias. We recruited 33 consecutive patients with frequent ventricular premature complexes (VPCs) without structural heart disease and often history of syncope or sudden death in family. Sixteen of the patients featured a phenotype typical of CPVT. In 17 patients, VPCs emerged also at rest. Exercise stress test and echocardiography were performed to each patient and 232 family members. Familial background was evident in 42% of cases (n = 14). We sequenced all the coding exons of the RyR2, FKBP1B, ATP2A2 and SLC8A1 genes from the index patients. Single channel recordings of a mutant RyR2 were performed in planar lipid bilayers."}
{"qid": "54d669003706e8952800000e", "original_text": "Iaconic acid levels are elevated in various medical conditions. Here are some examples: 1. Diabetes: Iaconic acid levels are elevated in diabetes, particularly in the context of insulin resistance and metabolic syndrome. 2. Obesity: Iaconic acid levels are often elevated in obese individuals due to increased lipolysis and oxidation of fatty acids. 3. Metabolic disorders: Elevated iaconic acid levels can be found in various metabolic disorders, including mitochondrial disorders, maple syrup urine disease, and hyperlipidemia. 4. Cancer: Iaconic acid levels can be increased in various types of cancer, including breast, prostate, and colon cancer. 5. Aging: Iaconic acid levels have been shown to increase with age, potentially contributing to age-related metabolic changes. It is important to note that these conditions are not mutually exclusive, and elevated iaconic acid levels can be found in individuals with multiple comorbidities. Measurement of iaconic acid levels can provide valuable insights into metabolic dysregulation and help identify potential therapeutic targets for metabolic disorders.", "label": 0, "is_selected": 0, "text": "Iaconic acid levels are elevated in various medical conditions. Here are some examples: 1. Diabetes: Iaconic acid levels are elevated in diabetes, particularly in the context of insulin resistance and metabolic syndrome. 2. Obesity: Iaconic acid levels are often elevated in obese individuals due to increased lipolysis and oxidation of fatty acids. 3. Metabolic disorders: Elevated iaconic acid levels can be found in various metabolic disorders, including mitochondrial disorders, maple syrup urine disease, and hyperlipidemia. 4. Cancer: Iaconic acid levels can be increased in various types of cancer, including breast, prostate, and colon cancer. 5. Aging: Iaconic acid levels have been shown to increase with age, potentially contributing to age-related metabolic changes. It is important to note that these conditions are not mutually exclusive, and elevated iaconic acid levels can be found in individuals with multiple comorbidities. Measurement of iaconic acid levels can provide valuable insights into metabolic dysregulation and help identify potential therapeutic targets for metabolic disorders."}
{"qid": "5503167be9bde69634000028", "original_text": "In autoimmune thyroiditis, thyrocytes are destroyed by an immune-mediated process that involves the activation of autoreactive T cells and B cells. These immune cells recognize the thyroid gland as foreign and launch an immune attack, leading to the destruction of thyrocytes. The autoantibodies produced by the immune system also contribute to the destruction of thyrocytes by facilitating the recognition and elimination of these cells by immune cells. The combination of immune-mediated injury and autoantibody production leads to the inflammation and degeneration of the thyroid gland, resulting in hypothyroidism.", "label": 0, "is_selected": 0, "text": "In autoimmune thyroiditis, thyrocytes are destroyed by an immune-mediated process that involves the activation of autoreactive T cells and B cells. These immune cells recognize the thyroid gland as foreign and launch an immune attack, leading to the destruction of thyrocytes. The autoantibodies produced by the immune system also contribute to the destruction of thyrocytes by facilitating the recognition and elimination of these cells by immune cells. The combination of immune-mediated injury and autoantibody production leads to the inflammation and degeneration of the thyroid gland, resulting in hypothyroidism."}
{"qid": "52fb19ab2059c6d71c00005c", "original_text": "To describe the outcomes of pregnancies complicated by rheumatoid arthritis (RA) and to estimate potential associations between disease characteristics and pregnancy outcomes. We reviewed all pregnancies complicated by RA delivered at our institution from June 2001 through June 2009. Fisher exact tests were used to calculate odds ratios. Univariable regression was performed using STATA 10.1 (StataCorp, College Station, TX). A p value of \u2264 0.05 was considered statistically significant. Forty-six pregnancies in 40 women were reviewed. Sixty percent of pregnancies had evidence of disease flare and 28% delivered prior to 37 weeks. We did not identify associations between preterm birth and active disease at conception or during pregnancy. In univariate analysis, discontinuation of medication because of pregnancy was associated with a significantly earlier gestational age at delivery (362/7 versus 383/7 weeks, p = 0.022). Women with RA may be at higher risk for preterm delivery.", "label": 1, "is_selected": 0, "text": "To describe the outcomes of pregnancies complicated by rheumatoid arthritis (RA) and to estimate potential associations between disease characteristics and pregnancy outcomes. We reviewed all pregnancies complicated by RA delivered at our institution from June 2001 through June 2009. Fisher exact tests were used to calculate odds ratios. Univariable regression was performed using STATA 10.1 (StataCorp, College Station, TX). A p value of \u2264 0.05 was considered statistically significant. Forty-six pregnancies in 40 women were reviewed. Sixty percent of pregnancies had evidence of disease flare and 28% delivered prior to 37 weeks. We did not identify associations between preterm birth and active disease at conception or during pregnancy. In univariate analysis, discontinuation of medication because of pregnancy was associated with a significantly earlier gestational age at delivery (362/7 versus 383/7 weeks, p = 0.022). Women with RA may be at higher risk for preterm delivery."}
{"qid": "54e0d1491388e8454a000014", "original_text": "Dyslipidaemia is a critical risk factor for the development of cardiovascular complications such as ischemic heart disease and stroke. Although statins are effective anti-dyslipidemic drugs, their usage is fraught with issues such as failure of adequate lipid control in 30% of cases and intolerance in select patients. The limited potential of other alternatives such as fibrates, bile acid sequestrants and niacin has spurred the search for novel drug molecules with better efficacy and safety.", "label": 1, "is_selected": 0, "text": "Dyslipidaemia is a critical risk factor for the development of cardiovascular complications such as ischemic heart disease and stroke. Although statins are effective anti-dyslipidemic drugs, their usage is fraught with issues such as failure of adequate lipid control in 30% of cases and intolerance in select patients. The limited potential of other alternatives such as fibrates, bile acid sequestrants and niacin has spurred the search for novel drug molecules with better efficacy and safety."}
{"qid": "5e776541835f4e4777000009", "original_text": "HIV-1 infection is associated with increased risk of tuberculosis and a safe and effective vaccine would assist control measures. We assessed the safety, immunogenicity, and efficacy of a candidate tuberculosis vaccine, modified vaccinia virus Ankara expressing antigen 85A (MVA85A), in adults infected with HIV-1. We did a randomised, double-blind, placebo-controlled, phase 2 trial of MVA85A in adults infected with HIV-1, at two clinical sites, in Cape Town, South Africa and Dakar, Senegal. Eligible participants were aged 18-50 years, had no evidence of active tuberculosis, and had baseline CD4 counts greater than 350 cells per \u03bcL if they had never received antiretroviral therapy or greater than 300 cells per \u03bcL (and with undetectable viral load before randomisation) if they were receiving antiretroviral therapy; participants with latent tuberculosis infection were eligible if they had completed at least 5 months of isoniazid preventive therapy, unless they had completed treatment for tuberculosis disease within 3 years before randomisation. Participants were randomly assigned (1:1) in blocks of four by randomly generated sequence to receive two intradermal injections of either MVA85A or placebo. Randomisation was stratified by antiretroviral therapy status and study site. Participants, nurses, investigators, and laboratory staff were masked to group allocation. The second (booster) injection of MVA85A or placebo was given 6-12 months after the first vaccination. The primary study outcome was safety in all vaccinated participants (the safety analysis population). Safety was assessed throughout the trial as defined in the protocol. Secondary outcomes were immunogenicity and vaccine efficacy against Mycobacterium tuberculosis infection and disease, assessed in the per-protocol population. Immunogenicity was assessed in a subset of participants at day 7 and day 28 after the first and second vaccination, and M tuberculosis infection and disease were assessed at the end of the study. The trial is registered with ClinicalTrials.gov, number NCT01151189. Between Aug 4, 2011, and April 24, 2013, 650 participants were enrolled and randomly assigned; 649 were included in the safety analysis (324 in the MVA85A group and 325 in the placebo group) and 645 in the per-protocol analysis (320 and 325). 513 (71%) participants had CD4 counts greater than 300 cells per \u03bcL and were receiving antiretroviral therapy; 136 (21%) had CD4 counts above 350 cells per \u03bcL and had never received antiretroviral therapy.", "label": 1, "is_selected": 0, "text": "HIV-1 infection is associated with increased risk of tuberculosis and a safe and effective vaccine would assist control measures. We assessed the safety, immunogenicity, and efficacy of a candidate tuberculosis vaccine, modified vaccinia virus Ankara expressing antigen 85A (MVA85A), in adults infected with HIV-1. We did a randomised, double-blind, placebo-controlled, phase 2 trial of MVA85A in adults infected with HIV-1, at two clinical sites, in Cape Town, South Africa and Dakar, Senegal. Eligible participants were aged 18-50 years, had no evidence of active tuberculosis, and had baseline CD4 counts greater than 350 cells per \u03bcL if they had never received antiretroviral therapy or greater than 300 cells per \u03bcL (and with undetectable viral load before randomisation) if they were receiving antiretroviral therapy; participants with latent tuberculosis infection were eligible if they had completed at least 5 months of isoniazid preventive therapy, unless they had completed treatment for tuberculosis disease within 3 years before randomisation. Participants were randomly assigned (1:1) in blocks of four by randomly generated sequence to receive two intradermal injections of either MVA85A or placebo. Randomisation was stratified by antiretroviral therapy status and study site. Participants, nurses, investigators, and laboratory staff were masked to group allocation. The second (booster) injection of MVA85A or placebo was given 6-12 months after the first vaccination. The primary study outcome was safety in all vaccinated participants (the safety analysis population). Safety was assessed throughout the trial as defined in the protocol. Secondary outcomes were immunogenicity and vaccine efficacy against Mycobacterium tuberculosis infection and disease, assessed in the per-protocol population. Immunogenicity was assessed in a subset of participants at day 7 and day 28 after the first and second vaccination, and M tuberculosis infection and disease were assessed at the end of the study. The trial is registered with ClinicalTrials.gov, number NCT01151189. Between Aug 4, 2011, and April 24, 2013, 650 participants were enrolled and randomly assigned; 649 were included in the safety analysis (324 in the MVA85A group and 325 in the placebo group) and 645 in the per-protocol analysis (320 and 325). 513 (71%) participants had CD4 counts greater than 300 cells per \u03bcL and were receiving antiretroviral therapy; 136 (21%) had CD4 counts above 350 cells per \u03bcL and had never received antiretroviral therapy."}
{"qid": "6026ed981cb411341a0000d2", "original_text": "The results of phase 2 randomized controlled trials for the prevention of episodic and chronic migraine demonstrating the efficacy and safety of four mAbs targeting the calcitonin gene-related peptide (CGRP) pathway [ALD403 (eptinezumab), AMG334 (erenumab), LY2951742 (galcanezumab) and TEV48125 (fremanezumab)] have been published recently, and phase 3 trials are in process.", "label": 1, "is_selected": 0, "text": "The results of phase 2 randomized controlled trials for the prevention of episodic and chronic migraine demonstrating the efficacy and safety of four mAbs targeting the calcitonin gene-related peptide (CGRP) pathway [ALD403 (eptinezumab), AMG334 (erenumab), LY2951742 (galcanezumab) and TEV48125 (fremanezumab)] have been published recently, and phase 3 trials are in process."}
{"qid": "587dfde9ae05ffb474000001", "original_text": "We present Micro-C XL, an improved method for analysis of chromosome folding at mononucleosome resolution. Using long crosslinkers and isolation of insoluble chromatin, Micro-C XL increases signal-to-noise ratio. Micro-C XL maps of budding and fission yeast genomes capture both short-range chromosome fiber features such as chromosomally interacting domains and higher order features such as centromere clustering.", "label": 1, "is_selected": 0, "text": "We present Micro-C XL, an improved method for analysis of chromosome folding at mononucleosome resolution. Using long crosslinkers and isolation of insoluble chromatin, Micro-C XL increases signal-to-noise ratio. Micro-C XL maps of budding and fission yeast genomes capture both short-range chromosome fiber features such as chromosomally interacting domains and higher order features such as centromere clustering."}
{"qid": "5c851c2675a4a5d219000006", "original_text": "Bezlotoxumab (Zinplava\u2122) is a fully human monoclonal antibody against Clostridium difficile toxin B indicated for the prevention of C. difficile infection (CDI) recurrence in patients with a high recurrence risk. It is the first agent approved for recurrence prevention and is administered as a single intravenous infusion in conjunction with standard-of-care (SoC) antibacterial treatment for CDI. In well-designed, placebo-controlled, phase 3 trials (MODIFY 1 and 2), a single infusion of bezlotoxumab, given in combination with SoC antibacterial therapy for CDI in adults, was effective in reducing CDI recurrence in the 12 weeks post-treatment, with this benefit being seen mainly in the patients at high recurrence risk. Bezlotoxumab did not impact the efficacy of the antibacterials being used to treat the CDI and, consistent with its benefits on CDI recurrence, appeared to reduce the need for subsequent antibacterials, thus minimizing further gut microbiota disruption.", "label": 1, "is_selected": 0, "text": "Bezlotoxumab (Zinplava\u2122) is a fully human monoclonal antibody against Clostridium difficile toxin B indicated for the prevention of C. difficile infection (CDI) recurrence in patients with a high recurrence risk. It is the first agent approved for recurrence prevention and is administered as a single intravenous infusion in conjunction with standard-of-care (SoC) antibacterial treatment for CDI. In well-designed, placebo-controlled, phase 3 trials (MODIFY 1 and 2), a single infusion of bezlotoxumab, given in combination with SoC antibacterial therapy for CDI in adults, was effective in reducing CDI recurrence in the 12 weeks post-treatment, with this benefit being seen mainly in the patients at high recurrence risk. Bezlotoxumab did not impact the efficacy of the antibacterials being used to treat the CDI and, consistent with its benefits on CDI recurrence, appeared to reduce the need for subsequent antibacterials, thus minimizing further gut microbiota disruption."}
{"qid": "6277e52256bf9aee6f000009", "original_text": "We propose a novel model based on a set of coupled delay differential equations with fourteen delays in order to accurately estimate the incubation period of COVID-19, employing publicly available data of confirmed corona cases. In this goal, we separate the total cases into fourteen groups for the corresponding fourteen incubation periods. The estimated mean incubation period we obtain is 6.74 days (95% Confidence Interval(CI): 6.35 to 7.13), and the 90th percentile is 11.64 days (95% CI: 11.22 to 12.17), corresponding to a good agreement with statistical supported studies. This model provides an almost zero-cost computational complexity to estimate the incubation period.", "label": 1, "is_selected": 0, "text": "We propose a novel model based on a set of coupled delay differential equations with fourteen delays in order to accurately estimate the incubation period of COVID-19, employing publicly available data of confirmed corona cases. In this goal, we separate the total cases into fourteen groups for the corresponding fourteen incubation periods. The estimated mean incubation period we obtain is 6.74 days (95% Confidence Interval(CI): 6.35 to 7.13), and the 90th percentile is 11.64 days (95% CI: 11.22 to 12.17), corresponding to a good agreement with statistical supported studies. This model provides an almost zero-cost computational complexity to estimate the incubation period."}
{"qid": "5322d3cb9b2d7acc7e000010", "original_text": "Tubulin acetylation is regulated by several enzymes, including tubulin acetyltransferases and tubulin deacetylases. The primary tubulin acetyltransferase involved in microtubule acetylation is p300, which acetylates tubulin at lysine 40 (K40). Another enzyme, p21-activated protein kinase (PAK), can also acetylate tubulin at K40 in response to extracellular signals. Tubulin deacetylases, such as tubulin deacetylase 1 (Tuj1), can remove acetyl groups from tubulin, leading to decreased microtubule stability. Other enzymes, including histone acetyltransferases, have also been shown to modify tubulin and regulate microtubule acetylation.", "label": 0, "is_selected": 1, "text": "Microtubule acetylation is a key step in the stability and transport of tubulin, one of the most important building blocks of protein synthesis in the human gut and a key factor in the regulation of many cellular processes, including cell proliferation and differentiation."}
{"qid": "587e0116ae05ffb474000002", "original_text": "There are several tools available for predicting regulatory interactions from ChIP-seq data. Some popular options include: 1. HISAT2: A popular tool for aligning ChIP-seq data to the genome and predicting regulatory interactions. It uses a Bayesian approach to estimate the probability of a genomic region being bound by a transcription factor. 2. DREAM: A tool that uses a hidden Markov model to predict regulatory interactions from ChIP-seq data. It can also predict the binding affinity and specificity of the transcription factor. 3. MACS2: A tool that uses a Bayesian approach to predict regulatory interactions from ChIP-seq data. It can also identify peaks of histone modification and predict the binding affinity of transcription factors. 4. ChIPseek: A tool that uses a Bayesian approach to predict regulatory interactions from ChIP-seq data. It can also identify peak regions and predict the binding affinity of transcription factors. 5. CRACK: A tool that uses a support vector machine (SVM) algorithm to predict regulatory interactions from ChIP-seq data. It can also predict the binding affinity and specificity of transcription factors. Please note that this list is not exhaustive and there are many other tools available for predicting regulatory interactions from ChIP-seq data.", "label": 0, "is_selected": 1, "text": "Here is a list of some of the most popular tools for predicting regulatory interactions from ChIP-seq data, as compiled by researchers at the University of California, Los Angeles (UCLA) and the Massachusetts Institute of Technology (MIT) in collaboration with the National Human Genome Research Council (NHGC) in the United States and the National Institutes of Health (NIH) in Canada, as well as by scientists at the universities of California and Massachusetts, and at the Massachusetts General Hospital (MGH) in Boston."}
{"qid": "51477de5d24251bc05000020", "original_text": "The three organs that are classically associated with the multiple endocrine neoplasia type 1 (MEN1) syndrome are the pituitary gland, thyroid gland, and parathyroid gland. MEN1 is a rare genetic disorder that affects the development and function of these endocrine glands, leading to the formation of tumors in one or more of them. The pituitary gland is the most commonly affected gland, followed by the thyroid gland and the parathyroid gland.", "label": 0, "is_selected": 1, "text": "A rare genetic disorder that affects the development and function of one or more of the endocrine glands has been identified by researchers at the University of California, Los Angeles (UCLA) and the Keck School of Medicine of the Keck College of Medicine at USC."}
{"qid": "552fac4fbc4f83e828000006", "original_text": "Ewing's tumour is the second most frequent primary tumour of bone. It is associated in 85% of cases with a specific and recurrent chromosome translocation, a t(11; 22)(q24; q12) which generates a fusion gene between the 5' part of EWS and the 3' part of FLI-1, a member of the ETS family. Less frequently, this gene fusion involves EWS and another member of the ETS family which can be: ERG, ETV1, E1AF or FEV depending on the cases. The EWS-ETS fusion is causative in the development of Ewing's tumour.", "label": 1, "is_selected": 0, "text": "Ewing's tumour is the second most frequent primary tumour of bone. It is associated in 85% of cases with a specific and recurrent chromosome translocation, a t(11; 22)(q24; q12) which generates a fusion gene between the 5' part of EWS and the 3' part of FLI-1, a member of the ETS family. Less frequently, this gene fusion involves EWS and another member of the ETS family which can be: ERG, ETV1, E1AF or FEV depending on the cases. The EWS-ETS fusion is causative in the development of Ewing's tumour."}
{"qid": "5a68a463b750ff4455000014", "original_text": "Chromatin features, such as histone modifications and chromatin structure, have been found to predict the location of genes associated with expression quantitative trait loci (eQTLs). Studies have shown that genes with high levels of histone H3 lysine 4 trimethylation (H3K4me3) are more likely to be eQTLs, while genes with high levels of histone H3 lysine 27 trimethylation (H3K27me3) are less likely to be eQTLs. Additionally, genes located in domains with specific chromatin structures, such as heterochromatin or euchromatin, are more likely to be eQTLs. These findings suggest that chromatin features can be used to identify genes that are likely to be associated with eQTLs.", "label": 0, "is_selected": 1, "text": "Histone modifications can be used to identify genes that are likely to be associated with quantitative trait loci (eQTLs), according to a study published in Plos One by researchers at the University of California, Los Angeles (UCLA) and the University College London (UCL)."}
{"qid": "58ab1f209ef3c34033000001", "original_text": "Histone variants play crucial roles in gene expression, genome integrity, and chromosome segregation. We report that the four H2A variants in Arabidopsis define different genomic features, contributing to overall genomic organization. The histone variant H2A.W marks heterochromatin specifically and acts in synergy with heterochromatic marks H3K9me2 and DNA methylation to maintain transposon silencing. In vitro, H2A.W enhances chromatin condensation by promoting fiber-to-fiber interactions via its conserved C-terminal motif.", "label": 1, "is_selected": 0, "text": "Histone variants play crucial roles in gene expression, genome integrity, and chromosome segregation. We report that the four H2A variants in Arabidopsis define different genomic features, contributing to overall genomic organization. The histone variant H2A.W marks heterochromatin specifically and acts in synergy with heterochromatic marks H3K9me2 and DNA methylation to maintain transposon silencing. In vitro, H2A.W enhances chromatin condensation by promoting fiber-to-fiber interactions via its conserved C-terminal motif."}
{"qid": "5503263fe9bde69634000030", "original_text": "Congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome (OMIM 604168) is an autosomal recessive developmental disorder that occurs in an endogamous group of Vlax Roma (Gypsies; refs. 1-3). We previously localized the gene associated with CCFDN to 18qter, where a conserved haplotype suggested a single founder mutation. In this study, we used recombination mapping to refine the gene position to a 155-kb critical interval. During haplotype analysis, we found that the non-transmitted chromosomes of some unaffected parents carried the conserved haplotype associated with the disease.", "label": 1, "is_selected": 0, "text": "Congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome (OMIM 604168) is an autosomal recessive developmental disorder that occurs in an endogamous group of Vlax Roma (Gypsies; refs. 1-3). We previously localized the gene associated with CCFDN to 18qter, where a conserved haplotype suggested a single founder mutation. In this study, we used recombination mapping to refine the gene position to a 155-kb critical interval. During haplotype analysis, we found that the non-transmitted chromosomes of some unaffected parents carried the conserved haplotype associated with the disease."}
{"qid": "5abbfd97fcf456587200001d", "original_text": "There are many reports about the role of rostral ventromedial medulla (RVM) in modulating stress-induced analgesia (SIA). In the previous study we demonstrated that temporal inactivation of RVM by lidocaine potentiated stress-induced analgesia. In this study, we investigated the effect of permanent lesion of the RVM on SIA by using formalin test as a model of acute inflammatory pain. Three sets of experiments were conducted: (1) Application of stress protocol (2) Formalin injection after exposing the animals to the swim stress (3) Either the relevant vehicle or dopamine receptor 1 (D1) agonist R-SKF38393 was injected into the RVM to cause a lesion. For permanent lesion of RVM, R-SKF38393 was injected into the RVM. Forced swim stress in water was employed in adult male rats. Nociceptive responses were measured by formalin test (50\u00b5l injection of formalin 2% subcutaneously into hind paw) and pain related behaviors were monitored for 90 min.", "label": 1, "is_selected": 0, "text": "There are many reports about the role of rostral ventromedial medulla (RVM) in modulating stress-induced analgesia (SIA). In the previous study we demonstrated that temporal inactivation of RVM by lidocaine potentiated stress-induced analgesia. In this study, we investigated the effect of permanent lesion of the RVM on SIA by using formalin test as a model of acute inflammatory pain. Three sets of experiments were conducted: (1) Application of stress protocol (2) Formalin injection after exposing the animals to the swim stress (3) Either the relevant vehicle or dopamine receptor 1 (D1) agonist R-SKF38393 was injected into the RVM to cause a lesion. For permanent lesion of RVM, R-SKF38393 was injected into the RVM. Forced swim stress in water was employed in adult male rats. Nociceptive responses were measured by formalin test (50\u00b5l injection of formalin 2% subcutaneously into hind paw) and pain related behaviors were monitored for 90 min."}
{"qid": "58a1c6b678275d0c4a000057", "original_text": "The nucleolus is the most prominent compartment in the nucleus and known as the site for ribosome biogenesis in eucaryotes. In contrast, there is no such equivalent structure for ribosome synthesis in procaryotes. This raises two concerns that how does the nucleolus evolve and that whether the nucleolus remains playing a single role in ribosome biogenesis along the evolution. Increasing data support new nucleolus functions, including signal recognition particle assembly, small RNA modification, telomerase maturation, cell-cycle and aging control, and cell stress sensor.", "label": 1, "is_selected": 0, "text": "The nucleolus is the most prominent compartment in the nucleus and known as the site for ribosome biogenesis in eucaryotes. In contrast, there is no such equivalent structure for ribosome synthesis in procaryotes. This raises two concerns that how does the nucleolus evolve and that whether the nucleolus remains playing a single role in ribosome biogenesis along the evolution. Increasing data support new nucleolus functions, including signal recognition particle assembly, small RNA modification, telomerase maturation, cell-cycle and aging control, and cell stress sensor."}
{"qid": "601cb4541cb411341a000024", "original_text": "Anti-Siglec-8 antibody is used to treat a rare genetic disorder called Morquio A syndrome, also known as mucopolysaccharidosis type IV (MPS IV). Morquio A syndrome is a debilitating disease caused by a deficiency of the enzyme sulfatase A, which leads to an accumulation of sugar chains in the body. The accumulation of these sugar chains causes progressive damage to the brain, spine, and other organs, resulting in a variety of symptoms including developmental delay, intellectual disability, joint stiffness, and short stature. Anti-Siglec-8 antibody therapy works by replacing the functional enzyme sulfatase A, which helps to break down the sugar chains and prevent their accumulation. This treatment is still experimental and is being studied in clinical trials to determine its safety and efficacy in humans.", "label": 0, "is_selected": 1, "text": "The US Food and Drug Administration (FDA) has granted orphan drug status to an anti-Siglec-8 antibody therapy for the treatment of a rare genetic disorder called Morquio A syndrome, which is a debilitating disease caused by a deficiency of the enzyme sulfatase A, which helps to break down sugar chains in the body."}
{"qid": "604bc5b41cb411341a000173", "original_text": "Extracting relations between bio-entities from biomedical literature is often a challenging task and also an essential step towards biomedical knowledge expansion. The BioCreative community has organized a shared task to evaluate the robustness of the causal relationship extraction algorithms in Biological Expression Language (BEL) from biomedical literature. We first map the sentence-level BEL statements in the BC-V training corpus to the corresponding text segments, thus generating hierarchically tagged training instances. A hierarchical sequence labeling model was afterwards induced from these training instances and applied to the test sentences in order to construct the BEL statements. The experimental results on extracting BEL statements from BioCreative V Track 4 test corpus show that our method achieves promising performance with an overall F-measure of 31.6%. Furthermore, it has the potential to be enhanced by adopting more advanced machine learning approaches. We propose a framework for hierarchical relation extraction using hierarchical sequence labeling on the instance-level training corpus derived from the original sentence-level corpus via word alignment. Its main advantage is that we can make full use of the original training corpus to induce the sequence labelers and then apply them to the test corpus.", "label": 1, "is_selected": 0, "text": "Extracting relations between bio-entities from biomedical literature is often a challenging task and also an essential step towards biomedical knowledge expansion. The BioCreative community has organized a shared task to evaluate the robustness of the causal relationship extraction algorithms in Biological Expression Language (BEL) from biomedical literature. We first map the sentence-level BEL statements in the BC-V training corpus to the corresponding text segments, thus generating hierarchically tagged training instances. A hierarchical sequence labeling model was afterwards induced from these training instances and applied to the test sentences in order to construct the BEL statements. The experimental results on extracting BEL statements from BioCreative V Track 4 test corpus show that our method achieves promising performance with an overall F-measure of 31.6%. Furthermore, it has the potential to be enhanced by adopting more advanced machine learning approaches. We propose a framework for hierarchical relation extraction using hierarchical sequence labeling on the instance-level training corpus derived from the original sentence-level corpus via word alignment. Its main advantage is that we can make full use of the original training corpus to induce the sequence labelers and then apply them to the test corpus."}
{"qid": "5c71d7ca7c78d6947100006b", "original_text": "Amgen and Novartis are developing erenumab (AIMOVIG\u2122, erenumab-aooe)-a fully human monoclonal antibody calcitonin gene-related peptide (CGRP) receptor antagonist-for the prevention of migraine. CGRP is a vasodilatory neuropeptide implicated in the pathophysiology of migraine and treatment with erenumab was associated with significant reductions in migraine frequency in phase II and III clinical trials. Based on these positive results erenumab was recently approved in the US for the preventive treatment of migraine in adults and has received a positive opinion in the EU for the prophylaxis of migraines in adults who have at least 4 migraine days per month.", "label": 1, "is_selected": 0, "text": "Amgen and Novartis are developing erenumab (AIMOVIG\u2122, erenumab-aooe)-a fully human monoclonal antibody calcitonin gene-related peptide (CGRP) receptor antagonist-for the prevention of migraine. CGRP is a vasodilatory neuropeptide implicated in the pathophysiology of migraine and treatment with erenumab was associated with significant reductions in migraine frequency in phase II and III clinical trials. Based on these positive results erenumab was recently approved in the US for the preventive treatment of migraine in adults and has received a positive opinion in the EU for the prophylaxis of migraines in adults who have at least 4 migraine days per month."}
{"qid": "621b85993a8413c653000041", "original_text": "Graves's disease and thyroiditis induce hyperthyroidism, the causes of which remain unclear, although they are involved with genetic and environmental factors. We aimed to evaluate polygenetic variants for hyperthyroidism risk and their interaction with metabolic parameters and nutritional intakes in an urban hospital-based cohort. A genome-wide association study (GWAS) of participants with (cases; n = 842) and without (controls, n = 38,799) hyperthyroidism was used to identify and select genetic variants. In clinical and lifestyle interaction with PRS, 312 participants cured of hyperthyroidism were excluded. Single nucleotide polymorphisms (SNPs) associated with gene-gene interactions were selected by hyperthyroidism generalized multifactor dimensionality reduction. Polygenic risk scores (PRSs) were generated by summing the numbers of selected SNP risk alleles. The best gene-gene interaction model included tumor-necrosis factor (TNF)_rs1800610, mucin 22 (MUC22)_rs1304322089, tribbles pseudokinase 2 (TRIB2)_rs1881145, cytotoxic T-lymphocyte-associated antigen 4 (CTLA4)_rs231775, lipoma-preferred partner (LPP)_rs6780858, and human leukocyte antigen (HLA)-J_ rs767861647.", "label": 1, "is_selected": 0, "text": "Graves's disease and thyroiditis induce hyperthyroidism, the causes of which remain unclear, although they are involved with genetic and environmental factors. We aimed to evaluate polygenetic variants for hyperthyroidism risk and their interaction with metabolic parameters and nutritional intakes in an urban hospital-based cohort. A genome-wide association study (GWAS) of participants with (cases; n = 842) and without (controls, n = 38,799) hyperthyroidism was used to identify and select genetic variants. In clinical and lifestyle interaction with PRS, 312 participants cured of hyperthyroidism were excluded. Single nucleotide polymorphisms (SNPs) associated with gene-gene interactions were selected by hyperthyroidism generalized multifactor dimensionality reduction. Polygenic risk scores (PRSs) were generated by summing the numbers of selected SNP risk alleles. The best gene-gene interaction model included tumor-necrosis factor (TNF)_rs1800610, mucin 22 (MUC22)_rs1304322089, tribbles pseudokinase 2 (TRIB2)_rs1881145, cytotoxic T-lymphocyte-associated antigen 4 (CTLA4)_rs231775, lipoma-preferred partner (LPP)_rs6780858, and human leukocyte antigen (HLA)-J_ rs767861647."}
{"qid": "5e7768f9835f4e477700000b", "original_text": "Delivery of therapeutic insulin via the pulmonary route has been the most investigated non-invasive alternative to the commonly used subcutaneous (SC) route for diabetes management. Despite discontinuation of the first inhalable insulin, Exubera\u00ae, due to suboptimal market acceptance, development of orally inhaled insulin delivery systems has been galvanized by the recent approval of Afrezza\u00ae and several others awaiting approval.", "label": 1, "is_selected": 0, "text": "Delivery of therapeutic insulin via the pulmonary route has been the most investigated non-invasive alternative to the commonly used subcutaneous (SC) route for diabetes management. Despite discontinuation of the first inhalable insulin, Exubera\u00ae, due to suboptimal market acceptance, development of orally inhaled insulin delivery systems has been galvanized by the recent approval of Afrezza\u00ae and several others awaiting approval."}
{"qid": "5e9206f92d3121100d000008", "original_text": "Autoantibodies to breast and other cancers are commonly present in cancer patients. A method to rapidly produce these anti-cancer autoantibodies in the lab would be valuable for understanding immune events and to generate candidate reagents for therapy and diagnostics. The purpose of this report is to evaluate sentinel nodes (SNs) of breast cancer patients as a source of anti-cancer antibodies. Radiotracer lymphatic mapping in 29 patients with breast cancer confirmed the identity of the SNs which provided source cells for this study. Flow cytometry demonstrated ~28% of the MNCs were B cells and ~44% of the B cells were class switched memory B cells. EBV-induced proliferation of B cells yielded tumor binding antibodies from 3 wells per 1000 but cultures were too unstable for detailed evaluations. Hybridomas generated by electrofusion produced IgG (48%), IgM (34%) and IgA (18%) antibody isotypes which were screened for binding to a panel of breast cancer cells of the major molecular subtypes. Tumor lysate binding was observed in 28% of the hybridoma clones and 10% of these bound whole tumor cells with unique binding patterns. More detailed evaluation of selected clones showed binding to the patient's own tumor. SNs are removed from more than 100,000 breast cancer patients in the US per year. Samples from these lymph nodes represent a substantial opportunity to generate anticancer antibodies.", "label": 1, "is_selected": 0, "text": "Autoantibodies to breast and other cancers are commonly present in cancer patients. A method to rapidly produce these anti-cancer autoantibodies in the lab would be valuable for understanding immune events and to generate candidate reagents for therapy and diagnostics. The purpose of this report is to evaluate sentinel nodes (SNs) of breast cancer patients as a source of anti-cancer antibodies. Radiotracer lymphatic mapping in 29 patients with breast cancer confirmed the identity of the SNs which provided source cells for this study. Flow cytometry demonstrated ~28% of the MNCs were B cells and ~44% of the B cells were class switched memory B cells. EBV-induced proliferation of B cells yielded tumor binding antibodies from 3 wells per 1000 but cultures were too unstable for detailed evaluations. Hybridomas generated by electrofusion produced IgG (48%), IgM (34%) and IgA (18%) antibody isotypes which were screened for binding to a panel of breast cancer cells of the major molecular subtypes. Tumor lysate binding was observed in 28% of the hybridoma clones and 10% of these bound whole tumor cells with unique binding patterns. More detailed evaluation of selected clones showed binding to the patient's own tumor. SNs are removed from more than 100,000 breast cancer patients in the US per year. Samples from these lymph nodes represent a substantial opportunity to generate anticancer antibodies."}
{"qid": "5c9158a5ecadf2e73f000008", "original_text": "On May 23, 2017, the US Food and Drug Administration (FDA) approved a treatment for cancer patients with positive microsatellite instability-high (MSI-H) markers or mismatch repair deficient (dMMR) markers. This approach is the first approved tumor treatment using a common biomarker rather than specified tumor locations in the body. FDA previously approved Keytruda for treatment of several types of malignancies, such as metastatic melanoma, metastatic non-small-cell lung cancer, recurrent or metastatic head and neck cancer, refractory Hodgkin lymphoma, and urothelial carcinoma, all of which carry positive programmed death-1/programmed death-ligand 1 biomarkers. Therefore, indications of Keytruda significantly expanded. Several types of malignancies are disclosed by MSI-H status due to dMMR and characterized by increased neoantigen load, which elicits intense host immune response in tumor microenvironment, including portions of colorectal and gastric carcinomas.", "label": 1, "is_selected": 0, "text": "On May 23, 2017, the US Food and Drug Administration (FDA) approved a treatment for cancer patients with positive microsatellite instability-high (MSI-H) markers or mismatch repair deficient (dMMR) markers. This approach is the first approved tumor treatment using a common biomarker rather than specified tumor locations in the body. FDA previously approved Keytruda for treatment of several types of malignancies, such as metastatic melanoma, metastatic non-small-cell lung cancer, recurrent or metastatic head and neck cancer, refractory Hodgkin lymphoma, and urothelial carcinoma, all of which carry positive programmed death-1/programmed death-ligand 1 biomarkers. Therefore, indications of Keytruda significantly expanded. Several types of malignancies are disclosed by MSI-H status due to dMMR and characterized by increased neoantigen load, which elicits intense host immune response in tumor microenvironment, including portions of colorectal and gastric carcinomas."}
{"qid": "5150f401d24251bc05000075", "original_text": "Sildenafil, an orally administered phosphodiesterase type 5 (PDE-5) inhibitor, was known for enhancing the downstream effects of NO. It was approved for treatment in patients with pulmonary arterial hypertension (PAH). Recently, a generic sildenafil (Unison Laboratories, Thailand) was proved to have the same bioequivalent as in the original formula. The authors conducted a 12-week case series to study the efficacy and safety of Elonza (generic sildenafil) in PAH patients. Comparison of both hemodynamic data from cardiac catheterization and clinical outcome such as six minute walk test (6MWT) were performed to assess the efficacy of generic sildenafil at the dosage of 50 mg given orally three times daily in patients with PAH over a 12 weeks period. There were 20 patients whose average age was 31.4 +/- 14.3 years old (13-58) and their average weight was 48.1 +/- 11.9 kg (31-79). There were three idiopathic pulmonary artery hypertensions (IPAH) and 17 congenital left to right shunts. There was a 15.1% decrease in pulmonary vascular resistance index (PVRi) from 20.5 +/- 13.9 to 17.4 +/- 2.9 Wood unit m2 at the end of 12 weeks (p = 0.044). The ratio of pulmonary to systemic vascular resistance (PVR/SVR) was also decreased from 0.71 +/- 0.57 to 0.52 +/- 0.41 (p = 0.014). 6MWT increased significantly from 271 +/- 59 meters (m) at baseline to 297 +/- 48 m, 307 +/- 43 m and 321 +/- 52 m at week 2, 6 and 12, respectively (p = 0.01). There was no significant change in other hemodynamic parameter, Borg dyspnea score, and functional class.", "label": 1, "is_selected": 0, "text": "Sildenafil, an orally administered phosphodiesterase type 5 (PDE-5) inhibitor, was known for enhancing the downstream effects of NO. It was approved for treatment in patients with pulmonary arterial hypertension (PAH). Recently, a generic sildenafil (Unison Laboratories, Thailand) was proved to have the same bioequivalent as in the original formula. The authors conducted a 12-week case series to study the efficacy and safety of Elonza (generic sildenafil) in PAH patients. Comparison of both hemodynamic data from cardiac catheterization and clinical outcome such as six minute walk test (6MWT) were performed to assess the efficacy of generic sildenafil at the dosage of 50 mg given orally three times daily in patients with PAH over a 12 weeks period. There were 20 patients whose average age was 31.4 +/- 14.3 years old (13-58) and their average weight was 48.1 +/- 11.9 kg (31-79). There were three idiopathic pulmonary artery hypertensions (IPAH) and 17 congenital left to right shunts. There was a 15.1% decrease in pulmonary vascular resistance index (PVRi) from 20.5 +/- 13.9 to 17.4 +/- 2.9 Wood unit m2 at the end of 12 weeks (p = 0.044). The ratio of pulmonary to systemic vascular resistance (PVR/SVR) was also decreased from 0.71 +/- 0.57 to 0.52 +/- 0.41 (p = 0.014). 6MWT increased significantly from 271 +/- 59 meters (m) at baseline to 297 +/- 48 m, 307 +/- 43 m and 321 +/- 52 m at week 2, 6 and 12, respectively (p = 0.01). There was no significant change in other hemodynamic parameter, Borg dyspnea score, and functional class."}
{"qid": "5324cf139b2d7acc7e00001f", "original_text": "Stress urinary incontinence (SUI) is a known complication after prostate surgery. To date no pharmacologic treatment is available. Currently Duloxetine, a serotonin and norepinephrine reuptake inhibitor, is available for women with SUI. This study investigates the effect of Duloxetine on men with SUI after prostate surgery. 56 patients were included in our study. 49 after radical prostatectomy and 7 after TURP. All patients were initially treated with pelvic floor exercises. Thereafter 40 mg Duloxetine was administered twice daily. When taking Duloxetine, the average use of incontinence pads decreased from 3.3 to 1.5 per day. 14 patients needed no and 18 a single pad per day. Most patients reported mild and temporary side effects, 13 patients assessed them to be moderate and 9 being severe. The results of this off-label use show that Duloxetine is effective in men with SUI after prostate surgery even if standard pelvic floor exercises have failed.", "label": 1, "is_selected": 0, "text": "Stress urinary incontinence (SUI) is a known complication after prostate surgery. To date no pharmacologic treatment is available. Currently Duloxetine, a serotonin and norepinephrine reuptake inhibitor, is available for women with SUI. This study investigates the effect of Duloxetine on men with SUI after prostate surgery. 56 patients were included in our study. 49 after radical prostatectomy and 7 after TURP. All patients were initially treated with pelvic floor exercises. Thereafter 40 mg Duloxetine was administered twice daily. When taking Duloxetine, the average use of incontinence pads decreased from 3.3 to 1.5 per day. 14 patients needed no and 18 a single pad per day. Most patients reported mild and temporary side effects, 13 patients assessed them to be moderate and 9 being severe. The results of this off-label use show that Duloxetine is effective in men with SUI after prostate surgery even if standard pelvic floor exercises have failed."}
{"qid": "5fe30efea43ad31278000038", "original_text": "The Gene Ontology Consortium provides gene expression data for yeast in the Yeast Gene Expression database (YeastGED). This database contains RNA-seq expression data for over 6,000 genes across different cellular conditions, including wild-type and mutant strains, as well as time-series data for various stress and treatment conditions. The data are derived from high-throughput sequencing experiments and are annotated with functional information from the Gene Ontology Consortium.", "label": 0, "is_selected": 0, "text": "The Gene Ontology Consortium provides gene expression data for yeast in the Yeast Gene Expression database (YeastGED). This database contains RNA-seq expression data for over 6,000 genes across different cellular conditions, including wild-type and mutant strains, as well as time-series data for various stress and treatment conditions. The data are derived from high-throughput sequencing experiments and are annotated with functional information from the Gene Ontology Consortium."}
{"qid": "5e4bf7876d0a27794100002c", "original_text": "In Drosophila, the Notch signaling pathway plays a crucial role in regulating the division of neural progenitor cells. Notch activation in these cells induces a state of cell-cycle arrest, allowing for proper timing of neural differentiation. Failure to activate Notch in neural progenitor cells can lead to excessive proliferation and a resulting overproduction of neurons, which can have detrimental effects on neural development and function. Therefore, the Notch pathway plays a critical role in regulating the balance between neural progenitor cell proliferation and differentiation.", "label": 0, "is_selected": 1, "text": "The Notch pathway plays a critical role in regulating the balance between neural progenitor cell proliferation and differentiation, which can have detrimental effects on the development and function of the human brain and spinal cord.Therefore, we have investigated the Notch pathway in the Drosophila melanogaster and found that it plays a key role in the regulation of neural development and differentiation."}
{"qid": "58861d413b87a8a738000002", "original_text": "The Davidson Trauma Scale (DTS) is a standardized assessment tool used to evaluate the symptoms of post-traumatic stress disorder (PTSD). The DTS assesses the frequency and intensity of several common PTSD symptoms, including: 1. Intrusive thoughts or flashbacks about the traumatic event 2. Avoidance of places, people, or activities that remind you of the traumatic event 3. Hyperarousal or feeling \"on edge\" 4. Difficulty sleeping or concentrating 5. Irritability or anger 6. Hypervigilance or exaggerated startling response 7. Loss of interest in activities that you used to enjoy 8. Social withdrawal or isolation 9. Depression or hopelessness Each of these symptoms is rated on a 5-point scale, with higher scores indicating greater severity of symptoms. The DTS is a widely used and well-validated instrument for assessing PTSD symptoms in both civilian and veteran populations.", "label": 0, "is_selected": 1, "text": "The Davidson Trauma Scale (DTS) is a standardized assessment tool used to evaluate the symptoms of post-traumatic stress disorder (PTSD) in both civilian and veteran populations, including those who have served in the armed forces and those who may have recently returned to civilian life after a traumatic event, such as a war, terrorist attack, or natural disaster."}
{"qid": "5314bd7ddae131f847000006", "original_text": "Homozygous or compound heterozygous mutations within the insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding leading to Donohue syndrome (\"Leprechaunism\"), which is characterized by excessive hyperglycemia with hyperinsulinism, pre- and postnatal growth retardation, distinct dysmorphism and early death. Missense mutations in the beta subunits are commonly associated with a milder impairment of insulin binding and milder phenotype with prolonged survival and less dysmorphism, the so called Rabson-Mendenhall syndrome.", "label": 1, "is_selected": 0, "text": "Homozygous or compound heterozygous mutations within the insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding leading to Donohue syndrome (\"Leprechaunism\"), which is characterized by excessive hyperglycemia with hyperinsulinism, pre- and postnatal growth retardation, distinct dysmorphism and early death. Missense mutations in the beta subunits are commonly associated with a milder impairment of insulin binding and milder phenotype with prolonged survival and less dysmorphism, the so called Rabson-Mendenhall syndrome."}
{"qid": "52e7870a98d023950500001a", "original_text": "The C1858T allele of the PTPN22 gene has been reported to confer risk for RA; but in some reports, the effect was restricted to RF- and/or anti-CCP-seropositive patients. Hungarian RA patients and matched controls were genotyped. The 1858T allele showed an increased prevalence in RA patients compared to controls. The 1858T allele represents a risk factor in the whole RA population (P = 0.001); an association was found both in RF-seropositive (P = 0.001) and anti-CCP-seropositive patients (P = 0.001), and in subjects with the combination of these factors (P = 0.002). In TT homozygotes, the estimated susceptibility to RA was more than double (OR = 5.04) of that seen in TC heterozygotes (OR = 1.89); the same gene dosage effect was observed in all seropositive RA subgroups.", "label": 1, "is_selected": 0, "text": "The C1858T allele of the PTPN22 gene has been reported to confer risk for RA; but in some reports, the effect was restricted to RF- and/or anti-CCP-seropositive patients. Hungarian RA patients and matched controls were genotyped. The 1858T allele showed an increased prevalence in RA patients compared to controls. The 1858T allele represents a risk factor in the whole RA population (P = 0.001); an association was found both in RF-seropositive (P = 0.001) and anti-CCP-seropositive patients (P = 0.001), and in subjects with the combination of these factors (P = 0.002). In TT homozygotes, the estimated susceptibility to RA was more than double (OR = 5.04) of that seen in TC heterozygotes (OR = 1.89); the same gene dosage effect was observed in all seropositive RA subgroups."}
{"qid": "5880c42fc872c95565000008", "original_text": "Liraglutide is an acylated glucagon-like peptide-1 (GLP-1) analogue that binds to serum albumin in vivo and is approved for once-daily treatment of diabetes as well as obesity. The aim of the present studies was to design a once weekly GLP-1 analogue by increasing albumin affinity and secure full stability against metabolic degradation.", "label": 1, "is_selected": 0, "text": "Liraglutide is an acylated glucagon-like peptide-1 (GLP-1) analogue that binds to serum albumin in vivo and is approved for once-daily treatment of diabetes as well as obesity. The aim of the present studies was to design a once weekly GLP-1 analogue by increasing albumin affinity and secure full stability against metabolic degradation."}
{"qid": "6206d06ec9dfcb9c09000041", "original_text": "Khellin is extracted from the plant species, Digitalis lanata. Also known as lady's diggon or threadleaf foxglove, Digitalis lanata is a perennial herb native to the Mediterranean region. The plant contains the glycoside digoxin, which is used to treat various heart conditions such as atrial fibrillation, ventricular tachycardia, and congestive heart failure. The leaves of the plant are typically harvested during the summer and autumn seasons, and the glycoside is extracted through a process involving maceration, distillation, or solvent extraction.", "label": 0, "is_selected": 1, "text": "Khellin is an anti-inflammatory drug used in the treatment of a number of heart conditions, including atrial fibrillation, ventricular tachycardia, and congestive heart failure. the plant contains the glycoside digoxin, which is used to treat various heart conditions such as atrial fibrillation and ventricular tachycardia."}
{"qid": "5c654c14e842deac67000025", "original_text": "Lucatumumab is a fully humanized anti-CD40 antibody that blocks interaction of CD40L with CD40 and also mediates antibody-dependent cell-mediated cytotoxicity (ADCC). We evaluated lucatumumab in a phase I clinical trial in chronic lymphocytic leukemia (CLL). Twenty-six patients with relapsed CLL were enrolled on five different dose cohorts administered weekly for 4 weeks. The maximally tolerated dose (MTD) of lucatumumab was 3.0 mg/kg. Four patients at doses of 4.5 mg/kg and 6.0 mg/kg experienced grade 3 or 4 asymptomatic elevated amylase and lipase levels. Of the 26 patients enrolled, 17 patients had stable disease (mean duration of 76 days, range 29-504 days) and one patient had a nodular partial response for 230 days.", "label": 1, "is_selected": 0, "text": "Lucatumumab is a fully humanized anti-CD40 antibody that blocks interaction of CD40L with CD40 and also mediates antibody-dependent cell-mediated cytotoxicity (ADCC). We evaluated lucatumumab in a phase I clinical trial in chronic lymphocytic leukemia (CLL). Twenty-six patients with relapsed CLL were enrolled on five different dose cohorts administered weekly for 4 weeks. The maximally tolerated dose (MTD) of lucatumumab was 3.0 mg/kg. Four patients at doses of 4.5 mg/kg and 6.0 mg/kg experienced grade 3 or 4 asymptomatic elevated amylase and lipase levels. Of the 26 patients enrolled, 17 patients had stable disease (mean duration of 76 days, range 29-504 days) and one patient had a nodular partial response for 230 days."}
{"qid": "601c2fb51cb411341a000013", "original_text": "There is an expanding role for interleukin (IL)-1 in diseases from gout to cancer. More than any other cytokine family, the IL-1 family is closely linked to innate inflammatory and immune responses. This linkage is because the cytoplasmic segment of all members of the IL-1 family of receptors contains a domain, which is highly homologous to the cytoplasmic domains of all toll-like receptors (TLRs). This domain, termed \"toll IL-1 receptor (TIR) domain,\" signals as does the IL-1 receptors; therefore, inflammation due to the TLR and the IL-1 families is nearly the same.", "label": 1, "is_selected": 0, "text": "There is an expanding role for interleukin (IL)-1 in diseases from gout to cancer. More than any other cytokine family, the IL-1 family is closely linked to innate inflammatory and immune responses. This linkage is because the cytoplasmic segment of all members of the IL-1 family of receptors contains a domain, which is highly homologous to the cytoplasmic domains of all toll-like receptors (TLRs). This domain, termed \"toll IL-1 receptor (TIR) domain,\" signals as does the IL-1 receptors; therefore, inflammation due to the TLR and the IL-1 families is nearly the same."}
{"qid": "589a247078275d0c4a000035", "original_text": "Dinutuximab is a chimeric (human-mouse) monoclonal antibody that is used for the treatment of glioblastoma, an aggressive and malignant form of brain cancer. Specifically, it is used in the treatment of progressive glioblastoma in adults who have received prior chemotherapy. Dinutuximab works by targeting the GD2 protein, which is overexpressed in glioblastoma cells, and induces apoptosis (cell death) in these cells. This treatment option is typically used in combination with other therapies, such as bevacizumab, temozolomide, and radiation therapy.", "label": 0, "is_selected": 1, "text": "The US Food and Drug Administration (FDA) has granted orphan drug status to Dinutuximab for the treatment of adults with brain cancer who have failed treatment with chemotherapy.<n> The European Medicines Agency (EMA) has also granted marketing authorisation for the drug in the European Union (EU), where it is used to treat patients with advanced brain cancer."}
{"qid": "56ffdc1ccf1c32585100000b", "original_text": "The most common editing modification in eukaryotic mRNA is the addition of a nucleotide called adenosine (A) at the end of the mRNA molecule, a process called polyadenylation. This modification is present in over 90% of eukaryotic mRNAs and serves to protect the mRNA from degradation, promote its translation, and regulate its stability and localization. Other editing modifications found in eukaryotic mRNA include the addition of a cap at the 5' end and the deletion of non-coding regions, but polyadenylation is the most widely occurring and functionally significant modification.", "label": 0, "is_selected": 0, "text": "The most common editing modification in eukaryotic mRNA is the addition of a nucleotide called adenosine (A) at the end of the mRNA molecule, a process called polyadenylation. This modification is present in over 90% of eukaryotic mRNAs and serves to protect the mRNA from degradation, promote its translation, and regulate its stability and localization. Other editing modifications found in eukaryotic mRNA include the addition of a cap at the 5' end and the deletion of non-coding regions, but polyadenylation is the most widely occurring and functionally significant modification."}
{"qid": "5e9eba150d431b5f73000005", "original_text": "Conserved noncoding elements (CNEs) constitute the majority of sequences under purifying selection in the human genome, yet their function remains largely unknown. Experimental evidence suggests that many of these elements play regulatory roles, but little is known about regulatory motifs contained within them. Here we describe a systematic approach to discover and characterize regulatory motifs within mammalian CNEs by searching for long motifs (12-22 nt) with significant enrichment in CNEs and studying their biochemical and genomic properties.", "label": 1, "is_selected": 0, "text": "Conserved noncoding elements (CNEs) constitute the majority of sequences under purifying selection in the human genome, yet their function remains largely unknown. Experimental evidence suggests that many of these elements play regulatory roles, but little is known about regulatory motifs contained within them. Here we describe a systematic approach to discover and characterize regulatory motifs within mammalian CNEs by searching for long motifs (12-22 nt) with significant enrichment in CNEs and studying their biochemical and genomic properties."}
{"qid": "5318813ab166e2b806000016", "original_text": "Splicing defects account for 16% of the mutant alleles in the PCCA and PCCB genes, encoding both subunits of the propionyl-CoA carboxylase (PCC) enzyme, defective in propionic acidemia, one of the most frequent organic acidemias causing variable neurological impairment. Most of the splicing mutations identified affect the conserved 3' splice (3' ss) or 5' splice (5' ss) sites, the latter predictably through lowering the strength of base pairing with U1snRNA. Among the 5' ss mutations we have focused on the c.1209+3A>G (IVS13+3A>G) mutation in the PCCA gene, identified in four patients (three homozygous and one heterozygous) of common geographical origin and causing exon 13 skipping.", "label": 1, "is_selected": 0, "text": "Splicing defects account for 16% of the mutant alleles in the PCCA and PCCB genes, encoding both subunits of the propionyl-CoA carboxylase (PCC) enzyme, defective in propionic acidemia, one of the most frequent organic acidemias causing variable neurological impairment. Most of the splicing mutations identified affect the conserved 3' splice (3' ss) or 5' splice (5' ss) sites, the latter predictably through lowering the strength of base pairing with U1snRNA. Among the 5' ss mutations we have focused on the c.1209+3A>G (IVS13+3A>G) mutation in the PCCA gene, identified in four patients (three homozygous and one heterozygous) of common geographical origin and causing exon 13 skipping."}
{"qid": "6026f0251cb411341a0000d6", "original_text": "Eptinezumab-jjmr (referred to as eptinezumab hereafter; Vyepti\u2122) is a humanised monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor.", "label": 1, "is_selected": 0, "text": "Eptinezumab-jjmr (referred to as eptinezumab hereafter; Vyepti\u2122) is a humanised monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor."}
{"qid": "5e6ea5b9c6a8763d23000008", "original_text": "In order to cross the skin barrier several techniques and carrier systems were developed to increase skin penetration of topical dermatics and to reduce systemic adverse effects by avoiding systemic application. Ultra-flexible vesicles, e.g. invasomes and core-multishell (CMS) nanotransporters are efficient drug delivery systems for dermatological applications. Electron paramagnetic resonance (EPR) spectroscopic techniques were used for the determination of localization and distribution of the spin label 3-carboxy-2,2,5,5-tetramethyl-1-pyrrolidinyloxy (PCA; logP=-1.7) within the carrier systems and the ability of the carriers to promote penetration of PCA into the skin. The results show an exclusive localization of PCA in the hydrophilic compartments of the invasome dispersion and the CMS nanotransporter solution. PCA penetration was enhanced 2.5 fold for CMS and 1.9 fold for invasomes compared to PCA solution. Investigation of penetration depth by step-wise removal of the stratum corneum by tape stripping revealed deepest PCA penetration for invasomes. UV-irradiation of PCA-exposed skin samples revealed that the spin label is still reactive. In conclusion novel polymer-based CMS nanotransporters and invasomes can favor the penetration of PCA or hydrophilic drugs.", "label": 1, "is_selected": 0, "text": "In order to cross the skin barrier several techniques and carrier systems were developed to increase skin penetration of topical dermatics and to reduce systemic adverse effects by avoiding systemic application. Ultra-flexible vesicles, e.g. invasomes and core-multishell (CMS) nanotransporters are efficient drug delivery systems for dermatological applications. Electron paramagnetic resonance (EPR) spectroscopic techniques were used for the determination of localization and distribution of the spin label 3-carboxy-2,2,5,5-tetramethyl-1-pyrrolidinyloxy (PCA; logP=-1.7) within the carrier systems and the ability of the carriers to promote penetration of PCA into the skin. The results show an exclusive localization of PCA in the hydrophilic compartments of the invasome dispersion and the CMS nanotransporter solution. PCA penetration was enhanced 2.5 fold for CMS and 1.9 fold for invasomes compared to PCA solution. Investigation of penetration depth by step-wise removal of the stratum corneum by tape stripping revealed deepest PCA penetration for invasomes. UV-irradiation of PCA-exposed skin samples revealed that the spin label is still reactive. In conclusion novel polymer-based CMS nanotransporters and invasomes can favor the penetration of PCA or hydrophilic drugs."}
{"qid": "5abcf66afcf4565872000026", "original_text": "Dupuytren's contracture is a fibroproliferative disorder of the hand characterized by an abnormal myofibroblast and fibroblast proliferation and extracellular matrix deposition leading to retraction and deformation of the palm. Recent studies have shown that molecules of extracellular matrix may coordinate morphogenesis, cell differentiation, and most importantly, fibrogenesis in tissue. Gelatinase A (MMP-2) is a member of the matrix metalloproteinase family of proteolytic enzymes that contribute to remodeling the extracellular matrix by degrading its components. The aim of this study was to determine the level of MMP-2 activation in the palmar fascia of patients with Dupuytren's contracture with reference to the clinical stages of disease progression and recurrence of the contracture after surgery. The level of relative MMP-2 activation, expressed by the active to latent MMP-2 ratio, was investigated with use of zymography and computerized densitometry in 16 normal and 71 pathologic tissues characterizing different clinical stages of the disease progression. We found that the level of MMP-2 activation was significantly elevated in the palmar fascias with Dupuytren's contracture compared with normal tissues. We did not find statistically significant differences between groups with different stages of the disease progression.", "label": 1, "is_selected": 0, "text": "Dupuytren's contracture is a fibroproliferative disorder of the hand characterized by an abnormal myofibroblast and fibroblast proliferation and extracellular matrix deposition leading to retraction and deformation of the palm. Recent studies have shown that molecules of extracellular matrix may coordinate morphogenesis, cell differentiation, and most importantly, fibrogenesis in tissue. Gelatinase A (MMP-2) is a member of the matrix metalloproteinase family of proteolytic enzymes that contribute to remodeling the extracellular matrix by degrading its components. The aim of this study was to determine the level of MMP-2 activation in the palmar fascia of patients with Dupuytren's contracture with reference to the clinical stages of disease progression and recurrence of the contracture after surgery. The level of relative MMP-2 activation, expressed by the active to latent MMP-2 ratio, was investigated with use of zymography and computerized densitometry in 16 normal and 71 pathologic tissues characterizing different clinical stages of the disease progression. We found that the level of MMP-2 activation was significantly elevated in the palmar fascias with Dupuytren's contracture compared with normal tissues. We did not find statistically significant differences between groups with different stages of the disease progression."}
{"qid": "5e46da9c3f5415952900000a", "original_text": "Xeroderma pigmentosum (XP) is a heritable human disorder characterized by defects in nucleotide excision repair (NER) and the development of skin cancer. Cells from XP group E (XP-E) patients have a defect in the UV-damaged DNA-binding protein complex (UV-DDB), involved in the damage recognition step of NER. UV-DDB comprises two subunits, products of the DDB1 and DDB2 genes, respectively. Mutations in the DDB2 gene account for the underlying defect in XP-E. The UV-DDB complex is a component of the newly identified cullin 4A-based ubiquitin E3 ligase, DDB1-CUL4A(DDB2). The E3 ubiquitin ligases recognize specific substrates and mediate their ubiquitination to regulate protein activity or target proteins for degradation by the proteasomal pathway.", "label": 1, "is_selected": 0, "text": "Xeroderma pigmentosum (XP) is a heritable human disorder characterized by defects in nucleotide excision repair (NER) and the development of skin cancer. Cells from XP group E (XP-E) patients have a defect in the UV-damaged DNA-binding protein complex (UV-DDB), involved in the damage recognition step of NER. UV-DDB comprises two subunits, products of the DDB1 and DDB2 genes, respectively. Mutations in the DDB2 gene account for the underlying defect in XP-E. The UV-DDB complex is a component of the newly identified cullin 4A-based ubiquitin E3 ligase, DDB1-CUL4A(DDB2). The E3 ubiquitin ligases recognize specific substrates and mediate their ubiquitination to regulate protein activity or target proteins for degradation by the proteasomal pathway."}
{"qid": "58a5b1fe60087bc10a000024", "original_text": "The activity of the p53 tumor suppressor protein and the c-Jun protooncogene is regulated by posttranslational modifications, such as phosphorylation or ubiquitination. In addition, covalent attachment of the ubiquitin-like modifier SUMO appears to modulate their transcriptional activity. Sumoylation proceeds via an enzymatic pathway that is mechanistically analogous to ubiquitination, but requires a different E1-activating enzyme and Ubc9, a SUMO-specific E2-conjugating enzyme. Here, we show that two members of the PIAS family, PIAS1 and PIASxbeta, act as specific E3-like ligases that promote sumoylation of p53 and c-Jun in vitro and in vivo. The PIAS proteins physically interact with both p53 and c-Jun. In addition, they bind to Ubc9, suggesting that they recruit the E2 enzyme to their respective substrate.", "label": 1, "is_selected": 0, "text": "The activity of the p53 tumor suppressor protein and the c-Jun protooncogene is regulated by posttranslational modifications, such as phosphorylation or ubiquitination. In addition, covalent attachment of the ubiquitin-like modifier SUMO appears to modulate their transcriptional activity. Sumoylation proceeds via an enzymatic pathway that is mechanistically analogous to ubiquitination, but requires a different E1-activating enzyme and Ubc9, a SUMO-specific E2-conjugating enzyme. Here, we show that two members of the PIAS family, PIAS1 and PIASxbeta, act as specific E3-like ligases that promote sumoylation of p53 and c-Jun in vitro and in vivo. The PIAS proteins physically interact with both p53 and c-Jun. In addition, they bind to Ubc9, suggesting that they recruit the E2 enzyme to their respective substrate."}
{"qid": "5e3a6c49b5b409ea53000017", "original_text": "Introduction: The amyloid-beta (A\u03b2) cascade hypothesis is that reducing A\u03b2 levels in the brain will be beneficial in treating Alzheimer's disease. A\u03b2 is formed by the cleavage of amyloid precursor protein by \u03b2-site amyloid precure protein cleaving enzyme (BACE1) and the BACE1 inhibitor verubecestat was developed to lower the brain levels of A\u03b2. However, in the EPOCH trial of verubecestat in mild-to-moderate Alzheimer's disease, it was not beneficial and increased adverse effects.Areas covered: Prior to completing EPOCH, APECS, which trialled verubecestat in prodromal Alzheimer's disease, was commenced. Like EPOCH, APECS was terminated early. In APECS, verubecestat 40 mg worsened cognition and increased adverse effects.Expert opinion: In recruiting subjects to clinical trials in Alzheimer's disease, a clinical diagnosis involving the measurement of A\u03b2 should be undertaken for all subjects, as this may help to clarify the findings. In my opinion, the failure of verubecestat in EPOCH and APECS probably could have been avoided if a safety and potential efficacy trial (phase 2) had been completed prior to starting phase 3. It seems to me that, as we have a poor understanding of the underlying mechanisms/cause of Alzheimer's disease, this is where the research emphasis should be, not phase 3 clinical trials.", "label": 1, "is_selected": 0, "text": "Introduction: The amyloid-beta (A\u03b2) cascade hypothesis is that reducing A\u03b2 levels in the brain will be beneficial in treating Alzheimer's disease. A\u03b2 is formed by the cleavage of amyloid precursor protein by \u03b2-site amyloid precure protein cleaving enzyme (BACE1) and the BACE1 inhibitor verubecestat was developed to lower the brain levels of A\u03b2. However, in the EPOCH trial of verubecestat in mild-to-moderate Alzheimer's disease, it was not beneficial and increased adverse effects.Areas covered: Prior to completing EPOCH, APECS, which trialled verubecestat in prodromal Alzheimer's disease, was commenced. Like EPOCH, APECS was terminated early. In APECS, verubecestat 40 mg worsened cognition and increased adverse effects.Expert opinion: In recruiting subjects to clinical trials in Alzheimer's disease, a clinical diagnosis involving the measurement of A\u03b2 should be undertaken for all subjects, as this may help to clarify the findings. In my opinion, the failure of verubecestat in EPOCH and APECS probably could have been avoided if a safety and potential efficacy trial (phase 2) had been completed prior to starting phase 3. It seems to me that, as we have a poor understanding of the underlying mechanisms/cause of Alzheimer's disease, this is where the research emphasis should be, not phase 3 clinical trials."}
{"qid": "588f952994c1512c50000007", "original_text": "Septo-optic dysplasia (De Morsier syndrome) is a developmental anomaly of mid-line brain structures and includes optic nerve hypoplasia, absence of the septum pellucidum and hypothalamo-pituitary abnormalities. We describe seven patients (four female, three male) who had at least two out of the three features necessary for the diagnosis of septo-optic dysplasia. Four patients had hypopituitarism and yet normal gonadotrophin secretion: one of these also had anti-diuretic hormone insufficiency; three had isolated GH deficiency and yet had premature puberty, with the onset of puberty at least a year earlier than would have been expected for their bone age.", "label": 1, "is_selected": 0, "text": "Septo-optic dysplasia (De Morsier syndrome) is a developmental anomaly of mid-line brain structures and includes optic nerve hypoplasia, absence of the septum pellucidum and hypothalamo-pituitary abnormalities. We describe seven patients (four female, three male) who had at least two out of the three features necessary for the diagnosis of septo-optic dysplasia. Four patients had hypopituitarism and yet normal gonadotrophin secretion: one of these also had anti-diuretic hormone insufficiency; three had isolated GH deficiency and yet had premature puberty, with the onset of puberty at least a year earlier than would have been expected for their bone age."}
{"qid": "5c72c9207c78d6947100007b", "original_text": "Current genome-wide ChIP-seq experiments on different epigenetic marks aim at unraveling the interplay between their regulation mechanisms. Published evaluation tools, however, allow testing for predefined hypotheses only. Here, we present a novel method for annotation-independent exploration of epigenetic data and their inter-correlation with other genome-wide features. Our method is based on a combinatorial genome segmentation solely using information on combinations of epigenetic marks. It does not require prior knowledge about the data (e.g. gene positions), but allows integrating the data in a straightforward manner. Thereby, it combines compression, clustering and visualization of the data in a single tool.", "label": 1, "is_selected": 0, "text": "Current genome-wide ChIP-seq experiments on different epigenetic marks aim at unraveling the interplay between their regulation mechanisms. Published evaluation tools, however, allow testing for predefined hypotheses only. Here, we present a novel method for annotation-independent exploration of epigenetic data and their inter-correlation with other genome-wide features. Our method is based on a combinatorial genome segmentation solely using information on combinations of epigenetic marks. It does not require prior knowledge about the data (e.g. gene positions), but allows integrating the data in a straightforward manner. Thereby, it combines compression, clustering and visualization of the data in a single tool."}
{"qid": "5a7617b183b0d9ea66000022", "original_text": "Rilotumumab is a monoclonal antibody drug that targets the protein tumor necrosis factor-alpha (TNF-\u03b1). TNF-\u03b1 is a cytokine that plays a central role in the inflammatory response, and it has been implicated in various diseases, including cancer, autoimmune disorders, and inflammatory conditions. Rilotumumab inhibits the activity of TNF-\u03b1, which can help reduce inflammation and modulate the immune response. Rilotumumab has been studied in the context of various diseases, including breast cancer, non-small cell lung cancer, and ulcerative colitis. In these conditions, TNF-\u03b1 has been shown to play a role in the progression of disease, and rilotumumab has been investigated as a potential therapeutic agent for its ability to inhibit TNF-\u03b1 and modulate the immune response. In summary, rilotumumab inhibits the activity of TNF-\u03b1, a cytokine that plays a central role in the inflammatory response and various diseases.", "label": 0, "is_selected": 1, "text": "Rilotumumab is an anti-inflammatory drug that has been investigated as a potential therapeutic agent in a number of diseases, including breast cancer, non-small cell lung cancer, and ulcerative colitis. in these conditions, and riloumumab has been studied as a possible therapeutic agent for its ability to inhibit the progression of disease."}
{"qid": "5e3eba5548dab47f26000009", "original_text": "Feline infectious peritonitis virus (FIP virus: FIPV), a feline coronavirus of the family Coronaviridae, causes a fatal disease called FIP in wild and domestic cat species. The genome of coronaviruses encodes a hydrophobic transmembrane protein, the envelope (E) protein. The E protein possesses ion channel activity.", "label": 1, "is_selected": 0, "text": "Feline infectious peritonitis virus (FIP virus: FIPV), a feline coronavirus of the family Coronaviridae, causes a fatal disease called FIP in wild and domestic cat species. The genome of coronaviruses encodes a hydrophobic transmembrane protein, the envelope (E) protein. The E protein possesses ion channel activity."}
{"qid": "5e43ee1f48dab47f26000012", "original_text": "The aim of the present study was to screen gastric cancer (GC) tissue and adjacent tissue for differences in mRNA and circular (circRNA) expression, to analyze the differences in circRNA and mRNA expression, and to investigate the circRNA expression in gastric carcinoma and its mechanism. circRNA and mRNA differential expression profiles generated using Agilent microarray technology were analyzed in the GC tissues and adjacent tissues. qRT-PCR was used to verify the differential expression of circRNAs and mRNAs according to the interactions between circRNAs and miRNAs as well as the possible existence of miRNA and mRNA interactions. We found that: i) the circRNA expression profile revealed 1,285 significant differences in circRNA expression, with circRNA expression downregulated in 594 samples and upregulated in 691 samples via interactions with miRNAs. The qRT-PCR validation experiments showed that hsa_circRNA_400071, hsa_circRNA_000543 and hsa_circRNA_001959 expression was consistent with the microarray analysis results. ii) 29,112 genes were found in the GC tissues and adjacent tissues, including 5,460 differentially expressed genes. Among them, 2,390 differentially expressed genes were upregulated and 3,070 genes were downregulated. Gene Ontology (GO) analysis of the differentially expressed genes revealed these genes involved in biological process classification, cellular component classification and molecular function classification. Pathway analysis of the differentially expressed genes identified 83 significantly enriched genes, including 28 upregulated genes and 55 downregulated genes.", "label": 1, "is_selected": 0, "text": "The aim of the present study was to screen gastric cancer (GC) tissue and adjacent tissue for differences in mRNA and circular (circRNA) expression, to analyze the differences in circRNA and mRNA expression, and to investigate the circRNA expression in gastric carcinoma and its mechanism. circRNA and mRNA differential expression profiles generated using Agilent microarray technology were analyzed in the GC tissues and adjacent tissues. qRT-PCR was used to verify the differential expression of circRNAs and mRNAs according to the interactions between circRNAs and miRNAs as well as the possible existence of miRNA and mRNA interactions. We found that: i) the circRNA expression profile revealed 1,285 significant differences in circRNA expression, with circRNA expression downregulated in 594 samples and upregulated in 691 samples via interactions with miRNAs. The qRT-PCR validation experiments showed that hsa_circRNA_400071, hsa_circRNA_000543 and hsa_circRNA_001959 expression was consistent with the microarray analysis results. ii) 29,112 genes were found in the GC tissues and adjacent tissues, including 5,460 differentially expressed genes. Among them, 2,390 differentially expressed genes were upregulated and 3,070 genes were downregulated. Gene Ontology (GO) analysis of the differentially expressed genes revealed these genes involved in biological process classification, cellular component classification and molecular function classification. Pathway analysis of the differentially expressed genes identified 83 significantly enriched genes, including 28 upregulated genes and 55 downregulated genes."}
{"qid": "6032866a1cb411341a000142", "original_text": "Commensal bacteria are microorganisms that live in a mutually beneficial relationship with their host, typically without causing harm or disease. These bacteria are present in various bodily sites, including the skin, respiratory tract, and gastrointestinal tract. They play important roles in the immune system, nutrient absorption, and maintenance of the gut microbiome. Examples of commensal bacteria include Streptococcus, Enterococcus, and Lactobacillus. While they are not essential for human health, commensal bacteria can have significant impacts on overall well-being and disease susceptibility.", "label": 0, "is_selected": 1, "text": "This report on the commensal bacteria market presents an in-depth quantitative and qualitative analysis of the factors influencing the growth of the market, as well as major market players, and their contribution to the overall market success. While they are not essential for human health, commensl bacteria can have significant impacts on overall well-being and disease susceptibility."}
{"qid": "601db4ac1cb411341a000048", "original_text": "Progerin is a protein that is produced when the Lamin A gene is mutated. Specifically, progerin is formed when there is a deletion of 18 nucleotides in the LMNA gene, which leads to a premature termination codon. This results in the production of a truncated form of the protein lamin A, which is known as progerin. Progerin is a nuclear protein that plays a critical role in maintaining the structure and function of nuclear membranes, and its accumulation is thought to contribute to the development of Hutchinson-Gilford progeria syndrome, a rare genetic disorder characterized by accelerated aging in children.", "label": 0, "is_selected": 0, "text": "Progerin is a protein that is produced when the Lamin A gene is mutated. Specifically, progerin is formed when there is a deletion of 18 nucleotides in the LMNA gene, which leads to a premature termination codon. This results in the production of a truncated form of the protein lamin A, which is known as progerin. Progerin is a nuclear protein that plays a critical role in maintaining the structure and function of nuclear membranes, and its accumulation is thought to contribute to the development of Hutchinson-Gilford progeria syndrome, a rare genetic disorder characterized by accelerated aging in children."}
{"qid": "5e6e8f92c6a8763d23000004", "original_text": "Long noncoding RNAs (lncRNAs) are more than 200 nucleotides in length and lack transcriptional ability. The biological function of lncRNAs in oral squamous cell carcinoma (OSCC) remains unclear. The aim of this study was to identify the dysfunction of lncRNA in OSCC. We analyzed the transcriptome profiles of human OSCC tissues and paired adjacent normal tissues from two patients through a next-generation sequencing approach. A total of 14 lncRNAs were upregulated (fold change \u22653) and 13 were downregulated (fold change \u2264-3) in OSCC tissues compared with the adjacent normal tissues. SOX21-AS1 was subjected to further analysis, revealing that the expression levels of SOX21-AS1 significantly decreased in OSCC compared with the adjacent normal tissue.", "label": 1, "is_selected": 0, "text": "Long noncoding RNAs (lncRNAs) are more than 200 nucleotides in length and lack transcriptional ability. The biological function of lncRNAs in oral squamous cell carcinoma (OSCC) remains unclear. The aim of this study was to identify the dysfunction of lncRNA in OSCC. We analyzed the transcriptome profiles of human OSCC tissues and paired adjacent normal tissues from two patients through a next-generation sequencing approach. A total of 14 lncRNAs were upregulated (fold change \u22653) and 13 were downregulated (fold change \u2264-3) in OSCC tissues compared with the adjacent normal tissues. SOX21-AS1 was subjected to further analysis, revealing that the expression levels of SOX21-AS1 significantly decreased in OSCC compared with the adjacent normal tissue."}
{"qid": "51486f7dd24251bc0500002e", "original_text": "A recent American Heart Association (AHA) Prevention Committee report recommended depression screening of all coronary heart disease patients using 2- and 9-item instruments from the Patient Health Questionnaire (PHQ-2 and PHQ-9) to identify patients who may need further assessment and treatment. Our objective was to assess the feasibility and results of such screening on inpatient cardiac units. In September 2007, the PHQ-2 was added to the nursing interview dataset on 3 cardiac units in a general hospital; this screen was completed as part of routine clinical care. Rates and results of depression screening, reasons for patients not being screened, and results of a nursing satisfaction survey were tabulated, and differences in baseline characteristics between screened and unscreened patients were analyzed via chi(2) and independent-samples t tests.", "label": 1, "is_selected": 0, "text": "A recent American Heart Association (AHA) Prevention Committee report recommended depression screening of all coronary heart disease patients using 2- and 9-item instruments from the Patient Health Questionnaire (PHQ-2 and PHQ-9) to identify patients who may need further assessment and treatment. Our objective was to assess the feasibility and results of such screening on inpatient cardiac units. In September 2007, the PHQ-2 was added to the nursing interview dataset on 3 cardiac units in a general hospital; this screen was completed as part of routine clinical care. Rates and results of depression screening, reasons for patients not being screened, and results of a nursing satisfaction survey were tabulated, and differences in baseline characteristics between screened and unscreened patients were analyzed via chi(2) and independent-samples t tests."}
{"qid": "5e92005c2d3121100d000003", "original_text": "The healthcare system faces various challenges in human immunodeficiency virus (HIV) therapy due to resistance to Anti-Retroviral Therapy (ART) as a consequence of the evolutionary process. Despite the success of antiretroviral drugs like Zidovudine, Zalcitabine, Raltegravir WHO ranks HIV as one of the deadliest diseases with a mortality of one million lives in 2016. Thus, there emerges an urgency of developing a novel anti-retroviral agent that combat resistant HIV strains. The clinical development of ART from a single drug regimen to current triple drug combination is very slow. The progression in the structural biology of the viral envelope prompted the discovery of novel targets, which can be demonstrated a proficient approach for drug design of anti-retroviral agents. The current review enlightens the recent updates in the structural biology of the viral envelope and focuses on CCR5 as a validated target as well as ways to overcome CCR5 resistance. The article also throws light on the SAR studies and most prevalent mutations in the receptor for designing CCR5 antagonists that can combat HIV-1 infection. To conclude, the paper lists diversified scaffolds that are in pipeline by various pharmaceutical companies that could provide an aid for developing novel CCR5 antagonists.", "label": 1, "is_selected": 0, "text": "The healthcare system faces various challenges in human immunodeficiency virus (HIV) therapy due to resistance to Anti-Retroviral Therapy (ART) as a consequence of the evolutionary process. Despite the success of antiretroviral drugs like Zidovudine, Zalcitabine, Raltegravir WHO ranks HIV as one of the deadliest diseases with a mortality of one million lives in 2016. Thus, there emerges an urgency of developing a novel anti-retroviral agent that combat resistant HIV strains. The clinical development of ART from a single drug regimen to current triple drug combination is very slow. The progression in the structural biology of the viral envelope prompted the discovery of novel targets, which can be demonstrated a proficient approach for drug design of anti-retroviral agents. The current review enlightens the recent updates in the structural biology of the viral envelope and focuses on CCR5 as a validated target as well as ways to overcome CCR5 resistance. The article also throws light on the SAR studies and most prevalent mutations in the receptor for designing CCR5 antagonists that can combat HIV-1 infection. To conclude, the paper lists diversified scaffolds that are in pipeline by various pharmaceutical companies that could provide an aid for developing novel CCR5 antagonists."}
{"qid": "5e476da1d14c9f295d000002", "original_text": "Marimastat [BB 2516, TA 2516] is a second-generation anticancer drug originally developed with British Biotech in Europe and North America. It is an orally active metalloprotease inhibitor of the same class as batimastat, and is the first compound in this class to have completed a pivotal clinical trial. Marimastat also has collagenase- and angiogenesis-inhibiting properties. British Biotech and Schering-Plough have signed an agreement enabling the latter to develop and market marimastat in North America and Europe. Under the terms of the agreement, British Biotech will receive an up-front license fee of 4 million US dollars and a 4 million US dollars equity investment in British Biotech by Schering-Plough. Schering-Plough holds rights to marimastat in all countries other than the Far East and Japan. The two companies are considering asking the FDA for accelerated approval in gastric cancer based on the secondary endpoint of progression-free survival. Marimastat is licensed to Tanabe Seiyaku in Japan, where phase II clinical trials are underway for the treatment of advanced gastric cancer and lung cancer. Further phase II trials in other tumour types are planned. The commencement of phase II trials in Japan resulted in a milestone payment of 5 million US dollars to British Biotech from Tanabe Seiyaku. Tanabe Seiyaku also holds rights to marimastat in the Far East.", "label": 1, "is_selected": 0, "text": "Marimastat [BB 2516, TA 2516] is a second-generation anticancer drug originally developed with British Biotech in Europe and North America. It is an orally active metalloprotease inhibitor of the same class as batimastat, and is the first compound in this class to have completed a pivotal clinical trial. Marimastat also has collagenase- and angiogenesis-inhibiting properties. British Biotech and Schering-Plough have signed an agreement enabling the latter to develop and market marimastat in North America and Europe. Under the terms of the agreement, British Biotech will receive an up-front license fee of 4 million US dollars and a 4 million US dollars equity investment in British Biotech by Schering-Plough. Schering-Plough holds rights to marimastat in all countries other than the Far East and Japan. The two companies are considering asking the FDA for accelerated approval in gastric cancer based on the secondary endpoint of progression-free survival. Marimastat is licensed to Tanabe Seiyaku in Japan, where phase II clinical trials are underway for the treatment of advanced gastric cancer and lung cancer. Further phase II trials in other tumour types are planned. The commencement of phase II trials in Japan resulted in a milestone payment of 5 million US dollars to British Biotech from Tanabe Seiyaku. Tanabe Seiyaku also holds rights to marimastat in the Far East."}
{"qid": "516e5f25298dcd4e5100007d", "original_text": "Topoisomerase II (Top2) is an enzyme that plays a crucial role in DNA replication, repair, and transcription. Several anticancer drugs target Top2, including: 1. Irinotecan (CPT-11): This is a topoisomerase inhibitor that selectively binds to Top2 and causes DNA damage, leading to cell death in cancer cells. 2. Etoposide: This drug binds to Top2 and inhibits its activity, causing DNA damage and cell death in cancer cells. 3. Teniposide: Similar to etoposide, teniposide also binds to Top2 and inhibits its activity, leading to DNA damage and cell death in cancer cells. 4. Paclitaxel (Taxol): Although not a direct inhibitor of Top2, paclitaxel binds to the microtubule protein and causes stabilization of microtubules, leading to cell death in cancer cells. 5. Docetaxel: Similar to paclitaxel, docetaxel also binds to the microtubule protein and causes stabilization of microtubules, leading to cell death in cancer cells. It's worth noting that these drugs can have severe side effects, such as nausea, vomiting, and bone marrow suppression, and should only be used under the proper medical supervision.", "label": 0, "is_selected": 1, "text": "A new class of drugs called Top2 inhibitors have been developed to treat a variety of cancers, including breast, lung, pancreatic, and ovarian cancer. Docetaxel: Similar to paclitaxel, docetaxel also binds to the microtubule protein and causes stabilization of microtubules, leading to cell death in cancer cells., etoposide: This drug binds to Top2 and inhibits its activity, causing DNA damage, cell death, and bone marrow suppression, and should only be used under the proper medical supervision."}
{"qid": "5c890ff475a4a5d219000010", "original_text": "Sideritis scardica, commonly known as Scardus, is a perennial herb native to the Balkans and the Mediterranean region. In traditional medicine, the plant has been used for various purposes. Here are some of its traditional uses: 1. Respiratory problems: Sideritis scardica has been used to treat respiratory issues such as bronchitis, asthma, and chronic obstructive pulmonary disease (COPD) due to its anti-inflammatory and expectorant properties. 2. Digestive issues: The herb has been used to treat digestive problems including dyspepsia, nausea, and diarrhea due to its carminative, antispasmodic, and antibacterial properties. 3. Infections: Sideritis scardica has been used to treat infections such as tonsillitis, pharyngitis, and sinusitis due to its antibacterial and anti-inflammatory properties. 4. Menstrual issues: The herb has been used to treat menstrual cramps, heavy bleeding, and other menstrual problems due to its anti-inflammatory and analgesic properties. 5. Skin problems: Sideritis scardica has been used to treat skin conditions such as acne, eczema, and psoriasis due to its anti-inflammatory and antibacterial properties. 6. Cardiovascular health: The herb has been used to treat cardiovascular issues such as hypertension and atherosclerosis due to its antioxidant and anti-inflammatory properties. 7. Immune system support: Sideritis scardica has been used to boost the immune system and prevent infections due to its immunomodulatory properties. 8. Kidney problems: The herb has been used to treat kidney issues such as nephritis and pyelitis due to its anti-inflammatory and diuretic properties. 9. Anemia: Sideritis scardica has been used to treat anemia due to its iron content and ability to increase red blood cell production. 10. Wound healing: The herb has been used to promote wound healing and reduce the risk of infection due to its antibacterial and anti-inflammatory properties. It is important to note that while Sideritis scardica has been used in traditional medicine for various purposes, its effectiveness and safety have not been extensively studied using modern scientific methods. As such, its use should be approached with caution, and it is recommended to consult with a healthcare professional before using the herb for medicinal purposes.", "label": 0, "is_selected": 0, "text": "Sideritis scardica, commonly known as Scardus, is a perennial herb native to the Balkans and the Mediterranean region. In traditional medicine, the plant has been used for various purposes. Here are some of its traditional uses: 1. Respiratory problems: Sideritis scardica has been used to treat respiratory issues such as bronchitis, asthma, and chronic obstructive pulmonary disease (COPD) due to its anti-inflammatory and expectorant properties. 2. Digestive issues: The herb has been used to treat digestive problems including dyspepsia, nausea, and diarrhea due to its carminative, antispasmodic, and antibacterial properties. 3. Infections: Sideritis scardica has been used to treat infections such as tonsillitis, pharyngitis, and sinusitis due to its antibacterial and anti-inflammatory properties. 4. Menstrual issues: The herb has been used to treat menstrual cramps, heavy bleeding, and other menstrual problems due to its anti-inflammatory and analgesic properties. 5. Skin problems: Sideritis scardica has been used to treat skin conditions such as acne, eczema, and psoriasis due to its anti-inflammatory and antibacterial properties. 6. Cardiovascular health: The herb has been used to treat cardiovascular issues such as hypertension and atherosclerosis due to its antioxidant and anti-inflammatory properties. 7. Immune system support: Sideritis scardica has been used to boost the immune system and prevent infections due to its immunomodulatory properties. 8. Kidney problems: The herb has been used to treat kidney issues such as nephritis and pyelitis due to its anti-inflammatory and diuretic properties. 9. Anemia: Sideritis scardica has been used to treat anemia due to its iron content and ability to increase red blood cell production. 10. Wound healing: The herb has been used to promote wound healing and reduce the risk of infection due to its antibacterial and anti-inflammatory properties. It is important to note that while Sideritis scardica has been used in traditional medicine for various purposes, its effectiveness and safety have not been extensively studied using modern scientific methods. As such, its use should be approached with caution, and it is recommended to consult with a healthcare professional before using the herb for medicinal purposes."}
{"qid": "5890eb22621ea6ff7e000006", "original_text": "To study the value of Pentraxin 3 (PTX3) in diagnosing the severity and cardiovascular function of the critically ill children. Method A total of 178 patients who were older than 28 days, with acute infection of respiratory or neurological system, excluding chronic or special disease, and admitted to the pediatric intensive care unit (PICU) of Hunan Children's Hospital from October 1, 2013 to April 30, 2014 were enrolled, including 102 male cases and 76 female cases. The ages ranged from 1 month to 13 years and 1 month, 78 of them were less than 1 year old ; 58 cases were between 1 to 3 years old; 42 cases were above 3 years old; 101 cases were diagnosed as respiratory system diseases, 77 cases had nervous system diseases. PTX3 was detected with enzyme-linked immunosorbent assay (ELISA) within 1 d after enrollment, at 3 days and 7 days, meanwhile, troponin, myocardial enzyme, brain-type natriuretic peptide (BNP), C-reactive protein (CRP), plasma calcitonin (PCT) and WBC etc. Were measured. According to the plasma PTX3 value which were measured within 24 h after enrollment the patients were divided into three groups: mildly elevated group (< 44 \u00b5g/L) 41 cases; moderately elevated group (44 - < 132 \u00b5g/L) in 66 cases; severely elevated group 71 cases (132 \u00b5g/L or higher). Those 178 patients were divided into 3 groups according to the degree of infection: non-sepsis group (78 cases), sepsis group (70 cases), severe sepsis group (30 cases), and in each group, those with heart failure were respectively 19 cases, 28 cases, 17 cases.", "label": 1, "is_selected": 0, "text": "To study the value of Pentraxin 3 (PTX3) in diagnosing the severity and cardiovascular function of the critically ill children. Method A total of 178 patients who were older than 28 days, with acute infection of respiratory or neurological system, excluding chronic or special disease, and admitted to the pediatric intensive care unit (PICU) of Hunan Children's Hospital from October 1, 2013 to April 30, 2014 were enrolled, including 102 male cases and 76 female cases. The ages ranged from 1 month to 13 years and 1 month, 78 of them were less than 1 year old ; 58 cases were between 1 to 3 years old; 42 cases were above 3 years old; 101 cases were diagnosed as respiratory system diseases, 77 cases had nervous system diseases. PTX3 was detected with enzyme-linked immunosorbent assay (ELISA) within 1 d after enrollment, at 3 days and 7 days, meanwhile, troponin, myocardial enzyme, brain-type natriuretic peptide (BNP), C-reactive protein (CRP), plasma calcitonin (PCT) and WBC etc. Were measured. According to the plasma PTX3 value which were measured within 24 h after enrollment the patients were divided into three groups: mildly elevated group (< 44 \u00b5g/L) 41 cases; moderately elevated group (44 - < 132 \u00b5g/L) in 66 cases; severely elevated group 71 cases (132 \u00b5g/L or higher). Those 178 patients were divided into 3 groups according to the degree of infection: non-sepsis group (78 cases), sepsis group (70 cases), severe sepsis group (30 cases), and in each group, those with heart failure were respectively 19 cases, 28 cases, 17 cases."}
{"qid": "5a74d9980384be9551000008", "original_text": "LHON (Leber's hereditary optic neuropathy) is a rare genetic disorder that affects the optic nerve and leads to sudden and severe vision loss. It is inherited in an autosomal dominant manner, meaning that a single copy of the mutated gene is enough to cause the condition. LHON typically affects young adults, usually between the ages of 20 and 40, and can result in permanent blindness. The disorder is caused by mutations in the mitochondrial DNA, which are responsible for producing energy for cells. There is currently no cure for LHON, but treatment options include vitamin supplements, steroids, and other medications to slow down the progression of the disease.", "label": 0, "is_selected": 1, "text": "Researchers at the University of California, Los Angeles, have discovered a gene that could help them develop a treatment for a condition that causes blindness in people with a single copy of the mutated gene, according to a report in the New England Journal of Medicine (NEJM)."}
{"qid": "5c89623bf9c2ba6b28000005", "original_text": "Ovarian Sertoli-Leydig cell tumors (SLCTs) are uncommon neoplasms that are occasionally associated with an elevated level of serum alpha fetoprotein (AFP), a marker of germ cell neoplasms, particularly yolk sac tumor (YST). We report 7 cases of ovarian SLCT (3 moderately differentiated, 2 poorly differentiated, 2 retiform) with heterologous intestinal-type glands, 6 of which were associated with elevated serum AFP. The intestinal-type mucinous glands were immunoreactive for SALL4 (4 cases), AFP (4 cases), glypican 3 (1 case), CDX2 (6 cases), and villin (7 cases), markers that are commonly expressed in YSTs, although the latter 2 markers would be expected to be positive in intestinal-type glands. We show that heterologous intestinal-type glands in ovarian SLCTs often have an endodermal sinus-like (YST-like) immunophenotype and stress that these should not be misinterpreted as microscopic foci of endodermal-type YST. Cases of ovarian SLCT with elevated serum AFP should be sampled extensively to look for foci of intestinal-type glands, the likely source of the AFP elevation in some of these neoplasms.", "label": 1, "is_selected": 0, "text": "Ovarian Sertoli-Leydig cell tumors (SLCTs) are uncommon neoplasms that are occasionally associated with an elevated level of serum alpha fetoprotein (AFP), a marker of germ cell neoplasms, particularly yolk sac tumor (YST). We report 7 cases of ovarian SLCT (3 moderately differentiated, 2 poorly differentiated, 2 retiform) with heterologous intestinal-type glands, 6 of which were associated with elevated serum AFP. The intestinal-type mucinous glands were immunoreactive for SALL4 (4 cases), AFP (4 cases), glypican 3 (1 case), CDX2 (6 cases), and villin (7 cases), markers that are commonly expressed in YSTs, although the latter 2 markers would be expected to be positive in intestinal-type glands. We show that heterologous intestinal-type glands in ovarian SLCTs often have an endodermal sinus-like (YST-like) immunophenotype and stress that these should not be misinterpreted as microscopic foci of endodermal-type YST. Cases of ovarian SLCT with elevated serum AFP should be sampled extensively to look for foci of intestinal-type glands, the likely source of the AFP elevation in some of these neoplasms."}
{"qid": "5e360b6a158f994d3a000007", "original_text": "To present a case of iatrogenic Horner's syndrome seen together with the heterochromia in the post-thyroidectomy period. A 23-year-old female patient was admitted to our clinic with complaints of low vision in the eye and difference in eye color that developed over the past two years. In the left eye, myosis and minimal ptosis (\u223c1 mm) was detected, and the color of the iris was lighter than the right eye. The pre-diagnosis of left iatrogenic Horner's syndrome was finalized after 0.5% topical apraclonidine test. Heterochromia can be observed in iatrogenic Horner's syndrome.", "label": 1, "is_selected": 0, "text": "To present a case of iatrogenic Horner's syndrome seen together with the heterochromia in the post-thyroidectomy period. A 23-year-old female patient was admitted to our clinic with complaints of low vision in the eye and difference in eye color that developed over the past two years. In the left eye, myosis and minimal ptosis (\u223c1 mm) was detected, and the color of the iris was lighter than the right eye. The pre-diagnosis of left iatrogenic Horner's syndrome was finalized after 0.5% topical apraclonidine test. Heterochromia can be observed in iatrogenic Horner's syndrome."}
{"qid": "5e2b07537d50947c2f000001", "original_text": "Cirsoid aneurysms, also known as scalp arteriovenous malformations (AVM), are rare congenital extracranial vascular anomalies that often present as an enlarging pulsatile scalp mass. A 14-yr-old male presented with a pulsatile scalp lesion that was first noticed 3 yr prior and had progressively enlarged. No history of trauma was reported. MRI demonstrated a 4 cm wide and 2 cm tall nidus and catheter angiography was performed to further define the vascular supply and drainage. The patient underwent transvenous endovascular embolization followed by surgical excision via a bicoronal incision, as shown in this operative video.", "label": 1, "is_selected": 0, "text": "Cirsoid aneurysms, also known as scalp arteriovenous malformations (AVM), are rare congenital extracranial vascular anomalies that often present as an enlarging pulsatile scalp mass. A 14-yr-old male presented with a pulsatile scalp lesion that was first noticed 3 yr prior and had progressively enlarged. No history of trauma was reported. MRI demonstrated a 4 cm wide and 2 cm tall nidus and catheter angiography was performed to further define the vascular supply and drainage. The patient underwent transvenous endovascular embolization followed by surgical excision via a bicoronal incision, as shown in this operative video."}
{"qid": "60273a161cb411341a0000d8", "original_text": "The ALPHEUS trial investigated the safety and efficacy of various drugs in patients with acute ischemic stroke. The specific drugs studied in the trial were: 1. Alteplase: This is a tissue plasminogen activator (tPA) that is commonly used to treat acute ischemic stroke. It works by breaking down blood clots and restoring blood flow to the affected area. 2. Aspirin: This is a nonsteroidal anti-inflammatory drug (NSAID) that was investigated for its potential to reduce the risk of stroke recurrence. 3. Celecoxib: This is a COX-2 inhibitor that was also investigated for its potential to reduce the risk of stroke recurrence. 4. Dipyridamole: This is a platelet aggregation inhibitor that was investigated for its potential to prevent blood clots from forming in the brain. 5. Heparin: This is an anticoagulant that was investigated for its potential to prevent blood clots from forming in the brain. 6. Leptadenir: This is a novel antithrombotic agent that was investigated for its potential to prevent blood clots from forming in the brain. It's important to note that the ALPHEUS trial did not find any of these drugs to be superior to standard of care treatment with tPA for patients with acute ischemic stroke. Therefore, the trial did not support the use of these drugs for this indication.", "label": 0, "is_selected": 1, "text": "The ALPHEUS trial was a multi-centre, randomised, double-blind, placebo-controlled trial that compared the use of six different drugs to treat acute stroke in patients who had suffered a previous stroke or who had had a previous heart attack or who were at high risk of having a future stroke, such as smokers or those who have had a heart attack in the previous 12 months, with a control group of patients who received the same drugs but with a different underlying condition such as high blood pressure, diabetes or heart disease."}
{"qid": "5c76be617c78d694710000a5", "original_text": "Birdshot chorioretinopathy (BSCR) is a rare form of autoimmune uveitis that can lead to severe visual impairment. Intriguingly, >95% of cases carry the HLA-A29 allele, which defines the strongest documented HLA association for a human disease. We have conducted a genome-wide association study in 96 Dutch and 27 Spanish cases, and 398 unrelated Dutch and 380 Spanish controls. Fine-mapping the primary MHC association through high-resolution imputation at classical HLA loci, identified HLA-A*29:02 as the principal MHC association (odds ratio (OR) = 157.5, 95% CI 91.6-272.6, P = 6.6 \u00d7 10(-74)).", "label": 1, "is_selected": 0, "text": "Birdshot chorioretinopathy (BSCR) is a rare form of autoimmune uveitis that can lead to severe visual impairment. Intriguingly, >95% of cases carry the HLA-A29 allele, which defines the strongest documented HLA association for a human disease. We have conducted a genome-wide association study in 96 Dutch and 27 Spanish cases, and 398 unrelated Dutch and 380 Spanish controls. Fine-mapping the primary MHC association through high-resolution imputation at classical HLA loci, identified HLA-A*29:02 as the principal MHC association (odds ratio (OR) = 157.5, 95% CI 91.6-272.6, P = 6.6 \u00d7 10(-74))."}
{"qid": "5c6d6b377c78d69471000039", "original_text": "The collection, management and visualization of clinical pedigree (family history) data is a core activity in clinical genetics centres. However, clinical pedigree datasets can be difficult to manage, as they are time consuming to capture, and can be difficult to build, manipulate and visualize graphically. Several standalone graphical pedigree editors and drawing applications exist but there are no freely available lightweight graphical pedigree editors that can be easily configured and incorporated into web applications. We developed 'pedigreejs', an interactive graphical pedigree editor written in JavaScript, which uses standard pedigree nomenclature. Pedigreejs provides an easily configurable, extensible and lightweight pedigree editor. It makes use of an open-source Javascript library to define a hierarchical layout and to produce images in scalable vector graphics (SVG) format that can be viewed and edited in web browsers.", "label": 1, "is_selected": 0, "text": "The collection, management and visualization of clinical pedigree (family history) data is a core activity in clinical genetics centres. However, clinical pedigree datasets can be difficult to manage, as they are time consuming to capture, and can be difficult to build, manipulate and visualize graphically. Several standalone graphical pedigree editors and drawing applications exist but there are no freely available lightweight graphical pedigree editors that can be easily configured and incorporated into web applications. We developed 'pedigreejs', an interactive graphical pedigree editor written in JavaScript, which uses standard pedigree nomenclature. Pedigreejs provides an easily configurable, extensible and lightweight pedigree editor. It makes use of an open-source Javascript library to define a hierarchical layout and to produce images in scalable vector graphics (SVG) format that can be viewed and edited in web browsers."}
{"qid": "5507ea9a0195c16935000008", "original_text": "Bidirectional ventricular tachycardia (BVT) is an uncommon type of polymorphic ventricular tachycardia (PVT) with alternating polarity of the QRS complex most commonly described digitalis toxicity. Recent data has demonstrated the possible molecular basis of this electrocardiographic phenomenon. To our knowledge this is the first reported case of BVT in a patient with orthotopic cardiac transplantation and coronary allograft vasculopathy.", "label": 1, "is_selected": 0, "text": "Bidirectional ventricular tachycardia (BVT) is an uncommon type of polymorphic ventricular tachycardia (PVT) with alternating polarity of the QRS complex most commonly described digitalis toxicity. Recent data has demonstrated the possible molecular basis of this electrocardiographic phenomenon. To our knowledge this is the first reported case of BVT in a patient with orthotopic cardiac transplantation and coronary allograft vasculopathy."}
{"qid": "5e35d7cd158f994d3a000005", "original_text": "Protein-protein interaction (PPI) networks are emerging as valuable prototypes to study important problems in molecular cellular biology and systems biomedicine. An analysis of the topological properties of a PPI network is very helpful for understanding the function and structure of networks. In this study, we analyzed the topological patterns in the BioPlex network containing interactions among 10,961 proteins; most interactions were previously undocumented. The BioPlex network is a comprehensive map of human protein interactions and represents the first phase of a long-term effort to profile the entire human ORFEOME collection.", "label": 1, "is_selected": 0, "text": "Protein-protein interaction (PPI) networks are emerging as valuable prototypes to study important problems in molecular cellular biology and systems biomedicine. An analysis of the topological properties of a PPI network is very helpful for understanding the function and structure of networks. In this study, we analyzed the topological patterns in the BioPlex network containing interactions among 10,961 proteins; most interactions were previously undocumented. The BioPlex network is a comprehensive map of human protein interactions and represents the first phase of a long-term effort to profile the entire human ORFEOME collection."}
{"qid": "5c5214207e3cb0e231000003", "original_text": "There are several reasons why potentially important genes may be ignored in genetic research, including: 1. Lack of understanding of the gene's function or its role in disease. 2. Limited availability of high-quality data or resources for studying the gene. 3. Difficulty in interpreting the results of genetic association studies due to complex gene-environment interactions. 4. Limited funding or resources for studying the gene. 5. Prioritization of more well-established or high-impact genes in the research pipeline. 6. Overlap with other genes that have similar functions or associations with disease. 7. Limited access to patient populations or sample sizes for studying the gene. 8. Difficulty in designing effective genetic screens or assays for the gene. I don't have an answer.", "label": 0, "is_selected": 0, "text": "There are several reasons why potentially important genes may be ignored in genetic research, including: 1. Lack of understanding of the gene's function or its role in disease. 2. Limited availability of high-quality data or resources for studying the gene. 3. Difficulty in interpreting the results of genetic association studies due to complex gene-environment interactions. 4. Limited funding or resources for studying the gene. 5. Prioritization of more well-established or high-impact genes in the research pipeline. 6. Overlap with other genes that have similar functions or associations with disease. 7. Limited access to patient populations or sample sizes for studying the gene. 8. Difficulty in designing effective genetic screens or assays for the gene. I don't have an answer."}
{"qid": "5c6473b2e842deac6700001b", "original_text": "On September 1, 2017, the FDA granted approval for gemtuzumab ozogamicin (Mylotarg; Pfizer Inc.) in combination with daunorubicin and cytarabine and as a monotherapy for the treatment of adult patients with newly diagnosed CD33-positive acute myeloid leukemia (AML). Gemtuzumab ozogamicin is a CD33-targeted antibody-drug conjugate joined to calicheamicin. Approval of gemtuzumab ozogamicin combination treatment was based on a randomized trial of 271 patients with newly diagnosed AML treated with daunorubicin and cytarabine with or without 3 mg/m2 fractionated gemtuzumab ozogamicin, which resulted in an event-free survival (EFS) of 13.6 months for gemtuzumab ozogamicin + daunorubicin and cytarabine and 8.8 months for daunorubicin and cytarabine alone", "label": 1, "is_selected": 0, "text": "On September 1, 2017, the FDA granted approval for gemtuzumab ozogamicin (Mylotarg; Pfizer Inc.) in combination with daunorubicin and cytarabine and as a monotherapy for the treatment of adult patients with newly diagnosed CD33-positive acute myeloid leukemia (AML). Gemtuzumab ozogamicin is a CD33-targeted antibody-drug conjugate joined to calicheamicin. Approval of gemtuzumab ozogamicin combination treatment was based on a randomized trial of 271 patients with newly diagnosed AML treated with daunorubicin and cytarabine with or without 3 mg/m2 fractionated gemtuzumab ozogamicin, which resulted in an event-free survival (EFS) of 13.6 months for gemtuzumab ozogamicin + daunorubicin and cytarabine and 8.8 months for daunorubicin and cytarabine alone"}
{"qid": "5e2a04feaa19d74431000009", "original_text": "Patients with secondary acute myeloid leukemia (sAML) arising from myelodysplastic syndromes have a poor prognosis marked by an increased resistance to chemotherapy. An urgent need exists for adjuvant treatments that can enhance or replace current therapeutic options. Here we show the potential of LB100, a small-molecule protein phosphatase 2 A (PP2A) inhibitor, as a monotherapy and chemosensitizing agent for sAML using an in-vitro and in-vivo approach.", "label": 1, "is_selected": 0, "text": "Patients with secondary acute myeloid leukemia (sAML) arising from myelodysplastic syndromes have a poor prognosis marked by an increased resistance to chemotherapy. An urgent need exists for adjuvant treatments that can enhance or replace current therapeutic options. Here we show the potential of LB100, a small-molecule protein phosphatase 2 A (PP2A) inhibitor, as a monotherapy and chemosensitizing agent for sAML using an in-vitro and in-vivo approach."}
{"qid": "5e355e20fbd6abf43b000065", "original_text": "Lamin B1 is a component of the nuclear lamina and plays a critical role in maintaining nuclear architecture, regulating gene expression and modulating chromatin positioning. We have previously shown that LMNB1 gene duplications cause autosomal dominant leukodystrophy (ADLD), a fatal adult onset demyelinating disease. The mechanisms by which increased LMNB1 levels cause ADLD are unclear. To address this, we used a transgenic mouse model where Lamin B1 overexpression is targeted to oligodendrocytes.", "label": 1, "is_selected": 0, "text": "Lamin B1 is a component of the nuclear lamina and plays a critical role in maintaining nuclear architecture, regulating gene expression and modulating chromatin positioning. We have previously shown that LMNB1 gene duplications cause autosomal dominant leukodystrophy (ADLD), a fatal adult onset demyelinating disease. The mechanisms by which increased LMNB1 levels cause ADLD are unclear. To address this, we used a transgenic mouse model where Lamin B1 overexpression is targeted to oligodendrocytes."}
{"qid": "56c048e2ef6e39474100001d", "original_text": "Meningococcal group B vaccine (Trumenba) to prevent more types of invasive meningococcal disease; antihemophilic factor (recombinant), porcine sequence (Obizur) to treat bleeding from acquired hemophilia A; and pirfenidone (Esbriet) and nintedanib (Ofev) for idiopathic pulmonary fibrosis.", "label": 1, "is_selected": 0, "text": "Meningococcal group B vaccine (Trumenba) to prevent more types of invasive meningococcal disease; antihemophilic factor (recombinant), porcine sequence (Obizur) to treat bleeding from acquired hemophilia A; and pirfenidone (Esbriet) and nintedanib (Ofev) for idiopathic pulmonary fibrosis."}
{"qid": "625ebe5ce764a53204000032", "original_text": "Nephropathic cystinosis is one of the only lysosomal storage diseases for which there is an effective therapy against the basic, pathologic process-cystine accumulation. Early diagnosis and therapy are critical to optimize the prognosis.", "label": 1, "is_selected": 0, "text": "Nephropathic cystinosis is one of the only lysosomal storage diseases for which there is an effective therapy against the basic, pathologic process-cystine accumulation. Early diagnosis and therapy are critical to optimize the prognosis."}
{"qid": "5e67cce31af46fc13000001d", "original_text": "CRAO stands for Central Retinal Artery Occlusion, which refers to a blockage of the main blood vessel that supplies blood to the central part of the retina in the eye. This blockage can cause sudden vision loss or disturbances in the central vision of one or both eyes. CRAO is a medical emergency that requires prompt evaluation and treatment to prevent further damage to the retina and vision loss. Treatment options may include medications, laser therapy, or surgery to restore blood flow to the affected area.", "label": 0, "is_selected": 0, "text": "CRAO stands for Central Retinal Artery Occlusion, which refers to a blockage of the main blood vessel that supplies blood to the central part of the retina in the eye. This blockage can cause sudden vision loss or disturbances in the central vision of one or both eyes. CRAO is a medical emergency that requires prompt evaluation and treatment to prevent further damage to the retina and vision loss. Treatment options may include medications, laser therapy, or surgery to restore blood flow to the affected area."}
{"qid": "589c8ef878275d0c4a000042", "original_text": "Proteins and their interactions govern virtually all cellular processes, such as regulation, signaling, metabolism, and structure. Most experimental findings pertaining to such interactions are discussed in research papers, which, in turn, get curated by protein interaction databases. Authors, editors, and publishers benefit from efforts to alleviate the tasks of searching for relevant papers, evidence for physical interactions, and proper identifiers for each protein involved. The BioCreative II.5 community challenge addressed these tasks in a competition-style assessment to evaluate and compare different methodologies, to make aware of the increasing accuracy of automated methods, and to guide future implementations. In this paper, we present our approaches for protein-named entity recognition, including normalization, and for extraction of protein-protein interactions from full text. Our overall goal is to identify efficient individual components, and we compare various compositions to handle a single full-text article in between 10 seconds and 2 minutes. We propose strategies to transfer document-level annotations to the sentence-level, which allows for the creation of a more fine-grained training corpus; we use this corpus to automatically derive around 5,000 patterns. We rank sentences by relevance to the task of finding novel interactions with physical evidence, using a sentence classifier built from this training corpus.", "label": 1, "is_selected": 0, "text": "Proteins and their interactions govern virtually all cellular processes, such as regulation, signaling, metabolism, and structure. Most experimental findings pertaining to such interactions are discussed in research papers, which, in turn, get curated by protein interaction databases. Authors, editors, and publishers benefit from efforts to alleviate the tasks of searching for relevant papers, evidence for physical interactions, and proper identifiers for each protein involved. The BioCreative II.5 community challenge addressed these tasks in a competition-style assessment to evaluate and compare different methodologies, to make aware of the increasing accuracy of automated methods, and to guide future implementations. In this paper, we present our approaches for protein-named entity recognition, including normalization, and for extraction of protein-protein interactions from full text. Our overall goal is to identify efficient individual components, and we compare various compositions to handle a single full-text article in between 10 seconds and 2 minutes. We propose strategies to transfer document-level annotations to the sentence-level, which allows for the creation of a more fine-grained training corpus; we use this corpus to automatically derive around 5,000 patterns. We rank sentences by relevance to the task of finding novel interactions with physical evidence, using a sentence classifier built from this training corpus."}
{"qid": "552fa32fbc4f83e828000001", "original_text": "CD56 and CD57 are commonly considered as natural killer and neuroectodermal markers, but their expression has been identified in a wide spectrum of neoplasms including some cases of Ewing's sarcoma (ES) and primitive neuroectodermal tumor (PNET). We report two cases of small, round blue cell tumor (SRBCT), in which flow cytometry immunophenotyping (FCI) detected strong expression of CD56 and CD57 (one case). Immunohistochemical staining with Leu-19 and Leu-7 confirmed the FI results. Although CD56 and CD57 expression is consistent with ES/PNET, it can be potentially misleading if results of FCI are interpreted in the absence of other findings. These cases suggest the utility of FCI in undifferentiated SRBCT.", "label": 1, "is_selected": 0, "text": "CD56 and CD57 are commonly considered as natural killer and neuroectodermal markers, but their expression has been identified in a wide spectrum of neoplasms including some cases of Ewing's sarcoma (ES) and primitive neuroectodermal tumor (PNET). We report two cases of small, round blue cell tumor (SRBCT), in which flow cytometry immunophenotyping (FCI) detected strong expression of CD56 and CD57 (one case). Immunohistochemical staining with Leu-19 and Leu-7 confirmed the FI results. Although CD56 and CD57 expression is consistent with ES/PNET, it can be potentially misleading if results of FCI are interpreted in the absence of other findings. These cases suggest the utility of FCI in undifferentiated SRBCT."}
{"qid": "5e36ad01b5b409ea53000006", "original_text": "The transcribed-ultraconserved regions (T-UCRs) are a novel class of non-coding RNAs, which are absolutely conserved (100%) between the orthologous regions of the human, rat and mouse genomes. Previous studies have described that several T-UCRs show differential expressions in cancers and might be involved in cancer development. We investigated the transcriptional levels of representative 26 T-UCRs and determined the regions that were differently expressed in prostate cancer (PCa) and gastric cancer (GC). A quantitative reverse transcription-polymerase chain reaction analysis revealed the downregulation of Uc.158+A expression by a DNA methylation-associated mechanism, which was restored by 5-Aza-dC (5-aza-2'-deoxycytidine) treatment. Bisulfite genomic sequencing using cell lines and tissue samples demonstrated cancer-specific CpG hypermethylation in both GC and PCa. However, Uc.416+A was only overexpressed in GC and we identified an miR-153 binding site in the possible regulatory region of Uc.416+A using online databases. Along with a forced expression or knockdown of miR-153 in MKN-74 GC cells, the transcriptional levels of Uc.416+A were significantly disturbed. A luciferase reporter gene assay supported the direct regulation of Uc.416+A expression by miR-153. Furthermore, Uc.416+A was associated with cell growth through the regulation of IGFBP6 (insulin-like growth factor-binding protein 6) in GC. These findings suggest an oncogenic role of Uc.416+A in GC, which suggests that our approach would provide new insights into functional studies of T-UCRs in cancer biology.", "label": 1, "is_selected": 0, "text": "The transcribed-ultraconserved regions (T-UCRs) are a novel class of non-coding RNAs, which are absolutely conserved (100%) between the orthologous regions of the human, rat and mouse genomes. Previous studies have described that several T-UCRs show differential expressions in cancers and might be involved in cancer development. We investigated the transcriptional levels of representative 26 T-UCRs and determined the regions that were differently expressed in prostate cancer (PCa) and gastric cancer (GC). A quantitative reverse transcription-polymerase chain reaction analysis revealed the downregulation of Uc.158+A expression by a DNA methylation-associated mechanism, which was restored by 5-Aza-dC (5-aza-2'-deoxycytidine) treatment. Bisulfite genomic sequencing using cell lines and tissue samples demonstrated cancer-specific CpG hypermethylation in both GC and PCa. However, Uc.416+A was only overexpressed in GC and we identified an miR-153 binding site in the possible regulatory region of Uc.416+A using online databases. Along with a forced expression or knockdown of miR-153 in MKN-74 GC cells, the transcriptional levels of Uc.416+A were significantly disturbed. A luciferase reporter gene assay supported the direct regulation of Uc.416+A expression by miR-153. Furthermore, Uc.416+A was associated with cell growth through the regulation of IGFBP6 (insulin-like growth factor-binding protein 6) in GC. These findings suggest an oncogenic role of Uc.416+A in GC, which suggests that our approach would provide new insights into functional studies of T-UCRs in cancer biology."}
{"qid": "58a5924060087bc10a000020", "original_text": "The renin-angiotensin system plays a key role in the initiation and maintenance of elevated blood pressure associated with altered intrauterine milieu. The current studies were undertaken to verify whether vascular response to ANG II is increased in adult offspring of low-protein fed dams (LP) compared with control (CTRL) and if so, to examine underlying mechanism(s). ANG II-induced contraction of carotid rings was increased in LP (E(max), the maximum asymptote of the curve, relative to maximal response to KCl 80 mM: 230 +/- 3% LP vs. 201 +/- 2% CTRL, P < 0.05). In both groups, contraction to ANG II was mediated solely by AT1R. Responses to thromboxane A2 analog U-46619 and to KCl 80 mM under step increases in tension were similar between groups. Endothelium depletion enhanced contraction to ANG II in both groups, more so in LP. Blockade of endothelin formation had no effect on response to ANG II, and ANG-(1-7) did not elicit vasomotor response in either group. Superoxide dismutase (SOD) analog Tempol normalized LP without modifying CTRL response to ANG II.", "label": 1, "is_selected": 0, "text": "The renin-angiotensin system plays a key role in the initiation and maintenance of elevated blood pressure associated with altered intrauterine milieu. The current studies were undertaken to verify whether vascular response to ANG II is increased in adult offspring of low-protein fed dams (LP) compared with control (CTRL) and if so, to examine underlying mechanism(s). ANG II-induced contraction of carotid rings was increased in LP (E(max), the maximum asymptote of the curve, relative to maximal response to KCl 80 mM: 230 +/- 3% LP vs. 201 +/- 2% CTRL, P < 0.05). In both groups, contraction to ANG II was mediated solely by AT1R. Responses to thromboxane A2 analog U-46619 and to KCl 80 mM under step increases in tension were similar between groups. Endothelium depletion enhanced contraction to ANG II in both groups, more so in LP. Blockade of endothelin formation had no effect on response to ANG II, and ANG-(1-7) did not elicit vasomotor response in either group. Superoxide dismutase (SOD) analog Tempol normalized LP without modifying CTRL response to ANG II."}
{"qid": "572099930fd6f91b6800000f", "original_text": "Yes, acid alpha-glucosidase (GAA) is the enzyme that is responsible for causing Pompe disease when mutations occur. GAA is essential for the breakdown and processing of glycogen, a complex carbohydrate that is stored in muscles and plays a critical role in muscle function. In Pompe disease, mutations in the GAA gene lead to a deficiency in this enzyme, resulting in the accumulation of glycogen in muscles and the progressive loss of muscle strength and function.", "label": 0, "is_selected": 1, "text": "Is Pompe disease caused by a mutation in the acid alpha-glucos (GAA) gene, or is it caused by an inherited defect in the enzyme that converts glycogen into glucose and glycogen back into muscle glycogen?... and is it possible to treat it?"}
{"qid": "54e22b62ae9738404b000011", "original_text": "Ehlers-Danlos syndrome (EDS) is a group of heritable disorders of connective tissue with skin, ligaments and blood vessels being the main sites affected. The commonest variant (EDS II) exhibits an autosomal dominant mode of inheritance and is characterized by joint hypermobility, cigarette paper scars, lax skin and excessive bruising. As yet no gene has been linked to EDS II, nor has linkage been established to a specific region of the genome. However, several candidate genes encoding proteins of the extracellular matrix have been excluded. Using an intragenic simple sequence repeat polymorphism, we report linkage of the COL5A1 gene, which encodes the alpha 1(V) chain of type V collagen, to EDS II.", "label": 1, "is_selected": 0, "text": "Ehlers-Danlos syndrome (EDS) is a group of heritable disorders of connective tissue with skin, ligaments and blood vessels being the main sites affected. The commonest variant (EDS II) exhibits an autosomal dominant mode of inheritance and is characterized by joint hypermobility, cigarette paper scars, lax skin and excessive bruising. As yet no gene has been linked to EDS II, nor has linkage been established to a specific region of the genome. However, several candidate genes encoding proteins of the extracellular matrix have been excluded. Using an intragenic simple sequence repeat polymorphism, we report linkage of the COL5A1 gene, which encodes the alpha 1(V) chain of type V collagen, to EDS II."}
{"qid": "530cf4e0c8a0b4a00c000004", "original_text": "Heterozygous mice bearing an Arg403Gln missense mutation in the alpha cardiac myosin heavy chain gene (alpha-MHC403/+) exhibit the histopathologic features of human familial hypertrophic cardiomyopathy. Surprisingly, homozygous alpha-MHC403/403 mice die by postnatal day 8. Here we report that neonatal lethality is caused by a fulminant dilated cardiomyopathy characterized by myocyte dysfunction and loss. Heart tissues from neonatal wild-type and alpha-MHC403/403 mice demonstrate equivalent switching of MHC isoforms; alpha isoforms in each increase from 30% at birth to 70% by day 6.", "label": 1, "is_selected": 0, "text": "Heterozygous mice bearing an Arg403Gln missense mutation in the alpha cardiac myosin heavy chain gene (alpha-MHC403/+) exhibit the histopathologic features of human familial hypertrophic cardiomyopathy. Surprisingly, homozygous alpha-MHC403/403 mice die by postnatal day 8. Here we report that neonatal lethality is caused by a fulminant dilated cardiomyopathy characterized by myocyte dysfunction and loss. Heart tissues from neonatal wild-type and alpha-MHC403/403 mice demonstrate equivalent switching of MHC isoforms; alpha isoforms in each increase from 30% at birth to 70% by day 6."}
{"qid": "6237ac143a8413c6530000b7", "original_text": "Adipokine leptin regulates neuroendocrine circuits that control energy expenditure, thermogenesis and weight loss. However, canonic regulators of leptin secretion, such as insulin and malonyl CoA, do not support these processes. We hypothesize that epiregulin (EREG), a growth factor that is secreted from fibroblasts under thermogenic and cachexia conditions, induces leptin secretion associated with energy dissipation. The effects of EREG on leptin secretion were studied ex vivo, in the intra-abdominal white adipose tissue (iAb WAT) explants, as well as in vivo, in WT mice with diet-induced obesity (DIO) and in ob/ob mice.", "label": 1, "is_selected": 0, "text": "Adipokine leptin regulates neuroendocrine circuits that control energy expenditure, thermogenesis and weight loss. However, canonic regulators of leptin secretion, such as insulin and malonyl CoA, do not support these processes. We hypothesize that epiregulin (EREG), a growth factor that is secreted from fibroblasts under thermogenic and cachexia conditions, induces leptin secretion associated with energy dissipation. The effects of EREG on leptin secretion were studied ex vivo, in the intra-abdominal white adipose tissue (iAb WAT) explants, as well as in vivo, in WT mice with diet-induced obesity (DIO) and in ob/ob mice."}
{"qid": "54d73e223706e89528000010", "original_text": "Gliolan is a brand name for the drug fluorescein. The generic name of Gliolan is fluorescein sodium.", "label": 0, "is_selected": 0, "text": "Gliolan is a brand name for the drug fluorescein. The generic name of Gliolan is fluorescein sodium."}
{"qid": "5a6e47b1b750ff4455000049", "original_text": "Yes, overproduction of transthyretin (TTR) is associated with amyloidosis-related neuropathy. TTR is a protein that is produced in the liver and accumulates in various tissues, including the nervous system, in cases of familial or senile amyloidosis. Specifically, TTR amyloid fibers are found in the peripheral nerves, where they disrupt the normal functioning of the nerve fibers, leading to neurological symptoms such as numbness, tingling, and weakness in the hands and feet. The neuropathy associated with TTR amyloidosis can be severe and debilitating, and can lead to significant disability and quality of life issues if left untreated.", "label": 0, "is_selected": 0, "text": "Yes, overproduction of transthyretin (TTR) is associated with amyloidosis-related neuropathy. TTR is a protein that is produced in the liver and accumulates in various tissues, including the nervous system, in cases of familial or senile amyloidosis. Specifically, TTR amyloid fibers are found in the peripheral nerves, where they disrupt the normal functioning of the nerve fibers, leading to neurological symptoms such as numbness, tingling, and weakness in the hands and feet. The neuropathy associated with TTR amyloidosis can be severe and debilitating, and can lead to significant disability and quality of life issues if left untreated."}
{"qid": "5c8ab614d558e5f23200000d", "original_text": "Asporin has been implicated as an oncogene in various types of human cancers; however, the roles of asporin in the development and progression of colorectal cancer (CRC) have not yet been determined. With clinical samples, we found that asporin was highly expressed in CRC tissues compared to adjacent normal tissues and the asporin expression levels were significantly associated with lymph node metastasis status and TNM stage of the patients. Through knockdown of asporin in CRC cell lines RKO and SW620 or overexpression of asporin in cell lines HT-29 and LoVo, we found that asporin could enhance wound healing, migration and invasion abilities of the CRC cells.", "label": 1, "is_selected": 0, "text": "Asporin has been implicated as an oncogene in various types of human cancers; however, the roles of asporin in the development and progression of colorectal cancer (CRC) have not yet been determined. With clinical samples, we found that asporin was highly expressed in CRC tissues compared to adjacent normal tissues and the asporin expression levels were significantly associated with lymph node metastasis status and TNM stage of the patients. Through knockdown of asporin in CRC cell lines RKO and SW620 or overexpression of asporin in cell lines HT-29 and LoVo, we found that asporin could enhance wound healing, migration and invasion abilities of the CRC cells."}
{"qid": "62513dc6e764a53204000014", "original_text": "Upadacitinib is a medication used to treat moderate to severe rheumatoid arthritis (RA) in adults. It is an oral, small molecule inhibitor of the enzyme janus kinase 1 (JAK1), which plays a key role in the signaling pathways that promote inflammation in RA. Upadacitinib has been shown to reduce symptoms, improve physical function, and slow radiographic progression of RA compared to placebo or other disease-modifying anti-rheumatic drugs (DMARDs). It is usually taken twice daily and may be used alone or in combination with other RA medications. Common side effects of upadacitinib include upper respiratory tract infections, headache, and diarrhea.", "label": 0, "is_selected": 0, "text": "Upadacitinib is a medication used to treat moderate to severe rheumatoid arthritis (RA) in adults. It is an oral, small molecule inhibitor of the enzyme janus kinase 1 (JAK1), which plays a key role in the signaling pathways that promote inflammation in RA. Upadacitinib has been shown to reduce symptoms, improve physical function, and slow radiographic progression of RA compared to placebo or other disease-modifying anti-rheumatic drugs (DMARDs). It is usually taken twice daily and may be used alone or in combination with other RA medications. Common side effects of upadacitinib include upper respiratory tract infections, headache, and diarrhea."}
{"qid": "56b469448525abca1e000007", "original_text": "Amyotrophic lateral sclerosis (ALS) is a progressive degeneration of upper and lower motor neurons. In the absence of any validated biological marker, the diagnosis of ALS depends upon recognition of characteristic symptoms and signs together with supportive electrophysiological findings. The diagnosis of ALS is easy to recognize in its fully developed form but during the early stages both false positive and false negative diagnoses are common. In clinical practice, diagnostic difficulties mostly arise with patients who present either with only upper motor neuron, or with only lower motor neuron signs.", "label": 1, "is_selected": 0, "text": "Amyotrophic lateral sclerosis (ALS) is a progressive degeneration of upper and lower motor neurons. In the absence of any validated biological marker, the diagnosis of ALS depends upon recognition of characteristic symptoms and signs together with supportive electrophysiological findings. The diagnosis of ALS is easy to recognize in its fully developed form but during the early stages both false positive and false negative diagnoses are common. In clinical practice, diagnostic difficulties mostly arise with patients who present either with only upper motor neuron, or with only lower motor neuron signs."}
{"qid": "606b648394d57fd879000069", "original_text": "HEp-2 cells are human cell lines that were derived in the 1970s from a patient with hepatocellular carcinoma (HCC), a type of liver cancer. The cells were established by Dr. George Klein and his colleagues at the National Cancer Institute (NCI) in Bethesda, Maryland. The cells were originally used for research purposes, including the study of viral infections and the development of new cancer therapies. Over time, HEp-2 cells have become widely used in the field of cell biology and have been applied to a variety of research areas, including cancer biology, immunology, and infectious diseases. Despite their long history, HEp-2 cells continue to be a valuable tool for researchers and have contributed significantly to our understanding of the biology of cancer and other diseases.", "label": 0, "is_selected": 1, "text": "The National Institutes of Health (NIH) has awarded the National Cancer Institute (NCI) a grant of more than $1m to support research into human embryonic stem cells (HEp-2 cells) and their role in cancer and other diseases, as well as the development of new cancer therapies and new treatments for viral infections."}
{"qid": "530f685c329f5fcf1e000002", "original_text": "Borna disease virus (BDV) is a nonsegmented negative-strand RNA virus that belongs to the Mononegavirales. Unlike other animal viruses of this order, BDV replicates and transcribes in the nucleus of infected cells. Previous studies have shown that BDV uses RNA splicing machinery for its mRNA expression. In the present study, we identified spliced RNAs that use an alternative 3' splice site, SA3, in BDV-infected cell lines as well as infected animal brain cells. Transient transfection analysis of cDNA clones of BDV RNA revealed that although SA3 is a favorable splice site in mammalian cells, utilization of SA3 is negatively regulated in infected cells. This negative splicing activity of the SA3 site is regulated by a putative cis-acting region, the exon splicing suppressor (ESS), within the polymerase exon of BDV. The BDV ESS contains similar motifs to other known ESSs present in viral and cellular genes. Furthermore, our results indicated that a functional polyadenylation signal just upstream of the BDV ESS is also involved in the regulation of alternative splicing of BDV.", "label": 1, "is_selected": 0, "text": "Borna disease virus (BDV) is a nonsegmented negative-strand RNA virus that belongs to the Mononegavirales. Unlike other animal viruses of this order, BDV replicates and transcribes in the nucleus of infected cells. Previous studies have shown that BDV uses RNA splicing machinery for its mRNA expression. In the present study, we identified spliced RNAs that use an alternative 3' splice site, SA3, in BDV-infected cell lines as well as infected animal brain cells. Transient transfection analysis of cDNA clones of BDV RNA revealed that although SA3 is a favorable splice site in mammalian cells, utilization of SA3 is negatively regulated in infected cells. This negative splicing activity of the SA3 site is regulated by a putative cis-acting region, the exon splicing suppressor (ESS), within the polymerase exon of BDV. The BDV ESS contains similar motifs to other known ESSs present in viral and cellular genes. Furthermore, our results indicated that a functional polyadenylation signal just upstream of the BDV ESS is also involved in the regulation of alternative splicing of BDV."}
{"qid": "56d1f790f22319765a000001", "original_text": "Two types of epidermal growth factor receptor (EGFR) mutations in exon 19 and exon 21 (ex19del and L858R) are prevalent in lung cancer patients and sensitive to targeted EGFR inhibition. A resistance mutation in exon 20 (T790M) has been found to accompany drug treatment when patients relapse. These three mutations are valuable companion diagnostic biomarkers for guiding personalized treatment. Quantitative polymerase chain reaction (qPCR)-based methods have been widely used in the clinic by physicians to guide treatment decisions. The aim of this study was to evaluate the technical and clinical sensitivity and specificity of the droplet digital polymerase chain reaction (ddPCR) method in detecting the three EGFR mutations in patients with lung cancer.", "label": 1, "is_selected": 0, "text": "Two types of epidermal growth factor receptor (EGFR) mutations in exon 19 and exon 21 (ex19del and L858R) are prevalent in lung cancer patients and sensitive to targeted EGFR inhibition. A resistance mutation in exon 20 (T790M) has been found to accompany drug treatment when patients relapse. These three mutations are valuable companion diagnostic biomarkers for guiding personalized treatment. Quantitative polymerase chain reaction (qPCR)-based methods have been widely used in the clinic by physicians to guide treatment decisions. The aim of this study was to evaluate the technical and clinical sensitivity and specificity of the droplet digital polymerase chain reaction (ddPCR) method in detecting the three EGFR mutations in patients with lung cancer."}
{"qid": "61f5fb64882a024a1000001a", "original_text": "Uveal melanoma is a disease that is distinct from cutaneous melanoma, with a low tumor mutational burden and a 1-year overall survival of approximately 50% in patients with metastatic uveal melanoma. Data showing a proven overall survival benefit with a systemic treatment are lacking.", "label": 1, "is_selected": 0, "text": "Uveal melanoma is a disease that is distinct from cutaneous melanoma, with a low tumor mutational burden and a 1-year overall survival of approximately 50% in patients with metastatic uveal melanoma. Data showing a proven overall survival benefit with a systemic treatment are lacking."}
{"qid": "56c58f1b5795f9a73e000001", "original_text": "The origin of mitochondria is still a subject of scientific debate, but the current consensus is that they are thought to have evolved from a group of bacteria known as alpha-proteobacteria. Specifically, mitochondria are believed to have originated from a subset of alpha-proteobacteria known as the \"Archeabacteria.\" This theory is supported by the presence of many similarities between mitochondria and the Archeabacteria, such as their cellular structures and genetic makeup.", "label": 0, "is_selected": 1, "text": "The mitochondria, the energy-producing \"power plants\" in our cells, are the building blocks of our cells and play an important role in the regulation of our immune system and the production of energy from our fat cells and from our bone marrow."}
{"qid": "58a0c09778275d0c4a000052", "original_text": "There are several classes of orally administered drugs used to treat diabetes, including: 1. Biguanides: Biguanides, such as metformin, work by decreasing glucose production in the liver and increasing insulin sensitivity in the body. 2. Sulfonylureas: These drugs stimulate the release of insulin from the pancreas, which helps to lower blood sugar levels. Examples of sulfonylureas include glyburide and glipizide. 3. Meglitinides: Meglitinides, such as repaglinide, stimulate the release of insulin from the pancreas, particularly after meals. 4. Thiazolidinediones (TZDs): TZDs, such as pioglitazone, increase insulin sensitivity in the body, particularly in the muscles and liver. 5. Dipeptidyl peptidase-4 (DPP-4) inhibitors: These drugs work by reducing the breakdown of the hormone incretin, which helps to increase insulin secretion and improve glucose tolerance. Examples of DPP-4 inhibitors include sitagliptin and saxagliptin. 6. Glucagon-like peptide-1 (GLP-1) receptor agonists: These drugs work by mimicking the action of the hormone GLP-1, which stimulates the release of insulin and inhibits the release of glucagon, leading to improved glucose control. Examples of GLP-1 receptor agonists include exenatide and liraglutide. It's important to note that the specific class of drug prescribed depends on the type of diabetes, the severity of the condition, and other individual factors, such as patient comorbidities and medication history.", "label": 0, "is_selected": 1, "text": "Diabetes is a condition in which the body does not produce enough insulin, a hormone that controls blood sugar levels. Glucagon-like peptide-1 (GLP-1) receptor inc: These drugs work by mimicking the action of the hormone GLP-1, which stimulates the release of insulin and inhibits the production of glucagon, leading to improved glucose control., ie, a greater ability to regulate blood glucose levels, and a reduced risk of heart attack, stroke, and kidney disease., et al., 2013."}
{"qid": "5c72bd967c78d69471000078", "original_text": "Bacterial superantigens, a diverse family of toxins, induce an inflammatory cytokine storm that can lead to lethal shock. CD28 is a homodimer expressed on T cells that functions as the principal costimulatory ligand in the immune response through an interaction with its B7 coligands, yet we show here that to elicit inflammatory cytokine gene expression and toxicity, superantigens must bind directly into the dimer interface of CD28. Preventing access of the superantigen to CD28 suffices to block its lethality.", "label": 1, "is_selected": 0, "text": "Bacterial superantigens, a diverse family of toxins, induce an inflammatory cytokine storm that can lead to lethal shock. CD28 is a homodimer expressed on T cells that functions as the principal costimulatory ligand in the immune response through an interaction with its B7 coligands, yet we show here that to elicit inflammatory cytokine gene expression and toxicity, superantigens must bind directly into the dimer interface of CD28. Preventing access of the superantigen to CD28 suffices to block its lethality."}
{"qid": "5e55046fb761aafe09000004", "original_text": "Neurokinin B (NKB) and kisspeptin are obligate for normal gonadotropin secretion, and links between gonadotropin-releasing hormone (GnRH) pulsatility and vasomotor symptoms have been proposed. Using a selective NKB receptor (NK3R) antagonist, the role of NKB in the hypergonadotropic state in menopausal women was explored. Eleven postmenopausal women were administered the NK3R antagonist MLE4901 at 40 mg twice daily orally for 7 days. Ten-minute blood sampling for 8 h was performed before and on the last day of NK3R antagonist treatment for luteinising hormone (LH) pulsatility analysis with kisspeptin-10 (0.3 \u00b5g/kg i.v. bolus) administered at 6 h on both days. Hot flash frequency and severity were self-reported for 7 days before and during NK3R antagonist administration. LH fell from 29.3 \u00b1 4.1 to 24.4 \u00b1 3.8 IU/L (p < 0.05) after 7 days of NK3R antagonist treatment, with no change in follicle-stimulating hormone (FSH). Basal (non-pulsatile) LH secretion was reduced (549.0 \u00b1 70.8 vs. 366.1 \u00b1 92.1 IU/L/6", "label": 1, "is_selected": 0, "text": "Neurokinin B (NKB) and kisspeptin are obligate for normal gonadotropin secretion, and links between gonadotropin-releasing hormone (GnRH) pulsatility and vasomotor symptoms have been proposed. Using a selective NKB receptor (NK3R) antagonist, the role of NKB in the hypergonadotropic state in menopausal women was explored. Eleven postmenopausal women were administered the NK3R antagonist MLE4901 at 40 mg twice daily orally for 7 days. Ten-minute blood sampling for 8 h was performed before and on the last day of NK3R antagonist treatment for luteinising hormone (LH) pulsatility analysis with kisspeptin-10 (0.3 \u00b5g/kg i.v. bolus) administered at 6 h on both days. Hot flash frequency and severity were self-reported for 7 days before and during NK3R antagonist administration. LH fell from 29.3 \u00b1 4.1 to 24.4 \u00b1 3.8 IU/L (p < 0.05) after 7 days of NK3R antagonist treatment, with no change in follicle-stimulating hormone (FSH). Basal (non-pulsatile) LH secretion was reduced (549.0 \u00b1 70.8 vs. 366.1 \u00b1 92.1 IU/L/6"}
{"qid": "5339edd6d6d3ac6a34000061", "original_text": "The clinical, morphological, and electrocardiographical relevance of delayed enhancement (DE) in cardiac magnetic resonance (CMR) was studied in patients with hypertrophic cardiomyopathy (HCM). A total of 56 patients underwent both gadolinium-enhanced CMR and 12-lead electrocardiogram. The CMR demonstrated DE at the left ventricular (LV) wall in 39 patients. The patients with DE included more cases with dilated phase of HCM, higher New York Heart Association (NYHA) classes and incidence of ventricular tachyarrhythmias (VT), lower LV ejection fraction (LVEF) and mean LV wall thickness (WT), and a larger ratio of maximum to minimum LVWT. The QRS duration was prolonged and the QRS axis deviated toward left with increases in the DE volume (r = 0.58 and r = 0.41, P < .01).", "label": 1, "is_selected": 0, "text": "The clinical, morphological, and electrocardiographical relevance of delayed enhancement (DE) in cardiac magnetic resonance (CMR) was studied in patients with hypertrophic cardiomyopathy (HCM). A total of 56 patients underwent both gadolinium-enhanced CMR and 12-lead electrocardiogram. The CMR demonstrated DE at the left ventricular (LV) wall in 39 patients. The patients with DE included more cases with dilated phase of HCM, higher New York Heart Association (NYHA) classes and incidence of ventricular tachyarrhythmias (VT), lower LV ejection fraction (LVEF) and mean LV wall thickness (WT), and a larger ratio of maximum to minimum LVWT. The QRS duration was prolonged and the QRS axis deviated toward left with increases in the DE volume (r = 0.58 and r = 0.41, P < .01)."}
{"qid": "57279ef20fd6f91b68000018", "original_text": "Members of the dynein family, consisting of cytoplasmic and axonemal isoforms, are motors that move towards the minus ends of microtubules. Cytoplasmic dynein-1 (dynein-1) plays roles in mitosis and cellular cargo transport, and is implicated in viral infections and neurodegenerative diseases. Cytoplasmic dynein-2 (dynein-2) performs intraflagellar transport and is associated with human skeletal ciliopathies. Dyneins share a conserved motor domain that couples cycles of ATP hydrolysis with conformational changes to produce movement. Here we present the crystal structure of the human cytoplasmic dynein-2 motor bound to the ATP-hydrolysis transition state analogue ADP.vanadate.", "label": 1, "is_selected": 0, "text": "Members of the dynein family, consisting of cytoplasmic and axonemal isoforms, are motors that move towards the minus ends of microtubules. Cytoplasmic dynein-1 (dynein-1) plays roles in mitosis and cellular cargo transport, and is implicated in viral infections and neurodegenerative diseases. Cytoplasmic dynein-2 (dynein-2) performs intraflagellar transport and is associated with human skeletal ciliopathies. Dyneins share a conserved motor domain that couples cycles of ATP hydrolysis with conformational changes to produce movement. Here we present the crystal structure of the human cytoplasmic dynein-2 motor bound to the ATP-hydrolysis transition state analogue ADP.vanadate."}
{"qid": "60805e204e6a4cf630000002", "original_text": "Kleefstra syndrome is caused by mutations in the CHRNA7 gene, which codes for the alpha-7 nicotinic acetylcholine receptor. This receptor is involved in the regulation of synaptic plasticity and neural development. The mutations lead to a disruption in the normal functioning of the receptor, resulting in cognitive impairments, motor delays, and other neurological features characteristic of Kleefstra syndrome.", "label": 0, "is_selected": 0, "text": "Kleefstra syndrome is caused by mutations in the CHRNA7 gene, which codes for the alpha-7 nicotinic acetylcholine receptor. This receptor is involved in the regulation of synaptic plasticity and neural development. The mutations lead to a disruption in the normal functioning of the receptor, resulting in cognitive impairments, motor delays, and other neurological features characteristic of Kleefstra syndrome."}
{"qid": "601ff4021cb411341a000075", "original_text": "Gregor Mendel passed away on January 6, 1884, in Brno, Austria-Hungary (now Czech Republic). He was 67 years old at the time of his death. Mendel's work on genetics and the laws of inheritance, which he first published in 1865, were largely forgotten for many years after his death, but were rediscovered in the 1900s and have since become a fundamental part of modern genetics.", "label": 0, "is_selected": 0, "text": "Gregor Mendel passed away on January 6, 1884, in Brno, Austria-Hungary (now Czech Republic). He was 67 years old at the time of his death. Mendel's work on genetics and the laws of inheritance, which he first published in 1865, were largely forgotten for many years after his death, but were rediscovered in the 1900s and have since become a fundamental part of modern genetics."}
{"qid": "517a8ce98ed59a060a000045", "original_text": "Recurrences develop in up to 20-50% of patients with acute pericarditis. Although different causes of recurrent pericarditis have been identified, the etiology remains obscure in most cases which are therefore labelled as idiopathic. Autoinflammatory syndromes include familial Mediterranean fever (FMF), due to mutations in the MEFV gene, and tumor necrosis factor receptor-associated periodic syndrome (TRAPS), due to mutations in the TNFRSF1A gene. Recurrent pericarditis is a common feature of both conditions, but it rarely occurs alone. Colchicine is the standard treatment for FMF, while patients with TRAPS do not respond to colchicine therapy, but are responsive to corticosteroids.", "label": 1, "is_selected": 0, "text": "Recurrences develop in up to 20-50% of patients with acute pericarditis. Although different causes of recurrent pericarditis have been identified, the etiology remains obscure in most cases which are therefore labelled as idiopathic. Autoinflammatory syndromes include familial Mediterranean fever (FMF), due to mutations in the MEFV gene, and tumor necrosis factor receptor-associated periodic syndrome (TRAPS), due to mutations in the TNFRSF1A gene. Recurrent pericarditis is a common feature of both conditions, but it rarely occurs alone. Colchicine is the standard treatment for FMF, while patients with TRAPS do not respond to colchicine therapy, but are responsive to corticosteroids."}
{"qid": "5880e089c872c9556500000b", "original_text": "Romosozumab, a monoclonal antibody that binds sclerostin, increases bone formation and decreases bone resorption. We enrolled 7180 postmenopausal women who had a T score of -2.5 to -3.5 at the total hip or femoral neck. Patients were randomly assigned to receive subcutaneous injections of romosozumab (at a dose of 210 mg) or placebo monthly for 12 months; thereafter, patients in each group received denosumab for 12 months, at a dose of 60 mg, administered subcutaneously every 6 months. The coprimary end points were the cumulative incidences of new vertebral fractures at 12 months and 24 months.", "label": 1, "is_selected": 0, "text": "Romosozumab, a monoclonal antibody that binds sclerostin, increases bone formation and decreases bone resorption. We enrolled 7180 postmenopausal women who had a T score of -2.5 to -3.5 at the total hip or femoral neck. Patients were randomly assigned to receive subcutaneous injections of romosozumab (at a dose of 210 mg) or placebo monthly for 12 months; thereafter, patients in each group received denosumab for 12 months, at a dose of 60 mg, administered subcutaneously every 6 months. The coprimary end points were the cumulative incidences of new vertebral fractures at 12 months and 24 months."}
{"qid": "601d72e61cb411341a000039", "original_text": "Hutchinson-Gilford progeria syndrome is an autosomal dominant, rare, fatal pediatric segmental premature aging disease. Cardiovascular and cerebrovascular diseases constitute the major cause of morbidity and mortality. Patients with the syndrome and severe aortic valve stenosis have been described in the literature, and for all of them a strategy of conservative management has been followed. We describe the first successful treatment of a 23-year-old Hutchinson-Gilford progeria syndrome patient with severe aortic stenosis who underwent transapical transcatheter aortic valve replacement.", "label": 1, "is_selected": 0, "text": "Hutchinson-Gilford progeria syndrome is an autosomal dominant, rare, fatal pediatric segmental premature aging disease. Cardiovascular and cerebrovascular diseases constitute the major cause of morbidity and mortality. Patients with the syndrome and severe aortic valve stenosis have been described in the literature, and for all of them a strategy of conservative management has been followed. We describe the first successful treatment of a 23-year-old Hutchinson-Gilford progeria syndrome patient with severe aortic stenosis who underwent transapical transcatheter aortic valve replacement."}
{"qid": "530cf4d5e2bfff940c000004", "original_text": "There are several common methods for gene prioritization analysis in bioinformatics and computational biology. These include: 1. Expression profiling: Compiling gene expression data from multiple samples to identify differentially expressed genes. 2. Genetic association studies: Analyzing genetic variants associated with a particular disease or trait to identify potential drug targets. 3. Systems biology: Using a comprehensive approach to model biological systems and identify potential drug targets. 4. Network analysis: Examining the interactions between genes and proteins to identify key regulators and potential drug targets. 5. Text mining: Analyzing large amounts of biomedical literature to identify potential drug targets and their mechanisms of action. 6. Machine learning: Using computational algorithms to identify potential drug targets based on large datasets and complex networks. It is important to note that the choice of method depends on the specific research question and the availability of data.", "label": 0, "is_selected": 0, "text": "There are several common methods for gene prioritization analysis in bioinformatics and computational biology. These include: 1. Expression profiling: Compiling gene expression data from multiple samples to identify differentially expressed genes. 2. Genetic association studies: Analyzing genetic variants associated with a particular disease or trait to identify potential drug targets. 3. Systems biology: Using a comprehensive approach to model biological systems and identify potential drug targets. 4. Network analysis: Examining the interactions between genes and proteins to identify key regulators and potential drug targets. 5. Text mining: Analyzing large amounts of biomedical literature to identify potential drug targets and their mechanisms of action. 6. Machine learning: Using computational algorithms to identify potential drug targets based on large datasets and complex networks. It is important to note that the choice of method depends on the specific research question and the availability of data."}
{"qid": "5c531e887e3cb0e231000018", "original_text": "Yes, ultraconserved enhancers play a crucial role in normal development. These enhancers are located far upstream of gene promoters and are highly conserved across species, indicating their functional importance. Studies have shown that disrupting ultraconserved enhancers can lead to developmental defects and disease, highlighting their essential role in normal development. For example, mutations in ultraconserved enhancers have been linked to neural tube defects, heart defects, and other developmental disorders. Therefore, ultraconserved enhancers are considered vital regulatory elements that contribute to the proper development and function of tissues and organs.", "label": 0, "is_selected": 1, "text": "Ultraconserved enhancers play a crucial role in normal development and have been linked to developmental defects and disease, highlighting their essential role in the proper development and function of tissues and organs, as well as their importance in the regulation of gene expression."}
{"qid": "5c6d88257c78d6947100003d", "original_text": "CGmapTools is a software tool designed to aid in the interpretation and visualization of chromosomal abnormalities, particularly those detected through karyotype analysis. It provides a comprehensive graphical representation of the chromosomal structure, enabling healthcare professionals to identify and characterize various types of chromosomal abnormalities, including numerical and structural changes. CGmapTools offers a range of features, including the ability to create detailed maps of chromosomal segments, identify and analyze specific genetic markers, and visualize the distribution of chromosomal abnormalities across different cell lines. The tool also allows users to compare the results of different karyotype analyses, facilitating the identification of recurrent chromosomal abnormalities. In addition, CGmapTools provides tools for the analysis of fluorescence in situ hybridization (FISH) data, enabling healthcare professionals to identify and interpret specific genetic markers associated with chromosomal abnormalities. The software can also be used to create educational materials, such as chromosomal maps and diagrams, to help patients and healthcare professionals understand and interpret chromosomal abnormalities. Overall, CGmapTools is a valuable resource for healthcare professionals involved in the diagnosis and management of chromosomal abnormalities, providing a user-friendly platform for the interpretation and visualization of complex genetic data.", "label": 0, "is_selected": 1, "text": "CGmapTools is a software tool designed to aid in the interpretation and interpretation of chromosomal abnormalities, particularly those detected through karyotype analysis.CGmapTools offers a range of features, including the ability to create detailed maps of chromosomal segments, identify and analyze specific genetic markers, and visualize the distribution of chromosome abnormalities across different cell lines.CGMapTools provides tools for the analysis of fluorescence in situ (FISH) data, enabling healthcare professionals to identify and interpretspecific genetic markers associated with chromosomal abnormalities."}
{"qid": "589a246078275d0c4a00002a", "original_text": "The TEMSO (Treatment of MS Orbis) trial was a phase III randomized, double-blind, placebo-controlled clinical trial conducted to evaluate the safety and efficacy of glatiramer acetate in the treatment of multiple sclerosis (MS). The trial was conducted between 1993 and 1997, and involved participants with relapsing-remitting MS. The study found that glatiramer acetate was effective in reducing the annualized relapse rate (ARR) in these participants, compared to placebo. The drug was approved by the U.S. Food and Drug Administration (FDA) based on the results of this trial in 1999, and is now available as an FDA-approved treatment for MS.", "label": 0, "is_selected": 1, "text": "The results of the TEMSO trial were published in the Journal of the American Academy of Neurology (JAA) in May 1998.<n> The TEM SO (Treatment of MS Orbis) trial was a phase III randomized, double-blind, placebo-controlled clinical trial conducted to evaluate the safety and efficacy of glatiramer acetate in the treatment of multiple sclerosis (MS)."}
{"qid": "5e44baaa48dab47f2600001a", "original_text": "Pyrotinib is a small molecule inhibitor that targets and inhibits various kinases, including: 1. ALK (anaplastic lymphoma kinase): Pyrotinib selectively inhibits ALK fusions with EML4 or KIF50, which are commonly found in non-small cell lung cancer (NSCLC). 2. ROS1 (ros1): Pyrotinib inhibits ROS1 fusions with KIF50 and EML4, also found in NSCLC. 3. AKT1: Pyrotinib shows weak inhibition of AKT1, which is involved in cell survival and proliferation. 4. MAP2K1/2 (mitogen-activated protein kinase kinase 1 and 2): Pyrotinib inhibits MAP2K1/2, which activates downstream signaling pathways, including the MAPK/ERK pathway. 5. CDK (cyclin-dependent kinase): Pyrotinib inhibits CDK1, 2, and 4, which are involved in regulating the cell cycle. It's important to note that the specificity and potency of Pyrotinib towards these kinases may vary depending on the context and specific molecular mechanism of each kinase.", "label": 0, "is_selected": 0, "text": "Pyrotinib is a small molecule inhibitor that targets and inhibits various kinases, including: 1. ALK (anaplastic lymphoma kinase): Pyrotinib selectively inhibits ALK fusions with EML4 or KIF50, which are commonly found in non-small cell lung cancer (NSCLC). 2. ROS1 (ros1): Pyrotinib inhibits ROS1 fusions with KIF50 and EML4, also found in NSCLC. 3. AKT1: Pyrotinib shows weak inhibition of AKT1, which is involved in cell survival and proliferation. 4. MAP2K1/2 (mitogen-activated protein kinase kinase 1 and 2): Pyrotinib inhibits MAP2K1/2, which activates downstream signaling pathways, including the MAPK/ERK pathway. 5. CDK (cyclin-dependent kinase): Pyrotinib inhibits CDK1, 2, and 4, which are involved in regulating the cell cycle. It's important to note that the specificity and potency of Pyrotinib towards these kinases may vary depending on the context and specific molecular mechanism of each kinase."}
{"qid": "553babc0f321868558000007", "original_text": "This study examines the microbiota associated with the progression of experimental peri-implantitis and periodontitis induced concurrently in partially edentulous adult monkeys. Root-form and plate-form implants with fixed prosthesis in place for at least 12 months and their corresponding opposite molar teeth were ligated for 6 months. The microbiota in plaque around these ligated dental implants and molars were studied at 0, 1, 2, 3, and 6 months post-ligation. Plaque samples were analyzed by dark-field microscopy and selective and non-selective culture. Putative periodontal pathogens were detected as a major component of the microbiota cultured from plaque samples obtained from experimental peri-implantitis sites. Overall, the types and relative proportions of putative periodontal pathogens in plaque associated with ligature-induced peri-implantitis and ligature-induced periodontitis were similar. Only levels of anaerobic Actinomyces and spirochetes were significantly different between both sites. Spirochete levels were significantly higher at peri-implantitis sites when compared with levels at periodontitis sites after 6 months, and spirochete levels increased significantly between 0 and 6 months post-ligation at implant sites. Levels of spirochetes correlated significantly with probing depth and bone loss at peri-implantitis sites. Overall, Actinomyces levels were higher at periodontitis sites. Porphyromonas species were not detected continuously as part of the peri-implantitis microbiota. In conclusion, this study finds that the microbiota associated with the progression of experimental peri-implantitis and periodontitis occurring concurrently in partially edentulous mouths are similar.", "label": 1, "is_selected": 0, "text": "This study examines the microbiota associated with the progression of experimental peri-implantitis and periodontitis induced concurrently in partially edentulous adult monkeys. Root-form and plate-form implants with fixed prosthesis in place for at least 12 months and their corresponding opposite molar teeth were ligated for 6 months. The microbiota in plaque around these ligated dental implants and molars were studied at 0, 1, 2, 3, and 6 months post-ligation. Plaque samples were analyzed by dark-field microscopy and selective and non-selective culture. Putative periodontal pathogens were detected as a major component of the microbiota cultured from plaque samples obtained from experimental peri-implantitis sites. Overall, the types and relative proportions of putative periodontal pathogens in plaque associated with ligature-induced peri-implantitis and ligature-induced periodontitis were similar. Only levels of anaerobic Actinomyces and spirochetes were significantly different between both sites. Spirochete levels were significantly higher at peri-implantitis sites when compared with levels at periodontitis sites after 6 months, and spirochete levels increased significantly between 0 and 6 months post-ligation at implant sites. Levels of spirochetes correlated significantly with probing depth and bone loss at peri-implantitis sites. Overall, Actinomyces levels were higher at periodontitis sites. Porphyromonas species were not detected continuously as part of the peri-implantitis microbiota. In conclusion, this study finds that the microbiota associated with the progression of experimental peri-implantitis and periodontitis occurring concurrently in partially edentulous mouths are similar."}
{"qid": "5c8d0a980101eac870000008", "original_text": "Although high risk HPVs are associated with an increased risk of prostate cancer it is not known if they have a causal role. The purpose of this study is to investigate the potential role of human papilloma viruses (HPVs) in prostate cancer. The aims are (i) to investigate the presence and confirm the identity of high risk HPVs in benign prostate tissues prior to the development of HPV positive prostate cancer in the same patients, and (ii) to determine if HPVs are biologically active. We used polymerase chain reaction (PCR) to identify HPVs in specimens from 52 Australian men with benign prostate biopsies who 1 to 10 years later developed prostate cancer. Immunohistochemistry (IHC) was used to assess the expression of HPV E7 oncoproteins, cytokeratin and prostate specific antigen (PSA). We used RNASeq data from The Cancer Genome Atlas (TCGA) to identify possible HPV RNA sequences in prostate cancer. HPV screening using standard PCR was conducted on 28 of the 52 sets of benign and later prostate cancers. HPV L1 genes were identified in 13 (46%) benign and 8 (29%) of 28 later prostate cancers in the same patients. HPV E7 genes were identified in 23 (82%) benign and 19 (68%) of 28 subsequent prostate cancers in the same patients. The same HPV types were present in both the benign and subsequent prostate cancers in 9 sets of specimens. HPV type 16 was identified in 15% of benign and 3% of prostate cancers. HPV type 18 was identified in 26% of benign and 16% of prostate cancers. Small numbers of HPV types 45, 47, 76 and 115 were also identified. High confidence RNA-Seq evidence for high risk HPV types 16 and 18 was identified in 12 (2%) of the 502 TCGA prostate cancer transcriptomes. High risk HPV E7 oncoprotein was positively expressed in 23 (82%) of 28 benign prostate specimens but only in 8 (29%) of 28 of the later prostate cancer specimens.", "label": 1, "is_selected": 0, "text": "Although high risk HPVs are associated with an increased risk of prostate cancer it is not known if they have a causal role. The purpose of this study is to investigate the potential role of human papilloma viruses (HPVs) in prostate cancer. The aims are (i) to investigate the presence and confirm the identity of high risk HPVs in benign prostate tissues prior to the development of HPV positive prostate cancer in the same patients, and (ii) to determine if HPVs are biologically active. We used polymerase chain reaction (PCR) to identify HPVs in specimens from 52 Australian men with benign prostate biopsies who 1 to 10 years later developed prostate cancer. Immunohistochemistry (IHC) was used to assess the expression of HPV E7 oncoproteins, cytokeratin and prostate specific antigen (PSA). We used RNASeq data from The Cancer Genome Atlas (TCGA) to identify possible HPV RNA sequences in prostate cancer. HPV screening using standard PCR was conducted on 28 of the 52 sets of benign and later prostate cancers. HPV L1 genes were identified in 13 (46%) benign and 8 (29%) of 28 later prostate cancers in the same patients. HPV E7 genes were identified in 23 (82%) benign and 19 (68%) of 28 subsequent prostate cancers in the same patients. The same HPV types were present in both the benign and subsequent prostate cancers in 9 sets of specimens. HPV type 16 was identified in 15% of benign and 3% of prostate cancers. HPV type 18 was identified in 26% of benign and 16% of prostate cancers. Small numbers of HPV types 45, 47, 76 and 115 were also identified. High confidence RNA-Seq evidence for high risk HPV types 16 and 18 was identified in 12 (2%) of the 502 TCGA prostate cancer transcriptomes. High risk HPV E7 oncoprotein was positively expressed in 23 (82%) of 28 benign prostate specimens but only in 8 (29%) of 28 of the later prostate cancer specimens."}
{"qid": "55031628e9bde69634000024", "original_text": "Pheochromocytomas (PCCs) and paragangliomas (PGLs) are rare neuroendocrine tumors of the adrenal glands and the sympathetic and parasympathetic paraganglia. They can occur sporadically or as a part of different hereditary tumor syndromes. About 30% of PCCs and PGLs are currently believed to be caused by germline mutations and several novel susceptibility genes have recently been discovered. The clinical presentation, including localization, malignant potential, and age of onset, varies depending on the genetic background of the tumors. By reviewing more than 1700 reported cases of hereditary PCC and PGL, a thorough summary of the genetics and clinical features of these tumors is given, both as part of the classical syndromes such as multiple endocrine neoplasia type 2 (MEN2), von Hippel-Lindau disease, neurofibromatosis type 1, and succinate dehydrogenase-related PCC-PGL and within syndromes associated with a smaller fraction of PCCs/PGLs, such as Carney triad, Carney-Stratakis syndrome, and MEN1. The review also covers the most recently discovered susceptibility genes including KIF1B\u03b2, EGLN1/PHD2, SDHAF2, TMEM127, SDHA, and MAX, as well as a comparison with the sporadic form. Further, the latest advances in elucidating the cellular pathways involved in PCC and PGL development are discussed in detail.", "label": 1, "is_selected": 0, "text": "Pheochromocytomas (PCCs) and paragangliomas (PGLs) are rare neuroendocrine tumors of the adrenal glands and the sympathetic and parasympathetic paraganglia. They can occur sporadically or as a part of different hereditary tumor syndromes. About 30% of PCCs and PGLs are currently believed to be caused by germline mutations and several novel susceptibility genes have recently been discovered. The clinical presentation, including localization, malignant potential, and age of onset, varies depending on the genetic background of the tumors. By reviewing more than 1700 reported cases of hereditary PCC and PGL, a thorough summary of the genetics and clinical features of these tumors is given, both as part of the classical syndromes such as multiple endocrine neoplasia type 2 (MEN2), von Hippel-Lindau disease, neurofibromatosis type 1, and succinate dehydrogenase-related PCC-PGL and within syndromes associated with a smaller fraction of PCCs/PGLs, such as Carney triad, Carney-Stratakis syndrome, and MEN1. The review also covers the most recently discovered susceptibility genes including KIF1B\u03b2, EGLN1/PHD2, SDHAF2, TMEM127, SDHA, and MAX, as well as a comparison with the sporadic form. Further, the latest advances in elucidating the cellular pathways involved in PCC and PGL development are discussed in detail."}
{"qid": "6200879ac9dfcb9c09000021", "original_text": "The Canadian C-Spine Rule (CCR) is a clinical decision rule used to determine the likelihood of a cervical spine injury in patients who have been trauma or assault victims. The rule takes into account several factors, including age, mechanism of injury, consciousness level, and certain physical signs. The CCR is used to identify patients who are at high risk of having a cervical spine injury and to determine whether immobilization is necessary. The rule has been widely studied and has been shown to be a reliable and accurate tool for evaluating patients with potential cervical spine injuries. It is commonly used in emergency departments and trauma centers to guide clinical decision-making and to improve patient outcomes.", "label": 0, "is_selected": 0, "text": "The Canadian C-Spine Rule (CCR) is a clinical decision rule used to determine the likelihood of a cervical spine injury in patients who have been trauma or assault victims. The rule takes into account several factors, including age, mechanism of injury, consciousness level, and certain physical signs. The CCR is used to identify patients who are at high risk of having a cervical spine injury and to determine whether immobilization is necessary. The rule has been widely studied and has been shown to be a reliable and accurate tool for evaluating patients with potential cervical spine injuries. It is commonly used in emergency departments and trauma centers to guide clinical decision-making and to improve patient outcomes."}
{"qid": "5e323d79fbd6abf43b000058", "original_text": "Secondary glioblastoma is a rare but possible complication of brain irradiation. Irradiation can cause damage to the brain tissue, leading to the development of new cancer cells. However, the risk of developing secondary glioblastoma is low, and the likelihood of this happening is even lower when the radiation therapy is targeted to the specific area of the brain affected by the original tumor. Studies have shown that the risk of secondary glioblastoma after brain irradiation is approximately 1-5% depending on the dose and fractionation of radiation. The risk is higher when the radiation is delivered to a larger area of the brain, and when the radiation is given at higher doses. It's important to note that secondary glioblastoma is a distinct entity from the original primary glioblastoma, and it has its own characteristic clinical and biological features. Therefore, the diagnosis and treatment of secondary glioblastoma may differ from the original primary glioblastoma. In summary, while brain irradiation can increase the risk of secondary glioblastoma, the risk is low, and the likelihood of this happening is even lower when the radiation therapy is targeted to the specific area of the brain affected by the original tumor.", "label": 0, "is_selected": 1, "text": "The risk of developing secondary glioblastoma after brain irradiation is low, and the likelihood of this happening is even lower when the radiation therapy is targeted to the specific area of the brain affected by the original tumor, according to a new study from the University of Texas MD Anderson Cancer Center in Houston, Texas, USA, and published in the Journal of the American Society of Radiation Oncology (JARDO) (doi: 10.1021/jARDO.2016.027).<n> In summary, while brain irradiation can increase the risk of secondary glioblastoma, the risk is low and the chance of this HAPPENing is even Lower when the Radiation Therapy is Targetted to the Specific Area of the BrainAffected by the Original tumor."}
{"qid": "5e5409776d0a277941000051", "original_text": "AZD0530 is an inhibitor of the enzyme Bruton's tyrosine kinase (BTK). BTK is a key component of the B-cell receptor signaling pathway and plays a crucial role in the activation and differentiation of B cells, including mature B cells and plasma cells. By inhibiting BTK, AZD0530 can reduce the activation and proliferation of B cells, which can be beneficial in the treatment of certain B-cell malignancies, such as chronic lymphocytic leukemia (CLL) and Waldenstr\u00f6m macroglobulinemia.", "label": 0, "is_selected": 1, "text": "The US Food and Drug Administration (FDA) has granted orphan drug status to AZD0530 for the treatment of B-cell lymphomas and Waldenstrm macroemia, two forms of bone marrow cancer, for which there are no approved therapies."}
{"qid": "51766e438ed59a060a000031", "original_text": "Selenocysteine (Sec) is co-translationally incorporated into selenoproteins at a reprogrammed UGA codon. In mammals, this requires a dedicated machinery comprising a stem-loop structure in the 3' UTR RNA (the SECIS element) and the specific SECIS Binding Protein 2. In this report, disorder-prediction methods and several biophysical techniques showed that ca. 70% of the SBP2 sequence is disordered, whereas the RNA binding domain appears to be folded and functional. These results are consistent with a recent report on the role of the Hsp90 chaperone for the folding of SBP2 and other functionally unrelated proteins bearing an RNA binding domain homologous to SBP2.", "label": 1, "is_selected": 0, "text": "Selenocysteine (Sec) is co-translationally incorporated into selenoproteins at a reprogrammed UGA codon. In mammals, this requires a dedicated machinery comprising a stem-loop structure in the 3' UTR RNA (the SECIS element) and the specific SECIS Binding Protein 2. In this report, disorder-prediction methods and several biophysical techniques showed that ca. 70% of the SBP2 sequence is disordered, whereas the RNA binding domain appears to be folded and functional. These results are consistent with a recent report on the role of the Hsp90 chaperone for the folding of SBP2 and other functionally unrelated proteins bearing an RNA binding domain homologous to SBP2."}
{"qid": "6200839bc9dfcb9c0900001d", "original_text": "A common predictive measure of postoperative nausea and vomiting (PONV) is the Apfel score. Although tested in many different operations, it has not been tested extensively in oral and maxillofacial surgery (OMFS). This study was designed to determine whether it applied to OMFS and whether there were other factors in this population that would improve its accuracy. A retrospective chart review was carried out on a randomly selected group of patients who had OMFS during a 10-month period. In addition to the Apfel score risk factors, PONV data were collected in relation to type of anesthetic induction and maintenance, type of surgery, use of maxillomandibular fixation (MMF), use of opioids, and anesthesia and surgery times. One-hundred and sixty-seven patients were included in the analysis; 24% had nausea and 11% had nausea and vomiting. Patients who had orthognathic or temporomandibular joint surgery had the highest rate of PONV. Young age, anesthesia and operation time, and use of MMF were also associated with increased PONV. Adding age, MMF or limited postoperative mouth opening, and surgery type to the Apfel score should make it more predictive in OMFS.", "label": 1, "is_selected": 0, "text": "A common predictive measure of postoperative nausea and vomiting (PONV) is the Apfel score. Although tested in many different operations, it has not been tested extensively in oral and maxillofacial surgery (OMFS). This study was designed to determine whether it applied to OMFS and whether there were other factors in this population that would improve its accuracy. A retrospective chart review was carried out on a randomly selected group of patients who had OMFS during a 10-month period. In addition to the Apfel score risk factors, PONV data were collected in relation to type of anesthetic induction and maintenance, type of surgery, use of maxillomandibular fixation (MMF), use of opioids, and anesthesia and surgery times. One-hundred and sixty-seven patients were included in the analysis; 24% had nausea and 11% had nausea and vomiting. Patients who had orthognathic or temporomandibular joint surgery had the highest rate of PONV. Young age, anesthesia and operation time, and use of MMF were also associated with increased PONV. Adding age, MMF or limited postoperative mouth opening, and surgery type to the Apfel score should make it more predictive in OMFS."}
{"qid": "61f5f580882a024a10000017", "original_text": "Liver fibrosis is the excessive expression and accumulation of extracellular matrix proteins in the liver. Fibrotic scarring occurs as the consequence of chronic injury and inflammation. While the successful treatment of hepatitis B and C reduced the burden of liver disease related to viral hepatitis, non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) are nowadays the leading causes of hepatic fibrosis worldwide. Although basic research activities have significantly advanced our understanding of the molecular disease pathogenesis, the present therapeutic options for fibrosis are still limited. In advanced disease stages, liver transplantation often remains the only curative treatment. This highlights the necessity of preventive strategies to avoid complications of fibrosis, particularly cirrhosis, portal hypertension and liver cancer. Lifestyle modifications (weight loss, exercise, healthy diet) are the basis for prevention and treatment of NAFLD-associated fibrosis. In the present review, we discuss recent advances in antifibrotic prevention and therapy. In particular, we review the current concepts for antifibrotic drug candidates in the treatment of NAFLD and NASH.", "label": 1, "is_selected": 0, "text": "Liver fibrosis is the excessive expression and accumulation of extracellular matrix proteins in the liver. Fibrotic scarring occurs as the consequence of chronic injury and inflammation. While the successful treatment of hepatitis B and C reduced the burden of liver disease related to viral hepatitis, non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) are nowadays the leading causes of hepatic fibrosis worldwide. Although basic research activities have significantly advanced our understanding of the molecular disease pathogenesis, the present therapeutic options for fibrosis are still limited. In advanced disease stages, liver transplantation often remains the only curative treatment. This highlights the necessity of preventive strategies to avoid complications of fibrosis, particularly cirrhosis, portal hypertension and liver cancer. Lifestyle modifications (weight loss, exercise, healthy diet) are the basis for prevention and treatment of NAFLD-associated fibrosis. In the present review, we discuss recent advances in antifibrotic prevention and therapy. In particular, we review the current concepts for antifibrotic drug candidates in the treatment of NAFLD and NASH."}
{"qid": "52f3a9ef2059c6d71c000012", "original_text": "Several studies have demonstrated that cell transplantation was effective for the therapy of myocardial infarction. However, little care has been taken for the blood supply indispensable to cell transplantation. This study is an investigation to evaluate the feasibility of in advance angiogenesis by gelatin microspheres incorporating basic fibroblast growth factor (bFGF) for the transplantation therapy of cardiomyocytes with an ischemic cardiomyopathy model. Rats with myocardial infarction received the intramuscular injection of culture medium (Control), or that containing fetal cardiomyocytes (TX) or gelatin microspheres incorporating bFGF (FGF), and gelatin microspheres incorporating bFGF plus fetal cardiomyocytes 1 week later (FGF-TX). The left ventricle (LV) function of rat hearts was assessed by echocardiography and cardiac catheterization 4 weeks later.", "label": 1, "is_selected": 0, "text": "Several studies have demonstrated that cell transplantation was effective for the therapy of myocardial infarction. However, little care has been taken for the blood supply indispensable to cell transplantation. This study is an investigation to evaluate the feasibility of in advance angiogenesis by gelatin microspheres incorporating basic fibroblast growth factor (bFGF) for the transplantation therapy of cardiomyocytes with an ischemic cardiomyopathy model. Rats with myocardial infarction received the intramuscular injection of culture medium (Control), or that containing fetal cardiomyocytes (TX) or gelatin microspheres incorporating bFGF (FGF), and gelatin microspheres incorporating bFGF plus fetal cardiomyocytes 1 week later (FGF-TX). The left ventricle (LV) function of rat hearts was assessed by echocardiography and cardiac catheterization 4 weeks later."}
{"qid": "54d670163706e8952800000f", "original_text": "There is a growing body of research into the genetic factors that contribute to adolescent idiopathic scoliosis (AIS). While the exact genetic causes of AIS are still not fully understood, several genes have been associated with an increased risk of developing the condition. One of the most well-established genes associated with AIS is the gene encoding the protein collagen type II (COLIA2). Mutations in this gene can lead to an overproduction of collagen II, which can contribute to the development of scoliosis. Other genes that have been linked to AIS include the genes encoding collagen type I (COL1A1 and COL1A2), fibulin-5 (FBLN5), and osteoporin (OPN). It's important to note that while these genes have been associated with AIS, the exact mechanisms by which they contribute to the development of the condition are not yet fully understood. Additionally, many people with AIS do not have any known genetic mutations, highlighting the complexity of this condition. In summary, while the genetic causes of AIS are not fully understood, several genes have been identified as being associated with an increased risk of developing the condition. Further research is needed to elucidate the underlying genetic mechanisms and to identify potential therapeutic targets for the treatment of AIS.", "label": 0, "is_selected": 1, "text": "This study aims to shed light on the genetic factors that contribute to the development of adolescent idiopathic scoliosis, and to identify potential therapeutic targets for the treatment of the condition, as well as to highlight the complexity of this condition and the need for further research into the underlying genetic mechanisms by which they contribute to this condition, and the potential treatment targets that may be available to those with this condition in the near future., according to researchers at the University of Queensland in Brisbane., Australia., in collaboration with the Queensland University of Technology (QUT)."}
{"qid": "5358e067f1005d6b5800000b", "original_text": "Coordination of protrusive and contractile cell-matrix contacts is important for cell adhesion and migration, but the mechanisms involved are not well understood. We report an unexpected direct association between fascin, an actin-bundling component of filopodia, microspikes and lamellipodial ribs, and protein kinase Calpha (PKCalpha), a regulator of focal adhesions. The association is detectable by protein-protein binding in vitro, by coimmunoprecipitation from cell extracts, and in live cells as fluorescence resonance energy transfer detected by fluorescence imaging lifetime microscopy. The interaction is physiologically regulated by the extracellular matrix context of cells, depends on activation of PKCalpha and is mediated by the C1B domain of PKCalpha. Strikingly, a fascin mutant, fascin S39D, associates constitutively with PKCalpha. Through use of a newly developed set of membrane-permeable peptides that separately inhibit either fascin/PKCalpha or fascin/actin binding, we have uncovered that specific blockade of the fascin/PKCalpha interaction increases cell migration on fibronectin in conjunction with increased fascin protrusions and remodeling of focal adhesions. These results identify the fascin-PKCalpha interaction as an important novel intersection in the regulation and networking of cell-matrix contacts.", "label": 1, "is_selected": 0, "text": "Coordination of protrusive and contractile cell-matrix contacts is important for cell adhesion and migration, but the mechanisms involved are not well understood. We report an unexpected direct association between fascin, an actin-bundling component of filopodia, microspikes and lamellipodial ribs, and protein kinase Calpha (PKCalpha), a regulator of focal adhesions. The association is detectable by protein-protein binding in vitro, by coimmunoprecipitation from cell extracts, and in live cells as fluorescence resonance energy transfer detected by fluorescence imaging lifetime microscopy. The interaction is physiologically regulated by the extracellular matrix context of cells, depends on activation of PKCalpha and is mediated by the C1B domain of PKCalpha. Strikingly, a fascin mutant, fascin S39D, associates constitutively with PKCalpha. Through use of a newly developed set of membrane-permeable peptides that separately inhibit either fascin/PKCalpha or fascin/actin binding, we have uncovered that specific blockade of the fascin/PKCalpha interaction increases cell migration on fibronectin in conjunction with increased fascin protrusions and remodeling of focal adhesions. These results identify the fascin-PKCalpha interaction as an important novel intersection in the regulation and networking of cell-matrix contacts."}
{"qid": "54dfbed11388e8454a000008", "original_text": "LINE-1 (Long Interspersed Nuclear Element-1) and Alu (Alu Element) are two types of retrotransposons, which are mobile genetic elements that can insert themselves into new locations within the genome. While LINE-1 and Alu are normally inactive, they can be induced to retrotranspose through the binding of specific proteins. The primary protein that induces LINE-1 inhibition is the DNA-binding protein, KRAB-ZNF (Kr\u00fcppel-associated box zinc finger protein). KRAB-ZNF binds to specific DNA sequences and recruits other proteins that suppress LINE-1 retrotransposition. Additionally, the protein CTCF (CCCTC-binding factor) has been shown to inhibit Alu retrotransposition by binding to the Alu repeat and preventing its retrotransposition. Other proteins, such as SUZ12 and SUZ12-like proteins, have also been implicated in the regulation of LINE-1 and Alu retrotransposition.", "label": 0, "is_selected": 0, "text": "LINE-1 (Long Interspersed Nuclear Element-1) and Alu (Alu Element) are two types of retrotransposons, which are mobile genetic elements that can insert themselves into new locations within the genome. While LINE-1 and Alu are normally inactive, they can be induced to retrotranspose through the binding of specific proteins. The primary protein that induces LINE-1 inhibition is the DNA-binding protein, KRAB-ZNF (Kr\u00fcppel-associated box zinc finger protein). KRAB-ZNF binds to specific DNA sequences and recruits other proteins that suppress LINE-1 retrotransposition. Additionally, the protein CTCF (CCCTC-binding factor) has been shown to inhibit Alu retrotransposition by binding to the Alu repeat and preventing its retrotransposition. Other proteins, such as SUZ12 and SUZ12-like proteins, have also been implicated in the regulation of LINE-1 and Alu retrotransposition."}
{"qid": "5e52a4ec6d0a277941000044", "original_text": "Global centering-based normalization is a commonly used normalization approach in mass spectrometry-based label-free proteomics. It scales the peptide abundances to have the same median intensities, based on an assumption that the majority of abundances remain the same across the samples.", "label": 1, "is_selected": 0, "text": "Global centering-based normalization is a commonly used normalization approach in mass spectrometry-based label-free proteomics. It scales the peptide abundances to have the same median intensities, based on an assumption that the majority of abundances remain the same across the samples."}
{"qid": "53354eafd6d3ac6a34000044", "original_text": "Little is known about the detailed phylogeny relationships of CRF 02_AG HIV-1 polymerase genes in Ghana. The use of the protease gene of HIV-1 for subtyping has shown conflicting results. The partial polymerase gene sequences of 25 HIV-1 strains obtained with Viroseq reagents were aligned with reference subtypes and alignments trimmed to a 300 bp protease, 661 bp and 1005 reverse transcriptase sequence alignments. Phylogenetic relationships of these alignments were determined with the Neighbour-Joining method using 1000 replicates and recombination patterns determined for the sequences with RIP 3.0 in the HIV sequence database. Unlike the other alignments, the protease gene had nodes with bootstrap values < 100% for repeat control sequences. Majority of the CRF 02_AG sequences from Ghana were made up of fragments of several strains of CRF 02_AG/AG strains.", "label": 1, "is_selected": 0, "text": "Little is known about the detailed phylogeny relationships of CRF 02_AG HIV-1 polymerase genes in Ghana. The use of the protease gene of HIV-1 for subtyping has shown conflicting results. The partial polymerase gene sequences of 25 HIV-1 strains obtained with Viroseq reagents were aligned with reference subtypes and alignments trimmed to a 300 bp protease, 661 bp and 1005 reverse transcriptase sequence alignments. Phylogenetic relationships of these alignments were determined with the Neighbour-Joining method using 1000 replicates and recombination patterns determined for the sequences with RIP 3.0 in the HIV sequence database. Unlike the other alignments, the protease gene had nodes with bootstrap values < 100% for repeat control sequences. Majority of the CRF 02_AG sequences from Ghana were made up of fragments of several strains of CRF 02_AG/AG strains."}
{"qid": "517138d98ed59a060a000003", "original_text": "Pathological conditions, including ischemia and heart failure, are associated with altered sodium channel function and increased late sodium current (I(Na,L)), leading to prolonged action potential duration, increased intracellular sodium and calcium concentrations, and arrhythmias. We used anemone toxin (ATX)-II to study the effects of increasing I(Na,L) on intracellular calcium cycling in rat isolated hearts. Cardiac contraction was abolished using paralytic agents. Ranolazine (RAN) was used to inhibit late I(Na). Hearts were loaded with fluo-4-acetoxymethyl ester, and myocyte intracellular calcium transients (CaTs) were measured using laser scanning confocal microscopy. ATX (1 nM) prolonged CaT duration at 50% recovery in hearts paced at a basal rate of 2 Hz and increased the sensitivity of the heart to the development of calcium alternans caused by fast pacing. ATX increased the time required for recovery of CaT amplitude following a previous beat, and ATX induced spontaneous calcium release waves during rapid pacing of the heart. ATX prolonged the duration of repolarization from the initiation of the activation to terminal repolarization in the pseudo-electrocardiogram. All actions of ATX were both reversed and prevented by subsequent or prior exposure, respectively, of hearts to RAN (10 microM). Most importantly, the increased vulnerability of the heart to the development of calcium alternans during rapid pacing was reversed or prevented by 10 microM RAN. These results suggest that enhancement of I(Na,L) alters calcium cycling. Reduction by RAN of I(Na,L)-induced dysregulation of calcium cycling could contribute to the antiarrhythmic actions of this agent in both reentrant and triggered arrhythmias.", "label": 1, "is_selected": 0, "text": "Pathological conditions, including ischemia and heart failure, are associated with altered sodium channel function and increased late sodium current (I(Na,L)), leading to prolonged action potential duration, increased intracellular sodium and calcium concentrations, and arrhythmias. We used anemone toxin (ATX)-II to study the effects of increasing I(Na,L) on intracellular calcium cycling in rat isolated hearts. Cardiac contraction was abolished using paralytic agents. Ranolazine (RAN) was used to inhibit late I(Na). Hearts were loaded with fluo-4-acetoxymethyl ester, and myocyte intracellular calcium transients (CaTs) were measured using laser scanning confocal microscopy. ATX (1 nM) prolonged CaT duration at 50% recovery in hearts paced at a basal rate of 2 Hz and increased the sensitivity of the heart to the development of calcium alternans caused by fast pacing. ATX increased the time required for recovery of CaT amplitude following a previous beat, and ATX induced spontaneous calcium release waves during rapid pacing of the heart. ATX prolonged the duration of repolarization from the initiation of the activation to terminal repolarization in the pseudo-electrocardiogram. All actions of ATX were both reversed and prevented by subsequent or prior exposure, respectively, of hearts to RAN (10 microM). Most importantly, the increased vulnerability of the heart to the development of calcium alternans during rapid pacing was reversed or prevented by 10 microM RAN. These results suggest that enhancement of I(Na,L) alters calcium cycling. Reduction by RAN of I(Na,L)-induced dysregulation of calcium cycling could contribute to the antiarrhythmic actions of this agent in both reentrant and triggered arrhythmias."}
{"qid": "602343051cb411341a00008d", "original_text": "Severe hypertriglyceridemia (sHTG) is a complex disorder of lipid metabolism characterized by plasma levels of triglyceride (TG) greater than 885 mg/dl (>10 mmol/L). The treatment of sHTG syndromes is challenging because conventional treatments are often ineffective in reducing TG under the threshold to prevent acute pancreatitis (AP). The inhibition of APOC3, which encodes a protein involved in triglyceride (TG)-rich lipoproteins (TGRLs) removal, has been reported to be a novel target for the treatment of sHTG. Volanesorsen is a second-generation antisense oligonucleotide inhibiting apoC-III transcription/translation that has been recently approved in Europe for Familial Chylomicronemia Syndrome (FCS) treatment.", "label": 1, "is_selected": 0, "text": "Severe hypertriglyceridemia (sHTG) is a complex disorder of lipid metabolism characterized by plasma levels of triglyceride (TG) greater than 885 mg/dl (>10 mmol/L). The treatment of sHTG syndromes is challenging because conventional treatments are often ineffective in reducing TG under the threshold to prevent acute pancreatitis (AP). The inhibition of APOC3, which encodes a protein involved in triglyceride (TG)-rich lipoproteins (TGRLs) removal, has been reported to be a novel target for the treatment of sHTG. Volanesorsen is a second-generation antisense oligonucleotide inhibiting apoC-III transcription/translation that has been recently approved in Europe for Familial Chylomicronemia Syndrome (FCS) treatment."}
{"qid": "5c73ace87c78d69471000084", "original_text": "Somatic point mutations at a key arginine residue (R132) within the active site of the metabolic enzyme isocitrate dehydrogenase 1 (IDH1) confer a novel gain of function in cancer cells, resulting in the production of d-2-hydroxyglutarate (2-HG), an oncometabolite. Elevated 2-HG levels are implicated in epigenetic alterations and impaired cellular differentiation. IDH1 mutations have been described in an array of hematologic malignancies and solid tumors. Here, we report the discovery of AG-120 (ivosidenib), an inhibitor of the IDH1 mutant enzyme that exhibits profound 2-HG lowering in tumor models and the ability to effect differentiation of primary patient AML samples ex vivo.", "label": 1, "is_selected": 0, "text": "Somatic point mutations at a key arginine residue (R132) within the active site of the metabolic enzyme isocitrate dehydrogenase 1 (IDH1) confer a novel gain of function in cancer cells, resulting in the production of d-2-hydroxyglutarate (2-HG), an oncometabolite. Elevated 2-HG levels are implicated in epigenetic alterations and impaired cellular differentiation. IDH1 mutations have been described in an array of hematologic malignancies and solid tumors. Here, we report the discovery of AG-120 (ivosidenib), an inhibitor of the IDH1 mutant enzyme that exhibits profound 2-HG lowering in tumor models and the ability to effect differentiation of primary patient AML samples ex vivo."}
{"qid": "58efa66070f9fc6f0f000005", "original_text": "Through search the possible randomized control trials, we make a renewed meta-analysis in order to assess the impact of aspirin in preventing the recurrence of colorectal adenoma. The Medicine/PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Chinese biomedical literature service system (SinoMed) databases were searched for the related randomized controlled trials until to the April 2016. Three different authors respectively evaluated the quality of studies and extracted data, and we used the STATA software to analyze, investigate heterogeneity between the data, using the fixed-effects model to calculate and merge data. 7 papers were included the renewed meta- analysis, among these studies, two pairs were identified as representing the same study population, with the only difference being the duration of follow-up. Thus there were only five papers included our meta-analysis, and one Chinese paper were also included the work. Results were categorized by the length of follow-up, different kinds of people, varied dose of oral aspirin. The relative of adenoma in patients taking aspirin vs placebo were 0.73 (95% CI 0.55-0.98, P=0.039) with 1 year follow up; 0.84 (95% CI 0.72-0.98, P=0.484) with greater than 1 year follow up; for the advanced adenoma, the RR 0.68 (95% CI 0.49-0.94, P=0.582),for one year; RR=0.75 (95% CI 0.52-1.07, P=0.552) for greater one year. Furthermore the white population could divided into two subgroups according to the different length of follow-up time.", "label": 1, "is_selected": 0, "text": "Through search the possible randomized control trials, we make a renewed meta-analysis in order to assess the impact of aspirin in preventing the recurrence of colorectal adenoma. The Medicine/PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Chinese biomedical literature service system (SinoMed) databases were searched for the related randomized controlled trials until to the April 2016. Three different authors respectively evaluated the quality of studies and extracted data, and we used the STATA software to analyze, investigate heterogeneity between the data, using the fixed-effects model to calculate and merge data. 7 papers were included the renewed meta- analysis, among these studies, two pairs were identified as representing the same study population, with the only difference being the duration of follow-up. Thus there were only five papers included our meta-analysis, and one Chinese paper were also included the work. Results were categorized by the length of follow-up, different kinds of people, varied dose of oral aspirin. The relative of adenoma in patients taking aspirin vs placebo were 0.73 (95% CI 0.55-0.98, P=0.039) with 1 year follow up; 0.84 (95% CI 0.72-0.98, P=0.484) with greater than 1 year follow up; for the advanced adenoma, the RR 0.68 (95% CI 0.49-0.94, P=0.582),for one year; RR=0.75 (95% CI 0.52-1.07, P=0.552) for greater one year. Furthermore the white population could divided into two subgroups according to the different length of follow-up time."}
{"qid": "5166f41a298dcd4e5100005b", "original_text": "Dynamic methylations and demethylations of histone lysine residues are important for gene regulation and are facilitated by histone methyltransferases and histone demethylases (HDMs). KDM5B/ Jarid1B/PLU1 is an H3K4me3/me2-specific lysine demethylase belonging to the JmjC domain-containing family of histone demethylases (JHDMs). Several studies have linked KDM5B to breast, prostate and skin cancer, highlighting its potential as a drug target. However, most inhibitor studies have focused on other JHDMs, and inhibitors for KDM5B remain to be explored. Here, we report the expression, purification and characterization of the catalytic core of recombinant KDM5B (ccKDM5B, residues 1-769). We show that ccKDM5B, recombinantly expressed in insect cells, demethylates H3K4me3 and H3K4me2 in vitro. The kinetic characterization showed that ccKDM5B has an apparent Michaelis constant (K(m) (app) ) value of 0.5 \u03bcm for its trimethylated substrate H3(1-15)K4me3, a considerably increased apparent substrate affinity than reported for related HDMs.", "label": 1, "is_selected": 0, "text": "Dynamic methylations and demethylations of histone lysine residues are important for gene regulation and are facilitated by histone methyltransferases and histone demethylases (HDMs). KDM5B/ Jarid1B/PLU1 is an H3K4me3/me2-specific lysine demethylase belonging to the JmjC domain-containing family of histone demethylases (JHDMs). Several studies have linked KDM5B to breast, prostate and skin cancer, highlighting its potential as a drug target. However, most inhibitor studies have focused on other JHDMs, and inhibitors for KDM5B remain to be explored. Here, we report the expression, purification and characterization of the catalytic core of recombinant KDM5B (ccKDM5B, residues 1-769). We show that ccKDM5B, recombinantly expressed in insect cells, demethylates H3K4me3 and H3K4me2 in vitro. The kinetic characterization showed that ccKDM5B has an apparent Michaelis constant (K(m) (app) ) value of 0.5 \u03bcm for its trimethylated substrate H3(1-15)K4me3, a considerably increased apparent substrate affinity than reported for related HDMs."}
{"qid": "56cae40b5795f9a73e000022", "original_text": "There is no established link between Crohn's disease (CD) and the consumption of refrigerated food. CD is a chronic inflammatory bowel disease (IBD) that affects the gastrointestinal tract, causing symptoms such as abdominal pain, diarrhea, and fatigue. While the exact cause of CD is not fully understood, research suggests that a combination of genetic and environmental factors are involved. However, there is no evidence to suggest that consuming refrigerated foods increases the risk of developing CD.", "label": 0, "is_selected": 0, "text": "There is no established link between Crohn's disease (CD) and the consumption of refrigerated food. CD is a chronic inflammatory bowel disease (IBD) that affects the gastrointestinal tract, causing symptoms such as abdominal pain, diarrhea, and fatigue. While the exact cause of CD is not fully understood, research suggests that a combination of genetic and environmental factors are involved. However, there is no evidence to suggest that consuming refrigerated foods increases the risk of developing CD."}
{"qid": "533c3571c45e133714000005", "original_text": "Mammalian long intergenic noncoding RNAs (lincRNAs) are best known for modulating transcription. Here we report a posttranscriptional function for lincRNA-p21 as a modulator of translation. Association of the RNA-binding protein HuR with lincRNA-p21 favored the recruitment of let-7/Ago2 to lincRNA-p21, leading to lower lincRNA-p21 stability. Under reduced HuR levels, lincRNA-p21 accumulated in human cervical carcinoma HeLa cells, increasing its association with JUNB and CTNNB1 mRNAs and selectively lowering their translation. With elevated HuR, lincRNA-p21 levels declined, which in turn derepressed JunB and \u03b2-catenin translation and increased the levels of these proteins. We propose that HuR controls translation of a subset of target mRNAs by influencing lincRNA-p21 levels.", "label": 1, "is_selected": 0, "text": "Mammalian long intergenic noncoding RNAs (lincRNAs) are best known for modulating transcription. Here we report a posttranscriptional function for lincRNA-p21 as a modulator of translation. Association of the RNA-binding protein HuR with lincRNA-p21 favored the recruitment of let-7/Ago2 to lincRNA-p21, leading to lower lincRNA-p21 stability. Under reduced HuR levels, lincRNA-p21 accumulated in human cervical carcinoma HeLa cells, increasing its association with JUNB and CTNNB1 mRNAs and selectively lowering their translation. With elevated HuR, lincRNA-p21 levels declined, which in turn derepressed JunB and \u03b2-catenin translation and increased the levels of these proteins. We propose that HuR controls translation of a subset of target mRNAs by influencing lincRNA-p21 levels."}
{"qid": "5c93ea7cecadf2e73f00001d", "original_text": "Macrophages are major targets for HIV-1, contribute to viral propagation in vivo, and are instrumental in the pathogenesis of HAND. While it is known that host sex affects HIV-1 viremia and influences the severity of HIV-1-associated neurocognitive disease, a cellular or molecular basis for these findings remains elusive. We explored whether sex affects HIV-1 infectivity of primary human macrophages and CD4+ T cells in vitro. Macrophages derived from female donors were less susceptible to HIV-1 infection than those derived from males. This sex-dependent difference in macrophage infectivity was independent of the requirement for CD4/CCR5-mediated virus entry and was not observed in CD4+ T cells. Investigations into the mechanism governing these sex-dependent differences revealed that the host restriction factor SAMHD1 exists in a hyperphosphorylated, less active state in male-derived macrophages. In addition, the major kinase responsible for SAMHD1 phosphorylation, CDK1, exhibited lower levels of expression in female-derived macrophages in all tested donor pairs.", "label": 1, "is_selected": 0, "text": "Macrophages are major targets for HIV-1, contribute to viral propagation in vivo, and are instrumental in the pathogenesis of HAND. While it is known that host sex affects HIV-1 viremia and influences the severity of HIV-1-associated neurocognitive disease, a cellular or molecular basis for these findings remains elusive. We explored whether sex affects HIV-1 infectivity of primary human macrophages and CD4+ T cells in vitro. Macrophages derived from female donors were less susceptible to HIV-1 infection than those derived from males. This sex-dependent difference in macrophage infectivity was independent of the requirement for CD4/CCR5-mediated virus entry and was not observed in CD4+ T cells. Investigations into the mechanism governing these sex-dependent differences revealed that the host restriction factor SAMHD1 exists in a hyperphosphorylated, less active state in male-derived macrophages. In addition, the major kinase responsible for SAMHD1 phosphorylation, CDK1, exhibited lower levels of expression in female-derived macrophages in all tested donor pairs."}
{"qid": "52e6c92598d0239505000019", "original_text": "The goal of this study was to comprehensively define the incidence of mutations in all exons of PIK3CA in both endometrioid endometrial cancer (EEC) and nonendometrioid endometrial cancer (NEEC). We resequenced all coding exons of PIK3CA and PTEN, and exons 1 and 2 of KRAS, from 108 primary endometrial tumors. Somatic mutations were confirmed by sequencing matched normal DNAs. The biochemical properties of a subset of novel PIK3CA mutations were determined by exogenously expressing wild type and mutant constructs in U2OS cells and measuring levels of AKT(Ser473) phosphorylation. Somatic PIK3CA mutations were detected in 52.4% of 42 EECs and 33.3% of 66 NEECs. Half (29 of 58) of all nonsynonymous PIK3CA mutations were in exons 1-7 and half were in exons 9 and 20. The exons 1-7 mutations localized to the ABD, ABD-RBD linker and C2 domains of p110\u03b1. Within these regions, Arg88, Arg93, Gly106, Lys111, Glu365, and Glu453, were recurrently mutated; Arg88, Arg93, and Lys111 formed mutation hotspots. The p110\u03b1-R93W, -G106R, -G106V, -K111E, -delP449-L455, and -E453K mutants led to increased levels of phospho-AKT(Ser473) compared to wild-type p110\u03b1. Overall, 62% of exons 1-7 PIK3CA mutants and 64% of exons 9-20 PIK3CA mutants were activating; 72% of exon 1-7 mutations have not previously been reported in endometrial cancer. Our study identified a new subgroup of endometrial cancer patients with activating mutations in the amino-terminal domains of p110\u03b1; these patients might be appropriate for consideration in clinical trials of targeted therapies directed against the PI3K pathway.", "label": 1, "is_selected": 0, "text": "The goal of this study was to comprehensively define the incidence of mutations in all exons of PIK3CA in both endometrioid endometrial cancer (EEC) and nonendometrioid endometrial cancer (NEEC). We resequenced all coding exons of PIK3CA and PTEN, and exons 1 and 2 of KRAS, from 108 primary endometrial tumors. Somatic mutations were confirmed by sequencing matched normal DNAs. The biochemical properties of a subset of novel PIK3CA mutations were determined by exogenously expressing wild type and mutant constructs in U2OS cells and measuring levels of AKT(Ser473) phosphorylation. Somatic PIK3CA mutations were detected in 52.4% of 42 EECs and 33.3% of 66 NEECs. Half (29 of 58) of all nonsynonymous PIK3CA mutations were in exons 1-7 and half were in exons 9 and 20. The exons 1-7 mutations localized to the ABD, ABD-RBD linker and C2 domains of p110\u03b1. Within these regions, Arg88, Arg93, Gly106, Lys111, Glu365, and Glu453, were recurrently mutated; Arg88, Arg93, and Lys111 formed mutation hotspots. The p110\u03b1-R93W, -G106R, -G106V, -K111E, -delP449-L455, and -E453K mutants led to increased levels of phospho-AKT(Ser473) compared to wild-type p110\u03b1. Overall, 62% of exons 1-7 PIK3CA mutants and 64% of exons 9-20 PIK3CA mutants were activating; 72% of exon 1-7 mutations have not previously been reported in endometrial cancer. Our study identified a new subgroup of endometrial cancer patients with activating mutations in the amino-terminal domains of p110\u03b1; these patients might be appropriate for consideration in clinical trials of targeted therapies directed against the PI3K pathway."}
{"qid": "602825a61cb411341a0000fa", "original_text": "Although carcinosarcoma occurs in various locations throughout the body, it rarely originates in the ovary. Chemotherapy has been minimally beneficial. This case describes a patient with carcinosarcoma of the ovary who responded minimally to chemotherapy used for epithelial carcinomas but had a complete response after receiving chemotherapy used for sarcomas. The patient relapsed within 1 year after receiving cisplatin therapy. She was treated with mesna, ifosfamide, Adriamycin, and dacarbazine (MAID) chemotherapy and after one cycle of chemotherapy she had no evidence of tumor. She has received six cycles of chemotherapy without evidence of progression 13+ months since beginning MAID therapy. MAID chemotherapy may be useful in the treatment of carcinosarcoma of the ovary.", "label": 1, "is_selected": 0, "text": "Although carcinosarcoma occurs in various locations throughout the body, it rarely originates in the ovary. Chemotherapy has been minimally beneficial. This case describes a patient with carcinosarcoma of the ovary who responded minimally to chemotherapy used for epithelial carcinomas but had a complete response after receiving chemotherapy used for sarcomas. The patient relapsed within 1 year after receiving cisplatin therapy. She was treated with mesna, ifosfamide, Adriamycin, and dacarbazine (MAID) chemotherapy and after one cycle of chemotherapy she had no evidence of tumor. She has received six cycles of chemotherapy without evidence of progression 13+ months since beginning MAID therapy. MAID chemotherapy may be useful in the treatment of carcinosarcoma of the ovary."}
{"qid": "58bbb64422d3005309000014", "original_text": "Biochemical modifications to mRNA, especially N6-methyladenosine (m6A) and 5-methylcytosine (m5C), have been recently shown to be associated with crucial biological functions. Despite the intriguing advancements, little is known so far about the dynamic landscape of RNA methylome across different cell types and how the epitranscriptome is regulated at the system level by enzymes, i.e., RNA methyltransferases and demethylases. To investigate this issue, a meta-analysis of m6A MeRIP-Seq datasets collected from 10 different experimental conditions (cell type/tissue or treatment) is performed, and the combinatorial epitranscriptome, which consists of 42 758 m6A sites, is extracted and divided into 3 clusters, in which the methylation sites are likely to be hyper- or hypo-methylated simultaneously (or co-methylated), indicating the sharing of a common methylation regulator. Four different clustering approaches are used, including K-means, hierarchical clustering (HC), Bayesian factor regression model (BFRM) and nonnegative matrix factorization (NMF) to unveil the co-methylation patterns.", "label": 1, "is_selected": 0, "text": "Biochemical modifications to mRNA, especially N6-methyladenosine (m6A) and 5-methylcytosine (m5C), have been recently shown to be associated with crucial biological functions. Despite the intriguing advancements, little is known so far about the dynamic landscape of RNA methylome across different cell types and how the epitranscriptome is regulated at the system level by enzymes, i.e., RNA methyltransferases and demethylases. To investigate this issue, a meta-analysis of m6A MeRIP-Seq datasets collected from 10 different experimental conditions (cell type/tissue or treatment) is performed, and the combinatorial epitranscriptome, which consists of 42 758 m6A sites, is extracted and divided into 3 clusters, in which the methylation sites are likely to be hyper- or hypo-methylated simultaneously (or co-methylated), indicating the sharing of a common methylation regulator. Four different clustering approaches are used, including K-means, hierarchical clustering (HC), Bayesian factor regression model (BFRM) and nonnegative matrix factorization (NMF) to unveil the co-methylation patterns."}
{"qid": "58bc666702b8c60953000004", "original_text": "Intracellular amyloid fibrils linked to neurodegenerative disease typically accumulate in an age-related manner, suggesting inherent cellular capacity for counteracting amyloid formation in early life. Metazoan molecular chaperones assist native folding and block polymerization of amyloidogenic proteins, preempting amyloid fibril formation. Chaperone capacity for amyloid disassembly, however, is unclear. Here, we show that a specific combination of human Hsp70 disaggregase-associated chaperone components efficiently disassembles \u03b1-synuclein amyloid fibrils characteristic of Parkinson's disease in vitro. Specifically, the Hsc70 chaperone, the class B J-protein DNAJB1, and an Hsp110 family nucleotide exchange factor (NEF) provide ATP-dependent activity that disassembles amyloids within minutes via combined fibril fragmentation and depolymerization. This ultimately generates non-toxic \u03b1-synuclein monomers. Concerted, rapid interaction cycles of all three chaperone components with fibrils generate the power stroke required for disassembly. This identifies a powerful human Hsp70 disaggregase activity that efficiently disassembles amyloid fibrils and points to crucial yet undefined biology underlying amyloid-based diseases.", "label": 1, "is_selected": 0, "text": "Intracellular amyloid fibrils linked to neurodegenerative disease typically accumulate in an age-related manner, suggesting inherent cellular capacity for counteracting amyloid formation in early life. Metazoan molecular chaperones assist native folding and block polymerization of amyloidogenic proteins, preempting amyloid fibril formation. Chaperone capacity for amyloid disassembly, however, is unclear. Here, we show that a specific combination of human Hsp70 disaggregase-associated chaperone components efficiently disassembles \u03b1-synuclein amyloid fibrils characteristic of Parkinson's disease in vitro. Specifically, the Hsc70 chaperone, the class B J-protein DNAJB1, and an Hsp110 family nucleotide exchange factor (NEF) provide ATP-dependent activity that disassembles amyloids within minutes via combined fibril fragmentation and depolymerization. This ultimately generates non-toxic \u03b1-synuclein monomers. Concerted, rapid interaction cycles of all three chaperone components with fibrils generate the power stroke required for disassembly. This identifies a powerful human Hsp70 disaggregase activity that efficiently disassembles amyloid fibrils and points to crucial yet undefined biology underlying amyloid-based diseases."}
{"qid": "550e866271445a662f000005", "original_text": "We evaluated the safety and efficacy of intetumumab in combination with docetaxel in patients with castrate-resistant metastatic prostate cancer. Patients and methods In this phase 1, open-label, multicenter, nonrandomized study, 75 mg/m\u00b2 docetaxel was administered on Day 1 of each of nine 21-day treatment cycles and intetumumab 5 or 10 mg/kg was administered on Days 1, 8, and 15 of Cycles 2 and 3 and on Day 1 of all subsequent cycles. The primary endpoint was the incidence of dose-limiting toxicities (DLTs) during Cycles 2 and 3. Secondary endpoints included serum prostate-specific antigen (PSA) response and objective response based on Response Evaluation Criteria in Solid Tumors (RECIST). Ten patients were treated (5 mg/kg n = 3, 10 mg/kg n = 7). No DLTs occurred.", "label": 1, "is_selected": 0, "text": "We evaluated the safety and efficacy of intetumumab in combination with docetaxel in patients with castrate-resistant metastatic prostate cancer. Patients and methods In this phase 1, open-label, multicenter, nonrandomized study, 75 mg/m\u00b2 docetaxel was administered on Day 1 of each of nine 21-day treatment cycles and intetumumab 5 or 10 mg/kg was administered on Days 1, 8, and 15 of Cycles 2 and 3 and on Day 1 of all subsequent cycles. The primary endpoint was the incidence of dose-limiting toxicities (DLTs) during Cycles 2 and 3. Secondary endpoints included serum prostate-specific antigen (PSA) response and objective response based on Response Evaluation Criteria in Solid Tumors (RECIST). Ten patients were treated (5 mg/kg n = 3, 10 mg/kg n = 7). No DLTs occurred."}
{"qid": "5713bc991174fb1755000010", "original_text": "Several genes have been identified as causative for autosomal dominant Charcot-Marie-Tooth (CMT) disease. These genes are responsible for the production of proteins involved in the structure and function of peripheral nerves. Here are some of the most well-established genes associated with autosomal dominant CMT: 1. PMP22 gene: The most commonly mutated gene in CMT is the peripheral myelin protein 22 (PMP22) gene, which codes for a protein involved in the formation of the myelin sheath around nerve fibers. 2. MPZ gene: The myelination and remyelination-associated gene (MPZ) encodes a protein involved in the formation and maintenance of the myelin sheath. Mutations in this gene can cause dominant CMT type 1A. 3. PMP22 duplication: Duplications of the PMP22 gene can also cause dominant CMT type 1B. 4. SH3TC gene: Mutations in the SH3 protein tyrosine kinase 1 (SH3TC) gene can cause dominant CMT type 2. 5. GDAP1 gene: Mutations in the glycoprotein non-metastatic domain containing 1 (GDAP1) gene can cause dominant CMT type 4. 6. KCNQ2/KCNQ3 genes: Mutations in the potassium ion channel subunits (KCNQ2 and KCNQ3) can cause dominant CMT type 1B. It's important to note that each of these genes can have varying degrees of severity and expression in CMT patients, and some individuals may carry mutations in multiple genes. A comprehensive genetic testing can help identify the specific genetic cause of CMT in an individual.", "label": 0, "is_selected": 0, "text": "Several genes have been identified as causative for autosomal dominant Charcot-Marie-Tooth (CMT) disease. These genes are responsible for the production of proteins involved in the structure and function of peripheral nerves. Here are some of the most well-established genes associated with autosomal dominant CMT: 1. PMP22 gene: The most commonly mutated gene in CMT is the peripheral myelin protein 22 (PMP22) gene, which codes for a protein involved in the formation of the myelin sheath around nerve fibers. 2. MPZ gene: The myelination and remyelination-associated gene (MPZ) encodes a protein involved in the formation and maintenance of the myelin sheath. Mutations in this gene can cause dominant CMT type 1A. 3. PMP22 duplication: Duplications of the PMP22 gene can also cause dominant CMT type 1B. 4. SH3TC gene: Mutations in the SH3 protein tyrosine kinase 1 (SH3TC) gene can cause dominant CMT type 2. 5. GDAP1 gene: Mutations in the glycoprotein non-metastatic domain containing 1 (GDAP1) gene can cause dominant CMT type 4. 6. KCNQ2/KCNQ3 genes: Mutations in the potassium ion channel subunits (KCNQ2 and KCNQ3) can cause dominant CMT type 1B. It's important to note that each of these genes can have varying degrees of severity and expression in CMT patients, and some individuals may carry mutations in multiple genes. A comprehensive genetic testing can help identify the specific genetic cause of CMT in an individual."}
{"qid": "5e31cceafbd6abf43b000052", "original_text": "Chromosome 19 is short but has higher relative density of genes than other chromosomes. Increasing number of the genes coding for proteins implicated in the pathogenesis of various human diseases have been mapped on chromosome 19. Mutations of low density lipoprotein receptor (LDL-R) result in one of the most frequent mendelian inherited disorder-familial hypercholesterolemia. Mutations of insulin receptor (INSR) are causative for rare syndromes of insulin resistance and some of non insulin dependent diabetes mellitus (NIDDM).", "label": 1, "is_selected": 0, "text": "Chromosome 19 is short but has higher relative density of genes than other chromosomes. Increasing number of the genes coding for proteins implicated in the pathogenesis of various human diseases have been mapped on chromosome 19. Mutations of low density lipoprotein receptor (LDL-R) result in one of the most frequent mendelian inherited disorder-familial hypercholesterolemia. Mutations of insulin receptor (INSR) are causative for rare syndromes of insulin resistance and some of non insulin dependent diabetes mellitus (NIDDM)."}
{"qid": "54fe09036ad7dcbc12000009", "original_text": "Fish anti-freeze proteins are a type of protein found in various species of fish, including cold-water fish such as trout and salmon. These proteins are capable of preventing the formation of ice crystals in cells and tissues, thereby protecting the fish from the harmful effects of freezing water temperatures. There are several different types of fish anti-freeze proteins, including: 1. Ice-binding protein (IBP): This protein binds to the surface of ice crystals and prevents them from growing larger. 2. Anti-freeze protein (AFP): This protein inhibits the formation of ice crystals by reducing the solubility of water in the cell membrane. 3. Glycoprotein: This protein is rich in carbohydrates and is found in the red blood cells of some fish. It helps to protect the cells from freezing by binding to water and preventing the formation of ice crystals. 4. Hydrophilic protein: This protein is soluble in water and helps to regulate the balance of water molecules in the cell. 5. Protein 1: This protein is found in the liver of some fish and helps to prevent the accumulation of lipids in the liver. It is important to note that while these proteins can provide protection against freezing, they are not a substitute for proper medical care. If you suspect that you or someone else has been exposed to cold temperatures for an extended period of time, it is important to seek medical attention immediately.", "label": 0, "is_selected": 1, "text": "Fish anti-freeze proteins are a type of protein found in various species of fish, including cold-water fish such as trout and salmon. These proteins are capable of preventing the formation of ice crystals in cells and tissues, thereby protecting the fish from the harmful effects of freezing water temperatures. If you suspect that you or someone else has been exposed to cold temperatures for an extended period of time, it is important to seek medical attention immediately. The best way to protect yourself from the effects of cold temperatures is to drink plenty of water, eat plenty of healthy food, and take care of your health."}
{"qid": "56f15c5a2ac5ed1459000012", "original_text": "Zinc-finger nucleases (ZFNs) are engineered site-specific DNA cleavage enzymes that may be designed to recognize long target sites and thus cut DNA with high specificity. ZFNs mediate permanent and targeted genetic alteration via induction of a double-strand break at a specific genomic site. Compared to conventional homology-based gene targeting, ZFNs can increase the targeting rate by up to 100,000-fold; gene disruption via mutagenic DNA repair is similarly efficient. The utility of ZFNs has been shown in many organisms, including insects, amphibians, plants, nematodes, and several mammals, including humans.", "label": 1, "is_selected": 0, "text": "Zinc-finger nucleases (ZFNs) are engineered site-specific DNA cleavage enzymes that may be designed to recognize long target sites and thus cut DNA with high specificity. ZFNs mediate permanent and targeted genetic alteration via induction of a double-strand break at a specific genomic site. Compared to conventional homology-based gene targeting, ZFNs can increase the targeting rate by up to 100,000-fold; gene disruption via mutagenic DNA repair is similarly efficient. The utility of ZFNs has been shown in many organisms, including insects, amphibians, plants, nematodes, and several mammals, including humans."}
{"qid": "6056fbfc94d57fd87900001d", "original_text": "Honey bees provision glandular secretions in the form of royal jelly as larval nourishment to developing queens. Exposure to chemicals and nutritional conditions can influence queen development and thus impact colony fitness. Previous research reports that royal jelly remains pesticide-free during colony-level exposure and that chemical residues are buffered by the nurse bees. However, the impacts of pesticides can also manifest in quality and quantity of royal jelly produced by nurse bees.", "label": 1, "is_selected": 0, "text": "Honey bees provision glandular secretions in the form of royal jelly as larval nourishment to developing queens. Exposure to chemicals and nutritional conditions can influence queen development and thus impact colony fitness. Previous research reports that royal jelly remains pesticide-free during colony-level exposure and that chemical residues are buffered by the nurse bees. However, the impacts of pesticides can also manifest in quality and quantity of royal jelly produced by nurse bees."}
{"qid": "530cf4fe960c95ad0c000007", "original_text": "Hydrochlorothiazide (HCTZ) is a thiazide diuretic medication used to treat various conditions, including: 1. Hypertension (high blood pressure): HCTZ helps to lower blood pressure by increasing urine production, which reduces the amount of fluid in the body and blood vessels. 2. Heart failure: HCTZ can help reduce fluid buildup in the body and improve symptoms of heart failure by reducing swelling and improving breathing. 3. Nephrogenic diabetic edema: HCTZ can help reduce fluid buildup in the body in people with nephrogenic diabetic edema, a rare condition. 4. Edema: HCTZ can help reduce swelling in the body, which can occur due to various conditions such as liver disease, kidney disease, or cancer. 5. Hyperaldosteronism: HCTZ can help reduce the levels of the hormone aldosterone in the body, which can cause fluid buildup and electrolyte imbalances. It's important to note that HCTZ is not recommended for use in pregnancy and breastfeeding without medical supervision. Always consult a healthcare professional before taking any medication, including HCTZ, to ensure safety and effectiveness.", "label": 0, "is_selected": 1, "text": "It's important to note that HCTZ is not recommended for use in pregnancy or breastfeeding without medical supervision, so it's best to consult a healthcare professional before taking any medication, including HCTZ, to ensure safety and effectiveness.Always consult a medical professional before using any medication (including HCTZ), such as diuretics, without supervision, as it can cause fluid and electrolyte imbalances in the body, which can occur without supervision."}
{"qid": "51593dc8d24251bc05000099", "original_text": "An atrazine-degrading strain Arthrobacter sp. ZXY-2 was originally isolated from Jilin Pesticide Plant (China). Strain ZXY-2 demonstrated excellent atrazine degradation performance and saline tolerance. Here we report the complete genome sequence of strain ZXY-2 contained a circular chromosome and five circular plasmids encoding for the mechanism of salt adaptation and pollutant degradation.", "label": 1, "is_selected": 0, "text": "An atrazine-degrading strain Arthrobacter sp. ZXY-2 was originally isolated from Jilin Pesticide Plant (China). Strain ZXY-2 demonstrated excellent atrazine degradation performance and saline tolerance. Here we report the complete genome sequence of strain ZXY-2 contained a circular chromosome and five circular plasmids encoding for the mechanism of salt adaptation and pollutant degradation."}
{"qid": "5e31cb85fbd6abf43b00004e", "original_text": "A mutation in the huntingtin (Htt) gene produces mutant Htt and Huntington's disease (HD), a neurodegenerative disorder. HD patients have oxidative damage in the brain, but the causes are unclear. Compared with controls, we found brain levels of NADPH oxidase (NOX) activity, which produces reactive oxygen species (ROS), elevated in human HD postmortem cortex and striatum and highest in striatum of presymptomatic individuals. Synaptosome fractions from cortex and striatum of HD(140Q/140Q) mice had elevated NOX activity at 3 months of age and a further rise at 6 and 12 months compared with synaptosomes of age-matched wild-type (WT) mice.", "label": 1, "is_selected": 0, "text": "A mutation in the huntingtin (Htt) gene produces mutant Htt and Huntington's disease (HD), a neurodegenerative disorder. HD patients have oxidative damage in the brain, but the causes are unclear. Compared with controls, we found brain levels of NADPH oxidase (NOX) activity, which produces reactive oxygen species (ROS), elevated in human HD postmortem cortex and striatum and highest in striatum of presymptomatic individuals. Synaptosome fractions from cortex and striatum of HD(140Q/140Q) mice had elevated NOX activity at 3 months of age and a further rise at 6 and 12 months compared with synaptosomes of age-matched wild-type (WT) mice."}
{"qid": "56ebee26107309bc2f000002", "original_text": "We describe an assay for transposase-accessible chromatin using sequencing (ATAC-seq), based on direct in vitro transposition of sequencing adaptors into native chromatin, as a rapid and sensitive method for integrative epigenomic analysis. ATAC-seq captures open chromatin sites using a simple two-step protocol with 500-50,000 cells and reveals the interplay between genomic locations of open chromatin, DNA-binding proteins, individual nucleosomes and chromatin compaction at nucleotide resolution. We discovered classes of DNA-binding factors that strictly avoided, could tolerate or tended to overlap with nucleosomes. Using ATAC-seq maps of human CD4(+) T cells from a proband obtained on consecutive days, we demonstrated the feasibility of analyzing an individual's epigenome on a timescale compatible with clinical decision-making.", "label": 1, "is_selected": 0, "text": "We describe an assay for transposase-accessible chromatin using sequencing (ATAC-seq), based on direct in vitro transposition of sequencing adaptors into native chromatin, as a rapid and sensitive method for integrative epigenomic analysis. ATAC-seq captures open chromatin sites using a simple two-step protocol with 500-50,000 cells and reveals the interplay between genomic locations of open chromatin, DNA-binding proteins, individual nucleosomes and chromatin compaction at nucleotide resolution. We discovered classes of DNA-binding factors that strictly avoided, could tolerate or tended to overlap with nucleosomes. Using ATAC-seq maps of human CD4(+) T cells from a proband obtained on consecutive days, we demonstrated the feasibility of analyzing an individual's epigenome on a timescale compatible with clinical decision-making."}
{"qid": "602905e81cb411341a000108", "original_text": "Yes, there is evidence to suggest a link between rare variants in the peroxisome proliferator-activated receptor gamma (PPARG) gene and the risk of developing type 1 diabetes. Several studies have identified rare variants in PPARG that are associated with an increased risk of type 1 diabetes, particularly in individuals with a family history of the disease. These variants are thought to affect the function of PPARG, which plays a critical role in glucose metabolism and insulin sensitivity. Several studies have reported an association between PPARG variants and an increased risk of type 1 diabetes. For example, a study published in the journal Nature Genetics in 2018 found that individuals with rare variants in PPARG were at increased risk of developing type 1 diabetes compared to those without these variants. Another study published in the journal Diabetes in 2017 found that certain PPARG variants were associated with an earlier age of onset of type 1 diabetes. While these findings are promising, it is important to note that the relationship between PPARG variants and type 1 diabetes is complex and multifactorial, and more research is needed to fully understand the underlying mechanisms. Additionally, while rare variants in PPARG may be associated with an increased risk of type 1 diabetes, the majority of individuals with type 1 diabetes do not have these variants, highlighting the need for continued research into the underlying genetic and environmental factors that contribute to the development of the disease.", "label": 0, "is_selected": 1, "text": "Is there evidence to suggest a link between rare variants in a gene and the risk of developing type 1 diabetes, as suggested by a study published in the journal Nature Genetics in 2018 and another study in the Journal of the American College of Cardiology in 2017?, asks Dr. Annalisa D'Alessandro, professor of medicine at the University of California, Los Angeles, and director of the Diabetes Prevention Research Unit at the Keck School of Medicine of the City of Los Angeles?, in a letter to the editor, published in JAMA Oncology in March 2019?, asks Professor of Medicine, University of Texas MD Anderson Cancer Center, and chief of the Division of Endocrinology, Diabetes, and Metabolism, at the UT Southwestern Medical Center, in an answer to your question about a gene that may be associated with an increased risk of type 1 Diabetes?"}
{"qid": "61f5924e882a024a1000000e", "original_text": "In a first, the FDA has approved an inhibitor of hypoxia-inducible factor-2\u03b1. The drug is also the first approved to treat von Hippel-Lindau disease-associated renal cell carcinoma, central nervous system hemangioblastomas, and pancreatic neuroendocrine tumors.", "label": 1, "is_selected": 0, "text": "In a first, the FDA has approved an inhibitor of hypoxia-inducible factor-2\u03b1. The drug is also the first approved to treat von Hippel-Lindau disease-associated renal cell carcinoma, central nervous system hemangioblastomas, and pancreatic neuroendocrine tumors."}
{"qid": "62793bad56bf9aee6f00001f", "original_text": "A prospective study was performed on 4,262 consecutive patients who had had skull examinations for recent head trauma. Clinical signs and symptoms and patient history were correlated with skull fractures and intracranial sequelae as identified on CT studies, in order to evaluate the predictive value of each clinical finding and to identify high-yield referral criteria. Ninety-seven skull fractures (3%) and 32 intracranial sequelae (0.7%) were observed. All the intracranial complications were observed in patients with fractures and with altered consciousness of some degrees (Glasgow Coma Scale score less than 13). Most patients were asymptomatic (41%) or showed \"low risk\" symptoms (29%): among them, neither fractures nor complications were observed. High-risk clinical signs, mainly expressing basilar fractures (as rhinorrhea, otorrhea, focal neurologic signs, retroauricular hematoma) demonstrated high predictive value (100%) for intracranial sequelae. Other \"moderate risk\" findings for intracranial injury--i.e. loss of consciousness at any time, antegrade or retrograde amnesia, multiple trauma, and possible skull penetration--showed a high correlation with skull fractures and a slightly lower one with intracranial sequelae. The most predictive finding for brain injury was the depressed level of consciousness: brain injuries were never observed in fully conscious patients; in altered consciousness with GCS 15-13 we observed 4% of skull fractures with no sequelae; at GCS values 12-9, 61% of skull fractures and 20% of sequelae were present, whereas at GCS less than 8, 100% of complicated fracture were observed. The finding of skull fracture showed 33% of predictivity for brain damage, which was, however, always associated with \"high or moderate risk\" clinical signs. Therefore, the authors suggest some guidelines for the management of patients with recent head trauma, including referral criteria for X-rays or CT studies, based on signs and symptoms with high, intermediate and low risk of developing intracranial sequelae.", "label": 1, "is_selected": 0, "text": "A prospective study was performed on 4,262 consecutive patients who had had skull examinations for recent head trauma. Clinical signs and symptoms and patient history were correlated with skull fractures and intracranial sequelae as identified on CT studies, in order to evaluate the predictive value of each clinical finding and to identify high-yield referral criteria. Ninety-seven skull fractures (3%) and 32 intracranial sequelae (0.7%) were observed. All the intracranial complications were observed in patients with fractures and with altered consciousness of some degrees (Glasgow Coma Scale score less than 13). Most patients were asymptomatic (41%) or showed \"low risk\" symptoms (29%): among them, neither fractures nor complications were observed. High-risk clinical signs, mainly expressing basilar fractures (as rhinorrhea, otorrhea, focal neurologic signs, retroauricular hematoma) demonstrated high predictive value (100%) for intracranial sequelae. Other \"moderate risk\" findings for intracranial injury--i.e. loss of consciousness at any time, antegrade or retrograde amnesia, multiple trauma, and possible skull penetration--showed a high correlation with skull fractures and a slightly lower one with intracranial sequelae. The most predictive finding for brain injury was the depressed level of consciousness: brain injuries were never observed in fully conscious patients; in altered consciousness with GCS 15-13 we observed 4% of skull fractures with no sequelae; at GCS values 12-9, 61% of skull fractures and 20% of sequelae were present, whereas at GCS less than 8, 100% of complicated fracture were observed. The finding of skull fracture showed 33% of predictivity for brain damage, which was, however, always associated with \"high or moderate risk\" clinical signs. Therefore, the authors suggest some guidelines for the management of patients with recent head trauma, including referral criteria for X-rays or CT studies, based on signs and symptoms with high, intermediate and low risk of developing intracranial sequelae."}
{"qid": "58ce5a1602b8c60953000049", "original_text": "To study the function of Rli1/ABCE1 in vivo, we used ribosome profiling and biochemistry to characterize its contribution to ribosome recycling. When Rli1 levels were diminished, 80S ribosomes accumulated both at stop codons and in the adjoining 3'UTRs of most mRNAs.", "label": 1, "is_selected": 0, "text": "To study the function of Rli1/ABCE1 in vivo, we used ribosome profiling and biochemistry to characterize its contribution to ribosome recycling. When Rli1 levels were diminished, 80S ribosomes accumulated both at stop codons and in the adjoining 3'UTRs of most mRNAs."}
{"qid": "5e7f6090835f4e477700001a", "original_text": "Daptacel and IPOL are both vaccines used to prevent tetanus, diphtheria, and pertussis (whooping cough) in infants and children. While both vaccines are effective in protecting against these diseases, they contain different components and are formulated differently. Daptacel is a combination vaccine that contains inactivated toxoids of tetanus and diphtheria, as well as pertussis antigens. It is typically given as a series of shots in infancy and childhood, with booster doses recommended every 10 years thereafter. IPOL, on the other hand, is a acellular pertussis vaccine that contains only the pertussis antigens. It is also given as a series of shots in infancy and childhood, with booster doses recommended every 5-10 years. In summary, while both Daptacel and IPOL are effective in preventing tetanus, diphtheria, and pertussis, they have different formulations and may be used interchangeably in some cases. However, it is important to consult with a healthcare provider to determine the appropriate vaccine for an individual child based on their medical history and other factors.", "label": 0, "is_selected": 0, "text": "Daptacel and IPOL are both vaccines used to prevent tetanus, diphtheria, and pertussis (whooping cough) in infants and children. While both vaccines are effective in protecting against these diseases, they contain different components and are formulated differently. Daptacel is a combination vaccine that contains inactivated toxoids of tetanus and diphtheria, as well as pertussis antigens. It is typically given as a series of shots in infancy and childhood, with booster doses recommended every 10 years thereafter. IPOL, on the other hand, is a acellular pertussis vaccine that contains only the pertussis antigens. It is also given as a series of shots in infancy and childhood, with booster doses recommended every 5-10 years. In summary, while both Daptacel and IPOL are effective in preventing tetanus, diphtheria, and pertussis, they have different formulations and may be used interchangeably in some cases. However, it is important to consult with a healthcare provider to determine the appropriate vaccine for an individual child based on their medical history and other factors."}
{"qid": "534ebb59288f4dae47000004", "original_text": "Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder that manifests in females, typically after the first year of life. It is a leading cause of mental retardation and autistic behavior in girls and women; a hallmark of the disease is incessant hand movements in the form of wringing, twisting, or clapping. It was recently discovered that RTT is caused by mutations in the methyl-CpG-binding protein 2 (MECP2) gene. MECP2 assists in the transcriptional silencing process via DNA methylation;", "label": 1, "is_selected": 0, "text": "Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder that manifests in females, typically after the first year of life. It is a leading cause of mental retardation and autistic behavior in girls and women; a hallmark of the disease is incessant hand movements in the form of wringing, twisting, or clapping. It was recently discovered that RTT is caused by mutations in the methyl-CpG-binding protein 2 (MECP2) gene. MECP2 assists in the transcriptional silencing process via DNA methylation;"}
{"qid": "5880b073c872c95565000003", "original_text": "Andexanet Alfa is an antidote for clotting factor inhibitors, particularly anti-Xa inhibitors. These inhibitors are used to treat various coagulopathies, such as hemophilia A and acquired hemostatic disorders. Andexanet Alfa works by binding to the inhibitors and reversing their activity, thereby restoring the body's ability to form blood clots. It is important to note that Andexanet Alfa is only effective against anti-Xa inhibitors and not against other types of inhibitors, such as anti-factor Xa or anti-protein C.", "label": 0, "is_selected": 0, "text": "Andexanet Alfa is an antidote for clotting factor inhibitors, particularly anti-Xa inhibitors. These inhibitors are used to treat various coagulopathies, such as hemophilia A and acquired hemostatic disorders. Andexanet Alfa works by binding to the inhibitors and reversing their activity, thereby restoring the body's ability to form blood clots. It is important to note that Andexanet Alfa is only effective against anti-Xa inhibitors and not against other types of inhibitors, such as anti-factor Xa or anti-protein C."}
{"qid": "5709f027cf1c32585100001f", "original_text": "The Pfam database is a comprehensive collection of protein domain families, which are clusters of related protein sequences that share a common structural or functional characteristic. The database contains over 12,000 domain families and is a valuable resource for identifying protein-protein interactions, predicting protein function, and understanding protein evolution. Pfam is regularly updated based on new protein structures and sequences, and it is widely used in bioinformatics research and biotechnology applications.", "label": 0, "is_selected": 0, "text": "The Pfam database is a comprehensive collection of protein domain families, which are clusters of related protein sequences that share a common structural or functional characteristic. The database contains over 12,000 domain families and is a valuable resource for identifying protein-protein interactions, predicting protein function, and understanding protein evolution. Pfam is regularly updated based on new protein structures and sequences, and it is widely used in bioinformatics research and biotechnology applications."}
{"qid": "58b9585c22d3005309000010", "original_text": "A report of three cases of craniosynostosis in X-linked hypophosphataemic rickets (XLH) is presented. The literature is reviewed, suggesting that craniosynostosis is relatively common in XLH and that boys may be more at risk than girls. It is recommended that radiological screening be offered to all patients with XLH.", "label": 1, "is_selected": 0, "text": "A report of three cases of craniosynostosis in X-linked hypophosphataemic rickets (XLH) is presented. The literature is reviewed, suggesting that craniosynostosis is relatively common in XLH and that boys may be more at risk than girls. It is recommended that radiological screening be offered to all patients with XLH."}
{"qid": "6252f0b7e764a5320400001f", "original_text": "Key scientific discoveries have resulted from genetic studies of Drosophila melanogaster, using a multitude of transgenic fly strains, the majority of which are constructed in a genetic background containing mutations in the white gene. Here we report that white mutant flies from w1118 strain undergo retinal degeneration. We observed also that w1118 mutants have progressive loss of climbing ability, shortened life span, as well as impaired resistance to various forms of stress. Retinal degeneration was abolished by transgenic expression of mini-white+ in the white null background w1118 . We conclude that beyond the classical eye-color phenotype, mutations in Drosophila white gene could impair several biological functions affecting parameters like mobility, life span and stress tolerance.", "label": 1, "is_selected": 0, "text": "Key scientific discoveries have resulted from genetic studies of Drosophila melanogaster, using a multitude of transgenic fly strains, the majority of which are constructed in a genetic background containing mutations in the white gene. Here we report that white mutant flies from w1118 strain undergo retinal degeneration. We observed also that w1118 mutants have progressive loss of climbing ability, shortened life span, as well as impaired resistance to various forms of stress. Retinal degeneration was abolished by transgenic expression of mini-white+ in the white null background w1118 . We conclude that beyond the classical eye-color phenotype, mutations in Drosophila white gene could impair several biological functions affecting parameters like mobility, life span and stress tolerance."}
{"qid": "5c72ba807c78d69471000076", "original_text": "This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Bladder Cancer focuses on systemic therapy for muscle-invasive urothelial bladder cancer, as substantial revisions were made in the 2017 updates, such as new recommendations for nivolumab, pembrolizumab, atezolizumab, durvalumab, and avelumab. The complete version of the NCCN Guidelines for Bladder Cancer addresses additional aspects of the management of bladder cancer, including non-muscle-invasive urothelial bladder cancer and nonurothelial histologies, as well as staging, evaluation, and follow-up.", "label": 1, "is_selected": 0, "text": "This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Bladder Cancer focuses on systemic therapy for muscle-invasive urothelial bladder cancer, as substantial revisions were made in the 2017 updates, such as new recommendations for nivolumab, pembrolizumab, atezolizumab, durvalumab, and avelumab. The complete version of the NCCN Guidelines for Bladder Cancer addresses additional aspects of the management of bladder cancer, including non-muscle-invasive urothelial bladder cancer and nonurothelial histologies, as well as staging, evaluation, and follow-up."}
{"qid": "58e120036fddd3e83e00000d", "original_text": "Cryptococcus neoformans is an opportunistic pathogen that can cause skin infections in immunocompromised individuals, including those with HIV/AIDS, cancer, and taking immunosuppressive medications. It is not a frequent cause of isolated skin infections in otherwise healthy individuals. Isolation of Cryptococcus neoformans from skin specimens typically requires culturing on specialized media, and treatment typically involves antifungal medications, such as amphotericin B or fluconazole.", "label": 0, "is_selected": 1, "text": "Cryptococcus neoformans is an opportunistic pathogen that can cause skin infections in immunocompromised individuals, including those with HIV/AIDS, cancer, and taking immunosuppressive medications, and it is not a frequent cause of isolated skin infections from otherwise healthy individuals."}
{"qid": "5139b31dbee46bd34c000004", "original_text": "Both multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE), its animal model, involve inflammatory attack on central nervous system (CNS) white matter, leading to demyelination and axonal damage. Changes in astrocytic morphology and function are also prominent features of MS and EAE. Resting astrocytes form a network that is interconnected through gap junctions, composed mainly of connexin43 (Cx43) protein. Although astrocytic gap junctional connectivity is known to be altered in many CNS pathologies, little is known about Cx43 expression in inflammatory demyelinating disease. Therefore, we evaluated the expression of Cx43 in spinal cords of EAE mice compared with healthy controls. Lumbar ventral white matter areas were heavily infiltrated with CD11beta-immunoreactive monocytes, and within these infiltrated regions loss of Cx43 immunoreactivity was evident.", "label": 1, "is_selected": 0, "text": "Both multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE), its animal model, involve inflammatory attack on central nervous system (CNS) white matter, leading to demyelination and axonal damage. Changes in astrocytic morphology and function are also prominent features of MS and EAE. Resting astrocytes form a network that is interconnected through gap junctions, composed mainly of connexin43 (Cx43) protein. Although astrocytic gap junctional connectivity is known to be altered in many CNS pathologies, little is known about Cx43 expression in inflammatory demyelinating disease. Therefore, we evaluated the expression of Cx43 in spinal cords of EAE mice compared with healthy controls. Lumbar ventral white matter areas were heavily infiltrated with CD11beta-immunoreactive monocytes, and within these infiltrated regions loss of Cx43 immunoreactivity was evident."}
{"qid": "5e67b8bb1af46fc13000001b", "original_text": "Jaundice is one of the notable markers of liver malfunction in our body, revealing a significant rise in the concentration of an endogenous yellow pigment bilirubin. We have described a method for measuring the optical spectrum of our conjunctiva and derived pigment concentration by using diffused reflection measurement. The method uses no prior model and is expected to work across the races (skin color) encompassing a wide range of age groups. An optical fiber-based setup capable of measuring the conjunctival absorption spectrum from 400 to 800 nm is used to monitor the level of bilirubin and is calibrated with the value measured from blood serum of the same human subject. We have also developed software in the LabVIEW platform for use in online monitoring of bilirubin levels in human subjects by nonexperts. The results demonstrate that relative absorption at 460 and 600 nm has a distinct correlation with that of the bilirubin concentration measured from blood serum. Statistical analysis revealed that our proposed method is in agreement with the conventional biochemical method. The innovative noncontact, low-cost technique is expected to have importance in monitoring jaundice in developing/underdeveloped countries, where the inexpensive diagnosis of jaundice with minimally trained manpower is obligatory.", "label": 1, "is_selected": 0, "text": "Jaundice is one of the notable markers of liver malfunction in our body, revealing a significant rise in the concentration of an endogenous yellow pigment bilirubin. We have described a method for measuring the optical spectrum of our conjunctiva and derived pigment concentration by using diffused reflection measurement. The method uses no prior model and is expected to work across the races (skin color) encompassing a wide range of age groups. An optical fiber-based setup capable of measuring the conjunctival absorption spectrum from 400 to 800 nm is used to monitor the level of bilirubin and is calibrated with the value measured from blood serum of the same human subject. We have also developed software in the LabVIEW platform for use in online monitoring of bilirubin levels in human subjects by nonexperts. The results demonstrate that relative absorption at 460 and 600 nm has a distinct correlation with that of the bilirubin concentration measured from blood serum. Statistical analysis revealed that our proposed method is in agreement with the conventional biochemical method. The innovative noncontact, low-cost technique is expected to have importance in monitoring jaundice in developing/underdeveloped countries, where the inexpensive diagnosis of jaundice with minimally trained manpower is obligatory."}
{"qid": "5c8436f875a4a5d219000002", "original_text": "The latent infection of Epstein-Barr virus (EBV) is associated with 1% of human cancer incidence. Poly(ADP-ribosyl)ation (PARylation) is a posttranslational modification catalyzed by poly(ADP-ribose) polymerases (PARPs) that mediate EBV replication during latency. In this study, we detail the mechanisms that drive cellular PARylation during latent EBV infection and the effects of PARylation on host gene expression and cellular function. EBV-infected B cells had higher PAR levels than EBV-negative B cells. Moreover, cellular PAR levels were up to 2-fold greater in type III than type I latently infected EBV B cells. We identified a positive association between expression of the EBV genome-encoded latency membrane protein 1 (LMP1) and PAR levels that was dependent upon PARP1.", "label": 1, "is_selected": 0, "text": "The latent infection of Epstein-Barr virus (EBV) is associated with 1% of human cancer incidence. Poly(ADP-ribosyl)ation (PARylation) is a posttranslational modification catalyzed by poly(ADP-ribose) polymerases (PARPs) that mediate EBV replication during latency. In this study, we detail the mechanisms that drive cellular PARylation during latent EBV infection and the effects of PARylation on host gene expression and cellular function. EBV-infected B cells had higher PAR levels than EBV-negative B cells. Moreover, cellular PAR levels were up to 2-fold greater in type III than type I latently infected EBV B cells. We identified a positive association between expression of the EBV genome-encoded latency membrane protein 1 (LMP1) and PAR levels that was dependent upon PARP1."}
{"qid": "530cefaaad0bf1360c000012", "original_text": "Restless Leg Syndrome (RLS) is a neurological disorder characterized by an uncomfortable sensation in the legs, often described as a creeping or crawling feeling. The exact cause of RLS is not fully understood, but several deficiencies have been linked to the condition. The most commonly identified deficiency associated with RLS is iron deficiency, particularly iron deficiency anemia. Iron is essential for the production of dopamine, a neurotransmitter involved in muscle movement and coordination. Low levels of iron cannot support the production of dopamine, leading to the development of RLS. Other potential deficiencies that may contribute to RLS include magnesium, vitamin E, and folate. However, it is important to note that RLS can also occur in individuals with sufficient levels of these nutrients. A thorough medical evaluation is necessary to determine the underlying cause of RLS in each individual.", "label": 0, "is_selected": 0, "text": "Restless Leg Syndrome (RLS) is a neurological disorder characterized by an uncomfortable sensation in the legs, often described as a creeping or crawling feeling. The exact cause of RLS is not fully understood, but several deficiencies have been linked to the condition. The most commonly identified deficiency associated with RLS is iron deficiency, particularly iron deficiency anemia. Iron is essential for the production of dopamine, a neurotransmitter involved in muscle movement and coordination. Low levels of iron cannot support the production of dopamine, leading to the development of RLS. Other potential deficiencies that may contribute to RLS include magnesium, vitamin E, and folate. However, it is important to note that RLS can also occur in individuals with sufficient levels of these nutrients. A thorough medical evaluation is necessary to determine the underlying cause of RLS in each individual."}
{"qid": "5339edd6d6d3ac6a34000061", "original_text": "Our aim was to determine whether myocardial fibrosis, detected by cardiovascular magnetic resonance (CMR), represents an arrhythmogenic substrate in hypertrophic cardiomyopathy (HCM). Myocardial fibrosis is identified frequently in HCM; however, the clinical significance of this finding is uncertain. We studied prevalence and frequency of tachyarrhythmias on 24-h ambulatory Holter electrocardiogram (ECG) with regard to delayed enhancement (DE) on contrast-enhanced CMR in 177 HCM patients (age 41 +/- 16 yrs; 95% asymptomatic or mildly symptomatic). Premature ventricular contractions (PVCs), couplets, and nonsustained ventricular tachycardia (NSVT) were more common in patients with DE than those without DE (PVCs: 89% vs. 72%; couplets: 40% vs. 17%; NSVT: 28% vs. 4%; p < 0.0001 to 0.007).", "label": 1, "is_selected": 0, "text": "Our aim was to determine whether myocardial fibrosis, detected by cardiovascular magnetic resonance (CMR), represents an arrhythmogenic substrate in hypertrophic cardiomyopathy (HCM). Myocardial fibrosis is identified frequently in HCM; however, the clinical significance of this finding is uncertain. We studied prevalence and frequency of tachyarrhythmias on 24-h ambulatory Holter electrocardiogram (ECG) with regard to delayed enhancement (DE) on contrast-enhanced CMR in 177 HCM patients (age 41 +/- 16 yrs; 95% asymptomatic or mildly symptomatic). Premature ventricular contractions (PVCs), couplets, and nonsustained ventricular tachycardia (NSVT) were more common in patients with DE than those without DE (PVCs: 89% vs. 72%; couplets: 40% vs. 17%; NSVT: 28% vs. 4%; p < 0.0001 to 0.007)."}
{"qid": "5335c7f2d6d3ac6a34000051", "original_text": "The sodium glucose cotransporter 2 (SGLT2) is expressed primarily in the kidneys and is involved in the reabsorption of filtered glucose in the renal tubule. Clinical trials of SGLT2 inhibitors in patients with type 2 diabetes mellitus demonstrate a significant clinical effect in decreasing serum glucose, hemoglobin A1C, body weight, systolic blood pressure, improving \u03b2-cell function, and minimizing the risk of hypoglycemia. This report reviews the potentially beneficial effects of SGLT2 inhibitors in type 2 diabetes mellitus, specifically focusing on canagliflozin, the only SGLT2 inhibitor approved for use in the United States.", "label": 1, "is_selected": 0, "text": "The sodium glucose cotransporter 2 (SGLT2) is expressed primarily in the kidneys and is involved in the reabsorption of filtered glucose in the renal tubule. Clinical trials of SGLT2 inhibitors in patients with type 2 diabetes mellitus demonstrate a significant clinical effect in decreasing serum glucose, hemoglobin A1C, body weight, systolic blood pressure, improving \u03b2-cell function, and minimizing the risk of hypoglycemia. This report reviews the potentially beneficial effects of SGLT2 inhibitors in type 2 diabetes mellitus, specifically focusing on canagliflozin, the only SGLT2 inhibitor approved for use in the United States."}
{"qid": "58ec709aeda5a5767200000e", "original_text": "Citicoline is approved in some countries for the treatment of acute ischaemic stroke. The drug has shown some evidence of efficacy in a pooled analysis. We sought to confirm the efficacy of citicoline in a larger trial. We undertook a randomised, placebo-controlled, sequential trial in patients with moderate-to-severe acute ischaemic stroke admitted at university hospitals in Germany, Portugal, and Spain. Using a centralised minimisation process, patients were randomly assigned in a 1:1 ratio to receive citicoline or placebo within 24 h after the onset of symptoms (1000 mg every 12 h intravenously during the first 3 days and orally thereafter for a total of 6 weeks [2\u00d7500 mg oral tablets given every 12 h]). All study participants were masked. The primary outcome was recovery at 90 days measured by a global test combining three measures of success: National Institutes of Health Stroke Scale \u22641, modified Rankin score \u22641, and Barthel Index \u226595. Safety endpoints included symptomatic intracranial haemorrhage in patients treated with recombinant tissue plasminogen activator, neurological deterioration, and mortality.", "label": 1, "is_selected": 0, "text": "Citicoline is approved in some countries for the treatment of acute ischaemic stroke. The drug has shown some evidence of efficacy in a pooled analysis. We sought to confirm the efficacy of citicoline in a larger trial. We undertook a randomised, placebo-controlled, sequential trial in patients with moderate-to-severe acute ischaemic stroke admitted at university hospitals in Germany, Portugal, and Spain. Using a centralised minimisation process, patients were randomly assigned in a 1:1 ratio to receive citicoline or placebo within 24 h after the onset of symptoms (1000 mg every 12 h intravenously during the first 3 days and orally thereafter for a total of 6 weeks [2\u00d7500 mg oral tablets given every 12 h]). All study participants were masked. The primary outcome was recovery at 90 days measured by a global test combining three measures of success: National Institutes of Health Stroke Scale \u22641, modified Rankin score \u22641, and Barthel Index \u226595. Safety endpoints included symptomatic intracranial haemorrhage in patients treated with recombinant tissue plasminogen activator, neurological deterioration, and mortality."}
{"qid": "55031d82e9bde6963400002c", "original_text": "To assess ictal adiponectin (ADP) levels before and after acute abortive treatment in women episodic migraineurs. Peripheral blood specimens were collected from women episodic migraineurs before and after acute abortive treatment with sumatriptan/naproxen sodium vs placebo. Univariate and multivariate models were utilized to examine the relationship between serum total ADP (T-ADP), ADP oligomers (high molecular weight [HMW], middle molecular weight, and low molecular weight [LMW]-ADP), and ADP ratio levels and pain severity. Paired t-tests and random intercept longitudinal models were utilized to assess the mean changes in T-ADP, ADP oligomers, and ratios over time in treatment responders and nonresponders. Twenty participants (11 responders, 9 nonresponders) have been studied to date. In all participants, increases in the HMW : LMW ADP ratio were associated with an increase in pain severity. For every 1 point increase in the HMW : LMW ratio, pain severity increased by 0.22 (Confidence Interval [CI]: 0.07, 0.37; P = .004). In contrast, for every 0.25 \u03bcg/mL increase in LMW-ADP, pain severity decreased by 0.20 (CI: -0.41, -0.002; P = .047). In treatment responders, T-ADP levels were reduced at 30 minutes (12.52 \u00b1 3.4; P = .03), 60 minutes (12.32 \u00b1 3.2; P = .017), and 120 minutes (12.65 \u00b1 3.2; P = .016) after treatment as compared with onset (13.48 \u00b1 3.8).", "label": 1, "is_selected": 0, "text": "To assess ictal adiponectin (ADP) levels before and after acute abortive treatment in women episodic migraineurs. Peripheral blood specimens were collected from women episodic migraineurs before and after acute abortive treatment with sumatriptan/naproxen sodium vs placebo. Univariate and multivariate models were utilized to examine the relationship between serum total ADP (T-ADP), ADP oligomers (high molecular weight [HMW], middle molecular weight, and low molecular weight [LMW]-ADP), and ADP ratio levels and pain severity. Paired t-tests and random intercept longitudinal models were utilized to assess the mean changes in T-ADP, ADP oligomers, and ratios over time in treatment responders and nonresponders. Twenty participants (11 responders, 9 nonresponders) have been studied to date. In all participants, increases in the HMW : LMW ADP ratio were associated with an increase in pain severity. For every 1 point increase in the HMW : LMW ratio, pain severity increased by 0.22 (Confidence Interval [CI]: 0.07, 0.37; P = .004). In contrast, for every 0.25 \u03bcg/mL increase in LMW-ADP, pain severity decreased by 0.20 (CI: -0.41, -0.002; P = .047). In treatment responders, T-ADP levels were reduced at 30 minutes (12.52 \u00b1 3.4; P = .03), 60 minutes (12.32 \u00b1 3.2; P = .017), and 120 minutes (12.65 \u00b1 3.2; P = .016) after treatment as compared with onset (13.48 \u00b1 3.8)."}
{"qid": "5fdb4112a43ad31278000016", "original_text": "Super-enhancers or stretch enhancers are clusters of active enhancers that often coordinate cell-type specific gene regulation during development and differentiation. In addition, the enrichment of disease-associated single nucleotide polymorphism in super-enhancers indicates their critical function in disease-specific gene regulation. However, little is known about the function of super-enhancers beyond gene regulation. In this study, through a comprehensive analysis of super-enhancers in 30 human cell/tissue types, we identified a new class of super-enhancers which are constitutively active across most cell/tissue types.", "label": 1, "is_selected": 0, "text": "Super-enhancers or stretch enhancers are clusters of active enhancers that often coordinate cell-type specific gene regulation during development and differentiation. In addition, the enrichment of disease-associated single nucleotide polymorphism in super-enhancers indicates their critical function in disease-specific gene regulation. However, little is known about the function of super-enhancers beyond gene regulation. In this study, through a comprehensive analysis of super-enhancers in 30 human cell/tissue types, we identified a new class of super-enhancers which are constitutively active across most cell/tissue types."}
{"qid": "514a0f4ad24251bc05000053", "original_text": "The clinical significance of tumor-infiltrating immune cells has been reported in a variety of human carcinomas including breast cancer. However, molecular signature of tumor-infiltrating immune cells and their prognostic value in breast cancer patients remain elusive. We hypothesized that a distinct network of immune function genes at the tumor site can predict a low risk versus high risk of distant relapse in breast cancer patients regardless of the status of ER, PR, or HER-2/neu in their tumors. We conducted retrospective studies in a diverse cohort of breast cancer patients with a 1-5 year tumor relapse versus those with up to 7 years relapse-free survival.", "label": 1, "is_selected": 0, "text": "The clinical significance of tumor-infiltrating immune cells has been reported in a variety of human carcinomas including breast cancer. However, molecular signature of tumor-infiltrating immune cells and their prognostic value in breast cancer patients remain elusive. We hypothesized that a distinct network of immune function genes at the tumor site can predict a low risk versus high risk of distant relapse in breast cancer patients regardless of the status of ER, PR, or HER-2/neu in their tumors. We conducted retrospective studies in a diverse cohort of breast cancer patients with a 1-5 year tumor relapse versus those with up to 7 years relapse-free survival."}
{"qid": "5e482160d14c9f295d00000c", "original_text": "Certainly! Here are five proteins with antioxidant properties: 1. Superoxide dismutase (SOD): This enzyme is found in various tissues, including the brain, and plays a crucial role in protecting cells against oxidative damage caused by superoxides. 2. Glutathione peroxidase (GPx): GPx is an enzyme that is present in the body's cells and tissues, and it helps to protect cells against damage caused by reactive oxygen species (ROS) by scavenging hydrogen peroxide. 3. Catalase (CAT): CAT is an enzyme found in many cells throughout the body, including cells in the brain, heart, and liver. It helps to neutralize hydrogen peroxide, a byproduct of oxidative metabolism, and prevent oxidative damage. 4. Ferritin: Ferritin is a protein that stores and releases iron in the body. It also has antioxidant properties, with the ability to scavenge free radicals and reduce oxidative stress. 5. Thioredoxin (Trx): Trx is a protein that acts as a glutathione-similar antioxidant enzyme, reducing oxidized glutathione and other oxidized thiols to their reduced forms, thereby protecting against oxidative damage. I hope this information is helpful! If you have any further questions, please don't hesitate to ask.", "label": 0, "is_selected": 0, "text": "Certainly! Here are five proteins with antioxidant properties: 1. Superoxide dismutase (SOD): This enzyme is found in various tissues, including the brain, and plays a crucial role in protecting cells against oxidative damage caused by superoxides. 2. Glutathione peroxidase (GPx): GPx is an enzyme that is present in the body's cells and tissues, and it helps to protect cells against damage caused by reactive oxygen species (ROS) by scavenging hydrogen peroxide. 3. Catalase (CAT): CAT is an enzyme found in many cells throughout the body, including cells in the brain, heart, and liver. It helps to neutralize hydrogen peroxide, a byproduct of oxidative metabolism, and prevent oxidative damage. 4. Ferritin: Ferritin is a protein that stores and releases iron in the body. It also has antioxidant properties, with the ability to scavenge free radicals and reduce oxidative stress. 5. Thioredoxin (Trx): Trx is a protein that acts as a glutathione-similar antioxidant enzyme, reducing oxidized glutathione and other oxidized thiols to their reduced forms, thereby protecting against oxidative damage. I hope this information is helpful! If you have any further questions, please don't hesitate to ask."}
{"qid": "52ce531f03868f1b06000031", "original_text": "The theoretical possibility of applying gene transfer methodologies to the human germline is explored. Transgenic methods for genetically manipulating embryos may in principle be applied to humans. In particular, microinjection of retroviral vector appears to hold the greatest promise, with transgenic primates already obtained from this approach. Sperm-mediated gene transfer offers potentially the easiest route to the human germline, however the requisite methodology is presently underdeveloped. Nuclear transfer (cloning) offers an alternative approach to germline genetic modification, however there are major health concerns associated with current nuclear transfer methods.", "label": 1, "is_selected": 0, "text": "The theoretical possibility of applying gene transfer methodologies to the human germline is explored. Transgenic methods for genetically manipulating embryos may in principle be applied to humans. In particular, microinjection of retroviral vector appears to hold the greatest promise, with transgenic primates already obtained from this approach. Sperm-mediated gene transfer offers potentially the easiest route to the human germline, however the requisite methodology is presently underdeveloped. Nuclear transfer (cloning) offers an alternative approach to germline genetic modification, however there are major health concerns associated with current nuclear transfer methods."}
{"qid": "5c83f858617e120c34000003", "original_text": "To evaluate the efficacy and safety of a tailored endovesical immunotherapy protocol with biweekly BCG for elderly Patients with high risk non muscle invasive bladder cancer (HG-NMIBC). We retrospectively evaluated data from 200 patients older than 80 years newly diagnosed with HG-NMIBC: 100 (group 1) with multiple comorbidities (WHO PS 2-3, ASA score \u22653, Charlson Comorbidity index \u22653, GFR<60 mL/min) were treated with BCG induction course administered biweekly; 100 (group 2) with statistically significant better conditions were treated with standard weekly BCG therapy. After the induction treatment disease-free patients underwent to at least one year of BCG maintenance therapy. Endpoints were: initial response to BCG, cancer-free survival and rate of progression at 2 years, rate of complications.", "label": 1, "is_selected": 0, "text": "To evaluate the efficacy and safety of a tailored endovesical immunotherapy protocol with biweekly BCG for elderly Patients with high risk non muscle invasive bladder cancer (HG-NMIBC). We retrospectively evaluated data from 200 patients older than 80 years newly diagnosed with HG-NMIBC: 100 (group 1) with multiple comorbidities (WHO PS 2-3, ASA score \u22653, Charlson Comorbidity index \u22653, GFR<60 mL/min) were treated with BCG induction course administered biweekly; 100 (group 2) with statistically significant better conditions were treated with standard weekly BCG therapy. After the induction treatment disease-free patients underwent to at least one year of BCG maintenance therapy. Endpoints were: initial response to BCG, cancer-free survival and rate of progression at 2 years, rate of complications."}
{"qid": "5fe3131fa43ad3127800004a", "original_text": "Exposure of renal mesangial cells to sphingosine 1-phosphate (S1P) leads to a rapid and transient activation of the mitogen- and stress-activated protein kinases but also the protein kinase B. Here, we show that S1P also induces phosphorylation of Smad proteins, which are members of the transforming growth factor-beta (TGF-beta) signaling device. However, Smad phosphorylation occurred more slowly with a maximal effect after 20-30 min of S1P stimulation when compared with the rapid activation of the MAPKs.", "label": 1, "is_selected": 0, "text": "Exposure of renal mesangial cells to sphingosine 1-phosphate (S1P) leads to a rapid and transient activation of the mitogen- and stress-activated protein kinases but also the protein kinase B. Here, we show that S1P also induces phosphorylation of Smad proteins, which are members of the transforming growth factor-beta (TGF-beta) signaling device. However, Smad phosphorylation occurred more slowly with a maximal effect after 20-30 min of S1P stimulation when compared with the rapid activation of the MAPKs."}
{"qid": "5e4adc296d0a277941000016", "original_text": "The underlying molecular processes representing stress responses to low-dose ionising radiation (LDIR) in mammals are just beginning to be understood. In particular, LDIR effects on the brain and their possible association with neurodegenerative disease are currently being explored using omics technologies. We describe a light-weight approach for the storage, analysis and distribution of relevant LDIR omics datasets. The data integration platform, called BRIDE, contains information from the literature as well as experimental information from transcriptomics and proteomics studies. It deploys a hybrid, distributed solution using both local storage and cloud technology.", "label": 1, "is_selected": 0, "text": "The underlying molecular processes representing stress responses to low-dose ionising radiation (LDIR) in mammals are just beginning to be understood. In particular, LDIR effects on the brain and their possible association with neurodegenerative disease are currently being explored using omics technologies. We describe a light-weight approach for the storage, analysis and distribution of relevant LDIR omics datasets. The data integration platform, called BRIDE, contains information from the literature as well as experimental information from transcriptomics and proteomics studies. It deploys a hybrid, distributed solution using both local storage and cloud technology."}
{"qid": "5c6e16eb7c78d6947100004e", "original_text": "Sweat chloride testing for diagnosis of cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab. We have developed a wearable sensor with an integrated salt bridge for real-time measurement of sweat chloride concentration. Here, in a proof-of-concept study, we compare the performance of the sensor to current clinical practice in CF patients and healthy subjects. Sweat was induced on both forearms of 10 individuals with CF and 10 healthy subjects using pilocarpine iontophoresis. A Macroduct sweat collection device was attached to one arm and sweat was collected for 30 min and then sent for laboratory analysis.", "label": 1, "is_selected": 0, "text": "Sweat chloride testing for diagnosis of cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab. We have developed a wearable sensor with an integrated salt bridge for real-time measurement of sweat chloride concentration. Here, in a proof-of-concept study, we compare the performance of the sensor to current clinical practice in CF patients and healthy subjects. Sweat was induced on both forearms of 10 individuals with CF and 10 healthy subjects using pilocarpine iontophoresis. A Macroduct sweat collection device was attached to one arm and sweat was collected for 30 min and then sent for laboratory analysis."}
{"qid": "5e94a8250d431b5f73000001", "original_text": "The armadillo repeat proteins were first found in armadillo gene of Drosophila. Since then a number of proteins containing armadillo repeats have been noticed and studied. These proteins that consist of 6 to 13 armadillo repeat domains are classified as family of armadillo repeat proteins. Recently, several studies indicated that armadillo repeat family of proteins play an important role in the tumorigenesis and maintenance of tissue integrity. ALEX1 (Arm protein lost in epithelial cancers, on chromosome X), contains two armadillo repeats domains, is expressed different in normal and carcinomas tissues.", "label": 1, "is_selected": 0, "text": "The armadillo repeat proteins were first found in armadillo gene of Drosophila. Since then a number of proteins containing armadillo repeats have been noticed and studied. These proteins that consist of 6 to 13 armadillo repeat domains are classified as family of armadillo repeat proteins. Recently, several studies indicated that armadillo repeat family of proteins play an important role in the tumorigenesis and maintenance of tissue integrity. ALEX1 (Arm protein lost in epithelial cancers, on chromosome X), contains two armadillo repeats domains, is expressed different in normal and carcinomas tissues."}
{"qid": "56cf27293975bb303a000003", "original_text": "Voltage-sensitive calcium channel conductance is essential for the nervous system to signal a painful event. However, intrathecal administration of L-type calcium channel blockers does not provide analgesia. The present investigation was designed to assess the safety and analgesic efficacy of ziconotide, a new N-type calcium channel blocker, when administered intrathecally to patients with acute postoperative pain. This randomized, double-blind, pilot study included patients undergoing elective total abdominal hysterectomy, radical prostatectomy, or total hip replacement. After intrathecal injection of local anesthetic and before surgical incision, a continuous intrathecal infusion of either placebo or 1 of 2 doses of ziconotide (0.7 microg/h or 7.0 microg/h) was started and continued for 48 to 72 hours postoperatively. Primary and secondary efficacy variables were the mean daily patient controlled analgesia (PCA) morphine equivalent consumption and visual analog pain intensity (VASPI) scores, respectively. Thirty patients received study drug; 26 were evaluable for efficacy. Mean daily PCA morphine equivalent consumption was less in patients receiving ziconotide than in placebo-treated patients, and the difference was statistically significant between 24 and 48 hours (P = .040).", "label": 1, "is_selected": 0, "text": "Voltage-sensitive calcium channel conductance is essential for the nervous system to signal a painful event. However, intrathecal administration of L-type calcium channel blockers does not provide analgesia. The present investigation was designed to assess the safety and analgesic efficacy of ziconotide, a new N-type calcium channel blocker, when administered intrathecally to patients with acute postoperative pain. This randomized, double-blind, pilot study included patients undergoing elective total abdominal hysterectomy, radical prostatectomy, or total hip replacement. After intrathecal injection of local anesthetic and before surgical incision, a continuous intrathecal infusion of either placebo or 1 of 2 doses of ziconotide (0.7 microg/h or 7.0 microg/h) was started and continued for 48 to 72 hours postoperatively. Primary and secondary efficacy variables were the mean daily patient controlled analgesia (PCA) morphine equivalent consumption and visual analog pain intensity (VASPI) scores, respectively. Thirty patients received study drug; 26 were evaluable for efficacy. Mean daily PCA morphine equivalent consumption was less in patients receiving ziconotide than in placebo-treated patients, and the difference was statistically significant between 24 and 48 hours (P = .040)."}
{"qid": "53061af558348c0f52000002", "original_text": "Although reactive oxygen species have been proposed to play a major role in the aging process, the exact molecular mechanisms remain elusive. In this study we investigate the effects of a perturbation in the ratio of Cu/Zn-superoxide dismutase activity (Sod1 dismutases .O2-to H2O2) to glutathione peroxidase activity (Gpx1 catalyses H2O2 conversion to H2O) on cell growth and development. Our data demonstrate that Sod1 transfected cell lines that have an elevation in the ratio of Sod1 activity to Gpx1 activity produce higher levels of H2O2 and exhibit well characterised markers of cellular senescence viz. slower proliferation and altered morphology. On the contrary, Sod1 transfected cell lines that have an unaltered ratio in the activity of these two enzymes, have unaltered levels of H2O2 and fail to show characteristics of senescence. Furthermore, fibroblasts established from individuals with Down syndrome have an increase in the ratio of Sod1 to Gpx1 activity compared with corresponding controls and senesce earlier. Interestingly, cells treated with H2O2 also show features of senescence and/or senesce earlier. We also show that Cip1 mRNA levels are elevated in Down syndrome cells, Sod1 transfectants with an altered Sod1 to Gpx1 activity ratio and those treated with H2O2, thus suggesting that the slow proliferation may be mediated by Cip1.", "label": 1, "is_selected": 0, "text": "Although reactive oxygen species have been proposed to play a major role in the aging process, the exact molecular mechanisms remain elusive. In this study we investigate the effects of a perturbation in the ratio of Cu/Zn-superoxide dismutase activity (Sod1 dismutases .O2-to H2O2) to glutathione peroxidase activity (Gpx1 catalyses H2O2 conversion to H2O) on cell growth and development. Our data demonstrate that Sod1 transfected cell lines that have an elevation in the ratio of Sod1 activity to Gpx1 activity produce higher levels of H2O2 and exhibit well characterised markers of cellular senescence viz. slower proliferation and altered morphology. On the contrary, Sod1 transfected cell lines that have an unaltered ratio in the activity of these two enzymes, have unaltered levels of H2O2 and fail to show characteristics of senescence. Furthermore, fibroblasts established from individuals with Down syndrome have an increase in the ratio of Sod1 to Gpx1 activity compared with corresponding controls and senesce earlier. Interestingly, cells treated with H2O2 also show features of senescence and/or senesce earlier. We also show that Cip1 mRNA levels are elevated in Down syndrome cells, Sod1 transfectants with an altered Sod1 to Gpx1 activity ratio and those treated with H2O2, thus suggesting that the slow proliferation may be mediated by Cip1."}
{"qid": "56d042ae3975bb303a00000d", "original_text": "In recent years, many personalized treatments have been developed for NSCLC (non-small-cell lung cancer) patients. Among these, gefitinib, erlotinib, and afatinib are selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for patients with EGFR gene mutations, while crizotinib and ceritinib are two new tyrosine kinase inhibitors directed against the echinoderm microtubule-like protein 4-anaplastic lymphoma kinase translocation. The possibility of these new molecules being used to treat patients without adenocarcinoma histology is notably small. For example, EGFR mutations and anaplastic lymphoma kinase fusion gene rearrangement are rare in patients with squamous cell carcinoma (generally <1%). Additionally, the benefit of targeted treatment approaches in patients with small-cell lung cancer histology is limited.", "label": 1, "is_selected": 0, "text": "In recent years, many personalized treatments have been developed for NSCLC (non-small-cell lung cancer) patients. Among these, gefitinib, erlotinib, and afatinib are selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for patients with EGFR gene mutations, while crizotinib and ceritinib are two new tyrosine kinase inhibitors directed against the echinoderm microtubule-like protein 4-anaplastic lymphoma kinase translocation. The possibility of these new molecules being used to treat patients without adenocarcinoma histology is notably small. For example, EGFR mutations and anaplastic lymphoma kinase fusion gene rearrangement are rare in patients with squamous cell carcinoma (generally <1%). Additionally, the benefit of targeted treatment approaches in patients with small-cell lung cancer histology is limited."}
{"qid": "61f7cca7882a024a1000002b", "original_text": "Pulmonary arterial hypertension is characterized by pulmonary vascular remodeling, cellular proliferation, and poor long-term outcomes. Dysfunctional bone morphogenetic protein pathway signaling is associated with both hereditary and idiopathic subtypes. Sotatercept, a novel fusion protein, binds activins and growth differentiation factors in the attempt to restore balance between growth-promoting and growth-inhibiting signaling pathways. In this 24-week multicenter trial, we randomly assigned 106 adults who were receiving background therapy for pulmonary arterial hypertension to receive subcutaneous sotatercept at a dose of 0.3 mg per kilogram of body weight every 3 weeks or 0.7 mg per kilogram every 3 weeks or placebo. The primary end point was the change from baseline to week 24 in pulmonary vascular resistance. Baseline characteristics were similar among the three groups. The least-squares mean difference between the sotatercept 0.3-mg group and the placebo group in the change from baseline to week 24 in pulmonary vascular resistance was -145.8 dyn \u00b7 sec \u00b7 cm-5 (95% confidence interval [CI], -241.0 to -50.6; P = 0.003). The least-squares mean difference between the sotatercept 0.7-mg group and the placebo group was -239.5 dyn \u00b7 sec \u00b7 cm-5 (95% CI, -329.3 to -149.7; P<0.001).", "label": 1, "is_selected": 0, "text": "Pulmonary arterial hypertension is characterized by pulmonary vascular remodeling, cellular proliferation, and poor long-term outcomes. Dysfunctional bone morphogenetic protein pathway signaling is associated with both hereditary and idiopathic subtypes. Sotatercept, a novel fusion protein, binds activins and growth differentiation factors in the attempt to restore balance between growth-promoting and growth-inhibiting signaling pathways. In this 24-week multicenter trial, we randomly assigned 106 adults who were receiving background therapy for pulmonary arterial hypertension to receive subcutaneous sotatercept at a dose of 0.3 mg per kilogram of body weight every 3 weeks or 0.7 mg per kilogram every 3 weeks or placebo. The primary end point was the change from baseline to week 24 in pulmonary vascular resistance. Baseline characteristics were similar among the three groups. The least-squares mean difference between the sotatercept 0.3-mg group and the placebo group in the change from baseline to week 24 in pulmonary vascular resistance was -145.8 dyn \u00b7 sec \u00b7 cm-5 (95% confidence interval [CI], -241.0 to -50.6; P = 0.003). The least-squares mean difference between the sotatercept 0.7-mg group and the placebo group was -239.5 dyn \u00b7 sec \u00b7 cm-5 (95% CI, -329.3 to -149.7; P<0.001)."}
{"qid": "5883bce3e56acf5176000003", "original_text": "Chromatin immunoprecipitation sequencing (ChIP-seq) is a powerful tool for identifying genomic regions bound by transcription factors and other proteins. The resulting data can be analyzed using various pipelines, depending on the specific research question and experimental design. Here are some common pipelines used for analyzing ChIP-nexus data: 1. Peak calling: This step involves identifying regions of the genome where the protein of interest is specifically bound. This is typically done using algorithms such as HISAT2, STAR, or BEDTools, which compare the sequencing data to a known reference genome and identify regions with significantly enriched reads. 2. Region annotation: After peak calling, the identified peaks are typically annotated to predict their functional significance. This may involve assigning peaks to histone modification types, identifying nearby gene promoters or enhancers, or predicting the binding affinity of the protein. Tools such as HaplotypeCaller, Bedtools, and MACS2 can be used for this purpose. 3. Motif analysis: This step involves identifying specific DNA sequences (motifs) that are enriched near the peaks identified in the previous step. This can provide insight into the binding preferences of the protein and help interpret the functional implications of the peaks. Tools such as MEME, MAVID, and HISAT2 can be used for motif analysis. 4. Integrative analysis: Finally, the ChIP-nexus data may be integrated with other types of genomic data, such as gene expression profiles or DNA sequence data, to provide a more comprehensive understanding of the protein's function. Tools such as Jupyter Notebook, R Studio, or Python can be used for this purpose. It's worth noting that the choice of pipeline will depend on the specific research question and experimental design, as well as the availability and compatibility of computational resources.", "label": 0, "is_selected": 0, "text": "Chromatin immunoprecipitation sequencing (ChIP-seq) is a powerful tool for identifying genomic regions bound by transcription factors and other proteins. The resulting data can be analyzed using various pipelines, depending on the specific research question and experimental design. Here are some common pipelines used for analyzing ChIP-nexus data: 1. Peak calling: This step involves identifying regions of the genome where the protein of interest is specifically bound. This is typically done using algorithms such as HISAT2, STAR, or BEDTools, which compare the sequencing data to a known reference genome and identify regions with significantly enriched reads. 2. Region annotation: After peak calling, the identified peaks are typically annotated to predict their functional significance. This may involve assigning peaks to histone modification types, identifying nearby gene promoters or enhancers, or predicting the binding affinity of the protein. Tools such as HaplotypeCaller, Bedtools, and MACS2 can be used for this purpose. 3. Motif analysis: This step involves identifying specific DNA sequences (motifs) that are enriched near the peaks identified in the previous step. This can provide insight into the binding preferences of the protein and help interpret the functional implications of the peaks. Tools such as MEME, MAVID, and HISAT2 can be used for motif analysis. 4. Integrative analysis: Finally, the ChIP-nexus data may be integrated with other types of genomic data, such as gene expression profiles or DNA sequence data, to provide a more comprehensive understanding of the protein's function. Tools such as Jupyter Notebook, R Studio, or Python can be used for this purpose. It's worth noting that the choice of pipeline will depend on the specific research question and experimental design, as well as the availability and compatibility of computational resources."}
{"qid": "5a74b1730384be9551000007", "original_text": "The AAV2-hRPE65v2 gene therapy drug targets the RPE65 gene, which is a retinal dystrophy-related gene that is associated with Leber congenital amaurosis (LCA), a rare and severe form of inherited retinal disease. The RPE65 gene encodes for the rhodopsin protein, which is involved in the visual cycle and is essential for the maintenance of photoreceptor function. Mutations in the RPE65 gene can lead to a deficiency in rhodopsin production, resulting in vision loss and blindness. The AAV2-hRPE65v2 gene therapy has been shown to successfully deliver a functional copy of the RPE65 gene to the retina, restoring rhodopsin production and improving vision in patients with LCA.", "label": 0, "is_selected": 0, "text": "The AAV2-hRPE65v2 gene therapy drug targets the RPE65 gene, which is a retinal dystrophy-related gene that is associated with Leber congenital amaurosis (LCA), a rare and severe form of inherited retinal disease. The RPE65 gene encodes for the rhodopsin protein, which is involved in the visual cycle and is essential for the maintenance of photoreceptor function. Mutations in the RPE65 gene can lead to a deficiency in rhodopsin production, resulting in vision loss and blindness. The AAV2-hRPE65v2 gene therapy has been shown to successfully deliver a functional copy of the RPE65 gene to the retina, restoring rhodopsin production and improving vision in patients with LCA."}
{"qid": "5c53131e7e3cb0e231000012", "original_text": "The introduction of measles vaccination programs and broad coverage worldwide has meant this infection a rare encounter for pediatricians. In Oman, with almost 100% measles vaccination coverage for children, this infection disappeared from the list of fever and rash differential diagnoses. Encephalitis is a well-known complication of measles infection and sometimes can be the only manifestation especially in adults. We report a seven-year-old Syrian immigrant who was admitted to the Royal Hospital, Muscat, with acute encephalitis secondary to wild measles infection. Although she had a classical presentation of measle infection, the diagnosis was missed in the private and regional hospital she attended before getting referred to Royal Hospital. She was later identified to be exposed to an outbreak of the infection in an unvaccinated population. Magnetic resonance imaging showed high signal intensity of both basal ganglia suggestive of measles encephalitis. The diagnosis was confirmed by detection of measles virus from her urine and blood, and a throat swab.", "label": 1, "is_selected": 0, "text": "The introduction of measles vaccination programs and broad coverage worldwide has meant this infection a rare encounter for pediatricians. In Oman, with almost 100% measles vaccination coverage for children, this infection disappeared from the list of fever and rash differential diagnoses. Encephalitis is a well-known complication of measles infection and sometimes can be the only manifestation especially in adults. We report a seven-year-old Syrian immigrant who was admitted to the Royal Hospital, Muscat, with acute encephalitis secondary to wild measles infection. Although she had a classical presentation of measle infection, the diagnosis was missed in the private and regional hospital she attended before getting referred to Royal Hospital. She was later identified to be exposed to an outbreak of the infection in an unvaccinated population. Magnetic resonance imaging showed high signal intensity of both basal ganglia suggestive of measles encephalitis. The diagnosis was confirmed by detection of measles virus from her urine and blood, and a throat swab."}
{"qid": "56d2ee61f22319765a000007", "original_text": "RNA methylation modifications have been found for decades of years, which occur at different RNA types of numerous species, and their distribution is species-specific. However, people rarely know their biological functions. There are several identified methylation modifications in eukaryotic messenger RNA (mRNA), such as N(7)-methylguanosine (m(7)G) at the cap, N(6)-methyl-2'-O-methyladenosine (m(6)Am), 2'-O-methylation (Nm) within the cap and the internal positions, and internal N(6)-methyladenosine (m(6)A) and 5-methylcytosine (m(5)C).", "label": 1, "is_selected": 0, "text": "RNA methylation modifications have been found for decades of years, which occur at different RNA types of numerous species, and their distribution is species-specific. However, people rarely know their biological functions. There are several identified methylation modifications in eukaryotic messenger RNA (mRNA), such as N(7)-methylguanosine (m(7)G) at the cap, N(6)-methyl-2'-O-methyladenosine (m(6)Am), 2'-O-methylation (Nm) within the cap and the internal positions, and internal N(6)-methyladenosine (m(6)A) and 5-methylcytosine (m(5)C)."}
{"qid": "5c61bacae842deac67000001", "original_text": "Cariprazine is an antipsychotic medication that has been approved for the treatment of mania and mixed episodes in bipolar I disorder. Studies have shown that cariprazine can be effective in reducing symptoms of mania and improving overall functioning in patients with bipolar disorder. A systematic review and meta-analysis of 14 randomized controlled trials found that cariprazine was associated with significant improvements in manic symptoms and quality of life compared to placebo. However, the review also noted that the evidence was limited by the small number of studies and the variability in study design. Further research is needed to fully understand the safety and efficacy of cariprazine for the treatment of bipolar disorder.", "label": 0, "is_selected": 0, "text": "Cariprazine is an antipsychotic medication that has been approved for the treatment of mania and mixed episodes in bipolar I disorder. Studies have shown that cariprazine can be effective in reducing symptoms of mania and improving overall functioning in patients with bipolar disorder. A systematic review and meta-analysis of 14 randomized controlled trials found that cariprazine was associated with significant improvements in manic symptoms and quality of life compared to placebo. However, the review also noted that the evidence was limited by the small number of studies and the variability in study design. Further research is needed to fully understand the safety and efficacy of cariprazine for the treatment of bipolar disorder."}
{"qid": "58f4c22170f9fc6f0f000018", "original_text": "Uhl's anomaly is a rare congenital anomaly characterized by a triad of findings: absent or hypoplastic kidney, absence of the superior mesenteric vein, and aberrant right subclavian artery. It is caused by a vascular defect during fetal development and can lead to urinary tract infections, pyelonephritis, and other complications. Treatment options include surgical repair or dialysis, depending on the severity of the condition.", "label": 0, "is_selected": 1, "text": "This patient has Uhl's anomaly, a rare congenital condition that affects the kidney and bladder and can lead to complications such as urinary tract infections, pyelonephritis, and other serious complications.<n> Treatment options include surgical repair or dialysis, depending on the severity of the condition."}
{"qid": "5e2a046caa19d74431000008", "original_text": "Patients with secondary acute myeloid leukemia (sAML) arising from myelodysplastic syndromes have a poor prognosis marked by an increased resistance to chemotherapy. An urgent need exists for adjuvant treatments that can enhance or replace current therapeutic options. Here we show the potential of LB100, a small-molecule protein phosphatase 2 A (PP2A) inhibitor, as a monotherapy and chemosensitizing agent for sAML using an in-vitro and in-vivo approach. We demonstrate that LB100 decreases cell viability through caspase activation and G2/M cell-cycle arrest.", "label": 1, "is_selected": 0, "text": "Patients with secondary acute myeloid leukemia (sAML) arising from myelodysplastic syndromes have a poor prognosis marked by an increased resistance to chemotherapy. An urgent need exists for adjuvant treatments that can enhance or replace current therapeutic options. Here we show the potential of LB100, a small-molecule protein phosphatase 2 A (PP2A) inhibitor, as a monotherapy and chemosensitizing agent for sAML using an in-vitro and in-vivo approach. We demonstrate that LB100 decreases cell viability through caspase activation and G2/M cell-cycle arrest."}
{"qid": "54da21bf4b1fd0d33c00000d", "original_text": "In Western blotting, a suitable loading control is indispensable for correcting errors in the total amount of loaded protein. Immunodetection of housekeeping proteins and total protein staining have traditionally been used as loading control methods. Direct Blue 71 (DB71) staining-a novel, sensitive, dye-binding staining method compatible with immunodetection-may offer advantages over these traditional loading control methods. Three common neuroscientific samples (human plasma, human oligodendrocytes, and rat brain) were employed to assess DB71 staining as a loading control method for Western blotting. DB71, CBB, one traditional housekeeping protein, and one protein of interest were comparatively assessed for reliability and repeatability and linear dynamic range over 2.5-40 \u03bcg of protein loaded. DB71's effect on the reliability and repeatability and linear dynamic range of immunoreaction were also assessed.", "label": 1, "is_selected": 0, "text": "In Western blotting, a suitable loading control is indispensable for correcting errors in the total amount of loaded protein. Immunodetection of housekeeping proteins and total protein staining have traditionally been used as loading control methods. Direct Blue 71 (DB71) staining-a novel, sensitive, dye-binding staining method compatible with immunodetection-may offer advantages over these traditional loading control methods. Three common neuroscientific samples (human plasma, human oligodendrocytes, and rat brain) were employed to assess DB71 staining as a loading control method for Western blotting. DB71, CBB, one traditional housekeeping protein, and one protein of interest were comparatively assessed for reliability and repeatability and linear dynamic range over 2.5-40 \u03bcg of protein loaded. DB71's effect on the reliability and repeatability and linear dynamic range of immunoreaction were also assessed."}
{"qid": "56c1f007ef6e39474100003b", "original_text": "Local control is fundamental, both for the curative as well as the palliative treatment of cancer. Tumor treating fields (TTFields) are low intensity (1 ? 2 V/cm), intermediate frequency (100 ? 200 kHz) alternating electric fields administered using insulated electrodes placed on the skin surrounding the region of a malignant tumor. TTFields were shown to destroy cells within the process of mitosis via apoptosis, thereby inhibiting tumor growth. TTFields have no effect on non-dividing cells.", "label": 1, "is_selected": 0, "text": "Local control is fundamental, both for the curative as well as the palliative treatment of cancer. Tumor treating fields (TTFields) are low intensity (1 ? 2 V/cm), intermediate frequency (100 ? 200 kHz) alternating electric fields administered using insulated electrodes placed on the skin surrounding the region of a malignant tumor. TTFields were shown to destroy cells within the process of mitosis via apoptosis, thereby inhibiting tumor growth. TTFields have no effect on non-dividing cells."}
{"qid": "5a8712af61bb38fb24000002", "original_text": "Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin. Research suggests that individuals with PsA are at a higher risk of developing depression compared to the general population. The exact link between PsA and depression is not fully understood, but several factors may contribute to this association. Firstly, the chronic pain and stiffness associated with PsA can lead to feelings of frustration, helplessness, and isolation, which can contribute to the development of depression. Additionally, the physical limitations caused by PsA can impact an individual's ability to perform daily activities and participate in social activities, further increasing the risk of depression. Secondly, inflammation in the body caused by PsA can have a profound impact on the nervous system, including the brain, which can lead to changes in mood and cognitive function. Studies have shown that individuals with PsA have higher levels of inflammatory markers in the cerebrospinal fluid compared to healthy individuals, which may contribute to the development of depression. Lastly, the stigma and shame associated with having a chronic disease like PsA can also contribute to the development of depression. Individuals with PsA may experience social isolation, loss of identity, and decreased self-esteem, all of which can increase the risk of depression. In conclusion, the link between PsA and depression is complex and involves a combination of factors. Understanding the underlying mechanisms and identifying the risk factors are crucial in developing effective strategies for prevention and treatment. If you or someone you know is experiencing symptoms of depression, it is essential to seek medical attention to receive appropriate treatment.", "label": 0, "is_selected": 0, "text": "Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin. Research suggests that individuals with PsA are at a higher risk of developing depression compared to the general population. The exact link between PsA and depression is not fully understood, but several factors may contribute to this association. Firstly, the chronic pain and stiffness associated with PsA can lead to feelings of frustration, helplessness, and isolation, which can contribute to the development of depression. Additionally, the physical limitations caused by PsA can impact an individual's ability to perform daily activities and participate in social activities, further increasing the risk of depression. Secondly, inflammation in the body caused by PsA can have a profound impact on the nervous system, including the brain, which can lead to changes in mood and cognitive function. Studies have shown that individuals with PsA have higher levels of inflammatory markers in the cerebrospinal fluid compared to healthy individuals, which may contribute to the development of depression. Lastly, the stigma and shame associated with having a chronic disease like PsA can also contribute to the development of depression. Individuals with PsA may experience social isolation, loss of identity, and decreased self-esteem, all of which can increase the risk of depression. In conclusion, the link between PsA and depression is complex and involves a combination of factors. Understanding the underlying mechanisms and identifying the risk factors are crucial in developing effective strategies for prevention and treatment. If you or someone you know is experiencing symptoms of depression, it is essential to seek medical attention to receive appropriate treatment."}
{"qid": "5895dfc97d9090f353000010", "original_text": "To review the clinical trials, pharmacologic characteristics, safety, and efficacy of the elvitegravir/cobicistat/emtricitabine/tenofovir single tablet formulation (Stribild). Literature searches were performed in MEDLINE (1948-September 2012) and PubMed (1966-September 2012) using the search terms GS-9137, elvitegravir, GS 9350, cobicistat, quad pill, Stribild, and integrase inhibitors. Abstracts from HIV/AIDS conferences were reviewed. Phase 3 studies evaluating the safety and efficacy of Stribild were preferentially evaluated, as well as relevant references from the published studies. Stribild contains complete antiretroviral therapy for HIV-1 infection in a single tablet. It is the first once-daily therapy option available with an integrase inhibitor and a novel pharmacokinetic boosting agent. Stribild has shown noninferiority in viral load suppression at 48 weeks when compared with dual nucleoside/nucleotide reverse transcriptase inhibitor and either a ritonavir-boosted protease inhibitor or nonnucleoside reverse transcriptase inhibitor regimen.", "label": 1, "is_selected": 0, "text": "To review the clinical trials, pharmacologic characteristics, safety, and efficacy of the elvitegravir/cobicistat/emtricitabine/tenofovir single tablet formulation (Stribild). Literature searches were performed in MEDLINE (1948-September 2012) and PubMed (1966-September 2012) using the search terms GS-9137, elvitegravir, GS 9350, cobicistat, quad pill, Stribild, and integrase inhibitors. Abstracts from HIV/AIDS conferences were reviewed. Phase 3 studies evaluating the safety and efficacy of Stribild were preferentially evaluated, as well as relevant references from the published studies. Stribild contains complete antiretroviral therapy for HIV-1 infection in a single tablet. It is the first once-daily therapy option available with an integrase inhibitor and a novel pharmacokinetic boosting agent. Stribild has shown noninferiority in viral load suppression at 48 weeks when compared with dual nucleoside/nucleotide reverse transcriptase inhibitor and either a ritonavir-boosted protease inhibitor or nonnucleoside reverse transcriptase inhibitor regimen."}
{"qid": "531dd4af267d7dd05300000d", "original_text": "Peripheral T-cell lymphomas (PTCL) are a diverse group of rare non-Hodgkin lymphomas (NHL) that carry a poor prognosis and are in need of effective therapies. Alisertib (MLN8237) an investigational agent that inhibits Aurora A Ser/Thr kinase has shown activity in PTCL patients. Here we demonstrate that aurora A and B are highly expressed in T-cell lymphoma cell lines. In PTCL patient samples aurora A was positive in 3 of 24 samples and co-expressed with aurora B. Aurora B was positive in tumor cells in 22 of 32 samples.", "label": 1, "is_selected": 0, "text": "Peripheral T-cell lymphomas (PTCL) are a diverse group of rare non-Hodgkin lymphomas (NHL) that carry a poor prognosis and are in need of effective therapies. Alisertib (MLN8237) an investigational agent that inhibits Aurora A Ser/Thr kinase has shown activity in PTCL patients. Here we demonstrate that aurora A and B are highly expressed in T-cell lymphoma cell lines. In PTCL patient samples aurora A was positive in 3 of 24 samples and co-expressed with aurora B. Aurora B was positive in tumor cells in 22 of 32 samples."}
{"qid": "58ec613ceda5a5767200000b", "original_text": "The authors report three cases of ischemic stroke in young adults that occurred during or after an airplane flight. Workup was negative for any cause of stroke other than the presence of a patent foramen ovale (PFO). There is an increasing awareness of deep vein thrombosis and pulmonary embolism occurring in relation to long flights. Individuals with a PFO under these circumstances may be vulnerable to stroke from paradoxic embolism. \"Economy class\" stroke syndrome may be underdiagnosed and is an eminently preventable cause of stroke.", "label": 1, "is_selected": 0, "text": "The authors report three cases of ischemic stroke in young adults that occurred during or after an airplane flight. Workup was negative for any cause of stroke other than the presence of a patent foramen ovale (PFO). There is an increasing awareness of deep vein thrombosis and pulmonary embolism occurring in relation to long flights. Individuals with a PFO under these circumstances may be vulnerable to stroke from paradoxic embolism. \"Economy class\" stroke syndrome may be underdiagnosed and is an eminently preventable cause of stroke."}
{"qid": "52b2d405f828ad283c000009", "original_text": "Rheumatoid Arthritis (RA) is an autoimmune disease characterized by the inflammation of joints and the formation of synovial inflammatory nodules. Several cell types have been implicated in the pathogenesis of RA, including: 1. T cells: T cells are the primary immune cells involved in the development of RA. Specifically, CD4+ T cells, also known as T helper cells, play a central role in the disease process. They produce cytokines such as IL-2 and IFN-\u03b3, which promote the production of additional T cells and the activation of immune cells. 2. B cells: B cells are also involved in the immune response and can produce autoantibodies that attack the body's own tissues. In RA, B cells produce antibodies that target the joint lining, leading to inflammation and joint damage. 3. Macrophages: Macrophages are a type of immune cell that can produce pro-inflammatory cytokines, such as TNF-\u03b1 and IL-1\u03b2, which promote joint inflammation. In RA, macrophages play a role in the destruction of joint tissue. 4. Neutrophils: Neutrophils are another type of immune cell that can contribute to joint inflammation in RA. They can migrate to the joints and release proteolytic enzymes that damage the joint tissue. 5. Fibroblasts: Fibroblasts are cells that produce collagen and other extracellular matrix proteins in the joint. In RA, fibroblasts can produce pro-inflammatory cytokines and promote the production of new collagen, leading to joint stiffness and pain. 6. Osteoclasts: Osteoclasts are cells that are responsible for breaking down bone tissue. In RA, osteoclasts are overactive, leading to bone loss and joint destruction. 7. Microglia: Microglia are cells that are responsible for maintaining the health of the joint tissue. In RA, microglia can produce pro-inflammatory cytokines and contribute to joint inflammation. These cell types, among others, are known to play a role in the development and progression of Rheumatoid Arthritis. Understanding the specific roles of each cell type is crucial for the development of effective therapies to treat this disease.", "label": 0, "is_selected": 0, "text": "Rheumatoid Arthritis (RA) is an autoimmune disease characterized by the inflammation of joints and the formation of synovial inflammatory nodules. Several cell types have been implicated in the pathogenesis of RA, including: 1. T cells: T cells are the primary immune cells involved in the development of RA. Specifically, CD4+ T cells, also known as T helper cells, play a central role in the disease process. They produce cytokines such as IL-2 and IFN-\u03b3, which promote the production of additional T cells and the activation of immune cells. 2. B cells: B cells are also involved in the immune response and can produce autoantibodies that attack the body's own tissues. In RA, B cells produce antibodies that target the joint lining, leading to inflammation and joint damage. 3. Macrophages: Macrophages are a type of immune cell that can produce pro-inflammatory cytokines, such as TNF-\u03b1 and IL-1\u03b2, which promote joint inflammation. In RA, macrophages play a role in the destruction of joint tissue. 4. Neutrophils: Neutrophils are another type of immune cell that can contribute to joint inflammation in RA. They can migrate to the joints and release proteolytic enzymes that damage the joint tissue. 5. Fibroblasts: Fibroblasts are cells that produce collagen and other extracellular matrix proteins in the joint. In RA, fibroblasts can produce pro-inflammatory cytokines and promote the production of new collagen, leading to joint stiffness and pain. 6. Osteoclasts: Osteoclasts are cells that are responsible for breaking down bone tissue. In RA, osteoclasts are overactive, leading to bone loss and joint destruction. 7. Microglia: Microglia are cells that are responsible for maintaining the health of the joint tissue. In RA, microglia can produce pro-inflammatory cytokines and contribute to joint inflammation. These cell types, among others, are known to play a role in the development and progression of Rheumatoid Arthritis. Understanding the specific roles of each cell type is crucial for the development of effective therapies to treat this disease."}
{"qid": "5ac0a36f19833b0d7b000002", "original_text": "Exosomes are small membrane vesicles (30-100nm in diameter) secreted by cells into extracellular space. The present study evaluated the effect of chemotherapeutic agents on exosome production and/or release, and quantified the contribution of exosomes to intercellular drug transfer and pharmacodynamics. Human cancer cells (breast MCF7, breast-to-lung metastatic LM2, ovarian A2780 and OVCAR4) were treated with paclitaxel (PTX, 2-1000nM) or doxorubicin (DOX, 20-1000nM) for 24-48h.", "label": 1, "is_selected": 0, "text": "Exosomes are small membrane vesicles (30-100nm in diameter) secreted by cells into extracellular space. The present study evaluated the effect of chemotherapeutic agents on exosome production and/or release, and quantified the contribution of exosomes to intercellular drug transfer and pharmacodynamics. Human cancer cells (breast MCF7, breast-to-lung metastatic LM2, ovarian A2780 and OVCAR4) were treated with paclitaxel (PTX, 2-1000nM) or doxorubicin (DOX, 20-1000nM) for 24-48h."}
{"qid": "5a6e2578b750ff445500003d", "original_text": "The \"DifferentialDNAloops\" package in Bioconductor is designed to analyze differential DNA loops from sequencing data. This package uses a novel approach based on a Bayesian non-parametric model to identify differentially looped regions between two or more samples. The package provides functions to estimate the loops and assess their significance, as well as to visualize the results in a convenient and interpretable format.", "label": 0, "is_selected": 1, "text": "A new package has been developed for the analysis of differential DNA loops from single-stranded DNA sequencing data, using a Bayesian non-parametric model, in order to assess the significance of the loops and their significance in a convenient and interpretable format."}
{"qid": "622deabc3a8413c6530000a6", "original_text": "SPRTN (Spermatogenesis-associated Protein 1) is a protein that plays a crucial role in the male germline development, particularly in the process of spermatogenesis. SPRTN is involved in the regulation of meiotic divisions and the formation of spermatids, and it has been shown to be essential for the proper progression of spermatogenesis. SPRTN mutations have been implicated in male infertility and infertility-associated disorders.", "label": 0, "is_selected": 1, "text": "The aim of this study is to investigate the role of SPRTN in male infertility and infertility-associated disorders by screening for mutations in SPRTN and comparing their results with those of control samples in a mouse model of male infertility, as well as to assess the impact of these mutations on the spermatogenesis process."}
{"qid": "58e115d66fddd3e83e00000a", "original_text": "Congenital disorders of glycosylation (CDG) are a growing group of inherited metabolic disorders where enzymatic defects in the formation or processing of glycolipids and/or glycoproteins lead to variety of different diseases. The deficiency of GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase, encoded by the human ortholog of ALG1 from yeast, is known as ALG1-CDG (CDG-Ik). The phenotypical, molecular and biochemical analysis of a severely affected ALG1-CDG patient is the focus of this paper. The patient's main symptoms were feeding problems and diarrhea, profound hypoproteinemia with massive ascites, muscular hypertonia, seizures refractory to treatment, recurrent episodes of apnoea, cardiac and hepatic involvement and coagulation anomalies.", "label": 1, "is_selected": 0, "text": "Congenital disorders of glycosylation (CDG) are a growing group of inherited metabolic disorders where enzymatic defects in the formation or processing of glycolipids and/or glycoproteins lead to variety of different diseases. The deficiency of GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase, encoded by the human ortholog of ALG1 from yeast, is known as ALG1-CDG (CDG-Ik). The phenotypical, molecular and biochemical analysis of a severely affected ALG1-CDG patient is the focus of this paper. The patient's main symptoms were feeding problems and diarrhea, profound hypoproteinemia with massive ascites, muscular hypertonia, seizures refractory to treatment, recurrent episodes of apnoea, cardiac and hepatic involvement and coagulation anomalies."}
{"qid": "5e4b62946d0a277941000024", "original_text": "TC-5214 (dexmecamylamine) is a nicotinic channel modulator that has previously been evaluated for treatment of major depression disorder (MDD) and is currently being evaluated by Targacept as a treatment for overactive bladder. A comprehensive population pharmacokinetic (POP PK) model of TC-5214 was developed using nonlinear mixed-effects modeling of pooled plasma concentration data from 6 early phase I studies in 179 healthy participants or patients with non-MDD and 1 phase II study in 68 MDD patients. Concentration-time profiles of TC-5214 after either single or multiple oral doses of TC-5214 was described by a one-compartment model with first-order absorption with lag time and first-order elimination. Covariate analysis revealed that creatinine clearance was a significant covariate on clearance and that body weight significantly influenced the central volume of distribution. The final model (with identified covariates) was used to simulate steady-state exposure for patients with impaired renal function. Results from forest plots reveal that patients with moderate to severe renal impairment or end stage renal disease are associated with significantly higher Cssmax and AUC compared to patients with normal renal function. The proposed final POP PK model could be employed in defining a TC-5214 dosage regimen in patients with impaired renal function.", "label": 1, "is_selected": 0, "text": "TC-5214 (dexmecamylamine) is a nicotinic channel modulator that has previously been evaluated for treatment of major depression disorder (MDD) and is currently being evaluated by Targacept as a treatment for overactive bladder. A comprehensive population pharmacokinetic (POP PK) model of TC-5214 was developed using nonlinear mixed-effects modeling of pooled plasma concentration data from 6 early phase I studies in 179 healthy participants or patients with non-MDD and 1 phase II study in 68 MDD patients. Concentration-time profiles of TC-5214 after either single or multiple oral doses of TC-5214 was described by a one-compartment model with first-order absorption with lag time and first-order elimination. Covariate analysis revealed that creatinine clearance was a significant covariate on clearance and that body weight significantly influenced the central volume of distribution. The final model (with identified covariates) was used to simulate steady-state exposure for patients with impaired renal function. Results from forest plots reveal that patients with moderate to severe renal impairment or end stage renal disease are associated with significantly higher Cssmax and AUC compared to patients with normal renal function. The proposed final POP PK model could be employed in defining a TC-5214 dosage regimen in patients with impaired renal function."}
{"qid": "5344155faeec6fbd07000005", "original_text": "Hunter disease or mucopolysaccharidosis II (MPS II) is a genetic disorder that follows an autosomal recessive inheritance pattern. This means that a child must inherit two copies of the mutated gene, one from each parent, in order to develop the condition. Each parent is a carrier of the mutation, meaning they have one copy of the mutated gene and one normal copy, and have a 25% chance of passing the mutation on to each child.", "label": 0, "is_selected": 0, "text": "Hunter disease or mucopolysaccharidosis II (MPS II) is a genetic disorder that follows an autosomal recessive inheritance pattern. This means that a child must inherit two copies of the mutated gene, one from each parent, in order to develop the condition. Each parent is a carrier of the mutation, meaning they have one copy of the mutated gene and one normal copy, and have a 25% chance of passing the mutation on to each child."}
{"qid": "5545e926d355485447000002", "original_text": "Yes, there is a role for the cylindromatosis tumor suppressor (CYLD) in lung cancer. CYLD is a negative regulator of the Wnt/\u03b2-catenin signaling pathway, which is known to be involved in the development and progression of lung cancer. Studies have shown that CYLD mutations are frequent in lung adenocarcinoma, the most common subtype of lung cancer, and are associated with a worse prognosis. CYLD mutations have also been observed in other subtypes of lung cancer, including squamous cell carcinoma and large cell carcinoma. Overall, CYLD is a promising target for the development of new therapeutic strategies for the treatment of lung cancer.", "label": 0, "is_selected": 0, "text": "Yes, there is a role for the cylindromatosis tumor suppressor (CYLD) in lung cancer. CYLD is a negative regulator of the Wnt/\u03b2-catenin signaling pathway, which is known to be involved in the development and progression of lung cancer. Studies have shown that CYLD mutations are frequent in lung adenocarcinoma, the most common subtype of lung cancer, and are associated with a worse prognosis. CYLD mutations have also been observed in other subtypes of lung cancer, including squamous cell carcinoma and large cell carcinoma. Overall, CYLD is a promising target for the development of new therapeutic strategies for the treatment of lung cancer."}
{"qid": "60281eb11cb411341a0000f5", "original_text": "Variants at 12q14 and 12q24 are associated with several common genetic disorders. At 12q14, variants have been linked to intellectual disability, epilepsy, and congenital anomalies. Specifically, duplications of 12q14 are associated with Wolf-Parkinson-White syndrome, a heart rhythm disorder. At 12q24, variants are implicated in breast cancer, ovarian cancer, and other cancers. For example, BRCA1 and BRCA2 are located at 12q24 and are well-known genetic susceptibility loci for breast and ovarian cancer.", "label": 0, "is_selected": 1, "text": "Genetic variants at 12q14 and 12q24 have been implicated in a number of diseases and cancer predisposition loci. For example, BRCA1 and BRCA2 are located at 12Q24 and are well-known genetic susceptibility loci for breast and ovarian cancer."}
{"qid": "58ee0dd5eda5a57672000013", "original_text": "White adipose tissue plays an integral role in energy metabolism and is governed by endocrine, autocrine, and neural signals. Neural control of adipose metabolism is mediated by sympathetic neurons that innervate the tissue. To investigate the effects of this innervation, an ex vivo system was developed in which 3T3-L1 adipocytes are cocultured with sympathetic neurons isolated from the superior cervical ganglia of newborn rats.", "label": 1, "is_selected": 0, "text": "White adipose tissue plays an integral role in energy metabolism and is governed by endocrine, autocrine, and neural signals. Neural control of adipose metabolism is mediated by sympathetic neurons that innervate the tissue. To investigate the effects of this innervation, an ex vivo system was developed in which 3T3-L1 adipocytes are cocultured with sympathetic neurons isolated from the superior cervical ganglia of newborn rats."}
{"qid": "5be94b87133db5eb78000020", "original_text": "Gene therapy has shown promise in restoring auditory function in individuals with certain forms of hearing loss. Research has focused on using viral vectors to deliver working copies of the defective genes responsible for hearing loss to the inner ear. These vectors can be introduced directly into the inner ear through a minimally invasive injection, allowing for targeted delivery of the therapeutic gene. Studies have demonstrated improved hearing in animal models of genetic hearing loss, and clinical trials are underway to evaluate the safety and efficacy of gene therapy in humans. However, it is important to note that current gene therapy techniques do not completely restore hearing, and the results can vary depending on the type and severity of the hearing loss. More research is needed to improve the efficacy and safety of gene therapy for hearing restoration.", "label": 0, "is_selected": 1, "text": "Gene therapy has the potential to improve the quality of life of people with genetic hearing loss, but more research is needed before this technology can be used in humans. More research is still needed to develop a safe and effective method of gene therapy for hearing restoration, and more clinical trials are needed to evaluate the safety and efficacy of this technology in people."}
{"qid": "5e3c80abb5b409ea53000024", "original_text": "Radiation enteritis is an old but emerging question induced by the application of radiation. However, no effective drugs for radiation enteritis in clinic. In this study, we found that thymoquinone (TQ) could mitigate intestinal damages induced by irradiation.", "label": 1, "is_selected": 0, "text": "Radiation enteritis is an old but emerging question induced by the application of radiation. However, no effective drugs for radiation enteritis in clinic. In this study, we found that thymoquinone (TQ) could mitigate intestinal damages induced by irradiation."}
{"qid": "533ba218fd9a95ea0d000007", "original_text": "Cardiac T1 mapping is a magnetic resonance imaging (MRI) technique used to measure the relaxation time of the myocardial tissue, known as T1, in the heart. The clinical indications for cardiac T1 mapping include: 1. Myocardial infarction: To assess cardiac injury after myocardial infarction and to monitor the effectiveness of reperfusion therapy. 2. Cardiomyopathy: To diagnose and differentiate various forms of cardiomyopathy, such as hypertrophic, dilated, and restrictive cardiomyopathy. 3. Heart failure: To evaluate the severity of heart failure and to monitor the response to treatment. 4. Congenital heart disease: To evaluate the structural abnormalities of the heart in patients with congenital heart disease. 5. valve disease: To evaluate the function of the heart valves and to monitor the effects of valve repair or replacement. 6. Electrophysiology: To evaluate the electrical activity of the heart, including abnormal heart rhythms, and to plan and guide catheter ablation procedures. 7. Cancer: To evaluate the extent of cardiac involvement in patients with cancer and to monitor the response to cancer treatment. I hope this information is useful. If you have any further questions, please let me know.", "label": 0, "is_selected": 1, "text": "The purpose of cardiac T1 mapping is to assess the structural and electrical activity of the heart in patients with a variety of conditions, such as heart failure, congenital heart disease, cancer, and other conditions. Congenital heart disease: To evaluate the structural abnormalities of the Heart in patients patients with congenital heart diseases. E catheter: To guide the use of catheters to treat cancer and to monitor the response to cancer treatment, including abnormal heart rhythms and to plan procedures."}
{"qid": "5e460f823f54159529000006", "original_text": "Galcanezumab is a humanized immunoglobulin G (IgG) monoclonal antibody (mAb) indicated for the prevention of migraine that binds to calcitonin gene-related peptide. A population pharmacokinetic (PK) analysis was performed to characterize galcanezumab PK using data pooled from 7 clinical studies. Clinical studies included healthy individuals and patients with episodic or chronic migraine who were administered between 5 and 300 mg galcanezumab. The PK data were analyzed using nonlinear mixed-effects modeling. Galcanezumab concentration-time data were described with a 1-compartment model with first-order absorption following subcutaneous administration and linear elimination. At the median body weight of 74 kg, the estimated population apparent clearance (CL/F) was 0.00785 L/h (34% IIV), the apparent volume of distribution was 7.33 L (34% IIV), and half-life was 27 days.", "label": 1, "is_selected": 0, "text": "Galcanezumab is a humanized immunoglobulin G (IgG) monoclonal antibody (mAb) indicated for the prevention of migraine that binds to calcitonin gene-related peptide. A population pharmacokinetic (PK) analysis was performed to characterize galcanezumab PK using data pooled from 7 clinical studies. Clinical studies included healthy individuals and patients with episodic or chronic migraine who were administered between 5 and 300 mg galcanezumab. The PK data were analyzed using nonlinear mixed-effects modeling. Galcanezumab concentration-time data were described with a 1-compartment model with first-order absorption following subcutaneous administration and linear elimination. At the median body weight of 74 kg, the estimated population apparent clearance (CL/F) was 0.00785 L/h (34% IIV), the apparent volume of distribution was 7.33 L (34% IIV), and half-life was 27 days."}
{"qid": "58e23ec66fddd3e83e000010", "original_text": "Invasion of alien species has been shown to cause detrimental effects on habitats of native species. Insect pollinators represent such examples; the introduction of commercial bumble bee species for crop pollination has resulted in competition for an ecological niche with native species, genetic disturbance caused by mating with native species, and pathogen spillover to native species.", "label": 1, "is_selected": 0, "text": "Invasion of alien species has been shown to cause detrimental effects on habitats of native species. Insect pollinators represent such examples; the introduction of commercial bumble bee species for crop pollination has resulted in competition for an ecological niche with native species, genetic disturbance caused by mating with native species, and pathogen spillover to native species."}
{"qid": "516e7fda298dcd4e51000081", "original_text": "The typical Western diet is not balanced in methyl nutrients that regulate the level of the methyl donor S-adenosylmethionine (SAM) and its derivative metabolite S-adenosylhomocysteine (SAH), which in turn may control the activity of certain methyltransferases. Feeding rodents with amino acid defined and methyl-imbalanced diet decreases hepatic SAM and causes liver cancers. RIZ1 (PRDM2 or KMT8) is a tumor suppressor and functions in transcriptional repression by methylating histone H3 lysine 9. Here we show that a methyl-balanced diet conferred additional survival benefits compared to a tumor-inducing methyl-imbalanced diet only in mice with wild type RIZ1 but not in mice deficient in RIZ1.", "label": 1, "is_selected": 0, "text": "The typical Western diet is not balanced in methyl nutrients that regulate the level of the methyl donor S-adenosylmethionine (SAM) and its derivative metabolite S-adenosylhomocysteine (SAH), which in turn may control the activity of certain methyltransferases. Feeding rodents with amino acid defined and methyl-imbalanced diet decreases hepatic SAM and causes liver cancers. RIZ1 (PRDM2 or KMT8) is a tumor suppressor and functions in transcriptional repression by methylating histone H3 lysine 9. Here we show that a methyl-balanced diet conferred additional survival benefits compared to a tumor-inducing methyl-imbalanced diet only in mice with wild type RIZ1 but not in mice deficient in RIZ1."}
{"qid": "532361fd9b2d7acc7e000013", "original_text": "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), the most common form of familial brain arteriopathy, is associated with deposition of granular osmiophilic material (GOM). We used immunohistochemistry and immunogold electron microscopy (EM) to examine the distribution of GOM and NOTCH3 ectodomain (N3ECD) protein in microvasculature of brain gray matter and white matter in patients with CADASIL, non-CADASIL hereditary small-vessel disease and sporadic age-related degenerative disease, and comparable-age controls. We observed intense immunostaining patterns with 2 different anti-N3ECD antibodies in CADASIL but not in young and older controls or other small-vessel disease patients. In addition, CADASIL samples exhibited immunoreactivity in arterial walls and in most capillaries.", "label": 1, "is_selected": 0, "text": "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), the most common form of familial brain arteriopathy, is associated with deposition of granular osmiophilic material (GOM). We used immunohistochemistry and immunogold electron microscopy (EM) to examine the distribution of GOM and NOTCH3 ectodomain (N3ECD) protein in microvasculature of brain gray matter and white matter in patients with CADASIL, non-CADASIL hereditary small-vessel disease and sporadic age-related degenerative disease, and comparable-age controls. We observed intense immunostaining patterns with 2 different anti-N3ECD antibodies in CADASIL but not in young and older controls or other small-vessel disease patients. In addition, CADASIL samples exhibited immunoreactivity in arterial walls and in most capillaries."}
{"qid": "6217dc9d3a8413c65300002d", "original_text": "Yes, NfL (neurofilament light chain) is a well-established biomarker of neurodegeneration. NfL is a protein component of neurofilaments, which are essential structural elements of neurons. In healthy individuals, NfL levels are relatively stable, but in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS), NfL levels are elevated due to neuronal loss and degeneration. NfL measurements in cerebrospinal fluid (CSF) or blood have been shown to accurately reflect the extent of neurodegeneration in these diseases, and have been proposed as potential diagnostic markers. Moreover, NfL levels have been linked to disease progression and treatment outcomes, making it a valuable tool for monitoring disease progression and evaluating treatment efficacy.", "label": 0, "is_selected": 1, "text": "Is NfL a biomarker of neurodegenerative disease?<n> In healthy individuals, Nf L levels are relatively stable, but in neurodegenerative diseases such as Alzheimer's disease, Parkinson's Disease, and amyotrophic lateral sclerosis (ALS),NfL levels are elevated due to neuronal loss and degeneration."}
{"qid": "5a804f71faa1ab7d2e00001d", "original_text": "Identifying large expansions of short tandem repeats (STRs), such as those that cause amyotrophic lateral sclerosis (ALS) and fragile X syndrome, is challenging for short-read whole-genome sequencing (WGS) data. A solution to this problem is an important step toward integrating WGS into precision medicine. We developed a software tool called ExpansionHunter that, using PCR-free WGS short-read data, can genotype repeats at the locus of interest, even if the expanded repeat is larger than the read length. We applied our algorithm to WGS data from 3001 ALS patients who have been tested for the presence of the C9orf72 repeat expansion with repeat-primed PCR (RP-PCR). Compared against this truth data, ExpansionHunter correctly classified all (212/212, 95% CI [0.98, 1.00]) of the expanded samples as either expansions (208) or potential expansions (4). Additionally, 99.9% (2786/2789, 95% CI [0.997, 1.00]) of the wild-type samples were correctly classified as wild type by this method with the remaining three samples identified as possible expansions.", "label": 1, "is_selected": 0, "text": "Identifying large expansions of short tandem repeats (STRs), such as those that cause amyotrophic lateral sclerosis (ALS) and fragile X syndrome, is challenging for short-read whole-genome sequencing (WGS) data. A solution to this problem is an important step toward integrating WGS into precision medicine. We developed a software tool called ExpansionHunter that, using PCR-free WGS short-read data, can genotype repeats at the locus of interest, even if the expanded repeat is larger than the read length. We applied our algorithm to WGS data from 3001 ALS patients who have been tested for the presence of the C9orf72 repeat expansion with repeat-primed PCR (RP-PCR). Compared against this truth data, ExpansionHunter correctly classified all (212/212, 95% CI [0.98, 1.00]) of the expanded samples as either expansions (208) or potential expansions (4). Additionally, 99.9% (2786/2789, 95% CI [0.997, 1.00]) of the wild-type samples were correctly classified as wild type by this method with the remaining three samples identified as possible expansions."}
{"qid": "6057a1ed94d57fd87900002f", "original_text": "The SWIM tool is a machine learning-based approach that identifies genes associated with glioblastoma, a type of aggressive brain cancer. Several genes have been identified as down-regulated in glioblastoma using SWIM tool, including: 1. TP53: A tumor suppressor gene that is mutated in many types of cancer, including glioblastoma. The SWIM tool has identified TP53 as a highly down-regulated gene in glioblastoma. 2. CDKN2A: A gene that encodes a protein involved in regulating the cell cycle. It is commonly mutated in glioblastoma and down-regulated using the SWIM tool. 3. PTEN: A tumor suppressor gene that is down-regulated in many cancers, including glioblastoma. The SWIM tool has identified PTEN as a down-regulated gene in glioblastoma. 4. STK11: A gene that encodes a protein involved in cell signaling pathways. It is down-regulated in glioblastoma according to the SWIM tool. 5. MTHFR: A gene that encodes a protein involved in methylene tetrahydrofolate reductase, which is involved in DNA methylation. The SWIM tool has identified MTHFR as a down-regulated gene in glioblastoma. 6. APC: A gene that encodes a protein involved in cell adhesion and signaling. The SWIM tool has identified APC as a down-regulated gene in glioblastoma. 7. PML: A gene that encodes a protein involved in cell survival and DNA repair. The SWIM tool has identified PML as a down-regulated gene in glioblastoma. 8. TET2: A gene that encodes a protein involved in DNA demethylation. The SWIM tool has identified TET2 as a down-regulated gene in glioblastoma. 9. IDH1/2: Genes that encode proteins involved in DNA metabolism. The SWIM tool has identified IDH1/2 as down-regulated genes in glioblastoma. 10. EP300: A gene that encodes a protein involved in transcriptional elongation. The SWIM tool has identified EP300 as a down-regulated gene in glioblastoma. It's important to note that the down-regulation of these genes in glioblastoma may be due to various factors such as mutations, methylation, or gene expression alterations. Further research is needed to understand the molecular mechanisms underlying the down-regulation of these genes in glioblastoma and their potential role in tumor progression.", "label": 0, "is_selected": 0, "text": "The SWIM tool is a machine learning-based approach that identifies genes associated with glioblastoma, a type of aggressive brain cancer. Several genes have been identified as down-regulated in glioblastoma using SWIM tool, including: 1. TP53: A tumor suppressor gene that is mutated in many types of cancer, including glioblastoma. The SWIM tool has identified TP53 as a highly down-regulated gene in glioblastoma. 2. CDKN2A: A gene that encodes a protein involved in regulating the cell cycle. It is commonly mutated in glioblastoma and down-regulated using the SWIM tool. 3. PTEN: A tumor suppressor gene that is down-regulated in many cancers, including glioblastoma. The SWIM tool has identified PTEN as a down-regulated gene in glioblastoma. 4. STK11: A gene that encodes a protein involved in cell signaling pathways. It is down-regulated in glioblastoma according to the SWIM tool. 5. MTHFR: A gene that encodes a protein involved in methylene tetrahydrofolate reductase, which is involved in DNA methylation. The SWIM tool has identified MTHFR as a down-regulated gene in glioblastoma. 6. APC: A gene that encodes a protein involved in cell adhesion and signaling. The SWIM tool has identified APC as a down-regulated gene in glioblastoma. 7. PML: A gene that encodes a protein involved in cell survival and DNA repair. The SWIM tool has identified PML as a down-regulated gene in glioblastoma. 8. TET2: A gene that encodes a protein involved in DNA demethylation. The SWIM tool has identified TET2 as a down-regulated gene in glioblastoma. 9. IDH1/2: Genes that encode proteins involved in DNA metabolism. The SWIM tool has identified IDH1/2 as down-regulated genes in glioblastoma. 10. EP300: A gene that encodes a protein involved in transcriptional elongation. The SWIM tool has identified EP300 as a down-regulated gene in glioblastoma. It's important to note that the down-regulation of these genes in glioblastoma may be due to various factors such as mutations, methylation, or gene expression alterations. Further research is needed to understand the molecular mechanisms underlying the down-regulation of these genes in glioblastoma and their potential role in tumor progression."}
{"qid": "58bc8e7a02b8c60953000007", "original_text": "Plantar fasciitis is a common cause of heel pain and is the result of a degenerative process of the plantar fascia at its calcaneal attachment. A case study of a preliminary experience with local injections of botulinum toxin A (BTX-A) for the treatment of chronic plantar fasciitis in a 43-year-old woman is presented. We injected the patient with 70 units of BTX-A (0.7mL) in 2 divided doses: 40 units (0.4mL) in the tender region of the heel, and 30 units (0.3mL) in the most tender point of the foot arch. Visual analog scale (VAS) and pressure pain threshold (PPT) were measured to evaluate the efficacy of BTX-A injections. Real-time, high-resolution ultrasonographic findings of the plantar fascia after BTX-A injections were also used for serial follow-ups. After BTX-A injection, decreased VAS values were reported and increased PPT was observed. In ultrasonographic studies, the thickness of the plantar fascia and the hypoechogenicity of the fascia were reduced. Decreased plantar fascia thickness was observed on the first and third week after BTX-A injections. The findings were compatible with the changes in pain assessed by VAS and PPT. Ultrasonographic findings also indicated a progressive decrease in the thickness of the underlying muscle belly.", "label": 1, "is_selected": 0, "text": "Plantar fasciitis is a common cause of heel pain and is the result of a degenerative process of the plantar fascia at its calcaneal attachment. A case study of a preliminary experience with local injections of botulinum toxin A (BTX-A) for the treatment of chronic plantar fasciitis in a 43-year-old woman is presented. We injected the patient with 70 units of BTX-A (0.7mL) in 2 divided doses: 40 units (0.4mL) in the tender region of the heel, and 30 units (0.3mL) in the most tender point of the foot arch. Visual analog scale (VAS) and pressure pain threshold (PPT) were measured to evaluate the efficacy of BTX-A injections. Real-time, high-resolution ultrasonographic findings of the plantar fascia after BTX-A injections were also used for serial follow-ups. After BTX-A injection, decreased VAS values were reported and increased PPT was observed. In ultrasonographic studies, the thickness of the plantar fascia and the hypoechogenicity of the fascia were reduced. Decreased plantar fascia thickness was observed on the first and third week after BTX-A injections. The findings were compatible with the changes in pain assessed by VAS and PPT. Ultrasonographic findings also indicated a progressive decrease in the thickness of the underlying muscle belly."}
{"qid": "5e776db8835f4e4777000011", "original_text": "The current review was designed to compare between the insulin inhalation systems Exubera and Afrezza and to investigate the reasons why Exubera was unsuccessful, when Afrezza maker is expecting their product to be felicitous.", "label": 1, "is_selected": 0, "text": "The current review was designed to compare between the insulin inhalation systems Exubera and Afrezza and to investigate the reasons why Exubera was unsuccessful, when Afrezza maker is expecting their product to be felicitous."}
{"qid": "621ebec63a8413c65300005d", "original_text": "Epistaxis, or nosebleeds, can occur during or after dental implant placement, but it is not a common complication. Dental implant placement is a surgical procedure that involves placing a titanium post into the jawbone to support a dental prosthesis. While the procedure is generally safe, there are some risks and complications that can occur, including epistaxis. The risk of epistaxis during dental implant placement is thought to be low, with studies suggesting that it occurs in less than 1% of cases. However, the risk may be higher in certain situations, such as when the implant is placed in the maxilla (the upper jawbone) or when the patient has a bleeding disorder or is taking certain medications that can thin the blood. There are several factors that can contribute to the development of epistaxis during dental implant placement, including: 1. Bone trauma: During the implant placement procedure, the bone can be damaged, leading to bleeding. 2. Irritation of the nasal mucosa: The implant insertion procedure can cause irritation of the nasal mucosa, leading to bleeding. 3. Infection: An infection in the jawbone or sinuses can lead to epistaxis. 4. Medications: Certain medications, such as blood thinners, can increase the risk of epistaxis. 5. Pre-existing conditions: Patients with pre-existing conditions such as hemophilia or von Willebrand's disease may be more prone to epistaxis during dental implant placement. In rare cases, epistaxis after dental implant placement can be severe and may require intervention to stop the bleeding. If you experience symptoms of epistaxis after dental implant placement, such as nosebleeds or bleeding from the implant site, seek medical attention immediately. A healthcare professional can evaluate the cause of the bleeding and provide appropriate treatment. In summary, while epistaxis is not a common complication of dental implant placement, it can occur in some cases. Understanding the risk factors and potential causes of epistaxis can help patients and dental professionals manage this complication effectively.", "label": 0, "is_selected": 1, "text": "If you have recently had a dental implant placement procedure, you may have experienced bleeding from the implant site, such as from the jawbone or from the nasal cavity. in summary, while epistaxis is not a common complication of dental implant placements, it can occur in some cases.. If you experience symptoms of Epistaxis after dental implant Placement, such at nosebleeds or bleeding from its site, seek medical attention immediately., please contact our office for a free consultation, or visit our website for more information at www.dentist.com.au or call our toll-free number at 0800  800-273-3217 800-273-3217 800-273-3217 to speak to one of our dentists about your case, or contact us online for a complimentary consultation., Please note that this article is written by a member of the American Academy of Periodontology and is not intended to be a substitute for professional medical advice."}
{"qid": "554763f0f35db75526000002", "original_text": "My patient received 62 units of botulinum toxin type A (BTX-A) for facial lines. Two weeks later, she found out that she was pregnant. Will this cause any harm to her fetus? Botulinum toxin is not expected to be present in systemic circulation following proper intramuscular or intradermal injection. Moreover, BTX-A, which has a high molecular weight, does not appear to cross the placenta.", "label": 1, "is_selected": 0, "text": "My patient received 62 units of botulinum toxin type A (BTX-A) for facial lines. Two weeks later, she found out that she was pregnant. Will this cause any harm to her fetus? Botulinum toxin is not expected to be present in systemic circulation following proper intramuscular or intradermal injection. Moreover, BTX-A, which has a high molecular weight, does not appear to cross the placenta."}
{"qid": "5a7376e33b9d13c708000009", "original_text": "Marijuana use has been increasing across the United States due to its legalization as both a medicinal and recreational product. A small number of case reports have described a pathological entity called vanishing lung syndrome (VLS), which is a rare bullous lung disease usually caused by tobacco smoking. Recent case reports have implicated marijuana in the development of VLS. We present a case of a 47-year-old man, who presented to our hospital with shortness of breath, fevers and a productive cough. On physical exam, he was tachypneic with audible stridor and absent right sided breath sounds.", "label": 1, "is_selected": 0, "text": "Marijuana use has been increasing across the United States due to its legalization as both a medicinal and recreational product. A small number of case reports have described a pathological entity called vanishing lung syndrome (VLS), which is a rare bullous lung disease usually caused by tobacco smoking. Recent case reports have implicated marijuana in the development of VLS. We present a case of a 47-year-old man, who presented to our hospital with shortness of breath, fevers and a productive cough. On physical exam, he was tachypneic with audible stridor and absent right sided breath sounds."}
{"qid": "5e64f1921af46fc130000018", "original_text": "Evidence generated through years of research has built a solid scientific foundation on the safety and efficacy of rotavirus vaccines, and has served to raise awareness of global rotavirus disease burden and the potential impact of vaccination. In this commentary, we explore the role that researchers can play in closing key gaps of knowledge, demand, and financing to support decision-making on introduction of new vaccines in developing countries. With safe and efficacious rotavirus vaccines now on the verge of widespread adoption, researchers can be vital advocates for their uptake into routine immunization programs.", "label": 1, "is_selected": 0, "text": "Evidence generated through years of research has built a solid scientific foundation on the safety and efficacy of rotavirus vaccines, and has served to raise awareness of global rotavirus disease burden and the potential impact of vaccination. In this commentary, we explore the role that researchers can play in closing key gaps of knowledge, demand, and financing to support decision-making on introduction of new vaccines in developing countries. With safe and efficacious rotavirus vaccines now on the verge of widespread adoption, researchers can be vital advocates for their uptake into routine immunization programs."}
{"qid": "54d630283706e89528000004", "original_text": "According to the latest medical research, carmustine wafers have been found to improve survival outcomes for patients with glioblastoma, a type of aggressive brain cancer. A systematic review and meta-analysis of randomized controlled trials published in the Journal of Clinical Oncology in 2020 found that patients treated with carmustine wafers had a significantly longer median overall survival compared to those treated with other treatments. Specifically, the median overall survival was 17.6 months for patients treated with carmustine wafers, compared to 12.7 months for those receiving other treatments. This represents a 37% improvement in survival for patients treated with carmustine wafers. Additionally, a separate meta-analysis published in the journal Neuro-Oncology in 2020 found that carmustine wafers were associated with improved progression-free survival, which is the length of time during which the tumor does not grow or spread. Overall, the available evidence suggests that carmustine wafers may be a valuable treatment option for glioblastoma patients.", "label": 0, "is_selected": 0, "text": "According to the latest medical research, carmustine wafers have been found to improve survival outcomes for patients with glioblastoma, a type of aggressive brain cancer. A systematic review and meta-analysis of randomized controlled trials published in the Journal of Clinical Oncology in 2020 found that patients treated with carmustine wafers had a significantly longer median overall survival compared to those treated with other treatments. Specifically, the median overall survival was 17.6 months for patients treated with carmustine wafers, compared to 12.7 months for those receiving other treatments. This represents a 37% improvement in survival for patients treated with carmustine wafers. Additionally, a separate meta-analysis published in the journal Neuro-Oncology in 2020 found that carmustine wafers were associated with improved progression-free survival, which is the length of time during which the tumor does not grow or spread. Overall, the available evidence suggests that carmustine wafers may be a valuable treatment option for glioblastoma patients."}
{"qid": "58bac71222d3005309000013", "original_text": "Gliomas are a type of brain tumor that can be caused by various genetic mutations, including histone mutations. Specifically, mutations in the histone H3 mutation are associated with gliomas. These mutations can lead to the overexpression of certain genes and disrupt normal cellular processes, contributing to the development and progression of gliomas. The most common histone H3 mutation in gliomas is the K27M mutation, which is found in approximately 70% of glioblastomas, the most aggressive and common type of glioma.", "label": 0, "is_selected": 1, "text": "The purpose of this study is to investigate the role of the histone H3 mutation in the development and progression of gliomas and to assess the potential of adoptive cell therapy in the treatment of patients with gliomatous brain cancers."}
{"qid": "58a326da60087bc10a00000e", "original_text": "The global incidence of obesity continues to rise and is a major driver of morbidity and mortality through cardiovascular and cerebrovascular diseases. Animal models used in the discovery of novel treatments for obesity range from straightforward measures of food intake in lean rodents to long-term studies in animals exhibiting obesity due to the continuous access to diets high in fat. The utility of these animal models can be extended to determine, for example, that weight loss is due to fat loss and/or assess whether beneficial changes in key plasma parameters (e.g. insulin) are evident. In addition, behavioural models such as the behavioural satiety sequence can be used to confirm that a drug treatment has a selective effect on food intake. Typically, animal models have excellent predictive validity whereby drug-induced weight loss in rodents subsequently translates to weight loss in man. However, despite this, at the time of writing orlistat (Europe; USA) remains the only drug currently marketed for the treatment of obesity, with sibutramine having recently been withdrawn from sale globally due to the increased incidence of serious, non-fatal cardiovascular events. While the utility of rodent models in predicting clinical weight loss is detailed, the review also discusses whether animals can be used to predict adverse events such as those seen with recent anti-obesity drugs in the clinic.", "label": 1, "is_selected": 0, "text": "The global incidence of obesity continues to rise and is a major driver of morbidity and mortality through cardiovascular and cerebrovascular diseases. Animal models used in the discovery of novel treatments for obesity range from straightforward measures of food intake in lean rodents to long-term studies in animals exhibiting obesity due to the continuous access to diets high in fat. The utility of these animal models can be extended to determine, for example, that weight loss is due to fat loss and/or assess whether beneficial changes in key plasma parameters (e.g. insulin) are evident. In addition, behavioural models such as the behavioural satiety sequence can be used to confirm that a drug treatment has a selective effect on food intake. Typically, animal models have excellent predictive validity whereby drug-induced weight loss in rodents subsequently translates to weight loss in man. However, despite this, at the time of writing orlistat (Europe; USA) remains the only drug currently marketed for the treatment of obesity, with sibutramine having recently been withdrawn from sale globally due to the increased incidence of serious, non-fatal cardiovascular events. While the utility of rodent models in predicting clinical weight loss is detailed, the review also discusses whether animals can be used to predict adverse events such as those seen with recent anti-obesity drugs in the clinic."}
{"qid": "5c9e738decadf2e73f000037", "original_text": "Mitochondria are organelles found in the cells of most eukaryotic organisms. They are responsible for generating energy for the cell through the process of cellular respiration. While mitochondria are vital for the survival and function of cells, they cannot transfer directly from one cell to another. Mitochondria are membrane-bound organelles that are enclosed within the cytoplasm of a cell. They have their own DNA, known as mtDNA, which is separate from the nuclear DNA found in the cell's nucleus. Mitochondria are unable to transfer their contents, including their DNA, to other cells. There are some exceptions to this general rule, however. For example, during the process of cell fusion, mitochondria from two adjacent cells can fuse to form a single mitochondrion in the fused cell. Additionally, some viruses can transfer mitochondrial genetic material into host cells, which can lead to the establishment of a viral infection. In summary, while mitochondria cannot directly transfer from one cell to another, there are some exceptions to this rule, such as during cell fusion or viral infection.", "label": 0, "is_selected": 0, "text": "Mitochondria are organelles found in the cells of most eukaryotic organisms. They are responsible for generating energy for the cell through the process of cellular respiration. While mitochondria are vital for the survival and function of cells, they cannot transfer directly from one cell to another. Mitochondria are membrane-bound organelles that are enclosed within the cytoplasm of a cell. They have their own DNA, known as mtDNA, which is separate from the nuclear DNA found in the cell's nucleus. Mitochondria are unable to transfer their contents, including their DNA, to other cells. There are some exceptions to this general rule, however. For example, during the process of cell fusion, mitochondria from two adjacent cells can fuse to form a single mitochondrion in the fused cell. Additionally, some viruses can transfer mitochondrial genetic material into host cells, which can lead to the establishment of a viral infection. In summary, while mitochondria cannot directly transfer from one cell to another, there are some exceptions to this rule, such as during cell fusion or viral infection."}
{"qid": "517a8bab8ed59a060a000040", "original_text": "The deiodinases present in the brain include: 1. Type 1 iodothyronine deiodinase (D1): found in various brain regions, including the hypothalamus, cerebral cortex, and hippocampus, and plays a key role in regulating thyroid hormone (TH) levels in the brain. 2. Type 2 iodothyronine deiodinase (D2): primarily found in the cerebral cortex and hippocampus, and is involved in regulating TH levels in the brain, particularly in the context of depression and cognitive impairment. 3. Triiodothyronine (T3) deiodinase (D3): primarily found in the brain, and plays a crucial role in regulating TH levels in the brain, particularly in the context of neurodegenerative diseases such as Alzheimer's disease. 4. Thyroid hormone (TH) transporter (THT): involved in the transport of TH molecules across the blood-brain barrier and is essential for maintaining TH homeostasis in the brain. It's important to note that the expression and activity of these deiodinases can be influenced by various factors, including genetics, diet, and environmental factors, which can alter TH homeostasis in the brain and contribute to various neurological disorders.", "label": 0, "is_selected": 0, "text": "The deiodinases present in the brain include: 1. Type 1 iodothyronine deiodinase (D1): found in various brain regions, including the hypothalamus, cerebral cortex, and hippocampus, and plays a key role in regulating thyroid hormone (TH) levels in the brain. 2. Type 2 iodothyronine deiodinase (D2): primarily found in the cerebral cortex and hippocampus, and is involved in regulating TH levels in the brain, particularly in the context of depression and cognitive impairment. 3. Triiodothyronine (T3) deiodinase (D3): primarily found in the brain, and plays a crucial role in regulating TH levels in the brain, particularly in the context of neurodegenerative diseases such as Alzheimer's disease. 4. Thyroid hormone (TH) transporter (THT): involved in the transport of TH molecules across the blood-brain barrier and is essential for maintaining TH homeostasis in the brain. It's important to note that the expression and activity of these deiodinases can be influenced by various factors, including genetics, diet, and environmental factors, which can alter TH homeostasis in the brain and contribute to various neurological disorders."}
{"qid": "569e7e99ceceede94d000003", "original_text": "The cap analysis of gene expression (CAGE) technology has been established to detect transcriptional starting sites (TSSs) and expression levels by utilizing 5' cDNA tags and PCR. It has been reported that the amount of templates is proportional to the amplification efficiency of PCR. CAGE has been used as a key technique for analyzing promoter activity and finding new transcripts including alternative spliced products and noncoding transcripts.", "label": 1, "is_selected": 0, "text": "The cap analysis of gene expression (CAGE) technology has been established to detect transcriptional starting sites (TSSs) and expression levels by utilizing 5' cDNA tags and PCR. It has been reported that the amount of templates is proportional to the amplification efficiency of PCR. CAGE has been used as a key technique for analyzing promoter activity and finding new transcripts including alternative spliced products and noncoding transcripts."}
{"qid": "626233dbe764a53204000034", "original_text": "F105-P is a medical device used for non-invasive ventilation (NIV) in patients with respiratory failure. It is a type of face mask that provides positive pressure ventilation to the lungs through a nasal interface, helping to improve lung function and reduce respiratory distress. The device is commonly used in emergency medicine and critical care settings to support patients with acute respiratory failure.", "label": 0, "is_selected": 1, "text": "F105-P is a medical device used for non-invasive ventilation (NIV) in patients with respiratory failure, and it is commonly used in emergency medicine and critical care settings to support patients with acute respiratory failure (ARF) and respiratory distress syndrome (RDS)."}
{"qid": "532f1452d6d3ac6a34000030", "original_text": "The successful use of proteasome inhibitors in clinical trials revealed the potential of the Ubiquitin Proteasome System for drug development. Protein remodeling through ubiquitylation is known to regulate the stability and activity of essential cellular factors through largely uncharacterized mechanisms. Here, we used Tandem repeated Ubiquitin Binding Entities (TUBEs) under non-denaturing conditions followed by mass spectrometry analysis to study global ubiquitylation events that may lead to the identification of potential drug targets. Using this approach we identified 643 proteins including known and unknown ubiquitin targets from human breast adenocarcinoma MCF7 cells treated with Adriamycin.", "label": 1, "is_selected": 0, "text": "The successful use of proteasome inhibitors in clinical trials revealed the potential of the Ubiquitin Proteasome System for drug development. Protein remodeling through ubiquitylation is known to regulate the stability and activity of essential cellular factors through largely uncharacterized mechanisms. Here, we used Tandem repeated Ubiquitin Binding Entities (TUBEs) under non-denaturing conditions followed by mass spectrometry analysis to study global ubiquitylation events that may lead to the identification of potential drug targets. Using this approach we identified 643 proteins including known and unknown ubiquitin targets from human breast adenocarcinoma MCF7 cells treated with Adriamycin."}
{"qid": "5ad35d01133db5eb78000003", "original_text": "Roberts syndrome and SC phocomelia syndrome are rare autosomal recessive genetic disorders representing the extremes of the spectrum of severity of the same condition, caused by mutations in ESCO2 gene. We report three new patients with Roberts syndrome from three unrelated consanguineous Egyptian families. All patients presented with growth retardation, mesomelic shortening of the limbs more in the upper than in the lower limbs and microcephaly. Patients were subjected to clinical, cytogenetic and radiologic examinations. Cytogenetic analysis showed the characteristic premature separation of centromeres and puffing of heterochromatic regions. Further, sequencing of the ESCO2 gene identified a novel mutation c.244_245dupCT (p.T83Pfs*20) in one family besides two previously reported mutations c.760_761insA (p.T254Nfs*27) and c.764_765delTT (p.F255Cfs*25). All mutations were in homozygous state, in exon 3.", "label": 1, "is_selected": 0, "text": "Roberts syndrome and SC phocomelia syndrome are rare autosomal recessive genetic disorders representing the extremes of the spectrum of severity of the same condition, caused by mutations in ESCO2 gene. We report three new patients with Roberts syndrome from three unrelated consanguineous Egyptian families. All patients presented with growth retardation, mesomelic shortening of the limbs more in the upper than in the lower limbs and microcephaly. Patients were subjected to clinical, cytogenetic and radiologic examinations. Cytogenetic analysis showed the characteristic premature separation of centromeres and puffing of heterochromatic regions. Further, sequencing of the ESCO2 gene identified a novel mutation c.244_245dupCT (p.T83Pfs*20) in one family besides two previously reported mutations c.760_761insA (p.T254Nfs*27) and c.764_765delTT (p.F255Cfs*25). All mutations were in homozygous state, in exon 3."}
{"qid": "53175e4fb166e2b806000008", "original_text": "Per genes, also known asperiod genes, play a crucial role in the regulation of circadian rhythm control. These genes are located in the suprachiasmatic nucleus (SCN) of the hypothalamus and are responsible for the production of two key hormones, melatonin and corticosterone, which are involved in the regulation of the circadian cycle. The per genes regulate the expression of these hormones and help to synchronize the body's internal clock with the external environment, ensuring proper circadian rhythm control. Studies have shown that mutations in the per gene can lead to disruptions in the circadian rhythm and sleep disturbances, highlighting the critical role of these genes in regulating the body's internal clock.", "label": 0, "is_selected": 1, "text": "Researchers at the University of California, San Francisco (UCSD) have discovered a new class of genes that regulate the body's internal clock and circadian rhythm, which affects sleep and day-to-day activities. Studies have shown that mutations in the per gene can lead to disruptions in the circadian rhythm and sleep disturbances, highlighting the critical role of these genes in regulating the body\u2019s internal Clock."}
{"qid": "5e338cf5fbd6abf43b00005d", "original_text": "The lessons learned from the Chernobyl disaster have become increasingly important after the second anniversary of the Fukushima, Japan nuclear accident. Historically, data from the Chernobyl reactor accident 27 years ago demonstrated a strong correlation with thyroid cancer, but data on the radiation effects of Chernobyl on breast cancer incidence have remained inconclusive. We reviewed the published literature on the effects of the Chernobyl disaster on breast cancer incidence, using Medline and Scopus from the time of the accident to December of 2010. Our findings indicate limited data and statistical flaws. Other confounding factors, such as discrepancies in data collection, make interpretation of the results from the published literature difficult. Re-analyzing the data reveals that the incidence of breast cancer in Chernobyl-disaster-exposed women could be higher than previously thought. We have learned little of the consequences of radiation exposure at Chernobyl except for its effects on thyroid cancer incidence. Marking the 27th year after the Chernobyl event, this report sheds light on a specific, crucial and understudied aspect of the results of radiation from a gruesome nuclear power plant disaster.", "label": 1, "is_selected": 0, "text": "The lessons learned from the Chernobyl disaster have become increasingly important after the second anniversary of the Fukushima, Japan nuclear accident. Historically, data from the Chernobyl reactor accident 27 years ago demonstrated a strong correlation with thyroid cancer, but data on the radiation effects of Chernobyl on breast cancer incidence have remained inconclusive. We reviewed the published literature on the effects of the Chernobyl disaster on breast cancer incidence, using Medline and Scopus from the time of the accident to December of 2010. Our findings indicate limited data and statistical flaws. Other confounding factors, such as discrepancies in data collection, make interpretation of the results from the published literature difficult. Re-analyzing the data reveals that the incidence of breast cancer in Chernobyl-disaster-exposed women could be higher than previously thought. We have learned little of the consequences of radiation exposure at Chernobyl except for its effects on thyroid cancer incidence. Marking the 27th year after the Chernobyl event, this report sheds light on a specific, crucial and understudied aspect of the results of radiation from a gruesome nuclear power plant disaster."}
{"qid": "5ad4d758133db5eb78000007", "original_text": "The pesticide rotenone has been shown to cause systemic inhibition of mitochondrial complex I activity, with consequent degeneration of dopamine neurons along the nigrostriatal pathway, as observed in Parkinson's disease (PD). Recently, intracranial infusion of rotenone was found to increase the protein levels of the Lewy body constituents, \u03b1-synuclein and small ubiquitin-related modifier-1(SUMO-1), in the lesioned hemisphere of the mouse brain. These findings are supportive of a mouse model of PD, but information about the dopamine-synthesizing enzyme, tyrosine hydroxylase (TH), an essential marker of dopaminergic status, was not reported.", "label": 1, "is_selected": 0, "text": "The pesticide rotenone has been shown to cause systemic inhibition of mitochondrial complex I activity, with consequent degeneration of dopamine neurons along the nigrostriatal pathway, as observed in Parkinson's disease (PD). Recently, intracranial infusion of rotenone was found to increase the protein levels of the Lewy body constituents, \u03b1-synuclein and small ubiquitin-related modifier-1(SUMO-1), in the lesioned hemisphere of the mouse brain. These findings are supportive of a mouse model of PD, but information about the dopamine-synthesizing enzyme, tyrosine hydroxylase (TH), an essential marker of dopaminergic status, was not reported."}
{"qid": "55031963e9bde6963400002a", "original_text": "Desmin-related myofibrillar myopathy (DRM) is a cardiac and skeletal muscle disease caused by mutations in the desmin (DES) gene. Mutations in the central 2B domain of DES cause skeletal muscle disease that typically precedes cardiac involvement. However, the prevalence of DES mutations in dilated cardiomyopathy (DCM) without skeletal muscle disease is not known. Denaturing high-performance liquid chromatography was used to screen DES for mutations in 116 DCM families from the Familial Dilated Cardiomyopathy Registry and in 309 subjects with DCM from the Beta-Blocker Evaluation of Survival Trial (BEST). DES mutations were transfected into SW13 and human smooth muscle cells and neonatal rat cardiac myocytes, and the effects on cytoskeletal desmin network architecture were analyzed with confocal microscopy.", "label": 1, "is_selected": 0, "text": "Desmin-related myofibrillar myopathy (DRM) is a cardiac and skeletal muscle disease caused by mutations in the desmin (DES) gene. Mutations in the central 2B domain of DES cause skeletal muscle disease that typically precedes cardiac involvement. However, the prevalence of DES mutations in dilated cardiomyopathy (DCM) without skeletal muscle disease is not known. Denaturing high-performance liquid chromatography was used to screen DES for mutations in 116 DCM families from the Familial Dilated Cardiomyopathy Registry and in 309 subjects with DCM from the Beta-Blocker Evaluation of Survival Trial (BEST). DES mutations were transfected into SW13 and human smooth muscle cells and neonatal rat cardiac myocytes, and the effects on cytoskeletal desmin network architecture were analyzed with confocal microscopy."}
{"qid": "58a872bd38c171fb5b000002", "original_text": "The Vel blood type is caused by a genetic mutation in the gene encoding the protein A, which is a critical component of the ABO blood group antigens. Specifically, the mutation affects the A gene on chromosome 9, leading to the production of a non-functional or defective protein A molecule. This results in the inability to express the ABO blood group antigen on the surface of red blood cells, which is why individuals with the Vel blood type have a unique blood group phenotype. The prevalence of the Vel blood type is approximately 1 in 100,000 individuals worldwide.", "label": 0, "is_selected": 0, "text": "The Vel blood type is caused by a genetic mutation in the gene encoding the protein A, which is a critical component of the ABO blood group antigens. Specifically, the mutation affects the A gene on chromosome 9, leading to the production of a non-functional or defective protein A molecule. This results in the inability to express the ABO blood group antigen on the surface of red blood cells, which is why individuals with the Vel blood type have a unique blood group phenotype. The prevalence of the Vel blood type is approximately 1 in 100,000 individuals worldwide."}
{"qid": "5318352fb166e2b806000011", "original_text": "Yes, mitofusin 2 (MFN2) is a receptor for Parkin. Parkin is a protein that plays a crucial role in the regulation of mitophagy, the process by which damaged mitochondria are degraded and removed from cells. MFN2 is a key component of the Parkin-mediated mitophagy pathway, and serves as a receptor for Parkin to facilitate the uptake and degradation of damaged mitochondria.", "label": 0, "is_selected": 1, "text": "How does mitofusin 2 (MFN2) affect mitochondrial function in Parkinson's disease and other neurodegenerative diseases such as dementia and Alzheimer's diseases?, How does MFN2 affect mitochondria?, What is Parkin and what is its role in mitochondrial function?, Can Parkin be used to treat neurodegenerative disorders?, Is Parkin a receptor for M"}
{"qid": "5544bcde5beec11c10000003", "original_text": "Evolutionary sequence conservation is an accepted criterion to identify noncoding regulatory sequences. We have used a transposon-based transgenic assay in zebrafish to evaluate noncoding sequences at the zebrafish ret locus, conserved among teleosts, and at the human RET locus, conserved among mammals. Most teleost sequences directed ret-specific reporter gene expression, with many displaying overlapping regulatory control. The majority of human RET noncoding sequences also directed ret-specific expression in zebrafish. Thus, vast amounts of functional sequence information may exist that would not be detected by sequence similarity approaches.", "label": 1, "is_selected": 0, "text": "Evolutionary sequence conservation is an accepted criterion to identify noncoding regulatory sequences. We have used a transposon-based transgenic assay in zebrafish to evaluate noncoding sequences at the zebrafish ret locus, conserved among teleosts, and at the human RET locus, conserved among mammals. Most teleost sequences directed ret-specific reporter gene expression, with many displaying overlapping regulatory control. The majority of human RET noncoding sequences also directed ret-specific expression in zebrafish. Thus, vast amounts of functional sequence information may exist that would not be detected by sequence similarity approaches."}
{"qid": "553fac39c6a5098552000001", "original_text": "Bacterial genomes displaying a strong bias between the leading and the lagging strand of DNA replication encode two DNA polymerases III, DnaE and PolC, rather than a single one. Replication is a highly unsymmetrical process, and the presence of two polymerases is therefore not unexpected. Using comparative genomics, we explored whether other processes have evolved in parallel with each polymerase. Extending previous in silico heuristics for the analysis of gene co-evolution, we analyzed the function of genes clustering with dnaE and polC. Clusters were highly informative. DnaE co-evolves with the ribosome, the transcription machinery, the core of intermediary metabolism enzymes. It is also connected to the energy-saving enzyme necessary for RNA degradation, polynucleotide phosphorylase.", "label": 1, "is_selected": 0, "text": "Bacterial genomes displaying a strong bias between the leading and the lagging strand of DNA replication encode two DNA polymerases III, DnaE and PolC, rather than a single one. Replication is a highly unsymmetrical process, and the presence of two polymerases is therefore not unexpected. Using comparative genomics, we explored whether other processes have evolved in parallel with each polymerase. Extending previous in silico heuristics for the analysis of gene co-evolution, we analyzed the function of genes clustering with dnaE and polC. Clusters were highly informative. DnaE co-evolves with the ribosome, the transcription machinery, the core of intermediary metabolism enzymes. It is also connected to the energy-saving enzyme necessary for RNA degradation, polynucleotide phosphorylase."}
{"qid": "530c7fa4970c65fa6b000012", "original_text": "Biallelic mutations in the neurofibromatosis 2 (NF2) gene are linked to schwannoma and meningioma tumorigenesis. Cells with NF2 mutations exhibit elevated levels of phosphorylated extracellular signal-regulated kinase (ERK) and aberrant cell-cell and cell-matrix contacts. The NF2 gene product, merlin, associates with adherens junction protein complexes, suggesting that part of its function as a tumor suppressor involves regulating cell junctions. Here, we find that a novel PDZ protein, called erbin, binds directly to the merlin-binding partner, EBP0, and regulates adherens junction dissociation through a MAP kinase-dependent mechanism.", "label": 1, "is_selected": 0, "text": "Biallelic mutations in the neurofibromatosis 2 (NF2) gene are linked to schwannoma and meningioma tumorigenesis. Cells with NF2 mutations exhibit elevated levels of phosphorylated extracellular signal-regulated kinase (ERK) and aberrant cell-cell and cell-matrix contacts. The NF2 gene product, merlin, associates with adherens junction protein complexes, suggesting that part of its function as a tumor suppressor involves regulating cell junctions. Here, we find that a novel PDZ protein, called erbin, binds directly to the merlin-binding partner, EBP0, and regulates adherens junction dissociation through a MAP kinase-dependent mechanism."}
{"qid": "5aa6800ad6d6b54f79000011", "original_text": "We present a 44-year-old man from a rural community in northern Ecuador who worked on a cattle farm where he was involved with primary veterinary care, including assistance during births (or calving) and placenta retention and artificial insemination, with minimal precautions. In September of 2009, quite abruptly, he developed asthenia and hypersomnia without any apparent cause or symptoms like fever, chills, or night sweats. On November 14, 2009, he suffered from pain and edema in the right testicle that coincided with pain in the abdomen. Clinical, serological, and bacteriological investigations confirmed the first case of unilateral orchitis in man in Ecuador caused by Brucella abortus biovar 1.", "label": 1, "is_selected": 0, "text": "We present a 44-year-old man from a rural community in northern Ecuador who worked on a cattle farm where he was involved with primary veterinary care, including assistance during births (or calving) and placenta retention and artificial insemination, with minimal precautions. In September of 2009, quite abruptly, he developed asthenia and hypersomnia without any apparent cause or symptoms like fever, chills, or night sweats. On November 14, 2009, he suffered from pain and edema in the right testicle that coincided with pain in the abdomen. Clinical, serological, and bacteriological investigations confirmed the first case of unilateral orchitis in man in Ecuador caused by Brucella abortus biovar 1."}
{"qid": "56a38f9b496b62f23f000004", "original_text": "To maintain genome function and stability, DNA sequence and its organization into chromatin must be duplicated during cell division. Understanding how entire chromosomes are copied remains a major challenge. Here, we use nascent chromatin capture (NCC) to profile chromatin proteome dynamics during replication in human cells. NCC relies on biotin-dUTP labelling of replicating DNA, affinity purification and quantitative proteomics. Comparing nascent chromatin with mature post-replicative chromatin, we provide association dynamics for 3,995 proteins. The replication machinery and 485 chromatin factors such as CAF-1, DNMT1 and SUV39h1 are enriched in nascent chromatin, whereas 170 factors including histone H1, DNMT3, MBD1-3 and PRC1 show delayed association. This correlates with H4K5K12diAc removal and H3K9me1 accumulation, whereas H3K27me3 and H3K9me3 remain unchanged. Finally, we combine NCC enrichment with experimentally derived chromatin probabilities to predict a function in nascent chromatin for 93 uncharacterized proteins, and identify FAM111A as a replication factor required for PCNA loading. Together, this provides an extensive resource to understand genome and epigenome maintenance.", "label": 1, "is_selected": 0, "text": "To maintain genome function and stability, DNA sequence and its organization into chromatin must be duplicated during cell division. Understanding how entire chromosomes are copied remains a major challenge. Here, we use nascent chromatin capture (NCC) to profile chromatin proteome dynamics during replication in human cells. NCC relies on biotin-dUTP labelling of replicating DNA, affinity purification and quantitative proteomics. Comparing nascent chromatin with mature post-replicative chromatin, we provide association dynamics for 3,995 proteins. The replication machinery and 485 chromatin factors such as CAF-1, DNMT1 and SUV39h1 are enriched in nascent chromatin, whereas 170 factors including histone H1, DNMT3, MBD1-3 and PRC1 show delayed association. This correlates with H4K5K12diAc removal and H3K9me1 accumulation, whereas H3K27me3 and H3K9me3 remain unchanged. Finally, we combine NCC enrichment with experimentally derived chromatin probabilities to predict a function in nascent chromatin for 93 uncharacterized proteins, and identify FAM111A as a replication factor required for PCNA loading. Together, this provides an extensive resource to understand genome and epigenome maintenance."}
{"qid": "514a1469d24251bc05000056", "original_text": "Yes, there is a pharmacogenetic test for trastuzumab, which is a drug used to treat HER2-positive breast cancer. The test is called the Breast Cancer Genetic Test (BCGT), and it analyzes several genetic markers, including HER2, to predict which patients are most likely to benefit from trastuzumab therapy. The test can help identify patients who are likely to experience a higher response rate or longer disease-free survival when treated with trastuzumab. Additionally, the test can help identify patients who may be at increased risk of cardiotoxicity associated with trastuzumab use. However, it's important to note that the BCGT is not yet widely available or recommended for routine use in clinical practice. Further research is needed to validate the test's predictive ability and to determine its clinical utility.", "label": 0, "is_selected": 1, "text": "Q: Is there a genetic test for trastuzumab, which is a drug used to treat HER2-positive breast cancer, and can it predict which patients are most likely to benefit from the therapy? The test is called the Breast Cancer Genetic Test (BCGT), and it can identify several genetic markers, including HER2, to predict which students are likely to enjoy a better response or longer disease-free survival when treated with trastozumab."}
